Psyllid ID: psy16081
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 493 | 2.2.26 [Sep-21-2011] | |||||||
| P49657 | 908 | Serine/threonine-protein | no | N/A | 0.878 | 0.476 | 0.846 | 0.0 | |
| Q63470 | 763 | Dual specificity tyrosine | yes | N/A | 0.862 | 0.557 | 0.816 | 0.0 | |
| Q61214 | 763 | Dual specificity tyrosine | yes | N/A | 0.862 | 0.557 | 0.816 | 0.0 | |
| Q13627 | 763 | Dual specificity tyrosine | yes | N/A | 0.862 | 0.557 | 0.816 | 0.0 | |
| Q2TAE3 | 750 | Dual specificity tyrosine | N/A | N/A | 0.858 | 0.564 | 0.811 | 0.0 | |
| Q9Y463 | 629 | Dual specificity tyrosine | no | N/A | 0.868 | 0.680 | 0.761 | 0.0 | |
| Q9Z188 | 629 | Dual specificity tyrosine | no | N/A | 0.868 | 0.680 | 0.758 | 0.0 | |
| Q0IJ08 | 751 | Dual specificity tyrosine | no | N/A | 0.858 | 0.563 | 0.811 | 0.0 | |
| Q8WQL7 | 882 | Dual specificity tyrosine | yes | N/A | 0.699 | 0.391 | 0.707 | 1e-144 | |
| A8X4H1 | 904 | Dual specificity tyrosine | N/A | N/A | 0.734 | 0.400 | 0.668 | 1e-141 |
| >sp|P49657|MNB_DROME Serine/threonine-protein kinase minibrain OS=Drosophila melanogaster GN=mnb PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 787 bits (2032), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/450 (84%), Positives = 410/450 (91%), Gaps = 17/450 (3%)
Query: 18 HAPLYGRLVAEE--PSCPGDIL-------------AMQARIPLQFRDPATAPLRKLSVDL 62
HAPLYGR V E P+ D++ AMQARIP FR+PA+ PLRKLSVDL
Sbjct: 45 HAPLYGRFVDAEDLPATHRDVMHHHSSPSSSSEVRAMQARIPNHFREPASGPLRKLSVDL 104
Query: 63 IKTYKHINEVYYAKKKRRAQQSQGED-SSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRY 121
IKTYKHINEVYYAKKKRRAQQ+QG+D SS+KKE+KLYN+GYDDDNHDYII++GEKFLDRY
Sbjct: 105 IKTYKHINEVYYAKKKRRAQQTQGDDDSSNKKERKLYNDGYDDDNHDYIIKNGEKFLDRY 164
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY 181
EIDSLIGKGSFGQVVKA+D EEQCHVAIKIIKNKKPFLNQAQIEVKLLE+MN+AD N Y
Sbjct: 165 EIDSLIGKGSFGQVVKAYDHEEQCHVAIKIIKNKKPFLNQAQIEVKLLEMMNRADAENKY 224
Query: 182 YIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP 241
YIV+LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF+QQLCTALLFLSTP
Sbjct: 225 YIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFLSTP 284
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYD 301
ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY YIQSRFYRSPEVLLGI YD
Sbjct: 285 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYHYIQSRFYRSPEVLLGIQYD 344
Query: 302 LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKM- 360
LAIDMWSLGCILVEMHTGEPLFSG NEVDQMNKIVEVLG+PPK+LLD AHKTRK+FDK+
Sbjct: 345 LAIDMWSLGCILVEMHTGEPLFSGCNEVDQMNKIVEVLGMPPKYLLDQAHKTRKFFDKIV 404
Query: 361 PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420
DGSY+LKK ++GRK K PGSR+LHDILGVE+GGPGGRRL EPGHSVSDYLKFKDLI RM
Sbjct: 405 ADGSYVLKKNQNGRKYKPPGSRKLHDILGVETGGPGGRRLDEPGHSVSDYLKFKDLILRM 464
Query: 421 LDYDPKTRITPYYALQHNFFKRTADESTNT 450
LD+DPKTR+TPYYALQHNFFKRTADE+TNT
Sbjct: 465 LDFDPKTRVTPYYALQHNFFKRTADEATNT 494
|
Role in the specific control of proper proliferation of optic lobe neuronal progeny. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|Q63470|DYR1A_RAT Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Rattus norvegicus GN=Dyrk1a PE=1 SV=2 | Back alignment and function description |
|---|
Score = 715 bits (1845), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/431 (81%), Positives = 393/431 (91%), Gaps = 6/431 (1%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKN
Sbjct: 133 RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN 192
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNT
Sbjct: 193 KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 252
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
NFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 253 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 312
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNK
Sbjct: 313 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 372
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDG-RKPKVPGSRRLHDILGVESG 393
IVEVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG R+ K PG+R+LH+ILGVE+G
Sbjct: 373 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWSLKKTKDGKREYKPPGTRKLHNILGVETG 432
Query: 394 GPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGT 453
GPGGRR GE GH+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE TNT
Sbjct: 433 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS-- 490
Query: 454 SGLGSMSTSPA 464
S+STSPA
Sbjct: 491 ---NSVSTSPA 498
|
May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|Q61214|DYR1A_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Mus musculus GN=Dyrk1a PE=1 SV=1 | Back alignment and function description |
|---|
Score = 714 bits (1844), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/431 (81%), Positives = 393/431 (91%), Gaps = 6/431 (1%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKN
Sbjct: 133 RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN 192
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNT
Sbjct: 193 KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 252
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
NFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 253 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 312
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNK
Sbjct: 313 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 372
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDG-RKPKVPGSRRLHDILGVESG 393
IVEVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG R+ K PG+R+LH+ILGVE+G
Sbjct: 373 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWSLKKTKDGKREYKPPGTRKLHNILGVETG 432
Query: 394 GPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGT 453
GPGGRR GE GH+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE TNT
Sbjct: 433 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS-- 490
Query: 454 SGLGSMSTSPA 464
S+STSPA
Sbjct: 491 ---NSVSTSPA 498
|
May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q13627|DYR1A_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Homo sapiens GN=DYRK1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/431 (81%), Positives = 393/431 (91%), Gaps = 6/431 (1%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKN
Sbjct: 133 RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN 192
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNT
Sbjct: 193 KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 252
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
NFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 253 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 312
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNK
Sbjct: 313 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 372
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDG-RKPKVPGSRRLHDILGVESG 393
IVEVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG R+ K PG+R+LH+ILGVE+G
Sbjct: 373 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 432
Query: 394 GPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGT 453
GPGGRR GE GH+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE TNT
Sbjct: 433 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS-- 490
Query: 454 SGLGSMSTSPA 464
S+STSPA
Sbjct: 491 ---NSVSTSPA 498
|
May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q2TAE3|DYR1A_XENLA Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Xenopus laevis GN=dyrk1a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/429 (81%), Positives = 388/429 (90%), Gaps = 6/429 (1%)
Query: 37 LAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKK 96
L Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE+K
Sbjct: 67 LPNQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKERK 126
Query: 97 LYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK 156
+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKNKK
Sbjct: 127 VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK 186
Query: 157 PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF 216
FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNTNF
Sbjct: 187 AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNF 246
Query: 217 RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
RGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL
Sbjct: 247 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 306
Query: 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
GQRIYQYIQSRFYRSPEVLLG PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQM+KIV
Sbjct: 307 GQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMSKIV 366
Query: 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDILGVESGGP 395
EVLG+PP H+LD A K RK+F+KMP+G++ LKK KDG+K K PG+R+LH+ILGVE+GGP
Sbjct: 367 EVLGIPPAHILDQAPKARKFFEKMPEGTWNLKKTKDGKKEYKPPGTRKLHNILGVENGGP 426
Query: 396 GGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSG 455
GGRR GE GH+V+DYLKFKD+I RMLDYD KTRI PYYALQH+FFK+TADE TNT
Sbjct: 427 GGRRAGESGHTVADYLKFKDVILRMLDYDAKTRIQPYYALQHSFFKKTADEGTNTS---- 482
Query: 456 LGSMSTSPA 464
S+STSPA
Sbjct: 483 -NSVSTSPA 490
|
May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9Y463|DYR1B_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Homo sapiens GN=DYRK1B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 686 bits (1771), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/431 (76%), Positives = 377/431 (87%), Gaps = 3/431 (0%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
D+ + R+PL FRD +APLRKLSVDLIKTYKHINEVYYAKKKRRAQQ+ +DSS+KKE
Sbjct: 25 DVRLLPRRLPLAFRDATSAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQAPPQDSSNKKE 84
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
KK+ N GYDDDNHDYI++ GE++L+RYEIDSLIGKGSFGQVVKA+D + Q VAIKIIKN
Sbjct: 85 KKVLNHGYDDDNHDYIVRSGERWLERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIKN 144
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIE++LLE+MN+ D YYIV LKRHFM+RNHLCLVFELLSYNLYDLLRNT
Sbjct: 145 KKAFLNQAQIELRLLELMNQHDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRNT 204
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
+FRGVSLNLTRK +QQLCTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 205 HFRGVSLNLTRKLAQQLCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 264
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN+
Sbjct: 265 QLGQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNR 324
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDILGVESG 393
IVEVLG+PP +LD A K RKYF+++P G + L++ K+ RK + PG+RRL ++LGV++G
Sbjct: 325 IVEVLGIPPAAMLDQAPKARKYFERLPGGGWTLRRTKELRKDYQGPGTRRLQEVLGVQTG 384
Query: 394 GPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGT 453
GPGGRR GEPGHS +DYL+F+DL+ RML+Y+P RI+P ALQH FF+RTADE+TNTG
Sbjct: 385 GPGGRRAGEPGHSPADYLRFQDLVLRMLEYEPAARISPLGALQHGFFRRTADEATNTGPA 444
Query: 454 SGLGSMSTSPA 464
S STSPA
Sbjct: 445 G--SSASTSPA 453
|
Dual-specificity kinase which possesses both serine/ threonine and tyrosine kinase activities. Enhances the transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits epithelial cell migration. Mediates colon carcinoma cell survival in mitogen-poor environments. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9Z188|DYR1B_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Mus musculus GN=Dyrk1b PE=1 SV=3 | Back alignment and function description |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/431 (75%), Positives = 377/431 (87%), Gaps = 3/431 (0%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
D+ + R+PL FRD A+APLRKLSVDLIKTYKHINEVYYAKKKRRAQQ+ +DSS KKE
Sbjct: 25 DVRLLPRRLPLAFRDAASAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQAPPQDSSTKKE 84
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
KK+ N GYDDDNHDYI++ GE++L+RYEIDSLIGKGSFGQVVKA+D + Q VAIKIIKN
Sbjct: 85 KKVLNHGYDDDNHDYIVRSGERWLERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIKN 144
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIE++LLE+MN+ D YYIV LKRHFM+RNHLCLVFELLSYNLYDLLRNT
Sbjct: 145 KKAFLNQAQIELRLLELMNQHDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRNT 204
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
+FRGVSLNLTRK +QQLCTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 205 HFRGVSLNLTRKLAQQLCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 264
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQM++
Sbjct: 265 QLGQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMSR 324
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDILGVESG 393
IVEVLG+PP +L+ A K RKYF+++P G + L++ K+ RK + PG+RRL ++LGV++G
Sbjct: 325 IVEVLGIPPAPMLEQAPKARKYFERLPGGGWTLRRTKELRKDYQGPGTRRLQEVLGVQTG 384
Query: 394 GPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGT 453
GPGGRR GEPGHS +DYL+F+DL+ RML+Y+P RI+P ALQH FF+RTADE+TNTG
Sbjct: 385 GPGGRRAGEPGHSPADYLRFQDLVLRMLEYEPAARISPLGALQHGFFRRTADEATNTGPA 444
Query: 454 SGLGSMSTSPA 464
S STSPA
Sbjct: 445 G--SSASTSPA 453
|
Dual-specificity kinase which possesses both serine/ threonine and tyrosine kinase activity. Enhances the transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits epithelial cell migration. Mediates colon carcinoma cell survival in mitogen-poor environments. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q0IJ08|DYR1A_XENTR Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Xenopus tropicalis GN=dyrk1a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/429 (81%), Positives = 389/429 (90%), Gaps = 6/429 (1%)
Query: 37 LAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKK 96
L Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE+K
Sbjct: 67 LPNQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKERK 126
Query: 97 LYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK 156
+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKNKK
Sbjct: 127 VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRAEQEWVAIKIIKNKK 186
Query: 157 PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF 216
FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNTNF
Sbjct: 187 AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNF 246
Query: 217 RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
RGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL
Sbjct: 247 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 306
Query: 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
GQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQM+KIV
Sbjct: 307 GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMSKIV 366
Query: 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDILGVESGGP 395
EVLG+PP H+LD A K RK+F+KMP+G++ LKK KDG+K K PG+R+LH++LGVE+GGP
Sbjct: 367 EVLGIPPAHILDQAPKARKFFEKMPEGTWNLKKTKDGKKEYKPPGTRKLHNLLGVETGGP 426
Query: 396 GGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSG 455
GGRR GE GH+V+DYLKFKDLI RMLDYD KTRI PYYALQH+FFK+TADE TNT
Sbjct: 427 GGRRGGESGHTVADYLKFKDLILRMLDYDAKTRIQPYYALQHSFFKKTADEGTNTS---- 482
Query: 456 LGSMSTSPA 464
S+STSPA
Sbjct: 483 -NSVSTSPA 490
|
May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8WQL7|MBK1_CAEEL Dual specificity tyrosine-phosphorylation-regulated kinase mbk-1 OS=Caenorhabditis elegans GN=mbk-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1321), Expect = e-144, Method: Compositional matrix adjust.
Identities = 247/349 (70%), Positives = 283/349 (81%), Gaps = 4/349 (1%)
Query: 98 YNEGYDDDNHDYIIQHGEKFLDRYEI--DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK 155
YN GYDD N+DYI+++GE F RY I D+ +GKGSFGQV KA+D + VAIKIIKNK
Sbjct: 303 YNNGYDDQNYDYILKNGEIFDKRYVILSDTPVGKGSFGQVTKAYDTLNKEEVAIKIIKNK 362
Query: 156 KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTN 215
K F +QAQIE+ LLE+ N D +N Y IV LK HF+ R HLCLVFELLSYNLYDLL+NT+
Sbjct: 363 KTFFDQAQIEIHLLELTNAHDKDNKYNIVTLKGHFVHRAHLCLVFELLSYNLYDLLKNTS 422
Query: 216 FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275
FRGVSLNL RKF+QQL LLFLS+PEL+IIHCDLKPEN+LL N KRS I+++DFGSSCQ
Sbjct: 423 FRGVSLNLARKFAQQLGKTLLFLSSPELSIIHCDLKPENVLLVNAKRSQIRVIDFGSSCQ 482
Query: 276 LGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
G RIYQYIQSRFYRSPEVLLGI YD IDMWSLGCILVEMHTGEPLF+GS+EVDQM KI
Sbjct: 483 TGHRIYQYIQSRFYRSPEVLLGIAYDTKIDMWSLGCILVEMHTGEPLFAGSSEVDQMMKI 542
Query: 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP--KVPGSRRLHDILGVESG 393
VEVLG+PPK +LD KT KYFDK DG Y KK +DG + K PG+R+LH+ILGV SG
Sbjct: 543 VEVLGMPPKEMLDIGPKTHKYFDKTEDGIYYCKKTRDGYRHTYKAPGARKLHEILGVTSG 602
Query: 394 GPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
GPGGRRLGEPGHSV DY KFKDLI RML +DPK RI+PYY ++H F K+
Sbjct: 603 GPGGRRLGEPGHSVEDYSKFKDLIKRMLQFDPKQRISPYYVVRHPFLKQ 651
|
Possible role in the function of olfactory neurons. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|A8X4H1|MBK1_CAEBR Dual specificity tyrosine-phosphorylation-regulated kinase mbk-1 OS=Caenorhabditis briggsae GN=mbk-1 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 503 bits (1294), Expect = e-141, Method: Compositional matrix adjust.
Identities = 246/368 (66%), Positives = 284/368 (77%), Gaps = 6/368 (1%)
Query: 98 YNEGYDDDNHDYIIQHGEKFLDRYEI--DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK 155
YN GYDD N+DYI+++GE F RY I D+ +GKGSFGQV KA+D + VAIKIIKNK
Sbjct: 342 YNNGYDDQNYDYILKNGEIFDKRYVILSDTPVGKGSFGQVTKAYDTVTKEEVAIKIIKNK 401
Query: 156 KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTN 215
K F +QAQIE+ LLE+ N D +N Y IV LK HF+ R HLCLVFELLSYNLYDLL+NTN
Sbjct: 402 KTFFDQAQIEIHLLELTNAHDKDNKYNIVTLKGHFVHRAHLCLVFELLSYNLYDLLKNTN 461
Query: 216 FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275
FRGVSLNL RKF+QQL LLFLS+PEL+IIHCDLKPEN+LL N KRS I+++DFGSSCQ
Sbjct: 462 FRGVSLNLARKFAQQLGKTLLFLSSPELSIIHCDLKPENVLLVNAKRSQIRVIDFGSSCQ 521
Query: 276 LGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
G RIYQYIQSRFYRSPEVLLGI YD IDMWSLGCILVEMHTGEPLF+GS+EVDQM KI
Sbjct: 522 TGHRIYQYIQSRFYRSPEVLLGIAYDTKIDMWSLGCILVEMHTGEPLFAGSSEVDQMMKI 581
Query: 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP--KVPGSRRLHDILGVESG 393
VEVLG+PPK +LD KT KYFDK DG Y KK +DG + K PG+R+LH+ILGV SG
Sbjct: 582 VEVLGMPPKEMLDIGPKTHKYFDKTEDGIYYCKKTRDGYRHTYKAPGARKLHEILGVTSG 641
Query: 394 GPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI--TPYYALQHNFFKRTADESTNTG 451
GPGGRRLGEPGHSV DY KFKDLI RML++DPK RI T + + H + +
Sbjct: 642 GPGGRRLGEPGHSVEDYSKFKDLIKRMLNFDPKQRILRTTLFPVSHTAYNQNLYHQQQID 701
Query: 452 GTSGLGSM 459
+GS+
Sbjct: 702 QVPAVGSV 709
|
Possible role in the function of olfactory neurons. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 493 | ||||||
| 242012319 | 540 | serine/threonine-protein kinase minibrai | 0.943 | 0.861 | 0.822 | 0.0 | |
| 347967212 | 1483 | AGAP002119-PB [Anopheles gambiae str. PE | 0.884 | 0.293 | 0.847 | 0.0 | |
| 347967214 | 928 | AGAP002119-PA [Anopheles gambiae str. PE | 0.884 | 0.469 | 0.847 | 0.0 | |
| 347967216 | 1263 | AGAP002119-PD [Anopheles gambiae str. PE | 0.884 | 0.345 | 0.847 | 0.0 | |
| 347967218 | 708 | AGAP002119-PC [Anopheles gambiae str. PE | 0.910 | 0.634 | 0.827 | 0.0 | |
| 157136011 | 508 | Dual specificity tyrosine-phosphorylatio | 0.910 | 0.883 | 0.821 | 0.0 | |
| 328793644 | 704 | PREDICTED: serine/threonine-protein kina | 0.900 | 0.630 | 0.845 | 0.0 | |
| 340710082 | 695 | PREDICTED: serine/threonine-protein kina | 0.900 | 0.638 | 0.845 | 0.0 | |
| 156543834 | 706 | PREDICTED: serine/threonine-protein kina | 0.902 | 0.630 | 0.841 | 0.0 | |
| 350413739 | 707 | PREDICTED: serine/threonine-protein kina | 0.900 | 0.628 | 0.845 | 0.0 |
| >gi|242012319|ref|XP_002426880.1| serine/threonine-protein kinase minibrain, putative [Pediculus humanus corporis] gi|212511109|gb|EEB14142.1| serine/threonine-protein kinase minibrain, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2125), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/474 (82%), Positives = 431/474 (90%), Gaps = 9/474 (1%)
Query: 1 MNFSVSLNTESAGEAV--SHAPLYGRLVAEEP----SCPGDILAMQARIPLQFRDPATAP 54
+ S + ++G+ + + PLYGRLV EE P DI AMQARIP FRDP++AP
Sbjct: 17 LTHSATFARRTSGQLIRTQYVPLYGRLVGEEQLETIREPADIQAMQARIPQHFRDPSSAP 76
Query: 55 LRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHG 114
LRKLSVDLIKTYKHINEVYYAKKKRRAQQ+QGED+SHKKE+K++NEGYDDDNHDYII++G
Sbjct: 77 LRKLSVDLIKTYKHINEVYYAKKKRRAQQTQGEDTSHKKERKIFNEGYDDDNHDYIIKNG 136
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
EKFLDRYEID+LIGKGSFGQVVKA+D EEQC VAIKIIKNKKPFLNQAQIEVKLLE+MN+
Sbjct: 137 EKFLDRYEIDNLIGKGSFGQVVKAYDHEEQCQVAIKIIKNKKPFLNQAQIEVKLLEMMNR 196
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
AD +N Y+IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF+QQLCTA
Sbjct: 197 ADADNKYFIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTA 256
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEV 294
LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEV
Sbjct: 257 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEV 316
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354
LLGIPYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNKI+EVLG+PPKH+LD AHK R
Sbjct: 317 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGTNEVDQMNKIIEVLGMPPKHILDQAHKAR 376
Query: 355 KYFDKMP-DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413
KYFDK+P DGSY+LK+PKDG+K + PG+RRLHDILGV+SGGPGGRRLGEPGH+V+DYLKF
Sbjct: 377 KYFDKLPSDGSYVLKRPKDGKKYRSPGTRRLHDILGVDSGGPGGRRLGEPGHTVADYLKF 436
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSGLGSMSTSPASAG 467
KDLI RMLD+DPKTR+TPYYALQ NFFKRT+DE TNT S G +STSPA +G
Sbjct: 437 KDLILRMLDFDPKTRVTPYYALQQNFFKRTSDEGTNTANKS--GRVSTSPAVSG 488
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347967212|ref|XP_003436034.1| AGAP002119-PB [Anopheles gambiae str. PEST] gi|333469706|gb|EGK97377.1| AGAP002119-PB [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2104), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/452 (84%), Positives = 415/452 (91%), Gaps = 16/452 (3%)
Query: 18 HAPLYGRLVAEE---------------PSCPGDILAMQARIPLQFRDPATAPLRKLSVDL 62
HAPLYGRLV EE P+ DI AM+ARIP+ FRDPATAPLRKLSVDL
Sbjct: 584 HAPLYGRLVTEEHLPAVHRDIHQRSISPTSSTDIRAMEARIPVLFRDPATAPLRKLSVDL 643
Query: 63 IKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYE 122
IKTYKHINEVYYAKKKRRAQQ+QGED+SHKKE+KLYN+GYDD+NHDYII++GEKFLDRYE
Sbjct: 644 IKTYKHINEVYYAKKKRRAQQTQGEDTSHKKERKLYNDGYDDENHDYIIKNGEKFLDRYE 703
Query: 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYY 182
IDSLIGKGSFGQVVKAFD EE+C VAIKIIKNKKPFLNQAQIEVKLLE+MN+AD N YY
Sbjct: 704 IDSLIGKGSFGQVVKAFDHEERCQVAIKIIKNKKPFLNQAQIEVKLLEMMNRADAENKYY 763
Query: 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
IV+LKRHFMWRNHLCLVFELLSYNL+DLLRNTNFRGVSLNLT+KF+QQLCTALLFLSTPE
Sbjct: 764 IVKLKRHFMWRNHLCLVFELLSYNLFDLLRNTNFRGVSLNLTKKFAQQLCTALLFLSTPE 823
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 302
LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL
Sbjct: 824 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 883
Query: 303 AIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMP- 361
AIDMWSLGCILVEMHTGEPLFSGSNE DQ+N+IVEVLG+PPKH+LD AHKTRK+F+K+P
Sbjct: 884 AIDMWSLGCILVEMHTGEPLFSGSNEADQINRIVEVLGMPPKHILDQAHKTRKFFEKLPS 943
Query: 362 DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421
DGSY+L+K ++ RK K PGSR+LHDILGVE+GGPGGRR GEPGHSVSDYLKFKDLI RML
Sbjct: 944 DGSYVLRKTQNQRKYKPPGSRKLHDILGVETGGPGGRRHGEPGHSVSDYLKFKDLILRML 1003
Query: 422 DYDPKTRITPYYALQHNFFKRTADESTNTGGT 453
DYDPKTR+TPYYALQHNFFKRT+DESTNT T
Sbjct: 1004 DYDPKTRVTPYYALQHNFFKRTSDESTNTANT 1035
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347967214|ref|XP_320918.5| AGAP002119-PA [Anopheles gambiae str. PEST] gi|333469705|gb|EAA43038.5| AGAP002119-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2099), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/452 (84%), Positives = 415/452 (91%), Gaps = 16/452 (3%)
Query: 18 HAPLYGRLVAEE---------------PSCPGDILAMQARIPLQFRDPATAPLRKLSVDL 62
HAPLYGRLV EE P+ DI AM+ARIP+ FRDPATAPLRKLSVDL
Sbjct: 29 HAPLYGRLVTEEHLPAVHRDIHQRSISPTSSTDIRAMEARIPVLFRDPATAPLRKLSVDL 88
Query: 63 IKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYE 122
IKTYKHINEVYYAKKKRRAQQ+QGED+SHKKE+KLYN+GYDD+NHDYII++GEKFLDRYE
Sbjct: 89 IKTYKHINEVYYAKKKRRAQQTQGEDTSHKKERKLYNDGYDDENHDYIIKNGEKFLDRYE 148
Query: 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYY 182
IDSLIGKGSFGQVVKAFD EE+C VAIKIIKNKKPFLNQAQIEVKLLE+MN+AD N YY
Sbjct: 149 IDSLIGKGSFGQVVKAFDHEERCQVAIKIIKNKKPFLNQAQIEVKLLEMMNRADAENKYY 208
Query: 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
IV+LKRHFMWRNHLCLVFELLSYNL+DLLRNTNFRGVSLNLT+KF+QQLCTALLFLSTPE
Sbjct: 209 IVKLKRHFMWRNHLCLVFELLSYNLFDLLRNTNFRGVSLNLTKKFAQQLCTALLFLSTPE 268
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 302
LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL
Sbjct: 269 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 328
Query: 303 AIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMP- 361
AIDMWSLGCILVEMHTGEPLFSGSNE DQ+N+IVEVLG+PPKH+LD AHKTRK+F+K+P
Sbjct: 329 AIDMWSLGCILVEMHTGEPLFSGSNEADQINRIVEVLGMPPKHILDQAHKTRKFFEKLPS 388
Query: 362 DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421
DGSY+L+K ++ RK K PGSR+LHDILGVE+GGPGGRR GEPGHSVSDYLKFKDLI RML
Sbjct: 389 DGSYVLRKTQNQRKYKPPGSRKLHDILGVETGGPGGRRHGEPGHSVSDYLKFKDLILRML 448
Query: 422 DYDPKTRITPYYALQHNFFKRTADESTNTGGT 453
DYDPKTR+TPYYALQHNFFKRT+DESTNT T
Sbjct: 449 DYDPKTRVTPYYALQHNFFKRTSDESTNTANT 480
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347967216|ref|XP_003436035.1| AGAP002119-PD [Anopheles gambiae str. PEST] gi|333469708|gb|EGK97379.1| AGAP002119-PD [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2092), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/452 (84%), Positives = 415/452 (91%), Gaps = 16/452 (3%)
Query: 18 HAPLYGRLVAEE---------------PSCPGDILAMQARIPLQFRDPATAPLRKLSVDL 62
HAPLYGRLV EE P+ DI AM+ARIP+ FRDPATAPLRKLSVDL
Sbjct: 584 HAPLYGRLVTEEHLPAVHRDIHQRSISPTSSTDIRAMEARIPVLFRDPATAPLRKLSVDL 643
Query: 63 IKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYE 122
IKTYKHINEVYYAKKKRRAQQ+QGED+SHKKE+KLYN+GYDD+NHDYII++GEKFLDRYE
Sbjct: 644 IKTYKHINEVYYAKKKRRAQQTQGEDTSHKKERKLYNDGYDDENHDYIIKNGEKFLDRYE 703
Query: 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYY 182
IDSLIGKGSFGQVVKAFD EE+C VAIKIIKNKKPFLNQAQIEVKLLE+MN+AD N YY
Sbjct: 704 IDSLIGKGSFGQVVKAFDHEERCQVAIKIIKNKKPFLNQAQIEVKLLEMMNRADAENKYY 763
Query: 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
IV+LKRHFMWRNHLCLVFELLSYNL+DLLRNTNFRGVSLNLT+KF+QQLCTALLFLSTPE
Sbjct: 764 IVKLKRHFMWRNHLCLVFELLSYNLFDLLRNTNFRGVSLNLTKKFAQQLCTALLFLSTPE 823
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 302
LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL
Sbjct: 824 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 883
Query: 303 AIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMP- 361
AIDMWSLGCILVEMHTGEPLFSGSNE DQ+N+IVEVLG+PPKH+LD AHKTRK+F+K+P
Sbjct: 884 AIDMWSLGCILVEMHTGEPLFSGSNEADQINRIVEVLGMPPKHILDQAHKTRKFFEKLPS 943
Query: 362 DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421
DGSY+L+K ++ RK K PGSR+LHDILGVE+GGPGGRR GEPGHSVSDYLKFKDLI RML
Sbjct: 944 DGSYVLRKTQNQRKYKPPGSRKLHDILGVETGGPGGRRHGEPGHSVSDYLKFKDLILRML 1003
Query: 422 DYDPKTRITPYYALQHNFFKRTADESTNTGGT 453
DYDPKTR+TPYYALQHNFFKRT+DESTNT T
Sbjct: 1004 DYDPKTRVTPYYALQHNFFKRTSDESTNTANT 1035
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347967218|ref|XP_003436036.1| AGAP002119-PC [Anopheles gambiae str. PEST] gi|333469707|gb|EGK97378.1| AGAP002119-PC [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 809 bits (2089), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/465 (82%), Positives = 418/465 (89%), Gaps = 16/465 (3%)
Query: 5 VSLNTESAGEAVSHAPLYGRLVAEE---------------PSCPGDILAMQARIPLQFRD 49
S N + HAPLYGRLV EE P+ DI AM+ARIP+ FRD
Sbjct: 16 ASGNVPDSTRQRHHAPLYGRLVTEEHLPAVHRDIHQRSISPTSSTDIRAMEARIPVLFRD 75
Query: 50 PATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDY 109
PATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQ+QGED+SHKKE+KLYN+GYDD+NHDY
Sbjct: 76 PATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQTQGEDTSHKKERKLYNDGYDDENHDY 135
Query: 110 IIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL 169
II++GEKFLDRYEIDSLIGKGSFGQVVKAFD EE+C VAIKIIKNKKPFLNQAQIEVKLL
Sbjct: 136 IIKNGEKFLDRYEIDSLIGKGSFGQVVKAFDHEERCQVAIKIIKNKKPFLNQAQIEVKLL 195
Query: 170 EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229
E+MN+AD N YYIV+LKRHFMWRNHLCLVFELLSYNL+DLLRNTNFRGVSLNLT+KF+Q
Sbjct: 196 EMMNRADAENKYYIVKLKRHFMWRNHLCLVFELLSYNLFDLLRNTNFRGVSLNLTKKFAQ 255
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY 289
QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY
Sbjct: 256 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY 315
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE DQ+N+IVEVLG+PPKH+LD
Sbjct: 316 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEADQINRIVEVLGMPPKHILDQ 375
Query: 350 AHKTRKYFDKMP-DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVS 408
AHKTRK+F+K+P DGSY+L+K ++ RK K PGSR+LHDILGVE+GGPGGRR GEPGHSVS
Sbjct: 376 AHKTRKFFEKLPSDGSYVLRKTQNQRKYKPPGSRKLHDILGVETGGPGGRRHGEPGHSVS 435
Query: 409 DYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGT 453
DYLKFKDLI RMLDYDPKTR+TPYYALQHNFFKRT+DESTNT T
Sbjct: 436 DYLKFKDLILRMLDYDPKTRVTPYYALQHNFFKRTSDESTNTANT 480
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|157136011|ref|XP_001656726.1| Dual specificity tyrosine-phosphorylation-regulated kinase [Aedes aegypti] gi|108881094|gb|EAT45319.1| AAEL003370-PA [Aedes aegypti] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2074), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/464 (82%), Positives = 413/464 (89%), Gaps = 15/464 (3%)
Query: 5 VSLNTESAGEAVSHAPLYGRLVAEE---------------PSCPGDILAMQARIPLQFRD 49
S N + HAPLYGRLV EE P+ DI AMQARIP FRD
Sbjct: 16 ASGNVPDSTRQRHHAPLYGRLVTEEHLPAAHRDIHQRSISPTSSTDIRAMQARIPSHFRD 75
Query: 50 PATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDY 109
P TAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQ+QGED+SHKKE+KLYN+GYDD+NHDY
Sbjct: 76 PTTAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQTQGEDTSHKKERKLYNDGYDDENHDY 135
Query: 110 IIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL 169
II++GEKFLDRYEIDSLIGKGSFGQVVKA+D EE+C VAIKIIKNK+PFL+QAQIEV LL
Sbjct: 136 IIKNGEKFLDRYEIDSLIGKGSFGQVVKAYDHEEECQVAIKIIKNKRPFLSQAQIEVNLL 195
Query: 170 EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229
E+MN+AD N YYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF+Q
Sbjct: 196 EMMNRADAENKYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQ 255
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY 289
QLCTALLFLS+ ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY
Sbjct: 256 QLCTALLFLSSQELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY 315
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE DQ+NKIVEVLG+PPKH+LD
Sbjct: 316 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEADQINKIVEVLGMPPKHILDQ 375
Query: 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409
AHKTRK+F+K+PDG+Y+L+K ++ RK K PG+R+LHDILGVE+GGPGGRR GEPGHSVSD
Sbjct: 376 AHKTRKFFEKLPDGTYVLRKTQNQRKYKAPGTRKLHDILGVETGGPGGRRHGEPGHSVSD 435
Query: 410 YLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGT 453
YLKFKDLI RMLDYDPKTR TPYYALQHNFFKRT+DESTNT T
Sbjct: 436 YLKFKDLILRMLDYDPKTRCTPYYALQHNFFKRTSDESTNTANT 479
|
Source: Aedes aegypti Species: Aedes aegypti Genus: Aedes Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328793644|ref|XP_392636.3| PREDICTED: serine/threonine-protein kinase minibrain-like isoform 1, partial [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/466 (84%), Positives = 419/466 (89%), Gaps = 22/466 (4%)
Query: 20 PLYGRLVAEEP--------------------SCPGDILAMQARIPLQFRDPATAPLRKLS 59
PLYGRLVAEEP P DI AMQARIP +FRDPATAPLRKLS
Sbjct: 80 PLYGRLVAEEPLPPTVCGGTGTGGGTGGIPQETPADIHAMQARIPHRFRDPATAPLRKLS 139
Query: 60 VDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLD 119
VDLIKTYKHINEVYYAKKKRRAQQ QGED SHKKE+KLYN+G+DDDNHDYII++GEKFLD
Sbjct: 140 VDLIKTYKHINEVYYAKKKRRAQQMQGEDGSHKKERKLYNDGWDDDNHDYIIKNGEKFLD 199
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN 179
RYEIDSLIGKGSFGQVVKAFD EEQ VAIKIIKNKKPFLNQAQIEV+LLE+MN+AD +N
Sbjct: 200 RYEIDSLIGKGSFGQVVKAFDHEEQTQVAIKIIKNKKPFLNQAQIEVRLLEMMNRADTDN 259
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
YYIV+LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF+QQLCTALLFLS
Sbjct: 260 KYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFLS 319
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP 299
TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP
Sbjct: 320 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP 379
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359
YDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNKIVEVLG+PPKH+LD AHK RKYFDK
Sbjct: 380 YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGMPPKHILDQAHKARKYFDK 439
Query: 360 MP-DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418
+P DGSY+LKK KDG+K K PG+RRLHDILGVESGGPGGRR+GEPGHS+SDYLKFKDLI
Sbjct: 440 VPTDGSYVLKKSKDGKKYKPPGTRRLHDILGVESGGPGGRRIGEPGHSISDYLKFKDLIL 499
Query: 419 RMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSGLGSMSTSPA 464
RMLD+DPKTR+TPYYALQHNFFKRTADE TNT + S +TSPA
Sbjct: 500 RMLDFDPKTRVTPYYALQHNFFKRTADEGTNT-NIAAANSANTSPA 544
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340710082|ref|XP_003393627.1| PREDICTED: serine/threonine-protein kinase minibrain-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/466 (84%), Positives = 419/466 (89%), Gaps = 22/466 (4%)
Query: 20 PLYGRLVAEEP--------------------SCPGDILAMQARIPLQFRDPATAPLRKLS 59
PLYGRLVAEEP P DI AMQARIP +FRDPATAPLRKLS
Sbjct: 71 PLYGRLVAEEPLPPTVCGGAGTGGGTGGVPQETPADIHAMQARIPHRFRDPATAPLRKLS 130
Query: 60 VDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLD 119
VDLIKTYKHINEVYYAKKKRRAQQ QGED SHKKE+KLYN+G+DDDNHDYII++GEKFLD
Sbjct: 131 VDLIKTYKHINEVYYAKKKRRAQQMQGEDGSHKKERKLYNDGWDDDNHDYIIKNGEKFLD 190
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN 179
RYEIDSLIGKGSFGQVVKAFD EEQ VAIKIIKNKKPFLNQAQIEV+LLE+MN+AD +N
Sbjct: 191 RYEIDSLIGKGSFGQVVKAFDHEEQTQVAIKIIKNKKPFLNQAQIEVRLLEMMNRADTDN 250
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
YYIV+LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF+QQLCTALLFLS
Sbjct: 251 KYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFLS 310
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP 299
TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP
Sbjct: 311 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP 370
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359
YDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNKIVEVLG+PPKH+LD AHK RKYFDK
Sbjct: 371 YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGMPPKHILDQAHKARKYFDK 430
Query: 360 MP-DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418
+P DGSY+LKK KDG+K K PG+RRLHDILGVESGGPGGRR+GEPGHS+SDYLKFKDLI
Sbjct: 431 VPTDGSYVLKKSKDGKKYKPPGTRRLHDILGVESGGPGGRRIGEPGHSISDYLKFKDLIL 490
Query: 419 RMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSGLGSMSTSPA 464
RMLD+DPKTR+TPYYALQHNFFKRTADE TNT + S +TSPA
Sbjct: 491 RMLDFDPKTRVTPYYALQHNFFKRTADEGTNT-NIAAANSANTSPA 535
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156543834|ref|XP_001606660.1| PREDICTED: serine/threonine-protein kinase minibrain-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2070), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/467 (84%), Positives = 420/467 (89%), Gaps = 22/467 (4%)
Query: 19 APLYGRLVAEEP--------------------SCPGDILAMQARIPLQFRDPATAPLRKL 58
APLYGRLVAEEP P DI AMQARIP +FRDPATAPLRKL
Sbjct: 66 APLYGRLVAEEPLPGAVCGAGGTGGGSGVMPQETPADIHAMQARIPHRFRDPATAPLRKL 125
Query: 59 SVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFL 118
SVDLIKTYKHINEVYYAKKKRRAQQ QGED SHKKE+KLYN+G+DDDNHDYII++GEKFL
Sbjct: 126 SVDLIKTYKHINEVYYAKKKRRAQQMQGEDGSHKKERKLYNDGWDDDNHDYIIKNGEKFL 185
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
DRYEIDSLIGKGSFGQVVKAFD EEQ VAIKIIKNKKPFLNQAQIEV+LLE+MN+AD +
Sbjct: 186 DRYEIDSLIGKGSFGQVVKAFDHEEQTQVAIKIIKNKKPFLNQAQIEVRLLEMMNRADTD 245
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
N YYIV+LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF+QQLCTALLFL
Sbjct: 246 NKYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFL 305
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI 298
STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI
Sbjct: 306 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI 365
Query: 299 PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFD 358
PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNKIVEVLG+PPKH+LD AHK RKYFD
Sbjct: 366 PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGMPPKHILDQAHKARKYFD 425
Query: 359 KMP-DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417
K+P DGSY+LKK K+G+K K+PG+RRLHDILGVE+GGPGGRR GEPGHS+SDYLKFKDLI
Sbjct: 426 KVPTDGSYVLKKSKEGKKYKLPGTRRLHDILGVETGGPGGRRHGEPGHSISDYLKFKDLI 485
Query: 418 FRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSGLGSMSTSPA 464
RMLD+DPKTR+TPYYALQHNFFKRTADE TNT + S +TSPA
Sbjct: 486 LRMLDFDPKTRVTPYYALQHNFFKRTADEGTNT-NIAAANSANTSPA 531
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350413739|ref|XP_003490095.1| PREDICTED: serine/threonine-protein kinase minibrain-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2070), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/466 (84%), Positives = 419/466 (89%), Gaps = 22/466 (4%)
Query: 20 PLYGRLVAEEP--------------------SCPGDILAMQARIPLQFRDPATAPLRKLS 59
PLYGRLVAEEP P DI AMQARIP +FRDPATAPLRKLS
Sbjct: 83 PLYGRLVAEEPLPPTVCGGAGTGGGTGGVPQETPADIHAMQARIPHRFRDPATAPLRKLS 142
Query: 60 VDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLD 119
VDLIKTYKHINEVYYAKKKRRAQQ QGED SHKKE+KLYN+G+DDDNHDYII++GEKFLD
Sbjct: 143 VDLIKTYKHINEVYYAKKKRRAQQMQGEDGSHKKERKLYNDGWDDDNHDYIIKNGEKFLD 202
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN 179
RYEIDSLIGKGSFGQVVKAFD EEQ VAIKIIKNKKPFLNQAQIEV+LLE+MN+AD +N
Sbjct: 203 RYEIDSLIGKGSFGQVVKAFDHEEQTQVAIKIIKNKKPFLNQAQIEVRLLEMMNRADTDN 262
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
YYIV+LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF+QQLCTALLFLS
Sbjct: 263 KYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFLS 322
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP 299
TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP
Sbjct: 323 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP 382
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359
YDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNKIVEVLG+PPKH+LD AHK RKYFDK
Sbjct: 383 YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGMPPKHILDQAHKARKYFDK 442
Query: 360 MP-DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418
+P DGSY+LKK KDG+K K PG+RRLHDILGVESGGPGGRR+GEPGHS+SDYLKFKDLI
Sbjct: 443 VPTDGSYVLKKSKDGKKYKPPGTRRLHDILGVESGGPGGRRIGEPGHSISDYLKFKDLIL 502
Query: 419 RMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSGLGSMSTSPA 464
RMLD+DPKTR+TPYYALQHNFFKRTADE TNT + S +TSPA
Sbjct: 503 RMLDFDPKTRVTPYYALQHNFFKRTADEGTNT-NIAAANSANTSPA 547
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 493 | ||||||
| FB|FBgn0259168 | 908 | mnb "minibrain" [Drosophila me | 0.884 | 0.480 | 0.807 | 2.5e-193 | |
| MGI|MGI:1330299 | 763 | Dyrk1a "dual-specificity tyros | 0.835 | 0.539 | 0.794 | 1.5e-179 | |
| RGD|2528 | 763 | Dyrk1a "dual-specificity tyros | 0.835 | 0.539 | 0.794 | 1.5e-179 | |
| UNIPROTKB|F8W9I9 | 541 | DYRK1A "Dual-specificity tyros | 0.835 | 0.761 | 0.794 | 1.9e-179 | |
| UNIPROTKB|Q13627 | 763 | DYRK1A "Dual specificity tyros | 0.835 | 0.539 | 0.794 | 1.9e-179 | |
| UNIPROTKB|F1N2J2 | 763 | DYRK1A "Uncharacterized protei | 0.835 | 0.539 | 0.791 | 5e-179 | |
| UNIPROTKB|E2R722 | 654 | DYRK1A "Uncharacterized protei | 0.835 | 0.629 | 0.791 | 8.1e-179 | |
| UNIPROTKB|I3L9V1 | 764 | LOC100625240 "Uncharacterized | 0.835 | 0.539 | 0.791 | 8.1e-179 | |
| UNIPROTKB|F1P0S9 | 756 | DYRK1A "Uncharacterized protei | 0.831 | 0.542 | 0.795 | 2.1e-178 | |
| UNIPROTKB|F1P9L4 | 751 | DYRK1A "Uncharacterized protei | 0.831 | 0.545 | 0.793 | 9.3e-178 |
| FB|FBgn0259168 mnb "minibrain" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1873 (664.4 bits), Expect = 2.5e-193, P = 2.5e-193
Identities = 366/453 (80%), Positives = 393/453 (86%)
Query: 11 SAGEAVSHAPLYGRLV-AEE--------------PSCPGDILAMQARIPLQFRDPATAPL 55
S G HAPLYGR V AE+ PS ++ AMQARIP FR+PA+ PL
Sbjct: 38 SGGGRQRHAPLYGRFVDAEDLPATHRDVMHHHSSPSSSSEVRAMQARIPNHFREPASGPL 97
Query: 56 RKLSVDLIKTYKHINEVYYAKKKRRAQQSQGED-SSHKKEKKLYNEGYDDDNHDYIIQHG 114
RKLSVDLIKTYKHINEVYYAKKKRRAQQ+QG+D SS+KKE+KLYN+GYDDDNHDYII++G
Sbjct: 98 RKLSVDLIKTYKHINEVYYAKKKRRAQQTQGDDDSSNKKERKLYNDGYDDDNHDYIIKNG 157
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
EKFLDRYEIDSLIGKGSFGQVVKA+D EEQCHVAIKIIKNKKPFLNQAQIEVKLLE+MN+
Sbjct: 158 EKFLDRYEIDSLIGKGSFGQVVKAYDHEEQCHVAIKIIKNKKPFLNQAQIEVKLLEMMNR 217
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
AD N YYIV+LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF+QQLCTA
Sbjct: 218 ADAENKYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTA 277
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEV 294
LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY YIQSRFYRSPEV
Sbjct: 278 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYHYIQSRFYRSPEV 337
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354
LLGI YDLAIDMWSLGCILVEMHTGEPLFSG NEVDQMNKIVEVLG+PPK+LLD AHKTR
Sbjct: 338 LLGIQYDLAIDMWSLGCILVEMHTGEPLFSGCNEVDQMNKIVEVLGMPPKYLLDQAHKTR 397
Query: 355 KYFDKM-PDGSYILKKPKDGRKPKVPGSRRLHDIXXXXXXXXXXXXXXXXXHSVSDYLKF 413
K+FDK+ DGSY+LKK ++GRK K PGSR+LHDI HSVSDYLKF
Sbjct: 398 KFFDKIVADGSYVLKKNQNGRKYKPPGSRKLHDILGVETGGPGGRRLDEPGHSVSDYLKF 457
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
KDLI RMLD+DPKTR+TPYYALQHNFFKRTADE
Sbjct: 458 KDLILRMLDFDPKTRVTPYYALQHNFFKRTADE 490
|
|
| MGI|MGI:1330299 Dyrk1a "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1743 (618.6 bits), Expect = 1.5e-179, P = 1.5e-179
Identities = 328/413 (79%), Positives = 368/413 (89%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKN
Sbjct: 133 RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN 192
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNT
Sbjct: 193 KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 252
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
NFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 253 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 312
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNK
Sbjct: 313 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 372
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDIXXXXXX 393
IVEVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG++ K PG+R+LH+I
Sbjct: 373 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWSLKKTKDGKREYKPPGTRKLHNILGVETG 432
Query: 394 XXXXXXXXXXXHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
H+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE
Sbjct: 433 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 485
|
|
| RGD|2528 Dyrk1a "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1743 (618.6 bits), Expect = 1.5e-179, P = 1.5e-179
Identities = 328/413 (79%), Positives = 368/413 (89%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKN
Sbjct: 133 RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN 192
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNT
Sbjct: 193 KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 252
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
NFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 253 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 312
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNK
Sbjct: 313 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 372
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDIXXXXXX 393
IVEVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG++ K PG+R+LH+I
Sbjct: 373 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWSLKKTKDGKREYKPPGTRKLHNILGVETG 432
Query: 394 XXXXXXXXXXXHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
H+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE
Sbjct: 433 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 485
|
|
| UNIPROTKB|F8W9I9 DYRK1A "Dual-specificity tyrosine-phosphorylation-regulated kinase 1A" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1742 (618.3 bits), Expect = 1.9e-179, P = 1.9e-179
Identities = 328/413 (79%), Positives = 368/413 (89%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKN
Sbjct: 133 RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN 192
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNT
Sbjct: 193 KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 252
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
NFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 253 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 312
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNK
Sbjct: 313 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 372
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDIXXXXXX 393
IVEVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG++ K PG+R+LH+I
Sbjct: 373 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 432
Query: 394 XXXXXXXXXXXHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
H+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE
Sbjct: 433 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 485
|
|
| UNIPROTKB|Q13627 DYRK1A "Dual specificity tyrosine-phosphorylation-regulated kinase 1A" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1742 (618.3 bits), Expect = 1.9e-179, P = 1.9e-179
Identities = 328/413 (79%), Positives = 368/413 (89%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKN
Sbjct: 133 RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN 192
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNT
Sbjct: 193 KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 252
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
NFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 253 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 312
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNK
Sbjct: 313 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 372
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDIXXXXXX 393
IVEVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG++ K PG+R+LH+I
Sbjct: 373 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 432
Query: 394 XXXXXXXXXXXHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
H+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE
Sbjct: 433 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 485
|
|
| UNIPROTKB|F1N2J2 DYRK1A "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1738 (616.9 bits), Expect = 5.0e-179, P = 5.0e-179
Identities = 327/413 (79%), Positives = 368/413 (89%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKN
Sbjct: 133 RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN 192
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNT
Sbjct: 193 KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 252
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
NFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 253 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 312
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNK
Sbjct: 313 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 372
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDIXXXXXX 393
IVEVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG++ K PG+R+LH+I
Sbjct: 373 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 432
Query: 394 XXXXXXXXXXXHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
H+V+DYLKFKDLI RMLDYDPK+RI PYYALQH+FFK+TADE
Sbjct: 433 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKSRIQPYYALQHSFFKKTADE 485
|
|
| UNIPROTKB|E2R722 DYRK1A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1736 (616.2 bits), Expect = 8.1e-179, P = 8.1e-179
Identities = 327/413 (79%), Positives = 367/413 (88%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKN
Sbjct: 133 RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN 192
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNT
Sbjct: 193 KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 252
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
NFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 253 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 312
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNK
Sbjct: 313 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 372
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDIXXXXXX 393
IVEVL +PP H+LD A K RK+F+K+PDG++ LKK KDG++ K PG+R+LH+I
Sbjct: 373 IVEVLSIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 432
Query: 394 XXXXXXXXXXXHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
H+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE
Sbjct: 433 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 485
|
|
| UNIPROTKB|I3L9V1 LOC100625240 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1736 (616.2 bits), Expect = 8.1e-179, P = 8.1e-179
Identities = 327/413 (79%), Positives = 367/413 (88%)
Query: 35 DILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKE 94
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN 154
+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKN
Sbjct: 133 RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN 192
Query: 155 KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
KK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNT
Sbjct: 193 KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT 252
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
NFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSC
Sbjct: 253 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 312
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
QLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNK
Sbjct: 313 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 372
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDIXXXXXX 393
IVEVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG++ K P +R+LH+I
Sbjct: 373 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPATRKLHNILGVETG 432
Query: 394 XXXXXXXXXXXHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
H+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE
Sbjct: 433 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 485
|
|
| UNIPROTKB|F1P0S9 DYRK1A "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1732 (614.8 bits), Expect = 2.1e-178, P = 2.1e-178
Identities = 327/411 (79%), Positives = 365/411 (88%)
Query: 37 LAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKK 96
L Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE+K
Sbjct: 67 LTNQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKERK 126
Query: 97 LYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK 156
+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKNKK
Sbjct: 127 VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK 186
Query: 157 PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF 216
FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNTNF
Sbjct: 187 AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNF 246
Query: 217 RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
RGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL
Sbjct: 247 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 306
Query: 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
GQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNKIV
Sbjct: 307 GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 366
Query: 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDIXXXXXXXX 395
EVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG++ K PG+R+LH+I
Sbjct: 367 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGP 426
Query: 396 XXXXXXXXXHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
H+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE
Sbjct: 427 GGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 477
|
|
| UNIPROTKB|F1P9L4 DYRK1A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1726 (612.6 bits), Expect = 9.3e-178, P = 9.3e-178
Identities = 326/411 (79%), Positives = 364/411 (88%)
Query: 37 LAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKK 96
L Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRR QQ QG+DSSHKKE+K
Sbjct: 64 LTNQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKERK 123
Query: 97 LYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK 156
+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VAIKIIKNKK
Sbjct: 124 VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK 183
Query: 157 PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF 216
FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLYDLLRNTNF
Sbjct: 184 AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNF 243
Query: 217 RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
RGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL
Sbjct: 244 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 303
Query: 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
GQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NEVDQMNKIV
Sbjct: 304 GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 363
Query: 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKP-KVPGSRRLHDIXXXXXXXX 395
EVL +PP H+LD A K RK+F+K+PDG++ LKK KDG++ K PG+R+LH+I
Sbjct: 364 EVLSIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGP 423
Query: 396 XXXXXXXXXHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
H+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE
Sbjct: 424 GGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 474
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q8WQL7 | MBK1_CAEEL | 2, ., 7, ., 1, 2, ., 1 | 0.7077 | 0.6997 | 0.3911 | yes | N/A |
| Q63470 | DYR1A_RAT | 2, ., 7, ., 1, 2, ., 2 | 0.8167 | 0.8620 | 0.5570 | yes | N/A |
| Q13627 | DYR1A_HUMAN | 2, ., 7, ., 1, 2, ., 1 | 0.8167 | 0.8620 | 0.5570 | yes | N/A |
| Q9Y463 | DYR1B_HUMAN | 2, ., 7, ., 1, 2, ., 1 | 0.7610 | 0.8681 | 0.6804 | no | N/A |
| Q61214 | DYR1A_MOUSE | 2, ., 7, ., 1, 2, ., 1 | 0.8167 | 0.8620 | 0.5570 | yes | N/A |
| Q9Z188 | DYR1B_MOUSE | 2, ., 7, ., 1, 2, ., 1 | 0.7587 | 0.8681 | 0.6804 | no | N/A |
| Q76NV1 | DYRK1_DICDI | 2, ., 7, ., 1, 2, ., 1 | 0.6424 | 0.6957 | 0.4102 | yes | N/A |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 493 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-70 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-55 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-54 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-49 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-46 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-46 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-45 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-44 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-44 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-41 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-41 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-40 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-39 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-39 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-37 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-37 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-37 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-36 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-36 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-36 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-36 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-35 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-35 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-33 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-33 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-33 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-33 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-32 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-32 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-32 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-32 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-31 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-31 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-30 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-30 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-29 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-29 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-29 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-29 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-29 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-27 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-27 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-26 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-26 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-25 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-24 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-23 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-23 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-21 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-16 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-05 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 0.002 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.004 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 8e-70
Identities = 102/325 (31%), Positives = 150/325 (46%), Gaps = 76/325 (23%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVN 178
YEI +G+GSFG+V A D + VAIK+IK KK + E+K+L+ +
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHP--- 57
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
IVRL F + L LV E +L+DLL+ +S + R + +Q+ +AL +
Sbjct: 58 ---NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEY 112
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVL 295
L I+H DLKPENILL +K+ DFG + QL G+++ ++ + Y +PEVL
Sbjct: 113 LH--SKGIVHRDLKPENILLDEDGH--VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL 168
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355
LG Y A+D+WSLG IL E+ TG+P F G +++ +
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLE------------------------ 204
Query: 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415
+ KK + P P P +S + KD
Sbjct: 205 ----------LFKKIGKPKPPFPP-----------------------PEWDISP--EAKD 229
Query: 416 LIFRMLDYDPKTRITPYYALQHNFF 440
LI ++L DP+ R+T ALQH FF
Sbjct: 230 LIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 3e-55
Identities = 102/327 (31%), Positives = 153/327 (46%), Gaps = 52/327 (15%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADV 177
YE +G+G++G V KA D + VA+K I+ + A E+ LL+ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHP-- 58
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
IV+L L LVFE +L L +S NL + QL L +
Sbjct: 59 ----NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDK-RPGPLSPNLIKSIMYQLLRGLAY 113
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYRSPEV 294
+ I+H DLKP+NIL+ + +K+ DFG + G + Y + + +YR+PE+
Sbjct: 114 CHSH--RILHRDLKPQNILI--NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 295 LLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353
LLG Y A+D+WS+GCI EM TG+PLF G +E+DQ+ KI ++LG P + ++
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE-------ES 222
Query: 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413
K+PD PK P + L +L RL G
Sbjct: 223 WPGVTKLPDYKPTF--------PKFPP-KDLEKVLP---------RLDPEG--------- 255
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFF 440
DL+ +ML Y+P RI+ AL+H +F
Sbjct: 256 IDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 1e-54
Identities = 106/330 (32%), Positives = 153/330 (46%), Gaps = 57/330 (17%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ-----AQIEVKLLEIMNKA 175
Y+ IG+G++G V KA D VAIK K K F ++ A E+KLL+ +N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK--KIKLRFESEGIPKTALREIKLLKELNHP 58
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
I++L F + L LVFE + +LY L++ RG+ +L + + QL L
Sbjct: 59 ------NIIKLLDVFRHKGDLYLVFEFMDTDLYKLIK-DRQRGLPESLIKSYLYQLLQGL 111
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIY-QYIQSRFYRSP 292
F + I+H DLKPEN+L+ +K+ DFG + G R Y Y+ +R+YR+P
Sbjct: 112 AFCHSH--GILHRDLKPENLLINTE--GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAP 167
Query: 293 EVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP-PKHLLDGA 350
E+LLG Y +D+WS+GCI E+ + PLF G +E+DQ+ KI LG P P+
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227
Query: 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410
R Y P K +P + + P
Sbjct: 228 SLARNYKFSFPK------------KAGMPLPKLFPNA------SPQAL------------ 257
Query: 411 LKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
DL+ +ML YDP RIT AL H +F
Sbjct: 258 ----DLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 114/335 (34%), Positives = 159/335 (47%), Gaps = 67/335 (20%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--------LNQAQIEVKLLEIM 172
Y++ +G G+FG V A + E VAIK K KK F L EVK L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNLR----EVKSLRKL 54
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
N+ N IV+LK F + L VFE + NLY L+++ + S ++ R Q+
Sbjct: 55 NEHP--N---IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----Y-QYIQS 286
L + H DLKPEN+L+ P+ +KI DFG L + I Y Y+ +
Sbjct: 110 QGLAHIHK--HGFFHRDLKPENLLVSGPEV--VKIADFG----LAREIRSRPPYTDYVST 161
Query: 287 RFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
R+YR+PE+LL Y +D+W+LGCI+ E++T PLF GS+E+DQ+ KI VLG P K
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK- 220
Query: 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405
P+G Y L R P+ + LH ++ P
Sbjct: 221 ------------QDWPEG-YKLASKLGFRFPQFAPT-SLHQLI--------------PNA 252
Query: 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
S + DLI ML +DPK R T ALQH +F
Sbjct: 253 S----PEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-51
Identities = 83/229 (36%), Positives = 120/229 (52%), Gaps = 14/229 (6%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNT 180
YE+ +G GSFG V KA VA+KI+K + + Q + + I+ + N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN- 59
Query: 181 YYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
IVRL F ++HL LV E +L+D L +S + +K + Q+ L +L
Sbjct: 60 --IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLH 115
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRSPEVLL 296
IIH DLKPENILL +KI DFG + +L + ++ + +Y +PEVLL
Sbjct: 116 --SNGIIHRDLKPENILLDE--NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 297 -GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
G Y +D+WSLG IL E+ TG+P FSG N +DQ+ I +LG P +
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE 220
|
Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 109/348 (31%), Positives = 153/348 (43%), Gaps = 81/348 (23%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-------EVKLLEIM 172
RYE+ IG G++G V A D VAIK I N F I E+KLL +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN--VF--DDLIDAKRILREIKLLRHL 56
Query: 173 NKADVNNTYYIVRLKRHFMWR-----NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF 227
+ I+ L N + +V EL+ +L+ ++++ LT
Sbjct: 57 RHEN------IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDH 104
Query: 228 SQ----QLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFG---SSCQLG 277
Q Q+ L +L + N+IH DLKP NIL+ C+ +KI DFG
Sbjct: 105 IQYFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCD-----LKICDFGLARGVDPDE 157
Query: 278 QRIYQ---YIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 333
Y+ +R+YR+PE+LL Y AID+WS+GCI E+ T +PLF G + +DQ+N
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN 217
Query: 334 KIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESG 393
IVEVLG P + L +K +Y+ PK KPK P S+
Sbjct: 218 LIVEVLGTPSEEDLKFITS-----EKAR--NYLKSLPK---KPKKPLSKLF--------- 258
Query: 394 GPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
PG DL+ +ML +DPK RIT AL H +
Sbjct: 259 -PGASPEA------------IDLLEKMLVFDPKKRITADEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 1e-47
Identities = 98/331 (29%), Positives = 152/331 (45%), Gaps = 52/331 (15%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNKA 175
++YE+ ++G+G++G V+K + VAIK K + + A EVK+L +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
+ IV LK F + L LVFE + L +LL + G+ + R + QL A+
Sbjct: 61 N------IVNLKEAFRRKGRLYLVFEYVERTLLELL-EASPGGLPPDAVRSYIWQLLQAI 113
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQYIQSRFYRS 291
+ NIIH D+KPENIL+ + +K+ DFG + + Y+ +R+YR+
Sbjct: 114 AYCH--SHNIIHRDIKPENILV--SESGVLKLCDFGFARALRARPASPLTDYVATRWYRA 169
Query: 292 PEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG-LPPKHLLDG 349
PE+L+G Y +D+W++GCI+ E+ GEPLF G +++DQ+ I + LG LPP H
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229
Query: 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409
+ R P+ S + R P S L
Sbjct: 230 SSNPRFAGVAFPEPSQPE--SLERRYPGKVSSPAL------------------------- 262
Query: 410 YLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
D + L DPK R+T LQH +F
Sbjct: 263 -----DFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 71/197 (36%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKADVNNTYYIV 184
+G+G FG V A D + VAIKIIK + L + E+++L+ +N IV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP------NIV 54
Query: 185 RLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL 243
+L F NHL LV E +L DLL+ N +S + + Q+ L +L
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLH--SN 111
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGIP- 299
IIH DLKPENILL + +K+ DFG S L + + + Y +PEVLLG
Sbjct: 112 GIIHRDLKPENILLDSDNGK-VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 300 YDLAIDMWSLGCILVEM 316
Y D+WSLG IL E+
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 104/326 (31%), Positives = 156/326 (47%), Gaps = 50/326 (15%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNT 180
Y+I IG+G+F +V+KA + + AIK +K F + Q+ L EI ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH--FKSLEQV-NNLREIQALRRLSPH 57
Query: 181 YYIVRLKRHFMWRNH--LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
I+RL R L LVFEL+ NLY+L++ R + + + QL +L +
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHM 116
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLL 296
I H D+KPENIL+ K +K+ DFGS + + +YI +R+YR+PE LL
Sbjct: 117 H--RNGIFHRDIKPENILI---KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLL 171
Query: 297 --GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354
G Y +D+W++GC+ E+ + PLF G+NE+DQ+ KI +VLG P +L K+R
Sbjct: 172 TDGY-YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230
Query: 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414
P K G G R+L + S
Sbjct: 231 HMNYNFP--------SKKGT-----GLRKLL-------------------PNASAE--GL 256
Query: 415 DLIFRMLDYDPKTRITPYYALQHNFF 440
DL+ ++L YDP RIT AL+H +F
Sbjct: 257 DLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 99/341 (29%), Positives = 155/341 (45%), Gaps = 75/341 (21%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQI-EVKLLEIMNKADV 177
YE + IG+G++G V KA DL VA+K ++ + + + + E+ LL+ + +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 178 NNTYYIVRLKR--HFMWRNH---LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
N IVRL H + L LVFE + +L L G+ + +QL
Sbjct: 61 PN---IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF---- 288
+ FL + I+H DLKP+NIL+ + + +KI DFG + RIY + +
Sbjct: 118 RGVDFLHSHR--IVHRDLKPQNILVTSDGQ--VKIADFGLA-----RIYSF-EMALTSVV 167
Query: 289 ----YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
YR+PEVLL Y +DMWS+GCI E+ PLF G++E DQ++KI +V+GLP +
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227
Query: 345 HLLDGAHKTRKYFDKMPDGSYILKK--PKDGRKPK---VPGSRRLHDILGVESGGPGGRR 399
++ P + + P + VP
Sbjct: 228 -------------EEWPRNVSLPRSSFPSYTPRSFKSFVPE------------------- 255
Query: 400 LGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
+ E G DL+ +ML ++P RI+ + ALQH +F
Sbjct: 256 ICEEGL---------DLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 7e-45
Identities = 88/326 (26%), Positives = 144/326 (44%), Gaps = 46/326 (14%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN 179
RY+I IG+G+ G V KA D E VA+K + ++ L L EI +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR--LEGGIPNQALREIKALQACQH 58
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
Y +V+L F + LV E + +L ++LR+ R + + + + L + ++
Sbjct: 59 PY-VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH 116
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQRIYQY---IQSRFYRSPEVL 295
I+H DLKP N+L+ +KI DFG + + Y + +R+YR+PE+L
Sbjct: 117 --ANGIMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 296 LGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354
G YD +D+W++GCI E+ G PLF G N+++Q+ + LG P + G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT--- 229
Query: 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414
+PD + I L +I P ++
Sbjct: 230 ----SLPDYNKITFPESKP--------IPLEEIF------P-----DASPEAL------- 259
Query: 415 DLIFRMLDYDPKTRITPYYALQHNFF 440
DL+ +L YDP R++ AL+H +F
Sbjct: 260 DLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 102/348 (29%), Positives = 158/348 (45%), Gaps = 73/348 (20%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
DRY+ S +G G++GQV AFD + VAIK K +PF Q+ I K
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPF--QSAIHAK----------- 59
Query: 179 NTYYIVRLKRHFMWRNHLCL--VF---ELLSYNLYDLLRNTNFRGVSLN---LTRKFSQ- 229
TY +RL +H N + L VF L + D+ T+ G LN +K S
Sbjct: 60 RTYRELRLLKHMDHENVIGLLDVFTPASSLE-DFQDVYLVTHLMGADLNNIVKCQKLSDD 118
Query: 230 -------QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 282
Q+ L ++ + IIH DLKP NI + + +KI+DFG + +
Sbjct: 119 HIQFLVYQILRGLKYIHSA--GIIHRDLKPSNIAV--NEDCELKILDFGLARHTDDEMTG 174
Query: 283 YIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341
Y+ +R+YR+PE++L + Y+ +D+WS+GCI+ E+ TG+ LF GS+ +DQ+ +I+ ++G
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234
Query: 342 PPKHLLDG--AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRR 399
P + LL + R Y +P + PK + ++
Sbjct: 235 PDEELLQKISSESARNYIQSLP------QMPK----------KDFKEVF----------- 267
Query: 400 LGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
G + DL+ +ML DP RIT AL H + D
Sbjct: 268 ---SGANP----LAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-44
Identities = 103/336 (30%), Positives = 159/336 (47%), Gaps = 65/336 (19%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKP-FLNQAQIEVKLLEIMNKADV 177
YE + IG+G++GQV KA + + VA+K I+ N+K F A E+KLL+ + ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
IV K + + +VFE + ++L LL + + + + + + +QL L +
Sbjct: 61 VRLKEIVTSKG----KGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKCYMKQLLEGLQY 115
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR---------F 288
L + I+H D+K NIL+ N +K+ DFG + R Y S +
Sbjct: 116 LHSN--GILHRDIKGSNILINN--DGVLKLADFGLA-----RPYTKRNSADYTNRVITLW 166
Query: 289 YRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
YR PE+LLG Y +DMWS+GCIL E+ G+P+F GS E++Q+ KI E+ G P
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP----- 221
Query: 348 DGAHKTRKY---FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404
T + K+P + KPK K RRL +
Sbjct: 222 -----TDENWPGVSKLPW--FENLKPKKPYK------RRLREFF---------------K 253
Query: 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
H + DL+ ++L DPK RI+ ALQH +F
Sbjct: 254 HLIDPS--ALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 92/335 (27%), Positives = 145/335 (43%), Gaps = 62/335 (18%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-----LNQAQI-EVKLLEIMN 173
RYE +G+G++ V KA D E VAIK IK + +N + E+KLL+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
+ I+ L F ++++ LVFE + +L ++++ + ++ + +
Sbjct: 61 HPN------IIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV-LTPADIKSYMLMTLR 113
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIY--QYIQSRFY 289
L +L I+H DLKP N+L+ +K+ DFG + G R Q + +R+Y
Sbjct: 114 GLEYLH--SNWILHRDLKPNNLLI--ASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWY 168
Query: 290 RSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348
R+PE+L G Y + +DMWS+GCI E+ P G +++DQ+ KI E LG P +
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228
Query: 349 GAHKTRKY--FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHS 406
G Y F P P P D L
Sbjct: 229 GVTSLPDYVEFKPFP------PTPLKQIFPAAS-----DDAL------------------ 259
Query: 407 VSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
DL+ R+L +P RIT AL+H +F
Sbjct: 260 --------DLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 103/337 (30%), Positives = 156/337 (46%), Gaps = 55/337 (16%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI---EVKLLEIMNKA 175
RY+ IG G++G V A D VAIK I + A+ E+K+L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
++ I+R + +V +L+ +L+ ++ + + ++ R F QL L
Sbjct: 65 NIIAIRDILRPPGADF--KDVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGL 120
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG-----SSCQLGQRIY--QYIQSRF 288
++ + N+IH DLKP N LL N + ++I DFG SS + + +Y+ +R+
Sbjct: 121 KYIHSA--NVIHRDLKPSN-LLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 289 YRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
YR+PE+LL +P Y AIDMWS+GCI EM LF G N V Q+ I+ VLG P + +L
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 348 D--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405
+ G+ + RKY +P RK VP I P
Sbjct: 237 NRIGSDRVRKYIQNLP------------RKQPVP----WSKIF------PKASP------ 268
Query: 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
+ DL+ +ML +DP+ RIT ALQH F +
Sbjct: 269 ------EALDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 7e-40
Identities = 123/386 (31%), Positives = 187/386 (48%), Gaps = 57/386 (14%)
Query: 70 NEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDR-YEIDSLIG 128
N+ K + ++ E+ SH N G D+D I + ++ Y++ ++IG
Sbjct: 21 NKGGSGKFEMNDKKLDEEERSHNN-----NAGEDEDEEKMIDNDINRSPNKSYKLGNIIG 75
Query: 129 KGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188
GSFG V +A ++ VAIK + + N+ + +K L +N + + YY K+
Sbjct: 76 NGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135
Query: 189 HFMWRN-HLCLVFELLSYNLYDLLR--NTNFRGVSLNLTRKFSQQLCTALLFLSTPELNI 245
+ +N L +V E + ++ ++ N + L L + +S QLC AL ++ + I
Sbjct: 136 N--EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK--FI 191
Query: 246 IHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLG-IPYDL 302
H DLKP+N LL +P +K+ DFGS+ L GQR YI SRFYR+PE++LG Y
Sbjct: 192 CHRDLKPQN-LLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTT 250
Query: 303 AIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFD-KMP 361
ID+WSLGCI+ EM G P+FSG + VDQ+ +I++VLG P + L + Y D K P
Sbjct: 251 HIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN--YADIKFP 308
Query: 362 DGSYILKKPKDGRK--PKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419
D KPKD +K PK G P ++ + I +
Sbjct: 309 D-----VKPKDLKKVFPK-----------------------GTPDDAI-------NFISQ 333
Query: 420 MLDYDPKTRITPYYALQHNFFKRTAD 445
L Y+P R+ P AL FF D
Sbjct: 334 FLKYEPLKRLNPIEALADPFFDDLRD 359
|
Length = 440 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 98/326 (30%), Positives = 147/326 (45%), Gaps = 61/326 (18%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ--------AQIEVKLLEIMNKADVN 178
IG+G++G V KA D VA+K I+ L A E+ LL+ +N +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR-----LETEDEGVPSTAIREISLLKELNHPN-- 59
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
IVRL N L LVFE L +L + ++ G+ L + + QL + +
Sbjct: 60 ----IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYRSPEVL 295
+ ++H DLKP+N+L+ + A+K+ DFG + G + Y + + +YR+PE+L
Sbjct: 116 HSHR--VLHRDLKPQNLLI--DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171
Query: 296 LGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354
LG Y +D+WS+GCI EM PLF G +E+DQ+ +I LG P + + G
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231
Query: 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414
Y P +D K VP D G+
Sbjct: 232 DYKPTFPKW-----ARQDLSKV-VPN----LDEDGL------------------------ 257
Query: 415 DLIFRMLDYDPKTRITPYYALQHNFF 440
DL+ +ML YDP RI+ ALQH +F
Sbjct: 258 DLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 106/351 (30%), Positives = 167/351 (47%), Gaps = 67/351 (19%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
L +YEI +GKG++G V KA D + VA+K I + F N + EIM ++
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQRTFREIMFLQEL 63
Query: 178 NNTYYIVRLKRHFMWRNH--LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF-SQQLCTA 234
+ IV+L N + LVFE + +L+ ++R + ++ +++ QL A
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR----ANILEDVHKRYIMYQLLKA 119
Query: 235 LLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFG---SSCQLGQRIYQ-----Y 283
L ++ + N+IH DLKP NILL C +K+ DFG S +L + Y
Sbjct: 120 LKYIHSG--NVIHRDLKPSNILLNSDCR-----VKLADFGLARSLSELEENPENPVLTDY 172
Query: 284 IQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342
+ +R+YR+PE+LLG Y +DMWS+GCIL EM G+PLF G++ ++Q+ KI+EV+G P
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232
Query: 343 PKHLLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRL 400
++ + D +P +KP D PK D L
Sbjct: 233 SAEDIESIKSPFAATMLDSLPS---RPRKPLDELLPKAS-----DDAL------------ 272
Query: 401 GEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNF---FKRTADEST 448
DL+ ++L ++P R+T AL+H + F +DE
Sbjct: 273 --------------DLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPV 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 111/347 (31%), Positives = 167/347 (48%), Gaps = 70/347 (20%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQA-QI--EVKLLEIMNKAD 176
RY+I +IGKGS+G V A D VAIK I + ++ A +I E+KLL ++ D
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 177 VNNTYYIV--RLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ----Q 230
+ +I+ +R F + +VFEL+ +L+ +++ + +LT + Q Q
Sbjct: 61 IVEIKHIMLPPSRREF---KDIYVVFELMESDLHQVIKAND------DLTPEHHQFFLYQ 111
Query: 231 LCTALLFLSTPELNIIHCDLKPENILL-CNPKRSAIKIVDFG----SSCQLGQRIY--QY 283
L AL ++ T N+ H DLKP+NIL + K +KI DFG + I+ Y
Sbjct: 112 LLRALKYIHTA--NVFHRDLKPKNILANADCK---LKICDFGLARVAFNDTPTAIFWTDY 166
Query: 284 IQSRFYRSPEVLLG---IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340
+ +R+YR+PE L G Y AID+WS+GCI E+ TG+PLF G N V Q++ I ++LG
Sbjct: 167 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225
Query: 341 LPPKHLLDGAH--KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGR 398
P + K R+Y M +K VP S++ P
Sbjct: 226 TPSPETISRVRNEKARRYLSSMR------------KKQPVPFSQKF----------PN-- 261
Query: 399 RLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445
+D L + L+ R+L +DPK R T AL +FK A
Sbjct: 262 ---------ADPLALR-LLERLLAFDPKDRPTAEEALADPYFKGLAK 298
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 102/349 (29%), Positives = 159/349 (45%), Gaps = 61/349 (17%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ-----AQIEVKLLEIM 172
L RY+ IG G+ G V A+D +VAIK K +PF N A E+ L++++
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLV 72
Query: 173 NKADVNNTYYIVRLKRHFMWR------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRK 226
N + I+ L F + + LV EL+ NL + + ++L +
Sbjct: 73 NHKN------IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQV--------IQMDLDHE 118
Query: 227 -----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-- 279
Q LC + L + IIH DLKP NI++ +KI+DFG + G
Sbjct: 119 RMSYLLYQMLC-GIKHLHSA--GIIHRDLKPSNIVV--KSDCTLKILDFGLARTAGTSFM 173
Query: 280 IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL 339
+ Y+ +R+YR+PEV+LG+ Y +D+WS+GCI+ EM G LF G++ +DQ NKI+E L
Sbjct: 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233
Query: 340 GLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDIL-GVESGGPGGR 398
G P + T + Y+ +P + D+L +S
Sbjct: 234 GTPSDEFMSRLQPTVRN--------YVENRP---KYAGYSFEELFPDVLFPPDSESHNKL 282
Query: 399 RLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
+ + +DL+ +ML DP+ RI+ ALQH + D S
Sbjct: 283 KASQA----------RDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 7e-37
Identities = 99/330 (30%), Positives = 161/330 (48%), Gaps = 52/330 (15%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII---KNKKPFLNQAQIEVKLLEIMNKA 175
++YE L+G+GS+G V+K E VAIK ++ K A E+++L+ +
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
++ N + R K+ LVFE + + + D L G+ + RK+ Q+ +
Sbjct: 61 NLVNLIEVFRRKKRLY------LVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGI 113
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY-QYIQSRFYRSP 292
F + NIIH D+KPENIL + +K+ DFG + L +Y Y+ +R+YR+P
Sbjct: 114 EFCHSH--NIIHRDIKPENIL--VSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAP 169
Query: 293 EVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG-LPPKHLLDGA 350
E+L+G Y A+D+W++GC++ EM TGEPLF G +++DQ+ I++ LG L P+H
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH----- 224
Query: 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410
++ F K P + + RL ++ +E P +R + V D
Sbjct: 225 ---QEIFQKNPLFAGM----------------RLPEVKEIE---PLEKRFPKLSGLVLDL 262
Query: 411 LKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
K + L DP R + L H FF
Sbjct: 263 AK------QCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 102/334 (30%), Positives = 157/334 (47%), Gaps = 57/334 (17%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-----PFLNQAQIEVKLLEIMN 173
D YE + I +G++G V +A D + VA+K +K +K P + +I + L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILL----- 59
Query: 174 KADVNNTYYIVRLKRHFMWRN--HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQL 231
K N IV +K + N + +V E + ++L L+ T + + + QL
Sbjct: 60 KLQHPN---IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQL 115
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ---SRF 288
+ + L + I+H DLK N+LL N R +KI DFG + + G + Y Q + +
Sbjct: 116 LSGVAHLH--DNWILHRDLKTSNLLLNN--RGILKICDFGLAREYGSPLKPYTQLVVTLW 171
Query: 289 YRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
YR+PE+LLG Y AIDMWS+GCI E+ T +PLF G +E+DQ+NKI ++LG P + +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231
Query: 348 DGAHKTRKYFDKMPD-GSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHS 406
G F ++P K + K + L D G
Sbjct: 232 PG-------FSELPGAKKKTFTKYPYNQLRKKFPALSLSD-NGF---------------- 267
Query: 407 VSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
DL+ R+L YDP RI+ AL+H +F
Sbjct: 268 --------DLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 106/362 (29%), Positives = 157/362 (43%), Gaps = 98/362 (27%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLE--EQCHVAIKIIKN---KKPFLNQAQIEVKLLEIMNK 174
RYE+ +G+G++G V A + E E+ VAIK I N KK +A E+KLL
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLL----- 55
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDL--LRNTNFRGVSL----------- 221
RHF R H + LYD+ + NF + L
Sbjct: 56 -------------RHF--RGHKNIT------CLYDMDIVFPGNFNELYLYEELMEADLHQ 94
Query: 222 ------NLT----RKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271
LT + F Q+ L ++ + N++H DLKP N LL N +KI DFG
Sbjct: 95 IIRSGQPLTDAHFQSFIYQILCGLKYIHSA--NVLHRDLKPGN-LLVNAD-CELKICDFG 150
Query: 272 SSC-------QLGQRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLF 323
+ + + +Y+ +R+YR+PE++L Y AID+WS+GCIL E+ +P+F
Sbjct: 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
Query: 324 SGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRR 383
G + VDQ+N+I++VLG P + L + +YI P PK P
Sbjct: 211 KGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQ-------NYIRSLPN---IPKKP---- 256
Query: 384 LHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443
ES P L DL+ ++L +DP RI+ AL+H +
Sbjct: 257 ------FESIFPNANPLA------------LDLLEKLLAFDPTKRISVEEALEHPYLAIW 298
Query: 444 AD 445
D
Sbjct: 299 HD 300
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 100/339 (29%), Positives = 160/339 (47%), Gaps = 64/339 (18%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIMNKADVNNTY 181
IG+G++G V A + E VAIK I N F N+ E+KLL ++ +V
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA--FDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 182 YIVR--LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
I+ + F N + +V+EL+ +L+ ++R++ + +S + + F QL L ++
Sbjct: 71 DIMPPPHREAF---NDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH 125
Query: 240 TPELNIIHCDLKPENILL---CNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPE 293
+ N++H DLKP N+LL C+ +KI DFG ++ + G + +Y+ +R+YR+PE
Sbjct: 126 SA--NVLHRDLKPSNLLLNANCD-----LKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 294 VLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH- 351
+LL Y AID+WS+GCI E+ +PLF G + V Q+ I E+LG P + L
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238
Query: 352 -KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410
K R+Y +P P+ +R P +
Sbjct: 239 EKARRYIRSLP------------YTPRQSFARLF------------------PHANPLAI 268
Query: 411 LKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
DL+ +ML +DP RIT AL H + D S
Sbjct: 269 ----DLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 5e-36
Identities = 102/321 (31%), Positives = 151/321 (47%), Gaps = 51/321 (15%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNKADVNNTYYI 183
IG+G++G V KA + VA+K I+ + + A E+ LL+ +N + I
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN------I 61
Query: 184 VRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL 243
V+L N L LVFE L +L + + G+ L L + + QL L F +
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR- 120
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYRSPEVLLGIP- 299
++H DLKP+N+L+ AIK+ DFG + G + Y + + +YR+PE+LLG
Sbjct: 121 -VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359
Y A+D+WSLGCI EM T LF G +E+DQ+ +I LG P + + G
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV-------TS 230
Query: 360 MPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419
+PD Y PK R+ ++ L E G +DL+ +
Sbjct: 231 LPD--YKPSFPKWARQD-------FSKVVPP---------LDEDG---------RDLLSQ 263
Query: 420 MLDYDPKTRITPYYALQHNFF 440
ML YDP RI+ AL H FF
Sbjct: 264 MLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 5e-36
Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 41/238 (17%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII-------KNKKPFLNQAQIEVKLLEIM 172
+YEI IGKGSFG+V + +K I K ++ A EVK+L+ +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE----DALNEVKILKKL 56
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQ-- 229
N I++ F + LC+V E +L ++ G + F +
Sbjct: 57 NHP------NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG------KPFPEEQ 104
Query: 230 ------QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 283
QLC AL +L I+H D+KP+NI L +K+ DFG S L
Sbjct: 105 ILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVL-SSTVDL 159
Query: 284 IQSR----FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
++ +Y SPE+ PY+ D+WSLGC+L E+ T + F G N ++ KI++
Sbjct: 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 83/233 (35%), Positives = 133/233 (57%), Gaps = 13/233 (5%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+++E+ ++G+G++G V+K E + VAIK K+ + + ++ L+++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
N IV LK F R L LVFE + N+ +LL GV R + QL A+ +
Sbjct: 61 N---IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWC 116
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQYIQSRFYRSPEV 294
+ I+H D+KPEN+L+ + +K+ DFG + L + +Y+ +R+YRSPE+
Sbjct: 117 HKND--IVHRDIKPENLLISH--NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG-LPPKHL 346
LLG PY A+DMWS+GCIL E+ G+PLF G +E+DQ+ I +VLG LP + +
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 101/343 (29%), Positives = 160/343 (46%), Gaps = 59/343 (17%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKAD 176
RY+ S IG+G++G V A VAIK I + F + E+K+L +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
+ I+R F N + +V EL+ +LY L++ + +S + + F Q+ L
Sbjct: 65 IIGILDIIR-PPSFESFNDVYIVQELMETDLYKLIKTQH---LSNDHIQYFLYQILRGLK 120
Query: 237 FLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFG------SSCQLGQRIYQYIQSR 287
++ + N++H DLKP N+LL C+ +KI DFG + +Y+ +R
Sbjct: 121 YIHSA--NVLHRDLKPSNLLLNTNCD-----LKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 288 FYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
+YR+PE++L Y AID+WS+GCIL EM + PLF G + + Q+N I+ VLG P +
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233
Query: 347 LDG--AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404
L+ + + R Y +P KPKVP ++ P
Sbjct: 234 LNCIISLRARNYIKSLP------------FKPKVPWNKLF------------------PN 263
Query: 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
L DL+ +ML ++P RIT AL H + ++ D S
Sbjct: 264 AD-PKAL---DLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS 302
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 79/247 (31%), Positives = 115/247 (46%), Gaps = 43/247 (17%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKI------IKNKKPFLNQAQIEVKLLEIMNK 174
++ +IG+GSF VV A + E AIKI IK KK + +IE K E++ +
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK--VKYVKIE-K--EVLTR 57
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
+N I++L F +L V E L +R + + TR ++ ++
Sbjct: 58 --LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILL 113
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---------------Q 278
AL +L + IIH DLKPENILL IKI DFG++ L
Sbjct: 114 ALEYLHS--KGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 279 RIYQYIQSRF--------YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVD 330
+ + RF Y SPE+L P + D+W+LGCI+ +M TG+P F GSNE
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 331 QMNKIVE 337
KI++
Sbjct: 230 TFQKILK 236
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 68/239 (28%), Positives = 114/239 (47%), Gaps = 26/239 (10%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIK---IIKNKKPFLNQAQIEVKLLEIMNKADVNN--T 180
L+G+GSFG V A D + +A+K + + + L + E++ I++ N
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIR---ILSSLQHPNIVR 63
Query: 181 YYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
YY +N L + E +S +L LL+ F + + RK+++Q+ L +L
Sbjct: 64 YYGSERDEE---KNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLH 118
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEV 294
I+H D+K NIL+ + +K+ DFG + +LG + ++ +PEV
Sbjct: 119 --SNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ-MNKIVEVLGLP--PKHLLDGA 350
+ G Y A D+WSLGC ++EM TG+P +S + KI P P+HL + A
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 74/217 (34%), Positives = 111/217 (51%), Gaps = 16/217 (7%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKADVNNTYYIV 184
+GKGSFG+V+ + A+K++K KK + + ++E L E I+++ + +IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK-KKKIIKRKEVEHTLTERNILSRINHP---FIV 56
Query: 185 RLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL 243
+L F L LV E L+ L S R ++ ++ AL +L L
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLH--SL 112
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRSPEVLLGIPY 300
II+ DLKPENILL IK+ DFG + +L G R + + Y +PEVLLG Y
Sbjct: 113 GIIYRDLKPENILLDA--DGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 301 DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
A+D WSLG +L EM TG+P F + + KI++
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (326), Expect = 2e-33
Identities = 84/339 (24%), Positives = 134/339 (39%), Gaps = 79/339 (23%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMNKAD 176
Y I +G+GSFG+V A D + VA+K++ +K + + E+++L A
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQIL-----AS 53
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGV-SLNLTRKFSQQLCTA 234
+N+ IV+L F L LV E + +L DLL+ +G S + Q+ +A
Sbjct: 54 LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---------QRIYQYIQ 285
L +L IIH D+KPENILL + +K++DFG + L +
Sbjct: 114 LEYLH--SKGIIHRDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 286 SRFYRSPEVLLGI---PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342
+ Y +PEVLLG+ + D+WSLG L E+ TG P F G ++ ++
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK----- 225
Query: 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGE 402
IL+ P +
Sbjct: 226 ----------------------IILELPTPSLASPLS----------------------- 240
Query: 403 PGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
P + DL+ ++L DPK R++ L H+
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 103/336 (30%), Positives = 149/336 (44%), Gaps = 63/336 (18%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNKAD 176
+YE + IG G++G V KA D VA+K ++ N+ EV LL+ + D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 177 VNNTYYIVRL-----KRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQL 231
N IVRL + LVFE + +L L G+ + +Q
Sbjct: 61 HPN---IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF 117
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY-------I 284
L FL I+H DLKPENIL+ + +K+ DFG + RIY +
Sbjct: 118 LRGLDFLHAN--CIVHRDLKPENILVTS--GGQVKLADFGLA-----RIYSCQMALTPVV 168
Query: 285 QSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
+ +YR+PEVLL Y +DMWS+GCI EM +PLF G++E DQ+ KI +++GLPP+
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228
Query: 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404
D P + + R P+ P + +I ESG
Sbjct: 229 -------------DDWPRDVTLPRGAFSPRGPR-PVQSVVPEI--EESGA---------- 262
Query: 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
L+ ML ++P RI+ + ALQH FF
Sbjct: 263 ----------QLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 99/337 (29%), Positives = 154/337 (45%), Gaps = 58/337 (17%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNKA 175
D YE IG+G++G+V KA D VA+K + +++ A E+ LL++++++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 176 DVNNTYYIVRLKR--HFMWRN---HLCLVFELLSYNL---YDLLRNTNFRGVSLNLTRKF 227
YIVRL H +N L LVFE L +L D R + + F
Sbjct: 61 I-----YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---I 284
QL + + ++H DLKP+N+L+ + ++ +KI D G + Y I
Sbjct: 116 MYQLLKGVAHCH--KHGVMHRDLKPQNLLV-DKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 285 QSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343
+ +YR+PEVLLG Y +D+WS+GCI EM +PLF G +E+ Q+ I ++LG P
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232
Query: 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403
+ + G K R + + + KP+D + V P G
Sbjct: 233 EQVWPGVSKLRDWHE------FPQWKPQDLSR-------------AVPDLSPEG------ 267
Query: 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
DL+ +ML YDP RI+ AL H +F
Sbjct: 268 ----------LDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 6e-33
Identities = 92/323 (28%), Positives = 151/323 (46%), Gaps = 55/323 (17%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKADVNNTYYIV 184
+G+G++ V K + VA+K I ++ + A E+ L++ + + IV
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHEN------IV 61
Query: 185 RLKRHFMWRNHLCLVFELLSYNLYDLLR-NTNFRGVSLNLTRKFSQQLCTALLFLSTPEL 243
RL N L LVFE + +L + + + N + F+ QL + F E
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--EN 119
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYRSPEVLLGI-P 299
++H DLKP+N+L+ KR +K+ DFG + G + + + + +YR+P+VLLG
Sbjct: 120 RVLHRDLKPQNLLI--NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359
Y +ID+WS+GCI+ EM TG PLF G+N DQ+ KI ++G P + G + +Y
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237
Query: 360 MPDGSYILKKPKDGRK--PKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417
P P+D ++ P LG+ DL+
Sbjct: 238 FP-----RYPPQDLQQLFPHADP-------LGI------------------------DLL 261
Query: 418 FRMLDYDPKTRITPYYALQHNFF 440
R+L +P+ RI+ + ALQH +F
Sbjct: 262 HRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 8e-33
Identities = 95/348 (27%), Positives = 154/348 (44%), Gaps = 78/348 (22%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+RY +G G+FG V A D +VAIK K KPF
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPF-------------STPVLAK 54
Query: 179 NTYYIVRLKRHFMWRNHLCL-------------VFELLSYNLYDLLRNTNFRGVSLNLTR 225
TY ++L +H N + L V ELL +L+ LL + R + +
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTS---RPLEKQFIQ 111
Query: 226 KFSQQLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQ 282
F Q+ L ++ + ++H DLKP NIL+ C+ +KI DFG + ++
Sbjct: 112 YFLYQILRGLKYVHSA--GVVHRDLKPSNILINENCD-----LKICDFGLARIQDPQMTG 164
Query: 283 YIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341
Y+ +R+YR+PE++L YD+ +D+WS GCI EM G+PLF G + V+Q + I ++LG
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT 224
Query: 342 PPKHLLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRR 399
PP +++ + T ++ +P ++ VP S + ++ P
Sbjct: 225 PPDDVINTICSENTLRFVQSLP------------KREPVPFSEK------FKNADPSAI- 265
Query: 400 LGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
DL+ +ML +DP+ RI+ AL H + D +
Sbjct: 266 ---------------DLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 98/335 (29%), Positives = 151/335 (45%), Gaps = 49/335 (14%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII---KNKKPFLNQAQIEVKLLEIMNKA 175
+YE + IG+G+FG+V KA + + VA+K + K+ F A E+K+L+++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 176 DVNNTYYIVRLKRHFM--WRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
+V N I R K ++ LVFE ++L LL N N + +L+ +K + L
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIKKVMKMLLN 130
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG-------SSCQLGQRIYQYIQS 286
L ++ I+H D+K NIL+ K +K+ DFG S R + +
Sbjct: 131 GLYYIHRN--KILHRDMKAANILIT--KDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 287 RFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
+YR PE+LLG Y IDMW GCI+ EM T P+ G+ E Q+ I ++ G
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246
Query: 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405
+ G K + F KM + P+ + R++ + L
Sbjct: 247 VWPGVDKL-ELFKKM-------ELPQGQK-------RKVKERL---------------KP 276
Query: 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
V D DLI ++L DP RI AL H+FF
Sbjct: 277 YVKDPHAL-DLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 98/356 (27%), Positives = 157/356 (44%), Gaps = 75/356 (21%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCH--VAIKIIKNKKPF---LNQAQI-EVKLL-EIM 172
+YEI+ IG+G++G+V KA + AIK K K ++Q+ E+ LL E+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLC--LVFELLSYNLYDLL---RNTNFRGVSLNLTRKF 227
++ N +V L F+ L+F+ ++L+ ++ R + ++ +
Sbjct: 61 HE----N---VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 228 SQQLCTALLFLSTPELN-IIHCDLKPENILL--CNPKRSAIKIVDFGSSCQLGQRIYQYI 284
Q+ + +L + N ++H DLKP NIL+ P+R +KI D G L + +
Sbjct: 114 LWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG----LARLFNAPL 166
Query: 285 QSRF----------YRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNE----- 328
+ YR+PE+LLG Y AID+W++GCI E+ T EP+F G
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226
Query: 329 ----VDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRL 384
DQ+ +I EVLG P + K KMP+ Y K K S L
Sbjct: 227 NPFQRDQLERIFEVLGTPTE-------KDWPDIKKMPE--Y--DTLMKDFKTKTYPSNSL 275
Query: 385 HDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
+ + P + DL+ ++L+YDP RIT AL+H +F
Sbjct: 276 AKWME-KHKKPDSQGF--------------DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 97/324 (29%), Positives = 153/324 (47%), Gaps = 56/324 (17%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNKADVNNTYYI 183
IG+G++G V K + + VA+K I+ ++ + A E+ LL+ + + I
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN------I 61
Query: 184 VRLKRHFMWRNHLCLVFELLSYNL---YDLLRNTNFRGVSLNLTRKFSQQLCTALLFLST 240
V L+ M + L L+FE LS +L D L + + L + + Q+ +LF +
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGILFCHS 119
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQY-IQSRFYRSPEVLLG 297
++H DLKP+N+L+ + IK+ DFG + G R+Y + + + +YR+PEVLLG
Sbjct: 120 RR--VLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 298 IP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356
P Y +D+WS+G I EM T +PLF G +E+DQ+ +I +LG P + + G Y
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235
Query: 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDL 416
+ P K K + V L E G DL
Sbjct: 236 KNTFP------KWKKGSLRSAVKN-------------------LDEDG---------LDL 261
Query: 417 IFRMLDYDPKTRITPYYALQHNFF 440
+ +ML YDP RI+ AL H +F
Sbjct: 262 LEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 99/340 (29%), Positives = 153/340 (45%), Gaps = 60/340 (17%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ--------AQIEVKLL 169
+D+YE IG+G++G V KA D +A+K I+ L Q A E+ LL
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-----LEQEDEGVPSTAIREISLL 55
Query: 170 EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229
+ M + IVRL+ L LVFE L +L + ++ + L + +
Sbjct: 56 KEMQHGN------IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQS 286
Q+ + + + ++H DLKP+N LL + + +A+K+ DFG + G + + + +
Sbjct: 110 QILRGIAYCHSHR--VLHRDLKPQN-LLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT 166
Query: 287 RFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
+YR+PE+LLG Y +D+WS+GCI EM +PLF G +E+D++ KI +LG P +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226
Query: 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405
G Y P K P VP + GV
Sbjct: 227 TWPGVTSLPDYKSAFP------KWPPKDLATVVPTL----EPAGV--------------- 261
Query: 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445
DL+ +ML DP RIT AL+H +FK D
Sbjct: 262 ---------DLLSKMLRLDPSKRITARAALEHEYFKDLGD 292
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 96/363 (26%), Positives = 154/363 (42%), Gaps = 95/363 (26%)
Query: 120 RYE-IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---------PFLNQAQIE---V 166
RY + +G+G++G+V KA+D VAIK +K + + I +
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 167 KLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRK 226
+ L+IMN+ N +V + ++ + + LV ++++ +L ++ + R LT
Sbjct: 69 RELKIMNEIKHENIMGLVDV---YVEGDFINLVMDIMASDLKKVV-DRKIR-----LTE- 118
Query: 227 FSQQLCTALLFLSTPEL----NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY- 281
SQ C L L+ + +H DL P NI + + KI DFG + + G Y
Sbjct: 119 -SQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI--NSKGICKIADFGLARRYGYPPYS 175
Query: 282 ------QYIQSR----------FYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFS 324
+ +Q R +YR+PE+L+G Y A+DMWS+GCI E+ TG+PLF
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235
Query: 325 GSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYI-LKKPKDGRKPKVPGSRR 383
G NE+DQ+ +I E+LG P + D P + L RKPK
Sbjct: 236 GENEIDQLGRIFELLGTPNE-------------DNWPQAKKLPLYTEFTPRKPK------ 276
Query: 384 LHDILGVESGGPGGRRLGEPGHSVSDYLKFK-----DLIFRMLDYDPKTRITPYYALQHN 438
+ DL+ +L +P RI+ AL+H
Sbjct: 277 ----------------------DLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314
Query: 439 FFK 441
+FK
Sbjct: 315 YFK 317
|
Length = 335 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 75/243 (30%), Positives = 137/243 (56%), Gaps = 26/243 (10%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN 179
R++I SL+G+G+FG+VV+A+D + + + A+KI++N + A+IE++ +E + +AD +
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPAD 189
Query: 180 TYYIVRLKRHFMWRN-HLCLVFELLSYNLYD-LLRNTNFRGVSLNLTRKFSQ---QLCTA 234
+ +++++R+F H+C+V L D ++++ F R +Q Q A
Sbjct: 190 RFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS------HRHLAQIIFQTGVA 243
Query: 235 LLFLSTPELNIIHCDLKPENILL--------------CNPKRSAIKIVDFGSSCQLGQRI 280
L + T EL+++H DLKPENIL+ P ++I D G C
Sbjct: 244 LDYFHT-ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSR 302
Query: 281 YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340
+ +R YRSPEV+LG+ + + DMWS+GCI+ E++TG+ L+ + ++ ++ + + LG
Sbjct: 303 TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362
Query: 341 LPP 343
P
Sbjct: 363 RLP 365
|
Length = 467 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 84/235 (35%), Positives = 131/235 (55%), Gaps = 19/235 (8%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIK--IIKNKKPFLNQ-AQIEVKLLEIMNKA 175
++YE S IG+GS+G V K + E VAIK + P + + A E+++L+ +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
++ N + R KR L LVFE + + + L N RGV +L +K Q A+
Sbjct: 61 NLVNLIEVFRRKRK------LHLVFEYCDHTVLNEL-EKNPRGVPEHLIKKIIWQTLQAV 113
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRSP 292
F + N IH D+KPENIL+ K+ IK+ DFG + L G Y+ +R+YR+P
Sbjct: 114 NF--CHKHNCIHRDVKPENILIT--KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169
Query: 293 EVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG-LPPKH 345
E+L+G Y +D+W++GC+ E+ TG+PL+ G ++VDQ+ I + LG L P+H
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 100/337 (29%), Positives = 154/337 (45%), Gaps = 79/337 (23%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQI-EVKLLEIMNKADVNNTYYI 183
IG+G++G V +A D VA+K ++ N++ + + + E+ LL + + I
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN------I 68
Query: 184 VRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFS--------QQLCTAL 235
V LK + HL +F ++ Y DL + N+ FS QL L
Sbjct: 69 VELK-EVVVGKHLDSIFLVMEYCEQDLAS------LLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ--------SR 287
+L E IIH DLK N+LL + + +KI DFG + R Y +
Sbjct: 122 QYLH--ENFIIHRDLKVSNLLLTD--KGCLKIADFGLA-----RTYGLPAKPMTPKVVTL 172
Query: 288 FYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
+YR+PE+LLG Y AIDMW++GCIL E+ +PL G +E++Q++ I+++LG P + +
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232
Query: 347 LDGAHKTRKYFDKMPD-GSYILKK-PKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404
G F +P G + L K P + K K P L E G
Sbjct: 233 WPG-------FSDLPLVGKFTLPKQPYNNLKHKFP-------------------WLSEAG 266
Query: 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
+ ++L L YDPK R T AL+ ++FK
Sbjct: 267 LRLLNFL---------LMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 70/222 (31%), Positives = 111/222 (50%), Gaps = 19/222 (8%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK-NKKPFLNQAQIEVKLLEIMNKADVNN 179
+EI IGKG FG+V KA VAIK+IK K + E+++L+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHP---- 57
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR--KFSQQLCTALL 236
IV+ ++ ++ L +V E S +L DLL++TN L ++ ++L L
Sbjct: 58 --NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLE 112
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ--YIQSRFYRSPEV 294
+L IIH D+K NILL + +K++DFG S QL + + + ++ +PEV
Sbjct: 113 YLH--SNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEV 168
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
+ G PYD D+WSLG +E+ G+P +S + + KI
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA 210
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-30
Identities = 102/353 (28%), Positives = 165/353 (46%), Gaps = 53/353 (15%)
Query: 103 DDDNHDYIIQHGEK---FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL 159
++D+ Y +Q + L RY+ IG G+ G V AFD +VA+K K +PF
Sbjct: 2 EEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQ 59
Query: 160 NQ-----AQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT 214
NQ A E+ LL+ +N ++ + + ++ + LV EL+ NL ++
Sbjct: 60 NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH-- 117
Query: 215 NFRGVSLNLTRK---FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271
+ L+ R Q LC S IIH DLKP NI++ +KI+DFG
Sbjct: 118 ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV--KSDCTLKILDFG 168
Query: 272 --SSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV 329
+ + Y+ +R+YR+PEV+LG+ Y +D+WS+GCI+ E+ G +F G++ +
Sbjct: 169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
Query: 330 DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILG 389
DQ NK++E LG P ++ T + +Y+ +P+ P + D +
Sbjct: 229 DQWNKVIEQLGTPSAEFMNRLQPTVR--------NYVENRPQ---YPGISFEELFPDWIF 277
Query: 390 VESGGPGGRRLGEPGHSVSDYLKF---KDLIFRMLDYDPKTRITPYYALQHNF 439
P S D LK +DL+ +ML DP RI+ AL+H +
Sbjct: 278 -------------PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 92/343 (26%), Positives = 155/343 (45%), Gaps = 58/343 (16%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIK--IIKNKKP-FLNQAQIEVKLLEIMNK 174
L YEI +G+G+FG+V KA ++ VA+K ++ N+K F A E+K+L+ +
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 175 ADVNN--TYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+V + R + R + +V + ++L LL N + + ++ + + + QL
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-LTESQIKCYMLQLL 125
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG-------------SSCQLGQR 279
+ +L E +I+H D+K NIL+ N + +KI DFG G R
Sbjct: 126 EGINYLH--ENHILHRDIKAANILIDN--QGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 280 IY-QYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
Y + +R+YR PE+LLG Y A+D+W +GC+ EM T P+ G +++DQ++ I +
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241
Query: 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGG 397
+ G P + G +P + R L + G GP G
Sbjct: 242 LCGTPTEETWPGW-------RSLPGCEGVHSFTNY--------PRTLEERFG--KLGPEG 284
Query: 398 RRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
DL+ ++L DP R+T AL+H +F
Sbjct: 285 ----------------LDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 104/357 (29%), Positives = 161/357 (45%), Gaps = 65/357 (18%)
Query: 105 DNHDYIIQHGEK---FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ 161
DN+ Y ++ G+ L RY+ IG G+ G V A+D + +VAIK K +PF NQ
Sbjct: 7 DNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQ 64
Query: 162 -----AQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF 216
A E+ L++ +N ++ + ++ + +V EL+ NL +++
Sbjct: 65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---- 120
Query: 217 RGVSLNLTRK---FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273
+ L+ R Q LC S IIH DLKP NI++ +KI+DFG +
Sbjct: 121 --MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV--KSDCTLKILDFGLA 173
Query: 274 CQLGQRIYQ--YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ 331
G Y+ +R+YR+PEV+LG+ Y +D+WS+GCI+ EM G LF G++ +DQ
Sbjct: 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 233
Query: 332 MNKIVEVLGLPPKHLLDGAHKT-RKYFDKMPD-GSYILKK-------PKDGRKPKVPGSR 382
NK++E LG P + T R Y + P Y +K P D K+ S+
Sbjct: 234 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 293
Query: 383 RLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNF 439
+DL+ +ML D RI+ ALQH +
Sbjct: 294 A------------------------------RDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 100/347 (28%), Positives = 156/347 (44%), Gaps = 75/347 (21%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+RY+ S +G G++G V AFD + VA+K K +PF Q+ I K
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPF--QSIIHAK----------- 61
Query: 179 NTYYIVRLKRHFMWRNHLCL--VF----ELLSYNLYDLLRNTNFRGVSLN-------LTR 225
TY +RL +H N + L VF L +N D+ T+ G LN LT
Sbjct: 62 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN--DVYLVTHLMGADLNNIVKCQKLTD 119
Query: 226 KFSQ----QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281
Q Q+ L ++ + +IIH DLKP N L + +KI+DFG + +
Sbjct: 120 DHVQFLIYQILRGLKYIHSA--DIIHRDLKPSN--LAVNEDCELKILDFGLARHTDDEMT 175
Query: 282 QYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340
Y+ +R+YR+PE++L + Y+ +D+WS+GCI+ E+ TG LF G++ +DQ+ I+ ++G
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235
Query: 341 LPPKHLLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGR 398
P LL + R Y + + PK ++
Sbjct: 236 TPGAELLKKISSESARNYIQSLT------QMPK----------MNFANVF---------- 269
Query: 399 RLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445
+G +V DL+ +ML D RIT AL H +F + D
Sbjct: 270 -IGANPLAV-------DLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 104/345 (30%), Positives = 160/345 (46%), Gaps = 64/345 (18%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLE 170
G++ +D+++I IG+G++GQV KA D + VA+K ++ K+ F A E+K+L
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR 61
Query: 171 IMNKADVNNTYYIVRLKRHFM----WRNHLCLVFELLSYNLYDLLRN--TNFRGVSLNLT 224
+N ++ N IV K+ + + LVFE + ++L LL + +F S +
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF---SEDHI 118
Query: 225 RKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 284
+ F +QL L + + N +H D+K NILL N + IK+ DFG + R+Y
Sbjct: 119 KSFMKQLLEGLNYCH--KKNFLHRDIKCSNILLNN--KGQIKLADFGLA-----RLYNSE 169
Query: 285 QSR---------FYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
+SR +YR PE+LLG Y AID+WS GCIL E+ T +P+F + E+ Q+
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGG 394
I + G P + K YF+ M KPK RRL +
Sbjct: 230 ISRLCGSPCPAVWPDVIKL-PYFNTM--------------KPKKQYRRRLREEFSF---- 270
Query: 395 PGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNF 439
P ++ DL+ ML DP R T AL +
Sbjct: 271 -------IPTPAL-------DLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 95/329 (28%), Positives = 145/329 (44%), Gaps = 53/329 (16%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNKAD 176
+YE IG+G++G V KA + E VA+K ++ + + + A E+ LL+ + +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
IVRL L LVFE +L + N + + + F QL L
Sbjct: 61 ------IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLA 113
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYRSPE 293
F N++H DLKP+N+L+ K +K+ DFG + G + Y + + +YR P+
Sbjct: 114 FCH--SHNVLHRDLKPQNLLI--NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 169
Query: 294 VLLGIP-YDLAIDMWSLGCILVEM-HTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351
VL G Y +IDMWS GCI E+ + G PLF G++ DQ+ +I +LG P + G
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229
Query: 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYL 411
K P P P + L ++ V GR
Sbjct: 230 KL----------------PDYKPYPMYPATTSLVNV--VPKLNSTGR------------- 258
Query: 412 KFKDLIFRMLDYDPKTRITPYYALQHNFF 440
DL+ +L +P RI+ ALQH +F
Sbjct: 259 ---DLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 79/261 (30%), Positives = 133/261 (50%), Gaps = 37/261 (14%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+RY+ + +G G++G V A+D + VA+K K +PF Q+ I +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPF--QSLIHAR----------- 59
Query: 179 NTYYIVRLKRHFMWRNHLCL--VFELLSY--NLYDLLRNTNFRGVSLNLTRKFSQ----- 229
TY +RL +H N + L VF + N ++ TN G LN K +
Sbjct: 60 RTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEH 119
Query: 230 ------QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 283
QL L ++ + IIH DLKP N+ + + ++I+DFG + Q + Y
Sbjct: 120 VQFLIYQLLRGLKYIHSA--GIIHRDLKPSNVAV--NEDCELRILDFGLARQADDEMTGY 175
Query: 284 IQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342
+ +R+YR+PE++L + Y+ +D+WS+GCI+ E+ G+ LF G++ +DQ+ +I+EV+G P
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235
Query: 343 PKHLLD--GAHKTRKYFDKMP 361
+L + RKY +P
Sbjct: 236 SPEVLKKISSEHARKYIQSLP 256
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 93/350 (26%), Positives = 159/350 (45%), Gaps = 69/350 (19%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIM 172
G +++D + G GS G V A D + VA+K I P + A E+K++ +
Sbjct: 4 GSRYMDLRPL----GCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL 59
Query: 173 NKADVNNTYYI-----------VRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSL 221
+ ++ Y + V N + +V E + +L ++L +S
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTEL---NSVYIVQEYMETDLANVLEQGP---LSE 113
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-- 279
R F QL L ++ + N++H DLKP N+ + N + +KI DFG + +
Sbjct: 114 EHARLFMYQLLRGLKYIHSA--NVLHRDLKPANVFI-NTEDLVLKIGDFGLARIVDPHYS 170
Query: 280 ----IYQYIQSRFYRSPEVLLGIP--YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 333
+ + + +++YRSP +LL P Y AIDMW+ GCI EM TG+PLF+G++E++QM
Sbjct: 171 HKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229
Query: 334 KIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDIL-GVES 392
I+E +P D + + +P S++ DG +P+ P L D+L GV
Sbjct: 230 LILE--SVPVVREED----RNELLNVIP--SFVR---NDGGEPRRP----LRDLLPGVNP 274
Query: 393 GGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
++ D + ++L ++P R+T AL H +
Sbjct: 275 ------------EAL-------DFLEQILTFNPMDRLTAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 103/348 (29%), Positives = 159/348 (45%), Gaps = 49/348 (14%)
Query: 106 NHDYIIQHGEK---FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ- 161
N Y ++ G+ L RY+ IG G+ G V A+D +VAIK K +PF NQ
Sbjct: 1 NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQT 58
Query: 162 ----AQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFR 217
A E+ L++ +N ++ + + ++ + LV EL+ NL +++
Sbjct: 59 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ----- 113
Query: 218 GVSLNLTRK---FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
+ L+ R Q LC S IIH DLKP NI++ +KI+DFG +
Sbjct: 114 -MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV--KSDCTLKILDFGLAR 167
Query: 275 QLGQRIYQ--YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQM 332
G Y+ +R+YR+PEV+LG+ Y +D+WS+GCI+ EM + LF G + +DQ
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
Query: 333 NKIVEVLGLPPKHLLDGAHKT-RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVE 391
NK++E LG P + T R Y + +PK G L
Sbjct: 228 NKVIEQLGTPCPEFMKKLQPTVRNYVEN---------------RPKYAG-------LTFP 265
Query: 392 SGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNF 439
P + H+ + +DL+ +ML DP RI+ ALQH +
Sbjct: 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNKADVNNTYYI 183
IG G+FG+V A +L+ +A+K I+ N + + E+K+LE++ ++ YY
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV-KYYG 66
Query: 184 VRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
V + H R + + E S L +LL + R + ++ R ++ QL L +L
Sbjct: 67 VEV--H---REKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH--S 117
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-------GQRIYQYIQSRFYRSPEVL 295
I+H D+KP NI L IK+ DFG + +L G+ + + Y +PEV+
Sbjct: 118 HGIVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 296 LGIPYD---LAIDMWSLGCILVEMHTGEPLFSG 325
G A D+WSLGC+++EM TG+ +S
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 11/220 (5%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN 179
+++ +GKGS+G V K L + A+K + ++Q + E + EI A VN+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS--MSQKEREDAVNEIRILASVNH 58
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSL--NLTRKFSQQLCTALL 236
I+ K F+ N LC+V E + +L + + + + QL L
Sbjct: 59 PN-IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-YQYIQSRFYRSPEVL 295
L E I+H DLK NILL +KI D G S L + + I + Y +PEV
Sbjct: 118 ALH--EQKILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVW 173
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
G PY D+WSLGC+L EM T P F + D K+
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 19/225 (8%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIK-IIKNKKP--FLNQAQIEVKLLEIMNKAD 176
Y++ LIG+G+FG V K +LE VAIK I K L E+ LL+ +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP- 59
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFEL-LSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
IV+ + L ++ E + +L +++ F +L + Q+ L
Sbjct: 60 -----NIVKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGL 112
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRSP 292
+L E +IH D+K NIL K +K+ DFG + +L + + + ++ +P
Sbjct: 113 AYLH--EQGVIHRDIKAANILT--TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168
Query: 293 EVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
EV+ A D+WSLGC ++E+ TG P + N + + +IV+
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 97/332 (29%), Positives = 151/332 (45%), Gaps = 53/332 (15%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMN 173
L+ Y+ +G+GS+ V K VA+K I+ + PF A E LL+ +
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLK 61
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
A++ + I+ K+ L LVFE L +L + + G+S++ R F QL
Sbjct: 62 HANIVTLHDIIHTKKT------LTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLR 114
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQY-IQSRFYR 290
L + + ++H DLKP+N+L+ R +K+ DFG + + + Y + + +YR
Sbjct: 115 GLAYCH--QRRVLHRDLKPQNLLISE--RGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170
Query: 291 SPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV-DQMNKIVEVLGLPPKHLLD 348
P+VLLG Y ++DMW +GCI EM TG PLF GS +V DQ++KI VLG P +
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230
Query: 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVS 408
G ++ KP R L + RL H
Sbjct: 231 GVSSNPEF------------KPYSFPFYP---PRPLINHAP---------RLDRIPHGE- 265
Query: 409 DYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
+L + L Y+PK RI+ A++H +F
Sbjct: 266 ------ELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-26
Identities = 80/237 (33%), Positives = 125/237 (52%), Gaps = 24/237 (10%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCH-VAIKIIKNKK-----PFLNQAQIEV-KLLEIM 172
+YE + IG+G++G+V KA DL+ VA+K ++ + P ++ V + LE
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+V + + + R L LVFE + +L L GV + QL
Sbjct: 62 EHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY-------IQ 285
L FL + ++H DLKP+NIL+ + + IK+ DFG + RIY + +
Sbjct: 121 RGLDFLHSHR--VVHRDLKPQNILVTSSGQ--IKLADFGLA-----RIYSFQMALTSVVV 171
Query: 286 SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342
+ +YR+PEVLL Y +D+WS+GCI EM +PLF GS++VDQ+ KI++V+GLP
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL-LEIMNKADVNNTYYIVR 185
+G G FG+V + A+K +K + Q + EI+ + N +IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE---CNHPFIVK 57
Query: 186 LKRHFMWRNHLCLVFEL-LSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTA---LLFLSTP 241
L R F + ++ ++ E L L+ +LR L +++ + A L F
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILR-------DRGLFDEYTARFYIACVVLAFEYLH 110
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGIP 299
II+ DLKPEN+LL +K+VDFG + +L GQ+ + + + Y +PE++L
Sbjct: 111 NRGIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ--MNKIVEVLG 340
YD ++D WSLG +L E+ TG P F +E N I++ G
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 77/251 (30%), Positives = 125/251 (49%), Gaps = 17/251 (6%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ-----AQIEVKLLEIMN 173
DRY +G G++G V A D VAIK K +PF ++ A E++LL+ M
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
+V + + LV + +L L+++ +S + + Q+
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLVYQMLK 129
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPE 293
L ++ IIH DLKP N L + +KI+DFG + Q + Y+ +R+YR+PE
Sbjct: 130 GLKYIHAA--GIIHRDLKPGN--LAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPE 185
Query: 294 VLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352
V+L + Y +D+WS+GCI+ EM TG+PLF G + +DQ+ +I++V G P K +
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245
Query: 353 T--RKYFDKMP 361
+ Y K+P
Sbjct: 246 EDAKNYVKKLP 256
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 31/233 (13%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNT 180
++I +G+GS+G V KA E VAIK++ ++ I K + I+ + D +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE---II-KEISILKQCD---S 57
Query: 181 YYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
YIV+ + L +V E + D+++ TN + +++ A+L+ +
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN---------KTLTEEEIAAILYQT 108
Query: 240 TPEL------NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYR 290
L IH D+K NILL + K+ DFG S QL + + I + F+
Sbjct: 109 LKGLEYLHSNKKIHRDIKAGNILL--NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWM 166
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343
+PEV+ I Y+ D+WSLG +EM G+P +S ++ M I + PP
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS---DIHPMRAIFMIPNKPP 216
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 72/227 (31%), Positives = 106/227 (46%), Gaps = 28/227 (12%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKADVNNTYYIV 184
I KG++G+V A AIK+I K + + Q++ L E I+++A + Y+V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVI-KKADMIRKNQVDQVLTERDILSQA---QSPYVV 56
Query: 185 RLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLN--LTRKFSQQLCTALLFLSTP 241
+L F + +L LV E L +L LL N SL+ + R + ++ AL +L
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLH-- 110
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQRIYQYIQSRF----------YR 290
IIH DLKP+NIL+ +K+ DFG S L +R Y
Sbjct: 111 SNGIIHRDLKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+PEV+LG + +D WSLGCIL E G P F G + I+
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 97/347 (27%), Positives = 145/347 (41%), Gaps = 70/347 (20%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-------EVKLLEIM 172
RY +G G++G V A D VAIK K +PF Q++I E+ LL+ M
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPF--QSEIFAKRAYRELTLLKHM 71
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTR--KFSQQ 230
+V + L F + D + L S+
Sbjct: 72 QHENV------IGLLDVF--------TSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED 117
Query: 231 LCTALLFLSTPELN------IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 284
L++ L IIH DLKP N L + +KI+DFG + + Y+
Sbjct: 118 KVQYLVYQMLCGLKYIHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHADAEMTGYV 175
Query: 285 QSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343
+R+YR+PEV+L + Y+ +D+WS+GCI+ EM TG+ LF G + +DQ+ +I++V G+P
Sbjct: 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP- 234
Query: 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403
G +K + SYI PK RK + P
Sbjct: 235 -----GPEFVQK-LEDKAAKSYIKSLPKYPRKD-------------FSTLFPKASPQA-- 273
Query: 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK--RTADEST 448
DL+ +ML+ D R+T AL+H +F R ADE T
Sbjct: 274 ----------VDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 78/271 (28%), Positives = 112/271 (41%), Gaps = 60/271 (22%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKAD 176
D +E+ +IG+G+FG+V D + A+K+++ K + + QI E I+ AD
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDIL--AD 57
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFE------LLSY-NLYDLLRNTNFRGVSLNLTRKFSQ 229
++ + IV+L F HL LV E L++ D+ R +
Sbjct: 58 ADSPW-IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE--------ETARFYIA 108
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQS 286
+L AL + +L IH D+KP+NIL+ IK+ DFG ++ R Y S
Sbjct: 109 ELVLALDSVH--KLGFIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 287 RF-----------------------------YRSPEVLLGIPYDLAIDMWSLGCILVEMH 317
Y +PEVL G PY L D WSLG IL EM
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 318 TGEPLFSGSNEVDQMNKIV---EVLGLPPKH 345
G P F + NKI+ E L PP
Sbjct: 225 YGFPPFYSDTLQETYNKIINWKESLRFPPDP 255
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 95/323 (29%), Positives = 140/323 (43%), Gaps = 53/323 (16%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYY 182
+G+GS+ V K VA+K+I K PF A E LL+ + A+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPF--TAIREASLLKGLKHAN------ 64
Query: 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
IV L + L VFE + +L + + G+ R F QL L ++
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIH--G 121
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEVLLG-I 298
+I+H DLKP+N+L+ +K+ DFG + Q + + +YR P+VLLG
Sbjct: 122 QHILHRDLKPQNLLISY--LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT 179
Query: 299 PYDLAIDMWSLGCILVEMHTGEPLFSG-SNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYF 357
Y A+D+W GCI +EM G+P F G S+ +Q+ KI VLG+P + G K Y
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY- 238
Query: 358 DKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417
KP+ K +L + +RL P K +DL
Sbjct: 239 -----------KPEWFLPCKPQ---QLRVVW---------KRLSRP-------PKAEDLA 268
Query: 418 FRMLDYDPKTRITPYYALQHNFF 440
+ML PK RI+ AL H +F
Sbjct: 269 SQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 127 IGKGSFGQV--VKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV---NNTY 181
+G+G +GQV K D E A+K +K K L + EV+ ++ + D+ +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIV--ALKRMK--KSLLFKLN-EVR--HVLTERDILTTTKSE 61
Query: 182 YIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLST 240
++V+L F +L L E + + LL N +S + R + ++ A+ L
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALH- 118
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPY 300
EL IH DLKPEN L+ IK+ DFG S + + S Y +PEVL G Y
Sbjct: 119 -ELGYIHRDLKPENFLI--DASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGY 175
Query: 301 DLAIDMWSLGCILVEMHTGEPLFSGSN 327
D +D WSLGC+L E G P FSGS
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
+ E IG+G+ G+V KA D VAIK ++ +K E+ +++
Sbjct: 18 RELYKNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK- 73
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTR--KFSQQL 231
N IV ++ + L +V E + L D++ R +N + +++
Sbjct: 74 -HPN----IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR---MNEPQIAYVCREV 125
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR---- 287
L +L + N+IH D+K +NILL K ++K+ DFG + QL + R
Sbjct: 126 LQGLEYLHS--QNVIHRDIKSDNILL--SKDGSVKLADFGFAAQLTKEK----SKRNSVV 177
Query: 288 ---FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEP 321
++ +PEV+ Y +D+WSLG + +EM GEP
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 70/223 (31%), Positives = 110/223 (49%), Gaps = 15/223 (6%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKAD 176
D +E +G GSFG+V+ + A+KI+ K + Q+E L E I+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS-KAKIVKLKQVEHVLNEKRILQSIR 59
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTN-FRGVSLNLTRKFSQQLCTA 234
++V L F ++L LV E + L+ LR + F + R ++ Q+ A
Sbjct: 60 ---HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF---PEPVARFYAAQVVLA 113
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEV 294
L +L + L+I++ DLKPEN+LL IKI DFG + ++ R Y + Y +PE+
Sbjct: 114 LEYLHS--LDIVYRDLKPENLLLD--SDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEI 169
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+L Y A+D W+LG ++ EM G P F N + KI+E
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 13/226 (5%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY 181
E ++G+GS G V K A+K I + Q+ +L + + +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLREL-KTLRSCESP--- 59
Query: 182 YIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLST 240
Y+V+ F + +V E + +L DLL+ + + ++Q+ L +L T
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT 117
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRSPEVLLG 297
+ +IIH D+KP N+L+ N + +KI DFG S L + Q ++ + Y SPE + G
Sbjct: 118 -KRHIIHRDIKPSNLLI-N-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 298 IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343
Y A D+WSLG L+E G+ F + + + PP
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP 220
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-21
Identities = 85/330 (25%), Positives = 144/330 (43%), Gaps = 58/330 (17%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIMNKAD 176
E D IG G+FG V D + VA+K K F N E+K+L +
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALK--KMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
V + I++ H + +V EL+ +L+ ++ + + +S + + F Q+ L
Sbjct: 61 VLSALDILQ-PPHIDPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLK 117
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG--------SSCQLGQRIYQYIQSRF 288
+L + I+H D+KP N+L+ + +KI DFG S + Q + +++
Sbjct: 118 YLHSA--GILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDESKHMTQEVV----TQY 169
Query: 289 YRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
YR+PE+L+G Y A+D+WS+GCI E+ LF + + Q++ I ++LG P +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229
Query: 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407
A + + ++IL+ P K P L+ S
Sbjct: 230 RSACEGAR--------AHILRGPH-----KPPSLPVLY------------------TLSS 258
Query: 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQH 437
+ L+ RML +DP RI+ AL H
Sbjct: 259 QATHEAVHLLCRMLVFDPDKRISAADALAH 288
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 91/320 (28%), Positives = 154/320 (48%), Gaps = 50/320 (15%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKADVNNTYYIV 184
+G+G++ V K + VA+K I+ +++ A EV LL+ + A++ + I+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 185 RLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN 244
+R L LVFE L +L L N +S++ + F QL L + +
Sbjct: 73 HTERC------LTLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH--KRK 123
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIY-QYIQSRFYRSPEVLLG-IPY 300
I+H DLKP+N+L+ ++ +K+ DFG + + + Y + + +YR P+VLLG Y
Sbjct: 124 ILHRDLKPQNLLI--NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 301 DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKM 360
IDMW +GCIL EM TG P+F GS ++++ I +LG P + G ++
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF---- 237
Query: 361 PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420
SY+ P+ +P + + RL D G+ DL+ +
Sbjct: 238 --RSYLF--PQYRAQPLINHAPRL-DTDGI------------------------DLLSSL 268
Query: 421 LDYDPKTRITPYYALQHNFF 440
L Y+ K+RI+ AL+H++F
Sbjct: 269 LLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 69/232 (29%), Positives = 102/232 (43%), Gaps = 28/232 (12%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII-----KNKKPFLNQAQIEVKLL-EIMNK 174
YE+ IGKGSFG V K + + K I K+ Q EV +L E+ +
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK--QQLVSEVNILRELKHP 59
Query: 175 ADVNNTYYIVRLKRHFMWR-NH-LCLVFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQ 229
IVR + R N L +V E +L L++ + + +
Sbjct: 60 -------NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 230 QLCTALL---FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---Y 283
QL AL S P ++H DLKP NI L + +K+ DFG + LG Y
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDA--NNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
+ + +Y SPE L + YD D+WSLGC++ E+ P F+ N++ +KI
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 21/256 (8%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ +EI +G G+FG+V KA + E A K+I+ K ++ ++E ++EI A N
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCN 67
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
+ YIV+L F W L ++ E D + RG++ + +Q+ AL +L
Sbjct: 68 H-PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQYIQSRFYRSPEVL 295
+ + IIH DLK N+LL IK+ DFG S + QR +I + ++ +PEV+
Sbjct: 127 HS--MKIIHRDLKAGNVLLT--LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 296 L-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE----VLGLPPKHL 346
+ PYD D+WSLG L+EM EP N + + KI + L P K
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242
Query: 347 LDGAHKTRKYFDKMPD 362
++ + DK P+
Sbjct: 243 MEFRDFLKTALDKHPE 258
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 88/337 (26%), Positives = 131/337 (38%), Gaps = 90/337 (26%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQA--QIEVKLLEIMNKAD 176
+ + + IGKGSFG+V KA D VAIK+I L +A +IE EI +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQ 55
Query: 177 VNN----TYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLN-LTRKFSQQ 230
+ YY LK +W ++ E + DLL+ + + R +
Sbjct: 56 CRSPYITKYYGSFLKGSKLW-----IIMEYCGGGSCLDLLKPGKLDETYIAFILR----E 106
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSR 287
+ L +L E IH D+K NILL +K+ DFG S QL + + ++ +
Sbjct: 107 VLLGLEYLH--EEGKIHRDIKAANILLSE--EGDVKLADFGVSGQLTSTMSKRNTFVGTP 162
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
F+ +PEV+ YD D+WSLG +E+ GEP S ++ M VL L PK+
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS---DLHPM----RVLFLIPKN-- 213
Query: 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407
P P + G+
Sbjct: 214 ---------------------NP-----PSLE------------------------GNKF 223
Query: 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTA 444
S FKD + L+ DPK R + L+H F K+
Sbjct: 224 SK--PFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 7e-20
Identities = 69/230 (30%), Positives = 106/230 (46%), Gaps = 33/230 (14%)
Query: 127 IGKGSFGQV----VKAFDLEEQCH-VAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY 181
+GKG FG+V VKA C + K +K +K A E K+LE ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGE-QMALNEKKILEKVS------SR 53
Query: 182 YIVRLKRHFMWRNHLCLVFEL-----LSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
+IV L F ++ LCLV L L Y++Y N G ++ Q+ L
Sbjct: 54 FIVSLAYAFETKDDLCLVMTLMNGGDLKYHIY----NVGEPGFPEARAIFYAAQIICGLE 109
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEV 294
L + I++ DLKPEN+LL + ++I D G + +L G++I + Y +PEV
Sbjct: 110 HLH--QRRIVYRDLKPENVLLDD--HGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV 165
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSG------SNEVDQMNKIVEV 338
L G YD ++D ++LGC L EM G F E+ + + V
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 18/244 (7%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185
++GKGSFG+V+ A A+K++K K L +E + E A ++ +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLK-KDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 186 LKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL 243
L F ++ L V E ++ ++ + R+ F R ++ ++ L FL E
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRF---DEPRARFYAAEIVLGLQFLH--ER 115
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGI 298
II+ DLK +N+LL IKI DFG C+ G S F Y +PE+L
Sbjct: 116 GIIYRDLKLDNVLL--DSEGHIKIADFGM-CKEGIL-GGVTTSTFCGTPDYIAPEILSYQ 171
Query: 299 PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT-RKYF 357
PY A+D W+LG +L EM G+ F G +E + I+E P+ L A + +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFL 231
Query: 358 DKMP 361
K P
Sbjct: 232 TKNP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 87/321 (27%), Positives = 147/321 (45%), Gaps = 50/321 (15%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKADVNNTYYIV 184
+G+G++ V K + VA+K I+ +++ A EV LL+ + A++ + IV
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 185 RLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN 244
+ L LVFE L +L + + +S++ + F Q+ L +
Sbjct: 74 HTDKS------LTLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH--RRK 124
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYRSPEVLLGIP-Y 300
++H DLKP+N+L+ +R +K+ DFG + Y + + +YR P+VLLG Y
Sbjct: 125 VLHRDLKPQNLLI--NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 301 DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKM 360
IDMW +GCI EM +G PLF GS D+++ I +LG P + G ++
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF---- 238
Query: 361 PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420
+Y PK +P + + RL D G+E L+ +
Sbjct: 239 --KNYNF--PKYKPQPLINHAPRL-DTEGIE------------------------LLTKF 269
Query: 421 LDYDPKTRITPYYALQHNFFK 441
L Y+ K RI+ A++H +F+
Sbjct: 270 LQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 67/251 (26%), Positives = 113/251 (45%), Gaps = 20/251 (7%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+E+ +IG+G++G+V KA + VAIKI+ + + + E +L +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 179 NTYYIVRLKR-HFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSL--NLTRKFSQQLCTA 234
T+Y +K+ + L LV EL ++ DL++ +G L ++
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRS 291
L +L E +IH D+K +NILL +K+VDFG S QL + + +I + ++ +
Sbjct: 126 LAYLH--ENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 292 PEVL-----LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
PEV+ YD D+WSLG +E+ G+P + + + KI PP
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR--NPPPT-- 237
Query: 347 LDGAHKTRKYF 357
L K F
Sbjct: 238 LKSPENWSKKF 248
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 61/238 (25%), Positives = 114/238 (47%), Gaps = 34/238 (14%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKII------KNKKPFLNQAQIEVKLLEIMNKADVNN 179
L+G+G+FG+V +D++ +A+K + K +N + E++LL+ + +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
Y +R L + E + ++ D L+ + ++ +TRK+++Q+ + +L
Sbjct: 69 YYGCLRD------DETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYL 120
Query: 239 STPELNIIHCDLKPENILLCNPKRSA---IKIVDFGSS------CQLGQRIYQYIQSRFY 289
+ I+H D+K NIL R + +K+ DFG+S C G + + ++
Sbjct: 121 HSNM--IVHRDIKGANIL-----RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
SPEV+ G Y D+WS+GC +VEM T +P + E + M I ++ P L
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQL 228
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE---IMNKADVNNTYYI 183
I KG+FG V A + AIK++K K + + Q+ E +M + + + Y+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGE---SPYV 59
Query: 184 VRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
+L F +++L LV E L+ + L++ G+ + +++ ++ + L +
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH--Q 115
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 302
IIH D+KPEN+L+ +K+ DFG S + G +++ + Y +PE +LG+ D
Sbjct: 116 RGIIHRDIKPENLLIDQ--TGHLKLTDFGLS-RNGLENKKFVGTPDYLAPETILGVGDDK 172
Query: 303 AIDMWSLGCILVEMHTGEPLFSGSNEVDQM 332
D WSLGC++ E G P F + D +
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFH-AETPDAV 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 74/217 (34%), Positives = 111/217 (51%), Gaps = 16/217 (7%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL 186
IGKGSFG+V++ + Q A+K I+ K ++++++ L E A VN + IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPF-IVPL 58
Query: 187 KRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN 244
K F L LV ++ + L R F L+ R ++ +L AL L + N
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRF---DLSRARFYTAELLCALENLH--KFN 113
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QRIYQYIQSRFYRSPEVLLGIPY 300
+I+ DLKPENILL + I + DFG C+L + + + Y +PE+LLG Y
Sbjct: 114 VIYRDLKPENILL--DYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 301 DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
A+D W+LG +L EM TG P F N + KI++
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 66/237 (27%), Positives = 114/237 (48%), Gaps = 24/237 (10%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKII------KNKKPFLNQAQIEVKLLEIMNKADVNN 179
L+G GSFG V + +L++ A+K + + + + Q + E+ LL + ++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
R + ++L + EL+ +L LL+ + + R +++Q+ L +L
Sbjct: 67 YLGTEREE------DNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYL 118
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLL 296
N +H D+K NIL+ +K+ DFG + Q+ + + S ++ +PEV+
Sbjct: 119 HDR--NTVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 297 GI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP--PKHLLDGA 350
Y LA D+WSLGC ++EM TG+P +S V + KI LP P HL D A
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 72/231 (31%), Positives = 118/231 (51%), Gaps = 21/231 (9%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKADVNNTYYIV 184
+G+G++ V K VA+K I+ +++ A EV LL+ + A++ + I+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 185 RLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNL--TRKFSQQLCTALLFLSTPE 242
++ L LVFE L +L L + G S+N+ + F QL L + +
Sbjct: 74 HTEKS------LTLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIY-QYIQSRFYRSPEVLLG-I 298
++H DLKP+N+L+ +R +K+ DFG + + + Y + + +YR P++LLG
Sbjct: 125 --VLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 299 PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
Y IDMW +GCI EM TG PLF GS +Q++ I +LG P + G
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 127 IGKGSFGQV----VKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYY 182
+GKG FG+V VK C K KK A +E ++LE +N + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN------SPF 54
Query: 183 IVRLKRHFMWRNHLCLVFELLS-----YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
IV L F + HLCLV L++ Y++Y N RG+ + +S Q+ +L
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIY----NVGERGLEMERVIHYSAQITCGILH 110
Query: 238 LSTPELNIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEV 294
L ++I++ D+KPEN+LL ++ D G + +L G+ I Q + Y +PE+
Sbjct: 111 LH--SMDIVYRDMKPENVLLDDQ---GNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEI 165
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
L PY +D +++GC + EM G F E
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 74/262 (28%), Positives = 125/262 (47%), Gaps = 22/262 (8%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
D +EI +G G+FG+V KA E A KII+ + ++ ++E ++EI ++
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECK 60
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
+ IV L + + N L ++ E D + RG++ R +Q+ AL FL
Sbjct: 61 HPN-IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEVL 295
+IH DLK NILL +K+ DFG S + Q+ +I + ++ +PEV+
Sbjct: 120 H--SHKVIHRDLKAGNILLT--LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 296 L-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350
PYD D+WSLG L+E+ EP +E++ M ++++L P L +
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPMRVLLKILKSEPPTLDQPS 232
Query: 351 HKTRKYFDKMPDGSYILKKPKD 372
+ + D + S ++K P D
Sbjct: 233 KWSSSFNDFL--KSCLVKDPDD 252
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 6e-18
Identities = 91/331 (27%), Positives = 148/331 (44%), Gaps = 53/331 (16%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNK 174
D YE +G+GS+ V K VA+K+I+ ++ PF A E LL+ +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLKH 62
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
A++ + I+ K L LVFE + +L + + + G+ + F QL
Sbjct: 63 ANIVLLHDIIHTKET------LTLVFEYVHTDLCQYM-DKHPGGLHPENVKLFLFQLLRG 115
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYRS 291
L ++ + I+H DLKP+N+L+ + +K+ DFG + + Y + + +YR
Sbjct: 116 LSYIH--QRYILHRDLKPQNLLISDT--GELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171
Query: 292 PEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV-DQMNKIVEVLGLPPKHLLDG 349
P+VLLG Y +DMW +GCI VEM G F G ++ DQ+ +I VLG P + G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231
Query: 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409
H + P+ + L PK+ R+ +L H+
Sbjct: 232 VHSLPHF---KPE-RFTLYSPKNLRQ--------------------AWNKLSYVNHA--- 264
Query: 410 YLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
+DL ++L PK R++ AL H +F
Sbjct: 265 ----EDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 9e-18
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 23/228 (10%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKAD 176
Y ++GKG+FG+ E+ V K + + A E+ +L ++ +
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY----NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+ YY HFM N L + E Y LYD + + + + Q+
Sbjct: 61 II-AYY-----NHFMDDNTLLIEME---YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFY 289
+A+ ++ + I+H D+K NI L K IK+ DFG S LG + + +Y
Sbjct: 112 SAVSYIH--KAGILHRDIKTLNIFLT--KAGLIKLGDFGISKILGSEYSMAETVVGTPYY 167
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
SPE+ G+ Y+ D+W+LGC+L E+ T + F +N ++ + KIV+
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 21/235 (8%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVK-----LLEIM 172
D E +G G+FG+V D + + A+K++ + L Q Q V L E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ-HVHNEKRVLKEVS 59
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQL 231
+ +I+RL + L ++ E + L+ LRN+ S + ++ ++
Sbjct: 60 HP-------FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEI 110
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRS 291
AL +L + I++ DLKPENILL K IK+ DFG + +L R + + Y +
Sbjct: 111 VCALEYLHS--KEIVYRDLKPENILL--DKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLA 166
Query: 292 PEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
PEV+ ++ A+D W+LG ++ EM G P F N KI+ P+HL
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHL 221
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 82/248 (33%), Positives = 119/248 (47%), Gaps = 35/248 (14%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV--NNTYYIV 184
IGKGSFG+V+ A + A+K++ KK L + E K IM + +V N +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL-QKKAILKKK--EQK--HIMAERNVLLKNVKHPF 57
Query: 185 RLKRHFMWRNHLCLVFELLSYN----LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLST 240
+ H+ ++ L F L N + L R +F R ++ ++ +AL +L
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR---ARFYAAEIASALGYLH- 113
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVL 295
LNII+ DLKPENILL + + + DFG C+ G + S F Y +PEVL
Sbjct: 114 -SLNIIYRDLKPENILL--DSQGHVVLTDFGL-CKEGIEHSK-TTSTFCGTPEYLAPEVL 168
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQM--NKIVEVLGLPP------KHLL 347
PYD +D W LG +L EM G P F S + +M N + + L L P +HLL
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDTAEMYDNILNKPLRLKPNISVSARHLL 227
Query: 348 DG-AHKTR 354
+G K R
Sbjct: 228 EGLLQKDR 235
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-17
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK---KPFLNQAQIEVKLLEIMNKAD 176
+YE ++G+G+FG V +Q V IK I + K AQ E ++L++++ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSL---NLTRKFSQQLCT 233
+ Y +F+ L +V E L R SL + F Q+
Sbjct: 61 IIEYY------ENFLEDKALMIVMEYAPGG--TLAEYIQKRCNSLLDEDTILHFFVQILL 112
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRS 291
AL + T I+H DLK +NILL + + +KI DFG S L + Y + + Y S
Sbjct: 113 ALHHVHTK--LILHRDLKTQNILL-DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYIS 169
Query: 292 PEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327
PE+ G PY+ D+W+LGC+L E+ + + F +N
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 17/228 (7%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185
IG+G+FG V K +A+K I++ Q ++ + L +M ++ YIV+
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS---SDCPYIVK 67
Query: 186 LKRHFMWRNHLCLVFELLSY---NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
+ EL+ Y + + + K + AL +L E
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-E 126
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS--RFYRSPEVLL---G 297
L IIH D+KP NILL + IK+ DFG S QL I + + R Y +PE +
Sbjct: 127 LKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 298 IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV-DQMNKIVEVLGLPPK 344
YD+ D+WSLG L E+ TG+ + N V DQ+ ++V+ G PP
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 31/214 (14%)
Query: 122 EIDSLIGKGSFGQVVKAF----DLEEQCHVAIKIIK------NKKPFLNQAQIEVKLLEI 171
E+ +G+G+FG+V K + VA+K +K ++ FL +A I
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEAS-------I 54
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQ 230
M K N IVRL L +V E + +L D LR + ++L + + Q
Sbjct: 55 MKKLSHPN---IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQ 110
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR--- 287
+ + +L N +H DL N L+ +KI DFG S + + Y +
Sbjct: 111 IAKGMEYLE--SKNFVHRDLAARNCLVTENLV--VKISDFGLSRDIYEDDYYRKRGGGKL 166
Query: 288 --FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTG 319
+ +PE L + D+WS G +L E+ T
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 88/343 (25%), Positives = 156/343 (45%), Gaps = 63/343 (18%)
Query: 127 IGKGSFGQVVKAF--DLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIV 184
+G+G++G V KA D +++ A+K I+ ++ + E+ LL + +V +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNV------I 61
Query: 185 RLKRHFMWRN--HLCLVFELLSYNLYDLLR-----NTNFRGVSL--NLTRKFSQQLCTAL 235
L++ F+ + + L+F+ ++L+ +++ N + + L ++ + Q+ +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 236 LFLSTPELNIIHCDLKPENILLCN--PKRSAIKIVD------FGSSCQLGQRIYQYIQSR 287
+L ++H DLKP NIL+ P+R +KI D F S + + + +
Sbjct: 122 HYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 288 FYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNE---------VDQMNKIVE 337
+YR+PE+LLG Y AID+W++GCI E+ T EP+F E DQ+++I
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGG 397
V+G P A K + KMP+ + KD R+ S + +
Sbjct: 240 VMGFP-------ADKDWEDIRKMPEYPTL---QKDFRRTTYANSSLIKYM---------- 279
Query: 398 RRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
H V K L+ ++L DP RIT ALQ +F
Sbjct: 280 -----EKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ +EI +G G+FG+V KA + E A K+I K ++ ++E ++EI A +
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCD 60
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
+ IV+L F + N+L ++ E + D + R ++ R +Q AL +L
Sbjct: 61 HPN-IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQYIQSRFYRSPEVL 295
E IIH DLK NIL IK+ DFG S + QR +I + ++ +PEV+
Sbjct: 120 H--ENKIIHRDLKAGNILFT--LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 296 L-----GIPYDLAIDMWSLGCILVEMHTGEP 321
+ PYD D+WSLG L+EM EP
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 88/343 (25%), Positives = 154/343 (44%), Gaps = 63/343 (18%)
Query: 127 IGKGSFGQVVKAF--DLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIV 184
+G+G++G V KA D ++ A+K I+ ++ + E+ LL + +V +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNV------I 61
Query: 185 RLKRHFMWR--NHLCLVFELLSYNLYDLLR-----NTNFRGVSL--NLTRKFSQQLCTAL 235
L++ F+ + L+F+ ++L+ +++ N + V L + + Q+ +
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 236 LFLSTPELNIIHCDLKPENILLCN--PKRSAIKIVD------FGSSCQLGQRIYQYIQSR 287
+L ++H DLKP NIL+ P+R +KI D F S + + + +
Sbjct: 122 HYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 288 FYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNE---------VDQMNKIVE 337
+YR+PE+LLG Y AID+W++GCI E+ T EP+F E DQ+++I
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239
Query: 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGG 397
V+G P A K + KMP+ S ++ KD R+ + +
Sbjct: 240 VMGFP-------ADKDWEDIKKMPEHSTLM---KDFRRNTYTNCSLIKYM---------- 279
Query: 398 RRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
H V K L+ ++L DP RIT A+Q +F
Sbjct: 280 -----EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 65/251 (25%), Positives = 118/251 (47%), Gaps = 34/251 (13%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLLEIMNKADV 177
R E LIG+G++G V + + VA+KII P + + I EV LL + ++
Sbjct: 5 RLE---LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLR----NTNFRGVSLNLTRKFSQQLC 232
N I + ++ L ++ E ++ L++ + V + +++
Sbjct: 62 PN---ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVII-------REVL 111
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFY 289
AL ++ ++ +IH D+K NIL+ N +K+ DFG + L Q + ++ + ++
Sbjct: 112 VALKYIH--KVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKRSTFVGTPYW 167
Query: 290 RSPEVLL-GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG--LPPKHL 346
+PEV+ G YD D+WSLG + EM TG P +S VD + + ++ PP+
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD---VDAF-RAMMLIPKSKPPRLE 223
Query: 347 LDGAHKTRKYF 357
+G K + F
Sbjct: 224 DNGYSKLLREF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 79/273 (28%), Positives = 119/273 (43%), Gaps = 40/273 (14%)
Query: 125 SLIGKGSFGQVVKAFDLEEQCHVAIKII----------KNKKPFLNQAQIEVKLLEIMNK 174
+LIG GSFG V + +A+K + K+ L+ E+ LL+ +
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
+ IV+ + +HL + E + L N N+ L R F +Q+
Sbjct: 66 EN------IVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKG 118
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL----------GQRIYQYI 284
L +L IIH D+K NIL+ N + IKI DFG S +L G R +
Sbjct: 119 LNYLHNR--GIIHRDIKGANILVDN--KGGIKISDFGISKKLEANSLSTKTNGAR--PSL 172
Query: 285 Q-SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE-VLGLP 342
Q S F+ +PEV+ Y D+WSLGC++VEM TG+ F ++ + KI E
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232
Query: 343 PKHLLDGA-HKTRKYFD----KMPDGSYILKKP 370
P ++ A K F+ K P + +LK P
Sbjct: 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-16
Identities = 56/237 (23%), Positives = 109/237 (45%), Gaps = 23/237 (9%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMNKADVNNTY 181
+G G+F +A D++ +A+K + + K + +M + + +
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH-- 64
Query: 182 YIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP 241
I+R+ +H L E ++ L + + + +++QL L +L
Sbjct: 65 -IIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLH-- 120
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-------QYIQSRFYRSPEV 294
E IIH D+K N+L+ + + ++I DFG++ +L + Q + + + +PEV
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQR-LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSG---SNEVDQMNKIVEVLGLP--PKHL 346
L G Y + D+WS+GC+++EM T +P ++ SN + + KI P P+HL
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 11/222 (4%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
L +E+ +G GSFG+V A + AIK +K K+ L Q++ E ++
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK-KREILKMKQVQHVAQEKSILMEL 75
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFE-LLSYNLYDLLRNTNFRGVSLNLTRKF-SQQLCTAL 235
++ + IV + F N + + E ++ L+ LR G N KF +L A
Sbjct: 76 SHPF-IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAF 131
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVL 295
+L +II+ DLKPEN+LL + +K+ DFG + ++ R + + Y +PEV+
Sbjct: 132 EYLH--SKDIIYRDLKPENLLL--DNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVI 187
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+ A+D W++G +L E G P F KI+
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229
|
Length = 329 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 6e-16
Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ---AQIEVKLLEIMNKAD 176
RYEI IG+GSFG++ A + H IK I K + + ++ EV LL M +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF-RGVSLNLTRKFSQQLCTAL 235
IV F L +V E DL++ N RGV + + S + +L
Sbjct: 61 ------IVTFFASFQENGRLFIVMEYCDGG--DLMKRINRQRGVLFSEDQILSWFVQISL 112
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSRFYRSP 292
+ I+H D+K +NI L A K+ DFG + QL + Y + + +Y SP
Sbjct: 113 GLKHIHDRKILHRDIKSQNIFLSKNGMVA-KLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 293 EVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327
E+ PY+ D+WSLGC+L E+ T + F G+N
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 8e-16
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK-NKKPFLNQAQIEVKLLEIMNKAD 176
+ YE+ IG G++G V KA D+ VAIK+IK Q E+ ++ +
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEI---SMLKECR 58
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY----NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
N IV ++ R+ L +V E Y +L D+ + T +S ++
Sbjct: 59 HPN---IVAYFGSYLRRDKLWIVME---YCGGGSLQDIYQVTR-GPLSELQIAYVCRETL 111
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFY 289
L +L E IH D+K NILL + +K+ DFG S QL I + +I + ++
Sbjct: 112 KGLAYLH--ETGKIHRDIKGANILLT--EDGDVKLADFGVSAQLTATIAKRKSFIGTPYW 167
Query: 290 RSPEVL---LGIPYDLAIDMWSLGCILVEMHTGEP 321
+PEV YD D+W+LG +E+ +P
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-16
Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 31/230 (13%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII-------KNKKPFLNQAQIEVKLLEIMN 173
+EI + IGKGSFG V K ++ A+K I + ++ +++A++ KL
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL----- 56
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
++ YI+R F+ + L +V E +L+ LL+ R + + +F Q+
Sbjct: 57 -----DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG------SSCQLGQRIYQYIQS 286
L L + + I+H D+K N+ L +KI D G + I + +
Sbjct: 112 LGLAHLHSKK--ILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNTNFANTI---VGT 164
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
+Y SPE+ PY+ D+W+LG +L E TG+ F +N+ + KI+
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 76/240 (31%), Positives = 118/240 (49%), Gaps = 28/240 (11%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV--NNTYYI 183
+IGKGSFG+V+ A E+ A+K+++ KK L + + + IM++ +V N +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQ-KKAILKKKEEK----HIMSERNVLLKNVKHP 56
Query: 184 VRLKRHFMWRNHLCLVFELLSYN----LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
+ HF ++ L F L N Y L R F R ++ ++ +AL +L
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR---ARFYAAEIASALGYLH 113
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEVLL 296
+ LNI++ DLKPENILL + I + DFG + + + + Y +PEVL
Sbjct: 114 S--LNIVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH 169
Query: 297 GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV-EVLGLPP------KHLLDG 349
PYD +D W LG +L EM G P F N + + I+ + L L P +HLL+G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 25/232 (10%)
Query: 125 SLIGKGSFGQVVKAFDLEEQCH---VAIKIIKNKKPFLNQ-----AQIEVKLLEIMNKAD 176
++GKG +G+V + + A+K++K NQ + E +LE +
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP- 60
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFS-QQLCTAL 235
+IV L F L L+ E LS +L + G+ + T F ++ AL
Sbjct: 61 -----FIVDLIYAFQTGGKLYLILEYLSGG--ELFMHLEREGIFMEDTACFYLSEISLAL 113
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSP 292
L II+ DLKPENILL + +K+ DFG S G + + + Y +P
Sbjct: 114 EHLHQ--QGIIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 293 EVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV-LGLPP 343
E+L+ + A+D WSLG ++ +M TG P F+ N ++KI++ L LPP
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP 221
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 69/229 (30%), Positives = 101/229 (44%), Gaps = 21/229 (9%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK-----NKKPFLN-QAQIEVKLLEIMN 173
RY + +GKGSFG V D + +K++K P QA E +LL ++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
IV+ F+ R+ C++ E +L L G +L+ + +
Sbjct: 61 HPA------IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS-ENQVCEWFI 113
Query: 233 TALLFLS-TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRF 288
LL + + I+H DLK +NI L K + +KI DFG S L + + +
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFL---KNNLLKIGDFGVSRLLMGSCDLATTFTGTPY 170
Query: 289 YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
Y SPE L YD D+WSLGCIL EM F G N + + +IVE
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 36/223 (16%)
Query: 122 EIDSLIGKGSFGQVVKAF----DLEEQCHVAIKIIKN------KKPFLNQAQIEVKLLEI 171
+ +G+G+FG+V K ++ VA+K +K + FL +A I
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREA-------RI 54
Query: 172 MNKADVNNTYYIVRLK---RHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKF 227
M K D N IV+L L +V E + +L D LR + +SL+ F
Sbjct: 55 MRKLDHPN---IVKLLGVCTE---EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSF 108
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR 287
+ Q+ + +L N IH DL N L+ +KI DFG S L Y ++
Sbjct: 109 ALQIARGMEYLE--SKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDYYKVKGG 164
Query: 288 ----FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSG 325
+ +PE L + D+WS G +L E+ T GE + G
Sbjct: 165 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPG 207
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 52/218 (23%), Positives = 84/218 (38%), Gaps = 48/218 (22%)
Query: 127 IGKGSFGQVVKAF---DLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYI 183
+G+G+FG+V K + VA+K +K + +K +M K N +
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF-LKEARVMKKLGHPN---V 58
Query: 184 VRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR-------KFSQQ 230
VRL + L LV E + +L D LR + S + F+ Q
Sbjct: 59 VRLLGVCTEEE-----PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR 290
+ + +L+ +H DL N L+ +KI DFG L + +Y +YR
Sbjct: 114 IAKGMEYLA--SKKFVHRDLAARNCLVGEDLV--VKISDFG----LSRDVYDD---DYYR 162
Query: 291 ------------SPEVLLGIPYDLAIDMWSLGCILVEM 316
+PE L + D+WS G +L E+
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 20/231 (8%)
Query: 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEV-----KLLEIMNKADVNN 179
+++G+G FG+V+ A + AIK +K K + + ++E ++ E N
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKALK-KGDIIARDEVESLMCEKRIFETANSE---R 60
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
++V L F +H+C V E + DL+ + + S ++ + L +L
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQSRFYRSPEVL 295
E I++ DLK +N+LL +KI DFG C+ G R + + + +PEVL
Sbjct: 119 --ENKIVYRDLKLDNLLL--DTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAPEVL 173
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
Y A+D W LG ++ EM GE F G +E + + IV P+ L
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 224
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 73/244 (29%), Positives = 110/244 (45%), Gaps = 16/244 (6%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185
++GKGSFG+V+ A AIK +K K L +E ++E A ++
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK-KDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 186 LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRG-VSLNLTRKFSQQLCTALLFLSTPELN 244
L F + HL V E L N DL+ + G R ++ ++ L FL
Sbjct: 61 LFCTFQTKEHLFFVMEYL--NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK--G 116
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGIP 299
II+ DLK +N+LL K IKI DFG C+ + S F Y +PE+L G
Sbjct: 117 IIYRDLKLDNVLL--DKDGHIKIADFGM-CKE-NMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT-RKYFD 358
Y+ ++D WS G +L EM G+ F G +E + + I+ P+ + A K F+
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFE 232
Query: 359 KMPD 362
+ P
Sbjct: 233 RDPT 236
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 17/225 (7%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK-NKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185
+G G+ G V K +A+K I+ + Q QI ++ L+I++K N+ YIV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQI-LRELDILHKC---NSPYIVG 63
Query: 186 LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNI 245
F + + E + D + + + K + + L +L + I
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE-KHKI 122
Query: 246 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-YIQSRFYRSPEVLLGIPYDLAI 304
IH D+KP NIL+ R IK+ DFG S QL + + ++ + Y +PE + G Y +
Sbjct: 123 IHRDVKPSNILV--NSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKS 180
Query: 305 DMWSLGCILVEMHTGEPLFSGSNE-----VDQMNKIVEVLGLPPK 344
D+WSLG L+E+ TG + N+ + + IV PP+
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN--EPPPR 223
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIMNKA 175
+E+ +IGKG+FG+V + + A+K + NK+ + + + E ++L+ +N
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYM-NKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELL-SYNL-YDLLRNTNFRGVSLNLTRKFSQQLCT 233
++V L F ++ LV +LL +L Y L + F S + + ++
Sbjct: 61 ------FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKF---SEEQVKFWICEIVL 111
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRS 291
AL +L IIH D+KP+NILL ++ + I DF + ++ + Y +
Sbjct: 112 ALEYLH--SKGIIHRDIKPDNILL--DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMA 167
Query: 292 PEVLLGIPYDLAIDMWSLGCILVEMHTG 319
PEVL Y +A+D WSLG E G
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 19/236 (8%)
Query: 121 YEIDSLIGKGSFGQVVKA-FDLEEQCHVAIKIIKNKKPFLNQAQIE--------VKLLEI 171
Y + +G G+FG V K Q +A+K I P + + E V + I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTR--KFS 228
+ K + + IVR + F+ + L +V +L+ L + + + R
Sbjct: 62 I-KEQLRHPN-IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 229 QQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQS 286
Q+ AL +L E I+H DL P NI+L + + I DFG + Q + +
Sbjct: 120 VQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQKQPESKLTSVVGT 176
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342
Y PE++ PY D+W+ GCIL +M T +P F +N + KIVE + P
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 26/227 (11%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK-----NKKPFLNQAQIEVKLLEIM 172
L ++I+ IGKG F V KA L + VA+K ++ + K + + E+ LL+ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR--KFSQ 229
+ + +++ F+ N L +V EL +L ++++ + + K+
Sbjct: 60 DHPN------VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV 113
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQS 286
QLC+AL + I+H D+KP N+ + +K+ D G + + + +
Sbjct: 114 QLCSALEHMH--SKRIMHRDIKPANVFIT--ATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 333
+Y SPE + Y+ D+WSLGC+L EM + F G D+MN
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 67/239 (28%), Positives = 115/239 (48%), Gaps = 26/239 (10%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE----IMNKADVNNTYY 182
IGKGSFG+V K D Q VAIKII L +A+ E++ ++ ++++ D + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD---SPY 63
Query: 183 IVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP 241
+ + ++ L ++ E L + DLLR F + K ++ L +L +
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSE 120
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGI 298
+ IH D+K N+LL ++ +K+ DFG + QL + ++ + F+ +PEV+
Sbjct: 121 KK--IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 299 PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYF 357
YD D+WSLG +E+ GEP ++++ M + + P L K K F
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP---PNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEF 232
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 62/246 (25%), Positives = 119/246 (48%), Gaps = 31/246 (12%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK------NKKPFLNQAQIEVKLLEIMNK 174
+ + L+G+G+FG+V +D + +A+K ++ +N + E++LL+ +
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
+ Y +R L + E + ++ D L++ + ++ N+TRK+++Q+
Sbjct: 64 ERIVQYYGCLRDPME----RTLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILE 117
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS------CQLGQRIYQYIQSR 287
+ +L + I+H D+K NIL +K+ DFG+S C G + +
Sbjct: 118 GVSYLHSNM--IVHRDIKGANIL--RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP----- 342
++ SPEV+ G Y D+WS+GC +VEM T +P ++ E + M I ++ P
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVL 230
Query: 343 PKHLLD 348
P H+ D
Sbjct: 231 PPHVSD 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 72/228 (31%), Positives = 112/228 (49%), Gaps = 22/228 (9%)
Query: 127 IGKGSFGQVVKA-FDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIMNKADVNNT 180
+G GSFG+V+ A + E+ VAIK + K + Q Q+ E K+L +N
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSK-IIKQKQVDHVFSERKILNYINHP----- 91
Query: 181 YYIVRLKRHFMWRNHLCLVFE-LLSYNLYDLLR-NTNFRGVSLNLTRKFSQQLCTALLFL 238
+ V L F ++L LV E ++ + LR N F ++ ++ Q+ L+F
Sbjct: 92 -FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---DVGCFYAAQI--VLIFE 145
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI 298
LNI++ DLKPEN+LL K IK+ DFG + + R Y + Y +PE+LL +
Sbjct: 146 YLQSLNIVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNV 203
Query: 299 PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
+ A D W+LG + E+ G P F + + KI+E + PK L
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFL 251
|
Length = 340 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 68/226 (30%), Positives = 110/226 (48%), Gaps = 18/226 (7%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185
+IGKGSFG+V+ A + A+K+++ K + Q + + ++ + + +V
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF-LVG 60
Query: 186 LKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL 243
L F L V + ++ + L R F R ++ ++ +A+ +L + L
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR---ARFYAAEVASAIGYLHS--L 115
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QRIYQYIQSRFYRSPEVLLGIP 299
NII+ DLKPENILL + + + DFG C+ G + + + Y +PEVL P
Sbjct: 116 NIIYRDLKPENILL--DSQGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQM--NKIVEVLGLPP 343
YD +D W LG +L EM G P F S +V QM N + + L LP
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFY-SRDVSQMYDNILHKPLQLPG 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 84/336 (25%), Positives = 133/336 (39%), Gaps = 82/336 (24%)
Query: 120 RYEIDSL--IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKA 175
R +D+ IG+GS G V A D VA+K + +K Q + E+ E IM
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDY 73
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
N IV + ++ + L +V E L L D++ +T ++ + A
Sbjct: 74 QHPN---IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKA 127
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRS 291
L FL +IH D+K ++ILL + R +K+ DFG Q+ + + + + + ++ +
Sbjct: 128 LSFLHAQ--GVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183
Query: 292 PEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351
PEV+ +PY +D+WSLG +++EM GEP
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEP------------------------------ 213
Query: 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYL 411
YF++ P L+ K R P + LH VS L
Sbjct: 214 ---PYFNEPP-----LQAMKRIRDNLPPKLKNLH--------------------KVSPRL 245
Query: 412 KFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
+ + RML DP R T L H F + S
Sbjct: 246 --RSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK--PFLNQAQIEVKLLEIMNKAD 176
D YE+ +IG G+ V A L VAIK I +K +++ + EV+ + N +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGV-SLNLTRKFSQQLCTA 234
V Y F+ + L LV LS +L D+++++ RG + +++
Sbjct: 61 VVKYY------TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRI----YQYIQSR 287
L +L + IH D+K NILL ++KI DFG S L G R ++ +
Sbjct: 115 LEYLHSNGQ--IHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 288 FYRSPEVL-LGIPYDLAIDMWSLGCILVEMHTGEPLFS 324
+ +PEV+ YD D+WS G +E+ TG +S
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 16/238 (6%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
D +EI IGKG++G+V K + + A+KI+ + + E +L+ ++
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
+Y + K+ + L LV EL + ++ DL++ RG + + L AL+
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME-EPIIAYILHEALMG 136
Query: 238 LSTPELN-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPE 293
L +N IH D+K NILL +K+VDFG S QL R + + F+ +PE
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194
Query: 294 VL-----LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
V+ L YD D+WSLG +E+ G+P + ++ M + ++ PP L
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA---DLHPMRALFKIPRNPPPTL 249
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 1e-13
Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 37/223 (16%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCH----VAIKIIKN------KKPFLNQAQIEVKLLEI 171
+ +G+G+FG+V K + VA+K +K + FL +A I
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREA-------RI 54
Query: 172 MNKADVNNTYYIVRLK---RHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKF 227
M K D N +V+L L +V E + +L LR +SL+ F
Sbjct: 55 MRKLDHPN---VVKLLGVCTE---EEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSF 107
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR 287
+ Q+ + +L N IH DL N L+ +KI DFG S L Y +
Sbjct: 108 ALQIARGMEYLE--SKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDYYRKRGG 163
Query: 288 ----FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSG 325
+ +PE L + D+WS G +L E+ T GE + G
Sbjct: 164 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 206
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 39/221 (17%)
Query: 126 LIGKGSFGQVV--------KAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
++GKG FG+V K + ++ IK K + LN+ QI K+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV--------- 57
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFEL-----LSYNLYDLLRNTNF---RGVSLNLTRKFSQ 229
N+ ++V L + ++ LCLV L L +++Y++ N F R V ++
Sbjct: 58 -NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVF------YAA 109
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSR 287
++ L L I++ DLKPENILL I+I D G + ++ G+ I + +
Sbjct: 110 EITCGLEDLHRE--RIVYRDLKPENILL--DDYGHIRISDLGLAVEIPEGETIRGRVGTV 165
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
Y +PEV+ Y + D W LGC++ EM G+ F E
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 71/243 (29%), Positives = 115/243 (47%), Gaps = 16/243 (6%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185
++GKGSFG+V+ A + + A+K +K K L +E ++E A ++
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALK-KDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 186 LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRK--FSQQLCTALLFLSTPEL 243
L F + HL V E L N DL+ + +G +L R ++ ++ L FL +
Sbjct: 61 LYCTFQTKEHLFFVMEFL--NGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSK-- 115
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQ-RIYQYIQSRFYRSPEVLLGIP 299
II+ DLK +N++L + IKI DFG C+ G R + + Y +PE+L G+
Sbjct: 116 GIIYRDLKLDNVML--DRDGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI-VEVLGLPPKHLLDGAHKTRKYFD 358
Y ++D WS G +L EM G+ F G +E + I V+ P + K F+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFE 232
Query: 359 KMP 361
+ P
Sbjct: 233 RDP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 11/211 (5%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK-NKKPFLNQAQIEVKLLEIMNKADVNNT 180
E S +G G+ G V K + +A K++ K + + QI ++ L+IM++ +
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV-RKQI-LRELQIMHEC---RS 62
Query: 181 YYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLST 240
YIV F+ N++C+ E + D + + + + K + + L +L
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-YIQSRFYRSPEVLLGIP 299
I+H D+KP NIL+ + R IK+ DFG S +L I ++ + Y SPE + G
Sbjct: 122 -VHRIMHRDIKPSNILVNS--RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGK 178
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVD 330
Y + D+WSLG ++E+ G+ F+ SN D
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 62/244 (25%), Positives = 117/244 (47%), Gaps = 34/244 (13%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----------LNQAQIEVKLLE 170
+ + L+G+G+FG+V +D + +A+K + PF +N + E++LL+
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQV----PFDPDSQETSKEVNALECEIQLLK 59
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQ 229
+ + Y +R L + E + ++ D L+ + ++ N+TR++++
Sbjct: 60 NLRHDRIVQYYGCLRDPE----EKKLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTR 113
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS------CQLGQRIYQY 283
Q+ + +L + I+H D+K NIL +K+ DFG+S C G I
Sbjct: 114 QILQGVSYLHSNM--IVHRDIKGANIL--RDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169
Query: 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343
+ ++ SPEV+ G Y D+WS+ C +VEM T +P ++ E + M I ++ P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA---EYEAMAAIFKIATQPT 226
Query: 344 KHLL 347
K +L
Sbjct: 227 KPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 39/221 (17%)
Query: 126 LIGKGSFGQV----VKAFDLEEQCH-VAIKIIKNKKP---FLNQAQIEVKLLEIMNKADV 177
++GKG FG+V V+A C + K IK +K LN+ +I K+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV--------- 57
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFEL-----LSYNLYDLLRNTNF---RGVSLNLTRKFSQ 229
N+ ++V L + ++ LCLV + L +++Y++ N F R + ++
Sbjct: 58 -NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDEQRAIF------YAA 109
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSR 287
+LC L L I++ DLKPENILL + R I+I D G + Q+ G+ + + +
Sbjct: 110 ELCCGLEDLQRER--IVYRDLKPENILLDD--RGHIRISDLGLAVQIPEGETVRGRVGTV 165
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
Y +PEV+ Y + D W LGC++ EM G+ F E
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNT 180
+E+ L+G G++GQV K ++ AIK++ + + E+ +L+ + T
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 181 YYIVRLKRHFM-WRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
YY +K++ + L LV E + ++ DL++NT + +++ L L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVL 295
+ +IH D+K +N+LL + + +K+VDFG S QL + R +I + ++ +PEV+
Sbjct: 128 H--QHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 296 L-----GIPYDLAIDMWSLGCILVEMHTGEP 321
YD D+WSLG +EM G P
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 27/273 (9%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
D +EI IGKG++G+V K + ++ A+KI+ + + E +L+ +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
+Y + K + L LV EL + ++ +L++ G L+ S L ALL
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD-EAMISYILYGALLG 140
Query: 238 LSTPELN-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPE 293
L N IIH D+K NILL +K+VDFG S QL R + + F+ +PE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 294 VL-----LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348
V+ YD D+WSLG +E+ G+P + V + KI PP LL
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPTLLH 255
Query: 349 GAHKTRKY-----------FDKMPDGSYILKKP 370
R + F+ P +++L+ P
Sbjct: 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 13/216 (6%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185
++GKGSFG+V+ A AIK++K K L ++ + E A ++
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLK-KDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 186 LKRHFMWRNHLCLVFELLSYNLYDLL-RNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN 244
L F ++ L V E + N DL+ + R +R ++ ++ AL+FL
Sbjct: 61 LHCCFQTKDRLFFVMEYV--NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH--G 116
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QRIYQYIQSRFYRSPEVLLGIPY 300
+I+ DLK +NILL K+ DFG C+ G + + Y +PE+L + Y
Sbjct: 117 VIYRDLKLDNILL--DAEGHCKLADFGM-CKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 301 DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
++D W+LG ++ EM G+P F NE D I+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 27/229 (11%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIK---IIKNKKPFLNQAQIEVKLLEIMNKAD 176
+Y IG+GSFG+ + E+ IK I K +++ EV +L M +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF-RGVSLNLTRKFSQ--QLCT 233
IV+ + F +L +V + DL + N RGV + Q+C
Sbjct: 61 ------IVQYQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQILDWFVQICL 112
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG------SSCQLGQRIYQYIQSR 287
AL + + I+H D+K +NI L K IK+ DFG S+ +L + I +
Sbjct: 113 ALKHVH--DRKILHRDIKSQNIFLT--KDGTIKLGDFGIARVLNSTVELARTC---IGTP 165
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
+Y SPE+ PY+ D+W+LGC+L EM T + F N + + KI+
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY-YIV 184
L+GKG+FG+V+ + + A+KI+K K+ + + ++ L E N+ N+ + ++
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTE--NRVLQNSRHPFLT 58
Query: 185 RLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
LK F + LC V E + + L R F S + R + ++ +AL +L + E
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF---SEDRARFYGAEIVSALDYLHS-E 114
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEVLLGIP 299
N+++ DLK EN++L K IKI DFG + G + + + Y +PEVL
Sbjct: 115 KNVVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 300 YDLAIDMWSLGCILVEMHTGE-PLFSGSNE 328
Y A+D W LG ++ EM G P ++ +E
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 68/249 (27%), Positives = 121/249 (48%), Gaps = 38/249 (15%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL 186
IG+GS G V A + VA+K + +K Q + E+ E++ D ++ +V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHEN-VVDM 84
Query: 187 KRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCT-------ALLFL 238
++ + L +V E L L D++ +T R +Q+ T AL +L
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHT----------RMNEEQIATVCLSVLRALSYL 134
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRSPEVL 295
+IH D+K ++ILL + R IK+ DFG Q+ + + + + + ++ +PEV+
Sbjct: 135 HNQ--GVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI 190
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT-- 353
+PY +D+WSLG +++EM GEP + + M +I + LPP+ + +HK
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD--NLPPR--VKDSHKVSS 246
Query: 354 --RKYFDKM 360
R + D M
Sbjct: 247 VLRGFLDLM 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 119 DRYEIDSLIGKGSFG--QVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKAD 176
+++ SL+G+G FG QVV+ + A+K++K K L Q + E +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIY--AMKVMK-KSVLLAQETV-SFFEEERDILS 56
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
++N+ +I +L+ F +++L LV E +L LL N ++ + + +L A+
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-NRYEDQFDEDMAQFYLAELVLAI 115
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------Y 289
S ++ +H D+KPEN+L+ + IK+ DFGS+ +L + + S+ Y
Sbjct: 116 H--SVHQMGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTAN--KMVNSKLPVGTPDY 169
Query: 290 RSPEVLLGI------PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
+PEVL + Y + D WSLG I EM G F N I+
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 19/221 (8%)
Query: 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIV 184
++GKGSFG+V+ A AIKI+K K + +E ++E A + ++
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILK-KDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 185 RLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
+L F + L V E ++ +Y + + F+ ++ ++ L FL
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF---YAAEISVGLFFLH--R 119
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YRSPEVLL 296
II+ DLK +N++L IKI DFG C+ + + + +R Y +PE++
Sbjct: 120 RGIIYRDLKLDNVML--DSEGHIKIADFGM-CK--EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 297 GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
PY ++D W+ G +L EM G+P F G +E + I+E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 31/236 (13%)
Query: 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIV 184
++GKGSFG+V+ A AIKI+K K + +E ++E A ++
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILK-KDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 185 RLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ--------QLCTALL 236
+L F + L V E + N DL+ + G KF + ++ L
Sbjct: 65 QLHSCFQTMDRLYFVMEYV--NGGDLMYHIQQVG-------KFKEPHAVFYAAEIAIGLF 115
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YR 290
FL + II+ DLK +N++L IKI DFG C+ + I+ +R Y
Sbjct: 116 FLHSK--GIIYRDLKLDNVML--DAEGHIKIADFGM-CK--ENIFGGKTTRTFCGTPDYI 168
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
+PE++ PY ++D W+ G +L EM G+P F G +E + I+E PK L
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 14/211 (6%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNT 180
+E+ ++G G++GQV K ++ AIK++ + + ++E+ +L+ + T
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 181 YYIVRLKRHFMWRN-HLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
YY +K+ + L LV E + ++ DL++NT + + +++ L L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVL 295
+ +IH D+K +N+LL + + +K+VDFG S QL + R +I + ++ +PEV+
Sbjct: 138 HAHK--VIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193
Query: 296 L-----GIPYDLAIDMWSLGCILVEMHTGEP 321
YD D+WSLG +EM G P
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE----IMNKADVNNTYY 182
IGKGSFG+V K D + VAIKII L +A+ E++ ++ ++++ D + Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD---SPY 63
Query: 183 IVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP 241
I R ++ L ++ E L + DLL+ + + ++ L +L +
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR---EILKGLDYLHSE 120
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGI 298
IH D+K N+LL ++ +K+ DFG + QL + ++ + F+ +PEV+
Sbjct: 121 RK--IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 299 PYDLAIDMWSLGCILVEMHTGEPLFS 324
YD D+WSLG +E+ GEP S
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 30/202 (14%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL 186
+G G+ G V KA+ L + +A+K+I Q QI + LEI+ K D + YI+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQI-MSELEILYKCD---SPYIIGF 64
Query: 187 KRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQL--------CTALLFL 238
F N + + E + G SL++ RK + + L +L
Sbjct: 65 YGAFFVENRISICTEFMD-------------GGSLDVYRKIPEHVLGRIAVAVVKGLTYL 111
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-YIQSRFYRSPEVLLG 297
+ L I+H D+KP N+L+ R +K+ DFG S QL I + Y+ + Y +PE + G
Sbjct: 112 WS--LKILHRDVKPSNMLV--NTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISG 167
Query: 298 IPYDLAIDMWSLGCILVEMHTG 319
Y + D+WSLG +E+ G
Sbjct: 168 EQYGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 73/242 (30%), Positives = 114/242 (47%), Gaps = 51/242 (21%)
Query: 126 LIGKGSFGQV--VKAFDLEEQCHV-AIKIIKNKKPFLN-----QAQIEVKLLEIMNKADV 177
++G+GSFG+V V+ + + A+K++K K L + ++E +L A+V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK--KATLKVRDRVRTKMERDIL-----AEV 55
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTR------------ 225
N+ + IV+L F L L+ + L RG L TR
Sbjct: 56 NHPF-IVKLHYAFQTEGKLYLILDFL-------------RGGDL-FTRLSKEVMFTEEDV 100
Query: 226 KFS-QQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIY 281
KF +L AL L + L II+ DLKPENILL + IK+ DFG S + ++ Y
Sbjct: 101 KFYLAELALALDHLHS--LGIIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEKKAY 156
Query: 282 QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV-LG 340
+ + Y +PEV+ + + D WS G ++ EM TG F G + + M I++ LG
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG 216
Query: 341 LP 342
+P
Sbjct: 217 MP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 85/328 (25%), Positives = 130/328 (39%), Gaps = 70/328 (21%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY 181
E+ L G+G+ G V K A+K I Q QI ++ LEI +
Sbjct: 5 ELSRL-GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQI-LRELEINKSC---KSP 59
Query: 182 YIVRLKRHFMWRNHLCLVFELLSY-------NLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
YIV+ F+ + + Y ++Y ++ R + + K ++ +
Sbjct: 60 YIVKYYGAFL-DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKG 117
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-QYIQSRFYRSPE 293
L +L IIH D+KP NILL ++ +K+ DFG S +L + + + FY +PE
Sbjct: 118 LSYLH--SRKIIHRDIKPSNILLT--RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPE 173
Query: 294 VLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353
+ G PY + D+WSLG L+E+ F E L P LL
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP----------LGPIELL------ 217
Query: 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413
SYI+ P P L D EPG+ + +F
Sbjct: 218 ----------SYIVNMP-------NP---ELKD---------------EPGNGIKWSEEF 242
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFK 441
KD I + L+ DP R TP+ L+H + K
Sbjct: 243 KDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 126 LIGKGSFGQV----VKAFDLEEQC-HVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADV 177
++GKG FG+V V+A C + K IK +K LN+ QI K+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV--------- 57
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFEL-----LSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
N+ ++V L + ++ LCLV + L +++Y N G ++ ++
Sbjct: 58 -NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY----NMGNPGFEEERALFYAAEIL 112
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYR 290
L L N ++ DLKPENILL I+I D G + ++ G+ I + + Y
Sbjct: 113 CGLEDLH--RENTVYRDLKPENILL--DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYM 168
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
+PEVL Y L+ D W LGC++ EM G+ F G E
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 19/211 (9%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY-YIV 184
L+GKG+FG+V+ + + A+KI+K K+ + + ++ L E ++ N + ++
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTE--SRVLKNTRHPFLT 58
Query: 185 RLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
LK F ++ LC V E ++ + L R F S + TR + ++ +AL +L + +
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVF---SEDRTRFYGAEIVSALDYLHSGK 115
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QRIYQYIQSRFYRSPEVLLGI 298
I++ DLK EN++L K IKI DFG C+ G + + + Y +PEVL
Sbjct: 116 --IVYRDLKLENLML--DKDGHIKITDFGL-CKEGITDAATMKTFCGTPEYLAPEVLEDN 170
Query: 299 PYDLAIDMWSLGCILVEMHTGE-PLFSGSNE 328
Y A+D W LG ++ EM G P ++ +E
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 64/242 (26%), Positives = 118/242 (48%), Gaps = 24/242 (9%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL 186
IG+GS G V A + VA+K++ +K Q + E+ E++ D + +V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQH-QNVVEM 83
Query: 187 KRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNI 245
+ ++ L ++ E L L D++ T + + + AL +L + +
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV---CESVLQALCYLHSQ--GV 138
Query: 246 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRSPEVLLGIPYDL 302
IH D+K ++ILL R +K+ DFG Q+ + + + + + ++ +PEV+ PY
Sbjct: 139 IHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 303 AIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT----RKYFD 358
+D+WSLG +++EM GEP + + V M ++ + PPK L AHK R + +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD--SPPPK--LKNAHKISPVLRDFLE 252
Query: 359 KM 360
+M
Sbjct: 253 RM 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 25/209 (11%)
Query: 126 LIGKGSFGQVVKA-FDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV--NNTYY 182
+IGKGSFG+V+ A L+ +C+ A+K+++ KK LN+ + + IM + +V N +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCY-AVKVLQ-KKIVLNRKEQK----HIMAERNVLLKNVKH 55
Query: 183 IVRLKRHFMWRNHLCLVFELLSYN----LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
+ H+ ++ L F L N + L R +F R ++ ++ +AL +L
Sbjct: 56 PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR---ARFYAAEIASALGYL 112
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ----YIQSRFYRSPEV 294
+ +NI++ DLKPENILL + + + DFG C+ G + + Y +PEV
Sbjct: 113 HS--INIVYRDLKPENILL--DSQGHVVLTDFGL-CKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLF 323
+ PYD +D W LG +L EM G P F
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 31/224 (13%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185
++GKGSFG+V A AIK +K K L +E ++E + ++
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 186 LKRHFMWRNHLCLVFELL----------SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
L F + +L V E L S + +DL R T + + ++ L
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY-----------AAEIICGL 109
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQ-RIYQYIQSRFYRS 291
FL + I++ DLK +NILL IKI DFG C+ LG + + + Y +
Sbjct: 110 QFLHSK--GIVYRDLKLDNILL--DTDGHIKIADFGM-CKENMLGDAKTCTFCGTPDYIA 164
Query: 292 PEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
PE+LLG Y+ ++D WS G +L EM G+ F G +E + I
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 6e-12
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE----IMNKADVNNTYY 182
IGKGSFG+V K D Q VAIKII L +A+ E++ ++ ++++ D + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD---SPY 63
Query: 183 IVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP 241
+ + ++ L ++ E L + DLL + + ++ L +L +
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHSE 120
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGI 298
+ IH D+K N+LL + +K+ DFG + QL + ++ + F+ +PEV+
Sbjct: 121 KK--IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 299 PYDLAIDMWSLGCILVEMHTGEP 321
YD D+WSLG +E+ GEP
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 66/239 (27%), Positives = 110/239 (46%), Gaps = 25/239 (10%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIE--VKLLEIMNKAD 176
D E+ +GKG++G V K +A+K I+ + L++++ + L+I++KA
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKA- 56
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLR--NTNFRGVSLNLTRKFSQQLCTA 234
+ YIV F + + E + D L G+ ++ R+ + +
Sbjct: 57 --VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY-IQSRFYRSPE 293
L FL E NIIH D+KP N+ L N +K+ DFG S L + + I + Y +PE
Sbjct: 115 LKFLKE-EHNIIHRDVKPTNV-LVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPE 171
Query: 294 VLLG------IPYDLAIDMWSLGCILVEMHTGE---PLFSGSNEVDQMNKIVEVLGLPP 343
+ Y + D+WSLG ++EM G P + +N Q++ IV+ G PP
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPP 228
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 22/231 (9%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
L+ E IG G+ GQV K + +A+K ++ +I + L +++ K+
Sbjct: 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL-DVVLKS-- 70
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
++ YIV+ +F+ + + + EL+S L LL+ + ++ K + + AL +
Sbjct: 71 HDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHY 129
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR-----FYRSP 292
L + +IH D+KP NILL +K+ DFG S G+ + ++R Y +P
Sbjct: 130 LKE-KHGVIHRDVKPSNILL--DASGNVKLCDFGIS---GRLVDSKAKTRSAGCAAYMAP 183
Query: 293 EVLLGIP-----YDLAIDMWSLGCILVEMHTGEPLFSGSN-EVDQMNKIVE 337
E + P YD+ D+WSLG LVE+ TG+ + E + + KI++
Sbjct: 184 E-RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 63/241 (26%), Positives = 119/241 (49%), Gaps = 35/241 (14%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIK------NKKPFLNQAQIEVKLLEIMNKADVNN 179
L+G+G+FG+V +D++ +A K ++ ++ + E++LL+ + +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 180 TYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
Y +R + L + E + ++ D L+ + ++ ++TRK+++Q+ + +L
Sbjct: 69 YYGCLRDRAE----KTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYL 122
Query: 239 STPELNIIHCDLKPENILLCNPKRSA--IKIVDFGSS------CQLGQRIYQYIQSRFYR 290
+ I+H D+K NIL + SA +K+ DFG+S C G I + ++
Sbjct: 123 HSNM--IVHRDIKGANIL----RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP-----PKH 345
SPEV+ G Y D+WSLGC +VEM T +P ++ E + M I ++ P P H
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIATQPTNPQLPSH 233
Query: 346 L 346
+
Sbjct: 234 I 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 127 IGKGSFGQVVKAFDLEEQCH-----------VAIKIIKNKKPFLNQAQIEVKLLEIMNKA 175
+G+G FG+V E C VA+K + + +++ E + +EI+
Sbjct: 12 LGEGHFGKV-------ELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE-REIEILRTL 63
Query: 176 DVNNTYYIVRLK--RHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
D IV+ K L L+ E L +L D L+ + ++L FS Q+C
Sbjct: 64 DHE---NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQIC 119
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-RIYQYIQSR---- 287
+ +L + IH DL NIL+ + +KI DFG + L + + Y Y++
Sbjct: 120 KGMDYLGSQRY--IHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 288 -FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT---------GEPLFSGSNEVDQM 332
F+ +PE L + A D+WS G L E+ T E L QM
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY-YIV 184
L+GKG+FG+V+ + + A+KI+K K+ + + ++ L E ++ N + ++
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILK-KEVIIAKDEVAHTLTE--SRVLQNTRHPFLT 58
Query: 185 RLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGV-SLNLTRKFSQQLCTALLFLSTPEL 243
LK F + LC V E N +L + + V S + R + ++ +AL +L
Sbjct: 59 ALKYSFQTHDRLCFVMEYA--NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH--SC 114
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEVLLGIPY 300
++++ DLK EN++L K IKI DFG G + + + Y +PEVL Y
Sbjct: 115 DVVYRDLKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 301 DLAIDMWSLGCILVEMHTGE-PLFSGSNEV 329
A+D W LG ++ EM G P ++ +E
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 120 RYEIDSLIGKGSFGQV---VKAFDLEEQCHVAIK-IIKNKKPFLNQAQIEVKLLEIMNKA 175
+Y I S + GS G+V K D E++ V +K + K P E+ +L+ ++
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGGKTP-----GREIDILKTISHR 146
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
I+ L + W++ +C+V +L+ + + + L ++L AL
Sbjct: 147 A------IINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEAL 198
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYR 290
+L IIH D+K ENI L P+ + + DFG++C+L Y + +
Sbjct: 199 AYLH--GRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGE-PLFS 324
SPE+L PY D+WS G +L EM LF
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 69/277 (24%), Positives = 124/277 (44%), Gaps = 37/277 (13%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI----EVKLLEIMN 173
L + I+ IG+G F +V +A L + VA+K ++ +A+ E+ LL+ +N
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRN--TNFRGVSLNLTRKFSQQ 230
+V ++ F+ N L +V EL + +L ++++ R + K+ Q
Sbjct: 61 HPNV------IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSR 287
LC+AL + + ++H D+KP N+ + +K+ D G + + + +
Sbjct: 115 LCSALEHMHSRR--VMHRDIKPANVFIT--ATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN-----KIVEVLGLP 342
+Y SPE + Y+ D+WSLGC+L EM + F G D+MN K +E P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEQCDYP 226
Query: 343 PKHLLDGAHKTRKYFD--------KMPDGSYILKKPK 371
P + + R+ + K PD +Y+ K
Sbjct: 227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 26/224 (11%)
Query: 126 LIGKGSFGQVVKA---FDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLLEIMNKADVNNT 180
+G GSFG V + + VA+K +K+ K E ++ ++ ++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 181 YYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
Y +V L +V EL +L D LR ++ ++ Q+ + +L
Sbjct: 62 YGVVLTHP-------LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR-------SP 292
+ IH DL NILL + + +KI DFG L Q + + +P
Sbjct: 115 SK--RFIHRDLAARNILLASDDK--VKIGDFGLMRALPQN-EDHYVMEEHLKVPFAWCAP 169
Query: 293 EVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335
E L + A D+W G L EM T GE ++G + + KI
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 35/79 (44%), Positives = 47/79 (59%), Gaps = 3/79 (3%)
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-YIQSRFYRSPEVLLGIPY 300
+ I+H D+KP NIL+ + R IK+ DFG S QL + ++ +R Y SPE L G Y
Sbjct: 118 KHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 301 DLAIDMWSLGCILVEMHTG 319
+ D+WSLG LVEM G
Sbjct: 176 TVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 121 YEIDS-----LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQA-QIEVKLLEIMNK 174
YE D ++GKG++G V A DL Q +AIK I + Q E+ L +
Sbjct: 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH 64
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKF-SQQLC 232
+ IV+ + E + +L LLR+ T F ++Q+
Sbjct: 65 RN------IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF---- 288
L +L + I+H D+K +N+L+ N +KI DFG+S +L F
Sbjct: 119 EGLKYLH--DNQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAG--INPCTETFTGTL 173
Query: 289 -YRSPEVLLGIP--YDLAIDMWSLGCILVEMHTGEPLF 323
Y +PEV+ P Y D+WSLGC +VEM TG+P F
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 126 LIGKGSFGQV----VKAFDLEEQCH-VAIKIIKNKKP---FLNQAQIEVKLLEIMNKADV 177
++GKG FG+V V+A C + K IK +K LN+ QI K+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV--------- 57
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFEL-----LSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
N+ ++V L + ++ LCLV L L +++Y + G ++ ++C
Sbjct: 58 -NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM----GEAGFEEGRAVFYAAEIC 112
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYR 290
L L I++ DLKPENILL + I+I D G + + GQ I + + Y
Sbjct: 113 CGLEDLHQER--IVYRDLKPENILLDD--HGHIRISDLGLAVHVPEGQTIKGRVGTVGYM 168
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLF 323
+PEV+ Y + D W+LGC+L EM G+ F
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY--YI 183
L+GKG+FG+V+ + + A+KI++ K+ + + ++ + E + NT ++
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTE---SRVLQNTRHPFL 57
Query: 184 VRLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP 241
LK F + LC V E + + L R F + R + ++ +AL +L +
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGAEIVSALEYLHSR 114
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QRIYQYIQSRFYRSPEVLLG 297
++++ D+K EN++L K IKI DFG C+ G + + + Y +PEVL
Sbjct: 115 --DVVYRDIKLENLML--DKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLED 169
Query: 298 IPYDLAIDMWSLGCILVEMHTGE-PLFSGSNE 328
Y A+D W LG ++ EM G P ++ +E
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN--QAQIEVKLLEIMNKADV 177
+Y + ++G+GSFG+ + + A+K I+ K ++ E LL M +
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN- 59
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
IV K F HL +V E +L ++ + + ++ Q+C +
Sbjct: 60 -----IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRSPE 293
+ E ++H D+K +NI L + +K+ DFGS+ L G Y+ + +Y PE
Sbjct: 115 HIH--EKRVLHRDIKSKNIFLT--QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170
Query: 294 VLLGIPYDLAIDMWSLGCILVEMHT 318
+ +PY+ D+WSLGCIL E+ T
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 68/246 (27%), Positives = 96/246 (39%), Gaps = 60/246 (24%)
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-YIQSRFYRSPEVLLGIPYDLA 303
I+H D+KP NIL+ + R IK+ DFG S QL + ++ +R Y SPE L G Y +
Sbjct: 125 IMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 304 IDMWSLGCILVEMHTG------------EPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351
D+WS+G LVEM G E +F E D P+ G
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES-----ETSPRPRPPGRP 237
Query: 352 KTRKYFDKMPDGS------YILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405
+ D P + YI+ +P PK+P + G E
Sbjct: 238 LSSYGPDSRPPMAIFELLDYIVNEP----PPKLPSG-----VFGAE-------------- 274
Query: 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGG----TSGLGSMST 461
F+D + + L +P R + H F KR+ E + G T GL ST
Sbjct: 275 -------FQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEEVDFAGWLCSTIGLNQPST 327
Query: 462 SPASAG 467
+AG
Sbjct: 328 PTHAAG 333
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 69/280 (24%), Positives = 124/280 (44%), Gaps = 43/280 (15%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQ----IEVKLLEIMN 173
L ++I+ IG+G F +V +A L ++ VA+K ++ + +A+ E+ LL+ +N
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLR--NTNFRGVSLNLTRKFSQQ 230
+V ++ F+ N L +V EL +L +++ R + K+ Q
Sbjct: 61 HPNV------IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSR 287
LC+A+ + + ++H D+KP N+ + +K+ D G + + + +
Sbjct: 115 LCSAVEHMHSRR--VMHRDIKPANVFIT--ATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI-----VEVLGLP 342
+Y SPE + Y+ D+WSLGC+L EM + F G D+MN +E P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLFSLCQKIEQCDYP 226
Query: 343 PKHLLDGAHKTRKYF-----------DKMPDGSYILKKPK 371
P L H + K D+ PD Y+ + K
Sbjct: 227 P---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 8e-11
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 19/217 (8%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
+K RYE IG+G+ G V A D+ VAIK I +K Q + E+ + EI+
Sbjct: 18 KKKYTRYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVM 70
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
++ N IV F+ + L +V E L+ +L D++ T + ++
Sbjct: 71 KELKNPN-IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI---AAVCRECLQ 126
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYR 290
AL FL + +IH D+K +N+LL ++K+ DFG Q+ + + + ++
Sbjct: 127 ALEFLHANQ--VIHRDIKSDNVLL--GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327
+PEV+ Y +D+WSLG + +EM GEP + N
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185
++GKGSFG+V+ A AIKI+K K + +E ++E A ++ +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILK-KDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65
Query: 186 LKRHFMWRNHLCLVFEL-----LSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLST 240
L F + L V E L Y + + R V ++ ++ L FL +
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF------YAAEIAIGLFFLHS 119
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YRSPEV 294
II+ DLK +N++L IKI DFG C+ + ++ + ++ Y +PE+
Sbjct: 120 K--GIIYRDLKLDNVML--DSEGHIKIADFGM-CK--ENMWDGVTTKTFCGTPDYIAPEI 172
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+ PY ++D W+ G +L EM G+ F G +E + I+E
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 74/279 (26%), Positives = 110/279 (39%), Gaps = 47/279 (16%)
Query: 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
I++LK F + CL+ +LY L R +++ + + A+ +L E
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLH--E 200
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQSRFYRSPEVLLGI 298
IIH D+K ENI + +P + + DFG++C + Y + + +PE+L
Sbjct: 201 NRIIHRDIKAENIFINHP--GDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARD 258
Query: 299 PYDLAIDMWSLGCILVEMHTGE-PLFS-----GSNEVD-QMNKIVEVLGLPPKHLLDGAH 351
PY A+D+WS G +L EM T LF G + D Q+ I+ G P A
Sbjct: 259 PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318
Query: 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGE-PGHSVSDY 410
D YI K RK PGSR P L E P
Sbjct: 319 ANL-------DEIYIGLAKKSSRK---PGSR------------PLWTNLYELP------- 349
Query: 411 LKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
+ + LI +ML +D R + L F+ D N
Sbjct: 350 IDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPN 388
|
Length = 391 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 13/129 (10%)
Query: 223 LTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 282
L R F++Q+ L +L + I+H DLK +N+L+ KI DFG S + IY
Sbjct: 109 LVRFFTEQVLEGLAYLHSK--GILHRDLKADNLLV--DADGICKISDFGISKK-SDDIYD 163
Query: 283 YIQ------SRFYRSPEV--LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
Q S F+ +PEV Y +D+WSLGC+++EM G +S + M K
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
Query: 335 IVEVLGLPP 343
+ PP
Sbjct: 224 LGNKRSAPP 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 38/123 (30%), Positives = 66/123 (53%), Gaps = 13/123 (10%)
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEVLLGIPYD 301
+IH D+K ++ILL + R +K+ DFG Q+ R + + ++ +PE++ +PY
Sbjct: 137 VIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 302 LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT----RKYF 357
+D+WSLG +++EM GEP + + M I + LPPK L HK + +
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPK--LKNLHKVSPSLKGFL 250
Query: 358 DKM 360
D++
Sbjct: 251 DRL 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 60/237 (25%), Positives = 113/237 (47%), Gaps = 22/237 (9%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
D I+ L G+G++G V K + +A+K I+ Q ++ + L M D
Sbjct: 2 DLEVIEEL-GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 179 NT--YYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSL--NLTRKFSQQLCTA 234
T +Y + +W +C+ E++ +L + +G+++ ++ K + + A
Sbjct: 61 YTVTFYGALFREGDVW---ICM--EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ--SRFYRSP 292
L +L + +L++IH D+KP N+L+ + +K+ DFG S L + + I + Y +P
Sbjct: 116 LEYLHS-KLSVIHRDVKPSNVLI--NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAP 172
Query: 293 EVLLG----IPYDLAIDMWSLGCILVEMHTGE-PLFSGSNEVDQMNKIVEVLGLPPK 344
E + YD+ D+WSLG ++E+ TG P S Q+ ++VE P+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSPQ 227
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 13/216 (6%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185
++GKGSFG+V+ A E A+K++K K L +E + E + N ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 186 LKRHFMWRNHLCLVFELLSYNLYDLLRNTN-FRGVSLNLTRKFSQQLCTALLFLSTPELN 244
L F + L V E + N DL+ + R R ++ ++ +AL+FL +
Sbjct: 61 LYCCFQTPDRLFFVMEFV--NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH--DKG 116
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGIPY 300
II+ DLK +N+LL K+ DFG C+ G + + Y +PE+L + Y
Sbjct: 117 IIYRDLKLDNVLL--DHEGHCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 301 DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
++D W++G +L EM G F NE D I+
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 26/203 (12%)
Query: 127 IGKGSFGQV----VKAFDLEEQCH-VAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY 181
+GKG FG+V ++A C + K +K +K + A +E ++L A V+ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY-EGAMVEKRIL-----AKVH-SR 53
Query: 182 YIVRLKRHFMWRNHLCLVFEL-----LSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
+IV L F + LCLV + L Y++Y++ + G ++ Q+ + L
Sbjct: 54 FIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNV--DEENPGFPEPRACFYTAQIISGLE 111
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQ-RIYQYIQSRFYRSPE 293
L + II+ DLKPEN+LL N ++I D G + +L GQ + Y + + +PE
Sbjct: 112 HLH--QRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE 167
Query: 294 VLLGIPYDLAIDMWSLGCILVEM 316
+L G YD ++D ++LG L EM
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKAD 176
+ +E LI G++G V E + A+K I NK+ + + QI+ +E I+ A+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKI-NKQNLILRNQIQQVFVERDILTFAE 59
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
++V + F + HLC+V E + + LL+N + +++ R + + AL
Sbjct: 60 ---NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLAL 114
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQ-YIQS---R 287
+L I+H DLKP+N+L+ + IK+ DFG S L +Y+ +I+
Sbjct: 115 EYLHN--YGIVHRDLKPDNLLITS--MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 288 F----------YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325
F Y +PEV+L Y +D W++G IL E G F G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 49/241 (20%)
Query: 119 DRYEIDSLIGKGSFGQVVKAF-----DLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMN 173
++ + +G+GSFG V + E + VAIK +N+ + +E +N
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT-------VNENASMRERIEFLN 58
Query: 174 KADVN---NTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLR-----NTNFRGVSLNLT 224
+A V N +++VRL +V EL++ +L LR N G+
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118
Query: 225 RKFSQ---QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281
+KF Q ++ + +L+ +H DL N ++ + +KI DFG + + IY
Sbjct: 119 QKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMV-AEDLT-VKIGDFG----MTRDIY 170
Query: 282 QYIQSRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSG-SN 327
+ + +YR +PE L + D+WS G +L EM T E + G SN
Sbjct: 171 E---TDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
Query: 328 E 328
E
Sbjct: 228 E 228
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 25/220 (11%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMNKADVNNTY 181
+IG+GS+ +V+ + + A+K+IK N ++ Q E + E +N
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFE-----TASNHP 56
Query: 182 YIVRLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
++V L F + L V E +S ++ + R R + R +S ++ AL FL
Sbjct: 57 FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLH 113
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVL 295
E II+ DLK +N+LL IK+ D+G C+ G R + + Y +PE+L
Sbjct: 114 --ERGIIYRDLKLDNVLL--DAEGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFS--GSNEVDQMN 333
G Y ++D W+LG ++ EM G F G ++ N
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 72/251 (28%), Positives = 109/251 (43%), Gaps = 38/251 (15%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQV--VKAFDLEEQ-CHVAIKIIKNKKPFLNQAQIEVKLLE 170
GE L+ YE+ IG G FG+V VK +E C AI K+ +Q IEV ++
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMR 67
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTN-----FRGVSLNLTR 225
+ + IVR F+ + + L + + DL RN F + +
Sbjct: 68 ELKHKN------IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 226 KFSQQLCTALLFLSTPE-----LNIIHCDLKPENILLCN---------------PKRSAI 265
++QL AL + + ++H DLKP+NI L R
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 266 KIVDFGSSCQLG--QRIYQYIQSRFYRSPEVLL--GIPYDLAIDMWSLGCILVEMHTGEP 321
KI DFG S +G + + + +Y SPE+LL YD DMW+LGCI+ E+ +G+
Sbjct: 182 KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 322 LFSGSNEVDQM 332
F +N Q+
Sbjct: 242 PFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 2e-10
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 40/200 (20%)
Query: 150 KIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY---- 205
KIIK K N IE + ++M +N +I +L L+ + Y
Sbjct: 47 KIIKAK----NFNAIEPMVHQLMK----DNPNFI-KLYYSVTTLKGHVLI---MDYIKDG 94
Query: 206 NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265
+L+DLL+ +S +K +QL AL L NIIH D+K EN+L + + I
Sbjct: 95 DLFDLLKKEGK--LSEAEVKKIIRQLVEALNDLHKH--NIIHNDIKLENVL-YDRAKDRI 149
Query: 266 KIVDFG-------SSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ D+G SC G Y F SPE + G YD++ D W++G + E+ T
Sbjct: 150 YLCDYGLCKIIGTPSCYDGTLDY------F--SPEKIKGHNYDVSFDWWAVGVLTYELLT 201
Query: 319 GEPLFSGSNE----VDQMNK 334
G+ F + ++ + K
Sbjct: 202 GKHPFKEDEDEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 67/230 (29%), Positives = 107/230 (46%), Gaps = 21/230 (9%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
D +EI +IG+G+FG+V + A+KI+ NK L +A+ E N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKIL-NKWEMLKRAETAC-FREERNVLVNG 58
Query: 179 NTYYIVRLKRHFMWRNHLCLVFEL-LSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
+ +I L F N+L LV + + +L LL R + ++ R + ++ A+
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIH- 116
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YRS 291
S +L+ +H D+KP+N+LL I++ DFGS ++ Q +QS Y S
Sbjct: 117 -SIHQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQD--GTVQSSVAVGTPDYIS 171
Query: 292 PEVLLGI-----PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
PE+L + Y D WSLG + EM GE F + V+ KI+
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 75/280 (26%), Positives = 118/280 (42%), Gaps = 73/280 (26%)
Query: 119 DRYEIDSLIGKGSFGQV--VKAFDLEEQCHV-AIKIIKNKKPFLNQAQI-----EVKLLE 170
D +E +IG+G+FG+V V+ D H+ A+K ++ K L + Q+ E +L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTG---HIYAMKKLR-KSEMLEKEQVAHVRAERDIL- 55
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLL--RNTNFRGVSLNLTRKF 227
A+ +N + +V+L F N+L L+ E L ++ LL ++T + TR +
Sbjct: 56 ----AEADNPW-VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT----FTEEETRFY 106
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG---------------- 271
+ T L S +L IH D+KP+N+LL + IK+ DFG
Sbjct: 107 IAE--TILAIDSIHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 272 -----------------------SSCQLGQRIYQY--IQSRFYRSPEVLLGIPYDLAIDM 306
+ + +R Y + + Y +PEV L Y+ D
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222
Query: 307 WSLGCILVEMHTGEPLFSGSNEVDQMNKIV---EVLGLPP 343
WSLG I+ EM G P F N + KI+ E L P
Sbjct: 223 WSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD 262
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 77/254 (30%), Positives = 110/254 (43%), Gaps = 52/254 (20%)
Query: 119 DRYEIDSLIGKGSFGQV--VKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKAD 176
D +EI +IG+G+FG+V VK + + A+KI+ NK L +A+ + D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQV--YAMKIL-NKWEMLKRAETAC----FREERD 53
Query: 177 V---NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
V + +I L F N+L LV + Y DLL L KF +L
Sbjct: 54 VLVNGDRRWITNLHYAFQDENNLYLVMDY--YVGGDLL----------TLLSKFEDRLPE 101
Query: 234 --ALLFL--------STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 283
A +L S +L +H D+KP+N+LL K I++ DFGS +L
Sbjct: 102 DMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRL--LADGT 157
Query: 284 IQSRF------YRSPEVLLGIP-----YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQM 332
+QS Y SPE+L + Y D WSLG + EM GE F + V+
Sbjct: 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
Query: 333 NKIV---EVLGLPP 343
KI+ E PP
Sbjct: 218 GKIMNHKEHFQFPP 231
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 63/248 (25%), Positives = 99/248 (39%), Gaps = 65/248 (26%)
Query: 126 LIGKGSFGQV-------------VKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIM 172
L+GKG G+V +K D +E +IK K + + E ++L +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKE-------MIKRNK--VKRVLTEQEILATL 58
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQL 231
+ ++ L F +LCLV + L+ LL+ + +S + R ++ ++
Sbjct: 59 DHP------FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QRIYQYIQSR 287
AL +L L I++ DLKPENILL + I + DF S Q +
Sbjct: 113 LLALEYLHL--LGIVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 288 -----------------------F-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHTG 319
F Y +PEV+ G + A+D W+LG +L EM G
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
Query: 320 EPLFSGSN 327
F GSN
Sbjct: 229 TTPFKGSN 236
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL 186
IG+G+ G V A D+ VAIK + ++ Q + E+ + EI+ + N IV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRE-NKNPNIVNY 81
Query: 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPELN 244
++ + L +V E L+ +L D++ T G + R+ Q AL FL + +
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----ALDFLHSNQ-- 135
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEVLLGIPYD 301
+IH D+K +NILL ++K+ DFG Q+ + + + ++ +PEV+ Y
Sbjct: 136 VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 302 LAIDMWSLGCILVEMHTGEPLFSGSN 327
+D+WSLG + +EM GEP + N
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL 186
IG+G+ G V A D+ VAI+ + ++ Q + E+ + EI+ + N IV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRE-NKNPNIVNY 82
Query: 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPELN 244
++ + L +V E L+ +L D++ T G + R+ Q AL FL + +
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----ALEFLHSNQ-- 136
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEVLLGIPYD 301
+IH D+K +NILL ++K+ DFG Q+ + + + ++ +PEV+ Y
Sbjct: 137 VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 302 LAIDMWSLGCILVEMHTGEPLFSGSN 327
+D+WSLG + +EM GEP + N
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 21/225 (9%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI----EVKLLEIMNKADVNNTY 181
+IG+G FG+V + A+K + K+ + Q + E +L +++ D
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP--- 57
Query: 182 YIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGV-SLNLTRKFSQQLCTALLFLST 240
+IV + F + LC + +L+ N DL + + GV S R ++ ++ L +
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLM--NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-YQYIQSRFYRSPEVLL-GI 298
+++ DLKP NILL + ++I D G +C ++ + + + Y +PEVL G
Sbjct: 116 R--FVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGT 171
Query: 299 PYDLAIDMWSLGCILVEMHTGEPLF-----SGSNEVDQMNKIVEV 338
YD + D +SLGC+L ++ G F +E+D+M V V
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 66/274 (24%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL-LEIMNKADVNNTYYIVR 185
+G G+FG+V A ++ + A+K ++ K L VK +I+ +AD ++VR
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD---NEWVVR 65
Query: 186 LKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL 243
L F +++L V + + + L+R F +L R + +L A+ S ++
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE---DLARFYIAELTCAVE--SVHKM 120
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFG-------------------------------- 271
IH D+KP+NIL+ + IK+ DFG
Sbjct: 121 GFIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 272 --SSCQLGQRI----------------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCIL 313
++C+ G R+ + + + Y +PEVLL Y D WS+G IL
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 314 VEMHTGEPLFSGSNEVDQMNKIVE---VLGLPPK 344
EM G+P F ++ K++ L +PP+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL 186
IG+G+ G V A D+ VAIK + ++ Q + E+ + EI+ + N IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRE-NKHPNIVNY 81
Query: 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPELN 244
++ + L +V E L+ +L D++ T G + R+ Q AL FL + +
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----ALEFLHSNQ-- 135
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEVLLGIPYD 301
+IH D+K +NILL ++K+ DFG Q+ + + + ++ +PEV+ Y
Sbjct: 136 VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 302 LAIDMWSLGCILVEMHTGEPLFSGSN 327
+D+WSLG + +EM GEP + N
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 57/249 (22%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
Y D IG+G+FG+V +A E VA+K++K + QA + + +M +
Sbjct: 8 EYVRD--IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAE 64
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGV-----SLNLTRKFS 228
D N IV+L +CL+FE ++Y +L + LR+ + R S + RK
Sbjct: 65 FDHPN---IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 229 Q---------QLCTA------LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273
QLC A + +LS E +H DL N L+ + +KI DFG
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRNCLV--GENMVVKIADFG-- 175
Query: 274 CQLGQRIYQYIQSRFYRS------------PEVLLGIPYDLAIDMWSLGCILVEMHTG-- 319
L + IY + +Y++ PE + Y D+W+ G +L E+ +
Sbjct: 176 --LSRNIY---SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230
Query: 320 EPLFSGSNE 328
+P + ++E
Sbjct: 231 QPYYGMAHE 239
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 84/322 (26%), Positives = 138/322 (42%), Gaps = 51/322 (15%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNK----KPFLNQAQIEVKLLEIMNKADVNNTY 181
+IG+GS+ +V+ + A+K++K + ++ Q E + E +A N
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFE---QASSNP-- 56
Query: 182 YIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLST 240
++V L F + L LV E + N DL+ + R + R ++ ++C AL FL
Sbjct: 57 FLVGLHSCFQTTSRLFLVIEYV--NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH- 113
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLL 296
E II+ DLK +N+LL IK+ D+G C+ G + + Y +PE+L
Sbjct: 114 -ERGIIYRDLKLDNVLL--DADGHIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 297 GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356
G Y ++D W+LG ++ EM G F + MN T Y
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-------------------TEDY 210
Query: 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDL 416
++ IL+KP R P+ + H + G + P R +P SD
Sbjct: 211 LFQV-----ILEKPI--RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT-- 261
Query: 417 IFRMLDYD--PKTRITPYYALQ 436
FR +D+D K ++TP + Q
Sbjct: 262 FFRSIDWDLLEKKQVTPPFKPQ 283
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL----GQRIYQYIQSRFYRSPEVLLG 297
+L II+ D+K ENILL + + DFG S + +R Y + + Y +PEV+ G
Sbjct: 123 QLGIIYRDIKLENILL--DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
Query: 298 IP--YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
+D A+D WSLG + E+ TG F+ E + ++I
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQA-QIEVKLLEIMNKADVNNT--YYI 183
IG GSFG V A D+ VAIK + N+ Q +K + + K NT Y
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 184 VRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL 243
L+ H W LV E + DLL + + + + L +L +
Sbjct: 83 CYLREHTAW-----LVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSH-- 134
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI---PY 300
N+IH D+K NILL P +K+ DFGS+ + ++ + ++ +PEV+L + Y
Sbjct: 135 NMIHRDVKAGNILLSEP--GLVKLGDFGSASIMAP-ANXFVGTPYWMAPEVILAMDEGQY 191
Query: 301 DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
D +D+WSLG +E+ +P N + + I +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ---AQIEVKLLEIMNKADVNNTYYI 183
+GKGS+G+V + IK + + + A+ E +LL + + I
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN------I 61
Query: 184 VRLKRHFMWRNHLCLVFELLSY----NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
V + W L++ ++ + +LY L+ + + N ++ Q+ AL +L
Sbjct: 62 VAYRES--WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFG------SSCQLGQRIYQYIQSRFYRSPE 293
E +I+H DLK +N+ L + + IK+ D G + C + + I + +Y SPE
Sbjct: 120 --EKHILHRDLKTQNVFLT--RTNIIKVGDLGIARVLENQCDMASTL---IGTPYYMSPE 172
Query: 294 VLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343
+ PY+ D+W+LGC + EM T + F+ + + +I+E LPP
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-KLPP 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 48/278 (17%)
Query: 111 IQHGEKFLDRYEIDSLIGKGSFGQV----VKAFDLEEQCHVAI---------------KI 151
++H ++FL + + + G+FG++ ++A E + + K
Sbjct: 140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKR 199
Query: 152 IKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLL 211
+K Q + E+ L +N ++ I+R + ++ + ++LY +
Sbjct: 200 VKAGSRAAIQLENEILALGRLNHENILKIEEILR------SEANTYMITQKYDFDLYSFM 253
Query: 212 RNTNFRGVS---LNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILL-CNPKRSAIKI 267
+ F L TR +QL A+ ++ +L IH D+K ENI L C+ K I +
Sbjct: 254 YDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKL--IHRDIKLENIFLNCDGK---IVL 308
Query: 268 VDFGSSCQLGQ----RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGE--P 321
DFG++ + Y ++ + SPE+L G Y D+WS G IL++M + + P
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368
Query: 322 LFSGS-NEVDQMNKIVEVLGL-------PPKHLLDGAH 351
+ G Q+ KI++ L + PP L D
Sbjct: 369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYID 406
|
Length = 501 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 39/215 (18%)
Query: 125 SLIGKGSFGQVVKAFDLEEQCH-----------VAIKIIKNKKP-FLNQAQIEVKLLEIM 172
+GKG+FG V E C VA+K +++ L + E+++L+ +
Sbjct: 10 QQLGKGNFGSV-------ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL 62
Query: 173 NKADVNNTYYIVRLKR--HFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQ 229
IV+ K + R +L LV E L Y +L D L+ R + ++
Sbjct: 63 QHD------NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER-LDHRKLLLYAS 115
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYI 284
Q+C + +L + +H DL NIL+ + R +KI DFG + L Q ++ +
Sbjct: 116 QICKGMEYLGS--KRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYKVREPG 171
Query: 285 QSR-FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+S F+ +PE L + +A D+WS G +L E+ T
Sbjct: 172 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 31/230 (13%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI----EVKLLEIMNKADVNNTY 181
+IG+G FG+V + A+K + K+ + Q + E +L +++ D
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP--- 57
Query: 182 YIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQ---LCTALLFL 238
+IV + F + L + +L+ N DL + + GV FS+ A + L
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLM--NGGDLHYHLSQHGV-------FSEAEMRFYAAEIIL 108
Query: 239 STPELN---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-YQYIQSRFYRSPEV 294
++ +++ DLKP NILL + ++I D G +C ++ + + + Y +PEV
Sbjct: 109 GLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 166
Query: 295 LL-GIPYDLAIDMWSLGCILVEMHTGEPLFSG-----SNEVDQMNKIVEV 338
L G+ YD + D +SLGC+L ++ G F +E+D+M + V
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKADVNNTYYIV 184
IGKG+FGQV + + + A+K++ +KK + + ++ + E I+ + ++ + +IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL-SKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 185 RLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
LK F + L LV + +S + L + F S + + + +L AL L +
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRF---SEDRAKFYIAELVLALEHLH--K 114
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQSRFYRSPEVLLGIP 299
+I++ DLKPENILL I + DFG S + + + Y +PEVLL
Sbjct: 115 YDIVYRDLKPENILL--DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 300 -YDLAIDMWSLGCILVEMHTG-EPLFSGSNEVDQMNKIV 336
Y +D WSLG ++ EM G P + + + QM + +
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFY--AEDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 17/217 (7%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK-NKKPFLNQAQIEVKLLEIMNKADVNNT--YYI 183
IG GSFG V A D+ VAIK + + K + Q +K ++ + + N+ Y
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 184 VRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL 243
L+ H W LV E + DLL + + + + L +L +
Sbjct: 93 CYLREHTAW-----LVMEYCLGSASDLLE-VHKKPLQEVEIAAITHGALQGLAYLHSH-- 144
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI---PY 300
N+IH D+K NILL P + +K+ DFGS+ + ++ + ++ +PEV+L + Y
Sbjct: 145 NMIHRDIKAGNILLTEPGQ--VKLADFGSA-SIASPANSFVGTPYWMAPEVILAMDEGQY 201
Query: 301 DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
D +D+WSLG +E+ +P N + + I +
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 33/76 (43%), Positives = 46/76 (60%), Gaps = 3/76 (3%)
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-YIQSRFYRSPEVLLGIPYDLA 303
I+H D+KP NIL+ + R IK+ DFG S QL + ++ +R Y SPE L G Y +
Sbjct: 125 IMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 304 IDMWSLGCILVEMHTG 319
D+WS+G LVE+ G
Sbjct: 183 SDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 68/275 (24%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-EVKL-LEIMNKADVNNTYYIV 184
+G G+FG+V A ++ A+K ++ KK LN+ Q+ VK +I+ +AD ++V
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLR-KKDVLNRNQVAHVKAERDILAEAD---NEWVV 64
Query: 185 RLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
+L F +++L V + + + L+R F V L R + +L A+ S +
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV---LARFYIAELTLAIE--SVHK 119
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFG------------------------------- 271
+ IH D+KP+NIL+ IK+ DFG
Sbjct: 120 MGFIHRDIKPDNILI--DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 272 ---SSCQLGQRI----------------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCI 312
S+C+ G R+ + + + Y +PEVLL Y D WS+G I
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 313 LVEMHTGEPLFSGSNEVDQMNKIV---EVLGLPPK 344
L EM G+P F + K++ L +PP+
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQ 272
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 60/233 (25%), Positives = 111/233 (47%), Gaps = 32/233 (13%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII-------KNKKPFLNQAQIEVKLLEIMN 173
Y++ +IG+G+FG+V Q A+K++ ++ F + + +IM
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER------DIMA 98
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
A N+ ++V+L F +L +V E + +L +L+ N + V + ++ ++
Sbjct: 99 FA---NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVV 152
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQYIQSRF 288
AL + + + +IH D+KP+N+LL K +K+ DFG+ ++ + R + +
Sbjct: 153 LALDAIHS--MGLIHRDVKPDNMLL--DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208
Query: 289 YRSPEVLLGIP----YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
Y SPEVL Y D WS+G L EM G+ F + V +KI++
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 60/273 (21%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHV-AIKIIKNKKPFLNQAQIEVKLLE--IMNKA 175
D +E +IG+G+FG+V + ++ H+ A+KI++ K L + Q+ E I+ +A
Sbjct: 1 DDFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEA 58
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLC-- 232
D ++V++ F + +L L+ E L ++ LL + L+ + +Q
Sbjct: 59 D---GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAE 109
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--------------- 277
T L + +L IH D+KP+N+LL + +K+ DFG L
Sbjct: 110 TVLAIDAIHQLGFIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167
Query: 278 -----------------------QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILV 314
Q Y + + Y +PEV + Y+ D WSLG I+
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 315 EMHTGEPLFSGSNEVDQMNKIV---EVLGLPPK 344
EM G P F + K++ E L PP+
Sbjct: 228 EMLIGYPPFCSETPQETYRKVMNWKETLVFPPE 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 51/214 (23%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMNKADVNNTYY 182
IG G FG V + LE++ VAIK I+ +++ F+ +AQ+ +KL K
Sbjct: 12 IGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSEEDFIEEAQVMMKLSH--PK-------- 60
Query: 183 IVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQ--------LCT 233
+V+L R+ +CLVFE + + L D LR RG KFSQ+ +C
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ--RG-------KFSQETLLGMCLDVCE 111
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY---QYIQS---R 287
+ +L N+IH DL N L+ + +K+ DFG + R QY S +
Sbjct: 112 GMAYLE--SSNVIHRDLAARNCLV--GENQVVKVSDFGMT-----RFVLDDQYTSSTGTK 162
Query: 288 F---YRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
F + SPEV Y D+WS G ++ E+ +
Sbjct: 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 27/231 (11%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV--- 177
+EI +IG+G+FG+V L+ V I NK L +A+ + DV
Sbjct: 3 FEILKVIGRGAFGEVA-VVKLKNADKVFAMKILNKWEMLKRAETAC----FREERDVLVN 57
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFEL-LSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
+ +I L F N+L LV + + +L LL R + ++ R + ++ A+
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAID 116
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YR 290
S +L+ +H D+KP+NIL+ I++ DFGS +L + +QS Y
Sbjct: 117 --SVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMED--GTVQSSVAVGTPDYI 170
Query: 291 SPEVLLGIP-----YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
SPE+L + Y D WSLG + EM GE F + V+ KI+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK-NKKPFLNQAQIEVKLLEIMNKADVNNT--YYI 183
IG GSFG V A D+ VAIK + + K + Q +K + + + NT Y
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 184 VRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL 243
L+ H W LV E + D+L + + + L +L +
Sbjct: 83 CYLREHTAW-----LVMEYCLGSASDIL-EVHKKPLQEVEIAAICHGALQGLAYLHS--H 134
Query: 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI---PY 300
IH D+K NILL P +K+ DFGS+ L ++ + ++ +PEV+L + Y
Sbjct: 135 ERIHRDIKAGNILLTEP--GTVKLADFGSA-SLVSPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 301 DLAIDMWSLGCILVEM-HTGEPLFS 324
D +D+WSLG +E+ PLF+
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 69/271 (25%), Positives = 115/271 (42%), Gaps = 60/271 (22%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHV-AIKIIKNKKPFLNQAQIEVKLLE--IMNKADV 177
+E +IG+G+FG+V + ++ HV A+KI++ K L + Q+ E I+ +AD
Sbjct: 3 FESLKVIGRGAFGEV-RLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEAD- 59
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLC--TA 234
+ ++V++ F + +L L+ E L ++ LL + LT + +Q T
Sbjct: 60 --SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETV 111
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----------------- 277
L S +L IH D+KP+N+LL + +K+ DFG L
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 278 ---------------------QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEM 316
Q + + + Y +PEV + Y+ D WSLG I+ EM
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 317 HTGEPLFSGSNEVDQMNKIV---EVLGLPPK 344
G P F + K++ E L PP+
Sbjct: 230 LIGYPPFCSETPQETYKKVMNWKETLIFPPE 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMNKADVNNTY 181
+IG+GS+ +V+ + + A+K++K N ++ Q E + E +N
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFE-----QASNHP 56
Query: 182 YIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLST 240
++V L F + L V E + N DL+ + R + R +S ++ AL +L
Sbjct: 57 FLVGLHSCFQTESRLFFVIEYV--NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH- 113
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLL 296
E II+ DLK +N+LL IK+ D+G C+ G R + + Y +PE+L
Sbjct: 114 -ERGIIYRDLKLDNVLL--DSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIAPEILR 169
Query: 297 GIPYDLAIDMWSLGCILVEMHTGEPLF 323
G Y ++D W+LG ++ EM G F
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQA-QIEVKLLEIMN 173
E F+ +EI G GSFG V A + VA+K + N+ Q +K ++ +
Sbjct: 21 EIFVGLHEI----GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 174 KADVNNT--YYIVRLKRHFMWRNHLCLVFELLSYNLYDLLR--NTNFRGVSLNLTRKFSQ 229
+ NT Y LK H W LV E + DLL + V + +
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAW-----LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL 131
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY 289
Q L +L + N+IH D+K NILL P + +K+ DFGS+ ++ + ++
Sbjct: 132 Q---GLAYLHSH--NMIHRDIKAGNILLTEPGQ--VKLADFGSA-SKSSPANSFVGTPYW 183
Query: 290 RSPEVLLGI---PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+PEV+L + YD +D+WSLG +E+ +P N + + I +
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 33/203 (16%)
Query: 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKADVNNTYY 182
+ IGKG FG V+ D Q VA+K +K+ + + L E +M N
Sbjct: 12 ATIGKGEFGDVMLG-DYRGQ-KVAVKCLKD-----DSTAAQAFLAEASVMTTLRHPN--- 61
Query: 183 IVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR---KFSQQLCTALLFL 238
+V+L + N L +V E ++ +L D LR+ RG ++ F+ +C + +L
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYL 118
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQYIQSRF---YRSPE 293
E N +H DL N+L+ K+ DFG GQ + + +PE
Sbjct: 119 E--EKNFVHRDLAARNVLVSE--DLVAKVSDFGLAKEASQGQDS-----GKLPVKWTAPE 169
Query: 294 VLLGIPYDLAIDMWSLGCILVEM 316
L + D+WS G +L E+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 58/237 (24%), Positives = 107/237 (45%), Gaps = 42/237 (17%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKAD---- 176
YE+ +IG+G+FG+V +++++K A + E++ ++D
Sbjct: 45 YEVVKVIGRGAFGEV--------------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF 90
Query: 177 --------VNNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKF 227
N+ ++V+L F +L +V E + +L +L+ N + R +
Sbjct: 91 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFY 147
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQY 283
+ ++ AL + + + IH D+KP+N+LL K +K+ DFG+ ++ + R
Sbjct: 148 TAEVVLALDAIHS--MGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 284 IQSRFYRSPEVLLGIP----YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
+ + Y SPEVL Y D WS+G L EM G+ F + V +KI+
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 68/279 (24%), Positives = 123/279 (44%), Gaps = 64/279 (22%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL---EIMNK 174
+ +++ +IG+G+FG+V +++++K ++ +KLL E++ +
Sbjct: 42 AEDFDVIKVIGRGAFGEV--------------QLVRHKS---SKQVYAMKLLSKFEMIKR 84
Query: 175 ADV------------NNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSL 221
+D N+ +IV+L F +L +V E + +L +L+ N + +
Sbjct: 85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPE 141
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--- 278
R ++ ++ AL + + + IH D+KP+N+LL K +K+ DFG+ ++
Sbjct: 142 KWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMDANGM 197
Query: 279 -RIYQYIQSRFYRSPEVLLGIP----YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 333
R + + Y SPEVL Y D WS+G L EM G+ F + V +
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
Query: 334 KIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKD 372
KI++ HK F PD I K+ KD
Sbjct: 258 KIMD-------------HKNSLTF---PDDIEISKQAKD 280
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 28/206 (13%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKN------KKPFLNQAQIEVKLLEIMNKADVNN 179
IGKG+FG V K L+ VA+K ++ K+ FL +A EI+ + D N
Sbjct: 2 KIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEA-------EILKQYDHPN 53
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
IV+L + + + +V EL+ +L LR R L + S + +L
Sbjct: 54 ---IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL-QMSLDAAAGMEYL 109
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE 293
+ N IH DL N L+ + + +KI DFG S + IY + +PE
Sbjct: 110 ESK--NCIHRDLAARNCLV--GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 294 VLLGIPYDLAIDMWSLGCILVEMHTG 319
L Y D+WS G +L E +
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 47/232 (20%)
Query: 123 IDSLIGKGSFGQVVKAFDLEEQ-----CHVAIKIIKNKKPFLNQAQI-----EVKLLEIM 172
+ +G+G FG+VVKA + VA+K++K + +++ E LL+ +
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQV 60
Query: 173 NKADVNNTY----------YIVRLKRHFMWRNHLCLVFEL-LSYNLYDLLRNTNF----- 216
N V Y IV ++ R+ L ++ SY D RN+++
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 217 -RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275
R +++ F+ Q+ + +L+ E+ ++H DL N+L+ ++ +KI DFG
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLAARNVLVAEGRK--MKISDFG---- 172
Query: 276 LGQRIYQ---YIQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
L + +Y+ Y++ R + E L Y D+WS G +L E+ T
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 35/129 (27%), Positives = 60/129 (46%), Gaps = 13/129 (10%)
Query: 225 RKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 284
K+++Q+ + +L ++H D+K N++L IK++DFG + +L
Sbjct: 105 CKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLM--PNGIIKLIDFGCARRLAWVGLHGT 160
Query: 285 QSRFYRS---------PEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
S +S PEV+ Y D+WS+GC + EM TG+P + + + M I
Sbjct: 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI 220
Query: 336 VEVLGLPPK 344
GL P+
Sbjct: 221 GAHRGLMPR 229
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 45/249 (18%)
Query: 119 DRYEIDSLIGKGSFGQVVKAF--DLE-EQCHVAIKIIKN------KKPFLNQAQIEVKLL 169
+ + IG+G FG V + E E+ VA+K KN ++ FL +A I
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI----- 60
Query: 170 EIMNKADVNNTYYIVRL----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLT 224
M + D + IV+L + +W +V EL L L+ + +L
Sbjct: 61 --MRQFDHPH---IVKLIGVITENPVW-----IVMELAPLGELRSYLQVNKYSLDLASLI 110
Query: 225 RKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 284
+S QL TAL +L + +H D+ N+L+ +P +K+ DFG S L Y Y
Sbjct: 111 -LYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESY-YK 164
Query: 285 QSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVE--MHTGEPLFSGSNEVDQMNKIV- 336
S+ + +PE + + A D+W G + E M +P N D + +I
Sbjct: 165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRIEN 223
Query: 337 -EVLGLPPK 344
E L +PP
Sbjct: 224 GERLPMPPN 232
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 23/144 (15%)
Query: 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256
CLV +LY L R + L ++QL +A+ ++ IIH D+K EN+L
Sbjct: 236 CLVLPKYRSDLYTYL-GARLRPLGLAQVTAVARQLLSAIDYIHGE--GIIHRDIKTENVL 292
Query: 257 LCNPKRSAIKIVDFGSSCQL-GQRIYQYIQSRFY---------RSPEVLLGIPYDLAIDM 306
+ P+ I + DFG++C G + F+ +PEVL G PY ++D+
Sbjct: 293 VNGPED--ICLGDFGAACFARGSW-----STPFHYGIAGTVDTNAPEVLAGDPYTPSVDI 345
Query: 307 WSLGCILVE--MHTGEPLFSGSNE 328
WS G ++ E +HT LFS S
Sbjct: 346 WSAGLVIFEAAVHTAS-LFSASRG 368
|
Length = 461 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 35/237 (14%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK---KPFLNQAQIEVKLLEIMNKAD 176
+Y I ++G G+ G V+ A + + A+K++ + + N+AQ EV L
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCL------- 85
Query: 177 VNNTYY-IVRLKRHFMWRN-----HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQ 229
+N ++ IV+ F ++ ++ ++ +L Y N DL + R + R F +
Sbjct: 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT---NRTFRE 142
Query: 230 QLCTALLFLS-------TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 282
LLF+ ++IH D+K NILLC+ +K+ DFG S +
Sbjct: 143 HE-AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS--NGLVKLGDFGFSKMYAATVSD 199
Query: 283 YIQSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
+ F Y +PE+ PY DM+SLG +L E+ T + F G N + M+K
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 34/206 (16%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQI-----EVKLLEIMNKADV 177
+G G FG+V + VA+K +K + K FL +AQI KL+++ +
Sbjct: 14 LGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
YIV EL+ Y +L + L+ R + L + Q+ + +
Sbjct: 73 EEPIYIVT---------------ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-YIQSRF---YRSP 292
+L N IH DL N+L+ + K+ DFG + + + IY+ ++F + +P
Sbjct: 118 YLE--AQNYIHRDLAARNVLVGE--NNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173
Query: 293 EVLLGIPYDLAIDMWSLGCILVEMHT 318
E L + + D+WS G +L E+ T
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 45/234 (19%)
Query: 119 DRYEIDSLIGKGSFGQV------------VKAFDLEEQCH----VAIKIIK---NKKPFL 159
R +G+G FG+V K F L+ + VA+K+++ NK
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK---- 60
Query: 160 NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFE----------LLSYNLYD 209
N +K ++IM++ N I+RL + + LC++ E L + +
Sbjct: 61 NARNDFLKEIKIMSRLKDPN---IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 210 LLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269
+ +S + + Q+ + + +LS+ LN +H DL N L+ K IKI D
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNCLV--GKNYTIKIAD 173
Query: 270 FGSSCQLGQRIYQYIQSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
FG S L Y IQ R + S E +L + A D+W+ G L E+ T
Sbjct: 174 FGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 22/229 (9%)
Query: 127 IGKGSFGQVVKAF--DLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIV 184
+G G+FG V K + + VA+KI+KN N ++ +LL N + YIV
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIV 59
Query: 185 RLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN 244
R+ LV EL + N N+T + Q+ + +L E N
Sbjct: 60 RMI-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-ELVHQVSMGMKYLE--ETN 115
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-RIYQYIQS------RFYRSPEVLLG 297
+H DL N+LL + KI DFG S LG Y ++ ++Y +PE +
Sbjct: 116 FVHRDLAARNVLLVTQHYA--KISDFGLSKALGADENYYKAKTHGKWPVKWY-APECMNY 172
Query: 298 IPYDLAIDMWSLGCILVEMHT-GEPLFSG--SNEVDQMNKIVEVLGLPP 343
+ D+WS G ++ E + G+ + G NEV QM + E + P
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQ 221
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 59/233 (25%), Positives = 91/233 (39%), Gaps = 48/233 (20%)
Query: 127 IGKGSFGQVVKAFDLEE---QCHVAIKIIK------NKKPFLNQAQIEVKLLEIMNKADV 177
+G G+FG VVK L + + VA+K +K KK FL +A + +L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--------- 53
Query: 178 NNTYYIVRL----KRHFMWRNHLCLVFELL---SYNLYDLLRNTNFRGVSLNLTRKFSQQ 230
+ IVRL K + LV EL Y L + L + Q
Sbjct: 54 -DHPCIVRLIGVCKGEPL-----MLVMELAPLGPLLKY-LKKRREIPVSDLKE---LAHQ 103
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQS-- 286
+ + +L + +H DL N+LL N R KI DFG S L G Y+ +
Sbjct: 104 VAMGMAYLE--SKHFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAGSDYYRATTAGR 159
Query: 287 ---RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335
++Y +PE + + D+WS G L E + G + + + +
Sbjct: 160 WPLKWY-APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 119 DRYEIDSLIGKGSFGQVVK--AFDLEEQ---CHVAIKIIKNKKPFLNQAQIEVKLLEIMN 173
+ +G G+FG+VV+ A+ L + VA+K++K ++ + + L+IM+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK-PTAHSSEREALMSELKIMS 93
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+ N IV L + ++ E Y +L + LR ++L FS Q+
Sbjct: 94 H--LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YI---QS 286
+ FL++ N IH DL N+LL + K +KI DFG L + I Y+ +
Sbjct: 152 KGMAFLASK--NCIHRDLAARNVLLTHGK--IVKICDFG----LARDIMNDSNYVVKGNA 203
Query: 287 RF---YRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
R + +PE + Y D+WS G +L E+ +
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 11/93 (11%)
Query: 245 IIHCDLKPENILLCNPK-RSAIKIVDFGSSCQLG----------QRIYQYIQSRFYRSPE 293
I+H DLKP+NI++ R K++DFG L R + + + Y +PE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
Query: 294 VLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS 326
L G P D+++ G I +E TG+ + G+
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGA 192
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 59/245 (24%), Positives = 98/245 (40%), Gaps = 57/245 (23%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL-LEIMNKADVNNTYYIVR 185
IG G+FG+V ++ A+K ++ + VK +I+ +AD ++V+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE---WVVK 65
Query: 186 LKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN 244
L F +++L V + + ++ LL +L R + +L A+ S ++
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEEDLARFYIAELTCAIE--SVHKMG 121
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFG--------------------------------- 271
IH D+KP+NIL+ + IK+ DFG
Sbjct: 122 FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 272 -SSC------QLGQRIYQYIQSRF------YRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
C + +R +Q + Y +PEVLL Y D WS+G IL EM
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 319 GEPLF 323
G+P F
Sbjct: 240 GQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 25/200 (12%)
Query: 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE---IMNKADVNNTYY 182
L+GKG+FG+V K L+++ VA+K K P ++++K L I+ + D N
Sbjct: 2 LLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLP----QELKIKFLSEARILKQYDHPN--- 53
Query: 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTR--KFSQQLCTALLFLST 240
IV+L R + +V EL+ D L + L + KF+ + +L +
Sbjct: 54 IVKLIGVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES 111
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-----QYIQSRFYRSPEVL 295
N IH DL N L+ + + +KI DFG S Q IY + I + + +PE L
Sbjct: 112 K--NCIHRDLAARNCLV--GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEAL 166
Query: 296 LGIPYDLAIDMWSLGCILVE 315
Y D+WS G +L E
Sbjct: 167 NYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 65/270 (24%), Positives = 105/270 (38%), Gaps = 51/270 (18%)
Query: 101 GYDDDNHDYIIQHGEKFLD-----RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK 155
DDD+ D +I +K + Y + + GS G+V A + V +KI +
Sbjct: 43 ESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI--GQ 100
Query: 156 KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTN 215
K IE LL+ +N V +R+K + C+V S +LY L
Sbjct: 101 KG---TTLIEAMLLQNVNHPSV------IRMKDTLVSGAITCMVLPHYSSDLYTYLTK-R 150
Query: 216 FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275
R + ++ +Q+ L +L IIH D+K ENI + + I D G++
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFI--NDVDQVCIGDLGAA-- 204
Query: 276 LGQRIYQYIQSRFY--------RSPEVLLGIPYDLAIDMWSLGCILVEM----HT----- 318
+ + F +PEVL Y+ D+WS G +L EM T
Sbjct: 205 ----QFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDP 260
Query: 319 ----GEPLFSGSNEVDQMNKIVEVLGLPPK 344
E + S + + KI+ L + P+
Sbjct: 261 PSTPEEYVKSCHS---HLLKIISTLKVHPE 287
|
Length = 357 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 64/247 (25%), Positives = 101/247 (40%), Gaps = 67/247 (27%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN--------KKPFLNQAQIEVKLL 169
+ RY+I LIGKG G+V A+D VA+K I+ KK FL +A+I L+
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 170 E--------IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNT-NFRGVS 220
I + D YY + + Y L LL++ +S
Sbjct: 61 HPGIVPVYSICSDGDP--VYYTMPY---------------IEGYTLKSLLKSVWQKESLS 103
Query: 221 LNLTRKFS--------QQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272
L K S ++C + ++ + ++H DLKP+NILL + I+D+G+
Sbjct: 104 KELAEKTSVGAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILL--GLFGEVVILDWGA 159
Query: 273 --SCQLGQRIYQYIQSRF-------------------YRSPEVLLGIPYDLAIDMWSLGC 311
+L + I Y +PE LLG+P + D+++LG
Sbjct: 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV 219
Query: 312 ILVEMHT 318
IL +M T
Sbjct: 220 ILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 46/222 (20%)
Query: 124 DSLIGKGSFGQVVKAFDLEE--QCHVAIKIIK------NKKPFLNQAQIEVKLLEIMNKA 175
+ +IG+G+FGQV++A ++ + + AIK++K + + F + ++ KL N
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN-- 64
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNF----------RGVSLNLT 224
I+ L R +L + E Y NL D LR + G + LT
Sbjct: 65 -------IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 225 R----KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 280
+F+ + T + +LS E IH DL N+L+ A KI DFG S G+ +
Sbjct: 118 SQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLVGE--NLASKIADFGLS--RGEEV 171
Query: 281 YQYIQSRFYRSPEVLLGIP------YDLAIDMWSLGCILVEM 316
Y++ R P + I Y D+WS G +L E+
Sbjct: 172 --YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMNKADVNNTYY 182
+G G FG+V VA+K +K + + FL +AQI KL + D Y
Sbjct: 14 LGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-----RHDKLVQLY 67
Query: 183 IVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP 241
V + + +V E +S +L D L++ R + L + Q+ + ++
Sbjct: 68 AV------VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE-- 119
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-SRF---YRSPEVLLG 297
+N IH DL+ NIL+ + KI DFG + + Y Q ++F + +PE L
Sbjct: 120 RMNYIHRDLRSANILVGD--GLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 298 IPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335
+ + D+WS G +L E+ T G + G N + + ++
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 121 YEIDSLIGKGSFGQV--VKAFDLEEQCHV-AIKIIK-----NKKPFLNQAQIEVKLLEIM 172
+E+ ++G G++G+V V+ + + A+K+++ K + + E +LE +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQ 230
++ ++V L F L L+ + +S L + NF S + R +S +
Sbjct: 62 RQSP-----FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNF---SEDEVRFYSGE 113
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL----GQRIYQYIQS 286
+ AL L +L I++ D+K ENILL + + DFG S + +R Y + +
Sbjct: 114 IILALEHLH--KLGIVYRDIKLENILL--DSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169
Query: 287 RFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
Y +PE++ G + A+D WSLG ++ E+ TG F+ E
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 118 LDRYEIDSL--IGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEI 171
+D E+ L +G G FG VV + VAIK+I+ ++ F+ +A ++
Sbjct: 1 IDPSELTFLKELGSGQFG-VVHLGKWRGKIDVAIKMIREGAMSEDDFIEEA-------KV 52
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQ 230
M K N +V+L + + +V E ++ L + LR + + L
Sbjct: 53 MMKLSHPN---LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL-DMCSD 108
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY---QYIQS- 286
+C A+ +L IH DL N L+ + + +K+ DFG + R QY S
Sbjct: 109 VCEAMEYLE--SNGFIHRDLAARNCLV--GEDNVVKVSDFGLA-----RYVLDDQYTSSQ 159
Query: 287 --RF---YRSPEVLLGIPYDLAIDMWSLGCILVEMHTG 319
+F + PEV + D+WS G ++ E+ +
Sbjct: 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 35/239 (14%)
Query: 123 IDSLIGKGSFGQVVKAFDLE--EQCH-VAIKIIKN------KKPFLNQAQIEVKLLEIMN 173
I+ +IG G FG+V + ++ VAIK +K + FL +A IM
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEAS-------IMG 60
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+ D N I+RL+ + ++ E + +L LR + + L + +
Sbjct: 61 QFDHPN---IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGML-RGIA 116
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY------IQS 286
+ + +LS E+N +H DL NIL+ + K+ DFG S +L Y I
Sbjct: 117 SGMKYLS--EMNYVHRDLAARNILVNSNLVC--KVSDFGLSRRLEDSEATYTTKGGKIPI 172
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVE-MHTGE-PLFSGSNEVDQMNKIVEVLGLPP 343
R + +PE + + A D+WS G ++ E M GE P + SN+ D + + + LPP
Sbjct: 173 R-WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-DVIKAVEDGYRLPP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL----GQRIYQYIQSRFYRSPEVLLG 297
+L II+ D+K ENILL + + DFG S + +R Y + + Y +P+++ G
Sbjct: 123 KLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 298 --IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+D A+D WS+G ++ E+ TG F+ E + +I
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR 222
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 118 LDRYEI--DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK----KPFLNQAQI--EVK-- 167
++R +I +G G +G+V + + VA+K +K + FL +A + E+K
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP 62
Query: 168 -LLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR 225
L++++ +YI+ E ++Y NL D LR N + V+ +
Sbjct: 63 NLVQLLGVCTREPPFYIIT---------------EFMTYGNLLDYLRECNRQEVNAVVLL 107
Query: 226 KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-YI 284
+ Q+ +A+ +L N IH DL N L+ +K+ DFG S + Y +
Sbjct: 108 YMATQISSAMEYLEKK--NFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA 163
Query: 285 QSRF---YRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
++F + +PE L + + D+W+ G +L E+ T
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNK 174
L + + +IG+G FG V++ ++ VA+K IK + FL + + M K
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEYTGQK--VAVKNIKCDVTAQAFLEETAV-------MTK 55
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
N +VRL + N L +V EL+S NL + LR VS+ +FS +
Sbjct: 56 LHHKN---LVRL-LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPE 293
+ +L + +L +H DL NIL+ + K+ DFG + + + +PE
Sbjct: 112 GMEYLESKKL--VHRDLAARNILV--SEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPE 167
Query: 294 VLLGIPYDLAIDMWSLGCILVEM 316
L + D+WS G +L E+
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 55/241 (22%), Positives = 99/241 (41%), Gaps = 61/241 (25%)
Query: 127 IGKGSFGQVVKA----FDLEEQCH-VAIKIIKN------KKPFLNQAQIEVKLLEIMNKA 175
+G+G+FG+V + E VA+K +K +K F +A E++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREA-------ELLTNF 65
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLN--------LTR- 225
N IV+ + +VFE + + +L LR+ L LT
Sbjct: 66 QHEN---IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 226 ---KFSQQLCTALLFLSTPELNIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQLGQRIY 281
+ + Q+ + +++L++ + +H DL N L+ + +KI DFG S + +Y
Sbjct: 123 QLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYD---LVVKIGDFGMS----RDVY 173
Query: 282 QYIQSRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMHT--GEPLFSGSN 327
+ +YR PE ++ + D+WS G +L E+ T +P + SN
Sbjct: 174 T---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230
Query: 328 E 328
E
Sbjct: 231 E 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGIP 299
++H DLK NI L IK+ DFG S Q + + S F Y +PE+
Sbjct: 190 MMHRDLKSANIFLM--PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR 247
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
Y DMWSLG IL E+ T F G ++ + M +++
Sbjct: 248 YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 46/220 (20%)
Query: 126 LIGKGSFGQVVKAFDLEE--QCHVAIKIIK------NKKPFLNQAQIEVKLLEIMNKADV 177
+IG+G+FGQV+KA ++ + AIK +K + + F + ++ KL N
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN---- 57
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNF----------RGVSLNLTR- 225
I+ L R +L L E + NL D LR + + L+
Sbjct: 58 -----IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 112
Query: 226 ---KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 282
F+ + + +LS + IH DL NIL+ + KI DFG S GQ +
Sbjct: 113 QLLHFAADVARGMDYLS--QKQFIHRDLAARNILV--GENYVAKIADFGLS--RGQEV-- 164
Query: 283 YIQSRFYRSPEVLLGIP------YDLAIDMWSLGCILVEM 316
Y++ R P + I Y D+WS G +L E+
Sbjct: 165 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 24/201 (11%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMNKADVNNTYY 182
+G G FG+V VA+K +K + + FL +AQI M K +
Sbjct: 14 LGAGQFGEVWMGT-WNGTTKVAVKTLKPGTMSPEAFLQEAQI-------MKKLRHDK--- 62
Query: 183 IVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP 241
+V+L + +V E +S +L D L++ + + L + Q+ + +L
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE-- 120
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-SRF---YRSPEVLLG 297
N IH DL NIL+ KI DFG + + Y + ++F + +PE
Sbjct: 121 SRNYIHRDLAARNILVGE--NLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 298 IPYDLAIDMWSLGCILVEMHT 318
+ + D+WS G +L E+ T
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 25/201 (12%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMNKADVNNTYY 182
+G+G FG+V VAIK +K + + FL +AQ+ KL + Y
Sbjct: 14 LGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL----RHEKLVQLYA 68
Query: 183 IVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP 241
+V + +V E +S +L D L+ + + L + Q+ + + ++
Sbjct: 69 VVS-------EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 119
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-SRF---YRSPEVLLG 297
+N +H DL+ NIL+ K+ DFG + + Y Q ++F + +PE L
Sbjct: 120 RMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 298 IPYDLAIDMWSLGCILVEMHT 318
+ + D+WS G +L E+ T
Sbjct: 178 GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 32/115 (27%), Positives = 56/115 (48%), Gaps = 12/115 (10%)
Query: 210 LLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269
L RN N ++L K++ Q+C + +L + +H DL N+L+ + + +KI D
Sbjct: 99 LPRNKN--KINLKQQLKYAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQ--VKIGD 152
Query: 270 FG--SSCQLGQRIYQYIQSR----FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
FG + + + Y F+ +PE L+ + +A D+WS G L E+ T
Sbjct: 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 66/240 (27%), Positives = 101/240 (42%), Gaps = 52/240 (21%)
Query: 118 LDRYEIDSLIGKGSFGQVVKA--FDLE---EQCHVAIKIIK---NKKPFLNQ-AQIEV-- 166
DR + +G+G+FGQVVKA L+ E VA+K++K +K + +++E+
Sbjct: 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMK 70
Query: 167 ---KLLEIMNKADVNNT----YYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGV 219
K I+N V Y +V H R+ L Y D R
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP----- 125
Query: 220 SLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275
LT+K F+ Q+ + FL++ + IH DL N+L+ + +KI DFG +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT--EDHVMKIADFGLA-- 179
Query: 276 LGQRIYQYIQSRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMHT--GEP 321
R +I +YR +PE L Y D+WS G +L E+ T G P
Sbjct: 180 ---RDIHHID--YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 34/206 (16%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNK-KPFLNQAQIEV---------KLLEIMNKAD 176
+G G FG+V + + + VAIKI+K+ Q EV L+ +
Sbjct: 14 LGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
V YI+ EL+ +L LR+ + + + + Q+ +
Sbjct: 73 VGEPVYIIT---------------ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF---YRSP 292
+L E N IH DL NIL+ + K+ DFG + + + +Y + + +P
Sbjct: 118 AYLE--EQNSIHRDLAARNILV--GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173
Query: 293 EVLLGIPYDLAIDMWSLGCILVEMHT 318
E + D+WS G +L EM T
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN-N 179
+E+ IG G++G V KA ++ AIK+IK +P + A ++ +++ + + N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
Y+ L+R +W +C+ F +L D+ T +S + S++ L +L
Sbjct: 70 AYFGSYLRRDKLW---ICMEF-CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH 123
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRSPEVLL 296
+ +H D+K NILL + +K+ DFG S Q+ I + +I + ++ +PEV
Sbjct: 124 SK--GKMHRDIKGANILLTD--NGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179
Query: 297 ---GIPYDLAIDMWSLGCILVEMHTGEP 321
Y+ D+W++G +E+ +P
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMNKADVN 178
+D +G+G FG+V VAIK +K + FL +AQI KL + D
Sbjct: 10 LDVKLGQGCFGEVWMG-TWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-----RHDKL 63
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
Y V + + +V E + +L D L+ + + + L + Q+ + +
Sbjct: 64 VPLYAV------VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-SRF---YRSPE 293
+ +N IH DL+ NIL+ + KI DFG + + Y Q ++F + +PE
Sbjct: 118 IE--RMNYIHRDLRAANILVGD--NLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 294 VLLGIPYDLAIDMWSLGCILVEMHT 318
L + + D+WS G +L E+ T
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 118 LDRYEIDSL--IGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLL-- 169
+D ++ L +G G FG VVK Q VAIK+IK ++ F+ +A++ +KL
Sbjct: 1 IDPKDLTFLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHE 59
Query: 170 EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229
+++ V + + +M ++ CL L+Y LR R L + +
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYM--SNGCL----LNY-----LREHGKRFQPSQLL-EMCK 107
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQRIYQYIQSRF 288
+C + +L + + IH DL N L+ + +K+ DFG S L + S+F
Sbjct: 108 DVCEGMAYLESKQF--IHRDLAARNCLV--DDQGCVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 289 ---YRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ PEVLL + D+W+ G ++ E+++
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 21/199 (10%)
Query: 127 IGKGSFGQVVKA-FDLE-EQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKADVNNTYY 182
+G G+FG V K + + +Q VAIK++K N+K ++ E EIM++ D Y
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREA---EIMHQLD---NPY 56
Query: 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242
IVR+ L LV E+ S + + ++++ + Q+ + +L
Sbjct: 57 IVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE--G 113
Query: 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YRSPEVLL 296
N +H DL N+LL N + KI DFG S LG Y + +PE +
Sbjct: 114 KNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 297 GIPYDLAIDMWSLGCILVE 315
+ D+WS G + E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 60/246 (24%), Positives = 108/246 (43%), Gaps = 40/246 (16%)
Query: 127 IGKGSFGQVVKA--FDLEEQCH---VAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNN 179
+G+G+FG+V K E+ VAIK +K + + E +L+ + +
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN--- 69
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSY-NLYD-LLRNTNFRGVSLNLTRKFSQ-------- 229
IV L C++FE L++ +L++ L+RN+ V + +
Sbjct: 70 ---IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 230 -----QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 284
Q+ + +LS+ + +H DL N L+ + +KI DFG S + Y +
Sbjct: 127 LHIAIQIAAGMEYLSSH--HFVHRDLAARNCLV-GEGLT-VKISDFGLSRDIYSADYYRV 182
Query: 285 QSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHT--GEPLFSGSN-EVDQMNKIV 336
QS+ + PE +L + D+WS G +L E+ + +P + SN EV +M +
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242
Query: 337 EVLGLP 342
++L P
Sbjct: 243 QLLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 49/211 (23%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNK---KPFLNQAQIE--------VKLLEIMNKA 175
IGKG FG V+ VA+K IKN + FL +A + V+LL ++
Sbjct: 14 IGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI--V 69
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSL---NLTRKFSQQLC 232
+ YIV +M + LV D LR+ RG S+ + KFS +C
Sbjct: 70 EEKGGLYIVT---EYMAKG--SLV---------DYLRS---RGRSVLGGDCLLKFSLDVC 112
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG-----SSCQLGQRIYQYIQSR 287
A+ +L N +H DL N+L+ + + K+ DFG SS Q ++
Sbjct: 113 EAMEYLEAN--NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEASSTQDTGKL-----PV 163
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ +PE L + D+WS G +L E+++
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 9/92 (9%)
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 288
Q+ + + +LS+ LN +H DL N L+ + IKI DFG S L Y IQ R
Sbjct: 146 QIASGMKYLSS--LNFVHRDLATRNCLV--GENLTIKIADFGMSRNLYAGDYYRIQGRAV 201
Query: 289 ----YRSPEVLLGIPYDLAIDMWSLGCILVEM 316
+ + E +L + A D+W+ G L E+
Sbjct: 202 LPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 48/248 (19%)
Query: 122 EIDSLIGKGSFGQV----VKAFDLEEQCHVAIKIIK------NKKPFLNQAQIEVKLLEI 171
+I+ +IG G FG+V +K E VAIK +K ++ FL++A I
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIF-VAIKTLKSGYTEKQRRDFLSEASI------- 58
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYD-LLRNTNFRGVSLNLTRKFSQQ 230
M + D N I+ L+ + ++ E + D LR + + + L +
Sbjct: 59 MGQFDHPN---IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGML-RG 114
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS-------------CQLG 277
+ + +LS E+N +H DL NIL+ + K+ DFG S LG
Sbjct: 115 IAAGMKYLS--EMNYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 278 QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVE-MHTGE-PLFSGSNEVDQMNKI 335
+I + +PE + + A D+WS G ++ E M GE P + SN+ D +N I
Sbjct: 171 GKI-----PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAI 224
Query: 336 VEVLGLPP 343
+ LPP
Sbjct: 225 EQDYRLPP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 127 IGKGSFGQV--VKAFDLEE--------QCH----VAIKIIKN--KKPFLNQAQIEVKLLE 170
+G+G FG+V +A L E VA+K+++ K N E+K++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS---YNLY--------DLLRNTNFRGV 219
+ + I+RL + + LC++ E + N + N V
Sbjct: 73 RLKNPN------IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 220 SLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279
S+ + Q+ + + +L++ LN +H DL N L+ N IKI DFG S L
Sbjct: 127 SIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCLVGN--HYTIKIADFGMSRNLYSG 182
Query: 280 IYQYIQS------RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
Y IQ R+ +LLG + A D+W+ G L EM T
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 11/98 (11%)
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ- 285
FS Q+ + FL++ N +H DL N+L+C K +KI DFG + + R YI
Sbjct: 244 FSYQVANGMEFLASK--NCVHRDLAARNVLICEGK--LVKICDFGLARDI-MRDSNYISK 298
Query: 286 -SRF----YRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
S F + +PE + Y D+WS G +L E+ T
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 45/176 (25%), Positives = 71/176 (40%), Gaps = 22/176 (12%)
Query: 182 YIVRLKRHFMWRNHLCLVFE------LLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
+V L ++ + + + LV + L S+ F + ++++ ++ AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS-------KFLNIPEECVKRWAAEMVVAL 98
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVL 295
L I+ DL P NILL R I++ F ++ Y +PEV
Sbjct: 99 DALH--REGIVCRDLNPNNILL--DDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVG 154
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLF----SGSNEVDQMNKIVEVLGLPPKHLL 347
A D WSLG IL E+ TG+ L SG N +N I E + + LL
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN-IPEWVSEEARSLL 209
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 10/98 (10%)
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYI 284
F+QQ+C + +L + + IH DL N+LL N + +KI DFG + + G Y+
Sbjct: 112 FAQQICEGMAYLHSQ--HYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEYYRVR 167
Query: 285 QSR----FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ F+ + E L + A D+WS G L E+ T
Sbjct: 168 EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 31/209 (14%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKL----LEIMN 173
+++ +G G FG+V A + VA+K +K + + FL +A + L L ++
Sbjct: 9 KLEKKLGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 67
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
YI+ FM + +L D L++ L FS Q+
Sbjct: 68 AVVTKEPIYIIT---EFMAKG-----------SLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-SRF---Y 289
+ F+ + N IH DL+ NIL+ KI DFG + + Y + ++F +
Sbjct: 114 GMAFIE--QRNYIHRDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+PE + + + D+WS G +L+E+ T
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 60/248 (24%), Positives = 98/248 (39%), Gaps = 57/248 (22%)
Query: 126 LIGKGSFGQVVK--AFDL----EEQCHVAIK------IIKNKKPFLNQAQIEVKLLEIMN 173
+G G+FG+V + A D+ VA+K + KK FL +A + M+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHL-------MS 54
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLL------RNTNFRGVSLNLTR-- 225
+ N IV+L + ++ EL+ DLL R F L L
Sbjct: 55 NFNHPN---IVKLLGVCLLNEPQYIIMELMEGG--DLLSYLRDARVERFGPPLLTLKELL 109
Query: 226 KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA---IKIVDFGSSCQLGQRIYQ 282
+ ++L +++ IH DL N L+ A +KI DFG L + IY+
Sbjct: 110 DICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG----LARDIYK 163
Query: 283 YIQSRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEV 329
S +YR +PE LL + D+WS G ++ E+ T G+ + N
Sbjct: 164 ---SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
Query: 330 DQMNKIVE 337
+ + +
Sbjct: 221 EVLQHVTA 228
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 37/120 (30%), Positives = 55/120 (45%), Gaps = 31/120 (25%)
Query: 206 NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265
+L DLLR FS Q+ + FL++ N IH D+ N+LL + R A
Sbjct: 210 DLDDLLR--------------FSSQVAQGMDFLASK--NCIHRDVAARNVLLTD-GRVA- 251
Query: 266 KIVDFGSSCQLGQRIYQ---YI---QSRF---YRSPEVLLGIPYDLAIDMWSLGCILVEM 316
KI DFG L + I Y+ +R + +PE + Y + D+WS G +L E+
Sbjct: 252 KICDFG----LARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 34/117 (29%), Positives = 53/117 (45%), Gaps = 17/117 (14%)
Query: 209 DLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268
+LL + G++ F+ Q+ + FL++ N +H DL N+LL K +KI
Sbjct: 224 NLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK--NCVHRDLAARNVLLAQGK--IVKIC 279
Query: 269 DFGSSCQLGQRI-----YQYIQSRF----YRSPEVLLGIPYDLAIDMWSLGCILVEM 316
DFG L + I Y S F + +PE + Y D+WS G +L E+
Sbjct: 280 DFG----LARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 16/86 (18%)
Query: 245 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSRFYRSPEVLLGIPYD 301
I+H D+KP N+L+ + K +KI DFG S L Q + + + Y SPE I D
Sbjct: 189 IVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSSVGTIAYMSPE---RINTD 243
Query: 302 L--------AIDMWSLGCILVEMHTG 319
L A D+WSLG ++E + G
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 50/222 (22%), Positives = 97/222 (43%), Gaps = 17/222 (7%)
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL 186
+G G FG+V + VA+K +K + E L++ + + Y +V
Sbjct: 14 LGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNI 245
+ + ++ E ++ +L D L++ V L FS Q+ + ++ N
Sbjct: 73 EEP------IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--NY 124
Query: 246 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-SRF---YRSPEVLLGIPYD 301
IH DL+ N+L+ + KI DFG + + Y + ++F + +PE + +
Sbjct: 125 IHRDLRAANVLV--SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 302 LAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP 342
+ D+WS G +L E+ T G+ + G + D M+ + +P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 23/88 (26%), Positives = 32/88 (36%), Gaps = 6/88 (6%)
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPE 293
A+ L +H K NILL + GS Q ++ +PE
Sbjct: 21 AVCLQCLGALRELHRQAKSGNILLTWDGL----LKLDGSVAFKTPE--QSRPDPYFMAPE 74
Query: 294 VLLGIPYDLAIDMWSLGCILVEMHTGEP 321
V+ G Y D++SLG L E E
Sbjct: 75 VIQGQSYTEKADIYSLGITLYEALDYEL 102
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 17/101 (16%)
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---Y 283
+S Q+ + FL++ + IH DL NILL + +KI DFG L + IY+ Y
Sbjct: 178 YSFQVARGMEFLASRK--CIHRDLAARNILLSE--NNVVKICDFG----LARDIYKDPDY 229
Query: 284 IQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
++ R +PE + Y D+WS G +L E+ +
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 33/241 (13%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEE----QCHVAIKIIKN-KKPFLNQAQIEVKLLEIMNKA 175
++ ++G G+FG V K + E + VAIK ++ P N+ EI+++A
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--------EILDEA 60
Query: 176 DVNNTY---YIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQL 231
V + ++ RL + + L+ +L+ + L D +R S L + Q+
Sbjct: 61 YVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL-NWCVQI 118
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRS 291
+ +L E ++H DL N+L+ P+ +KI DFG + LG +Y + +
Sbjct: 119 AKGMNYLE--ERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEY-HAEGGKV 173
Query: 292 P------EVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSG--SNEVDQMNKIVEVLGLP 342
P E +L Y D+WS G + E+ T G + G ++E+ + + E L P
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 233
Query: 343 P 343
P
Sbjct: 234 P 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 18/35 (51%), Positives = 23/35 (65%)
Query: 289 YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLF 323
Y +PE+LLG P+ A+D W+LG L E TG P F
Sbjct: 546 YLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF 580
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 51/235 (21%)
Query: 127 IGKGSFGQVVKAFDLEEQCH----------VAIKIIKNKKPFLNQA-QIEVKLLEIMNKA 175
+G+G+FG+V A +CH VA+K +K Q Q E +LL ++
Sbjct: 13 LGEGAFGKVFLA-----ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ 67
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRG----------------V 219
+IVR L +VFE + + DL R G +
Sbjct: 68 ------HIVRFYGVCTEGRPLLMVFEYMRHG--DLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 220 SLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279
+L + Q+ + +++L++ L+ +H DL N L+ + +KI DFG S +
Sbjct: 120 TLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLV--GQGLVVKIGDFGMSRDIYST 175
Query: 280 IYQYIQSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHT--GEPLFSGSN 327
Y + R + PE +L + D+WS G +L E+ T +P + SN
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 57/242 (23%), Positives = 110/242 (45%), Gaps = 48/242 (19%)
Query: 127 IGKGSFGQVVKA--FDL---EEQCHVAIKIIKN-----KKPFLNQAQIEVKLLEIMNKAD 176
+G+G+FG+V A ++L +++ VA+K +K+ +K F +A++ L
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-------- 64
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSL-------NLTRK-- 226
+IV+ + + L +VFE + + +L LR V + LT+
Sbjct: 65 --QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 227 --FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 284
+QQ+ +++L++ + +H DL N L+ + +KI DFG S + Y +
Sbjct: 123 LHIAQQIAAGMVYLASQ--HFVHRDLATRNCLV--GENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 285 QSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHT--GEPLFSGSNEVDQMNKIVE 337
+ PE ++ + D+WSLG +L E+ T +P + SN N+++E
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIE 233
Query: 338 VL 339
+
Sbjct: 234 CI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 493 | |||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| KOG2052|consensus | 513 | 99.97 | ||
| KOG1152|consensus | 772 | 99.97 | ||
| KOG0200|consensus | 609 | 99.97 | ||
| KOG0576|consensus | 829 | 99.97 | ||
| KOG1025|consensus | 1177 | 99.97 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345|consensus | 378 | 99.96 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1024|consensus | 563 | 99.95 | ||
| KOG0590|consensus | 601 | 99.94 | ||
| KOG1164|consensus | 322 | 99.94 | ||
| KOG1163|consensus | 341 | 99.93 | ||
| KOG0603|consensus | 612 | 99.93 | ||
| KOG1165|consensus | 449 | 99.92 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0606|consensus | 1205 | 99.9 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1240|consensus | 1431 | 99.88 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG4158|consensus | 598 | 99.85 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0195|consensus | 448 | 99.83 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1166|consensus | 974 | 99.83 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1033|consensus | 516 | 99.78 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0590|consensus | 601 | 99.7 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1023|consensus | 484 | 99.67 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0601|consensus | 524 | 99.59 | ||
| KOG0606|consensus | 1205 | 99.57 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG1266|consensus | 458 | 99.4 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| KOG0601|consensus | 524 | 99.32 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| KOG1243|consensus | 690 | 99.15 | ||
| KOG3087|consensus | 229 | 99.1 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| KOG2137|consensus | 700 | 98.92 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| KOG3741|consensus | 655 | 98.74 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| KOG0576|consensus | 829 | 98.33 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| KOG1235|consensus | 538 | 98.25 | ||
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.81 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.68 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.59 | |
| KOG1035|consensus | 1351 | 97.56 | ||
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.53 | |
| KOG2270|consensus | 520 | 97.48 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 97.44 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.39 | |
| KOG1093|consensus | 725 | 97.37 | ||
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.31 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.29 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.16 | |
| KOG2268|consensus | 465 | 96.93 | ||
| PLN02236 | 344 | choline kinase | 96.92 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.84 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.81 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.63 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.41 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.34 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.23 | |
| KOG1826|consensus | 2724 | 96.07 | ||
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.01 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.9 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.88 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.79 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.76 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.71 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.68 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.59 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.5 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.32 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.92 | |
| KOG1236|consensus | 565 | 94.69 | ||
| PTZ00296 | 442 | choline kinase; Provisional | 93.57 |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-72 Score=568.55 Aligned_cols=400 Identities=52% Similarity=0.817 Sum_probs=344.7
Q ss_pred cCCcccCCCCCCchhhhhHHHHHHhhhhhHHHHHHHHHHhhhhcCCCCchhhhhhhccCCCCCCCCcceeeccceecCcE
Q psy16081 42 RIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRY 121 (493)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 121 (493)
.....+|.....++...+.++.+++..++..++.....+.++....... .....+++++..+|.+...+.+..+|
T Consensus 114 ~~~~~~~~~~~~~~~~~~~s~~e~~ei~~~~~~~~~~~~~~~~~t~~~~-----~~~~~~~~~~~~dY~~v~~d~i~~rY 188 (586)
T KOG0667|consen 114 RENSGLRPSQASPLYKHSLSLIETYEIINYPEVYFVGLNAKKVLTFPSE-----GINTKNFDDEDGDYQLVVNDHIAYRY 188 (586)
T ss_pred ccccCcCchhhhhhhccccchhhhhhccChHHhhhhccccccccCCCcc-----cccCCCCCCCCCceeEEecceeEEEE
Confidence 3445677777888889999999999999988776555544333222222 22233377788889988888888899
Q ss_pred EEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEE
Q psy16081 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFE 201 (493)
Q Consensus 122 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E 201 (493)
+|++.||+|+||+|.+|.|..|++.||||++++.+.+..+...|+.+|+.++..+..+..|||+++++|..++|+|||+|
T Consensus 189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 99999999999999999999999999999999999999999999999999998888888899999999999999999999
Q ss_pred ecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCccc
Q psy16081 202 LLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281 (493)
Q Consensus 202 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~ 281 (493)
+++.+|+++++.+.+.+++...++.|++||+.||.+|| +.+|||||||||||||++.....|||+|||+|+..++..+
T Consensus 269 LL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy 346 (586)
T KOG0667|consen 269 LLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY 346 (586)
T ss_pred hhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCceeEEecccccccCCcce
Confidence 99999999999999999999999999999999999999 6899999999999999888888999999999999999999
Q ss_pred cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCC
Q psy16081 282 QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMP 361 (493)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~ 361 (493)
++++|++|+|||+++|.+|+.++||||||||++||++|.|+|.|.++.|+++.|++.+|.||..|++.+++++.||++.
T Consensus 347 tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~- 425 (586)
T KOG0667|consen 347 TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSL- 425 (586)
T ss_pred eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhcc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred CCCceecCCCC-CCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCC
Q psy16081 362 DGSYILKKPKD-GRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 362 ~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~ 440 (493)
.+.+....... .+....+..+..........++|++.+-.+......++..|+|||.+||++||.+|+|+.|+|+||||
T Consensus 426 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl 505 (586)
T KOG0667|consen 426 KGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFL 505 (586)
T ss_pred CCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccc
Confidence 22222222211 12224445555555555666677666666677777788899999999999999999999999999999
Q ss_pred CCCccCCCC
Q psy16081 441 KRTADESTN 449 (493)
Q Consensus 441 ~~~~~~~~~ 449 (493)
+........
T Consensus 506 ~~~~~~~~~ 514 (586)
T KOG0667|consen 506 TGTSLERRN 514 (586)
T ss_pred ccccccccC
Confidence 976655443
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-59 Score=451.84 Aligned_cols=350 Identities=29% Similarity=0.374 Sum_probs=255.6
Q ss_pred ccccccCCCCC--cchhhhhccCCc----------ccCCCCCCc-hhhhhHHHHHHhhhhhHHHHHHHHHHhhhhcCCCC
Q psy16081 23 GRLVAEEPSCP--GDILAMQARIPL----------QFRDPATAP-LRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDS 89 (493)
Q Consensus 23 ~~~~~~~~~~~--~~~~~~~~~~~~----------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~ 89 (493)
-|++||++.|+ .....+++++.. +||.-.... -..+..|.+.+.+.+|.....+..+|......+..
T Consensus 65 ~f~fGR~~~~d~~ln~~~~s~~~~~i~~~~~~~~~~f~~dr~~~sn~~y~~DhS~nGT~VN~e~i~k~~~r~lkN~dei~ 144 (475)
T KOG0615|consen 65 EFTFGRGDSCDAPLNLNNVSNKHFKILLYNKISKIHFRIDRDKNSNRVYLHDHSRNGTFVNDEMIGKGLSRILKNGDEIS 144 (475)
T ss_pred eEEecCCCcccccccCccccccchheeeeeeeeeeeecccCCCccceEEEEecccCcccccHhHhhccccccccCCCEEE
Confidence 38899999998 333335554331 233222221 13455688888888998888888777665544433
Q ss_pred chhhhhhhc--cCCCCCCCCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc--------
Q psy16081 90 SHKKEKKLY--NEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL-------- 159 (493)
Q Consensus 90 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-------- 159 (493)
..-...+.+ .....+.. .-..+.+.+.|.+.+.||+|+||.|-+|+++.||+.||||++.+.....
T Consensus 145 is~p~~~~~v~~~~s~d~~----~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~ 220 (475)
T KOG0615|consen 145 ISIPALKIFVFEDLSRDSS----KVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKT 220 (475)
T ss_pred eccchhheeeeecccchhc----cCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccch
Confidence 221111111 11111111 1122346788999999999999999999999999999999998543222
Q ss_pred hHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH
Q psy16081 160 NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238 (493)
Q Consensus 160 ~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L 238 (493)
...++|++++. ..+||+||+++++|+..++.||||||++ |+|++.+..+. .+.++..+.+++||+.|+.||
T Consensus 221 ~~v~~EieILk------kL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYL 292 (475)
T KOG0615|consen 221 RDVQNEIEILK------KLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYL 292 (475)
T ss_pred hhhHHHHHHHH------hcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHH
Confidence 11234544443 3468889999999999999999999995 59999997765 588999999999999999999
Q ss_pred hCCCCCccccCCCCCcEEeeCC-CCCcEEEEecccccccCC--ccccccccCcCCchhhhcCCC---CCchhhHHHHHHH
Q psy16081 239 STPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIP---YDLAIDMWSLGCI 312 (493)
Q Consensus 239 hs~~~~iiHrDlKp~NILl~~~-~~~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvi 312 (493)
| +.||+||||||+|||+.++ ++..+||+|||+|+..++ -+.+.||||.|.|||++.+.. +..++||||||||
T Consensus 293 H--~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcv 370 (475)
T KOG0615|consen 293 H--SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCV 370 (475)
T ss_pred H--HcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccce
Confidence 9 5899999999999999655 567899999999998854 467899999999999999775 3458999999999
Q ss_pred HHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhcccc
Q psy16081 313 LVEMHTGEPLFSGSNEVD-QMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVE 391 (493)
Q Consensus 313 l~elltG~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 391 (493)
||-||+|.+||++..... ...+|.+ |.|... .+
T Consensus 371 LfvcLsG~pPFS~~~~~~sl~eQI~~-------------------------G~y~f~---------p~------------ 404 (475)
T KOG0615|consen 371 LFVCLSGYPPFSEEYTDPSLKEQILK-------------------------GRYAFG---------PL------------ 404 (475)
T ss_pred EEEEeccCCCcccccCCccHHHHHhc-------------------------Cccccc---------Ch------------
Confidence 999999999998765433 3333332 222110 00
Q ss_pred CCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 392 SGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.|..+++ +.+|||.+||.+||++|||+.|||+||||+....
T Consensus 405 -----------~w~~Ise--ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 405 -----------QWDRISE--EALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred -----------hhhhhhH--HHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 1112222 7899999999999999999999999999996543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-56 Score=435.01 Aligned_cols=290 Identities=35% Similarity=0.514 Sum_probs=235.8
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCC-cceEEEeceeeeecc
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN-TYYIVRLKRHFMWRN 194 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~-~~~Iv~l~~~~~~~~ 194 (493)
.+.++|.++++||.|+||.||+|+.+.+++.||||.++++-.. ..|..-++++..+...+ |||||+|.+++.+.+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s----~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc----HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3567999999999999999999999999999999999854322 22333333333333334 899999999999988
Q ss_pred -eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 -HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 -~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+|||||+.+|+++++.. .+.|++..++.|+.||++||+|+| +.|+.||||||+|||+ .....|||+|||+|
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi--~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILI--SGNDVIKIADFGLA 157 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEe--cccceeEecccccc
Confidence 99999999999999999887 478999999999999999999999 5799999999999999 45778999999999
Q ss_pred cccC--CccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 274 CQLG--QRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 274 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
+... .+.+.++.|++|+|||+++. ..|+.+.||||+|||++|+.+-+|.|.|.++.|++.+|.+++|.|....|..+
T Consensus 158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 9885 45678999999999999985 46999999999999999999999999999999999999999999988777654
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.+...-+. |.+. +. ....+.+++.. ...++.+||.+||.|||.+|||
T Consensus 238 ~~La~~mn------f~~P--------~~-~~~~l~~L~p~------------------~s~~~~~li~~ll~WDP~kRpT 284 (538)
T KOG0661|consen 238 YNLASAMN------FRFP--------QV-KPSPLKDLLPN------------------ASSEAASLIERLLAWDPDKRPT 284 (538)
T ss_pred HHHHHHhc------cCCC--------cC-CCCChHHhCcc------------------cCHHHHHHHHHHhcCCCccCcc
Confidence 33221111 1111 11 11223333321 1127889999999999999999
Q ss_pred HHHHhcCCCCCCCccCC
Q psy16081 431 PYYALQHNFFKRTADES 447 (493)
Q Consensus 431 ~~e~L~Hp~~~~~~~~~ 447 (493)
|.|+|+||||+......
T Consensus 285 A~~al~~pffq~~~~~~ 301 (538)
T KOG0661|consen 285 ASQALQHPFFQVGRASG 301 (538)
T ss_pred HHHHhcCcccccccccc
Confidence 99999999999765443
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-55 Score=407.41 Aligned_cols=286 Identities=30% Similarity=0.498 Sum_probs=228.3
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|+.+.++|+|+||.||+|+++.||+.||||++...+... ...++ .+++++.+....|+|+|.|+++|.....++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~--~VkKI-AlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP--VVKKI-ALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH--HHHHH-HHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 57899999999999999999999999999999997544321 11111 2233334444567789999999999999999
Q ss_pred EEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 199 VFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 199 V~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|+|||+.++++.|.... .+++...++.++.|++.|+.|+|+ .++|||||||+|||| ..++.+||||||+|+.+..
T Consensus 79 VFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILi--t~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILI--TQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred EeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEE--ecCCcEEeccchhhHhhcC
Confidence 99999999999887766 589999999999999999999996 579999999999999 7899999999999988853
Q ss_pred ---ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 279 ---RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 279 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
..+.++.|++|+|||.+.| .+|+.++||||+||++.||++|.+.|.|.++.|++..|+..+|.....-..-. ..+
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF-~~N 232 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF-SSN 232 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh-ccC
Confidence 3567899999999999998 68999999999999999999999999999999999999999996654433322 223
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
.||..+. +..+ .-..|..+++..+.+ .+.||+.+||..||.+|++.+|+
T Consensus 233 ~~F~Gv~-----lP~~----~~~epLe~k~p~~s~----------------------~~ld~~k~cL~~dP~~R~sc~ql 281 (396)
T KOG0593|consen 233 PFFHGVR-----LPEP----EHPEPLERKYPKISN----------------------VLLDLLKKCLKMDPDDRLSCEQL 281 (396)
T ss_pred Cceeeee-----cCCC----CCccchhhhcccchH----------------------HHHHHHHHHhcCCccccccHHHH
Confidence 3443321 1100 011111222222211 57899999999999999999999
Q ss_pred hcCCCCCCCc
Q psy16081 435 LQHNFFKRTA 444 (493)
Q Consensus 435 L~Hp~~~~~~ 444 (493)
|.||||.++.
T Consensus 282 l~H~yFd~~~ 291 (396)
T KOG0593|consen 282 LHHPYFDGFI 291 (396)
T ss_pred hcChHHHHHH
Confidence 9999997653
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-53 Score=421.52 Aligned_cols=266 Identities=31% Similarity=0.487 Sum_probs=217.6
Q ss_pred eeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEe
Q psy16081 111 IQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 111 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
.+....-.++|+++++||+|+||.||+|+.+.||+.||+|++++.... ......|+.+|. ....++||+|
T Consensus 133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~------~~ds~~vVKL 206 (550)
T KOG0605|consen 133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILA------EVDSPWVVKL 206 (550)
T ss_pred hccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhh------hcCCCcEEEE
Confidence 344444578999999999999999999999999999999999864422 122223333332 2567789999
Q ss_pred ceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 187 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
+..|++.+++||||||++| ++..+|.+.. .|+++.++.++.+++.|+.-+| +.|+|||||||+|+|| |..|++
T Consensus 207 yYsFQD~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLi--D~~GHi 280 (550)
T KOG0605|consen 207 YYSFQDKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLI--DAKGHI 280 (550)
T ss_pred EEEecCCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheee--cCCCCE
Confidence 9999999999999999955 9999998764 6999999999999999999999 6899999999999999 899999
Q ss_pred EEEecccccccCC-------------------------c-------------------------cccccccCcCCchhhh
Q psy16081 266 KIVDFGSSCQLGQ-------------------------R-------------------------IYQYIQSRFYRSPEVL 295 (493)
Q Consensus 266 kL~DFG~a~~~~~-------------------------~-------------------------~~~~~gt~~y~aPE~~ 295 (493)
||+|||||..+.. . .+..+|||.|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 9999999843200 0 1125899999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCC
Q psy16081 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRK 375 (493)
Q Consensus 296 ~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (493)
.+.+|+..+|+|||||||||||.|.|||.+.++.+++.+|+..-... .|
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l------------~f------------------- 409 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL------------KF------------------- 409 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc------------cC-------------------
Confidence 99999999999999999999999999999999999999998742110 00
Q ss_pred CCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC---HHHHhcCCCCCCCccCCC
Q psy16081 376 PKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT---PYYALQHNFFKRTADEST 448 (493)
Q Consensus 376 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t---~~e~L~Hp~~~~~~~~~~ 448 (493)
|... ..+ .+++|||.+||. ||++|+- ++||-+||||+.+..+.-
T Consensus 410 ---P~~~-----------------------~~s--~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l 456 (550)
T KOG0605|consen 410 ---PEEV-----------------------DLS--DEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHL 456 (550)
T ss_pred ---CCcC-----------------------ccc--HHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchh
Confidence 0000 000 278999999999 9999995 999999999999876543
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=409.03 Aligned_cols=254 Identities=35% Similarity=0.518 Sum_probs=217.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|+++++||+|+||+||+++.+.|++.||+|+++++... ......|+.+++. .+||+||+++..|++.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~------v~hPFiv~l~ysFQt~ 97 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSK------IKHPFIVKLIYSFQTE 97 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHh------CCCCcEeeeEEecccC
Confidence 56899999999999999999999999999999999865432 2233344444433 6799999999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|||+||+. |.|+-.|.+.. .++++.++.++.+|+.||.||| +.|||||||||+|||| |..|+|+|+|||+
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILL--d~~GHi~LtDFgL 171 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILL--DEQGHIKLTDFGL 171 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeee--cCCCcEEEecccc
Confidence 99999999995 49999998664 6999999999999999999999 5799999999999999 8999999999999
Q ss_pred cccc---CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChhhhh
Q psy16081 273 SCQL---GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL-GLPPKHLLD 348 (493)
Q Consensus 273 a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~ 348 (493)
|+.. +....++|||+.|||||++.+.+|+.++|+|||||++|||++|.+||.+.+....+.+|...- ..+|..+
T Consensus 172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~l-- 249 (357)
T KOG0598|consen 172 CKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYL-- 249 (357)
T ss_pred chhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccC--
Confidence 9754 334567899999999999999999999999999999999999999999999999988887642 1111000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
+ .+.+|||.++|..||++|
T Consensus 250 -----------------------------------------------------------s--~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 250 -----------------------------------------------------------S--EEARDLLKKLLKRDPRQR 268 (357)
T ss_pred -----------------------------------------------------------C--HHHHHHHHHHhccCHHHh
Confidence 0 167899999999999999
Q ss_pred C----CHHHHhcCCCCCCCccC
Q psy16081 429 I----TPYYALQHNFFKRTADE 446 (493)
Q Consensus 429 ~----t~~e~L~Hp~~~~~~~~ 446 (493)
+ .+.++-+||||..+..+
T Consensus 269 Lg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 269 LGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred cCCCCChHHhhcCcccccCCHH
Confidence 6 78999999999987654
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-53 Score=427.31 Aligned_cols=250 Identities=31% Similarity=0.460 Sum_probs=216.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccC----cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK----KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.+|...+.||+|||+.||.+++..+|+.||+|++.++ .........|+++ +....|||||+++++|++.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeI------Hr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEI------HRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHH------HHhcCCCcEEeeeeEeecCC
Confidence 4799999999999999999999999999999999752 2223333344443 44556888999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
++|||+|+|.. +|.++++.. +.++|.+++.+++||+.||.|||+ .+|||||||..|||| +++.+|||+|||+|
T Consensus 92 nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL--~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFL--NENMNVKIGDFGLA 165 (592)
T ss_pred ceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheee--cCcCcEEeccccee
Confidence 99999999965 888887743 579999999999999999999995 689999999999999 78999999999999
Q ss_pred cccC---CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 274 CQLG---QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 274 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
..+. ++..+.||||.|+|||++...+++..+||||+|||||-||+|+|||...+-.+.+.+|...-...|..+.
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls--- 242 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLS--- 242 (592)
T ss_pred eeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccC---
Confidence 8875 6778999999999999999999999999999999999999999999999999999999875433332211
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.+++|||.+||+.||.+|||
T Consensus 243 ------------------------------------------------------------~~A~dLI~~lL~~~P~~Rps 262 (592)
T KOG0575|consen 243 ------------------------------------------------------------AEAKDLIRKLLRPNPSERPS 262 (592)
T ss_pred ------------------------------------------------------------HHHHHHHHHHhcCCcccCCC
Confidence 06789999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy16081 431 PYYALQHNFFKRT 443 (493)
Q Consensus 431 ~~e~L~Hp~~~~~ 443 (493)
++++|.|+||++.
T Consensus 263 l~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 263 LDEVLDHPFFKSG 275 (592)
T ss_pred HHHHhcCHhhhCC
Confidence 9999999999543
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=412.74 Aligned_cols=323 Identities=36% Similarity=0.654 Sum_probs=271.5
Q ss_pred CCCCCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcce
Q psy16081 103 DDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYY 182 (493)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~ 182 (493)
++....++++.++.+.++|.+++.||+|+||.|..|.+..++..||||++++...+......|+.+++.+...+..+-.-
T Consensus 73 dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 73 DDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred CCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceE
Confidence 56677899999999999999999999999999999999999999999999988888888899999999998887667777
Q ss_pred EEEeceeeeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC--
Q psy16081 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-- 260 (493)
Q Consensus 183 Iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-- 260 (493)
+|.+.++|+..++.|||+|.++-++++++..+++..++...++.+++||+.+++||| +.+++|-||||+|||+.+.
T Consensus 153 cv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSSEY 230 (415)
T ss_pred EEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEeccce
Confidence 999999999999999999999999999999999999999999999999999999999 5789999999999999632
Q ss_pred ----------------CCCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 261 ----------------KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 261 ----------------~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
++..|||+|||.|+...+.-...+.|+.|+|||++++-+++.++||||+||||+|+.+|..+|+
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 1346999999999988888888899999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCC
Q psy16081 325 GSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404 (493)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 404 (493)
++++.++++.+...+|.+|..|+.... ..+||..-. -.|.......--++-......+.....
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~r-ldw~e~~~~~~~k~v~~~ckpl~~~~~--------------- 373 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTR-KEKYFRRGR-LDWPEVSSKGKSKYVFEPCKPLKKYML--------------- 373 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhh-hHhhhhccc-ccCccccccccchhhhcCCccHHHHhc---------------
Confidence 999999999999999999999998765 445555431 111100000000111112222222221
Q ss_pred CCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 405 ~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
+...+...|+|||++||.+||.+|+|+.|||.||||++..
T Consensus 374 ~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 374 QDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred cCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 1122334799999999999999999999999999999753
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-53 Score=385.47 Aligned_cols=279 Identities=33% Similarity=0.546 Sum_probs=235.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|..+++||+|.||.||+|++..||+.||||.++.... ....+.+|++.+.++. |+||+.|+++|...+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~------h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK------HPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc------CcchhhhhhhccCCCc
Confidence 478889999999999999999999999999999985432 2456677777776654 6679999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+.||+|||+-+|...++... ..++...++.++.+++.||+|||. ..|+||||||.|+|+ +.+|.+||+|||+|+.
T Consensus 76 l~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLi--s~~g~lKiADFGLAr~ 150 (318)
T KOG0659|consen 76 LSLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLI--SSDGQLKIADFGLARF 150 (318)
T ss_pred eEEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEE--cCCCcEEeecccchhc
Confidence 99999999999999998766 579999999999999999999995 689999999999999 7899999999999999
Q ss_pred cCCccc---cccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQRIY---QYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~~~~---~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
++.+.. ..+-|++|+|||.+.|. .|+..+||||.|||+.||+.|.|.|.|.++.||+..|...+|.|....|+.+.
T Consensus 151 f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 151 FGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 875432 33679999999999985 59999999999999999999999999999999999999999999999888877
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
...+|.+-. +.|.+ .+..++.. ...++.||+.+||.+||.+|+|+
T Consensus 231 ~lpdY~~~~----------------~~P~~-~~~~lf~a------------------as~d~ldLl~~m~~ynP~~Rita 275 (318)
T KOG0659|consen 231 SLPDYVKIQ----------------QFPKP-PLNNLFPA------------------ASSDALDLLSKMLTYNPKKRITA 275 (318)
T ss_pred ccccHHHHh----------------cCCCC-cccccccc------------------ccHHHHHHHHhhhccCchhcccH
Confidence 666554321 01100 11111111 11156899999999999999999
Q ss_pred HHHhcCCCCCCC
Q psy16081 432 YYALQHNFFKRT 443 (493)
Q Consensus 432 ~e~L~Hp~~~~~ 443 (493)
.|+|+|+||+..
T Consensus 276 ~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 276 SQALKHPYFKSL 287 (318)
T ss_pred HHHhcchhhhcC
Confidence 999999999953
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=416.20 Aligned_cols=255 Identities=31% Similarity=0.447 Sum_probs=222.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
..+|.+++.||.|+|++|++|+++.+++.||||++.++- ....-..+|...|..|. +||.|++|+..|+++
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-----~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-----GHPGIVKLYFTFQDE 146 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-----CCCCeEEEEEEeecc
Confidence 457999999999999999999999999999999986421 12234455666666665 788999999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
..+|+|+||++ |+|+++|.+.+ .|++..++.++.||+.||+|||+ .|||||||||+|||| |+++++||+|||.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILL--d~dmhikITDFGs 220 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILL--DKDGHIKITDFGS 220 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeE--cCCCcEEEeeccc
Confidence 99999999995 59999998764 69999999999999999999994 799999999999999 8999999999999
Q ss_pred ccccCCc----------------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy16081 273 SCQLGQR----------------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 273 a~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~ 336 (493)
|+.+... ...++||..|.+||++.....+..+|+|+||||||.|+.|.|||.+.+++-++++|+
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~ 300 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ 300 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence 9876321 145899999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHH
Q psy16081 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDL 416 (493)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL 416 (493)
+.....|..+. +.+.||
T Consensus 301 ~l~y~fp~~fp---------------------------------------------------------------~~a~dL 317 (604)
T KOG0592|consen 301 ALDYEFPEGFP---------------------------------------------------------------EDARDL 317 (604)
T ss_pred HhcccCCCCCC---------------------------------------------------------------HHHHHH
Confidence 87544433211 167899
Q ss_pred HhHccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 417 IFRMLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 417 i~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
|+++|..||.+|+|++||.+||||..+..+
T Consensus 318 v~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 318 IKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred HHHHHccCccccccHHHHhhCcccccCChh
Confidence 999999999999999999999999988754
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=393.61 Aligned_cols=288 Identities=31% Similarity=0.524 Sum_probs=232.1
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
+..-.+.|+.++.|++|+||.||+|+|+.|++.||+|.++..+ .+.-...+|+.++. ..+|||||.+..+.
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl------~~~H~NIV~vkEVV 144 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILL------KARHPNIVEVKEVV 144 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHH------hcCCCCeeeeEEEE
Confidence 4455678999999999999999999999999999999998543 23334445554443 34588899999988
Q ss_pred ee--cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 191 MW--RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 191 ~~--~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
.. -+.+|||||||+.+|..++..-. +.++..+++.++.|++.||+||| ...|+||||||+|+|+ ...|.+||+
T Consensus 145 vG~~~d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm--~~~G~lKia 219 (419)
T KOG0663|consen 145 VGSNMDKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLL--SHKGILKIA 219 (419)
T ss_pred eccccceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheee--ccCCcEEec
Confidence 74 35799999999999999987665 57999999999999999999999 5789999999999999 688999999
Q ss_pred ecccccccCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 269 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 269 DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|||+|+.++.+ .+..+-|.+|+|||.++|. .|++++||||+|||+.||++++|.|.|..+.+++.+|...+|.|.+
T Consensus 220 DFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 220 DFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred ccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence 99999999877 5566779999999999986 5999999999999999999999999999999999999999999999
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.+|+........ . .+.+. ..+. ..+...+.. -+.++ .-.||+.++|.+|
T Consensus 300 ~iwpg~~~lp~~-k-----~~~f~-----~~py----n~lr~kF~~--------------~~lse--~g~~Lln~llt~d 348 (419)
T KOG0663|consen 300 AIWPGYSELPAV-K-----KMTFS-----EHPY----NNLRKKFGA--------------LSLSE--QGFDLLNKLLTYD 348 (419)
T ss_pred ccCCCccccchh-h-----ccccC-----CCCc----hhhhhhccc--------------cccch--hHHHHHHHHhccC
Confidence 998865433211 0 00000 0000 011111100 00112 5689999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q psy16081 425 PKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~~~~ 443 (493)
|.+|+||.|+|+|+||...
T Consensus 349 P~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 349 PGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccccccHHHhhcccccccC
Confidence 9999999999999999964
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=400.25 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=212.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEcc--CcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc-
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN--KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN- 194 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~- 194 (493)
.++.+.++.||+|+.|+||+|+++.|++.+|+|++.. +....++..+|.+++. ..++||||++++.|...+
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~------~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILR------SCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHh------hCCCCCeeeEeEEEEeCCc
Confidence 4567778999999999999999999999999999942 2223344444444432 236888999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.++|+||||++ +|.++++.. +.+++....+++.++++||.|||. +++||||||||+|||+ +..|.|||||||.+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLv--NskGeVKicDFGVS 226 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLV--NSKGEVKICDFGVS 226 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeee--ccCCCEEecccccc
Confidence 49999999965 888888765 469999999999999999999995 3789999999999999 78999999999999
Q ss_pred cccCCc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHhCCCChhhh
Q psy16081 274 CQLGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS-----NEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 274 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~-----~~~~~~~~i~~~~~~~p~~~~ 347 (493)
..+.+. ..+++||..|||||.+.+..|+.++||||||+.++||.+|+.||... +..+.+..|+. .||....
T Consensus 227 ~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~lP 303 (364)
T KOG0581|consen 227 GILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPRLP 303 (364)
T ss_pred HHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCCCC
Confidence 887555 47899999999999999999999999999999999999999999874 44455555543 1211110
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
. + ..+ .+|.+||..||++||.+
T Consensus 304 ~--------------~------------------------------------------~fS--~ef~~FV~~CL~Kdp~~ 325 (364)
T KOG0581|consen 304 E--------------G------------------------------------------EFS--PEFRSFVSCCLRKDPSE 325 (364)
T ss_pred c--------------c------------------------------------------cCC--HHHHHHHHHHhcCCccc
Confidence 0 0 011 18999999999999999
Q ss_pred CCCHHHHhcCCCCCCCccCCC
Q psy16081 428 RITPYYALQHNFFKRTADEST 448 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~~~~~~ 448 (493)
|||++|+|+|||+++......
T Consensus 326 R~s~~qLl~Hpfi~~~~~~~v 346 (364)
T KOG0581|consen 326 RPSAKQLLQHPFIKKFEDPNV 346 (364)
T ss_pred CCCHHHHhcCHHHhhcccccc
Confidence 999999999999998766544
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-52 Score=383.84 Aligned_cols=259 Identities=28% Similarity=0.421 Sum_probs=222.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++++.||.|+||.|.+++.+.+|..||+|++.+.+. ....+. .....+-+.+....||++++|++.|.+.+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-VklKQv-eH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-VKLKQV-EHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-HHHHHH-HHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 4689999999999999999999999999999999975431 111222 22233333344456899999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
|||||++| .|+.++++.+ .+++..++.++.||+.||+|||+ .+|++|||||+|||| |.+|.+||+|||+|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLl--D~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLL--DQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeee--ccCCcEEEEeccceEEe
Confidence 99999955 9999998764 69999999999999999999995 789999999999999 89999999999999999
Q ss_pred CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
.....+.||||.|+|||++..++|+.++|+|||||++|||+.|.+||.+.+...++.+|++.--..|..+
T Consensus 195 ~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~f---------- 264 (355)
T KOG0616|consen 195 SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYF---------- 264 (355)
T ss_pred cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCccc----------
Confidence 9889999999999999999999999999999999999999999999999999999999987533332211
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CH
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TP 431 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~ 431 (493)
.. +++|||.++|+.|-.+|. -.
T Consensus 265 -s~----------------------------------------------------~~kdLl~~LL~vD~t~R~gnlknG~ 291 (355)
T KOG0616|consen 265 -SS----------------------------------------------------DAKDLLKKLLQVDLTKRFGNLKNGV 291 (355)
T ss_pred -CH----------------------------------------------------HHHHHHHHHHhhhhHhhhcCcCCCc
Confidence 10 789999999999999994 46
Q ss_pred HHHhcCCCCCCCccCC
Q psy16081 432 YYALQHNFFKRTADES 447 (493)
Q Consensus 432 ~e~L~Hp~~~~~~~~~ 447 (493)
.+|..||||..+..+.
T Consensus 292 ~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 292 EDIKNHPWFKGVDWEA 307 (355)
T ss_pred cccccCcccccccHHH
Confidence 7899999999876653
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=393.20 Aligned_cols=288 Identities=35% Similarity=0.537 Sum_probs=234.0
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccC---cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK---KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+..+|..++.||+|+||.|..+.++.+|+.||||.+.+. .......-+|+++++ +..|+||+.+.+.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr------~~~HeNIi~l~di~~p 92 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLR------HLRHENIIGLLDIFRP 92 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHH------HhcCCCcceEEeeccc
Confidence 4456777789999999999999999999999999988621 112223333433333 3346779999998865
Q ss_pred -----cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 193 -----RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 193 -----~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
-+.+|+|+|+|+-+|.+.++... .++.+.+..++.||+.||.|+|+ .+|+||||||.|+|+ +.+..+||
T Consensus 93 ~~~~~f~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~--n~~c~lKI 166 (359)
T KOG0660|consen 93 PSRDKFNDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLL--NADCDLKI 166 (359)
T ss_pred ccccccceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhc--ccccccccchhheee--ccCCCEEe
Confidence 35789999999999999998764 49999999999999999999995 799999999999999 78888999
Q ss_pred EecccccccC-----CccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 268 VDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 268 ~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
+|||+|+... ..++.++.|++|+|||++.. ..|+.++||||+||||.||++|++.|.|.+..+|+..|++.+|.
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 9999999884 45678899999999999976 46999999999999999999999999999999999999999999
Q ss_pred CChhhhhhcc--chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhH
Q psy16081 342 PPKHLLDGAH--KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419 (493)
Q Consensus 342 ~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~ 419 (493)
|+...+.... +.+.|....+.. ....+.+++... + ..++||+++
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~----------------p~~~f~~~fp~a----------------~--p~AidLlek 292 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQI----------------PKQPFSSIFPNA----------------N--PLAIDLLEK 292 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCC----------------CCCCHHHHcCCC----------------C--HHHHHHHHH
Confidence 9988887654 344566554421 112223332210 0 167899999
Q ss_pred ccCCCCCCCCCHHHHhcCCCCCCCccCCCC
Q psy16081 420 MLDYDPKTRITPYYALQHNFFKRTADESTN 449 (493)
Q Consensus 420 mL~~dP~~R~t~~e~L~Hp~~~~~~~~~~~ 449 (493)
||.+||.+|+|++|||+||||..+.+.+..
T Consensus 293 mL~fdP~kRita~eAL~hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 293 MLVFDPKKRITAEEALAHPYLAPYHDPEDE 322 (359)
T ss_pred HhccCccccCCHHHHhcChhhhhhcCCccC
Confidence 999999999999999999999998776554
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=407.30 Aligned_cols=281 Identities=32% Similarity=0.503 Sum_probs=232.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccC---cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK---KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
...+.|+.+++||+|+||.||+|++..||+.||+|.++.. ..+.....+|+.+|+.| +||||++|.+...+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l------~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL------DHPNIIKLEEIVTS 187 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc------CCCcccceeeEEEe
Confidence 3456799999999999999999999999999999998743 34556667777777665 46779999999887
Q ss_pred c--ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 193 R--NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 193 ~--~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
. ..+|||+|||+.+|..++.... -.|++.+++.|++||+.||.|||+ +||+|||||.+|||| |.+|.+||+||
T Consensus 188 ~~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLi--dn~G~LKiaDF 262 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILI--DNNGVLKIADF 262 (560)
T ss_pred cCCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEE--cCCCCEEeccc
Confidence 6 6899999999999999997654 469999999999999999999994 899999999999999 78999999999
Q ss_pred ccccccCC----ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 271 GSSCQLGQ----RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 271 G~a~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+|+.+.. ..+..+-|.+|+|||.++|. .|+.++|+||+||||.||++|+|.|.|.++.+|+.+|.+.+|.|.+.
T Consensus 263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred cceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 99986643 35566789999999999986 59999999999999999999999999999999999999999999988
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
.|.. .+.. ++.. -++..+-.+++.+.+.. .. ....+|+..||.+||
T Consensus 343 ~W~~-~kLP-~~~~--------------~kp~~~y~r~l~E~~~~----------------~~--~~~l~Ll~~lL~ldP 388 (560)
T KOG0600|consen 343 YWPV-SKLP-HATI--------------FKPQQPYKRRLRETFKD----------------FP--ASALDLLEKLLSLDP 388 (560)
T ss_pred cccc-ccCC-cccc--------------cCCCCcccchHHHHhcc----------------CC--HHHHHHHHHHhccCc
Confidence 7661 1111 1111 11222223344443211 11 167899999999999
Q ss_pred CCCCCHHHHhcCCCCC
Q psy16081 426 KTRITPYYALQHNFFK 441 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~ 441 (493)
.+|.||.++|+|+||+
T Consensus 389 ~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 389 DKRGTASSALQSEYFT 404 (560)
T ss_pred cccccHHHHhcCcccc
Confidence 9999999999999994
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=396.86 Aligned_cols=317 Identities=34% Similarity=0.606 Sum_probs=275.2
Q ss_pred Ccceeeccceec-CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcC--CCCcceE
Q psy16081 107 HDYIIQHGEKFL-DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKAD--VNNTYYI 183 (493)
Q Consensus 107 ~~~~~~~~~~~~-~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~--~~~~~~I 183 (493)
....+..|+.|. .+|.+.++||-|.|++||+|+|..+.+.||+|+++....+...+..|++++..++..+ ..+..+|
T Consensus 65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred CCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 345788899998 8999999999999999999999999999999999988888888899999999999877 7777789
Q ss_pred EEeceeeee----cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC
Q psy16081 184 VRLKRHFMW----RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN 259 (493)
Q Consensus 184 v~l~~~~~~----~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~ 259 (493)
|+|++.|.. ..|+|||+|+++.+|+.+|...++++++...++.|++||+.||.|||. ++||||-||||+|||++.
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCS 223 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeec
Confidence 999999985 459999999999999999999999999999999999999999999998 799999999999999850
Q ss_pred C-------------------------------------------------------------------------------
Q psy16081 260 P------------------------------------------------------------------------------- 260 (493)
Q Consensus 260 ~------------------------------------------------------------------------------- 260 (493)
+
T Consensus 224 ~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~ 303 (590)
T KOG1290|consen 224 TEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESY 303 (590)
T ss_pred cccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------C----------------------------------------------
Q psy16081 261 ---------------------------------K---------------------------------------------- 261 (493)
Q Consensus 261 ---------------------------------~---------------------------------------------- 261 (493)
.
T Consensus 304 n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~ 383 (590)
T KOG1290|consen 304 NNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPD 383 (590)
T ss_pred ccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCC
Confidence 0
Q ss_pred ------CCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHH
Q psy16081 262 ------RSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS------NEV 329 (493)
Q Consensus 262 ------~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~------~~~ 329 (493)
+-.|||+|||-||......+.-++|+.|+|||++.|.+|++.+||||++|+++||+||..+|.-. .+.
T Consensus 384 ~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 384 IPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred CCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 01379999999999998889999999999999999999999999999999999999999999643 367
Q ss_pred HHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcch
Q psy16081 330 DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409 (493)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (493)
++++.|++.+|..|..+....+.+++||++.++- .... +-.++| |.++| +...+++.++
T Consensus 464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~L----rhI~--~LK~Wp----L~~VL-----------~eKY~~s~e~ 522 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGEL----RHIR--RLKPWP----LYEVL-----------IEKYEWSEED 522 (590)
T ss_pred HHHHHHHHHHhhccHHHHhcCcchHhhhccccce----eccc--ccCCCc----HHHHH-----------HHHhCCCHHH
Confidence 8999999999999999999999999999986531 1100 001111 22222 2345678888
Q ss_pred hhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 410 YLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 410 ~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
..+|.|||.-||+++|++|+||.++|+|||+..+..
T Consensus 523 A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 523 AQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHHHHHHHHHHhcCccccccHHHHhcCccccCCCC
Confidence 899999999999999999999999999999997654
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=387.88 Aligned_cols=280 Identities=34% Similarity=0.558 Sum_probs=227.9
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec-----c
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR-----N 194 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~-----~ 194 (493)
.|.-.+++|.|+||.||+|....+++.||||.+-.++. -..+|..++. ...|||||+|..+|... -
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~------~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMR------KLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHH------hcCCcCeeeEEEEEEecCCCchh
Confidence 58888999999999999999999999999998865543 3345666655 33578899999999743 2
Q ss_pred eeEEEEEecccCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 195 HLCLVFELLSYNLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 195 ~~~lV~E~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
++.||||||+.+|++.++.. ....++.-.++-+..||++||.|||+ .|||||||||.|||++ .+.|.+||||||+
T Consensus 96 ~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD-~~tg~LKicDFGS 172 (364)
T KOG0658|consen 96 YLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVD-PDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEc-CCCCeEEeccCCc
Confidence 56799999999999999842 22468889999999999999999995 7899999999999995 4779999999999
Q ss_pred cccc--CCccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQL--GQRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
|+.+ +++..+++-|++|+|||.+.|. .|+.++||||.|||+.||+.|++.|.|.+..+|+..|++.+|.|..+.+..
T Consensus 173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 9887 5567789999999999999986 599999999999999999999999999999999999999999999888776
Q ss_pred ccchhh--hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 350 AHKTRK--YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 350 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
+..... -|.++.. .+|.+.. ......+..||+.++|.++|.+
T Consensus 253 mn~~y~~~~~p~ik~-------------------------------~~~~~~~-----~~~~~~d~~dll~~~L~Y~P~~ 296 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKA-------------------------------HPWHKVF-----FKRLPPDALDLLSKLLQYSPSK 296 (364)
T ss_pred cCcccccccCccccc-------------------------------ccceeec-----ccCCCHHHHHHHHHHhccChhh
Confidence 543211 0111110 1111100 0001126789999999999999
Q ss_pred CCCHHHHhcCCCCCCCccCC
Q psy16081 428 RITPYYALQHNFFKRTADES 447 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~~~~~ 447 (493)
|.|+.|+|.||||....+..
T Consensus 297 R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 297 RLSALEALAHPFFDELRDPN 316 (364)
T ss_pred cCCHHHHhcchhhHHhhCcC
Confidence 99999999999999877663
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=384.27 Aligned_cols=258 Identities=33% Similarity=0.481 Sum_probs=213.3
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
..++|.+.+.||+|+||+||+|+++.++..||||.+.++... .+-...|+.++.+++ |+|||.+++++..+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~------H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK------HPNIVRLLDCIEDD 81 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC------CcceeeEEEEEecC
Confidence 456899999999999999999999999999999999755321 122244555554443 78899999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CC---CcEEEE
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KR---SAIKIV 268 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~---~~ikL~ 268 (493)
+++|||||||. |+|.++++... .+++..++.++.||+.||++|| +.+||||||||+||||+.+ .+ ..+||+
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 99999999995 69999998764 6999999999999999999999 5799999999999999654 22 569999
Q ss_pred ecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 269 DFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 269 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
|||+|+.+... ..+.|||+.|||||++....|+.|+|+||+|+|||+|++|++||...+..+.+..+.+.-...|.
T Consensus 158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~-- 235 (429)
T KOG0595|consen 158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV-- 235 (429)
T ss_pred ccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc--
Confidence 99999988654 45789999999999999999999999999999999999999999999988888766543222111
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
+++++. . .+.+|+...|..||.
T Consensus 236 -------------------------------------~~~~~s-------------------~--~~~~Ll~~ll~~~~~ 257 (429)
T KOG0595|consen 236 -------------------------------------LPAELS-------------------N--PLRELLISLLQRNPK 257 (429)
T ss_pred -------------------------------------hhhhcc-------------------C--chhhhhhHHHhcCcc
Confidence 001100 0 346899999999999
Q ss_pred CCCCHHHHhcCCCCCCCc
Q psy16081 427 TRITPYYALQHNFFKRTA 444 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~~ 444 (493)
+|.+..+-+.|+++....
T Consensus 258 ~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 258 DRISFEDFFDHPFLAANP 275 (429)
T ss_pred ccCchHHhhhhhhcccCc
Confidence 999999999999997654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-49 Score=412.01 Aligned_cols=303 Identities=28% Similarity=0.512 Sum_probs=240.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec-cee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR-NHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~-~~~ 196 (493)
.++|+++++||+|+||+||+|.+..+++.||||+++...........|+.+++.+.+.+..+|++|++++++|... +++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 5789999999999999999999999999999999975544455667899999999998888888999999998764 589
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC--------------C
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK--------------R 262 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~--------------~ 262 (493)
|+|||+++++|.+++... ..+++..++.++.||+.||.|||+ +.|||||||||+|||+..+. .
T Consensus 208 ~iv~~~~g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~-~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEeccCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 999999999999988765 368999999999999999999995 36899999999999994322 1
Q ss_pred CcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 263 SAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
..+||+|||++..........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..+.+.++.+
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 25999999998766666667889999999999999999999999999999999999999999999999999999999999
Q ss_pred Chhhhhhcc--chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 343 PKHLLDGAH--KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 343 p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
|..+..... ....+|+....-... .....+..+... ...........+.|||.+|
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~-----------~~~~~~~~~~~~~dli~~m 421 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPC------------TDPKHLARIARA-----------RPVREVIRDDLLCDLIYGL 421 (467)
T ss_pred CHHHHhhccchhHHHHhhhccccccc------------CCHHHHHhhhcc-----------cchhhhhchHHHHHHHHHh
Confidence 888765432 223344332210000 000000000000 0000000113688999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
|.+||++|||++|+|+||||......
T Consensus 422 L~~dP~~R~ta~e~L~Hp~~~~~~~~ 447 (467)
T PTZ00284 422 LHYDRQKRLNARQMTTHPYVLKYYPE 447 (467)
T ss_pred CCcChhhCCCHHHHhcCccccccCCc
Confidence 99999999999999999999976543
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=405.20 Aligned_cols=256 Identities=29% Similarity=0.429 Sum_probs=219.9
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
-.++|.++++||+|+||+|+++..+.+++.||||++++.. ........|.++++... +||++++|+.+|+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-----~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-----RHPFLVNLFSCFQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-----cCCeEeeccccccc
Confidence 3578999999999999999999999999999999998643 33455666777776655 79999999999999
Q ss_pred cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 193 RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 193 ~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
.+++|+||||+.|+. +......+.+++..++.|++.|+.||.||| +.||||||||.+|||| |..|++||+|||+
T Consensus 441 ~~~l~fvmey~~Ggd--m~~~~~~~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLL--D~eGh~kiADFGl 514 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGD--LMHHIHTDVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLL--DTEGHVKIADFGL 514 (694)
T ss_pred CCeEEEEEEecCCCc--EEEEEecccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEE--cccCcEEeccccc
Confidence 999999999996633 333333357999999999999999999999 5789999999999999 8999999999999
Q ss_pred cccc---CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQL---GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
++.. +...+++||||.|||||++.+..|+.++|+|||||+|||||+|.+||.|+++.+....|+..-..-|..+.
T Consensus 515 cKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls-- 592 (694)
T KOG0694|consen 515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS-- 592 (694)
T ss_pred ccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc--
Confidence 9764 56778999999999999999999999999999999999999999999999999999999763221111110
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.++.++++++|..||++|+
T Consensus 593 -------------------------------------------------------------~ea~~il~~ll~k~p~kRL 611 (694)
T KOG0694|consen 593 -------------------------------------------------------------KEAIAIMRRLLRKNPEKRL 611 (694)
T ss_pred -------------------------------------------------------------HHHHHHHHHHhccCccccc
Confidence 1678999999999999999
Q ss_pred C-----HHHHhcCCCCCCCccC
Q psy16081 430 T-----PYYALQHNFFKRTADE 446 (493)
Q Consensus 430 t-----~~e~L~Hp~~~~~~~~ 446 (493)
- +++|.+||||..+...
T Consensus 612 G~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 612 GSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred CCCCCCchhhhhCCccccCCHH
Confidence 6 5889999999987643
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=402.70 Aligned_cols=256 Identities=31% Similarity=0.453 Sum_probs=216.6
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+-|++++.||+|+-|.|.+|++..||+.+|||++.+... .....++|+.+++.+ .||||++++++|+..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi------~HpnVl~LydVwe~~ 84 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI------EHPNVLRLYDVWENK 84 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh------cCCCeeeeeeeeccC
Confidence 4568999999999999999999999999999999976521 233445566555544 477799999999999
Q ss_pred ceeEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
.++|||+||+ +|.|++++..++ ++++.++.+++.||+.|+.|+|. .+||||||||+|+|| |..++|||+|||+
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLL--d~~~nIKIADFGM 158 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLL--DVKNNIKIADFGM 158 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhh--hcccCEeeeccce
Confidence 9999999999 559999998775 69999999999999999999995 789999999999999 6777799999999
Q ss_pred cccc--CCccccccccCcCCchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQL--GQRIYQYIQSRFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
|... +.-..+.||+|.|+|||++.|.+|+ .++||||+|||||.||+|+.||++++....+.++..+....|..
T Consensus 159 AsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~---- 234 (786)
T KOG0588|consen 159 ASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSN---- 234 (786)
T ss_pred eecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCc----
Confidence 9654 3446789999999999999999986 79999999999999999999999888877777776542222211
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
++ .++.|||++||++||++|+
T Consensus 235 ---------------------------------------------------------Is--~eaQdLLr~ml~VDp~~Ri 255 (786)
T KOG0588|consen 235 ---------------------------------------------------------IS--SEAQDLLRRMLDVDPSTRI 255 (786)
T ss_pred ---------------------------------------------------------CC--HHHHHHHHHHhccCccccc
Confidence 11 1789999999999999999
Q ss_pred CHHHHhcCCCCCCCccCCC
Q psy16081 430 TPYYALQHNFFKRTADEST 448 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~~~~~ 448 (493)
|.+||++|||+.+......
T Consensus 256 T~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 256 TTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred cHHHHhhCchhhcCCCCCh
Confidence 9999999999998765543
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=375.98 Aligned_cols=288 Identities=35% Similarity=0.565 Sum_probs=236.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
...|+.+++||+|+||+||+|+.+.+|+.||+|.++.... ......+|+.+++.+.+.+ | ||.|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~---~--iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHAN---H--IVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCc---c--eEEEEeeeeecc
Confidence 4568888899999999999999999999999999975432 5667788888888776554 2 999999999887
Q ss_pred ------eeEEEEEecccCHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 195 ------HLCLVFELLSYNLYDLLRNTNF--RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 195 ------~~~lV~E~~~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.++|||||++.+|..++..... .+++...++.+++||+.||+|||+ .+|+||||||.|||| ++.|.+|
T Consensus 85 ~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi--~~~G~lK 160 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLI--SSSGVLK 160 (323)
T ss_pred cccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEE--CCCCcEe
Confidence 8999999999999999987653 368889999999999999999996 689999999999999 6799999
Q ss_pred EEecccccccCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 267 IVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 267 L~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
|+|||+|+..+-+ .+..++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+..+.+++.+|.+.+|+|
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 9999999876532 4456789999999999987 69999999999999999999999999999999999999999999
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
....|+.......|-.. .+..+....+..++.... ....||+.+||+
T Consensus 241 ~e~~Wp~v~~~~~~k~~---------------f~~~~~~~~l~~~~~~~~------------------~~~~dll~~~L~ 287 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAP---------------FPKWPGPKDLSSILPKLD------------------PDGIELLSKLLQ 287 (323)
T ss_pred CccCCCCcccccccccc---------------CcCCCCccchHHhccccC------------------ccHHHHHHHHhc
Confidence 98887765433222110 011111222222221110 157899999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCccCC
Q psy16081 423 YDPKTRITPYYALQHNFFKRTADES 447 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~~~~~ 447 (493)
+||++|+|++.+|.||||.......
T Consensus 288 y~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 288 YDPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred cCcccCcCHHHHhcChhhcccccch
Confidence 9999999999999999999765443
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=396.52 Aligned_cols=254 Identities=35% Similarity=0.470 Sum_probs=213.3
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc------cchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
...++|.+.+.||+|+||+|++|.+..+++.||||++..... ......+|+.+++.+. +||||++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~-----~HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR-----SHPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc-----cCCCEeEEEEE
Confidence 456789999999999999999999999999999998765311 2233444554444332 37789999999
Q ss_pred eeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC-CcEEE
Q psy16081 190 FMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKI 267 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~-~~ikL 267 (493)
+.....+|+|||||.| +|++++... ..+.+..++++++||+.|+.|||+ .||+||||||+|||+ +.+ +++||
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENill--d~~~~~~Kl 162 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILL--DGNEGNLKL 162 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEe--cCCCCCEEE
Confidence 9999999999999965 999999883 469999999999999999999995 799999999999999 566 99999
Q ss_pred Eeccccccc---CCccccccccCcCCchhhhcCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 268 VDFGSSCQL---GQRIYQYIQSRFYRSPEVLLGIP-YD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 268 ~DFG~a~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
+|||++... +....+.|||+.|+|||++.+.. |+ .++|||||||+||.|++|..||...+....+.+|...--..
T Consensus 163 ~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~ 242 (370)
T KOG0583|consen 163 SDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI 242 (370)
T ss_pred eccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC
Confidence 999999877 34567899999999999999988 86 79999999999999999999999988877777765432111
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
|.... + .++++||.+||.
T Consensus 243 p~~~~------------------------------------------------------------S--~~~~~Li~~mL~ 260 (370)
T KOG0583|consen 243 PSYLL------------------------------------------------------------S--PEARSLIEKMLV 260 (370)
T ss_pred CCCcC------------------------------------------------------------C--HHHHHHHHHHcC
Confidence 11100 0 167999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCC
Q psy16081 423 YDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~ 442 (493)
.||.+|+|+.++++||||+.
T Consensus 261 ~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 261 PDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCcccCCCHHHHhhChhhcc
Confidence 99999999999999999997
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=365.07 Aligned_cols=259 Identities=31% Similarity=0.416 Sum_probs=214.9
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.|.+.|++.+.||+|.|+.|++|.+..||+.+|+|++..++ ...+..++|..+.. ...|||||+|.+.+..
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~------~LqHP~IvrL~~ti~~ 81 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR------KLQHPNIVRLHDSIQE 81 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHH------hcCCCcEeehhhhhcc
Confidence 56788999999999999999999999999999999986432 23344455555444 3457889999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEEec
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVDF 270 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~DF 270 (493)
..+.|||+|+|.| +|..-+... .-+++..+..+++||+.||.|+|+ .||||||+||+|+|+.+ +...-+||+||
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred cceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeeccc
Confidence 9999999999965 888776554 358999999999999999999995 79999999999999953 34456999999
Q ss_pred ccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 271 GSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 271 G~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
|+|..++.. ...+.|||.|||||++...+|+..+|||+.|||||.||.|.+||.+.+..+.+++|++.-...+.
T Consensus 158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~---- 233 (355)
T KOG0033|consen 158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS---- 233 (355)
T ss_pred ceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC----
Confidence 999888633 34678999999999999999999999999999999999999999999999999998864221111
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.+|..+++ +.+|||++||..||.+|
T Consensus 234 -----------------------------------------------------~~w~~is~--~Ak~LvrrML~~dP~kR 258 (355)
T KOG0033|consen 234 -----------------------------------------------------PEWDTVTP--EAKSLIRRMLTVNPKKR 258 (355)
T ss_pred -----------------------------------------------------cccCcCCH--HHHHHHHHHhccChhhh
Confidence 01112222 78999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q psy16081 429 ITPYYALQHNFFKRT 443 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~ 443 (493)
+|+.|+|+|||+..-
T Consensus 259 Ita~EAL~HpWi~~r 273 (355)
T KOG0033|consen 259 ITADEALKHPWICNR 273 (355)
T ss_pred ccHHHHhCCchhcch
Confidence 999999999999854
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=353.93 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=227.3
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|++.+.||+|.||.||+|+.+.++-.||+|++.+.. ....+.+..+.+++....+.+||||++++++|.+...+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 3578999999999999999999999999999999997543 44555566666666667788899999999999999999
Q ss_pred EEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
||++||. .|+|+..|.......+++.....++.|++.||.|+| ..+||||||||+|+|+ +..+.+||+|||.+..
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLl--g~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLL--GSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhcc--CCCCCeeccCCCceee
Confidence 9999999 569999998777678999999999999999999999 5789999999999999 6788999999999987
Q ss_pred c-CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 276 L-GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 276 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
. .....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||.+.+..+.+++|.+.--..|..+
T Consensus 174 ~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~i-------- 245 (281)
T KOG0580|consen 174 APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTI-------- 245 (281)
T ss_pred cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCccc--------
Confidence 7 4556789999999999999999999999999999999999999999999999999999987633332111
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
+. .+.|||.+||.++|.+|.+..|+
T Consensus 246 -----------------------------------------------------s~--~a~dlI~~ll~~~p~~r~~l~~v 270 (281)
T KOG0580|consen 246 -----------------------------------------------------SG--GAADLISRLLVKNPIERLALTEV 270 (281)
T ss_pred -----------------------------------------------------Ch--hHHHHHHHHhccCccccccHHHH
Confidence 00 67899999999999999999999
Q ss_pred hcCCCCCCC
Q psy16081 435 LQHNFFKRT 443 (493)
Q Consensus 435 L~Hp~~~~~ 443 (493)
+.|||+...
T Consensus 271 ~~hpwI~a~ 279 (281)
T KOG0580|consen 271 MDHPWIVAN 279 (281)
T ss_pred hhhHHHHhc
Confidence 999999753
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=373.94 Aligned_cols=279 Identities=31% Similarity=0.488 Sum_probs=220.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|++.++||.|+||.||+|.+..+++.||+|+++.... .......|+.++..+ +|+||+++++++...+.
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~ 77 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL------KHANIVTLHDIIHTERC 77 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC------CCCCEeeEEEEEcCCCe
Confidence 3579999999999999999999999999999999874321 122334455444333 57789999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~--~~~~~~kl~DfG~~~~ 152 (288)
T cd07871 78 LTLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLI--NEKGELKLADFGLARA 152 (288)
T ss_pred EEEEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEE--CCCCCEEECcCcceee
Confidence 99999999999999886543 357899999999999999999995 789999999999999 6788999999999976
Q ss_pred cCC---ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQ---RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...+....
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 153 KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 532 2234567899999999976 468999999999999999999999999999999999999999999888776554
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
....|....-. .+. ...+.+. ....+ .+++|||.+||.+||.+|||+
T Consensus 233 ~~~~~~~~~~~-~~~--------------~~~~~~~----------------~~~~~--~~~~dll~~mL~~dp~~R~t~ 279 (288)
T cd07871 233 SNEEFRSYLFP-QYR--------------AQPLINH----------------APRLD--TDGIDLLSSLLLYETKSRISA 279 (288)
T ss_pred cchhhhccccC-ccC--------------CCchHHh----------------CCCCC--HHHHHHHHHhcCcCcccCCCH
Confidence 43333221100 000 0000000 00011 167899999999999999999
Q ss_pred HHHhcCCCC
Q psy16081 432 YYALQHNFF 440 (493)
Q Consensus 432 ~e~L~Hp~~ 440 (493)
+|+|+||||
T Consensus 280 ~~~l~hp~f 288 (288)
T cd07871 280 EAALRHSYF 288 (288)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=383.84 Aligned_cols=332 Identities=36% Similarity=0.605 Sum_probs=277.5
Q ss_pred cCCCCCCCCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCC
Q psy16081 99 NEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178 (493)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~ 178 (493)
.+.+++....|.+..++.+-.+|.+..-.|+|-|++|..|.+..-|..||||++++.......-..|+.+|+.|+..+..
T Consensus 412 ~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~E 491 (752)
T KOG0670|consen 412 QDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPE 491 (752)
T ss_pred ccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCch
Confidence 34567788899999999999999999999999999999999999999999999998888888889999999999999998
Q ss_pred CcceEEEeceeeeecceeEEEEEecccCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEe
Q psy16081 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTN-FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILL 257 (493)
Q Consensus 179 ~~~~Iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl 257 (493)
+..|+++|+.+|...+|+|||||-+.-+|.+.|++.+ .-++....++.+++|++.||..|- ++||+|+||||+|||+
T Consensus 492 dk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 492 DKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILV 569 (752)
T ss_pred hhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEe
Confidence 8889999999999999999999999999999997643 346899999999999999999998 6899999999999999
Q ss_pred eCCCCCcEEEEecccccccCC-ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy16081 258 CNPKRSAIKIVDFGSSCQLGQ-RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 258 ~~~~~~~ikL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~ 336 (493)
. .....+||||||.|...++ ..+.+.-+++|.|||+++|.+|+...|+||.||.||||.||+..|.|..+.+++...+
T Consensus 570 N-E~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 570 N-ESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred c-cCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 4 4667899999999987754 5667778999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCC--CC----CCCCCccchhhccccCCCCCCCcCCCCCCCcchh
Q psy16081 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGR--KP----KVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410 (493)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (493)
+.-|..|..|+........-|+.....-|.-....-.+ .. -.|...-..++++.. ..+.....-.
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q---------~~~deq~~~~ 719 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQ---------RLPDEQPKIV 719 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccC---------CCCchhHHHH
Confidence 99999999999988777777776554333211111111 00 011111122222211 1122233344
Q ss_pred hhHHHHHhHccCCCCCCCCCHHHHhcCCCCCC
Q psy16081 411 LKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 411 ~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~ 442 (493)
..|.|||.+||..||++|+|+.|||+||||+.
T Consensus 720 ~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 720 QQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 57999999999999999999999999999984
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=370.19 Aligned_cols=278 Identities=33% Similarity=0.533 Sum_probs=215.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcC-CCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeee---
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLE-EQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM--- 191 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~--- 191 (493)
++|++++.||+|+||+||+|.+.. +++.||||+++..... ......|..++.. .....||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~---l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH---LETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHh---hcccCCCCcceEEEEEeccc
Confidence 379999999999999999999855 4788999998743221 2233445444443 44456888999999885
Q ss_pred --ecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 192 --WRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 192 --~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
....+++||||++++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~--~~~~~~kl~D 153 (290)
T cd07862 78 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILV--TSSGQIKLAD 153 (290)
T ss_pred CCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEE--cCCCCEEEcc
Confidence 3456899999999999999976655568999999999999999999994 789999999999999 6788999999
Q ss_pred cccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 270 FGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 270 FG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+.+..+.+....+
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9999765432 34567899999999999989999999999999999999999999999999999999998887765443
Q ss_pred hhccch-hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 348 DGAHKT-RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 348 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
...... ...|... ....+..+.. .. ...+.+||.+||..||+
T Consensus 234 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~----------------~~--~~~~~~li~~~l~~~P~ 276 (290)
T cd07862 234 PRDVALPRQAFHSK-------------------SAQPIEKFVT----------------DI--DELGKDLLLKCLTFNPA 276 (290)
T ss_pred hhhhcccchhccCC-------------------CCCCHHHHcc----------------CC--CHHHHHHHHHHhccCch
Confidence 221110 0000000 0001111110 01 12678999999999999
Q ss_pred CCCCHHHHhcCCCC
Q psy16081 427 TRITPYYALQHNFF 440 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~ 440 (493)
+|||+.|+|+||||
T Consensus 277 ~R~s~~~~l~hp~f 290 (290)
T cd07862 277 KRISAYSALSHPYF 290 (290)
T ss_pred hcCCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=380.24 Aligned_cols=264 Identities=31% Similarity=0.485 Sum_probs=222.9
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
...+.+.|++.+.||+|.||.||+|+++.||+.+|+|++.+.... .....+|+.+++.+.. |||||.+.+.
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~-----hpniv~l~~~ 104 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG-----HPNIVQLKDA 104 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC-----CCCEEEEEEE
Confidence 345667899999999999999999999999999999999765432 2456677777766542 8889999999
Q ss_pred eeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC--CcEE
Q psy16081 190 FMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR--SAIK 266 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~--~~ik 266 (493)
|++.+.+++|||+|. |.|++.+... .+++..+..++.||+.++.|||+ .||+||||||+|+|+..... +.+|
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEE
Confidence 999999999999995 5999999876 29999999999999999999995 89999999999999965443 5799
Q ss_pred EEecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 267 IVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 267 L~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
++|||++..... .....+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+......+|...-...+
T Consensus 180 ~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~- 258 (382)
T KOG0032|consen 180 LIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT- 258 (382)
T ss_pred EeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC-
Confidence 999999987765 56788999999999999999999999999999999999999999999998888776655311110
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.++|..+++ .++|||++||..|
T Consensus 259 --------------------------------------------------------~~~w~~is~--~akd~i~~ll~~d 280 (382)
T KOG0032|consen 259 --------------------------------------------------------SEPWDDISE--SAKDFIRKLLEFD 280 (382)
T ss_pred --------------------------------------------------------CCCccccCH--HHHHHHHHhcccC
Confidence 111222222 7899999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCccC
Q psy16081 425 PKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
|.+|+|+.++|+|||++.....
T Consensus 281 p~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 281 PRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred cccCCCHHHHhcCccccCCccc
Confidence 9999999999999999975333
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=357.86 Aligned_cols=266 Identities=32% Similarity=0.481 Sum_probs=214.4
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
.+-+.|...++||.|..++|.+|.++.+|..+|+|++...... ......|....+.-.......||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4456788889999999999999999999999999998632110 011112222222222233458999999999999
Q ss_pred ecceeEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
.+..+++|+|+| .|.|+|+|...- .+++..++++++|++.|++|||. .+||||||||+|||+ +++.+|||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILl--ddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILL--DDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheee--ccccceEEecc
Confidence 999999999999 569999997653 69999999999999999999994 789999999999999 78899999999
Q ss_pred cccccc--CCccccccccCcCCchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 271 GSSCQL--GQRIYQYIQSRFYRSPEVLLG------IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 271 G~a~~~--~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
|+|+.+ ++.....||||+|+|||.+.. .+|+..+|+||+|||||-|+.|.+||......-++..|++.-
T Consensus 168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk--- 244 (411)
T KOG0599|consen 168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK--- 244 (411)
T ss_pred ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc---
Confidence 999988 566788999999999999962 369999999999999999999999998777777777777632
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
|.+.. | +|...++ ..+|||.+||.
T Consensus 245 ----------------------yqF~s---------p-----------------------eWadis~--~~KdLIsrlLq 268 (411)
T KOG0599|consen 245 ----------------------YQFRS---------P-----------------------EWADISA--TVKDLISRLLQ 268 (411)
T ss_pred ----------------------cccCC---------c-----------------------chhhccc--cHHHHHHHHHe
Confidence 21111 0 1111222 67999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 423 YDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
+||.+|+|++|+|+||||.++...
T Consensus 269 Vdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 269 VDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred eCchhcccHHHHhcChHHHHHHHh
Confidence 999999999999999999766443
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=383.51 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=214.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchH---HHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ---AQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~---~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|.+.+.||+|+||.||+|+.+.|.+.||+|.+.+.....++ ..+|+++++.+ +|||||.++++|+...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l------kHpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL------KHPNIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc------CCcchhhHHHhhcccce
Confidence 5788999999999999999999999999999999765433333 34444444433 47779999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|+|.|||.|+|+.+|.... .++++.++.++.++..||.|||+ .+|+|||+||.|||+ +..+.+|+||||+|+.
T Consensus 76 ~~vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl--~~~~~~KlcdFg~Ar~ 149 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILL--EKGGTLKLCDFGLARA 149 (808)
T ss_pred EEEEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeee--cCCCceeechhhhhhh
Confidence 99999999999999997664 69999999999999999999995 689999999999999 8999999999999988
Q ss_pred cCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.+.. .+...|||.|||||++.+..|+..+|+||||||+|||++|+|||...........|...-..+|..+
T Consensus 150 m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~------ 223 (808)
T KOG0597|consen 150 MSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTA------ 223 (808)
T ss_pred cccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccc------
Confidence 7654 2456799999999999999999999999999999999999999998887777777765332222211
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
-..|++|++++|..||.+|+|=.
T Consensus 224 ---------------------------------------------------------S~~f~nfl~gLL~kdP~~RltW~ 246 (808)
T KOG0597|consen 224 ---------------------------------------------------------SSSFVNFLQGLLIKDPAQRLTWT 246 (808)
T ss_pred ---------------------------------------------------------cHHHHHHHHHHhhcChhhcccHH
Confidence 01789999999999999999999
Q ss_pred HHhcCCCCCCCc
Q psy16081 433 YALQHNFFKRTA 444 (493)
Q Consensus 433 e~L~Hp~~~~~~ 444 (493)
+++.|||.++..
T Consensus 247 ~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 247 DLLGHPFWKGKI 258 (808)
T ss_pred HHhcChHHhhhh
Confidence 999999998653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=367.00 Aligned_cols=280 Identities=34% Similarity=0.575 Sum_probs=213.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|++.+.||+|+||+||+|++..+++.||||+++..... ......|+.++. ..+|+||++++++|...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLR------TLKQENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHH------hCCCccccchhhhEecCCE
Confidence 4799999999999999999999999999999998754221 222333443333 3357789999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|+||||+++++.+.+.... ..+++..++.++.||+.||.||| ..+|+||||||+|||+ +.++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLI--SHNDVLKLCDFGFARN 149 (287)
T ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEE--cCCCcEEEeeccCccc
Confidence 99999999887777665433 46899999999999999999999 4789999999999999 6788999999999977
Q ss_pred cCCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.... .....|++.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+....+..+...+....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 6432 234578999999999999899999999999999999999999999998888888888877766655443221
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
....+.. .. + +........... .....+ ..+.|||++||++||++|||+
T Consensus 230 ~~~~~~~-~~---~----------~~~~~~~~~~~~---------------~~~~~s--~~~~dll~~~L~~~P~~R~s~ 278 (287)
T cd07848 230 SNPRFHG-LR---F----------PAVNHPQSLERR---------------YLGILS--GVLLDLMKNLLKLNPTDRYLT 278 (287)
T ss_pred ccchhcc-cc---c----------CcccCcccHHHh---------------hhcccC--HHHHHHHHHHccCCcccCCCH
Confidence 1100000 00 0 000000000000 000011 268999999999999999999
Q ss_pred HHHhcCCCC
Q psy16081 432 YYALQHNFF 440 (493)
Q Consensus 432 ~e~L~Hp~~ 440 (493)
+|+|+||||
T Consensus 279 ~~~l~hp~f 287 (287)
T cd07848 279 EQCLNHPAF 287 (287)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=367.59 Aligned_cols=259 Identities=28% Similarity=0.386 Sum_probs=217.6
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
-.+.|++++.||+|.-|+||+|....++..+|+|++.+... .....+.|.++|.. .+||++..|+..|+.
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~------lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSL------LDHPFLPTLYASFET 148 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHh------cCCCccchhhheeec
Confidence 35689999999999999999999999999999999975322 23344555555443 468899999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
+.+.|||||||+| +|..+++++..+.+++..++.++.+++.||+|||. +|||+|||||+|||| .++|+|.|+||.
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILv--redGHIMLsDFD 224 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILV--REDGHIMLSDFD 224 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEE--ecCCcEEeeecc
Confidence 9999999999955 99999999988899999999999999999999995 899999999999999 789999999999
Q ss_pred cccccC------------------------------------C-----------------------ccccccccCcCCch
Q psy16081 272 SSCQLG------------------------------------Q-----------------------RIYQYIQSRFYRSP 292 (493)
Q Consensus 272 ~a~~~~------------------------------------~-----------------------~~~~~~gt~~y~aP 292 (493)
++.... . ....++||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 873210 0 01135788889999
Q ss_pred hhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCC
Q psy16081 293 EVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKD 372 (493)
Q Consensus 293 E~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (493)
|++.|.+.+.++|+|+|||+|||||.|..||.|.+..+++.+|+..--..|..
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~--------------------------- 357 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE--------------------------- 357 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC---------------------------
Confidence 99999999999999999999999999999999999999999887531111100
Q ss_pred CCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC----HHHHhcCCCCCCCccC
Q psy16081 373 GRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT----PYYALQHNFFKRTADE 446 (493)
Q Consensus 373 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t----~~e~L~Hp~~~~~~~~ 446 (493)
+ +.-.+++|||+++|.+||.+|+- |.||-+||||+++.+.
T Consensus 358 ------------------------------~----~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 358 ------------------------------P----EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred ------------------------------C----cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 0 01117899999999999999999 9999999999988765
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=369.85 Aligned_cols=285 Identities=29% Similarity=0.456 Sum_probs=215.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|++.+.||+|+||+||+|.+..+++.||||+++..... ......|+.++.. .+|+||+++++++.+.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~------l~h~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKG------LKHANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhh------CCCCCcCeEEEEEecCCe
Confidence 36899999999999999999999999999999998743221 1233344444433 357789999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 78 LTLVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLI--SDTGELKLADFGLARA 152 (303)
T ss_pred EEEEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--CCCCCEEECCCCccee
Confidence 99999999999999887543 468999999999999999999995 789999999999999 6788999999999875
Q ss_pred cCC---ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQ---RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGS-NEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
... .....++|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+. +..+.+..+...++.+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 153 KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred ccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence 432 22346789999999998764 5899999999999999999999999875 445677777777777765544332
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.....+ .. ..+. ......+..... .......+.|||.+||++||++|||
T Consensus 233 ~~~~~~-~~---~~~~-----------~~~~~~~~~~~~----------------~~~~~~~~~dli~~mL~~dp~~R~s 281 (303)
T cd07869 233 HSLPHF-KP---ERFT-----------LYSPKNLRQAWN----------------KLSYVNHAEDLASKLLQCFPKNRLS 281 (303)
T ss_pred hhcccc-cc---cccc-----------ccCCccHHHHhh----------------ccCCChHHHHHHHHHhccCchhccC
Confidence 211110 00 0000 000011111100 0001126789999999999999999
Q ss_pred HHHHhcCCCCCCCc
Q psy16081 431 PYYALQHNFFKRTA 444 (493)
Q Consensus 431 ~~e~L~Hp~~~~~~ 444 (493)
+.|+|+||||+...
T Consensus 282 ~~~~l~h~~f~~~~ 295 (303)
T cd07869 282 AQAALSHEYFSDLP 295 (303)
T ss_pred HHHHhcCcccccCC
Confidence 99999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=374.77 Aligned_cols=260 Identities=29% Similarity=0.476 Sum_probs=225.4
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++.+-|.+.+.||+|.|+.|-+|++.-||+.||||++.+.+...-. -..++.+++......|||||+|+++......
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s---t~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS---TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh---hhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 4567799999999999999999999999999999999876533221 2233444444555678889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|||+|+-++ +|+++|.+.. .++.++.+++++.||+.|+.|+| ++.+|||||||+||.+- .+-|-+||+|||++.
T Consensus 92 lyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFF-EKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFF-EKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEe-eecCceEeeeccccc
Confidence 9999999955 9999998766 58999999999999999999999 68999999999999886 578999999999997
Q ss_pred cc--CCccccccccCcCCchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 275 QL--GQRIYQYIQSRFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 275 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.+ ++...+.||+..|-|||+++|..|+ +++||||||||||.|.+|++||...++.+.+..|++.-...|.+..
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS---- 243 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVS---- 243 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhh----
Confidence 66 6678899999999999999999998 5899999999999999999999999999999999886444443321
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
+ +++|||..||..||.+|.|.
T Consensus 244 ---------------------------------------------------------~--eCrdLI~sMLvRdPkkRAsl 264 (864)
T KOG4717|consen 244 ---------------------------------------------------------K--ECRDLIQSMLVRDPKKRASL 264 (864)
T ss_pred ---------------------------------------------------------H--HHHHHHHHHHhcCchhhccH
Confidence 1 78999999999999999999
Q ss_pred HHHhcCCCCCCCcc
Q psy16081 432 YYALQHNFFKRTAD 445 (493)
Q Consensus 432 ~e~L~Hp~~~~~~~ 445 (493)
++|..|+|++....
T Consensus 265 EeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 265 EEIVSTSWLQAGDR 278 (864)
T ss_pred HHHhccccccCCCC
Confidence 99999999997643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=376.62 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=208.6
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......|..++. ..+||||+++++.+.+.
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~------~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM------ELSHPFIVNMMCSFQDE 90 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH------hCCCCCCCcEEEEEEcC
Confidence 4689999999999999999999999999999999874321 1122333433333 33578899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll--~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLL--DNKGHVKVTDFGF 164 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEE--CCCCCEEEeeccC
Confidence 999999999955 8999887653 58999999999999999999995 789999999999999 6788999999999
Q ss_pred ccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 273 SCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 273 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
+..........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.....|.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~-------- 236 (329)
T PTZ00263 165 AKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN-------- 236 (329)
T ss_pred ceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC--------
Confidence 988777666788999999999999999999999999999999999999999988776666555431000000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC--
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT-- 430 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t-- 430 (493)
..+ ..+.+||.+||..||.+|++
T Consensus 237 -----------------------------------------------------~~~--~~~~~li~~~L~~dP~~R~~~~ 261 (329)
T PTZ00263 237 -----------------------------------------------------WFD--GRARDLVKGLLQTDHTKRLGTL 261 (329)
T ss_pred -----------------------------------------------------CCC--HHHHHHHHHHhhcCHHHcCCCC
Confidence 000 16789999999999999997
Q ss_pred ---HHHHhcCCCCCCCc
Q psy16081 431 ---PYYALQHNFFKRTA 444 (493)
Q Consensus 431 ---~~e~L~Hp~~~~~~ 444 (493)
+++++.||||....
T Consensus 262 ~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 262 KGGVADVKNHPYFHGAN 278 (329)
T ss_pred CCCHHHHhcCCccCCCC
Confidence 79999999998753
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=375.08 Aligned_cols=297 Identities=30% Similarity=0.478 Sum_probs=220.0
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc-
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN- 194 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~- 194 (493)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.......... ....+++......+|+||++++++|...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHH---HHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 45689999999999999999999999999999999986432111111 11222223333446888999999987543
Q ss_pred -----eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 195 -----HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 195 -----~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
.+|+||||++++|.+.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~--~~~~~~kl~D 166 (359)
T cd07876 95 LEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVV--KSDCTLKILD 166 (359)
T ss_pred ccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEE--CCCCCEEEec
Confidence 5799999999998887743 47889999999999999999995 789999999999999 6788999999
Q ss_pred cccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 270 FGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 270 FG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.|+..++
T Consensus 167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9999765332 34567899999999999999999999999999999999999999999999999999999998887665
Q ss_pred hhccch-hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 348 DGAHKT-RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 348 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
...... ..+....+... .......+.+++. +. ...........+.+||.+||.+||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~-----~~-----~~~~~~~~~~~~~~li~~mL~~dP~ 304 (359)
T cd07876 247 NRLQPTVRNYVENRPQYP------------GISFEELFPDWIF-----PS-----ESERDKLKTSQARDLLSKMLVIDPD 304 (359)
T ss_pred HHHHHHHHHHHhhCCCCC------------Ccchhhhcccccc-----cc-----ccccccccchhHHHHHHHHhccCcc
Confidence 543322 22222111100 0000000000000 00 0000000112688999999999999
Q ss_pred CCCCHHHHhcCCCCCCCcc
Q psy16081 427 TRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~~~ 445 (493)
+|||+.|+|+||||+.+.+
T Consensus 305 ~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 305 KRISVDEALRHPYITVWYD 323 (359)
T ss_pred cCCCHHHHhcCchhhhhcC
Confidence 9999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=370.99 Aligned_cols=281 Identities=33% Similarity=0.530 Sum_probs=217.0
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec---
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR--- 193 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~--- 193 (493)
+|++.++||+|+||.||+|++..+++.||||++...... ......|+.++ ...+||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l------~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLL------RLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHH------HhCCCCCEeeecceEeccCCC
Confidence 589999999999999999999999999999998642211 11223333333 334588899999988643
Q ss_pred --ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 194 --NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 194 --~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
..+|+|||||+++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll--~~~~~~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILA--NADCKLKICDFG 148 (338)
T ss_pred CCceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEE--CCCCcEEEccCc
Confidence 3589999999999999887543 58999999999999999999995 789999999999999 778899999999
Q ss_pred cccccCCc------cccccccCcCCchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 272 SSCQLGQR------IYQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 272 ~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+...++..+.+.++.++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99754221 134578999999999876 5789999999999999999999999999999899999999999888
Q ss_pred hhhhhhccc--hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 344 KHLLDGAHK--TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 344 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
......... ...++..+... ....+...+ ......+.+||.+||
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~----------------~~~~~~~~~------------------~~~~~~~~~li~~~l 274 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKK----------------QPVPFSQKF------------------PNADPLALRLLERLL 274 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhccc----------------CCCchHHhc------------------CCCChHHHHHHHHHc
Confidence 776654322 11222211100 000000000 000126789999999
Q ss_pred CCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 422 DYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
..||++|||++|+|+||||+.....
T Consensus 275 ~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 275 AFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred CcCcccCCCHHHHhcCchhhhcCcc
Confidence 9999999999999999999876543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=368.30 Aligned_cols=252 Identities=28% Similarity=0.376 Sum_probs=207.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++.+.||+|+||.||+|.+..+++.||||++..... .......|..+ ....+||||+++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~------l~~l~hp~iv~~~~~~~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRV------LKEVSHPFIIRLFWTEHDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHH------HHhCCCCcHhhhHhhhccCC
Confidence 468999999999999999999999999999999864321 11122233333 33345788999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli--~~~~~~kl~Dfg~~ 148 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILL--DKEGHIKLTDFGFA 148 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEE--CCCCCEEEEecCcc
Confidence 99999999965 8999987653 68999999999999999999995 789999999999999 67889999999999
Q ss_pred cccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 274 CQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......|.
T Consensus 149 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--------- 219 (291)
T cd05612 149 KKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR--------- 219 (291)
T ss_pred hhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc---------
Confidence 87766666678999999999999999999999999999999999999999988877766666432100000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC---
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT--- 430 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t--- 430 (493)
..+ ..+++||++||..||.+|++
T Consensus 220 ----------------------------------------------------~~~--~~~~~li~~~l~~dp~~R~~~~~ 245 (291)
T cd05612 220 ----------------------------------------------------HLD--LYAKDLIKKLLVVDRTRRLGNMK 245 (291)
T ss_pred ----------------------------------------------------cCC--HHHHHHHHHHcCCCHHHccCCcc
Confidence 000 16789999999999999995
Q ss_pred --HHHHhcCCCCCCCcc
Q psy16081 431 --PYYALQHNFFKRTAD 445 (493)
Q Consensus 431 --~~e~L~Hp~~~~~~~ 445 (493)
++++++||||+....
T Consensus 246 ~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 246 NGADDVKNHRWFKSVDW 262 (291)
T ss_pred CCHHHHhcCccccCCCH
Confidence 999999999987544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=362.39 Aligned_cols=278 Identities=33% Similarity=0.557 Sum_probs=216.9
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee----
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW---- 192 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~---- 192 (493)
+|++++.||+|+||+||+|.+..+++.||+|+++.... .......|..++..+.. .+|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA---FDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhh---cCCCCeeeeeeeeccccCC
Confidence 58999999999999999999999999999999874321 12344556666655543 357889999998864
Q ss_pred -cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 -RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 -~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
...+++||||+.++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili--~~~~~~kl~dfg 153 (288)
T cd07863 78 RETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILV--TSGGQVKLADFG 153 (288)
T ss_pred CCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--CCCCCEEECccC
Confidence 346899999999999999876655569999999999999999999995 789999999999999 678899999999
Q ss_pred cccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 272 SSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 272 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
++...... .....+|..|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+.++....+.+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 99766433 2345688999999999999999999999999999999999999999998899999988887766544322
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.... +...+. ......+.++. ...+ ..+.|||.+||.+||++||
T Consensus 234 ~~~~-------~~~~~~-----------~~~~~~~~~~~----------------~~~~--~~~~~li~~~L~~dP~~R~ 277 (288)
T cd07863 234 DVTL-------PRGAFS-----------PRGPRPVQSVV----------------PEIE--ESGAQLLLEMLTFNPHKRI 277 (288)
T ss_pred cccc-------cccccC-----------CCCCCchHHhC----------------cCcC--HHHHHHHHHHhccCcccCC
Confidence 1100 000000 00000001100 0111 2678999999999999999
Q ss_pred CHHHHhcCCCC
Q psy16081 430 TPYYALQHNFF 440 (493)
Q Consensus 430 t~~e~L~Hp~~ 440 (493)
|+.|+++||||
T Consensus 278 t~~~~l~hp~f 288 (288)
T cd07863 278 SAFRALQHPFF 288 (288)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=361.27 Aligned_cols=265 Identities=28% Similarity=0.404 Sum_probs=211.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.+.|++...||.|..++||+|+...+++.||||++.-.+-. .. -..+..++......+||||++.+..|..+..+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~---ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-ND---LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hh---HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 35799999999999999999999999999999999743211 11 123344444455667899999999999999999
Q ss_pred EEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||.|| .|+++++++..-..+++|..+..|+++++.||.||| +.|.||||||+.|||| +.+|.|||+|||.+-.+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi--~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILI--DSDGTVKLADFGVSASL 176 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEE--cCCCcEEEcCceeeeee
Confidence 999999 569999998877788999999999999999999999 5899999999999999 78999999999997544
Q ss_pred C---Cc----cccccccCcCCchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 277 G---QR----IYQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 277 ~---~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
. .+ ..+++||++|||||++.. .+|+.|+||||||++..||.+|..||....+...+-.-++ +.||....
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCccc
Confidence 2 21 256689999999999764 4799999999999999999999999998777666543332 33331110
Q ss_pred hhccch-hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 348 DGAHKT-RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 348 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
...++. ..-| + ..|+.+|..||.+||.
T Consensus 255 ~~~~~d~~k~~-------------------------------------------~---------ksf~e~i~~CL~kDP~ 282 (516)
T KOG0582|consen 255 SGLDKDEDKKF-------------------------------------------S---------KSFREMIALCLVKDPS 282 (516)
T ss_pred ccCChHHhhhh-------------------------------------------c---------HHHHHHHHHHhhcCcc
Confidence 000000 0000 0 1789999999999999
Q ss_pred CCCCHHHHhcCCCCCCCc
Q psy16081 427 TRITPYYALQHNFFKRTA 444 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~~ 444 (493)
+|||+.++|+|+||+...
T Consensus 283 kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 283 KRPTASKLLKHAFFKKAK 300 (516)
T ss_pred cCCCHHHHhccHHHhhcc
Confidence 999999999999998765
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=352.51 Aligned_cols=217 Identities=30% Similarity=0.420 Sum_probs=180.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEece-eeeecce
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKR-HFMWRNH 195 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~-~~~~~~~ 195 (493)
-..+|+|+++||+|+||+||++.+..+|+.||.|.+.-........+ .++.++..++..+|||||+.++ .|..++.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq---~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQ---DCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHH---HHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 34579999999999999999999999999999998874332222222 2333334444456888999998 5666666
Q ss_pred -eEEEEEec-ccCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC--ccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 196 -LCLVFELL-SYNLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELN--IIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 196 -~~lV~E~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~--iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
++|||||| .|+|.+++++ ...+.+++..+++++.|++.||..+|+.=.. |+||||||.||+| +.+|.+||+|
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl--~~~gvvKLGD 171 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL--TANGVVKLGD 171 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE--cCCCceeecc
Confidence 89999999 4699998864 3335699999999999999999999973123 8999999999999 7899999999
Q ss_pred cccccccCCcc---ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy16081 270 FGSSCQLGQRI---YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338 (493)
Q Consensus 270 FG~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 338 (493)
||+++.+.... .+++|||.||+||.+.+.+|+.++||||+||++|||+.-.+||.+.+-.+...+|...
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg 243 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG 243 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence 99999987653 4689999999999999999999999999999999999999999999777777777654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=372.05 Aligned_cols=249 Identities=28% Similarity=0.411 Sum_probs=198.6
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
+.||+|+||.||+|++..+|+.||||+++....... ......+.++......+||||+++++.|...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAK--DEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh--HHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 479999999999999999999999999974321101 111122223333334468889999999999999999999996
Q ss_pred c-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc---CCcc
Q psy16081 205 Y-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRI 280 (493)
Q Consensus 205 ~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~---~~~~ 280 (493)
+ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++... ....
T Consensus 79 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll--~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 79 GGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLML--DKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEE--CCCCCEEEeeCCCCcccccCCCcc
Confidence 5 888888654 368999999999999999999995 789999999999999 67889999999998754 2233
Q ss_pred ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccC
Q psy16081 281 YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKM 360 (493)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 360 (493)
...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.......|.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~---------------- 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR---------------- 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----------------
Confidence 4568999999999999999999999999999999999999999887766555544321000000
Q ss_pred CCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CHHHHh
Q psy16081 361 PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TPYYAL 435 (493)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~~e~L 435 (493)
..+ ..+.+||.+||..||++|| ++.+++
T Consensus 217 ---------------------------------------------~~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 249 (323)
T cd05571 217 ---------------------------------------------TLS--PEAKSLLAGLLKKDPKQRLGGGPEDAKEIM 249 (323)
T ss_pred ---------------------------------------------CCC--HHHHHHHHHHccCCHHHcCCCCCCCHHHHH
Confidence 001 1688999999999999999 899999
Q ss_pred cCCCCCCCc
Q psy16081 436 QHNFFKRTA 444 (493)
Q Consensus 436 ~Hp~~~~~~ 444 (493)
+||||....
T Consensus 250 ~h~~f~~~~ 258 (323)
T cd05571 250 EHRFFASIN 258 (323)
T ss_pred cCCCcCCCC
Confidence 999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=370.48 Aligned_cols=296 Identities=30% Similarity=0.486 Sum_probs=220.6
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR-- 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~-- 193 (493)
.+.++|++.+.||+|+||.||+|++..+++.||||++............ ..+++......+|+||+++++.+...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~---~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR---AYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHH---HHHHHHHHHhcCCCCccccceeeccccc
Confidence 3467999999999999999999999999999999998743221111111 12222223334578899999887643
Q ss_pred ----ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 194 ----NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 194 ----~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
..+|+||||++++|.+.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll--~~~~~~kL~D 169 (364)
T cd07875 98 LEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVV--KSDCTLKILD 169 (364)
T ss_pred ccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEE--CCCCcEEEEe
Confidence 35799999999999888753 37889999999999999999995 799999999999999 6788999999
Q ss_pred cccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 270 FGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 270 FG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++++.++.|...++
T Consensus 170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9999776543 23467899999999999999999999999999999999999999999999999999999998877665
Q ss_pred hhccch-hhhhccCCCC-CceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 348 DGAHKT-RKYFDKMPDG-SYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 348 ~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
...... ..++...+.. .+. +..+.. ....+. ...........++|||.+||.+||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~-~~~~~~-----~~~~~~~~~~~~~dll~~mL~~dP 306 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYS-----------------FEKLFP-DVLFPA-----DSEHNKLKASQARDLLSKMLVIDA 306 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCC-----------------hHhhCc-cccccc-----cccccccccHHHHHHHHHhcCcCc
Confidence 544322 2222221110 000 000000 000000 000001111268899999999999
Q ss_pred CCCCCHHHHhcCCCCCCCcc
Q psy16081 426 KTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.+|||+.|+|+||||..+.+
T Consensus 307 ~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 307 SKRISVDEALQHPYINVWYD 326 (364)
T ss_pred ccCCCHHHHhcCcccccccC
Confidence 99999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=361.97 Aligned_cols=260 Identities=26% Similarity=0.371 Sum_probs=201.7
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
|++.+.||+|+||+||+|.+..+++.||||++...... ....+..++.++......+|++|+++.+.+.+.+.+|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 78899999999999999999999999999998643211 1111112222333333345778999999999999999999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC-
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ- 278 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~- 278 (493)
||+.+ +|.+.+.......+++..+..++.||+.||.|||+ .||+||||||+|||+ ++++.+||+|||++.....
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill--~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILL--DDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEE--CCCCCEEEeeCCCcEEcCCC
Confidence 99965 88877765444468999999999999999999994 799999999999999 6788999999999976543
Q ss_pred -ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhh
Q psy16081 279 -RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYF 357 (493)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 357 (493)
......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.......+.. +
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~- 224 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE----------Y- 224 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccccc----------C-
Confidence 2345678999999999999999999999999999999999999998765433333222211110000 0
Q ss_pred ccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC-----HH
Q psy16081 358 DKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT-----PY 432 (493)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t-----~~ 432 (493)
. ...+ ..+.+||++||..||.+||| ++
T Consensus 225 -----------------------~-----------------------~~~s--~~~~~li~~~l~~~P~~R~~~~~~~~~ 256 (285)
T cd05631 225 -----------------------S-----------------------EKFS--EDAKSICRMLLTKNPKERLGCRGNGAA 256 (285)
T ss_pred -----------------------C-----------------------ccCC--HHHHHHHHHHhhcCHHHhcCCCCCCHH
Confidence 0 0001 16889999999999999997 89
Q ss_pred HHhcCCCCCCCcc
Q psy16081 433 YALQHNFFKRTAD 445 (493)
Q Consensus 433 e~L~Hp~~~~~~~ 445 (493)
++++||||.....
T Consensus 257 ~~~~h~~~~~~~~ 269 (285)
T cd05631 257 GVKQHPIFKNINF 269 (285)
T ss_pred HHhcCHhhcCCCH
Confidence 9999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=380.93 Aligned_cols=282 Identities=34% Similarity=0.607 Sum_probs=215.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec----
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR---- 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~---- 193 (493)
..+|+++++||+|+||.||+|.+..+++.||||++.... .....|+.++..+ +|+||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l------~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNL------NHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhc------CCCCCcceeeeEeeccccc
Confidence 467999999999999999999999999999999886433 2234455555443 477799998887532
Q ss_pred ----ceeEEEEEecccCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 194 ----NHLCLVFELLSYNLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 194 ----~~~~lV~E~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
..+++||||++++|.+++... ....+++..++.++.||+.||.|||+ .|||||||||+|||++ ...+.+||
T Consensus 136 ~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~-~~~~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLID-PNTHTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEc-CCCCceee
Confidence 257899999999988877532 23468999999999999999999995 7899999999999993 23457999
Q ss_pred EecccccccC--CccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 268 VDFGSSCQLG--QRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 268 ~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
+|||+|+.+. ......+||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+.+..+++.+++..++.|+.
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9999997663 233456889999999998764 6999999999999999999999999999999999999999998876
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
..+..... .| ..+. + +. .....+...+. .. ...++++||.+||.+|
T Consensus 293 ~~~~~~~~--~~-~~~~---~----------~~-~~~~~l~~~~p--------------~~---~~~~~~~li~~~L~~d 338 (440)
T PTZ00036 293 DQLKEMNP--NY-ADIK---F----------PD-VKPKDLKKVFP--------------KG---TPDDAINFISQFLKYE 338 (440)
T ss_pred HHHHHhch--hh-hccc---C----------Cc-cCchhHHHHhc--------------cC---CCHHHHHHHHHHCCCC
Confidence 65543211 01 0000 0 00 00001111110 00 0126899999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCcc
Q psy16081 425 PKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~~~~~~ 445 (493)
|.+|||+.|+|+||||....+
T Consensus 339 P~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 339 PLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hhHCcCHHHHhCChhHHhhhc
Confidence 999999999999999987644
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=376.13 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=210.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
...|....+||+|+-|.||.|+...+++.||||.+....+...+. ++.++..+.-.+|+|||++++.|...+.++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keL-----ilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKEL-----LLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhh-----hHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 457888899999999999999999999999999998654332222 222233333456888999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+|||||+| +|.+.+.... ++|.++..++++++.||+|||. .||||||||.+|||+ ..+|.+||+|||++..+
T Consensus 347 VVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL--~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILL--TMDGSVKLTDFGFCAQI 419 (550)
T ss_pred EEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEe--ccCCcEEEeeeeeeecc
Confidence 99999955 8888887653 9999999999999999999994 799999999999999 67888999999999877
Q ss_pred CC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 277 GQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 277 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
.. ...+.+|||+|||||++....|+.++||||||++++||+-|+|||-..+...-+..|... |.|..
T Consensus 420 ~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~l--------- 489 (550)
T KOG0578|consen 420 SEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKL--------- 489 (550)
T ss_pred ccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCc---------
Confidence 54 346789999999999999999999999999999999999999999988877777776543 22210
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
+. + +.++- .|+|||.+||+.|+++|+||.|
T Consensus 490 --------------k~-----------~-----------------------~klS~--~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 490 --------------KN-----------P-----------------------EKLSP--ELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred --------------CC-----------c-----------------------cccCH--HHHHHHHHHhhcchhcCCCHHH
Confidence 00 0 01111 7899999999999999999999
Q ss_pred HhcCCCCCCC
Q psy16081 434 ALQHNFFKRT 443 (493)
Q Consensus 434 ~L~Hp~~~~~ 443 (493)
+|+||||+..
T Consensus 520 LL~HpFl~~a 529 (550)
T KOG0578|consen 520 LLEHPFLKMA 529 (550)
T ss_pred HhcChhhhhc
Confidence 9999999643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=367.62 Aligned_cols=294 Identities=32% Similarity=0.491 Sum_probs=220.7
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch---HHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN---QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++.+.||+|+||.||+|.+..+++.||||++........ ....|..++ ...+|+||++++++|..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l------~~l~h~niv~~~~~~~~ 87 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM------KCVNHKNIISLLNVFTP 87 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHH------HHhCCCchhceeeeeec
Confidence 356899999999999999999999999999999999874322212 222233333 23357889999998864
Q ss_pred c------ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 R------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
. ..+|+||||++++|.+.+.. .+++..+..++.||+.||.||| +.||+||||||+|||+ +.++.+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill--~~~~~~k 159 (355)
T cd07874 88 QKSLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVV--KSDCTLK 159 (355)
T ss_pred cccccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEE--CCCCCEE
Confidence 3 35799999999998887753 3788999999999999999999 4799999999999999 6788999
Q ss_pred EEecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 267 IVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 267 L~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.+..
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 160 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred EeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999999776543 23567899999999999999999999999999999999999999999999999999998888776
Q ss_pred hhhhhccc-hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 345 HLLDGAHK-TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 345 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
.++..... ...++...+..... .....+.+.+ .+ ............+.+||.+||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~-----~~-----~~~~~~~~~~~~~~~li~~mL~~ 297 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGL------------TFPKLFPDSL-----FP-----ADSEHNKLKASQARDLLSKMLVI 297 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccc------------cchhhccccc-----cc-----cccccccccchHHHHHHHHHhcC
Confidence 66554332 22333322211000 0000000000 00 00000111112678999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q psy16081 424 DPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
||++|||+.|+|+||||..+.+
T Consensus 298 dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 298 DPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred CchhcCCHHHHhcCcchhcccC
Confidence 9999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=366.22 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=204.3
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
|++++.||+|+||.||+|.+..+++.||||+++... ........|..+++. ....+||||+++++++...+++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~---~~~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET---ANSERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh---ccccCCCChhceeeEEEcCCEE
Confidence 678999999999999999999999999999997432 111223334433333 3445688999999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+.+ +|...+.. ..+++..+..++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill--~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLL--DTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEE--CCCCcEEeCcccCCcc
Confidence 999999965 88777754 35899999999999999999999 4799999999999999 6788999999999865
Q ss_pred cC---CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LG---QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.. ......+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.......|..
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~------- 223 (324)
T cd05589 151 GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF------- 223 (324)
T ss_pred CCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC-------
Confidence 32 23345679999999999999999999999999999999999999999888777766654421110000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC---
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI--- 429 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~--- 429 (493)
.. ..+.+||.+||..||.+||
T Consensus 224 ------------------------------------------------------~~--~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 224 ------------------------------------------------------LS--REAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred ------------------------------------------------------CC--HHHHHHHHHHhhcCHhHcCCCC
Confidence 00 1678999999999999999
Q ss_pred --CHHHHhcCCCCCCCc
Q psy16081 430 --TPYYALQHNFFKRTA 444 (493)
Q Consensus 430 --t~~e~L~Hp~~~~~~ 444 (493)
++.++++||||....
T Consensus 248 ~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 248 EKDAEDVKKQPFFRDIN 264 (324)
T ss_pred CCCHHHHhhCCCcCCCC
Confidence 799999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=362.81 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=200.3
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc--e
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN--H 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~--~ 195 (493)
.++...+.||+|+||+||++.+..+|+..|||.+.... ...+....|+.++..++ |||||+.++...... .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~------~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN------HPNIVQYYGSSSSRENDE 90 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC------CCCEEeeCCccccccCee
Confidence 35778899999999999999999999999999886431 11334566666665543 777999999855544 6
Q ss_pred eEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC-CCcEEEEecccc
Q psy16081 196 LCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK-RSAIKIVDFGSS 273 (493)
Q Consensus 196 ~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~-~~~ikL~DFG~a 273 (493)
+++.|||+. |+|.+++.+... .+++..++.+.+||+.||.|||+ .|||||||||+|||+ +. ++.+||+|||++
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl--~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILL--DPSNGDVKLADFGLA 165 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEE--eCCCCeEEeccCccc
Confidence 999999995 599999988765 79999999999999999999995 789999999999999 55 689999999999
Q ss_pred cccCC------ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChh
Q psy16081 274 CQLGQ------RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGS-NEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 274 ~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~p~~ 345 (493)
..... ......||+.|||||++..+ ....++|||||||++.||+||.+||... ...+.+..|......|
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P--- 242 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP--- 242 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC---
Confidence 76652 23357899999999999963 3335999999999999999999999873 3333332322111000
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
.+ +..+ ++ +.+|||.+||..||
T Consensus 243 -------------------------------~i--p~~l-----------------------s~--~a~~Fl~~C~~~~p 264 (313)
T KOG0198|consen 243 -------------------------------EI--PDSL-----------------------SD--EAKDFLRKCFKRDP 264 (313)
T ss_pred -------------------------------CC--Cccc-----------------------CH--HHHHHHHHHhhcCc
Confidence 00 0111 11 67899999999999
Q ss_pred CCCCCHHHHhcCCCCCCCcc
Q psy16081 426 KTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~~~ 445 (493)
++||||.++|+|||.+....
T Consensus 265 ~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 265 EKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ccCcCHHHHhhChhhhcccc
Confidence 99999999999999987544
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=374.40 Aligned_cols=279 Identities=24% Similarity=0.384 Sum_probs=213.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++++.||+|+||.||+|.+..+++.||||.... .....|+.++..+ +||||++++++|......|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l------~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAI------NHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhC------CCCCCCCEeEEEEECCeeE
Confidence 3579999999999999999999999999999997642 2345566665544 4788999999999999999
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
+|+|++.++|.+++... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+++...
T Consensus 160 lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll--~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 160 LILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFI--NHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEE--cCCCCEEEEeCCcccccc
Confidence 99999999999988664 358999999999999999999995 689999999999999 678899999999996542
Q ss_pred ----CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHHhCCCChhh
Q psy16081 278 ----QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS-------NEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 278 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~-------~~~~~~~~i~~~~~~~p~~~ 346 (493)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||... +...++..+...++.+|..+
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 2234568999999999999999999999999999999999999876542 34567788888888776544
Q ss_pred hhhccc-hhhhh-ccCCCCCceecCCCCCCCCCCCCCcc-chhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 347 LDGAHK-TRKYF-DKMPDGSYILKKPKDGRKPKVPGSRR-LHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 347 ~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
...... ....+ ..... . ...+..+. +..+. ....++.+||.+||.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~-~-----------~~~~~~~~~~~~~~-------------------~~~~~l~~Li~~mL~~ 362 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKK-S-----------SRKPGSRPLWTNLY-------------------ELPIDLEYLICKMLAF 362 (391)
T ss_pred CcchhHHHHHHHHHHHhc-c-----------CCCCCCCCCHHHHh-------------------hhhhhHHHHHHHHhcC
Confidence 321110 11111 10000 0 00000000 00000 0112688999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCc
Q psy16081 424 DPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
||++|||++|+|+||||+.+.
T Consensus 363 dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 363 DAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred ChhhCCCHHHHhcChhhccCC
Confidence 999999999999999998653
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=318.99 Aligned_cols=279 Identities=32% Similarity=0.547 Sum_probs=234.8
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccC---cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK---KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|.-.++||+|.||+||+|+++.+++.||+|.++.. ........+|+-++.++.|. |||++++....+..+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhk------nivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK------NIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhc------ceeehhhhhccCcee
Confidence 466678999999999999999999999999998743 34467788898888888755 499999999999999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
.+|+|||..+|..++...+ ..++...++.++.|++.||.|+|+| ++.||||||.|+|| +.+|.+||+|||+++.+
T Consensus 77 tlvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh--nvlhrdlkpqnlli--n~ngelkladfglaraf 151 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH--NVLHRDLKPQNLLI--NRNGELKLADFGLARAF 151 (292)
T ss_pred EEeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh--hhhhccCCcceEEe--ccCCcEEecccchhhhc
Confidence 9999999999999988766 4699999999999999999999974 79999999999999 89999999999999988
Q ss_pred CCccc---cccccCcCCchhhhcCCC-CCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQRIY---QYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMH-TGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~~~---~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell-tG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
+-+.. ..+-|.+|++|.++.|.. |++..|+||-|||+.|+. .|+|.|.+.+..+++.+|...+|.|.+..|+...
T Consensus 152 gipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred CCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 76543 345688999999999865 999999999999999999 5999999999999999999999999988887665
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
+...|-. .+..|...++.+|...-.. .-.||++++|.-+|.+|+++
T Consensus 232 ~lpdyk~----------------yp~ypattswsqivp~lns------------------~grdllqkll~cnp~qrisa 277 (292)
T KOG0662|consen 232 KLPDYKP----------------YPIYPATTSWSQIVPKLNS------------------TGRDLLQKLLKCNPAQRISA 277 (292)
T ss_pred cCCCCcc----------------cCCccccchHHHHhhhhcc------------------hhHHHHHHHhccCcccccCH
Confidence 5443311 1223444445444332110 23699999999999999999
Q ss_pred HHHhcCCCCCCC
Q psy16081 432 YYALQHNFFKRT 443 (493)
Q Consensus 432 ~e~L~Hp~~~~~ 443 (493)
+++|+||||...
T Consensus 278 eaalqhpyf~d~ 289 (292)
T KOG0662|consen 278 EAALQHPYFSDF 289 (292)
T ss_pred HHHhcCcccccc
Confidence 999999999853
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=373.53 Aligned_cols=255 Identities=29% Similarity=0.422 Sum_probs=203.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++++.||+|+||+||+|++..+++.||||++..... .......|+.++.. .+|+||+++++.|.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~------l~h~~iv~~~~~~~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE------ADNPWVVKLYYSFQDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh------CCCCCCcceEEEEEcCC
Confidence 479999999999999999999999999999999974321 11223334444333 34888999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
++||||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~ 148 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLL--DAKGHIKLSDFGLC 148 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEE--CCCCCEEEeecccc
Confidence 99999999955 8999887643 58999999999999999999994 789999999999999 77889999999998
Q ss_pred cccCCc-----------------------------------------cccccccCcCCchhhhcCCCCCchhhHHHHHHH
Q psy16081 274 CQLGQR-----------------------------------------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCI 312 (493)
Q Consensus 274 ~~~~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 312 (493)
..+... ....+||+.|+|||++.+..++.++|||||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 228 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence 654211 112469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccC
Q psy16081 313 LVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVES 392 (493)
Q Consensus 313 l~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 392 (493)
+|||++|.+||.+.+..+.+..+.+..... ..+...
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~~~~~---------- 264 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKIINWKETL----------------------------------QFPDEV---------- 264 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCcc----------------------------------CCCCCC----------
Confidence 999999999999888776665554310000 000000
Q ss_pred CCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC---HHHHhcCCCCCCCcc
Q psy16081 393 GGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT---PYYALQHNFFKRTAD 445 (493)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t---~~e~L~Hp~~~~~~~ 445 (493)
..+ ..+++||.+||. ||.+|++ +.|+|+||||.....
T Consensus 265 -------------~~s--~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 265 -------------PLS--PEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred -------------CCC--HHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 001 167899999997 9999998 999999999997654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=360.95 Aligned_cols=283 Identities=28% Similarity=0.465 Sum_probs=221.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|.+.+.||+|+||+||+|++..+++.||||+++.... .......|+.++.. .+|+||+++++++..++.
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~------l~h~~iv~~~~~~~~~~~ 78 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKD------LKHANIVTLHDIVHTDKS 78 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHh------CCCCCcceEEEEEeeCCe
Confidence 3679999999999999999999999999999999874322 11233344444433 357789999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
.|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 79 LTLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLI--NERGELKLADFGLARA 153 (309)
T ss_pred EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--CCCCCEEECcccccee
Confidence 99999999999999886543 358999999999999999999994 789999999999999 6788999999999976
Q ss_pred cCCc---cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...++...
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 154 KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred cCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 5322 234567899999999876 458999999999999999999999999999999999999999998887776544
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
....+.+. ....+. ...+... ....+ .+++|||.+||.+||.+|||+
T Consensus 234 ~~~~~~~~-~~~~~~--------------~~~~~~~----------------~~~~~--~~~~~li~~~L~~dp~~R~t~ 280 (309)
T cd07872 234 SNDEFKNY-NFPKYK--------------PQPLINH----------------APRLD--TEGIELLTKFLQYESKKRISA 280 (309)
T ss_pred chhhhhhh-hcCccC--------------CCchhhh----------------ccCCC--HHHHHHHHHhccCChhhCCCH
Confidence 33222211 000000 0000000 00011 167899999999999999999
Q ss_pred HHHhcCCCCCCCc
Q psy16081 432 YYALQHNFFKRTA 444 (493)
Q Consensus 432 ~e~L~Hp~~~~~~ 444 (493)
.|+|+||||+...
T Consensus 281 ~e~l~h~~~~~~~ 293 (309)
T cd07872 281 EEAMKHAYFRSLG 293 (309)
T ss_pred HHHhcChhhhhcc
Confidence 9999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=373.63 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=200.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++++.||+|+||+||+|.+..+++.||||++...... ......|+.++ ...+|+||++++++|.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il------~~l~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL------AESDSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHH------HhCCCCCcceEEEEEEcCC
Confidence 4699999999999999999999999999999998643211 12223333333 3346888999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
++||||||+. ++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll--~~~~~~kl~DfGla 148 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILI--DRGGHIKLSDFGLS 148 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEE--CCCCCEEEeecccc
Confidence 9999999995 5999988754 46899999999999999999999 4799999999999999 67889999999998
Q ss_pred cccCCc--------------------------------------------------cccccccCcCCchhhhcCCCCCch
Q psy16081 274 CQLGQR--------------------------------------------------IYQYIQSRFYRSPEVLLGIPYDLA 303 (493)
Q Consensus 274 ~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~ 303 (493)
+..... ....+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence 532110 012469999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCcc
Q psy16081 304 IDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRR 383 (493)
Q Consensus 304 ~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (493)
+|||||||++|||++|.+||.+.+..+.+..+....... ..|...
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~p~~~- 273 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL----------------------------------YFPDDI- 273 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc----------------------------------CCCCCC-
Confidence 999999999999999999999888777766655311000 000000
Q ss_pred chhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC---CCHHHHhcCCCCCCCc
Q psy16081 384 LHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR---ITPYYALQHNFFKRTA 444 (493)
Q Consensus 384 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R---~t~~e~L~Hp~~~~~~ 444 (493)
..+ ..+.|||.+||. +|.+| +|+.|+++||||+...
T Consensus 274 ----------------------~~s--~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 274 ----------------------HLS--VEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred ----------------------CCC--HHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 000 167899999998 77776 5999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=370.03 Aligned_cols=253 Identities=29% Similarity=0.405 Sum_probs=207.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCC-eEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQ-CHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|++.+.||+|+||.||+|.+..++ ..||||++..... .......|..++. ..+||||+++++++.+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~------~l~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN------YINHPFCVNLYGSFKD 102 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHH------hCCCCCCcceEEEEEe
Confidence 467999999999999999999876655 7899999864221 1122233443333 3458889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+|+||||+. ++|.+++.... .+++..+..++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl--~~~~~ikL~DFG 176 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLL--DKDGFIKMTDFG 176 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEE--CCCCCEEEecCC
Confidence 999999999995 58999987653 5899999999999999999999 4799999999999999 678899999999
Q ss_pred cccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 272 SSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 272 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
++..........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.......+.......|.
T Consensus 177 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~------- 249 (340)
T PTZ00426 177 FAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK------- 249 (340)
T ss_pred CCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC-------
Confidence 9988766666778999999999999989999999999999999999999999988877666665432111000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC--
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-- 429 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-- 429 (493)
..+ ..+.+||++||..||++|+
T Consensus 250 ------------------------------------------------------~~~--~~~~~li~~~l~~dp~~R~~~ 273 (340)
T PTZ00426 250 ------------------------------------------------------FLD--NNCKHLMKKLLSHDLTKRYGN 273 (340)
T ss_pred ------------------------------------------------------CCC--HHHHHHHHHHcccCHHHcCCC
Confidence 000 1678999999999999996
Q ss_pred ---CHHHHhcCCCCCCCcc
Q psy16081 430 ---TPYYALQHNFFKRTAD 445 (493)
Q Consensus 430 ---t~~e~L~Hp~~~~~~~ 445 (493)
|++++++||||..+..
T Consensus 274 ~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 274 LKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred CCCCHHHHHcCCCcCCCCH
Confidence 8999999999997654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=368.82 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=202.1
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++++.||+|+||+||+|.+..+++.||||++..... .......|+.++ ...+|++|+++++.+.+.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il------~~~~~~~iv~~~~~~~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL------VEADSLWVVKMFYSFQDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHH------HhCCCCCcceEEEEEecCC
Confidence 479999999999999999999999999999999974321 111222333333 2335788999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|||||||++ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi--~~~~~vkL~DFGla 148 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLL--DSKGHVKLSDFGLC 148 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEE--CCCCCEEEeeccCc
Confidence 99999999965 899998764 369999999999999999999994 799999999999999 67889999999998
Q ss_pred cccCCc--------------------------------------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHH
Q psy16081 274 CQLGQR--------------------------------------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVE 315 (493)
Q Consensus 274 ~~~~~~--------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~e 315 (493)
...... ....+||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence 654211 123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCC
Q psy16081 316 MHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGP 395 (493)
Q Consensus 316 lltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 395 (493)
|++|.+||.+.+..+.+.++........ .|.
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------------~p~--------------- 259 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKVMNWKETLI----------------------------------FPP--------------- 259 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCcCccc----------------------------------CCC---------------
Confidence 9999999999888777776654211000 000
Q ss_pred CCCcCCCCCCCcchhhhHHHHHhHccCCCCC---CCCCHHHHhcCCCCCCCccC
Q psy16081 396 GGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK---TRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~---~R~t~~e~L~Hp~~~~~~~~ 446 (493)
....++ ++++||.+|+. +|. .||+++|+++||||+.....
T Consensus 260 --------~~~~s~--~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 260 --------EVPISE--KAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred --------cCCCCH--HHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 000111 67899999775 454 45899999999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=359.22 Aligned_cols=261 Identities=29% Similarity=0.387 Sum_probs=208.0
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---------------cchHHHHHHHHHHHHhhcCCC
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---------------FLNQAQIEVKLLEIMNKADVN 178 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------------~~~~~~~e~~~~~~l~~~~~~ 178 (493)
+.+..++|++.+.||+|.||.|.+|++..+++.||||++.+++. ......+|+.++.. .
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk------l 165 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK------L 165 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh------c
Confidence 34667899999999999999999999999999999999975321 01233444444433 3
Q ss_pred CcceEEEeceeeee--cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 179 NTYYIVRLKRHFMW--RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 179 ~~~~Iv~l~~~~~~--~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
+|+|||+|+++..+ .+.+|||+|||..+-..+..... ..+++.++++|++++..||+|||. .|||||||||+|+|
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSNLL 242 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheE
Confidence 56789999999986 46899999999653333332221 128999999999999999999996 68999999999999
Q ss_pred eeCCCCCcEEEEecccccccCC--------ccccccccCcCCchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 257 LCNPKRSAIKIVDFGSSCQLGQ--------RIYQYIQSRFYRSPEVLLGIP----YDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~~~--------~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
| +++|++||+|||.+..... ......|||.|+|||.+.+.. .+.+.||||+||+||.|+.|+.||-
T Consensus 243 l--~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 243 L--SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred E--cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 9 6779999999999986621 233578999999999998732 3579999999999999999999999
Q ss_pred CCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCC
Q psy16081 325 GSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404 (493)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 404 (493)
+....+...+|++.--..|.
T Consensus 321 ~~~~~~l~~KIvn~pL~fP~------------------------------------------------------------ 340 (576)
T KOG0585|consen 321 DDFELELFDKIVNDPLEFPE------------------------------------------------------------ 340 (576)
T ss_pred cchHHHHHHHHhcCcccCCC------------------------------------------------------------
Confidence 99999999999863111110
Q ss_pred CCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 405 ~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
..+.++.++|||.+||.+||++|++..++..|||.++..+.
T Consensus 341 -~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 341 -NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred -cccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 00122378999999999999999999999999999987544
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.16 Aligned_cols=283 Identities=30% Similarity=0.552 Sum_probs=219.6
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++++.||+|+||+||+|.+..+++.||||++....... .....|+.++ ...+|+||++++++|..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l------~~l~h~~iv~~~~~~~~ 85 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL------KHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHH------HhcCCCchhhhhhhhcc
Confidence 34578999999999999999999999999999999986432111 1222333333 33457889999998864
Q ss_pred c------ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 R------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
. ..+|+++|+++++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~--~~~~~~k 158 (343)
T cd07878 86 ATSIENFNEVYLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAV--NEDCELR 158 (343)
T ss_pred cccccccCcEEEEeecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEE--CCCCCEE
Confidence 3 457999999988998887643 59999999999999999999994 789999999999999 6788999
Q ss_pred EEecccccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 267 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 267 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++..
T Consensus 159 l~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 159 ILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred EcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999999887776677789999999999987 468999999999999999999999999999889999999888887766
Q ss_pred hhhhccc--hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 346 LLDGAHK--TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 346 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
.+..... ...+....+.. + ...+..++. .. ...+.|||.+||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~---------------~-~~~~~~~~~----------------~~--~~~~~~li~~mL~~ 284 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHM---------------P-QQDLKKIFR----------------GA--NPLAIDLLEKMLVL 284 (343)
T ss_pred HHHhcchhhHHHHhhccccc---------------c-chhHHHhcc----------------CC--CHHHHHHHHHHcCC
Confidence 5543221 11122111100 0 000000000 00 11578999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q psy16081 424 DPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
||.+|||+.|+|+||||.....
T Consensus 285 dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 285 DSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred ChhhCCCHHHHhcCcchhccCC
Confidence 9999999999999999987544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=365.36 Aligned_cols=263 Identities=28% Similarity=0.376 Sum_probs=209.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||.||+|.+..+++.||||+++.... ........+..++......+|+||+++++.+...+++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 369999999999999999999999999999999974321 111111222223333334458889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~--~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLI--DASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEE--CCCCCEEEEeCcCCcccc
Confidence 9999955 9999986543 58999999999999999999994 789999999999999 678899999999998776
Q ss_pred CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhh
Q psy16081 278 QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYF 357 (493)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 357 (493)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+.........
T Consensus 153 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------------- 219 (333)
T cd05600 153 TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR------------- 219 (333)
T ss_pred cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC-------------
Confidence 6666778999999999999999999999999999999999999999988877766655432110000
Q ss_pred ccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 358 DKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
+.. ..+....+ .++.+||.+||..+|.+|||++|+++|
T Consensus 220 ---------------------~~~-------------------~~~~~~~s--~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 ---------------------PVY-------------------DDPRFNLS--DEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---------------------CCC-------------------CccccccC--HHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 00000011 178899999999999999999999999
Q ss_pred CCCCCCc
Q psy16081 438 NFFKRTA 444 (493)
Q Consensus 438 p~~~~~~ 444 (493)
|||....
T Consensus 258 ~~~~~~~ 264 (333)
T cd05600 258 PFFKEVD 264 (333)
T ss_pred cccCCCC
Confidence 9999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=368.90 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=199.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.|++++.||+|+||+||+|++..+++.||||++...... ......|+.++. ..+|+||+++++++.+.++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~------~l~h~~iv~l~~~~~~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILA------EADNEWVVKLYYSFQDKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH------hcCCCCeeeeEEEEecCCE
Confidence 588999999999999999999999999999999743211 112233333333 3457889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+++ +|.+++.... .+++..++.++.||+.||.||| ..||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili--~~~~~~kL~DFGl~~ 149 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILI--DLDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEE--CCCCCEEEeeCcCCc
Confidence 9999999955 8999887653 5899999999999999999999 4799999999999999 678899999999975
Q ss_pred ccCC--------------------------------------------------ccccccccCcCCchhhhcCCCCCchh
Q psy16081 275 QLGQ--------------------------------------------------RIYQYIQSRFYRSPEVLLGIPYDLAI 304 (493)
Q Consensus 275 ~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 304 (493)
.+.. .....+||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence 3210 01235799999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccc
Q psy16081 305 DMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRL 384 (493)
Q Consensus 305 DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 384 (493)
|||||||++|||++|.+||...+..+....+....... ..+...
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~~~~~-- 273 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL----------------------------------HIPPQV-- 273 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc----------------------------------CCCCCC--
Confidence 99999999999999999999887766555554311100 000000
Q ss_pred hhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC--CCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 385 HDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD--YDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~--~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
..+ .+++|||.+||. .+|..|+|+.++++||||+....
T Consensus 274 ---------------------~~s--~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 274 ---------------------KLS--PEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred ---------------------CCC--HHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 001 168899999654 45556999999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=363.77 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=194.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCcc-----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKP-----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
+|++++.||+|+||.||+|++. .+++.||+|++..... .......|..++..+ .+|++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV-----RQSPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhc-----cCCCCcccEEEEEe
Confidence 4889999999999999999764 4789999999864221 112223344433322 25788999999999
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
..+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili--~~~~~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILL--DSEGHVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEE--CCCCCEEEeeC
Confidence 99999999999965 8999886543 5899999999999999999999 4789999999999999 67889999999
Q ss_pred ccccccCC----ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCCh
Q psy16081 271 GSSCQLGQ----RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL-GLPPK 344 (493)
Q Consensus 271 G~a~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~ 344 (493)
|+++.... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+.... ...+
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~- 228 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP- 228 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC-
Confidence 99976522 22346799999999999875 48899999999999999999999997543221111111100 0000
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.. +. .. ...+.+||.+||..|
T Consensus 229 --------------------------------~~--~~-----------------------~~--~~~~~~li~~~l~~d 249 (332)
T cd05614 229 --------------------------------PF--PS-----------------------FI--GPEAQDLLHKLLRKD 249 (332)
T ss_pred --------------------------------CC--CC-----------------------CC--CHHHHHHHHHHcCCC
Confidence 00 00 00 016789999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCCc
Q psy16081 425 PKTRI-----TPYYALQHNFFKRTA 444 (493)
Q Consensus 425 P~~R~-----t~~e~L~Hp~~~~~~ 444 (493)
|++|| +++++++||||+...
T Consensus 250 p~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 250 PKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999 889999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=360.58 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=202.3
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
+|++++.||+|+||.||+|.+..+++.||||++..... .......|..++ ... .+|++|++++++|...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l---~~~--~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL---ALP--GKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHH---Hhc--CCCCceeeeEEEEEcCCE
Confidence 48899999999999999999999999999999974321 111222233322 222 245679999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||. .||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill--~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVML--DAEGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEE--cCCCCEEEeecCcce
Confidence 9999999955 8988886543 58999999999999999999994 799999999999999 678899999999986
Q ss_pred cc---CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 275 QL---GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 275 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.......|.
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~------- 222 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK------- 222 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence 43 22334567999999999999999999999999999999999999999988877776666432110000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
..+ ..+.+||.+||..||.+|++.
T Consensus 223 ------------------------------------------------------~~~--~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 ------------------------------------------------------SLS--KEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------------------------------------------------------CCC--HHHHHHHHHHhhcCHHHcCCC
Confidence 000 167899999999999999986
Q ss_pred -----HHHhcCCCCCCCcc
Q psy16081 432 -----YYALQHNFFKRTAD 445 (493)
Q Consensus 432 -----~e~L~Hp~~~~~~~ 445 (493)
+++++||||.....
T Consensus 247 ~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 247 GPTGERDIREHAFFRRIDW 265 (324)
T ss_pred CCCCHHHHhcCCCcCCCCH
Confidence 89999999987643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.76 Aligned_cols=256 Identities=32% Similarity=0.461 Sum_probs=206.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++++.||+|+||+||+|.+..+++.||||+++... ........|..++. ..+|+||+++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~------~~~~~~i~~~~~~~~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA------DADSPWIVKLYYSFQDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHH------hcCCCCccchhhheecCC
Confidence 47999999999999999999999999999999997432 11122333333333 334888999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
++|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||. .||+||||||+|||+ +.++.+||+|||++
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll--~~~~~~kL~Dfg~~ 148 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILI--DADGHIKLADFGLC 148 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEE--CCCCCEEeecCCCC
Confidence 99999999954 999998765 469999999999999999999995 799999999999999 77889999999999
Q ss_pred cccCCcc--------------------------------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q psy16081 274 CQLGQRI--------------------------------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEP 321 (493)
Q Consensus 274 ~~~~~~~--------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 321 (493)
....... ....||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 7654322 34578999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCC
Q psy16081 322 LFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401 (493)
Q Consensus 322 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 401 (493)
||.+.+..+...++....... ..|....
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~p~~~~------------------ 256 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESL----------------------------------RFPPDPP------------------ 256 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcc----------------------------------cCCCCCC------------------
Confidence 999888776666655411000 0000000
Q ss_pred CCCCCcchhhhHHHHHhHccCCCCCCCCC-HHHHhcCCCCCCCccC
Q psy16081 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRIT-PYYALQHNFFKRTADE 446 (493)
Q Consensus 402 ~~~~~~~~~~~~~dLi~~mL~~dP~~R~t-~~e~L~Hp~~~~~~~~ 446 (493)
. ...+.+||.+||. ||.+|++ ++|+|+||||......
T Consensus 257 -----~--~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 257 -----V--SPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred -----C--CHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence 0 1178899999998 9999999 9999999999986554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=358.29 Aligned_cols=283 Identities=27% Similarity=0.480 Sum_probs=206.1
Q ss_pred eeeEeeeCCeEEEEEEEc--CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--cceeEEE
Q psy16081 124 DSLIGKGSFGQVVKAFDL--EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW--RNHLCLV 199 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~--~~~~~lV 199 (493)
..+||+|+||+||+|.+. .+++.||||.+.... ......+|+.++..+ +||||+++++.|.. ...+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLREL------KHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhc------CCCCCcceeeeEecCCCcEEEEE
Confidence 368999999999999865 467899999987443 233455666665544 47789999999864 4578999
Q ss_pred EEecccCHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC--CCCCcEEEEec
Q psy16081 200 FELLSYNLYDLLRNTN-------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN--PKRSAIKIVDF 270 (493)
Q Consensus 200 ~E~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~--~~~~~ikL~DF 270 (493)
|||++++|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||+.. +..+.+||+||
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9999999998875321 1248899999999999999999994 78999999999999943 34578999999
Q ss_pred ccccccCCc------cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHH
Q psy16081 271 GSSCQLGQR------IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNE---------VDQMNK 334 (493)
Q Consensus 271 G~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~---------~~~~~~ 334 (493)
|++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+. .+++.+
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 999766432 2346789999999999874 589999999999999999999999976443 467888
Q ss_pred HHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHH
Q psy16081 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414 (493)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (493)
+...++.|+...+............... +. ..... ...+...+. ......+ ..++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--------~~~~~-~~~~~~~~~------------~~~~~~~--~~~~ 291 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKD--FR--------RNTYT-NCSLIKYME------------KHKVKPD--SKAF 291 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhh--hh--------ccccC-cccccchHH------------hcCCCCC--hHHH
Confidence 8888888877766543321111000000 00 00000 000000000 0000111 2688
Q ss_pred HHHhHccCCCCCCCCCHHHHhcCCCC
Q psy16081 415 DLIFRMLDYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 415 dLi~~mL~~dP~~R~t~~e~L~Hp~~ 440 (493)
|||.+||.+||.+|||++|+|+||||
T Consensus 292 dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 292 HLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=364.13 Aligned_cols=261 Identities=27% Similarity=0.395 Sum_probs=204.1
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||+||+|.+..+++.||||+++....... .....+.++.......+|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQ--ETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhh--hHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 469999999999999999999999999999999974321101 111112222222334568889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+++ +|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++..+.
T Consensus 79 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll--~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLI--DRTGHIKLADFGSAARLT 153 (330)
T ss_pred EECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEE--CCCCCEEeccCCCCeECC
Confidence 9999954 9999887653 369999999999999999999994 789999999999999 678899999999997664
Q ss_pred Cc----cccccccCcCCchhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 278 QR----IYQYIQSRFYRSPEVLL------GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 278 ~~----~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
.. .....||+.|+|||++. +..++.++|||||||++|+|++|..||...+....+.++.......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----- 228 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL----- 228 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc-----
Confidence 32 12347899999999997 4568899999999999999999999999887766666554321000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
..|... ..+ ..+.+||++||. ||.+
T Consensus 229 -----------------------------~~~~~~-----------------------~~~--~~~~~li~~ll~-~p~~ 253 (330)
T cd05601 229 -----------------------------KFPEDP-----------------------KVS--SDFLDLIQSLLC-GQKE 253 (330)
T ss_pred -----------------------------CCCCCC-----------------------CCC--HHHHHHHHHHcc-Chhh
Confidence 000000 001 168899999998 9999
Q ss_pred CCCHHHHhcCCCCCCCccC
Q psy16081 428 RITPYYALQHNFFKRTADE 446 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~~~~ 446 (493)
|||++++++||||......
T Consensus 254 R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 254 RLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred CCCHHHHhCCCCcCCCCHH
Confidence 9999999999999976543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=359.81 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=203.2
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
+|++++.||+|+||+||+|++..+++.||||++++...... ...+....+........+|++|+++++++...+.+|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-DDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 48899999999999999999999999999999975321111 11111111111112234678899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC-
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG- 277 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~- 277 (493)
|||+.+ +|.+.+.... .+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 80 ~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill--~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 80 MEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEE--CCCCcEEEccCCCceecCC
Confidence 999954 8988886543 58999999999999999999994 789999999999999 678899999999987542
Q ss_pred --CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 278 --QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 278 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+.......|.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----------- 222 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----------- 222 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-----------
Confidence 2234567999999999999999999999999999999999999999998887777666542111100
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC-----
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT----- 430 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t----- 430 (493)
..+ .++.+||.+||..||.+|++
T Consensus 223 --------------------------------------------------~~s--~~~~~li~~~l~~~p~~R~~~~~~~ 250 (323)
T cd05616 223 --------------------------------------------------SMS--KEAVAICKGLMTKHPGKRLGCGPEG 250 (323)
T ss_pred --------------------------------------------------cCC--HHHHHHHHHHcccCHHhcCCCCCCC
Confidence 000 16789999999999999998
Q ss_pred HHHHhcCCCCCCCc
Q psy16081 431 PYYALQHNFFKRTA 444 (493)
Q Consensus 431 ~~e~L~Hp~~~~~~ 444 (493)
..++++||||....
T Consensus 251 ~~~i~~h~~~~~~~ 264 (323)
T cd05616 251 ERDIKEHAFFRYID 264 (323)
T ss_pred HHHHhcCCCcCCCC
Confidence 48999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=366.14 Aligned_cols=283 Identities=27% Similarity=0.426 Sum_probs=215.6
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc-----
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN----- 194 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~----- 194 (493)
+|++.++||+|+||+||+|.+..+++.||||++........... .+.+++..+...+|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK---RVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHH---HHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 47889999999999999999999999999999864321111111 1222222233345788999999998776
Q ss_pred eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 195 HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 195 ~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
++|+||||+.++|.+.+... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili--~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 78 EIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLV--NSNCVLKICDFGLAR 151 (372)
T ss_pred eEEEEeeccccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEE--CCCCCEEecccccee
Confidence 89999999999999888654 368999999999999999999995 789999999999999 678899999999997
Q ss_pred ccCCc----cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 275 QLGQR----IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 275 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
..... .....+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+++..|.+.++.++...+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 65322 2345678999999999875 489999999999999999999999999999999999999999887765543
Q ss_pred ccc-hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 350 AHK-TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 350 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
... ...++...+. .. ..+..+... .......+.+||.+||.+||++|
T Consensus 232 ~~~~~~~~~~~~~~--------------~~---~~~~~~~~~---------------~~~~~~~~~~li~~mL~~dP~~R 279 (372)
T cd07853 232 ACEGARAHILRGPH--------------KP---PSLPVLYTL---------------SSQATHEAVHLLCRMLVFDPDKR 279 (372)
T ss_pred hhHHHHHHHHhCCC--------------CC---CchHHhccc---------------CCCCCHHHHHHHHHhCCCChhhC
Confidence 221 1111111000 00 000000000 00011278999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q psy16081 429 ITPYYALQHNFFKRT 443 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~ 443 (493)
||+.|+|+||||...
T Consensus 280 ~t~~e~l~hp~~~~~ 294 (372)
T cd07853 280 ISAADALAHPYLDEG 294 (372)
T ss_pred cCHHHHhcCHhhCCC
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=361.37 Aligned_cols=247 Identities=27% Similarity=0.398 Sum_probs=199.0
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
++||+|+||+||+|++..+++.||||+++.... .......|..++. ...+||||+++++++...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-----~~~~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILS-----LARNHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHH-----hccCCCchhceeeEEEcCCEEEEEE
Confidence 479999999999999999999999999874321 1111222222222 2236889999999999999999999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC--
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-- 277 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~-- 277 (493)
||+++ +|.+++... ..+++..+..++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli--~~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLL--DHEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEE--CCCCcEEEeeCCCCeecCcC
Confidence 99965 888888654 36899999999999999999999 4789999999999999 678899999999986542
Q ss_pred -CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 278 -QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 278 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.......|..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----------- 218 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----------- 218 (320)
T ss_pred CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCC-----------
Confidence 22345679999999999999999999999999999999999999999988777766654311100000
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH-----
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP----- 431 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~----- 431 (493)
.. ..+.+||.+||..||.+|+++
T Consensus 219 --------------------------------------------------~~--~~~~~li~~~L~~dP~~R~~~~~~~~ 246 (320)
T cd05590 219 --------------------------------------------------LS--QDAVDILKAFMTKNPTMRLGSLTLGG 246 (320)
T ss_pred --------------------------------------------------CC--HHHHHHHHHHcccCHHHCCCCCCCCC
Confidence 00 167899999999999999998
Q ss_pred -HHHhcCCCCCCCcc
Q psy16081 432 -YYALQHNFFKRTAD 445 (493)
Q Consensus 432 -~e~L~Hp~~~~~~~ 445 (493)
+++++||||..+..
T Consensus 247 ~~~~~~h~~f~~~~~ 261 (320)
T cd05590 247 EEAILRHPFFKELDW 261 (320)
T ss_pred HHHHHcCCCcCCCCH
Confidence 99999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=358.11 Aligned_cols=250 Identities=28% Similarity=0.410 Sum_probs=197.0
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
++||+|+||.||+|.+..+++.||||+++....... ...+..+.+........+||||+++++++...+++|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 469999999999999999999999999974321111 1111111121112223478899999999999999999999995
Q ss_pred c-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC---Ccc
Q psy16081 205 Y-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRI 280 (493)
Q Consensus 205 ~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~---~~~ 280 (493)
+ +|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.... ...
T Consensus 80 gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill--~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 80 GGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLL--DKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEE--CCCCCEEEccCcCCeECCCCCCcc
Confidence 5 8988886543 68999999999999999999994 789999999999999 678899999999997542 223
Q ss_pred ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccC
Q psy16081 281 YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKM 360 (493)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 360 (493)
...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+.......|.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------- 217 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR---------------- 217 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----------------
Confidence 4567999999999999999999999999999999999999999988876666555321100000
Q ss_pred CCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH-HHHhcCCC
Q psy16081 361 PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP-YYALQHNF 439 (493)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~-~e~L~Hp~ 439 (493)
... ..+.+||.+||..||.+||++ .++++|||
T Consensus 218 ---------------------------------------------~~~--~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05592 218 ---------------------------------------------WIS--KEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250 (316)
T ss_pred ---------------------------------------------CCC--HHHHHHHHHHccCCHHHcCCChHHHHcCcc
Confidence 000 167899999999999999986 58899999
Q ss_pred CCCCc
Q psy16081 440 FKRTA 444 (493)
Q Consensus 440 ~~~~~ 444 (493)
|....
T Consensus 251 ~~~~~ 255 (316)
T cd05592 251 FRGID 255 (316)
T ss_pred cCCCC
Confidence 98764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=357.95 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=196.7
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
++||+|+||.||+|.+..+++.||||+++.... .......|..++ ....+|++|++++++|.+.+++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l-----~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVL-----ALAWENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHH-----HhccCCCCccCeeEEEEeCCEEEEEE
Confidence 479999999999999999999999999974321 111122222222 22346889999999999999999999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc---
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--- 276 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~--- 276 (493)
||+.+ +|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVML--DRDGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEE--CCCCCEEeCccCCCeecccC
Confidence 99965 898888654 358999999999999999999994 799999999999999 67889999999998643
Q ss_pred CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.......|.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~------------ 217 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR------------ 217 (316)
T ss_pred CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------------
Confidence 22344567999999999999999999999999999999999999999988776655554321100000
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH-HHHh
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP-YYAL 435 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~-~e~L 435 (493)
..+ .++.+||.+||..||.+|+++ ++++
T Consensus 218 -------------------------------------------------~~~--~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 -------------------------------------------------WIT--KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -------------------------------------------------CCC--HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 000 167899999999999999998 5899
Q ss_pred cCCCCCCCc
Q psy16081 436 QHNFFKRTA 444 (493)
Q Consensus 436 ~Hp~~~~~~ 444 (493)
+||||....
T Consensus 247 ~h~~f~~~~ 255 (316)
T cd05620 247 GHPFFKTIN 255 (316)
T ss_pred cCCCcCCCC
Confidence 999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=359.01 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=197.6
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
+.||+|+||.||+|.+..+|+.||+|+++....... .....+..++......+||||+++++.|...+.+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh--HHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 479999999999999999999999999974321100 111112222333334468889999999999999999999996
Q ss_pred c-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC---cc
Q psy16081 205 Y-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RI 280 (493)
Q Consensus 205 ~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~---~~ 280 (493)
+ +|..++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..... ..
T Consensus 79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 79 GGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEE--cCCCCEEecccHHhccccCCCCcc
Confidence 5 8888876543 68999999999999999999995 789999999999999 6788999999999865322 22
Q ss_pred ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccC
Q psy16081 281 YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKM 360 (493)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 360 (493)
...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.......|.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~---------------- 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---------------- 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----------------
Confidence 3467999999999999999999999999999999999999999887776665554321100000
Q ss_pred CCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CHHHHh
Q psy16081 361 PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TPYYAL 435 (493)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~~e~L 435 (493)
..+ ..+.+||.+||..||.+|+ ++.+++
T Consensus 217 ---------------------------------------------~~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~~l 249 (323)
T cd05595 217 ---------------------------------------------TLS--PEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 249 (323)
T ss_pred ---------------------------------------------CCC--HHHHHHHHHHccCCHHHhCCCCCCCHHHHH
Confidence 000 1678999999999999998 999999
Q ss_pred cCCCCCCCc
Q psy16081 436 QHNFFKRTA 444 (493)
Q Consensus 436 ~Hp~~~~~~ 444 (493)
+||||....
T Consensus 250 ~h~~~~~~~ 258 (323)
T cd05595 250 EHRFFLSIN 258 (323)
T ss_pred cCCCcCCCC
Confidence 999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=350.01 Aligned_cols=284 Identities=29% Similarity=0.479 Sum_probs=219.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|++++.||.|+||.||+|.+..+++.||+|.++.... .......|+.++..+ +|+||+++++++...+.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~nI~~~~~~~~~~~~ 78 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHANIVTLHDIIHTEKS 78 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc------CCCCcceEEEEEecCCe
Confidence 4679999999999999999999999999999999864322 122333444444333 57789999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+|+||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 79 LTLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLI--NERGELKLADFGLARA 153 (301)
T ss_pred EEEEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEE--CCCCcEEECcCcchhc
Confidence 99999999999999887543 358999999999999999999995 789999999999999 6788999999999876
Q ss_pred cCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+++..+...++.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 5322 2234678899999998764 58899999999999999999999999999989999999888888776654432
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
....+... ....+ .. ..+.. .....+ ..+.|||.+||..||.+|||+
T Consensus 234 ~~~~~~~~-~~~~~-----------~~---~~~~~----------------~~~~~~--~~~~~li~~ml~~dp~~R~t~ 280 (301)
T cd07873 234 SNEEFKSY-NYPKY-----------RA---DCLHN----------------HAPRLD--SDGAELLSKLLQFEGRKRISA 280 (301)
T ss_pred cccccccc-ccCcc-----------cc---ccHHh----------------hcCCCC--HHHHHHHHHHhcCCcccCcCH
Confidence 21111000 00000 00 00000 000111 167899999999999999999
Q ss_pred HHHhcCCCCCCCcc
Q psy16081 432 YYALQHNFFKRTAD 445 (493)
Q Consensus 432 ~e~L~Hp~~~~~~~ 445 (493)
+|+|+||||+...+
T Consensus 281 ~eil~h~~f~~~~~ 294 (301)
T cd07873 281 EEAMKHPYFHCLGE 294 (301)
T ss_pred HHHhcCcccccccc
Confidence 99999999987664
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=357.72 Aligned_cols=246 Identities=27% Similarity=0.402 Sum_probs=199.2
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
++||+|+||.||+|++..+++.||||+++.... .......|..++.. ..+||+|++++++|...+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~-----~~~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILAL-----AAKHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHh-----ccCCCCccceeeEEEcCCeEEEEE
Confidence 469999999999999999999999999874321 11122233333222 236889999999999999999999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC--
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-- 277 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~-- 277 (493)
||+.+ +|.+.+... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill--~~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILL--DAEGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEE--CCCCCEEEeecccceecccC
Confidence 99965 888888654 368999999999999999999994 789999999999999 678899999999986542
Q ss_pred -CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 278 -QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 278 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.......|..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~----------- 218 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW----------- 218 (321)
T ss_pred CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-----------
Confidence 22345678999999999999999999999999999999999999999988877776665321100000
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-------
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI------- 429 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~------- 429 (493)
.+ .++.+||.+||..||++|+
T Consensus 219 --------------------------------------------------~~--~~~~~ll~~~L~~dp~~R~~~~~~~~ 246 (321)
T cd05591 219 --------------------------------------------------LS--KEAVSILKAFMTKNPNKRLGCVASQG 246 (321)
T ss_pred --------------------------------------------------CC--HHHHHHHHHHhccCHHHcCCCCCCCC
Confidence 00 1678999999999999999
Q ss_pred CHHHHhcCCCCCCCc
Q psy16081 430 TPYYALQHNFFKRTA 444 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~ 444 (493)
+++++++||||....
T Consensus 247 ~~~~~~~hp~~~~~~ 261 (321)
T cd05591 247 GEDAIKQHPFFKEID 261 (321)
T ss_pred CHHHHhcCCccCCCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=355.78 Aligned_cols=246 Identities=32% Similarity=0.444 Sum_probs=195.4
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc
Q psy16081 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY 205 (493)
Q Consensus 127 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~ 205 (493)
||+|+||.||+|.+..+++.||||+++..... ..... .++.++......+||||+++++.+...+.+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVT---HTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHH---HHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998642211 11111 112222223334688899999999999999999999955
Q ss_pred -CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC---ccc
Q psy16081 206 -NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIY 281 (493)
Q Consensus 206 -~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~---~~~ 281 (493)
+|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 78 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 78 GELFHHLQRE--GRFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEE--CCCCcEEEEECcccccCccCCCccc
Confidence 899988764 35899999999999999999999 4789999999999999 6788999999999875422 233
Q ss_pred cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCC
Q psy16081 282 QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMP 361 (493)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~ 361 (493)
..+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+.
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----------------- 214 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----------------- 214 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC-----------------
Confidence 567999999999999999999999999999999999999999987766655554321000000
Q ss_pred CCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC---CHHHHhcCC
Q psy16081 362 DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI---TPYYALQHN 438 (493)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~---t~~e~L~Hp 438 (493)
..+ ..+.+||.+||..||.+|| ++.|+|+||
T Consensus 215 --------------------------------------------~~~--~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 215 --------------------------------------------GFD--RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred --------------------------------------------cCC--HHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 000 1688999999999999997 589999999
Q ss_pred CCCCCc
Q psy16081 439 FFKRTA 444 (493)
Q Consensus 439 ~~~~~~ 444 (493)
||....
T Consensus 249 ~~~~~~ 254 (312)
T cd05585 249 FFSQLS 254 (312)
T ss_pred CcCCCC
Confidence 999763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=358.75 Aligned_cols=249 Identities=27% Similarity=0.406 Sum_probs=197.5
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHH-HHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL-EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~-~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
++||+|+||+||+|++..+++.||||++......... ....++ +........+||||+++++.+...+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK--EQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhh--HHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 4799999999999999999999999998643211111 111111 1111234457889999999999999999999999
Q ss_pred cc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC---Cc
Q psy16081 204 SY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QR 279 (493)
Q Consensus 204 ~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~---~~ 279 (493)
.+ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.... ..
T Consensus 79 ~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 79 NGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILL--DSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEE--CCCCcEEEeccCCCcccccCCCc
Confidence 65 898888654 368999999999999999999994 789999999999999 678899999999986532 22
Q ss_pred cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhcc
Q psy16081 280 IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~ 359 (493)
....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.......+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------------- 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK---------------- 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----------------
Confidence 3456799999999999999999999999999999999999999998877666655543100000
Q ss_pred CCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH----HHHh
Q psy16081 360 MPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP----YYAL 435 (493)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~----~e~L 435 (493)
. .. ...+.+||.+||..||.+||++ .+++
T Consensus 217 ----------------------~-----------------------~~--~~~~~~li~~~l~~~p~~R~~~~~~~~~il 249 (323)
T cd05575 217 ----------------------P-----------------------NI--SVSARHLLEGLLQKDRTKRLGAKDDFLEIK 249 (323)
T ss_pred ----------------------C-----------------------CC--CHHHHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence 0 00 0168899999999999999998 6999
Q ss_pred cCCCCCCCc
Q psy16081 436 QHNFFKRTA 444 (493)
Q Consensus 436 ~Hp~~~~~~ 444 (493)
+||||....
T Consensus 250 ~~~~~~~~~ 258 (323)
T cd05575 250 NHVFFSSIN 258 (323)
T ss_pred cCCCcCCCC
Confidence 999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=357.47 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=196.4
Q ss_pred eeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCccc-----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 124 DSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKPF-----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
+++||+|+||.||+|++. .+++.||||+++..... ......|..+++ ..+||||+++++.|..++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~------~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILE------AVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHH------hCCCCchhceeeEEecCCe
Confidence 368999999999999864 47899999998743211 112233433333 3357889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+.+ +|.+.+.... .+.+..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 75 LYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILL--DAQGHVKLTDFGLCK 148 (323)
T ss_pred EEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEE--CCCCCEEEeeCcCCe
Confidence 9999999965 8988886543 58899999999999999999994 789999999999999 678899999999986
Q ss_pred ccC---CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 275 QLG---QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 275 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... ......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+....+..+.......|.
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~------- 221 (323)
T cd05584 149 ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP------- 221 (323)
T ss_pred ecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence 442 2233457999999999999989999999999999999999999999988776666555431100000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC--
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-- 429 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-- 429 (493)
..+ ..+.+||.+||..||++||
T Consensus 222 ------------------------------------------------------~~~--~~~~~li~~~l~~~p~~R~~~ 245 (323)
T cd05584 222 ------------------------------------------------------YLT--PEARDLLKKLLKRNPSSRLGA 245 (323)
T ss_pred ------------------------------------------------------CCC--HHHHHHHHHHcccCHhHcCCC
Confidence 000 1678999999999999999
Q ss_pred ---CHHHHhcCCCCCCCc
Q psy16081 430 ---TPYYALQHNFFKRTA 444 (493)
Q Consensus 430 ---t~~e~L~Hp~~~~~~ 444 (493)
+++++++||||....
T Consensus 246 ~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 246 GPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred CCCCHHHHhcCCCcCCCC
Confidence 899999999998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=359.07 Aligned_cols=249 Identities=28% Similarity=0.395 Sum_probs=196.7
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
++||+|+||.||+|.+..+++.||||++........ .....++.++......+||||+++.+.+...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK--DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh--hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 469999999999999999999999999974321111 111122222333344568889999999999999999999996
Q ss_pred c-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC---cc
Q psy16081 205 Y-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RI 280 (493)
Q Consensus 205 ~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~---~~ 280 (493)
+ +|.+.+... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..... ..
T Consensus 79 ~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll--~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 79 GGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLML--DKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEE--CCCCcEEEecCcCCccCCCccccc
Confidence 5 888887654 368999999999999999999995 789999999999999 6788999999999875422 23
Q ss_pred ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccC
Q psy16081 281 YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKM 360 (493)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 360 (493)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......|
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----------------- 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----------------- 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC-----------------
Confidence 356799999999999999999999999999999999999999988776555444321100000
Q ss_pred CCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CHHHHh
Q psy16081 361 PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TPYYAL 435 (493)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~~e~L 435 (493)
. ..+ ..+.+||.+||..||++|+ ++.|++
T Consensus 216 ---------------------~-----------------------~~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 216 ---------------------R-----------------------TLS--ADAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred ---------------------C-----------------------CCC--HHHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 0 000 1678999999999999997 899999
Q ss_pred cCCCCCCCc
Q psy16081 436 QHNFFKRTA 444 (493)
Q Consensus 436 ~Hp~~~~~~ 444 (493)
+||||....
T Consensus 250 ~h~~~~~~~ 258 (328)
T cd05593 250 RHSFFTGVN 258 (328)
T ss_pred cCCCcCCCC
Confidence 999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=366.61 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=200.6
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
+|+++++||+|+||+||+|++..+++.||||++..... .......|+.++. ..+|+||+++++.|.+.++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~------~~~h~~iv~~~~~~~~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILA------EADNEWVVRLYYSFQDKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHH------hCCCCcCCeEEEEEEeCCE
Confidence 58999999999999999999999999999999874321 1122333433333 3467889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+|||||++ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl--~~~g~~kL~DFGla~ 149 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILI--DRDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--CCCCCEEEeECCCCc
Confidence 9999999965 8999887643 58999999999999999999994 789999999999999 678899999999975
Q ss_pred ccCC--------------------------------------------------ccccccccCcCCchhhhcCCCCCchh
Q psy16081 275 QLGQ--------------------------------------------------RIYQYIQSRFYRSPEVLLGIPYDLAI 304 (493)
Q Consensus 275 ~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 304 (493)
.+.. .....+||+.|+|||++.+..|+.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence 3210 01134789999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccc
Q psy16081 305 DMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRL 384 (493)
Q Consensus 305 DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 384 (493)
|||||||+||||++|.+||.+.+..+...++....... ..|..
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~p~~--- 272 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL----------------------------------HIPPQ--- 272 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc----------------------------------CCCCc---
Confidence 99999999999999999999888766655554311000 00000
Q ss_pred hhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC---HHHHhcCCCCCCCcc
Q psy16081 385 HDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT---PYYALQHNFFKRTAD 445 (493)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t---~~e~L~Hp~~~~~~~ 445 (493)
...+ .++.+||.+|+ .||.+|++ ++|+++||||.....
T Consensus 273 --------------------~~~s--~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 273 --------------------AKLS--PEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred --------------------ccCC--HHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 0011 16789999986 59999998 999999999987643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=360.26 Aligned_cols=250 Identities=28% Similarity=0.396 Sum_probs=197.8
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
+.||+|+||+||+|.+..+++.||+|+++....... ........++......+|+||+++.+.|...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~--~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK--DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh--hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 469999999999999999999999999974321111 111122223333344568889999999999999999999996
Q ss_pred c-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC---Ccc
Q psy16081 205 Y-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRI 280 (493)
Q Consensus 205 ~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~---~~~ 280 (493)
+ +|.+++... ..+++..++.++.||+.||.|||+ ..||+||||||+|||+ +.++.+||+|||++.... ...
T Consensus 79 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 79 GGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEE--CCCCCEEEecCCCCeecCCCCccc
Confidence 5 888887654 358999999999999999999995 2689999999999999 678899999999986532 223
Q ss_pred ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccC
Q psy16081 281 YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKM 360 (493)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 360 (493)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......|.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~---------------- 217 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR---------------- 217 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----------------
Confidence 4567999999999999999999999999999999999999999887766555444321000000
Q ss_pred CCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CHHHHh
Q psy16081 361 PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TPYYAL 435 (493)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~~e~L 435 (493)
.. ...+.+||.+||..||++|+ ++.+++
T Consensus 218 ---------------------------------------------~~--~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 218 ---------------------------------------------TL--SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred ---------------------------------------------CC--CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 00 01688999999999999997 999999
Q ss_pred cCCCCCCCc
Q psy16081 436 QHNFFKRTA 444 (493)
Q Consensus 436 ~Hp~~~~~~ 444 (493)
+||||....
T Consensus 251 ~h~~~~~~~ 259 (325)
T cd05594 251 QHKFFAGIV 259 (325)
T ss_pred cCCCcCCCC
Confidence 999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=339.60 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=212.4
Q ss_pred eecCcEEEe-eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 116 KFLDRYEID-SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 116 ~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
.++++|.+- ++||-|-.|.|..|.++.|++.+|+|++... ..+.+|+++ |.....|+|||.++++|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeL-----Hw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVEL-----HWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhh-----hhhhcCCCceEEeehhhhhhc
Confidence 456778874 6899999999999999999999999999743 455666654 3345678899999999863
Q ss_pred --cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEE
Q psy16081 193 --RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIV 268 (493)
Q Consensus 193 --~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~ 268 (493)
...+.+|||.|+| .|+..+.......+++.++..|+.||+.|+.|||+ .+|.||||||+|+|.+.. .+..+||+
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCCcceEec
Confidence 4578899999955 99999998887789999999999999999999995 789999999999999543 45679999
Q ss_pred ecccccccC--CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCC
Q psy16081 269 DFGSSCQLG--QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV----DQMNKIVEVLGLP 342 (493)
Q Consensus 269 DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~ 342 (493)
|||+|+... ....+.|-||+|.|||++-...|+..+|+||+|||||.||+|.|||.+.... .+..+|.......
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 999998765 4566889999999999999999999999999999999999999999875431 2223332221111
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
| .++|..+++ +.+|+|+++|.
T Consensus 287 P---------------------------------------------------------~pEWs~VSe--~aKdlIR~LLk 307 (400)
T KOG0604|consen 287 P---------------------------------------------------------EPEWSCVSE--AAKDLIRKLLK 307 (400)
T ss_pred C---------------------------------------------------------ChhHhHHHH--HHHHHHHHHhc
Confidence 1 112233444 78999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 423 YDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
.+|.+|+|++|++.|||+.+....
T Consensus 308 t~PteRlTI~~~m~hpwi~~~~~v 331 (400)
T KOG0604|consen 308 TEPTERLTIEEVMDHPWINQYEAV 331 (400)
T ss_pred CCchhheeHHHhhcCchhcccccC
Confidence 999999999999999999976544
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=365.53 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=200.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++++.||+|+||+||+|.+..+++.||||++..... .......|+.++.. .+|+||+++++.|.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~------l~h~~iv~~~~~~~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE------ADNEWVVKLYYSFQDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHh------CCCCCcceEEEEEEcCC
Confidence 369999999999999999999999999999999864221 12233344444433 35778999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+|
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill--~~~~~ikL~DFG~a 148 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILI--DRDGHIKLTDFGLC 148 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEE--CCCCCEEEEeCCCC
Confidence 9999999995 58999987653 58999999999999999999994 789999999999999 67889999999997
Q ss_pred cccCC----------------------------------------------ccccccccCcCCchhhhcCCCCCchhhHH
Q psy16081 274 CQLGQ----------------------------------------------RIYQYIQSRFYRSPEVLLGIPYDLAIDMW 307 (493)
Q Consensus 274 ~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 307 (493)
..+.. .....+||+.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 43210 01134799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhh
Q psy16081 308 SLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDI 387 (493)
Q Consensus 308 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 387 (493)
||||++|||++|++||.+.+..+....+....... ..+...
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~~~~~----- 269 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTL----------------------------------HIPSQA----- 269 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHHHHHHHhccCccc----------------------------------cCCCCC-----
Confidence 99999999999999999887766655443210000 000000
Q ss_pred ccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC---CHHHHhcCCCCCCCc
Q psy16081 388 LGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI---TPYYALQHNFFKRTA 444 (493)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~---t~~e~L~Hp~~~~~~ 444 (493)
..+ ..+.+||.+|+ .+|.+|+ |+.|+++||||..+.
T Consensus 270 ------------------~~s--~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 270 ------------------KLS--REASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred ------------------CCC--HHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 000 16789999977 5999999 999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=355.04 Aligned_cols=257 Identities=28% Similarity=0.353 Sum_probs=199.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++++.||+|+||+||++++..+++.||||++.+... ....+..|..++ ...+|+||++++++|.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l------~~~~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL------VNGDRRWITNLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHH------HhCCCCCCCceEEEEecCC
Confidence 479999999999999999999999999999999864211 111122233322 2346788999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
++|+||||+. ++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~ 149 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLL--DKNGHIRLADFGSC 149 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEE--CCCCCEEEEECCce
Confidence 9999999995 59999986533 46899999999999999999999 4789999999999999 67889999999998
Q ss_pred cccCCc----cccccccCcCCchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 274 CQLGQR----IYQYIQSRFYRSPEVLLG-----IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 274 ~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~- 228 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ- 228 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc-
Confidence 765332 123568999999999973 3578899999999999999999999998877766666543211000
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.+. .....+ ..+.+||++||..+
T Consensus 229 ---------------------------------~~~----------------------~~~~~~--~~~~~li~~ll~~~ 251 (331)
T cd05597 229 ---------------------------------FPP----------------------DVTDVS--EEAKDLIRRLICSP 251 (331)
T ss_pred ---------------------------------CCC----------------------ccCCCC--HHHHHHHHHHccCc
Confidence 000 000011 16889999999765
Q ss_pred CCC--CCCHHHHhcCCCCCCCc
Q psy16081 425 PKT--RITPYYALQHNFFKRTA 444 (493)
Q Consensus 425 P~~--R~t~~e~L~Hp~~~~~~ 444 (493)
+++ |++++++++||||....
T Consensus 252 ~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 252 ETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred ccccCCCCHHHHhcCCCCCCCC
Confidence 544 88999999999998754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=352.91 Aligned_cols=262 Identities=27% Similarity=0.341 Sum_probs=200.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.++||+|+||+||++.+..+++.||+|++.+.... ... ....+.++.......+|++|+++++.+.+.+++|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRA-ETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-Hhh-HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 4799999999999999999999999999999998642211 010 11112222222334578889999999999999999
Q ss_pred EEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+. ++|.+++.+.. ..+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 v~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili--~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLM 153 (332)
T ss_pred EEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEE--CCCCCEEEeecchheecc
Confidence 999995 59999987643 35899999999999999999999 4789999999999999 678899999999987653
Q ss_pred Cc----cccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 278 QR----IYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 278 ~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
.. ....+||+.|+|||++. ...++.++|||||||++|||++|++||.+.+..+.+.++.......+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----- 228 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ----- 228 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc-----
Confidence 22 22357999999999996 34688999999999999999999999998887777666643110000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC-
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT- 427 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~- 427 (493)
.|. . ....+ ..+++||++||..++.+
T Consensus 229 -----------------------------~p~--~--------------------~~~~s--~~~~~li~~ll~~~~~r~ 255 (332)
T cd05623 229 -----------------------------FPA--Q--------------------VTDVS--EDAKDLIRRLICSREHRL 255 (332)
T ss_pred -----------------------------CCC--c--------------------cccCC--HHHHHHHHHHccChhhhc
Confidence 000 0 00011 17889999999765544
Q ss_pred -CCCHHHHhcCCCCCCCcc
Q psy16081 428 -RITPYYALQHNFFKRTAD 445 (493)
Q Consensus 428 -R~t~~e~L~Hp~~~~~~~ 445 (493)
|+|++|+++||||.....
T Consensus 256 ~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 256 GQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred CCCCHHHHhCCCCcCCCCH
Confidence 789999999999997653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.76 Aligned_cols=253 Identities=30% Similarity=0.465 Sum_probs=213.7
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+..+|++.+.||+|+||.|-+|++...|+.||||.+++.+. ...+..+.+.+++......|||||+.++++|+..+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI--kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI--KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc--ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 34589999999999999999999999999999999986542 2223333444444445566788999999999999999
Q ss_pred EEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
.|||||. +|.|++++.... .+++..++.|++||..|+.|+| +.+++|||||.+|||| |.++++||+|||++..
T Consensus 129 vivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILL--D~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILL--DQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHh--hccceecccchhheee--cCCCCeeeeccchhhh
Confidence 9999999 559999998764 6999999999999999999999 5789999999999999 8899999999999987
Q ss_pred cCCc--cccccccCcCCchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQR--IYQYIQSRFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
+... ..++||+|.|.+||++.|.+|. +.+|.|||||+||.|..|..||+|.+....+.+|...
T Consensus 203 y~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G-------------- 268 (668)
T KOG0611|consen 203 YADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG-------------- 268 (668)
T ss_pred hccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc--------------
Confidence 7543 5689999999999999999985 7899999999999999999999999888777777542
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.|. .|.. .+ ...-||+.||.+||++|.|++
T Consensus 269 -----------aYr-----------EP~~-------------------------PS---dA~gLIRwmLmVNP~RRATie 298 (668)
T KOG0611|consen 269 -----------AYR-----------EPET-------------------------PS---DASGLIRWMLMVNPERRATIE 298 (668)
T ss_pred -----------ccc-----------CCCC-------------------------Cc---hHHHHHHHHHhcCcccchhHH
Confidence 221 1100 01 456899999999999999999
Q ss_pred HHhcCCCCC
Q psy16081 433 YALQHNFFK 441 (493)
Q Consensus 433 e~L~Hp~~~ 441 (493)
++-.|=|+.
T Consensus 299 DiAsHWWvN 307 (668)
T KOG0611|consen 299 DIASHWWVN 307 (668)
T ss_pred HHhhhheee
Confidence 999998875
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=352.81 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=201.8
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
+|++.+.||+|+||+||+|.+..+++.||||++...... ......|..++. ...+|++|+++.+++...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-----~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-----LQDKPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-----hccCCCchhheeeEEecCCE
Confidence 378889999999999999999999999999998743211 111222332222 22356779999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+++ +|.+++.... .+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill--~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVML--DSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEE--CCCCCEEEecccccc
Confidence 9999999965 8988886543 5899999999999999999999 4799999999999999 678899999999987
Q ss_pred ccCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 275 QLGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 275 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+.......|.
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~------- 222 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK------- 222 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------
Confidence 5422 233457899999999999999999999999999999999999999988877766666542110000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC-
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT- 430 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t- 430 (493)
..+ ..+.+||.+||..||.+|++
T Consensus 223 ------------------------------------------------------~~~--~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 ------------------------------------------------------SLS--KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------------------------------------------------------cCC--HHHHHHHHHHcccCHhhCCCC
Confidence 000 16789999999999999997
Q ss_pred ----HHHHhcCCCCCCCc
Q psy16081 431 ----PYYALQHNFFKRTA 444 (493)
Q Consensus 431 ----~~e~L~Hp~~~~~~ 444 (493)
.+++++||||....
T Consensus 247 ~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 247 GPEGERDIREHAFFRRID 264 (323)
T ss_pred CCCCHHHHhcCcccCCCC
Confidence 57999999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=384.14 Aligned_cols=254 Identities=30% Similarity=0.437 Sum_probs=215.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccC----cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK----KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|+|+++||+|+||.|.+++.+.|++.||+|++++. ......+..|+.++. ..+.++|++|+..|++.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv------~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMV------FGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHH------cCCcHHHHHHHHHhcCc
Confidence 46899999999999999999999999999999999752 233445566666543 33467899999999999
Q ss_pred ceeEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+++|+||||| +|+|..++.+.. .++++++++|+..|..||.-|| ++|+|||||||+|||| |..|+|||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLl--d~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLL--DKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEe--cccCcEeeccchh
Confidence 9999999999 559999997654 6999999999999999999999 5899999999999999 8999999999999
Q ss_pred ccccCCc----cccccccCcCCchhhhc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH---hC
Q psy16081 273 SCQLGQR----IYQYIQSRFYRSPEVLL----G-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV---LG 340 (493)
Q Consensus 273 a~~~~~~----~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~---~~ 340 (493)
+-.+... ....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||...+-.+++.+|+.- +.
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS 301 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence 9777543 45679999999999996 2 46999999999999999999999999999999999999864 11
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
.|+. ..+++ .++|||+++
T Consensus 302 FP~~------------------------------------------------------------~~VSe--eakdLI~~l 319 (1317)
T KOG0612|consen 302 FPDE------------------------------------------------------------TDVSE--EAKDLIEAL 319 (1317)
T ss_pred CCcc------------------------------------------------------------cccCH--HHHHHHHHH
Confidence 1100 00111 789999987
Q ss_pred cCCCCCCCCC---HHHHhcCCCCCCCccC
Q psy16081 421 LDYDPKTRIT---PYYALQHNFFKRTADE 446 (493)
Q Consensus 421 L~~dP~~R~t---~~e~L~Hp~~~~~~~~ 446 (493)
|. +|+.|.. ++++-.||||.+..+.
T Consensus 320 l~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 320 LC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred hc-ChhhhcccccHHHHHhCccccCCChh
Confidence 76 7889999 9999999999988764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=360.41 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=202.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+..... ......+.++.......+||||++++++|.+.+++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 467999999999999999999999999999999986422110 111111222333334456888999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+|||||++ +|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+|...
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl--~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLL--DKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEE--CCCCCEEEEecccceec
Confidence 99999954 999988653 48999999999999999999994 789999999999999 67889999999999776
Q ss_pred CCc----cccccccCcCCchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 277 GQR----IYQYIQSRFYRSPEVLLGIP----YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 277 ~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
... ....+||+.|+|||++.+.. ++.++|||||||+||+|++|.+||.+.+....+.+|+.......
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----- 267 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN----- 267 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC-----
Confidence 432 23567999999999997643 78999999999999999999999998887777766654211100
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC-
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT- 427 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~- 427 (493)
.|.. ...+ ..+++||.+||..++.+
T Consensus 268 -----------------------------~p~~-----------------------~~~s--~~~~~li~~~L~~~~~r~ 293 (370)
T cd05621 268 -----------------------------FPED-----------------------VEIS--KHAKNLICAFLTDREVRL 293 (370)
T ss_pred -----------------------------CCCc-----------------------ccCC--HHHHHHHHHHccCchhcc
Confidence 0000 0001 16789999999865544
Q ss_pred -CCCHHHHhcCCCCCCCc
Q psy16081 428 -RITPYYALQHNFFKRTA 444 (493)
Q Consensus 428 -R~t~~e~L~Hp~~~~~~ 444 (493)
|+|+.|+++||||+...
T Consensus 294 ~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 294 GRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred CCCCHHHHhcCcccCCCC
Confidence 89999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=355.74 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=195.9
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHH-HHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL-EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~-~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
++||+|+||+||+|++..+++.||||++......... ....++ +........+|+||+++++.|.+.+.+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK--EQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhh--HHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4799999999999999999999999998643211111 111111 1111234456889999999999999999999999
Q ss_pred cc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC---c
Q psy16081 204 SY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---R 279 (493)
Q Consensus 204 ~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~---~ 279 (493)
++ +|...+... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..... .
T Consensus 79 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 79 NGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILL--DSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEE--CCCCCEEEccCCCCccCCCCCCc
Confidence 65 888877654 358999999999999999999994 789999999999999 6788999999999875322 2
Q ss_pred cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhcc
Q psy16081 280 IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~ 359 (493)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.......+.......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----------------- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQL----------------- 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC-----------------
Confidence 335678999999999999899999999999999999999999999887666555543210000
Q ss_pred CCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH----HHHh
Q psy16081 360 MPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP----YYAL 435 (493)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~----~e~L 435 (493)
+ ......+.+||.+||..||.+|+++ .+++
T Consensus 216 -------------------~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~ 249 (321)
T cd05603 216 -------------------P---------------------------GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIK 249 (321)
T ss_pred -------------------C---------------------------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHh
Confidence 0 0001167899999999999999976 5999
Q ss_pred cCCCCCCCcc
Q psy16081 436 QHNFFKRTAD 445 (493)
Q Consensus 436 ~Hp~~~~~~~ 445 (493)
+|+||.....
T Consensus 250 ~~~~~~~~~~ 259 (321)
T cd05603 250 NHVFFSPINW 259 (321)
T ss_pred CCCCcCCCCH
Confidence 9999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=352.99 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=198.3
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
+.||+|+||+||+|.+..+++.||||+++.... .......|..++.. . .+|+||+++++++...+++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~---~--~~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLAL---A--GKHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHh---c--cCCCCccceeeEEEcCCEEEEEE
Confidence 479999999999999999999999999974321 11222233333322 2 26889999999999999999999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc---
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--- 276 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~--- 276 (493)
||+.+ +|.+.+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++...
T Consensus 76 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLL--DSEGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEE--CCCCcEEecccCCCeecCcC
Confidence 99965 888887655 369999999999999999999994 789999999999999 67889999999998653
Q ss_pred CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......|.
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~------------ 217 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR------------ 217 (318)
T ss_pred CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC------------
Confidence 22234467899999999999999999999999999999999999999988776665554321000000
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH-----
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP----- 431 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~----- 431 (493)
..+ ..+.+||++||..||.+|||+
T Consensus 218 -------------------------------------------------~~~--~~~~~li~~~l~~dP~~R~s~~~~~~ 246 (318)
T cd05570 218 -------------------------------------------------WLS--KEAKSILKSFLTKNPEKRLGCLPTGE 246 (318)
T ss_pred -------------------------------------------------cCC--HHHHHHHHHHccCCHHHcCCCCCCCH
Confidence 000 167899999999999999999
Q ss_pred HHHhcCCCCCCCcc
Q psy16081 432 YYALQHNFFKRTAD 445 (493)
Q Consensus 432 ~e~L~Hp~~~~~~~ 445 (493)
.++++||||.....
T Consensus 247 ~~ll~~~~~~~~~~ 260 (318)
T cd05570 247 QDIKGHPFFREIDW 260 (318)
T ss_pred HHHhcCCCcCCCCH
Confidence 99999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=362.74 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=203.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.++||+|+||.||+|++..+++.||||++...... .......+.++.......+|+||+++++++.+.+++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45799999999999999999999999999999999642210 0011111222223333456888999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++... .+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl--~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEE--cCCCCEEEEeccceeec
Confidence 99999954 899888653 48899999999999999999995 789999999999999 77899999999999766
Q ss_pred CCc----cccccccCcCCchhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 277 GQR----IYQYIQSRFYRSPEVLLGI----PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 277 ~~~----~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
... ....+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+....+..|.......
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------ 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL------ 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC------
Confidence 432 2356799999999999754 38899999999999999999999999988776666665321100
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC-
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT- 427 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~- 427 (493)
..|.. ...+ ..+.+||.+||..+|.+
T Consensus 267 ----------------------------~~~~~-----------------------~~~s--~~~~~li~~~L~~~p~r~ 293 (370)
T cd05596 267 ----------------------------TFPDD-----------------------IEIS--KQAKDLICAFLTDREVRL 293 (370)
T ss_pred ----------------------------CCCCc-----------------------CCCC--HHHHHHHHHHccChhhcc
Confidence 00000 0011 17899999999999988
Q ss_pred -CCCHHHHhcCCCCCCCc
Q psy16081 428 -RITPYYALQHNFFKRTA 444 (493)
Q Consensus 428 -R~t~~e~L~Hp~~~~~~ 444 (493)
|+|++|+++||||+...
T Consensus 294 ~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 294 GRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred CCCCHHHHhcCcccCCCC
Confidence 99999999999998744
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=353.31 Aligned_cols=262 Identities=26% Similarity=0.337 Sum_probs=201.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||+||++++..+++.||||++...... .......+.++.......+|++|+++++++.+.+++|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML--KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH--hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4799999999999999999999999999999998642211 11111112222222334468889999999999999999
Q ss_pred EEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+. ++|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 v~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill--~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEE--cCCCCEEEEeccceeecc
Confidence 999995 59999987643 36899999999999999999999 4799999999999999 678899999999997664
Q ss_pred Ccc----ccccccCcCCchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 278 QRI----YQYIQSRFYRSPEVLLG-----IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 278 ~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
... ...+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+.++.......+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----- 228 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ----- 228 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc-----
Confidence 321 23579999999999976 4688999999999999999999999998877766665543110000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC-
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT- 427 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~- 427 (493)
.+..+. ... ..+.+||.+||..++.+
T Consensus 229 -------------------------------~p~~~~--------------------~~~--~~~~~li~~ll~~~~~~~ 255 (331)
T cd05624 229 -------------------------------FPSHIT--------------------DVS--EEAKDLIQRLICSRERRL 255 (331)
T ss_pred -------------------------------CCCccc--------------------cCC--HHHHHHHHHHccCchhhc
Confidence 000000 001 16889999999976654
Q ss_pred -CCCHHHHhcCCCCCCCcc
Q psy16081 428 -RITPYYALQHNFFKRTAD 445 (493)
Q Consensus 428 -R~t~~e~L~Hp~~~~~~~ 445 (493)
|++++++++||||+....
T Consensus 256 ~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 256 GQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred CCCCHHHHhcCCCcCCCCH
Confidence 579999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=352.84 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=197.6
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
+.||+|+||+||+|.+..+++.||||+++.... .......|..++ ....+||||+++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-----~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVL-----SLAWEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHH-----HhccCCCcCcceEEEEEeCCEEEEEE
Confidence 479999999999999999999999999974321 111122222222 22347889999999999999999999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC--
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-- 277 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~-- 277 (493)
||+.+ +|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILL--DTDGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEE--CCCCCEEEccCCcceECCCC
Confidence 99954 999888754 358999999999999999999994 789999999999999 678899999999986532
Q ss_pred -CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 278 -QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 278 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+.......|.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~------------ 217 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR------------ 217 (316)
T ss_pred CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------------
Confidence 2234567899999999999999999999999999999999999999988776665554321000000
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH-HHh
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY-YAL 435 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~-e~L 435 (493)
..+ ..+.+||.+||..||.+||++. +++
T Consensus 218 -------------------------------------------------~~~--~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 218 -------------------------------------------------WLT--REAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -------------------------------------------------cCC--HHHHHHHHHHhccCHhhcCCChHHHH
Confidence 000 1678999999999999999996 999
Q ss_pred cCCCCCCCcc
Q psy16081 436 QHNFFKRTAD 445 (493)
Q Consensus 436 ~Hp~~~~~~~ 445 (493)
+||||.....
T Consensus 247 ~h~~~~~~~~ 256 (316)
T cd05619 247 QHPFFREIDW 256 (316)
T ss_pred cCcccCCCCH
Confidence 9999988653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=361.48 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=202.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++++.||+|+||+||+|.+..+++.||||+++.... .......|+.++ ...+|++|+++++.|.+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l------~~l~~~~iv~~~~~~~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDIL------VEADGAWVVKMFYSFQDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHH------HhCCCCCEeeEEEEEEcCC
Confidence 468999999999999999999999999999999974221 112223333333 2335788999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
++||||||+.+ +|.+++.+.. .+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli--~~~~~vkL~DfG~~ 148 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLL--DAKGHVKLSDFGLC 148 (360)
T ss_pred EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEE--CCCCCEEEeeccCC
Confidence 99999999965 8999887643 5899999999999999999999 4799999999999999 67889999999998
Q ss_pred cccCCc--------------------------------------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHH
Q psy16081 274 CQLGQR--------------------------------------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVE 315 (493)
Q Consensus 274 ~~~~~~--------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~e 315 (493)
..+... ....+||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence 644211 123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCC
Q psy16081 316 MHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGP 395 (493)
Q Consensus 316 lltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 395 (493)
|++|.+||.+.+..+.+.++....... ..|.
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~p~--------------- 259 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWKETL----------------------------------VFPP--------------- 259 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCCCce----------------------------------ecCC---------------
Confidence 999999999888777666655311000 0000
Q ss_pred CCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC---CHHHHhcCCCCCCCcc
Q psy16081 396 GGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI---TPYYALQHNFFKRTAD 445 (493)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~---t~~e~L~Hp~~~~~~~ 445 (493)
....+ ..+++||.+|+ .||.+|+ +++|+++||||+....
T Consensus 260 --------~~~~s--~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 260 --------EVPIS--EKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred --------CCCCC--HHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 00011 16789999987 4999999 4899999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=353.18 Aligned_cols=203 Identities=30% Similarity=0.418 Sum_probs=170.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|++++.||+|+||.||++++..++..||+|++..... ....+..|+.++. ..+|+||+++++++...+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH------ECNSPYIVGFYGAFYSDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHH------HCCCCCCCeEEEEEEECCE
Confidence 4689999999999999999999999999999999874321 1122333433333 3357889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+++||||+++ +|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||+ +.++.+||+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILV--NSRGEIKLCDFGVSG 152 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEE--cCCCcEEEccCcccc
Confidence 9999999965 8999887643 58999999999999999999996 2469999999999999 678899999999997
Q ss_pred ccCCc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy16081 275 QLGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ 331 (493)
Q Consensus 275 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~ 331 (493)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.
T Consensus 153 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 210 (331)
T cd06649 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210 (331)
T ss_pred cccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 66433 3456789999999999999999999999999999999999999987766443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=354.13 Aligned_cols=190 Identities=29% Similarity=0.459 Sum_probs=159.6
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
++||+|+||.||+|.+..+++.||||+++.... .......|..++.. ..+||||++++++|.+.+.+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~-----~~~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFET-----ASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh-----ccCCCCCCceEEEEEcCCEEEEEE
Confidence 479999999999999999999999999974321 11223334443332 236889999999999999999999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc---
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--- 276 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~--- 276 (493)
||+++ +|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEE--CCCCCEEECcCccccccccC
Confidence 99965 888887654 36999999999999999999999 4799999999999999 67889999999998643
Q ss_pred CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 2234456899999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.49 Aligned_cols=277 Identities=32% Similarity=0.538 Sum_probs=214.7
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|++.+.||.|+||.||+|++..+++.||||+++.... .......|+.++..+ +|+||+++++.+..++.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL------QHPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc------CCCCEeeeEEEEeeCCeE
Confidence 48899999999999999999999999999999864321 123344455544433 478899999999999999
Q ss_pred EEEEEecccCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+.++|.+++..... ..+++..++.++.||+.||.|||+ .||+|+||||+|||+ +.++.+||+|||++..
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 75 YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLI--DNKGVIKLADFGLARA 150 (285)
T ss_pred EEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEE--cCCCcEEECcccceee
Confidence 99999999899888865332 468999999999999999999994 789999999999999 6788999999999876
Q ss_pred cCCcc---ccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQRI---YQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.+... ....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+...++.+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 151 FGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred cCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 54322 234568889999998764 47899999999999999999999999998888888888887777666554433
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
....|....+.... ..+.+. ....+ .++.+||++||..||.+|||+
T Consensus 231 ~~~~~~~~~~~~~~----------------~~~~~~----------------~~~~~--~~~~~li~~~l~~dP~~Rpt~ 276 (285)
T cd07861 231 SLPDYKNTFPKWKK----------------GSLRSA----------------VKNLD--EDGLDLLEKMLIYDPAKRISA 276 (285)
T ss_pred hhHHHHhhccccCc----------------chhHHh----------------cCCCC--HHHHHHHHHHhcCChhhCCCH
Confidence 33222221110000 000000 00011 167899999999999999999
Q ss_pred HHHhcCCCC
Q psy16081 432 YYALQHNFF 440 (493)
Q Consensus 432 ~e~L~Hp~~ 440 (493)
.+++.||||
T Consensus 277 ~~ll~~~~~ 285 (285)
T cd07861 277 KKALNHPYF 285 (285)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=337.04 Aligned_cols=292 Identities=30% Similarity=0.491 Sum_probs=226.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCC----eEEEEEEEccCc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQ----CHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vAvK~~~~~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
...|++...||+|+||.||+|....++ +.+|||.++..+ .....+.+|+.+++++. |+||+.|..+|
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~------h~nvi~Lv~Vf 96 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK------HPNVISLVKVF 96 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc------CCcchhHHHHH
Confidence 457999999999999999999665554 378999998543 34566788888887775 55699999998
Q ss_pred ee-cceeEEEEEecccCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC--CCCc
Q psy16081 191 MW-RNHLCLVFELLSYNLYDLLRNTN---FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP--KRSA 264 (493)
Q Consensus 191 ~~-~~~~~lV~E~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~--~~~~ 264 (493)
.. +..++|++||.+.+|++.|+... .+.++...++.++.||+.|+.|||+ .-|+||||||.|||+..| +.|.
T Consensus 97 l~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 97 LSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred hccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCe
Confidence 87 78899999999999999986432 2458999999999999999999995 579999999999999432 5699
Q ss_pred EEEEecccccccCCccc------cccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---------H
Q psy16081 265 IKIVDFGSSCQLGQRIY------QYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSN---------E 328 (493)
Q Consensus 265 ikL~DFG~a~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~---------~ 328 (493)
+||+|||+++.+.+... ..+-|.+|+|||.++|. .|+.++||||+|||+.||++-.|.|.+.. .
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 99999999998866433 34568899999999986 59999999999999999999999998743 3
Q ss_pred HHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcc
Q psy16081 329 VDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVS 408 (493)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 408 (493)
.+++.+|.+.+|.|.+..|+...+..+|-+.+.+ ...... ....|..+........+
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~-------f~~~~~----~n~sL~~~~~~~k~k~~------------ 311 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSD-------FRRHYY----DNVSLHKYYHKHKVKDP------------ 311 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHH-------hHHhhc----CcchHHHHHHHhcCCCc------------
Confidence 5899999999999999888876655444221111 000000 00112222221111111
Q ss_pred hhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 409 DYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 409 ~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
...+|+.+||.+||.+|+|++|+|+|+||+..
T Consensus 312 ---~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 312 ---SALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred ---hHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 36799999999999999999999999999865
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=356.38 Aligned_cols=250 Identities=28% Similarity=0.382 Sum_probs=195.0
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc-hHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc
Q psy16081 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL-NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY 205 (493)
Q Consensus 127 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~ 205 (493)
||+|+||+||+|.+..+++.||||++....... ............+......+||+|+++++.|...+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999986422110 1111111122223333334789999999999999999999999955
Q ss_pred -CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC---Cccc
Q psy16081 206 -NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIY 281 (493)
Q Consensus 206 -~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~---~~~~ 281 (493)
+|.+.+... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili--~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILL--DATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEE--CCCCCEEEecCCcCcCCCCCCCCcc
Confidence 898888654 358999999999999999999995 789999999999999 678899999999986542 2234
Q ss_pred cccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccC
Q psy16081 282 QYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKM 360 (493)
Q Consensus 282 ~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 360 (493)
..+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------------- 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---------------- 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC----------------
Confidence 56799999999999865 4899999999999999999999999988776655554321000000
Q ss_pred CCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC----CHHHHhc
Q psy16081 361 PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI----TPYYALQ 436 (493)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~----t~~e~L~ 436 (493)
...+ ..+.+||.+||..||.+|| ++.|+++
T Consensus 219 --------------------------------------------~~~~--~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 --------------------------------------------NVLS--DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --------------------------------------------ccCC--HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0001 1678999999999999998 7999999
Q ss_pred CCCCCCCc
Q psy16081 437 HNFFKRTA 444 (493)
Q Consensus 437 Hp~~~~~~ 444 (493)
||||....
T Consensus 253 h~~~~~~~ 260 (330)
T cd05586 253 HPFFADID 260 (330)
T ss_pred CccccCCC
Confidence 99998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=357.14 Aligned_cols=277 Identities=24% Similarity=0.320 Sum_probs=205.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
.+|++++.||+|+||.||+|.+..+++.||+|+..... ...|..++.. .+|+||+++++++...+..|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----~~~E~~~l~~------l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----TLIEAMLLQN------VNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----cHHHHHHHHh------CCCCCCcChhheEEeCCeeEE
Confidence 47999999999999999999999999999999864322 2335554443 357789999999999999999
Q ss_pred EEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 199 VFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 199 V~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|||++.++|.+++.... ..+++..++.++.||+.||.|||. .|||||||||+|||+ +..+.+||+|||++.....
T Consensus 135 v~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFI--NDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--CCCCCEEEecCcccccccc
Confidence 99999999999887544 468999999999999999999994 789999999999999 6788899999999975432
Q ss_pred --ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC---------HHHHHHHHHHHhCCCChhh
Q psy16081 279 --RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTG-EPLFSGSN---------EVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 279 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~---------~~~~~~~i~~~~~~~p~~~ 346 (493)
......||+.|+|||++.+..++.++|||||||++|||+++ .++|.... ....+..++..++..|..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 23456789999999999999999999999999999999985 45554322 1234555666666555443
Q ss_pred hhh--ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 347 LDG--AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 347 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
... ......+++.... .+ .+.. .. ..+. .......+.+||.+||.+|
T Consensus 290 ~~~~~~~~~~~~~~~~~~----------~~---~~~~-~~-~~~~----------------~~~~~~~~~~li~~mL~~d 338 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASL----------ER---QPYT-RY-PCFQ----------------RVNLPIDGEFLVHKMLTFD 338 (357)
T ss_pred CCCCccHHHHHHHhhccc----------CC---Cccc-cc-HHHh----------------ccCCCchHHHHHHHHHcCC
Confidence 311 1111122211000 00 0000 00 0000 0000115678999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q psy16081 425 PKTRITPYYALQHNFFKR 442 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~~~ 442 (493)
|++|||+.|+|+||||+.
T Consensus 339 P~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 339 AAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cccCcCHHHHhcCchhcc
Confidence 999999999999999985
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=344.72 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=201.6
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
.|++.++||+|+||+||++.+..+++.||||++...... ....+....+++......+|+||+++++.+...+++|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh--hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 488999999999999999999999999999998643211 111111122222223333578899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|||+.+ +|.+++.......+++..+..++.||+.||.|||+ .||+||||||+||++ ++++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILL--DDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEE--CCCCCEEEeeCCCceecCC
Confidence 999964 88888765444568999999999999999999995 689999999999999 6788999999999976532
Q ss_pred --ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 279 --RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 279 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
.....+|++.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.......+.. +
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~ 224 (285)
T cd05605 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE----------Y 224 (285)
T ss_pred CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccc----------c
Confidence 2234578999999999999899999999999999999999999998876544443333221100000 0
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CH
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TP 431 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~ 431 (493)
.. ... ..+.+||.+||..||.+|| ++
T Consensus 225 ~~-----------------------------------------------~~~--~~~~~li~~~l~~~P~~R~~~~~~~~ 255 (285)
T cd05605 225 SE-----------------------------------------------KFS--EAARSICRQLLTKDPGFRLGCRGEGA 255 (285)
T ss_pred Cc-----------------------------------------------ccC--HHHHHHHHHHccCCHHHhcCCCCCCH
Confidence 00 001 1678999999999999999 99
Q ss_pred HHHhcCCCCCCCc
Q psy16081 432 YYALQHNFFKRTA 444 (493)
Q Consensus 432 ~e~L~Hp~~~~~~ 444 (493)
+++++||||....
T Consensus 256 ~~l~~~~~~~~~~ 268 (285)
T cd05605 256 EEVKAHPFFRTAN 268 (285)
T ss_pred HHHhcCcCccCCC
Confidence 9999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=355.00 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=196.9
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
+.||+|+||+||+|.+..+|+.||||++........... ...+.+........+||||+++++.+...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ-KHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHH-HHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999999999999999999999999974321111111 1111111122334578899999999999999999999996
Q ss_pred c-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC---Ccc
Q psy16081 205 Y-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRI 280 (493)
Q Consensus 205 ~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~---~~~ 280 (493)
+ +|...+... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.... ...
T Consensus 80 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll--~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 80 GGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILL--DSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEE--CCCCCEEEeecCCcccCCCCCCCc
Confidence 5 888887654 368999999999999999999994 799999999999999 678899999999986532 223
Q ss_pred ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccC
Q psy16081 281 YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKM 360 (493)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 360 (493)
...+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.......+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----------------- 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----------------- 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC-----------------
Confidence 456799999999999999999999999999999999999999998877666555543100000
Q ss_pred CCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH----HHHhc
Q psy16081 361 PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP----YYALQ 436 (493)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~----~e~L~ 436 (493)
+ .. ...+.+||++||..||.+||++ .++++
T Consensus 217 ------------------------------------------~--~~--~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 217 ------------------------------------------P--GA--SLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred ------------------------------------------C--CC--CHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 0 00 0167899999999999999987 59999
Q ss_pred CCCCCCCc
Q psy16081 437 HNFFKRTA 444 (493)
Q Consensus 437 Hp~~~~~~ 444 (493)
||||....
T Consensus 251 h~~f~~~~ 258 (325)
T cd05604 251 HPFFESLS 258 (325)
T ss_pred CCCcCCCC
Confidence 99998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=354.13 Aligned_cols=246 Identities=28% Similarity=0.393 Sum_probs=197.0
Q ss_pred eeeEeeeCCeEEEEEEE---cCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 124 DSLIGKGSFGQVVKAFD---LEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~---~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
++.||+|+||.||++++ ..+|+.||||++...... ......|+.++ ...+|+||+++++.+...+.+|
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l------~~l~h~niv~~~~~~~~~~~~~ 74 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL------AEVNHPFIVKLHYAFQTEGKLY 74 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH------HhCCCCCcccEEEEEEcCCEEE
Confidence 36799999999999976 357899999999743211 11222233332 2335788999999999999999
Q ss_pred EEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+. ++|.+.+... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 75 LILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILL--DEEGHIKLTDFGLSKES 148 (318)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEE--CCCCcEEEeeccCCccc
Confidence 9999995 5899988654 358999999999999999999995 789999999999999 67889999999998765
Q ss_pred CCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.......|.
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~--------- 219 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ--------- 219 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC---------
Confidence 332 34567899999999999989999999999999999999999999988877666655431110000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC---
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT--- 430 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t--- 430 (493)
..+ ..+.+||++||..||++|||
T Consensus 220 ----------------------------------------------------~~~--~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 ----------------------------------------------------FLS--PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----------------------------------------------------CCC--HHHHHHHHHHhhcCHhHcCCCCC
Confidence 000 16789999999999999999
Q ss_pred --HHHHhcCCCCCCCc
Q psy16081 431 --PYYALQHNFFKRTA 444 (493)
Q Consensus 431 --~~e~L~Hp~~~~~~ 444 (493)
++++++||||....
T Consensus 246 ~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 246 DGVEEIKRHPFFSTID 261 (318)
T ss_pred CCHHHHhCCCCcCCCC
Confidence 78899999998764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=351.21 Aligned_cols=298 Identities=32% Similarity=0.495 Sum_probs=223.3
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ......|+.++. ..+|+||++++++|..
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~~~~~~~~ 86 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK------LVNHKNIIGLLNVFTP 86 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHH------hcCCCCCcceeeeecc
Confidence 3467899999999999999999999999999999998642211 112223333333 3357789999998864
Q ss_pred c------ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 R------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
. .++|+||||++++|.+.+... +++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~--~~~~~~k 158 (353)
T cd07850 87 QKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVV--KSDCTLK 158 (353)
T ss_pred CCCccccCcEEEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEE--CCCCCEE
Confidence 3 357999999999999887542 8899999999999999999995 799999999999999 6788999
Q ss_pred EEecccccccCCcc--ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 267 IVDFGSSCQLGQRI--YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 267 L~DFG~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.|+.
T Consensus 159 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 159 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred EccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999998765432 3456788999999999999999999999999999999999999999999999999999999988
Q ss_pred hhhhhccch-hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 345 HLLDGAHKT-RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 345 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
.+....... ..++...+... ...+.+++.... .+.. ..+. .......+.+||.+||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~-~~~~--~~~~--~~~~~~~~~~li~~~L~~ 297 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYA----------------GYSFEELFPDVL-FPPD--SESH--NKLKASQARDLLSKMLVI 297 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCC----------------CcchhhhCcccc-cCcc--cccc--cccchhHHHHHHHHHcCC
Confidence 776654332 22222111000 000011100000 0000 0000 001112678999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccCCC
Q psy16081 424 DPKTRITPYYALQHNFFKRTADEST 448 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~~~~ 448 (493)
||++|||+.|+|+||||..+.....
T Consensus 298 dP~~R~t~~eiL~~~~~~~~~~~~~ 322 (353)
T cd07850 298 DPEKRISVDDALQHPYINVWYDPSE 322 (353)
T ss_pred ChhhCcCHHHHhcChhHhhccCCcc
Confidence 9999999999999999997766443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=352.74 Aligned_cols=249 Identities=28% Similarity=0.398 Sum_probs=197.8
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHH-HhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEI-MNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~-l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
+.||+|+||+||+|++..+++.||+|++....... ...+..++.+ .......+|+||+++++.+...+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh--hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 47999999999999999999999999997432111 1111222221 11223456889999999999999999999999
Q ss_pred cc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC---Cc
Q psy16081 204 SY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QR 279 (493)
Q Consensus 204 ~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~---~~ 279 (493)
.+ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.... ..
T Consensus 79 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili--~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 79 NGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEE--CCCCCEEEccCCCCcccccCCCC
Confidence 65 888888654 358899999999999999999994 789999999999999 678899999999987542 22
Q ss_pred cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhcc
Q psy16081 280 IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~ 359 (493)
....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~---------------- 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---------------- 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----------------
Confidence 3456799999999999999999999999999999999999999998887776666543100000
Q ss_pred CCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH----HHh
Q psy16081 360 MPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY----YAL 435 (493)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~----e~L 435 (493)
. ... ..+.+||.+||..||.+|+++. +++
T Consensus 217 ----------------------~-----------------------~~~--~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 217 ----------------------P-----------------------NIT--NSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred ----------------------C-----------------------CCC--HHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 0 000 1678999999999999999876 899
Q ss_pred cCCCCCCCc
Q psy16081 436 QHNFFKRTA 444 (493)
Q Consensus 436 ~Hp~~~~~~ 444 (493)
+|+||....
T Consensus 250 ~~~~~~~~~ 258 (325)
T cd05602 250 NHIFFSPIN 258 (325)
T ss_pred cCcccCCCC
Confidence 999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=357.17 Aligned_cols=251 Identities=30% Similarity=0.441 Sum_probs=203.0
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.|..++.||+|+||.||+|.+..+++.||+|++.... ......+.|+.++..+. ++||.+.++.|..+..++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~------~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD------SPNITEYYGSYLKGTKLW 87 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC------cchHHhhhhheeecccHH
Confidence 5777899999999999999999999999999997432 22334445555554433 467999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
++||||+| ++.++++... .+.+..+..++++++.||.|||+ .+.+|||||+.|||+ ...|.+||+|||.+.++
T Consensus 88 iiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~--s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILL--SESGDVKLADFGVAGQL 161 (467)
T ss_pred HHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhh--cceecccccccceeE--eccCcEEEEecceeeee
Confidence 99999955 8999997664 35888899999999999999996 679999999999999 45699999999999777
Q ss_pred CCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... ..+++|||+|||||++.+..|+.++||||||++.+||++|.||+....++..+..|-+ ..
T Consensus 162 ~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-------~~------- 227 (467)
T KOG0201|consen 162 TNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-------SA------- 227 (467)
T ss_pred echhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-------CC-------
Confidence 542 3688999999999999998999999999999999999999999987665322222211 00
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
++.+.. ..+ ..|++||..||++||+.||||.+
T Consensus 228 ---------------------------PP~L~~-------------------~~S--~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 228 ---------------------------PPRLDG-------------------DFS--PPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred ---------------------------CCcccc-------------------ccC--HHHHHHHHHHhhcCcccCcCHHH
Confidence 000000 000 16899999999999999999999
Q ss_pred HhcCCCCCCCc
Q psy16081 434 ALQHNFFKRTA 444 (493)
Q Consensus 434 ~L~Hp~~~~~~ 444 (493)
+|+|+|+++..
T Consensus 260 LLKh~FIk~a~ 270 (467)
T KOG0201|consen 260 LLKHKFIKRAK 270 (467)
T ss_pred HhhhHHHHhcC
Confidence 99999998744
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=350.62 Aligned_cols=244 Identities=27% Similarity=0.322 Sum_probs=195.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeE-EEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc-
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCH-VAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN- 194 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~-vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~- 194 (493)
...+.+.||+|+||+||+|... |+. ||||++...... ...+..|+.++.. .+|||||++++++....
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~------l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSR------LRHPNIVQFYGACTSPPG 113 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHh------CCCCCeeeEEEEEcCCCC
Confidence 4555677999999999999654 455 999999754322 2345555555544 56888999999999887
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC-ccccCCCCCcEEeeCCCCC-cEEEEecc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN-IIHCDLKPENILLCNPKRS-AIKIVDFG 271 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~-iiHrDlKp~NILl~~~~~~-~ikL~DFG 271 (493)
.++|||||++ |+|.+++.......+++..+..++.||+.|+.|||+ .+ ||||||||+|||+ +.++ ++||+|||
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv--~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILV--DLKGKTLKIADFG 189 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEE--cCCCCEEEECCCc
Confidence 7999999995 599999977444679999999999999999999996 56 9999999999999 6776 99999999
Q ss_pred cccccCC---ccccccccCcCCchhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 272 SSCQLGQ---RIYQYIQSRFYRSPEVLL--GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 272 ~a~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
+++.... ..+...||+.|||||++. ...|+.|+||||||++||||+||+.||.+.........++.....|+..
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p- 268 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP- 268 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC-
Confidence 9977753 444578999999999999 5689999999999999999999999999988855555554332222100
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
......+..||.+||..||.
T Consensus 269 ------------------------------------------------------------~~~~~~l~~l~~~CW~~dp~ 288 (362)
T KOG0192|consen 269 ------------------------------------------------------------KECPPHLSSLMERCWLVDPS 288 (362)
T ss_pred ------------------------------------------------------------ccCCHHHHHHHHHhCCCCCC
Confidence 00112788999999999999
Q ss_pred CCCCHHHHhc
Q psy16081 427 TRITPYYALQ 436 (493)
Q Consensus 427 ~R~t~~e~L~ 436 (493)
+||+..+++.
T Consensus 289 ~RP~f~ei~~ 298 (362)
T KOG0192|consen 289 RRPSFLEIVS 298 (362)
T ss_pred cCCCHHHHHH
Confidence 9999998764
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=339.80 Aligned_cols=259 Identities=28% Similarity=0.397 Sum_probs=215.9
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
-.++|..+++||+|.||.|-+|+.+.+++.||||++++.... ....-...+.+-+.+..-+||++..|...|+..+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii--akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII--AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhee--ehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 357899999999999999999999999999999999854321 111122233333344456799999999999999999
Q ss_pred EEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+ +|.|+-.|.+. +.++++.++.+-..|..||.|||+ .+||.||||.+|+|+ |++|+|||+|||+++.
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlL--DkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLL--DKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhhee--ccCCceEeeecccchh
Confidence 9999999 55888877665 479999999999999999999996 789999999999999 8999999999999965
Q ss_pred c---CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 L---GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
- +....++||||.|+|||++....|+.++|+|.+||+||||++|+.||...+.......|...--..|..+
T Consensus 318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~l------ 391 (516)
T KOG0690|consen 318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTL------ 391 (516)
T ss_pred cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccC------
Confidence 4 5677899999999999999999999999999999999999999999999888777777654321111110
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC--
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT-- 430 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t-- 430 (493)
. .+++.|+..+|..||.+|+-
T Consensus 392 --------------------------------s-------------------------~eAktLLsGLL~kdP~kRLGgG 414 (516)
T KOG0690|consen 392 --------------------------------S-------------------------PEAKTLLSGLLKKDPKKRLGGG 414 (516)
T ss_pred --------------------------------C-------------------------HHHHHHHHHHhhcChHhhcCCC
Confidence 0 06789999999999999984
Q ss_pred ---HHHHhcCCCCCCCccC
Q psy16081 431 ---PYYALQHNFFKRTADE 446 (493)
Q Consensus 431 ---~~e~L~Hp~~~~~~~~ 446 (493)
+.|+.+|+||..+..+
T Consensus 415 pdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 415 PDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred chhHHHHHhhhhhccCCHH
Confidence 8999999999987643
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=345.19 Aligned_cols=283 Identities=28% Similarity=0.503 Sum_probs=203.5
Q ss_pred eeeEeeeCCeEEEEEEEcC--CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--cceeEEE
Q psy16081 124 DSLIGKGSFGQVVKAFDLE--EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW--RNHLCLV 199 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~--~~~~~lV 199 (493)
..+||+|+||+||+|.+.. ++..||+|.+.... .......|..++..+ +|+||+++++++.. ...+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLREL------KHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhC------CCCCeeeEEEEEeccCCCeEEEE
Confidence 3689999999999998654 66899999987433 223445565555443 47789999999853 5678999
Q ss_pred EEecccCHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC--CCCCcEEEEec
Q psy16081 200 FELLSYNLYDLLRNTN-------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN--PKRSAIKIVDF 270 (493)
Q Consensus 200 ~E~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~--~~~~~ikL~DF 270 (493)
|||++++|.+++.... ...+++..++.++.||+.||.|||+ .+|+||||||+|||+.. +.++.+||+||
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9999999988875321 1247899999999999999999995 78999999999999943 34578999999
Q ss_pred ccccccCCc------cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHH
Q psy16081 271 GSSCQLGQR------IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNE---------VDQMNK 334 (493)
Q Consensus 271 G~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~---------~~~~~~ 334 (493)
|+++..... .....+|+.|+|||++.+. .++.++|||||||++|||++|.+||....+ .+++.+
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 999766432 2345778999999999874 589999999999999999999999976442 356777
Q ss_pred HHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHH
Q psy16081 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414 (493)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (493)
+...++.+....+........+...... + +..... ...+...+. ... ......++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~-~~~~~~~~~------------~~~--~~~~~~~~ 291 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKD--F--------RRTTYA-NSSLIKYME------------KHK--VKPDSKVF 291 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhh--h--------cccccC-Cchhhhhhh------------ccc--CCCChHHH
Confidence 8888887776665544333222111100 0 000000 000000000 000 01112688
Q ss_pred HHHhHccCCCCCCCCCHHHHhcCCCC
Q psy16081 415 DLIFRMLDYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 415 dLi~~mL~~dP~~R~t~~e~L~Hp~~ 440 (493)
+||.+||..||.+|||+.|+|+||||
T Consensus 292 ~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 292 LLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHHhccCcccccCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=350.14 Aligned_cols=189 Identities=27% Similarity=0.438 Sum_probs=158.2
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
++||+|+||+||+|.+..+++.||+|+++.... .......|..++. ...+||||+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-----~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFE-----QASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHH-----hcCCCCcCCceeeEEEeCCEEEEEE
Confidence 479999999999999999999999999974321 1112223333222 2346889999999999999999999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC--
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-- 277 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~-- 277 (493)
||+.+ +|..++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili--~~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEE--CCCCCEEEeeCCccccccCC
Confidence 99965 888877654 369999999999999999999995 789999999999999 678899999999986532
Q ss_pred -CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 278 -QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 278 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 23345679999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=376.10 Aligned_cols=267 Identities=28% Similarity=0.398 Sum_probs=205.2
Q ss_pred eeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEec
Q psy16081 111 IQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLK 187 (493)
Q Consensus 111 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~ 187 (493)
+..++.+.++|++++.||+|+||+||+|.+..+++.||+|++...... ...+..|+.++.. ..|||||+++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~------L~HPNIVrl~ 78 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE------LKHKNIVRYI 78 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHH------cCCCCcCeEE
Confidence 345667788999999999999999999999999999999998743221 2223334444333 3578899999
Q ss_pred eeeee--cceeEEEEEeccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCC-----CCccccCCCCCcEEe
Q psy16081 188 RHFMW--RNHLCLVFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPE-----LNIIHCDLKPENILL 257 (493)
Q Consensus 188 ~~~~~--~~~~~lV~E~~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~-----~~iiHrDlKp~NILl 257 (493)
++|.. ...+||||||+++ +|.++|... ....+++..++.|+.||+.||.|||... .+||||||||+||||
T Consensus 79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 99865 3579999999965 999988642 2246999999999999999999999632 459999999999999
Q ss_pred eCC---------------CCCcEEEEecccccccCCc--cccccccCcCCchhhhcC--CCCCchhhHHHHHHHHHHHHh
Q psy16081 258 CNP---------------KRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHT 318 (493)
Q Consensus 258 ~~~---------------~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt 318 (493)
+.+ ..+.+||+|||++..+... ....+||+.|+|||++.+ ..++.++||||||||||+|++
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 531 2345999999999766432 234579999999999965 458999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCC
Q psy16081 319 GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGR 398 (493)
Q Consensus 319 G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 398 (493)
|.+||...+....+..++......+.
T Consensus 239 Gk~PF~~~~~~~qli~~lk~~p~lpi------------------------------------------------------ 264 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISELKRGPDLPI------------------------------------------------------ 264 (1021)
T ss_pred CCCCCCcCCcHHHHHHHHhcCCCCCc------------------------------------------------------
Confidence 99999876655444333221100000
Q ss_pred cCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 399 RLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 399 ~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.. ....+.+||..||..||.+|||+.|+|.||||.....
T Consensus 265 ------~~--~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 265 ------KG--KSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred ------CC--CCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 00 0016889999999999999999999999999986644
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=340.94 Aligned_cols=276 Identities=32% Similarity=0.533 Sum_probs=210.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|++.+.||+|+||.||+|.+..+|+.||+|+++.... .......|+.++..+ +|+||+++++++.+.+.+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l------~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL------KHKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc------CCCCeeeHHHHhccCCce
Confidence 58899999999999999999999999999999864321 122334455544433 477899999999999999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
|+|+||++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+||++ +.++.+||+|||++...
T Consensus 75 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 75 TLVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLI--NKNGELKLADFGLARAF 149 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEE--cCCCcEEECccchhhcc
Confidence 9999999999999886543 358999999999999999999994 789999999999999 67789999999999765
Q ss_pred CCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPL-FSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... .....+++.|+|||++.+. .++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.++...+....
T Consensus 150 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 150 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh
Confidence 432 2234678899999999875 479999999999999999998776 56677778888888887777655443322
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
....+ ...+ ..+....+.... ...+ .++.+||++||..||.+|||+
T Consensus 230 ~~~~~-~~~~---------------~~~~~~~~~~~~----------------~~~~--~~~~~li~~~l~~~P~~R~t~ 275 (284)
T cd07839 230 KLPDY-KPYP---------------MYPATTSLVNVV----------------PKLN--STGRDLLQNLLVCNPVQRISA 275 (284)
T ss_pred hcccc-cccC---------------CCCCcchhhhhc----------------ccCC--HHHHHHHHHHhcCChhhcCCH
Confidence 11111 0000 000000000000 0011 278899999999999999999
Q ss_pred HHHhcCCCC
Q psy16081 432 YYALQHNFF 440 (493)
Q Consensus 432 ~e~L~Hp~~ 440 (493)
+|+|+||||
T Consensus 276 ~~il~h~~f 284 (284)
T cd07839 276 EEALQHPYF 284 (284)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=354.99 Aligned_cols=259 Identities=26% Similarity=0.380 Sum_probs=201.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... . ......+.++.......+||||+++++.+...+++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-K-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-h-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 46899999999999999999999999999999998642211 0 011111222223333456888999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll--~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEE--CCCCCEEEEeCCceeEc
Confidence 99999965 898888654 48999999999999999999994 799999999999999 67889999999999766
Q ss_pred CCc----cccccccCcCCchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 277 GQR----IYQYIQSRFYRSPEVLLGIP----YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 277 ~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
... ....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+....+.+|.......+
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----- 267 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT----- 267 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc-----
Confidence 432 23567999999999997643 88999999999999999999999999887777666654211100
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC-
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT- 427 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~- 427 (493)
.|... ..+ ..+++||.+||..++.+
T Consensus 268 -----------------------------~~~~~-----------------------~~s--~~~~~li~~~L~~~~~r~ 293 (371)
T cd05622 268 -----------------------------FPDDN-----------------------DIS--KEAKNLICAFLTDREVRL 293 (371)
T ss_pred -----------------------------CCCcC-----------------------CCC--HHHHHHHHHHcCChhhhc
Confidence 00000 001 16789999999844433
Q ss_pred -CCCHHHHhcCCCCCCCc
Q psy16081 428 -RITPYYALQHNFFKRTA 444 (493)
Q Consensus 428 -R~t~~e~L~Hp~~~~~~ 444 (493)
|++++|+++||||+...
T Consensus 294 ~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 294 GRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred CCCCHHHHhcCcccCCCC
Confidence 78999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=333.27 Aligned_cols=252 Identities=34% Similarity=0.498 Sum_probs=203.2
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHH---HHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI---EVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~---e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
|++++.||+|+||+||++.+..+++.||+|++............ |..+++.+ .|+||+++++++.....+|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL------RHPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH------TBTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc------ccccccccccccccccccc
Confidence 78999999999999999999999999999999865433232222 44444443 3677999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+|||++.+ +|.+++... ..+++..+..++.||+.||.+||+ .+|+|+||||+|||+ +.++.++|+|||.+...
T Consensus 75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~--~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILL--DENGEVKLIDFGSSVKL 148 (260)
T ss_dssp EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEE--STTSEEEESSGTTTEES
T ss_pred cccccccccccccccccc--cccccccccccccccccccccccc--ccccccccccccccc--ccccccccccccccccc
Confidence 99999977 999999833 358999999999999999999995 699999999999999 68889999999999753
Q ss_pred ---CCccccccccCcCCchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 277 ---GQRIYQYIQSRFYRSPEVLL-GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 277 ---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
........++..|+|||++. +..++.++||||||+++|+|++|..||......+....+.+.............
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 226 (260)
T PF00069_consen 149 SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS-- 226 (260)
T ss_dssp TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc--
Confidence 33445677899999999998 788999999999999999999999999988555555444443221111100000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
......+.+||.+||..||++|||+.
T Consensus 227 ------------------------------------------------------~~~~~~l~~li~~~l~~~p~~R~~~~ 252 (260)
T PF00069_consen 227 ------------------------------------------------------REKSEELRDLIKKMLSKDPEQRPSAE 252 (260)
T ss_dssp ------------------------------------------------------TTSHHHHHHHHHHHSSSSGGGSTTHH
T ss_pred ------------------------------------------------------chhHHHHHHHHHHHccCChhHCcCHH
Confidence 00012789999999999999999999
Q ss_pred HHhcCCCC
Q psy16081 433 YALQHNFF 440 (493)
Q Consensus 433 e~L~Hp~~ 440 (493)
++++||||
T Consensus 253 ~l~~~~~~ 260 (260)
T PF00069_consen 253 ELLKHPWF 260 (260)
T ss_dssp HHHTSGGG
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.24 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=198.2
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
.|++.++||+|+||+||+|.+..+++.||||.+........ ..+..++.++......+|++|+.+++.+.+.+.+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch--HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 37788999999999999999999999999999864321111 1111112222222333577899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|||+.+ +|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.++|+|||++.....
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEE--CCCCCEEEeeccceeecCC
Confidence 999965 8988886555456999999999999999999999 4799999999999999 6788899999999876532
Q ss_pred --ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhhhhccch
Q psy16081 279 --RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVD---QMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 279 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
......|+..|+|||++.+..++.++|||||||++|+|++|.+||....... ....+.... +.
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~--------- 222 (285)
T cd05630 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QE--------- 222 (285)
T ss_pred CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hh---------
Confidence 2234578999999999999999999999999999999999999998654321 111111100 00
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC---
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT--- 430 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t--- 430 (493)
.+.. .. ...+.+||.+||..||++|||
T Consensus 223 -~~~~-----------------------------------------------~~--~~~~~~li~~~l~~~p~~R~s~~~ 252 (285)
T cd05630 223 -EYSE-----------------------------------------------KF--SPDARSLCKMLLCKDPKERLGCQG 252 (285)
T ss_pred -hcCc-----------------------------------------------cC--CHHHHHHHHHHhhcCHHHccCCCC
Confidence 0000 00 016789999999999999999
Q ss_pred --HHHHhcCCCCCCCcc
Q psy16081 431 --PYYALQHNFFKRTAD 445 (493)
Q Consensus 431 --~~e~L~Hp~~~~~~~ 445 (493)
++|+++||||.+...
T Consensus 253 ~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 253 GGAREVKEHPLFKQINF 269 (285)
T ss_pred CchHHHHcChhhhccCH
Confidence 999999999987533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=349.46 Aligned_cols=258 Identities=28% Similarity=0.385 Sum_probs=218.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce-e
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH-L 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~-~ 196 (493)
.++|..++++|+|+||.+++++++..++.|++|.+........... ....++..+....|||||.+.+.|..++. +
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~---~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR---SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH---HHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence 3679999999999999999999999999999999975543322222 12222222333568889999999999888 9
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
||||+||+| ++.+.+.......++++.+..++.||+.|+.||| +.+|+|||||+.||++ ..++.|||.|||+|+.
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifl--tk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFL--TKDKKVKLGDFGLAKI 155 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhc--cccCceeecchhhhhh
Confidence 999999965 9999998877667999999999999999999999 5789999999999999 6778899999999999
Q ss_pred cCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
++.. ..+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|.+.+....+.+|......|-..+.
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~y----- 230 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMY----- 230 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccc-----
Confidence 8765 35789999999999999999999999999999999999999999999999999999886543322111
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
..++..||..||..+|..||++.
T Consensus 231 ---------------------------------------------------------s~el~~lv~~~l~~~P~~RPsa~ 253 (426)
T KOG0589|consen 231 ---------------------------------------------------------SSELRSLVKSMLRKNPEHRPSAL 253 (426)
T ss_pred ---------------------------------------------------------cHHHHHHHHHHhhcCCccCCCHH
Confidence 01788999999999999999999
Q ss_pred HHhcCCCCCCCc
Q psy16081 433 YALQHNFFKRTA 444 (493)
Q Consensus 433 e~L~Hp~~~~~~ 444 (493)
++|.+|.+....
T Consensus 254 ~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 254 ELLRRPHLLRYL 265 (426)
T ss_pred HHhhChhhhhHH
Confidence 999999998543
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=339.20 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=190.9
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 127 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
||+|+||+||+|.+..+++.||||++...... ......|+.++. ..+|+||+++.++|...+++|+||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~------~l~~~~i~~~~~~~~~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILA------KVHSRFIVSLAYAFQTKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHH------hCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence 69999999999999999999999998643211 112223333332 33578899999999999999999999
Q ss_pred ccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc
Q psy16081 203 LSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279 (493)
Q Consensus 203 ~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~ 279 (493)
+++ +|.+.+... ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++......
T Consensus 75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLL--DNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCCEEEeeCccceecCCC
Confidence 965 887776432 22458999999999999999999994 789999999999999 67888999999999765432
Q ss_pred ---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 280 ---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 280 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.......+..
T Consensus 151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 219 (280)
T cd05608 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT----------- 219 (280)
T ss_pred CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC-----------
Confidence 234578999999999999999999999999999999999999998654322222211110000000
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CH
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TP 431 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~ 431 (493)
.+. ... ..+.+||.+||..||++|| |+
T Consensus 220 -----------------------~~~-----------------------~~~--~~~~~li~~~l~~~P~~R~~~~~~~~ 251 (280)
T cd05608 220 -----------------------YPD-----------------------KFS--PASKSFCEALLAKDPEKRLGFRDGNC 251 (280)
T ss_pred -----------------------Ccc-----------------------cCC--HHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence 000 000 1688999999999999999 89
Q ss_pred HHHhcCCCCCCCc
Q psy16081 432 YYALQHNFFKRTA 444 (493)
Q Consensus 432 ~e~L~Hp~~~~~~ 444 (493)
+++++||||+...
T Consensus 252 ~~~l~h~~~~~~~ 264 (280)
T cd05608 252 DGLRTHPLFRDLN 264 (280)
T ss_pred HHHhcChhhhcCC
Confidence 9999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=346.69 Aligned_cols=202 Identities=30% Similarity=0.424 Sum_probs=168.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|++.++||.|+||.||+|.+..++..+|+|++..... ....+..|+.++.. .+|+||++++++|.+.++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~------l~h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE------CNSPYIVGFYGAFYSDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHH------CCCCcccceeEEEEECCE
Confidence 4689999999999999999999999999999999874321 11233344444433 357889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||+ ..+|+||||||+|||+ +.++.+||+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili--~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILV--NSRGEIKLCDFGVSG 152 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEE--cCCCCEEEeeCCcch
Confidence 9999999955 9999987643 58899999999999999999995 2479999999999999 677889999999997
Q ss_pred ccCCc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy16081 275 QLGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVD 330 (493)
Q Consensus 275 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~ 330 (493)
..... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred hhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 65432 334578999999999999899999999999999999999999998765533
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=337.58 Aligned_cols=287 Identities=29% Similarity=0.489 Sum_probs=215.9
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
+|++.+.||+|+||.||+|.+..+++.||||.++...........+..+..++......+|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 48889999999999999999999999999999975432211111111122222222333578899999999999999999
Q ss_pred EEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc
Q psy16081 200 FELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279 (493)
Q Consensus 200 ~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~ 279 (493)
|||++++|.+++.... ..+++..+..++.||+.||.|||. .||+|+||||+|||+ +.++.++|+|||++......
T Consensus 81 ~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLI--ASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEE--cCCCCEEEccceeeeeccCC
Confidence 9999779999987654 368999999999999999999995 689999999999999 67889999999999776432
Q ss_pred ---cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 280 ---IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 280 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.++...++.+....+........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 223456788999999865 4578999999999999999999999999888888888888777766655443222211
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
+..... ........++ ......+.+||.+||.+||.+|||+.|+|
T Consensus 236 ~~~~~~-----------------~~~~~~~~~~------------------~~~~~~~~~li~~~l~~~P~~R~s~~e~l 280 (298)
T cd07841 236 YVEFKP-----------------FPPTPLKQIF------------------PAASDDALDLLQRLLTLNPNKRITARQAL 280 (298)
T ss_pred cccccc-----------------cCCcchhhhc------------------ccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 111000 0000000000 00112789999999999999999999999
Q ss_pred cCCCCCCCccC
Q psy16081 436 QHNFFKRTADE 446 (493)
Q Consensus 436 ~Hp~~~~~~~~ 446 (493)
+||||+.....
T Consensus 281 ~~~~~~~~~~~ 291 (298)
T cd07841 281 EHPYFSNDPAP 291 (298)
T ss_pred hCccccCCCCC
Confidence 99999975433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=319.62 Aligned_cols=289 Identities=28% Similarity=0.490 Sum_probs=241.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--ce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR--NH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~--~~ 195 (493)
.++|++.+++|+|.|+.||.|.+..++++++||+++..+ .....+|+++++.+. .++||++|++...+. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~-----gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLR-----GGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhcc-----CCCCeeehhhhhcCccccC
Confidence 578999999999999999999999999999999997543 366788888887654 678899999998764 45
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
..||+||+.+.-+..|- ..++.-.++.++.+++.||.|+|| +||+|||+||.|++|+. +.-.++|+|+|+|..
T Consensus 110 paLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh-~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEF 182 (338)
T ss_pred chhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeech-hhceeeeeecchHhh
Confidence 68999999884444332 247888999999999999999996 79999999999999953 566799999999976
Q ss_pred c--CCccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 L--GQRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPL-FSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
. +......+.++.|.-||.+... .|+..-|+|||||+|..|+..+.| |.|.++.|++.+|.+.+|...
T Consensus 183 YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e-------- 254 (338)
T KOG0668|consen 183 YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE-------- 254 (338)
T ss_pred cCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH--------
Confidence 6 4455677889999999999875 489999999999999999987755 579999999999999998642
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcC-CCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRL-GEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
...|.. ++.+..++.+.+|++..+..+|.+.+ .++.|-++. ++.|||.++|.+|..+|+|
T Consensus 255 -l~~Yl~----------------KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~p--eaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 255 -LYAYLN----------------KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSP--EAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred -HHHHHH----------------HHccCCChhHhhHhhccccccHHHhCCccccccCCh--HHHHHHHHHHhhccccccc
Confidence 122332 34566778899999999999998876 556666655 7899999999999999999
Q ss_pred HHHHhcCCCCCCCccCC
Q psy16081 431 PYYALQHNFFKRTADES 447 (493)
Q Consensus 431 ~~e~L~Hp~~~~~~~~~ 447 (493)
|+|++.||||....+..
T Consensus 316 akEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 316 AKEAMAHPYFAPVREAE 332 (338)
T ss_pred hHHHhcCchHHHHHHHh
Confidence 99999999999765543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=357.46 Aligned_cols=279 Identities=23% Similarity=0.301 Sum_probs=202.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
..+|.+.+.||+|+||.||+|.+..+++.||||.... .....|+.++..+ +|+|||++++++...+..|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L------~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRL------SHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHC------CCCCCCcEEEEEEECCEEE
Confidence 3479999999999999999999999999999996432 2344566665544 4778999999999999999
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
+|||++.++|.+++.... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+++...
T Consensus 237 lv~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl--~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 237 LVLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLV--NGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEE--CCCCCEEEcccCCceecc
Confidence 999999999999886543 369999999999999999999994 789999999999999 677889999999997653
Q ss_pred Cc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCC------HHHHHHHHHHHhCCCChh
Q psy16081 278 QR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLF-SGSN------EVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 278 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf-~~~~------~~~~~~~i~~~~~~~p~~ 345 (493)
.. ....+||+.|+|||++.+..++.++|||||||+||||++|..|+ .... ...++.+++...+.....
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 22 12356899999999999999999999999999999999987654 3221 124455555544332211
Q ss_pred hhhhc--cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 346 LLDGA--HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 346 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
+.... .....+..... .... .....+.+.. +. ..+ ..+.+||.+||.+
T Consensus 392 ~~~~~~~~l~~~~~~~~~----~~~~----~~~~~~~~~~---~~-----------------~~~--~~~~dli~~mL~~ 441 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAA----RNRR----PAYTRPAWTR---YY-----------------KLD--LDVEYLVCRALTF 441 (461)
T ss_pred CCCCcchHHHHHHHhhhh----cccC----CccCCcchhh---hc-----------------ccc--chHHHHHHHHccc
Confidence 11000 00000100000 0000 0000000000 00 011 1678999999999
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q psy16081 424 DPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~ 442 (493)
||++|||+.|||+||||+.
T Consensus 442 DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 442 DGARRPSAAELLRLPLFQS 460 (461)
T ss_pred ChhhCcCHHHHhhCcccCC
Confidence 9999999999999999974
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=352.60 Aligned_cols=283 Identities=24% Similarity=0.406 Sum_probs=212.9
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEc--CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDL--EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+..+|++++.||+|+||.||+|... .+++.||||.+.... ....|+.++..+ +|+||+++++.|...
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l------~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTI------SHRAIINLIHAYRWK 158 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhc------CCCCccceeeeEeeC
Confidence 34568999999999999999999754 356889999886432 334566655544 477899999999999
Q ss_pred ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 194 NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 194 ~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
..+|+|||++.++|.+++... ..+++..++.++.||+.||.||| +.|||||||||+|||+ +.++.+||+|||++
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill--~~~~~~~l~DfG~a 232 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFL--DEPENAVLGDFGAA 232 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEE--cCCCCEEEccCccc
Confidence 999999999999999998543 46999999999999999999999 4789999999999999 67889999999999
Q ss_pred cccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChh
Q psy16081 274 CQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN---EVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 274 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~~p~~ 345 (493)
+..... .....||+.|+|||++.+..|+.++|||||||++|||++|..||.+.. ....+..+.+.++..+..
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 766432 234679999999999999999999999999999999999999997654 456777777777665543
Q ss_pred hhhhcc-chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 346 LLDGAH-KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 346 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
...... .....|..... . ..... .+...+.. ... ..++.+||.+||.+|
T Consensus 313 ~~~~~~~~~~~~~~~~~~---~-------~~~~~----~~~~~~~~--------------~~~--~~~~~~li~~ml~~d 362 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAI---V-------LRPPY----TIPPVIRK--------------YGM--HMDVEYLIAKMLTFD 362 (392)
T ss_pred cCCccchhHHHHHHhhcc---c-------ccCCc----cccchhhc--------------cCc--chhHHHHHHHHhccC
Confidence 322111 01111111100 0 00000 00000000 000 126789999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCc
Q psy16081 425 PKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~~~~~ 444 (493)
|++|||+.|+|.||||.+..
T Consensus 363 p~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 363 QEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred hhhCCCHHHHhhCchhhccc
Confidence 99999999999999998643
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=349.93 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=189.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|+++++||+|+||+||+|.+..+++.||||++..... ....+..|+.++ ...+|+||+++++++...+.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l------~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL------RDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHH------HhCCCCCcceeeeEeccCCe
Confidence 3568888999999999999999999999999999864321 112233343333 33457889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+.+ +|.+. ....+..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 147 ~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll--~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLI--NSAKNVKIADFGVSR 216 (353)
T ss_pred EEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEE--cCCCCEEEcccccce
Confidence 9999999966 65432 235677888999999999999994 789999999999999 678899999999997
Q ss_pred ccCCc---cccccccCcCCchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChh
Q psy16081 275 QLGQR---IYQYIQSRFYRSPEVLLG-----IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL-GLPPKH 345 (493)
Q Consensus 275 ~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~ 345 (493)
.+... .....||..|+|||++.. ...+.++|||||||++|||++|+.||......+....+.... ..++.
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 295 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE- 295 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC-
Confidence 66432 235678999999999853 234569999999999999999999997433222211111110 00000
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
. .......+.+||.+||..||
T Consensus 296 --------------------------------~---------------------------~~~~~~~l~~li~~~l~~~P 316 (353)
T PLN00034 296 --------------------------------A---------------------------PATASREFRHFISCCLQREP 316 (353)
T ss_pred --------------------------------C---------------------------CCccCHHHHHHHHHHccCCh
Confidence 0 00001178999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy16081 426 KTRITPYYALQHNFFKRT 443 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~ 443 (493)
++|||+.|+|+||||.+.
T Consensus 317 ~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 317 AKRWSAMQLLQHPFILRA 334 (353)
T ss_pred hhCcCHHHHhcCcccccC
Confidence 999999999999999974
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=344.92 Aligned_cols=247 Identities=27% Similarity=0.443 Sum_probs=192.2
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
++||+|+||+||+|.+..+++.||||+++.... .......|..++.. ..+|++|+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~-----~~~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQ-----ASSNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh-----hcCCCCEeeEEEEEEeCCEEEEEE
Confidence 479999999999999999999999999974321 11222333333332 235788999999999999999999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc---
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--- 276 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~--- 276 (493)
||+.+ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLL--DADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEE--eCCCCEEEeccccceeccCC
Confidence 99955 888887654 359999999999999999999995 789999999999999 67889999999998753
Q ss_pred CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCChhhhhhc
Q psy16081 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE------VDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~------~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... .+.+..+... .+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~------- 220 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KPI------- 220 (327)
T ss_pred CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CCC-------
Confidence 2234457899999999999999999999999999999999999999964221 1111111110 000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
..| ...+ ..+.+||.+||..||.+|++
T Consensus 221 --------------------------~~p-------------------------~~~~--~~~~~li~~~L~~dP~~R~~ 247 (327)
T cd05617 221 --------------------------RIP-------------------------RFLS--VKASHVLKGFLNKDPKERLG 247 (327)
T ss_pred --------------------------CCC-------------------------CCCC--HHHHHHHHHHhccCHHHcCC
Confidence 000 0001 16789999999999999998
Q ss_pred ------HHHHhcCCCCCCCc
Q psy16081 431 ------PYYALQHNFFKRTA 444 (493)
Q Consensus 431 ------~~e~L~Hp~~~~~~ 444 (493)
.+++++||||....
T Consensus 248 ~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 248 CQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred CCCCCCHHHHHcCCCCCCCC
Confidence 47999999999765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.41 Aligned_cols=277 Identities=34% Similarity=0.565 Sum_probs=216.2
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|++++.||.|+||.||+|.+..+++.||||++...... ......|+.++..+ +|+||+++++++.+.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL------NHPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc------CCCCCcchhhhcccCCcE
Confidence 488999999999999999999999999999988643221 12334454444433 477899999999999999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
|+||||+.++|.+++.......+++..+..++.||+.||.|||. .+++|+||+|+||++ +.++.+||+|||++...
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill--~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 75 YLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLI--NTEGAIKLADFGLARAF 150 (284)
T ss_pred EEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--CCCCCEEEeeccchhhc
Confidence 99999998899998876555578999999999999999999994 789999999999999 67889999999998765
Q ss_pred CCc---cccccccCcCCchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
... .....++..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.++.+.+.++.+.++.++..+++....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 151 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 432 22345688899999987654 68899999999999999999999999999899999999888887766554332
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
...+-...+.. ....+.+++. ..+ ..+++||.+||..||.+|||++
T Consensus 231 ~~~~~~~~~~~----------------~~~~~~~~~~----------------~~~--~~~~~li~~~l~~~P~~Rpt~~ 276 (284)
T cd07860 231 LPDYKPSFPKW----------------ARQDFSKVVP----------------PLD--EDGRDLLSQMLHYDPNKRISAK 276 (284)
T ss_pred HHHHHhhcccc----------------cccCHHHHcc----------------cCC--HHHHHHHHHhcCCCcccCCCHH
Confidence 22221111100 0000111100 011 1678999999999999999999
Q ss_pred HHhcCCCC
Q psy16081 433 YALQHNFF 440 (493)
Q Consensus 433 e~L~Hp~~ 440 (493)
++|+||||
T Consensus 277 ~~l~~~~f 284 (284)
T cd07860 277 AALAHPFF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=332.96 Aligned_cols=278 Identities=31% Similarity=0.572 Sum_probs=215.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|++.+.||.|+||.||+|.+..+++.||||++..... .......|+.++. ..+|+||+++++++...+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~------~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQ------ACQHPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHH------hCCCCCCcceeeEEecCCee
Confidence 58899999999999999999999999999999875431 1223333444333 23478899999999999999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
|+|+||++++|.+++.... ..+++..++.++.||+.||.|||+ .|++|+||||+||++ +.++.++|+|||++...
T Consensus 75 ~~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~--~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 75 VLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLI--SADGVLKIADFGLARLF 149 (286)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEE--cCCCcEEEeeeeecccc
Confidence 9999999779999987554 569999999999999999999995 689999999999999 66888999999999776
Q ss_pred CCc----cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQR----IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.++...+..+...++.+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred cCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 433 3345788899999998764 46899999999999999999999999999999999999888877665544322
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
....+ ..+. + .......+.++. .+....+.+||++||..||++|||+
T Consensus 230 ~~~~~-~~~~---~-----------~~~~~~~~~~~~------------------~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 230 SLPDY-NKIT---F-----------PESKPIPLEEIF------------------PDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred Ccchh-hccc---C-----------CCCCcchHHHhC------------------CCccHHHHHHHHHHhccChhhCCCH
Confidence 21111 0000 0 000000011110 0111378999999999999999999
Q ss_pred HHHhcCCCCC
Q psy16081 432 YYALQHNFFK 441 (493)
Q Consensus 432 ~e~L~Hp~~~ 441 (493)
+++|+||||.
T Consensus 277 ~~~l~h~~~~ 286 (286)
T cd07832 277 AEALRHPYFT 286 (286)
T ss_pred HHHhhCcCcC
Confidence 9999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=331.34 Aligned_cols=281 Identities=31% Similarity=0.442 Sum_probs=213.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|.+++.||+|+||.||+|.+..+++.||||++...... ......|..++..+ .|+||+++.+++...+.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL------KHANIVLLHDIIHTKET 77 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc------CCCCEeEEEEEEecCCe
Confidence 46899999999999999999999999999999998643221 12334455444433 46779999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
.|+||||++++|.+.+.... ..+.+..++.++.||+.||.|||. .||+|+||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 78 LTFVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLI--SYLGELKLADFGLARA 152 (291)
T ss_pred EEEEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEE--cCCCcEEEeccccccc
Confidence 99999999889988876543 357888999999999999999995 689999999999999 6788999999999875
Q ss_pred cCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSN-EVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
.... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+ ..+.+..+...++.|...+....
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 153 KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred cCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence 4322 2344578899999999764 58899999999999999999999998654 45677777788887776665544
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.....+........ ....+..+. ........+.+||.+||..||.+|||
T Consensus 233 ~~~~~~~~~~~~~~---------------~~~~~~~~~----------------~~~~~~~~~~~ll~~~l~~dp~~R~t 281 (291)
T cd07870 233 SKLPNYKPEWFLPC---------------KPQQLRVVW----------------KRLSRPPKAEDLASQMLMMFPKDRIS 281 (291)
T ss_pred hhcccccchhcccc---------------CCcchhhhc----------------cccCCChHHHHHHHHHhCcCcccCcC
Confidence 33322222110000 000000000 00111227889999999999999999
Q ss_pred HHHHhcCCCC
Q psy16081 431 PYYALQHNFF 440 (493)
Q Consensus 431 ~~e~L~Hp~~ 440 (493)
+.|++.||||
T Consensus 282 ~~~~l~h~~~ 291 (291)
T cd07870 282 AQDALLHPYF 291 (291)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.51 Aligned_cols=280 Identities=33% Similarity=0.538 Sum_probs=211.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|++.+.||.|+||.||+|.+..+++.||||++..... .......|+.++..+ .+|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l-----~~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQML-----SESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHc-----cCCCCccceeeeEeecCC
Confidence 469999999999999999999999999999998864321 123344455544433 246789999999987666
Q ss_pred -----eEEEEEecccCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 196 -----LCLVFELLSYNLYDLLRNTN---FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 196 -----~~lV~E~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
.|+||||++++|.+++.... ...+++..++.++.||+.||.|||. .||+||||||+||++++ .++.+||
T Consensus 76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~-~~~~~kl 152 (295)
T cd07837 76 NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDK-QKGLLKI 152 (295)
T ss_pred CCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEec-CCCeEEE
Confidence 89999999999998886532 2358999999999999999999994 78999999999999942 3788999
Q ss_pred EecccccccCCc---cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 268 VDFGSSCQLGQR---IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 268 ~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.++.+.+.++...++.++
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred eecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999998765332 223356888999999876 4579999999999999999999999999988888888888777776
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
...+........+... +.. ....+.... ... ...+.+||.+||..
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~----------------~~~~~~~~~----------------~~~--~~~~~~~i~~~l~~ 277 (295)
T cd07837 233 EQVWPGVSKLRDWHEF-PQW----------------KPQDLSRAV----------------PDL--SPEGLDLLQKMLRY 277 (295)
T ss_pred hhhCcchhhccchhhc-Ccc----------------cchhHHHhc----------------ccc--CHHHHHHHHHHccC
Confidence 5554332221111100 000 000000000 001 12688999999999
Q ss_pred CCCCCCCHHHHhcCCCCC
Q psy16081 424 DPKTRITPYYALQHNFFK 441 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~ 441 (493)
||.+|||+.|+|.||||+
T Consensus 278 ~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 278 DPAKRISAKAALTHPYFD 295 (295)
T ss_pred ChhhcCCHHHHhcCCCcC
Confidence 999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.93 Aligned_cols=257 Identities=26% Similarity=0.360 Sum_probs=202.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.|+..+.||+|+||+||+|.+..+++.||+|++...... ......|+.++. ..+|++|+.+.+.+..++.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~------~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILE------KVNSQFVVNLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHH------HcCCcCceeEEEEEecCCE
Confidence 377889999999999999999999999999998643211 112233443333 3356779999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+.+ +|.+++.......+++..+..++.|++.||.|||+ .||+||||||+||++ +.++.+||+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili--~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILL--DDYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEE--CCCCCEEEecCCcce
Confidence 9999999965 88887765544569999999999999999999994 789999999999999 667889999999986
Q ss_pred ccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 275 QLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 275 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... ......|+..|+|||++.+..++.++|+|||||++|+|++|.+||.+.........+............
T Consensus 151 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~----- 225 (285)
T cd05632 151 KIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS----- 225 (285)
T ss_pred ecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccC-----
Confidence 5532 223457899999999999989999999999999999999999999887665544444332111100000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC--
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT-- 430 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t-- 430 (493)
.... ..+.+|+.+||..||++|||
T Consensus 226 ----------------------------------------------------~~~~--~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 226 ----------------------------------------------------AKFS--EEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ----------------------------------------------------ccCC--HHHHHHHHHHccCCHhHcCCCc
Confidence 0000 16789999999999999999
Q ss_pred ---HHHHhcCCCCCCCcc
Q psy16081 431 ---PYYALQHNFFKRTAD 445 (493)
Q Consensus 431 ---~~e~L~Hp~~~~~~~ 445 (493)
+.++++|+||.....
T Consensus 252 ~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 252 EEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred ccChHHHHcChhhhcCCH
Confidence 899999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=332.17 Aligned_cols=284 Identities=32% Similarity=0.543 Sum_probs=219.1
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|++.+.||+|+||+||+|.+..+++.||||.+...... ......|..++.. .+|+||+++++++...++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~------l~h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKE------MQHGNIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHh------ccCCCEeeEEEEEecCCe
Confidence 5799999999999999999999999999999988643211 1233344444333 347789999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
.|+||||++++|.+.+.......+++..++.++.||+.||.|||. .+|+|+||||+||+++. .++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~-~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 76 LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDR-RTNALKLADFGLARA 152 (294)
T ss_pred EEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEEC-CCCEEEEcccccccc
Confidence 999999998899998876554457889999999999999999994 78999999999999942 456799999999976
Q ss_pred cCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+...++....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 153 FGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 5432 2334668899999998764 58899999999999999999999999988888888888888888777766544
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
....+....+. + + ...+... ....+ ..+.+||.+||..||++||++
T Consensus 233 ~~~~~~~~~~~--~-------------~-~~~~~~~----------------~~~~~--~~~~~~i~~~l~~~P~~Rps~ 278 (294)
T PLN00009 233 SLPDYKSAFPK--W-------------P-PKDLATV----------------VPTLE--PAGVDLLSKMLRLDPSKRITA 278 (294)
T ss_pred cchhhhhhccc--C-------------C-CCCHHHh----------------CcCCC--hHHHHHHHHHccCChhhCcCH
Confidence 33333221110 0 0 0000000 00011 168899999999999999999
Q ss_pred HHHhcCCCCCCCcc
Q psy16081 432 YYALQHNFFKRTAD 445 (493)
Q Consensus 432 ~e~L~Hp~~~~~~~ 445 (493)
.++++||||..+..
T Consensus 279 ~~~l~~~~~~~~~~ 292 (294)
T PLN00009 279 RAALEHEYFKDLGD 292 (294)
T ss_pred HHHhcCchHhHHhc
Confidence 99999999997643
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=352.54 Aligned_cols=256 Identities=31% Similarity=0.471 Sum_probs=207.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
+.|+|+..||-|+||.||+|.++.++-..|.|++..+. .....+..|+. +|..+ .||+||+|++.|..++.++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIe---ILa~C---dHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIE---ILAEC---DHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhh---hhhcC---CChHHHHHHHHHhccCceE
Confidence 45788899999999999999999999899999987432 22233333333 33333 3888999999999999999
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc-
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL- 276 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~- 276 (493)
|+.|||+|+-.+.+.-.-.+.+.++.+..+++|++.||.|||+ .+|||||||..|||+ ..+|.|+|+|||.+-..
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~--TldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILL--TLDGDIRLADFGVSAKNK 181 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEE--EecCcEeeecccccccch
Confidence 9999998765554443444789999999999999999999996 689999999999999 68899999999998544
Q ss_pred --CCccccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 277 --GQRIYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 277 --~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
.+....++|||+|||||+.. ..+|+.++||||||++|.||.-+.||-...+++..+.+|.+.- || .++..
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--PP-TLlqP 258 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP-TLLQP 258 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--CC-cccCc
Confidence 34466899999999999986 4579999999999999999999999999999988888887631 11 11100
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
..| -..|.||+.+||..||..||
T Consensus 259 --------------------------------------------S~W-------------s~~F~DfLk~cL~Knp~~Rp 281 (1187)
T KOG0579|consen 259 --------------------------------------------SHW-------------SRSFSDFLKRCLVKNPRNRP 281 (1187)
T ss_pred --------------------------------------------chh-------------hhHHHHHHHHHHhcCCccCC
Confidence 000 01789999999999999999
Q ss_pred CHHHHhcCCCCCCCc
Q psy16081 430 TPYYALQHNFFKRTA 444 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~ 444 (493)
++.|+|+||||+...
T Consensus 282 ~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 282 PAAQLLKHPFVQNAP 296 (1187)
T ss_pred CHHHHhhCcccccCC
Confidence 999999999999553
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=336.32 Aligned_cols=283 Identities=32% Similarity=0.470 Sum_probs=216.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec-
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR- 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~- 193 (493)
.++|++.+.||.|+||.||+|.+..+|+.||+|+++..... ......|+.++..+ +|+||+++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~ 79 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL------RHPNIVELKEVVVGKH 79 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC------CCCCCcceEEEEecCC
Confidence 56899999999999999999999999999999998643211 12233455544433 467799999998755
Q ss_pred -ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 -NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 -~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||++++|.+++.... ..+++..+..++.||+.||.|||+ .|++||||||+||++ +.++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~--~~~~~~kL~dfg~ 154 (309)
T cd07845 80 LDSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLL--TDKGCLKIADFGL 154 (309)
T ss_pred CCeEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--CCCCCEEECccce
Confidence 5689999999989998887543 468999999999999999999995 789999999999999 6788999999999
Q ss_pred ccccCCc---cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 273 SCQLGQR---IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 273 a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
+...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+...++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 155 ARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred eeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 9776432 223345778999999876 458999999999999999999999999999999999999998888766554
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
....... .+.+.+.. .+. ..+.... ......+.|||.+||.+||++|
T Consensus 235 ~~~~~~~------~~~~~~~~--------~~~-~~~~~~~------------------~~~~~~~~~li~~ml~~dp~~R 281 (309)
T cd07845 235 GFSDLPL------VGKFTLPK--------QPY-NNLKHKF------------------PWLSEAGLRLLNFLLMYDPKKR 281 (309)
T ss_pred hhhcccc------cccccccC--------CCC-CchHHhc------------------cccCHHHHHHHHHHhcCChhhC
Confidence 3221100 00000000 000 0000000 0001267899999999999999
Q ss_pred CCHHHHhcCCCCCCCc
Q psy16081 429 ITPYYALQHNFFKRTA 444 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~~ 444 (493)
||++|+|+||||+...
T Consensus 282 ~t~~~il~h~~f~~~~ 297 (309)
T cd07845 282 ATAEEALESSYFKEKP 297 (309)
T ss_pred cCHHHHhcChhhccCC
Confidence 9999999999998543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.40 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=202.3
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc--
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN-- 194 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~-- 194 (493)
..++|.+.++||+|+||+||+|.+..+++.||||++........... ....++......+|++|+++...+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~---~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN---RAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHH---HHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 34689999999999999999999999999999999875432212211 1222233333446788999888775432
Q ss_pred ------eeEEEEEecc-cCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 195 ------HLCLVFELLS-YNLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 195 ------~~~lV~E~~~-~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
.+++||||+. |+|.+++... ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl--~~~~~v 182 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILL--CSNGLV 182 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEE--eCCCCE
Confidence 4789999996 4999988643 23468999999999999999999995 789999999999999 678899
Q ss_pred EEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy16081 266 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340 (493)
Q Consensus 266 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 340 (493)
||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..+.....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999999765432 2356799999999999999999999999999999999999999998877666555543111
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
.+ + +. .. ...+.+||.+|
T Consensus 263 ~~-----------------~--------------------~~-----------------------~~--~~~l~~li~~~ 280 (496)
T PTZ00283 263 DP-----------------L--------------------PP-----------------------SI--SPEMQEIVTAL 280 (496)
T ss_pred CC-----------------C--------------------CC-----------------------CC--CHHHHHHHHHH
Confidence 00 0 00 00 01688999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
|..||.+|||+.++|+|||++..
T Consensus 281 L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 281 LSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred cccChhhCcCHHHHHhCHHHHHh
Confidence 99999999999999999998754
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=333.41 Aligned_cols=254 Identities=29% Similarity=0.447 Sum_probs=207.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
+-|.++.+||+|+||.||+|.++.+|..+|||.+... ...+..++.+.+++.++ .+++|+.++.|.....+++
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~---S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCK---SKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcC---CchhhhhhhhhccCCceEe
Confidence 3588999999999999999999999999999988643 34444555556666665 4569999999999999999
Q ss_pred EEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|||||+ |++.+.++..+ ..++++++..+++.-+.||.||| ...-||||||..|||+ +.+|..||+|||.|.++.
T Consensus 106 VMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILL--NT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILL--NTDGIAKLADFGVAGQLT 180 (502)
T ss_pred ehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEE--cccchhhhhhccccchhh
Confidence 999995 58888887554 67999999999999999999999 4678999999999999 788999999999998886
Q ss_pred Cc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 278 QR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 278 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.. ..+.+|||+|||||++...+|+.++||||||+...||..|+|||..-.++..+-.| -..||..
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPT--------- 248 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPT--------- 248 (502)
T ss_pred hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCC---------
Confidence 54 45789999999999999999999999999999999999999999875543221111 0111110
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
-+..+ .+++ +|.|||++||...|++|-|+.++
T Consensus 249 -------------------------------------------F~KPE---~WS~--~F~DFi~~CLiK~PE~R~TA~~L 280 (502)
T KOG0574|consen 249 -------------------------------------------FKKPE---EWSS--EFNDFIRSCLIKKPEERKTALRL 280 (502)
T ss_pred -------------------------------------------CCChH---hhhh--HHHHHHHHHhcCCHHHHHHHHHH
Confidence 00001 1112 78999999999999999999999
Q ss_pred hcCCCCCCCc
Q psy16081 435 LQHNFFKRTA 444 (493)
Q Consensus 435 L~Hp~~~~~~ 444 (493)
++|||++...
T Consensus 281 ~~H~FiknA~ 290 (502)
T KOG0574|consen 281 CEHTFIKNAP 290 (502)
T ss_pred hhhhhhcCCC
Confidence 9999998654
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=329.82 Aligned_cols=281 Identities=31% Similarity=0.499 Sum_probs=213.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|++.+.||.|+||.||+|.+..+++.||||.+...... ......|+.++..+ +|+||+++++++...++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL------KHANIVTLHDIIHTKKT 77 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC------CCcceeeEEEEEecCCe
Confidence 46899999999999999999999999999999998643211 12333455544433 47789999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
.|+||||++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 78 LTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLI--SERGELKLADFGLARA 152 (291)
T ss_pred EEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEE--cCCCCEEECccccccc
Confidence 99999999999999887654 36899999999999999999999 4789999999999999 6788999999999865
Q ss_pred cCCc---cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSN-EVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.. ..+++..+.+.++.+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 153 KSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred cCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 4321 122346788999999876 458999999999999999999999998766 56777778888887766655443
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.....+..... .......+...+ ........+.+||.+||..||++|||
T Consensus 233 ~~~~~~~~~~~---------------~~~~~~~~~~~~----------------~~~~~~~~~~~li~~~L~~~p~~Rps 281 (291)
T cd07844 233 SSNPEFKPYSF---------------PFYPPRPLINHA----------------PRLDRIPHGEELALKFLQYEPKKRIS 281 (291)
T ss_pred hhccccccccc---------------cccCChhHHHhC----------------cCCCCchhHHHHHHHHhccCcccccC
Confidence 32222111100 000000000000 00111126789999999999999999
Q ss_pred HHHHhcCCCC
Q psy16081 431 PYYALQHNFF 440 (493)
Q Consensus 431 ~~e~L~Hp~~ 440 (493)
+.|+|+||||
T Consensus 282 ~~e~l~~~~f 291 (291)
T cd07844 282 AAEAMKHPYF 291 (291)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.03 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=191.7
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 127 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
||+|+||+||++.+..+|+.||+|++...... ......|..++. ..+||||+++.+.+....++|+||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~------~l~hp~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE------KVNSPFIVNLAYAFESKTHLCLVMSL 74 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHH------hcCCCcEEEEEEEEecCCeEEEEEec
Confidence 69999999999999999999999998642211 111222433333 33578899999999999999999999
Q ss_pred ccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc--
Q psy16081 203 LSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-- 279 (493)
Q Consensus 203 ~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~-- 279 (493)
+.+ +|.+++.......+++..+..++.||+.||.||| +.||+||||||+|||+ +.++.++|+|||++......
T Consensus 75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili--~~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLL--DDQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEE--cCCCCEEEeeceeeeecCCCce
Confidence 965 8888886655456899999999999999999999 5799999999999999 67888999999998766432
Q ss_pred cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhcc
Q psy16081 280 IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~ 359 (493)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+....-.. .
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------~ 214 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED----------------E 214 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----------------c
Confidence 234578999999999999899999999999999999999999997654321111111110000 0
Q ss_pred CCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH----HHHh
Q psy16081 360 MPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP----YYAL 435 (493)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~----~e~L 435 (493)
.. . ...... .++.|||.+||..||++|||+ ++++
T Consensus 215 ~~----------------~------------------------~~~~~~--~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 215 VK----------------F------------------------EHQNFT--EESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cc----------------c------------------------ccccCC--HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 00 0 000001 168999999999999999999 7788
Q ss_pred cCCCCCCCc
Q psy16081 436 QHNFFKRTA 444 (493)
Q Consensus 436 ~Hp~~~~~~ 444 (493)
.||||..+.
T Consensus 253 ~h~~f~~~~ 261 (277)
T cd05607 253 KHEFFKTIN 261 (277)
T ss_pred cChhhcCCC
Confidence 999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=363.60 Aligned_cols=295 Identities=22% Similarity=0.326 Sum_probs=205.8
Q ss_pred eeccceecCcEEEeeeEeeeCCeEEEEEEEcCCC-eEEEEE------------------EEccCcccchHHHHHHHHHHH
Q psy16081 111 IQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQ-CHVAIK------------------IIKNKKPFLNQAQIEVKLLEI 171 (493)
Q Consensus 111 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vAvK------------------~~~~~~~~~~~~~~e~~~~~~ 171 (493)
+..+..+.++|+++++||+|+||+||+|..+... ..+++| .+.........+..|+.++.
T Consensus 140 ~~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~- 218 (501)
T PHA03210 140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG- 218 (501)
T ss_pred cccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHH-
Confidence 3445667789999999999999999998764432 222222 11111111222333444333
Q ss_pred HhhcCCCCcceEEEeceeeeecceeEEEEEecccCHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhCCCCCcccc
Q psy16081 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF---RGVSLNLTRKFSQQLCTALLFLSTPELNIIHC 248 (493)
Q Consensus 172 l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHr 248 (493)
..+|+||+++++++...+..|+|+|++.++|++++..... .......++.++.||+.||.|||+ .|||||
T Consensus 219 -----~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHr 291 (501)
T PHA03210 219 -----RLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHR 291 (501)
T ss_pred -----hCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecC
Confidence 3357889999999999999999999999999988764331 123466788899999999999995 789999
Q ss_pred CCCCCcEEeeCCCCCcEEEEecccccccCCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC-C
Q psy16081 249 DLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPL-F 323 (493)
Q Consensus 249 DlKp~NILl~~~~~~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p-f 323 (493)
||||+|||+ +.++.+||+|||++..+... ....+||+.|+|||++.+..|+.++|||||||+||||++|..+ |
T Consensus 292 DLKP~NILl--~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 292 DIKLENIFL--NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCHHHEEE--CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 999999999 67889999999999776432 2346799999999999999999999999999999999998754 4
Q ss_pred CC--CCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCC
Q psy16081 324 SG--SNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401 (493)
Q Consensus 324 ~~--~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 401 (493)
.. .+...++.+++..++.+...+.+... .+|+.+....+.. ....+..++... .
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~i~~~~~~~------------~~~~~~~~~~~~-~-------- 425 (501)
T PHA03210 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPC---KLFDYIDSAEIDH------------AGHSVPPLIRNL-G-------- 425 (501)
T ss_pred cCCCCCHHHHHHHHHHhcccChhhcCCcHH---HHHHHhhhhhccc------------CccchhhHHHhc-C--------
Confidence 32 34556777777766655443322211 1222211111100 000111111100 0
Q ss_pred CCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 402 ~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
. ...+.++|.+||.+||.+|||+.|+|+||||.....+
T Consensus 426 -----~--~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 426 -----L--PADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred -----C--ChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCch
Confidence 0 1167899999999999999999999999999875433
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.38 Aligned_cols=252 Identities=25% Similarity=0.286 Sum_probs=201.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCC-CeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEE-QCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+...... ...+..|+ ..+...+||||++++++|...+++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~------~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSEL------HCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHH------HHHHhCCCCCEeEEEEEEEECCEE
Confidence 4599999999999999999998877 788999976533211 11222233 333345688899999999999999
Q ss_pred EEEEEecc-cCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 197 CLVFELLS-YNLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 197 ~lV~E~~~-~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
||||||+. ++|.+++... ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll--~~~~~~kL~DFgla 216 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFL--MPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEE--CCCCcEEEEeCcCc
Confidence 99999995 5998877542 22358899999999999999999995 789999999999999 67889999999999
Q ss_pred cccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 274 CQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 274 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+.
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~----- 291 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF----- 291 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence 876432 2345799999999999999999999999999999999999999998877766665543211000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
+. ..+ ..+.+||.+||..||++|
T Consensus 292 --------------------------------~~-----------------------~~s--~~~~~li~~~L~~dP~~R 314 (478)
T PTZ00267 292 --------------------------------PC-----------------------PVS--SGMKALLDPLLSKNPALR 314 (478)
T ss_pred --------------------------------Cc-----------------------cCC--HHHHHHHHHHhccChhhC
Confidence 00 000 168899999999999999
Q ss_pred CCHHHHhcCCCCCC
Q psy16081 429 ITPYYALQHNFFKR 442 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~ 442 (493)
||+.++|.|+|++.
T Consensus 315 ps~~~~l~~~~~~~ 328 (478)
T PTZ00267 315 PTTQQLLHTEFLKY 328 (478)
T ss_pred cCHHHHHhCHHHHH
Confidence 99999999999864
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=326.75 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=198.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
+.|++.+.||+|+||.||+|.+..+++.||||.+...............+..++......+|+||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46899999999999999999999999999999986432211111111122222333334468889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+||+.+ +|.+++.... .+++..++.++.|++.||.||| +.||+||||||+||++ +.++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv--~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILR--DSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE--cCCCCEEEeecccceecc
Confidence 9999965 8988887553 5899999999999999999999 5799999999999999 677889999999987553
Q ss_pred Ccc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 278 QRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 278 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... ....++..|+|||++.+..++.++|||||||++|+|++|++||...+.......+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 226 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--------- 226 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC---------
Confidence 211 23567889999999999899999999999999999999999998765554443332210000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
..+ .... ..+.+||.+||..||.+|||+
T Consensus 227 -------------------------~~~-------------------------~~~~--~~~~~li~~~l~~~p~~Rpt~ 254 (263)
T cd06625 227 -------------------------QLP-------------------------SHVS--PDARNFLRRTFVENAKKRPSA 254 (263)
T ss_pred -------------------------CCC-------------------------ccCC--HHHHHHHHHHhhcCcccCCCH
Confidence 000 0000 167899999999999999999
Q ss_pred HHHhcCCCC
Q psy16081 432 YYALQHNFF 440 (493)
Q Consensus 432 ~e~L~Hp~~ 440 (493)
.|+|+||||
T Consensus 255 ~~ll~~~~~ 263 (263)
T cd06625 255 EELLRHFFV 263 (263)
T ss_pred HHHhhCCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=329.66 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=199.0
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec---
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR--- 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~--- 193 (493)
..+.|++.+.||+|+||+||+|.+..+++.||+|++............|+.++..+ .+|+||+++++.|...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~-----~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKY-----SHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHh-----cCCCCeeeEeeEEeecCCC
Confidence 45679999999999999999999999999999999975543334455555555433 2578899999998753
Q ss_pred ---ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 194 ---NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 194 ---~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
..+|+||||+++ +|.+++.......+++..+..++.|++.||.|||+ .+|+|+||||+||++ ++++.+||+|
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili--~~~~~~~l~D 154 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLL--TENAEVKLVD 154 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEE--CCCCCEEEcc
Confidence 468999999965 99998876544568999999999999999999995 689999999999999 6788899999
Q ss_pred cccccccCC---ccccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 270 FGSSCQLGQ---RIYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 270 FG~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
||++..... ......|+..|+|||++. +..++.++|||||||++|||++|..||...........+...
T Consensus 155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~--- 231 (272)
T cd06637 155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--- 231 (272)
T ss_pred CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---
Confidence 999976533 233467889999999986 345889999999999999999999999765543332221110
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
+. ... . ..... ..+.+||.+||
T Consensus 232 ~~--------------~~~-------------------~-----------------------~~~~~--~~~~~li~~~l 253 (272)
T cd06637 232 PA--------------PRL-------------------K-----------------------SKKWS--KKFQSFIESCL 253 (272)
T ss_pred CC--------------CCC-------------------C-----------------------CCCcC--HHHHHHHHHHc
Confidence 00 000 0 00000 16889999999
Q ss_pred CCCCCCCCCHHHHhcCCCC
Q psy16081 422 DYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~Hp~~ 440 (493)
..||.+|||+.++++||||
T Consensus 254 ~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 254 VKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCChhhCCCHHHHhhCCCC
Confidence 9999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.95 Aligned_cols=279 Identities=31% Similarity=0.498 Sum_probs=206.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+..|+.++..+ .|+||+++++.+.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL------KHPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC------CCCCEeeeeeEEeeCCE
Confidence 479999999999999999999999999999998864321 122334455544433 46789999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|+||||+++++++.+.... ..+++..++.++.||+.||.|||+ .||+|+||||+||++ +.++.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~ 149 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILI--TKQGQIKLCDFGFARI 149 (286)
T ss_pred EEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEE--cCCCcEEECcccccee
Confidence 99999999886555544332 358999999999999999999994 789999999999999 6778999999999976
Q ss_pred cCCc---cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+...........
T Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 150 LTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 6433 234567889999999876 458899999999999999999999999988878777777665533221111100
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
...|+... ..+.......+... .... ...+.+||.+||..||++|||+
T Consensus 230 -~~~~~~~~----------------~~~~~~~~~~~~~~-------------~~~~--~~~~~~li~~~l~~~p~~Rp~~ 277 (286)
T cd07847 230 -TNQFFKGL----------------SIPEPETREPLESK-------------FPNI--SSPALSFLKGCLQMDPTERLSC 277 (286)
T ss_pred -cccccccc----------------cCCCcccccCHHHH-------------hccC--CHHHHHHHHHHhcCCccccCCH
Confidence 00111100 00000000000000 0001 1268899999999999999999
Q ss_pred HHHhcCCCC
Q psy16081 432 YYALQHNFF 440 (493)
Q Consensus 432 ~e~L~Hp~~ 440 (493)
.|++.||||
T Consensus 278 ~eil~~~~f 286 (286)
T cd07847 278 EELLEHPYF 286 (286)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=328.98 Aligned_cols=277 Identities=34% Similarity=0.562 Sum_probs=209.6
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--ceeEE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR--NHLCL 198 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~--~~~~l 198 (493)
|++.+.||+|+||.||+|.+..+++.||+|+++........... ...+..+ ....+|+||+++++++.+. +.+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~-~~e~~~l--~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQAL--RRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhH-HHHHHHH--hhcCCCCCccceEEEEecCCCCcEEE
Confidence 67889999999999999999999999999998753222121111 1111112 2233588899999999987 89999
Q ss_pred EEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 199 VFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 199 V~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
||||++++|.+.+.... ..+++..++.++.||+.||.|||. .|++||||||+||++ +. +.+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l--~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILI--KD-DILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEE--cC-CCeEEEeccccccccc
Confidence 99999999999887643 368999999999999999999994 789999999999999 45 8999999999976643
Q ss_pred c--cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 279 R--IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 279 ~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
. .....++..|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+.+.++.++..+.......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS-- 229 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc--
Confidence 2 234567889999998754 45789999999999999999999999999999999999998888877663221111
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
....+.... .....+..+.. .....+.+||.+||..||++|||++++|
T Consensus 230 -----~~~~~~~~~---------~~~~~~~~~~~------------------~~~~~~~~li~~~l~~~P~~R~~~~~~l 277 (282)
T cd07831 230 -----RHMNYNFPS---------KKGTGLRKLLP------------------NASAEGLDLLKKLLAYDPDERITAKQAL 277 (282)
T ss_pred -----ccccccCcc---------cccccHHHHcc------------------cccHHHHHHHHHHhccCcccccCHHHHh
Confidence 000000000 00000000000 0012789999999999999999999999
Q ss_pred cCCCC
Q psy16081 436 QHNFF 440 (493)
Q Consensus 436 ~Hp~~ 440 (493)
+||||
T Consensus 278 ~~~~~ 282 (282)
T cd07831 278 RHPYF 282 (282)
T ss_pred hCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=339.13 Aligned_cols=258 Identities=28% Similarity=0.388 Sum_probs=209.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+.|..-++||+||||.|+-|+.+.||+.||+|.+.++. ....-...|..+++.++ .++||.+-..|+..+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~------s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS------SPFIVSLAYAFETKD 258 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc------cCcEEEEeeeecCCC
Confidence 56888899999999999999999999999999886432 23344455666665543 447999999999999
Q ss_pred eeEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+||||..| +|+|.=.|.+.+..++++..++.++.+|+.||.+|| ..+||+|||||+|||| |+.|+|+|+|+|+|
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILL--Dd~GhvRISDLGLA 334 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILL--DDHGHVRISDLGLA 334 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheee--ccCCCeEeeccceE
Confidence 999999999 458877776666678999999999999999999999 5899999999999999 89999999999999
Q ss_pred cccC--CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 274 CQLG--QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 274 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
+.+. +.....+||.+|||||++.+..|+...|+|||||+||||+.|+.||....+..-...+....-..+....
T Consensus 335 vei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~---- 410 (591)
T KOG0986|consen 335 VEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS---- 410 (591)
T ss_pred EecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----
Confidence 8874 4566779999999999999999999999999999999999999999865543333222222111111100
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC-
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT- 430 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t- 430 (493)
. ..++ ++++|++.+|..||.+|+-
T Consensus 411 ------------------------------~-----------------------kFS~--eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 411 ------------------------------D-----------------------KFSE--EAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ------------------------------c-----------------------ccCH--HHHHHHHHHHccCHHHhccC
Confidence 0 0111 7899999999999999985
Q ss_pred ----HHHHhcCCCCCCCcc
Q psy16081 431 ----PYYALQHNFFKRTAD 445 (493)
Q Consensus 431 ----~~e~L~Hp~~~~~~~ 445 (493)
++++-+||||+.+..
T Consensus 436 rg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 436 RGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred CCcCcchhhhCcccccCCH
Confidence 579999999997654
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=336.73 Aligned_cols=285 Identities=31% Similarity=0.510 Sum_probs=210.7
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcC--CCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLE--EQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+|++.++||+|+||.||+|.+.. +++.||||++.... ........|+.++.. .+||||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~------l~h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE------LKHENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHh------cCCCCccceEEEEeCC
Confidence 58899999999999999999988 89999999997532 122333444444433 3477899999999988
Q ss_pred --ceeEEEEEecccCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC----CCc
Q psy16081 194 --NHLCLVFELLSYNLYDLLRNTN---FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK----RSA 264 (493)
Q Consensus 194 --~~~~lV~E~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~----~~~ 264 (493)
+.+|+||||++++|.+++.... ...+++..++.++.||+.||.|||+ .+|+||||||+|||+ +. ++.
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~--~~~~~~~~~ 150 (316)
T cd07842 75 ADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILV--MGEGPERGV 150 (316)
T ss_pred CCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEE--cCCCCccce
Confidence 8899999999998888775332 1258999999999999999999994 789999999999999 55 788
Q ss_pred EEEEecccccccCCcc------ccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------
Q psy16081 265 IKIVDFGSSCQLGQRI------YQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEV-------- 329 (493)
Q Consensus 265 ikL~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~-------- 329 (493)
+||+|||++....... ...+++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 9999999997654322 234678889999998774 5899999999999999999999999865532
Q ss_pred -HHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcc
Q psy16081 330 -DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVS 408 (493)
Q Consensus 330 -~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 408 (493)
..+..+++.++.+....+........+...... ......+. ..+....... ..
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~-~~~~~~~~~~---------------~~ 284 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKD----------FKTKTYPS-NSLAKWMEKH---------------KK 284 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhh----------ccCCCCCC-ccHHHHHHhc---------------cC
Confidence 456777777777766655443332222111000 00000000 1111111100 01
Q ss_pred hhhhHHHHHhHccCCCCCCCCCHHHHhcCCCC
Q psy16081 409 DYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 409 ~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~ 440 (493)
....+.+||.+||.+||++|||+.|+++||||
T Consensus 285 ~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 285 PDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 11268999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=337.94 Aligned_cols=283 Identities=32% Similarity=0.527 Sum_probs=213.8
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec-
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR- 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~- 193 (493)
+.++|++.++||+|+||.||+|.+..+++.||||++..... .......|+.++.. .+|+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~------l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRR------FKHENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHh------CCCCCcCchhheeeccc
Confidence 35789999999999999999999999999999999863221 11222333333333 3477899999876644
Q ss_pred ----ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 194 ----NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 194 ----~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
.++|+|+||++++|.+.+... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill--~~~~~~kl~d 149 (336)
T cd07849 77 FESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLL--NTNCDLKICD 149 (336)
T ss_pred ccccceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEE--CCCCCEEECc
Confidence 358999999999998888653 58999999999999999999995 789999999999999 6788999999
Q ss_pred cccccccCCc------cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 270 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 270 FG~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
||++...... .....|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++.+
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~ 229 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9998765321 123568899999999765 468999999999999999999999999998888888888888877
Q ss_pred Chhhhhhccc--hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 343 PKHLLDGAHK--TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 343 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
+...+..... ...++...+... ...+..++ ......+.+||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~------------------~~~~~~~~~li~~~ 275 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKP----------------KVPWNKLF------------------PNADPKALDLLDKM 275 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCC----------------cccHHHHh------------------cccCcHHHHHHHHH
Confidence 6554432111 111111111000 00000000 00112688999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
|..||++|||+.|+++||||....+.
T Consensus 276 l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 276 LTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred cCCChhhCcCHHHHhcCccccccCCC
Confidence 99999999999999999999977554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=331.60 Aligned_cols=282 Identities=31% Similarity=0.476 Sum_probs=210.5
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ......|+.++. ...||+|+++++++...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~------~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQ------LLKHENVVNLIEICRTK 83 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHH------hCCCCCccceEEEEecc
Confidence 346899999999999999999999999999999988643211 112233444333 33477799999988654
Q ss_pred c--------eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 194 N--------HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 194 ~--------~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
. ..|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .|++|+||||+||++ +.++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~--~~~~~~ 158 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILI--TKDGIL 158 (310)
T ss_pred cccccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEE--CCCCcE
Confidence 3 459999999999998886543 358999999999999999999995 689999999999999 678899
Q ss_pred EEEecccccccCCc-------cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q psy16081 266 KIVDFGSSCQLGQR-------IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337 (493)
Q Consensus 266 kL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 337 (493)
||+|||++...... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999765322 1234567889999998765 478999999999999999999999999988888888888
Q ss_pred HhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHH
Q psy16081 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417 (493)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi 417 (493)
..+..+..+++..... ..++.... . .. ........+ ........+.|||
T Consensus 239 ~~~~~~~~~~~~~~~~-~~~~~~~~-----~--~~-------~~~~~~~~l----------------~~~~~~~~~~dli 287 (310)
T cd07865 239 LCGSITPEVWPGVDKL-ELFKKMEL-----P--QG-------QKRKVKERL----------------KPYVKDPHALDLI 287 (310)
T ss_pred HhCCCChhhcccccch-hhhhhccC-----C--Cc-------cchhhHHhc----------------ccccCCHHHHHHH
Confidence 7777766655443221 11111100 0 00 000000000 0000112678999
Q ss_pred hHccCCCCCCCCCHHHHhcCCCC
Q psy16081 418 FRMLDYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 418 ~~mL~~dP~~R~t~~e~L~Hp~~ 440 (493)
.+||..||.+|||++|+|+||||
T Consensus 288 ~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 288 DKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHhcCChhhccCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=338.26 Aligned_cols=202 Identities=20% Similarity=0.229 Sum_probs=159.3
Q ss_pred EeeeEeee--CCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 123 IDSLIGKG--SFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 123 ~~~~LG~G--~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
++++||+| +|++||++.+..+|+.||||++......... ...+.+++......+||||++++++|..++.+|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEM---VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHH---HHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 56789999 7899999999999999999998743211111 111222222333446888999999999999999999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~ 279 (493)
||+.+ +|.+++.......+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.++++|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~--~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILI--SVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEE--ecCCcEEEcccchhhccccc
Confidence 99965 89998876544568999999999999999999994 789999999999999 67788999999875433110
Q ss_pred ----------cccccccCcCCchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy16081 280 ----------IYQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ 331 (493)
Q Consensus 280 ----------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~ 331 (493)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 112345677999999986 4689999999999999999999999987655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=328.33 Aligned_cols=276 Identities=33% Similarity=0.563 Sum_probs=215.7
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
|++.+.||.|++|+||+|.+..+|..||||++..... .......|+.++..+ +|++|+++++++.+.+..|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l------~~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL------NHPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc------CCCCccCHhheeccCCeEE
Confidence 6778999999999999999999999999999874321 112334455444433 4778999999999999999
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
+||||++++|.+++.......+++..+..++.||+.||.|||. .+++|+||+|+||++ +.++.++|+|||++....
T Consensus 75 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~--~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 75 LVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLI--DREGALKLADFGLARAFG 150 (283)
T ss_pred EEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEE--cCCCcEEEeecccccccC
Confidence 9999998899998876544468999999999999999999995 689999999999999 568899999999997654
Q ss_pred Ccc---ccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 278 QRI---YQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 278 ~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... ....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++.+..+.+....+......
T Consensus 151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 151 VPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred CCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 321 233568889999998764 5789999999999999999999999999988888888888888877766554333
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
..+....+..... ..... ....+ ..+.+||.+||+.||.+|||++|
T Consensus 231 ~~~~~~~~~~~~~----------------~~~~~----------------~~~~~--~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 231 PDYKPTFPKWARQ----------------DLSKV----------------VPNLD--EDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred hhhhhhccccccc----------------chhhh----------------cCCCC--HHHHHHHHHHhcCChhhCcCHHH
Confidence 3332222211000 00000 00011 26889999999999999999999
Q ss_pred HhcCCCC
Q psy16081 434 ALQHNFF 440 (493)
Q Consensus 434 ~L~Hp~~ 440 (493)
+++||||
T Consensus 277 il~~~~~ 283 (283)
T cd07835 277 ALQHPYF 283 (283)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=330.21 Aligned_cols=280 Identities=33% Similarity=0.498 Sum_probs=214.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR-- 193 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~-- 193 (493)
++|++.+.||.|+||.||+|.+..+++.||+|.++..... ......|..++..+ .|+||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL------QHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc------CCCCEEEEEEEEEecCC
Confidence 5799999999999999999999999999999999743221 11223344433332 478899999999877
Q ss_pred ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 194 NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 194 ~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
+.+|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+|+||||+|||+ +.++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili--~~~~~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLL--NNRGILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEE--CCCCcEEEeecCce
Confidence 8999999999989999887644 368999999999999999999995 689999999999999 67889999999999
Q ss_pred cccCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 274 CQLGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 274 ~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
...... .....+++.|+|||++.+. .++.++|||||||++|+|++|.+||......+.+.++...++.++...++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred eeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 776543 2345678889999999765 468999999999999999999999999999999999999888887766654
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.......... .+ .......+...+. ...+. ..+.+||++||..||++||
T Consensus 234 ~~~~~~~~~~----~~-----------~~~~~~~~~~~~~--------------~~~~~--~~~~~li~~~l~~~p~~R~ 282 (293)
T cd07843 234 FSELPGAKKK----TF-----------TKYPYNQLRKKFP--------------ALSLS--DNGFDLLNRLLTYDPAKRI 282 (293)
T ss_pred hhccchhccc----cc-----------ccccchhhhcccc--------------ccCCC--hHHHHHHHHHhccCccccC
Confidence 3221111000 00 0000000000000 00011 2678999999999999999
Q ss_pred CHHHHhcCCCC
Q psy16081 430 TPYYALQHNFF 440 (493)
Q Consensus 430 t~~e~L~Hp~~ 440 (493)
|+.|+|+||||
T Consensus 283 t~~ell~~~~f 293 (293)
T cd07843 283 SAEDALKHPYF 293 (293)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=320.52 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=201.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.......... .....++......+|+||+++++++...+..|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER---EEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHH---HHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 4788999999999999999999999999999986432211111 1222222333344688899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|||+.+ +|.+++.......+++..+..++.||+.||.||| +.||+|+||||+||++ +.++.++|+|||++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili--~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEE--eCCCCEEEcccccceeccC
Confidence 999965 9999987754457899999999999999999999 4799999999999999 5678899999999876643
Q ss_pred c---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 279 R---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 279 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
. .....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+......+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 222 (256)
T cd08529 154 NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS----------- 222 (256)
T ss_pred ccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----------
Confidence 2 22446888999999999999999999999999999999999999988766555554331100000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
. .....+.++|++||..+|++||++.+++
T Consensus 223 --------------------------~-------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 251 (256)
T cd08529 223 --------------------------Q-------------------------MYSQQLAQLIDQCLTKDYRQRPDTFQLL 251 (256)
T ss_pred --------------------------c-------------------------ccCHHHHHHHHHHccCCcccCcCHHHHh
Confidence 0 0011688999999999999999999999
Q ss_pred cCCCC
Q psy16081 436 QHNFF 440 (493)
Q Consensus 436 ~Hp~~ 440 (493)
+|||+
T Consensus 252 ~~~~~ 256 (256)
T cd08529 252 RNPSL 256 (256)
T ss_pred hCCCC
Confidence 99996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=331.29 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=219.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
..+|..+.+||+|+||.|.++..+.+.+.||||++++.. ..+....|..+.+.-...-....|+++.|..+|+.-+.+|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDV-iiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDV-IIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccce-eeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 457999999999999999999999999999999998543 2334444555544444444556789999999999999999
Q ss_pred EEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+ +|+|.-.+.+- ..+.+..+..++.+|+.||-|||+ .|||+||||.+|||| |..|+|||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmL--d~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEe--ccCCceEeeeccccccc
Confidence 999999 45887777654 469999999999999999999994 799999999999999 88999999999999654
Q ss_pred ---CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 277 ---GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 277 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
+....++||||.|+|||++.-.+|+.++|+||+||+||||+.|++||.+.++.+..+.|++..-.-|..+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKsl------- 573 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSL------- 573 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccc-------
Confidence 3456689999999999999999999999999999999999999999999999999999987533222221
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH--
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP-- 431 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~-- 431 (493)
+ .++.+++..+|...|.+|+-+
T Consensus 574 ------------------------------------------------------S--kEAv~ickg~ltK~P~kRLGcg~ 597 (683)
T KOG0696|consen 574 ------------------------------------------------------S--KEAVAICKGLLTKHPGKRLGCGP 597 (683)
T ss_pred ------------------------------------------------------c--HHHHHHHHHHhhcCCccccCCCC
Confidence 1 167899999999999999875
Q ss_pred ---HHHhcCCCCCCCccC
Q psy16081 432 ---YYALQHNFFKRTADE 446 (493)
Q Consensus 432 ---~e~L~Hp~~~~~~~~ 446 (493)
+++-.||||..+..+
T Consensus 598 ~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 598 EGERDIREHPFFRRIDWE 615 (683)
T ss_pred ccccchhhCcchhhccHH
Confidence 689999999988764
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=342.20 Aligned_cols=243 Identities=23% Similarity=0.287 Sum_probs=205.7
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
.+.+++.||+|-||.||+|.... ...||||.++........+.+|+.++..|+ |++||++++++..++.+|||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~------H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLR------HEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCc------ccCeEEEEEEEecCCceEEE
Confidence 45667899999999999997543 358999999876666677778888877665 45599999999998899999
Q ss_pred EEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
||||. |+|.++|+......+.......|+.|||.|++||++ .++|||||...|||+ +++..+||+|||+|+...+
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV--~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILV--DEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheee--ccCceEEEcccccccccCC
Confidence 99995 699999998666779999999999999999999995 689999999999999 7888999999999996665
Q ss_pred cccc-cccc---CcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 279 RIYQ-YIQS---RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 279 ~~~~-~~gt---~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
..+. ..|. ..|.|||++....|+.|||||||||+||||+| |+.||.+.+..+.+..+.+...+|.....
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~C------ 429 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGC------ 429 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCC------
Confidence 5443 2332 34999999999999999999999999999998 99999999999999999876555432211
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
...+.+++..||..+|++|||.+.
T Consensus 430 --------------------------------------------------------P~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 430 --------------------------------------------------------PDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred --------------------------------------------------------CHHHHHHHHHHhhCCcccCCCHHH
Confidence 116889999999999999999986
Q ss_pred Hh
Q psy16081 434 AL 435 (493)
Q Consensus 434 ~L 435 (493)
+.
T Consensus 454 L~ 455 (468)
T KOG0197|consen 454 LR 455 (468)
T ss_pred HH
Confidence 54
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.98 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=197.7
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-cceeEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-RNHLCL 198 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-~~~~~l 198 (493)
+|++++.||+|+||.||++.+..+++.||||.+.................+.+. ..+|++|+++.+.+.. +..+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~---~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLS---QLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHH---hCCCCCeeeeeeeecCCCCEEEE
Confidence 489999999999999999999999999999998643322122222222222232 3346779999988764 446899
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+++ +|.+++.......+++..+..++.|++.||.+|| +.||+|+||||+||++ +.++.++|+|||++....
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~--~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFL--TRTNIIKVGDLGIARVLE 153 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEE--ecCCcEEEecccceEEec
Confidence 9999965 8999887654456899999999999999999999 4799999999999999 678899999999997653
Q ss_pred Cc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 278 QR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 278 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.. .....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+......+..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---------- 223 (257)
T cd08223 154 NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP---------- 223 (257)
T ss_pred ccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc----------
Confidence 32 23456888999999999999999999999999999999999999887765554444331100000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
...+ ..+.+||.+||..||++|||+.++
T Consensus 224 --------------------------------------------------~~~~--~~~~~li~~~l~~~p~~Rp~~~~~ 251 (257)
T cd08223 224 --------------------------------------------------KDYS--PELGELIATMLSKRPEKRPSVKSI 251 (257)
T ss_pred --------------------------------------------------cccC--HHHHHHHHHHhccCcccCCCHHHH
Confidence 0000 168899999999999999999999
Q ss_pred hcCCCC
Q psy16081 435 LQHNFF 440 (493)
Q Consensus 435 L~Hp~~ 440 (493)
++||||
T Consensus 252 l~~~~~ 257 (257)
T cd08223 252 LRQPYI 257 (257)
T ss_pred hcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.93 Aligned_cols=288 Identities=27% Similarity=0.509 Sum_probs=220.0
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR-- 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~-- 193 (493)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.......... ..+.+++......+|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHH---HHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 45688999999999999999999999999999999986432111111 1122222333334678899999988643
Q ss_pred ----ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 194 ----NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 194 ----~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
+..|+|+++++++|.+++... .+++..++.++.||+.||.||| +.||+||||||+||++ +.++.+||+|
T Consensus 91 ~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll--~~~~~~kl~d 163 (345)
T cd07877 91 LEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAV--NEDCELKILD 163 (345)
T ss_pred ccccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEE--cCCCCEEEec
Confidence 457999999988998887643 4899999999999999999999 4789999999999999 6788999999
Q ss_pred cccccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 270 FGSSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 270 FG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
||++...........++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+....+.++..+..
T Consensus 164 fg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 164 FGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred ccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 9999877666666788999999999877 468899999999999999999999999988888888898888888777765
Q ss_pred hccch--hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 349 GAHKT--RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 349 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
..... ..++...+. .+ ...+.+.. .. ....+++||.+||..||.
T Consensus 244 ~~~~~~~~~~~~~~~~---------------~~-~~~~~~~~----------------~~--~~~~~~~li~~~L~~dp~ 289 (345)
T cd07877 244 KISSESARNYIQSLTQ---------------MP-KMNFANVF----------------IG--ANPLAVDLLEKMLVLDSD 289 (345)
T ss_pred hcccHhHHHHHHHhcc---------------cC-Ccchhhhc----------------CC--CCHHHHHHHHHHcCCChh
Confidence 43321 111111100 00 00000000 00 112688999999999999
Q ss_pred CCCCHHHHhcCCCCCCCccCC
Q psy16081 427 TRITPYYALQHNFFKRTADES 447 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~~~~~ 447 (493)
+|||+.++|+||||.+.....
T Consensus 290 ~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 290 KRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred hcCCHHHHhcChhhhhcCCCC
Confidence 999999999999999765433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=339.72 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=196.2
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEcc---CcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN---KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.|+++++||+||.+.||++.. .+...||+|.+.. +......+..|+.+|+.+.-. -+||+|+++-..++++
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~-----~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGH-----DKIIQLYDYEVTDGYL 435 (677)
T ss_pred hhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCC-----ceEEEEeeeeccCceE
Confidence 599999999999999999974 4456677776542 233456677888888877643 4599999999999999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
||||||-+-+|..+|.+... .+....++.+..||+.|+.++| +.||||.||||.|+|+ -.|.+||+|||+|..+
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLl---VkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLL---VKGRLKLIDFGIANAI 509 (677)
T ss_pred EEEeecccccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHH--HhceeecCCCcccEEE---EeeeEEeeeechhccc
Confidence 99999988899999987653 2343488999999999999999 5689999999999999 4688999999999887
Q ss_pred CCcc-----ccccccCcCCchhhhcCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy16081 277 GQRI-----YQYIQSRFYRSPEVLLGIP-----------YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340 (493)
Q Consensus 277 ~~~~-----~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 340 (493)
.... ...+||+.||+||.+.... .+.++||||||||||+|+.|++||..-. .+++++... .
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI-~ 586 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI-T 586 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh-c
Confidence 6543 3568999999999997433 5689999999999999999999997422 112222111 0
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
.|.. .+..+.++..+ +++|+++.|
T Consensus 587 ~P~~------------------------------------------------------~Iefp~~~~~~--~li~~mK~C 610 (677)
T KOG0596|consen 587 DPNH------------------------------------------------------EIEFPDIPEND--ELIDVMKCC 610 (677)
T ss_pred CCCc------------------------------------------------------cccccCCCCch--HHHHHHHHH
Confidence 0100 00111111122 589999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
|.+||.+|||+.++|+|||++..
T Consensus 611 L~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 611 LARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred HhcCcccCCCcHHHhcCcccccc
Confidence 99999999999999999999974
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=336.75 Aligned_cols=283 Identities=29% Similarity=0.526 Sum_probs=216.4
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|.+.+.||+|+||.||+|++..+++.||||++..... .......|..++. ...|+||++++++|..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~------~l~h~niv~~~~~~~~ 85 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK------HMQHENVIGLLDVFTS 85 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHH------hcCCCCccchhheecc
Confidence 345689999999999999999999999999999999864321 1122333443333 3357789999999875
Q ss_pred cc------eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 RN------HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~~------~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.. .+|+|+||+..+|.+++. ..+++..+..++.|++.||.|||. .+|+||||||+|||+ +.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll--~~~~~~k 157 (342)
T cd07879 86 AVSGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAV--NEDCELK 157 (342)
T ss_pred cccCCCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCCEE
Confidence 43 469999999888776652 258999999999999999999995 689999999999999 6788999
Q ss_pred EEecccccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 267 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 267 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+|||++...........++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+....+.+...
T Consensus 158 L~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 158 ILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred EeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999999876655556678899999999976 468999999999999999999999999998888899999888877766
Q ss_pred hhhhccch--hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 346 LLDGAHKT--RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 346 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
+....... ..+....+ .. ....+..+.. .....+.+||.+||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~---------------~~-~~~~~~~~~~------------------~~~~~~~~li~~~l~~ 283 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLP---------------KY-PRKDFSTLFP------------------KASPQAVDLLEKMLEL 283 (342)
T ss_pred HHHHhcccchHHHHhhcC---------------Cc-ccchHHHHhc------------------CCCHHHHHHHHHHcCC
Confidence 65433221 11111000 00 0000000000 0112678999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccC
Q psy16081 424 DPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
||.+|||+.|+|.||||....+.
T Consensus 284 dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 284 DVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred ChhhCcCHHHHhcCcchhhcccc
Confidence 99999999999999999987554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=325.75 Aligned_cols=279 Identities=33% Similarity=0.562 Sum_probs=212.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|++.+.||+|+||.||+|.+..+++.||||+++.... .......|+.++..+ .|+||+++++++...+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL------RHENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc------CCCCeeehhheEEECCE
Confidence 479999999999999999999999999999999874322 223444555544433 37779999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|+||||+++++.+.+.... ..+++..+..++.||+.||.||| +.+++|+||+|+||++ ++++.+||+|||++..
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~--~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 75 LYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILV--SESGVLKLCDFGFARA 149 (288)
T ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEE--CCCCCEEEEeeecccc
Confidence 99999999887666554443 35899999999999999999999 4789999999999999 6788999999999877
Q ss_pred cCCc----cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQR----IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
.... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...++..+..+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred cCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 6443 2346778899999999988 8899999999999999999999999998888888888777776555443322
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCC-CccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPG-SRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.....+.. . ....+. ...+.+.. + . ....++.+||++||..||++||
T Consensus 230 ~~~~~~~~-~--------------~~~~~~~~~~~~~~~------~---------~--~~~~~~~~li~~~l~~~p~~Rp 277 (288)
T cd07833 230 SSNPRFAG-V--------------AFPEPSQPESLERRY------P---------G--KVSSPALDFLKACLRMDPKERL 277 (288)
T ss_pred ccCccccc-c--------------ccCCCCCcHHHHHhc------C---------C--ccchHHHHHHHHHhccCchhcc
Confidence 21110000 0 000000 00000000 0 0 0012789999999999999999
Q ss_pred CHHHHhcCCCC
Q psy16081 430 TPYYALQHNFF 440 (493)
Q Consensus 430 t~~e~L~Hp~~ 440 (493)
|++++++||||
T Consensus 278 s~~~il~~~~f 288 (288)
T cd07833 278 TCDELLQHPYF 288 (288)
T ss_pred cHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=337.62 Aligned_cols=285 Identities=30% Similarity=0.545 Sum_probs=222.2
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... .......|+.++. ...|+||+++.+++..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~~~~~~~~ 85 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK------HMDHENVIGLLDVFTP 85 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHH------hccCCCHHHHHHHhhc
Confidence 456789999999999999999999999999999999864221 1122223433333 2357789999988876
Q ss_pred cce------eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 RNH------LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~~~------~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.+. +|+|+||++++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+||++ +.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill--~~~~~~k 158 (343)
T cd07851 86 ASSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAV--NEDCELK 158 (343)
T ss_pred cccccccccEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEE--CCCCCEE
Confidence 654 8999999988999998753 58999999999999999999994 789999999999999 6788899
Q ss_pred EEecccccccCCccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 267 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 267 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+|||++...........++..|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++..
T Consensus 159 L~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 159 ILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred EccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99999998876666667789999999998763 68899999999999999999999999999889999999988888777
Q ss_pred hhhhccch--hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 346 LLDGAHKT--RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 346 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
++...... ..|....+.. ....+..+. ... ...+.|||.+||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~----------------~~~--s~~l~dli~~~l~~ 284 (343)
T cd07851 239 LLQKISSESARNYIQSLPQM----------------PKKDFKEVF----------------SGA--NPLAIDLLEKMLVL 284 (343)
T ss_pred HHhhccchhHHHHHHhcccc----------------CCCCHHHHh----------------ccC--CHHHHHHHHHhCCC
Confidence 66543211 1111111100 000000000 000 12789999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccCC
Q psy16081 424 DPKTRITPYYALQHNFFKRTADES 447 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~~~ 447 (493)
||.+|||+.|+++||||.++....
T Consensus 285 ~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 285 DPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred ChhhCCCHHHHhcCCCccccCCCc
Confidence 999999999999999999876554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.70 Aligned_cols=257 Identities=29% Similarity=0.397 Sum_probs=206.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||.||++.+..+++.||||++...... .......+..++......+|+||+++++++.+.+.+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV--KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 4699999999999999999999999999999998643211 00111112222222333348889999999999999999
Q ss_pred EEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+ +++|.+++... ..+++..+..++.||+.||.|||+ .||+|+||+|+|||+ +.++.+||+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili--~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 79 VMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLL--DSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEE--CCCCCEEEeeCCCccccC
Confidence 99999 56999998765 368999999999999999999994 799999999999999 678899999999998876
Q ss_pred CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhh
Q psy16081 278 QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYF 357 (493)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 357 (493)
......++++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......|.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 219 (290)
T cd05580 153 GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS------------- 219 (290)
T ss_pred CCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc-------------
Confidence 6666678899999999999888999999999999999999999999887755555544321000000
Q ss_pred ccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CHH
Q psy16081 358 DKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TPY 432 (493)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~~ 432 (493)
.. ...+.+||.+||..||.+|+ +++
T Consensus 220 ------------------------------------------------~~--~~~l~~li~~~l~~~p~~R~~~~~~~~~ 249 (290)
T cd05580 220 ------------------------------------------------FF--SPDAKDLIRNLLQVDLTKRLGNLKNGVN 249 (290)
T ss_pred ------------------------------------------------cC--CHHHHHHHHHHccCCHHHccCcccCCHH
Confidence 00 01678999999999999999 999
Q ss_pred HHhcCCCCCCCccC
Q psy16081 433 YALQHNFFKRTADE 446 (493)
Q Consensus 433 e~L~Hp~~~~~~~~ 446 (493)
|+++||||......
T Consensus 250 ~l~~~~~~~~~~~~ 263 (290)
T cd05580 250 DIKNHPWFAGIDWI 263 (290)
T ss_pred HHHcCcccccCCHH
Confidence 99999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=332.21 Aligned_cols=259 Identities=28% Similarity=0.384 Sum_probs=203.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||+||+|.+..+++.||||.+....... ......+..++..+....|++|+++++.+...+..|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK--RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch--HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 36999999999999999999999999999999987543211 1111112222222333347889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+.+ +|.+++.......+++..++.++.||+.||.||| ..|++|+||||+||++ +.++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILL--HESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEE--cCCCCEEEeecchhhccc
Confidence 9999955 9999987655557999999999999999999999 4799999999999999 667889999999986542
Q ss_pred Cc--------------------------------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 278 QR--------------------------------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 278 ~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 11 1134678899999999999999999999999999999999999998
Q ss_pred CCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCC
Q psy16081 326 SNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405 (493)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 405 (493)
.+....+..+.......+ ..
T Consensus 235 ~~~~~~~~~~~~~~~~~~------------------------------------~~------------------------ 254 (316)
T cd05574 235 SNRDETFSNILKKEVTFP------------------------------------GS------------------------ 254 (316)
T ss_pred CchHHHHHHHhcCCccCC------------------------------------Cc------------------------
Confidence 877666554432100000 00
Q ss_pred CcchhhhHHHHHhHccCCCCCCCCC----HHHHhcCCCCCCCc
Q psy16081 406 SVSDYLKFKDLIFRMLDYDPKTRIT----PYYALQHNFFKRTA 444 (493)
Q Consensus 406 ~~~~~~~~~dLi~~mL~~dP~~R~t----~~e~L~Hp~~~~~~ 444 (493)
......+.+||.+||..||++||| ++|+|+||||+...
T Consensus 255 -~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 255 -PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred -cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 000117899999999999999999 99999999998643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.90 Aligned_cols=284 Identities=30% Similarity=0.519 Sum_probs=217.4
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ......|+.++. ..+|+||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK------HMKHENVIGLLDVFTP 85 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHH------hcCCCCccceeeeecC
Confidence 4567899999999999999999999999999999998643211 112233333333 3357789999999876
Q ss_pred cc------eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 RN------HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~~------~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.. .+|+||||++++|.+++... .+++..++.++.||+.||.||| ..||+||||||+||++ +.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill--~~~~~~k 158 (343)
T cd07880 86 DLSLDRFHDFYLVMPFMGTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAV--NEDCELK 158 (343)
T ss_pred CccccccceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE--cCCCCEE
Confidence 54 46999999988998887643 5899999999999999999999 4789999999999999 6788899
Q ss_pred EEecccccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 267 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 267 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+|||++...........+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+....+..+.+..+.++..
T Consensus 159 l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 159 ILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred EeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999999877666556678999999999986 458899999999999999999999999988888888888877776655
Q ss_pred hhhhccch--hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 346 LLDGAHKT--RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 346 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
+....... ..+....+.. ....+..+. ... ...+.+||.+||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~----------------~~~--~~~~~~li~~~l~~ 284 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRF----------------RKKDFRSLL----------------PNA--NPLAVNVLEKMLVL 284 (343)
T ss_pred HHHhhcchhHHHHHHhcccc----------------CcchHHHhc----------------cCC--ChHHHHHHHHHcCC
Confidence 54432211 1111111100 000000000 001 11688999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccC
Q psy16081 424 DPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
||.+|||+.++++||||+.....
T Consensus 285 dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 285 DAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred ChhhCCCHHHHhcCccHhhhcCc
Confidence 99999999999999999987554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=336.04 Aligned_cols=285 Identities=32% Similarity=0.525 Sum_probs=219.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
.++|++.+.||.|+||.||+|.+..+++.||+|++..... .......|+.++.. .+|+||++++++|..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~------l~h~~iv~~~~~~~~~~ 77 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRH------FKHDNIIAIRDILRPPG 77 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHh------cCCCCccCHHHhccccC
Confidence 3689999999999999999999999999999999874322 12223334443333 347789999988763
Q ss_pred --cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 193 --RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 193 --~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
...+|+||||++++|.+++.... .+++..++.++.||+.||.|||. .+|+||||||+||++ +.++.+||+||
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~--~~~~~~kl~df 151 (334)
T cd07855 78 ADFKDVYVVMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLV--NEDCELRIGDF 151 (334)
T ss_pred CCCceEEEEEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--cCCCcEEeccc
Confidence 35789999999889988886543 58999999999999999999994 789999999999999 67889999999
Q ss_pred ccccccCCc-------cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 271 GSSCQLGQR-------IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 271 G~a~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
|++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+...++..+...++.|
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred ccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 998665321 124578889999999876 458999999999999999999999999999889999999999999
Q ss_pred Chhhhhhccc--hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 343 PKHLLDGAHK--TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 343 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
+...+..... ...++...+.. ....+.++.. .....+.+||++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~------------------~~~~~~~~li~~~ 277 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRK----------------QPVPWSKIFP------------------KASPEALDLLSQM 277 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccC----------------CCCCHHHHcc------------------cCCHHHHHHHHHH
Confidence 8877654321 11122111100 0000000000 0012789999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCCccCCC
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRTADEST 448 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~~~~~~ 448 (493)
|..||.+|||+.++++||||.+......
T Consensus 278 l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 278 LQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred ccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 9999999999999999999997655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=343.78 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=207.1
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
.|.-++.||.|+||.||-|++..|.+.||||.+..... .....+ .++.++..++...|||++.+.++|-.+...+|
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWq---DIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ---DILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHH---HHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 46678899999999999999999999999999874322 111222 23333444444568889999999999999999
Q ss_pred EEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 199 VFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 199 V~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|||||=|+-.|++.-.. .++-+..+..|+.+.+.||.|||+ .+.||||||..|||| .+.|.|||+|||.|... .
T Consensus 104 VMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILL--se~g~VKLaDFGSAsi~-~ 177 (948)
T KOG0577|consen 104 VMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILL--SEPGLVKLADFGSASIM-A 177 (948)
T ss_pred HHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEe--cCCCeeeeccccchhhc-C
Confidence 99999776666664333 468999999999999999999997 479999999999999 78999999999998654 3
Q ss_pred ccccccccCcCCchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 279 RIYQYIQSRFYRSPEVLLG---IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
+..+++|||+|||||+++. +.|+-++||||||+++.||.-.+||+-..+.+.-+..|...-...
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt------------- 244 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT------------- 244 (948)
T ss_pred chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC-------------
Confidence 4568999999999999974 579999999999999999999999998888888888886531100
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
+ +...+++ .|..||..||..-|.+|||.+++|
T Consensus 245 --------------------------------------------L--qs~eWS~--~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 245 --------------------------------------------L--QSNEWSD--YFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred --------------------------------------------C--CCchhHH--HHHHHHHHHHhhCcccCCcHHHHh
Confidence 0 0011222 789999999999999999999999
Q ss_pred cCCCCCCCc
Q psy16081 436 QHNFFKRTA 444 (493)
Q Consensus 436 ~Hp~~~~~~ 444 (493)
.|+|+.+-.
T Consensus 277 ~H~fv~R~R 285 (948)
T KOG0577|consen 277 KHRFVLRER 285 (948)
T ss_pred hcchhccCC
Confidence 999998654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.72 Aligned_cols=283 Identities=32% Similarity=0.518 Sum_probs=214.5
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+.++|.+.+.||+|+||+||+|.+..+++.||||.+...... ......|+.++. ..+|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~------~l~h~ni~~~~~~~~~~ 76 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR------HLDHENVIAIKDIMPPP 76 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHH------hcCCCCccchHHheecc
Confidence 346899999999999999999999999999999998643211 122223333333 23577899999988654
Q ss_pred -----ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 194 -----NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 194 -----~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
..+|+|+||++++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+||++ +.++.+||+
T Consensus 77 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~--~~~~~~kL~ 150 (337)
T cd07858 77 HREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLL--NANCDLKIC 150 (337)
T ss_pred cccccCcEEEEEeCCCCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEE--cCCCCEEEC
Confidence 358999999999999988754 369999999999999999999995 789999999999999 677899999
Q ss_pred ecccccccCCc---cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 269 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 269 DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.+..+.++.
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 151 DFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred cCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99999766432 234567889999999875 46899999999999999999999999998888888888888887766
Q ss_pred hhhhhcc--chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 345 HLLDGAH--KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 345 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
..+.... ....+....+... ...+... .......+.+||++||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~------------------~~~~~~~~~~li~~~l~ 276 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTP----------------RQSFARL------------------FPHANPLAIDLLEKMLV 276 (337)
T ss_pred HHhhhcCchhhhHHHHhcCccc----------------ccCHHHH------------------cccCCHHHHHHHHHHhc
Confidence 5542111 1111211111000 0000000 00011268899999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 423 YDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.||++|||++|+|+||||.....
T Consensus 277 ~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 277 FDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred CChhhccCHHHHHcCcchhhhcC
Confidence 99999999999999999986533
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=333.02 Aligned_cols=293 Identities=28% Similarity=0.382 Sum_probs=205.3
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
++|++.+.||+|+||.||++.+..++..||+|.+..... ...+...|+.+ ....+|+||++++++|...+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~------l~~l~h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKV------LHECNSPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHH------HHhCCCCCCCeEEEEEeeCCEE
Confidence 369999999999999999999999999999999864321 11222333333 3334678899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++... ..+++..+..++.||+.||.|||+ ..+++||||||+|||+ +.++.+||+|||++..
T Consensus 75 ~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILV--NSRGEIKLCDFGVSGQ 149 (308)
T ss_pred EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEE--ecCCcEEEccCCCccc
Confidence 999999965 899998765 368999999999999999999996 3589999999999999 6678899999999866
Q ss_pred cCCc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 276 LGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 276 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.... ....++++.|+|||++.+..++.++|||||||++|+|++|..||...+...... +.. ..+..........
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~-~~~---~~~~~~~~~~~~~- 224 (308)
T cd06615 150 LIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA-MFG---RPVSEGEAKESHR- 224 (308)
T ss_pred ccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH-hhc---CccccccccCCcc-
Confidence 5332 345678999999999998889999999999999999999999998765433222 111 1111000000000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
.. .......+......+++........ ...+..... .++.+||.+||..||++|||+.|+
T Consensus 225 --------------~~-~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~li~~~l~~~P~~Rpt~~~l 284 (308)
T cd06615 225 --------------PV-SGHPPDSPRPMAIFELLDYIVNEPP---PKLPSGAFS--DEFQDFVDKCLKKNPKERADLKEL 284 (308)
T ss_pred --------------cc-cCCCCCccchhhHHHHHHHHhcCCC---ccCcCcccC--HHHHHHHHHHccCChhhCcCHHHH
Confidence 00 0000000000011111110000000 000111111 268999999999999999999999
Q ss_pred hcCCCCCCCccCC
Q psy16081 435 LQHNFFKRTADES 447 (493)
Q Consensus 435 L~Hp~~~~~~~~~ 447 (493)
++||||.+...+.
T Consensus 285 l~~~~~~~~~~~~ 297 (308)
T cd06615 285 TKHPFIKRAELEE 297 (308)
T ss_pred hcChhhhhccccc
Confidence 9999998765443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=323.51 Aligned_cols=277 Identities=31% Similarity=0.524 Sum_probs=215.3
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
+|++.++||.|++|+||+|++..+++.||||+++.... .......|+.++..+ +|+||+++++.+...+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL------KHENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh------cCCCEeeeeeeEeeCCcEE
Confidence 48899999999999999999999999999999875322 123333444444433 4778999999999999999
Q ss_pred EEEEecccCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSYNLYDLLRNTN-FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||++++|.+++.... ...+++..+..++.||+.||.|||+ .||+||||||+||++ +.++.++|+|||++...
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~--~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLI--NKRGELKLADFGLARAF 150 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEE--CCCCcEEEeecchhhhh
Confidence 999999999999886543 2358999999999999999999995 789999999999999 67889999999999765
Q ss_pred CCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++.+....|....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 432 2234568889999998764 578999999999999999999999999998889999888888777666554433
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
...+....+.. .......+.. .....+.++|.+||+.||.+|||+.
T Consensus 231 ~~~~~~~~~~~----------------~~~~~~~~~~------------------~~~~~~~~~i~~~l~~~p~~R~~~~ 276 (284)
T cd07836 231 LPEYKPTFPRY----------------PPQDLQQLFP------------------HADPLGIDLLHRLLQLNPELRISAH 276 (284)
T ss_pred CchhcccccCC----------------ChHHHHHHhh------------------hcCcHHHHHHHHHhcCCcccCCCHH
Confidence 22222111100 0000001100 0012688999999999999999999
Q ss_pred HHhcCCCC
Q psy16081 433 YALQHNFF 440 (493)
Q Consensus 433 e~L~Hp~~ 440 (493)
|+++||||
T Consensus 277 ~~l~~~~f 284 (284)
T cd07836 277 DALQHPWF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=323.70 Aligned_cols=276 Identities=33% Similarity=0.517 Sum_probs=211.2
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce--
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH-- 195 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~-- 195 (493)
|++.+.||.|+||.||+|.+..+++.||||+++..... ......|..++..+ ...+|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQL---ESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHh---hccCCCCcceEEEEEeeccCCC
Confidence 67889999999999999999888999999999743221 12233344444444 34458889999999998776
Q ss_pred ---eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 196 ---LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 196 ---~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+|+||||+.++|.+++.......+++..++.++.||+.||.|||. .+++|+||+|+||++ +.++.+||+|||+
T Consensus 78 ~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili--~~~~~~~l~dfg~ 153 (287)
T cd07838 78 ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILV--TSDGQVKIADFGL 153 (287)
T ss_pred CceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEE--ccCCCEEEeccCc
Confidence 999999998899998876544468999999999999999999994 789999999999999 6678999999999
Q ss_pred ccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 273 SCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 273 a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
+...... .....++..|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+.++.+....+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 9776432 23445788899999999999999999999999999999999999999998988888877665433221111
Q ss_pred cc-hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 351 HK-TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 351 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.. ....+.. .......+.+ .+....+.+||++||..||.+||
T Consensus 234 ~~~~~~~~~~-------------------~~~~~~~~~~------------------~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 234 VSLPRSSFPS-------------------YTPRSFKSFV------------------PEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred cccchhhccc-------------------ccccchhhhh------------------hhhhHHHHHHHHHHhccCCccCC
Confidence 00 0000000 0000000000 01112678999999999999999
Q ss_pred CHHHHhcCCCC
Q psy16081 430 TPYYALQHNFF 440 (493)
Q Consensus 430 t~~e~L~Hp~~ 440 (493)
|+.|+++||||
T Consensus 277 ~~~~il~~~~~ 287 (287)
T cd07838 277 SAFEALQHPYF 287 (287)
T ss_pred CHHHHhcCcCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=326.30 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=198.2
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee----
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW---- 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~---- 192 (493)
..+.|++.+.||.|+||+||+|.+..+++.||+|++............|..++..+ .+|+||++++++|..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~-----~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKY-----SHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHh-----cCCCcEEEEeeehhccccc
Confidence 45689999999999999999999999999999999875443333444454444443 257889999999853
Q ss_pred --cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 193 --RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 193 --~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
.+.+|+||||+++ +|.+++.......+++..+..++.||+.||.|||+ .||+|+||||+||++ +.++.++|+|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili--~~~~~~~l~d 164 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLL--TENAEVKLVD 164 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCCEEEee
Confidence 4678999999965 89998876554568899999999999999999995 789999999999999 6788899999
Q ss_pred cccccccCC---ccccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 270 FGSSCQLGQ---RIYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 270 FG~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
||++..... ......|++.|+|||++. +..++.++|||||||++|+|++|.+||........+..+...
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~--- 241 (282)
T cd06636 165 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--- 241 (282)
T ss_pred CcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---
Confidence 999876532 233467889999999986 346888999999999999999999999765543332221110
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
.+... . ... ....+.+||++||
T Consensus 242 ~~~~~------------------------------------------------------~--~~~--~~~~~~~li~~cl 263 (282)
T cd06636 242 PPPKL------------------------------------------------------K--SKK--WSKKFIDFIEGCL 263 (282)
T ss_pred CCCCC------------------------------------------------------c--ccc--cCHHHHHHHHHHh
Confidence 00000 0 000 0117899999999
Q ss_pred CCCCCCCCCHHHHhcCCCC
Q psy16081 422 DYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~Hp~~ 440 (493)
..||.+|||+.|+|+||||
T Consensus 264 ~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 264 VKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=329.28 Aligned_cols=285 Identities=30% Similarity=0.535 Sum_probs=221.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++.+.||.|+||.||+|.+..+++.||||++..... .......|+.++..+ .||||+++.++|..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~ 80 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL------RHENIISLSDIFIS 80 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc------CCCCeeeEeeeEec
Confidence 456789999999999999999999999999999998753221 122333444443333 47789999999875
Q ss_pred -cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 -RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 -~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+..|+|+||++++|.+++... .+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.++|+|||
T Consensus 81 ~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili--~~~~~~~l~dfg 153 (328)
T cd07856 81 PLEDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILI--NENCDLKICDFG 153 (328)
T ss_pred CCCcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeE--CCCCCEEeCccc
Confidence 5678999999988998888643 47888999999999999999994 789999999999999 678899999999
Q ss_pred cccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 272 SSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 272 ~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
++...........++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.+.++.++..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 154 LARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 99876655556678889999999876 56899999999999999999999999999888888888899998887776543
Q ss_pred cch--hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 351 HKT--RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 351 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
... ..++...+... .....+.+ ......+.+||++||..||++|
T Consensus 234 ~~~~~~~~~~~~~~~~----------------~~~~~~~~------------------~~~~~~~~~li~~~l~~~P~~R 279 (328)
T cd07856 234 CSENTLRFVQSLPKRE----------------PVPFSEKF------------------KNADPSAIDLLEKMLVFDPQKR 279 (328)
T ss_pred cchhhHHHHhhccccC----------------CCcHHHHc------------------CCCCHHHHHHHHHHcCCChhhC
Confidence 221 12221111000 00000000 0001278999999999999999
Q ss_pred CCHHHHhcCCCCCCCccCC
Q psy16081 429 ITPYYALQHNFFKRTADES 447 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~~~~~ 447 (493)
||+.+++.||||.......
T Consensus 280 ~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 280 ISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred CCHHHHhcCCccccccCCc
Confidence 9999999999998765543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.58 Aligned_cols=286 Identities=29% Similarity=0.484 Sum_probs=214.6
Q ss_pred ecCcEEE-eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchH---------HHHHHHHHHHHhhcCCCCcceEEEe
Q psy16081 117 FLDRYEI-DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ---------AQIEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 117 ~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~---------~~~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
+.++|.. .+.||.|+||+||+|.+..+++.||||+++........ ...+..+.+++......+|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4467765 47799999999999999999999999998643221100 0001112222222333457889999
Q ss_pred ceeeeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 187 KRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 187 ~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
++++...+..|+||||+.++|.+++.... .+++..+..++.||+.||.||| +.||+|+||||+||++ +.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~nill--~~~~~~k 159 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFI--NSKGICK 159 (335)
T ss_pred eEEEecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHeEE--CCCCCEE
Confidence 99999999999999999999999986543 5899999999999999999999 4789999999999999 6788999
Q ss_pred EEecccccccCC-----------------ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q psy16081 267 IVDFGSSCQLGQ-----------------RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328 (493)
Q Consensus 267 L~DFG~a~~~~~-----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~ 328 (493)
|+|||++..... ......++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999876541 11223467789999999864 478999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcc
Q psy16081 329 VDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVS 408 (493)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 408 (493)
.+.+..+.+.++.++...+........+.... ......+..+.. ..
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~----------------~~- 285 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFT-----------------PRKPKDLKTIFP----------------NA- 285 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccC-----------------cCCcccHHHhCc----------------CC-
Confidence 99999999988887765544332211111000 000011111100 00
Q ss_pred hhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 409 DYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 409 ~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
...+.+||.+||..||++|||++|+|.||||+..
T Consensus 286 -~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 286 -SDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred -ChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 1268899999999999999999999999999865
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.03 Aligned_cols=284 Identities=35% Similarity=0.545 Sum_probs=220.8
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc--
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN-- 194 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~-- 194 (493)
+|++.+.||.|+||.||+|.+..+++.||||++..... .......|+.++. ..+|+||+++.+++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~------~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLR------HLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHH------hcCCcchhhhhhhhcccCcc
Confidence 58899999999999999999999999999999875321 1223333333332 234788999999998775
Q ss_pred ---eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 195 ---HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 195 ---~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+|+||||++++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.++|+|||
T Consensus 75 ~~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili--~~~~~~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILV--NSNCDLKICDFG 148 (330)
T ss_pred cccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--cCCCCEEEcccC
Confidence 899999999989999887543 69999999999999999999995 689999999999999 667899999999
Q ss_pred cccccCCc------cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 272 SSCQLGQR------IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 272 ~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
++...... .....+++.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence 99766443 3345678899999999988 7999999999999999999999999999999999999999888876
Q ss_pred hhhhhcc--chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 345 HLLDGAH--KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 345 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
..+.... ....+....+.. ....+..+. ......+.+||++||.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~------------------~~~~~~~~~li~~~l~ 274 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKK----------------PKKPLSKLF------------------PGASPEAIDLLEKMLV 274 (330)
T ss_pred hHhhhccccchhhHHhhcccC----------------CcchhHHhc------------------ccCCHHHHHHHHHHcc
Confidence 6554211 111121111100 000000000 0011268899999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCccCCCC
Q psy16081 423 YDPKTRITPYYALQHNFFKRTADESTN 449 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~~~~~~~ 449 (493)
+||.+|||++++++||||.+....+..
T Consensus 275 ~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 275 FDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred CChhhCCCHHHHHhCccHHhhcccccC
Confidence 999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=328.44 Aligned_cols=283 Identities=32% Similarity=0.460 Sum_probs=213.9
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
++...++|++.+.||.|+||+||+|.+..+++.||||+++.... .......|..++. ..+||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~------~l~h~~i~~~~~~~ 75 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR------QLNHRNIVNLKEIV 75 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHH------hCCCCCeeeeehee
Confidence 34567889999999999999999999999999999999874321 1122233333332 33578899999998
Q ss_pred eecc----------eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC
Q psy16081 191 MWRN----------HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP 260 (493)
Q Consensus 191 ~~~~----------~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~ 260 (493)
.+.. .+|+|+||+++++.+.+.... ..+++..++.++.||+.||.||| +.||+|+||||+||++ +
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili--~ 150 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILL--N 150 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE--C
Confidence 7654 899999999998888886543 46899999999999999999999 4799999999999999 6
Q ss_pred CCCcEEEEecccccccCCcc----ccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy16081 261 KRSAIKIVDFGSSCQLGQRI----YQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 261 ~~~~ikL~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i 335 (493)
.++.+||+|||++....... ....++..|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~ 230 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230 (302)
T ss_pred CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 78899999999997654322 223457789999998754 5789999999999999999999999998888888888
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
.+..+.++...++.......+........ ..++.... .... ...+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~----------------~~~~--~~~~~~ 277 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQ---------------YRRRLREE----------------FSFI--PTPALD 277 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccc---------------cccchhhh----------------cCCC--CHHHHH
Confidence 88887776655443322211111000000 00000000 0001 127899
Q ss_pred HHhHccCCCCCCCCCHHHHhcCCCC
Q psy16081 416 LIFRMLDYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 416 Li~~mL~~dP~~R~t~~e~L~Hp~~ 440 (493)
||.+||..||.+|||+.++++||||
T Consensus 278 li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 278 LLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHHHccCChhhCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=323.91 Aligned_cols=278 Identities=34% Similarity=0.532 Sum_probs=204.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|++.++||+|+||.||+|.+..+++.||+|++...... ...+..|+.++ ...+|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l------~~l~h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRML------KQLRHENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHH------HhcCCcchhhHHHhcccCCe
Confidence 4699999999999999999999989999999988643321 12223333332 23357889999999999999
Q ss_pred eEEEEEecccC-HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~~-L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.|+|+||+.++ |.++.... ..+++..+..++.||+.||.|||+ .||+|+||+|+||++ ++++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~--~~~~~~~l~dfg~~~ 148 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILV--SQSGVVKLCDFGFAR 148 (286)
T ss_pred EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEE--CCCCcEEEEeeeeee
Confidence 99999999874 44444332 358999999999999999999994 789999999999999 678899999999987
Q ss_pred ccCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 275 QLGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 275 ~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
..... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+....+..........
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 149 TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred eccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 65332 2345678899999999764 4788999999999999999999999988888888888776665432211110
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
... ..+.... . ...+....+... .... ...+.+||.+||..||.+|||
T Consensus 229 ~~~-~~~~~~~-----~--------~~~~~~~~~~~~----------------~~~~--~~~~~~li~~~l~~~P~~Rp~ 276 (286)
T cd07846 229 QKN-PLFAGMR-----L--------PEVKEIEPLEKR----------------FPKL--SGLVLDLAKQCLRIDPDDRPS 276 (286)
T ss_pred ccc-hHhhccc-----c--------ccccCcchHHHh----------------CCCc--CHHHHHHHHHHhcCCcccchh
Confidence 000 0000000 0 000000000000 0001 126899999999999999999
Q ss_pred HHHHhcCCCC
Q psy16081 431 PYYALQHNFF 440 (493)
Q Consensus 431 ~~e~L~Hp~~ 440 (493)
+.++++||||
T Consensus 277 ~~~il~~~~~ 286 (286)
T cd07846 277 SSQLLHHEFF 286 (286)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=323.11 Aligned_cols=261 Identities=27% Similarity=0.405 Sum_probs=200.2
Q ss_pred eeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 111 IQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 111 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
+.......++|++.+.||+|+||.||+|.+..+++.||+|++............|..++..+. +|+||+++++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~ 84 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKFYGMY 84 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh-----cCCCeeeeeeee
Confidence 344456678999999999999999999999999999999998754333344555666555543 477899999987
Q ss_pred e-----ecceeEEEEEeccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC
Q psy16081 191 M-----WRNHLCLVFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR 262 (493)
Q Consensus 191 ~-----~~~~~~lV~E~~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~ 262 (493)
. ..+.+|+||||+++ +|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||++ +.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili--~~~ 160 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILL--TTE 160 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEEE--CCC
Confidence 4 34678999999965 888877532 22458899999999999999999995 689999999999999 667
Q ss_pred CcEEEEecccccccCCc---cccccccCcCCchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy16081 263 SAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLG-----IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~ 334 (493)
+.+||+|||++...... .....|++.|+|||++.. ..++.++|||||||++|+|++|.+||...+....+..
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 88999999998765432 234568899999999853 4588999999999999999999999987654333222
Q ss_pred HHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHH
Q psy16081 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414 (493)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (493)
+... .++. . ..+. .. ...+.
T Consensus 241 ~~~~--~~~~---------------------------------~----------------------~~~~-~~--~~~~~ 260 (286)
T cd06638 241 IPRN--PPPT---------------------------------L----------------------HQPE-LW--SNEFN 260 (286)
T ss_pred cccc--CCCc---------------------------------c----------------------cCCC-Cc--CHHHH
Confidence 1110 0000 0 0000 00 01688
Q ss_pred HHHhHccCCCCCCCCCHHHHhcCCCC
Q psy16081 415 DLIFRMLDYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 415 dLi~~mL~~dP~~R~t~~e~L~Hp~~ 440 (493)
+||.+||..||.+|||+.|+++|+||
T Consensus 261 ~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 261 DFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHccCCcccCCCHHHHhhcccC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=323.91 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=197.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||.||+|.+..+|+.||||+++.......+.....+ ........+|+||+++++++...+.+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e---~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMD---LDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHH---HHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 4689999999999999999999999999999998754221111111111 1111234578899999999999999999
Q ss_pred EEEecccCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 199 VFELLSYNLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 199 V~E~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
||||++++|.+++... ....+++..+..++.||+.||.|||+ ..+++||||||+|||+ +.++.+||+|||++...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~--~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLI--NRNGQVKLCDFGISGYL 154 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEE--CCCCCEEEeeccccccc
Confidence 9999999988887542 22458999999999999999999995 2489999999999999 67889999999999766
Q ss_pred CCcc--ccccccCcCCchhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhhhh
Q psy16081 277 GQRI--YQYIQSRFYRSPEVLLG----IPYDLAIDMWSLGCILVEMHTGEPLFSGS-NEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 277 ~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
.... ....++..|+|||++.+ ..++.++|+|||||++|+|++|..||... ...+.+..+... .++.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~----- 227 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSPQ----- 227 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCCC-----
Confidence 4332 23467889999999865 45789999999999999999999999643 222333322211 0000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.+. .... ..+.+||.+||..||.+||
T Consensus 228 ----------------------------~~~------------------------~~~~--~~l~~li~~~l~~~p~~Rp 253 (283)
T cd06617 228 ----------------------------LPA------------------------EKFS--PEFQDFVNKCLKKNYKERP 253 (283)
T ss_pred ----------------------------CCc------------------------cccC--HHHHHHHHHHccCChhhCc
Confidence 000 0000 1688999999999999999
Q ss_pred CHHHHhcCCCCCCCc
Q psy16081 430 TPYYALQHNFFKRTA 444 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~ 444 (493)
|+.++++||||....
T Consensus 254 ~~~~il~~~~~~~~~ 268 (283)
T cd06617 254 NYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHhcCchhhhcc
Confidence 999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.35 Aligned_cols=272 Identities=29% Similarity=0.431 Sum_probs=206.5
Q ss_pred cCcEEE-eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEI-DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+-|++ .++||+|+|+.|--|....++..||||++.+... .....-+|+ +.+.+. ..|+||+.|+++|++++.
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREV---e~f~~C--qgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREV---ETFYQC--QGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHH---HHHHHh--cCCccHHHHHHHhcccce
Confidence 334544 3689999999999999999999999999976532 122223333 334433 378899999999999999
Q ss_pred eEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEEecccc
Q psy16081 196 LCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSS 273 (493)
Q Consensus 196 ~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~DFG~a 273 (493)
+|||||-| +|.|+..|.+.. .+++.++.++.++|+.||.||| ..||.||||||+|||-.+. .-.-+|||||.+.
T Consensus 151 FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeeccccc
Confidence 99999999 558888887654 5999999999999999999999 5899999999999998533 2345899999987
Q ss_pred cccC----------CccccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy16081 274 CQLG----------QRIYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338 (493)
Q Consensus 274 ~~~~----------~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 338 (493)
.... ....+.+|+..|||||+.. ..-|+.++|.||||||||.||+|.+||.|.-..+-
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC------- 299 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC------- 299 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC-------
Confidence 4331 2244678888999999985 23599999999999999999999999987543211
Q ss_pred hCCCChhhhhhcc----chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHH
Q psy16081 339 LGLPPKHLLDGAH----KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414 (493)
Q Consensus 339 ~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (493)
-|++.. --...|..+.+|.|-+.. +.|+-+++ +.+
T Consensus 300 -------GWdrGe~Cr~CQ~~LFesIQEGkYeFPd--------------------------------kdWahIS~--eak 338 (463)
T KOG0607|consen 300 -------GWDRGEVCRVCQNKLFESIQEGKYEFPD--------------------------------KDWAHISS--EAK 338 (463)
T ss_pred -------CccCCCccHHHHHHHHHHHhccCCcCCh--------------------------------hhhHHhhH--HHH
Confidence 000000 012445555555553221 12333333 789
Q ss_pred HHHhHccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 415 DLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 415 dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
|||..+|..|+.+|.++.++|+|||+++...+
T Consensus 339 dlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 339 DLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 99999999999999999999999999988765
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=323.30 Aligned_cols=260 Identities=28% Similarity=0.394 Sum_probs=200.4
Q ss_pred ccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 113 HGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 113 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
......++|.+.+.||+|+||.||+|.+..+++.||+|++............|..++..+ .+|+||+++++++..
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-----~~h~ni~~~~~~~~~ 90 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL-----PNHPNVVKFYGMFYK 90 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHh-----cCCCCeEEEEEEEEe
Confidence 334567899999999999999999999999999999999875433333444555544433 257889999999875
Q ss_pred c-----ceeEEEEEeccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc
Q psy16081 193 R-----NHLCLVFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 193 ~-----~~~~lV~E~~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ 264 (493)
. +.+|+||||+++ +|.+++... ....+++..++.++.|++.||.||| ..+|+|+||||+||++ +.++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nili--~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILL--TTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEE--cCCCC
Confidence 3 368999999965 888887532 2245899999999999999999999 4789999999999999 67788
Q ss_pred EEEEecccccccCCc---cccccccCcCCchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy16081 265 IKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGI-----PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 265 ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~ 336 (493)
+||+|||++...... .....|+..|+|||++... .++.++|||||||++|+|++|++||...+....+..+.
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 999999998765422 2345678899999998643 36899999999999999999999998766554443332
Q ss_pred HHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHH
Q psy16081 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDL 416 (493)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL 416 (493)
.. ++..+. .+ ......+.+|
T Consensus 247 ~~---~~~~~~------------------------------------------------------~~---~~~~~~l~~l 266 (291)
T cd06639 247 RN---PPPTLL------------------------------------------------------HP---EKWCRSFNHF 266 (291)
T ss_pred cC---CCCCCC------------------------------------------------------cc---cccCHHHHHH
Confidence 11 000000 00 0000168899
Q ss_pred HhHccCCCCCCCCCHHHHhcCCCCC
Q psy16081 417 IFRMLDYDPKTRITPYYALQHNFFK 441 (493)
Q Consensus 417 i~~mL~~dP~~R~t~~e~L~Hp~~~ 441 (493)
|.+||..||++||++.|+++||||+
T Consensus 267 i~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 267 ISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHhhcChhhCcCHHHHhcCcccC
Confidence 9999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.10 Aligned_cols=204 Identities=26% Similarity=0.393 Sum_probs=159.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|++.++||+|+||.||+|.+. .+++.||||+++..... ......|..++..+ .+||||+++++++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~~h~niv~~~~~~ 80 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHI-----GNHLNVVNLLGAC 80 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHh-----ccCcceeeEEeEe
Confidence 368999999999999999999752 34578999998743211 12233344333332 2688899999988
Q ss_pred eec-ceeEEEEEecc-cCHHHHHhccC-----------------------------------------------------
Q psy16081 191 MWR-NHLCLVFELLS-YNLYDLLRNTN----------------------------------------------------- 215 (493)
Q Consensus 191 ~~~-~~~~lV~E~~~-~~L~~~l~~~~----------------------------------------------------- 215 (493)
... +.+|+||||++ |+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 46899999995 49998886432
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc-----cccc
Q psy16081 216 -------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQY 283 (493)
Q Consensus 216 -------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~ 283 (493)
...+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++..... ....
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~--~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEE--cCCCcEEEeecccccccccCcchhcccCC
Confidence 1247788899999999999999994 799999999999999 67889999999999765322 1123
Q ss_pred cccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy16081 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVD 330 (493)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~ 330 (493)
.+++.|+|||++.+..++.++|||||||+||||++ |.+||.+....+
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~ 284 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 45678999999999999999999999999999997 999998765433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=326.70 Aligned_cols=280 Identities=29% Similarity=0.462 Sum_probs=211.9
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
..++|++.++||.|+||.||+|.+..+++.||||++..... .......|..++..+ +|+||+++++.+...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 79 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL------KHPNVVPLIDMAVER 79 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc------CCCCccchhhheecc
Confidence 36799999999999999999999999999999998864321 122344455554433 467799999887543
Q ss_pred --------ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 194 --------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 194 --------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
..+|+|+||++++|.+.+.... ..+++..++.++.||+.||.|||+ .||+|+||||+|||+ +.++.+
T Consensus 80 ~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~--~~~~~~ 154 (311)
T cd07866 80 PDKSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILI--DNQGIL 154 (311)
T ss_pred cccccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--CCCCCE
Confidence 3579999999998888876543 469999999999999999999995 789999999999999 678899
Q ss_pred EEEecccccccCCcc--------------ccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy16081 266 KIVDFGSSCQLGQRI--------------YQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVD 330 (493)
Q Consensus 266 kL~DFG~a~~~~~~~--------------~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~ 330 (493)
||+|||++....... ....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+...
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999997553221 123567889999998764 58999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchh
Q psy16081 331 QMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410 (493)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (493)
....+....+.++...+..+......-+... ....+..+.+... . ..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~----------------~--~~ 281 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHS---------------FTNYPRTLEERFG----------------K--LG 281 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhccccccccc---------------CCCCCccHHHHcc----------------c--CC
Confidence 9999888888776655443322111100000 0000011111000 0 01
Q ss_pred hhHHHHHhHccCCCCCCCCCHHHHhcCCCC
Q psy16081 411 LKFKDLIFRMLDYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 411 ~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~ 440 (493)
..+.+||.+||..||.+|||+.|++.||||
T Consensus 282 ~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 282 PEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 268899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=321.15 Aligned_cols=254 Identities=30% Similarity=0.454 Sum_probs=202.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
++|++.+.||.|+||.||+|.+..+++.||+|++..... .......|+.++.. . .|+||+++.+++.+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~---l---~h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ---C---RSPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHH---c---CCCCeeeeeEEEEECCeE
Confidence 468899999999999999999999999999999874321 11223334333332 2 377899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+|+||+++ +|.+++... .+++..+..++.||+.||.|||. .+++|+||+|+||++ +.++.++|+|||++..
T Consensus 75 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILL--SEEGDVKLADFGVSGQ 147 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEE--CCCCCEEEccccccee
Confidence 999999965 899888754 58999999999999999999994 789999999999999 6788999999999977
Q ss_pred cCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... .....++..|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+..... +.
T Consensus 148 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~-------- 217 (274)
T cd06609 148 LTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP--PS-------- 217 (274)
T ss_pred ecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC--CC--------
Confidence 7543 3355788899999999998899999999999999999999999987665444333322100 00
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.. ... ....+.++|.+||..||++|||++
T Consensus 218 -------~~------------------------------------------~~~--~~~~~~~~l~~~l~~~p~~Rpt~~ 246 (274)
T cd06609 218 -------LE------------------------------------------GNK--FSKPFKDFVSLCLNKDPKERPSAK 246 (274)
T ss_pred -------Cc------------------------------------------ccc--cCHHHHHHHHHHhhCChhhCcCHH
Confidence 00 000 011688999999999999999999
Q ss_pred HHhcCCCCCCCccC
Q psy16081 433 YALQHNFFKRTADE 446 (493)
Q Consensus 433 e~L~Hp~~~~~~~~ 446 (493)
++++||||+.....
T Consensus 247 ~il~~~~~~~~~~~ 260 (274)
T cd06609 247 ELLKHKFIKKAKKT 260 (274)
T ss_pred HHhhChhhcCCCcc
Confidence 99999999975443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=316.37 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=200.8
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ......|+.++. ..+|+||+++.+++...++.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~------~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLS------NMKHPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHH------hCCCCCeeeeEeeecCCCeE
Confidence 589999999999999999999999999999998643211 123333333333 33577899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+|+||+.+ +|.+.+.......+++..+..++.|++.||.|||+ .+++|+||+|+|||+ +.++.++|+|||++..
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~--~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFL--TKDGTIKLGDFGIARV 150 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEE--cCCCCEEEeeccceee
Confidence 999999965 99998876544468999999999999999999994 789999999999999 6778899999999976
Q ss_pred cCCcc---ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQRI---YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
..... ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--------- 221 (256)
T cd08218 151 LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV--------- 221 (256)
T ss_pred cCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---------
Confidence 64432 234678899999999998999999999999999999999999988776666555532110000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
. ......+.++|.+||..||.+||++.
T Consensus 222 ----------------------------~-------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 248 (256)
T cd08218 222 ----------------------------S-------------------------SHYSYDLRNLVSQLFKRNPRDRPSVN 248 (256)
T ss_pred ----------------------------c-------------------------ccCCHHHHHHHHHHhhCChhhCcCHH
Confidence 0 00011688999999999999999999
Q ss_pred HHhcCCCC
Q psy16081 433 YALQHNFF 440 (493)
Q Consensus 433 e~L~Hp~~ 440 (493)
++|+||||
T Consensus 249 ~vl~~~~~ 256 (256)
T cd08218 249 SILEKNFI 256 (256)
T ss_pred HHhhCcCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=325.68 Aligned_cols=256 Identities=31% Similarity=0.516 Sum_probs=197.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
+.|+++++||.|+||.||+|.+..+++.||+|++..... .......|+.++ ...+|+||+++++.+..++.+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l------~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEIL------ATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHH------HhCCCCcEeeeEEEEEeCCeEE
Confidence 579999999999999999999999999999999874321 112222233322 2345788999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|..++.... ..+++..+..++.||+.||.|||. .+|+||||||+||++ +.++.+||+|||++...
T Consensus 86 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLL--TLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEE--cCCCCEEEccCccceec
Confidence 99999976 6666665433 468999999999999999999994 789999999999999 67889999999998654
Q ss_pred CCc---cccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
... .....+++.|+|||++. ...++.++|||||||++|+|++|.+||...+......++.... ++. .
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~-~-- 235 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPT-L-- 235 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Ccc-C--
Confidence 322 23456888999999985 3457889999999999999999999998766544433332110 000 0
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
... ......+.+||.+||..||++|
T Consensus 236 ------------------------------~~~-------------------------~~~~~~~~~li~~~l~~~p~~R 260 (292)
T cd06644 236 ------------------------------SQP-------------------------SKWSMEFRDFLKTALDKHPETR 260 (292)
T ss_pred ------------------------------CCC-------------------------cccCHHHHHHHHHHhcCCcccC
Confidence 000 0000167899999999999999
Q ss_pred CCHHHHhcCCCCCCCcc
Q psy16081 429 ITPYYALQHNFFKRTAD 445 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~~~ 445 (493)
||+.++++||||..+..
T Consensus 261 p~~~~il~~~~~~~~~~ 277 (292)
T cd06644 261 PSAAQLLEHPFVSSVTS 277 (292)
T ss_pred cCHHHHhcCcccccccc
Confidence 99999999999986543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=319.00 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=196.0
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch----HHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN----QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
+|.+...||+|+||.||+|.+..+++.||+|.+........ .......+..++......+|+||+++++++...++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47788999999999999999999999999998864332211 00111112222222333457889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.++||||+++ +|.+++... ..+++..+..++.|++.||.||| +.|++||||+|+||++ +.++.++|+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~--~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILV--DNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEE--cCCCCEEecccCCCc
Confidence 9999999965 898888654 35899999999999999999999 4789999999999999 678899999999987
Q ss_pred ccCCc---------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 275 QLGQR---------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 275 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
..... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+....+..+..... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~- 231 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS--PE- 231 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC--Cc-
Confidence 66421 1134578899999999998999999999999999999999999987655444333322100 00
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
.+ ... ...+.+||++||..||
T Consensus 232 --------------------------------~~-------------------------~~~--~~~~~~li~~~l~~~p 252 (267)
T cd06628 232 --------------------------------IP-------------------------SNI--SSEAIDFLEKTFEIDH 252 (267)
T ss_pred --------------------------------CC-------------------------ccc--CHHHHHHHHHHccCCc
Confidence 00 000 1167899999999999
Q ss_pred CCCCCHHHHhcCCCC
Q psy16081 426 KTRITPYYALQHNFF 440 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~ 440 (493)
.+|||+.|+++||||
T Consensus 253 ~~Rp~~~~il~~~~~ 267 (267)
T cd06628 253 NKRPTAAELLKHPFL 267 (267)
T ss_pred hhCcCHHHHhhCCCC
Confidence 999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=332.16 Aligned_cols=283 Identities=30% Similarity=0.461 Sum_probs=206.8
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR-- 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~-- 193 (493)
+..+|.+.+.||.|+||.||+|.+..+++.||+|++..... .......|+.++.. .+|+||+++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~------l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRR------LDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHh------cCCCcchhhHhhhccccc
Confidence 34689999999999999999999999999999999865432 12233344444332 3577799998776643
Q ss_pred ------------ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC
Q psy16081 194 ------------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK 261 (493)
Q Consensus 194 ------------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~ 261 (493)
..+|+||||++++|.+++... .+++..++.++.||+.||.||| +.||+||||||+||+++ ..
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nili~-~~ 150 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFIN-TE 150 (342)
T ss_pred ccccccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEc-CC
Confidence 368999999998998888643 4899999999999999999999 47899999999999994 25
Q ss_pred CCcEEEEecccccccCCc------cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy16081 262 RSAIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334 (493)
Q Consensus 262 ~~~ikL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~ 334 (493)
++.+||+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 230 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 567999999999765322 122357888999998765 4688999999999999999999999999888888777
Q ss_pred HHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHH
Q psy16081 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414 (493)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (493)
+.+............ +...++.. . .....+....+..++. ..+ .++.
T Consensus 231 ~~~~~~~~~~~~~~~------~~~~~~~~--~-------~~~~~~~~~~~~~~~~----------------~~~--~~~~ 277 (342)
T cd07854 231 ILESVPVVREEDRNE------LLNVIPSF--V-------RNDGGEPRRPLRDLLP----------------GVN--PEAL 277 (342)
T ss_pred HHHhcCCCChHHhhh------hhhhhhhh--h-------hhcccccCCCHHHHcc----------------CCC--HHHH
Confidence 776655443322211 11111000 0 0000000001111100 011 1688
Q ss_pred HHHhHccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 415 DLIFRMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 415 dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
+||.+||..||.+|||+.|+|+||||+.+.
T Consensus 278 ~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 278 DFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred HHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=314.99 Aligned_cols=285 Identities=31% Similarity=0.499 Sum_probs=226.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEcc---CcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN---KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
.+.|+-+.+||+|.||.||+|+...+|+.||+|++-- +..+.....+|+++++.+.|. |++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHe------nv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHE------NVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcch------hHHHHHHHHhhcc
Confidence 4568888999999999999999999999999986542 455666777788877776544 36666665532
Q ss_pred ------cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 ------RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ------~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
+..+||||.+|+.+|..+|.+.. ..++...+++++++++.||.|+|. ..|+|||+||.|+|| +.++.+|
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLI--t~dgilk 164 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLI--TKDGILK 164 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEE--cCCceEE
Confidence 34589999999999999997654 469999999999999999999995 679999999999999 7899999
Q ss_pred EEecccccccCC-------ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy16081 267 IVDFGSSCQLGQ-------RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338 (493)
Q Consensus 267 L~DFG~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 338 (493)
|+|||+++.+.. ..+..+-|.+|++||.++|. .|+++.|||..||||.||++|.+.|++..+..++..|...
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 999999976632 23445668999999999985 5999999999999999999999999999999999999999
Q ss_pred hCCCChhhhhhccchhhhhccC-----CCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhH
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKM-----PDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (493)
+|....+.|+...+..-| ..+ +.+.|+ .+.+.+. |.. . ..+.
T Consensus 245 cGs~tkevWP~~d~lpL~-~sie~ePl~~~~~r----------------kv~n~~k-----p~~----------k-d~~a 291 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLY-QSIELEPLPKGQKR----------------KVKNRLK-----PYV----------K-DDEA 291 (376)
T ss_pred hccCCcccCCCcccchHH-HhccCCCCCcchhh----------------hhhhhcc-----ccc----------C-ChhH
Confidence 999888888776554322 222 122211 1111111 100 0 1156
Q ss_pred HHHHhHccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 414 ~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
.||+.+||.+||.+|+++.|+|.|.||-.-...
T Consensus 292 ~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 292 LDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred HHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 899999999999999999999999999865443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.88 Aligned_cols=281 Identities=32% Similarity=0.539 Sum_probs=214.3
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCC--CeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEE--QCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
+|++.+.||+|+||.||+|.+..+ +..||||++..... .......|..++..+ .+|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHF-----RGHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHh-----cCCCChheeeeeeeecc
Confidence 488999999999999999999888 89999999864211 122333444444332 257889999987543
Q ss_pred --cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 193 --RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 193 --~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
...+|+++||++++|.+++... ..+++..++.++.||+.||.|||. .||+||||||+|||+ +.++.+||+||
T Consensus 76 ~~~~~~~~~~e~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili--~~~~~~kl~Df 149 (332)
T cd07857 76 GNFNELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLV--NADCELKICDF 149 (332)
T ss_pred ccCCcEEEEEecccCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEE--cCCCCEEeCcC
Confidence 2468999999999999988654 368999999999999999999994 789999999999999 67889999999
Q ss_pred ccccccCCc-------cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 271 GSSCQLGQR-------IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 271 G~a~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
|++..+... .....|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..++..++.+
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence 999765321 223578899999998876 468999999999999999999999999999999999999999988
Q ss_pred Chhhhhhccchh--hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 343 PKHLLDGAHKTR--KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 343 p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
+...+....... .+........ ...+..+. ......+.+||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~------------------~~~~~~~~~li~~~ 275 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIP----------------KKPFESIF------------------PNANPLALDLLEKL 275 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccC----------------CcchHhhC------------------CCCCHHHHHHHHHH
Confidence 876654432211 1111100000 00000000 00112688999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
|..||.+|||+.|+++||||..+.+
T Consensus 276 l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 276 LAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred ccCCcccCCCHHHHhcChhhhhhcC
Confidence 9999999999999999999987754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=317.93 Aligned_cols=250 Identities=30% Similarity=0.478 Sum_probs=199.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+..|..++..+ +|+||+++++.+....++|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC------DSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC------CCCcEeeeeeeeecCCcEEE
Confidence 579999999999999999999998899999999875432 34445555544433 67889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+||+++ +|.+++.... ..+++..++.++.||+.||.||| ..+|+|+||+|+||++ +.++.++|+|||++....
T Consensus 76 ~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~--~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 76 VMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILL--NEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEE--CCCCcEEEcccccchhcc
Confidence 9999976 8888886533 46899999999999999999999 4789999999999999 678889999999997764
Q ss_pred Ccc---ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 278 QRI---YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 278 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
... ....++..|+|||++.+..++.++|||||||++|+|++|.+||...+.......+... .+..
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~--------- 218 (256)
T cd06612 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPPT--------- 218 (256)
T ss_pred cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CCCC---------
Confidence 432 3445788999999999999999999999999999999999999876544332221110 0000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
+. .+ ... ...+.+||.+||..||.+|||+.|+
T Consensus 219 --~~-------------------------------------------~~-~~~--~~~~~~~i~~~l~~~P~~Rps~~~i 250 (256)
T cd06612 219 --LS-------------------------------------------DP-EKW--SPEFNDFVKKCLVKDPEERPSAIQL 250 (256)
T ss_pred --CC-------------------------------------------ch-hhc--CHHHHHHHHHHHhcChhhCcCHHHH
Confidence 00 00 000 0168899999999999999999999
Q ss_pred hcCCCC
Q psy16081 435 LQHNFF 440 (493)
Q Consensus 435 L~Hp~~ 440 (493)
|+||||
T Consensus 251 l~~~~~ 256 (256)
T cd06612 251 LQHPFI 256 (256)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=323.36 Aligned_cols=254 Identities=24% Similarity=0.415 Sum_probs=192.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|+++++||+|+||.||+|.+..+++.||||++..... .. ....+..++......+|+||+++++.+...+..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VE---LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hH---HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 368889999999999999999999999999999864321 11 11122223333333467889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+++ +|..+ ..+++..+..++.||+.||.||| +.||+|+||||+|||+ +.++.++|+|||++....
T Consensus 77 v~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill--~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 77 CTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLV--NTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEE--CCCCCEEEeeCCcceecc
Confidence 9999977 55332 24788899999999999999999 4799999999999999 678899999999997664
Q ss_pred Cc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhhhhccch
Q psy16081 278 QR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ---MNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 278 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~---~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
.. ....+|+..|+|||++.+..++.++|||||||++|+|++|..||......+. ...........
T Consensus 147 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 215 (279)
T cd06619 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE----------- 215 (279)
T ss_pred cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----------
Confidence 33 3456789999999999999999999999999999999999999975321110 00000000000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
.. .. . +.... ...+.+||.+||..||++||++++
T Consensus 216 ------~~--------------~~----------------------~--~~~~~--~~~~~~li~~~l~~~P~~Rp~~~e 249 (279)
T cd06619 216 ------DP--------------PV----------------------L--PVGQF--SEKFVHFITQCMRKQPKERPAPEN 249 (279)
T ss_pred ------CC--------------CC----------------------C--CCCcC--CHHHHHHHHHHhhCChhhCCCHHH
Confidence 00 00 0 00000 116889999999999999999999
Q ss_pred HhcCCCCCCC
Q psy16081 434 ALQHNFFKRT 443 (493)
Q Consensus 434 ~L~Hp~~~~~ 443 (493)
+++||||...
T Consensus 250 il~~~~~~~~ 259 (279)
T cd06619 250 LMDHPFIVQY 259 (279)
T ss_pred HhcCcccccc
Confidence 9999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=345.36 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=196.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEc-cCcccchHHHHHHHHHHHHhhcCCCCcceEEEecee-eee---
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK-NKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH-FMW--- 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~-~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~-~~~--- 192 (493)
..+++|.+.|.+|||+.||+|.+...|..||+|++- ..+.......+|+.+++.|. +|+|||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~-----gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS-----GHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc-----CCCceeeEeccccccccC
Confidence 347889999999999999999999988999999775 34445566677777766554 68889999993 221
Q ss_pred c---ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 193 R---NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 193 ~---~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
. -.++|.||||. |+|.|++......+|++.++++|+.|+++|+.+||..+..|||||||-||||| ..+++.|||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl--s~~g~~KLC 188 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL--SADGNYKLC 188 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE--cCCCCEEeC
Confidence 1 25789999997 59999998666567999999999999999999999888889999999999999 678899999
Q ss_pred ecccccccCCcc------------ccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16081 269 DFGSSCQLGQRI------------YQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 333 (493)
Q Consensus 269 DFG~a~~~~~~~------------~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~ 333 (493)
|||.|+...... .....|+.|+|||++. +.+.+.|+|||+|||+||-|+....||.......
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--- 265 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--- 265 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---
Confidence 999996542211 1235689999999985 6789999999999999999999999998653221
Q ss_pred HHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhH
Q psy16081 334 KIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413 (493)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (493)
|+ ++.|. +|.-.+. ...|
T Consensus 266 -Il-------------------------ng~Y~-----------~P~~p~y-------------------------s~~l 283 (738)
T KOG1989|consen 266 -IL-------------------------NGNYS-----------FPPFPNY-------------------------SDRL 283 (738)
T ss_pred -EE-------------------------ecccc-----------CCCCccH-------------------------HHHH
Confidence 11 12221 1111111 1278
Q ss_pred HHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 414 KDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 414 ~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
++||+.||+.||.+||++.|++.+
T Consensus 284 ~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 284 KDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHHHHhccCcccCCCHHHHHHH
Confidence 999999999999999999998864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=320.50 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=193.0
Q ss_pred ecCcEEEeeeE--eeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 117 FLDRYEIDSLI--GKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 117 ~~~~y~~~~~L--G~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+.++|++.+.+ |.|+||.||++.+..+++.+|+|++..... .. .|......+ .+|+||+++++.|...+
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~--~e~~~~~~~-----~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF--NA--IEPMVHQLM-----KDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc--ch--hhHHHHHHh-----hcCCCEEEEEEEEecCC
Confidence 34566776665 999999999999999999999999874321 11 122222222 15788999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC-cEEEEeccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS-AIKIVDFGS 272 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~-~ikL~DFG~ 272 (493)
.+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+ .|++||||||+||++ +.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~--~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLY--DRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEE--eCCCCeEEEecCcc
Confidence 9999999995 59999987653 68999999999999999999994 789999999999999 4455 899999999
Q ss_pred ccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhhcc
Q psy16081 273 SCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ-MNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 273 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~~p~~~~~~~~ 351 (493)
+...... ....++..|+|||++.+..++.++|||||||++|+|++|..||......+. ...+......+. .
T Consensus 157 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~------ 228 (267)
T PHA03390 157 CKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL-P------ 228 (267)
T ss_pred ceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC-C------
Confidence 8766543 234688999999999999999999999999999999999999986543321 111111000000 0
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC-
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT- 430 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t- 430 (493)
. .+ . ....+.+||.+||+.||.+|++
T Consensus 229 ----~------------------------~~-----------------------~--~~~~~~~li~~~l~~~p~~R~~~ 255 (267)
T PHA03390 229 ----F------------------------IK-----------------------N--VSKNANDFVQSMLKYNINYRLTN 255 (267)
T ss_pred ----c------------------------cc-----------------------c--cCHHHHHHHHHHhccChhhCCch
Confidence 0 00 0 0017899999999999999996
Q ss_pred HHHHhcCCCCC
Q psy16081 431 PYYALQHNFFK 441 (493)
Q Consensus 431 ~~e~L~Hp~~~ 441 (493)
.+|+|+||||.
T Consensus 256 ~~~~l~h~~~~ 266 (267)
T PHA03390 256 YNEIIKHPFLK 266 (267)
T ss_pred HHHHhcCCccc
Confidence 59999999996
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=324.64 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=200.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..+|++.+.||.|+||.||+|.+..+++.||+|.+...... ......|..++. ...|+||+++++.|....+.
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~------~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR------ENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHH------hCCCCCEeeEEEEEEeCCEE
Confidence 35899999999999999999999999999999998743321 222333433332 23577899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+.+ +|.+++... .+++..+..++.|++.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill--~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--cCCCCEEECccccchh
Confidence 999999965 898888643 47899999999999999999994 789999999999999 6788999999999876
Q ss_pred cCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... .....+++.|+|||.+.+..++.++|||||||++|+|++|++||...+....+..+... +.++.
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~-------- 236 (296)
T cd06654 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL-------- 236 (296)
T ss_pred ccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCC--------
Confidence 5322 23457888999999999988999999999999999999999999877654433322210 00000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
+... .. ...+.+||.+||..||++|||+.
T Consensus 237 --------------------------~~~~-----------------------~~--~~~l~~li~~~l~~~p~~Rpt~~ 265 (296)
T cd06654 237 --------------------------QNPE-----------------------KL--SAIFRDFLNRCLDMDVEKRGSAK 265 (296)
T ss_pred --------------------------CCcc-----------------------cc--CHHHHHHHHHHCcCCcccCcCHH
Confidence 0000 00 01678999999999999999999
Q ss_pred HHhcCCCCCCCc
Q psy16081 433 YALQHNFFKRTA 444 (493)
Q Consensus 433 e~L~Hp~~~~~~ 444 (493)
++++||||....
T Consensus 266 eil~~~~~~~~~ 277 (296)
T cd06654 266 ELLQHQFLKIAK 277 (296)
T ss_pred HHhhChhhhccC
Confidence 999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.27 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=202.3
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|++++.||.|+||.||.+++..+++.+++|.+...... ...+..|+.+++. .+|+||+++++++.+.+.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~------~~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSL------LQHPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHh------CCCCCeeEEEeEEecCCeE
Confidence 589999999999999999999999999999988643211 2233344443333 3577899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
++||||+.+ +|.+++.......+++..+..++.|++.+|.|||+ .|++|+||+|+||++ +.++.+||+|||++..
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~--~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFL--TKAGLIKLGDFGISKI 150 (256)
T ss_pred EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEE--eCCCCEEECcCcceEE
Confidence 999999965 99999876544568999999999999999999994 789999999999999 6778899999999976
Q ss_pred cCCcc---ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQRI---YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
..... ....+++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+..
T Consensus 151 ~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------- 222 (256)
T cd08221 151 LGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV-------- 222 (256)
T ss_pred cccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc--------
Confidence 64332 3457899999999999888999999999999999999999999987776666655421000000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
... ...+.+||.+||..||.+|||+.
T Consensus 223 ----------------------------------------------------~~~--~~~~~~~i~~~l~~~p~~R~s~~ 248 (256)
T cd08221 223 ----------------------------------------------------SVY--SSELISLVHSLLQQDPEKRPTAD 248 (256)
T ss_pred ----------------------------------------------------ccc--CHHHHHHHHHHcccCcccCCCHH
Confidence 000 01688999999999999999999
Q ss_pred HHhcCCCC
Q psy16081 433 YALQHNFF 440 (493)
Q Consensus 433 e~L~Hp~~ 440 (493)
++|+|||+
T Consensus 249 ~ll~~~~l 256 (256)
T cd08221 249 EVLDQPLL 256 (256)
T ss_pred HHhhCcCC
Confidence 99999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=321.15 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=191.1
Q ss_pred eEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch----HHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEE
Q psy16081 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN----QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFE 201 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E 201 (493)
+||+|+||.||++.+..+++.||||.+........ ....+..+ +......+|++|+.+.+.+...+..|+|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM---LSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHH---HHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 48999999999999999999999999865332111 11222222 233344568889999999999999999999
Q ss_pred eccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc-
Q psy16081 202 LLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR- 279 (493)
Q Consensus 202 ~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~- 279 (493)
|+.+ +|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.++|+|||++......
T Consensus 78 ~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~--~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 78 LMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEE--CCCCCEEEccCCcceeccccC
Confidence 9965 8888886543 58999999999999999999995 789999999999999 67889999999998765432
Q ss_pred cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 280 IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVD--QMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||....... .+..... ..+.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~------------- 216 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNV------------- 216 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCc-------------
Confidence 234578999999999874 568999999999999999999999997543211 1111100 0000
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CH
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TP 431 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~ 431 (493)
. +. ... ...+.+||.+||..||.+|+ |+
T Consensus 217 --------------------~------~~-------------------~~~--~~~~~~li~~~l~~~p~~R~~~~~~~~ 249 (279)
T cd05633 217 --------------------E------LP-------------------DSF--SPELKSLLEGLLQRDVSKRLGCLGRGA 249 (279)
T ss_pred --------------------C------Cc-------------------ccc--CHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence 0 00 000 11688999999999999999 69
Q ss_pred HHHhcCCCCCCCcc
Q psy16081 432 YYALQHNFFKRTAD 445 (493)
Q Consensus 432 ~e~L~Hp~~~~~~~ 445 (493)
+++++||||+.+..
T Consensus 250 ~~~~~h~~~~~~~~ 263 (279)
T cd05633 250 QEVKEHVFFKGIDW 263 (279)
T ss_pred HHHHhCccccCCCH
Confidence 99999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=317.05 Aligned_cols=255 Identities=28% Similarity=0.420 Sum_probs=198.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
++|++.+.||.|+||+||+|.+..++..+|+|++..... .......|...+. ...|++|+++++.+...+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~------~l~~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMS------QCNHPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHH------hcCCCCEEEEEEEEeeCCEE
Confidence 479999999999999999999888999999999864332 1223333443332 23577899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
|+|||++.+ +|.+++..... ..+++..+..++.||+.||.||| +.||+|+||||+||++ ++++.++|+|||++.
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~--~~~~~~~l~df~~~~ 150 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILL--GEDGSVKIADFGVSA 150 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEE--cCCCCEEEcccchHH
Confidence 999999965 88888876432 46899999999999999999999 5799999999999999 567889999999986
Q ss_pred ccCCcc-------ccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 275 QLGQRI-------YQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 275 ~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
...... ....|+..|+|||++... .++.++|+|||||++|+|++|..||...+....+.++... .+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~ 227 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSL 227 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCc
Confidence 664321 234688899999999877 7899999999999999999999999876655444333221 00000
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
. ... +..... ..+.+||.+||..||+
T Consensus 228 -----------~---------------------~~~--------------------~~~~~~--~~~~~li~~~l~~~p~ 253 (267)
T cd06610 228 -----------E---------------------TGA--------------------DYKKYS--KSFRKMISLCLQKDPS 253 (267)
T ss_pred -----------C---------------------Ccc--------------------cccccc--HHHHHHHHHHcCCChh
Confidence 0 000 000001 1678999999999999
Q ss_pred CCCCHHHHhcCCCC
Q psy16081 427 TRITPYYALQHNFF 440 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~ 440 (493)
+|||+.++++||||
T Consensus 254 ~Rp~~~~ll~~p~~ 267 (267)
T cd06610 254 KRPTAEELLKHKFF 267 (267)
T ss_pred hCcCHHHHhhCCCC
Confidence 99999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.90 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=195.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch-HHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN-QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~-~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
+|++.+.||+|+||+||+|.+ .+++.+|||.++....... .......+.+++......+|+||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478889999999999999976 5789999999874332111 11111123333333344457789999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+||+.+ +|.+++.... .+++..+..++.||+.||.||| ..+|+|+||+|+||++ +.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 80 FMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVML--MPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEE--CCCCeEEeccchhhHhhh
Confidence 9999965 8999886543 5889999999999999999999 4789999999999999 678899999999986542
Q ss_pred C---------ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 278 Q---------RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 278 ~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
. ......++..|+|||++.+..++.++|||||||++|+|++|..||...+.......+....+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 229 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR---- 229 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC----
Confidence 1 122356788999999999989999999999999999999999999876554443333221111000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.+ ... ...+.+||++||..||.+|
T Consensus 230 -----------~~-------------------------------------------~~~--~~~~~~~i~~~l~~~p~~R 253 (265)
T cd06631 230 -----------LP-------------------------------------------DSF--SAAAIDFVTSCLTRDQHER 253 (265)
T ss_pred -----------CC-------------------------------------------CCC--CHHHHHHHHHHhcCCcccC
Confidence 00 000 1168899999999999999
Q ss_pred CCHHHHhcCCCC
Q psy16081 429 ITPYYALQHNFF 440 (493)
Q Consensus 429 ~t~~e~L~Hp~~ 440 (493)
||+.|+|+||||
T Consensus 254 p~~~~~l~~~~~ 265 (265)
T cd06631 254 PSALQLLRHDFL 265 (265)
T ss_pred CCHHHHhcCCCC
Confidence 999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=313.94 Aligned_cols=250 Identities=28% Similarity=0.375 Sum_probs=200.0
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|++.+.||+|+||.||+|.+..+++.+|||.+...... ......|+.++ ...+|+||+++++.+...+.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l------~~~~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVL------KLLSHPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHH------hhCCCCchhheeeeEecCCEE
Confidence 589999999999999999999999999999998643221 12223333333 333578899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
++||||+++ +|.+++.......+++..+..++.|++.+|.|||+ .||+|+||||+||+++ +.++.+||+|||++..
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~-~~~~~~~l~d~~~~~~ 151 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLD-KHKMVVKIGDFGISKI 151 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEc-CCCCEEEEccCCCcee
Confidence 999999965 99999976554568999999999999999999994 7999999999999994 2455689999999987
Q ss_pred cCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 276 LGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 276 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
.... .....++..|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 220 (256)
T cd08220 152 LSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP----------- 220 (256)
T ss_pred cCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC-----------
Confidence 6543 234568889999999998889999999999999999999999998877655544443211000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
.+ . . ....+.+||.+||..||.+|||+.|
T Consensus 221 ------~~--------------------~-----------------------~--~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 221 ------IS--------------------D-----------------------R--YSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred ------CC--------------------C-----------------------C--cCHHHHHHHHHHccCChhhCCCHHH
Confidence 00 0 0 0016889999999999999999999
Q ss_pred HhcCCCC
Q psy16081 434 ALQHNFF 440 (493)
Q Consensus 434 ~L~Hp~~ 440 (493)
+++||||
T Consensus 250 ll~~p~~ 256 (256)
T cd08220 250 IMAQPIC 256 (256)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=325.48 Aligned_cols=257 Identities=27% Similarity=0.387 Sum_probs=200.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..+|++++.||.|+||.||+|.+..+++.||||.+...... ......|..+ ....+|+||++++++|...++.
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~------l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV------MRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHH------HHhCCCCCEeeEEEEEecCCEE
Confidence 46899999999999999999999999999999998643321 1122223322 2334678899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++... .+++..+..++.|++.||.|||+ .||+||||||+|||+ +.++.++|+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili--~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQ 164 (297)
T ss_pred EEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCCEEECcCccceE
Confidence 999999965 888888653 48899999999999999999994 789999999999999 6788999999999876
Q ss_pred cCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... .....+++.|+|||.+.+..++.++|+|||||++|+|++|.+||.+.+....+..+.. .+.++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~-------- 235 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL-------- 235 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCCC--------
Confidence 5332 2345688899999999998899999999999999999999999987654332211110 000000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
... ......+.+||.+||..||++|||+.
T Consensus 236 --------------------------~~~-------------------------~~~~~~~~~li~~~l~~~p~~Rps~~ 264 (297)
T cd06656 236 --------------------------QNP-------------------------ERLSAVFRDFLNRCLEMDVDRRGSAK 264 (297)
T ss_pred --------------------------CCc-------------------------cccCHHHHHHHHHHccCChhhCcCHH
Confidence 000 00011678999999999999999999
Q ss_pred HHhcCCCCCCCccCC
Q psy16081 433 YALQHNFFKRTADES 447 (493)
Q Consensus 433 e~L~Hp~~~~~~~~~ 447 (493)
++++||||.......
T Consensus 265 ~il~~~~~~~~~~~~ 279 (297)
T cd06656 265 ELLQHPFLKLAKPLS 279 (297)
T ss_pred HHhcCchhccccccc
Confidence 999999999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=316.24 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=195.0
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
+.||.|+||.||+|.+..+++.||||++............ ....+........+|+||+++++.+...+.+|+|+||+.
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVT-NVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHH-HHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 5799999999999999999999999998643211111111 111111112233478899999999999999999999996
Q ss_pred c-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCccccc
Q psy16081 205 Y-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 283 (493)
Q Consensus 205 ~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~~~ 283 (493)
+ +|.+++.... .+++..+..++.||+.||.|||+ .+++|+||+|+||++ +.++.+||+|||++..... ....
T Consensus 81 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~-~~~~ 153 (260)
T cd05611 81 GGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLI--DQTGHLKLTDFGLSRNGLE-NKKF 153 (260)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEE--CCCCcEEEeecccceeccc-cccC
Confidence 5 8998886543 58999999999999999999995 789999999999999 6778899999999876543 2345
Q ss_pred cccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCC
Q psy16081 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDG 363 (493)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 363 (493)
.++..|+|||.+.+..++.++||||||+++|+|++|.+||...+.......+.......+...
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------- 216 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEV----------------- 216 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcc-----------------
Confidence 688899999999988899999999999999999999999988776655544432110000000
Q ss_pred CceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH---HHHhcCCCC
Q psy16081 364 SYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP---YYALQHNFF 440 (493)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~---~e~L~Hp~~ 440 (493)
.. .....+.+||.+||..||++|||+ +|+|.||||
T Consensus 217 ---------------------~~---------------------~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 217 ---------------------KE---------------------FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred ---------------------cc---------------------cCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 00 000168899999999999999954 799999999
Q ss_pred CCCc
Q psy16081 441 KRTA 444 (493)
Q Consensus 441 ~~~~ 444 (493)
....
T Consensus 255 ~~~~ 258 (260)
T cd05611 255 KSIN 258 (260)
T ss_pred hcCC
Confidence 8653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=308.52 Aligned_cols=261 Identities=28% Similarity=0.406 Sum_probs=207.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhh-cCCCCcceEEEeceeeeecceeE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK-ADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~-~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
++.+++..||.|+.|+||+++.+.+|...|||.+...... +.-.+++.-+.. ......|+||+.+++|..+..++
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk----ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK----EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH----HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 3456678899999999999999999999999999754321 112223332222 22335789999999999999999
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
+.||.|.-.+..+++... +.++|..+-++...++.||.||-. +.+|||||+||+|||+ |+.|+|||||||++..+-
T Consensus 168 IcMelMs~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILl--De~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILL--DERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHHHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEE--ccCCCEEeecccccceee
Confidence 999999877777776554 569999999999999999999976 5789999999999999 899999999999997664
Q ss_pred Cc--cccccccCcCCchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 278 QR--IYQYIQSRFYRSPEVLLG---IPYDLAIDMWSLGCILVEMHTGEPLFSGS-NEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 278 ~~--~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
+. .+...|-+.|||||.+.- ..|+..+||||||+.|+||.||..||.+. .+.+.+.+|.+. .||. ++...
T Consensus 244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~--L~~~~ 319 (391)
T KOG0983|consen 244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPL--LPGHM 319 (391)
T ss_pred cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCC--CCccc
Confidence 43 345678899999999963 36999999999999999999999999985 466777777762 2221 00000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
+ .+ ..|.+|+..||..|+.+||.-
T Consensus 320 -----------------------------------------g-------------FS--p~F~~fv~~CL~kd~r~RP~Y 343 (391)
T KOG0983|consen 320 -----------------------------------------G-------------FS--PDFQSFVKDCLTKDHRKRPKY 343 (391)
T ss_pred -----------------------------------------C-------------cC--HHHHHHHHHHhhcCcccCcch
Confidence 0 00 178999999999999999999
Q ss_pred HHHhcCCCCCCCccCC
Q psy16081 432 YYALQHNFFKRTADES 447 (493)
Q Consensus 432 ~e~L~Hp~~~~~~~~~ 447 (493)
.++|+|||+...+...
T Consensus 344 ~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 344 NKLLEHPFIKRYETAE 359 (391)
T ss_pred HHHhcCcceeecchhh
Confidence 9999999999876544
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=320.39 Aligned_cols=280 Identities=34% Similarity=0.548 Sum_probs=213.4
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
|++.+.||.|+||+||+|.+..+++.||||.+............ ...+..+. ...+|+||+++++.+...+..|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~-~~e~~~l~--~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLR--KLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHH-HHHHHHHH--hccCCCCchhHHHHhhcCCcEEEEE
Confidence 67889999999999999999889999999998744322121111 11122222 2224888999999999999999999
Q ss_pred EecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC--
Q psy16081 201 ELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-- 278 (493)
Q Consensus 201 E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~-- 278 (493)
||++++|.+.+.......+++..+..++.|++.+|.|||+ .|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i--~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEE--cCCCCEEEeecccceeccCCC
Confidence 9998899998876654568999999999999999999994 789999999999999 6788999999999976644
Q ss_pred ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhh
Q psy16081 279 RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYF 357 (493)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 357 (493)
......++..|+|||++.+ ..++.++|+|||||++++|++|.+||......+.+.++...++.+....+.........+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 2334678889999998854 458999999999999999999999999999999999999988887765543322111111
Q ss_pred ccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 358 DKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
. +.+... ....+.+.+. .....+.+||++||..||++|||++|++.|
T Consensus 234 ~------~~~~~~---------~~~~~~~~~~------------------~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 G------FRFPQF---------APTSLHQLIP------------------NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred c------cccccc---------ccccHHHHcc------------------cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 000000 0000011000 001278999999999999999999999999
Q ss_pred CCC
Q psy16081 438 NFF 440 (493)
Q Consensus 438 p~~ 440 (493)
|||
T Consensus 281 ~~~ 283 (283)
T cd07830 281 PYF 283 (283)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.43 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=201.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.+|++.+.||.|+||.||+|.+..+++.||||.+...... ......|..++ ...+|+||+++++.+...+.+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l------~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVM------KELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHH------HhcCCCceeeeeeeEecCceEE
Confidence 4799999999999999999999999999999998643321 12223333332 2335788999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+|+||+.+ +|.+++... .+++..+..++.|++.||.|||+ .|++|+||||+||++ +.++.+||+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili--~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 93 VVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLL--GMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCCEEEccCccchhc
Confidence 99999965 888877643 48999999999999999999995 789999999999999 67889999999998765
Q ss_pred CCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... .....++..|+|||.+.+..++.++|||||||++|+|++|.+||.+.+.......+... +.++..
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~-------- 236 (296)
T cd06655 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQ-------- 236 (296)
T ss_pred ccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcccC--------
Confidence 432 22346888999999999988999999999999999999999999987765554433221 000000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
.. .... ..+.+||++||..||.+|||+.+
T Consensus 237 --------------------------~~-----------------------~~~~--~~~~~li~~~l~~dp~~Rpt~~~ 265 (296)
T cd06655 237 --------------------------NP-----------------------EKLS--PIFRDFLNRCLEMDVEKRGSAKE 265 (296)
T ss_pred --------------------------Cc-----------------------ccCC--HHHHHHHHHHhhcChhhCCCHHH
Confidence 00 0000 16789999999999999999999
Q ss_pred HhcCCCCCCCcc
Q psy16081 434 ALQHNFFKRTAD 445 (493)
Q Consensus 434 ~L~Hp~~~~~~~ 445 (493)
+++||||.....
T Consensus 266 il~~~~~~~~~~ 277 (296)
T cd06655 266 LLQHPFLKLAKP 277 (296)
T ss_pred HhhChHhhhccc
Confidence 999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=318.13 Aligned_cols=255 Identities=29% Similarity=0.411 Sum_probs=199.3
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc--
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN-- 194 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~-- 194 (493)
..++|++.+.||.|+||.||+|.+..+++.||+|++.........+..|..++..+ .+|+||++++++|....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~-----~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKY-----SNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHh-----cCCCChheEEEEEEecCCC
Confidence 35789999999999999999999999999999999876544334455555555443 25778999999997644
Q ss_pred ----eeEEEEEeccc-CHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 195 ----HLCLVFELLSY-NLYDLLRNTN--FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 195 ----~~~lV~E~~~~-~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
.+|+||||+++ +|.+++.... ...+++..++.++.|++.||.|||+ .+++|+||+|+||++ +.++.+||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~--~~~~~~~l 154 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILL--TKNAEVKL 154 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEE--ccCCeEEE
Confidence 58999999976 8888876432 3468999999999999999999995 789999999999999 67788999
Q ss_pred EecccccccCCc---cccccccCcCCchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy16081 268 VDFGSSCQLGQR---IYQYIQSRFYRSPEVLLG-----IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL 339 (493)
Q Consensus 268 ~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 339 (493)
+|||++...... .....++..|+|||++.. ..++.++|||||||+||+|++|.+||...+....+..+...
T Consensus 155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~- 233 (275)
T cd06608 155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN- 233 (275)
T ss_pred CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc-
Confidence 999998665332 234568889999999864 34788999999999999999999999876554444433221
Q ss_pred CCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhH
Q psy16081 340 GLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419 (493)
Q Consensus 340 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~ 419 (493)
++..+. .+ ......+.+||.+
T Consensus 234 --~~~~~~------------------------------------------------------~~---~~~~~~~~~li~~ 254 (275)
T cd06608 234 --PPPTLK------------------------------------------------------SP---ENWSKKFNDFISE 254 (275)
T ss_pred --CCCCCC------------------------------------------------------ch---hhcCHHHHHHHHH
Confidence 000000 00 0001168899999
Q ss_pred ccCCCCCCCCCHHHHhcCCCC
Q psy16081 420 MLDYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 420 mL~~dP~~R~t~~e~L~Hp~~ 440 (493)
||..||++|||+.|+++|||+
T Consensus 255 ~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 255 CLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HhhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=320.43 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=194.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
++|++.+.||+|+||.||+|.+..+++.||+|+++..... ......|..++ ....|+||+++++.+...+.+|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~------~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMM------KDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHH------HhCCCCCeeeEEEEEEeCCEEE
Confidence 5789999999999999999999999999999998744211 11222333332 2335788999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++.... .+++..+..++.||+.||.|||. .||+|+||||+||++ +.++.+||+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili--~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILL--TDNGHVKLADFGVSAQI 156 (267)
T ss_pred EEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--CCCCCEEECcceeeeEc
Confidence 99999965 8998886543 68999999999999999999994 789999999999999 67888999999998765
Q ss_pred CCc---cccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
... .....|+..|+|||++. ...++.++|||||||++|+|++|.+||........+..+......++.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~------ 230 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK------ 230 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCc------
Confidence 432 23457899999999985 456889999999999999999999999765543332222111000000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
+.+ .......+.+||.+||..||++|||
T Consensus 231 ---------------------------------~~~-------------------~~~~~~~~~~li~~~l~~~P~~R~~ 258 (267)
T cd06645 231 ---------------------------------LKD-------------------KMKWSNSFHHFVKMALTKNPKKRPT 258 (267)
T ss_pred ---------------------------------ccc-------------------cCCCCHHHHHHHHHHccCCchhCcC
Confidence 000 0000016789999999999999999
Q ss_pred HHHHhcCCC
Q psy16081 431 PYYALQHNF 439 (493)
Q Consensus 431 ~~e~L~Hp~ 439 (493)
++++++|||
T Consensus 259 ~~~ll~~~~ 267 (267)
T cd06645 259 AEKLLQHPF 267 (267)
T ss_pred HHHHhcCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=318.13 Aligned_cols=277 Identities=36% Similarity=0.581 Sum_probs=212.3
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--ce
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR--NH 195 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~--~~ 195 (493)
|++.+.||.|+||.||+|.+..+++.||||++.... ........|..++..+ +|+|++++++.+... +.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL------RHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc------cCCCeeeheeeEecCCCCc
Confidence 678899999999999999999999999999997542 1122333444444433 377899999999988 89
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
.|+|+||++++|.+++.... ..+++..++.++.||+.||.|||. .|++|+||||+||++ ++++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~--~~~~~~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILI--NNDGVLKLADFGLARP 149 (287)
T ss_pred EEEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEE--cCCCCEEEccccceee
Confidence 99999999989999887653 368999999999999999999994 789999999999999 6788999999999976
Q ss_pred cCCc----cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQR----IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.+..+.+....+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred ccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 6543 233456788999998875 45889999999999999999999999999988888888887777665544332
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.... ++... ....+....+.+.+... ....+.++|++||..||.+|||
T Consensus 230 ~~~~-~~~~~--------------~~~~~~~~~~~~~~~~~-----------------~~~~~~~~i~~~l~~~P~~Rp~ 277 (287)
T cd07840 230 SKLP-WFENL--------------KPKKPYKRRLREFFKHL-----------------IDPSALDLLDKLLTLDPKKRIS 277 (287)
T ss_pred ccch-hhhhc--------------cccccchhHHHHHhccc-----------------CCHHHHHHHHHHcCCChhhCcC
Confidence 2110 00000 00000111111111100 1127899999999999999999
Q ss_pred HHHHhcCCCC
Q psy16081 431 PYYALQHNFF 440 (493)
Q Consensus 431 ~~e~L~Hp~~ 440 (493)
+.++++||||
T Consensus 278 ~~~~l~~~~~ 287 (287)
T cd07840 278 ADQALQHEYF 287 (287)
T ss_pred HHHHhhCcCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=322.87 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=199.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
++|++++.||+|+||.||+|.+..+++.||+|.++..... ......|..++. ..+|+||+++++.+...+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~------~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILH------KAVSPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHH------hcCCCcHHhhhhheecCCeE
Confidence 4688999999999999999999999999999988643211 122233333332 33578899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTN-FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
|+||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+ +.+|+|+||||+||++ +.++.+||+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~ 151 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLV--NGNGQVKLCDFGVSG 151 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEE--CCCCCEEEeecCCcc
Confidence 999999976 8877776531 2358999999999999999999995 3689999999999999 568899999999997
Q ss_pred ccCCc-cccccccCcCCchhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 275 QLGQR-IYQYIQSRFYRSPEVLLGI------PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 275 ~~~~~-~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|..||...........+.......+....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd06622 152 NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP 231 (286)
T ss_pred cccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC
Confidence 65432 3345678899999998654 3588999999999999999999999765544433333222111100000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
. .. ..++.+||.+||..||.+
T Consensus 232 ----------------------------------~-----------------------~~--~~~~~~li~~~l~~~p~~ 252 (286)
T cd06622 232 ----------------------------------S-----------------------GY--SDDAQDFVAKCLNKIPNR 252 (286)
T ss_pred ----------------------------------c-----------------------cc--CHHHHHHHHHHcccCccc
Confidence 0 00 116789999999999999
Q ss_pred CCCHHHHhcCCCCCCCccC
Q psy16081 428 RITPYYALQHNFFKRTADE 446 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~~~~ 446 (493)
||++.++++||||......
T Consensus 253 Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 253 RPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred CCCHHHHhcChhhhhccCC
Confidence 9999999999999876544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=318.60 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=199.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||.|+||.||+|.+..+++.||+|++...... ..+..++.++.......|+||+++++.+...+.+|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE----AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh----HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 3688889999999999999999999999999998754321 112222233332223348889999999999999999
Q ss_pred EEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+||++ ++|.+++.... ..+++..+..++.||+.||.|||+ ..|++|+||||+||++ +.++.++|+|||.+....
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~--~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILV--NSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC-CCCeecCCCCHHHEEE--CCCCCEEEeecccchhhH
Confidence 999997 49999887653 468999999999999999999995 2799999999999999 668889999999987654
Q ss_pred Ccc-ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 278 QRI-YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN-----EVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 278 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~-----~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... ....++..|+|||++.+..++.++|||||||++|+|++|..||...+ ..+.+..+.. .++...
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~----- 224 (265)
T cd06605 153 NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPRL----- 224 (265)
T ss_pred HHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCCCC-----
Confidence 321 23678889999999999999999999999999999999999997642 1122222211 000000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
+ ....+ ..+.+||.+||..||++|||+
T Consensus 225 ---------------------------~------------------------~~~~~--~~~~~li~~~l~~~p~~Rpt~ 251 (265)
T cd06605 225 ---------------------------P------------------------SGKFS--PDFQDFVNLCLIKDPRERPSY 251 (265)
T ss_pred ---------------------------C------------------------hhhcC--HHHHHHHHHHcCCCchhCcCH
Confidence 0 00000 168899999999999999999
Q ss_pred HHHhcCCCCCCCc
Q psy16081 432 YYALQHNFFKRTA 444 (493)
Q Consensus 432 ~e~L~Hp~~~~~~ 444 (493)
.|++.||||+++.
T Consensus 252 ~~ll~~~~~~~~~ 264 (265)
T cd06605 252 KELLEHPFIKKYE 264 (265)
T ss_pred HHHhhCchhhccc
Confidence 9999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=315.89 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=190.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--cceeE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW--RNHLC 197 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~--~~~~~ 197 (493)
+|++.+.||+|+||.||+|.+..++..||+|++...............+.+++......+|+||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6889999999999999999999999999999886432111111111111122222223357789999998875 36789
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+|+||+++ +|.+++.... .+++...+.++.||+.||.||| ..+|+||||||+||++ +.++.+||+|||++...
T Consensus 83 l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~--~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILR--DSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEE--CCCCCEEEccCCCcccc
Confidence 99999965 8999887543 4899999999999999999999 4789999999999999 67888999999998755
Q ss_pred CCc------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 277 GQR------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 277 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
... .....++..|+|||++.+..++.++|||||||++|+|++|++||...+.......+..... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-~~------- 228 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-NP------- 228 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-CC-------
Confidence 321 1234578889999999998899999999999999999999999987654433332211000 00
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
..+ . ... ..+.+|| +||..||++|||
T Consensus 229 --------------------------~~~------~-------------------~~~--~~~~~li-~~~~~~p~~Rp~ 254 (266)
T cd06651 229 --------------------------QLP------S-------------------HIS--EHARDFL-GCIFVEARHRPS 254 (266)
T ss_pred --------------------------CCc------h-------------------hcC--HHHHHHH-HHhcCChhhCcC
Confidence 000 0 000 1567888 577789999999
Q ss_pred HHHHhcCCCCC
Q psy16081 431 PYYALQHNFFK 441 (493)
Q Consensus 431 ~~e~L~Hp~~~ 441 (493)
++|+++||||+
T Consensus 255 ~~eil~hp~~~ 265 (266)
T cd06651 255 AEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCcccc
Confidence 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=335.80 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=195.4
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
-+||+|+||+||-|+|..|...+|||-+..+. .+.+-.-.|+.+ +....|.|||+.++.+..++++-|.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaL------H~~LrHkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIAL------HSTLRHKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHH------HHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence 37999999999999999999999999886433 222333344444 44445667999999999999999999999
Q ss_pred cc-CHHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC---
Q psy16081 204 SY-NLYDLLRNTNFRGV--SLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--- 277 (493)
Q Consensus 204 ~~-~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~--- 277 (493)
+| +|.++|+..- +++ .+..+-.+.+||++||.||| +..|||||||-+|||+. .-.|.+||+|||-++.+.
T Consensus 655 PGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvN-TySGvlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVN-TYSGVLKISDFGTSKRLAGIN 730 (1226)
T ss_pred CCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEe-eccceEEecccccchhhccCC
Confidence 55 8888887543 456 78899999999999999999 57899999999999995 688999999999998773
Q ss_pred CccccccccCcCCchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 278 QRIYQYIQSRFYRSPEVLLGI--PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
.-..++.||..|||||++..+ +|+.++|||||||++.||.||+|||..... |...|... .
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-------------pqAAMFkV-----G 792 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS-------------PQAAMFKV-----G 792 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC-------------hhHhhhhh-----c
Confidence 334578999999999999865 599999999999999999999999974322 22222110 0
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
+|.. ..|.+.. .+. +++.||.+|+..||.+||+|.++|
T Consensus 793 myKv-----------------HP~iPee-----------------------lsa--eak~FilrcFepd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 793 MYKV-----------------HPPIPEE-----------------------LSA--EAKNFILRCFEPDPCDRPSAKDLL 830 (1226)
T ss_pred ceec-----------------CCCCcHH-----------------------HHH--HHHHHHHHHcCCCcccCccHHHhc
Confidence 0110 0011111 111 678999999999999999999999
Q ss_pred cCCCCCCC
Q psy16081 436 QHNFFKRT 443 (493)
Q Consensus 436 ~Hp~~~~~ 443 (493)
++||++..
T Consensus 831 ~DpFlq~~ 838 (1226)
T KOG4279|consen 831 QDPFLQHN 838 (1226)
T ss_pred cCcccccC
Confidence 99999865
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=318.09 Aligned_cols=276 Identities=36% Similarity=0.604 Sum_probs=213.0
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
|++.+.||.|++|.||+|.+..+++.+|+|.+...... ......|..++..+ +|++|+++++.+...+.+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL------NHPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh------cCCCcchHHHhhccCCCEE
Confidence 56788999999999999999889999999998744322 22333344333332 3677999999999999999
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
+|+||++++|.+.+.... ..+++..+..++.||+.||.|||. .+|+|+||||+||++ +.++.++|+|||.+....
T Consensus 75 ~v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili--~~~~~~~l~df~~~~~~~ 149 (283)
T cd05118 75 LVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLI--NTEGVLKLADFGLARSFG 149 (283)
T ss_pred EEEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEE--CCCCcEEEeeeeeeEecC
Confidence 999999999999887654 468999999999999999999994 789999999999999 677899999999997665
Q ss_pred Ccc---ccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 278 QRI---YQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 278 ~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... ....++..|+|||.+.+. .++.++|+|||||++|+|++|++||.+.+..+.+.++.+.++.+....+......
T Consensus 150 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 150 SPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred CCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 432 234577889999999877 7899999999999999999999999999999999998888887765554433221
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
..+.. +.... . ......++ .... ...+.+||.+||..||.+||++.+
T Consensus 230 ~~~~~------~~~~~-----~----~~~~~~~~----------------~~~~--~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 230 ARNYK------FSFPK-----K----AGMPLPKL----------------FPNA--SPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred hhhhh------hhhcc-----c----cccCHHHh----------------hhhh--CHHHHHHHHHHhccCcccCcCHHH
Confidence 11100 00000 0 00000000 0011 127899999999999999999999
Q ss_pred HhcCCCC
Q psy16081 434 ALQHNFF 440 (493)
Q Consensus 434 ~L~Hp~~ 440 (493)
++.||||
T Consensus 277 ll~~~~~ 283 (283)
T cd05118 277 ALAHPYF 283 (283)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=331.86 Aligned_cols=213 Identities=24% Similarity=0.267 Sum_probs=177.9
Q ss_pred CCCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceE
Q psy16081 105 DNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYI 183 (493)
Q Consensus 105 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~I 183 (493)
....|.+.+...++++|.-.++||+|+||.||+|.. .++..||||++...... ..++..|+.++. ..+|+|+
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls------~l~H~Nl 133 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILS------RLRHPNL 133 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHh------cCCCcCc
Confidence 345567777888899999999999999999999974 44599999988754433 344555555543 4457889
Q ss_pred EEeceeeeecc-eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC-CCCccccCCCCCcEEeeCC
Q psy16081 184 VRLKRHFMWRN-HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP-ELNIIHCDLKPENILLCNP 260 (493)
Q Consensus 184 v~l~~~~~~~~-~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~-~~~iiHrDlKp~NILl~~~ 260 (493)
|+|+++|.+.+ +.+||+|||.+ +|.+.|.......++|..+.+|+.+++.||+|||.. ...||||||||+|||| |
T Consensus 134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL--D 211 (361)
T KOG1187|consen 134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL--D 211 (361)
T ss_pred ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE--C
Confidence 99999999988 59999999964 999999765432789999999999999999999984 3369999999999999 7
Q ss_pred CCCcEEEEecccccccCC-cccc--c-cccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy16081 261 KRSAIKIVDFGSSCQLGQ-RIYQ--Y-IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS 326 (493)
Q Consensus 261 ~~~~ikL~DFG~a~~~~~-~~~~--~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~ 326 (493)
++.++||+|||+|+.... .... . .||.+|+|||++..+..+.++|||||||+|+||++|+.+.+..
T Consensus 212 ~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 899999999999976654 3222 2 7999999999999989999999999999999999999888754
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=319.00 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=193.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .......|+.++. ...|+||+++++.+...+.+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~------~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVK------ECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHH------hcCCCCeeeeeEEEEeCCEE
Confidence 3579999999999999999999999999999999874321 1222333444333 33577899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||++ +.++.+||+|||++..
T Consensus 82 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill--~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILL--TDNGDVKLADFGVAAK 155 (267)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEE--CCCCCEEECcCcccee
Confidence 999999965 888888654 368999999999999999999994 799999999999999 6788899999999976
Q ss_pred cCCc---cccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
.... .....++..|+|||.+. ...++.++|||||||++|||++|.+||......+....+......++
T Consensus 156 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 229 (267)
T cd06646 156 ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP------ 229 (267)
T ss_pred ecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC------
Confidence 6432 23456888999999985 34578899999999999999999999965443222111111000000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
..+ . ....+ ..+.+||++||..||++||
T Consensus 230 ---------------------------~~~------~-----------------~~~~~--~~~~~li~~~l~~~P~~Rp 257 (267)
T cd06646 230 ---------------------------KLK------D-----------------KTKWS--STFHNFVKISLTKNPKKRP 257 (267)
T ss_pred ---------------------------CCc------c-----------------ccccC--HHHHHHHHHHhhCChhhCc
Confidence 000 0 00001 2788999999999999999
Q ss_pred CHHHHhcCCC
Q psy16081 430 TPYYALQHNF 439 (493)
Q Consensus 430 t~~e~L~Hp~ 439 (493)
|++++|+|+|
T Consensus 258 ~~~~il~~l~ 267 (267)
T cd06646 258 TAERLLTHLF 267 (267)
T ss_pred CHHHHhcCCC
Confidence 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.84 Aligned_cols=285 Identities=33% Similarity=0.550 Sum_probs=216.4
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......|+.++..+ .+|+||++++++|..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l-----~~h~ni~~~~~~~~~ 78 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQEL-----GDHPNIVKLLNVIKA 78 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHh-----cCCCCccceeeeecc
Confidence 456789999999999999999999999999999998853211 112222333333322 257889999998864
Q ss_pred c--ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 193 R--NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 193 ~--~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
. ..+|+||||++++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+||++ +.++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill--~~~~~~kl~d~ 151 (337)
T cd07852 79 ENDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILL--NSDCRVKLADF 151 (337)
T ss_pred CCCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--cCCCcEEEeec
Confidence 3 468999999999999988654 57889999999999999999994 799999999999999 77889999999
Q ss_pred ccccccCCc--------cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 271 GSSCQLGQR--------IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 271 G~a~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
|++...... .....|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+.++....+.
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred cchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 998755321 224568889999998865 45889999999999999999999999999988999999888887
Q ss_pred CChhhhhhccc--hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhH
Q psy16081 342 PPKHLLDGAHK--TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419 (493)
Q Consensus 342 ~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~ 419 (493)
++...+..... ...+++.+....+ ..+.+++ ......+.+||.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~------------------~~~~~~l~~li~~ 277 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPR----------------KPLDELL------------------PKASDDALDLLKK 277 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccc----------------cchhhhc------------------cCCCHHHHHHHHH
Confidence 77655443321 1111111111000 0000000 0011278999999
Q ss_pred ccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 420 MLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 420 mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
||..||.+|||+.++++||||.+....
T Consensus 278 ~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 278 LLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred hccCCcccccCHHHHhhChhhhhhccC
Confidence 999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=333.19 Aligned_cols=255 Identities=28% Similarity=0.440 Sum_probs=209.3
Q ss_pred cEEE--eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 120 RYEI--DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 120 ~y~~--~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
-|+| .++||+|-||+||-|+++.+|+.||||++.+.+ ....+...|+.+++.+ +||.||.+...|+..+
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l------~HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL------HHPGIVNLECMFETPE 636 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc------CCCCeeEEEEeecCCc
Confidence 4555 478999999999999999999999999997533 2234555666665543 5677999999999999
Q ss_pred eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEEecccc
Q psy16081 195 HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~DFG~a 273 (493)
.+++|||-+.|+.++++.......+++...+.++.||+.||.||| ..+|+||||||+|||+.+. .-..+||||||+|
T Consensus 637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccce
Confidence 999999999999999998777678999999999999999999999 5799999999999999533 3467999999999
Q ss_pred cccCCcc--ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCChhhhhhc
Q psy16081 274 CQLGQRI--YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV-LGLPPKHLLDGA 350 (493)
Q Consensus 274 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~ 350 (493)
+.+++.. ...+|||.|+|||++.+++|+..-||||.|||+|--|+|..||..+. |+-.+|.+. +-.||..
T Consensus 715 RiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~P----- 787 (888)
T KOG4236|consen 715 RIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNP----- 787 (888)
T ss_pred eecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCc-----
Confidence 9998865 36789999999999999999999999999999999999999997433 222233221 1122221
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
|..++. .++|||..+|++.-++|.|
T Consensus 788 -----------------------------------------------------W~eis~--~AidlIn~LLqVkm~kRys 812 (888)
T KOG4236|consen 788 -----------------------------------------------------WSEISP--EAIDLINNLLQVKMRKRYS 812 (888)
T ss_pred -----------------------------------------------------hhhcCH--HHHHHHHHHHHHHHHHhcc
Confidence 111222 6789999999999999999
Q ss_pred HHHHhcCCCCCCCc
Q psy16081 431 PYYALQHNFFKRTA 444 (493)
Q Consensus 431 ~~e~L~Hp~~~~~~ 444 (493)
.++.|.|||++...
T Consensus 813 vdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 813 VDKSLSHPWLQDYQ 826 (888)
T ss_pred hHhhccchhhhcch
Confidence 99999999999764
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=319.84 Aligned_cols=253 Identities=30% Similarity=0.418 Sum_probs=197.3
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
-|++.+.||.|+||.||+|.+..++..+|+|.+..... .......|+.++ . ..+|+||+++++.+...+..|+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l---~---~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDIL---A---SCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHH---H---HCCCCCeeeEEEEEeeCCEEEE
Confidence 36788999999999999999999999999999864321 112223333332 2 2357889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+||+++ +|..++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 80 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili--~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 80 LIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILF--TLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEE--ccCCCEEEcccccccccc
Confidence 9999966 6766665432 468999999999999999999994 789999999999999 678889999999986553
Q ss_pred Cc---cccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 278 QR---IYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 278 ~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
.. .....++..|+|||++. +..++.++|||||||++|+|++|.+||...+..+....+........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 228 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL------ 228 (282)
T ss_pred ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC------
Confidence 22 23456889999999984 34578899999999999999999999988776665555433211000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
+.+. .. ...+.+||.+||..||.+||
T Consensus 229 -----------------------------~~~~-----------------------~~--~~~~~~li~~~l~~~p~~Rp 254 (282)
T cd06643 229 -----------------------------AQPS-----------------------RW--SSEFKDFLKKCLEKNVDARW 254 (282)
T ss_pred -----------------------------CCcc-----------------------cc--CHHHHHHHHHHccCChhhCc
Confidence 0000 00 01689999999999999999
Q ss_pred CHHHHhcCCCCCCC
Q psy16081 430 TPYYALQHNFFKRT 443 (493)
Q Consensus 430 t~~e~L~Hp~~~~~ 443 (493)
|+.++++||||...
T Consensus 255 ~~~~il~~~~~~~~ 268 (282)
T cd06643 255 TTTQLLQHPFVTVN 268 (282)
T ss_pred CHHHHhcCCCEecc
Confidence 99999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=319.99 Aligned_cols=259 Identities=26% Similarity=0.384 Sum_probs=200.1
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||.||++.+..+++.||||.+........ .....+.+++......+|+||+++++.+..++++|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILR--NQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhH--HHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 368999999999999999999999999999999864321101 111122222223334467889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+++ +|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||+++...
T Consensus 79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll--~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 79 VMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEE--CCCCCEEEeeCCCccccC
Confidence 9999965 898888665 358999999999999999999994 789999999999999 678899999999986321
Q ss_pred Cc------------------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy16081 278 QR------------------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL 339 (493)
Q Consensus 278 ~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 339 (493)
.. .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+.+..+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 00 012356788999999999899999999999999999999999998877666555544321
Q ss_pred CCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhH
Q psy16081 340 GLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419 (493)
Q Consensus 340 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~ 419 (493)
...+.. .... ...+.+||.+
T Consensus 233 ~~~~~~----------------------------------------------------------~~~~--~~~~~~li~~ 252 (305)
T cd05609 233 IEWPEG----------------------------------------------------------DEAL--PADAQDLISR 252 (305)
T ss_pred cCCCCc----------------------------------------------------------cccC--CHHHHHHHHH
Confidence 100000 0000 1167899999
Q ss_pred ccCCCCCCCCC---HHHHhcCCCCCCCcc
Q psy16081 420 MLDYDPKTRIT---PYYALQHNFFKRTAD 445 (493)
Q Consensus 420 mL~~dP~~R~t---~~e~L~Hp~~~~~~~ 445 (493)
||..||++||| +.++|+||||.....
T Consensus 253 ~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 253 LLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred HhccChhhccCccCHHHHHhCccccCCCH
Confidence 99999999998 899999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=312.13 Aligned_cols=252 Identities=31% Similarity=0.411 Sum_probs=198.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... .......|..++ ...+|+||+++++.+.+.+.+|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l------~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISML------KECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHH------HhCCCCChhceEEEEEeCCEEE
Confidence 579999999999999999999999999999999875432 122333333333 3346788999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||++ +.++.+||+|||++...
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILL--TEDGDVKLADFGVSAQL 151 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEE--CCCCCEEECccccchhh
Confidence 99999976 8888776542 46899999999999999999999 4789999999999999 67888999999999766
Q ss_pred CCc---cccccccCcCCchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGI---PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
... .....++..|+|||.+.+. .++.++|||||||++|+|++|.+||...+.......+... ...+..+..
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~-- 228 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS-NFPPPKLKD-- 228 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCccccc--
Confidence 432 2345788899999999877 7999999999999999999999999887655544333221 000000000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.......+.+||++||..||.+|||
T Consensus 229 -------------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rpt 253 (262)
T cd06613 229 -------------------------------------------------------KEKWSPVFHDFIKKCLTKDPKKRPT 253 (262)
T ss_pred -------------------------------------------------------hhhhhHHHHHHHHHHcCCChhhCCC
Confidence 0000116789999999999999999
Q ss_pred HHHHhcCCC
Q psy16081 431 PYYALQHNF 439 (493)
Q Consensus 431 ~~e~L~Hp~ 439 (493)
+.+++.|+|
T Consensus 254 ~~~il~~~~ 262 (262)
T cd06613 254 ATKLLQHPF 262 (262)
T ss_pred HHHHhcCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=317.46 Aligned_cols=275 Identities=34% Similarity=0.558 Sum_probs=216.3
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
|++.+.||+|+||.||+|++..+++.||+|++.... ........|+.++..+ +|++|+++++++.+.+.++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL------KHPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc------CCCCHHHHHhhhhcCCceE
Confidence 567889999999999999999999999999997542 2223334444444333 3778999999999999999
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
+||||++++|.+++.... ..+++..+..++.|++.||.|||. .||+||||+|+||++ ++++.++|+|||++....
T Consensus 75 ~v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~--~~~~~~~l~d~g~~~~~~ 149 (282)
T cd07829 75 LVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILI--NRDGVLKLADFGLARAFG 149 (282)
T ss_pred EEecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEE--cCCCCEEEecCCcccccC
Confidence 999999999999997653 358999999999999999999994 789999999999999 668899999999997664
Q ss_pred Ccc---ccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 278 QRI---YQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 278 ~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... ....++..|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+.++...++.+....+......
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 150 IPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred CCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 332 234557789999999876 7899999999999999999999999999999999999999888877776554333
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
. +++..-. .+ ......+.+. .. ...+.+||.+||..||++|||+.+
T Consensus 230 ~-~~~~~~~-~~--------------~~~~~~~~~~----------------~~--~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 230 P-DYKPTFP-KF--------------PPKDLEKVLP----------------RL--DPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred c-ccccccc-cc--------------CccchHHhcc----------------cc--cHHHHHHHHHhhccCcccCCCHHH
Confidence 2 1111000 00 0000000000 00 127899999999999999999999
Q ss_pred HhcCCCC
Q psy16081 434 ALQHNFF 440 (493)
Q Consensus 434 ~L~Hp~~ 440 (493)
++.||||
T Consensus 276 ~l~~p~~ 282 (282)
T cd07829 276 ALKHPYF 282 (282)
T ss_pred HhhCcCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=320.54 Aligned_cols=255 Identities=31% Similarity=0.466 Sum_probs=199.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.++|++.+.||.|+||+||+|.+..+++.||+|++..... ....+..|+.++.. .+|+||+++++.+...+.+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~------l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE------CKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHh------CCCCceeEEEEEEecCCeE
Confidence 3579999999999999999999988999999999864321 11223334433332 3477899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++.... ..+++..++.++.|++.||.||| +.+|+|+||||+||++ +.++.++|+|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili--~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 78 WILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILL--TLDGDVKLADFGVSAK 152 (280)
T ss_pred EEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEE--CCCCCEEEccCccchh
Confidence 999999966 8888876543 46999999999999999999999 4789999999999999 6788999999999865
Q ss_pred cCC---ccccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 276 LGQ---RIYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
... ......+++.|+|||++. +..++.++|||||||++|+|++|.+||...+....+..+.... ++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~--- 227 (280)
T cd06611 153 NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--PPT--- 227 (280)
T ss_pred hcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--CCC---
Confidence 532 223456889999999985 3457889999999999999999999998876655444332210 000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
+. .+. ... ..+.+||.+||..||.+
T Consensus 228 ---------~~---------------------~~~-----------------------~~~--~~~~~li~~~l~~~p~~ 252 (280)
T cd06611 228 ---------LD---------------------QPS-----------------------KWS--SSFNDFLKSCLVKDPDD 252 (280)
T ss_pred ---------cC---------------------Ccc-----------------------cCC--HHHHHHHHHHhccChhh
Confidence 00 000 000 16789999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy16081 428 RITPYYALQHNFFKRT 443 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~ 443 (493)
|||+.++|+||||...
T Consensus 253 Rps~~~il~~~~~~~~ 268 (280)
T cd06611 253 RPTAAELLKHPFVSDQ 268 (280)
T ss_pred CcCHHHHhcChhhccc
Confidence 9999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=317.61 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=192.0
Q ss_pred eEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch----HHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEE
Q psy16081 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN----QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFE 201 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E 201 (493)
+||+|+||.||+|.+..+++.||||++........ ....|..++.. ....+|++|+++.+.+...+.+|+|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL---VSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHH---HHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 48999999999999999999999999875322111 12223333333 333568889999999999999999999
Q ss_pred eccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC-c
Q psy16081 202 LLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-R 279 (493)
Q Consensus 202 ~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~-~ 279 (493)
|+.| +|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||++..... .
T Consensus 78 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili--~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 78 LMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEE--CCCCCEEEccCcCccccCccC
Confidence 9965 888877654 358999999999999999999994 789999999999999 6788899999999876543 2
Q ss_pred cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhc
Q psy16081 280 IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFD 358 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 358 (493)
....+|+..|+|||++.+. .++.++|||||||++|+|++|..||......+...........++
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 216 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--------------- 216 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC---------------
Confidence 2345789999999999854 689999999999999999999999987532211110000000000
Q ss_pred cCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CHHH
Q psy16081 359 KMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TPYY 433 (493)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~~e 433 (493)
..+ ...+ ..+.+||.+||..||.+|+ ++.+
T Consensus 217 ------------------~~~-------------------------~~~s--~~~~~li~~~l~~~p~~R~~~~~~~~~~ 251 (278)
T cd05606 217 ------------------ELP-------------------------DSFS--PELRSLLEGLLQRDVNRRLGCLGRGAQE 251 (278)
T ss_pred ------------------CCC-------------------------CcCC--HHHHHHHHHHhhcCHHhccCCCCCCHHH
Confidence 000 0001 1789999999999999999 9999
Q ss_pred HhcCCCCCCCcc
Q psy16081 434 ALQHNFFKRTAD 445 (493)
Q Consensus 434 ~L~Hp~~~~~~~ 445 (493)
+++||||.....
T Consensus 252 ll~~~~~~~~~~ 263 (278)
T cd05606 252 VKEHPFFRSLDW 263 (278)
T ss_pred HHhCccccCCCc
Confidence 999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=312.56 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=192.3
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc------chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF------LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+|++.++||+|+||.||+|.+..+++.||||.+...... ......|+.++.. ..|+||+++++++.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~------l~h~~i~~~~~~~~~ 75 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN------LLHERIVQYYGCLRD 75 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHh------cCCCCeeeEEeEecc
Confidence 4689999999999999999999999999999988632211 1122334333332 357789999999876
Q ss_pred c--ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 193 R--NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 193 ~--~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
. ..+|+||||+++ +|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||||+|||+ +.++.++|+|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~--~~~~~~~l~D 149 (265)
T cd06652 76 PMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILR--DSVGNVKLGD 149 (265)
T ss_pred CCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEe--cCCCCEEECc
Confidence 3 568899999965 8999886543 48899999999999999999994 789999999999999 6788999999
Q ss_pred cccccccCC------ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 270 FGSSCQLGQ------RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 270 FG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
||++..... ......++..|+|||++.+..++.++|||||||++|+|++|++||...+....+..+.. .+.
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~ 226 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT 226 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC
Confidence 999875432 22335688899999999988899999999999999999999999987654433322211 110
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
... .| ......+.++|++||.
T Consensus 227 ~~~-------------------------------~~---------------------------~~~~~~~~~~i~~~l~- 247 (265)
T cd06652 227 NPV-------------------------------LP---------------------------PHVSDHCRDFLKRIFV- 247 (265)
T ss_pred CCC-------------------------------Cc---------------------------hhhCHHHHHHHHHHhc-
Confidence 000 00 0001167899999994
Q ss_pred CCCCCCCHHHHhcCCCCC
Q psy16081 424 DPKTRITPYYALQHNFFK 441 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~ 441 (493)
+|++|||++++++|||+.
T Consensus 248 ~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 248 EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ChhhCCCHHHHhcCcccC
Confidence 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=323.55 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=199.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.+.|.....||.|+||.||++.+..++..||||.+..... .......|. ......+|+||+++++.+...++.
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~------~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV------VIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHH------HHHHhCCCCcHHHHHHheecCCeE
Confidence 3456667889999999999999999999999999864321 111222232 333344688899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++... .+++..+..++.||+.||.|||+ .+|+||||||+||++ +.++.++|+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill--~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 95 WVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILL--TSDGRIKLSDFGFCAQ 167 (292)
T ss_pred EEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEE--cCCCCEEEccCcchhh
Confidence 999999966 787777543 48999999999999999999995 689999999999999 6678999999999865
Q ss_pred cCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... .....++..|+|||++.+..++.++|||||||++|||++|..||.+.+....+..+.........
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 239 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK-------- 239 (292)
T ss_pred cccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc--------
Confidence 5322 23457889999999999889999999999999999999999999887765554443321110000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.. ...+ ..+.+||.+||..||.+|||++
T Consensus 240 ---------------------------~~-----------------------~~~~--~~~~~li~~~l~~~P~~Rpt~~ 267 (292)
T cd06658 240 ---------------------------DS-----------------------HKVS--SVLRGFLDLMLVREPSQRATAQ 267 (292)
T ss_pred ---------------------------cc-----------------------cccC--HHHHHHHHHHccCChhHCcCHH
Confidence 00 0000 1678999999999999999999
Q ss_pred HHhcCCCCCCCcc
Q psy16081 433 YALQHNFFKRTAD 445 (493)
Q Consensus 433 e~L~Hp~~~~~~~ 445 (493)
|+++||||.....
T Consensus 268 ~il~~~~~~~~~~ 280 (292)
T cd06658 268 ELLQHPFLKLAGP 280 (292)
T ss_pred HHhhChhhhccCC
Confidence 9999999996433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=316.81 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=198.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
..|+..+.||.|+||.||+|.+..+++.||||++..... ..... .+..++......+|+||+++++++.+.+.+|+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIE---DIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHH---HHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 357888999999999999999999999999999874321 11111 12222222233457889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+++ +|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++ +.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~--~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLL--SEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEE--cCCCCEEEcccccceecc
Confidence 9999965 899888653 48899999999999999999994 799999999999999 677889999999996654
Q ss_pred Cc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 278 QR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 278 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.. .....++..|+|||++.+..++.++|+|||||++|||++|.+||...+.......+... .++.
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~---------- 220 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--NPPT---------- 220 (277)
T ss_pred CCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--CCCC----------
Confidence 32 22346788899999999888999999999999999999999999876554333222110 0000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
+. ......+.+||.+||..||++|||+.++
T Consensus 221 -----------------------------~~---------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~i 250 (277)
T cd06640 221 -----------------------------LT---------------------GEFSKPFKEFIDACLNKDPSFRPTAKEL 250 (277)
T ss_pred -----------------------------Cc---------------------hhhhHHHHHHHHHHcccCcccCcCHHHH
Confidence 00 0001167899999999999999999999
Q ss_pred hcCCCCCCCcc
Q psy16081 435 LQHNFFKRTAD 445 (493)
Q Consensus 435 L~Hp~~~~~~~ 445 (493)
++||||.....
T Consensus 251 l~~~~~~~~~~ 261 (277)
T cd06640 251 LKHKFIVKNAK 261 (277)
T ss_pred HhChHhhhcch
Confidence 99999987644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=333.97 Aligned_cols=255 Identities=29% Similarity=0.382 Sum_probs=208.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
...|.+.+.||+|.|+.|.++++..++..||||++.+........+.+...++ .....+|||||+++.+......+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~---imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVD---IMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHH---HHHhcCCcceeeeeeeeeecceeE
Confidence 46799999999999999999999999999999999765433333233333333 334456888999999999999999
Q ss_pred EEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+ +|.+++++.+.. .+.+..++.++.|+..|++|||+ .+|||||||.+|||| +.+.++||+|||++..+
T Consensus 132 lV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL--~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILL--DENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhccc--ccccceeeeccccceee
Confidence 999999 559999998775 47779999999999999999995 689999999999999 78888999999999877
Q ss_pred C--CccccccccCcCCchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 277 G--QRIYQYIQSRFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 277 ~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
. ....++||++.|.|||++.+..|+ +.+|+||+|++||-|++|..||.+.+-.+.-.+.+.
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~---------------- 269 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR---------------- 269 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------------
Confidence 4 446689999999999999998875 799999999999999999999998764433222211
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
|.|+ +|. .++. ++.+||++||..+|.+|++++|
T Consensus 270 ---------gk~r-----------Ip~-------------------------~ms~--dce~lLrk~lvl~Pskr~~~dq 302 (596)
T KOG0586|consen 270 ---------GKYR-----------IPF-------------------------YMSC--DCEDLLRKFLVLNPSKRGPCDQ 302 (596)
T ss_pred ---------eeec-----------ccc-------------------------eeec--hhHHHHHHhhccCccccCCHHH
Confidence 1111 110 1111 6789999999999999999999
Q ss_pred HhcCCCCCCCc
Q psy16081 434 ALQHNFFKRTA 444 (493)
Q Consensus 434 ~L~Hp~~~~~~ 444 (493)
++.|.|+....
T Consensus 303 im~~~W~n~~~ 313 (596)
T KOG0586|consen 303 IMKDRWRNDLL 313 (596)
T ss_pred hhhhcccchhh
Confidence 99999997543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.58 Aligned_cols=247 Identities=18% Similarity=0.237 Sum_probs=190.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|++.+.||+|+||.||+|.+. ..+..||+|+++....... ...+++++......+||||+++++++...++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ----RRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHH----HHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 47999999999999999999765 4567899999875432111 1122233333333468899999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+++ +|.+++.... ..+++..++.++.||+.||.||| +.|++||||||+|||+ +.++.+||+|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili--~~~~~~~l~dfg~~~ 155 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLV--NSDLVCKISGFRRLQ 155 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEE--cCCCcEEECCCcccc
Confidence 9999999966 7887876543 46899999999999999999999 5799999999999999 678899999999876
Q ss_pred ccCCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 275 QLGQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 275 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
...... ....++..|+|||++.+..++.++|||||||++||+++ |.+||.+.+..+.+..+.+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 230 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP----- 230 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC-----
Confidence 542221 12234568999999999999999999999999999775 99999988776665555332111100
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
......+.+++.+||..||.+||
T Consensus 231 ---------------------------------------------------------~~~~~~~~~li~~c~~~~p~~RP 253 (266)
T cd05064 231 ---------------------------------------------------------RNCPNLLHQLMLDCWQKERGERP 253 (266)
T ss_pred ---------------------------------------------------------CCCCHHHHHHHHHHcCCCchhCC
Confidence 00011678999999999999999
Q ss_pred CHHHHhc
Q psy16081 430 TPYYALQ 436 (493)
Q Consensus 430 t~~e~L~ 436 (493)
|++|+++
T Consensus 254 ~~~~i~~ 260 (266)
T cd05064 254 RFSQIHS 260 (266)
T ss_pred CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=317.17 Aligned_cols=238 Identities=19% Similarity=0.206 Sum_probs=190.2
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc----hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee----ccee
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL----NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW----RNHL 196 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~----~~~~ 196 (493)
..||+|++|.||+|.. +|+.||||+++...... ..+..|+.++.. .+||||+++++++.+ ...+
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~------l~h~nIv~~~g~~~~~~~~~~~~ 97 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRR------IDSNNILKIYGFIIDIVDDLPRL 97 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHh------cCCCCEEEEeeeEEecccCCCce
Confidence 5799999999999975 78999999997543222 223344444433 357789999999877 4578
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
++||||+.+ +|.+++... ..+++.....++.|++.||.|||. ..+++||||||+|||+ ++++.+||+|||++..
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~Hrdlkp~nill--~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLV--TENYKLKIICHGLEKI 172 (283)
T ss_pred EEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh-cCCCCCCcCChhhEEE--CCCCcEEEcccchHhh
Confidence 999999965 899998764 368999999999999999999995 2589999999999999 6788999999999987
Q ss_pred cCCccccccccCcCCchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 276 LGQRIYQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
.........|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+......++.
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 243 (283)
T PHA02988 173 LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL--------- 243 (283)
T ss_pred hccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC---------
Confidence 7665566778999999999976 67999999999999999999999999988777666655432111100
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
+ ......+.+||.+||+.||++|||+.+
T Consensus 244 -------------------------~---------------------------~~~~~~l~~li~~cl~~dp~~Rps~~e 271 (283)
T PHA02988 244 -------------------------P---------------------------LDCPLEIKCIVEACTSHDSIKRPNIKE 271 (283)
T ss_pred -------------------------C---------------------------CcCcHHHHHHHHHHhcCCcccCcCHHH
Confidence 0 000117899999999999999999999
Q ss_pred Hhc
Q psy16081 434 ALQ 436 (493)
Q Consensus 434 ~L~ 436 (493)
+++
T Consensus 272 ll~ 274 (283)
T PHA02988 272 ILY 274 (283)
T ss_pred HHH
Confidence 985
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=310.02 Aligned_cols=254 Identities=28% Similarity=0.383 Sum_probs=196.2
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--cceeE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW--RNHLC 197 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~--~~~~~ 197 (493)
+|++.+.||.|+||.||+|.+..+++.||+|++............ +..++......+|+||+++++.+.. ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~---~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ---LVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHH---HHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 488999999999999999999999999999998643322122111 1222222333457789999998764 45689
Q ss_pred EEEEeccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCC---CCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 198 LVFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTP---ELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~---~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
+||||+++ +|.+++... ....+++..++.++.||+.||.|||.. ..+|+|+||||+||++ +.++.+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili--~~~~~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL--DANNNVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE--ecCCCEEEeccc
Confidence 99999965 898888653 124689999999999999999999932 3689999999999999 677899999999
Q ss_pred cccccCCcc---ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 272 SSCQLGQRI---YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 272 ~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
++....... ....++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..... +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------ 228 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-R------ 228 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-C------
Confidence 998765432 345788999999999998899999999999999999999999998775444333322100 0
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.++ . .....+.+|+.+||..||.+|
T Consensus 229 ----------~~~--------------------~-------------------------~~~~~~~~l~~~~l~~~p~~R 253 (265)
T cd08217 229 ----------RIP--------------------Y-------------------------RYSSELNEVIKSMLNVDPDKR 253 (265)
T ss_pred ----------CCc--------------------c-------------------------ccCHHHHHHHHHHccCCcccC
Confidence 000 0 000168899999999999999
Q ss_pred CCHHHHhcCCCC
Q psy16081 429 ITPYYALQHNFF 440 (493)
Q Consensus 429 ~t~~e~L~Hp~~ 440 (493)
||+.++|+|||+
T Consensus 254 p~~~~il~~~~~ 265 (265)
T cd08217 254 PSTEELLQLPLI 265 (265)
T ss_pred CCHHHHhhCCCC
Confidence 999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.51 Aligned_cols=260 Identities=26% Similarity=0.351 Sum_probs=193.9
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
+|+..+.||+|+||.||++.+..+++.||||.+...... ......|..++. ....|+||+++++++...+..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~-----~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM-----RSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHH-----HhcCCCCEeeeeeEEecCCcEE
Confidence 566778999999999999999999999999998743221 112222332222 2224788999999999999999
Q ss_pred EEEEecccCHHHHHh---ccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 198 LVFELLSYNLYDLLR---NTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 198 lV~E~~~~~L~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+||||++.++.++.. ......+++..+..++.|++.||.|||+ ..+|+||||||+|||+ +.++.+||+|||++.
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~ 156 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILL--DRNGNIKLCDFGISG 156 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEE--ccCCcEEEeecchhH
Confidence 999999877655432 2222468999999999999999999995 3589999999999999 677889999999997
Q ss_pred ccCCc--cccccccCcCCchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 275 QLGQR--IYQYIQSRFYRSPEVLLGI---PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 275 ~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
..... .....|++.|+|||++.+. .++.++|||||||++|+|++|++||..... ....+.+.....+...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~--- 231 (288)
T cd06616 157 QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL--- 231 (288)
T ss_pred HhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC---
Confidence 65432 2344678899999999876 689999999999999999999999976541 2222222111000000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
+. ...... ..++.+||.+||..||++||
T Consensus 232 -----------------------------~~---------------------~~~~~~--~~~l~~li~~~l~~~p~~Rp 259 (288)
T cd06616 232 -----------------------------SN---------------------SEEREF--SPSFVNFINLCLIKDESKRP 259 (288)
T ss_pred -----------------------------CC---------------------cCCCcc--CHHHHHHHHHHccCChhhCc
Confidence 00 000001 12789999999999999999
Q ss_pred CHHHHhcCCCCCCCc
Q psy16081 430 TPYYALQHNFFKRTA 444 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~ 444 (493)
|++++++||||....
T Consensus 260 t~~~i~~~~~~~~~~ 274 (288)
T cd06616 260 KYKELLEHPFIKDYE 274 (288)
T ss_pred CHHHHhcChhhhchh
Confidence 999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=310.49 Aligned_cols=254 Identities=29% Similarity=0.437 Sum_probs=196.3
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
+|+..+.||+|+||+||+|.+..+++.||+|.+..........+....+..++......+|++|+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47778999999999999999988999999999864332111111111222222223334577899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
+||+++ +|.+++.... .+++..+..++.||+.||.|||+ .||+|+||+|+||++ +.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~--~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILV--DTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCCEEEccCccceeccc
Confidence 999965 8999887543 58899999999999999999994 799999999999999 6788999999999876543
Q ss_pred c--cccccccCcCCchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 279 R--IYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 279 ~--~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
. .....++..|+|||.+.... ++.++|+|||||++|+|++|.+||......+....+......+.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 222 (258)
T cd06632 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP------------ 222 (258)
T ss_pred cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCC------------
Confidence 3 24566888999999998776 89999999999999999999999987664444433322100000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
++ ... ...+.+||.+||..||.+|||+.+++
T Consensus 223 ----~~-------------------------------------------~~~--~~~~~~li~~~l~~~p~~Rp~~~~~l 253 (258)
T cd06632 223 ----IP-------------------------------------------DHL--SDEAKDFILKCLQRDPSLRPTAAELL 253 (258)
T ss_pred ----cC-------------------------------------------CCc--CHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 00 000 11688999999999999999999999
Q ss_pred cCCCC
Q psy16081 436 QHNFF 440 (493)
Q Consensus 436 ~Hp~~ 440 (493)
.|||+
T Consensus 254 ~~~~~ 258 (258)
T cd06632 254 EHPFV 258 (258)
T ss_pred cCCCC
Confidence 99997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=320.79 Aligned_cols=258 Identities=23% Similarity=0.301 Sum_probs=200.3
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
...+|++.+.||+|+||+||+|.+..+++.||+|++......... ....+..++......+|+||+++.+++.+.+..
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE--KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHH--HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 346799999999999999999999999999999998643211111 111222222233334678899999999999999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
|+||||+.+++.+++.... ..+++..+..++.||+.||.|||+ .+|+|+||+|+||++ +.++.+||+|||++...
T Consensus 91 ~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~--~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILL--TEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEE--CCCCCEEEeecCcceec
Confidence 9999999999888876443 358999999999999999999994 789999999999999 67889999999998655
Q ss_pred CCccccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 277 GQRIYQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... ....+++.|+|||++. ...++.++|||||||++|||++|.+||.+.+.......+... .++..
T Consensus 166 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~-------- 234 (307)
T cd06607 166 SPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTL-------- 234 (307)
T ss_pred CCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCCC--------
Confidence 432 3457888999999985 356889999999999999999999999877655544333210 00000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
+ . ......+.+||.+||..||.+|||+.+
T Consensus 235 -------------------------~-~-------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 263 (307)
T cd06607 235 -------------------------S-S-------------------------NDWSDYFRNFVDSCLQKIPQDRPSSEE 263 (307)
T ss_pred -------------------------C-c-------------------------hhhCHHHHHHHHHHhcCChhhCcCHHH
Confidence 0 0 000016889999999999999999999
Q ss_pred HhcCCCCCCC
Q psy16081 434 ALQHNFFKRT 443 (493)
Q Consensus 434 ~L~Hp~~~~~ 443 (493)
++.||||...
T Consensus 264 il~~~~~~~~ 273 (307)
T cd06607 264 LLKHRFVLRE 273 (307)
T ss_pred HhcChhhccc
Confidence 9999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=310.37 Aligned_cols=246 Identities=26% Similarity=0.426 Sum_probs=196.7
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
+|++.+.||.|+||.||++.+..+++.||+|.++.... .......|..++.. ..|+||+++++.+...+++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~------l~h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAK------MKHPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHh------CCCCCcceEEEEEEECCEEE
Confidence 58899999999999999999999999999999864321 12233334444332 35778999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++.......+++..+..++.||+.||.||| +.||+|+||||+||++ +.++.++|+|||++...
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili--~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFL--TQNGKVKLGDFGSARLL 150 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEE--CCCCcEEEcccCcceee
Confidence 99999965 8999887655456899999999999999999999 4799999999999999 67889999999999766
Q ss_pred CCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... .....|++.|+|||++.+..++.++|+|||||++|+|++|.+||...+.......+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 220 (255)
T cd08219 151 TSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---------- 220 (255)
T ss_pred cccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC----------
Confidence 432 2345788899999999998999999999999999999999999988766555444432110000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
+. ..+ ..+.+||.+||..||++|||+.+
T Consensus 221 ---------------------------~~-----------------------~~~--~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 221 ---------------------------PS-----------------------HYS--YELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred ---------------------------Cc-----------------------ccC--HHHHHHHHHHHhCCcccCCCHHH
Confidence 00 000 16789999999999999999999
Q ss_pred HhcC
Q psy16081 434 ALQH 437 (493)
Q Consensus 434 ~L~H 437 (493)
++.-
T Consensus 249 il~~ 252 (255)
T cd08219 249 ILSR 252 (255)
T ss_pred Hhhc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=313.05 Aligned_cols=258 Identities=22% Similarity=0.382 Sum_probs=194.8
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc-hHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL-NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
+|+..+.||+|+||.||++.+..+++.||+|++....... .+......+..++.......|+||+++++.+.+.+++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987433111 111111222222233333457789999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC-CcEEEEeccccccc
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFGSSCQL 276 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~-~~ikL~DFG~a~~~ 276 (493)
|+||+.+ +|.+++.... .+++..+..++.||+.||.|||+ .|++|+||||+||++ +.+ ..+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~--~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLI--DSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--cCCCCEEEEccccccccc
Confidence 9999965 8988887543 68999999999999999999994 799999999999999 444 46999999998766
Q ss_pred CCc-------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 277 GQR-------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 277 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
... .....++..|+|||++.+..++.++|||||||++|+|++|..||...+.......+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 229 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA----- 229 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC-----
Confidence 432 12346788999999999888999999999999999999999999765433332222221000000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
..+. ......+.+||.+||..||.+||
T Consensus 230 --------------------------------~~~~---------------------~~~~~~~~~~i~~~l~~~p~~R~ 256 (268)
T cd06630 230 --------------------------------PSIP---------------------EHLSPGLRDVTLRCLELQPEDRP 256 (268)
T ss_pred --------------------------------CCCc---------------------hhhCHHHHHHHHHHcCCCcccCc
Confidence 0000 00011688999999999999999
Q ss_pred CHHHHhcCCCCC
Q psy16081 430 TPYYALQHNFFK 441 (493)
Q Consensus 430 t~~e~L~Hp~~~ 441 (493)
|+.++++||||+
T Consensus 257 ~~~~ll~~~~~~ 268 (268)
T cd06630 257 PSRELLKHPVFR 268 (268)
T ss_pred CHHHHhcCcccC
Confidence 999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=314.50 Aligned_cols=251 Identities=26% Similarity=0.362 Sum_probs=197.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
+|++.+.||.|+||.||+|.+..+++.||+|++....... ......+.+++......+||||+++++.+...+.+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE--KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc--hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 4899999999999999999999999999999997433211 01122223333333344688899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
+||+.+ +|.+.+... ..+++..+..++.||+.||.|||. .+++|+||||+||++ ++++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~--~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 79 VDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILL--DEQGHVHITDFNIATKVTP 152 (258)
T ss_pred EeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEE--cCCCCEEEeecccccccCC
Confidence 999965 899888765 368999999999999999999994 789999999999999 6788999999999876644
Q ss_pred c--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhccchh
Q psy16081 279 R--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV--DQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 279 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
. .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.. +.+...... ...
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~---------- 219 (258)
T cd05578 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADV---------- 219 (258)
T ss_pred CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccc----------
Confidence 3 33456788899999999988999999999999999999999999876642 221111110 000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH--H
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP--Y 432 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~--~ 432 (493)
..+ ......+.+||.+||..||.+||++ +
T Consensus 220 ----------------------~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 250 (258)
T cd05578 220 ----------------------LYP---------------------------ATWSTEAIDAINKLLERDPQKRLGDNLK 250 (258)
T ss_pred ----------------------cCc---------------------------ccCcHHHHHHHHHHccCChhHcCCccHH
Confidence 000 0000278899999999999999999 9
Q ss_pred HHhcCCCC
Q psy16081 433 YALQHNFF 440 (493)
Q Consensus 433 e~L~Hp~~ 440 (493)
|+++||||
T Consensus 251 ~l~~~~~~ 258 (258)
T cd05578 251 DLKNHPYF 258 (258)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=316.19 Aligned_cols=250 Identities=28% Similarity=0.369 Sum_probs=192.1
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 127 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
||+|+||+||+|.+..+++.||+|++...... ...+..|..++ ...+|+||+++.+.+...+.+|+||||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l------~~l~~~~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL------EKVSSRFIVSLAYAFETKDDLCLVMTL 74 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHH------HhCCCCCEeeeeeEEecCCeEEEEEec
Confidence 69999999999999999999999998643211 11122233333 233478899999999999999999999
Q ss_pred ccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC--c
Q psy16081 203 LSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--R 279 (493)
Q Consensus 203 ~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~--~ 279 (493)
+.+ +|.+++.......+++..+..++.|++.||.|||. .|++|+||+|+||++ +.++.+||+|||++..... .
T Consensus 75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~ 150 (277)
T cd05577 75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLL--DDHGNVRISDLGLAVELKGGKK 150 (277)
T ss_pred CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEE--CCCCCEEEccCcchhhhccCCc
Confidence 965 89988876554568999999999999999999994 799999999999999 6788999999999876542 2
Q ss_pred cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhcc
Q psy16081 280 IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~ 359 (493)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+......-+.
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 215 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV--------------- 215 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc---------------
Confidence 23456778899999999888999999999999999999999999765542211111111000000
Q ss_pred CCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC-----CHHHH
Q psy16081 360 MPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI-----TPYYA 434 (493)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~-----t~~e~ 434 (493)
.. . ... ...+.+||.+||..||.+|| ++.++
T Consensus 216 -----------------~~--~-----------------------~~~--~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 216 -----------------EY--P-----------------------DKF--SPEAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred -----------------cC--C-----------------------ccC--CHHHHHHHHHHccCChhHccCCCcccHHHH
Confidence 00 0 000 11688999999999999999 99999
Q ss_pred hcCCCCCCCcc
Q psy16081 435 LQHNFFKRTAD 445 (493)
Q Consensus 435 L~Hp~~~~~~~ 445 (493)
++||||.....
T Consensus 252 l~h~~~~~~~~ 262 (277)
T cd05577 252 REHPLFKDLNW 262 (277)
T ss_pred HhChhhhcCCh
Confidence 99999987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=311.41 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=194.8
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-
Q psy16081 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY- 205 (493)
Q Consensus 127 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~- 205 (493)
||.|+||.||+|.+..+++.||+|++....... ...+..+..++......+|+||+++++.+.+.+.+|+|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE--TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh--hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 699999999999999999999999987432111 11111222222223334578899999999999999999999965
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc--cccc
Q psy16081 206 NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQY 283 (493)
Q Consensus 206 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~--~~~~ 283 (493)
+|.+++.... .+++..+..++.||+.||.|||+ .+++|+||||+||++ +.++.++|+|||++...... ....
T Consensus 79 ~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv--~~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 79 ELWTILRDRG--LFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred cHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEE--cCCCCEEEeeCCcccccCcccccccc
Confidence 9999987653 58999999999999999999994 789999999999999 67889999999999877543 3445
Q ss_pred cccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChhhhhhccchhhhhccCC
Q psy16081 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN--EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMP 361 (493)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~--~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~ 361 (493)
.++..|+|||.+.+..++.++|+|||||++|+|++|..||.... ..+....+......+
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------- 213 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL------------------- 213 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC-------------------
Confidence 78899999999998889999999999999999999999998766 433433333100000
Q ss_pred CCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC-----HHHHhc
Q psy16081 362 DGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT-----PYYALQ 436 (493)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t-----~~e~L~ 436 (493)
..| . .. ...+.+||.+||..||.+||| ++|+++
T Consensus 214 ---------------~~~------------------------~-~~--~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 ---------------EFP------------------------N-YI--DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ---------------CCC------------------------c-cc--CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 000 0 00 116899999999999999999 999999
Q ss_pred CCCCCCCc
Q psy16081 437 HNFFKRTA 444 (493)
Q Consensus 437 Hp~~~~~~ 444 (493)
||||....
T Consensus 252 ~~~~~~~~ 259 (262)
T cd05572 252 HKWFNGFD 259 (262)
T ss_pred ChhhhCCC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=309.22 Aligned_cols=253 Identities=30% Similarity=0.439 Sum_probs=199.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
++|++.+.||+|++|.||+|.+..+++.||||++..... .......|...+.. ..|+||+++++.+...+.+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~------l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS------CESPYVVKCYGAFYKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHh------cCCCCeeeEEEEEccCCeE
Confidence 368899999999999999999999999999999875432 12233333333332 2377899999999999999
Q ss_pred EEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
++||||++ ++|.+++... ..+++..+..++.||+.||.|||+ ..+++|+||+|+||++ +.++.++|+|||++..
T Consensus 75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~-~~~~~H~~l~~~ni~~--~~~~~~~l~df~~~~~ 149 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT-KRHIIHRDIKPSNLLI--NSKGEVKIADFGISKV 149 (264)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhc-cCCCccCCCCHHHEEE--CCCCCEEEccCcccee
Confidence 99999997 5999998765 468999999999999999999994 1789999999999999 6788999999999977
Q ss_pred cCCcc---ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhhhh
Q psy16081 276 LGQRI---YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE---VDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 276 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~p~~~~~~ 349 (493)
..... ....++..|+|||.+.+..++.++|+||||+++|+|++|.+||...+. .+....+.. .....
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~---- 222 (264)
T cd06623 150 LENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPPPS---- 222 (264)
T ss_pred cccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCCCC----
Confidence 64332 245678899999999998999999999999999999999999987642 222222221 00000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
. .. .. ....+.+||++||..+|++||
T Consensus 223 ----------------------------~--~~----------------------~~--~~~~l~~li~~~l~~~p~~R~ 248 (264)
T cd06623 223 ----------------------------L--PA----------------------EE--FSPEFRDFISACLQKDPKKRP 248 (264)
T ss_pred ----------------------------C--Cc----------------------cc--CCHHHHHHHHHHccCChhhCC
Confidence 0 00 00 011689999999999999999
Q ss_pred CHHHHhcCCCCCCC
Q psy16081 430 TPYYALQHNFFKRT 443 (493)
Q Consensus 430 t~~e~L~Hp~~~~~ 443 (493)
|+.|+++||||+..
T Consensus 249 ~~~~ll~~~~~~~~ 262 (264)
T cd06623 249 SAAELLQHPFIKKA 262 (264)
T ss_pred CHHHHHhCHHHHhc
Confidence 99999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=308.78 Aligned_cols=249 Identities=29% Similarity=0.403 Sum_probs=197.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|++.+.||+|+||.||+|.+..++..||+|.+.... ........|+.++. ..+|+||+++++.+...+.+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~------~~~h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLA------KMKHPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHH------hCCCCChhhhhheeccCCeE
Confidence 5889999999999999999999999999999986432 11223333443333 33477899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC-CcEEEEeccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFGSSC 274 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~-~~ikL~DFG~a~ 274 (493)
|+|+||+.+ +|.+++.......+++..+..++.||+.||.|||+ .+++|+||||+||+++ ++ ..+||+|||.+.
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~ 150 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLS--KNGMVAKLGDFGIAR 150 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEc--CCCCeEEecccccch
Confidence 999999965 99998876554468999999999999999999994 7899999999999994 44 457999999997
Q ss_pred ccCCcc---ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 275 QLGQRI---YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 275 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
...... ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 218 (257)
T cd08225 151 QLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------ 218 (257)
T ss_pred hccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc------------
Confidence 665432 23468889999999998889999999999999999999999998776555443332210
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
+.... ......+.++|.+||..+|++|||+
T Consensus 219 -----~~~~~---------------------------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~ 248 (257)
T cd08225 219 -----FAPIS---------------------------------------------PNFSRDLRSLISQLFKVSPRDRPSI 248 (257)
T ss_pred -----CCCCC---------------------------------------------CCCCHHHHHHHHHHhccChhhCcCH
Confidence 00000 0000168899999999999999999
Q ss_pred HHHhcCCCC
Q psy16081 432 YYALQHNFF 440 (493)
Q Consensus 432 ~e~L~Hp~~ 440 (493)
.++++||||
T Consensus 249 ~~ll~~~~~ 257 (257)
T cd08225 249 TSILKRPFL 257 (257)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=316.60 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=197.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
++|++++.||+|+||+||++.+..+++.||+|++..... ....+..|+.++ ...+|+||+++++.+...+.+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l------~~l~h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM------HECRSPYIVSFYGAFLNENNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHH------HHcCCCCcceEeeeEecCCEE
Confidence 578999999999999999999999999999998864321 122333343333 233578899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++... ..+++..+..++.+++.||.|||. ..+++||||||+||++ +.++.++|+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~--~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILV--NSRGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEE--CCCCcEEEccCCcccc
Confidence 999999965 888877654 358999999999999999999995 3589999999999999 6788999999999865
Q ss_pred cCC-ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQ-RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ----MNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~----~~~i~~~~~~~p~~~~~~~ 350 (493)
... ......|+..|+|||++.+..++.++|||||||++|+|++|..||......+. ...+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------------ 221 (284)
T cd06620 154 LINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL------------ 221 (284)
T ss_pred hhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH------------
Confidence 432 22345789999999999988999999999999999999999999986554211 0001000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
+..+.... ....+ .......+.+||.+||..||.+|||
T Consensus 222 ------~~~~~~~~----------~~~~~--------------------------~~~~~~~~~~li~~~l~~dp~~Rpt 259 (284)
T cd06620 222 ------LQQIVQEP----------PPRLP--------------------------SSDFPEDLRDFVDACLLKDPTERPT 259 (284)
T ss_pred ------HHHHhhcc----------CCCCC--------------------------chhcCHHHHHHHHHHhcCCcccCcC
Confidence 00000000 00000 0000116789999999999999999
Q ss_pred HHHHhcCCCCCCCc
Q psy16081 431 PYYALQHNFFKRTA 444 (493)
Q Consensus 431 ~~e~L~Hp~~~~~~ 444 (493)
+.|+++|+||.+..
T Consensus 260 ~~e~~~~~~~~~~~ 273 (284)
T cd06620 260 PQQLCAMPPFIQAL 273 (284)
T ss_pred HHHHhcCccccccc
Confidence 99999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=296.60 Aligned_cols=253 Identities=28% Similarity=0.359 Sum_probs=190.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc----
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN---- 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~---- 194 (493)
++|++.++||.|||+-||++++..+++.||+|++.-.. ..+.| ..++++...+..+||||++++++...+.
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e-~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIE-EALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHH-HHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 58999999999999999999999999999999886432 12222 2334444445566789999999876443
Q ss_pred -eeEEEEEec-ccCHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 195 -HLCLVFELL-SYNLYDLLRNTNF--RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 195 -~~~lV~E~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
..||+++|. .|+|.+.+..... ..+++..+..|+.+|+.||.+||.....+.||||||.|||+ .+.+.++|.||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl--s~~~~~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL--SDSGLPVLMDL 173 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe--cCCCceEEEec
Confidence 499999999 6789998865332 34899999999999999999999765569999999999999 56789999999
Q ss_pred ccccccCCc------------cccccccCcCCchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy16081 271 GSSCQLGQR------------IYQYIQSRFYRSPEVLLG---IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 271 G~a~~~~~~------------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i 335 (493)
|.++...-. ...-..|..|+|||.+.- ...+.++|||||||+||.|+.|..||.- +
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~ 244 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------I 244 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------H
Confidence 999765321 112234777999999964 4578999999999999999999999952 1
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
.+. .|+..+ ...+-++.+|...+..+ .+.+
T Consensus 245 ~~~-----------------------GgSlaL--Av~n~q~s~P~~~~yse-------------------------~l~~ 274 (302)
T KOG2345|consen 245 YQQ-----------------------GGSLAL--AVQNAQISIPNSSRYSE-------------------------ALHQ 274 (302)
T ss_pred hhc-----------------------CCeEEE--eeeccccccCCCCCccH-------------------------HHHH
Confidence 110 111111 11112233333333222 7789
Q ss_pred HHhHccCCCCCCCCCHHHHhcC
Q psy16081 416 LIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 416 Li~~mL~~dP~~R~t~~e~L~H 437 (493)
||..||+.||.+||++.+++.+
T Consensus 275 lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 275 LIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999999999999864
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=313.64 Aligned_cols=254 Identities=25% Similarity=0.434 Sum_probs=199.9
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.|++.+.||.|+||.||+|.+..+++.||||++.... ........|+.++..+.. ..|+||+++++++......|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~---~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ---SQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc---CCCCCeeeEeeeeeeCCEEE
Confidence 4788899999999999999999999999999986432 223345556666555543 45788999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+.+ +|.+++... .+++..+..++.||+.||.||| +.||+|+||+|+||++ +.++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILV--TNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEE--cCCCCEEEccCCceeec
Confidence 99999965 888887653 5899999999999999999999 5799999999999999 66889999999999766
Q ss_pred CCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
... .....|+..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.........+... .++.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~-------- 221 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPR-------- 221 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCC--------
Confidence 432 2345688899999998754 5789999999999999999999999876543322111100 0000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.+. .. ....+.+||.+||..||.+|||+.
T Consensus 222 -------------------------~~~------------------------~~--~~~~~~~~i~~~l~~~p~~R~~~~ 250 (277)
T cd06917 222 -------------------------LED------------------------NG--YSKLLREFVAACLDEEPKERLSAE 250 (277)
T ss_pred -------------------------CCc------------------------cc--CCHHHHHHHHHHcCCCcccCcCHH
Confidence 000 00 011688999999999999999999
Q ss_pred HHhcCCCCCCCc
Q psy16081 433 YALQHNFFKRTA 444 (493)
Q Consensus 433 e~L~Hp~~~~~~ 444 (493)
+++.|+||+...
T Consensus 251 ~il~~~~~~~~~ 262 (277)
T cd06917 251 ELLKSKWIKAHS 262 (277)
T ss_pred HHhhChHhhccc
Confidence 999999998654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=311.17 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=194.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--cee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR--NHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~--~~~ 196 (493)
++|+..+.||.|++|.||+|.+..+++.||+|++...... ..+..+..++......+|+||++++++|.+. +.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP----DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch----HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 4689999999999999999999999999999998743221 1112222223333344688899999998653 478
Q ss_pred EEEEEeccc-CHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 197 CLVFELLSY-NLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
|+||||+++ +|.+++.. .....+++..+..++.||+.||.|||+ .|++|+||+|+||++ +.++.++|+|||++
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~--~~~~~~~l~dfg~~ 152 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILL--TRKGQVKLCDFGVS 152 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--ecCCeEEEeecccc
Confidence 999999965 88887643 222458999999999999999999994 789999999999999 56788999999998
Q ss_pred cccCCcc-ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChhhh
Q psy16081 274 CQLGQRI-YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE-----VDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 274 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-----~~~~~~i~~~~~~~p~~~~ 347 (493)
....... ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... .+....+.. .....+
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~- 228 (287)
T cd06621 153 GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPNPEL- 228 (287)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCchhh-
Confidence 6654332 345678889999999999999999999999999999999999986522 111111111 000000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
... +.........+.+||.+||..||.+
T Consensus 229 ----------~~~------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~ 256 (287)
T cd06621 229 ----------KDE------------------------------------------PGNGIKWSEEFKDFIKQCLEKDPTR 256 (287)
T ss_pred ----------ccC------------------------------------------CCCCCchHHHHHHHHHHHcCCCccc
Confidence 000 0000000126889999999999999
Q ss_pred CCCHHHHhcCCCCCCCc
Q psy16081 428 RITPYYALQHNFFKRTA 444 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~~ 444 (493)
|||+.|+++||||+...
T Consensus 257 Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 257 RPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCHHHHHhCccccccc
Confidence 99999999999997543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=332.46 Aligned_cols=247 Identities=29% Similarity=0.396 Sum_probs=204.2
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.+.|.+...+|.|+|+.|-.|.+..+++..+||++.+.. .+.+.|..++. ...+|+||+++.+.+.+..+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~-----~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISL-----LVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhh-----hhcCCCcceeecceecCCce
Confidence 46788999999999999999999999999999999997652 23333443332 34578899999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.|+|||++.| .+.+.+.... .....+..|+.+|+.|+.|||. .|||||||||+|||+. +..++++|+|||.++
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLD-GSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeec-CCCCcEEEEEechhh
Confidence 9999999965 7777776654 2237788899999999999995 7999999999999995 477889999999999
Q ss_pred ccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.......+.+-|..|.|||++....|+.++||||||++||+||+|+.||...... ..|....+.++..
T Consensus 465 ~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s--------- 532 (612)
T KOG0603|consen 465 ELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS--------- 532 (612)
T ss_pred hCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc---------
Confidence 8887766777888999999999999999999999999999999999999876655 2222222222110
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
..+++ .++|||++||+.||.+|+++.|+
T Consensus 533 --------------------------------------------------~~vS~--~AKdLl~~LL~~dP~~Rl~~~~i 560 (612)
T KOG0603|consen 533 --------------------------------------------------ECVSD--EAKDLLQQLLQVDPALRLGADEI 560 (612)
T ss_pred --------------------------------------------------cccCH--HHHHHHHHhccCChhhCcChhhh
Confidence 12233 78999999999999999999999
Q ss_pred hcCCCC
Q psy16081 435 LQHNFF 440 (493)
Q Consensus 435 L~Hp~~ 440 (493)
+.||||
T Consensus 561 ~~h~w~ 566 (612)
T KOG0603|consen 561 GAHPWF 566 (612)
T ss_pred ccCcch
Confidence 999999
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.70 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=197.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
-|++.+.||+|+||.||+|.+..+++.||||++..... ....+..|+.++ ...+|+||+++++++..++.+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l------~~l~h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL------SQCDSPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHH------HhcCCCCEeEEEEEEEeCCeEE
Confidence 37788999999999999999999999999998864321 111222333332 3345788999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++... .+++..+..++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||++...
T Consensus 79 lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i--~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 79 IIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLL--SEHGEVKLADFGVAGQL 151 (277)
T ss_pred EEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEE--CCCCCEEEeecccceec
Confidence 99999966 888887643 4899999999999999999999 4799999999999999 67788999999998765
Q ss_pred CCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||...........+... .++.
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~--------- 220 (277)
T cd06641 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NPPT--------- 220 (277)
T ss_pred ccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CCCC---------
Confidence 432 22346788899999999888999999999999999999999999876654443332110 0000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
+. ......+.++|.+||..||.+||++.+
T Consensus 221 ------------------------------~~---------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (277)
T cd06641 221 ------------------------------LE---------------------GNYSKPLKEFVEACLNKEPSFRPTAKE 249 (277)
T ss_pred ------------------------------CC---------------------cccCHHHHHHHHHHccCChhhCcCHHH
Confidence 00 000116889999999999999999999
Q ss_pred HhcCCCCCCCcc
Q psy16081 434 ALQHNFFKRTAD 445 (493)
Q Consensus 434 ~L~Hp~~~~~~~ 445 (493)
+++||||.+...
T Consensus 250 ~l~~~~~~~~~~ 261 (277)
T cd06641 250 LLKHKFIVRFAK 261 (277)
T ss_pred HHhCHHHhhhhh
Confidence 999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.69 Aligned_cols=258 Identities=20% Similarity=0.279 Sum_probs=196.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
..++|++.++||+|+||.||+|..+. .+..||+|.+...... .. ...+.+++......+|+||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RE---RIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HH---HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 35689999999999999999997542 3568999988643211 11 112233333334445788999999999
Q ss_pred ecceeEEEEEecc-cCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC
Q psy16081 192 WRNHLCLVFELLS-YNLYDLLRNTN--------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR 262 (493)
Q Consensus 192 ~~~~~~lV~E~~~-~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~ 262 (493)
..+..|+||||+. ++|.+++.... ....++..+..++.||+.||.||| +.+|+||||||+|||+ +.+
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili--~~~ 155 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMV--AHD 155 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEE--cCC
Confidence 9999999999995 59999986532 123467788999999999999999 4789999999999999 678
Q ss_pred CcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy16081 263 SAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 336 (493)
+.++|+|||+++...... ....++..|+|||.+.+..++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999987553321 12244667999999999899999999999999999998 789998877666554443
Q ss_pred HHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHH
Q psy16081 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDL 416 (493)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL 416 (493)
.... ++ .+ ......+.+|
T Consensus 236 ~~~~-~~----------------------------------~~---------------------------~~~~~~~~~l 253 (288)
T cd05061 236 DGGY-LD----------------------------------QP---------------------------DNCPERVTDL 253 (288)
T ss_pred cCCC-CC----------------------------------CC---------------------------CCCCHHHHHH
Confidence 2100 00 00 0001268999
Q ss_pred HhHccCCCCCCCCCHHHHhc------CCCCCCCc
Q psy16081 417 IFRMLDYDPKTRITPYYALQ------HNFFKRTA 444 (493)
Q Consensus 417 i~~mL~~dP~~R~t~~e~L~------Hp~~~~~~ 444 (493)
|.+||..||++|||+.++++ ||||..+.
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 254 MRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 99999999999999999987 99998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.66 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=193.8
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc----hHHH-HHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL----NQAQ-IEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~-~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+|.+.+.||.|+||.||+|.+..+++.||||.++...... .... ....+..++......+|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999999999999999886321100 0000 0111222223333446788999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+ .+++|+||+|+||++ +.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~--~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLV--DADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEE--cCCCeEEEeecccc
Confidence 99999999955 899988765 368999999999999999999995 689999999999999 67889999999999
Q ss_pred cccCCc-----cccccccCcCCchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 274 CQLGQR-----IYQYIQSRFYRSPEVLLGIP--YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 274 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
...... .....++..|+|||++.+.. ++.++|+|||||++|+|++|..||...+....+..+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 231 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP---- 231 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC----
Confidence 765432 22345788999999998754 8999999999999999999999997655443332221100000
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
..+. . ....-...+.+||.+||..||.
T Consensus 232 ------------------------------~~~~-----~------------------~~~~~~~~~~~li~~~l~~~p~ 258 (272)
T cd06629 232 ------------------------------PIPP-----D------------------VSMNLSPVALDFLNACFTINPD 258 (272)
T ss_pred ------------------------------cCCc-----c------------------ccccCCHHHHHHHHHHhcCChh
Confidence 0000 0 0000011789999999999999
Q ss_pred CCCCHHHHhcCCCC
Q psy16081 427 TRITPYYALQHNFF 440 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~ 440 (493)
+|||+.++|+||||
T Consensus 259 ~Rps~~~il~~~~~ 272 (272)
T cd06629 259 NRPTARELLQHPFI 272 (272)
T ss_pred hCCCHHHHhhCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.92 Aligned_cols=208 Identities=24% Similarity=0.329 Sum_probs=163.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcC----------------CCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLE----------------EQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNT 180 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~----------------~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~ 180 (493)
++|++.++||+|+||.||+|.+.. ++..||||++..... ....+..|+.++. ...|
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~------~l~h 78 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILS------RLKD 78 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHh------hcCC
Confidence 579999999999999999997532 345799999875321 1122333443333 3357
Q ss_pred ceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCC-----------------CCCCHHHHHHHHHHHHHHHHHHhCCC
Q psy16081 181 YYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNF-----------------RGVSLNLTRKFSQQLCTALLFLSTPE 242 (493)
Q Consensus 181 ~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~Lhs~~ 242 (493)
+||+++++++.+.+..|+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+
T Consensus 79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-- 156 (304)
T cd05096 79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-- 156 (304)
T ss_pred CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--
Confidence 8899999999999999999999955 99988854321 236788899999999999999995
Q ss_pred CCccccCCCCCcEEeeCCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHH
Q psy16081 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMH 317 (493)
Q Consensus 243 ~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 317 (493)
.||+||||||+|||+ +.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||+
T Consensus 157 ~~ivH~dlkp~Nill--~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 157 LNFVHRDLATRNCLV--GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CCccccCcchhheEE--cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 789999999999999 678899999999997653321 1234467899999999889999999999999999998
Q ss_pred h--CCCCCCCCCHHHHHHHHH
Q psy16081 318 T--GEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 318 t--G~~pf~~~~~~~~~~~i~ 336 (493)
+ +..||.+.+..+.+..+.
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~ 255 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAG 255 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHH
Confidence 6 668888776665554443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=316.01 Aligned_cols=261 Identities=27% Similarity=0.377 Sum_probs=198.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.+.||+|+||.||+|.+..+++.||||+++.............+ ++.+ .....|+||+++++++.+...+|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e-~~~~--~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD-LDVV--LKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHH-HHHH--HhccCCCchHhhheeeecCCeEE
Confidence 36799999999999999999999988999999999743221111111111 1111 22335889999999999999999
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
+||||+++++.+++.... ..+++..+..++.||+.||.|||+ ..||+||||+|+||++ ++++.+||+|||++..+.
T Consensus 91 ~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill--~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 91 ICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILL--DASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEE--cCCCCEEECccccchhcc
Confidence 999999888888776543 368999999999999999999996 2589999999999999 678899999999997654
Q ss_pred Cc--cccccccCcCCchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhhc
Q psy16081 278 QR--IYQYIQSRFYRSPEVLLGIP----YDLAIDMWSLGCILVEMHTGEPLFSGSNE-VDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 278 ~~--~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
.. .....++..|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+.+..+..... +
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~------- 237 (296)
T cd06618 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP--P------- 237 (296)
T ss_pred CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC--C-------
Confidence 32 22345778899999997654 88999999999999999999999976332 233333221100 0
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
..+.. ......+.+||.+||..||.+|||
T Consensus 238 --------------------------~~~~~-------------------------~~~~~~l~~li~~~l~~~p~~Rp~ 266 (296)
T cd06618 238 --------------------------SLPPN-------------------------EGFSPDFCSFVDLCLTKDHRKRPK 266 (296)
T ss_pred --------------------------CCCCC-------------------------CCCCHHHHHHHHHHccCChhhCCC
Confidence 00000 000116899999999999999999
Q ss_pred HHHHhcCCCCCCCcc
Q psy16081 431 PYYALQHNFFKRTAD 445 (493)
Q Consensus 431 ~~e~L~Hp~~~~~~~ 445 (493)
++++++||||+....
T Consensus 267 ~~~il~~~~~~~~~~ 281 (296)
T cd06618 267 YRELLQHPFIRRYET 281 (296)
T ss_pred HHHHhcChhhhccch
Confidence 999999999997543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.58 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=196.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+.|++.+.||+|+||.||+|.+..+++.||+|++...... ......|+.+ ....+|+||+++++.+...+.+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~------l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITV------LSQCDSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHH------HHcCCCCccHhhhcccccCCce
Confidence 3577788999999999999999999999999998643211 1122233322 2334688899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++.. ..+++..++.++.||+.||.|||. .|++|+||+|+||++ +.++.++|+|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i--~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLL--SEQGDVKLADFGVAGQ 150 (277)
T ss_pred EEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEE--eCCCCEEEcccccccc
Confidence 999999965 88888754 358999999999999999999994 799999999999999 5678899999999976
Q ss_pred cCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
+... .....++..|+|||++.+..++.++|||||||++|||++|.+||...........+... .++
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~--------- 219 (277)
T cd06642 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--SPP--------- 219 (277)
T ss_pred ccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--CCC---------
Confidence 6432 22346788899999999989999999999999999999999999765544332221110 000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
. + .......+.+||.+||..+|.+|||+.
T Consensus 220 ------------------------~------~---------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~ 248 (277)
T cd06642 220 ------------------------T------L---------------------EGQYSKPFKEFVEACLNKDPRFRPTAK 248 (277)
T ss_pred ------------------------C------C---------------------CcccCHHHHHHHHHHccCCcccCcCHH
Confidence 0 0 000011678999999999999999999
Q ss_pred HHhcCCCCCCCcc
Q psy16081 433 YALQHNFFKRTAD 445 (493)
Q Consensus 433 e~L~Hp~~~~~~~ 445 (493)
++++||||..+..
T Consensus 249 ~il~~~~~~~~~~ 261 (277)
T cd06642 249 ELLKHKFITRYTK 261 (277)
T ss_pred HHHHhHHHHHHhh
Confidence 9999999987543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=328.67 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=188.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCC-----CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEE-----QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|++.+.||+|+||.||+|++..+ +..||||+++..... ......|+.++..+ .+|+||++++++|
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-----~~h~nIv~~~~~~ 111 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHL-----GQHKNIVNLLGAC 111 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhh-----ccCCceeeEeeEe
Confidence 35799999999999999999986544 357999999743321 12233344444332 2588899999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccC------------------------------------------------------
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTN------------------------------------------------------ 215 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~------------------------------------------------------ 215 (493)
...+.+|+|||||. |+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999995 59999885421
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCccc
Q psy16081 216 --------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281 (493)
Q Consensus 216 --------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~ 281 (493)
...+++..++.++.||+.||.|||+ .||+||||||+|||+ ++++.+||+|||++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~--~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLL--TDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEE--eCCCeEEEeeceeeeeccCCcc
Confidence 1247888899999999999999995 789999999999999 5678899999999976543211
Q ss_pred -----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 282 -----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 282 -----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
...++..|+|||++.+..++.++|||||||++|+|++ |.+||........+..+......++
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~------------ 335 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS------------ 335 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc------------
Confidence 1234567999999999899999999999999999997 9999987554333333322100000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
.+ . . ...++.+||.+||..||.+|||+.+++
T Consensus 336 ----------------------~~------------------------~-~--~~~~l~~li~~cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 336 ----------------------RP------------------------D-F--APPEIYSIMKMCWNLEPTERPTFSQIS 366 (374)
T ss_pred ----------------------CC------------------------C-C--CCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 00 0 0 001789999999999999999999987
Q ss_pred c
Q psy16081 436 Q 436 (493)
Q Consensus 436 ~ 436 (493)
+
T Consensus 367 ~ 367 (374)
T cd05106 367 Q 367 (374)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=307.82 Aligned_cols=244 Identities=23% Similarity=0.291 Sum_probs=194.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||.||++... .+..+|+|.+.........+..|+.++..+ +||||+++++++...+.+|+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL------SHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC------CCCCceeEEEEEccCCCEEE
Confidence 46889999999999999999764 456899998875443334555566555544 47789999999999999999
Q ss_pred EEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||++ ++|.+++.... ..+++..+..++.|++.||.||| +.||+||||||+||++ +.++.+||+|||.+....
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i--~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLV--SSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEE--cCCCeEEECCCCCccccC
Confidence 999996 58999887543 35899999999999999999999 4789999999999999 678889999999987653
Q ss_pred Cccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 278 QRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 278 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... ...++..|+|||++.+..++.++|||||||++|+|++ |++||...+..+.+..+........
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 222 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR--------- 222 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---------
Confidence 3211 2234557999999998899999999999999999999 9999998877666666543211000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
+ . .....+.+||.+||..||.+|||+.
T Consensus 223 --------------------------~------------------------~---~~~~~~~~li~~c~~~~p~~Rps~~ 249 (256)
T cd05114 223 --------------------------P------------------------K---LASMTVYEVMYSCWHEKPEGRPTFA 249 (256)
T ss_pred --------------------------C------------------------C---CCCHHHHHHHHHHccCCcccCcCHH
Confidence 0 0 0001678999999999999999999
Q ss_pred HHhc
Q psy16081 433 YALQ 436 (493)
Q Consensus 433 e~L~ 436 (493)
++++
T Consensus 250 ~l~~ 253 (256)
T cd05114 250 ELLR 253 (256)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=313.51 Aligned_cols=248 Identities=34% Similarity=0.501 Sum_probs=199.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|.+.+.||+|+||.||+|.+..+++.||+|++...... ......|..++.. .. +|+||+++++.+...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~---l~--~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR---LN--GHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHh---cc--cCCCchhHHHHhcCCc
Confidence 4799999999999999999999999999999998753211 1122223333222 21 4888999999999999
Q ss_pred eeEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+|||++ +++|.+++.... .+++..+..++.|++.||.|||+ .|++|+||||+||++ +.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i--~~~~~~~l~df~~~ 149 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILL--DKDMHIKITDFGTA 149 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEE--CCCCCEEecCCccc
Confidence 999999999 559999987653 69999999999999999999994 789999999999999 67888999999998
Q ss_pred cccCCcc-----------------------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy16081 274 CQLGQRI-----------------------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVD 330 (493)
Q Consensus 274 ~~~~~~~-----------------------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~ 330 (493)
....... ....++..|+|||++.+..++.++|||||||+++++++|..||...+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 7654322 12456788999999998889999999999999999999999999877655
Q ss_pred HHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchh
Q psy16081 331 QMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410 (493)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (493)
.+..+.......+.. ..
T Consensus 230 ~~~~~~~~~~~~~~~---------------------------------------------------------------~~ 246 (280)
T cd05581 230 TFQKILKLEYSFPPN---------------------------------------------------------------FP 246 (280)
T ss_pred HHHHHHhcCCCCCCc---------------------------------------------------------------cC
Confidence 554443211111000 01
Q ss_pred hhHHHHHhHccCCCCCCCCCH----HHHhcCCCC
Q psy16081 411 LKFKDLIFRMLDYDPKTRITP----YYALQHNFF 440 (493)
Q Consensus 411 ~~~~dLi~~mL~~dP~~R~t~----~e~L~Hp~~ 440 (493)
..+.+||++||..||.+|||+ +++|+||||
T Consensus 247 ~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 247 PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 167899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=318.51 Aligned_cols=251 Identities=27% Similarity=0.458 Sum_probs=196.4
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
|.....||+|+||.||+|.+..+++.||||++...... ......|+ ......+|+||+++++.+...+..|+|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~------~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEV------VIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHH------HHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 33455799999999999999999999999998643221 11222222 223334678899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
+||+++ +|.+++... .+++..+..++.||+.||.||| +.||+||||||+||++ +.++.+||+|||++.....
T Consensus 97 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill--~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 97 MEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILL--TLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred EecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEE--ccCCcEEEeechhHhhccc
Confidence 999965 787776543 4899999999999999999999 4789999999999999 6788999999999865543
Q ss_pred c---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 279 R---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 279 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
. .....++..|+|||++.+..++.++|||||||++|||++|.+||...+..+.+..+... ++.. +..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~-~~~------ 239 (297)
T cd06659 170 DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPPK-LKN------ 239 (297)
T ss_pred ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCCC-ccc------
Confidence 2 23467889999999999989999999999999999999999999877765555433211 0000 000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
..... ..+.+||++||..||.+|||+.+++
T Consensus 240 ------------------------------------------------~~~~~--~~l~~~i~~~l~~~P~~Rps~~~ll 269 (297)
T cd06659 240 ------------------------------------------------AHKIS--PVLRDFLERMLTREPQERATAQELL 269 (297)
T ss_pred ------------------------------------------------cCCCC--HHHHHHHHHHhcCCcccCcCHHHHh
Confidence 00000 1678999999999999999999999
Q ss_pred cCCCCCCCc
Q psy16081 436 QHNFFKRTA 444 (493)
Q Consensus 436 ~Hp~~~~~~ 444 (493)
+||||....
T Consensus 270 ~~~~~~~~~ 278 (297)
T cd06659 270 DHPFLLQTG 278 (297)
T ss_pred hChhhccCC
Confidence 999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=306.87 Aligned_cols=253 Identities=30% Similarity=0.426 Sum_probs=194.6
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
+|++.+.||+|+||.||+|.+..+++.||+|+++........ ...+..++......+|+||+++++.+...+.+++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT---IKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHH---HHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 588999999999999999999989999999998754432111 12222222233334577899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
+||+.+ +|.+++.... .+++..+..++.|++.||.||| +.||+|+||+|+||++ +.++.+||+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~--~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 78 MEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEE--CCCCCEEEcccccccccCC
Confidence 999965 8999887643 4889999999999999999999 4789999999999999 6688999999999876643
Q ss_pred cc-------ccccccCcCCchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 279 RI-------YQYIQSRFYRSPEVLLGIP---YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 279 ~~-------~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
.. ....++..|+|||++.+.. ++.++|||||||++|+|++|..||...+........... +..+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~---- 226 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP---- 226 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC----
Confidence 21 1345788899999998766 889999999999999999999999765432222221111 10000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.|.. ......+.+||.+||..||.+|
T Consensus 227 -----------------------------~~~~-------------------------~~~~~~~~~li~~~l~~~p~~R 252 (264)
T cd06626 227 -----------------------------IPDS-------------------------LQLSPEGKDFLDRCLESDPKKR 252 (264)
T ss_pred -----------------------------CCcc-------------------------cccCHHHHHHHHHHccCCcccC
Confidence 0000 0001167899999999999999
Q ss_pred CCHHHHhcCCCC
Q psy16081 429 ITPYYALQHNFF 440 (493)
Q Consensus 429 ~t~~e~L~Hp~~ 440 (493)
||+.+++.|||+
T Consensus 253 ~~~~~i~~~~~~ 264 (264)
T cd06626 253 PTASELLQHPFV 264 (264)
T ss_pred CCHHHHhcCCCC
Confidence 999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.27 Aligned_cols=253 Identities=29% Similarity=0.439 Sum_probs=198.9
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
.|...+.||.|++|.||++.+..+++.||+|++...... ......|+. .....+|+||+++++++...++.|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~------~l~~~~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV------IMRDYQHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHH------HHHHcCCCChheEEEEEEcCCeEEE
Confidence 355567999999999999999999999999988643211 112222333 2333457889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+||+.+ +|.+++.. ..+++..+..++.||+.||.|||+ .||+||||+|+||++ +.++.++|+|||++....
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 94 VMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILL--TSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEE--cCCCcEEEcccccchhhc
Confidence 9999965 89888876 358999999999999999999995 789999999999999 678899999999886553
Q ss_pred Cc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 278 QR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 278 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|..||...+....+..+... .++. ..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~~~~-~~------- 236 (285)
T cd06648 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPPK-LK------- 236 (285)
T ss_pred cCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--CCCC-Cc-------
Confidence 32 23356889999999999988999999999999999999999999887765555444321 0000 00
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
+ ..... ..+.+||++||..||++|||+.++
T Consensus 237 -----------------------------------------------~-~~~~~--~~l~~li~~~l~~~p~~Rpt~~~i 266 (285)
T cd06648 237 -----------------------------------------------N-LHKVS--PRLRSFLDRMLVRDPAQRATAAEL 266 (285)
T ss_pred -----------------------------------------------c-cccCC--HHHHHHHHHHcccChhhCcCHHHH
Confidence 0 00000 168899999999999999999999
Q ss_pred hcCCCCCCCcc
Q psy16081 435 LQHNFFKRTAD 445 (493)
Q Consensus 435 L~Hp~~~~~~~ 445 (493)
++||||....+
T Consensus 267 l~~~~~~~~~~ 277 (285)
T cd06648 267 LNHPFLAKAGP 277 (285)
T ss_pred ccCcccccCCC
Confidence 99999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=308.70 Aligned_cols=246 Identities=21% Similarity=0.286 Sum_probs=196.3
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
.+|.+.+.||+|+||.||+|.+..+++.||+|++............|..++..+ .|++|+++++++...+.+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI------KHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC------CCCChhheEEEEcCCCCcEE
Confidence 468899999999999999999999999999999875443333444555544433 46789999999999999999
Q ss_pred EEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||++ ++|.+++.......+++..++.++.|++.||.||| ..|++||||||+|||+ ++++.+||+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~--~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEE--cCCCcEEeCCCccccccc
Confidence 999995 48999987655456899999999999999999999 4799999999999999 678889999999997665
Q ss_pred Cccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 278 QRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 278 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... ...++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.......
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------- 225 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME---------- 225 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC----------
Confidence 4322 1223557999999999999999999999999999998 999998876655544432210000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
. . ......+.+||.+||..||.+|||+.
T Consensus 226 -------------------------~--~-------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~ 253 (263)
T cd05052 226 -------------------------R--P-------------------------EGCPPKVYELMRACWQWNPSDRPSFA 253 (263)
T ss_pred -------------------------C--C-------------------------CCCCHHHHHHHHHHccCCcccCCCHH
Confidence 0 0 00011789999999999999999999
Q ss_pred HHhc
Q psy16081 433 YALQ 436 (493)
Q Consensus 433 e~L~ 436 (493)
++++
T Consensus 254 ~l~~ 257 (263)
T cd05052 254 EIHQ 257 (263)
T ss_pred HHHH
Confidence 9976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=328.09 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=201.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.-|..++.||-|+||+|-++....|...||+|.+++.... ......|+.+|.+. ..++||+|+..|++++
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA------Dn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA------DNEWVVRLYYSFQDKD 702 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc------CCcceEEEEEEeccCC
Confidence 4588899999999999999999999999999999754321 22234455554433 3557999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+||||++ |++..+|.+.+ -|.|++++.++.++..|+++.| ++|+|||||||+|||| |.+|+|||+||||+
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILI--DrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILI--DRDGHIKLTDFGLC 776 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEE--ccCCceeeeecccc
Confidence 9999999995 59999987764 5999999999999999999999 7999999999999999 89999999999998
Q ss_pred cccCC----c-----------------------------------------cccccccCcCCchhhhcCCCCCchhhHHH
Q psy16081 274 CQLGQ----R-----------------------------------------IYQYIQSRFYRSPEVLLGIPYDLAIDMWS 308 (493)
Q Consensus 274 ~~~~~----~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 308 (493)
.-+.. . ....+||+.|+|||++...+|+..+|+||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 54310 0 00147899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhc
Q psy16081 309 LGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDIL 388 (493)
Q Consensus 309 lGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 388 (493)
.|||||||+.|++||......+.-.+|++ ++.|++-.. ...
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq~kv~n---------------w~~~l~~~~-------------------~~~----- 897 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQYKVIN---------------WRNFLHIPY-------------------QGN----- 897 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcceeeeee---------------hhhcccccc-------------------ccc-----
Confidence 99999999999999988766555444432 111111100 000
Q ss_pred cccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC---HHHHhcCCCCCCCccCC
Q psy16081 389 GVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT---PYYALQHNFFKRTADES 447 (493)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t---~~e~L~Hp~~~~~~~~~ 447 (493)
.+ .++.|||.++ .-+++.|+- ++|+-.||||+.+...+
T Consensus 898 ------------------ls--~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 898 ------------------LS--KEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred ------------------cC--HHHHHHHHHH-hcChhhhhcccchhhhhcCccccccchHh
Confidence 00 1678999874 457888884 67899999999987654
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=329.82 Aligned_cols=254 Identities=25% Similarity=0.283 Sum_probs=193.0
Q ss_pred eccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 112 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
...+...+...+...||+|.||+||+|.+..+ ||||+++.......+.+.....+..++. -.|-||+-+.+++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkk---TRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKK---TRHENILLFMGACM 458 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhh---cchhhheeeehhhc
Confidence 33445556788899999999999999987654 9999998655443433333332222222 33556999999999
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
.... .||..+|+| +|+.+|+... ..|....++.|++||++|+.|||+ ++|||||||..||+| .+++.|||+||
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl--~~~~kVkIgDF 532 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFL--HEDLKVKIGDF 532 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEE--ccCCcEEEecc
Confidence 7776 999999988 8999987655 569999999999999999999996 689999999999999 66699999999
Q ss_pred cccccc-----CCccccccccCcCCchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCC
Q psy16081 271 GSSCQL-----GQRIYQYIQSRFYRSPEVLLG---IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE-VLGL 341 (493)
Q Consensus 271 G~a~~~-----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~-~~~~ 341 (493)
|++... ........|...|||||++.. .+|+..+|||||||++|||++|..||.. +..|++..++. .+..
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRGYLM 611 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEecccccC
Confidence 998543 233456678888999999984 3699999999999999999999999994 44444322221 1111
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
|.... ...+...++++|+..||
T Consensus 612 pd~s~----------------------------------------------------------~~s~~pk~mk~Ll~~C~ 633 (678)
T KOG0193|consen 612 PDLSK----------------------------------------------------------IRSNCPKAMKRLLSDCW 633 (678)
T ss_pred ccchh----------------------------------------------------------hhccCHHHHHHHHHHHH
Confidence 11000 00112237899999999
Q ss_pred CCCCCCCCCHHHHhc
Q psy16081 422 DYDPKTRITPYYALQ 436 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~ 436 (493)
.+++++||+..++|.
T Consensus 634 ~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 634 KFDREERPLFPQLLS 648 (678)
T ss_pred hcCcccCccHHHHHH
Confidence 999999999999886
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=313.90 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=193.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCC-----eEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQ-----CHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
++|++.+.||+|+||.||+|.+...+ ..||+|.++.... ....+..|+.++. ..+|+||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~------~l~h~~i~~~~~~~~ 78 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS------DLQHPNIVCLLGVCT 78 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHH------hcCCcccceEEEEEc
Confidence 47899999999999999999876655 7899999864321 1122333444333 335788999999999
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNF--------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
..+..|++|||+++ +|.+++..... ..+++..+..++.||+.||.|||. .||+||||||+||+
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil 156 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCL 156 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEE
Confidence 99999999999965 99998865321 357889999999999999999994 78999999999999
Q ss_pred eeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy16081 257 LCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVD 330 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~ 330 (493)
+ ++++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus 157 ~--~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 157 V--GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred E--cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9 67788999999999765322 223456788999999998899999999999999999998 999999887766
Q ss_pred HHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchh
Q psy16081 331 QMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410 (493)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (493)
....+......+. +. ...
T Consensus 235 ~~~~i~~~~~~~~-------------------------------------~~-------------------------~~~ 252 (283)
T cd05048 235 VIEMIRSRQLLPC-------------------------------------PE-------------------------DCP 252 (283)
T ss_pred HHHHHHcCCcCCC-------------------------------------cc-------------------------cCC
Confidence 6555433110000 00 000
Q ss_pred hhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 411 LKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 411 ~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
.++.+|+.+||..||.+|||+.|++++
T Consensus 253 ~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 253 ARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 178999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=328.21 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=189.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEE-----cCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFD-----LEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|++.+.||+|+||.||+|++ ..++..||||+++..... ......|+.++..+ .+||||++++++|
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l-----~~HpnIv~l~~~~ 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL-----GNHINIVNLLGAC 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHh-----cCCcceeeeeeee
Confidence 35799999999999999999964 346778999999743221 12233444444433 2588999999999
Q ss_pred eecceeEEEEEeccc-CHHHHHhccC------------------------------------------------------
Q psy16081 191 MWRNHLCLVFELLSY-NLYDLLRNTN------------------------------------------------------ 215 (493)
Q Consensus 191 ~~~~~~~lV~E~~~~-~L~~~l~~~~------------------------------------------------------ 215 (493)
...+..|+|||||++ +|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999954 9998886432
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 216 -------------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 216 -------------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
...+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill--~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILL--THGRITKICDFGLARDI 264 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEE--ECCCcEEEecCccceec
Confidence 1146788899999999999999995 789999999999999 56778999999999766
Q ss_pred CCccc-----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 277 GQRIY-----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 277 ~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
..... ...++..|+|||++.+..++.++|||||||++|||++ |.+||.+......+.+++.....+.
T Consensus 265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------- 337 (375)
T cd05104 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML------- 337 (375)
T ss_pred cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-------
Confidence 43221 1234567999999999999999999999999999998 8999987654433333222100000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.+ . ....++.+||.+||..||++|||
T Consensus 338 ---------------------------~~------------------------~---~~~~~l~~li~~cl~~dP~~RPs 363 (375)
T cd05104 338 ---------------------------SP------------------------E---CAPSEMYDIMKSCWDADPLKRPT 363 (375)
T ss_pred ---------------------------CC------------------------C---CCCHHHHHHHHHHccCChhHCcC
Confidence 00 0 00116889999999999999999
Q ss_pred HHHHhcC
Q psy16081 431 PYYALQH 437 (493)
Q Consensus 431 ~~e~L~H 437 (493)
+.|+++.
T Consensus 364 ~~eil~~ 370 (375)
T cd05104 364 FKQIVQL 370 (375)
T ss_pred HHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.46 Aligned_cols=299 Identities=17% Similarity=0.185 Sum_probs=196.1
Q ss_pred eeEeee--CCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 125 SLIGKG--SFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 125 ~~LG~G--~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
..||+| +||+||++.+..+++.||||++........... .+.++.......+|+||++++++|...+.+|+||||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLK---ALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHH---HHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 456666 999999999999999999999874332211111 122222223345688899999999999999999999
Q ss_pred ccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC---
Q psy16081 203 LSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--- 278 (493)
Q Consensus 203 ~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~--- 278 (493)
+.+ +|.+++.......+++..+..++.||+.||.||| +.||+||||||+|||+ +.++.++++||+.+.....
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill--~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE--eCCCcEEEechHHHhhhhccCc
Confidence 965 8999887655456899999999999999999999 4799999999999999 5678899999986533211
Q ss_pred c-------cccccccCcCCchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 279 R-------IYQYIQSRFYRSPEVLLGI--PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 279 ~-------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
. .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+......+..+.......+......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 0 0112345569999999864 478999999999999999999999988776555444443222111110000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
......+..... .+............. .. .+. ..... ..........+++||++||.+||++||
T Consensus 237 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~--~~---~~~--------~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rp 300 (328)
T cd08226 237 PCEESRMKNSQS--GVDSGIGESVVAAGM--TQ---TMT--------SERLR-TPSSKTFSPAFQNLVELCLQQDPEKRP 300 (328)
T ss_pred chhhhhhccchh--hhhcccccchhcccc--cc---ccc--------ccccc-chhhhhhhHHHHHHHHHHccCCcccCC
Confidence 000000000000 000000000000000 00 000 00000 000011223789999999999999999
Q ss_pred CHHHHhcCCCCCCCccC
Q psy16081 430 TPYYALQHNFFKRTADE 446 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~~~ 446 (493)
|+.|+|+||||......
T Consensus 301 ta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 301 SASSLLSHAFFKQVKEQ 317 (328)
T ss_pred CHHHHhhCHHHHHHHHh
Confidence 99999999999877654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.36 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=199.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.++|++.+.||+|+||.||++.+..++..||+|.+...... ......|+ .......|+||+++++.+...+..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~------~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI------LVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHH------HHHhhcCCCCeeehhheeeeCCcE
Confidence 46899999999999999999999889999999998633211 11222222 223334688899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+|+||+.+ +|.+++... .+++..+..++.|++.||.||| +.|++|+||||+||++ +.++.+||+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili--~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQ 164 (293)
T ss_pred EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEE--cCCCCEEEccCcceec
Confidence 999999965 898888654 4789999999999999999999 4789999999999999 6778899999999865
Q ss_pred cCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... .....+++.|+|||++.+..++.++|||||||++|++++|.+||...+..+.+..+.. .+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------- 234 (293)
T cd06647 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------- 234 (293)
T ss_pred ccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------
Confidence 5332 2334688899999999988899999999999999999999999987655433222110 00000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.+.. ... ...+.+||++||..||.+|||+.
T Consensus 235 -------------------------~~~~-----------------------~~~--~~~l~~li~~~l~~~p~~Rp~~~ 264 (293)
T cd06647 235 -------------------------LQNP-----------------------EKL--SAIFRDFLNRCLEMDVEKRGSAK 264 (293)
T ss_pred -------------------------CCCc-----------------------ccc--CHHHHHHHHHHccCChhhCcCHH
Confidence 0000 000 11678999999999999999999
Q ss_pred HHhcCCCCCCCccCC
Q psy16081 433 YALQHNFFKRTADES 447 (493)
Q Consensus 433 e~L~Hp~~~~~~~~~ 447 (493)
+++.||||+.....+
T Consensus 265 ~il~h~~~~~~~~~~ 279 (293)
T cd06647 265 ELLQHPFLKIAKPLS 279 (293)
T ss_pred HHhcCHHHhcCcccc
Confidence 999999998655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=329.69 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=200.6
Q ss_pred EeeeEeeeCCeEEEEEEEcCCCeEEEEEEEcc-----CcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce--
Q psy16081 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN-----KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH-- 195 (493)
Q Consensus 123 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~-----~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~-- 195 (493)
...+||+|+|-+||+|.|..+|..||--.++. .......+..|+ ..++..+|+||++++++|.+...
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev------~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEV------HLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHH------HHHccCCCCceeeeeeheecCCCce
Confidence 45789999999999999999999998543331 111223333333 44455678889999999998765
Q ss_pred eEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+-+|+|++ .|+|..++++.. .++...++.|++||+.||.|||++..+|||||||.+||+|. ...|.|||+|+|+|.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin-G~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN-GNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc-CCcCceeecchhHHH
Confidence 77899999 679999998764 69999999999999999999999999999999999999995 467899999999998
Q ss_pred ccCCcc-ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 275 QLGQRI-YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS-NEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 275 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
...... ...+|||.|||||+.. ..|+..+||||||+.|+||.|+..||+.- +...+++++.. |..|..
T Consensus 195 l~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~s------- 264 (632)
T KOG0584|consen 195 LLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAA------- 264 (632)
T ss_pred HhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHH-------
Confidence 886554 4469999999999998 58999999999999999999999999864 45555555544 222222
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
|.++. .+++++||.+||.. ..+|+|+.
T Consensus 265 ----l~kV~------------------------------------------------dPevr~fIekCl~~-~~~R~sa~ 291 (632)
T KOG0584|consen 265 ----LSKVK------------------------------------------------DPEVREFIEKCLAT-KSERLSAK 291 (632)
T ss_pred ----hhccC------------------------------------------------CHHHHHHHHHHhcC-chhccCHH
Confidence 11111 12789999999999 99999999
Q ss_pred HHhcCCCCCCC
Q psy16081 433 YALQHNFFKRT 443 (493)
Q Consensus 433 e~L~Hp~~~~~ 443 (493)
|+|+||||+.-
T Consensus 292 eLL~d~Ff~~d 302 (632)
T KOG0584|consen 292 ELLKDPFFDED 302 (632)
T ss_pred HHhhChhhccc
Confidence 99999999964
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=307.25 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=194.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|+++++||+|+||.||+|.+. ++..||+|.+............|..++.. .+|+||+++++.+...+..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~------l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKT------LQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHh------CCCCCeeeEEEEEcCCCCcE
Confidence 357999999999999999999854 56779999887543333344445554443 35778999999999999999
Q ss_pred EEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+. ++|.+++.......+++..+..++.||+.||.|||. .+++||||||+||++ +.++.+||+|||++...
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili--~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLV--SESLMCKIADFGLARVI 153 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEe--cCCCcEEECCCccceec
Confidence 9999995 599999876555568999999999999999999994 789999999999999 67889999999999776
Q ss_pred CCccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
..... ...++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+......+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 225 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR-------- 225 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 43221 2234567999999998889999999999999999998 9999988776665555432211000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
. .....++.+||.+||..||++|||+
T Consensus 226 -----------------------------~-------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 251 (261)
T cd05072 226 -----------------------------M-------------------------ENCPDELYDIMKTCWKEKAEERPTF 251 (261)
T ss_pred -----------------------------C-------------------------CCCCHHHHHHHHHHccCCcccCcCH
Confidence 0 0000167899999999999999999
Q ss_pred HHHhc
Q psy16081 432 YYALQ 436 (493)
Q Consensus 432 ~e~L~ 436 (493)
+++++
T Consensus 252 ~~i~~ 256 (261)
T cd05072 252 DYLQS 256 (261)
T ss_pred HHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=303.31 Aligned_cols=249 Identities=31% Similarity=0.455 Sum_probs=199.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|.+.+.||.|+||.||++.+..+++.||+|++..... .......|..++. ..+|+|++++.+.+...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~------~l~~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILK------KLNHPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHH------hcCCCChhheEEEEecCCEE
Confidence 58899999999999999999999999999999875432 1222333333333 23377899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTN--FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
++|+|++++ +|.+.+.... ...+++..+..++.||+.||.|||. .|++|+||+|+||++ +.++.++|+|||++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~--~~~~~~~l~d~~~~ 150 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFL--TSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEE--cCCCcEEECCccce
Confidence 999999976 8999887642 3569999999999999999999995 699999999999999 66788999999999
Q ss_pred cccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 274 CQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 274 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
...... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+......+
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 222 (258)
T cd08215 151 KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-------- 222 (258)
T ss_pred eecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC--------
Confidence 766443 234578889999999999899999999999999999999999998776554444432210000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
++ . .. ...+.++|.+||..||.+|||
T Consensus 223 ---------~~--------------------~-----------------------~~--~~~~~~~i~~~l~~~p~~Rp~ 248 (258)
T cd08215 223 ---------IP--------------------S-----------------------QY--SSELRNLVSSLLQKDPEERPS 248 (258)
T ss_pred ---------CC--------------------C-----------------------CC--CHHHHHHHHHHcCCChhhCcC
Confidence 00 0 00 017889999999999999999
Q ss_pred HHHHhcCCCC
Q psy16081 431 PYYALQHNFF 440 (493)
Q Consensus 431 ~~e~L~Hp~~ 440 (493)
+.++|+||||
T Consensus 249 ~~~ll~~~~~ 258 (258)
T cd08215 249 IAQILQSPFI 258 (258)
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=317.30 Aligned_cols=267 Identities=29% Similarity=0.375 Sum_probs=202.5
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchH--HHHHHHHHHHHhhcCCCCcceEEEeceeee-
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ--AQIEVKLLEIMNKADVNNTYYIVRLKRHFM- 191 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~--~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~- 191 (493)
..+.++|-++.+||+|||+.||+|.|....+.||||+-...+.+.++ .......+++...+....||.||+++++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 45678999999999999999999999999999999986543332221 112223344444455567788999999997
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEEe
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVD 269 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~D 269 (493)
+.+.+|-|+|||+| +|.=+|+.. +-+++.+++.|+.||..||.||...+.+|||-||||.||||.+ +..|.|||+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 45678999999988 554455544 4699999999999999999999987889999999999999954 2457899999
Q ss_pred cccccccCCcc----------ccccccCcCCchhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH--
Q psy16081 270 FGSSCQLGQRI----------YQYIQSRFYRSPEVLLGI----PYDLAIDMWSLGCILVEMHTGEPLFSGSNEV-DQM-- 332 (493)
Q Consensus 270 FG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~-- 332 (493)
||+++.+.... ....||.+|++||++.-. ..+.++||||+|||+|.|+.|+.||...... +++
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 99998875432 246789999999998743 4789999999999999999999999754322 221
Q ss_pred HHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhh
Q psy16081 333 NKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLK 412 (493)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (493)
..|++... -..|. ...++. +
T Consensus 697 NTIlkAtE-----------------------------------VqFP~-----------------------KPvVss--e 716 (775)
T KOG1151|consen 697 NTILKATE-----------------------------------VQFPP-----------------------KPVVSS--E 716 (775)
T ss_pred hchhccee-----------------------------------ccCCC-----------------------CCccCH--H
Confidence 11111100 00000 001111 6
Q ss_pred HHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 413 FKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 413 ~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.++||++||.+--++|+...|+-.||||...
T Consensus 717 AkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 717 AKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred HHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 7999999999999999999999999999863
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=306.82 Aligned_cols=251 Identities=28% Similarity=0.421 Sum_probs=188.3
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
.+.....||+|+||.||+|.+..++..||+|.+..... .......|+.++.. .+|+||+++++++...+..++
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~------l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY------LKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHh------cCCCCeeeeeeeeccCCEEEE
Confidence 34445689999999999999999999999998864321 12233444444333 357789999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGV--SLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||+.+ +|.+++.... ..+ ++..+..++.||+.||.||| ..||+||||||+||+++ ...+.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~-~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEc-CCCCeEEEecchhhee
Confidence 9999965 8999887542 234 78888999999999999999 47999999999999994 2357899999999876
Q ss_pred cCC---ccccccccCcCCchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQ---RIYQYIQSRFYRSPEVLLGIP--YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
... ......+++.|+|||++.+.. ++.++|||||||++|+|++|.+||...................+
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 231 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP------- 231 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCC-------
Confidence 532 123346788999999987643 88999999999999999999999975432211110000000000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
..+ ......+.+||.+||..+|.+|||
T Consensus 232 --------------------------~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt 258 (268)
T cd06624 232 --------------------------EIP---------------------------ESLSAEAKNFILRCFEPDPDKRAS 258 (268)
T ss_pred --------------------------CCC---------------------------cccCHHHHHHHHHHcCCCchhCCC
Confidence 000 000116889999999999999999
Q ss_pred HHHHhcCCCC
Q psy16081 431 PYYALQHNFF 440 (493)
Q Consensus 431 ~~e~L~Hp~~ 440 (493)
+.|++.||||
T Consensus 259 ~~~ll~~~~~ 268 (268)
T cd06624 259 AHDLLQDPFL 268 (268)
T ss_pred HHHHHhCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=313.24 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=198.3
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
.|...+.||+|+||+||+|++..+++.||+|++......... ....+..++......+|+|++++++++.+.+..|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE--KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 466778899999999999999999999999998643221111 111222222333334578899999999999999999
Q ss_pred EEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc
Q psy16081 200 FELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279 (493)
Q Consensus 200 ~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~ 279 (493)
|||+.+++.+++.... ..+++..+..++.||+.||.|||+ .||+|+||||+||++ +.++.+||+|||++.....
T Consensus 100 ~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili--~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 100 MEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred EecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEE--CCCCCEEEeecCCCcccCC-
Confidence 9999999988886543 468999999999999999999994 789999999999999 6778899999999865432
Q ss_pred cccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 280 IYQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
.....|+..|+|||++. +..++.++|||||||++|+|++|.+||...+.......+.... .+...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~---------- 241 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLQ---------- 241 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCC----------
Confidence 33557888999999985 3568899999999999999999999998877655555443210 00000
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
..... ..+.+||.+||..+|.+|||+.++++
T Consensus 242 -----------------------------------------------~~~~~--~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 -----------------------------------------------SNEWT--DSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -----------------------------------------------ccccC--HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 15789999999999999999999999
Q ss_pred CCCCCCC
Q psy16081 437 HNFFKRT 443 (493)
Q Consensus 437 Hp~~~~~ 443 (493)
||||...
T Consensus 273 ~~~~~~~ 279 (313)
T cd06633 273 HDFVRRD 279 (313)
T ss_pred CcccCCC
Confidence 9999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=309.29 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=191.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ..+..++.++......+|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE----QDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3579999999999999999999877 7889999988643211 111222223333334467889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC-CCcE
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNF-----RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK-RSAI 265 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~-~~~i 265 (493)
.+..|+||||+. ++|.+++..... ..+++..+..++.||+.||.|||+ .+++||||||+|||++.+. ...+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcce
Confidence 999999999995 599998865431 248899999999999999999995 6899999999999995322 3469
Q ss_pred EEEecccccccCCccc-----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q psy16081 266 KIVDFGSSCQLGQRIY-----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVL 339 (493)
Q Consensus 266 kL~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 339 (493)
||+|||++........ ....+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 238 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999976633211 2223457999999999899999999999999999997 999999877665544332210
Q ss_pred CCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhH
Q psy16081 340 GLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419 (493)
Q Consensus 340 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~ 419 (493)
... .+ ... ...+.+|+.+
T Consensus 239 ~~~-----------------------------------~~-------------------------~~~--~~~~~~~i~~ 256 (277)
T cd05036 239 RLD-----------------------------------PP-------------------------KGC--PGPVYRIMTD 256 (277)
T ss_pred cCC-----------------------------------CC-------------------------CCC--CHHHHHHHHH
Confidence 000 00 000 0167899999
Q ss_pred ccCCCCCCCCCHHHHhcC
Q psy16081 420 MLDYDPKTRITPYYALQH 437 (493)
Q Consensus 420 mL~~dP~~R~t~~e~L~H 437 (493)
||..||++|||+.++++|
T Consensus 257 cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 257 CWQHTPEDRPNFATILER 274 (277)
T ss_pred HcCCCcccCcCHHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=313.78 Aligned_cols=256 Identities=24% Similarity=0.310 Sum_probs=200.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
..|...+.||+|+||.||++++..++..||+|++........ .....+..++......+|+|++++++++.+.+..|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN--EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch--HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 458888999999999999999999999999999864322111 111223333333344467889999999999999999
Q ss_pred EEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 199 VFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 199 V~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
||||+.++|.+.+.... ..+++..+..++.||+.||.||| +.+|+||||+|+||++ +.++.+||+|||++.....
T Consensus 103 v~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~--~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 103 VMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILL--TEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEE--CCCCCEEEecCCCccccCC
Confidence 99999999888876443 45899999999999999999999 4789999999999999 6788999999999865443
Q ss_pred ccccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 279 RIYQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
.....+++.|+|||++. +..++.++|||||||++|+|++|.+||...+....+..+......+..
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 245 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ----------- 245 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC-----------
Confidence 33457888999999984 456899999999999999999999999877666555554432110000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
.... ...+.+||.+||..||.+|||+.+++
T Consensus 246 ------------------------------------------------~~~~--~~~l~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 246 ------------------------------------------------SNEW--SDYFRNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred ------------------------------------------------Cccc--cHHHHHHHHHHccCCcccCcCHHHHH
Confidence 0000 01678999999999999999999999
Q ss_pred cCCCCCCC
Q psy16081 436 QHNFFKRT 443 (493)
Q Consensus 436 ~Hp~~~~~ 443 (493)
+|+|+...
T Consensus 276 ~~~~~~~~ 283 (317)
T cd06635 276 KHMFVLRE 283 (317)
T ss_pred hChhhhcc
Confidence 99999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.90 Aligned_cols=249 Identities=32% Similarity=0.493 Sum_probs=199.1
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
+|++.+.||+|++|.||++.+..+++.|++|++..... .......|..++.. .+|++|+++.+++...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~------l~~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKK------CKHPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHh------CCCCCEeEEEEEEecCCeEEE
Confidence 47889999999999999999998999999999975432 22333444433332 237789999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+||+++ +|.+++.... ..+++..+..++.|++.||.+||. .|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILL--TSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEE--ccCCeEEEeecccccccc
Confidence 9999975 8988887653 468999999999999999999994 799999999999999 668899999999997776
Q ss_pred Ccc--ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 278 QRI--YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 278 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
... ....++..|+|||++.+..++.++|||||||++|+|++|..||...+....+..+.. ...+.
T Consensus 150 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~----------- 216 (253)
T cd05122 150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPG----------- 216 (253)
T ss_pred ccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCC-----------
Confidence 543 556788899999999988899999999999999999999999987654444333221 00000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
.. ........+.+||.+||..||.+|||+.|+|
T Consensus 217 ----~~-------------------------------------------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l 249 (253)
T cd05122 217 ----LR-------------------------------------------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLL 249 (253)
T ss_pred ----cC-------------------------------------------cccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 00 0000012688999999999999999999999
Q ss_pred cCCC
Q psy16081 436 QHNF 439 (493)
Q Consensus 436 ~Hp~ 439 (493)
+|||
T Consensus 250 ~~~~ 253 (253)
T cd05122 250 KHPF 253 (253)
T ss_pred cCCC
Confidence 9999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=304.48 Aligned_cols=245 Identities=22% Similarity=0.276 Sum_probs=191.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||+||+|.+.. +..||||.++........+..|..++. ..+||||+++++++...+.+|+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~------~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMM------KLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHh------cCCCCCeeeEEEEEccCCCcEE
Confidence 468999999999999999997643 456999988754332333444444333 3457889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+.+ +|.+++.... ..+++..+..++.||+.||.||| +.|++|+||||+|||+ +.++.+||+|||++....
T Consensus 77 v~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili--~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 77 VTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLV--DDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEE--cCCCCEEECCCccceecC
Confidence 9999955 8999887543 36899999999999999999999 4789999999999999 677899999999987653
Q ss_pred Ccc-cc---ccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 278 QRI-YQ---YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 278 ~~~-~~---~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
... .. ..++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+......+...
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 224 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH------- 224 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCC-------
Confidence 322 11 234457999999998889999999999999999998 999998777665555543321110000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.. ...+.+++.+||..||.+|||+.
T Consensus 225 -----------------------------------------------------~~--~~~~~~li~~cl~~~p~~Rp~~~ 249 (256)
T cd05113 225 -----------------------------------------------------LA--SEKVYAIMYSCWHEKAEERPTFQ 249 (256)
T ss_pred -----------------------------------------------------CC--CHHHHHHHHHHcCCCcccCCCHH
Confidence 00 01789999999999999999999
Q ss_pred HHhcC
Q psy16081 433 YALQH 437 (493)
Q Consensus 433 e~L~H 437 (493)
+++++
T Consensus 250 ~ll~~ 254 (256)
T cd05113 250 QLLSS 254 (256)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=308.09 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=190.6
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
..++|++.+.||+|+||.||+|.+.. ++..||||++...... .. ...+..++......+|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~---~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RE---RIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-HH---HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 35689999999999999999997642 4578999988643211 11 112223333333446788999999999
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCC--------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNF--------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR 262 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~ 262 (493)
..+..++||||+++ +|.+++..... ..+++..+..++.|++.||.||| +.|++||||||+|||+ +++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~--~~~ 155 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMV--AED 155 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEE--cCC
Confidence 99999999999965 89998865321 23577888999999999999999 4789999999999999 678
Q ss_pred CcEEEEecccccccCCccc-----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy16081 263 SAIKIVDFGSSCQLGQRIY-----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 336 (493)
+.++|+|||++........ ...+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+.
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 8999999999875533221 2344678999999999899999999999999999998 789998877665555443
Q ss_pred HHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHH
Q psy16081 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDL 416 (493)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL 416 (493)
.....+. + ......+.+|
T Consensus 236 ~~~~~~~-----------------------------------~---------------------------~~~~~~~~~l 253 (277)
T cd05062 236 EGGLLDK-----------------------------------P---------------------------DNCPDMLFEL 253 (277)
T ss_pred cCCcCCC-----------------------------------C---------------------------CCCCHHHHHH
Confidence 2100000 0 0001168899
Q ss_pred HhHccCCCCCCCCCHHHHhcC
Q psy16081 417 IFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 417 i~~mL~~dP~~R~t~~e~L~H 437 (493)
|.+||..||++|||+.|++++
T Consensus 254 i~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 254 MRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.64 Aligned_cols=248 Identities=31% Similarity=0.434 Sum_probs=192.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc------cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+|.+.+.||+|+||.||++.+..++..+++|+++.... ...+...|..++ ...+||||+++++++.+.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l------~~l~h~~i~~~~~~~~~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLL------SKLDHPAIVKFHASFLER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHH------HhCCCCcHHHHHHHHhcC
Confidence 58899999999999999999988888788887763221 111222233322 334588899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 194 NHLCLVFELLSY-NLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
...|+||||+.+ +|.+++.. .....+++..++.++.|++.||.||| +.|++|+||||+||++. ++.+||+||
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~---~~~~~l~d~ 149 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLK---NNLLKIGDF 149 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEee---cCCEeeccc
Confidence 999999999965 88887754 22346899999999999999999999 47999999999999993 356999999
Q ss_pred ccccccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 271 GSSCQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 271 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
|++...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+... .++. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~-~- 225 (260)
T cd08222 150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTPS-L- 225 (260)
T ss_pred CceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCCC-C-
Confidence 998765332 22456788999999998888999999999999999999999999876655544443321 0000 0
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
+ ......+.+||.+||..||++
T Consensus 226 -------------~---------------------------------------------~~~~~~~~~li~~~l~~~p~~ 247 (260)
T cd08222 226 -------------P---------------------------------------------ETYSRQLNSIMQSMLNKDPSL 247 (260)
T ss_pred -------------c---------------------------------------------chhcHHHHHHHHHHhcCChhh
Confidence 0 000016789999999999999
Q ss_pred CCCHHHHhcCCCC
Q psy16081 428 RITPYYALQHNFF 440 (493)
Q Consensus 428 R~t~~e~L~Hp~~ 440 (493)
||++.|+++||||
T Consensus 248 Rp~~~~il~~~~~ 260 (260)
T cd08222 248 RPSAAEILRNPFI 260 (260)
T ss_pred CcCHHHHhhCCCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=302.42 Aligned_cols=289 Identities=33% Similarity=0.472 Sum_probs=227.6
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccC---cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec-
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK---KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR- 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~- 193 (493)
..+|.-++.+|.|+- .|..+.|.-+++.||+|.+... ......+.+|..++.. .+|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~------v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKC------VNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhh------hcccceeeeeeccCccc
Confidence 357888899999998 8889999999999999987532 1223344555555443 4566799999999754
Q ss_pred -----ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 194 -----NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 194 -----~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
..+|+|||+|..+|.+.+.. .++-..++.++.|++.|+.|||+ .||+||||||+||++ +.+..+||.
T Consensus 89 ~l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv--~~~~~lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVV--NSDCTLKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHh--cceeecccCccccee--cchhheeec
Confidence 36799999999999998873 37788999999999999999995 799999999999999 788899999
Q ss_pred ecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 269 DFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 269 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
|||+|+..+.. .+.++.|+.|+|||++.+.+|...+||||+|||+.||++|...|.|.+..++..+|++.+|.|...+
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 99999877654 5678899999999999999999999999999999999999999999999999999999999999888
Q ss_pred hhhccch-hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 347 LDGAHKT-RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 347 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
..+.... +.|+...+.... ..-...+.+.+- ....+.+..+...+.||+.+||..||
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~------------~~f~~~fpD~~f----------~~~~e~~~~~~~~ardll~~MLvi~p 298 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQA------------ISFSELFPDSLF----------PVVLEGSKLDCSLARDLLSKMLVIDP 298 (369)
T ss_pred HHHhhHHHHHHhhcChHhhc------------cchhhhCCcccc----------cccccCCccchHHHHHHHHHhhccCh
Confidence 8776543 344442221111 000111111111 11112222333367899999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy16081 426 KTRITPYYALQHNFFKRT 443 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~ 443 (493)
++|+++++||+||||+-|
T Consensus 299 e~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 299 EKRISVDDALRHPYIKVW 316 (369)
T ss_pred hhcccHHHHhcCCeeeee
Confidence 999999999999999855
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=303.96 Aligned_cols=246 Identities=21% Similarity=0.305 Sum_probs=195.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.+.||+|+||.||+|.+. +++.||||.++.......++..|..++..+ +|+||+++++++...+.+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL------RHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC------CCCCccceeEEEecCCCee
Confidence 467999999999999999999864 457899999875443334455555554443 4678999999999999999
Q ss_pred EEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+ +++|.+++.......+++..+..++.|++.||.||| +.||+||||||+||++ +.++.+||+|||++...
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLV--GENNICKVADFGLARVI 153 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEE--cCCCCEEECCcceEEEc
Confidence 999999 569999997655456899999999999999999999 5799999999999999 67888999999999776
Q ss_pred CCccc-cccc---cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQRIY-QYIQ---SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~~~-~~~g---t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
..... ...+ +..|+|||++.+..++.++|||||||++|+|++ |++||.+.+....+..+......+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 226 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP------- 226 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence 53321 2222 346999999999899999999999999999999 99999987766655554332111000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
......+.+||.+||..||.+|||+
T Consensus 227 -------------------------------------------------------~~~~~~~~~li~~~l~~~P~~Rp~~ 251 (261)
T cd05068 227 -------------------------------------------------------PGCPKELYDIMLDCWKEDPDDRPTF 251 (261)
T ss_pred -------------------------------------------------------CcCCHHHHHHHHHHhhcCcccCCCH
Confidence 0000168899999999999999999
Q ss_pred HHHhc
Q psy16081 432 YYALQ 436 (493)
Q Consensus 432 ~e~L~ 436 (493)
.++++
T Consensus 252 ~~l~~ 256 (261)
T cd05068 252 ETLQW 256 (261)
T ss_pred HHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=309.92 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=192.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
++|.+.+.||+|+||.||+|.+.. +++.||||+++..... ...+..|+.++..+ .|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~ 78 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF------QHENIVKFYGVCT 78 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc------CCCCchheeeEEe
Confidence 468899999999999999998643 4688999998754321 23444455444433 4678999999999
Q ss_pred ecceeEEEEEeccc-CHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTN------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~ 258 (493)
.....|+||||+.+ +|.+++.... ...+++..+..++.||+.||.|||. .|++||||||+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili- 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLV- 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEE-
Confidence 99999999999955 9999886532 1347889999999999999999994 789999999999999
Q ss_pred CCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy16081 259 NPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQM 332 (493)
Q Consensus 259 ~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 332 (493)
+.++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 156 -~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 156 -GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred -cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 67799999999999754322 123345678999999999999999999999999999998 99999887776655
Q ss_pred HHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhh
Q psy16081 333 NKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLK 412 (493)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (493)
..+......++. .... ..
T Consensus 235 ~~~~~~~~~~~~------------------------------------------------------------~~~~--~~ 252 (280)
T cd05049 235 ECITQGRLLQRP------------------------------------------------------------RTCP--SE 252 (280)
T ss_pred HHHHcCCcCCCC------------------------------------------------------------CCCC--HH
Confidence 544321100000 0000 16
Q ss_pred HHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 413 FKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 413 ~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
+.+||++||..||++|||+.|+++
T Consensus 253 ~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 253 VYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHH
Confidence 889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=303.57 Aligned_cols=203 Identities=24% Similarity=0.426 Sum_probs=163.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||.||+|++..+++.||||.+........ .....+..++......+|+||+++++++.+.+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA--KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCH--HHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 579999999999999999999999999999998764221111 111112222223333468889999999999999999
Q ss_pred EEEeccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 199 VFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||+++ +|.+++... ....+++..+..++.||+.||.||| +.+++|+||||+||++ +.++.++|+|||++..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~--~~~~~~~l~d~g~~~~ 155 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFI--TATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEE--cCCCCEEECcccccee
Confidence 9999965 888877532 2234789999999999999999999 4799999999999999 6778899999999876
Q ss_pred cCCcc---ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 276 LGQRI---YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 276 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
..... ....+++.|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 64322 23568889999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=315.86 Aligned_cols=245 Identities=20% Similarity=0.252 Sum_probs=186.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeE----EEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCH----VAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+|++.+.||+|+||+||+|.+..+++. ||||+++.... ....+..|.. .....+|+||+++++++..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~------~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY------VMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHH------HHHhCCCCCCCeEEEEEcC
Confidence 4699999999999999999987766654 89999864321 1122222332 3334468889999999876
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
. ..++|+||+. |+|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill--~~~~~~kl~DfG 154 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLV--KTPQHVKITDFG 154 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEe--cCCCcEEEcccc
Confidence 4 5789999995 58999987654 358899999999999999999994 789999999999999 677889999999
Q ss_pred cccccCCccc-----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 272 SSCQLGQRIY-----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 272 ~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
+++....... ...++..|+|||++.+..++.++|||||||++|||++ |.+||.+....+.. .+......++.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~- 232 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ- 232 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC-
Confidence 9987643221 1223567999999999999999999999999999997 99999876654432 22221000000
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
. . .....+.++|.+||..||
T Consensus 233 -----------------------------------~----------------------~---~~~~~~~~li~~cl~~~p 252 (316)
T cd05108 233 -----------------------------------P----------------------P---ICTIDVYMIMVKCWMIDA 252 (316)
T ss_pred -----------------------------------C----------------------C---CCCHHHHHHHHHHccCCh
Confidence 0 0 000167899999999999
Q ss_pred CCCCCHHHHhcC
Q psy16081 426 KTRITPYYALQH 437 (493)
Q Consensus 426 ~~R~t~~e~L~H 437 (493)
.+|||+.+++.+
T Consensus 253 ~~Rps~~~l~~~ 264 (316)
T cd05108 253 DSRPKFRELIIE 264 (316)
T ss_pred hhCcCHHHHHHH
Confidence 999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=304.05 Aligned_cols=245 Identities=21% Similarity=0.317 Sum_probs=191.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.++||+|+||.||+|.+..+ ..||||+++........+..|..++..+ +|+||+++++.+. .+..|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l------~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC------CCCCcceEEEEEC-CCCcE
Confidence 46799999999999999999987655 4599999975443334455555554433 4677999998875 46689
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||.+...
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill--~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILV--GENLVCKVADFGLARLI 152 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEE--cCCCcEEeccCCceeec
Confidence 99999965 9999997654446899999999999999999999 4789999999999999 66888999999999766
Q ss_pred CCccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
..... ...++..|+|||++.+..++.++|||||||++|+|++ |.+||.+....+.+..+......+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 224 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------- 224 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC--------
Confidence 43321 2334567999999998899999999999999999999 8999988776655544432110000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
.......+.+||.+||..||++|||+
T Consensus 225 ------------------------------------------------------~~~~~~~l~~li~~~l~~~p~~Rp~~ 250 (262)
T cd05071 225 ------------------------------------------------------PPECPESLHDLMCQCWRKEPEERPTF 250 (262)
T ss_pred ------------------------------------------------------ccccCHHHHHHHHHHccCCcccCCCH
Confidence 00001168899999999999999999
Q ss_pred HHHhc
Q psy16081 432 YYALQ 436 (493)
Q Consensus 432 ~e~L~ 436 (493)
.++++
T Consensus 251 ~~~~~ 255 (262)
T cd05071 251 EYLQA 255 (262)
T ss_pred HHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=309.99 Aligned_cols=248 Identities=24% Similarity=0.307 Sum_probs=189.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCe--EEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQC--HVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~--~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++.+.||+|+||.||+|.+..++. .+|+|.++.... ....+..|..++..+ .+||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-----~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL-----GHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhh-----cCCCchhheEEEEccCC
Confidence 579999999999999999998877764 468888763221 112233344433332 25888999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN 259 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~ 259 (493)
.+|+||||+++ +|.+++.... ...+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill-- 152 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLV-- 152 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEE--
Confidence 99999999964 9999986532 124788999999999999999999 4799999999999999
Q ss_pred CCCCcEEEEecccccccCCcccc--ccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy16081 260 PKRSAIKIVDFGSSCQLGQRIYQ--YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 260 ~~~~~ikL~DFG~a~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 336 (493)
+.++.+||+|||++......... ...+..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~ 232 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232 (297)
T ss_pred CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 67888999999998654322222 223456999999999899999999999999999997 999998877666555443
Q ss_pred HHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHH
Q psy16081 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDL 416 (493)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL 416 (493)
.....+. +. .. ...+.+|
T Consensus 233 ~~~~~~~-------------------------------------~~-----------------------~~--~~~~~~l 250 (297)
T cd05089 233 QGYRMEK-------------------------------------PR-----------------------NC--DDEVYEL 250 (297)
T ss_pred cCCCCCC-------------------------------------CC-----------------------CC--CHHHHHH
Confidence 2111000 00 00 0168899
Q ss_pred HhHccCCCCCCCCCHHHHhcC
Q psy16081 417 IFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 417 i~~mL~~dP~~R~t~~e~L~H 437 (493)
|.+||..||.+|||++++++.
T Consensus 251 i~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 251 MRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=302.80 Aligned_cols=239 Identities=23% Similarity=0.325 Sum_probs=183.9
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
+.||+|+||.||+|.+..+++.||+|.+..... ....+..|..++. ..+|+||+++++++...+.+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~------~l~h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILK------QYSHPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHH------hCCCCCcceEEEEEcCCCCeEEEEee
Confidence 369999999999999999999999998764321 1223334444333 33578899999999999999999999
Q ss_pred ccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCccc
Q psy16081 203 LSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281 (493)
Q Consensus 203 ~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~ 281 (493)
+.+ +|.+++.... ..+++..+..++.|++.||.||| +.||+||||||+|||+ +.++.+||+|||++........
T Consensus 75 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 75 VQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLV--TEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred ccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEE--cCCCcEEECccccCcccccccc
Confidence 965 8998886543 35899999999999999999999 4789999999999999 6778899999999876543221
Q ss_pred cc-----cccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 282 QY-----IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 282 ~~-----~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
.. ..+..|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+......+
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~------------- 216 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP------------- 216 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC-------------
Confidence 11 12345999999999899999999999999999997 999997665544333332210000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
.+ ......+.+||.+||..||++|||+.+++
T Consensus 217 ------------------------~~-------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 247 (252)
T cd05084 217 ------------------------CP-------------------------ELCPDAVYRLMERCWEYDPGQRPSFSTVH 247 (252)
T ss_pred ------------------------Cc-------------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 00 00011688999999999999999999997
Q ss_pred c
Q psy16081 436 Q 436 (493)
Q Consensus 436 ~ 436 (493)
+
T Consensus 248 ~ 248 (252)
T cd05084 248 Q 248 (252)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=312.35 Aligned_cols=275 Identities=21% Similarity=0.230 Sum_probs=185.9
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-C
Q psy16081 131 SFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-N 206 (493)
Q Consensus 131 ~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~ 206 (493)
++|.||++++..+++.||||++..... .......|+.++. ..+|+||++++++|...+..|++|||+++ +
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~------~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSR------QLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHH------hcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 445566666677999999999875421 1223333433333 23578899999999999999999999965 8
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc-------
Q psy16081 207 LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR------- 279 (493)
Q Consensus 207 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~------- 279 (493)
|.+++.......+++..+..++.||+.||.|||. .+|+||||||+|||+ +.++.+||+|||.+......
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili--~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILL--SGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEE--ecCCceEEecCccceeecccccccccc
Confidence 8888876544568999999999999999999994 689999999999999 56788999999998654211
Q ss_pred ---cccccccCcCCchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 280 ---IYQYIQSRFYRSPEVLLGI--PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 280 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.....++..|+|||++.+. .++.++|||||||++|||++|..||...+....+.... .+..+..+ .... ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~-~~~~-~~ 237 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV--RGTVPCLL-DKST-YP 237 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCcccc-ccCc-hh
Confidence 1234567789999999763 58899999999999999999999998766544332211 11111110 0000 00
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
........... ............ .......+ .++.+||++||.+||++|||+.|+
T Consensus 238 ~~~~~~~~~~~----~~~~~~~~~~~~-------------------~~~~~~~~--~~~~~li~~~l~~~P~~Rpt~~~l 292 (314)
T cd08216 238 LYEDSMSQSRS----SNEHPNNRDSVD-------------------HPYTRTFS--EHFHQFVELCLQRDPESRPSASQL 292 (314)
T ss_pred hhcCCcCcccc----cccccchhhhhh-------------------cchhhHHH--HHHHHHHHHHhhcCCCcCcCHHHH
Confidence 00000000000 000000000000 00000111 268899999999999999999999
Q ss_pred hcCCCCCCCc
Q psy16081 435 LQHNFFKRTA 444 (493)
Q Consensus 435 L~Hp~~~~~~ 444 (493)
|+||||+...
T Consensus 293 l~~p~~~~~~ 302 (314)
T cd08216 293 LNHSFFKQCK 302 (314)
T ss_pred hcCchHhhhc
Confidence 9999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=302.47 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=193.9
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
...++|+++++||+|+||.||+|.. .+++.||+|.+.........+..|..++..+ +|+||+++++++. .+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~-~~~ 74 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL------QHPRLVRLYAVVT-QEP 74 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc------CCcCeeeEEEEEc-cCC
Confidence 3456899999999999999999985 4578899999875554444555555544433 4677999998874 567
Q ss_pred eEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.|+||||+. ++|.+++.......+++..+..++.|++.||.||| +.|++||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i--~~~~~~~l~dfg~~~ 150 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILV--SETLCCKIADFGLAR 150 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEE--cCCCCEEEccCccee
Confidence 899999995 59999987655556899999999999999999999 4789999999999999 678889999999997
Q ss_pred ccCCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 275 QLGQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 275 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
...... ....++..|+|||++.+..++.++|||||||++|||++ |++||.+.+..+....+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 224 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR------ 224 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC------
Confidence 664221 12334567999999998889999999999999999999 9999988776655544432111000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.. . ...++.+||.+||..||++||
T Consensus 225 -------------------------------~~-----------------------~--~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05067 225 -------------------------------PD-----------------------N--CPEELYELMRLCWKEKPEERP 248 (260)
T ss_pred -------------------------------CC-----------------------C--CCHHHHHHHHHHccCChhhCC
Confidence 00 0 001689999999999999999
Q ss_pred CHHHHhc
Q psy16081 430 TPYYALQ 436 (493)
Q Consensus 430 t~~e~L~ 436 (493)
|+++++.
T Consensus 249 ~~~~l~~ 255 (260)
T cd05067 249 TFEYLRS 255 (260)
T ss_pred CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=341.49 Aligned_cols=145 Identities=29% Similarity=0.426 Sum_probs=120.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|.++++||+|+||+||+|.+..+++.||||+++..... ...+..|..++ ....|+||++++..+...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l------~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL------ALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHH------HhcCCCCcCeEEEEEEEC
Confidence 46899999999999999999999999999999999743321 12223333332 334578899999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+++||||||+. ++|.+++.... .+++..++.++.||+.||.|||. .+||||||||+|||+ +.++.+||+|||+
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl--~~~g~vkL~DFGl 150 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLI--SNEGHIKLTDFGL 150 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEE--cCCCCEEEEeCCC
Confidence 99999999995 59999886543 58899999999999999999995 689999999999999 6778999999998
Q ss_pred cc
Q psy16081 273 SC 274 (493)
Q Consensus 273 a~ 274 (493)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 74
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=322.18 Aligned_cols=263 Identities=28% Similarity=0.429 Sum_probs=216.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
..+++++..||-||||.|=++.-......+|+|++++.. ..+..+.|.-..+.-.... .+.++||+|+..|.+..++|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~h-IVdtkQqeHv~sEr~Im~~-~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKH-IVDTKQQEHVFSERNIMME-CRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhh-ccchhHHHHHHhHHHHHHh-cCchHHHHHHHHhccchhhh
Confidence 346778889999999999998765555568999998543 2233333332222221122 23678999999999999999
Q ss_pred EEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+.||-| +|.|+..|+..+ .|.+..++.++..++.|++|||+ .|||+|||||+|+|| +.+|.+||.|||+|+.+
T Consensus 497 mLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllL--d~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLL--DNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheee--ccCCceEEeehhhHHHh
Confidence 999999 779999998765 59999999999999999999995 789999999999999 88999999999999988
Q ss_pred C--CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 277 G--QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 277 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
+ ....++||||.|.|||++++++.+.++|.||||+++||||+|.|||++.+++..+..|.+..... .
T Consensus 571 ~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-----~------ 639 (732)
T KOG0614|consen 571 GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-----E------ 639 (732)
T ss_pred ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-----h------
Confidence 5 45678999999999999999999999999999999999999999999999999999998864321 0
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC----
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT---- 430 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t---- 430 (493)
. .+++++ ...+||+++-..+|.+|+-
T Consensus 640 -----------------------~------------------Pr~I~k---------~a~~Lik~LCr~~P~ERLG~~~~ 669 (732)
T KOG0614|consen 640 -----------------------F------------------PRRITK---------TATDLIKKLCRDNPTERLGYQKG 669 (732)
T ss_pred -----------------------c------------------ccccch---------hHHHHHHHHHhcCcHhhhccccC
Confidence 0 011111 5679999999999999997
Q ss_pred -HHHHhcCCCCCCCccCCCC
Q psy16081 431 -PYYALQHNFFKRTADESTN 449 (493)
Q Consensus 431 -~~e~L~Hp~~~~~~~~~~~ 449 (493)
+.+|-+|.||.....+.-.
T Consensus 670 gI~DIkkH~Wf~gfdweglr 689 (732)
T KOG0614|consen 670 GINDIKKHRWFEGFDWEGLR 689 (732)
T ss_pred ChHHHHhhhhhhcCChhhhh
Confidence 8999999999988776543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.64 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=192.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc------chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF------LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+|++.+.||+|+||.||+|.+..+++.||+|++...... ...+..|+.++. ..+|+||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~------~l~h~~i~~~~~~~~~ 75 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLK------NLRHDRIVQYYGCLRD 75 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHH------HcCCCCcceEEEEEEc
Confidence 4799999999999999999999999999999987532111 112233333333 3357779999999876
Q ss_pred c--ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 193 R--NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 193 ~--~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
. +.+++|+||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .|++|+||||+||++ +.++.++|+|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i--~~~~~~~l~d 149 (264)
T cd06653 76 PEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILR--DSAGNVKLGD 149 (264)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEE--cCCCCEEECc
Confidence 4 468999999965 8988887543 48899999999999999999994 789999999999999 6788899999
Q ss_pred cccccccCC------ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 270 FGSSCQLGQ------RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 270 FG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
||++..... ......++..|+|||++.+..++.++|+|||||++|+|++|++||..........++. ..+.
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~ 226 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPT 226 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCC
Confidence 999976532 1224568889999999999889999999999999999999999998765544433322 1111
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
....+ .... ..+.+||++||.
T Consensus 227 ~~~~p--------------------------------------------------------~~~~--~~~~~~i~~~l~- 247 (264)
T cd06653 227 KPMLP--------------------------------------------------------DGVS--DACRDFLKQIFV- 247 (264)
T ss_pred CCCCC--------------------------------------------------------cccC--HHHHHHHHHHhc-
Confidence 00000 0011 168899999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q psy16081 424 DPKTRITPYYALQHNFF 440 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~ 440 (493)
+|..|||+.+++.|||.
T Consensus 248 ~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 248 EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CcccCccHHHHhcCCCC
Confidence 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=335.15 Aligned_cols=274 Identities=21% Similarity=0.269 Sum_probs=182.6
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCC----CeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEecee---
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEE----QCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH--- 189 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~--- 189 (493)
..++|++.++||+|+||.||+|++..+ +..||||++.... ..|..+.+.+.+... .+++.+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e~l~~~~~---~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNERVRRACP---NSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHHHHHhhch---hhHHHHHHhhhc
Confidence 356899999999999999999999988 9999999886322 122222222222111 111111111
Q ss_pred ---eeecceeEEEEEeccc-CHHHHHhccCCC------------------CCCHHHHHHHHHHHHHHHHHHhCCCCCccc
Q psy16081 190 ---FMWRNHLCLVFELLSY-NLYDLLRNTNFR------------------GVSLNLTRKFSQQLCTALLFLSTPELNIIH 247 (493)
Q Consensus 190 ---~~~~~~~~lV~E~~~~-~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiH 247 (493)
......++||+||+++ +|.+++...... ......+..++.||+.||.|||+ .+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEe
Confidence 2346689999999965 898888654311 01234567899999999999995 78999
Q ss_pred cCCCCCcEEeeCCCCCcEEEEecccccccCC----ccccccccCcCCchhhhcCC----------------------CCC
Q psy16081 248 CDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQYIQSRFYRSPEVLLGI----------------------PYD 301 (493)
Q Consensus 248 rDlKp~NILl~~~~~~~ikL~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~----------------------~~~ 301 (493)
|||||+|||++ +.++.+||+|||+|+.+.. .....++|+.|+|||.+... .++
T Consensus 279 RDLKP~NILl~-~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFS-EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEe-CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999999994 2467899999999976532 23456889999999976432 244
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCC
Q psy16081 302 LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGS 381 (493)
Q Consensus 302 ~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (493)
.++|||||||+||||+++..+ ..+....+.++....+.....+....... ..+..
T Consensus 358 ~k~DVwSlGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-----------------------~~~~~ 412 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVAWRKLVEPR-----------------------ASPDL 412 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHHHHHhhccc-----------------------cchhh
Confidence 567999999999999986655 34444555555554444322221110000 00000
Q ss_pred ccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 382 RRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 382 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
....+++. .+...++|||.+||.+||++|||+.|+|+||||++...
T Consensus 413 ~~~~~~~d------------------~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 413 RRGFEVLD------------------LDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hhhhhhcc------------------ccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 00000000 01115679999999999999999999999999987543
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=304.21 Aligned_cols=248 Identities=31% Similarity=0.423 Sum_probs=194.3
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-
Q psy16081 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY- 205 (493)
Q Consensus 127 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~- 205 (493)
||.|+||.||+|.+..+++.||+|++....... ......+..++.......|+||+++++.+...+..|+|+||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR--KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh--hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999999999999999986433211 11111222223333334588899999999999999999999965
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc------
Q psy16081 206 NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR------ 279 (493)
Q Consensus 206 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~------ 279 (493)
+|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||++ +.++.++|+|||++......
T Consensus 79 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 79 DLASLLENVG--SLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEE--cCCCCEEEEecccchhcccCcccccc
Confidence 9999887654 6899999999999999999999 5799999999999999 67889999999998654322
Q ss_pred -----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 280 -----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 280 -----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.....++..|+|||++.+..++.++|||||||++|+|++|..||......+....+......++..
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 223 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--------- 223 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc---------
Confidence 223467888999999998889999999999999999999999998877665554443310000000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH---
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP--- 431 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~--- 431 (493)
..-...+.+||.+||..||.+|||+
T Consensus 224 ----------------------------------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~ 251 (265)
T cd05579 224 ----------------------------------------------------VEVSDEAIDLISKLLVPDPEKRLGAKSI 251 (265)
T ss_pred ----------------------------------------------------ccCCHHHHHHHHHHhcCCHhhcCCCccH
Confidence 0001178899999999999999999
Q ss_pred HHHhcCCCCCCC
Q psy16081 432 YYALQHNFFKRT 443 (493)
Q Consensus 432 ~e~L~Hp~~~~~ 443 (493)
.++|+||||..+
T Consensus 252 ~~~l~~~~~~~~ 263 (265)
T cd05579 252 EEIKNHPFFKGI 263 (265)
T ss_pred HHHhcCccccCC
Confidence 999999999865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=308.38 Aligned_cols=246 Identities=22% Similarity=0.295 Sum_probs=191.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEE-----cCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFD-----LEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
++|.+.+.||+|+||+||++.+ ..++..||+|.+..... ....+..|+.++.. ..|++|+++++++..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~------l~h~~i~~~~~~~~~ 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN------LQHEHIVKFYGVCVE 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHh------CCCCCcceEEEEEec
Confidence 4689999999999999999975 33567799998864321 12233344443332 357789999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccC-----------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTN-----------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP 260 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~ 260 (493)
.+.+|+||||+. ++|.+++.... ...+++..+..++.||+.||.||| +.|++||||||+|||+ +
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili--~ 154 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLV--G 154 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEE--c
Confidence 999999999996 48999886432 124899999999999999999999 4789999999999999 6
Q ss_pred CCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy16081 261 KRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNK 334 (493)
Q Consensus 261 ~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~ 334 (493)
.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 78899999999997653322 22334678999999999899999999999999999998 9999988877666555
Q ss_pred HHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHH
Q psy16081 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414 (493)
Q Consensus 335 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (493)
+......+. .. .. ...+.
T Consensus 235 i~~~~~~~~-------------------------------------~~-----------------------~~--~~~l~ 252 (288)
T cd05093 235 ITQGRVLQR-------------------------------------PR-----------------------TC--PKEVY 252 (288)
T ss_pred HHcCCcCCC-------------------------------------CC-----------------------CC--CHHHH
Confidence 543110000 00 00 01689
Q ss_pred HHHhHccCCCCCCCCCHHHHhc
Q psy16081 415 DLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 415 dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
+||.+||..||.+|||+.+++.
T Consensus 253 ~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 253 DLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=299.08 Aligned_cols=252 Identities=28% Similarity=0.370 Sum_probs=197.1
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
+|++.+.||.|+||.||++.+..+++.+|+|.+........... .+..++......+|+||+++.+.+......|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~---~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE---DAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHH---HHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 58899999999999999999999999999999874332111111 112222222333477899999999999999999
Q ss_pred EEeccc-CHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 200 FELLSY-NLYDLLRNTN--FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
|||+++ +|.+++.... ...+++..+..++.|++.||.|||+ .|++|+||+|+||++ +.++.+||+|||++...
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~--~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILL--VANDLVKIGDLGISKVL 153 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEE--ecCCcEEEeeccchhhh
Confidence 999965 8988876521 2458999999999999999999994 789999999999999 55788999999999776
Q ss_pred CCcc-ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 277 GQRI-YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 277 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
.... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+......+
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 220 (256)
T cd08530 154 KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP------------- 220 (256)
T ss_pred ccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-------------
Confidence 5432 23467889999999999999999999999999999999999998877654443332210000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
.+ .....++.++|.+||..||++|||+.+++
T Consensus 221 ----~~---------------------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 221 ----IP---------------------------------------------PIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251 (256)
T ss_pred ----Cc---------------------------------------------hhhCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 00 00011689999999999999999999999
Q ss_pred cCCCC
Q psy16081 436 QHNFF 440 (493)
Q Consensus 436 ~Hp~~ 440 (493)
+||++
T Consensus 252 ~~p~~ 256 (256)
T cd08530 252 ASPAV 256 (256)
T ss_pred cCCCC
Confidence 99985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=306.82 Aligned_cols=247 Identities=20% Similarity=0.247 Sum_probs=189.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEc----CCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDL----EEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~----~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
++|++.+.||+|+||+||+|.+. .++..||+|.++..... ...+..|..++. ...|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~------~l~h~niv~~~~~~~~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMA------ELHHPNIVCLLGVVTQ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHh------hCCCCCeeeEEEEEec
Confidence 56899999999999999999853 45688999998743221 122333443333 3357889999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTN---------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
.+..|+||||+.+ +|.+++.... ...+++..+..++.||+.||.||| +.||+||||||+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nil 156 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNIL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEE
Confidence 9999999999965 8999885321 123788889999999999999999 478999999999999
Q ss_pred eeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy16081 257 LCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVD 330 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~ 330 (493)
+ +.++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |.+||.+....+
T Consensus 157 i--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05090 157 I--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234 (283)
T ss_pred E--cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9 66788999999999765322 123345667999999998889999999999999999998 999998877655
Q ss_pred HHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchh
Q psy16081 331 QMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410 (493)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (493)
....+..... ++ .+ ....
T Consensus 235 ~~~~~~~~~~-~~------------------------------------~~-------------------------~~~~ 252 (283)
T cd05090 235 VIEMVRKRQL-LP------------------------------------CS-------------------------EDCP 252 (283)
T ss_pred HHHHHHcCCc-CC------------------------------------CC-------------------------CCCC
Confidence 5444432110 00 00 0001
Q ss_pred hhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 411 LKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 411 ~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
..+.+||.+||..||++||++.+++++
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 253 PRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 168899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.12 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=185.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
++|++++.||+|+||.||+|.+.. +++.||+|+++..... ......|+.++..+ .+|+||+++++++.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l-----~~h~niv~~~~~~~ 81 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHI-----GHHLNVVNLLGACT 81 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhh-----ccCcchhheeeeEe
Confidence 579999999999999999997543 4578999998743211 11222333333222 25788999999876
Q ss_pred e-cceeEEEEEeccc-CHHHHHhccCC-----------------------------------------------------
Q psy16081 192 W-RNHLCLVFELLSY-NLYDLLRNTNF----------------------------------------------------- 216 (493)
Q Consensus 192 ~-~~~~~lV~E~~~~-~L~~~l~~~~~----------------------------------------------------- 216 (493)
. +..+++||||+.+ +|.+++.....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 4578999999965 89888854221
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc-----cccccc
Q psy16081 217 ------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQ 285 (493)
Q Consensus 217 ------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~g 285 (493)
..+++..+..++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++..+... .....+
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill--~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEE--eCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 25789999999999999999999 4799999999999999 56788999999999765322 122344
Q ss_pred cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCC
Q psy16081 286 SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGS 364 (493)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 364 (493)
+..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.........+
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 295 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM---------------------- 295 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC----------------------
Confidence 667999999999999999999999999999998 999998755433332222110000
Q ss_pred ceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 365 YILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
.. +. . ...++.+++.+||..+|++|||+.|+++|
T Consensus 296 ------------~~------------------------~~-~--~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 ------------RA------------------------PE-Y--ATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ------------CC------------------------Cc-c--CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 00 0 00168899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=302.84 Aligned_cols=244 Identities=19% Similarity=0.246 Sum_probs=191.7
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
+|++.+.||+|+||.||+|.+. ++..+|||++.........+..|+.++.. ..|+||+++++++...+..|+|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~------l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMK------LSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHh------CCCCCEEEEEEEEcCCCceEEE
Confidence 5889999999999999999875 56789999987543333344445544443 3477899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|||+++ +|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+||++ +.++.+||+|||++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i--~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLV--GEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEE--CCCCcEEECCcccceeccc
Confidence 999955 8999987544 36899999999999999999999 4789999999999999 6788999999999976543
Q ss_pred ccc-ccc---ccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 279 RIY-QYI---QSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 279 ~~~-~~~---gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... ... ++..|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+......+.
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 222 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---------- 222 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC----------
Confidence 221 112 2346999999999899999999999999999999 8999988776655544432111000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
. ......+.+|+.+||..+|++|||+.|
T Consensus 223 ---------------------------~-------------------------~~~~~~~~~li~~cl~~~p~~Rpt~~~ 250 (256)
T cd05059 223 ---------------------------P-------------------------KLAPTEVYTIMYSCWHEKPEDRPAFKK 250 (256)
T ss_pred ---------------------------C-------------------------CCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 0 000116889999999999999999999
Q ss_pred HhcC
Q psy16081 434 ALQH 437 (493)
Q Consensus 434 ~L~H 437 (493)
+++.
T Consensus 251 ~l~~ 254 (256)
T cd05059 251 LLSQ 254 (256)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=305.57 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=191.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCC-----CeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEE-----QCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|++.+.||+|+||.||+|.+... +..||+|.+..... ... ...+.+++......+|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRE---RIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHH---HHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 46899999999999999999987654 48899999864321 111 1122223333333467889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTN--------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS 263 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~ 263 (493)
....|+||||++ ++|.+++.... ...+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill--~~~~ 156 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMV--AEDL 156 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEE--cCCC
Confidence 999999999995 59999886432 123688899999999999999999 4789999999999999 6788
Q ss_pred cEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q psy16081 264 AIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVE 337 (493)
Q Consensus 264 ~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~ 337 (493)
.+||+|||+++..... .....++..|+|||.+.+..++.++|||||||++||+++ |.+||.+.+..+....+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 9999999998765332 223456778999999998889999999999999999998 9999988776655444431
Q ss_pred HhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHH
Q psy16081 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417 (493)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi 417 (493)
. ..++ .|. . ....+.+||
T Consensus 237 ~-~~~~----------------------------------~~~-------------------------~--~~~~~~~li 254 (277)
T cd05032 237 G-GHLD----------------------------------LPE-------------------------N--CPDKLLELM 254 (277)
T ss_pred C-CCCC----------------------------------CCC-------------------------C--CCHHHHHHH
Confidence 1 0000 000 0 011688999
Q ss_pred hHccCCCCCCCCCHHHHhc
Q psy16081 418 FRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 418 ~~mL~~dP~~R~t~~e~L~ 436 (493)
.+||..||++|||+.++++
T Consensus 255 ~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 255 RMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHcCCChhhCCCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=306.44 Aligned_cols=206 Identities=17% Similarity=0.217 Sum_probs=158.7
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCcccc-hHHH-----HHHHHHHHHhhcCCCCcceEEEe
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKPFL-NQAQ-----IEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~~-~~~~-----~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
...++|++.++||+|+||+||+|.+..+ +..+|+|+........ .+.. .+......+.......|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3446899999999999999999998877 6778888654322111 1100 01112222333445568889998
Q ss_pred ceeeeecc----eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC
Q psy16081 187 KRHFMWRN----HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR 262 (493)
Q Consensus 187 ~~~~~~~~----~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~ 262 (493)
++++.... ..++++|++..++.+.+.... ..++..++.++.||+.||.|||+ .+|+||||||+|||+ +.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill--~~~ 162 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMV--DGN 162 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--cCC
Confidence 88765443 457889988778877775432 36788899999999999999994 789999999999999 677
Q ss_pred CcEEEEecccccccCC----------ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 263 SAIKIVDFGSSCQLGQ----------RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
+.++|+|||+|+.+.. ......||+.|+|||++.+..++.++|||||||++|||++|.+||.+..
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 8899999999976531 1123468999999999999999999999999999999999999998764
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=309.79 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=196.6
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
|....+||+|+||.||++.+..+++.||||++..... .......|..++ ...+|+||+++++.|...++.|+|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l------~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIM------RDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHH------HhcCCcchhheeeEEEeCCEEEEE
Confidence 3344789999999999999999999999998853321 111222333322 234578899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|||+++ +|.+++... .+++..+..++.|++.||.|||+ .|++|+||||+||++ +.++.++|+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv--~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 96 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILL--THDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--CCCCCEEEcccccceeccc
Confidence 999966 787776543 48999999999999999999995 689999999999999 6778899999999865543
Q ss_pred c---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 279 R---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 279 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
. .....+++.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+.+..+...+...
T Consensus 169 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------- 235 (292)
T cd06657 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK------------- 235 (292)
T ss_pred ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-------------
Confidence 2 234568899999999988889999999999999999999999998877665554443211100
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
+... ... ...+.+||.+||..||.+|||+.++|
T Consensus 236 -~~~~--------------------------------------------~~~--~~~l~~li~~~l~~~P~~R~~~~~ll 268 (292)
T cd06657 236 -LKNL--------------------------------------------HKV--SPSLKGFLDRLLVRDPAQRATAAELL 268 (292)
T ss_pred -cCCc--------------------------------------------ccC--CHHHHHHHHHHHhCCcccCcCHHHHh
Confidence 0000 000 01678999999999999999999999
Q ss_pred cCCCCCCCcc
Q psy16081 436 QHNFFKRTAD 445 (493)
Q Consensus 436 ~Hp~~~~~~~ 445 (493)
+||||.....
T Consensus 269 ~~~~~~~~~~ 278 (292)
T cd06657 269 KHPFLAKAGP 278 (292)
T ss_pred cChHHhccCC
Confidence 9999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.74 Aligned_cols=203 Identities=25% Similarity=0.319 Sum_probs=159.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeE----EEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCH----VAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++.+.||+|+||+||+|.+..+++. ||+|.+..... .... ..+...+......+|+||+++++++. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~---~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTF---QEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHH---HHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 4788999999999999999998877764 67777643211 1111 12222222234457889999999876 45
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
..++|+||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .+++||||||+|||+ +.++.+||+|||++
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili--~~~~~~kl~Dfg~~ 156 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILL--KSDSIVQIADFGVA 156 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEE--cCCCcEEEcCCccc
Confidence 6789999995 59999987543 468999999999999999999994 789999999999999 67889999999999
Q ss_pred cccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy16081 274 CQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQ 331 (493)
Q Consensus 274 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~ 331 (493)
+..... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 220 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 765322 123346678999999998899999999999999999998 9999987765443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=339.88 Aligned_cols=204 Identities=25% Similarity=0.327 Sum_probs=163.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.++||+|+||.||+|++..+++.||||++......... ....+++++......+||||+++++++.+.+..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~--~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPL--LKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHH--HHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 6899999999999999999999999999999998743211111 11122222333333458889999999999999999
Q ss_pred EEEeccc-CHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 199 VFELLSY-NLYDLLRNTN---------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
||||++| +|.+++.... ...+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILL--d~dg~vKLi 155 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILL--GLFGEVVIL 155 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEE--cCCCCEEEE
Confidence 9999965 8988886321 1235667788999999999999995 789999999999999 678899999
Q ss_pred ecccccccCCc---------------------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 269 DFGSSCQLGQR---------------------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 269 DFG~a~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||...+
T Consensus 156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 99999765110 112468999999999999999999999999999999999999998754
Q ss_pred H
Q psy16081 328 E 328 (493)
Q Consensus 328 ~ 328 (493)
.
T Consensus 236 ~ 236 (932)
T PRK13184 236 G 236 (932)
T ss_pred h
Confidence 3
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=308.11 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=196.2
Q ss_pred cEEEeeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCcc-----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKP-----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
.|++.+.||.|+||.||+|.+. .+|+.||+|+++.... .......|+.++..+. +|++|++++++|.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc-----cCCChhceeeEee
Confidence 4889999999999999999875 4789999999874321 1223344555444332 4678999999999
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
.+..+|+||||+.+ +|.+++.... .+++..+..++.||+.||.||| +.|++||||||+|||+ +.++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~--~~~~~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILL--DSNGHVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEE--CCCCCEEEeeC
Confidence 99999999999965 8999887653 5889999999999999999999 4799999999999999 67889999999
Q ss_pred ccccccCCc----cccccccCcCCchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 271 GSSCQLGQR----IYQYIQSRFYRSPEVLLGI--PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 271 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|++...... .....|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+.+.......
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 229 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC
Confidence 998765432 2345688999999999753 4788999999999999999999999754332222222221100000
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
+.+ ..-...+.+||++||..|
T Consensus 230 ----------------------------------~~~-------------------------~~~~~~~~~ll~~~l~~~ 250 (290)
T cd05613 230 ----------------------------------PYP-------------------------QEMSALAKDIIQRLLMKD 250 (290)
T ss_pred ----------------------------------CCC-------------------------ccCCHHHHHHHHHHhcCC
Confidence 000 000116789999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCCcc
Q psy16081 425 PKTRI-----TPYYALQHNFFKRTAD 445 (493)
Q Consensus 425 P~~R~-----t~~e~L~Hp~~~~~~~ 445 (493)
|.+|| ++++++.||||+....
T Consensus 251 p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 251 PKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred HHHhcCCCCCCHHHHHcCcccccCCH
Confidence 99997 8999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.18 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=191.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
++|++.+.||+|+||+||+|.+..+ ...||||+++..... ...+..|..++ ...+|+||+++++.+...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l------~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIM------GQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHH------HhCCCCCcceEeEEEecC
Confidence 5799999999999999999987654 468999988643221 11222233332 333578899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+..|+||||+.+ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.++|+|||+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili--~~~~~~~l~dfg~ 152 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILV--NSNLVCKVSDFGL 152 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEE--cCCCCEEECccch
Confidence 999999999965 8999887644 36899999999999999999999 4799999999999999 6788899999999
Q ss_pred ccccCCcc---c--cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 273 SCQLGQRI---Y--QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 273 a~~~~~~~---~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
+....... . ...++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.+....+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 230 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP-- 230 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 98764211 1 1233567999999999899999999999999999998 99999876665555544332111100
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
......+.+|+.+||..||+
T Consensus 231 ------------------------------------------------------------~~~~~~l~~li~~cl~~~p~ 250 (266)
T cd05033 231 ------------------------------------------------------------MDCPSALYQLMLDCWQKDRN 250 (266)
T ss_pred ------------------------------------------------------------CCCCHHHHHHHHHHcCCCcc
Confidence 00011688999999999999
Q ss_pred CCCCHHHHhcC
Q psy16081 427 TRITPYYALQH 437 (493)
Q Consensus 427 ~R~t~~e~L~H 437 (493)
+|||+.|++++
T Consensus 251 ~Rp~~~ei~~~ 261 (266)
T cd05033 251 ERPTFSQIVST 261 (266)
T ss_pred cCcCHHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.08 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=192.5
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|++.++||+|+||.||+|.+. ++..||+|.+.........+..|+.++..+ +|++|+++++++. .+..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l------~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL------RHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc------CCCceEEEEeEEC-CCCc
Confidence 3468999999999999999999765 567799999976544344455555554433 4667999998875 4568
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+.+ +|.+++.......+++..+..++.|++.||.|||. .+|+||||||+||++ ++++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili--~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILV--GDGLVCKIADFGLARL 151 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEE--eCCceEEeCCceeeee
Confidence 999999965 99999876555568999999999999999999994 789999999999999 5678899999999976
Q ss_pred cCCccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
...... ...++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 224 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC------- 224 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 543221 2234557999999998899999999999999999999 9999988776666555432111000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.......+.+||.+||..||.+|||
T Consensus 225 -------------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rpt 249 (260)
T cd05070 225 -------------------------------------------------------PQDCPISLHELMLQCWKKDPEERPT 249 (260)
T ss_pred -------------------------------------------------------CCcCCHHHHHHHHHHcccCcccCcC
Confidence 0000116889999999999999999
Q ss_pred HHHHhc
Q psy16081 431 PYYALQ 436 (493)
Q Consensus 431 ~~e~L~ 436 (493)
+.++++
T Consensus 250 ~~~l~~ 255 (260)
T cd05070 250 FEYLQS 255 (260)
T ss_pred HHHHHH
Confidence 999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=305.21 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=196.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..+|++.++||.|+||.||+|.+.. ++.+|+|++..... .......|..++. ..+|+||+++++++...+..
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~------~l~~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALK------RLRHKHLISLFAVCSVGEPV 77 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHh------cCCCcchhheeeeEecCCCe
Confidence 3578999999999999999999877 89999999875432 2233333433332 33578899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++.......+++..+..++.||+.||.||| +.||+|+||||+||++ +.++.+||+|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv--~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILV--GEDLVCKVADFGLARL 153 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEE--cCCceEEEccccchhh
Confidence 999999965 9999998765566899999999999999999999 5789999999999999 6788899999999976
Q ss_pred cCCccc---cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQRIY---QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
...... ...++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+......+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 226 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP------- 226 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCC-------
Confidence 644322 2234567999999998899999999999999999998 89999888776666655432111000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
......+.++|.+||..||.+|||+
T Consensus 227 -------------------------------------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~ 251 (261)
T cd05148 227 -------------------------------------------------------AKCPQEIYKIMLECWAAEPEDRPSF 251 (261)
T ss_pred -------------------------------------------------------CCCCHHHHHHHHHHcCCCchhCcCH
Confidence 0001168899999999999999999
Q ss_pred HHHhc
Q psy16081 432 YYALQ 436 (493)
Q Consensus 432 ~e~L~ 436 (493)
.++++
T Consensus 252 ~~l~~ 256 (261)
T cd05148 252 KALRE 256 (261)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=311.47 Aligned_cols=257 Identities=24% Similarity=0.318 Sum_probs=197.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.+.|+..+.||+|+||+||+|++..+++.||||.+......... ....+.+++......+|+|++++.+++...+..+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE--KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChH--HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 34588889999999999999999999999999988632211111 1111222233333345778999999999999999
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
+||||+.++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||+ +.++.++|+|||++....
T Consensus 92 lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 92 LVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILL--SEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEE--CCCCcEEECCcccceeec
Confidence 999999888888776443 458999999999999999999994 789999999999999 677899999999987654
Q ss_pred CccccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 278 QRIYQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.. ....+++.|+|||++. ...++.++|||||||++|+|++|..||...+..+....+..... +..
T Consensus 167 ~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~---------- 234 (308)
T cd06634 167 PA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PAL---------- 234 (308)
T ss_pred Cc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-CCc----------
Confidence 32 3457889999999985 34688899999999999999999999987655544443332100 000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
. ... ....+.+||.+||..+|.+|||+.++
T Consensus 235 ------~------------------------------------------~~~--~~~~~~~li~~cl~~~P~~Rp~~~~l 264 (308)
T cd06634 235 ------Q------------------------------------------SGH--WSEYFRNFVDSCLQKIPQDRPTSEVL 264 (308)
T ss_pred ------C------------------------------------------ccc--ccHHHHHHHHHHhhCCcccCCCHHHH
Confidence 0 000 00167899999999999999999999
Q ss_pred hcCCCCCCC
Q psy16081 435 LQHNFFKRT 443 (493)
Q Consensus 435 L~Hp~~~~~ 443 (493)
++|||+...
T Consensus 265 l~~~~~~~~ 273 (308)
T cd06634 265 LKHRFVLRE 273 (308)
T ss_pred hhCcccccc
Confidence 999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=299.44 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=197.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.++||+|+||.||+|.+. ++..||||.+............|+.++.. .+|+||+++++++......+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~------l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKK------LRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhh------CCCCCEeeeeeeeecCCceE
Confidence 468999999999999999999865 55789999998654444455555555443 34778999999999889999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+.+ +|.+++.......+++..+..++.||+.||.||| +.||+|+||||+||++ +.++.+||+|||++...
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili--~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILV--GENLVCKIADFGLARLI 153 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEE--cCCCCEEECccccceec
Confidence 99999965 9999997765556899999999999999999999 5789999999999999 67789999999999776
Q ss_pred CCccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
..... ....+..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+....+..+......+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 226 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP------- 226 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence 53211 2223467999999999899999999999999999998 99999988777666665432111100
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
......+.+++.+||..||.+|||+
T Consensus 227 -------------------------------------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~ 251 (261)
T cd05034 227 -------------------------------------------------------PNCPEELYDLMLQCWDKDPEERPTF 251 (261)
T ss_pred -------------------------------------------------------CCCCHHHHHHHHHHcccCcccCCCH
Confidence 0001168899999999999999999
Q ss_pred HHHhc
Q psy16081 432 YYALQ 436 (493)
Q Consensus 432 ~e~L~ 436 (493)
+++++
T Consensus 252 ~~l~~ 256 (261)
T cd05034 252 EYLQS 256 (261)
T ss_pred HHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.01 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=204.2
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
...+.|++.+.||.|+||.||+|.+..++..||+|++............|..++. ..+|+||+++++.+...+.
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~------~l~~~~i~~~~~~~~~~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMK------DCKHPNIVDYYDSYLVGDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHH------HCCCCCeeEEEEEEEECCE
Confidence 3456799999999999999999999888999999999754432223333443332 3346789999999999999
Q ss_pred eEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.|+|+||++ ++|.+++.... ..+++..+..++.||+.||.|||. .||+|+||+|+||++ +.++.++|+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i--~~~~~~~l~d~~~~~ 164 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILL--SKDGSVKLADFGFAA 164 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEE--cCCCCEEECccchhh
Confidence 999999997 59999997654 368999999999999999999994 799999999999999 678899999999986
Q ss_pred ccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 275 QLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 275 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
..... .....++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+... ..++..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~------ 237 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPPLK------ 237 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCc------
Confidence 55332 22345788899999999888999999999999999999999999877665544443321 000000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
... . ....+.+||.+||..||.+|||+
T Consensus 238 ----------------------------~~~-----------------------~--~~~~l~~li~~~l~~~p~~Rpt~ 264 (286)
T cd06614 238 ----------------------------NPE-----------------------K--WSPEFKDFLNKCLVKDPEKRPSA 264 (286)
T ss_pred ----------------------------chh-----------------------h--CCHHHHHHHHHHhccChhhCcCH
Confidence 000 0 00168899999999999999999
Q ss_pred HHHhcCCCCCCC
Q psy16081 432 YYALQHNFFKRT 443 (493)
Q Consensus 432 ~e~L~Hp~~~~~ 443 (493)
.++++|+||++.
T Consensus 265 ~~il~~~~~~~~ 276 (286)
T cd06614 265 EELLQHPFLKKA 276 (286)
T ss_pred HHHhhChHhhcc
Confidence 999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=310.60 Aligned_cols=248 Identities=25% Similarity=0.278 Sum_probs=188.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeE--EEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCH--VAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~--vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++.+.||+|+||.||+|.+..++.. +|+|.++.... ....+..|+.++..+ .+|+||+++++++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l-----~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL-----GHHPNIINLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHh-----cCCCCcceEEEEECCCC
Confidence 5799999999999999999998877754 57776653211 112333444444333 25788999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN 259 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~ 259 (493)
.+|+||||+. ++|.+++.... ...+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~Nili-- 157 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILV-- 157 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEe--
Confidence 9999999996 49999886532 124789999999999999999999 5799999999999999
Q ss_pred CCCCcEEEEecccccccCCccc--cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy16081 260 PKRSAIKIVDFGSSCQLGQRIY--QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 260 ~~~~~ikL~DFG~a~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 336 (493)
+.++.+||+|||++........ ...++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 6788899999999864322111 1223567999999988889999999999999999998 999998776655443321
Q ss_pred HHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHH
Q psy16081 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDL 416 (493)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL 416 (493)
...... . + ... ...+.+|
T Consensus 238 ~~~~~~-----------------------------------~------------------------~-~~~--~~~~~~l 255 (303)
T cd05088 238 QGYRLE-----------------------------------K------------------------P-LNC--DDEVYDL 255 (303)
T ss_pred cCCcCC-----------------------------------C------------------------C-CCC--CHHHHHH
Confidence 100000 0 0 000 0167899
Q ss_pred HhHccCCCCCCCCCHHHHhcC
Q psy16081 417 IFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 417 i~~mL~~dP~~R~t~~e~L~H 437 (493)
|.+||..||.+|||++++|++
T Consensus 256 i~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 256 MRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=295.93 Aligned_cols=248 Identities=31% Similarity=0.491 Sum_probs=196.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--c
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR--N 194 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~--~ 194 (493)
+|.+.+.||+|++|.||+|.+..+++.|++|++..... .......|...+..+ +|++|+++++.+... +
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL------QHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc------CCCCEeeEEEEEecCCCC
Confidence 47888999999999999999999999999999875442 123333344433332 377899999999988 8
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+++|+||+. ++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++ +.++.++|+|||.+
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i--~~~~~~~l~d~~~~ 148 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILV--DSDGVVKLADFGCA 148 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEE--cCCCCEEEcccccE
Confidence 9999999994 59999887654 68999999999999999999994 799999999999999 56789999999999
Q ss_pred cccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhh
Q psy16081 274 CQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE-VDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 274 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~~p~~~~ 347 (493)
...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+. ......+... ...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~----- 222 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS-GEP----- 222 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc-CCC-----
Confidence 777543 2345678899999999988899999999999999999999999987651 1111111100 000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
..++ . .. ...+.+||.+||..||.+
T Consensus 223 ----------~~~~--------------------~-----------------------~~--~~~l~~~i~~~l~~~p~~ 247 (260)
T cd06606 223 ----------PEIP--------------------E-----------------------HL--SEEAKDFLRKCLRRDPKK 247 (260)
T ss_pred ----------cCCC--------------------c-----------------------cc--CHHHHHHHHHhCcCChhh
Confidence 0000 0 00 127899999999999999
Q ss_pred CCCHHHHhcCCCC
Q psy16081 428 RITPYYALQHNFF 440 (493)
Q Consensus 428 R~t~~e~L~Hp~~ 440 (493)
|||+.|+++||||
T Consensus 248 Rp~~~~ll~~~~~ 260 (260)
T cd06606 248 RPTADELLQHPFL 260 (260)
T ss_pred CCCHHHHhhCCCC
Confidence 9999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=299.30 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=191.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++...||+|+||.||+|.+..+ ..+|+|.+............|+.++..+ .|++|+++++++. .+..|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL------RHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC------CCCCeeeEEEEEc-CCCcE
Confidence 35799999999999999999987655 4699998875443334445555555443 4677999998875 56789
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+.+ +|.+++.......+++..+..++.||+.||.||| +.||+|+||||+||++ ++++.++|+|||++...
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill--~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILV--GDNLVCKIADFGLARLI 152 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEE--cCCCeEEECCCccceEc
Confidence 99999965 9999997655455899999999999999999999 5789999999999999 67889999999999765
Q ss_pred CCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.... ....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....+......+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 224 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC-------- 224 (260)
T ss_pred cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 4321 12235567999999998899999999999999999999 9999998776665554432111000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
. ......+.+||.+||..||.+|||+
T Consensus 225 -----------------------------~-------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05069 225 -----------------------------P-------------------------QGCPESLHELMKLCWKKDPDERPTF 250 (260)
T ss_pred -----------------------------C-------------------------cccCHHHHHHHHHHccCCcccCcCH
Confidence 0 0000168899999999999999999
Q ss_pred HHHhc
Q psy16081 432 YYALQ 436 (493)
Q Consensus 432 ~e~L~ 436 (493)
+++++
T Consensus 251 ~~i~~ 255 (260)
T cd05069 251 EYIQS 255 (260)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=299.01 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=193.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||.|+||.||+|.. .++.||||.++.......+...|..++.. .+|+||+++++.+.+.+..|+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~------l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTT------LRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHh------cCCcceeeeEEEEcCCCCeEE
Confidence 4788999999999999999975 47899999997554323334444444333 347789999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+++ +|.+++.......+++..+..++.|++.||.||| ..||+|+||||+||++ +.++.+||+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili--~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLV--SEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEE--eCCCCEEEcccccccccc
Confidence 9999975 9999987665446899999999999999999999 4789999999999999 678899999999998775
Q ss_pred CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 278 QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
........+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+......
T Consensus 154 ~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 218 (256)
T cd05039 154 QGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM--------------- 218 (256)
T ss_pred cccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---------------
Confidence 44444445667999999998889999999999999999997 99999877665544333221000
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
..+ ......+.+||.+||..+|.+|||+.++++
T Consensus 219 --~~~---------------------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 --EAP---------------------------------------------EGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --CCc---------------------------------------------cCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 000017889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=295.00 Aligned_cols=247 Identities=28% Similarity=0.462 Sum_probs=197.2
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+|++.+.||+|++|.||++.+..+++.||+|.+...... ......|..++ . ...|++++++++++.+.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l---~---~l~~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLL---K---NLKHPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHH---H---hCCCCCccEEEEEEEeCCEE
Confidence 588999999999999999999999999999999755421 12222333322 2 33477899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
++||||+++ +|.+++... ..+++..+..++.|++.||.|||+ .||+|+||||+||++ +.++.++|+|||++..
T Consensus 75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILT--TKDGVVKLADFGVATK 148 (254)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEE--CCCCCEEEecccccee
Confidence 999999966 898888765 468999999999999999999994 789999999999999 5678999999999977
Q ss_pred cCCcc---ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQRI---YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
..... ....++..|+|||.+.+..++.++||||||+++|+|++|.+||...+.......+..... +
T Consensus 149 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~---------- 217 (254)
T cd06627 149 LNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH-P---------- 217 (254)
T ss_pred cCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC-C----------
Confidence 65432 345678899999999888899999999999999999999999987665444333221000 0
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.. . .... ..+.+||.+||..||++|||+.
T Consensus 218 ------~~--------------------~-----------------------~~~~--~~~~~~i~~~l~~~p~~R~~~~ 246 (254)
T cd06627 218 ------PL--------------------P-----------------------EGIS--PELKDFLMQCFQKDPNLRPTAK 246 (254)
T ss_pred ------CC--------------------C-----------------------CCCC--HHHHHHHHHHHhCChhhCcCHH
Confidence 00 0 0000 1688999999999999999999
Q ss_pred HHhcCCCC
Q psy16081 433 YALQHNFF 440 (493)
Q Consensus 433 e~L~Hp~~ 440 (493)
+++.||||
T Consensus 247 ~~l~~~~~ 254 (254)
T cd06627 247 QLLKHPWI 254 (254)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=298.37 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=193.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
.+|++.+.||.|+||.||+|.+. ++..+|+|++.........+..|..++..+ +|++|+++++++......|+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL------SHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC------CCCCeeeEEEEEccCCceEE
Confidence 46889999999999999999875 467899999875443344555566555543 46779999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+.+ +|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.+||+|||++....
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLV--GENQVVKVSDFGMTRFVL 151 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEE--cCCCeEEECCCcceeecc
Confidence 9999965 8888886543 35889999999999999999999 4789999999999999 677889999999987654
Q ss_pred Cccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 278 QRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 278 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... ...++..|+|||++.+..++.++|||||||++|||++ |.+||......+....+.+......
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 222 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK--------- 222 (256)
T ss_pred cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---------
Confidence 3321 2234567999999998899999999999999999998 9999987776655544422110000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
+ .. ....+.+|+.+||..||++|||+.
T Consensus 223 --------------------------~--~~-------------------------~~~~~~~l~~~~l~~~p~~Rp~~~ 249 (256)
T cd05112 223 --------------------------P--RL-------------------------ASQSVYELMQHCWKERPEDRPSFS 249 (256)
T ss_pred --------------------------C--CC-------------------------CCHHHHHHHHHHcccChhhCCCHH
Confidence 0 00 001688999999999999999999
Q ss_pred HHhcC
Q psy16081 433 YALQH 437 (493)
Q Consensus 433 e~L~H 437 (493)
+++++
T Consensus 250 ~~l~~ 254 (256)
T cd05112 250 LLLHQ 254 (256)
T ss_pred HHHHh
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=304.26 Aligned_cols=246 Identities=19% Similarity=0.255 Sum_probs=185.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCe----EEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQC----HVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++.++||+|+||+||+|.+..+++ .||||+++..... . .+..+..+.......+|+||+++++.+.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~--~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--K--ANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH--H--HHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 579999999999999999998877776 4899998643211 1 11122222223334467889999998875 4
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
..++++||+. |+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ ++++.+||+|||++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~--~~~~~~kL~dfG~~ 156 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLV--KSPNHVKITDFGLA 156 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEE--cCCCcEEECCCCce
Confidence 5789999995 59999887543 358999999999999999999994 789999999999999 56778999999999
Q ss_pred cccCCccc-----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 274 CQLGQRIY-----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 274 ~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
........ ...+++.|+|||.+.+..++.++|||||||++|||++ |.+||......+....+... ..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--- 232 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERLPQ--- 232 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCCC---
Confidence 76643221 1233567999999999899999999999999999998 99999876654443322211 00000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
. ......+.++|.+||..||++
T Consensus 233 ---------------------------------~-------------------------~~~~~~~~~li~~~l~~dp~~ 254 (279)
T cd05109 233 ---------------------------------P-------------------------PICTIDVYMIMVKCWMIDSEC 254 (279)
T ss_pred ---------------------------------C-------------------------ccCCHHHHHHHHHHcCCChhh
Confidence 0 000016789999999999999
Q ss_pred CCCHHHHhc
Q psy16081 428 RITPYYALQ 436 (493)
Q Consensus 428 R~t~~e~L~ 436 (493)
|||+.++++
T Consensus 255 Rp~~~~l~~ 263 (279)
T cd05109 255 RPRFRELVD 263 (279)
T ss_pred CcCHHHHHH
Confidence 999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.41 Aligned_cols=203 Identities=25% Similarity=0.446 Sum_probs=164.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||.||+|.+..+++.||||.+...... .......+..++......+|+||++++++|...+..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh--hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 4688999999999999999999999999999988643211 11111122223333333457889999999999999999
Q ss_pred EEEeccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 199 VFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
||||+.+ +|.+++... ....+++..+..++.||+.||.||| +.|++|+||||+||++ +.++.++|+|||++..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili--~~~~~~~l~dfg~~~~ 155 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFI--TATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEE--cCCCCEEECcchhhhc
Confidence 9999965 898888642 2235899999999999999999999 5799999999999999 6788999999999876
Q ss_pred cCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
.... .....++..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 6432 224568889999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.10 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=191.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCC-----CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEE-----QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|++.+.||+|+||.||++.+... ...||+|++...... ......|+.++..+ .+|+||+++++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~~h~~i~~~~~~~ 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI-----GKHKNIINLLGVC 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhh-----cCCCCeeeEEEEE
Confidence 46799999999999999999987643 378999998743211 11223343333322 2578899999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcE
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNT--------------NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENI 255 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NI 255 (493)
...+.+++||||+. ++|.+++... ....+++..+..++.||+.||.||| +.+|+||||||+||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~Ni 163 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAARNV 163 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccceeeE
Confidence 99999999999995 4999988642 2345899999999999999999999 47899999999999
Q ss_pred EeeCCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy16081 256 LLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEV 329 (493)
Q Consensus 256 Ll~~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~ 329 (493)
|+ +.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 164 l~--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 164 LV--TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EE--cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 99 678899999999997664321 11234567999999999899999999999999999997 99999887665
Q ss_pred HHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcch
Q psy16081 330 DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409 (493)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (493)
+....+....... .+ ...
T Consensus 242 ~~~~~~~~~~~~~-----------------------------------~~---------------------------~~~ 259 (293)
T cd05053 242 ELFKLLKEGYRME-----------------------------------KP---------------------------QNC 259 (293)
T ss_pred HHHHHHHcCCcCC-----------------------------------CC---------------------------CCC
Confidence 5544432210000 00 000
Q ss_pred hhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 410 YLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 410 ~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
...+.+||.+||..||.+|||+.|++++
T Consensus 260 ~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 260 TQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1168899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=298.38 Aligned_cols=241 Identities=24% Similarity=0.324 Sum_probs=191.5
Q ss_pred eeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
+.||+|+||.||+|.+... +..||||++...... ......|...+. ..+|+||+++++++.....+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~------~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMK------KLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHh------hcCCCChheeeeeecCCCceEEE
Confidence 4699999999999998866 899999999754322 223333433333 33477899999999999999999
Q ss_pred EEec-ccCHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 200 FELL-SYNLYDLLRNTN-------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 200 ~E~~-~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
|||+ +++|.+++.... ...+++..+..++.||+.||.|||. .||+|+||||+||++ +.++.+||+|||
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili--~~~~~~~l~dfg 150 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLV--GEDLVVKISDFG 150 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEE--CCCCcEEEcccc
Confidence 9999 569999987652 2468999999999999999999994 789999999999999 677899999999
Q ss_pred cccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 272 SSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 272 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
.+...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 228 (262)
T cd00192 151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK-- 228 (262)
T ss_pred cccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 99776543 234456788999999998899999999999999999999 6999998876666555443100000
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
+. .. ..++.++|.+||..||
T Consensus 229 ---------------------------------------------------------~~-~~--~~~~~~li~~~l~~~p 248 (262)
T cd00192 229 ---------------------------------------------------------PE-YC--PDELYELMLSCWQLDP 248 (262)
T ss_pred ---------------------------------------------------------Cc-cC--ChHHHHHHHHHccCCc
Confidence 00 00 1178899999999999
Q ss_pred CCCCCHHHHhcC
Q psy16081 426 KTRITPYYALQH 437 (493)
Q Consensus 426 ~~R~t~~e~L~H 437 (493)
.+|||+.|+++|
T Consensus 249 ~~Rps~~~l~~~ 260 (262)
T cd00192 249 EDRPTFSELVER 260 (262)
T ss_pred ccCcCHHHHHHh
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=299.34 Aligned_cols=243 Identities=22% Similarity=0.277 Sum_probs=189.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee-ecceeE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM-WRNHLC 197 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~-~~~~~~ 197 (493)
++|++.+.||+|+||.||++.. .+..||+|.++... ....+..|..++.. .+|++|+++++++. ..+..|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-~~~~~~~e~~~l~~------l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQ------LRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-hHHHHHHHHHHHHh------CCCCCeeeEEEEEEcCCCceE
Confidence 4789999999999999999964 47889999986432 22334445444443 34677999998754 456789
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++.......+++..+..++.||+.||.|||+ .||+||||||+||++ +.++.+||+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA 152 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEE--cCCCcEEecCCccceec
Confidence 99999965 99999876554458899999999999999999994 789999999999999 67889999999999766
Q ss_pred CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
........++..|+|||++.+..++.++|||||||++|+|++ |++||...+..+....+.......
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 219 (256)
T cd05082 153 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD------------- 219 (256)
T ss_pred cccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-------------
Confidence 544444455678999999999899999999999999999997 999998766555444432210000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
. . ......+.+||.+||..||++|||+.+++
T Consensus 220 ----~--------------------~-------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 250 (256)
T cd05082 220 ----A--------------------P-------------------------DGCPPVVYDVMKQCWHLDAATRPSFLQLR 250 (256)
T ss_pred ----C--------------------C-------------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 0 0 00011688999999999999999999997
Q ss_pred c
Q psy16081 436 Q 436 (493)
Q Consensus 436 ~ 436 (493)
+
T Consensus 251 ~ 251 (256)
T cd05082 251 E 251 (256)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=306.19 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=191.6
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEE-----cCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFD-----LEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|.+.+.||+|+||.||+|.+ ..++..||||+++..... ......|..++..+ .+|+||+++++++
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~~h~~iv~~~~~~ 108 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL-----GNHENIVNLLGAC 108 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhc-----cCCCCcceEEEEE
Confidence 35899999999999999999975 234568999998743221 12233344444332 2578899999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
...+.+|+||||+. ++|.+++.......+++..+..++.||+.||.|||+ .+|+|+||||+|||+ +.++.++|+|
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~--~~~~~~~l~d 184 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLL--THGKIVKICD 184 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEE--cCCCeEEECC
Confidence 99999999999996 599999876544458999999999999999999995 789999999999999 6778899999
Q ss_pred cccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 270 FGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 270 FG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+....+...+.......++
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 264 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA 264 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC
Confidence 99997654321 12345677999999999999999999999999999998 9999987665444433322100000
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
. +. ... ..+.+||.+||..
T Consensus 265 ----------------------------------~------------------------~~-~~~--~~~~~li~~cl~~ 283 (302)
T cd05055 265 ----------------------------------Q------------------------PE-HAP--AEIYDIMKTCWDA 283 (302)
T ss_pred ----------------------------------C------------------------CC-CCC--HHHHHHHHHHcCC
Confidence 0 00 000 1688999999999
Q ss_pred CCCCCCCHHHHhc
Q psy16081 424 DPKTRITPYYALQ 436 (493)
Q Consensus 424 dP~~R~t~~e~L~ 436 (493)
||++|||+.|+++
T Consensus 284 ~p~~Rpt~~ell~ 296 (302)
T cd05055 284 DPLKRPTFKQIVQ 296 (302)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=301.60 Aligned_cols=245 Identities=20% Similarity=0.273 Sum_probs=185.2
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCcccch---HHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKPFLN---QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~~~---~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
|.+++.||+|+||.||+|....+ +..||||+++....... .+..|...+ ...+|+||+++++.+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l------~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACM------KDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHH------HhCCCCCeeeEEeeeccCC
Confidence 56789999999999999987653 47899999875332212 223333332 2345778999999876554
Q ss_pred e------eEEEEEeccc-CHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC
Q psy16081 195 H------LCLVFELLSY-NLYDLLRNTN----FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS 263 (493)
Q Consensus 195 ~------~~lV~E~~~~-~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~ 263 (493)
. .++||||+.+ +|..++.... ...+++..+..++.|++.||.|||. .+|+||||||+||++ ++++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~--~~~~ 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCML--REDM 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEE--CCCC
Confidence 4 7999999965 8888774432 2358999999999999999999994 789999999999999 6788
Q ss_pred cEEEEecccccccCCccc-----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q psy16081 264 AIKIVDFGSSCQLGQRIY-----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVE 337 (493)
Q Consensus 264 ~ikL~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~ 337 (493)
.+||+|||+++....... ...++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+..
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~ 230 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH 230 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999976543221 2234567999999998899999999999999999999 9999988776655444432
Q ss_pred HhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHH
Q psy16081 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417 (493)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi 417 (493)
..... .+ . .....+.++|
T Consensus 231 ~~~~~-----------------------------------~~------------------------~---~~~~~~~~li 248 (273)
T cd05035 231 GNRLK-----------------------------------QP------------------------E---DCLDELYDLM 248 (273)
T ss_pred CCCCC-----------------------------------CC------------------------c---CCCHHHHHHH
Confidence 10000 00 0 0011789999
Q ss_pred hHccCCCCCCCCCHHHHhcC
Q psy16081 418 FRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 418 ~~mL~~dP~~R~t~~e~L~H 437 (493)
.+||..||.+|||+.|++++
T Consensus 249 ~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 249 YSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=305.29 Aligned_cols=246 Identities=21% Similarity=0.269 Sum_probs=189.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+|.+.+.||+|+||.||+|.+. .++..+|+|.+...... ...+..|+.. ....+|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~------l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL------LTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHH------HhcCCCCCcceEEEEEcc
Confidence 46889999999999999999754 34567999988643311 1223333333 333457889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEe
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNF--------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILL 257 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl 257 (493)
.+..++||||+. ++|.+++..... ..+++..++.++.||+.||.||| ..||+||||||+|||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLV 156 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEE
Confidence 999999999995 499999865321 24789999999999999999999 4789999999999999
Q ss_pred eCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy16081 258 CNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQ 331 (493)
Q Consensus 258 ~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~ 331 (493)
+.++.++|+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++ |.+||...+..+.
T Consensus 157 --~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 157 --GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred --ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 67889999999999765432 123445778999999999999999999999999999998 9999988776655
Q ss_pred HHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhh
Q psy16081 332 MNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYL 411 (493)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (493)
+..+....... . . .....
T Consensus 235 ~~~~~~~~~~~-----------------------------------~--~-------------------------~~~~~ 252 (291)
T cd05094 235 IECITQGRVLE-----------------------------------R--P-------------------------RVCPK 252 (291)
T ss_pred HHHHhCCCCCC-----------------------------------C--C-------------------------ccCCH
Confidence 44432210000 0 0 00011
Q ss_pred hHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 412 KFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 412 ~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
.+.+||.+||..||++|||+.++++
T Consensus 253 ~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 253 EVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHH
Confidence 6889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=307.32 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=189.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcC-------CCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLE-------EQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
.++|.+.+.||+|+||.||++.+.. +...||+|+++.... .......|+.++..+ ..|+||+++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-----~~h~~i~~~~~ 91 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-----GKHKNIINLLG 91 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHh-----cCCCCEeeEEE
Confidence 4689999999999999999997643 235799999874321 111222333333222 25788999999
Q ss_pred eeeecceeEEEEEeccc-CHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 189 HFMWRNHLCLVFELLSY-NLYDLLRNTNF--------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~~-~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
++...+.+|+||||+++ +|.+++..... ..+++..+..++.||+.||.||| +.|++||||||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~ 169 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAAR 169 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHH
Confidence 99999999999999965 99999875421 24888999999999999999999 479999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ +.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 170 Nill--~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 170 NVLV--TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred heEE--cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999 677899999999987654321 11223467999999999899999999999999999998 899998766
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+....+....... . +.
T Consensus 248 ~~~~~~~~~~~~~~~-----------------------------------~------------------------~~--- 265 (307)
T cd05098 248 VEELFKLLKEGHRMD-----------------------------------K------------------------PS--- 265 (307)
T ss_pred HHHHHHHHHcCCCCC-----------------------------------C------------------------CC---
Confidence 544444332110000 0 00
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
....++.+||.+||..+|.+|||+.+++++
T Consensus 266 ~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 266 NCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 001178899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=318.61 Aligned_cols=235 Identities=24% Similarity=0.352 Sum_probs=188.1
Q ss_pred EeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 123 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
-++-||.|+-|.||+|+ -.++.||||.++.- .+.++ .|+++..|+||+.+.++|.....+||||||
T Consensus 128 ELeWlGSGaQGAVF~Gr--l~netVAVKKV~el------kETdI------KHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGR--LHNETVAVKKVREL------KETDI------KHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred hhhhhccCcccceeeee--ccCceehhHHHhhh------hhhhH------HHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 35679999999999995 45789999987622 22222 344555688899999999999999999999
Q ss_pred c-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc--
Q psy16081 203 L-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-- 279 (493)
Q Consensus 203 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~-- 279 (493)
| .|-|++.|+..+ .+.......+..+|+.|+.|||.| .|||||||.-|||| ..+..|||+|||-++...+.
T Consensus 194 Ca~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~h--KIIHRDLKSPNiLI--s~~d~VKIsDFGTS~e~~~~ST 267 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLH--KIIHRDLKSPNILI--SYDDVVKISDFGTSKELSDKST 267 (904)
T ss_pred cccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHh--hHhhhccCCCceEe--eccceEEeccccchHhhhhhhh
Confidence 9 568999998764 799999999999999999999975 59999999999999 45667999999999887654
Q ss_pred cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhcc
Q psy16081 280 IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~ 359 (493)
...++||..|||||++.+.+.+.|+|||||||||||||||..||...+...++. ..
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw--------------GV---------- 323 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW--------------GV---------- 323 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE--------------ec----------
Confidence 346899999999999999999999999999999999999999998654332211 00
Q ss_pred CCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCC
Q psy16081 360 MPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHN 438 (493)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp 438 (493)
+..... .|.+ .++..-|+=||+.||.-.|..||+..|+|.|=
T Consensus 324 -GsNsL~-----------LpvP-------------------------stcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 324 -GSNSLH-----------LPVP-------------------------STCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred -cCCccc-----------ccCc-------------------------ccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 000000 0000 11122688899999999999999999999994
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.93 Aligned_cols=203 Identities=23% Similarity=0.342 Sum_probs=160.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCC-----CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEE-----QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|.++++||+|+||.||+|.+... +..||||+++..... ...+..|+.++..+ ..||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l-----~~HpnIv~l~~~~ 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHL-----GPHLNIVNLLGAC 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-----CCCCCeeeEEEEE
Confidence 46789999999999999999986433 457999999643221 12233344333322 2488999999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccC------------------------------------------------------
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTN------------------------------------------------------ 215 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~------------------------------------------------------ 215 (493)
...+.+|||||||. |+|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999995 49988875421
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcE
Q psy16081 216 ----------------------------------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENI 255 (493)
Q Consensus 216 ----------------------------------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NI 255 (493)
...+++..+..++.||+.||.|||+ .+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Ni 268 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhE
Confidence 1247788889999999999999994 7899999999999
Q ss_pred EeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy16081 256 LLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEV 329 (493)
Q Consensus 256 Ll~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~ 329 (493)
|+ +.++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 269 ll--~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 269 LL--AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EE--eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99 56788999999999765332 122345678999999999899999999999999999997 99999865443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=306.81 Aligned_cols=247 Identities=21% Similarity=0.229 Sum_probs=189.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCC-----CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEE-----QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
.+|++.+.||+|+||.||+|.+..+ +..||||+++..... ...+..|..+ .....|+||+++++.+.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~------~~~l~h~~iv~~~~~~~ 78 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMM------RSRLQHPNIVCLLGVVT 78 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHH------HhcCCCCCcCeEEEEEc
Confidence 4588899999999999999987543 578999998744321 1122223332 23345788999999999
Q ss_pred ecceeEEEEEeccc-CHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
..+..++++||+.+ +|.+++.... ...+++..+..++.|++.||.|||+ .||+||||||+|||
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil 156 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVL 156 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheE
Confidence 99999999999965 8888874211 1247888899999999999999994 78999999999999
Q ss_pred eeCCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy16081 257 LCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVD 330 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~ 330 (493)
+ ++++.+||+|||+++...... ....+++.|+|||++.+..++.++|||||||++|||++ |.+||.+....+
T Consensus 157 ~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 157 V--FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred e--cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9 567889999999987653221 23345678999999998889999999999999999998 889998877766
Q ss_pred HHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchh
Q psy16081 331 QMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410 (493)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (493)
.+..+......+. + ....
T Consensus 235 ~~~~i~~~~~~~~-----------------~---------------------------------------------~~~~ 252 (283)
T cd05091 235 VIEMIRNRQVLPC-----------------P---------------------------------------------DDCP 252 (283)
T ss_pred HHHHHHcCCcCCC-----------------C---------------------------------------------CCCC
Confidence 6655543211000 0 0001
Q ss_pred hhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 411 LKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 411 ~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
..+.+|+.+||+.||.+|||+.++++.
T Consensus 253 ~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 253 AWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 167899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=300.76 Aligned_cols=244 Identities=18% Similarity=0.212 Sum_probs=182.7
Q ss_pred EEeeeEeeeCCeEEEEEEEcCCCe--EEEEEEEccCcccch---HHHHHHHHHHHHhhcCCCCcceEEEeceeeeec---
Q psy16081 122 EIDSLIGKGSFGQVVKAFDLEEQC--HVAIKIIKNKKPFLN---QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR--- 193 (493)
Q Consensus 122 ~~~~~LG~G~fg~V~~~~~~~~~~--~vAvK~~~~~~~~~~---~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~--- 193 (493)
.+.++||+|+||.||+|.+..++. .||||.++....... .+..|..+ +. ..+|+||+++++.+...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~---l~---~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVC---MK---EFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHH---HH---hCCCCCcceEEEEEccCCcc
Confidence 467899999999999999877765 699998875322112 22223332 22 23577899999876432
Q ss_pred ---ceeEEEEEecc-cCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 194 ---NHLCLVFELLS-YNLYDLLRNT----NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 194 ---~~~~lV~E~~~-~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
...++||||+. ++|.+++... ....+++..+..++.||+.||.|||. .+|+||||||+|||+ +.++.+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~--~~~~~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCML--NENMNV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEE--cCCCCE
Confidence 35789999996 5888877432 12348899999999999999999994 789999999999999 678899
Q ss_pred EEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q psy16081 266 KIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVL 339 (493)
Q Consensus 266 kL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 339 (493)
||+|||++....... ....+++.|+|||++.+..++.++|||||||++|||++ |.+||.+....+....+....
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 231 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998764322 12245667999999999999999999999999999999 899998876655444433210
Q ss_pred CCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhH
Q psy16081 340 GLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419 (493)
Q Consensus 340 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~ 419 (493)
..+ . . ......+.++|.+
T Consensus 232 ~~~-----------------------------------~--~-------------------------~~~~~~~~~li~~ 249 (272)
T cd05075 232 RLK-----------------------------------Q--P-------------------------PDCLDGLYSLMSS 249 (272)
T ss_pred CCC-----------------------------------C--C-------------------------CCCCHHHHHHHHH
Confidence 000 0 0 0001168899999
Q ss_pred ccCCCCCCCCCHHHHhcC
Q psy16081 420 MLDYDPKTRITPYYALQH 437 (493)
Q Consensus 420 mL~~dP~~R~t~~e~L~H 437 (493)
||..||++|||+.+++++
T Consensus 250 ~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 250 CWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HcCCCcccCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=298.95 Aligned_cols=247 Identities=21% Similarity=0.254 Sum_probs=190.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCe---EEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQC---HVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|+..+.||+|+||.||+|.+..++. .+|||.++..... ... ..+..++.......|+||+++.+++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~-~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQR---QDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH-HHH---HHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 478889999999999999999876654 7999988643211 111 112222223334457889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.|+||||+++ +|.+++.... ..+++..+..++.|++.||.||| +.|++||||||+||++ +.++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili--~~~~~~kl~dfg~~~ 155 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILV--NSNLECKVSDFGLSR 155 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEE--cCCCcEEECCCccce
Confidence 9999999965 8888886543 46899999999999999999999 4789999999999999 678889999999987
Q ss_pred ccCCcccc------ccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 275 QLGQRIYQ------YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 275 ~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
........ ...+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 232 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP--- 232 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC---
Confidence 65432111 112346999999998889999999999999999997 99999887766666555432111100
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
.....++.+|+.+||..||.+
T Consensus 233 -----------------------------------------------------------~~~~~~~~~li~~c~~~~p~~ 253 (268)
T cd05063 233 -----------------------------------------------------------MDCPSAVYQLMLQCWQQDRAR 253 (268)
T ss_pred -----------------------------------------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 000116789999999999999
Q ss_pred CCCHHHHhc
Q psy16081 428 RITPYYALQ 436 (493)
Q Consensus 428 R~t~~e~L~ 436 (493)
||++.++++
T Consensus 254 Rp~~~~i~~ 262 (268)
T cd05063 254 RPRFVDIVN 262 (268)
T ss_pred CcCHHHHHH
Confidence 999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=295.86 Aligned_cols=199 Identities=28% Similarity=0.463 Sum_probs=164.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++.+.||+|+||.||+|.+..+++.||+|.++..... ......|+.++. ..+|++|+++++.+...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~------~~~~~~i~~~~~~~~~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK------QLDHPNVIKYLASFIENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHH------hCCCCCeeeeeeeeecCC
Confidence 5799999999999999999999989999999988632211 122333433333 335677999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
..++||||+++ +|.+++... ....+++..+..++.||+.||.||| +.||+|+||||+||++ +.++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~--~~~~~~~l~d~~ 151 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFI--TATGVVKLGDLG 151 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEE--CCCCcEEEeccc
Confidence 99999999965 999888642 2245899999999999999999999 4799999999999999 678889999999
Q ss_pred cccccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 272 SSCQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 272 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred eeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 98765432 234568889999999999899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.32 Aligned_cols=245 Identities=29% Similarity=0.340 Sum_probs=184.1
Q ss_pred EEeeeEeeeCCeEEEEEEEc----CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 122 EIDSLIGKGSFGQVVKAFDL----EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 122 ~~~~~LG~G~fg~V~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
++.+.||.|+||.||+|... ..+..|+||+++.... ..... .+++++......+||||+++++++...+.++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-~~~~~---~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-EEEEE---EFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-HHHHH---HHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc-cccce---eeeeccccccccccccccccccccccccccc
Confidence 46789999999999999887 4568899999964321 11112 2222223222336788999999999888899
Q ss_pred EEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+|+||+. |+|.++|.......+++..+..++.||+.||.|||+ .+|+|+||+++|||+ +.++.+||+|||++...
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill--~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILL--DSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEE--ETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccc--ccccccccccccccccc
Confidence 9999996 599999988744579999999999999999999995 689999999999999 67889999999999776
Q ss_pred CCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 277 GQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 277 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
... .........|+|||++.+..++.++||||||+++|||++ |+.||...+..+....+.+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------ 227 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIP------ 227 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSB------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceec------
Confidence 321 122345667999999998889999999999999999999 78999988887776666432111100
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
. .....+.++|..||..||++|||
T Consensus 228 -------------------------------~-------------------------~~~~~~~~li~~C~~~~p~~RPs 251 (259)
T PF07714_consen 228 -------------------------------D-------------------------NCPKDIYSLIQQCWSHDPEKRPS 251 (259)
T ss_dssp -------------------------------T-------------------------TSBHHHHHHHHHHT-SSGGGS--
T ss_pred -------------------------------c-------------------------chhHHHHHHHHHHcCCChhhCcC
Confidence 0 00116789999999999999999
Q ss_pred HHHHhc
Q psy16081 431 PYYALQ 436 (493)
Q Consensus 431 ~~e~L~ 436 (493)
+.++++
T Consensus 252 ~~~i~~ 257 (259)
T PF07714_consen 252 FQEILQ 257 (259)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=296.78 Aligned_cols=239 Identities=34% Similarity=0.497 Sum_probs=192.8
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 127 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
||.|+||.||++.+..+++.||+|++..... .......|+.++..+ +|++|+++++.+...+..|+||||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI------NHPFIVKLHYAFQTEEKLYLVLEY 74 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc------CCCcHHHHHHHeecCCeeEEEEec
Confidence 6999999999999988999999999875432 112333444443333 377899999999999999999999
Q ss_pred c-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc--
Q psy16081 203 L-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-- 279 (493)
Q Consensus 203 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~-- 279 (493)
+ +++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||++ +.++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~--~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 75 APGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILL--DADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEE--cCCCcEEEeecCcceecccCCC
Confidence 9 569999987653 5899999999999999999999 4899999999999999 67788999999999766442
Q ss_pred -cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhc
Q psy16081 280 -IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFD 358 (493)
Q Consensus 280 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 358 (493)
.....++..|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+... ..+
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--------------- 211 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PLR--------------- 211 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CCC---------------
Confidence 34566788999999999888999999999999999999999999877764444444320 000
Q ss_pred cCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH---HHHh
Q psy16081 359 KMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP---YYAL 435 (493)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~---~e~L 435 (493)
. +. .. ...+.+||++||..||++|||+ ++++
T Consensus 212 -------------------~--~~-----------------------~~--~~~l~~~i~~~l~~~p~~R~~~~~~~~l~ 245 (250)
T cd05123 212 -------------------F--PE-----------------------FL--SPEARDLISGLLQKDPTKRLGSGGAEEIK 245 (250)
T ss_pred -------------------C--CC-----------------------CC--CHHHHHHHHHHhcCCHhhCCCcccHHHHH
Confidence 0 00 00 0167899999999999999999 9999
Q ss_pred cCCCC
Q psy16081 436 QHNFF 440 (493)
Q Consensus 436 ~Hp~~ 440 (493)
+||||
T Consensus 246 ~~~~f 250 (250)
T cd05123 246 AHPFF 250 (250)
T ss_pred hCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=303.11 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=192.3
Q ss_pred cEEEeeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCcc-----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKP-----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
+|++.+.||+|+||.||++.+. .+++.||||+++.... .......|..++..+ .+|++|+++.+.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~-----~~~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV-----RRCPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhc-----cCCcchhhhheeee
Confidence 4889999999999999999864 4678999999874321 112223344333322 35788999999999
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
....+|+||||+.+ +|.+.+... ..+++..++.++.|++.+|.||| ..+++||||||+||++ +.++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~--~~~~~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILL--DSEGHVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEE--CCCCCEEEEEC
Confidence 99999999999965 898888654 35899999999999999999999 4789999999999999 67788999999
Q ss_pred ccccccCCc----cccccccCcCCchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 271 GSSCQLGQR----IYQYIQSRFYRSPEVLLGIP--YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 271 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|++...... .....|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...........+.+...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---- 225 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL---- 225 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH----
Confidence 998765332 12346788999999998765 78899999999999999999999975432222112111100
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.... +.+. .. ...+.+||.+||..|
T Consensus 226 -------------~~~~-----------------~~~~-----------------------~~--~~~l~~li~~~l~~~ 250 (288)
T cd05583 226 -------------KSKP-----------------PFPK-----------------------TM--SAEARDFIQKLLEKD 250 (288)
T ss_pred -------------ccCC-----------------CCCc-----------------------cc--CHHHHHHHHHHhcCC
Confidence 0000 0000 00 016789999999999
Q ss_pred CCCCCC---HHHHhcCCCCCCCcc
Q psy16081 425 PKTRIT---PYYALQHNFFKRTAD 445 (493)
Q Consensus 425 P~~R~t---~~e~L~Hp~~~~~~~ 445 (493)
|++||| +.++|+||||+.+..
T Consensus 251 p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 251 PKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HhhccCcchHHHHhcCcccccCCH
Confidence 999998 567899999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.39 Aligned_cols=180 Identities=23% Similarity=0.299 Sum_probs=152.5
Q ss_pred eCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-CHH
Q psy16081 130 GSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLY 208 (493)
Q Consensus 130 G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~ 208 (493)
|.||.||+|++..+++.||+|++..... ...|.. ..+ ...||||+++++++...+..|+||||+.+ +|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~--~~~----~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERL--TII----PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHH--HHH----hcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 8999999999999999999999975421 122221 111 12478899999999999999999999965 899
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCccccccccCc
Q psy16081 209 DLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF 288 (493)
Q Consensus 209 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~ 288 (493)
+++.... .+++..+..++.|++.||.||| +.||+||||||+||++ +.++.++|+|||.+...........++..
T Consensus 74 ~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 147 (237)
T cd05576 74 SHISKFL--NIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILL--DDRGHIQLTYFSRWSEVEDSCDGEAVENM 147 (237)
T ss_pred HHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEE--cCCCCEEEecccchhccccccccCCcCcc
Confidence 9887653 5899999999999999999999 5799999999999999 67888999999998777665555667788
Q ss_pred CCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 289 YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 289 y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
|+|||.+.+..++.++||||+||++|||++|..||..
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999999888899999999999999999999988753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=304.97 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=189.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcC-------CCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLE-------EQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
.++|.+.+.||+|+||.||+|.+.. ....||+|+++..... ...+..|+.++.. ...|+||+++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~-----l~~h~~iv~~~~ 85 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKL-----IGKHKNIINLLG 85 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHh-----ccCCCCeeeEEE
Confidence 3589999999999999999997632 3467999998743221 1222334333322 225888999999
Q ss_pred eeeecceeEEEEEecc-cCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 189 HFMWRNHLCLVFELLS-YNLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~-~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
++...+.+|+||||+. ++|.+++.... ...+++..+..++.||+.||.||| +.||+||||||+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~ 163 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAAR 163 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccce
Confidence 9999999999999995 49999986532 134888999999999999999999 479999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ +.++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 164 Nill--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 164 NVLV--TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred eEEE--cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 9999 667889999999997664321 12233457999999999899999999999999999999 899998877
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+....+....... .+ .
T Consensus 242 ~~~~~~~~~~~~~~~-----------------------------------~~---------------------------~ 259 (314)
T cd05099 242 VEELFKLLREGHRMD-----------------------------------KP---------------------------S 259 (314)
T ss_pred HHHHHHHHHcCCCCC-----------------------------------CC---------------------------C
Confidence 666555443210000 00 0
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
....++++||.+||..||++|||+.++++
T Consensus 260 ~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 260 NCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00116889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=333.15 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=202.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCC-----eEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQ-----CHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
...-++.+.||+|+||.||.|.-.... ..||||.++.. ...+.+..++++...++..+|||||++++.+.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 346778899999999999999765432 34899988753 234445566666666777889999999999999
Q ss_pred cceeEEEEEec-ccCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 RNHLCLVFELL-SYNLYDLLRNTN-----FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~~~~~lV~E~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
....+|++||| +|+|..+|++.. ...++......++.||+.|..||++ .++|||||...|+|| +....+|
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL--~~~r~VK 842 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLL--DERRVVK 842 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheee--cccCcEE
Confidence 99999999999 459999998762 2458899999999999999999994 789999999999999 6789999
Q ss_pred EEecccccccCC-ccccccc----cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q psy16081 267 IVDFGSSCQLGQ-RIYQYIQ----SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLG 340 (493)
Q Consensus 267 L~DFG~a~~~~~-~~~~~~g----t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~ 340 (493)
|+|||+|+.+-. ..+..-+ ...|||||.+..+.|+.++|||||||+|||+++ |..||.+.++.+.+...++.-.
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR 922 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc
Confidence 999999995533 3332222 246999999999999999999999999999997 9999999999888876665432
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
.++.. ... ..+.++|..|
T Consensus 923 L~~P~-----------------------------------------------------------~CP---~~ly~lM~~C 940 (1025)
T KOG1095|consen 923 LDPPS-----------------------------------------------------------YCP---EKLYQLMLQC 940 (1025)
T ss_pred cCCCC-----------------------------------------------------------CCC---hHHHHHHHHH
Confidence 22211 111 1678999999
Q ss_pred cCCCCCCCCCHHHHhc
Q psy16081 421 LDYDPKTRITPYYALQ 436 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~ 436 (493)
|+.+|++||+...+++
T Consensus 941 W~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 941 WKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ccCChhhCccHHHHHh
Confidence 9999999999999997
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=297.61 Aligned_cols=236 Identities=24% Similarity=0.312 Sum_probs=180.9
Q ss_pred eEeeeCCeEEEEEEE--cCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 126 LIGKGSFGQVVKAFD--LEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~--~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
.||+|+||.||+|.+ ..++..||||+++..... ...+..|..++. ...|+||+++++++. .+..++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~------~l~h~~i~~~~~~~~-~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQ------QLDNPYIVRMIGICE-AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHH------hCCCCCcceEEEEEc-CCCcEEEE
Confidence 589999999999964 457899999998744321 122233333332 335788999998875 45779999
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~ 279 (493)
||+++ +|.+++... ..+++..+..++.||+.||.||| +.||+||||||.|||+ +.++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill--~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 75 ELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLL--VTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEE--cCCCeEEECCCccccccCCC
Confidence 99965 898888654 35899999999999999999999 4789999999999999 66788999999999766432
Q ss_pred cc------cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 280 IY------QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 280 ~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.. ...++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.+....+
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---------- 218 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME---------- 218 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC----------
Confidence 21 1233568999999988889999999999999999998 999998877766655543211000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.| ......+.+||.+||..||++|||+.
T Consensus 219 -------------------------~~---------------------------~~~~~~l~~li~~~~~~~p~~Rp~~~ 246 (257)
T cd05116 219 -------------------------CP---------------------------QRCPPEMYDLMKLCWTYGVDERPGFA 246 (257)
T ss_pred -------------------------CC---------------------------CCCCHHHHHHHHHHhccCchhCcCHH
Confidence 00 00011788999999999999999999
Q ss_pred HHhc
Q psy16081 433 YALQ 436 (493)
Q Consensus 433 e~L~ 436 (493)
+|.+
T Consensus 247 ~i~~ 250 (257)
T cd05116 247 VVEL 250 (257)
T ss_pred HHHH
Confidence 8864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=301.97 Aligned_cols=245 Identities=23% Similarity=0.322 Sum_probs=186.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
+|++.+.||+|+||.||+|.+.. ....+|+|.+...... ......|+.++. ..+||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~~~~~~~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLK------QVNHPHVIKLYGACSQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHh------hCCCCCEeeEEEEEec
Confidence 47888999999999999998753 3367999988643321 122333433333 3357889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccC
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTN----------------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCD 249 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrD 249 (493)
.+..|+|+||+. ++|.+++.... ...+++..+..++.|++.||.||| +.+|+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~d 152 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRD 152 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhh
Confidence 999999999996 48988875421 124788999999999999999999 57899999
Q ss_pred CCCCcEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q psy16081 250 LKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLF 323 (493)
Q Consensus 250 lKp~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf 323 (493)
|||+|||+ ++++.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|+|++ |.+||
T Consensus 153 ikp~nill--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 153 LAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhhheEEE--cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 99999999 66788999999999765322 122344667999999999899999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCC
Q psy16081 324 SGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403 (493)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 403 (493)
.+.........+......+. +
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-------------------------------------~---------------------- 251 (290)
T cd05045 231 PGIAPERLFNLLKTGYRMER-------------------------------------P---------------------- 251 (290)
T ss_pred CCCCHHHHHHHHhCCCCCCC-------------------------------------C----------------------
Confidence 87765544433221100000 0
Q ss_pred CCCcchhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 404 ~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
......+.+||.+||+.||++|||+.|+++
T Consensus 252 ---~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 252 ---ENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred ---CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000117889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.93 Aligned_cols=257 Identities=30% Similarity=0.435 Sum_probs=205.0
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+.-++.-...||.|.||.||-|.+..||+..|||-++.... .......|..++ ...+|||+|+.+++-.++
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vl------E~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVL------EGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHH------HhccCccccccCceeecH
Confidence 34467777899999999999999999999999998764332 222333444444 444678899999999999
Q ss_pred ceeEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.++|.|||| +|+|.+++.... -.++...+.+..|++.|+.|||. .|||||||||.||+| +.+|.||++|||.
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~L--d~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILL--DFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceee--ecCCcEEeecccc
Confidence 9999999999 558999987653 47888899999999999999994 689999999999999 7889999999999
Q ss_pred ccccCCc-------cccccccCcCCchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 273 SCQLGQR-------IYQYIQSRFYRSPEVLLGI---PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 273 a~~~~~~-------~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
|..+... .....||+.|||||++.+. +...++||||||||+.||+||+.||...+..-++.-.+.....|
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence 9877443 3457899999999999864 46789999999999999999999998766655544444433322
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
+ +|.. +.. +-.|||.+||.
T Consensus 1461 q----------------------------------~P~~--ls~-------------------------~g~dFle~Cl~ 1479 (1509)
T KOG4645|consen 1461 Q----------------------------------IPER--LSS-------------------------EGRDFLEHCLE 1479 (1509)
T ss_pred C----------------------------------Cchh--hhH-------------------------hHHHHHHHHHh
Confidence 1 1111 111 45799999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 423 YDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
.||++||++.|+|+|.|-+...++
T Consensus 1480 ~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1480 QDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred cCchhhhHHHHHHHhhcccccccc
Confidence 999999999999999998755443
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=298.66 Aligned_cols=245 Identities=21% Similarity=0.257 Sum_probs=189.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCC---eEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQ---CHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
++|++.+.||+|+||.||+|.+..++ ..||+|.++..... ...+..|+.+ ....+||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~------l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASI------MGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHH------HHhCCCCCcceEEEEEecC
Confidence 47899999999999999999876544 37999988643211 1122223332 2334688899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+..|+||||+++ +|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+|||+ +.++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili--~~~~~~~l~dfg~ 152 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILV--NSNLVCKVSDFGL 152 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEE--CCCCeEEeCCCCc
Confidence 999999999965 8988887654 35899999999999999999999 5789999999999999 6788999999999
Q ss_pred ccccCCccc------cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 273 SCQLGQRIY------QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 273 a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
+........ ...++..|+|||++.+..++.++|+|||||++|++++ |..||......+....+.+....+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 230 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-- 230 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC--
Confidence 976643211 1122457999999999899999999999999999886 9999988776665555443211100
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
. ......+.+|+.+||..+|
T Consensus 231 -----------------------------------~-------------------------~~~~~~~~~li~~~l~~~p 250 (267)
T cd05066 231 -----------------------------------P-------------------------MDCPAALHQLMLDCWQKDR 250 (267)
T ss_pred -----------------------------------C-------------------------CCCCHHHHHHHHHHcccCc
Confidence 0 0001167899999999999
Q ss_pred CCCCCHHHHhc
Q psy16081 426 KTRITPYYALQ 436 (493)
Q Consensus 426 ~~R~t~~e~L~ 436 (493)
.+|||+.++++
T Consensus 251 ~~Rp~~~~i~~ 261 (267)
T cd05066 251 NERPKFEQIVS 261 (267)
T ss_pred hhCCCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=298.72 Aligned_cols=241 Identities=26% Similarity=0.279 Sum_probs=182.7
Q ss_pred eeEeeeCCeEEEEEEEcCCCe--EEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQC--HVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~--~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
+.||+|+||.||+|.+..++. .+|+|.++... ........|+.++..+. +||||+++++++...+.+|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc-----cCCCeeeEEEEEecCCCceEEE
Confidence 368999999999999888775 46888876322 11223334444443332 5788999999999999999999
Q ss_pred Eecc-cCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 201 ELLS-YNLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 201 E~~~-~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
||+. ++|.+++.... ...+++..+..++.|++.||.||| +.|++||||||+|||+ ++++.+
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili--~~~~~~ 151 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILV--GENYVA 151 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEE--cCCCeE
Confidence 9995 59999986532 124789999999999999999999 4799999999999999 678899
Q ss_pred EEEecccccccCCccc--cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 266 KIVDFGSSCQLGQRIY--QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 266 kL~DFG~a~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
||+|||++........ ....+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.......
T Consensus 152 kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (270)
T cd05047 152 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231 (270)
T ss_pred EECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCC
Confidence 9999999854322111 1223557999999998899999999999999999997 999998766555444332110000
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
.+ ......+.+|+.+||.
T Consensus 232 -----------------------------------~~---------------------------~~~~~~~~~li~~~l~ 249 (270)
T cd05047 232 -----------------------------------KP---------------------------LNCDDEVYDLMRQCWR 249 (270)
T ss_pred -----------------------------------CC---------------------------CcCCHHHHHHHHHHcc
Confidence 00 0000167899999999
Q ss_pred CCCCCCCCHHHHhc
Q psy16081 423 YDPKTRITPYYALQ 436 (493)
Q Consensus 423 ~dP~~R~t~~e~L~ 436 (493)
.||.+|||+.++++
T Consensus 250 ~~p~~Rps~~~il~ 263 (270)
T cd05047 250 EKPYERPSFAQILV 263 (270)
T ss_pred cChhhCCCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=294.98 Aligned_cols=237 Identities=24% Similarity=0.337 Sum_probs=181.4
Q ss_pred eeEeeeCCeEEEEEEEcCCC---eEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQ---CHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
++||+|+||.||+|....++ ..||+|.+...... ......|..++ ....|+||+++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l------~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVM------AQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHH------HhcCCCCeeeEEEEEc-CCceEEE
Confidence 47999999999999876655 78999998754321 12223333333 3346788999999876 5578999
Q ss_pred EEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|||+. ++|.+++.... .+++..+..++.|++.||.|||. .+++|+||||+|||+ +.++.+||+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili--~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 74 MELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLL--VNRHQAKISDFGMSRALGA 147 (257)
T ss_pred EEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEE--cCCCcEEeccccccceeec
Confidence 99995 48999997654 68999999999999999999994 789999999999999 6788999999999976643
Q ss_pred ccccc------cccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 279 RIYQY------IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 279 ~~~~~------~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
..... .++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+......+
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 218 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP--------- 218 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---------
Confidence 32211 12356999999999899999999999999999998 999998776655544432210000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
.+ . .. ...+.+||.+||..||.+|||+
T Consensus 219 --------------------------~~------------------------~-~~--~~~l~~li~~cl~~~p~~Rp~~ 245 (257)
T cd05060 219 --------------------------RP------------------------E-EC--PQEIYSIMLSCWKYRPEDRPTF 245 (257)
T ss_pred --------------------------CC------------------------C-CC--CHHHHHHHHHHhcCChhhCcCH
Confidence 00 0 00 0168899999999999999999
Q ss_pred HHHhc
Q psy16081 432 YYALQ 436 (493)
Q Consensus 432 ~e~L~ 436 (493)
.++++
T Consensus 246 ~~l~~ 250 (257)
T cd05060 246 SELES 250 (257)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=294.12 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=192.0
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCC----eEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQ----CHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~----~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+++.+.||.|+||.||+|.+..++ ..||+|+++.... .......|+.++.. .+|+||+++++.+.+.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~------l~~~~i~~~~~~~~~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRK------LDHPNIVKLLGVCTEEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHh------cCCCchheEEEEEcCCC
Confidence 356789999999999999988766 8999999975432 12333444444333 25778999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
..|+||||+.+ +|.+++.......+++..+..++.||+.||.||| +.+++|+||||+||++ +.++.++|+|||++
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~--~~~~~~~l~dfg~~ 150 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLV--GENLVVKISDFGLS 150 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEE--ccCCeEEEcccCCc
Confidence 99999999965 9999987654333899999999999999999999 4789999999999999 67789999999999
Q ss_pred cccCCccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 274 CQLGQRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 274 ~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
........ ...+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 225 (258)
T smart00219 151 RDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK----- 225 (258)
T ss_pred eecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-----
Confidence 76654311 1235678999999988889999999999999999998 8999988766666555432110000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
+ . . ....+.+++.+||..||++|
T Consensus 226 ------------------------------~------------------------~-~--~~~~~~~~i~~~l~~~p~~R 248 (258)
T smart00219 226 ------------------------------P------------------------E-N--CPPEIYKLMLQCWAEDPEDR 248 (258)
T ss_pred ------------------------------C------------------------C-c--CCHHHHHHHHHHCcCChhhC
Confidence 0 0 0 01178899999999999999
Q ss_pred CCHHHHhc
Q psy16081 429 ITPYYALQ 436 (493)
Q Consensus 429 ~t~~e~L~ 436 (493)
||+.|+++
T Consensus 249 pt~~~ll~ 256 (258)
T smart00219 249 PTFSELVE 256 (258)
T ss_pred cCHHHHHh
Confidence 99999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.34 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=210.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-----
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW----- 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~----- 192 (493)
.+.|++...||.|.+|.||+++++.+++.+|||++........+.+.|..++.. ..+|||++.++++|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~-----~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKK-----YSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHh-----ccCCCCcceEEEEEEEecCCC
Confidence 567999999999999999999999999999999998665544555555555432 3478899999999974
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
++.++||||||+ |+.-|++++.....+.|..+..|++.++.||.+||. ..+||||||-.|||+ +.++.|||+|||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLL--T~e~~VKLvDFG 168 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLL--TENAEVKLVDFG 168 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEE--eccCcEEEeeee
Confidence 468999999995 599999988777789999999999999999999994 679999999999999 688999999999
Q ss_pred cccccCC---ccccccccCcCCchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 272 SSCQLGQ---RIYQYIQSRFYRSPEVLLGI-----PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 272 ~a~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
.+.++.. ...+.+|||+|||||++... .|+..+|+||||++..||.-|.||+....+...+-.|-. -||
T Consensus 169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPP 245 (953)
T KOG0587|consen 169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPP 245 (953)
T ss_pred eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCC
Confidence 9988754 45688999999999999743 488899999999999999999999987766554443321 111
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
..+. +..+| -.+|.|||..||..
T Consensus 246 PkLk----rp~kW-----------------------------------------------------s~~FndFIs~cL~K 268 (953)
T KOG0587|consen 246 PKLK----RPKKW-----------------------------------------------------SKKFNDFISTCLVK 268 (953)
T ss_pred cccc----chhhH-----------------------------------------------------HHHHHHHHHHHHhh
Confidence 1110 00000 01789999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q psy16081 424 DPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~ 443 (493)
|-++||+..++|+|||++..
T Consensus 269 d~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 269 DYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ccccCcchhhhccCCccccc
Confidence 99999999999999999854
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=297.11 Aligned_cols=195 Identities=20% Similarity=0.266 Sum_probs=147.9
Q ss_pred eeEeeeCCeEEEEEEEcC------------CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 125 SLIGKGSFGQVVKAFDLE------------EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~------------~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
+.||+|+||.||+|+... ....||+|++..... .. ...+.+++......+||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~---~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--DI---SLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--hH---HHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 368999999999997432 234688998764321 11 1122223333334468889999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC-----CcEE
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR-----SAIK 266 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~-----~~ik 266 (493)
....++||||+++ +|..++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+..+.. ..++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999976 6666665433 458999999999999999999994 78999999999999943221 1389
Q ss_pred EEecccccccCCccccccccCcCCchhhhc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH
Q psy16081 267 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLL-GIPYDLAIDMWSLGCILVEMH-TGEPLFSGSNE 328 (493)
Q Consensus 267 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tG~~pf~~~~~ 328 (493)
++|||++...... ....++..|+|||++. +..++.++|||||||++|||+ .|..||.....
T Consensus 153 l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 153 LSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred eCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 9999998655322 3456788899999987 467899999999999999998 58888876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=295.75 Aligned_cols=242 Identities=23% Similarity=0.303 Sum_probs=189.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++.+.||+|+||.||++. .+++.||+|+++... .......|+.++. ..+|+||+++++.+.. +..|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~------~~~~~~i~~~~~~~~~-~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMT------KLHHKNLVRLLGVILH-NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHH------hCCCCCcCeEEEEEcC-CCcEE
Confidence 469999999999999999985 578899999986432 2233344444333 3357789999999875 45799
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+.+ +|.+++.......+++..+..++.|++.||.||| +.|++||||||+||++ +.++.+||+|||++....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili--~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILV--SEDGVAKVSDFGLARVGS 151 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEE--cCCCcEEECCCccceecc
Confidence 9999964 9999997665456899999999999999999999 5799999999999999 677889999999987654
Q ss_pred CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 278 QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
........+..|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+.......+
T Consensus 152 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 218 (254)
T cd05083 152 MGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP------------- 218 (254)
T ss_pred ccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCC-------------
Confidence 43333444667999999998899999999999999999997 9999987766554433322100000
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
. ... ...+.+||.+||..+|++|||+.++++
T Consensus 219 ------------------------~-----------------------~~~--~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 219 ------------------------P-----------------------EGC--PADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ------------------------C-----------------------CcC--CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 000 016789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=303.64 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=191.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc-------CCCeEEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL-------EEQCHVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
.++|.+.+.||+|+||.||+|+.. .++..||+|++.... ........|+.++..+ .+|+||+++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~~h~~i~~~~~ 88 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-----GKHKNIINLLG 88 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhh-----ccCCCchheeE
Confidence 468999999999999999999753 234579999886432 1122344444444333 25788999999
Q ss_pred eeeecceeEEEEEeccc-CHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 189 HFMWRNHLCLVFELLSY-NLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~~-~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
++...+.+|+||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+ .||+||||||+
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~ 166 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAAR 166 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccc
Confidence 99999999999999965 9999886532 1247888899999999999999994 78999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ +.++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 167 Nili--~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLV--TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEE--cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999 677899999999997664321 22345677999999999899999999999999999998 889998877
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+....+....... . + .
T Consensus 245 ~~~~~~~~~~~~~~~-----------------------------------~------------------------~---~ 262 (304)
T cd05101 245 VEELFKLLKEGHRMD-----------------------------------K------------------------P---A 262 (304)
T ss_pred HHHHHHHHHcCCcCC-----------------------------------C------------------------C---C
Confidence 666555443210000 0 0 0
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
.....+.+||.+||..+|.+|||+.|+++.
T Consensus 263 ~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 263 NCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 001168899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=299.72 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=188.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+|.+.++||+|+||.||++... .++..+|+|.+..... ....+..|..++. ...|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~------~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT------VLQHQHIVRFYGVCTE 78 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHh------cCCCCCCceEEEEEec
Confidence 46888999999999999999643 3567899998864321 1223333443333 3357789999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCC-------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNF-------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~ 258 (493)
.+..|+||||+.+ +|.+++..... ..+++..+..++.||+.||.||| +.||+||||||+|||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~- 155 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLV- 155 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEE-
Confidence 9999999999965 89998865421 24789999999999999999999 5789999999999999
Q ss_pred CCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy16081 259 NPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQM 332 (493)
Q Consensus 259 ~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 332 (493)
++++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||......+.+
T Consensus 156 -~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 156 -GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred -cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 578889999999987553221 12334678999999999999999999999999999998 99999877766655
Q ss_pred HHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhh
Q psy16081 333 NKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLK 412 (493)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (493)
..+........ + ......
T Consensus 235 ~~~~~~~~~~~-----------------------------------~---------------------------~~~~~~ 252 (280)
T cd05092 235 ECITQGRELER-----------------------------------P---------------------------RTCPPE 252 (280)
T ss_pred HHHHcCccCCC-----------------------------------C---------------------------CCCCHH
Confidence 44432110000 0 000016
Q ss_pred HHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 413 FKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 413 ~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
+.+||.+||..||.+||++.++++
T Consensus 253 ~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 253 VYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 789999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=300.72 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=189.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+..|+.++.. .+|+||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~------l~h~~iv~~~~~~ 77 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE------FDHPNIVKLLGVC 77 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHh------cCCCchheEEEEE
Confidence 3579999999999999999998743 678999999864321 11223334443333 3578899999999
Q ss_pred eecceeEEEEEeccc-CHHHHHhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccC
Q psy16081 191 MWRNHLCLVFELLSY-NLYDLLRNTN--------------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCD 249 (493)
Q Consensus 191 ~~~~~~~lV~E~~~~-~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrD 249 (493)
...+.+|+||||+++ +|.+++.... ...+++..+..++.||+.||.||| ..+++|||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~d 155 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRD 155 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeeccc
Confidence 999999999999965 9999886421 124678889999999999999999 47999999
Q ss_pred CCCCcEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q psy16081 250 LKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLF 323 (493)
Q Consensus 250 lKp~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf 323 (493)
|||+|||+ +.++.++|+|||++...... ......+..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 156 l~p~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 156 LATRNCLV--GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred ccHhheEe--cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999 67889999999998755322 112234567999999999899999999999999999997 88899
Q ss_pred CCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCC
Q psy16081 324 SGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403 (493)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 403 (493)
.+.+..+....+......+ .+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-----------------------------------~~------------------------ 254 (288)
T cd05050 234 YGMAHEEVIYYVRDGNVLS-----------------------------------CP------------------------ 254 (288)
T ss_pred CCCCHHHHHHHHhcCCCCC-----------------------------------CC------------------------
Confidence 8776655544432210000 00
Q ss_pred CCCcchhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 404 ~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
......+.+||.+||..||.+|||+.|+++
T Consensus 255 ---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 255 ---DNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ---CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 000126889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=309.24 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=184.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEE-----cCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFD-----LEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
++|++.+.||+|+||.||+|.+ ..+++.||||+++..... ......|+.++..+ .+|+||+++++++.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~~h~niv~~~~~~~ 81 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI-----GHHLNVVNLLGACT 81 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhc-----cCCccHhhhcceee
Confidence 5899999999999999999974 346789999999743211 12233344443332 25788999999876
Q ss_pred ec-ceeEEEEEeccc-CHHHHHhccCC-----------------------------------------------------
Q psy16081 192 WR-NHLCLVFELLSY-NLYDLLRNTNF----------------------------------------------------- 216 (493)
Q Consensus 192 ~~-~~~~lV~E~~~~-~L~~~l~~~~~----------------------------------------------------- 216 (493)
.. ..+++|||||++ +|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 568999999955 99988864321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc-----
Q psy16081 217 ------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----- 279 (493)
Q Consensus 217 ------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~----- 279 (493)
..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEE--cCCCcEEEEecccccccccCcchhh
Confidence 136778888999999999999994 799999999999999 67889999999999765322
Q ss_pred cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhc
Q psy16081 280 IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFD 358 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 358 (493)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||.+......+...+.....+
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 301 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------- 301 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC----------------
Confidence 112234567999999999899999999999999999997 999997654332222221100000
Q ss_pred cCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 359 KMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
..+ . .. ...+.+++.+||..||++|||+.|+++|
T Consensus 302 ------------------~~~------------------------~-~~--~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ------------------RAP------------------------D-YT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ------------------CCC------------------------C-CC--CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 0 00 0167899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=298.85 Aligned_cols=195 Identities=20% Similarity=0.284 Sum_probs=150.8
Q ss_pred eeEeeeCCeEEEEEEEcCCCeE-------EEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCH-------VAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~-------vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+.||+|+||+||+|.+..++.. ||+|.+..... ....+..|.. ......|+||+++++.+...+..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~------~l~~~~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAAS------MMSQLSHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHH------HHHhCCCCChhheeeEEEeCCCc
Confidence 3699999999999987665443 88888754321 1112222222 23334678899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC------CcEEEEe
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR------SAIKIVD 269 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~------~~ikL~D 269 (493)
++||||+++ +|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+|||++++.. +.++++|
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 999999965 8888887544 36899999999999999999999 579999999999999954322 2379999
Q ss_pred cccccccCCccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhC-CCCCCCCCHH
Q psy16081 270 FGSSCQLGQRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTG-EPLFSGSNEV 329 (493)
Q Consensus 270 FG~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG-~~pf~~~~~~ 329 (493)
||++...... ....++..|+|||++.+. .++.++|||||||++|+|++| .+||...+..
T Consensus 152 ~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~ 212 (258)
T cd05078 152 PGISITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212 (258)
T ss_pred cccccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH
Confidence 9998655432 345678899999999874 589999999999999999998 5777655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=293.99 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=191.3
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|++.+.||+|+||.||++.+. .+..+|+|.+.........+..|+.++.. .+|+||+++.+.+.. ...
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~------l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKT------LQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHh------cCCCCcceEEEEEcC-CCe
Confidence 4578999999999999999999754 55679999887543333344445544433 346779999999887 788
Q ss_pred EEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
++||||++ ++|.+++.......+++..+..++.||+.||.||| +.|++|+||||+||++ +.++.+||+|||++..
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILV--SASLVCKIADFGLARV 151 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEE--cCCCcEEECCCcceee
Confidence 99999996 49999997655456888999999999999999999 4799999999999999 6788999999999876
Q ss_pred cCCccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
...... ...++..|+|||++.+..++.++|+|||||++|++++ |.+||.+.+..+....+......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------- 223 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-------- 223 (260)
T ss_pred ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC--------
Confidence 543211 2234567999999998889999999999999999998 999998877655554443211100
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.. ......+.+++.+||..||++|||
T Consensus 224 -----------------------------~~-------------------------~~~~~~~~~~i~~~l~~~p~~Rp~ 249 (260)
T cd05073 224 -----------------------------RP-------------------------ENCPEELYNIMMRCWKNRPEERPT 249 (260)
T ss_pred -----------------------------Cc-------------------------ccCCHHHHHHHHHHcccCcccCcC
Confidence 00 000116889999999999999999
Q ss_pred HHHHhc
Q psy16081 431 PYYALQ 436 (493)
Q Consensus 431 ~~e~L~ 436 (493)
+.++++
T Consensus 250 ~~~l~~ 255 (260)
T cd05073 250 FEYIQS 255 (260)
T ss_pred HHHHHH
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=294.32 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=194.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcC-CCeEEEEEEEccCcccc-----hHHHHHHHHHHHHhhc-CCCCcceEEEeceeeee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLE-EQCHVAIKIIKNKKPFL-----NQAQIEVKLLEIMNKA-DVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~~~-----~~~~~e~~~~~~l~~~-~~~~~~~Iv~l~~~~~~ 192 (493)
.|++.+.||+|+||.||+|.+.. +++.+|||.+....... ........+..++... ...+|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37888999999999999999887 68899999886322110 0111111222223222 24578899999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
.++.|+||||+.+ +|.+++.. .....+++..++.++.|++.||.|||+ ..+++|+||||+|||+ +.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~--~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIML--GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEE--CCCCcEEEec
Confidence 9999999999965 88887743 222458999999999999999999995 3689999999999999 6788999999
Q ss_pred cccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 270 FGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 270 FG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
||++...... .....|+..|+|||++.+..++.++|||||||++|+|++|.+||...+.......+.+....+...
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE-- 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCc--
Confidence 9999766433 234568889999999999889999999999999999999999998776665555444321111000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
... ...+.+||.+||..||++
T Consensus 236 ---------------------------------------------------------~~~--~~~l~~li~~cl~~~p~~ 256 (269)
T cd08528 236 ---------------------------------------------------------GMY--SEDVTDVITSCLTPDAEA 256 (269)
T ss_pred ---------------------------------------------------------ccC--CHHHHHHHHHHCCCCCcc
Confidence 000 016889999999999999
Q ss_pred CCCHHHHhcC
Q psy16081 428 RITPYYALQH 437 (493)
Q Consensus 428 R~t~~e~L~H 437 (493)
|||+.|+..+
T Consensus 257 Rp~~~e~~~~ 266 (269)
T cd08528 257 RPDIIQVSAM 266 (269)
T ss_pred CCCHHHHHHH
Confidence 9999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.66 Aligned_cols=254 Identities=22% Similarity=0.263 Sum_probs=191.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCC----------------eEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCC
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQ----------------CHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNN 179 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----------------~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~ 179 (493)
.++|++++.||+|+||.||+|.+..++ ..||+|++..... ....+..|+.++..+ .
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l------~ 77 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL------S 77 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc------C
Confidence 357999999999999999999876544 5689999874432 122333444444433 4
Q ss_pred cceEEEeceeeeecceeEEEEEeccc-CHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccC
Q psy16081 180 TYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTN---------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCD 249 (493)
Q Consensus 180 ~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrD 249 (493)
|+||+++++++..++..++|||++.+ +|.+++.... ...+++..++.++.|++.||.|||+ .||+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~d 155 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRD 155 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccc
Confidence 67899999999999999999999965 8998886543 1258999999999999999999994 7899999
Q ss_pred CCCCcEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCC
Q psy16081 250 LKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT--GEPL 322 (493)
Q Consensus 250 lKp~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~p 322 (493)
|||+||++ +.++.++|+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 156 lkp~Nili--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 156 LATRNCLV--GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred cchhceee--cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 99999999 56789999999998765322 123345678999999998889999999999999999998 7889
Q ss_pred CCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCC
Q psy16081 323 FSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGE 402 (493)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 402 (493)
|...+..+.+..+......... ....+ .
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~----------------------~ 261 (296)
T cd05051 234 YEHLTDQQVIENAGHFFRDDGR------------------------------QIYLP----------------------R 261 (296)
T ss_pred CCCcChHHHHHHHHhccccccc------------------------------cccCC----------------------C
Confidence 9877666655544332110000 00000 0
Q ss_pred CCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 403 PGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 403 ~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
+. ....++.+||.+||..||.+|||+.|+++
T Consensus 262 ~~---~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 262 PP---NCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cc---CCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 00 00127899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.00 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=189.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCe---EEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQC---HVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+.|++.+.||+|+||.||+|.+..+++ .||||++..... ....+..|..++ ....||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l------~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM------GQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHH------HhCCCcCcceEEEEECCC
Confidence 468899999999999999999877664 699999864321 112233333333 334588899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+++||||+++ +|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||++ +.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili--~~~~~~kl~dfg~ 152 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILV--NSNLVCKVSDFGL 152 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEE--cCCCcEEECCCcc
Confidence 999999999965 8888886543 45899999999999999999999 4799999999999999 6788999999999
Q ss_pred ccccCCccc--c---cc---ccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 273 SCQLGQRIY--Q---YI---QSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 273 a~~~~~~~~--~---~~---gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
+........ . .. .+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+......+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 232 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP 232 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 876533211 1 11 1346999999999899999999999999999886 9999988776665555532111110
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
. .+....+.+++.+||..
T Consensus 233 ~--------------------------------------------------------------~~~~~~~~~li~~~l~~ 250 (269)
T cd05065 233 P--------------------------------------------------------------MDCPTALHQLMLDCWQK 250 (269)
T ss_pred c--------------------------------------------------------------ccCCHHHHHHHHHHcCC
Confidence 0 00011678999999999
Q ss_pred CCCCCCCHHHHhc
Q psy16081 424 DPKTRITPYYALQ 436 (493)
Q Consensus 424 dP~~R~t~~e~L~ 436 (493)
||.+|||+.+++.
T Consensus 251 ~p~~Rp~~~~i~~ 263 (269)
T cd05065 251 DRNARPKFGQIVS 263 (269)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=292.24 Aligned_cols=242 Identities=25% Similarity=0.278 Sum_probs=186.0
Q ss_pred eeEeeeCCeEEEEEEEcC-CC--eEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLE-EQ--CHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFE 201 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~-~~--~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E 201 (493)
++||+|+||.||+|.+.. ++ ..||||.+...... .....+..++......+|+||+++++.+.. ..+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 468999999999998765 33 36999998754321 111122223333334457889999999988 89999999
Q ss_pred ecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCcc
Q psy16081 202 LLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 280 (493)
Q Consensus 202 ~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~ 280 (493)
|+. ++|.+.+.......+++..+..++.|++.||.||| +.|++|+||||+||++ +.++.+||+|||++..+....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~--~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEE--ecCCEEEeccccccccccccc
Confidence 995 59999987654346899999999999999999999 4799999999999999 567899999999997764321
Q ss_pred ------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 281 ------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 281 ------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
....++..|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+.......+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 221 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE---------- 221 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC----------
Confidence 12346678999999999899999999999999999998 9999988777666555543100000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
.+ ......+.+||.+||..+|++|||+.+
T Consensus 222 ------------------------~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ 250 (257)
T cd05040 222 ------------------------RP---------------------------EACPQDIYNVMLQCWAHNPADRPTFAA 250 (257)
T ss_pred ------------------------CC---------------------------ccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence 00 000116789999999999999999999
Q ss_pred Hhc
Q psy16081 434 ALQ 436 (493)
Q Consensus 434 ~L~ 436 (493)
+++
T Consensus 251 ~~~ 253 (257)
T cd05040 251 LRE 253 (257)
T ss_pred HHH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.09 Aligned_cols=255 Identities=29% Similarity=0.419 Sum_probs=188.4
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR-- 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~-- 193 (493)
....+|+.++.||+||||.||+|+++-+|+.||||++.... ....-.++++++..+...+|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 45678999999999999999999999999999999987542 222233444444445555788898887765321
Q ss_pred --------------------------------------------------------------------------------
Q psy16081 194 -------------------------------------------------------------------------------- 193 (493)
Q Consensus 194 -------------------------------------------------------------------------------- 193 (493)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred -------------------------------------ceeEEEEEecccCHHHH-HhccCCCCCCHHHHHHHHHHHHHHH
Q psy16081 194 -------------------------------------NHLCLVFELLSYNLYDL-LRNTNFRGVSLNLTRKFSQQLCTAL 235 (493)
Q Consensus 194 -------------------------------------~~~~lV~E~~~~~L~~~-l~~~~~~~l~~~~~~~i~~qi~~aL 235 (493)
..+||-||||+.++... +..+.. .-..+..+++++||+.||
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFREILEGL 710 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHHHHHHH
Confidence 13689999998865554 444432 114788899999999999
Q ss_pred HHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC---------------------CccccccccCcCCchhh
Q psy16081 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---------------------QRIYQYIQSRFYRSPEV 294 (493)
Q Consensus 236 ~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~---------------------~~~~~~~gt~~y~aPE~ 294 (493)
.|+| +.|||||||||.||+| +.++.|||+|||+|+... ...+..+||..|+|||+
T Consensus 711 aYIH--~~giIHRDLKP~NIFL--d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 711 AYIH--DQGIIHRDLKPRNIFL--DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHH--hCceeeccCCcceeEE--cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999 5789999999999999 788899999999997620 12345789999999999
Q ss_pred hcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC--ChhhhhhccchhhhhccCCCCCceecC
Q psy16081 295 LLGIP---YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP--PKHLLDGAHKTRKYFDKMPDGSYILKK 369 (493)
Q Consensus 295 ~~~~~---~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (493)
+.+.. |+.|+|||||||||+||+ .||...-+. ..++..+..+ |.. ..||+.
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMER---a~iL~~LR~g~iP~~--------~~f~~~---------- 842 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMER---ASILTNLRKGSIPEP--------ADFFDP---------- 842 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHh---ccCCchHHH---HHHHHhcccCCCCCC--------cccccc----------
Confidence 98765 999999999999999998 457643222 1222222211 100 011110
Q ss_pred CCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCC
Q psy16081 370 PKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 370 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~ 442 (493)
.+ ..-..+|++||..||.+||||.|+|++.||-.
T Consensus 843 ----------------------------------~~-----~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 843 ----------------------------------EH-----PEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred ----------------------------------cc-----hHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 00 13368999999999999999999999999984
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.14 Aligned_cols=196 Identities=22% Similarity=0.292 Sum_probs=149.6
Q ss_pred eEeeeCCeEEEEEEEcCC------------------------CeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcc
Q psy16081 126 LIGKGSFGQVVKAFDLEE------------------------QCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY 181 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~~~~------------------------~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~ 181 (493)
.||+|+||.||+|....+ ...||+|++..... .....+.+++......+|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-----DIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-----HHHHHHHHHHHHHhcCCCC
Confidence 699999999999974321 24588998864321 1112233333334455688
Q ss_pred eEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC
Q psy16081 182 YIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP 260 (493)
Q Consensus 182 ~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~ 260 (493)
||+++++++.+.+..|+||||+++ +|..++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++..
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEecc
Confidence 999999999999999999999976 7777775433 46899999999999999999999 4799999999999999532
Q ss_pred -----CCCcEEEEecccccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHH
Q psy16081 261 -----KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMH-TGEPLFSGSNEVD 330 (493)
Q Consensus 261 -----~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tG~~pf~~~~~~~ 330 (493)
....+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|.+||.+....+
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred CcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 1234899999998654322 23457788999999876 56899999999999999985 7999998765443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.57 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=190.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCC-------CeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEE-------QCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
..+|++++.||+|+||.||+|++... +..||+|+++.... ....+..|+.++..+ .+|+||+++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~~h~~iv~~~~ 85 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMI-----GKHKNIINLLG 85 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhh-----cCCCCeeeeeE
Confidence 35799999999999999999986432 34699998874321 122334444444333 25778999999
Q ss_pred eeeecceeEEEEEeccc-CHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 189 HFMWRNHLCLVFELLSY-NLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~~-~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
++...+.+|+||||+++ +|.+++.... ...+++..+..++.||+.||.||| +.||+||||||+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~ 163 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAAR 163 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccc
Confidence 99999999999999955 9999886532 134788889999999999999999 479999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ +.++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+
T Consensus 164 Nill--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 164 NVLV--TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred eEEE--cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999 677889999999997654321 11233457999999999999999999999999999998 899998877
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+....+......+ .+ .
T Consensus 242 ~~~~~~~~~~~~~~~-----------------------------------~~---------------------------~ 259 (334)
T cd05100 242 VEELFKLLKEGHRMD-----------------------------------KP---------------------------A 259 (334)
T ss_pred HHHHHHHHHcCCCCC-----------------------------------CC---------------------------C
Confidence 666554443210000 00 0
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
.....+.+||.+||..+|.+|||+.|++++
T Consensus 260 ~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 260 NCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 000168899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=294.05 Aligned_cols=265 Identities=27% Similarity=0.343 Sum_probs=204.3
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
.+-+..||.|+||+|++..++.+|+..|||.++..... .+...-+++.-......+.||||++++....++..+|.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~---keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE---KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch---HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 44467899999999999999999999999999854421 111222223333455678889999999999999999999
Q ss_pred EecccCHHHHHh---ccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 201 ELLSYNLYDLLR---NTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 201 E~~~~~L~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+|+-+|..+.+ ......++++..-.|......||.||-. +..|||||+||+|||+ +..|.+||||||++..+-
T Consensus 143 ELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILl--dr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILL--DRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEE--ecCCCEeeecccchHhHH
Confidence 999876554432 2233468999999999999999999976 5789999999999999 889999999999998775
Q ss_pred Ccc--ccccccCcCCchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhhccc
Q psy16081 278 QRI--YQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHTGEPLFSGSNE-VDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 278 ~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
+.. +.-.|-+.|||||.+.. .+|+.++||||||++|||+.||..||.+.+. .+++..++. |.||.-..+
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~~---- 293 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLFD---- 293 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecCc----
Confidence 543 34568888999999964 4699999999999999999999999987553 345544443 223211100
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.+.++--..++.||.-||.+|-..||.-.
T Consensus 294 ---------------------------------------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~ 322 (361)
T KOG1006|consen 294 ---------------------------------------------------KECVHYSFSMVRFINTCLIKDRSDRPKYD 322 (361)
T ss_pred ---------------------------------------------------ccccccCHHHHHHHHHHhhcccccCcchh
Confidence 00011112689999999999999999999
Q ss_pred HHhcCCCCCCCccCCC
Q psy16081 433 YALQHNFFKRTADEST 448 (493)
Q Consensus 433 e~L~Hp~~~~~~~~~~ 448 (493)
+++++||+.....+..
T Consensus 323 ~Lk~~~fyr~y~~~~~ 338 (361)
T KOG1006|consen 323 DLKKFPFYRMYAVEGP 338 (361)
T ss_pred hhhcCchhhhhhhcCC
Confidence 9999999998766544
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.20 Aligned_cols=250 Identities=21% Similarity=0.267 Sum_probs=188.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|.+.+.||+|+||.||+|++. .+++.||||+++..... ......|..++..+ ..|+||+++++++
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-----~~H~niv~~~~~~ 110 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHL-----GPHLNIVNLLGAC 110 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhc-----CCCCCeEEEEEEE
Confidence 457889999999999999999854 35678999999743211 11223343333322 2378899999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccC------------------------------------------------------
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTN------------------------------------------------------ 215 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~------------------------------------------------------ 215 (493)
...+.+|+|||||. |+|.+++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999995 59999886432
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 216 ------------------------------------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 216 ------------------------------------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
...+++..+..++.||+.||.||| ..+|+||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrdlkp~ 268 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCVHRDLAAR 268 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcCcccCCcc
Confidence 123677788899999999999999 478999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ ++++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 269 NiLl--~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLI--CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEE--eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999 56788999999999765321 123456788999999999889999999999999999998 899998765
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+.+...+.....++ . +. ..
T Consensus 347 ~~~~~~~~~~~~~~~~----------------------------------~------------------------p~-~~ 367 (401)
T cd05107 347 MNEQFYNAIKRGYRMA----------------------------------K------------------------PA-HA 367 (401)
T ss_pred chHHHHHHHHcCCCCC----------------------------------C------------------------CC-CC
Confidence 5444333322100000 0 00 00
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
..++.+||.+||..||.+||++.++++.
T Consensus 368 --~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 368 --SDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred --CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1178899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=295.01 Aligned_cols=205 Identities=23% Similarity=0.325 Sum_probs=163.1
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCe----EEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQC----HVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+|++.+.||+|+||+||+|.+..+++ .||+|.+...... ......|...+. ..+|+||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~------~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMA------SVDHPHVVRLLGICLS 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHH------hCCCCCcceEEEEEec
Confidence 578999999999999999999876664 5899988644321 112223333332 3357889999999886
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
...++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~--~~~~~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLV--KTPQHVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEE--cCCCeEEECCCc
Confidence 78999999995 59999887654 358999999999999999999994 799999999999999 677889999999
Q ss_pred cccccCCccc--c---ccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy16081 272 SSCQLGQRIY--Q---YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 272 ~a~~~~~~~~--~---~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i 335 (493)
++........ . ..++..|+|||.+....++.++|+|||||++||+++ |.+||.+....+....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 224 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9976643221 1 122457999999998899999999999999999998 99999887765554444
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=290.43 Aligned_cols=241 Identities=25% Similarity=0.360 Sum_probs=183.3
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
++||+|+||.||+|.. .++..||+|++..... .. .+..+..++.......|+||+++++.+...+..++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~--~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP--QE--LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC--HH--HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 3689999999999975 4688999999864321 11 11122222222333468889999999999999999999995
Q ss_pred c-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCccc--
Q psy16081 205 Y-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-- 281 (493)
Q Consensus 205 ~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~-- 281 (493)
+ +|.+++.... ..+++..+..++.|++.||.|+| ..|++||||||+||++ +.++.+||+|||++........
T Consensus 76 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 76 GGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLV--GENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEE--cCCCeEEECCCccceecccccccc
Confidence 5 8988886543 35889999999999999999999 4789999999999999 6788899999999875543222
Q ss_pred --cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhc
Q psy16081 282 --QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFD 358 (493)
Q Consensus 282 --~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 358 (493)
...++..|+|||++.+..++.++|||||||++|++++ |..||.+.........+.......
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 214 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMS---------------- 214 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 1233556999999998889999999999999999998 999998776655444332210000
Q ss_pred cCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 359 KMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
.+ ......+.+|+.+||..||++|||+.++++.
T Consensus 215 -~~---------------------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 215 -CP---------------------------------------------QKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -CC---------------------------------------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 00 0001178899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=289.51 Aligned_cols=238 Identities=24% Similarity=0.344 Sum_probs=184.1
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
++||.|+||.||+|.+.. ++.||+|++...... ...+..|..+ .....|++|+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~------l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEI------LKQYDHPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHH------HHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence 469999999999999877 999999988754321 1222333333 3334578899999999999999999999
Q ss_pred ccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCccc
Q psy16081 203 LSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281 (493)
Q Consensus 203 ~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~ 281 (493)
+.+ +|.+++.... ..+++..+..++.+++.||.||| +.+++||||||+|||+ +.++.+||+|||++........
T Consensus 74 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 74 VPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLV--GENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEE--cCCCcEEEeeccccccccCCcc
Confidence 954 8999886543 35889999999999999999999 4789999999999999 6788999999999976542221
Q ss_pred c-----ccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 282 Q-----YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 282 ~-----~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
. ...+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+......+.
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~------------ 216 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA------------ 216 (251)
T ss_pred eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCC------------
Confidence 1 122456999999998899999999999999999999 8999987766544443322110000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
+. .....+.+||.+||..+|.+|||+.|++
T Consensus 217 -------------------------~~-------------------------~~~~~~~~li~~~l~~~p~~Rp~~~ell 246 (251)
T cd05041 217 -------------------------PQ-------------------------LCPEEIYRLMLQCWAYDPENRPSFSEIY 246 (251)
T ss_pred -------------------------Cc-------------------------cCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 00 0001688999999999999999999998
Q ss_pred c
Q psy16081 436 Q 436 (493)
Q Consensus 436 ~ 436 (493)
+
T Consensus 247 ~ 247 (251)
T cd05041 247 N 247 (251)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=299.88 Aligned_cols=208 Identities=24% Similarity=0.331 Sum_probs=162.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCC--------------eEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQ--------------CHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYY 182 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~--------------~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~ 182 (493)
++|++.+.||+|+||.||+|++..++ ..||||++..... ....+..|+.++.. .+|+|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~------l~h~~ 78 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSR------LKNPN 78 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHh------CCCCC
Confidence 57999999999999999999875432 3599999874321 11223334444333 35778
Q ss_pred EEEeceeeeecceeEEEEEeccc-CHHHHHhccCC----------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCC
Q psy16081 183 IVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNF----------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLK 251 (493)
Q Consensus 183 Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~----------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlK 251 (493)
|+++++++...+..|+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+ .|++|||||
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlk 156 (295)
T cd05097 79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLA 156 (295)
T ss_pred cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccC
Confidence 99999999999999999999965 89888854321 136888899999999999999994 789999999
Q ss_pred CCcEEeeCCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q psy16081 252 PENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT--GEPLFS 324 (493)
Q Consensus 252 p~NILl~~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~pf~ 324 (493)
|+|||+ +.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 157 p~Nill--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 157 TRNCLV--GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred hhhEEE--cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 999999 567889999999987553221 12234667999999999899999999999999999988 678998
Q ss_pred CCCHHHHHHHHH
Q psy16081 325 GSNEVDQMNKIV 336 (493)
Q Consensus 325 ~~~~~~~~~~i~ 336 (493)
..+..+.+..+.
T Consensus 235 ~~~~~~~~~~~~ 246 (295)
T cd05097 235 LLSDEQVIENTG 246 (295)
T ss_pred ccChHHHHHHHH
Confidence 877666555443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=295.59 Aligned_cols=249 Identities=18% Similarity=0.239 Sum_probs=188.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcC----CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLE----EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW- 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~- 192 (493)
.++|++.++||+|+||.||+|.+.. ++..||+|++...... .+.. .+..++......+|+||+++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~---~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE-IQVT---LLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH-HHHH---HHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3579999999999999999998876 3688999988643211 1111 11222222233368889999998765
Q ss_pred cceeEEEEEecc-cCHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNF------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
....++++||++ ++|.+++..... ..+++..+..++.||+.||.||| +.+++||||||+||++ ++++.+
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~--~~~~~~ 156 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVI--DEELQV 156 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEE--cCCCcE
Confidence 567899999996 589888865422 35899999999999999999999 5789999999999999 677899
Q ss_pred EEEecccccccCCccc-----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q psy16081 266 KIVDFGSSCQLGQRIY-----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVL 339 (493)
Q Consensus 266 kL~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 339 (493)
||+|||+++.+..... ...++..|+|||++.+..++.++|||||||++||+++ |++||...+..+....+....
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 9999999976533211 2334667999999999899999999999999999998 999998877655443332210
Q ss_pred CCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhH
Q psy16081 340 GLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419 (493)
Q Consensus 340 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~ 419 (493)
..+ .. ......+.+++.+
T Consensus 237 ~~~-------------------------------------~~-------------------------~~~~~~~~~li~~ 254 (280)
T cd05043 237 RLA-------------------------------------QP-------------------------INCPDELFAVMAC 254 (280)
T ss_pred CCC-------------------------------------CC-------------------------CcCCHHHHHHHHH
Confidence 000 00 0001168899999
Q ss_pred ccCCCCCCCCCHHHHhc
Q psy16081 420 MLDYDPKTRITPYYALQ 436 (493)
Q Consensus 420 mL~~dP~~R~t~~e~L~ 436 (493)
||..||++|||+.++++
T Consensus 255 ~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 255 CWALDPEERPSFSQLVQ 271 (280)
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=290.17 Aligned_cols=196 Identities=29% Similarity=0.487 Sum_probs=174.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEcc----CcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN----KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|.++++||+|+|++|.+++.+.|.+.||+|++++ .....+..+.|..+.+.. .|||++|.|..+|+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~a-----sn~pflvglhscfqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-----SNNPFLVGLHSCFQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhc-----cCCCeEEehhhhhccc
Confidence 4689999999999999999999999999999999874 344566677787777653 4789999999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
..+++|.||+.| +|.=.+.++ ++++++.++.+...|+.||.||| ++|||.||||.+|+|| |..|+|||+|+|+
T Consensus 324 srlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh--~rgiiyrdlkldnvll--daeghikltdygm 397 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLL--DAEGHIKLTDYGM 397 (593)
T ss_pred ceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEE--ccCCceeecccch
Confidence 999999999955 765444433 57999999999999999999999 5899999999999999 8899999999999
Q ss_pred cccc---CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 273 SCQL---GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 273 a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
++.- +....++||||.|+|||++.+..|+..+|+|+|||+|+||+.|+.||.
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 9654 455678999999999999999999999999999999999999999996
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=290.88 Aligned_cols=284 Identities=26% Similarity=0.461 Sum_probs=214.2
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec-----ce
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR-----NH 195 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~-----~~ 195 (493)
.+..+.||-|+||.||.+.|..+|+.||+|.+.+-- .....-..+.+++..+....|.|++..++..+-. ..
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 334578999999999999999999999999876432 2222222333333334444555677777766532 35
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|+|.|+|..+|...+... +.++.+.++-+++||+.||.|||+ .+|.||||||.|+|+ +.+..+||||||+++.
T Consensus 132 iYV~TELmQSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLV--NSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLV--NSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHHhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEe--ccCceEEecccccccc
Confidence 7899999999998888755 369999999999999999999996 789999999999999 7889999999999987
Q ss_pred cCC----ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQ----RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
... .++..+-|.+|+|||+++|. .|+.++||||.|||+.||+-.+..|...++.+++..|.+.+|.|..+.+...
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 643 24556678899999999986 5999999999999999999999999999999999999999999987766544
Q ss_pred cchh-hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 351 HKTR-KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 351 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
..-. .-.-. ...+.|....+..+-. +.+. + -+..+++.+||..||.+|+
T Consensus 286 CEGAk~H~LR--------------~~~k~Ps~~vLYtlsS-------------~~~~-~--heav~~~~~~l~~d~dkri 335 (449)
T KOG0664|consen 286 CEGAKNHVLR--------------AGLRAPDTQRLYKIAS-------------PDDK-N--HEAVDLLQKLLHFDPDKRI 335 (449)
T ss_pred hhhhHHHhhc--------------cCCCCCCccceeeecC-------------Cccc-c--hHHHHHHHHHhCCCCcccc
Confidence 3211 00000 0011111122222111 0000 0 1567999999999999999
Q ss_pred CHHHHhcCCCCCCC
Q psy16081 430 TPYYALQHNFFKRT 443 (493)
Q Consensus 430 t~~e~L~Hp~~~~~ 443 (493)
+.++++.|++..+.
T Consensus 336 s~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 336 SVEEALQHRYLEEG 349 (449)
T ss_pred cHhhhccccccccc
Confidence 99999999999764
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=290.77 Aligned_cols=237 Identities=24% Similarity=0.280 Sum_probs=180.3
Q ss_pred eEeeeCCeEEEEEEEc--CCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEE
Q psy16081 126 LIGKGSFGQVVKAFDL--EEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFE 201 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E 201 (493)
.||+|+||.||+|.+. .++..||||++..... ....+..|..++.. ..|+||+++++.+. .+..++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~------l~h~~ii~~~~~~~-~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQ------LDNPYIVRMIGVCE-AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHh------cCCCCeEEEEEEEc-CCCeEEEEE
Confidence 4899999999999765 4566799999875422 11223444444443 35778999999876 457899999
Q ss_pred eccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCcc
Q psy16081 202 LLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 280 (493)
Q Consensus 202 ~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~ 280 (493)
|+++ +|.+++.... ..+++..+..++.||+.||.|||. .|++||||||+|||+ +.++.+||+|||++.......
T Consensus 75 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 75 MASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLL--VNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred eCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEE--cCCCcEEeccCCccccccCCc
Confidence 9965 8988886433 468999999999999999999994 789999999999999 677889999999997553321
Q ss_pred c------cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 281 Y------QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 281 ~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
. ...++..|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....+......+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 218 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD----------- 218 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-----------
Confidence 1 1122467999999998889999999999999999996 999998877665544443211000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
. ......++.+||.+||..||++||++.+
T Consensus 219 ------------------------~---------------------------~~~~~~~l~~li~~c~~~~~~~Rp~~~~ 247 (257)
T cd05115 219 ------------------------C---------------------------PAECPPEMYALMKDCWIYKWEDRPNFAK 247 (257)
T ss_pred ------------------------C---------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 0 0001127889999999999999999999
Q ss_pred Hhc
Q psy16081 434 ALQ 436 (493)
Q Consensus 434 ~L~ 436 (493)
+.+
T Consensus 248 i~~ 250 (257)
T cd05115 248 VEE 250 (257)
T ss_pred HHH
Confidence 865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.67 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=197.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
.+.+..+.||+|+||+||+|.... ....||||.++.... ...++++|..++..+ +|+|||+|++.|.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l------~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL------QHPNIVRLLGVCR 559 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc------cCCCeEEEEEEEc
Confidence 456677899999999999996432 346799999985543 345667777766655 4667999999999
Q ss_pred ecceeEEEEEec-ccCHHHHHhccC--------CCC----CCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee
Q psy16081 192 WRNHLCLVFELL-SYNLYDLLRNTN--------FRG----VSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258 (493)
Q Consensus 192 ~~~~~~lV~E~~-~~~L~~~l~~~~--------~~~----l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~ 258 (493)
.++.+|||+||| .|+|.++|+... ... ++..+...|+.||+.|+.||.+ ..+|||||...|+|+
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLV- 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLV- 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhcee-
Confidence 999999999999 569999996432 122 7888999999999999999995 569999999999999
Q ss_pred CCCCCcEEEEecccccccCCccccccc-----cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy16081 259 NPKRSAIKIVDFGSSCQLGQRIYQYIQ-----SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQM 332 (493)
Q Consensus 259 ~~~~~~ikL~DFG~a~~~~~~~~~~~g-----t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 332 (493)
.++..|||+|||+++..-...+-..+ ...|||||.++.+.|+++||||||||+|||+++ |+-||.+..+.+.+
T Consensus 637 -ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 637 -GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred -ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 68889999999999876433222222 456999999999999999999999999999997 99999999999999
Q ss_pred HHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhh
Q psy16081 333 NKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLK 412 (493)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (493)
+.|.+.--. ..|+. ...+
T Consensus 716 e~i~~g~lL-----------------------------------------------------------~~Pe~---CP~~ 733 (774)
T KOG1026|consen 716 ECIRAGQLL-----------------------------------------------------------SCPEN---CPTE 733 (774)
T ss_pred HHHHcCCcc-----------------------------------------------------------cCCCC---CCHH
Confidence 888753111 01111 1227
Q ss_pred HHHHHhHccCCCCCCCCCHHHHh
Q psy16081 413 FKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 413 ~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
+.+|+..||..+|.+||++.||-
T Consensus 734 vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 734 VYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHHHHhhcCcccCCCHHHHH
Confidence 89999999999999999999863
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=293.66 Aligned_cols=242 Identities=21% Similarity=0.288 Sum_probs=181.5
Q ss_pred eeEeeeCCeEEEEEEEcCCC------eEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQ------CHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~------~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+.||+|+||.||+|.+.... +.||||.+..... ....+..|..+ ....+|+||+++++++...+..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~------l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHL------MSNFNHPNIVKLLGVCLLNEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHH------HHhcCCCCeeeEeeeecCCCCe
Confidence 36999999999999876443 7899998864321 12222333333 3344688899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC---CCcEEE
Q psy16081 197 CLVFELLSY-NLYDLLRNTN-----FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK---RSAIKI 267 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~---~~~ikL 267 (493)
|+||||+.+ +|.+++.... ...+++..+..++.||+.||.||| +.+++|+||||+||+++++. ...++|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEE
Confidence 999999964 9999886532 234788999999999999999999 47899999999999994322 127999
Q ss_pred EecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 268 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 268 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc
Confidence 999998755322 112344678999999999999999999999999999998 99999877765554443211000
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
. . .. . ....+.+||.+||
T Consensus 233 ~-----------------------------------~--~~-----------------------~--~~~~~~~li~~~l 250 (269)
T cd05044 233 Q-----------------------------------K--PE-----------------------N--CPDKIYQLMTNCW 250 (269)
T ss_pred C-----------------------------------C--cc-----------------------c--chHHHHHHHHHHc
Confidence 0 0 00 0 0016789999999
Q ss_pred CCCCCCCCCHHHHhc
Q psy16081 422 DYDPKTRITPYYALQ 436 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~ 436 (493)
..+|.+|||+.++++
T Consensus 251 ~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 251 AQDPSERPTFDRIQE 265 (269)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=294.44 Aligned_cols=196 Identities=26% Similarity=0.337 Sum_probs=155.9
Q ss_pred cCcE-EEeeeEeeeCCeEEEEEE----EcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRY-EIDSLIGKGSFGQVVKAF----DLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y-~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++| ++++.||+|+||+||++. ...+++.||+|+++.... ....+..|+.++. ...|+||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~------~l~h~~i~~~~~~~ 75 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILK------TLYHENIVKYKGCC 75 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHH------hCCCCCEeeEEEEE
Confidence 3566 899999999999998864 345788999999875422 1122233433333 33577899999987
Q ss_pred eec--ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 191 MWR--NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 191 ~~~--~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
... ..+|+||||+.+ +|.+++... .+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili--~~~~~~~l 148 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLL--DNDRLVKI 148 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEE--cCCCcEEE
Confidence 653 468999999965 888888654 4899999999999999999999 4789999999999999 67788999
Q ss_pred EecccccccCCccc------cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy16081 268 VDFGSSCQLGQRIY------QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS 326 (493)
Q Consensus 268 ~DFG~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~ 326 (493)
+|||++........ ...++..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred eecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 99999976643221 223456799999999888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=291.33 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=186.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
++|.+.+.||+|+||.||+|.+... ...||||....... ....+..|+.+ .....|+||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~------l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI------MRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHH------HHhCCCCchhceeEEEcC-
Confidence 4688999999999999999987544 35689998864331 11222333333 333357889999998875
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+..|+||||+. ++|.+++.... ..+++..+..++.||+.||.||| +.+++||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili--~~~~~~~l~d~g~ 153 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLV--SSPDCVKLGDFGL 153 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEE--ecCCCeEEccCce
Confidence 56789999995 49999987643 35899999999999999999999 4789999999999999 5678899999999
Q ss_pred ccccCCccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 273 SCQLGQRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 273 a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
+........ ...++..|+|||.+.+..++.++|||||||++|||++ |.+||.+.+..+....+......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 229 (270)
T cd05056 154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM---- 229 (270)
T ss_pred eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC----
Confidence 876543211 1223457999999998889999999999999999986 9999988876665544432110000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
.. .....+.+||.+||..+|.+
T Consensus 230 ---------------------------------~~-------------------------~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 230 ---------------------------------PP-------------------------NCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred ---------------------------------CC-------------------------CCCHHHHHHHHHHcCCChhh
Confidence 00 00116889999999999999
Q ss_pred CCCHHHHhcC
Q psy16081 428 RITPYYALQH 437 (493)
Q Consensus 428 R~t~~e~L~H 437 (493)
|||+.+++..
T Consensus 252 Rpt~~~~~~~ 261 (270)
T cd05056 252 RPRFTELKAQ 261 (270)
T ss_pred CcCHHHHHHH
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=310.37 Aligned_cols=250 Identities=23% Similarity=0.294 Sum_probs=195.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCe---E-EEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQC---H-VAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~-vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+++-.+.++||+|+||.||+|..+..+. . ||||..+.... .......+++.+.+.....+|+|||+++++...+
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~--~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE--LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc--ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 4566667999999999999998766432 3 89998874221 1111222334444444456788899999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
..++||||+|. |+|.++|++... .++..+...++.+.+.||+|||+ .++|||||-..|+|+ ..++.+||+|||+
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~--~~~~~vKISDFGL 308 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLY--SKKGVVKISDFGL 308 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHhee--cCCCeEEeCcccc
Confidence 99999999995 599999987652 69999999999999999999995 689999999999999 5667789999999
Q ss_pred ccccCCccc-c-cc-ccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH-hCCCChhhh
Q psy16081 273 SCQLGQRIY-Q-YI-QSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEV-LGLPPKHLL 347 (493)
Q Consensus 273 a~~~~~~~~-~-~~-gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~ 347 (493)
++....... . .+ -...|+|||.+....|+.++|||||||++||+++ |..||.+....+...+|+.. ...+...
T Consensus 309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~-- 386 (474)
T KOG0194|consen 309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS-- 386 (474)
T ss_pred ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--
Confidence 876542111 1 11 2456999999999999999999999999999998 89999999999988888542 2221110
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
.....+..++.+|+..||++
T Consensus 387 ------------------------------------------------------------~~p~~~~~~~~~c~~~~p~~ 406 (474)
T KOG0194|consen 387 ------------------------------------------------------------KTPKELAKVMKQCWKKDPED 406 (474)
T ss_pred ------------------------------------------------------------CCHHHHHHHHHHhccCChhh
Confidence 01126678999999999999
Q ss_pred CCCHHHHhc
Q psy16081 428 RITPYYALQ 436 (493)
Q Consensus 428 R~t~~e~L~ 436 (493)
|||+.++.+
T Consensus 407 R~tm~~i~~ 415 (474)
T KOG0194|consen 407 RPTMSTIKK 415 (474)
T ss_pred ccCHHHHHH
Confidence 999999875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=289.34 Aligned_cols=242 Identities=19% Similarity=0.258 Sum_probs=177.1
Q ss_pred eeEeeeCCeEEEEEEEcC---CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee-ecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLE---EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM-WRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~-~~~~~~lV~ 200 (493)
+.||+|+||.||+|.+.. .+..||||.+..... .... ..+..+.......+|+||+++++.+. .++..|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEV---EQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHH---HHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 468999999999998654 346799998853221 1111 11122222233456888999999765 455689999
Q ss_pred Eecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc
Q psy16081 201 ELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279 (493)
Q Consensus 201 E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~ 279 (493)
||+. ++|.+++.... ...++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++......
T Consensus 77 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili--~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEE--cCCCcEEECCccccccccCC
Confidence 9995 59999886543 34677888899999999999999 5799999999999999 67788999999999755321
Q ss_pred c-------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 280 I-------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 280 ~-------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
. ....++..|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+......+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 222 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL--------- 222 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC---------
Confidence 1 12344667999999998899999999999999999999 577887766554433332110000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
. +. .....+.+++.+||..||++|||+
T Consensus 223 --------------------------~------------------------~~---~~~~~~~~li~~cl~~~p~~Rp~~ 249 (262)
T cd05058 223 --------------------------Q------------------------PE---YCPDPLYEVMLSCWHPKPEMRPTF 249 (262)
T ss_pred --------------------------C------------------------CC---cCCHHHHHHHHHHcCCChhhCCCH
Confidence 0 00 000167899999999999999999
Q ss_pred HHHhcC
Q psy16081 432 YYALQH 437 (493)
Q Consensus 432 ~e~L~H 437 (493)
.|+++.
T Consensus 250 ~~il~~ 255 (262)
T cd05058 250 SELVSR 255 (262)
T ss_pred HHHHHH
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=295.72 Aligned_cols=205 Identities=25% Similarity=0.351 Sum_probs=161.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcC----------------CCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLE----------------EQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNT 180 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~----------------~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~ 180 (493)
++|++.++||+|+||.||++.+.. ++..||+|++..... ....+..|+.++..+ +|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l------~~ 78 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL------KD 78 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC------CC
Confidence 579999999999999999985432 345799999874321 122344455444333 46
Q ss_pred ceEEEeceeeeecceeEEEEEecc-cCHHHHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCC
Q psy16081 181 YYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNF---------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDL 250 (493)
Q Consensus 181 ~~Iv~l~~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDl 250 (493)
+||+++++++...+..|+||||+. ++|.+++..... ..+++..+..++.||+.||.|||+ .||+||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl 156 (296)
T cd05095 79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDL 156 (296)
T ss_pred CCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccC
Confidence 789999999999999999999996 499998865321 236788899999999999999994 78999999
Q ss_pred CCCcEEeeCCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCC
Q psy16081 251 KPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT--GEPLF 323 (493)
Q Consensus 251 Kp~NILl~~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~pf 323 (493)
||+|||+ +.++.++|+|||++..+.... ....++..|+|||+..+..++.++|||||||++|||++ |..||
T Consensus 157 kp~Nili--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 157 ATRNCLV--GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred ChheEEE--cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 9999999 678899999999997653321 12233567999999998899999999999999999998 77999
Q ss_pred CCCCHHHHHH
Q psy16081 324 SGSNEVDQMN 333 (493)
Q Consensus 324 ~~~~~~~~~~ 333 (493)
...+..+.+.
T Consensus 235 ~~~~~~~~~~ 244 (296)
T cd05095 235 SQLSDEQVIE 244 (296)
T ss_pred cccChHHHHH
Confidence 8766655443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=291.26 Aligned_cols=205 Identities=19% Similarity=0.275 Sum_probs=154.1
Q ss_pred eeEeeeCCeEEEEEEEcC--CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 125 SLIGKGSFGQVVKAFDLE--EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
+.||+|+||+||+|.... ....+|+|.+..... ... ...+++++......+|+||+++++.+...+.+|+||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~--~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDE--QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHH--HHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 368999999999996433 445788887753321 111 11122222222334688899999999999999999999
Q ss_pred ccc-CHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 203 LSY-NLYDLLRNTNF---RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 203 ~~~-~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
+.+ +|.+++..... ...++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQL--TADLSVKIGDYGLALEQYP 152 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEe--cCCCcEEEecccccccccc
Confidence 965 99998865432 23467888999999999999999 4789999999999999 6788999999999865422
Q ss_pred c-----cccccccCcCCchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q psy16081 279 R-----IYQYIQSRFYRSPEVLLG-------IPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVE 337 (493)
Q Consensus 279 ~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~ 337 (493)
. .....++..|+|||++.. ..++.++|||||||++|||++ |.+||....+.+.+..+..
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 224 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR 224 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh
Confidence 1 122334667999999753 357889999999999999999 8899988776666555543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.76 Aligned_cols=201 Identities=21% Similarity=0.259 Sum_probs=153.4
Q ss_pred eeEeeeCCeEEEEEEEc--CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 125 SLIGKGSFGQVVKAFDL--EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
+.||+|+||.||+|... .++..+|+|.++....... +..+.+++......+|+||+++++.+.+...+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE----QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 36899999999999754 3567899998874432111 11222222333344688899999999999999999999
Q ss_pred cc-cCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 203 LS-YNLYDLLRNTN---FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 203 ~~-~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
++ ++|.+++.... ....++..+..++.|++.||.||| +.+++||||||+||++ +.++.+||+|||++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~--~~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLL--TADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEE--cCCCcEEECCccccccccC
Confidence 96 58998886432 123567788899999999999999 4789999999999999 6788999999999865432
Q ss_pred cc-----ccccccCcCCchhhhcCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy16081 279 RI-----YQYIQSRFYRSPEVLLGI-------PYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMN 333 (493)
Q Consensus 279 ~~-----~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~ 333 (493)
.. ....++..|+|||++.+. .++.++|||||||++|||++ |.+||......+...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 220 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT 220 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence 21 223567789999998642 36789999999999999996 999998766655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=288.93 Aligned_cols=190 Identities=22% Similarity=0.297 Sum_probs=151.3
Q ss_pred eeEeeeCCeEEEEEEEcCCC----------eEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQ----------CHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~----------~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+.||+|+||.||+|.+..++ ..|++|++.........+..|..+ ....+|+||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~------l~~l~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASL------MSQLSHKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHH------HHcCCCcchhheeeEEec-C
Confidence 46899999999999988776 458888876443222223333332 333467889999999888 7
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC-------cEE
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS-------AIK 266 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~-------~ik 266 (493)
..++||||+.+ +|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+|||++ .++ .+|
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~--~~~~~~~~~~~~k 148 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVA--RYGLNEGYVPFIK 148 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEe--cCccccCCceeEE
Confidence 88999999965 8888887644 26899999999999999999999 47899999999999994 444 799
Q ss_pred EEecccccccCCccccccccCcCCchhhhcCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 267 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI--PYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 267 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|+|||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+
T Consensus 149 l~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 149 LSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred eCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 999999977654 2334567789999999876 78999999999999999999 578887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=293.96 Aligned_cols=194 Identities=25% Similarity=0.344 Sum_probs=155.8
Q ss_pred cEEEeeeEeeeCCeEEEEEEE----cCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFD----LEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~----~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
-|++++.||+|+||.||+|.. ..++..||+|.++.... ....+..|+.++.. ..|+||+++.+++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~------l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN------LYHENIVKYKGICTED 78 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHh------CCCCCeeeeeeEEecC
Confidence 368899999999999999974 45788999999864321 12233344444333 3577899999998775
Q ss_pred --ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 194 --NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 194 --~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
...++||||+++ +|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+|||+ +.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~--~~~~~~~l~df 153 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLV--ESEHQVKIGDF 153 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEE--cCCCCEEECCC
Confidence 578999999955 8998886543 35899999999999999999999 5799999999999999 56788999999
Q ss_pred ccccccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 271 GSSCQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 271 G~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
|++..+.... ....++..|+|||++.+..++.++|||||||++|+|+++..|+.
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 9997664321 13445667999999999899999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=295.75 Aligned_cols=247 Identities=20% Similarity=0.246 Sum_probs=184.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCe----EEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQC----HVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++.+.||+|+||.||+|.+..+++ .||+|++...... . .. ..+..+.......+|+||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~-~-~~--~~~~~e~~~~~~l~h~niv~~~~~~~~-~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP-K-AN--VEFMDEALIMASMDHPHLVRLLGVCLS-P 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH-H-HH--HHHHHHHHHHHhCCCCCcccEEEEEcC-C
Confidence 468899999999999999999887776 4788887643221 1 11 112222223333468889999998875 4
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
..++|+||+. |+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill--~~~~~~kL~Dfg~~ 156 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLV--KSPNHVKITDFGLA 156 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeee--cCCCceEEcccccc
Confidence 5789999996 58999886543 358899999999999999999994 789999999999999 56778999999999
Q ss_pred cccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 274 CQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 274 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+... +......++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~--- 232 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERLPQ--- 232 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCC---
Confidence 7654321 12334668999999999999999999999999999997 999998765443322 2211000000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
. ......+.+++.+||..||++
T Consensus 233 ---------------------------------~-------------------------~~~~~~~~~li~~c~~~~p~~ 254 (303)
T cd05110 233 ---------------------------------P-------------------------PICTIDVYMVMVKCWMIDADS 254 (303)
T ss_pred ---------------------------------C-------------------------CCCCHHHHHHHHHHcCCChhh
Confidence 0 000016789999999999999
Q ss_pred CCCHHHHhcC
Q psy16081 428 RITPYYALQH 437 (493)
Q Consensus 428 R~t~~e~L~H 437 (493)
|||+.++++.
T Consensus 255 Rp~~~~l~~~ 264 (303)
T cd05110 255 RPKFKELAAE 264 (303)
T ss_pred CcCHHHHHHH
Confidence 9999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=287.33 Aligned_cols=248 Identities=19% Similarity=0.254 Sum_probs=190.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
++|++++.||+|+||+||+|+.+. +.+.||+|.+...... ...+..|..++..+ +|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL------SHKNVVRLLGLCR 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc------CCcceeeeEEEEC
Confidence 578999999999999999998654 3567999988644321 23445555554433 4678999999999
Q ss_pred ecceeEEEEEecc-cCHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC
Q psy16081 192 WRNHLCLVFELLS-YNLYDLLRNTNF-------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS 263 (493)
Q Consensus 192 ~~~~~~lV~E~~~-~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~ 263 (493)
+.+..|+||||++ ++|.+++..... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili--~~~~ 154 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLV--SSQR 154 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEE--eCCC
Confidence 9999999999996 599999875441 158999999999999999999994 789999999999999 6678
Q ss_pred cEEEEecccccccCCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q psy16081 264 AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEV 338 (493)
Q Consensus 264 ~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~ 338 (493)
.++|+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||........+..+...
T Consensus 155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~ 234 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234 (275)
T ss_pred cEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC
Confidence 8999999998654321 123345677999999998889999999999999999998 88999776554444433211
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
... .+... .....+.++|.
T Consensus 235 ~~~------------------------------------~~~~~-------------------------~~~~~l~~~i~ 253 (275)
T cd05046 235 KLE------------------------------------LPVPE-------------------------GCPSRLYKLMT 253 (275)
T ss_pred CcC------------------------------------CCCCC-------------------------CCCHHHHHHHH
Confidence 000 00000 00016889999
Q ss_pred HccCCCCCCCCCHHHHhcC
Q psy16081 419 RMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 419 ~mL~~dP~~R~t~~e~L~H 437 (493)
+||..||.+|||+.|++++
T Consensus 254 ~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 254 RCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHcCCCcccCCCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=289.10 Aligned_cols=196 Identities=27% Similarity=0.369 Sum_probs=155.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEE----EcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAF----DLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW- 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~- 192 (493)
++|++.+.||+|+||+||+|. +..+++.||||.+..... ....+..|+.++.. ..|+||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~------l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS------LQHDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHh------CCCCCeeEEEEEEccC
Confidence 468999999999999999997 456789999999874432 12233445444433 357789999988653
Q ss_pred -cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 193 -RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 193 -~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
...+|+||||++ ++|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+|||+ +.++.+||+||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili--~~~~~~~l~df 152 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILV--ESENRVKIGDF 152 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEE--CCCCeEEECCC
Confidence 357899999995 59999986543 35899999999999999999999 4799999999999999 67788999999
Q ss_pred ccccccCCccc------cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 271 GSSCQLGQRIY------QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 271 G~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
|++........ ...++..|+|||++.+..++.++|||||||++|||++|..++..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 99986643221 11223459999999998999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=286.76 Aligned_cols=248 Identities=19% Similarity=0.247 Sum_probs=183.0
Q ss_pred EEEeeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc---
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN--- 194 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~--- 194 (493)
|.+.+.||+|+||.||+|.+. .+++.||||++.......... ..+..++......+|+||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDI---EEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHH---HHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 567889999999999999854 357899999987533211111 11222223333446788999999886432
Q ss_pred ---eeEEEEEecc-cCHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 195 ---HLCLVFELLS-YNLYDLLRNTN----FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 195 ---~~~lV~E~~~-~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
..++++||+. ++|.+++.... ...+++..+..++.||+.||.|||+ .||+||||||+||++ +.++.+|
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili--~~~~~~k 153 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCML--NENMTVC 153 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEE--cCCCCEE
Confidence 2478899995 58877764321 1247889999999999999999994 789999999999999 6788899
Q ss_pred EEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q psy16081 267 IVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLG 340 (493)
Q Consensus 267 L~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~ 340 (493)
|+|||++....... ....+++.|++||.+.+..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999997654321 22334567999999999899999999999999999999 8999988776555444432100
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
.. .+ ......+.+|+.+|
T Consensus 234 ~~-----------------------------------~~---------------------------~~~~~~~~~l~~~~ 251 (273)
T cd05074 234 LK-----------------------------------QP---------------------------PDCLEDVYELMCQC 251 (273)
T ss_pred CC-----------------------------------CC---------------------------CCCCHHHHHHHHHH
Confidence 00 00 00011688999999
Q ss_pred cCCCCCCCCCHHHHhcC
Q psy16081 421 LDYDPKTRITPYYALQH 437 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~H 437 (493)
|..+|.+|||+.+++++
T Consensus 252 l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 252 WSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=283.46 Aligned_cols=203 Identities=19% Similarity=0.262 Sum_probs=153.2
Q ss_pred eEeeeCCeEEEEEEEcCC--CeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 126 LIGKGSFGQVVKAFDLEE--QCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
.||+|+||.||+|..... ...+++|.++..... .....++++.......+||||+++++.+.+....|+||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS----KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh----HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 699999999999975433 235667766533211 11222233333334456889999999999999999999999
Q ss_pred cc-CHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC--
Q psy16081 204 SY-NLYDLLRNTN--FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-- 278 (493)
Q Consensus 204 ~~-~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~-- 278 (493)
.+ +|.+++.... ...+.+..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++.....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~--~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFL--TSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEE--cCCccEEecccccccccCcch
Confidence 65 9999887542 234677788899999999999999 4789999999999999 6788999999999854321
Q ss_pred ---ccccccccCcCCchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy16081 279 ---RIYQYIQSRFYRSPEVLLG-------IPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 279 ---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 336 (493)
.....+++..|+|||++.. ..++.++|||||||++|||++ |.+||...++.+.+..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 222 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI 222 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 1234567889999999853 246789999999999999996 678998777766665554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=287.86 Aligned_cols=197 Identities=26% Similarity=0.339 Sum_probs=159.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEc----CCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDL----EEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~----~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
..|++.+.||+|+||.||+|... .+++.||||+++..... ...+..|+.++.. ..|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~------l~~~~i~~~~~~~~~ 77 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRT------LDHENIVKYKGVCEK 77 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHh------CCCCChheEEeeeec
Confidence 35788899999999999999854 34889999999755432 3334444444333 346789999998877
Q ss_pred --cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 193 --RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 193 --~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
....|+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .||+|+||||+||++ +.++.++|+|
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~--~~~~~~~l~d 152 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILV--ESEDLVKISD 152 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEE--cCCCCEEEcc
Confidence 5689999999954 9999987543 358999999999999999999994 789999999999999 6778999999
Q ss_pred cccccccCCccc------cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy16081 270 FGSSCQLGQRIY------QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS 326 (493)
Q Consensus 270 FG~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~ 326 (493)
||++........ ...++..|+|||.+.+..++.++|||||||++|||++|..||...
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 999977653211 123345699999999889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.73 Aligned_cols=203 Identities=22% Similarity=0.335 Sum_probs=145.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc----------------CCCeEEEEEEEccCccc-c--------------hHHHHHH
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL----------------EEQCHVAIKIIKNKKPF-L--------------NQAQIEV 166 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~----------------~~~~~vAvK~~~~~~~~-~--------------~~~~~e~ 166 (493)
.++|++.++||+|+||+||+|.+. ..++.||||.++..... . .....|.
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 23567999998643211 0 1112233
Q ss_pred HHHHHHhhcCCCCcceEEEeceeeee--------cceeEEEEEeccc-CHHHHHhccC----------------------
Q psy16081 167 KLLEIMNKADVNNTYYIVRLKRHFMW--------RNHLCLVFELLSY-NLYDLLRNTN---------------------- 215 (493)
Q Consensus 167 ~~~~~l~~~~~~~~~~Iv~l~~~~~~--------~~~~~lV~E~~~~-~L~~~l~~~~---------------------- 215 (493)
.++..+.+.. ..+.++++++++|.. .+..+|||||+++ +|.+++....
T Consensus 224 ~~l~~l~~~~-l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKIKRNP-IAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHhhccc-chhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 3333443321 233456777777653 3568999999965 8888876421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCcc--c--cccccCcCCc
Q psy16081 216 FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--Y--QYIQSRFYRS 291 (493)
Q Consensus 216 ~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~--~--~~~gt~~y~a 291 (493)
...+++..++.++.||+.+|.|||. .+|+||||||+|||+ +.++.+||+|||++....... . ...+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLV--TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEE--CCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 0124677889999999999999994 789999999999999 667889999999996553221 1 2234789999
Q ss_pred hhhhcCCC--------------------CC--chhhHHHHHHHHHHHHhCCC-CCCC
Q psy16081 292 PEVLLGIP--------------------YD--LAIDMWSLGCILVEMHTGEP-LFSG 325 (493)
Q Consensus 292 PE~~~~~~--------------------~~--~~~DvwSlGvil~elltG~~-pf~~ 325 (493)
||.+.... |+ .+.||||+|||+|+|++|.. ||.+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99986432 12 24799999999999999985 7754
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=307.21 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=210.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCC---eEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQ---CHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
....|.++||.|.||.|++|+.+..| ..||||.++..- .......+|.+........||||++|.++......
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy----tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc----cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 45778899999999999999887766 459999998542 12223455666666777889999999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+.||.|||++ +|..+|+.+. ..|+.-+...+++.|+.|+.||. ++++|||||...|||+ +.+..+|++|||+++
T Consensus 705 vMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILV--NsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILV--NSNLVCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheee--ccceEEEecccccee
Confidence 9999999966 8888888777 45999999999999999999999 5899999999999999 789999999999999
Q ss_pred ccCCcccccccc------CcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 275 QLGQRIYQYIQS------RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 275 ~~~~~~~~~~gt------~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
.+.+.......| ..|.|||.+....++.++||||+|++|||.++ |..||-...+.|.++.|.+.++.||.-
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm-- 857 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM-- 857 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC--
Confidence 885543222222 46999999999999999999999999999885 999999999999999999988877642
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
++...|..|+..||++|-.+
T Consensus 858 ------------------------------------------------------------DCP~aL~qLMldCWqkdR~~ 877 (996)
T KOG0196|consen 858 ------------------------------------------------------------DCPAALYQLMLDCWQKDRNR 877 (996)
T ss_pred ------------------------------------------------------------CCcHHHHHHHHHHHHHHhhc
Confidence 22237889999999999999
Q ss_pred CCCHHHHhcC
Q psy16081 428 RITPYYALQH 437 (493)
Q Consensus 428 R~t~~e~L~H 437 (493)
||+..||+.+
T Consensus 878 RP~F~qiV~~ 887 (996)
T KOG0196|consen 878 RPKFAQIVST 887 (996)
T ss_pred CCCHHHHHHH
Confidence 9999999864
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.90 Aligned_cols=199 Identities=30% Similarity=0.382 Sum_probs=163.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc---
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN--- 194 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~--- 194 (493)
-+...+.||+||||.||+++++.+|+.||||.++... .......+|+++++.+ +|+|||++++.-+...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL------nh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL------NHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc------CchhhhhhcccCCccccCc
Confidence 4556789999999999999999999999999998533 1123334455554443 3777999999876544
Q ss_pred ---eeEEEEEec-ccCHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC--CCcEEE
Q psy16081 195 ---HLCLVFELL-SYNLYDLLRN-TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK--RSAIKI 267 (493)
Q Consensus 195 ---~~~lV~E~~-~~~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~--~~~ikL 267 (493)
...+||||| +|+|...+.. .+..++++...+.++.++..||.||| +.|||||||||.||++.... ...-||
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCceEEee
Confidence 568999999 5599999864 33467999999999999999999999 67999999999999994333 334799
Q ss_pred EecccccccCC--ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy16081 268 VDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGS 326 (493)
Q Consensus 268 ~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~ 326 (493)
+|||.|+.+.+ .....+||+.|++||+... +.|+.-+|.|||||++|+++||..||...
T Consensus 166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 166 TDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999998865 4568899999999999994 78999999999999999999999999643
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=309.28 Aligned_cols=247 Identities=31% Similarity=0.419 Sum_probs=189.3
Q ss_pred eeeEeeeCCeE-EEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 124 DSLIGKGSFGQ-VVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 124 ~~~LG~G~fg~-V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
.+++|.|+-|+ ||+|. ..|+.||||.+-. .....+++|+..+. ....|||||+.++.-.++.++||+.|+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~--e~~~~A~rEi~lL~-----eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE--EFFDFAQREIQLLQ-----ESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh--HhHHHHHHHHHHHH-----hccCCCceEEEEeeccCCceEEEEehH
Confidence 46789999985 58884 5789999998742 34456677776654 345799999999999999999999999
Q ss_pred cccCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC---CCCCcEEEEecccccccC
Q psy16081 203 LSYNLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN---PKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 203 ~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~---~~~~~ikL~DFG~a~~~~ 277 (493)
|..+|.+++... .......-..+.++.|++.||++||+ .+||||||||.||||+- +....++|+|||+++.+.
T Consensus 585 C~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 585 CACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 999999999873 11111223457789999999999995 89999999999999964 344679999999998885
Q ss_pred Cc------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 278 QR------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTG-EPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 278 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
.. .....||-+|+|||++.+..-+.++||||||||+|+.++| ..||...-..+ ..|+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~------------- 727 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT------------- 727 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc-------------
Confidence 32 3355789999999999998888999999999999999986 89997543221 12221
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
+.|.+-... ...|. ++.|||.+||.+||..||+
T Consensus 728 ------------~~~~L~~L~----------------------------------~~~d~-eA~dLI~~ml~~dP~~RPs 760 (903)
T KOG1027|consen 728 ------------GNYTLVHLE----------------------------------PLPDC-EAKDLISRMLNPDPQLRPS 760 (903)
T ss_pred ------------Cccceeeec----------------------------------cCchH-HHHHHHHHhcCCCcccCCC
Confidence 111111100 00011 6789999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy16081 431 PYYALQHNFFKRT 443 (493)
Q Consensus 431 ~~e~L~Hp~~~~~ 443 (493)
|.++|.||||=..
T Consensus 761 a~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 761 ATDVLNHPLFWDS 773 (903)
T ss_pred HHHHhCCCccCCh
Confidence 9999999999544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=269.21 Aligned_cols=239 Identities=38% Similarity=0.543 Sum_probs=188.3
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-CH
Q psy16081 131 SFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NL 207 (493)
Q Consensus 131 ~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L 207 (493)
+||.||+|.+..+++.||+|++...... ...+..|...+..+ +|++|+++++.+......++|+|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL------KHPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC------CCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 6899999999889999999999754322 23444444444333 677899999999999999999999977 99
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC--ccccccc
Q psy16081 208 YDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQ 285 (493)
Q Consensus 208 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~--~~~~~~g 285 (493)
.+++.... .+++..+..++.+++.++.+||. .+++|+||+|.||++ +.++.++|+|||.+..... ......+
T Consensus 75 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 148 (244)
T smart00220 75 FDLLKKRG--RLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILL--DEDGHVKLADFGLARQLDPGGLLTTFVG 148 (244)
T ss_pred HHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEE--CCCCcEEEccccceeeeccccccccccC
Confidence 99887654 38999999999999999999994 689999999999999 5668999999999987755 3455678
Q ss_pred cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCc
Q psy16081 286 SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSY 365 (493)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 365 (493)
+..|+|||.+.+..++.++||||||+++++|++|..||......+...............
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------- 208 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-------------------- 208 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc--------------------
Confidence 889999999998889999999999999999999999998743333222222110000000
Q ss_pred eecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCC
Q psy16081 366 ILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440 (493)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~ 440 (493)
.... ....+.+++.+||..||++||++.++++||||
T Consensus 209 -------------------------------------~~~~--~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 -------------------------------------PEWK--ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -------------------------------------cccc--CCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0000 00178899999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=291.49 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=204.4
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
+.....+||-|-||.||.|+++.-.--||||.++.+.....++..|..++..+ +|||+|+|+++|..+..+|||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei------kHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI------KHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh------cCccHHHHhhhhccCCCeEEE
Confidence 45566899999999999999999999999999987766667777777776665 467799999999999999999
Q ss_pred EEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
.|||. |+|+++|+.++...++.-....++.||..|+.||. ..++|||||...|.|+ .++..+||+|||+++.+..
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLV--gEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLV--GENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--Hhhhhhhhhhhhhccc--cccceEEeeccchhhhhcC
Confidence 99995 59999999988777888888999999999999999 5789999999999999 6888999999999998866
Q ss_pred cccc-cccc---CcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 279 RIYQ-YIQS---RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 279 ~~~~-~~gt---~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
..++ ..|. .-|.|||-+.-..++.|+|||+|||+|||+.| |..||.+-+-...+..+.+.
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg--------------- 482 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG--------------- 482 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc---------------
Confidence 5443 3443 34999999999999999999999999999997 99999998876666555442
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
|+++.++- +...+.+|++.||.|.|.+||+..|
T Consensus 483 -----------yRM~~PeG------------------------------------CPpkVYeLMraCW~WsPsDRPsFae 515 (1157)
T KOG4278|consen 483 -----------YRMDGPEG------------------------------------CPPKVYELMRACWNWSPSDRPSFAE 515 (1157)
T ss_pred -----------ccccCCCC------------------------------------CCHHHHHHHHHHhcCCcccCccHHH
Confidence 22222211 1127789999999999999999887
Q ss_pred Hhc
Q psy16081 434 ALQ 436 (493)
Q Consensus 434 ~L~ 436 (493)
+-+
T Consensus 516 iHq 518 (1157)
T KOG4278|consen 516 IHQ 518 (1157)
T ss_pred HHH
Confidence 643
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=285.74 Aligned_cols=301 Identities=25% Similarity=0.377 Sum_probs=209.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcC---CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLE---EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.+.|.++++||.|+|++||++.+.. ..+.||+|.+.... .......|.+++..+.- +.||+++.+++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG-----~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGG-----SDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhcc-----chhhhcchhhhcc
Confidence 345679999999999999999999887 78999999887433 34667778888777653 4469999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
++..++|+||++. .-.+++. .++...++.+++.++.||.++| ..|||||||||.|+|.. ...+.-.|+|||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n-~~t~rg~LvDFg 178 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYN-RRTQRGVLVDFG 178 (418)
T ss_pred CCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccc-cccCCceEEech
Confidence 9999999999987 5555554 3678999999999999999999 58999999999999995 466777999999
Q ss_pred cccccC-----------------C------------------------------ccccccccCcCCchhhhcCCC-CCch
Q psy16081 272 SSCQLG-----------------Q------------------------------RIYQYIQSRFYRSPEVLLGIP-YDLA 303 (493)
Q Consensus 272 ~a~~~~-----------------~------------------------------~~~~~~gt~~y~aPE~~~~~~-~~~~ 303 (493)
+|.... . ......||++|+|||++...+ -+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 986110 0 001246899999999998764 6889
Q ss_pred hhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCC-C
Q psy16081 304 IDMWSLGCILVEMHTGEPLF-SGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPG-S 381 (493)
Q Consensus 304 ~DvwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 381 (493)
+||||.|||+.-++++..|| ...++.+.+..|+..+|.-.-...........++.+ ++ ....+. .
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~k------------sn-~~~~~e~~ 325 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQK------------SN-IPTIPELR 325 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecc------------cc-ccccHHHH
Confidence 99999999999999999886 456777778888777664322211111110001110 00 000000 0
Q ss_pred ccchhh-ccccCCCCCCCcCCCCCCCcchh-hhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 382 RRLHDI-LGVESGGPGGRRLGEPGHSVSDY-LKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 382 ~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
..+..+ ++........ -.+.....+.. ..+.||+++||+.||.+|+|++++|+||||.....
T Consensus 326 ~~f~s~~~~~~~~~~q~--n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 326 VNFETLHIESIYKSRQP--NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred hchhccChhhccccccc--ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 000000 0000000000 00111111111 16789999999999999999999999999995443
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=288.73 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=194.3
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+...+.++||+|-||.|.+|. ...+.+||||+++.... ....+..|++++.. ..||||++|+++|..++.+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsq------LkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSR------LKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhc------cCCCCeeEEEeeeecCCch
Confidence 457788999999999999996 44579999999985432 23444555555443 3688899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+|+|||++ +|.+++.......+.-.....|+.||+.|++||.+ .+||||||.+.|+|+ ++++++||+|||+++.
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv--~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLV--DGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh--hchhhccccccceee--cCcccEEecCcccccc
Confidence 999999965 99999987754444555667799999999999995 789999999999999 8999999999999986
Q ss_pred cCCcc-cc----ccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 276 LGQRI-YQ----YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMH--TGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 276 ~~~~~-~~----~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell--tG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
+-... +. .+-...|||||.+..+.+++++|+|+||++|||++ +...||....+.+.....-+.+..++...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~-- 764 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV-- 764 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce--
Confidence 63322 22 23356799999999999999999999999999976 57899988777666555444332221110
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
| +..|... ...+.+||.+||..|-++|
T Consensus 765 ----------------~----------------------------------l~~P~~c---p~~lyelml~Cw~~es~~R 791 (807)
T KOG1094|consen 765 ----------------V----------------------------------LSRPPAC---PQGLYELMLRCWRRESEQR 791 (807)
T ss_pred ----------------e----------------------------------ccCCCcC---cHHHHHHHHHHhchhhhcC
Confidence 0 0111111 1167899999999999999
Q ss_pred CCHHHHhc
Q psy16081 429 ITPYYALQ 436 (493)
Q Consensus 429 ~t~~e~L~ 436 (493)
||.+++..
T Consensus 792 PsFe~lh~ 799 (807)
T KOG1094|consen 792 PSFEQLHL 799 (807)
T ss_pred CCHHHHHH
Confidence 99999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=317.25 Aligned_cols=189 Identities=21% Similarity=0.273 Sum_probs=154.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
..|...++||+|+||.||+|++..++..||||.++.... ....|+.. +. ..+|||||++++++.+.+..|+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~---l~---~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIAD---MG---KLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHH---Hh---hCCCCCcceEEEEEEcCCCCEE
Confidence 456777899999999999999989999999999864332 11223332 32 2368889999999999999999
Q ss_pred EEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC-CCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 199 VFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP-ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 199 V~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~-~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
||||++ ++|.+++. .+++..+..++.||+.||.|||.+ ..+|+||||||+||++ +.++..++. ||.+...
T Consensus 761 v~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~--~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 761 IHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII--DGKDEPHLR-LSLPGLL 832 (968)
T ss_pred EEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE--CCCCceEEE-ecccccc
Confidence 999996 58999885 378999999999999999999964 5689999999999999 555556654 6655433
Q ss_pred CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 277 GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
.. .....+|+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus 833 ~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 833 CT-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred cc-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 22 1234688999999999999999999999999999999999999953
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=287.55 Aligned_cols=244 Identities=24% Similarity=0.341 Sum_probs=187.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcC----CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLE----EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+...+.++||.|-||.||+|.-.. ..-.||||..+..... ...|.. +.+........||||++|++.+. ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~---d~tekf-lqEa~iMrnfdHphIikLIGv~~-e~ 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP---DDTEKF-LQEASIMRNFDHPHIIKLIGVCV-EQ 463 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh---hhHHHH-HHHHHHHHhCCCcchhheeeeee-cc
Confidence 344556789999999999997432 2345899988764321 122322 23333344567889999999997 46
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
..+||||++. |.|..+|..+. ..++......++.||+.||.|||+ ..+|||||...|||+ .....+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLV--sSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILV--SSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheee--cCcceeeecccchh
Confidence 7899999995 58999998665 468899999999999999999996 679999999999999 45667999999999
Q ss_pred cccCCccc-cc-cc--cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 274 CQLGQRIY-QY-IQ--SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 274 ~~~~~~~~-~~-~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
+.+....+ .. .| ..-|||||.+.-..++.++|||-|||.|||++. |..||.+-.+.|.+-.|.++-..|-.
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P---- 614 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP---- 614 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC----
Confidence 98865533 21 12 334999999999999999999999999999884 99999998777776655543222211
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
..+.+.+..|+.+||.+||.+|
T Consensus 615 ----------------------------------------------------------~nCPp~LYslmskcWayeP~kR 636 (974)
T KOG4257|consen 615 ----------------------------------------------------------PNCPPALYSLMSKCWAYEPSKR 636 (974)
T ss_pred ----------------------------------------------------------CCCChHHHHHHHHHhccCcccC
Confidence 1122378899999999999999
Q ss_pred CCHHHH
Q psy16081 429 ITPYYA 434 (493)
Q Consensus 429 ~t~~e~ 434 (493)
|+..|+
T Consensus 637 Prftei 642 (974)
T KOG4257|consen 637 PRFTEI 642 (974)
T ss_pred CcHHHH
Confidence 998764
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=289.45 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=198.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCC-C--eEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEE-Q--CHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~-~--~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
++..+.++||+|+||.|++|.+..- | ..||||+++.... ....+.+|+..+ -...|+|+++|++...+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M------~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHM------LKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHH------HhccCcceeEEeeeecc-
Confidence 3566778999999999999987653 2 4589999986543 234444444443 34457789999999876
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
..+.||||++. |+|++.|++.....|.....-.|+.||+.|+.||.+ .++|||||...|||+ -....|||+|||+
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlll--asprtVKI~DFGL 258 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLL--ASPRTVKICDFGL 258 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhhee--cccceeeeecccc
Confidence 77899999995 599999988555668888999999999999999996 689999999999999 4566899999999
Q ss_pred ccccCCcccccc--c----cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 273 SCQLGQRIYQYI--Q----SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 273 a~~~~~~~~~~~--g----t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
.+.++.....++ + ...|.|||.+....|+.++|||+|||++|||++ |+.||.|....+++.+|.+.-..
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL---- 334 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL---- 334 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC----
Confidence 998865433332 2 235999999999999999999999999999997 88999999999988888643111
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
.++..+.+ ++.+++..||..+|
T Consensus 335 -------------------------------------------------------pRPk~cse---dIY~imk~cWah~p 356 (1039)
T KOG0199|consen 335 -------------------------------------------------------PRPKYCSE---DIYQIMKNCWAHNP 356 (1039)
T ss_pred -------------------------------------------------------CCCCCChH---HHHHHHHHhccCCc
Confidence 11112222 67899999999999
Q ss_pred CCCCCHHHHhcCCCCC
Q psy16081 426 KTRITPYYALQHNFFK 441 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~ 441 (493)
++|||...|.+.-+..
T Consensus 357 aDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 357 ADRPTFSAIREDLVLA 372 (1039)
T ss_pred cccccHHHHHHhHHHH
Confidence 9999999886554443
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=249.69 Aligned_cols=212 Identities=25% Similarity=0.372 Sum_probs=174.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHh-hcCCCCcceEEEeceeeeecceeE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMN-KADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~-~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
+....+..||+|+||.|-+.++..+|...|+|.++..-.. +...+++..+. .......|++|++++.......++
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~----q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS----QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh----HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 4455567899999999999999999999999999754431 12223333333 345668899999999999999999
Q ss_pred EEEEecccCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 198 LVFELLSYNLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+.||.|.-+|..+.++ .....++|..+-+|+..+..||.|||+ ++.+||||+||+|||| +..|++|+||||.+..
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLI--n~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILI--NYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEE--ccCCcEEEccccccee
Confidence 9999998887765543 222468999999999999999999999 6899999999999999 8999999999999988
Q ss_pred cCCcccc--ccccCcCCchhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHH
Q psy16081 276 LGQRIYQ--YIQSRFYRSPEVLLG----IPYDLAIDMWSLGCILVEMHTGEPLFSG-SNEVDQMNKIVE 337 (493)
Q Consensus 276 ~~~~~~~--~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~~i~~ 337 (493)
+.+.... -.|...|||||.+.. ..|+-++||||||+.+.||.+++.||.. ..+.+++.++++
T Consensus 199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 8665443 457778999999863 3799999999999999999999999975 567788888876
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=269.98 Aligned_cols=192 Identities=27% Similarity=0.318 Sum_probs=157.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc----
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN---- 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~---- 194 (493)
...+++.+||+|.||.||+|. -+++.||||++... ....++.|..+.+.. ...|+||+++++.-...+
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~--~kqs~~~Ek~Iy~lp----~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ--EKQSFQNEKNIYSLP----GMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCHH--HHHHHHhHHHHHhcc----CccchhHHHhhchhccCCcccc
Confidence 456678899999999999995 56699999999643 346677787776544 456888999988865444
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhC-------CCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLST-------PELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs-------~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.++||+||.+ |+|.++|..+ .++|....+++.-++.||+|||. ++.+|+|||||..|||+ ..++.+.
T Consensus 282 eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv--K~DlTcc 356 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV--KNDLTCC 356 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE--ccCCcEE
Confidence 7899999995 5999999876 49999999999999999999997 24679999999999999 5678899
Q ss_pred EEecccccccCC-----ccccccccCcCCchhhhcCCC-CC-----chhhHHHHHHHHHHHHhCCCCC
Q psy16081 267 IVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGIP-YD-----LAIDMWSLGCILVEMHTGEPLF 323 (493)
Q Consensus 267 L~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlGvil~elltG~~pf 323 (493)
|+|||+|..+.. .....+||..|||||++.+.- +. ...||||+|.|||||++.-.-+
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999999977642 223468999999999998742 32 4799999999999999865443
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=259.04 Aligned_cols=256 Identities=21% Similarity=0.244 Sum_probs=188.1
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR-- 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~-- 193 (493)
.+..+..+.+.||+|.||.||+|.+ .|+.||||++....+.....+.|+..-..| +|.||+.++..=..+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmL------RHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVML------RHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHh------ccchhhhhhhccccCCC
Confidence 3456788999999999999999954 578999999986655444444444433333 355688887764433
Q ss_pred --ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCccccCCCCCcEEeeCCCCCc
Q psy16081 194 --NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP------ELNIIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 194 --~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~------~~~iiHrDlKp~NILl~~~~~~~ 264 (493)
..++||.+|.+ |+|+|+|... .++.+...+++..++.||++||.. +..|.|||||..|||+ .+++.
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--Kkn~~ 354 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGT 354 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE--ccCCc
Confidence 37999999995 5999999875 589999999999999999999972 3569999999999999 68899
Q ss_pred EEEEecccccccCC-------ccccccccCcCCchhhhcCCC----CC--chhhHHHHHHHHHHHHhC----------CC
Q psy16081 265 IKIVDFGSSCQLGQ-------RIYQYIQSRFYRSPEVLLGIP----YD--LAIDMWSLGCILVEMHTG----------EP 321 (493)
Q Consensus 265 ikL~DFG~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~----~~--~~~DvwSlGvil~elltG----------~~ 321 (493)
+.|+|+|+|....+ ..+..+||..|||||++...- +. ..+||||||.|+||++.. .+
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 99999999966543 345679999999999997532 22 479999999999999853 24
Q ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCC
Q psy16081 322 LFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401 (493)
Q Consensus 322 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 401 (493)
||.+- .|.++.+.++..+..-......+.
T Consensus 435 Pyyd~---------------------------------------------------Vp~DPs~eeMrkVVCv~~~RP~ip 463 (513)
T KOG2052|consen 435 PYYDV---------------------------------------------------VPSDPSFEEMRKVVCVQKLRPNIP 463 (513)
T ss_pred CcccC---------------------------------------------------CCCCCCHHHHhcceeecccCCCCC
Confidence 44321 112222222222222222222233
Q ss_pred CCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 402 ~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
..|.+.+....+-.|++.||..||..|.|+--+-
T Consensus 464 nrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 464 NRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 4455566666788999999999999999986543
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=272.72 Aligned_cols=197 Identities=25% Similarity=0.403 Sum_probs=173.1
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---------cchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.|..++.||.|+||.|++|.++.+...|+||.+.+.+- .....-.|+.++..++... |+||++++++|
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~s---H~NIlKlLdfF 638 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHS---HENILKLLDFF 638 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcC---ccchhhhhhee
Confidence 59999999999999999999999999999999875432 2233455888887776554 77799999999
Q ss_pred eecceeEEEEEec-cc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 191 MWRNHLCLVFELL-SY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 191 ~~~~~~~lV~E~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
++++++||+||-- +| +|++++..+. .++|.+++.|++|+..|+++|| ..||||||||-+|+.+ +.+|-+||+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenviv--d~~g~~kli 712 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIV--DSNGFVKLI 712 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccc--ccCceecccccccEEE--ecCCeEEEe
Confidence 9999999999998 45 9999998765 5999999999999999999999 5799999999999999 899999999
Q ss_pred eccccccc-CCccccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 269 DFGSSCQL-GQRIYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 269 DFG~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
|||.|... ..+...++||..|.|||++.|..| +..-|||+||++||-+.....||..
T Consensus 713 dfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999666 446678999999999999999876 5789999999999999999999863
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=281.46 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=187.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcC-------CCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLE-------EQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
++..+.+.||+|.||+|++|.-.. ....||||.++..... ......|..++ .....|+||+.++++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m-----~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVL-----KELGKHPNIVNLLGA 370 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHH-----HHhcCCcchhhheee
Confidence 445666799999999999996331 1467999998754322 12223333333 234478899999999
Q ss_pred eeecceeEEEEEec-ccCHHHHHhccC------C--------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCc
Q psy16081 190 FMWRNHLCLVFELL-SYNLYDLLRNTN------F--------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPEN 254 (493)
Q Consensus 190 ~~~~~~~~lV~E~~-~~~L~~~l~~~~------~--------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~N 254 (493)
+..++.+++|+||+ .|+|.++++... . ..++......++.||+.|++||++ .++|||||...|
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLAaRN 448 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLAARN 448 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhhhhh
Confidence 99999999999999 469999998765 0 128888999999999999999995 689999999999
Q ss_pred EEeeCCCCCcEEEEecccccccCCc-cccccc-----cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 255 ILLCNPKRSAIKIVDFGSSCQLGQR-IYQYIQ-----SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 255 ILl~~~~~~~ikL~DFG~a~~~~~~-~~~~~g-----t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
||+ .++..+||+|||+|+..... .+...+ ...|||||.+....|+.++|||||||+|||+++ |..||.+-.
T Consensus 449 VLi--~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 449 VLI--TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred EEe--cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999 56778999999999865332 222222 234999999999999999999999999999997 889998744
Q ss_pred -HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCC
Q psy16081 328 -EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHS 406 (493)
Q Consensus 328 -~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 406 (493)
..+.+..+.+ +.|+..|.+.
T Consensus 527 ~~~~l~~~l~~-----------------------------------------------------------G~r~~~P~~c 547 (609)
T KOG0200|consen 527 PTEELLEFLKE-----------------------------------------------------------GNRMEQPEHC 547 (609)
T ss_pred cHHHHHHHHhc-----------------------------------------------------------CCCCCCCCCC
Confidence 4444333322 1223333343
Q ss_pred cchhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 407 VSDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 407 ~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
.. ++.++++.||..+|++||+..|+.+
T Consensus 548 ~~---eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 548 SD---EIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CH---HHHHHHHHHhCCCcccCCCHHHHHH
Confidence 22 6789999999999999999998775
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=278.04 Aligned_cols=256 Identities=25% Similarity=0.334 Sum_probs=205.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.++|+++..||.|+||.||+++|+.+++..|||+++.... ...-.+.|+-+ .+--.|+||+.+++.+-.++.+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~------~~dc~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGM------LRDCRHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceee------eecCCCcChHHHHhhhhhhcCc
Confidence 4689999999999999999999999999999999985432 23333444333 2334678899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+++||||++ +|.+...-. ..+++.++..+++..+++|.|||+ .|=+|||||-.|||+ .+.|.+|++|||.+-.
T Consensus 88 wicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanill--td~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILL--TDEGDVKLADFGVSAQ 161 (829)
T ss_pred EEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhc--CCcccccccccceee--cccCceeecccCchhh
Confidence 999999976 777665443 369999999999999999999995 688999999999999 6788999999999977
Q ss_pred cCC---ccccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 276 LGQ---RIYQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
++. ....++||++|||||+-. .+.|...+|||++|+...|+---.+|--...+...+..+.+....||.--
T Consensus 162 itati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk--- 238 (829)
T KOG0576|consen 162 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK--- 238 (829)
T ss_pred hhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc---
Confidence 754 345789999999999974 45799999999999999999988888666666555555544433333210
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
. .. . .+..|.+|++.+|..+|++||
T Consensus 239 -------------------D-----------k~-----------------------k--ws~~fh~fvK~altknpKkRp 263 (829)
T KOG0576|consen 239 -------------------D-----------KT-----------------------K--WSEFFHNFVKGALTKNPKKRP 263 (829)
T ss_pred -------------------C-----------Cc-----------------------c--chHHHHHHHHHHhcCCCccCC
Confidence 0 00 0 112678999999999999999
Q ss_pred CHHHHhcCCCCCCC
Q psy16081 430 TPYYALQHNFFKRT 443 (493)
Q Consensus 430 t~~e~L~Hp~~~~~ 443 (493)
|++.+|+|||....
T Consensus 264 taeklL~h~fvs~~ 277 (829)
T KOG0576|consen 264 TAEKLLQHPFVSQT 277 (829)
T ss_pred Chhhheeceeeccc
Confidence 99999999999865
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=268.86 Aligned_cols=205 Identities=24% Similarity=0.353 Sum_probs=165.8
Q ss_pred EEeeeEeeeCCeEEEEEEEcCCCe----EEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 122 EIDSLIGKGSFGQVVKAFDLEEQC----HVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 122 ~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
+.+++||+|+||+||+|.+...|+ .||||++..... .+.-.+++++.-.+....|||+++|++++.... +-
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~----~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS----PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC----chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 345799999999999999877765 478888864432 222334555555566678999999999999766 88
Q ss_pred EEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
||++||+ |+|.++++... ..+.......|..||++|+.||| +.++|||||-..|||+ ..-..+||+|||+++.+
T Consensus 774 lvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLV--ksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLV--KSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheee--cCCCeEEEEecchhhcc
Confidence 9999996 59999998755 46888999999999999999999 6789999999999999 56678999999999888
Q ss_pred CCcccccc---c--cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy16081 277 GQRIYQYI---Q--SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 277 ~~~~~~~~---g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 336 (493)
......+. | .+-|||-|.+....|+.++|||||||++||++| |..|+.+....++-..+.
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence 65433322 2 334999999999999999999999999999997 999999877665544433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=291.07 Aligned_cols=195 Identities=19% Similarity=0.258 Sum_probs=145.4
Q ss_pred eEEEeceee-------eecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCc
Q psy16081 182 YIVRLKRHF-------MWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPEN 254 (493)
Q Consensus 182 ~Iv~l~~~~-------~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~N 254 (493)
||+++++.| .....++++||+++++|.++|.... ..+++..++.++.||+.||.|||+ .|||||||||+|
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~gIvHrDlKP~N 110 (793)
T PLN00181 34 YVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHS--QGIVVHNVRPSC 110 (793)
T ss_pred HHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHh--CCeeeccCCchh
Confidence 567777766 2334678889999999999997543 469999999999999999999994 799999999999
Q ss_pred EEeeC-----------------CCCCcEEEEecccccccCC-------------------ccccccccCcCCchhhhcCC
Q psy16081 255 ILLCN-----------------PKRSAIKIVDFGSSCQLGQ-------------------RIYQYIQSRFYRSPEVLLGI 298 (493)
Q Consensus 255 ILl~~-----------------~~~~~ikL~DFG~a~~~~~-------------------~~~~~~gt~~y~aPE~~~~~ 298 (493)
|||.. +.++.+||+|||+++.... .....+||+.|||||++.+.
T Consensus 111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 190 (793)
T PLN00181 111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS 190 (793)
T ss_pred EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC
Confidence 99942 2345677778887754211 01124678899999999999
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCC
Q psy16081 299 PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKV 378 (493)
Q Consensus 299 ~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (493)
.|+.++|||||||+||||++|.+||.... ..+..+... ..++.. .
T Consensus 191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~-~~~~~~-~------------------------------- 235 (793)
T PLN00181 191 SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR-VLPPQI-L------------------------------- 235 (793)
T ss_pred CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh-hcChhh-h-------------------------------
Confidence 99999999999999999999999875321 111111111 011000 0
Q ss_pred CCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 379 PGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 379 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.......+++.+||..||.+|||+.|+|+||||...
T Consensus 236 -----------------------------~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 236 -----------------------------LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred -----------------------------hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 000145689999999999999999999999999753
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-31 Score=240.88 Aligned_cols=201 Identities=22% Similarity=0.348 Sum_probs=162.3
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEece-eeeecc
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKR-HFMWRN 194 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~-~~~~~~ 194 (493)
.+.+.|.|.+.||+|.||.+-+|.++.++..+++|.+...-....++.+|..- ......|.||+.-++ .|+..+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY-----~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHY-----SFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhcc-----ceeeccchhhhHHHHHHhhcCc
Confidence 35678999999999999999999999999999999887543334445544432 223345666776655 477888
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+.+++||++ |+|.+-+.. .++.+...++++.|++.||.|+|+ .++||||||.+||||-+.+.-.|||||||+.
T Consensus 96 ~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeeecccc
Confidence 9999999996 588777655 368999999999999999999996 6899999999999997666678999999999
Q ss_pred cccCCccccccccCcCCchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy16081 274 CQLGQRIYQYIQSRFYRSPEVLLGI-----PYDLAIDMWSLGCILVEMHTGEPLFSGS 326 (493)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~ 326 (493)
+..+.......-+-.|-+||++... ...+.+|+|.||+|+|.+|||.+||+..
T Consensus 171 ~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 171 RKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred cccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 8877665555556679999988643 2568899999999999999999999743
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=225.01 Aligned_cols=179 Identities=39% Similarity=0.542 Sum_probs=150.5
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 127 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
||+|++|.||++.+..+++.+++|++...... ......|...+..+. |++|+++++++......++|+|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN------HPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC------CCCeeeEeeeeecCCeEEEEEecCC
Confidence 68999999999998888999999999755431 244555555555443 3679999999999899999999998
Q ss_pred -cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC-CCcEEEEecccccccCCc---
Q psy16081 205 -YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQLGQR--- 279 (493)
Q Consensus 205 -~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~-~~~ikL~DFG~a~~~~~~--- 279 (493)
++|.+++.... ..+++..+..++.+++.+|.+||. .|++|+||+|.||++ +. .+.++|+|||.+......
T Consensus 75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~--~~~~~~~~l~d~~~~~~~~~~~~~ 149 (215)
T cd00180 75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILL--DSDNGKVKLADFGLSKLLTSDKSL 149 (215)
T ss_pred CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEE--eCCCCcEEEecCCceEEccCCcch
Confidence 59999887653 358999999999999999999995 699999999999999 45 678999999999877554
Q ss_pred cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHH
Q psy16081 280 IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEM 316 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~el 316 (493)
.....+...|++||.+... .++.+.|+|+||+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 3456678889999999887 888999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=228.08 Aligned_cols=206 Identities=34% Similarity=0.475 Sum_probs=168.3
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
|.+.+.||.|++|+||+|.+..+++.+|+|.+..... .......|...+..+ .|++++++++++...+..++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~------~~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL------KHPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC------CCCChhhheeeeecCCceEE
Confidence 5678999999999999999988899999999975432 123334444443333 56779999999998899999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+|++++ +|.+++..... .+++.....++.+++.+|.+||. .+++|+||+|.||++ +.++.++|+|||++....
T Consensus 75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v--~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILL--GMDGLVKLADFGLARFIH 149 (225)
T ss_pred EEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--cCCCCEEEeeCceeeEec
Confidence 9999977 99999876531 28899999999999999999995 699999999999999 566899999999998775
Q ss_pred Ccc----ccccccCcCCchhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHH-HHHHHHHH
Q psy16081 278 QRI----YQYIQSRFYRSPEVL-LGIPYDLAIDMWSLGCILVEMHTGEPLFSG-SNEV-DQMNKIVE 337 (493)
Q Consensus 278 ~~~----~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~-~~~~~i~~ 337 (493)
... ....++..|++||.+ ....++.++|+||||+++++|++|++||.+ .+.. ...+.|..
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 543 456778889999999 666788899999999999999999999977 4443 45555544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=217.31 Aligned_cols=169 Identities=23% Similarity=0.205 Sum_probs=127.0
Q ss_pred cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCcccccc
Q psy16081 205 YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 284 (493)
Q Consensus 205 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~~~~ 284 (493)
|+|.+++.... ..+++..++.++.||+.||.|||. .+ ||+|||+ +.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~--~~~~~~~~--fG~~~~~~~~~--~~ 65 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILL--TWDGLLKL--DGSVAFKTPEQ--SR 65 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeE--cCccceee--ccceEeecccc--CC
Confidence 57888887543 469999999999999999999995 34 9999999 67888998 99997665432 36
Q ss_pred ccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhccchhhhhccCCCC
Q psy16081 285 QSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV-DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDG 363 (493)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 363 (493)
||+.|+|||++.+..|+.++|||||||++|||++|.+||...... ..+..+..........
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------ 127 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR------------------ 127 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc------------------
Confidence 899999999999999999999999999999999999999765432 2222222211100000
Q ss_pred CceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCC
Q psy16081 364 SYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~ 442 (493)
..+ .. ....+...+.+||.+||..||.+|||+.|+++|+|+..
T Consensus 128 -------------~~~---~~--------------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 128 -------------DRS---NL--------------------ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -------------ccc---cH--------------------HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 000 00 00011115899999999999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=228.49 Aligned_cols=249 Identities=20% Similarity=0.222 Sum_probs=191.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCC-----eEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQ-----CHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
..++++..++-+|.||.||.|.++... +.|-||.++... .+.+...-+.+.+. .....|+|++.+.+...+
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~l-ly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESML-LYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHH-HhcCcCCCccceeEEEee
Confidence 457888889999999999999766432 446677665432 33343333334333 334459999999988765
Q ss_pred c-ceeEEEEEecc-cCHHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc
Q psy16081 193 R-NHLCLVFELLS-YNLYDLLRNTN------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 193 ~-~~~~lV~E~~~-~~L~~~l~~~~------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ 264 (493)
+ ...++++.+++ |+|..+|.... .+.++..+...++.|++.|++|||. .||||.||...|.+| |+...
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNCvI--dd~Lq 434 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNCVI--DDQLQ 434 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhccee--hhhee
Confidence 4 46678888885 59999887322 2346777888999999999999995 689999999999999 77889
Q ss_pred EEEEecccccccCCccccccc-----cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q psy16081 265 IKIVDFGSSCQLGQRIYQYIQ-----SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEV 338 (493)
Q Consensus 265 ikL~DFG~a~~~~~~~~~~~g-----t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~ 338 (493)
+||+|=.+++.+-...+...| ...||+||.+.+..|+.++|+|||||+||||+| |+.|+..-++.++..-+.++
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 999999999887655554444 345999999999999999999999999999997 99999999988887666553
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
.+ +.. | .++..+++..+.
T Consensus 515 yR--------------------------laQ---------------------------------P---~NCPDeLf~vMa 532 (563)
T KOG1024|consen 515 YR--------------------------LAQ---------------------------------P---FNCPDELFTVMA 532 (563)
T ss_pred ce--------------------------ecC---------------------------------C---CCCcHHHHHHHH
Confidence 22 111 1 112227899999
Q ss_pred HccCCCCCCCCCHHHHhc
Q psy16081 419 RMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 419 ~mL~~dP~~R~t~~e~L~ 436 (493)
.||..+|++||+.+|+..
T Consensus 533 cCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 533 CCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHhcCcccCCCHHHHHH
Confidence 999999999999999753
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=252.66 Aligned_cols=271 Identities=23% Similarity=0.339 Sum_probs=200.8
Q ss_pred cCcE-EEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRY-EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.| ....++|.|++|.|+.+......+.++.|.++... ...........+..++.......|++++..+..+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 4455 45688999999999998877777777777554210 222333333336666766777889999888888777666
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
.+-+||||+++|+.++.... .++...+..+++||+.|+.|+|+ .||.||||||+|+++ ..+|.+||+|||.+..
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~--~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLV--TENGILKIIDFGAASV 469 (601)
T ss_pred chhhhhcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEE--ecCCceEEeecCccee
Confidence 66669999889999998752 48888999999999999999994 799999999999999 6788999999999865
Q ss_pred cCC-------ccccccccCcCCchhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 276 LGQ-------RIYQYIQSRFYRSPEVLLGIPYDL-AIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 276 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
+.. .....+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+...
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------------- 535 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------------- 535 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------------
Confidence 522 234578899999999999999985 8999999999999999999997654332211
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
+......+ ....-+..++...+. ...+.+|.+||++||.+
T Consensus 536 --------~~~~~~~~-----------~~~~~~~~~~~~~lp---------------------~~~~~~~~~~l~~~P~~ 575 (601)
T KOG0590|consen 536 --------KTNNYSDQ-----------RNIFEGPNRLLSLLP---------------------RETRIIIYRMLQLDPTK 575 (601)
T ss_pred --------hhhccccc-----------cccccChHHHHHhch---------------------hhHHHHHHHHccCChhh
Confidence 00000000 000001111111111 14579999999999999
Q ss_pred CCCHHHHhcCCCCCCCccCCC
Q psy16081 428 RITPYYALQHNFFKRTADEST 448 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~~~~~~ 448 (493)
|+|+++|++.+||+.+..+..
T Consensus 576 R~ti~~i~~d~W~~~i~~c~v 596 (601)
T KOG0590|consen 576 RITIEQILNDEWIRSIECCHV 596 (601)
T ss_pred eecHHHHhhChHhhhcceEEe
Confidence 999999999999998877654
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-25 Score=220.24 Aligned_cols=206 Identities=26% Similarity=0.280 Sum_probs=170.2
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCC-eEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceee-eeccee
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQ-CHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF-MWRNHL 196 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~-~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~-~~~~~~ 196 (493)
+|.+.++||+|+||.||+|.+..++ +.+|+|+..... ........|..++..+.. .....++..+++.. ....+-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~--~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK--KNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh--hcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999988775 689999876532 222367888888888876 22223477888888 577889
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC-C--CcEEEEecccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK-R--SAIKIVDFGSS 273 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~-~--~~ikL~DFG~a 273 (493)
|+||++++.+|.++......+.++...+.+++.|++.+|.++| +.|++||||||+|++++... . ..+.|+|||++
T Consensus 97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 9999999999999987666678999999999999999999999 58999999999999995432 2 46999999999
Q ss_pred c--ccC-C---------c-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy16081 274 C--QLG-Q---------R-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV 329 (493)
Q Consensus 274 ~--~~~-~---------~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~ 329 (493)
+ ... . . ...+.||..|.++.+..+...+.+.|+||++.++.+++.|..||.+....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 8 321 1 1 12355999999999999999999999999999999999999999776543
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=203.77 Aligned_cols=225 Identities=24% Similarity=0.330 Sum_probs=182.6
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|.++++||.|+||.+|+|....+|+.||||+-.++ ....+...|.++.++++..- .|..+..++.+..+-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~-----GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGV-----GIPHIRHYGTEKDYN 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCC-----CCchhhhhccccccc
Confidence 357899999999999999999999999999999987643 34567788888888887543 266667777888899
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEEecccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~DFG~a~~ 275 (493)
.||||+++.+|.+++.-+. +.++...+..++-|++.-++|+|. .++|||||||+|+|++-+ ....+.|+|||+|+.
T Consensus 87 vlVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEeccchhh
Confidence 9999999999999887655 569999999999999999999994 789999999999999422 334689999999976
Q ss_pred cCC----------ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH-hCC
Q psy16081 276 LGQ----------RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV---DQMNKIVEV-LGL 341 (493)
Q Consensus 276 ~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~-~~~ 341 (493)
... ......||..|.+-....+...+...|+-|+|.+|.++.-|..||++-... ..+++|.+. ...
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 632 123467999999999999888899999999999999999999999985543 445556553 445
Q ss_pred CChhhhhhc
Q psy16081 342 PPKHLLDGA 350 (493)
Q Consensus 342 ~p~~~~~~~ 350 (493)
|++.++...
T Consensus 244 ~ie~LC~G~ 252 (341)
T KOG1163|consen 244 PIEVLCKGF 252 (341)
T ss_pred CHHHHhCCC
Confidence 555555443
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-27 Score=238.16 Aligned_cols=240 Identities=27% Similarity=0.376 Sum_probs=191.5
Q ss_pred eEeeeCCeEEEEEEE---cCCCeEEEEEEEccCcccch---HHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 126 LIGKGSFGQVVKAFD---LEEQCHVAIKIIKNKKPFLN---QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~---~~~~~~vAvK~~~~~~~~~~---~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
.+|.|+||.|+++.. ...+..+|+|++++...... ....|..+++ ...+|+++|++...|+.+..++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~-----~~~~~~f~v~lhyafqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILA-----FVHNTPFLVKLHYAFQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHh-----hccCCCceeeeeeeeccccchhHh
Confidence 379999999998753 34577899999875432211 2223333333 334688899999999999999999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
+++..| .|+..+.+. ..+.+...+.+...++.+++++| +.+|+|||+|++||++ +.+|++++.|||+++..-.
T Consensus 76 ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enill--d~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLL--LLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred hhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceee--cccCccccCCchhhhHhHh
Confidence 999955 888777554 35788888999999999999999 6899999999999999 8999999999999987644
Q ss_pred ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhc
Q psy16081 279 RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFD 358 (493)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 358 (493)
.... |||..|||||++. ....++|+||||++++||++|..||.+ +...+|.+.--..|..++.
T Consensus 150 ~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~---------- 212 (612)
T KOG0603|consen 150 EKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSA---------- 212 (612)
T ss_pred hhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhH----------
Confidence 3333 9999999999998 578899999999999999999999988 6777777632222222211
Q ss_pred cCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH-----HH
Q psy16081 359 KMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP-----YY 433 (493)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~-----~e 433 (493)
.+.++++.|+..+|..|.-. .|
T Consensus 213 -----------------------------------------------------~a~~~~~~l~~r~p~nrLg~~~~~~~e 239 (612)
T KOG0603|consen 213 -----------------------------------------------------EARSLFRQLFKRNPENRLGAGPDGVDE 239 (612)
T ss_pred -----------------------------------------------------HHHHHHHHHHhhCHHHHhccCcchhHH
Confidence 56799999999999999865 79
Q ss_pred HhcCCCCCCCccC
Q psy16081 434 ALQHNFFKRTADE 446 (493)
Q Consensus 434 ~L~Hp~~~~~~~~ 446 (493)
+++|+||+.+...
T Consensus 240 ik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 240 IKQHEFFQSIDWN 252 (612)
T ss_pred HhccchheeeeHh
Confidence 9999999987654
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=205.62 Aligned_cols=211 Identities=24% Similarity=0.307 Sum_probs=174.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
-.|++.++||+|+||..+.|++.-+++.||||.-. .+...-+...|.+....|... +.|...+.+-...-+-.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~-----~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGT-----EGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCC-----CCCCceeeeccccchhhh
Confidence 36999999999999999999999999999999754 333445677787777777633 236666666677778899
Q ss_pred EEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC---CCCcEEEEecccccc
Q psy16081 199 VFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP---KRSAIKIVDFGSSCQ 275 (493)
Q Consensus 199 V~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~---~~~~ikL~DFG~a~~ 275 (493)
|+|+++.+|.|++.-+. +.|+...+..++.|++.-++|+|+ ..+|.|||||+|+||+.. ....|.|+|||+|+.
T Consensus 102 VidLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99999999999887665 689999999999999999999996 579999999999999532 335689999999987
Q ss_pred cCCc----------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHH
Q psy16081 276 LGQR----------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG---SNEVDQMNKIVEV 338 (493)
Q Consensus 276 ~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~---~~~~~~~~~i~~~ 338 (493)
.... .....||..||+-...+|..-+...|+-|||-++++.|-|..||.| .+..+-+++|-+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 7433 2346799999999999999999999999999999999999999987 4455666666543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-23 Score=204.72 Aligned_cols=259 Identities=32% Similarity=0.421 Sum_probs=192.3
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
|.+.+.||.|+||.||++.+. ..+|+|.+...... ...+..|..++..+.+. ++|+++.+.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~-----~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP-----PNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCC-----cceeeEEEEEecCCEE
Confidence 778899999999999999877 78999998754332 23344444444433322 2699999999877788
Q ss_pred EEEEEeccc-CHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC-cEEEEecccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS-AIKIVDFGSS 273 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~-~ikL~DFG~a 273 (493)
+++++++.+ ++.+++..... ..+.......++.|++.++.|+|. .+++||||||+||++ +..+ .++++|||++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~--~~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILL--DRDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeee--cCCCCeEEEeccCcc
Confidence 999999976 77766654421 158999999999999999999994 789999999999999 5555 6999999999
Q ss_pred cccCCc---------cccccccCcCCchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHH
Q psy16081 274 CQLGQR---------IYQYIQSRFYRSPEVLLG---IPYDLAIDMWSLGCILVEMHTGEPLFSGSNE---VDQMNKIVEV 338 (493)
Q Consensus 274 ~~~~~~---------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~ 338 (493)
...... ....+||..|+|||.+.+ ..++...|+||+|++++++++|..||..... .......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 755432 356789999999999998 5789999999999999999999999887664 2333333322
Q ss_pred hCCC-ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHH
Q psy16081 339 LGLP-PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417 (493)
Q Consensus 339 ~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi 417 (493)
...+ ... .. ..... ......+.+++
T Consensus 230 ~~~~~~~~-------------------------------~~--~~~~~---------------------~~~~~~~~~~~ 255 (384)
T COG0515 230 LPTPSLAS-------------------------------PL--SPSNP---------------------ELISKAASDLL 255 (384)
T ss_pred cCCccccc-------------------------------cc--Ccccc---------------------chhhHHHHHHH
Confidence 2211 000 00 00000 00112578999
Q ss_pred hHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 418 FRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 418 ~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.+|+..+|..|.+..+...++|......
T Consensus 256 ~~~~~~~~~~r~~~~~~~~~~~~~~~~~ 283 (384)
T COG0515 256 KKLLAKDPKNRLSSSSDLSHDLLAHLKL 283 (384)
T ss_pred HHHHhcCchhcCCHHHHhhchHhhCccc
Confidence 9999999999999999999977765443
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-24 Score=226.66 Aligned_cols=222 Identities=26% Similarity=0.349 Sum_probs=166.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|..++.|..|+||.||.++++.+.+.+|+|+-+ +.. +++. ++.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l----------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL----------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch----------hhhc--cccccCCccee-------------
Confidence 468999999999999999999999999999996533 210 1110 11122222233
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+=..+++... .++.+. +.+++||| ..||+|||+||+|+|| ..-|++|++|||+++...
T Consensus 136 -------gDc~tllk~~g--~lPvdm--------vla~Eylh--~ygivhrdlkpdnllI--T~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -------GDCATLLKNIG--PLPVDM--------VLAVEYLH--SYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -------chhhhhcccCC--CCcchh--------hHHhHhhc--cCCeecCCCCCCccee--eecccccccchhhhhhhh
Confidence 33333443322 233332 78899999 4899999999999999 678999999999986532
Q ss_pred Cc------------------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy16081 278 QR------------------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL 339 (493)
Q Consensus 278 ~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 339 (493)
.. ..+.|||+.|+|||++.-.+|+..+|+|++|+|+||.+.|..||.++..++.+...+.-.
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 11 124599999999999999999999999999999999999999999999999888887654
Q ss_pred CCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhH
Q psy16081 340 GLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419 (493)
Q Consensus 340 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~ 419 (493)
...|+.... -..++.|+|.+
T Consensus 275 i~wpE~dea------------------------------------------------------------~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 275 IEWPEEDEA------------------------------------------------------------LPPEAQDLIEQ 294 (1205)
T ss_pred ccccccCcC------------------------------------------------------------CCHHHHHHHHH
Confidence 433322110 00178999999
Q ss_pred ccCCCCCCCC---CHHHHhcCCCCCCCccC
Q psy16081 420 MLDYDPKTRI---TPYYALQHNFFKRTADE 446 (493)
Q Consensus 420 mL~~dP~~R~---t~~e~L~Hp~~~~~~~~ 446 (493)
+|+.+|..|. .+-++.+|+||+...+.
T Consensus 295 LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 295 LLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred HHHhChHhhcccchhhhhhhccceeecccc
Confidence 9999999997 46789999999987654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=208.66 Aligned_cols=170 Identities=19% Similarity=0.224 Sum_probs=123.5
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcC-CCeEEEEEEEccCc------ccchHHHHHHHHHHHHhhcCCCCcceEE-Ee
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLE-EQCHVAIKIIKNKK------PFLNQAQIEVKLLEIMNKADVNNTYYIV-RL 186 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~------~~~~~~~~e~~~~~~l~~~~~~~~~~Iv-~l 186 (493)
..+.++|.+.++||+|+||+||+|++.. +++.||||++.... .....+.+|..++..+. |++|+ .+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~------h~~iv~~l 87 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR------GIGVVPQL 87 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc------CCCCCcEE
Confidence 3567889999999999999999998876 67888999875321 11234566666666554 44465 34
Q ss_pred ceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCC-CCCcEEeeCCCCCc
Q psy16081 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDL-KPENILLCNPKRSA 264 (493)
Q Consensus 187 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDl-Kp~NILl~~~~~~~ 264 (493)
++ .+..||||||+.| +|. .+.. .. ...++.|++.+|.|||+ .||+|||| ||+|||+ +.++.
T Consensus 88 ~~----~~~~~LVmE~~~G~~L~-~~~~-----~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv--~~~~~ 150 (365)
T PRK09188 88 LA----TGKDGLVRGWTEGVPLH-LARP-----HG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLM--GPDGE 150 (365)
T ss_pred EE----cCCcEEEEEccCCCCHH-HhCc-----cc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEE--cCCCC
Confidence 33 2468999999976 665 2211 11 14678999999999994 79999999 9999999 56788
Q ss_pred EEEEecccccccCCc-----------cccccccCcCCchhhhcCCC------CCchhhHH
Q psy16081 265 IKIVDFGSSCQLGQR-----------IYQYIQSRFYRSPEVLLGIP------YDLAIDMW 307 (493)
Q Consensus 265 ikL~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 307 (493)
+||+|||+|+.+... .....+++.|+|||++.... .+..+|-|
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999999999866432 13456788899999997432 33456666
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=196.01 Aligned_cols=202 Identities=23% Similarity=0.304 Sum_probs=129.6
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCC---------cc------eEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN---------TY------YIV 184 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~---------~~------~Iv 184 (493)
.+...+.||.|+|+.||.+++..|++.+|||++...... .....+.-..+.+....... |- -++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~-~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADA-SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTT-HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccccc-chHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 466778999999999999999999999999988633211 11111111111111111000 11 123
Q ss_pred Eecee---eeec---c-----eeEEEEEecccCHHHHHhc---cCCC--CCCHHHHHHHHHHHHHHHHHHhCCCCCcccc
Q psy16081 185 RLKRH---FMWR---N-----HLCLVFELLSYNLYDLLRN---TNFR--GVSLNLTRKFSQQLCTALLFLSTPELNIIHC 248 (493)
Q Consensus 185 ~l~~~---~~~~---~-----~~~lV~E~~~~~L~~~l~~---~~~~--~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHr 248 (493)
++-+. +... . ..+++|+-+.++|.+++.- .... .+.......+..|+++.+++||+ .|+||+
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~--~GlVHg 169 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS--YGLVHG 169 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--TTEEES
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh--cceEec
Confidence 32211 1111 1 3478899998888877542 2211 12233445566899999999995 799999
Q ss_pred CCCCCcEEeeCCCCCcEEEEecccccccCCccccccccCcCCchhhhcCC--------CCCchhhHHHHHHHHHHHHhCC
Q psy16081 249 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI--------PYDLAIDMWSLGCILVEMHTGE 320 (493)
Q Consensus 249 DlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSlGvil~elltG~ 320 (493)
||||+|+++ +.+|.++|+||+.....+........+..|.+||..... .++.+.|.|+||+++|.|+||.
T Consensus 170 di~~~nfll--~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 170 DIKPENFLL--DQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp T-SGGGEEE---TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEEE--cCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999 788999999999988777765545556789999987542 4789999999999999999999
Q ss_pred CCCCCC
Q psy16081 321 PLFSGS 326 (493)
Q Consensus 321 ~pf~~~ 326 (493)
.||...
T Consensus 248 lPf~~~ 253 (288)
T PF14531_consen 248 LPFGLS 253 (288)
T ss_dssp -STCCC
T ss_pred CCCCCC
Confidence 999754
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=223.90 Aligned_cols=193 Identities=24% Similarity=0.369 Sum_probs=147.1
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.|...+.||.+.|=+|.+|++.. |. |+||++.+..+. ...+.++++. ++ ....++||++.+......+...|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~---ik-~~l~~~pn~lPfqk~~~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEE---IK-FALMKAPNCLPFQKVLVTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHH---HH-HHhhcCCcccchHHHHHhhHHHH
Confidence 57778999999999999997543 44 999999765533 2233222222 22 33446778998888877788889
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc-
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL- 276 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~- 276 (493)
||-+|+..+|+|.|....+ +.+-+.+.|+.||+.||.-+| +.||+|+|||.+|||| ..=+-+.|+||..-+..
T Consensus 98 lvRqyvkhnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILi--TSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 98 LVRQYVKHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILI--TSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHHHhhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEE--eeechhhhhcccccCCcc
Confidence 9999999999999976653 778888899999999999999 6899999999999999 45667899999876432
Q ss_pred -CCc----ccccccc----CcCCchhhhcCCC-----------CCchhhHHHHHHHHHHHHh-CCCCCC
Q psy16081 277 -GQR----IYQYIQS----RFYRSPEVLLGIP-----------YDLAIDMWSLGCILVEMHT-GEPLFS 324 (493)
Q Consensus 277 -~~~----~~~~~gt----~~y~aPE~~~~~~-----------~~~~~DvwSlGvil~ellt-G~~pf~ 324 (493)
.++ ...+..| .+|+|||.+.... .+++-||||+||+++||++ |+|||.
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 211 1122222 3599999986421 6789999999999999997 799995
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=182.12 Aligned_cols=169 Identities=12% Similarity=0.161 Sum_probs=122.0
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchH----------HHHHHHHHHHHhhcCCCCcceEEEe
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ----------AQIEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~----------~~~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
+.++|++.++||.|+||.||++.+ ++..+|||++......... +++|...+..+.+.. |..+
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G------I~~~ 100 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG------LASL 100 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC------CCcc
Confidence 467999999999999999999744 4678999999743322222 355666666665543 4444
Q ss_pred ceeeee--------cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEe
Q psy16081 187 KRHFMW--------RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILL 257 (493)
Q Consensus 187 ~~~~~~--------~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl 257 (493)
.+++.. .+..+|||||++| +|.++.. +++ ....+++.+|..+| ..|++||||||+||++
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH--~~gi~H~Dikp~Nili 168 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH--QHGMVSGDPHKGNFIV 168 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH--HcCCccCCCChHHEEE
Confidence 444332 3468999999987 7877631 233 24669999999999 5799999999999999
Q ss_pred eCCCCCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHH
Q psy16081 258 CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMH 317 (493)
Q Consensus 258 ~~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 317 (493)
+.++ ++|+|||......+.... ..+++...|+.++|+||||+.+..+.
T Consensus 169 --~~~g-i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 --SKNG-LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred --eCCC-EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence 4556 999999988655332111 12455667888999999999987654
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=185.78 Aligned_cols=146 Identities=23% Similarity=0.306 Sum_probs=116.5
Q ss_pred CCCcceEEEeceeeeec---------------------------ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHH
Q psy16081 177 VNNTYYIVRLKRHFMWR---------------------------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229 (493)
Q Consensus 177 ~~~~~~Iv~l~~~~~~~---------------------------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~ 229 (493)
...|||||++..+|.+. ..+|+||.....+|.+++.... .+....+.++.
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~la 348 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILA 348 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHH
Confidence 36899999999998754 3589999999999999997653 67788889999
Q ss_pred HHHHHHHHHhCCCCCccccCCCCCcEEe--eCCCCCcEEEEecccccccCC---------ccccccccCcCCchhhhcCC
Q psy16081 230 QLCTALLFLSTPELNIIHCDLKPENILL--CNPKRSAIKIVDFGSSCQLGQ---------RIYQYIQSRFYRSPEVLLGI 298 (493)
Q Consensus 230 qi~~aL~~Lhs~~~~iiHrDlKp~NILl--~~~~~~~ikL~DFG~a~~~~~---------~~~~~~gt~~y~aPE~~~~~ 298 (493)
|+++|+.||| +.||.|||||.+|||+ ++|.-..+.|+|||++---.. .....-|.-.-||||+....
T Consensus 349 QlLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 349 QLLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999 5689999999999999 334445689999998732211 11223456668999999754
Q ss_pred C-----C-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 299 P-----Y-DLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 299 ~-----~-~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
+ . -.++|.|+.|.+.||++....||.+..
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG 461 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccc
Confidence 3 1 258999999999999999999998743
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=173.73 Aligned_cols=139 Identities=20% Similarity=0.214 Sum_probs=102.4
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---------------------------hHHHHHHHHHHHHhhcC
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---------------------------NQAQIEVKLLEIMNKAD 176 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---------------------------~~~~~e~~~~~~l~~~~ 176 (493)
...||+|+||.||+|.+. +|+.||||+++...... .....|...+..+....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999886 89999999997532110 11233777777776544
Q ss_pred CCCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-hCCCCCccccCCCCCc
Q psy16081 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL-STPELNIIHCDLKPEN 254 (493)
Q Consensus 177 ~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L-hs~~~~iiHrDlKp~N 254 (493)
. .+|+++. .. ..+|||||++| ++...+... ..+++..+..++.||+.+|.++ | ..||+||||||+|
T Consensus 81 v-~~p~~~~------~~-~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~N 148 (190)
T cd05147 81 I-PCPEPIL------LK-SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYN 148 (190)
T ss_pred C-CCCcEEE------ec-CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHH
Confidence 3 3344432 12 23899999987 444432222 3689999999999999999999 6 4689999999999
Q ss_pred EEeeCCCCCcEEEEecccccccCC
Q psy16081 255 ILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 255 ILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
||++ ++.++|+|||+|.....
T Consensus 149 Ili~---~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 149 LLYH---DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred EEEE---CCcEEEEEccccccCCC
Confidence 9994 36799999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-21 Score=176.68 Aligned_cols=207 Identities=20% Similarity=0.222 Sum_probs=160.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
...+..+|.....|..|+|++. |..+++|+++... ........+.++...++...||||+.+++.|....++.++
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~---~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVRE---VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhccCCCccccccccc--Ccchhhhhhhhhh---cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 3455678899999999999764 4557778876432 1223334455666667778899999999999999999999
Q ss_pred EEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
..||+ |+|++.|.....-..+..++.+++.+|+.|++|||+.+.-|.---|....++++++-...+-.+|--++.+...
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~g 345 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVG 345 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeeccc
Confidence 99996 59999998877666788999999999999999999976555566789999999443344455556555543322
Q ss_pred ccccccccCcCCchhhhcCCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy16081 279 RIYQYIQSRFYRSPEVLLGIPYD---LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i 335 (493)
..-+|.||+||.+..++-+ .++|+|||++++|||.|...||....+++.-.+|
T Consensus 346 ----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 346 ----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred ----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 2346889999999987644 5899999999999999999999988887765554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=169.77 Aligned_cols=139 Identities=21% Similarity=0.222 Sum_probs=100.8
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---------------------------chHHHHHHHHHHHHhhcC
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---------------------------LNQAQIEVKLLEIMNKAD 176 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---------------------------~~~~~~e~~~~~~l~~~~ 176 (493)
...||+|+||+||+|.+. +|+.||||+++..... ......|...+..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999977 8999999998754211 011234556666665443
Q ss_pred CCCcceEEEeceeeeecceeEEEEEecccC-HHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCc
Q psy16081 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYD-LLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPEN 254 (493)
Q Consensus 177 ~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~~-L~~-~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~N 254 (493)
. ..|.++ . . ...||||||++|. +.. .+.. ..++......++.|++.++.++|+ ..||+||||||+|
T Consensus 81 i-~~p~~~---~--~--~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~-~~givHrDlkP~N 148 (190)
T cd05145 81 V-PVPEPI---L--L--KKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQ-EAGLVHGDLSEYN 148 (190)
T ss_pred C-CCceEE---E--e--cCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCChhh
Confidence 2 112121 1 1 1248999999773 433 3332 247888999999999999999994 2799999999999
Q ss_pred EEeeCCCCCcEEEEecccccccCC
Q psy16081 255 ILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 255 ILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
||+ + ++.++|+|||++.....
T Consensus 149 Ill--~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 149 ILY--H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEE--E-CCCEEEEEcccceecCC
Confidence 999 4 67899999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=202.65 Aligned_cols=194 Identities=25% Similarity=0.363 Sum_probs=157.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.+.|.|.+.||+|+||+||+|.... |+.||+|+-+... ..++-.-.+++++|. . .-.+.|+++...+...+.-+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~--~WEfYI~~q~~~RLk-~--~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN--PWEFYICLQVMERLK-P--QMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC--ceeeeehHHHHHhhc-h--hhhcchHHHHHHHccCCcce
Confidence 4579999999999999999998766 9999999876433 234444444555555 1 11223777777777888889
Q ss_pred EEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-----CCCCcEEEEecc
Q psy16081 198 LVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-----PKRSAIKIVDFG 271 (493)
Q Consensus 198 lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-----~~~~~ikL~DFG 271 (493)
||+||.+ |+|++++.. .+.+++..+..+..|++..++.|| ..+|||+||||+|.||.. .+...++|||||
T Consensus 771 lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999995 599999973 357999999999999999999999 578999999999999942 234569999999
Q ss_pred ccccc-----CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q psy16081 272 SSCQL-----GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEP 321 (493)
Q Consensus 272 ~a~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 321 (493)
.+..+ +......++|-.+-.+|+..|.+++..+|.|.|+.+++-||.|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99554 223455678889999999999999999999999999999999974
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.4e-19 Score=161.33 Aligned_cols=182 Identities=15% Similarity=0.118 Sum_probs=131.7
Q ss_pred EEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch-----HHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN-----QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 122 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.+...|++|+||+|+++. ..+..++.+.+........ .+.+|.+++..+.+ +++|.+++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~-----~~~vP~ll~~----~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDG-----LPRTPRLLHW----DGR 73 (218)
T ss_pred ccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCC-----CCCCCEEEEE----cCE
Confidence 356899999999999874 3678888887765443222 35678877776643 2335555553 346
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCC-CCCcEEeeCCCCCcEEEEeccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDL-KPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDl-Kp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
|+||||+.| +|.+.+.. . ...++.|++.+|.++| ..||+|||| ||+|||+ +.++.++|+|||+|.
T Consensus 74 ~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv--~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLV--QEDGSPAVIDFQLAV 140 (218)
T ss_pred EEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEE--cCCCCEEEEECCCce
Confidence 999999977 66543211 1 1357889999999999 579999999 7999999 567889999999997
Q ss_pred ccCCccc----------------cccccCcCCchhhhcCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 275 QLGQRIY----------------QYIQSRFYRSPEVLLGI-PYD-LAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 275 ~~~~~~~----------------~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
....... ....++.|++|+.-.-- ..+ ...++++.|+-+|.++|+..|+-+++
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 5543221 12347778888765432 334 57889999999999999999887654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=161.31 Aligned_cols=139 Identities=17% Similarity=0.153 Sum_probs=105.6
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccC-cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc---eeE-E
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK-KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN---HLC-L 198 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~---~~~-l 198 (493)
.+.||+|+||.||. +..++.. +||++... ........+|+.++..+.+ ....||||++++++++++. .++ +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~-~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSR-RLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhc-cCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 47899999999995 6667666 69988643 2234567888888888865 3456899999999999873 434 7
Q ss_pred EEEecc---cCHHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHhCCCCCccccCCCCCcEEeeCC--CCCcEEEEeccc
Q psy16081 199 VFELLS---YNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL-LFLSTPELNIIHCDLKPENILLCNP--KRSAIKIVDFGS 272 (493)
Q Consensus 199 V~E~~~---~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~~Lhs~~~~iiHrDlKp~NILl~~~--~~~~ikL~DFG~ 272 (493)
|+||++ ++|.+++.+. .+++. ..++.|++.++ .|||+ .+||||||||+|||++.. .+..++|+||+.
T Consensus 83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 899954 5999999663 35555 35678888777 89995 689999999999999532 334799999544
Q ss_pred c
Q psy16081 273 S 273 (493)
Q Consensus 273 a 273 (493)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=182.54 Aligned_cols=118 Identities=31% Similarity=0.453 Sum_probs=102.2
Q ss_pred ceeEEEEEeccc-CHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 194 NHLCLVFELLSY-NLYDLLR-NTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~-~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.++||.|++|.. +|.++|. .......++.....++.|++.|+.| ++.+|+|+||.||++ ..+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~--~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFF--SDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhcccccccc--ccchhhhhhhhh
Confidence 468999999954 9999997 3444567888999999999999998 579999999999999 456689999999
Q ss_pred cccccCC---------ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh
Q psy16081 272 SSCQLGQ---------RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318 (493)
Q Consensus 272 ~a~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt 318 (493)
+...... ..+...||..||+||.+.+..|+.++||||||+||+|++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9866543 2356789999999999999999999999999999999997
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=165.62 Aligned_cols=144 Identities=19% Similarity=0.131 Sum_probs=105.7
Q ss_pred cEEEeeeEeeeCCeEEEEEE-EcCCCeEEEEEEEccCccc-------------------------chHHHHHHHHHHHHh
Q psy16081 120 RYEIDSLIGKGSFGQVVKAF-DLEEQCHVAIKIIKNKKPF-------------------------LNQAQIEVKLLEIMN 173 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~-~~~~~~~vAvK~~~~~~~~-------------------------~~~~~~e~~~~~~l~ 173 (493)
-|.+.+.||+|+||.||+|. +..+|+.||||+++..... ......|...+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37788999999999999998 6779999999998743210 012356777777776
Q ss_pred hcCCCCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC-ccccCCC
Q psy16081 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN-IIHCDLK 251 (493)
Q Consensus 174 ~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~-iiHrDlK 251 (493)
... .. +.+++.. ...+|||||++| +|....... ..+.......++.||+.+|.+||. .| |+|||||
T Consensus 109 ~~~-i~---~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~Dik 176 (237)
T smart00090 109 EAG-VP---VPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK--EGELVHGDLS 176 (237)
T ss_pred hcC-CC---CCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCCCC
Confidence 421 11 2233221 235899999988 555543222 245666778999999999999994 68 9999999
Q ss_pred CCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 252 PENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 252 p~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|+||++ + .+.++|+|||.+...+.
T Consensus 177 p~NIli--~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILV--H-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEE--E-CCCEEEEEChhhhccCC
Confidence 999999 4 67899999999875544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-16 Score=149.97 Aligned_cols=133 Identities=21% Similarity=0.241 Sum_probs=99.3
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---------hHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---------NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---------~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
+.||+|++|.||+|.+ ++..|+||+........ .....|..++..+.+.. |.....++...+.
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~------i~~p~~~~~~~~~ 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG------VNVPAVYFVDPEN 73 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCC------CCCCeEEEEeCCC
Confidence 5799999999999975 67889999865322111 12344555655554432 3333334556677
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.++||||++| +|.+++.... . ....++.+++.+|.++|. .|++|+|++|.|||++ .+.++|+|||.+.
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~---~~~~~liDf~~a~ 142 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS---GGKIYLIDFGLAE 142 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE---CCCEEEEECCccc
Confidence 8999999976 8888875432 2 778899999999999994 7899999999999993 6789999999986
Q ss_pred cc
Q psy16081 275 QL 276 (493)
Q Consensus 275 ~~ 276 (493)
..
T Consensus 143 ~~ 144 (211)
T PRK14879 143 FS 144 (211)
T ss_pred CC
Confidence 53
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.4e-19 Score=186.88 Aligned_cols=258 Identities=25% Similarity=0.342 Sum_probs=188.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcC-CCeEEEEEEEccCcccchH---HHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLE-EQCHVAIKIIKNKKPFLNQ---AQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~~~~~---~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
..|.+.+.||+|+|+.|-++.... +...+|+|.+......... ...|..+.. ...+|.|++++++.....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~-----~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQK-----KLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccc-----cccccccccccCCccCCCc
Confidence 467888889999999999987643 3456777776543211111 122322222 2223888999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC-cEEEEeccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS-AIKIVDFGS 272 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~-~ikL~DFG~ 272 (493)
..++++++..| ++++-+........+......++.|+..++.|+|. +.++.|+||||+|.++ +.++ .++++|||+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l--~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLL--DESGSALKIADFGL 171 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchh--ccCCCcccCCCchh
Confidence 99999999855 88887743333367888899999999999999996 4789999999999999 6677 899999999
Q ss_pred ccccCC------ccccccc-cCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 273 SCQLGQ------RIYQYIQ-SRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 273 a~~~~~------~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|..+.. .....+| ++.|+|||...+. ......|+||+|+++.-+++|..|+......+.
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~------------- 238 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG------------- 238 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-------------
Confidence 977654 1335678 9999999999985 456789999999999999999999875543221
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.|+..... . ... --.++....+ ...+++.++|..+
T Consensus 239 ----------~~~~~~~~--------~--~~~-----------------------~~~~~~~~~~--~~~~~l~k~l~~~ 273 (601)
T KOG0590|consen 239 ----------RYSSWKSN--------K--GRF-----------------------TQLPWNSISD--QAHDLLHKILKEN 273 (601)
T ss_pred ----------cceeeccc--------c--ccc-----------------------ccCccccCCh--hhhhcccccccCC
Confidence 00000000 0 000 0001111222 5679999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q psy16081 425 PKTRITPYYALQHNFFKR 442 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~~~ 442 (493)
|..|.+.+++-.+||+..
T Consensus 274 ~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 274 PSNRLSIEELKLDNWLSS 291 (601)
T ss_pred chhccccccccccccccc
Confidence 999999999999999998
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=147.73 Aligned_cols=137 Identities=21% Similarity=0.236 Sum_probs=99.1
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc-----------------------hHHHHHHHHHHHHhhcCC
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL-----------------------NQAQIEVKLLEIMNKADV 177 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-----------------------~~~~~e~~~~~~l~~~~~ 177 (493)
|.+.+.||+|+||.||+|.+ .+|+.||||++....... .....|..++..+.....
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 77789999999999999986 479999999876432110 123445555555544321
Q ss_pred CCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 178 NNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 178 ~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
.+...++ ....|+||||++| +|.++... .....++.+|+.++.++|. .||+||||||+||+
T Consensus 96 ----~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~--~gi~H~Dl~p~Nil 157 (198)
T cd05144 96 ----PVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK--HGIIHGDLSEFNIL 157 (198)
T ss_pred ----CCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH--CCCCcCCCCcccEE
Confidence 1333332 2456899999977 66544221 3456788999999999994 79999999999999
Q ss_pred eeCCCCCcEEEEecccccccCC
Q psy16081 257 LCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~~~ 278 (493)
+ ++++.++|+|||.+.....
T Consensus 158 l--~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 V--DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred E--cCCCcEEEEECCccccCCC
Confidence 9 6688999999999966544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.1e-16 Score=144.34 Aligned_cols=129 Identities=22% Similarity=0.212 Sum_probs=94.5
Q ss_pred eEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---------chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---------LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---------~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.||+|+||.||+|. .++..|++|+....... ......|..++..+.+... . +..+ ++...+..
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-~---~p~~--~~~~~~~~ 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGV-N---TPVV--YDVDPDNK 72 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCC-C---CCEE--EEEECCCC
Confidence 48999999999997 46788999986532211 1234457777766665431 2 2222 23345667
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
++||||++| +|.+++.... . .++.+++.+|.+|| ..|++|+|++|.||++ + ++.++++|||++..
T Consensus 73 ~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~--~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLH--KAGIVHGDLTTSNIIV--R-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHH--HCCeecCCCCcceEEE--E-CCcEEEEECCCCcC
Confidence 999999976 8888765421 1 78999999999999 5799999999999999 4 67899999999865
Q ss_pred c
Q psy16081 276 L 276 (493)
Q Consensus 276 ~ 276 (493)
.
T Consensus 139 ~ 139 (199)
T TIGR03724 139 S 139 (199)
T ss_pred C
Confidence 3
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-16 Score=162.64 Aligned_cols=144 Identities=20% Similarity=0.297 Sum_probs=118.7
Q ss_pred CCcceEEEeceeeeecceeEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 178 NNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 178 ~~~~~Iv~l~~~~~~~~~~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
..|.|+.++++.+.+...+++|.+|| .|+|.|.+.... ..+++.-...++++|+.||.|||+...+ .|+.|+..|.+
T Consensus 4 l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~-~hg~l~s~nCl 81 (484)
T KOG1023|consen 4 LDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIG-YHGALKSSNCL 81 (484)
T ss_pred cchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcce-eeeeeccccce
Confidence 34667999999999999999999999 569999998744 4678888888999999999999974333 99999999999
Q ss_pred eeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCC-------CCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 257 LCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIP-------YDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
+ +....+||+|||+....... .....-...|.|||.+.+.. .+.+.||||||++++|+++...||.
T Consensus 82 v--d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 82 V--DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred e--eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 9 78999999999998665321 11112234599999998742 4678999999999999999999998
Q ss_pred C
Q psy16081 325 G 325 (493)
Q Consensus 325 ~ 325 (493)
.
T Consensus 160 ~ 160 (484)
T KOG1023|consen 160 L 160 (484)
T ss_pred c
Confidence 6
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.9e-16 Score=142.91 Aligned_cols=138 Identities=22% Similarity=0.288 Sum_probs=92.3
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHH-------------------------HHHHHHHHHHhhcCCC
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQA-------------------------QIEVKLLEIMNKADVN 178 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~-------------------------~~e~~~~~~l~~~~~~ 178 (493)
.+.||+|+||+||+|.+. +++.||||+++.......+. ..|...+..+.....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~- 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV- 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC-
Confidence 568999999999999876 89999999987532211111 122233333322110
Q ss_pred CcceEEEeceeeeecceeEEEEEeccc-CHH-HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 179 NTYYIVRLKRHFMWRNHLCLVFELLSY-NLY-DLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 179 ~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
.+.+.+.+ ...++||||+++ .+. ..+.... .. ..++.++.+++.++.++|. ..+|+|+||||+||+
T Consensus 80 ---~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~-~~~ivH~Dl~p~Nil 147 (187)
T cd05119 80 ---PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYR-EAGLVHGDLSEYNIL 147 (187)
T ss_pred ---CCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhh-ccCcCcCCCChhhEE
Confidence 12222222 346899999976 221 2222111 11 6678899999999999995 278999999999999
Q ss_pred eeCCCCCcEEEEecccccccCC
Q psy16081 257 LCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~~~ 278 (493)
+ + ++.++|+|||.+.....
T Consensus 148 i--~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 148 V--D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E--E-CCcEEEEECcccccccC
Confidence 9 4 77899999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=162.82 Aligned_cols=136 Identities=21% Similarity=0.210 Sum_probs=97.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---------cchHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
...|...+.||+|+||+||+|..... .+++|+...+.. .......|..++..+. |++|+....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~p~~ 403 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR------RAGVPTPVI 403 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc------ccCCCeeEE
Confidence 34556788999999999999976443 344443221110 0123344555555554 334555555
Q ss_pred eeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 189 HFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
++......++||||++| +|.+++. ....++.+++.+|.+|| +.||+||||||+|||+ .++.++|
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl---~~~~~~l 468 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV---RDDRLYL 468 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE---ECCcEEE
Confidence 66666778999999966 8888774 34678999999999999 5799999999999999 3567999
Q ss_pred Eeccccccc
Q psy16081 268 VDFGSSCQL 276 (493)
Q Consensus 268 ~DFG~a~~~ 276 (493)
+|||+++..
T Consensus 469 iDFGla~~~ 477 (535)
T PRK09605 469 IDFGLGKYS 477 (535)
T ss_pred EeCcccccC
Confidence 999998653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-15 Score=130.93 Aligned_cols=134 Identities=19% Similarity=0.197 Sum_probs=105.0
Q ss_pred EeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 123 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
+++.||.|+++.||++.+. +..++||+...... ......|...++.+.+. ...+.+++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~----~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-GADREREVAILQLLARK----GLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHc----CCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999764 37899999865432 45677888888888765 12366777777777889999999
Q ss_pred ccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 203 LSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE-LNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 203 ~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~-~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+.+ .+..+ +......++.+++.+|..+|... .+++|+||+|+|||+ +..+.++++|||.+.
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~--~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV--DDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE--ECCcEEEEEeccccc
Confidence 976 33322 45666778999999999999632 479999999999999 456889999999985
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.3e-16 Score=157.60 Aligned_cols=255 Identities=25% Similarity=0.268 Sum_probs=190.8
Q ss_pred cCcEEEeeeEee--eCCeEEEEEEE--cCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGK--GSFGQVVKAFD--LEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~--G~fg~V~~~~~--~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
...|.+...+|. |.+|.||.+.. ..++..+|+|.-+... ......-.++-+...+.....|++.++....++..
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCcccccC
Confidence 456778889999 99999999988 8889999999743211 11112222333445567777889999999999999
Q ss_pred ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHhCCCCCccccCCCCCcEEeeCCCC-CcEEEE
Q psy16081 194 NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCT----ALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIV 268 (493)
Q Consensus 194 ~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~~Lhs~~~~iiHrDlKp~NILl~~~~~-~~ikL~ 268 (493)
+.+++-+|+|+++|..+..... .-++....+..+.+... ||..+|+ .+++|-|+||.||++ ..+ ..++++
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~--~~~~~s~~~~ 265 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFT--TSDWTSCKLT 265 (524)
T ss_pred CcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheec--ccccceeecC
Confidence 9999999999999988886554 34788888888888888 9999996 689999999999999 455 789999
Q ss_pred ecccccccCCcc--------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHH
Q psy16081 269 DFGSSCQLGQRI--------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS--NEVDQMNKIVEV 338 (493)
Q Consensus 269 DFG~a~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~--~~~~~~~~i~~~ 338 (493)
|||+...++... ....|...|++||.+.+ -++.+.|++|||.++.+..+|..++... +...++..+.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-- 342 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-- 342 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--
Confidence 999998775432 12256777999999876 6889999999999999999998776543 2221111110
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
.|.+ |++. .+. ++...+.
T Consensus 343 ---ip~e----------~~~~---------------------------------------------~s~----~l~~~~~ 360 (524)
T KOG0601|consen 343 ---IPLE----------FCEG---------------------------------------------GSS----SLRSVTS 360 (524)
T ss_pred ---Cchh----------hhcC---------------------------------------------cch----hhhhHHH
Confidence 0100 0000 000 3445899
Q ss_pred HccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 419 RMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 419 ~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
.|++.||..|++++.++.|+++....
T Consensus 361 ~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 361 QMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred HhcCcchhhhhHHHHHhccccccchh
Confidence 99999999999999999999998543
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.9e-16 Score=164.83 Aligned_cols=262 Identities=24% Similarity=0.241 Sum_probs=194.0
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
-.+.+.+.+-+-+|+|+.++.+.-..+|...++|+............. .+...-+....+.+|.++...-.|.....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~--s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYE--SIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhcccccc--ccCCccCccccCCCCceecccCCCCCCCCc
Confidence 346788888999999999999987788877777766533211111000 011111112235667788777777778899
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+||++|+++ +|...+.... ..+.+..+.+...+..++.+||+ ..++|+|++|.|+|+ ...+..+++|||....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~--~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLI--AYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc--chhhcccccccchhh--cccCCcccCccccccc
Confidence 999999965 8888887654 57888888899999999999995 559999999999999 6889999999984321
Q ss_pred cC----------------------------------CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q psy16081 276 LG----------------------------------QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEP 321 (493)
Q Consensus 276 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 321 (493)
.+ .......||+.|.+||.+.+.....++|+|++|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 10 00123468899999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCC
Q psy16081 322 LFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401 (493)
Q Consensus 322 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 401 (493)
||...........|....-..|.
T Consensus 1034 p~na~tpq~~f~ni~~~~~~~p~--------------------------------------------------------- 1056 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRDIPWPE--------------------------------------------------------- 1056 (1205)
T ss_pred CCCCcchhhhhhccccCCCCCCC---------------------------------------------------------
Confidence 99988776666555432111100
Q ss_pred CCCCCcchhhhHHHHHhHccCCCCCCCCCHH---HHhcCCCCCCCccC
Q psy16081 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPY---YALQHNFFKRTADE 446 (493)
Q Consensus 402 ~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~---e~L~Hp~~~~~~~~ 446 (493)
....-.....+++.++|..+|.+|..+. ++-.|+||+....+
T Consensus 1057 ---g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1057 ---GPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred ---CccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence 0000111568999999999999999998 99999999987654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=7e-14 Score=133.65 Aligned_cols=134 Identities=18% Similarity=0.198 Sum_probs=95.1
Q ss_pred eeEe-eeCCeEEEEEEEcCCCeEEEEEEEccCc--------------ccchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 125 SLIG-KGSFGQVVKAFDLEEQCHVAIKIIKNKK--------------PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 125 ~~LG-~G~fg~V~~~~~~~~~~~vAvK~~~~~~--------------~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
..|| .||.|+||.+.. .+..++||.+.... .......+|..++..+.+...+ ++..+..
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~----vP~pl~~ 110 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLP----VPRPIAA 110 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCC----CceeEee
Confidence 5688 899999999864 47889999885311 1123456677777777665432 3444444
Q ss_pred eeec-c---eeEEEEEeccc--CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC
Q psy16081 190 FMWR-N---HLCLVFELLSY--NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS 263 (493)
Q Consensus 190 ~~~~-~---~~~lV~E~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~ 263 (493)
...+ . ..++|||+++| +|.+++... .+++. .+.||+.+|.+|| ..||+||||||+|||+ +.++
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NILv--~~~~ 179 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNILL--DPDG 179 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEEE--cCCC
Confidence 3322 2 23599999975 788887543 34543 3678999999999 5799999999999999 5567
Q ss_pred cEEEEecccccc
Q psy16081 264 AIKIVDFGSSCQ 275 (493)
Q Consensus 264 ~ikL~DFG~a~~ 275 (493)
.++|+|||.+..
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 899999999854
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.6e-13 Score=129.24 Aligned_cols=140 Identities=19% Similarity=0.235 Sum_probs=107.8
Q ss_pred cceEEEeceeeeecc-----eeEEEEEec-ccCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCC
Q psy16081 180 TYYIVRLKRHFMWRN-----HLCLVFELL-SYNLYDLLRNTN--FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLK 251 (493)
Q Consensus 180 ~~~Iv~l~~~~~~~~-----~~~lV~E~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlK 251 (493)
|-|||+++.+|.+.. ...++.||| .+++..+|++.. ...+.....++|+-||+.||.|||+....|+|+++.
T Consensus 126 HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlT 205 (458)
T KOG1266|consen 126 HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLT 205 (458)
T ss_pred HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcc
Confidence 445999998887654 478899999 568999887532 245788888999999999999999999999999999
Q ss_pred CCcEEeeCCCCCcEEEEeccccccc-------CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q psy16081 252 PENILLCNPKRSAIKIVDFGSSCQL-------GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEP 321 (493)
Q Consensus 252 p~NILl~~~~~~~ikL~DFG~a~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 321 (493)
.+-|++ ..++-||+.--...... ........+-++|.|||.-.....+.++|||+||....+|..|..
T Consensus 206 c~tifi--q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 206 CDTIFI--QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred hhheee--cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 999999 57777776422111100 001122345678999999888788899999999999999998875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.4e-12 Score=133.68 Aligned_cols=142 Identities=20% Similarity=0.222 Sum_probs=91.1
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchH-------------------------------------------
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ------------------------------------------- 161 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~------------------------------------------- 161 (493)
+.||.|++|+||+|+. .+|+.||||+.+..- ...
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i--~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld 199 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGI--EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD 199 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCc--HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence 6799999999999985 578999999986421 111
Q ss_pred HHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHH-HHHHHh
Q psy16081 162 AQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCT-ALLFLS 239 (493)
Q Consensus 162 ~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~-aL~~Lh 239 (493)
+..|...++.+... ..++++|.-..-++...+..+|||||++| +|.++..... .+.. ...++.+++. .+..+|
T Consensus 200 f~~Ea~n~~~~~~~-~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 200 LRREAANASELGEN-FKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHHh-cCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHH
Confidence 11222222333211 11233333222223334557999999977 7777654321 1122 2345555555 356677
Q ss_pred CCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 240 s~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
..|++|+|+||.||++ +.++.++|+|||++..++.
T Consensus 275 --~~g~~H~D~hPgNilv--~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 --RDGFFHADLHPGNIFV--LKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --hCCceeCCCCcccEEE--CCCCcEEEEeCCCeeECCH
Confidence 4799999999999999 6778999999999977754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.7e-13 Score=142.42 Aligned_cols=147 Identities=18% Similarity=0.273 Sum_probs=91.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-----------------------------------cchHH
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-----------------------------------FLNQA 162 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-----------------------------------~~~~~ 162 (493)
...|+. +.||+|++|+||+|+.+.+|+.||||+++..-. +....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445766 789999999999999888899999999974310 00111
Q ss_pred HHHHHH------HHHHhhcCCCCcceEEEeceee-eecceeEEEEEeccc-CHHHH--HhccCC--CCCCHHHHHHHHHH
Q psy16081 163 QIEVKL------LEIMNKADVNNTYYIVRLKRHF-MWRNHLCLVFELLSY-NLYDL--LRNTNF--RGVSLNLTRKFSQQ 230 (493)
Q Consensus 163 ~~e~~~------~~~l~~~~~~~~~~Iv~l~~~~-~~~~~~~lV~E~~~~-~L~~~--l~~~~~--~~l~~~~~~~i~~q 230 (493)
..|..+ +..+... ..+.+ .+.+-..+ ......+|||||+.| .+.+. +...+. ..+.+..+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~-f~~~~-~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRN-FEDSD-MLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHH-ccCCC-CeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 112222 2222211 11111 22222222 224566899999977 77663 332211 12445555566666
Q ss_pred HHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC----cEEEEecccccccCC
Q psy16081 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRS----AIKIVDFGSSCQLGQ 278 (493)
Q Consensus 231 i~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~----~ikL~DFG~a~~~~~ 278 (493)
++. .|++|+|+||.||++. .++ .++++|||++..++.
T Consensus 276 if~---------~GffHaDpHPGNIlv~--~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VFR---------DGFFHADMHPGNIFVS--YDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHh---------CCeeeCCCChHHeEEe--cCCCCCCeEEEEecceEEECCH
Confidence 542 5899999999999994 444 899999999977754
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.9e-13 Score=136.80 Aligned_cols=202 Identities=24% Similarity=0.216 Sum_probs=145.7
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEc-CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDL-EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.....+|..+..||.|.|+.|+.+... .++..|++|.+.+.-. ..+..+..+.+..-.....-|.++++....|...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 345678999999999999999998755 6788999998764332 1222222222222222233455588888888888
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
.+.|+-.|||.+ ++...+. -...+.+...+++..|++.++-++|+ ..++|+|+||+||++.++. +..++.|||.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~-~~~~~~~~~~ 413 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDG-FFSKLGDFGC 413 (524)
T ss_pred ccccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccch-hhhhcccccc
Confidence 888999999965 4333221 11347888999999999999999994 7899999999999996533 7889999999
Q ss_pred ccccCCcccccccc-CcC-CchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy16081 273 SCQLGQRIYQYIQS-RFY-RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLF 323 (493)
Q Consensus 273 a~~~~~~~~~~~gt-~~y-~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf 323 (493)
+..+.-......+. +.| .+++......+..+.|++|||.-+.+.++|.+.-
T Consensus 414 ~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 414 WTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ccccceecccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 87654333333333 334 3555555667889999999999999999998643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-11 Score=111.66 Aligned_cols=129 Identities=17% Similarity=0.107 Sum_probs=90.4
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
++.|+.|.++.||++.. .++.|++|+.............|...++.+..... +.+++... ....++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~-----~P~~~~~~--~~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGI-----GPKLYYFD--PETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCC-----CCceEEEe--CCCCeEEEEec
Confidence 46789999999999975 47889999976543223345778888888765432 22333332 23457999999
Q ss_pred cc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCC---CCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 204 SY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE---LNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 204 ~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~---~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+| ++.+. ......++.+++.+|..||... .+++|+|++|.||+++ ++.++++|||.+.
T Consensus 74 ~G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~---~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD---DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE---CCeEEEEeccccc
Confidence 87 44322 0112345789999999999632 1259999999999993 4579999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.8e-11 Score=110.23 Aligned_cols=138 Identities=22% Similarity=0.226 Sum_probs=96.7
Q ss_pred eeEeeeCCeEEEEEEEcC------CCeEEEEEEEccCc--------------cc---------c----hHHHHHHHHHHH
Q psy16081 125 SLIGKGSFGQVVKAFDLE------EQCHVAIKIIKNKK--------------PF---------L----NQAQIEVKLLEI 171 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~------~~~~vAvK~~~~~~--------------~~---------~----~~~~~e~~~~~~ 171 (493)
..||.|--+.||.|.... .+..+|||+.+... .+ . ...+.|...+..
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999997553 35789999875210 00 1 122367888888
Q ss_pred HhhcCCCCcceEEEeceeeeecceeEEEEEeccc-CHH-HHHhccCCCCCCHHHHHHHHHHHHHHHHHH-hCCCCCcccc
Q psy16081 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLY-DLLRNTNFRGVSLNLTRKFSQQLCTALLFL-STPELNIIHC 248 (493)
Q Consensus 172 l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L-hs~~~~iiHr 248 (493)
+.....+ -|.++ .+ ..-+|||||+++ ++. ..++.. .++......+..+++.+|..+ | +.||||+
T Consensus 83 l~~~Gv~-vP~pi---~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H--~~glVHG 149 (197)
T cd05146 83 MQKAGIP-CPEVV---VL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYK--ECNLVHA 149 (197)
T ss_pred HHHcCCC-CCeEE---Ee----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHH--hCCeecC
Confidence 8776533 23233 22 456899999976 332 223322 245566777889999999988 7 5799999
Q ss_pred CCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 249 DLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 249 DlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
||++.|||+. ++.+.|+|||.+.....
T Consensus 150 DLs~~NIL~~---~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH---DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE---CCcEEEEECCCceeCCC
Confidence 9999999993 46799999999876643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.1e-10 Score=118.13 Aligned_cols=167 Identities=16% Similarity=0.200 Sum_probs=121.5
Q ss_pred EEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecccCHHHHHhccCC
Q psy16081 137 KAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF 216 (493)
Q Consensus 137 ~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~ 216 (493)
.|..+.++..|.|.+.+.... ...-...+.+.++....||+|+++++.++..+.+|||+|-+.. |...+.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~--- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE--- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc-HHHHHHH---
Confidence 355677889999998875543 1122233444555666789999999999999999999999843 2233332
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCcc---ccccccCcCCchh
Q psy16081 217 RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSRFYRSPE 293 (493)
Q Consensus 217 ~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~---~~~~gt~~y~aPE 293 (493)
++.......+.||+.||.|||. +.+++|++|.-+.|++ +..|..||++|.+++...... ....---.|..|+
T Consensus 101 --l~~~~v~~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfV--n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 101 --LGKEEVCLGLFQILAALSFLND-DCNLVHGNVCKDSVFV--NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred --hHHHHHHHHHHHHHHHHHHHhc-cCCeeeccEeeeeEEE--cCCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 2245566678999999999986 6899999999999999 789999999999986543222 1111112366676
Q ss_pred hhcCCCCCchhhHHHHHHHHHHHHhC
Q psy16081 294 VLLGIPYDLAIDMWSLGCILVEMHTG 319 (493)
Q Consensus 294 ~~~~~~~~~~~DvwSlGvil~elltG 319 (493)
.+.... -..|.|-|||++++++.|
T Consensus 176 ~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCccc--cchhhhhHHHHHHHHhCc
Confidence 554322 467999999999999999
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-09 Score=96.05 Aligned_cols=142 Identities=21% Similarity=0.176 Sum_probs=101.8
Q ss_pred EeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc---c------cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---P------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 123 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+..|-+|+-+.|+++. ..|+.+.||.-..+. + .......|.+++..+.... |.-..-+|.+.
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~G------I~~P~l~~~D~ 82 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALG------IPAPRLIFIDT 82 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhC------CCCceEEEEec
Confidence 56789999999999994 567888888533221 1 1233455777776666554 32233355666
Q ss_pred ceeEEEEEeccc--CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC-CcEEEEec
Q psy16081 194 NHLCLVFELLSY--NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDF 270 (493)
Q Consensus 194 ~~~~lV~E~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~-~~ikL~DF 270 (493)
..-+|+|||++| ++.+++...............+++.|-..+.-||. .+|||+||..+||++..+.+ -.+.++||
T Consensus 83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEEEee
Confidence 777899999988 88888876554444444557899999999999995 68999999999999964322 23489999
Q ss_pred cccc
Q psy16081 271 GSSC 274 (493)
Q Consensus 271 G~a~ 274 (493)
|++.
T Consensus 161 gls~ 164 (229)
T KOG3087|consen 161 GLSS 164 (229)
T ss_pred cchh
Confidence 9984
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-09 Score=101.89 Aligned_cols=142 Identities=13% Similarity=0.113 Sum_probs=97.5
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec---ceeEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR---NHLCLV 199 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~---~~~~lV 199 (493)
+.|+.|..+.||++... +|+.+++|+...... .......|..+++.+..... . +.+++.+.... +..++|
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~-~---vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGV-P---VPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCC-C---CCCEEEECCCCCccCCceEE
Confidence 57899999999999753 368899998765432 34567888888888776422 2 33344444332 356899
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP------------------------------------- 241 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~------------------------------------- 241 (493)
|||++| ++.+.+.. ..+++.....++.+++.+|..||.-
T Consensus 79 ~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 79 MERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999977 55443321 2356666666777777777777641
Q ss_pred -----------------CCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 242 -----------------ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 242 -----------------~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
...+||+|+.|.|||++++..+.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999943215668999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6e-09 Score=92.93 Aligned_cols=128 Identities=20% Similarity=0.162 Sum_probs=88.6
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---------cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
..+++|+-+.+|.+.. -|..+++|.=..+.- -.....+|.+++..+.....+ .| .-++.+.+.
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~-~P-----~v~dvD~~~ 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVP-VP-----IVYDVDPDN 73 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCC-CC-----eEEEEcCCC
Confidence 4678999999999854 344466664332211 122345577777777766532 22 223445677
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
..|+|||++| .|.+.+... ...++..+-..+.-|| ..||||+||.++||++. ++.+.++|||++.
T Consensus 74 ~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~---~~~i~~IDfGLg~ 139 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILS---GGRIYFIDFGLGE 139 (204)
T ss_pred CEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEe---CCcEEEEECCccc
Confidence 7899999988 666677654 1346777777788899 57999999999999993 3449999999985
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-08 Score=98.21 Aligned_cols=133 Identities=13% Similarity=0.038 Sum_probs=94.0
Q ss_pred EEEEEEEcCCCeEEEEEEEccCc------------ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-----ccee
Q psy16081 134 QVVKAFDLEEQCHVAIKIIKNKK------------PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-----RNHL 196 (493)
Q Consensus 134 ~V~~~~~~~~~~~vAvK~~~~~~------------~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-----~~~~ 196 (493)
.|+++. -.|+.|.||...... .....+.+|...+..+.....+. ..++.+.+. ...-
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIpt----P~pVa~~e~~~~~~~~~s 110 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDT----MTGVAFGERGSNPATRTS 110 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCC----CCeeEEEEecCCCcccee
Confidence 355552 356788888664322 01114778888888888776543 233333332 2356
Q ss_pred EEEEEeccc--CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-----CCCCcEEEEe
Q psy16081 197 CLVFELLSY--NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-----PKRSAIKIVD 269 (493)
Q Consensus 197 ~lV~E~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-----~~~~~ikL~D 269 (493)
+||+|++++ +|.+++........+......++.+++..+.-|| ..||+|+|+++.|||+.. ++...+.|+|
T Consensus 111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 899999977 6888876432234567788899999999999999 579999999999999953 2356799999
Q ss_pred ccccc
Q psy16081 270 FGSSC 274 (493)
Q Consensus 270 FG~a~ 274 (493)
|+.+.
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99885
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.9e-10 Score=116.47 Aligned_cols=155 Identities=19% Similarity=0.306 Sum_probs=110.6
Q ss_pred HHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCcc------cc------ccccCcCCchhhh
Q psy16081 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI------YQ------YIQSRFYRSPEVL 295 (493)
Q Consensus 228 ~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~------~~------~~gt~~y~aPE~~ 295 (493)
+.+...||.|+|. ..++||++|.|++|.+ +..+.+||+.|+++....... +. ......|.|||++
T Consensus 105 l~~v~dgl~flh~-sAk~VH~ni~p~~i~~--na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHR-SAKVVHGNIQPEAIVV--NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhcc-Ccceeecccchhheee--ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 4455589999998 4799999999999999 789999999999985543311 11 1123459999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCC
Q psy16081 296 LGIPYDLAIDMWSLGCILVEMH-TGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGR 374 (493)
Q Consensus 296 ~~~~~~~~~DvwSlGvil~ell-tG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (493)
.+...+.++|++||||++|-+. .|+..|.+.........-...++.. .+.
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~---------------------~~~-------- 232 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG---------------------AFG-------- 232 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc---------------------ccc--------
Confidence 9988899999999999999998 6676665543322221111110000 000
Q ss_pred CCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 375 KPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 375 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
. +-+-..++++=|.++|..|+..||++.+++..|||+...
T Consensus 233 ---------------~---------------s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 233 ---------------Y---------------SNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred ---------------c---------------cccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 0 000111788999999999999999999999999998643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.8e-08 Score=92.28 Aligned_cols=128 Identities=23% Similarity=0.325 Sum_probs=74.5
Q ss_pred EEEEEEEcCCCeEEEEEEEccCc--------------c-------------cchHHHHHHHHHHHHhhcCCCCcceEEEe
Q psy16081 134 QVVKAFDLEEQCHVAIKIIKNKK--------------P-------------FLNQAQIEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 134 ~V~~~~~~~~~~~vAvK~~~~~~--------------~-------------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
.||.|.. .+|..+|||+.+... . .....+.|.+.|..+..... + +.++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv-~---vP~p 75 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGV-P---VPKP 75 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT--S---S--E
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCc-c---CCcE
Confidence 3899975 567899999875311 0 01223456666666655432 1 3333
Q ss_pred ceeeeecceeEEEEEecc--cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HhCCCCCccccCCCCCcEEeeCCCCC
Q psy16081 187 KRHFMWRNHLCLVFELLS--YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF-LSTPELNIIHCDLKPENILLCNPKRS 263 (493)
Q Consensus 187 ~~~~~~~~~~~lV~E~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~-Lhs~~~~iiHrDlKp~NILl~~~~~~ 263 (493)
+.+ ..-+|||||++ |.....+.... ++......++.+++..+.. +| ..||||+||.+.|||+. ++
T Consensus 76 ~~~----~~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~--~~- 143 (188)
T PF01163_consen 76 YDY----NRNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVD--DG- 143 (188)
T ss_dssp EEE----ETTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEE--TT-
T ss_pred EEE----eCCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEee--cc-
Confidence 322 23479999998 63333333321 2244566677788875555 46 57999999999999994 33
Q ss_pred cEEEEecccccccCC
Q psy16081 264 AIKIVDFGSSCQLGQ 278 (493)
Q Consensus 264 ~ikL~DFG~a~~~~~ 278 (493)
.+.|+|||.+.....
T Consensus 144 ~~~iIDf~qav~~~~ 158 (188)
T PF01163_consen 144 KVYIIDFGQAVDSSH 158 (188)
T ss_dssp CEEE--GTTEEETTS
T ss_pred eEEEEecCcceecCC
Confidence 799999999866543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.7e-07 Score=92.85 Aligned_cols=166 Identities=20% Similarity=0.209 Sum_probs=120.1
Q ss_pred CeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee----cceeEEEEEeccc-
Q psy16081 132 FGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW----RNHLCLVFELLSY- 205 (493)
Q Consensus 132 fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~----~~~~~lV~E~~~~- 205 (493)
-.+.|+|....+|..|++|++...+. ........++.++.+ .|.|||.+.++|.. +..+++|++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl------~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL------CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh------ccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 35789999999999999999943221 111222233334433 35569999999873 4578999999965
Q ss_pred -CHHHHHhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 206 -NLYDLLRNT-------------NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 206 -~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
+|+++.-.. ...+.++..+|.++.||..||.++|+ .|+..+-|.|.+||+ +.+..|+|...|
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv--~G~~RIriS~C~ 438 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILV--TGKMRIRISGCG 438 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEe--eCcceEEEeccc
Confidence 788865321 12346889999999999999999995 688889999999999 566688998888
Q ss_pred cccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q psy16081 272 SSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEP 321 (493)
Q Consensus 272 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 321 (493)
....+..... |-+.+ -.+-|.=.||.+++.|.||..
T Consensus 439 i~Dvl~~d~~-----------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 439 IMDVLQEDPT-----------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ceeeecCCCC-----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 7655433321 11111 246788899999999999964
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=9.3e-07 Score=87.86 Aligned_cols=189 Identities=13% Similarity=0.167 Sum_probs=126.6
Q ss_pred EeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee-------e-cc
Q psy16081 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM-------W-RN 194 (493)
Q Consensus 123 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~-------~-~~ 194 (493)
..+.||+|+-+.+|-.- .-...+.|+...-........ +++| .+.+.||- +.+.-.|- + ..
T Consensus 15 ~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa~~aqk-----~a~l--a~~p~~p~-~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 15 PGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPAAQAQK-----VAEL--AATPDAPL-LNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCccccCCccceeeecc---hhhchhheeecCCCchHHHHH-----HHHh--ccCCCCcc-hhhhhcccHHHhhCCCccc
Confidence 45789999999999752 222344577764332222211 1222 23344442 22211111 1 12
Q ss_pred eeEEEEEeccc--CHHHHHh----ccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 195 HLCLVFELLSY--NLYDLLR----NTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 195 ~~~lV~E~~~~--~L~~~l~----~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
..-+.|..+.| ....++. +..+....|+-..+.++.|+.+.+-||. .|.+-+|+.++|+|+ .+.+.+.|.
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lV--sd~~~V~LV 159 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLV--SDDSKVVLV 159 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceee--ecCceEEEE
Confidence 36788888865 4555543 3334457899999999999999999995 689999999999999 567788888
Q ss_pred ecccccccCC--ccccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q psy16081 269 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTG-EPLFSGS 326 (493)
Q Consensus 269 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG-~~pf~~~ 326 (493)
|-..-....+ .....+|...|.+||... +..-+...|.|.|||+++++|.| +.||+|-
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 7654332222 223457888999999876 34456789999999999999987 9999874
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.9e-06 Score=79.62 Aligned_cols=142 Identities=13% Similarity=0.062 Sum_probs=102.8
Q ss_pred eeeCCeEEEEEEEcCCCeEEEEEEEccC-------cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--cceeEE
Q psy16081 128 GKGSFGQVVKAFDLEEQCHVAIKIIKNK-------KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW--RNHLCL 198 (493)
Q Consensus 128 G~G~fg~V~~~~~~~~~~~vAvK~~~~~-------~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~--~~~~~l 198 (493)
|+||-+.|+... ..|+.+-+|.-.+. +-....+..|...+..+.....+ -|-++ ..+.-.. .-.-+|
T Consensus 27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEEE
Confidence 678999999874 33446888865411 22356788899999999988766 33333 1111111 124689
Q ss_pred EEEeccc--CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 199 VFELLSY--NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 199 V~E~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+|-+++ +|.+++........+......++.+++..+.-|| ..|+.|+|+-+.|||+..++...++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9999975 8988887655455678888999999999999999 5799999999999999433333499999987643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.2e-06 Score=81.80 Aligned_cols=109 Identities=22% Similarity=0.229 Sum_probs=81.3
Q ss_pred chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec----ceeEEEEEeccc--CHHHHHhccCCCCCCHHHHHHHHHHHH
Q psy16081 159 LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR----NHLCLVFELLSY--NLYDLLRNTNFRGVSLNLTRKFSQQLC 232 (493)
Q Consensus 159 ~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~----~~~~lV~E~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~ 232 (493)
......|...+..+.....+- .+.+.+.... ...+||+|++++ +|.+++.... ..+......++.+++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~t----P~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPT----PEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALA 128 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCC----CcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHH
Confidence 356778888888888766542 3333333332 245899999976 6888887643 266777889999999
Q ss_pred HHHHHHhCCCCCccccCCCCCcEEeeCCC-CCcEEEEecccccc
Q psy16081 233 TALLFLSTPELNIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQ 275 (493)
Q Consensus 233 ~aL~~Lhs~~~~iiHrDlKp~NILl~~~~-~~~ikL~DFG~a~~ 275 (493)
..+.-|| ..||+|+|+++.|||+..++ ...+.|+||+.+..
T Consensus 129 ~~i~~lH--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 129 RLIAKLH--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHH--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 58999999999999995332 23799999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=6.2e-07 Score=84.85 Aligned_cols=136 Identities=21% Similarity=0.245 Sum_probs=88.6
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-----------------c------cchHHHHHHHHHHHHhhcCC
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-----------------P------FLNQAQIEVKLLEIMNKADV 177 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-----------------~------~~~~~~~e~~~~~~l~~~~~ 177 (493)
+.+..+||-|--+.||.|.+. .|.++|||.=+... . ....+++|.+.|..+.....
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 446789999999999999854 78999999643110 0 12245667777777765411
Q ss_pred CCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 178 NNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 178 ~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
. |.+.+ +.+..++|||+++| .|...-. +......++..|+.-+.-.. ..||||+|+.+-|||
T Consensus 172 ~----VP~P~----~~nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~--~~GiVHGDlSefNIl 234 (304)
T COG0478 172 K----VPKPI----AWNRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAY--RRGIVHGDLSEFNIL 234 (304)
T ss_pred C----CCCcc----ccccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHH--HcCccccCCchheEE
Confidence 1 22222 23567899999988 4443321 22333334444444444333 378999999999999
Q ss_pred eeCCCCCcEEEEeccccccc
Q psy16081 257 LCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~ 276 (493)
+ +++|.+.++||=-+...
T Consensus 235 V--~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 235 V--TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred E--ecCCCEEEEeCcccccC
Confidence 9 67888999999765443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=8.7e-07 Score=93.06 Aligned_cols=146 Identities=19% Similarity=0.222 Sum_probs=89.1
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-----------------------------------cch------HHH
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-----------------------------------FLN------QAQ 163 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-----------------------------------~~~------~~~ 163 (493)
..|+.++-|+||+|+. .+|+.||||+.+..-. +.. .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6799999999999985 4599999999753210 000 112
Q ss_pred HHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCC
Q psy16081 164 IEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE 242 (493)
Q Consensus 164 ~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~ 242 (493)
.|..-++.+... ..+.+.|.--.-+++..+.-.|+|||++| .+.+...-.. .+++...+.....++.----+.
T Consensus 210 ~EA~n~~~~~~n-f~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~---- 283 (517)
T COG0661 210 REAANAERFREN-FKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLR---- 283 (517)
T ss_pred HHHHHHHHHHHH-cCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHh----
Confidence 233333333322 22344444333444456677899999988 6666532221 2344333222222211111121
Q ss_pred CCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc
Q psy16081 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279 (493)
Q Consensus 243 ~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~ 279 (493)
-|+.|+|..|.||++ +.+|.+.+.|||+...++..
T Consensus 284 dgffHaDpHpGNi~v--~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 DGFFHADPHPGNILV--RSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cCccccCCCccceEE--ecCCcEEEEcCcceecCCHH
Confidence 379999999999999 67799999999998777543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.38 E-value=8.6e-06 Score=76.90 Aligned_cols=146 Identities=19% Similarity=0.214 Sum_probs=81.1
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
++.|+.|..+.||++.... ..+++|+.... ........|..+++.+..... ..|-++............+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~-pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGI-PVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTS-BS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCC-CCceEEeecccccccccceEEEEEe
Confidence 4689999999999997544 58999997644 344667788888888886654 2233332221222334579999999
Q ss_pred cc-CHHH----------------HHh---cc--CCCCCCHHH------HHHH---------------HHHHHH-HHHHH-
Q psy16081 204 SY-NLYD----------------LLR---NT--NFRGVSLNL------TRKF---------------SQQLCT-ALLFL- 238 (493)
Q Consensus 204 ~~-~L~~----------------~l~---~~--~~~~l~~~~------~~~i---------------~~qi~~-aL~~L- 238 (493)
+| .+.. .+. .. ....+.... ...+ ...+.. .+..+
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 77 5554 111 11 111111100 0000 011111 22222
Q ss_pred ---h-CCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 239 ---S-TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 239 ---h-s~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+ .....++|+|+.|.|||++ ++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~-~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVD-PSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEE-SSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceee-eccceeEEEecccce
Confidence 2 1246799999999999995 256666899998874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.7e-06 Score=78.17 Aligned_cols=138 Identities=20% Similarity=0.204 Sum_probs=89.1
Q ss_pred eEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc-------------------------hHHHHHHHHHHHHhhcCCCCc
Q psy16081 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL-------------------------NQAQIEVKLLEIMNKADVNNT 180 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-------------------------~~~~~e~~~~~~l~~~~~~~~ 180 (493)
.|..|--+.||+|. ..++..||||+++...... .....|..-|..+......
T Consensus 55 ~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr-- 131 (268)
T COG1718 55 CISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR-- 131 (268)
T ss_pred eecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC--
Confidence 66777788999996 3678999999986422110 1122344444444443321
Q ss_pred ceEEEeceeeeecceeEEEEEecccCH--HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee
Q psy16081 181 YYIVRLKRHFMWRNHLCLVFELLSYNL--YDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258 (493)
Q Consensus 181 ~~Iv~l~~~~~~~~~~~lV~E~~~~~L--~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~ 258 (493)
+.+-+.++ .-.|||||++... .-.|+.- ++....+..+..+++..+.-|.. ..++||+||..-|||+
T Consensus 132 --vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~-~a~LVHgDLSEyNiL~- 200 (268)
T COG1718 132 --VPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK-EAGLVHGDLSEYNILV- 200 (268)
T ss_pred --CCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH-hcCcccccchhhheEE-
Confidence 22222222 3479999997541 1112211 23344678888899998888874 4799999999999999
Q ss_pred CCCCCcEEEEecccccccCCc
Q psy16081 259 NPKRSAIKIVDFGSSCQLGQR 279 (493)
Q Consensus 259 ~~~~~~ikL~DFG~a~~~~~~ 279 (493)
. .+.+.|||||-|.....+
T Consensus 201 -~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 201 -H-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred -E-CCeEEEEECccccccCCC
Confidence 3 677999999998766543
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.6e-08 Score=103.23 Aligned_cols=187 Identities=19% Similarity=0.122 Sum_probs=133.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcce-EEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYY-IVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~-Iv~l~~~~~~~~~~ 196 (493)
+..|...+-+++|++++++|.+...+...+ .+.+... .....++++|.. .+ ||| .+..++.++.+++.
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK---~n---~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDK---VN---NPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHH---cc---CCCCcccccccCCccccc
Confidence 345666678999999999999877666555 7766422 223334444433 33 344 67777777788899
Q ss_pred EEEEEecccC--HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 197 CLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 197 ~lV~E~~~~~--L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.++++++++. ......... -.+.+-....+.+.-..+|+++|+ ..=+|+| ||+. .++..|..||+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~--~~~~~~d----~~l~---s~~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHS--SYKVHRD----NILG---SEEEVKLLDFAVPP 379 (829)
T ss_pred chhhhhhcCCccccccCChhh-Hhhhhhhhhhhhhhhccccccccc--ccccCcc----cccc---cccccccccccCCc
Confidence 9999999643 322221111 113344455667777788999995 2248888 8888 34668999999998
Q ss_pred ccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 275 QLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 275 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
.+... .....+++.|+|||+..+..+....|.||+|+-..++.-|-+|-..
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 88765 5677899999999999999999999999999987788888877654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.1e-05 Score=74.86 Aligned_cols=141 Identities=15% Similarity=0.197 Sum_probs=89.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch----------HHHHHHHHHHHHhhc--CCCCcceEEE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN----------QAQIEVKLLEIMNKA--DVNNTYYIVR 185 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~----------~~~~e~~~~~~l~~~--~~~~~~~Iv~ 185 (493)
.++|.+.+++-......|.+. .-+|+.+++|..+....-.+ ...++......+... .....++++.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 467899999988888888877 45678999998764321111 112222222333221 1222333444
Q ss_pred eceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc
Q psy16081 186 LKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 186 l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ 264 (493)
..-.+......+|||||++| .|.+... +.+ .+...|..++.-+| +.|+.|+|..|.|+++. ++.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH--~~G~~HGD~hpgNFlv~---~~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH--KHGFYHGDPHPGNFLVS---NNG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH--HcCCccCCCCcCcEEEE---CCc
Confidence 44444444566799999988 6655421 222 24456677788999 57999999999999994 344
Q ss_pred EEEEecccccc
Q psy16081 265 IKIVDFGSSCQ 275 (493)
Q Consensus 265 ikL~DFG~a~~ 275 (493)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.8e-05 Score=74.97 Aligned_cols=72 Identities=13% Similarity=0.053 Sum_probs=51.2
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
..||+|..+.||+. .+..+++|+..... .......|.+++..+.....+ +.+.+.+....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glp----vP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIP----TPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCC----CCceEEEEecCCeeeeeeeecC
Confidence 57899999999984 24467889876432 334567888888888755432 3444555556667889999997
Q ss_pred c
Q psy16081 205 Y 205 (493)
Q Consensus 205 ~ 205 (493)
|
T Consensus 78 G 78 (226)
T TIGR02172 78 G 78 (226)
T ss_pred C
Confidence 7
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.3e-05 Score=83.99 Aligned_cols=145 Identities=18% Similarity=0.210 Sum_probs=86.3
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc------------------------------------------cchHH
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP------------------------------------------FLNQA 162 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------------------------------------------~~~~~ 162 (493)
+.||.-+.|+|++|+.+. |+.||||+-+..-. +..++
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999998554 99999998653210 11111
Q ss_pred HHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-CH--HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh
Q psy16081 163 QIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NL--YDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239 (493)
Q Consensus 163 ~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L--~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lh 239 (493)
++-.++.+.+.+.+...--.|.+++ +.....-.|+||||+| -+ .+.+.+. +++...+..-+.+...-.-+.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~~qIf~- 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYLEQIFK- 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHHHHHHh-
Confidence 2222222222222211111123332 2234567899999976 33 3455544 355554444333333222222
Q ss_pred CCCCCccccCCCCCcEEeeCC--CCCcEEEEecccccccCCc
Q psy16081 240 TPELNIIHCDLKPENILLCNP--KRSAIKIVDFGSSCQLGQR 279 (493)
Q Consensus 240 s~~~~iiHrDlKp~NILl~~~--~~~~ikL~DFG~a~~~~~~ 279 (493)
.|++|+|=.|.||++..+ .++.+.+-|||+...+...
T Consensus 320 ---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 ---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 479999999999999632 4678999999998776554
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=7.3e-05 Score=69.08 Aligned_cols=133 Identities=20% Similarity=0.279 Sum_probs=92.4
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-----------------ccchHHHHHHHHHHHHhhcCCCCcceEEEec
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-----------------PFLNQAQIEVKLLEIMNKADVNNTYYIVRLK 187 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-----------------~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~ 187 (493)
..||+|+.-.||.- ......+||++.... ....+..+|......+.......+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57999999999874 445567899887544 2245666677666666633334455699999
Q ss_pred eeeeecceeEEEEEecc---c----CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC
Q psy16081 188 RHFMWRNHLCLVFELLS---Y----NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP 260 (493)
Q Consensus 188 ~~~~~~~~~~lV~E~~~---~----~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~ 260 (493)
++.+++..+-+|+|.+. | +|.+++.+. .++. .....+.++ ..||- +.+|+.+||+|.||++...
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~--~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLL--DHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHH--HcCCeecCCCcccEEEEec
Confidence 99999999999999972 2 578888554 3555 444444444 44444 3469999999999999755
Q ss_pred CCCc--EEEEe
Q psy16081 261 KRSA--IKIVD 269 (493)
Q Consensus 261 ~~~~--ikL~D 269 (493)
.++. +.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 5444 77777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.7e-05 Score=72.37 Aligned_cols=74 Identities=9% Similarity=-0.037 Sum_probs=49.4
Q ss_pred eEeeeCC-eEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 126 LIGKGSF-GQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 126 ~LG~G~f-g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
.|-.|.. ..||++.. .+..+.||+..... ......|..++..+... .. +.+++.+....+..++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~--~~---vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP--TYELEREAERLRWLAGK--LP---VPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc--ccchHHHHHHHHHHHhc--CC---CCeEEEEEecCCccEEEEEeeC
Confidence 3445555 78999853 34678889876432 34567788888888754 22 4556666665567899999997
Q ss_pred c-CHH
Q psy16081 205 Y-NLY 208 (493)
Q Consensus 205 ~-~L~ 208 (493)
| .+.
T Consensus 76 G~~l~ 80 (244)
T cd05150 76 GVPAA 80 (244)
T ss_pred CccHh
Confidence 7 444
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00012 Score=69.88 Aligned_cols=75 Identities=8% Similarity=-0.041 Sum_probs=42.8
Q ss_pred eeEeeeCCe-EEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 125 SLIGKGSFG-QVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 125 ~~LG~G~fg-~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
+.|+.|+.. .||+. +..+++|+... .........|.+++..+........|-++..-..-......++||+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567877776 48986 23477787653 223457788888888886431122332332111111112458899998
Q ss_pred cc
Q psy16081 204 SY 205 (493)
Q Consensus 204 ~~ 205 (493)
+|
T Consensus 77 ~G 78 (235)
T cd05155 77 EG 78 (235)
T ss_pred cC
Confidence 76
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0003 Score=79.37 Aligned_cols=80 Identities=10% Similarity=-0.014 Sum_probs=51.3
Q ss_pred eeeEeeeCCeEEEEEEEcCCC--eEEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec---cee
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQ--CHVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR---NHL 196 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~--~~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~---~~~ 196 (493)
++.|+.|.+..+|+......+ ..+++|+..... .......+|..+++.+....... +.+++.++.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vp---VP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVP---VPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCC---CCcEEEEecCCCcCCCc
Confidence 577899999999998654432 467777654322 12245778888888886322222 44555555443 467
Q ss_pred EEEEEecccC
Q psy16081 197 CLVFELLSYN 206 (493)
Q Consensus 197 ~lV~E~~~~~ 206 (493)
|+||||++|.
T Consensus 120 flVME~v~G~ 129 (822)
T PLN02876 120 FYIMEYLEGR 129 (822)
T ss_pred eEEEEecCCc
Confidence 8999999773
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00015 Score=64.58 Aligned_cols=131 Identities=21% Similarity=0.219 Sum_probs=84.7
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
-.+.+.||+|++|.||+|.+ .|..+|+|+-+ ........+.|.++++++.-.... -+++.+ +.-.+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~-----p~vy~y----g~~~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVT-----PEVYFY----GEDFIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCC-----ceEEEe----chhhhhh
Confidence 34567899999999999964 56789999876 344557788899999988866532 122222 2234559
Q ss_pred Eeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCC-CCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 201 ELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDL-KPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 201 E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDl-Kp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
||+.| .|.++.... + ++-...++..---|- ..||-|..| .|..++|. .++.+.|+||..|...
T Consensus 92 e~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD--~~GI~H~El~~~~k~vlv--~~~~~~iIDFd~At~k 156 (201)
T COG2112 92 EYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLD--RLGIEHGELSRPWKNVLV--NDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHH--HhccchhhhcCCceeEEe--cCCcEEEEEccchhhc
Confidence 99988 777665321 1 222333334322233 478999888 45555553 3347999999998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00038 Score=63.99 Aligned_cols=129 Identities=22% Similarity=0.316 Sum_probs=87.2
Q ss_pred CcEEEeeeEeeeCC-eEEEEEEEcCCCeEEEEEEEcc---Cc-------------------ccchHHHHHHHHHHHHhhc
Q psy16081 119 DRYEIDSLIGKGSF-GQVVKAFDLEEQCHVAIKIIKN---KK-------------------PFLNQAQIEVKLLEIMNKA 175 (493)
Q Consensus 119 ~~y~~~~~LG~G~f-g~V~~~~~~~~~~~vAvK~~~~---~~-------------------~~~~~~~~e~~~~~~l~~~ 175 (493)
.+++.++.||.|.- |.||++. -+|+.||+|+++. .. .....+..|.+....+...
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57999999999999 9999995 5678999999431 00 1123445566666666665
Q ss_pred CCCCcceEEEeceeeeec------------------ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q psy16081 176 DVNNTYYIVRLKRHFMWR------------------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237 (493)
Q Consensus 176 ~~~~~~~Iv~l~~~~~~~------------------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~ 237 (493)
...+. .-|+.+++..-. ....||.||+...- .+.. .-+.+|..-+..
T Consensus 115 ~~e~~-~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGL-WAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred cccCc-eEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHH
Confidence 54331 137877776322 12357778774421 1222 235567777888
Q ss_pred HhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 238 Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
+| ..||+-+|+++.|..= | ||+|||.+
T Consensus 180 ~~--k~gI~~~Dv~~~ny~~-----G--~lvDfs~~ 206 (207)
T PF13095_consen 180 LH--KLGIVPRDVKPRNYRG-----G--KLVDFSSS 206 (207)
T ss_pred HH--HCCeeeccCccccccC-----C--EEEecccC
Confidence 89 6899999999999763 2 89999975
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00067 Score=64.48 Aligned_cols=73 Identities=21% Similarity=0.322 Sum_probs=46.6
Q ss_pred eeeEeeeCCeEEEEEEEcC-CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEe
Q psy16081 124 DSLIGKGSFGQVVKAFDLE-EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~ 202 (493)
++.|..|-...||++.... .++.|++|+.............|..++..+..... .| +++..+. + .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl--~P---~v~~~~~--~--~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGL--AP---KLYATFQ--N--GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCC--CC---eEEEEeC--C--cEEEEe
Confidence 4577888888999986432 35789999876443333344578888888776543 22 3333322 2 379999
Q ss_pred ccc
Q psy16081 203 LSY 205 (493)
Q Consensus 203 ~~~ 205 (493)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0014 Score=65.37 Aligned_cols=76 Identities=8% Similarity=-0.024 Sum_probs=46.9
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEec-e--eeeecceeEEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLK-R--HFMWRNHLCLVFE 201 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~-~--~~~~~~~~~lV~E 201 (493)
+.|+.|...++|+... .+ ..+++|++. . ........+..+++.+.....+ .|-++.-. + +....+..++++|
T Consensus 28 ~~l~~G~~n~~y~v~t-~~-g~~vLK~~~-~-~~~~~l~~~~~~l~~L~~~glp-vP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTT-TQ-GEYVLTLFE-R-LTAEDLPFFLGLMQHLAARGVP-VPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEe-CC-CcEEEEEec-c-CChHHhHHHHHHHHHHHHCCCC-CCcceeCCCCCEeeeeCCEEEEEEE
Confidence 4577788889999853 23 368899875 2 2234555677777777655443 33344321 1 1123566789999
Q ss_pred eccc
Q psy16081 202 LLSY 205 (493)
Q Consensus 202 ~~~~ 205 (493)
|++|
T Consensus 103 ~l~G 106 (319)
T PRK05231 103 FLEG 106 (319)
T ss_pred ecCC
Confidence 9976
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.001 Score=74.39 Aligned_cols=189 Identities=23% Similarity=0.278 Sum_probs=121.1
Q ss_pred CcceEEEeceeeeecce----eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 179 NTYYIVRLKRHFMWRNH----LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 179 ~~~~Iv~l~~~~~~~~~----~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
.|+|++.++.+-..+.. +.+..|+|.+ ++...+.... ..+....+.+..+++.||.|+|++ ...|.-|..+
T Consensus 240 ~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~--~l~~v~L~~s 315 (1351)
T KOG1035|consen 240 AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL--SLEHVVLSAS 315 (1351)
T ss_pred ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh--ccceeEEecc
Confidence 34556666555443322 2334567755 7777776554 578899999999999999999974 2333322222
Q ss_pred ---cEEeeCCCCCcEEEE--ecccccccCCccc--cccccCcCCchhhhcCCCCCc--hhhHHHHHHHHHHHHhCCCCCC
Q psy16081 254 ---NILLCNPKRSAIKIV--DFGSSCQLGQRIY--QYIQSRFYRSPEVLLGIPYDL--AIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 254 ---NILl~~~~~~~ikL~--DFG~a~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~--~~DvwSlGvil~elltG~~pf~ 324 (493)
+-.. +..+...++ ||+.+..+..... ....+..|.++|......+.. ..|+|.+|..+..+..|..+-.
T Consensus 316 ~~~~~~~--~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~ 393 (1351)
T KOG1035|consen 316 SSKESTV--DGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISE 393 (1351)
T ss_pred ccccccc--CccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccc
Confidence 1111 344556666 8888877654432 334566688899888766654 4799999999999988875421
Q ss_pred CCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCC
Q psy16081 325 GSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404 (493)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 404 (493)
-. ..+.. +.+..
T Consensus 394 ~~------~~~~~------------------~l~~~-------------------------------------------- 405 (1351)
T KOG1035|consen 394 KS------AVPVS------------------LLDVL-------------------------------------------- 405 (1351)
T ss_pred cc------cchhh------------------hhccc--------------------------------------------
Confidence 10 00000 00000
Q ss_pred CCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 405 ~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
+. ....+++.+|+.-|+++|+++.+++.|+|......
T Consensus 406 -~~---~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 406 -ST---SELLDALPKCLDEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred -cc---hhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence 00 03468999999999999999999999999985443
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0028 Score=64.94 Aligned_cols=76 Identities=25% Similarity=0.189 Sum_probs=50.9
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccC--------cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK--------KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~--------~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+.||.|.+..||++.+..+++.|+||.-... .........|...+..+....... +.+++.+ +.+..
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~---VPkV~~~--D~~~~ 106 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDL---VPKVYHY--DEELA 106 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCC---CCeEEEE--CCCCC
Confidence 6799999999999987644468999974311 123455677777777766443222 4455444 44567
Q ss_pred EEEEEeccc
Q psy16081 197 CLVFELLSY 205 (493)
Q Consensus 197 ~lV~E~~~~ 205 (493)
++|||++++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999965
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00097 Score=66.09 Aligned_cols=140 Identities=25% Similarity=0.300 Sum_probs=95.9
Q ss_pred EeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc---------------------------ccchHHHHHHHHHHHHhhc
Q psy16081 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---------------------------PFLNQAQIEVKLLEIMNKA 175 (493)
Q Consensus 123 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---------------------------~~~~~~~~e~~~~~~l~~~ 175 (493)
+--+|..|--+.||.|. ..+|..+|||+++..- .....++.|.+-+..++..
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 34578899999999997 5668889999875210 0112334455556666555
Q ss_pred CCCCcceEEEeceeeeecceeEEEEEecccC--HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 176 ~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~~--L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
..+... -+-| ..-.|||+|++.+ -.-.|+.. .++...++.+-+|++.-+.-|.. .+++||.||.=-
T Consensus 227 GIP~Pe-PIlL-------k~hVLVM~FlGrdgw~aPkLKd~---~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLSEf 294 (520)
T KOG2270|consen 227 GIPCPE-PILL-------KNHVLVMEFLGRDGWAAPKLKDA---SLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLSEF 294 (520)
T ss_pred CCCCCC-ceee-------ecceEeeeeccCCCCcCcccccc---cCChHHHHHHHHHHHHHHHHHHH-Hhceeccchhhh
Confidence 433221 1111 1246999999753 22234333 37788888888888888888865 688999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|+|+ ..|.+.|||.+-+.....
T Consensus 295 N~Ly---hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 295 NLLY---HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred hheE---ECCEEEEEEccccccCCC
Confidence 9999 678899999998865543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0028 Score=62.72 Aligned_cols=76 Identities=12% Similarity=0.084 Sum_probs=51.8
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee---cceeEEEE
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW---RNHLCLVF 200 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~---~~~~~lV~ 200 (493)
.+.||.|..+.||.... .++ .+.+|..+. ......+..|...++.+....... +.++++.+.+ .+..+|||
T Consensus 19 ~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vp---VP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 19 VECISEQPYAALWALYD-SQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVR---MPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eeecCCccceeEEEEEc-CCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCC---cCcEEEEeccCCcCCCeEEEE
Confidence 46899999999999843 223 477787543 223457888999888887643233 4455554433 46689999
Q ss_pred Eeccc
Q psy16081 201 ELLSY 205 (493)
Q Consensus 201 E~~~~ 205 (493)
|+++|
T Consensus 93 E~i~G 97 (297)
T PRK10593 93 ERLRG 97 (297)
T ss_pred eccCC
Confidence 99976
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0015 Score=64.67 Aligned_cols=72 Identities=18% Similarity=0.179 Sum_probs=46.3
Q ss_pred eeEeeeCCeEEEEEEEcC------CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 125 SLIGKGSFGQVVKAFDLE------EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
+.|..|--..||++.... +++.|++|+.............|..++..+..... .| +++..+. + .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~--~P---~~~~~~~--~--~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNL--GP---KLYGIFP--N--GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCC--CC---ceEEEeC--C--Cc
Confidence 456667777889886432 25789999987544444566788888888876552 22 3333332 1 35
Q ss_pred EEEeccc
Q psy16081 199 VFELLSY 205 (493)
Q Consensus 199 V~E~~~~ 205 (493)
|+||++|
T Consensus 75 v~e~i~G 81 (302)
T cd05156 75 IEEFIPS 81 (302)
T ss_pred hhheeCC
Confidence 8898866
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00053 Score=70.56 Aligned_cols=172 Identities=19% Similarity=0.219 Sum_probs=104.1
Q ss_pred HHHHHHhhcCCCCcceEEEeceeeee-cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCc
Q psy16081 167 KLLEIMNKADVNNTYYIVRLKRHFMW-RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNI 245 (493)
Q Consensus 167 ~~~~~l~~~~~~~~~~Iv~l~~~~~~-~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~i 245 (493)
.++.+........|++....+++... .....+|+|+++-+|.+.++.......+ +. | | ++
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~~~s----------~~-~----~----~~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLKDES----------LL-A----H----GV 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcccchhh----------hc-c----c----cc
Confidence 34444444444456667766666542 2357899999999999998765421111 00 1 1 23
Q ss_pred cccCCCCCcEEeeCCCCCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 246 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 246 iHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
.| -||+ +++| -++. ..... ..+|+||||+|.++.++..|...+..
T Consensus 89 ~~-----~~~~---------~~td-~~~t----~~~~~----------------~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 89 LH-----LNII---------YITD-HFLT----KYPSP----------------IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ce-----ehhh---------hccc-cccc----cCCCC----------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 32 1222 2333 0100 00111 11499999999999999999998888
Q ss_pred CCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCC
Q psy16081 326 SNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405 (493)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 405 (493)
..+.+++..+.+....+.....-.... ++
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~----------------------------------~~----------------- 162 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEH----------------------------------LI----------------- 162 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHH----------------------------------HH-----------------
Confidence 777777777766544433222111100 00
Q ss_pred CcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 406 ~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.++....+.++..+|+-..|..||.+.++++|+-|+.+
T Consensus 163 ~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 163 QLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 01111267899999999999999999999999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0025 Score=62.85 Aligned_cols=144 Identities=15% Similarity=0.142 Sum_probs=80.6
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEec-e--eeeecceeEEEE
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLK-R--HFMWRNHLCLVF 200 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~-~--~~~~~~~~~lV~ 200 (493)
.+.|..|....+|++.. ++..+++|+... ........|..+++.+.....+ -|-++... + .....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~-vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLP-VPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCC-CCccccCCCCcEeeeeCCceEEEE
Confidence 45677888889999853 345688998764 2335566788888888765433 22222211 1 112345678999
Q ss_pred Eeccc-CHH-----------HHH---hcc--CCC-------CCCHHHH--H--------HHHHHHHHHHHHHhC-----C
Q psy16081 201 ELLSY-NLY-----------DLL---RNT--NFR-------GVSLNLT--R--------KFSQQLCTALLFLST-----P 241 (493)
Q Consensus 201 E~~~~-~L~-----------~~l---~~~--~~~-------~l~~~~~--~--------~i~~qi~~aL~~Lhs-----~ 241 (493)
++++| .+. ..+ ... ... ...+... . .....+..++.++.. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 99976 321 111 110 000 0011100 0 011112233344331 1
Q ss_pred CCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 242 ~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
..++||+|+.|.|||+ ++++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~--~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLF--DGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEE--eCCceEEEeehhhhc
Confidence 3579999999999999 455556899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.002 Score=62.19 Aligned_cols=135 Identities=14% Similarity=0.127 Sum_probs=74.4
Q ss_pred eEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc-hHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL-NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
.+..|-.+.+|+.. .+++.+++|+........ .....|..++..+..... .|.++.. . . -++||||++
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~--~P~~i~~---~--~--~~~v~e~i~ 71 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGL--APKPILV---N--E--HWLLVEWLE 71 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC--CCceEEE---e--C--CEEEEEecc
Confidence 34567778899885 456788899765332221 245778888888876543 2334322 1 2 368999997
Q ss_pred c-CHH--------------HHHh---ccCC--CCCCHH-HHHHHHHHH---------HHHHHHHhC------CCCCcccc
Q psy16081 205 Y-NLY--------------DLLR---NTNF--RGVSLN-LTRKFSQQL---------CTALLFLST------PELNIIHC 248 (493)
Q Consensus 205 ~-~L~--------------~~l~---~~~~--~~l~~~-~~~~i~~qi---------~~aL~~Lhs------~~~~iiHr 248 (493)
| .+. +.+. .... ..++.. .+..+..++ ...+..+.. ....++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 6 321 1111 1111 111211 111221111 111221211 02358999
Q ss_pred CCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 249 DLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 249 DlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
|+.|.|||++ +++ +.|+||..|.
T Consensus 152 Dl~~~Nil~~--~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 152 DVHAYNLVVT--PQG-LKLIDWEYAS 174 (256)
T ss_pred CCCcCcEEEe--CCC-CEEEeccccC
Confidence 9999999994 444 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.01 Score=58.94 Aligned_cols=144 Identities=15% Similarity=0.175 Sum_probs=79.3
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEece---eeeecceeEEEE
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKR---HFMWRNHLCLVF 200 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~---~~~~~~~~~lV~ 200 (493)
.+.++.|.-..||++.. .++ .+++|+..... .......|..+++.+.....+ .|-++.-.+ .....+..++|+
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~p-vp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLP-VPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCC-CCccccCCCCCeehhcCCeEEEEE
Confidence 56677887789999853 333 57789875421 134455677777777654432 233333221 112245678999
Q ss_pred Eeccc-CH----H-------HHH---hccCCCCC-----------CHHHH--H----------HHHHHHHHHHHHHhC--
Q psy16081 201 ELLSY-NL----Y-------DLL---RNTNFRGV-----------SLNLT--R----------KFSQQLCTALLFLST-- 240 (493)
Q Consensus 201 E~~~~-~L----~-------~~l---~~~~~~~l-----------~~~~~--~----------~i~~qi~~aL~~Lhs-- 240 (493)
||++| .+ . ..+ .... .++ .|... . .....+...+.++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~-~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAG-AHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhh-ccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 99866 21 0 111 1100 011 00000 0 011122334444421
Q ss_pred ---CCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 241 ---PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 241 ---~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
...++||+|+.+.||+++ .++.+.|+||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~--~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFD--GDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEE--CCceEEEeeccccc
Confidence 247899999999999994 45556899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.00086 Score=65.42 Aligned_cols=136 Identities=20% Similarity=0.277 Sum_probs=89.3
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEc----------cCc-------c------cchHHHHHHHHHHHHhhcC
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK----------NKK-------P------FLNQAQIEVKLLEIMNKAD 176 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~----------~~~-------~------~~~~~~~e~~~~~~l~~~~ 176 (493)
-+.+.++||-|.-+-||++-+ ..|...++|+-+ .+. . ..-.+..|...++.+....
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367889999999999999974 457888888532 111 0 0123456777777777644
Q ss_pred CCCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcE
Q psy16081 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENI 255 (493)
Q Consensus 177 ~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NI 255 (493)
.+ +.+.++ .+..|+|||++.| .|...-.-. ....+...+..-+.-|. ..|+||||..==||
T Consensus 172 fp----VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~~lm~~Iv~la--~~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 172 FP----VPKPID----HNRHCVVMELVDGYPLRQVRHVE--------DPPTLYDDLMGLIVRLA--NHGLIHGDFNEFNI 233 (465)
T ss_pred CC----CCCccc----ccceeeHHHhhcccceeeeeecC--------ChHHHHHHHHHHHHHHH--HcCceecccchhee
Confidence 32 333333 4567899999976 555432211 12234444444455555 46899999999999
Q ss_pred EeeCCCCCcEEEEeccccccc
Q psy16081 256 LLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 256 Ll~~~~~~~ikL~DFG~a~~~ 276 (493)
++ .+++.+++|||--....
T Consensus 234 mv--~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 234 MV--KDDDKIVVIDFPQMVST 252 (465)
T ss_pred EE--ecCCCEEEeechHhhcc
Confidence 99 56778999999765444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.011 Score=59.81 Aligned_cols=140 Identities=19% Similarity=0.187 Sum_probs=78.5
Q ss_pred eeEeeeCCeEEEEEEEcC----CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLE----EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~ 200 (493)
..|-.|-.-.+|++.... +++.|++|+........-....|..++..+....... ++++.+.. + .|.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P-----~~~~~~~~-g---~v~ 112 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGP-----RLLGRFPN-G---RVE 112 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCC-----ceEEEECC-c---eEE
Confidence 455557777888885322 3468999988654444444577888888888766422 23344422 2 578
Q ss_pred Eeccc-CHHH--------------HH---hccCC--C--CCCHHHHHHHHHHHH-----------------HH---HH-H
Q psy16081 201 ELLSY-NLYD--------------LL---RNTNF--R--GVSLNLTRKFSQQLC-----------------TA---LL-F 237 (493)
Q Consensus 201 E~~~~-~L~~--------------~l---~~~~~--~--~l~~~~~~~i~~qi~-----------------~a---L~-~ 237 (493)
||+++ .+.. .+ +.... . ...+..+..+..++. .. |. .
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99865 3321 11 11110 0 111222323322211 11 11 1
Q ss_pred HhC--CCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 238 LST--PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 238 Lhs--~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+.. ....++|+|+++.|||+. ++++.+.|+||..|.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~-~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMID-EETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEe-CCCCcEEEEeehhcc
Confidence 221 135689999999999995 234679999998874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.004 Score=57.18 Aligned_cols=101 Identities=22% Similarity=0.297 Sum_probs=72.1
Q ss_pred HHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhCCC
Q psy16081 165 EVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRN-TNFRGVSLNLTRKFSQQLCTALLFLSTPE 242 (493)
Q Consensus 165 e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~ 242 (493)
|.-++..+.... ++.+++++|- -++|.||.+. ++.+.... ......+|..+.+++.+++..+.+++...
T Consensus 9 E~lll~~l~~~~-----~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 9 EPLLLQLLQGSE-----PFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred HHHHHHHcCCCC-----CCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 555565555433 4899999883 2568999974 55422100 11124689999999999999999997532
Q ss_pred C-CccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 243 L-NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 243 ~-~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
. .+.-+|++|+|+-+ ++++.+|++|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv--~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGV--NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEE--eCCCcEEEEechhcchh
Confidence 2 26679999999999 57788999999987544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.016 Score=58.37 Aligned_cols=75 Identities=21% Similarity=0.173 Sum_probs=48.0
Q ss_pred eEeeeCCeEEEEEEEcCCCeEEEEEEEc----c----CcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIK----N----KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~----~----~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.||-|...-||++.+..+++-|+||.-. . -+........|...+......... ++.+++ +.+.....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~---~vP~vy--~~D~e~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPH---LVPRIF--HFDTEMAV 76 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCcc---ccCeEE--EEccccce
Confidence 5799999999999875444689999532 1 133345666777777666543322 244443 33455667
Q ss_pred EEEEeccc
Q psy16081 198 LVFELLSY 205 (493)
Q Consensus 198 lV~E~~~~ 205 (493)
+|||+++.
T Consensus 77 ~vMEdL~~ 84 (370)
T TIGR01767 77 TVMEDLSH 84 (370)
T ss_pred ehHhhCcc
Confidence 99999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.024 Score=56.91 Aligned_cols=72 Identities=14% Similarity=0.253 Sum_probs=44.7
Q ss_pred eeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFE 201 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E 201 (493)
+.|..|=-..+|++..... +..|++|+........-....|..+++.+...... .+++.++. .+ +|.+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~-----P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFG-----AKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCC-----CceeEEeC-Cc---Eeeh
Confidence 4454466677888854332 34788998865544455567888888888876643 23333442 22 4788
Q ss_pred eccc
Q psy16081 202 LLSY 205 (493)
Q Consensus 202 ~~~~ 205 (493)
|+.+
T Consensus 91 fi~g 94 (330)
T PLN02421 91 FINA 94 (330)
T ss_pred hhcC
Confidence 8755
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.1 Score=51.74 Aligned_cols=30 Identities=27% Similarity=0.354 Sum_probs=25.1
Q ss_pred CCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 242 ~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
..++||+|+.+.||+++ . +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~--~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLK--D-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEe--C-CcEEEEECcccc
Confidence 36899999999999994 3 568999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.045 Score=54.44 Aligned_cols=31 Identities=13% Similarity=0.252 Sum_probs=27.0
Q ss_pred CCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 242 ~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
..++||+|+.+.|||+ ++++.+.|+||..++
T Consensus 195 ~~~lcHgD~~~~Nvl~--~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLY--DETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEE--cCCCCEEEEEhhhcc
Confidence 4589999999999999 566778999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.13 Score=51.53 Aligned_cols=73 Identities=11% Similarity=-0.061 Sum_probs=43.7
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEece--eeeecceeEEEEEeccc
Q psy16081 131 SFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKR--HFMWRNHLCLVFELLSY 205 (493)
Q Consensus 131 ~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~--~~~~~~~~~lV~E~~~~ 205 (493)
.-..||++. ..++..+++|+.+.......+...|..++..+.....+-.. .+..-+ ....++..+.|+++++|
T Consensus 37 ~eN~vy~v~-~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~-p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFG-DEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVA-PLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEe-cCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCC-CccCCCCEEEEECCEEEEEEeeeCC
Confidence 345688885 34567799998864333445667788888888764433110 011112 12234667889999866
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.0023 Score=73.44 Aligned_cols=143 Identities=9% Similarity=-0.060 Sum_probs=99.9
Q ss_pred CcceEEEeceeee--ecceeEEEEEec-ccCHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhCC---CCCccccCC
Q psy16081 179 NTYYIVRLKRHFM--WRNHLCLVFELL-SYNLYDLLRNTNF--RGVSLNLTRKFSQQLCTALLFLSTP---ELNIIHCDL 250 (493)
Q Consensus 179 ~~~~Iv~l~~~~~--~~~~~~lV~E~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~Lhs~---~~~iiHrDl 250 (493)
.|+++.....-.. .....+.+++|+ .|.+++.|.+... ..+...-+....++...+..-+|+. ..-.+|++|
T Consensus 1287 ~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~L 1366 (2724)
T KOG1826|consen 1287 KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSL 1366 (2724)
T ss_pred hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhh
Confidence 3454554333332 234568899999 5689998865432 2233444444444545555555542 112689999
Q ss_pred CCCcEEeeCCCCCcEEEEecccccccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy16081 251 KPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLF 323 (493)
Q Consensus 251 Kp~NILl~~~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf 323 (493)
|+-|.+| ..+-.+|+.++|+.+..... .....+++.|++|++.....++.++|+|+.|+.+|+..-|.++|
T Consensus 1367 kf~lpmI--Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1367 KFTLPMI--VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhccce--ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999 56677999999999843322 33556788899999999989999999999999999999888776
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.049 Score=55.52 Aligned_cols=77 Identities=22% Similarity=0.253 Sum_probs=51.4
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEE----cc---CcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKII----KN---KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~----~~---~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.+.||-|.-.-||++.+...++-|+||.- +. -+........|...+..+....... +.+++ +.+....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~---VP~vy--~~D~e~~ 108 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGL---VPKVY--LFDSVMN 108 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCc---CCeEE--EECcHHh
Confidence 57889999999999987444567999853 21 1234566677888888776654322 44443 3345666
Q ss_pred EEEEEeccc
Q psy16081 197 CLVFELLSY 205 (493)
Q Consensus 197 ~lV~E~~~~ 205 (493)
.+|||+++.
T Consensus 109 ~~vMEdL~~ 117 (409)
T PRK12396 109 CCVMEDLSD 117 (409)
T ss_pred hHHHHhCcc
Confidence 789999854
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.068 Score=52.23 Aligned_cols=30 Identities=23% Similarity=0.474 Sum_probs=24.0
Q ss_pred CCccccCCCCCcEEeeCCCCCc-EEEEeccccc
Q psy16081 243 LNIIHCDLKPENILLCNPKRSA-IKIVDFGSSC 274 (493)
Q Consensus 243 ~~iiHrDlKp~NILl~~~~~~~-ikL~DFG~a~ 274 (493)
..+||+|+.|.|||++ +++. .-|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~--~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILID--EDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEe--CCCCEEEEECcHhcc
Confidence 4589999999999994 3244 5699999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.13 Score=51.05 Aligned_cols=31 Identities=16% Similarity=0.374 Sum_probs=25.4
Q ss_pred CCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 243 ~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
..++|+|+.+.||++. ...-+-|+||+++..
T Consensus 198 ~~lvHGD~~~gNlii~--~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIID--PGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEe--CCCeeEEEecccccc
Confidence 3699999999999995 344489999999853
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.029 Score=52.36 Aligned_cols=31 Identities=39% Similarity=0.621 Sum_probs=20.7
Q ss_pred CCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 243 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 243 ~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.-++|.||.|.|||+. +.++.++|+||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~-~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILIN-NKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEET-SSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEec-cCCCeEEEecHHHHh
Confidence 4689999999999993 467789999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.1 Score=53.60 Aligned_cols=75 Identities=12% Similarity=0.035 Sum_probs=46.7
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEcc-----Cc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN-----KK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~-----~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.||.|....||+..+ .+..|+||.-.. .. ........|...+..+....... +.+++.+.. +.
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~---VPkVy~~de--d~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDH---VPEVYHFDR--TM 109 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCC---CCeEEEECC--CC
Confidence 57889999999999876 345688996431 11 13344455555555554432223 555555544 45
Q ss_pred eEEEEEeccc
Q psy16081 196 LCLVFELLSY 205 (493)
Q Consensus 196 ~~lV~E~~~~ 205 (493)
.++|||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 6889999955
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.14 Score=59.24 Aligned_cols=149 Identities=14% Similarity=0.172 Sum_probs=77.9
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhc-CCCCcceEEEec-eee----ee-cc--e
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKA-DVNNTYYIVRLK-RHF----MW-RN--H 195 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~-~~~~~~~Iv~l~-~~~----~~-~~--~ 195 (493)
+.|+ |..-.+|+.. ..+|..+++|+.+... .......+...+..+... .....|.++.-. +-+ .. .+ +
T Consensus 31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEE-eCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 3456778875 3567789999987532 234445566666666543 122233344322 111 11 12 5
Q ss_pred eEEEEEeccc-CHHHH--------------H---hc--cC------CCCCCHH-----------------HHHHHHHHHH
Q psy16081 196 LCLVFELLSY-NLYDL--------------L---RN--TN------FRGVSLN-----------------LTRKFSQQLC 232 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~--------------l---~~--~~------~~~l~~~-----------------~~~~i~~qi~ 232 (493)
.+-+++|++| .+.+. + .. .. .+.+.|+ ..+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 6778999987 44330 0 00 00 0111221 1122233333
Q ss_pred HHHH-----HHhCCCCCccccCCCCCcEEeeCCCCCcEE-EEeccccccc
Q psy16081 233 TALL-----FLSTPELNIIHCDLKPENILLCNPKRSAIK-IVDFGSSCQL 276 (493)
Q Consensus 233 ~aL~-----~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik-L~DFG~a~~~ 276 (493)
..+. .+.....++||.|+.+.|||++.+..+.+. |+|||.+..-
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 3222 222224679999999999999533322555 9999998543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.031 Score=54.87 Aligned_cols=75 Identities=11% Similarity=0.098 Sum_probs=49.8
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
.+.|+.|.-..+|+.. .+++.+.||+-. ......+..|..-++.|....... +.+.+.+....+.-+|||||+
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~---vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIR---VPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSB---S--EEEEEE-SSCCEEEEE--
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCC---CCeEEEEEeecCCceEEEEee
Confidence 4678999999999985 678889999876 334567888999999886655444 556666666666779999998
Q ss_pred cc
Q psy16081 204 SY 205 (493)
Q Consensus 204 ~~ 205 (493)
+.
T Consensus 95 ~~ 96 (288)
T PF03881_consen 95 EM 96 (288)
T ss_dssp --
T ss_pred cC
Confidence 43
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.026 Score=56.27 Aligned_cols=74 Identities=19% Similarity=0.161 Sum_probs=56.8
Q ss_pred ecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 192 WRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 192 ~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
...+.|++|++-++.+.-. .. -.+.++..|+.+.+..+.-+.. +..+=|||+.-.|||| + .|+|.|+||-
T Consensus 297 e~~y~yl~~kdhgt~is~i-k~-----~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLI--d-~GnvtLIDfk 366 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII-KA-----DRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILI--D-EGNVTLIDFK 366 (488)
T ss_pred CceEEEEEEecCCceeeee-ec-----ccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceee--e-cCceEEEEee
Confidence 3457788888887654321 11 3467778888887777777765 5789999999999999 5 8999999999
Q ss_pred cccc
Q psy16081 272 SSCQ 275 (493)
Q Consensus 272 ~a~~ 275 (493)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9973
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.16 Score=50.88 Aligned_cols=143 Identities=20% Similarity=0.292 Sum_probs=77.9
Q ss_pred eEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee--ecc--eeEEEEE
Q psy16081 126 LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM--WRN--HLCLVFE 201 (493)
Q Consensus 126 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~--~~~--~~~lV~E 201 (493)
.|.+ .-..||++.. .+|+ +++|+.... ....+...|..++..+......-..=+..+-+-.. -.+ +.+-|++
T Consensus 33 ~l~s-~eN~~f~~~~-~~g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDGR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEe-cCCC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 4567888853 3333 499998865 45577777888888777655332111222222211 123 7788999
Q ss_pred ecccCHHH-------------HH---hc--cCC--------CCCCHHH----H---------HHHHHHHHHHHHHHhC--
Q psy16081 202 LLSYNLYD-------------LL---RN--TNF--------RGVSLNL----T---------RKFSQQLCTALLFLST-- 240 (493)
Q Consensus 202 ~~~~~L~~-------------~l---~~--~~~--------~~l~~~~----~---------~~i~~qi~~aL~~Lhs-- 240 (493)
|++|.... ++ .. ..+ ....|.. . .....++...+..+..
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 99773222 11 00 000 0112220 0 0122233333333322
Q ss_pred ----CCCC--ccccCCCCCcEEeeCCCCC-cEEEEeccccc
Q psy16081 241 ----PELN--IIHCDLKPENILLCNPKRS-AIKIVDFGSSC 274 (493)
Q Consensus 241 ----~~~~--iiHrDlKp~NILl~~~~~~-~ikL~DFG~a~ 274 (493)
...+ +||+|+.|.||+++ ... .+.++|||-++
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d--~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFD--DDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEc--CCCCeeeEEEccccc
Confidence 1223 99999999999994 443 48899999875
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.31 Score=49.90 Aligned_cols=73 Identities=12% Similarity=0.141 Sum_probs=43.2
Q ss_pred eeeEeeeCCeEEEEEEEcCCC------eEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQ------CHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~------~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.+.|..|=-..+|++...... +.|.+++........-..+.|..++..+...... .++++.|. -+
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glg-----P~l~~~f~----~g 125 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFG-----PKIIGRFG----DF 125 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCC-----CeEEEecC----CE
Confidence 345655777889988643221 2255554433333334456788888888766532 34445553 25
Q ss_pred EEEEeccc
Q psy16081 198 LVFELLSY 205 (493)
Q Consensus 198 lV~E~~~~ 205 (493)
+|.||++|
T Consensus 126 ~l~efIeG 133 (383)
T PTZ00384 126 TIQEWVEG 133 (383)
T ss_pred EEEEEecc
Confidence 89999976
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.16 Score=47.37 Aligned_cols=73 Identities=23% Similarity=0.287 Sum_probs=49.9
Q ss_pred EEEeceeeeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC
Q psy16081 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR 262 (493)
Q Consensus 183 Iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~ 262 (493)
|++|..- ..-.+-+++|.|-.- ..... .++..=+.+|...|+...+.+|+|..|+||+- |+.
T Consensus 118 ilrL~ND--n~~~yGvIlE~Cy~~-------------~i~~~-N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~--D~~ 179 (308)
T PF07387_consen 118 ILRLKND--NNYKYGVILERCYKI-------------KINFS-NFITAGIKDLMDFHSENQHCLHGDCNPDNIMC--DKF 179 (308)
T ss_pred eeEeecC--CCceeEEEEeeccCc-------------ccchh-HHHHHhHHHHHHhhccCCCeecCCCChhheee--cCC
Confidence 7777732 233456899998320 00011 11222246678889767899999999999999 899
Q ss_pred CcEEEEecccc
Q psy16081 263 SAIKIVDFGSS 273 (493)
Q Consensus 263 ~~ikL~DFG~a 273 (493)
|.+||.|-+.-
T Consensus 180 G~lKlVDP~~L 190 (308)
T PF07387_consen 180 GYLKLVDPVCL 190 (308)
T ss_pred CCEEecChhhh
Confidence 99999998753
|
The function of this family is unknown. |
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.13 Score=52.19 Aligned_cols=60 Identities=25% Similarity=0.298 Sum_probs=41.5
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~ 258 (493)
...||-+|+.| ++..++.... .++...++++.-...||.-+-- --+++|.|+.|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~-vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLI-VDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHH-hhcceecccCCCcEEEE
Confidence 44667778877 8888887654 4555666666655566543322 24799999999999994
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.87 Score=47.62 Aligned_cols=74 Identities=19% Similarity=0.060 Sum_probs=47.1
Q ss_pred EeeeEeeeCCeEEEEEEEcC--------CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 123 IDSLIGKGSFGQVVKAFDLE--------EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 123 ~~~~LG~G~fg~V~~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
-++.|..|=--.+|++.... +++.|.+++........-....|..++..+....... ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P-----~l~~~f~--- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAP-----QLLNTFS--- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCC-----ceEEEeC---
Confidence 34667667677888886432 2568999988655444445677888888888765432 3334442
Q ss_pred eeEEEEEeccc
Q psy16081 195 HLCLVFELLSY 205 (493)
Q Consensus 195 ~~~lV~E~~~~ 205 (493)
-..|.||++|
T Consensus 181 -gg~I~efi~g 190 (442)
T PTZ00296 181 -GGRIEEWLYG 190 (442)
T ss_pred -CCEEEEeeCC
Confidence 2457888865
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 493 | ||||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-162 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-161 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-160 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-74 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-74 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-73 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-44 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-43 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-42 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-41 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-41 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-41 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-36 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-36 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-32 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-31 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-31 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 8e-31 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-30 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-29 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-28 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-28 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-28 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-28 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-28 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-28 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-28 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-28 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-28 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-28 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-28 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-28 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-28 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-28 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-28 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-27 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-27 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-27 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-27 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-27 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-27 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-27 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-27 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-27 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-27 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-27 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-27 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-27 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-27 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-27 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-27 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-27 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-27 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-27 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-27 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-27 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-27 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-27 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-27 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-27 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-27 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-27 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-27 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-27 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-27 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-27 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-27 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-27 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-27 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-27 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-27 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-27 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-27 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-27 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-27 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-26 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-26 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-26 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-26 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-26 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-26 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-26 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-26 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-26 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-26 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-26 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-26 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-26 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-26 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-25 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-25 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-25 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-25 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-25 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-25 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-25 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-25 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-25 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-25 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-25 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-25 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-25 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-25 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-25 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-25 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-25 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-25 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-25 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-25 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-25 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-25 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-24 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-24 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-24 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-24 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-24 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-24 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-24 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-24 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-24 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-24 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-24 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-24 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-24 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-24 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-24 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-24 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-24 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-24 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-23 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-23 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-23 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-23 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-23 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-23 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-23 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-23 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-23 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-23 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-23 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-23 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-23 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-23 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-23 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-23 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-23 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-23 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-23 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-23 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-23 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-23 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-23 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-23 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-23 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-23 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-23 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-23 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-23 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-23 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-23 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-23 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-23 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-23 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-23 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-23 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-23 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-23 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-23 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-23 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-23 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-23 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-23 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-23 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-23 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-23 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-23 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-23 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-23 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-23 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-23 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-23 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-23 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-23 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-23 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-23 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-23 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-23 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-23 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-23 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-23 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-23 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-23 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-23 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-23 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-22 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-22 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-22 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-22 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-22 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-22 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-22 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-22 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-22 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-22 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-22 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-22 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-21 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-20 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-20 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-20 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-20 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-17 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-16 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-15 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-15 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-15 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-15 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-15 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-15 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-15 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-15 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-15 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-15 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-15 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-15 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-15 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-14 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-13 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-13 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-13 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-13 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-13 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-13 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-13 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-13 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-09 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-09 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 4e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 9e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 5e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 6e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 6e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-04 | ||
| 3e7e_A | 365 | Structure And Substrate Recruitment Of The Human Sp | 5e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-04 |
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3E7E|A Chain A, Structure And Substrate Recruitment Of The Human Spindle Checkpoint Kinase Bub Length = 365 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 493 | |||
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 0.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 0.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-164 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-162 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-157 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-146 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-77 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-64 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 9e-64 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-63 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-62 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-62 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-58 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-58 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-58 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 9e-58 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-57 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-57 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-56 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-55 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-55 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-55 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-55 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-55 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-54 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-54 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-54 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-54 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-54 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 9e-54 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-53 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-53 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 9e-53 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 8e-51 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-50 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-50 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-46 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-46 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-45 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 8e-45 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-43 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-42 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-42 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-42 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 9e-42 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-41 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-41 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-41 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 8e-41 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-40 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-04 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-40 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-40 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-40 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-39 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-39 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-39 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-39 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-39 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-04 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 7e-39 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-38 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-38 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-04 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 8e-38 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-05 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-37 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-04 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-37 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-04 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-37 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-37 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-37 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-37 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-04 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-37 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-37 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-04 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-37 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-04 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-37 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-36 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 9e-04 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-36 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 7e-04 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-36 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-04 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-36 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-04 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 7e-36 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 8e-36 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-04 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-35 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-35 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-04 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-35 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-35 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-35 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-04 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 7e-35 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-34 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-04 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-34 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-34 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-34 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-34 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-33 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-05 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-33 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-33 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 9e-04 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-33 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-05 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-33 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-33 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-33 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-32 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-04 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-32 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 7e-04 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-32 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 5e-04 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-32 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-04 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-32 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-32 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-31 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-30 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-30 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-29 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-29 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-29 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-29 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-28 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-28 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-28 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-28 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-28 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-28 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-28 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 6e-28 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-28 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-04 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 8e-28 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-27 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-27 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-27 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 8e-27 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-26 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-26 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-26 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-26 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-26 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 8e-26 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 9e-26 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-25 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-25 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-25 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-25 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-25 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-25 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-25 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-25 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 5e-25 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 8e-25 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 8e-25 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 9e-25 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-24 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-24 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-24 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-24 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-24 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-24 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-23 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-23 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-23 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-23 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-23 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-22 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-22 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-22 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-22 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-22 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 8e-22 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-21 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-21 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-20 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-20 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-20 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-19 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-19 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 8e-19 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-18 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-18 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-18 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 8e-18 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-17 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-17 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 8e-17 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-16 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 9e-16 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-15 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-15 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-15 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-15 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-15 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-15 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-15 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-15 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 9e-15 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-14 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-14 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 8e-14 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 9e-14 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-13 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-13 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-13 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 5e-13 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 8e-13 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 9e-13 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-12 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-12 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-12 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-12 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-12 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-12 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-12 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-12 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-12 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-12 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-12 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-12 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-11 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-11 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-11 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-11 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-11 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-11 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-11 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-11 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 6e-11 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-10 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-10 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-10 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 9e-10 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-09 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-09 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-09 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-09 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-09 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-05 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-04 |
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 543 bits (1400), Expect = 0.0
Identities = 299/359 (83%), Positives = 335/359 (93%), Gaps = 1/359 (0%)
Query: 89 SSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVA 148
SSHKKE+K+YN+GYDDDN+DYI+++GEK++DRYEIDSLIGKGSFGQVVKA+D EQ VA
Sbjct: 24 SSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVA 83
Query: 149 IKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLY 208
IKIIKNKK FLNQAQIEV+LLE+MNK D YYIV LKRHFM+RNHLCLVFE+LSYNLY
Sbjct: 84 IKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY 143
Query: 209 DLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268
DLLRNTNFRGVSLNLTRKF+QQ+CTALLFL+TPEL+IIHCDLKPENILLCNPKRSAIKIV
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203
Query: 269 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
DFGSSCQLGQRIYQYIQSRFYRSPEVLLG+PYDLAIDMWSLGCILVEMHTGEPLFSG+NE
Sbjct: 204 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
Query: 329 VDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDG-RKPKVPGSRRLHDI 387
VDQMNKIVEVLG+PP H+LD A K RK+F+K+PDG++ LKK KDG R+ K PG+R+LH+I
Sbjct: 264 VDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNI 323
Query: 388 LGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
LGVE+GGPGGRR GE GH+V+DYLKFKDLI RMLDYDPKTRI PYYALQH+FFK+TADE
Sbjct: 324 LGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 530 bits (1367), Expect = 0.0
Identities = 160/409 (39%), Positives = 225/409 (55%), Gaps = 20/409 (4%)
Query: 37 LAMQARIPLQFRDPATAPLRKLSV---DLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKK 93
+ P+ ++KL+ I +Y I + KKR+
Sbjct: 23 MGKVKATPMTPEQAMKQYMQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTGG-------- 74
Query: 94 EKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK 153
N GYDDD Y+ + RYE+ +IGKGSFGQVVKA+D + HVA+K+++
Sbjct: 75 ---PNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR 131
Query: 154 NKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRN 213
N+K F QA E+++LE + K D +NT ++ + +F +RNH+C+ FELLS NLY+L++
Sbjct: 132 NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK 191
Query: 214 TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273
F+G SL L RKF+ + L L + IIHCDLKPENILL RS IK++DFGSS
Sbjct: 192 NKFQGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
Query: 274 CQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 333
C QR+Y YIQSRFYR+PEV+LG Y + IDMWSLGCIL E+ TG PL G +E DQ+
Sbjct: 250 CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309
Query: 334 KIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESG 393
++E+LG+P + LLD + + + + Y + G R L G
Sbjct: 310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKL---RG 366
Query: 394 GPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
P R G D L F D + + L++DP R+TP AL+H + +R
Sbjct: 367 PPESREWGNALKGCDDPL-FLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 467 bits (1204), Expect = e-164
Identities = 98/378 (25%), Positives = 181/378 (47%), Gaps = 47/378 (12%)
Query: 89 SSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVA 148
H ++ DD+ + + G + + + +G G+FG+V+ ++ + + A
Sbjct: 5 HHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYA 64
Query: 149 IKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLY 208
+K+++N K + A+IE +L+ + D+NN IV+ FM+ +H+CL+FE L +LY
Sbjct: 65 VKVVRNIKKYTRSAKIEADILKKIQNDDINN-NNIVKYHGKFMYYDHMCLIFEPLGPSLY 123
Query: 209 DLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-------- 260
+++ N+ G + + + ++ AL +L ++++ H DLKPENILL +P
Sbjct: 124 EIITRNNYNGFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLIT 181
Query: 261 ---------------KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAID 305
K + IK++DFG + I +R YR+PEV+L + +D++ D
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSD 241
Query: 306 MWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR--KYFDKMPDG 363
MWS GC+L E++TG LF ++ + + ++ PK++L A KT KY +K
Sbjct: 242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK---D 298
Query: 364 SYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423
L P++ S + + P + + + F D ++ +L
Sbjct: 299 ELKLAWPENASSIN---SIK-------------HVKKCLPLYKIIKHELFCDFLYSILQI 342
Query: 424 DPKTRITPYYALQHNFFK 441
DP R +P L+H F +
Sbjct: 343 DPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 462 bits (1192), Expect = e-162
Identities = 113/366 (30%), Positives = 177/366 (48%), Gaps = 39/366 (10%)
Query: 103 DDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEE-QCHVAIKIIKNKKPFLNQ 161
DD + + G+ +RYEI +G+G+FG+VV+ D + VA+KII+N +
Sbjct: 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62
Query: 162 AQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSL 221
A++E+ +L+ + + D N + V + F + H+C+ FELL N ++ L+ NF+ L
Sbjct: 63 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-----------------PKRSA 264
R + QLC AL FL E + H DLKPENIL N K ++
Sbjct: 123 PHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 265 IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFS 324
I++ DFGS+ + + +R YR PEV+L + + D+WS+GCIL E + G LF
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240
Query: 325 GSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRL 384
+ + + ++LG P H++ K KYF K G + DGR K + L
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRKQ-KYFYK--GGLVWDENSSDGRYVK-ENCKPL 296
Query: 385 HDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTA 444
+ +S ++++ DL+ RML++DP RIT AL H FF
Sbjct: 297 KSYMLQDS---------------LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
Query: 445 DESTNT 450
E +
Sbjct: 342 PEERSF 347
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 449 bits (1156), Expect = e-157
Identities = 108/355 (30%), Positives = 172/355 (48%), Gaps = 39/355 (10%)
Query: 106 NHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQC-HVAIKIIKNKKPFLNQAQI 164
+ I Q G+ RYEI +G+G+FG+VV+ D + HVA+KI+KN + A+
Sbjct: 1 SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS 60
Query: 165 EVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLT 224
E+++LE +N D N+T+ V++ F H+C+VFELL + YD ++ F L+
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHI 120
Query: 225 RKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-----------------PKRSAIKI 267
RK + Q+C ++ FL + H DLKPENIL IK+
Sbjct: 121 RKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 268 VDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327
VDFGS+ + + +R YR+PEV+L + + D+WS+GCIL+E + G +F +
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDI 387
+ + + +LG PKH++ K RKYF + + + L +
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRK-RKYFH---HDRLDWDEHSSAGRYVSRACKPLKEF 294
Query: 388 LGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
+ + ++ + DLI +ML+YDP RIT AL+H FF
Sbjct: 295 MLSQD---------------VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 421 bits (1084), Expect = e-146
Identities = 111/385 (28%), Positives = 169/385 (43%), Gaps = 43/385 (11%)
Query: 103 DDDNHDYIIQHGEKFLD-RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ 161
+ GE + D RY + +G G F V A D+ HVA+KI++ K +
Sbjct: 2 YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA 61
Query: 162 AQIEVKLLEIMNKADVNN-----TYYIVRLKRHFMWRN----HLCLVFELLSYNLYDLLR 212
A+ E+KLL+ +N AD +I++L HF + H+ +VFE+L NL L++
Sbjct: 62 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 213 NTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA----IKIV 268
RG+ L ++ S+QL L ++ IIH D+KPEN+L+ IKI
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180
Query: 269 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG--- 325
D G++C + IQ+R YRSPEVLLG P+ D+WS C++ E+ TG+ LF
Sbjct: 181 DLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 326 ---SNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSR 382
+ + D + +I+E+LG P +LL TR +F+ R
Sbjct: 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR----------GLLRNISKLKFW 290
Query: 383 RLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
L D+L + S + + D + ML DP+ R + H + K
Sbjct: 291 PLEDVL-----------TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
Query: 443 TAD-ESTNTGGTSGLGSMSTSPASA 466
T E GS S P
Sbjct: 340 TLGMEEIRVPDRELYGSGSDIPGWF 364
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 3e-77
Identities = 97/401 (24%), Positives = 176/401 (43%), Gaps = 82/401 (20%)
Query: 100 EGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL 159
Y + ++++ G+ F RY + +G G F V ++D++ + VA+K++K+ + +
Sbjct: 19 NDYCKGGY-HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT 77
Query: 160 NQAQIEVKLLEIMNKADVNNT--YYIVRLKRHFMWR----NHLCLVFELLSYNLYDLLRN 213
A E++LL+ + +D N+ +V+L F H+C+VFE+L ++L +
Sbjct: 78 ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK 137
Query: 214 TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP------------- 260
+N++G+ L +K QQ+ L +L T + IIH D+KPENILL
Sbjct: 138 SNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 261 ----------------------------------KRSAIKIVDFGSSCQLGQRIYQYIQS 286
++ +KI D G++C + + + IQ+
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG------SNEVDQMNKIVEVLG 340
R YRS EVL+G Y+ D+WS C+ E+ TG+ LF + + D + I+E+LG
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRL 400
P+ L+ ++++F K G + L ++L +
Sbjct: 317 KVPRKLIVAGKYSKEFFTK--KGDL--------KHITKLKPWGLFEVL-----------V 355
Query: 401 GEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
+ S + F D + ML+ P+ R T L+H +
Sbjct: 356 EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-64
Identities = 97/348 (27%), Positives = 155/348 (44%), Gaps = 54/348 (15%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
K +DR++++ + G+G+FG V + VAIK + F N+ ++ L +++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH 78
Query: 175 ADVNNTYYIVRLKRHFMWRNH-------LCLVFELLSYNLYDLLRNTNFRG--VSLNLTR 225
+ IV+L+ +F L +V E + L+ RN R L +
Sbjct: 79 PN------IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 226 KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQY 283
F QL ++ L P +N+ H D+KP N+L+ N +K+ DFGS+ +L + Y
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 284 IQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342
I SR+YR+PE++ G Y A+D+WS+GCI EM GEP+F G N Q+++IV VLG P
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 343 PKHLLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRL 400
+ +L T +P S D ++
Sbjct: 252 SREVLRKLNPSHTDVDLYN---------------SKGIPWSNVFSDHSLKDA--KEAY-- 292
Query: 401 GEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADEST 448
DL+ +L Y P+ R+ PY AL H +F D +T
Sbjct: 293 --------------DLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 9e-64
Identities = 92/337 (27%), Positives = 155/337 (45%), Gaps = 51/337 (15%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN 179
Y +IG GSFG V +A + VAIK + K F N+ E++++ ++ ++
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 111
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRG--VSLNLTRKFSQQLCTALLF 237
Y +L LV + + +Y + R+ + + + + + QL +L +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVL 295
+ + I H D+KP+N+LL +P + +K+ DFGS+ QL G+ YI SR+YR+PE++
Sbjct: 172 IHS--FGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 228
Query: 296 LG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354
G Y +ID+WS GC+L E+ G+P+F G + VDQ+ +I++VLG P TR
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP----------TR 278
Query: 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLH---DILGVESGGPGGRRLGEPGHSVSDYL 411
+ +M K P+ P ++ +
Sbjct: 279 EQIREMNPNYTEFKFPQ---IKAHPWTKVFRPRTPPEAI--------------------- 314
Query: 412 KFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADEST 448
L R+L+Y P R+TP A H+FF D +
Sbjct: 315 ---ALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-63
Identities = 90/331 (27%), Positives = 142/331 (42%), Gaps = 50/331 (15%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK--KPFLNQAQI-EVKLLEIMNK 174
+++YE IG+GS+G V K + + VAIK P + + + E+++L+ +
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK- 60
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
N +V L F + L LVFE + + L RGV +L + + Q A
Sbjct: 61 -HPN----LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQA 114
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIY-QYIQSRFYRS 291
+ F + N IH D+KPENIL+ K S IK+ DFG + L Y + +R+YRS
Sbjct: 115 VNFC--HKHNCIHRDVKPENILIT--KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRS 170
Query: 292 PEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350
PE+L+G Y +D+W++GC+ E+ +G PL+ G ++VDQ+ I + LG
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV- 229
Query: 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410
F S + + P L + P
Sbjct: 230 ------FSTNQYFSGV-------KIPDPEDMEPLELKF---------PNISYPAL----- 262
Query: 411 LKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
L+ L DP R+T L H +F+
Sbjct: 263 ----GLLKGCLHMDPTERLTCEQLLHHPYFE 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-62
Identities = 90/333 (27%), Positives = 149/333 (44%), Gaps = 54/333 (16%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-----PFLNQAQIEVKLLEIM 172
+++YE L+G+GS+G V+K + + VAIK A E+KLL+ +
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK--IAMREIKLLKQL 81
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+V L + LVFE + + + D L G+ + +K+ Q+
Sbjct: 82 RHE------NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQII 134
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIY-QYIQSRFY 289
+ F NIIH D+KPEN +L + + +K+ DFG + L +Y + +R+Y
Sbjct: 135 NGIGFC--HSHNIIHRDIKPEN-ILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWY 190
Query: 290 RSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348
R+PE+L+G + Y A+D+W++GC++ EM GEPLF G +++DQ+ I+ LG +
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250
Query: 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVS 408
F+K P + + R P++ L +L E
Sbjct: 251 L-------FNKNPVFAGV-------RLPEIKEREPLERRY---------PKLSEVVI--- 284
Query: 409 DYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
DL + L DP R L H+FF+
Sbjct: 285 ------DLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-62
Identities = 98/378 (25%), Positives = 160/378 (42%), Gaps = 61/378 (16%)
Query: 86 GEDSSHKKEKKLYNEGYDDDNHDYII-----QHGEKFLDRYEIDSLIGKGSFGQVVKAFD 140
S+ + DD N + + GE+ Y +IG GSFG V +A
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL 61
Query: 141 LEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200
+E VAIK + K F N+ E++++ I+ +V + L LV
Sbjct: 62 VESD-EVAIKKVLQDKRFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 201 ELLSYNLYDLLRNTNFRG--VSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258
E + +Y R+ + + L + + QL +L ++ + + I H D+KP+N LL
Sbjct: 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQN-LLL 174
Query: 259 NPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVE 315
+P +K++DFGS+ L G+ YI SR+YR+PE++ G Y ID+WS GC++ E
Sbjct: 175 DPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE 234
Query: 316 MHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG--AHKTRKYFDKMPDGSYILKKPKDG 373
+ G+PLF G + +DQ+ +I++VLG P + + + F ++
Sbjct: 235 LMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI------------- 281
Query: 374 RKPKVPGSRRLH---DILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430
P S+ + DLI R+L+Y P R+T
Sbjct: 282 --RPHPFSKVFRPRTPPDAI------------------------DLISRLLEYTPSARLT 315
Query: 431 PYYALQHNFFKRTADEST 448
AL H FF
Sbjct: 316 AIEALCHPFFDELRTGEA 333
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 95/371 (25%), Positives = 165/371 (44%), Gaps = 93/371 (25%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
E +Y + +G GSFG V + FD+E A+K + + N+ E+ ++++++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR---ELDIMKVLD- 58
Query: 175 ADVNNTYYIVRLKRHFMWR--------------------------------------NHL 196
I++L +F +L
Sbjct: 59 -----HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 197 CLVFELLSYNLYDLLRNTNFRG--VSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPEN 254
++ E + L+ +L++ G + +NL + QL A+ F+ + L I H D+KP+N
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--LGICHRDIKPQN 171
Query: 255 ILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGC 311
+L+ N K + +K+ DFGS+ +L + YI SRFYR+PE++LG Y +ID+WS+GC
Sbjct: 172 LLV-NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 312 ILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG--AHKTRKYFDKMPDGSYILKK 369
+ E+ G+PLFSG +DQ+ +I++++G P K + H T F +
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL--------- 281
Query: 370 PKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429
+ L + G P ++ DL+ ++L Y+P RI
Sbjct: 282 ------KAKDWRKILPE--------------GTPSLAI-------DLLEQILRYEPDLRI 314
Query: 430 TPYYALQHNFF 440
PY A+ H FF
Sbjct: 315 NPYEAMAHPFF 325
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-58
Identities = 94/345 (27%), Positives = 152/345 (44%), Gaps = 54/345 (15%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIM 172
L RY+ IG G+ G V A+D + +VAIK K +PF NQ E+ L++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ--- 229
N ++ + ++ + +V EL+ NL +++ + L +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------MELDHERMSYLL 133
Query: 230 -QLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIY--QY 283
Q+ + L + IIH DLKP NI++ C +KI+DFG + G Y
Sbjct: 134 YQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCT-----LKILDFGLARTAGTSFMMTPY 186
Query: 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343
+ +R+YR+PEV+LG+ Y +D+WS+GCI+ EM G LF G++ +DQ NK++E LG P
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 344 KHLLDGAH-KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGE 402
+ R Y + P + + P +
Sbjct: 247 PEFMKKLQPTVRTYVENRP------------KYAGYSFEKLF----------PDVLFPAD 284
Query: 403 PGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
H+ + +DL+ +ML D RI+ ALQH + D S
Sbjct: 285 SEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 329
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 9e-58
Identities = 99/385 (25%), Positives = 163/385 (42%), Gaps = 57/385 (14%)
Query: 80 RAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKF--LDRYEIDSLIGKGSFGQVVK 137
+ Q + S K + D+ + + F L RY+ IG G+ G V
Sbjct: 22 QGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEV-GDSTFTVLKRYQNLKPIGSGAQGIVCA 80
Query: 138 AFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIMNKADVNNTYYIVRLKRHFMW 192
A+D +VAIK K +PF NQ E+ L++ +N ++ + + ++
Sbjct: 81 AYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138
Query: 193 RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ----QLCTALLFLSTPELNIIHC 248
+ LV EL+ NL +++ L + Q+ + L + IIH
Sbjct: 139 FQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS--AGIIHR 188
Query: 249 DLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRFYRSPEVLLGIPYDLA 303
DLKP NI++ C +KI+DFG + G Y+ +R+YR+PEV+LG+ Y
Sbjct: 189 DLKPSNIVVKSDCT-----LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 304 IDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH-KTRKYFDKMPD 362
+D+WS+GCI+ EM + LF G + +DQ NK++E LG P + R Y + P
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP- 302
Query: 363 GSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422
+ + + P + H+ + +DL+ +ML
Sbjct: 303 -----------KYAGLTFPKLF----------PDSLFPADSEHNKLKASQARDLLSKMLV 341
Query: 423 YDPKTRITPYYALQHNFFKRTADES 447
DP RI+ ALQH + D +
Sbjct: 342 IDPAKRISVDDALQHPYINVWYDPA 366
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-57
Identities = 59/309 (19%), Positives = 118/309 (38%), Gaps = 48/309 (15%)
Query: 98 YNEGYDDDNHDYIIQHGEKF---LDRYEIDSLIGKGSFGQVVKA-----FDLEEQCHVAI 149
Y ++ I+ +F + L+G+G+F QV +A D + + +
Sbjct: 41 YPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVL 100
Query: 150 KIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLY 208
K+ K + I +L+E + + + ++ +++N LV EL SY L
Sbjct: 101 KVQK--PANPWEFYIGTQLMERLKP---SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155
Query: 209 DLL---RNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP----- 260
+ + +NT + + L F+ ++ + + + IIH D+KP+N +L N
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV--HDCEIIHGDIKPDNFILGNGFLEQD 213
Query: 261 ----KRSAIKIVDFGSSCQL-----GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGC 311
+ + ++D G S + G ++ ++ E+L P++ ID + +
Sbjct: 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAA 273
Query: 312 ILVEMHTGEPL--------------FSGSNEVDQMNKIVEV-LGLPPKHLLDGAHKTRKY 356
+ M G + F +D N+ V L +P H L R+
Sbjct: 274 TVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333
Query: 357 FDKMPDGSY 365
K+ Y
Sbjct: 334 LKKVFQQHY 342
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-57
Identities = 99/347 (28%), Positives = 145/347 (41%), Gaps = 68/347 (19%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK------NKKPFLNQAQIEVK 167
G RYE + IG G++G V KA D VA+K ++ EV
Sbjct: 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVA 63
Query: 168 LLEIMNKADVNNTYYIVRLK-----RHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLN 222
LL + + N +VRL + LVFE + +L L G+
Sbjct: 64 LLRRLEAFEHPN---VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 223 LTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 282
+ +Q L FL I+H DLKPENIL+ + +K+ DFG L RIY
Sbjct: 121 TIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTS--GGTVKLADFG----LA-RIYS 171
Query: 283 YIQSRF--------YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
Q YR+PEVLL Y +DMWS+GCI EM +PLF G++E DQ+ K
Sbjct: 172 -YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 230
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGG 394
I +++GLPP+ +P G++ + P R + ++
Sbjct: 231 IFDLIGLPPEDDWPR-------DVSLPRGAFPPRGP-----------RPVQSVV------ 266
Query: 395 PGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
+ E G L+ ML ++P RI+ + ALQH++
Sbjct: 267 ---PEMEESGA---------QLLLEMLTFNPHKRISAFRALQHSYLH 301
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 6e-56
Identities = 83/344 (24%), Positives = 141/344 (40%), Gaps = 66/344 (19%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIMN 173
Y + +G G++G V A D VAIK K +PF ++ E+ LL+ M
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ---- 229
+V + LV + +L ++ + + Q
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL--------KFSEEKIQYLVY 133
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQYIQS 286
Q+ L ++ + ++H DLKP N+ + C +KI+DFG + + Y+ +
Sbjct: 134 QMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCE-----LKILDFGLARHADAEMTGYVVT 186
Query: 287 RFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
R+YR+PEV+L Y+ +D+WS+GCI+ EM TG+ LF G + +DQ+ +I++V G+P
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 346 LLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403
+ + Y +P + P+ + P
Sbjct: 247 FVQKLNDKAAKSYIQSLP------------QTPRKD----FTQLF--------------P 276
Query: 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
S DL+ +ML+ D R+T AL H FF+ D
Sbjct: 277 RAS-PQAA---DLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 316
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-55
Identities = 100/340 (29%), Positives = 149/340 (43%), Gaps = 66/340 (19%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCH-VAIKIIK---NKKPFLNQAQIEVKLLEIMNK 174
+YE + IG+G++G+V KA DL+ VA+K ++ ++ EV +L +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 175 ADVNNTYYIVRLK-----RHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229
+ N +VRL L LVFE + +L L GV +
Sbjct: 71 FEHPN---VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 288
QL L FL ++H DLKP+NIL+ + IK+ DFG L RIY Q
Sbjct: 128 QLLRGLDFLH--SHRVVHRDLKPQNILVTS--SGQIKLADFG----LA-RIYS-FQMALT 177
Query: 289 -------YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341
YR+PEVLL Y +D+WS+GCI EM +PLF GS++VDQ+ KI++V+GL
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401
P + +P ++ K + K V +
Sbjct: 238 PGEEDWPR-------DVALPRQAFHSKSAQPIEK-FVT-------------------DID 270
Query: 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
E G DL+ + L ++P RI+ Y AL H +F+
Sbjct: 271 ELGK---------DLLLKCLTFNPAKRISAYSALSHPYFQ 301
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-55
Identities = 81/357 (22%), Positives = 139/357 (38%), Gaps = 77/357 (21%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIM 172
RY +G G G V A D + VAIK K + + E+K++ +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK----KIVLTDPQSVKHALREIKIIRRL 65
Query: 173 N-----------KADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSL 221
+ + V N + +V E + +L ++L
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTEL---NSVYIVQEYMETDLANVLE-------QG 115
Query: 222 NLTRKFSQ----QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG------ 271
L + ++ QL L ++ + N++H DLKP N+ + N + +KI DFG
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANLFI-NTEDLVLKIGDFGLARIMD 172
Query: 272 SSCQLGQRIYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVD 330
+ + + +++YRSP +LL Y AIDMW+ GCI EM TG+ LF+G++E++
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232
Query: 331 QMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGV 390
QM I+E + + + YI +P P ++ L
Sbjct: 233 QMQLILESIPVVHEEDRQELLSVIP--------VYIRNDMT---EPHKPLTQLL------ 275
Query: 391 ESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
PG S + + D + ++L + P R+T AL H + +
Sbjct: 276 ------------PGIS-REAV---DFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-55
Identities = 89/344 (25%), Positives = 142/344 (41%), Gaps = 65/344 (18%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIMN 173
Y +G G++G V A D VAIK K +PF ++ E++LL+ M
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ---- 229
+V + LV + +L L++ L Q
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-------HEKLGEDRIQFLVY 135
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQYIQS 286
Q+ L ++ IIH DLKP N+ + C +KI+DFG + Q + Y+ +
Sbjct: 136 QMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCE-----LKILDFGLARQADSEMTGYVVT 188
Query: 287 RFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
R+YR+PEV+L Y +D+WS+GCI+ EM TG+ LF GS+ +DQ+ +I++V G PP
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248
Query: 346 LLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403
+ + + + Y +P K IL
Sbjct: 249 FVQRLQSDEAKNYMKGLP------------ELEKKD----FASIL--------------T 278
Query: 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
S + +L+ +ML D + R+T AL H +F+ D
Sbjct: 279 NAS-PLAV---NLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-55
Identities = 91/374 (24%), Positives = 159/374 (42%), Gaps = 86/374 (22%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ--AQ---IEVKLLEIM 172
L +YE+ +GKG++G V K+ D VA+K K F N AQ E+ +L +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTEL 65
Query: 173 NKADVNNTYYIVRLK-----RHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF 227
+ + N IV L + + LVF+ + +L+ ++R + L
Sbjct: 66 SGHE--N---IVNLLNVLRADND---RDVYLVFDYMETDLHAVIR-------ANILEPVH 110
Query: 228 SQ----QLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRI 280
Q QL + +L + ++H D+KP NILL C+ +K+ DFG S
Sbjct: 111 KQYVVYQLIKVIKYLHSG--GLLHRDMKPSNILLNAECH-----VKVADFGLSRSFVNIR 163
Query: 281 YQ------------------------YIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVE 315
Y+ +R+YR+PE+LLG Y IDMWSLGCIL E
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223
Query: 316 MHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD--GAHKTRKYFDKMPDGSYILKKPKDG 373
+ G+P+F GS+ ++Q+ +I+ V+ P ++ + + + +
Sbjct: 224 ILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLK------------ 271
Query: 374 RKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433
K ++ S + ++ ++ + L DL+ ++L ++P RI+
Sbjct: 272 EKVEIRQSNKRDIFTKWKNLLL---KINPKADCNEEAL---DLLDKLLQFNPNKRISAND 325
Query: 434 ALQHNFFKRTADES 447
AL+H F + +
Sbjct: 326 ALKHPFVSIFHNPN 339
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 6e-55
Identities = 92/333 (27%), Positives = 153/333 (45%), Gaps = 49/333 (14%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKAD 176
+++ +G G++ V K + +VA+K +K +++ + A E+ L++ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE- 63
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF----RGVSLNLTRKFSQQLC 232
IVRL N L LVFE + +L + + RG+ LNL + F QL
Sbjct: 64 -----NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFY 289
L F E I+H DLKP+N+L+ R +K+ DFG + G + + + + +Y
Sbjct: 119 QGLAFC--HENKILHRDLKPQNLLINK--RGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174
Query: 290 RSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348
R+P+VL+G Y +ID+WS GCIL EM TG+PLF G+N+ +Q+ I +++G P + L
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVS 408
K+P Y + +P R L +L + L
Sbjct: 235 S-------VTKLPK--YNPNIQQ---RPP----RDLRQVLQPHT----KEPLDGNLM--- 271
Query: 409 DYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
D + +L +P R++ AL H +F
Sbjct: 272 ------DFLHGLLQLNPDMRLSAKQALHHPWFA 298
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-54
Identities = 93/332 (28%), Positives = 146/332 (43%), Gaps = 53/332 (15%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNK 174
+ +YE IG+G++G V KA + E VA+K ++ + + + A E+ LL+ +
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
IVRL L LVFE +L + N + + + F QL
Sbjct: 61 K------NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKG 113
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYRS 291
L F N++H DLKP+N+L+ +K+ +FG + G + Y + + +YR
Sbjct: 114 LGFCH--SRNVLHRDLKPQNLLINR--NGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 292 PEVLLGIP-YDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
P+VL G Y +IDMWS GCI E+ G PLF G++ DQ+ +I +LG P +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409
K+PD Y P P + L +++ +L G
Sbjct: 230 -------MTKLPD--YK-------PYPMYPATTSLVNVV---------PKLNATGR---- 260
Query: 410 YLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
DL+ +L +P RI+ ALQH +F
Sbjct: 261 -----DLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-54
Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 57/333 (17%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-----PFLNQAQIEVKLLEIM 172
+++Y IG+G++G V KA + + A+K I+ +K P E+ +L+ +
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPS--TTIREISILKEL 57
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+ IV+L + L LVFE L +L LL G+ + F QL
Sbjct: 58 KHS------NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLL 110
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFY 289
+ + + ++H DLKP+N+L+ +KI DFG + G + +Y I + +Y
Sbjct: 111 NGIAYCH--DRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWY 166
Query: 290 RSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348
R+P+VL+G Y ID+WS+GCI EM G PLF G +E DQ+ +I +LG P
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVS 408
++P Y P L + L E G
Sbjct: 227 N-------VTELPK--YDPNFTVYEPLP-------WESFL---------KGLDESGI--- 258
Query: 409 DYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
DL+ +ML DP RIT AL+H +FK
Sbjct: 259 ------DLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-54
Identities = 90/344 (26%), Positives = 153/344 (44%), Gaps = 65/344 (18%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIMN 173
+RY+ S +G G++G V AFD + VA+K + PF + E++LL+ M
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKRTYRELRLLKHMK 86
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ---- 229
+V + R N + LV L+ +L ++++ LT Q
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-------CQKLTDDHVQFLIY 139
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQYIQS 286
Q+ L ++ + +IIH DLKP N+ + C +KI+DFG + + Y+ +
Sbjct: 140 QILRGLKYIHSA--DIIHRDLKPSNLAVNEDCE-----LKILDFGLARHTADEMTGYVAT 192
Query: 287 RFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
R+YR+PE++L Y+ +D+WS+GCI+ E+ TG LF G++ +DQ+ I+ ++G P
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 346 LLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403
LL + R Y + + PK+ ++
Sbjct: 253 LLKKISSESARNYIQSLT------------QMPKMN----FANVF--------------I 282
Query: 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
G + + DL+ +ML D RIT AL H +F + D
Sbjct: 283 GAN-PLAV---DLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 2e-54
Identities = 88/337 (26%), Positives = 149/337 (44%), Gaps = 56/337 (16%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-----PFLNQAQIEVKL 168
+ +++Y+ +G+G++G V KA D + + VA+K I+ P A E+ L
Sbjct: 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPS--TAIREISL 72
Query: 169 LEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFS 228
L+ ++ IV L L LVFE + +L +L G+ + + +
Sbjct: 73 LKELHHP------NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYL 125
Query: 229 QQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQ 285
QL + + I+H DLKP+N+L+ + A+K+ DFG + G + Y +
Sbjct: 126 YQLLRGVAHCH--QHRILHRDLKPQNLLINS--DGALKLADFGLARAFGIPVRSYTHEVV 181
Query: 286 SRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
+ +YR+P+VL+G Y ++D+WS+GCI EM TG+PLF G + DQ+ KI +LG P
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241
Query: 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404
++P + + + I+ + G
Sbjct: 242 REWPQ-------VQELPL--WKQRTF-----QVFEK-KPWSSII---------PGFCQEG 277
Query: 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
DL+ ML +DP RI+ A+ H +FK
Sbjct: 278 I---------DLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 3e-54
Identities = 87/330 (26%), Positives = 138/330 (41%), Gaps = 50/330 (15%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKA 175
++ Y +G+G++ V K VA+K I+ +++ A EV LL+ + A
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
IV L L LVFE L +L L + ++++ + F QL L
Sbjct: 61 ------NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGL 113
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYRSP 292
+ ++H DLKP+N+L+ R +K+ DFG + Y + + +YR P
Sbjct: 114 AYC--HRQKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169
Query: 293 EVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351
++LLG Y IDMW +GCI EM TG PLF GS +Q++ I +LG P + G
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG-- 227
Query: 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYL 411
+ + PK L RL G
Sbjct: 228 -----ILSNEE--FKTYNY-----PKYRA-EALLSHA---------PRLDSDGA------ 259
Query: 412 KFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
DL+ ++L ++ + RI+ A++H FF
Sbjct: 260 ---DLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 9e-54
Identities = 104/340 (30%), Positives = 152/340 (44%), Gaps = 57/340 (16%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-----PFLNQAQIEVKL 168
+DRY + +G+G++G+V KA D VAIK I+ + P A EV L
Sbjct: 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG--TAIREVSL 86
Query: 169 LEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFS 228
L+ + I+ LK + L L+FE +L + VS+ + + F
Sbjct: 87 LKELQHR------NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFL 138
Query: 229 QQLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQY-- 283
QL + F + +H DLKP+N+LL + +KI DFG + G I Q+
Sbjct: 139 YQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 284 -IQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341
I + +YR PE+LLG Y ++D+WS+ CI EM PLF G +E+DQ+ KI EVLGL
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256
Query: 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401
P G +PD + PK + L +L G L
Sbjct: 257 PDDTTWPG-------VTALPD--WKQSFPK-------FRGKTLKRVL--------GALLD 292
Query: 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
+ G DL+ ML+ DP RI+ AL+H +F
Sbjct: 293 DEGL---------DLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 85/363 (23%), Positives = 135/363 (37%), Gaps = 77/363 (21%)
Query: 113 HGEKF--LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI------ 164
E Y + I GS+G V D E VAIK + N I
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 165 ------EVKLLEIMNKADVNNTYYIVR--LKRHFMWRNHLCLVFELLSYNLYDLLRNTNF 216
E++LL + ++ I + + L LV EL+ +L ++ +
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM---HKLYLVTELMRTDLAQVIHDQR- 128
Query: 217 RGVSLNLTRKFSQ----QLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVD 269
+ ++ + Q + L L ++H DL P NILL + I I D
Sbjct: 129 ----IVISPQHIQYFMYHILLGLHVLHEA--GVVHRDLHPGNILLADNND-----ITICD 177
Query: 270 FG--SSCQLGQRIYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGS 326
F Y+ R+YR+PE+++ + +DMWS GC++ EM + LF GS
Sbjct: 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 327 NEVDQMNKIVEVLGLPPKHLLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRL 384
+Q+NKIVEV+G P + + R Y P + +
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL-----------SNVPARAWTAVV 286
Query: 385 HDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTA 444
P L DLI +ML+++P+ RI+ AL+H +F+
Sbjct: 287 ------------------PTAD-PVAL---DLIAKMLEFNPQRRISTEQALRHPYFESLF 324
Query: 445 DES 447
D
Sbjct: 325 DPL 327
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-53
Identities = 100/352 (28%), Positives = 158/352 (44%), Gaps = 77/352 (21%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIMN 173
RY S IG+G++G V A+D + VAIK I PF +Q E+K+L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFR 83
Query: 174 KADVNNTYYIVR--LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ-- 229
++ I+R + +V +L+ +LY LL+ + +L+
Sbjct: 84 HENIIGINDIIRAPTIEQM---KDVYIVQDLMETDLYKLLK-------TQHLSNDHICYF 133
Query: 230 --QLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFG------SSCQLGQ 278
Q+ L ++ + N++H DLKP N+LL C+ +KI DFG
Sbjct: 134 LYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTG 186
Query: 279 RIYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+ +Y+ +R+YR+PE++L Y +ID+WS+GCIL EM + P+F G + +DQ+N I+
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246
Query: 338 VLGLPPKHLLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGP 395
+LG P + L+ K R Y +P K KVP +R
Sbjct: 247 ILGSPSQEDLNCIINLKARNYLLSLP------------HKNKVPWNRLF----------- 283
Query: 396 GGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
P S L DL+ +ML ++P RI AL H + ++ D S
Sbjct: 284 -------PNAD-SKAL---DLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 9e-53
Identities = 87/361 (24%), Positives = 148/361 (40%), Gaps = 85/361 (23%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIM 172
+++ SL+G+G++G V A VAIK I+ PF E+K+L+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHF 66
Query: 173 NKADVNNTYYIVR--LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ- 229
++ + I R +F N + ++ EL+ +L+ ++ L+ Q
Sbjct: 67 KHENIITIFNIQRPDSFENF---NEVYIIQELMQTDLHRVISTQM-------LSDDHIQY 116
Query: 230 ---QLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIY-- 281
Q A+ L N+IH DLKP N+L+ C+ +K+ DFG + + +
Sbjct: 117 FIYQTLRAVKVLHGS--NVIHRDLKPSNLLINSNCD-----LKVCDFGLARIIDESAADN 169
Query: 282 -----------QYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEV 329
+++ +R+YR+PEV+L Y A+D+WS GCIL E+ P+F G +
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229
Query: 330 DQMNKIVEVLGLPPKHLLDGA---HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHD 386
Q+ I ++G P + R+Y +P P P +
Sbjct: 230 HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLP------------MYPAAPLEKMF-- 275
Query: 387 ILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
P + + DL+ RML +DP RIT AL+H + + D
Sbjct: 276 ----------------PRVN-PKGI---DLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315
Query: 447 S 447
+
Sbjct: 316 N 316
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-51
Identities = 84/338 (24%), Positives = 142/338 (42%), Gaps = 64/338 (18%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI----------EVK 167
RYE +G+G F V KA D VAIK IK ++++ E+K
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK----LGHRSEAKDGINRTALREIK 64
Query: 168 LLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF 227
LL+ ++ N I+ L F ++++ LVF+ + +L ++++ + ++ + + +
Sbjct: 65 LLQELS--HPN----IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAY 117
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---I 284
L +L + I+H DLKP N+LL +K+ DFG + G Y +
Sbjct: 118 MLMTLQGLEYLH--QHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQV 173
Query: 285 QSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343
+R+YR+PE+L G Y + +DMW++GCIL E+ P G +++DQ+ +I E LG P
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 233
Query: 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403
+ +PD P G+
Sbjct: 234 EEQWPD-------MCSLPDYVTFKSFPGIPLHHIFS-------------------AAGDD 267
Query: 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
DLI + ++P RIT AL+ +F
Sbjct: 268 LL---------DLIQGLFLFNPCARITATQALKMKYFS 296
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-50
Identities = 81/343 (23%), Positives = 152/343 (44%), Gaps = 64/343 (18%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-EVKLLEIMNKADV 177
D Y++ +G+G + +V +A ++ V +KI+K P + E+K+LE + +
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENL-RGGP 91
Query: 178 NNTYYIVRLKRHFMWRNH--LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
N I+ L LVFE + N D ++ ++ R + ++ AL
Sbjct: 92 N----IITLADIVKDPVSRTPALVFEHV--NNTDF--KQLYQTLTDYDIRFYMYEILKAL 143
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-------YIQSRF 288
+ + + I+H D+KP N+++ + + ++++D+G L Y + SR+
Sbjct: 144 DYCHS--MGIMHRDVKPHNVMI-DHEHRKLRLIDWG----LA-EFYHPGQEYNVRVASRY 195
Query: 289 YRSPEVLLGIP-YDLAIDMWSLGCILVEMHTG-EPLFSGSNEVDQMNKIVEVLGLPPKH- 345
++ PE+L+ YD ++DMWSLGC+L M EP F G + DQ+ +I +VLG +
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 346 LLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403
+D ++ D + R + R +H E
Sbjct: 256 YIDKYNIELDPRFNDILG------------RHSRKRWERFVH---------------SEN 288
Query: 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
H VS + D + ++L YD ++R+T A++H +F +
Sbjct: 289 QHLVSP--EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 4e-50
Identities = 86/348 (24%), Positives = 141/348 (40%), Gaps = 71/348 (20%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-----PFLNQAQIEVKLLEIM 172
+ +YE + IG+G+FG+V KA + VA+K + + P A E+K+L+++
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLL 73
Query: 173 NKADVNNTYYIVRLK--------RHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLT 224
N +V L + + + LVF+ ++L LL N + +L+
Sbjct: 74 K--HEN----VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEI 126
Query: 225 RKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRI 280
++ Q L L ++ I+H D+K N+L+ +K+ DFG S +
Sbjct: 127 KRVMQMLLNGLYYIH--RNKILHRDMKAANVLITR--DGVLKLADFGLARAFSLAKNSQP 182
Query: 281 YQYIQ---SRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
+Y + +YR PE+LLG Y ID+W GCI+ EM T P+ G+ E Q+ I
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 337 EVLGLPPKHLLDGAHKTRKY---FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESG 393
++ G T + D + + R++ D L
Sbjct: 243 QLCGSI----------TPEVWPNVDNYELYEKL--------ELVKGQKRKVKDRLKAYVR 284
Query: 394 GPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
P DLI ++L DP RI AL H+FF
Sbjct: 285 DPYAL----------------DLIDKLLVLDPAQRIDSDDALNHDFFW 316
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 83/372 (22%), Positives = 153/372 (41%), Gaps = 67/372 (18%)
Query: 103 DDDNHDY---IIQHGEKFLDRYEIDSL-IGKGSFGQVVKAFDLEEQ--CHVAIKIIKNKK 156
D ++D+ + E+ D +E + +G+G++G V KA + + A+K I+
Sbjct: 1 DKMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE-GT 59
Query: 157 PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR--NHLCLVFELLSYNLYDLLR-- 212
A E+ LL + N ++ L++ F+ + L+F+ ++L+ +++
Sbjct: 60 GISMSACREIALLRELK--HPN----VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFH 113
Query: 213 -----NTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILL--CNPKRSAI 265
N + + + Q+ + +L ++H DLKP NIL+ P+R +
Sbjct: 114 RASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRV 171
Query: 266 KIVDFGSSCQLGQ--RIYQYIQSR----FYRSPEVLLGIP-YDLAIDMWSLGCILVEMHT 318
KI D G + + + +YR+PE+LLG Y AID+W++GCI E+ T
Sbjct: 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231
Query: 319 GEPLFSGSNEV---------DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKK 369
EP+F E DQ+++I V+G P + KMP+ S ++K
Sbjct: 232 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWED-------IKKMPEHSTLMKD 284
Query: 370 PKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429
+ + + + L+ ++L DP RI
Sbjct: 285 FRRNTYTNCSLIKYMEKH---------KVKPDSKAF---------HLLQKLLTMDPIKRI 326
Query: 430 TPYYALQHNFFK 441
T A+Q +F
Sbjct: 327 TSEQAMQDPYFL 338
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 93/422 (22%), Positives = 151/422 (35%), Gaps = 124/422 (29%)
Query: 98 YNEGYDDDNHDYIIQHGEKF--LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK 155
++ + + Q + D Y I LIG+GS+G V A+D + +VAIK +
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR- 61
Query: 156 KPFLNQAQI-----EVKLLEIMNKADVNNTYYIVR--LKRHFMWRNHLCLVFELLSYNLY 208
F + E+ +L + + Y ++ F + L +V E+ +L
Sbjct: 62 -MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF---DELYIVLEIADSDLK 117
Query: 209 DLLRNTNFRGVSLNLTRKFSQ----QLCTALLFLSTPELNIIHCDLKPENILL---CNPK 261
L + F LT + + L F+ IIH DLKP N LL C+
Sbjct: 118 KLFKTPIF------LTEEHIKTILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCS-- 167
Query: 262 RSAIKIVDFG-------------------------SSCQLGQRIYQYIQSRFYRSPEVLL 296
+K+ DFG + L +++ ++ +R+YR+PE++L
Sbjct: 168 ---VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224
Query: 297 GIP-YDLAIDMWSLGCILVEMHTG-----------EPLFSGS-----------------N 327
Y +ID+WS GCI E+ PLF GS +
Sbjct: 225 LQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKS 284
Query: 328 EVDQMNKIVEVLGLPPKHLLD--GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLH 385
DQ+N I ++G P + L + KY P + + L
Sbjct: 285 NRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP------------HRKPIN----LK 328
Query: 386 DILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445
P S D + +L+ ML ++P RIT AL H + K
Sbjct: 329 QKY--------------PSIS-DDGI---NLLESMLKFNPNKRITIDQALDHPYLKDVRK 370
Query: 446 ES 447
+
Sbjct: 371 KK 372
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-45
Identities = 64/289 (22%), Positives = 106/289 (36%), Gaps = 23/289 (7%)
Query: 58 LSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKF 117
VDL + ++ + +R + + + ++ + GYD + F
Sbjct: 9 SGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQ-------SPGYDPSRPE------SFF 55
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
++ S +G GS+G+V K E+ A+K PF KL E+ + V
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS--MSPFRGPKDRARKLAEVGSHEKV 113
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
VRL++ + L L EL +L + + + AL
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAH 172
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRSPEVL 295
L ++H D+KP NI L R K+ DFG +LG Y +PE+L
Sbjct: 173 LH--SQGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL 228
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
G Y A D++SLG ++E+ L G Q+ +
Sbjct: 229 QG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAG 276
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-45
Identities = 101/453 (22%), Positives = 163/453 (35%), Gaps = 132/453 (29%)
Query: 75 AKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKF--LDRYEIDSLIGKGSF 132
A ++ +Q S ++E + + + + + + DRYEI LIG GS+
Sbjct: 7 AAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSY 66
Query: 133 GQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIMNKADVNNTYYIVR-- 185
G V +A+D E+ VAIK I F + E+ +L +N V IV
Sbjct: 67 GHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK 124
Query: 186 LKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ----QLCTALLFLSTP 241
F + L +V E+ + L R + LT + L + ++ +
Sbjct: 125 DVEKF---DELYVVLEIADSDFKKLFRTPVY------LTELHIKTLLYNLLVGVKYVHSA 175
Query: 242 ELNIIHCDLKPENILL---CNPKRSAIKIVDFG--------------------------- 271
I+H DLKP N L+ C+ +K+ DFG
Sbjct: 176 --GILHRDLKPANCLVNQDCS-----VKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 272 --SSCQLGQRIY-QYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHT--------- 318
+ +R ++ +R+YR+PE++L Y AID+WS+GCI E+
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 319 --GEPLFSGSN--------------------EVDQMNKIVEVLGLPPKHLLD--GAHKTR 354
PLF GS+ DQ+N I +LG P + ++ +
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414
+Y P ++ L + P S +D +
Sbjct: 349 RYIRIFP------------KREGTD----LAERF--------------PASS-ADAI--- 374
Query: 415 DLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
L+ RML ++P RIT L H FFK
Sbjct: 375 HLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-43
Identities = 61/348 (17%), Positives = 118/348 (33%), Gaps = 91/348 (26%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII---KNKKPFLNQAQIEVKLLEIMNKAD 176
Y I IG G +V + + ++Q AIK + + L+ + E+ L +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--- 84
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
++ I+RL + + ++ +V E + +L L+ + + + + + + A+
Sbjct: 85 -QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVH 141
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-----GQRIYQYIQSRFYRS 291
+ + I+H DLKP N L+ + +K++DFG + Q+ + + Y
Sbjct: 142 TIH--QHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 292 PEVLLGIP-----------YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340
PE + + D+WSLGCIL M G+ F +Q++K
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISK------ 248
Query: 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRL 400
+ + + P
Sbjct: 249 -------------------------LHAIIDPNHEIEFPDI------------------- 264
Query: 401 GEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADEST 448
L+ D++ L DPK RI+ L H + +
Sbjct: 265 ------PEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 54/230 (23%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII---KNKKPFLNQAQIEVKLLEIM 172
+ +++Y IG+GSFG+ + E+ IK I + +++ EV +L
Sbjct: 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL--- 77
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQL 231
A++ + IV+ + F L +V + +L+ + + + Q+
Sbjct: 78 --ANMKHPN-IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR---- 287
C AL + + I+H D+K +NI L K +++ DFG + L + + ++
Sbjct: 135 CLALKHVH--DRKILHRDIKSQNIFLT--KDGTVQLGDFGIARVLNSTV-ELARACIGTP 189
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+Y SPE+ PY+ D+W+LGC+L E+ T + F + + + KI+
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-42
Identities = 57/238 (23%), Positives = 94/238 (39%), Gaps = 24/238 (10%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---PFLNQAQIEVKLLEI 171
+ YE+ IG GS+G+ K + + K + EV LL
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL-- 59
Query: 172 MNKADVNNTYYIVRLKRHFMWR--NHLCLVFELLS-YNLYDLLRNTNFRGVSL--NLTRK 226
++ + IVR + R L +V E +L ++ L +
Sbjct: 60 ---RELKHPN-IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 227 FSQQLCTALLFL---STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 283
QL AL S ++H DLKP N+ L + +K+ DFG + L +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD--GKQNVKLGDFGLARILNHD-TSF 172
Query: 284 IQSR----FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
++ +Y SPE + + Y+ D+WSLGC+L E+ P F+ ++ + KI E
Sbjct: 173 AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-42
Identities = 61/349 (17%), Positives = 119/349 (34%), Gaps = 89/349 (25%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEI--MNKADV 177
Y I IG G +V + + ++Q AIK + ++ + ++ EI +NK
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQ 66
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
++ I+RL + + ++ +V E + +L L+ + + + + + + A+
Sbjct: 67 HSDK-IIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 123
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-----GQRIYQYIQSRFYRSP 292
+ + I+H DLKP N L+ + +K++DFG + Q+ + + Y P
Sbjct: 124 IH--QHGIVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 293 EVLLGIP-----------YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341
E + + D+WSLGCIL M G+ F +Q++K+
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKL------ 230
Query: 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401
+ + P
Sbjct: 231 -------------------------HAIIDPNHEIEFP---------------------- 243
Query: 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNT 450
+D++ L DPK RI+ L H + +
Sbjct: 244 ---DIPEK--DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 287
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-42
Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 22/236 (9%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLL 169
G L + I+ IG+G F +V +A L + VA+K ++ E+ LL
Sbjct: 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL 86
Query: 170 EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSL--NLTRK 226
+ +N +++ F+ N L +V EL +L ++++ + + K
Sbjct: 87 KQLNHP------NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQY 283
+ QLC+AL + ++H D+KP N+ + +K+ D G + +
Sbjct: 141 YFVQLCSALEHMH--SRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS--NEVDQMNKIVE 337
+ + +Y SPE + Y+ D+WSLGC+L EM + F G N KI +
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 50/358 (13%), Positives = 99/358 (27%), Gaps = 89/358 (24%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----------------------P 157
+ ++ + G V D+E A+K+
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 158 FLNQAQIEVKLLEIMNKADVNNTYYIVRLK--RHFMWRNHLCLVFELLSYNLYDLLRNTN 215
+A+ +LL + V + +L + + L+ S +L L +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 216 FRGV-----SLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270
F V + + QL L ++H P+N+ + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQ--SKGLVHGHFTPDNLFIM--PDGRLMLGDV 238
Query: 271 GSSCQLGQRIYQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
+ ++G R Y E L + A++ W LG + + F
Sbjct: 239 SALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 329 VDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDIL 388
+ + L +P L F
Sbjct: 299 GIKGSWKRPSLRVPGTDSLA--------FGSCTP-------------------------- 324
Query: 389 GVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
+ D++K LI R L++D + R+ P A++ F + +E
Sbjct: 325 ------------------LPDFVK--TLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 63/338 (18%), Positives = 111/338 (32%), Gaps = 82/338 (24%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN 179
+ ++G G+ G +V + + VA+K I + A EV+LL ++
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRIL--PECFSFADREVQLLRESDEHP--- 78
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
++R R + EL + L + + +F + L QQ + L L
Sbjct: 79 --NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE-PITLLQQTTSGLAHLH 135
Query: 240 TPELNIIHCDLKPENILLCNPKRSA---IKIVDFGSSCQLGQRIYQYIQ------SRFYR 290
LNI+H DLKP NIL+ P I DFG +L + + + + +
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 291 SPEVLLGIP---YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
+PE+L +D++S GC+ + + G P
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE--------------------GSHP---- 229
Query: 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407
+ + + IL P
Sbjct: 230 --------FGKSLQRQANILLGACSLDCL-------------------------HPEKHE 256
Query: 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445
++LI +M+ DP+ R + + L+H FF
Sbjct: 257 DV--IARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-41
Identities = 56/267 (20%), Positives = 113/267 (42%), Gaps = 15/267 (5%)
Query: 76 KKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQV 135
+ + +G+ + + + + + LD Y+I +G G+FG V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 136 VKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKADVNNTYYIVRLKRHFMWR 193
+ + + A K + + E E M+ +V L F
Sbjct: 174 HRVTERATGNNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPT---LVNLHDAFEDD 226
Query: 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKP 252
N + +++E +S L++ + + + + +S + ++ +Q+C L + E N +H DLKP
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKP 283
Query: 253 ENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLG 310
ENI+ + + +K++DFG + L Q + + + +PEV G P DMWS+G
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG 343
Query: 311 CILVEMHTGEPLFSGSNEVDQMNKIVE 337
+ + +G F G N+ + + +
Sbjct: 344 VLSYILLSGLSPFGGENDDETLRNVKS 370
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-41
Identities = 44/240 (18%), Positives = 85/240 (35%), Gaps = 26/240 (10%)
Query: 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKA 175
++ + IG G FG V K + C AIK KKP + L E+ A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS--KKPLAGSVDEQNALREVYAHA 65
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSL--NLTRKFSQQLC 232
+ ++VR + +H+ + E + +L D + + Q+
Sbjct: 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 233 TALLFLSTPELNIIHCDLKPENILLCN-----------------PKRSAIKIVDFGSSCQ 275
L ++ ++++H D+KP NI + + KI D G +
Sbjct: 126 RGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 276 LGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
+ + + EVL + D+++L +V EPL ++ ++ +
Sbjct: 184 ISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 72/274 (26%), Positives = 115/274 (41%), Gaps = 45/274 (16%)
Query: 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKA 175
++ +E +++G+G+FGQVVKA + + + AIK I++ + L+ EV LL +N
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 176 DVNNTYYIVRLKRHFMWRNH-------------LCLVFELLSYN-LYDLLRNTNFRGVSL 221
Y+VR ++ R + L + E LYDL+ + N
Sbjct: 63 ------YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQR 115
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281
+ + +Q+ AL ++ IIH DLKP NI + + +KI DFG + + + +
Sbjct: 116 DEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFID--ESRNVKIGDFGLAKNVHRSLD 171
Query: 282 QYIQSR-----------------FYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLF 323
Y + EVL G Y+ IDM+SLG I EM P
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFS 229
Query: 324 SGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYF 357
+G V+ + K+ V P D K K
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKI 263
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 8/48 (16%), Positives = 15/48 (31%)
Query: 403 PGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNT 450
P + K +I ++D+DP R L + +
Sbjct: 250 PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 94/398 (23%), Positives = 152/398 (38%), Gaps = 85/398 (21%)
Query: 65 TYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEID 124
T+ +N K KRR + E + K++ + D D + + D Y +
Sbjct: 85 TF--VNTELVGKGKRRPLNNNSEIALSLSRNKVFV--FFDLTVDDQSVYPKALRDEYIMS 140
Query: 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE-------IMNKADV 177
+G G+ G+V AF+ + VAI+II +K+ F + E I+ K +
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRII-SKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
I+++K F ++ +V EL+ L+D + + + + Q+ A+
Sbjct: 200 PC---IIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQ 253
Query: 237 FLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPE 293
+L E IIH DLKPEN+LL + + IKI DFG S L + + Y +PE
Sbjct: 254 YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311
Query: 294 VLLGI---PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350
VL+ + Y+ A+D WSLG IL +G P FS +
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------------------ 353
Query: 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410
D++ G Y VS+
Sbjct: 354 ------KDQITSGKYNFIPE--------------------------------VWAEVSE- 374
Query: 411 LKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADEST 448
K DL+ ++L DPK R T AL+H + + +
Sbjct: 375 -KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 411
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 55/242 (22%), Positives = 91/242 (37%), Gaps = 33/242 (13%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
++F ++ LIG G FGQV KA + IK +K +A+ EVK L
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKAL----- 58
Query: 175 ADVNNTYYIVRLKRHFM----------------WRNHLCLVFELLS-YNLYDLLRNTNFR 217
A +++ IV + L + E L +
Sbjct: 59 AKLDHVN-IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 218 GVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277
+ L + +Q+ + ++ +I+ DLKP NI L +KI DFG L
Sbjct: 118 KLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLV--DTKQVKIGDFGLVTSLK 173
Query: 278 Q--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEM-HTGEPLFSGSNEVDQMNK 334
+ + + Y SPE + Y +D+++LG IL E+ H + F S +
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD 233
Query: 335 IV 336
+
Sbjct: 234 GI 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-40
Identities = 62/349 (17%), Positives = 119/349 (34%), Gaps = 89/349 (25%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEI--MNKADV 177
Y I IG G +V + + ++Q AIK + ++ + ++ EI +NK
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQ 113
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
++ I+RL + + ++ +V E + +L L+ + + + + + + A+
Sbjct: 114 HSDK-IIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 170
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-----GQRIYQYIQSRFYRSP 292
+ + I+H DLKP N L+ +K++DFG + Q+ + + Y P
Sbjct: 171 IH--QHGIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 293 EVLLGIP-----------YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341
E + + D+WSLGCIL M G+ F +Q++K+
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKL------ 277
Query: 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401
+ + P
Sbjct: 278 -------------------------HAIIDPNHEIEFP---------------------- 290
Query: 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNT 450
L+ D++ L DPK RI+ L H + +
Sbjct: 291 ---DIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 16/226 (7%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
++ ++Y I +G+G FG V + + + K +K K + E+ I+N
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEI---SILNI 57
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLN--LTRKFSQQL 231
A N I+ L F L ++FE +S ++++ + LN + Q+
Sbjct: 58 ARHRN---ILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQV 111
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFY 289
C AL FL NI H D++PENI+ + S IKI++FG + QL G + Y
Sbjct: 112 CEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
+PEV A DMWSLG ++ + +G F + I
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 54/335 (16%), Positives = 110/335 (32%), Gaps = 56/335 (16%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ + ++G+G+ V + + AIK+ N FL ++++ E++ K +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHK 67
Query: 179 NTYYIVRLKRHF--MWRNHLCLVFELLSY-NLYDLL-RNTNFRGVSLNLTRKFSQQLCTA 234
N IV+L H L+ E +LY +L +N G+ + + +
Sbjct: 68 N---IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPK--RSAIKIVDFGSSCQL--GQRIYQYIQSRFYR 290
+ L E I+H ++KP NI+ + +S K+ DFG++ +L ++ + Y
Sbjct: 125 MNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 291 SPEVLLGI--------PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342
P++ Y +D+WS+G TG F + +++
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY----- 237
Query: 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGE 402
G + +P S L
Sbjct: 238 --------KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR---------------- 273
Query: 403 PGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437
+ L ++ +L+ D +
Sbjct: 274 ---GLQVLLT--PVLANILEADQEKCWGFDQFFAE 303
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 57/279 (20%), Positives = 118/279 (42%), Gaps = 22/279 (7%)
Query: 67 KHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSL 126
+ + ++ K R + + + + K Y + + + D Y+I
Sbjct: 2 RGSHHHHHHGSKVRGKYDGPKINDYDKF---YEDIWKKYVPQPVEVKQGSVYDYYDILEE 58
Query: 127 IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLLEIMNKADVNNTYYIV 184
+G G+FG V + + K I L++ + E+ IMN+ ++
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFIN-TPYPLDKYTVKNEI---SIMNQLHHPK---LI 111
Query: 185 RLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLN--LTRKFSQQLCTALLFLSTP 241
L F + + L+ E LS L+D + ++ + +Q C L +
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH-- 166
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGIP 299
E +I+H D+KPENI+ K S++KI+DFG + +L + + + + +PE++ P
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338
DMW++G + + +G F+G ++++ + +
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 78/342 (22%), Positives = 132/342 (38%), Gaps = 73/342 (21%)
Query: 117 FLDRYEIDSL---IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMN 173
F Y++D +G+GSF K + A+KII + Q E+ +
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEI---TALK 60
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYD-LLRNTNFRGVSLNLTRKFSQQL 231
+ + IV+L F + H LV ELL+ L++ + + +F S ++L
Sbjct: 61 LCEGHP--NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHF---SETEASYIMRKL 115
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFGSSCQL---GQRIYQYIQSR 287
+A+ + ++ ++H DLKPEN+L + IKI+DFG + Q + +
Sbjct: 116 VSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL 173
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
Y +PE+L YD + D+WSLG IL M +G+ F + VE+
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI--------- 224
Query: 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407
K+ G + + GE +V
Sbjct: 225 ---------MKKIKKGDFSFE--------------------------------GEAWKNV 243
Query: 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
S + KDLI +L DP R+ + + + + S+N
Sbjct: 244 SQ--EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 65/253 (25%), Positives = 115/253 (45%), Gaps = 16/253 (6%)
Query: 89 SSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVA 148
S +E + +I + Y+ +G G++G+V+ D A
Sbjct: 7 HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66
Query: 149 IKIIKNKKPFLNQAQIEVKL-LEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YN 206
IKII K + ++ + ++ D N I++L F + + LV E
Sbjct: 67 IKII-RKTSVSTSSNSKLLEEVAVLKLLDHPN---IMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 207 LYD-LLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK-RSA 264
L+D ++ F + +Q+ + + +L + NI+H DLKPEN+LL + + +
Sbjct: 123 LFDEIIHRMKF---NEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDAL 177
Query: 265 IKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPL 322
IKIVDFG S +++ + + + +Y +PEVL YD D+WS+G IL + G P
Sbjct: 178 IKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPP 236
Query: 323 FSGSNEVDQMNKI 335
F G + + + K+
Sbjct: 237 FGGQTDQEILRKV 249
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 13/37 (35%), Positives = 21/37 (56%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNT 450
KDLI +ML +D + RI+ AL+H + K + +
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESG 305
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 149 bits (376), Expect = 7e-39
Identities = 71/348 (20%), Positives = 123/348 (35%), Gaps = 60/348 (17%)
Query: 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLL 169
+ +E+ +G G FG V++ + VAIK + + N+ + E+
Sbjct: 7 SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEI--- 63
Query: 170 EIMNKADVNNTYYIVRL------KRHFMWRNHLCLVFELLS-YNLYDLL-RNTNFRGVSL 221
+IM K + N +V + + L E +L L + N G+
Sbjct: 64 QIMKKLNHPN---VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQL--GQ 278
R + +AL +L E IIH DLKPENI+L P+R KI+D G + +L G+
Sbjct: 121 GPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 279 RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338
+++ + Y +PE+L Y + +D WS G + E TG F + + Q + V
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238
Query: 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGR 398
+ D K+ +P +++
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG-------------------------- 272
Query: 399 RLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
K + + ML + + R T F+
Sbjct: 273 -------------KLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 64/358 (17%), Positives = 116/358 (32%), Gaps = 105/358 (29%)
Query: 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMN 173
++L +E +G+G FG V +A + + C+ AIK I+ N++ + EVK L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 174 KADVNNTYYIVRLKRHFM------------WRNHLCLVFELLS-YNLYDLLRNTNFRG-V 219
IVR ++ + +L + +L NL D +
Sbjct: 62 HP------GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 220 SLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--- 276
++ Q+ A+ FL ++H DLKP NI +K+ DFG +
Sbjct: 116 ERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFT--MDDVVKVGDFGLVTAMDQD 171
Query: 277 ------------GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFS 324
R + ++ Y SPE + G Y +D++SLG IL E+ P +
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFST 229
Query: 325 GSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRL 384
V + + ++ + P + +
Sbjct: 230 QMERVRTLTDV-----------------------------------RNLKFPPLFTQK-- 252
Query: 385 HDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
Y ++ ML P R +++ F+
Sbjct: 253 -------------------------YPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-38
Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 17/237 (7%)
Query: 106 NHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIE 165
++ F DRY+ ++GKGSFG+V+ D A+K+I +K+ + E
Sbjct: 13 PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKE 71
Query: 166 VKLLE--IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYD-LLRNTNFRGVSL 221
L E ++ + D N I++L F + + LV E+ + L+D ++ F S
Sbjct: 72 SLLREVQLLKQLDHPN---IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SE 125
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSSCQL--GQ 278
+ +Q+ + + ++ + I+H DLKPEN+LL + K + I+I+DFG S +
Sbjct: 126 VDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 279 RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
++ I + +Y +PEVL G YD D+WS G IL + +G P F+G+NE D + K+
Sbjct: 184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 14/36 (38%), Positives = 19/36 (52%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
KDLI +ML Y P RI+ AL H + + E +
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS 294
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 63/285 (22%), Positives = 105/285 (36%), Gaps = 56/285 (19%)
Query: 104 DDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQ 163
+N + + +Y + IG+GS+G V A + + + AIKI+ K +
Sbjct: 11 RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70
Query: 164 IEVKL---LEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS---------------- 204
++ + +M K N I RL + ++CLV EL
Sbjct: 71 DVERIKTEVRLMKKLHHPN---IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127
Query: 205 ---------------YNLYDLLRNTNFRGVSLNLTRKFS--------QQLCTALLFLSTP 241
+ N + G +L +Q+ +AL +L
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-- 185
Query: 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-------GQRIYQYIQSRFYRSPEV 294
I H D+KPEN L K IK+VDFG S + + + ++ +PEV
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 295 LLGI--PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
L Y D WS G +L + G F G N+ D +++++
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN 290
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 9/36 (25%), Positives = 18/36 (50%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
+DL+ +L+ + R ALQH + + +D+
Sbjct: 308 RDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 16/233 (6%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE---- 170
+K D Y+I +G G F V K + A K IK ++ ++ + + +E
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQ 229
I+ + +N ++ L + R + L+ EL+S L+D L +S F +
Sbjct: 68 ILRQVLHHN---VITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIK 122
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKR--SAIKIVDFGSSCQL--GQRIYQYIQ 285
Q+ + +L I H DLKPENI+L + IK++DFG + ++ G
Sbjct: 123 QILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180
Query: 286 SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338
+ + +PE++ P L DMWS+G I + +G F G + + + I V
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 9/36 (25%), Positives = 18/36 (50%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
KD I ++L + + R+T AL+H + ++
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAM 285
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 25/265 (9%)
Query: 87 EDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCH 146
+ LY +G + Y+ + K + Y +G G++G+V+ +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 147 VAIKIIKNKKPFLNQAQIEVKL-----------LEIMNKADVNNTYYIVRLKRHFMWRNH 195
AIK+IK + + + K + ++ D N I++L F + +
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN---IIKLFDVFEDKKY 120
Query: 196 LCLVFELLS-YNLYD-LLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253
LV E L++ ++ F +Q+ + + +L + NI+H D+KPE
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKF---DECDAANIMKQILSGICYLH--KHNIVHRDIKPE 175
Query: 254 NILLCNPK-RSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLG 310
NILL N IKIVDFG S ++ + + +Y +PEVL Y+ D+WS G
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCG 234
Query: 311 CILVEMHTGEPLFSGSNEVDQMNKI 335
I+ + G P F G N+ D + K+
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKV 259
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 13/35 (37%), Positives = 17/35 (48%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADEST 448
K+LI ML YD R T AL + K+ A+
Sbjct: 279 KELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 89/388 (22%), Positives = 142/388 (36%), Gaps = 83/388 (21%)
Query: 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL-- 169
+ + D Y + +G G+ G+V AF+ + VAIKII +K+ F + E
Sbjct: 3 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKII-SKRKFAIGSAREADPALN 61
Query: 170 -----EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYD-LLRNTNFRGVSLN 222
EI+ K + I+++K F ++ +V EL+ L+D ++ N
Sbjct: 62 VETEIEILKKLNHPC---IIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRL---KEA 114
Query: 223 LTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSS--CQLGQR 279
+ + Q+ A+ +L E IIH DLKPEN+LL + + IKI DFG S
Sbjct: 115 TCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 280 IYQYIQSRFYRSPEVLLGI---PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
+ + Y +PEVL+ + Y+ A+D WSLG IL +G P FS +
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---- 228
Query: 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPG 396
D++ G Y
Sbjct: 229 --------------------KDQITSGKYNFIPE-------------------------- 242
Query: 397 GRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSGL 456
VS+ K DL+ ++L DPK R T AL+H + + + S
Sbjct: 243 ------VWAEVSE--KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 294
Query: 457 GSMSTSPASAGGSLPLLLSSLEVQPPPS 484
+ P E + +
Sbjct: 295 NESTALPQVLAQPSTSRKRPREGEAEGA 322
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 14/225 (6%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
+ ++G G+F +V A+K IK K P + +E + ++ K
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLE-NEIAVLKK 62
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYD-LLRNTNFRGVSLNLTRKFSQQLC 232
N IV L+ + H LV +L+S L+D +L + + QQ+
Sbjct: 63 IKHEN---IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY---TEKDASLVIQQVL 116
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFG-SSCQLGQRIYQYIQSRFYR 290
+A+ +L E I+H DLKPEN+L P+ S I I DFG S + + + Y
Sbjct: 117 SAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYV 174
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
+PEVL PY A+D WS+G I + G P F E KI
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 71/364 (19%), Positives = 124/364 (34%), Gaps = 103/364 (28%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
+ + + ++G GS G VV + + VA+K + F + A +E+ +++ +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRML--IDFCDIALMEI---KLLTE 64
Query: 175 ADV--NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNL-----TRKF 227
+D N ++R L + EL + NL DL+ + N +L L
Sbjct: 65 SDDHPN----VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA-----------IKIVDFGSSCQL 276
+Q+ + + L L IIH DLKP+NIL+ R I I DFG +L
Sbjct: 121 LRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 277 GQRIYQYIQ-------SRFYRSPEVLLGI-------PYDLAIDMWSLGCILVEM-HTGEP 321
+ + +R+PE+L +ID++S+GC+ + G+
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 322 LFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGS 381
F + I++ + K
Sbjct: 239 PFGDKYSRESN---------------------------------IIRGIFSLDEMKCL-- 263
Query: 382 RRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
S+ DLI +M+D+DP R T L+H F
Sbjct: 264 ---------------------HDRSLIAEAT--DLISQMIDHDPLKRPTAMKVLRHPLFW 300
Query: 442 RTAD 445
+
Sbjct: 301 PKSK 304
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 15/227 (6%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL-LEIMN 173
KF D Y++ +GKG+F V + A KII N K + +++ I
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICR 60
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYD-LLRNTNFRGVSLNLTRKFSQQL 231
K N IVRL + LVF+L++ L++ ++ + S QQ+
Sbjct: 61 KLQHPN---IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQI 114
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSSCQL--GQRIYQYIQSRF 288
++ + I+H +LKPEN+LL + K +A+K+ DFG + ++ + + + +
Sbjct: 115 LESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 172
Query: 289 YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
Y SPEVL PY +D+W+ G IL + G P F ++ +I
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 12/36 (33%), Positives = 17/36 (47%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
K LI ML +PK RIT AL+ + ++
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 55/328 (16%), Positives = 109/328 (33%), Gaps = 56/328 (17%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ + ++G+G+ V + + AIK+ N FL ++++ E++ K +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHK 67
Query: 179 NTYYIVRLKRHF--MWRNHLCLVFELLSY-NLYDLL-RNTNFRGVSLNLTRKFSQQLCTA 234
N IV+L H L+ E +LY +L +N G+ + + +
Sbjct: 68 N---IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 235 LLFLSTPELNIIHCDLKPENILLCNP--KRSAIKIVDFGSSCQL--GQRIYQYIQSRFYR 290
+ L E I+H ++KP NI+ +S K+ DFG++ +L ++ + Y
Sbjct: 125 MNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 291 SPEVLLGI--------PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342
P++ Y +D+WS+G TG F + +++
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY----- 237
Query: 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGE 402
G + +P S L L V
Sbjct: 238 --------KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL----------- 278
Query: 403 PGHSVSDYLKFKDLIFRMLDYDPKTRIT 430
++ +L+ D +
Sbjct: 279 ----------LTPVLANILEADQEKCWG 296
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 15/236 (6%)
Query: 108 DYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVK 167
++++ KF D Y++ +GKG+F V + A KII N K + +++
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLE 76
Query: 168 L-LEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYD-LLRNTNFRGVSLNLT 224
I K N IVRL + LVF+L++ L++ ++ + S
Sbjct: 77 REARICRKLQHPN---IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---SEADA 130
Query: 225 RKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSSCQL--GQRIY 281
QQ+ ++ + I+H +LKPEN+LL + K +A+K+ DFG + ++ + +
Sbjct: 131 SHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188
Query: 282 QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+ + Y SPEVL PY +D+W+ G IL + G P F ++ +I
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 12/46 (26%), Positives = 19/46 (41%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSGLGSM 459
K LI ML +PK RIT AL+ + ++ + +
Sbjct: 262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCL 307
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 75/234 (32%), Positives = 121/234 (51%), Gaps = 16/234 (6%)
Query: 108 DYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVK 167
+ F +RY I ++GKGSFG+V+K D Q A+K+I NK N+ +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTIL 69
Query: 168 L-LEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYD-LLRNTNFRGVSLNLT 224
+E++ K D N I++L + +V EL + L+D +++ F S +
Sbjct: 70 REVELLKKLDHPN---IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDA 123
Query: 225 RKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIY 281
+ +Q+ + + ++ + NI+H DLKPENILL + + IKI+DFG S ++
Sbjct: 124 ARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 282 QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
I + +Y +PEVL G YD D+WS G IL + +G P F G NE D + ++
Sbjct: 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 13/34 (38%), Positives = 21/34 (61%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
KDLI +ML + P RIT L+H + ++ + E+
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 18/238 (7%)
Query: 111 IQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE 170
+ E D Y+ +G G F V K + A K IK ++ ++ + + +E
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 171 ----IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYD-LLRNTNFRGVSLNLT 224
I+ + N ++ L + + + L+ EL++ L+D L + +
Sbjct: 63 REVSILKEIQHPN---VITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEA 116
Query: 225 RKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR--SAIKIVDFGSSCQL--GQRI 280
+F +Q+ + +L L I H DLKPENI+L + IKI+DFG + ++ G
Sbjct: 117 TEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 281 YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338
+ + +PE++ P L DMWS+G I + +G F G + + + + V
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 16/233 (6%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE---- 170
+K D Y+I +G G F V K + A K IK ++ ++ + + +E
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQ 229
I+ + N I+ L + R + L+ EL+S L+D L +S F +
Sbjct: 68 ILRQVLHPN---IITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIK 122
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNP--KRSAIKIVDFGSSCQL--GQRIYQYIQ 285
Q+ + +L I H DLKPENI+L + IK++DFG + ++ G
Sbjct: 123 QILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180
Query: 286 SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338
+ + +PE++ P L DMWS+G I + +G F G + + + I V
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 9/36 (25%), Positives = 17/36 (47%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
KD I ++L + + R+T AL+H + +
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM 285
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 15/252 (5%)
Query: 91 HKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDS-LIGKGSFGQVVKAFDLEEQCHVAI 149
H +N Q E F + Y + S +G+G F V + A
Sbjct: 2 HHHHHHSSGVDLGTEN--LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAA 59
Query: 150 KIIKNKKPFLNQAQIEVKLLE--IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-N 206
K +K ++ Q L E ++ + ++ L + + + L+ E +
Sbjct: 60 KFLKKRR--RGQDCRAEILHEIAVLEL--AKSCPRVINLHEVYENTSEIILILEYAAGGE 115
Query: 207 LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAI 265
++ L VS N + +Q+ + +L + NI+H DLKP+NILL + I
Sbjct: 116 IFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 266 KIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLF 323
KIVDFG S ++ + + + + Y +PE+L P A DMW++G I + T F
Sbjct: 174 KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233
Query: 324 SGSNEVDQMNKI 335
G + + I
Sbjct: 234 VGEDNQETYLNI 245
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 9/35 (25%), Positives = 17/35 (48%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADEST 448
D I +L +P+ R T L H++ ++ E+
Sbjct: 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 24/232 (10%)
Query: 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE----IM 172
D YE+ +G G F V K A K IK ++ ++ + + +E I+
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLT----RKF 227
+ N I+ L F + + L+ EL+S L+D L LT +F
Sbjct: 63 REIRHPN---IITLHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQF 113
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR--SAIKIVDFGSSCQL--GQRIYQY 283
+Q+ + +L I H DLKPENI+L + IK++DFG + ++ G
Sbjct: 114 LKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171
Query: 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
+ + +PE++ P L DMWS+G I + +G F G + + + I
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 8e-04
Identities = 13/34 (38%), Positives = 20/34 (58%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
KD I R+L DPK R+T +L+H++ K +
Sbjct: 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 17/224 (7%)
Query: 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE----I 171
F D YE+ +IGKG F V + + E A+KI+ + F + + + L+ I
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTEDLKREASI 79
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYD--LLRNTNFRGVSLNLTRKFS 228
+ + IV L + L +VFE + +L + R S + +
Sbjct: 80 CHMLKHPH---IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 229 QQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQL---GQRIYQYI 284
+Q+ AL + + NIIH D+KP +LL + + SA +K+ FG + QL G +
Sbjct: 137 RQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 285 QSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
+ + +PEV+ PY +D+W G IL + +G F G+ E
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/36 (44%), Positives = 19/36 (52%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
KDL+ RML DP RIT Y AL H + K +
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYK 299
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 23/283 (8%)
Query: 64 KTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEI 123
+ EV+ + + +S D H + Y +
Sbjct: 34 SGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD--HRIVTAKQGAVNSFYTV 91
Query: 124 DSL--IGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLLEIMNKADVNN 179
+G G FGQV K + +A KIIK + ++ ++ E+ +MN+ D N
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIK-TRGMKDKEEVKNEI---SVMNQLDHAN 147
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLN--LTRKFSQQLCTALL 236
+++L F +N + LV E + L+D + + +L T F +Q+C +
Sbjct: 148 ---LIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIR 201
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEV 294
+ ++ I+H DLKPENIL N IKI+DFG + + +++ + + +PEV
Sbjct: 202 HMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+ DMWS+G I + +G F G N+ + +N I+
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 73/228 (32%), Positives = 116/228 (50%), Gaps = 18/228 (7%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IM 172
F +RY I ++GKGSFG+V+K D Q A+K+I L E ++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS--AKNKDTSTILREVELL 75
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYD-LLRNTNFRGVSLNLTRKFSQQ 230
K D N I++L + +V EL + L+D +++ F S + + +Q
Sbjct: 76 KKLDHPN---IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQ 129
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFGSSCQL--GQRIYQYIQSR 287
+ + + ++ + NI+H DLKPENILL + ++ IKI+DFG S ++ I +
Sbjct: 130 VFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
+Y +PEVL G YD D+WS G IL + +G P F G NE D + ++
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 13/33 (39%), Positives = 20/33 (60%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
KDLI +ML + P RIT L+H + ++ + E
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 61/333 (18%), Positives = 115/333 (34%), Gaps = 74/333 (22%)
Query: 113 HGEKFLDRYEIDS-LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEI 171
D Y++ ++G G G+V++ F A+K++ + + +
Sbjct: 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG 81
Query: 172 MNKADVNNTYYIVRLKRHF----MWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRK 226
+ IV + + + L ++ E + L+ ++ + + +
Sbjct: 82 PH---------IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE 132
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFGSSCQL-GQRIYQYI 284
+ + TA+ FL NI H D+KPEN+L + ++ + +K+ DFG + + +
Sbjct: 133 IMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC 190
Query: 285 QSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
+ +Y +PEVL YD + DMWSLG I+ + G P F + +
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--------- 241
Query: 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404
++ G Y
Sbjct: 242 ------------KRRIRLGQYGFP--------------------------------NPEW 257
Query: 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437
VS+ K LI +L DP R+T + H
Sbjct: 258 SEVSE--DAKQLIRLLLKTDPTERLTITQFMNH 288
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-35
Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 17/229 (7%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLLEIM 172
D + +G G+FG V + IK I + + QI E+ E++
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEI---EVL 74
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLN--LTRKFSQ 229
D N I+++ F +++ +V E L + + + RG +L+ + +
Sbjct: 75 KSLDHPN---IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFGSSCQL--GQRIYQYIQS 286
Q+ AL + +++H DLKPENIL + S IKI+DFG + + +
Sbjct: 132 QMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
Y +PEV D+WS G ++ + TG F+G++ + K
Sbjct: 190 ALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA 237
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 11/28 (39%), Positives = 16/28 (57%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFK 441
DL+ +ML DP+ R + L H +FK
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 66/244 (27%), Positives = 109/244 (44%), Gaps = 16/244 (6%)
Query: 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL-- 169
+ + L+ +EI +GKG FG V A + + + +A+K++ + L +A +E +L
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRRE 59
Query: 170 -EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKF 227
EI + N I+RL +F + L+ E +Y L+ T +
Sbjct: 60 VEIQSHLRHPN---ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATY 114
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-GQRIYQYIQS 286
+L AL + +IH D+KPEN+LL +KI DFG S R +
Sbjct: 115 ITELANALSYCH--SKRVIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSRRTDLCGT 170
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
Y PE++ G +D +D+WSLG + E G+P F + + +I V P +
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
Query: 347 LDGA 350
+GA
Sbjct: 231 TEGA 234
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 88/368 (23%), Positives = 136/368 (36%), Gaps = 98/368 (26%)
Query: 113 HGEKFLDRYEIDS-LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLL 169
+F D Y++ ++G+G+ +V +L A+KII K+P ++++ EV
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKII-EKQPGHIRSRVFREV--- 61
Query: 170 EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTR---- 225
E++ + ++ L F + LVFE + RG S+ L+
Sbjct: 62 EMLYQ--CQGHRNVLELIEFFEEEDRFYLVFEKM-------------RGGSI-LSHIHKR 105
Query: 226 -KFS--------QQLCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFG--SS 273
F+ Q + +AL FL I H DLKPENIL +P + S +KI DF S
Sbjct: 106 RHFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163
Query: 274 CQLGQRIYQYIQSR--------FYRSPEVLLGI-----PYDLAIDMWSLGCILVEMHTGE 320
+L Y +PEV+ YD D+WSLG IL + +G
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223
Query: 321 PLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPG 380
P F G D E L F+ + +G Y
Sbjct: 224 PPFVGRCGSDCGWDRGEACPACQNML----------FESIQEGKYEFP------------ 261
Query: 381 SRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
+ +S KDLI ++L D K R++ LQH +
Sbjct: 262 --------------------DKDWAHISC--AAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
Query: 441 KRTADEST 448
+ A E+T
Sbjct: 300 QGCAPENT 307
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 16/229 (6%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL-LEIM 172
+F + Y++ +GKG+F V + + A II N K + +++ I
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMII-NTKKLSARDHQKLEREARIC 64
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYD-LLRNTNFRGVSLNLTRKFSQQ 230
N IVRL H L+F+L++ L++ ++ + S QQ
Sbjct: 65 RLLKHPN---IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY---SEADASHCIQQ 118
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSSCQL---GQRIYQYIQS 286
+ A+L ++ ++H +LKPEN+LL + K +A+K+ DFG + ++ Q + + +
Sbjct: 119 ILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
Y SPEVL PY +D+W+ G IL + G P F ++ +I
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 13/36 (36%), Positives = 20/36 (55%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
KDLI +ML +P RIT AL+H + + ++
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASC 280
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-35
Identities = 56/272 (20%), Positives = 101/272 (37%), Gaps = 37/272 (13%)
Query: 75 AKKKRRAQQSQGEDSSHKKEK-KLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFG 133
AK +R +++ + EK K + Y ++ H H +G+GSFG
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM--THQP----------RVGRGSFG 72
Query: 134 QVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193
+V + D + A+K + E+ ++ IV L
Sbjct: 73 EVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSP------RIVPLYGAVREG 122
Query: 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKP 252
+ + ELL +L L++ + + + Q L +L I+H D+K
Sbjct: 123 PWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLH--TRRILHGDVKA 178
Query: 253 ENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR--------FYRSPEVLLGIPYDLAI 304
+N+LL + S + DFG + L + +PEV++G P D +
Sbjct: 179 DNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 305 DMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
D+WS C+++ M G ++ KI
Sbjct: 238 DIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 269
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 20/228 (8%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLLEIM 172
Y +++ IG+GS+G+V A + A K I K + + E+ EIM
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI-PKYFVEDVDRFKQEI---EIM 60
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYD-LLRNTNFRGVSLNLTRKFSQQ 230
D N I+RL F + LV EL + L++ ++ F + + +
Sbjct: 61 KSLDHPN---IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF---RESDAARIMKD 114
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFGSS--CQLGQRIYQYIQSR 287
+ +A+ + +LN+ H DLKPEN L S +K++DFG + + G+ + + +
Sbjct: 115 VLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
+Y SP+VL G Y D WS G ++ + G P FS + + M KI
Sbjct: 173 YYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI 219
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 14/34 (41%), Positives = 20/34 (58%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
+ LI R+L PK RIT AL+H +F++ S
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 68/378 (17%), Positives = 131/378 (34%), Gaps = 89/378 (23%)
Query: 76 KKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDS-LIGKGSFGQ 134
+ + + + +D Y++ S ++G G G+
Sbjct: 18 APPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGK 77
Query: 135 VVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF---- 190
V++ F+ Q A+K++++ + ++ + + + IVR+ +
Sbjct: 78 VLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPH---------IVRIVDVYENLY 128
Query: 191 MWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFS--------QQLCTALLFLSTPE 242
R L +V E L +L RG + F+ + + A+ +L
Sbjct: 129 AGRKCLLIVMECLDGG--ELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLH--S 179
Query: 243 LNIIHCDLKPENILLCNPKR-SAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGIP 299
+NI H D+KPEN+L + + + +K+ DFG + + + + +Y +PEVL
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 239
Query: 300 YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDK 359
YD + DMWSLG I+ + G P F ++ + + +
Sbjct: 240 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------------------KTR 278
Query: 360 MPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419
+ G Y P VS+ +K LI
Sbjct: 279 IRMGQYEFPNP--------------------------------EWSEVSEEVK--MLIRN 304
Query: 420 MLDYDPKTRITPYYALQH 437
+L +P R+T + H
Sbjct: 305 LLKTEPTQRMTITEFMNH 322
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 81/369 (21%), Positives = 142/369 (38%), Gaps = 42/369 (11%)
Query: 87 EDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCH 146
E+ ++++ E + + GE D +E S +G G+ G V K
Sbjct: 5 EELELDEQQRKRLEAFLTQKQ----KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 147 VAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL--- 203
+A K+I + + QI ++ L+++++ + YIV F + + E +
Sbjct: 61 MARKLIHLEIKPAIRNQI-IRELQVLHECNSP---YIVGFYGAFYSDGEISICMEHMDGG 116
Query: 204 SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS 263
S L +L+ + + K S + L +L + I+H D+KP NIL+ R
Sbjct: 117 S--LDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVN--SRG 169
Query: 264 AIKIVDFGSSCQLGQRIYQ-YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPL 322
IK+ DFG S QL + ++ +R Y SPE L G Y + D+WS+G LVEM G
Sbjct: 170 EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
Query: 323 FSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSR 382
+ + + + P +P +
Sbjct: 230 IPPPDAKELELMFGCQVEGDAA--------------ETPPRPRTPGRPLNKFGMDSRPPM 275
Query: 383 RLHDILG--VESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFF 440
+ ++L V P +L S+ F+D + + L +P R + H F
Sbjct: 276 AIFELLDYIVNEPPP---KLPSGVFSLE----FQDFVNKCLIKNPAERADLKQLMVHAFI 328
Query: 441 KRTADESTN 449
KR+ E +
Sbjct: 329 KRSDAEEVD 337
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 5e-34
Identities = 66/396 (16%), Positives = 117/396 (29%), Gaps = 138/396 (34%)
Query: 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMN 173
++L +E +G+G FG V +A + + C+ AIK I+ N++ + EVK L +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 174 KA---------------------------------------------------DVNNTYY 182
D +T
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 183 IVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGV-SLNLTRKFSQQLCTALLFLST 240
V + + +L + +L NL D + + Q+ A+ FL
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH- 181
Query: 241 PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---------------RIYQYIQ 285
++H DLKP NI +K+ DFG + Q +
Sbjct: 182 -SKGLMHRDLKPSNIFFT--MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238
Query: 286 SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
++ Y SPE + G Y +D++SLG IL E+ FS E +
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQMERVR-------------- 281
Query: 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405
I+ ++ + P + +
Sbjct: 282 --------------------IITDVRNLKFPLLFTQK----------------------- 298
Query: 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
Y + ++ ML P R +++ F+
Sbjct: 299 ----YPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 54/376 (14%), Positives = 120/376 (31%), Gaps = 74/376 (19%)
Query: 90 SHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAI 149
K + + + + ++ +K+++ Y I + +G F +++ ++ A+
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYAL 59
Query: 150 KIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY-------------YIVRLKRHFMWRNHL 196
K K + + ++ + + Y + + + +
Sbjct: 60 KKY-EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEV 118
Query: 197 CLVFELLSY-NLYDLLRN------TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCD 249
+++E + ++ + + + + + + + ++ E NI H D
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRD 177
Query: 250 LKPENILLCNPKRSAIKIVDFG-SSCQLGQRIYQYIQSRFYRSPEVLLGIP--YDLAIDM 306
+KP NIL+ K +K+ DFG S + ++I + + PE +D+
Sbjct: 178 VKPSNILM--DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 307 WSLGCILVEMHTGEPLFSGSNEVDQM-NKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSY 365
WSLG L M FS + ++ N I + P
Sbjct: 236 WSLGICLYVMFYNVVPFSLKISLVELFNNIRTK----------------NI--EYPLDRN 277
Query: 366 ILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425
P +K + +S+ D + L +P
Sbjct: 278 HFLYPLTNKKSTCSNN------------------------FLSNED--IDFLKLFLRKNP 311
Query: 426 KTRITPYYALQHNFFK 441
RIT AL+H +
Sbjct: 312 AERITSEDALKHEWLA 327
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 75 AKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQ 134
A+ + D+ K + LY + ++ ++F +Y+ +IG+G
Sbjct: 50 QSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSV 109
Query: 135 VVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL------LEIMNKADVNNTYYIVRLKR 188
V + A+KI++ L+ Q+E I+ + V +I+ L
Sbjct: 110 VRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ--VAGHPHIITLID 167
Query: 189 HFMWRNHLCLVFELLSY-NLYD-LLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNII 246
+ + + LVF+L+ L+D L S TR + L A+ FL NI+
Sbjct: 168 SYESSSFMFLVFDLMRKGELFDYLTEKVAL---SEKETRSIMRSLLEAVSFLH--ANNIV 222
Query: 247 HCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGI------ 298
H DLKPENILL + I++ DFG SC L G+++ + + Y +PE+L
Sbjct: 223 HRDLKPENILLDD--NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHP 280
Query: 299 PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
Y +D+W+ G IL + G P F ++ + I
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 17/29 (58%), Positives = 21/29 (72%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKR 442
KDLI R+L DP+ R+T ALQH FF+R
Sbjct: 337 KDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 50/232 (21%), Positives = 85/232 (36%), Gaps = 33/232 (14%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII-KNKKPFLNQAQIEVKLLEIMNKADVN 178
Y +G+G F V L + A+K I +++ +AQ E + + N
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP--- 86
Query: 179 NTYYIVRLKRHFM----WRNHLCLVFELLSY-NLYDLLRNTNFRGVSL--NLTRKFSQQL 231
I+RL + + ++ L+ L++ + +G L + +
Sbjct: 87 ---NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS------------CQLGQR 279
C L + H DLKP NILL + + ++D GS Q
Sbjct: 144 CRGLEAIHAK--GYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 280 IYQYIQSRFYRSPEVLLGIPY---DLAIDMWSLGCILVEMHTGEPLFSGSNE 328
+ YR+PE+ + D D+WSLGC+L M GE + +
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 58/241 (24%), Positives = 101/241 (41%), Gaps = 20/241 (8%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL---LEIMNK 174
RY +GKG F + + D + + A KI+ L + K+ + I
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRS 71
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRG-VSLNLTRKFSQQLC 232
+ +V F + + +V EL L +L + R ++ R + +Q+
Sbjct: 72 LAHQH---VVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIV 125
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFY 289
+L +IH DLK N+ L + +KI DFG + ++ G+R + Y
Sbjct: 126 LGCQYLH--RNRVIHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
+PEVL + +D+WS+GCI+ + G+P F S + +I + PKH+
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241
Query: 350 A 350
A
Sbjct: 242 A 242
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 9e-04
Identities = 11/29 (37%), Positives = 12/29 (41%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKR 442
LI +ML DP R T L FF
Sbjct: 243 ASLIQKMLQTDPTARPTINELLNDEFFTS 271
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 69/244 (28%), Positives = 108/244 (44%), Gaps = 28/244 (11%)
Query: 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE- 170
F + YE ++G+G V + A+KII + + + EV+ L
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKII-DVTGGGSFSAEEVQELRE 68
Query: 171 -------IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYD-LLRNTNFRGVSL 221
I+ K V+ I++LK + LVF+L+ L+D L S
Sbjct: 69 ATLKEVDILRK--VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL---SE 123
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQR 279
TRK + L + L +LNI+H DLKPENILL + IK+ DFG SCQL G++
Sbjct: 124 KETRKIMRALLEVICALH--KLNIVHRDLKPENILLDD--DMNIKLTDFGFSCQLDPGEK 179
Query: 280 IYQYIQSRFYRSPEVLLGI------PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 333
+ + + Y +PE++ Y +DMWS G I+ + G P F ++ +
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239
Query: 334 KIVE 337
I+
Sbjct: 240 MIMS 243
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 14/35 (40%), Positives = 18/35 (51%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADEST 448
KDL+ R L P+ R T AL H FF++ E
Sbjct: 261 KDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 58/241 (24%), Positives = 101/241 (41%), Gaps = 20/241 (8%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL---LEIMNK 174
RY +GKG F + + D + + A KI+ L + K+ + I
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRS 97
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRG-VSLNLTRKFSQQLC 232
+ +V F + + +V EL L +L + R ++ R + +Q+
Sbjct: 98 LAHQH---VVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIV 151
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFY 289
+L +IH DLK N+ L + +KI DFG + ++ G+R + Y
Sbjct: 152 LGCQYLH--RNRVIHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
+PEVL + +D+WS+GCI+ + G+P F S + +I + PKH+
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 267
Query: 350 A 350
A
Sbjct: 268 A 268
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 32/246 (13%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL---LEIMNK 174
+D ++I +GKG FG V A + + + +A+K++ + L + +E +L +EI +
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ--LEKEGVEHQLRREIEIQSH 70
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
N I+R+ +F R + L+ E LY L+ + F ++L
Sbjct: 71 LRHPN---ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELAD 125
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF----- 288
AL + E +IH D+KPEN+L+ + +KI DFG S + S
Sbjct: 126 ALHYCH--ERKVIHRDIKPENLLM--GYKGELKIADFGWS--------VHAPSLRRRTMC 173
Query: 289 ----YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
Y PE++ G +D +D+W G + E G P F + + +IV V P
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 233
Query: 345 HLLDGA 350
L DG+
Sbjct: 234 FLSDGS 239
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 18/250 (7%)
Query: 103 DDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK-NKKPFLNQ 161
++ + + + + D ++GKG++G V DL Q +AIK I +
Sbjct: 6 EEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP 65
Query: 162 AQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVS 220
E+ L + + IV+ F + + E + +L LLR+
Sbjct: 66 LHEEIALHKHLKHK------NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 221 L-NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--- 276
+++Q+ L +L + I+H D+K +N+L+ N +KI DFG+S +L
Sbjct: 120 NEQTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLI-NTYSGVLKISDFGTSKRLAGI 176
Query: 277 GQRIYQYIQSRFYRSPEVLLGIP--YDLAIDMWSLGCILVEMHTGEPLFSG-SNEVDQMN 333
+ + Y +PE++ P Y A D+WSLGC ++EM TG+P F M
Sbjct: 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF 236
Query: 334 KIVEVLGLPP 343
K+ P
Sbjct: 237 KVGMFKVHPE 246
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 15/259 (5%)
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYE-IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK 153
++ N+ DD G R+ D IG+GSF V K D E VA ++
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 154 NKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM----WRNHLCLVFELLSY-NLY 208
++K L +++ + E + + IVR + + + LV EL++ L
Sbjct: 61 DRK--LTKSERQRFKEEAEMLKGLQHPN-IVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117
Query: 209 DLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268
L+ F+ + + + R + +Q+ L FL T IIH DLK +NI + ++KI
Sbjct: 118 TYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI-TGPTGSVKIG 174
Query: 269 DFGSSCQLGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327
D G + I + + +PE+ YD ++D+++ G ++EM T E +S
Sbjct: 175 DLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233
Query: 328 EVDQMNKIVEVLGLPPKHL 346
Q+ + V G+ P
Sbjct: 234 NAAQIYRRV-TSGVKPASF 251
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 1e-32
Identities = 36/274 (13%), Positives = 88/274 (32%), Gaps = 49/274 (17%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL-------------------- 159
+++G+ ++A D E + + +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 160 ---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHF--MWRNHLCLVFELLSYNLYDLL--- 211
QA++ ++ + + ++R++ MW ++ + NL
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 212 --RNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269
++ + + + + + Q+ L L ++H L+P +I+L +R + +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLD--QRGGVFLTG 249
Query: 270 FGSSCQLGQRIYQYIQSRFYRSPEVLL-----------GIPYDLAIDMWSLGCILVEMHT 318
F + G R SR + PE+ + D W+LG ++ +
Sbjct: 250 FEHLVRDGAR-VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 319 GEPLFSGSNEVDQMNKIVE-VLGLPP--KHLLDG 349
+ + + I +P + LL+G
Sbjct: 309 ADLPITKDAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 7/33 (21%), Positives = 16/33 (48%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446
+ L+ L Y + R+ P A++ +++ E
Sbjct: 337 RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 69/240 (28%), Positives = 113/240 (47%), Gaps = 17/240 (7%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL---EIMNK 174
++ +++ +L+GKGSF V +A + VAIK+I K + +A + ++ +I +
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA--MYKAGMVQRVQNEVKIHCQ 67
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCT 233
+ I+ L +F N++ LV E+ + L+N + S N R F Q+ T
Sbjct: 68 LKHPS---ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIIT 123
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYR 290
+L+L I+H DL N+LL + IKI DFG + QL ++ Y + Y
Sbjct: 124 GMLYLH--SHGILHRDLTLSNLLL--TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350
SPE+ + L D+WSLGC+ + G P F + +NK+V P L A
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEA 239
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 7e-04
Identities = 12/39 (30%), Positives = 19/39 (48%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGG 452
KDLI ++L +P R++ L H F R + + G
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 25/235 (10%)
Query: 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEI 171
++ +F D YE+ IG GS+ + A+KII K E+ EI
Sbjct: 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEI---EI 68
Query: 172 MNK-ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYD-LLRNTNFRGVSLNLTRKFS 228
+ + N I+ LK + ++ +V EL+ L D +LR F S
Sbjct: 69 LLRYGQHPN---IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF---SEREASAVL 122
Query: 229 QQLCTALLFLSTPELNIIHCDLKPENILLCNPKR--SAIKIVDFGSSCQL---GQRIYQY 283
+ + +L ++H DLKP NIL + +I+I DFG + QL +
Sbjct: 123 FTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180
Query: 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ---MNKI 335
+ + +PEVL YD A D+WSLG +L M TG F+ + + +I
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 11/36 (30%), Positives = 16/36 (44%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
KDL+ +ML DP R+T L+H +
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 113 HGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIM 172
+ + D +E++S +G+G+ V + Q A+K++K K + E+ ++
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVRTEI---GVL 102
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYD-LLRNTNFRGVSLNLTRKFSQQ 230
+ N I++LK F + LV EL++ L+D ++ + S +Q
Sbjct: 103 LRLSHPN---IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY---SERDAADAVKQ 156
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFGSSCQL--GQRIYQYIQSR 287
+ A+ +L E I+H DLKPEN+L P + +KI DFG S + + +
Sbjct: 157 ILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP 214
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCIL 313
Y +PE+L G Y +DMWS+G I
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 12/24 (50%), Positives = 18/24 (75%)
Query: 414 KDLIFRMLDYDPKTRITPYYALQH 437
KDL+ +++ DPK R+T + ALQH
Sbjct: 283 KDLVRKLIVLDPKKRLTTFQALQH 306
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 22/230 (9%)
Query: 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-------PFLNQAQI 164
+ E +Y++ L+G G FG V + + VAIK ++ + P + +
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 165 EVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRG-VSL 221
EV LL+ ++ ++RL F + L+ E L+D + RG +
Sbjct: 96 EVVLLKKVSSGFSG----VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQE 148
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281
L R F Q+ A+ ++H D+K ENIL+ + R +K++DFGS L +Y
Sbjct: 149 ELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVY 205
Query: 282 QYIQ-SRFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEV 329
+R Y PE + Y + +WSLG +L +M G+ F E+
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 255
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-32
Identities = 55/236 (23%), Positives = 91/236 (38%), Gaps = 35/236 (14%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII-KNKKPFLNQAQIEVKLLEIMNKADVN 178
R + ++ +G F V +A D+ A+K + N++ EV ++ ++
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP-- 86
Query: 179 NTYYIVRLKRHFMWRNH--------LCLVFELLSYNLYDLLRNTNFRG-VSLNLTRKFSQ 229
IV+ L+ EL L + L+ RG +S + K
Sbjct: 87 ---NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR-- 287
Q C A+ + + IIH DLK EN+LL N IK+ DFGS+ + ++
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTISHYPDYSWSAQRR 201
Query: 288 -------------FYRSPEVL---LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327
YR+PE++ P D+W+LGCIL + + F
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 60/333 (18%), Positives = 116/333 (34%), Gaps = 91/333 (27%)
Query: 111 IQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE 170
I+ D ++G G G+V++ F+ Q A+K++++ + ++ + +
Sbjct: 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ 69
Query: 171 IMNKADVNNTYYIVRLKRHF----MWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR 225
+ IVR+ + R L +V E L L+ +++ + +
Sbjct: 70 CPH---------IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 226 KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDFGSSCQLGQRIYQYI 284
+ + + A+ +L +NI H D+KPEN+L + + + +K+ DFG
Sbjct: 121 EIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFG------------- 165
Query: 285 QSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
+ E YD + DMWSLG I+ + G P F ++ + +
Sbjct: 166 -----FAKETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------- 210
Query: 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404
++ G Y P
Sbjct: 211 ------------KTRIRMGQYEFPNP--------------------------------EW 226
Query: 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437
VS+ + K LI +L +P R+T + H
Sbjct: 227 SEVSE--EVKMLIRNLLKTEPTQRMTITEFMNH 257
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 20/230 (8%)
Query: 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-------PFLNQAQI 164
+ E F Y + L+GKG FG V L ++ VAIK+I + +
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 165 EVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN--LYDLLRNTNFRG-VSL 221
EV LL + + ++RL F + LV E L+D + +G +
Sbjct: 84 EVALLWKVGAGGGHP--GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGE 138
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281
+R F Q+ A+ + ++H D+K ENIL+ + +R K++DFGS L Y
Sbjct: 139 GPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILI-DLRRGCAKLIDFGSGALLHDEPY 195
Query: 282 QYIQ-SRFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEV 329
+R Y PE + Y L +WSLG +L +M G+ F E+
Sbjct: 196 TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI 245
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 51/238 (21%), Positives = 101/238 (42%), Gaps = 21/238 (8%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKA 175
D E +G+G++G V K + +A+K I+ + ++ L+I +
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRT 62
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSL--NLTRKFSQQLCT 233
+ + V + + EL+ +L + +G ++ ++ K + +
Sbjct: 63 --VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ--YIQSRFYRS 291
AL L + +L++IH D+KP N+L+ +K+ DFG S L + + + Y +
Sbjct: 121 ALEHLHS-KLSVIHRDVKPSNVLIN--ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMA 177
Query: 292 PEVLLG----IPYDLAIDMWSLGCILVEMHTGE-PLFSGSNEVDQMNKIVEVLGLPPK 344
PE + Y + D+WSLG ++E+ P S Q+ ++VE P+
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE--EPSPQ 233
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 28/233 (12%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKA 175
+ ++ ++G+GSF VV A +L AIKI++ K+ + + ++ E +M++
Sbjct: 29 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVTRERDVMSR- 86
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVF------ELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229
+++ + V+L F L ELL Y + + +F TR ++
Sbjct: 87 -LDHPF-FVKLYFTFQDDEKLYFGLSYAKNGELLKY----IRKIGSF---DETCTRFYTA 137
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 288
++ +AL +L IIH DLKPENILL + I+I DFG++ L Q + F
Sbjct: 138 EIVSALEYLH--GKGIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANSFV 193
Query: 289 ----YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
Y SPE+L + D+W+LGCI+ ++ G P F NE KI++
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 62/255 (24%), Positives = 115/255 (45%), Gaps = 20/255 (7%)
Query: 101 GYDDDNHDYIIQHGEKF---LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP 157
G Y+ G+++ ++ E +G G+ GQV K + +A+K ++
Sbjct: 4 GSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63
Query: 158 FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFR 217
+I + L+++ K+ ++ YIV+ F+ + + EL+ + L+
Sbjct: 64 KEENKRI-LMDLDVVLKS--HDCPYIVQCFGTFITNTDVFIAMELMGTCA-EKLKKRMQG 119
Query: 218 GVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277
+ + K + + AL +L + +IH D+KP NILL +R IK+ DFG S +L
Sbjct: 120 PIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLD--ERGQIKLCDFGISGRLV 176
Query: 278 QRIYQ--YIQSRFYRSPEVL-----LGIPYDLAIDMWSLGCILVEMHTGE-PLFSGSNEV 329
+ Y +PE + YD+ D+WSLG LVE+ TG+ P + +
Sbjct: 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236
Query: 330 DQMNKIVEVLGLPPK 344
+ + K+++ PP
Sbjct: 237 EVLTKVLQ--EEPPL 249
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 67/241 (27%), Positives = 112/241 (46%), Gaps = 21/241 (8%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII-KNKKPFLNQAQI--EVKLLE 170
+ + Y + IGKG+F +V A + VAIKII K + + ++ EV++++
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRG-VSLNLTRKFS 228
I+N IV+L L L+ E S ++D L G + R
Sbjct: 70 ILNHP------NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKF 120
Query: 229 QQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQS 286
+Q+ +A+ + + I+H DLK EN+LL IKI DFG S +G ++ + +
Sbjct: 121 RQIVSAVQYCH--QKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLDAFCGA 176
Query: 287 RFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
Y +PE+ G YD +D+WSLG IL + +G F G N + +++ P +
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236
Query: 346 L 346
+
Sbjct: 237 M 237
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 109 YIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL 168
++I + E E++ ++G+G+FG V KA + VAIK I+++ +E++
Sbjct: 3 HMIDYKE-----IEVEEVVGRGAFGVVCKAKWRAKD--VAIKQIESES-ERKAFIVELRQ 54
Query: 169 LEIMNKADVNNTYYIVRLKRHFM--WRNHLCLVFELLSY-NLYDLLRNTNFRG-VSLNLT 224
L +N IV+ N +CLV E +LY++L +
Sbjct: 55 LSRVNHP------NIVK----LYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA 104
Query: 225 RKFSQQLCTALLFL-STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 283
+ Q + +L S +IH DLKP N+LL + +KI DFG++C + +
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA-GGTVLKICDFGTACDIQTHMTNN 163
Query: 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325
S + +PEV G Y D++S G IL E+ T F
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 83/329 (25%), Positives = 115/329 (34%), Gaps = 71/329 (21%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
DRY+ IG G+FG D + VA+K I+ Q E+ +
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHP-- 76
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
IVR K + HL ++ E S LY+ + N S + R F QQL + +
Sbjct: 77 ----NIVRFKEVILTPTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVS 130
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEV 294
+ + I H DLK EN LL +KI DFG S L + + + Y +PEV
Sbjct: 131 YCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 295 LLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353
LL YD D+WS G L M G F E K ++ +L
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ-------RILSV---- 237
Query: 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413
KY +PD I P L
Sbjct: 238 -KY--SIPDDIRI---------------------------SPECCHL------------- 254
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKR 442
I R+ DP TRI+ H++F +
Sbjct: 255 ---ISRIFVADPATRISIPEIKTHSWFLK 280
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
+ + IG+G++G V K +A+K I++ Q Q+ + L+++ ++
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL-LMDLDVVMRS-- 77
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELL---SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
++ YIV+ + EL+ Y + + + + K + A
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ--YIQSRFYRSP 292
L L L IIH D+KP NILL + IK+ DFG S QL I + R Y +P
Sbjct: 138 LNHLKE-NLKIIHRDIKPSNILLD--RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 194
Query: 293 EVL----LGIPYDLAIDMWSLGCILVEMHTGE-PLFSGSNEVDQMNKIVEVLGLPPK 344
E + YD+ D+WSLG L E+ TG P ++ DQ+ ++V+ G PP+
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQ 249
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 68/253 (26%), Positives = 114/253 (45%), Gaps = 34/253 (13%)
Query: 113 HGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---------PFLNQAQ 163
++ +Y S +G G+FG V A D E+ V +K IK +K P L +
Sbjct: 18 CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 164 IEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY--NLYD-LLRNTNFRGVS 220
+E+ +L + A I+++ F + LV E +L+ + R+
Sbjct: 78 LEIAILSRVEHA------NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL---D 128
Query: 221 LNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQ 278
L +QL +A+ +L +IIH D+K ENI++ + IK++DFGS+ + G+
Sbjct: 129 EPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVI--AEDFTIKLIDFGSAAYLERGK 184
Query: 279 RIYQYIQSRFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
Y + + Y +PEVL+G PY ++MWSLG L + E F ++ + VE
Sbjct: 185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE 238
Query: 338 VLGLPPKHLLDGA 350
PP +
Sbjct: 239 AAIHPPYLVSKEL 251
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 63/337 (18%), Positives = 122/337 (36%), Gaps = 81/337 (24%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII-KNKKP-FLNQAQIEVKLLEIM 172
F++ +++ +G+G++G+V A + + VA+KI+ + + E+ + +++
Sbjct: 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQL 231
N +V+ H N L E S L+D + G+ ++F QL
Sbjct: 63 NHE------NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQL 114
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--- 288
+++L + I H D+KPEN+LL +KI DFG + + + ++
Sbjct: 115 MAGVVYLHG--IGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 289 --YRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
Y +PE+L + +D+WS G +L M GE LP
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LP--- 207
Query: 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405
+D+ D +K + P
Sbjct: 208 -----------WDQPSDSCQEYSD-WKEKKTYLN-----------------------PWK 232
Query: 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
+ L+ ++L +P RIT + ++ +
Sbjct: 233 KIDSAPL--ALLHKILVENPSARITIPDIKKDRWYNK 267
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 69/262 (26%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 83 QSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKF-LDRYEIDSLIGKGSFGQVVKAFDL 141
+ + S + K+ + +D + LD+++ +G GSFG+V+
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 142 EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF- 200
E H A+KI+ K+ + QIE L E VN + +V+L+ F ++L +V
Sbjct: 64 ESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPF-LVKLEFSFKDNSNLYMVME 121
Query: 201 -----ELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENI 255
E+ S+ L R F S R ++ Q+ +L L++I+ DLKPEN+
Sbjct: 122 YVAGGEMFSH----LRRIGRF---SEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENL 172
Query: 256 LLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVE 315
L+ ++ I++ DFG + ++ R + + +PE++L Y+ A+D W+LG ++ E
Sbjct: 173 LI--DQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 316 MHTGEPLFSGSNEVDQMNKIVE 337
M G P F + KIV
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVS 252
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 63/349 (18%), Positives = 118/349 (33%), Gaps = 45/349 (12%)
Query: 119 DRYEIDSLIGKG--SFGQVVKAFDLEEQCHVAIKII---KNKKPFLNQAQIEVKLLEIMN 173
YE+ ++IGKG V A +V ++ I + Q E+ + ++ N
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
IV + F+ N L +V ++Y + DL+ G++ Q +
Sbjct: 85 HP------NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI----------YQ 282
AL ++ + +H +K +IL+ + + S+ +
Sbjct: 139 KALDYIH--HMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 283 YIQSRFYRSPEVL--LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340
++ + SPEVL YD D++S+G E+ G F ++ ++E L
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK---DMPATQMLLEKLN 251
Query: 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRL 400
LLD + + P S + + G P R
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRS-----VANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306
Query: 401 GEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
F + + L +P R + L H+FFK+ ++
Sbjct: 307 SP---------HFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-28
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+Y IG+G+ G V A D+ VAI+ + ++ Q + E+ + EI+ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENK 75
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
N IV ++ + L +V E L+ +L D++ T + ++ AL F
Sbjct: 76 NP-NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI---AAVCRECLQALEF 131
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRSPEV 294
L +IH D+K +NILL ++K+ DFG Q+ + + + ++ +PEV
Sbjct: 132 LH--SNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEP 321
+ Y +D+WSLG + +EM GEP
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 35/272 (12%), Positives = 82/272 (30%), Gaps = 46/272 (16%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--------------------- 158
+++G+ ++A D E + + +
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 159 --LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF--MWRNHLCLVFELLSYNLYDLLRNT 214
QA++ ++ + + ++R++ MW ++ + NL
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 215 NFRG-----VSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269
+ + + + Q+ L L ++H L+P +I+L +R + +
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLD--QRGGVFLTG 254
Query: 270 FGSSCQLGQRIYQYIQSRF----YRSPEVLLGIP-----YDLAIDMWSLGCILVEMHTGE 320
F + G I F + +L A D W+LG + + +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 321 PLFSGSNEVDQMNKIV-EVLGLPP--KHLLDG 349
+ + I +P + LL+G
Sbjct: 315 LPNTDDAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 7/77 (9%)
Query: 413 FKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSGLGSMSTSPASAGGSLPL 472
+ L+ L Y + R+ P A++ +++ E L P GG+ P
Sbjct: 340 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE---LSAALPLYQTDGEPTREGGAPP- 395
Query: 473 LLSSLEVQPPPSTAATS 489
S QP + AA +
Sbjct: 396 ---SGTSQPDEAGAAEA 409
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 73/385 (18%), Positives = 136/385 (35%), Gaps = 81/385 (21%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
F++ +++ +G+G++G+V A + + VA+KI+ K+ I+ EI
Sbjct: 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK---KEICIN 59
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCT 233
+N+ +V+ H N L E S L+D + G+ ++F QL
Sbjct: 60 KMLNHE-NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMA 116
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF----- 288
+++L + I H D+KPEN+LL +KI DFG + + + ++
Sbjct: 117 GVVYLHG--IGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 289 YRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
Y +PE+L + +D+WS G +L M GE + ++ Q
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------------- 217
Query: 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407
Y D +Y+ P +
Sbjct: 218 --------YSDWKEKKTYLN-----------------------------------PWKKI 234
Query: 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNTGGTSGLGSMSTSPASAG 467
L+ ++L +P RIT + ++ + + + S
Sbjct: 235 DSAPL--ALLHKILVENPSARITIPDIKKDRWYNKPLKKGA----KRPRVTSGGVSESPS 288
Query: 468 GSLPLLLSSLEVQPPPSTAATSESD 492
G + S+L+ P S + T S
Sbjct: 289 GFSKHIQSNLDFSPVNSASRTPGSG 313
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 49/235 (20%), Positives = 87/235 (37%), Gaps = 26/235 (11%)
Query: 104 DDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQ 163
+ + E E + IGKG FG V K ++++ VAIK + + +
Sbjct: 9 PKSRLPTLADNE-----IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLI-LGDSEGETE 62
Query: 164 IEVKLLEIMNKADVNNTYYIVRLKRH-----FM--WRNHLCLVFELLSY-NLYDLLRNTN 215
+ K E + I+ H N +V E + +LY L +
Sbjct: 63 MIEKFQEFQREVF------IMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKA 116
Query: 216 FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA---IKIVDFGS 272
+ ++ + + + ++ I+H DL+ NI L + +A K+ DFG
Sbjct: 117 -HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 273 SCQLGQRIYQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHTGEPLFSG 325
S Q + + + + +PE + Y D +S IL + TGE F
Sbjct: 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 13/223 (5%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
+ + ++GKG FG+V A K ++ KK + + L E V
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE-KKRIKKRKGEAMALNEKQILEKV 241
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDL---LRNTNFRGVSLNLTRKFSQQLCTA 234
N+ + +V L + ++ LCLV L+ N DL + + G ++ ++C
Sbjct: 242 NSRF-VVSLAYAYETKDALCLVLTLM--NGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSP 292
L L I++ DLKPENILL I+I D G + + GQ I + + Y +P
Sbjct: 299 LEDLH--RERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 293 EVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
EV+ Y + D W+LGC+L EM G+ F + + ++
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ IG+GS G V A + VA+K++ +K Q + E+ E++ D
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQ 100
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
+ +V + + ++ L ++ E L L D++ + + + AL +
Sbjct: 101 HF-NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRL---NEEQIATVCEAVLQALAY 156
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRSPEV 294
L +IH D+K ++ILL +K+ DFG Q+ + + + + + ++ +PEV
Sbjct: 157 LHAQ--GVIHRDIKSDSILLTL--DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 212
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEP 321
+ Y +D+WSLG +++EM GEP
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEP 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 58/265 (21%), Positives = 100/265 (37%), Gaps = 20/265 (7%)
Query: 63 IKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYE 122
+ Y H + Y QG + G D + + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGR---AGSLKDPDVAELFFKDDPEKLFS 57
Query: 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTY- 181
IG GSFG V A D+ VAIK + + Q K +I+ +
Sbjct: 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMS-----YSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 182 --YIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
++ + ++ + LV E + DLL + + + L +L
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH 171
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI- 298
N+IH D+K NILL +K+ DFGS+ + ++ + ++ +PEV+L +
Sbjct: 172 --SHNMIHRDVKAGNILLSE--PGLVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMD 226
Query: 299 --PYDLAIDMWSLGCILVEMHTGEP 321
YD +D+WSLG +E+ +P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKP 251
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 42/236 (17%), Positives = 78/236 (33%), Gaps = 43/236 (18%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVN 178
+ + + G++ K + +K++K + E L I
Sbjct: 13 NFLTKLNENHSGELWKGRWQGN--DIVVKVLKVRDWSTRKSRDFNEECPRLRIF------ 64
Query: 179 NTYYIVRLKRH-----FM------WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRK 226
H + H L+ + Y +LY++L V + K
Sbjct: 65 ---------SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC--QLGQRIYQYI 284
F+ + + FL T E I L ++++ +I Q R+Y
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSFQSPGRMYAPA 173
Query: 285 QSRFYRSPEVLLGIPYDL---AIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+ +PE L P D + DMWS +L E+ T E F+ + ++ K+
Sbjct: 174 ----WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL 225
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 16/226 (7%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
D + ++G+G FG+V A K + KK + + ++E A V
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN-KKRLKKRKGYQGAMVEKKILAKV 242
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFEL-----LSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
++ + IV L F + LCLV + + Y++Y++ + G ++ Q+
Sbjct: 243 HSRF-IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIV 299
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFY 289
+ L L + NII+ DLKPEN+LL ++I D G + +L + Y + +
Sbjct: 300 SGLEHLH--QRNIIYRDLKPENVLL--DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
+PE+LLG YD ++D ++LG L EM F E + ++
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 64/260 (24%), Positives = 114/260 (43%), Gaps = 24/260 (9%)
Query: 89 SSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVA 148
+ +K K + N + I+ + YE+ +IG+G+FG+V + A
Sbjct: 39 PALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 98
Query: 149 IKIIKNKKPFLNQAQIEVKLLE--IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-Y 205
+K++ K + ++ E IM A N+ ++V+L F +L +V E +
Sbjct: 99 MKLLS-KFEMIKRSDSAFFWEERDIMAFA---NSPWVVQLFYAFQDDRYLYMVMEYMPGG 154
Query: 206 NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265
+L +L+ N + R ++ ++ AL + + IH D+KP+N+LL K +
Sbjct: 155 DLVNLMSNYDV---PEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLD--KSGHL 207
Query: 266 KIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLG----IPYDLAIDMWSLGCILVEM 316
K+ DFG+ ++ + + Y SPEVL Y D WS+G L EM
Sbjct: 208 KLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
Query: 317 HTGEPLFSGSNEVDQMNKIV 336
G+ F + V +KI+
Sbjct: 267 LVGDTPFYADSLVGTYSKIM 286
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 31/232 (13%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
L ++I +G GSFG+V + A+K++K K+ + Q+E E + + V
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIV 63
Query: 178 NNTYYIVRLKRHFMWRNHLCLVF------ELLSYNLYDLLRNTNFRGVSLNLTRKFSQQL 231
+ + I+R+ F + ++ EL S L ++ F + + ++ ++
Sbjct: 64 THPF-IIRMWGTFQDAQQIFMIMDYIEGGELFSL----LRKSQRF---PNPVAKFYAAEV 115
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY------QYIQ 285
C AL +L +II+ DLKPENILL K IKI DFG + + Y YI
Sbjct: 116 CLALEYLH--SKDIIYRDLKPENILLD--KNGHIKITDFGFAKYVPDVTYTLCGTPDYI- 170
Query: 286 SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+PEV+ PY+ +ID WS G ++ EM G F SN + KI+
Sbjct: 171 -----APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 71/361 (19%), Positives = 124/361 (34%), Gaps = 102/361 (28%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMN 173
L++Y + IGKGS+G V A++ + + A+K++ +KK + QA +
Sbjct: 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVL-SKKKLIRQAGFPRRPPPRGT 66
Query: 174 KADVNNTYY-------------IVRLKRH-----------FMWRNHLCLVFELLSY-NLY 208
+ I++ H +HL +VFEL++ +
Sbjct: 67 RPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM 126
Query: 209 DLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268
++ S + R + Q L + +L IIH D+KP N+L+ IKI
Sbjct: 127 EVPTLKPL---SEDQARFYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGH--IKIA 179
Query: 269 DFGSSCQLGQRIYQYIQ----SRFYRSPEVLLGI--PYD-LAIDMWSLGCILVEMHTGEP 321
DFG S + + + + + +PE L + A+D+W++G L G+
Sbjct: 180 DFGVSNEF-KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 322 LFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGS 381
F + +KI K++ + PD I
Sbjct: 239 PFMDERIMCLHSKI----------------KSQAL--EFPDQPDI--------------- 265
Query: 382 RRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
+ L I RMLD +P++RI H +
Sbjct: 266 ------------AEDLKDL----------------ITRMLDKNPESRIVVPEIKLHPWVT 297
Query: 442 R 442
R
Sbjct: 298 R 298
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 27/236 (11%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKA 175
D +EI +IG+G+F +V + A+KI+ K L + ++ E ++
Sbjct: 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN-KWDMLKRGEVSCFREERDVLVNG 118
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
D +I +L F N+L LV E +L LL R + + R + ++ A
Sbjct: 119 D---RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMA 174
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------ 288
+ + L +H D+KP+NILL + I++ DFGS +L ++S
Sbjct: 175 IDSVH--RLGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLR--ADGTVRSLVAVGTPD 228
Query: 289 YRSPEVLLGI-------PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
Y SPE+L + Y D W+LG EM G+ F + + KIV
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 47/241 (19%)
Query: 117 FLDRYEID-------SLIGKGSFGQVVKAFDLEEQCH--VAIKIIKNKKPFLNQAQI--- 164
FL ++I LIGKG FGQV H VAI++I ++ +Q +
Sbjct: 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGR-----WHGEVAIRLIDIERDNEDQLKAFKR 78
Query: 165 EVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNL 223
EV + N +V M HL ++ L LY ++R+ + +N
Sbjct: 79 EVM---AYRQTRHEN---VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNK 131
Query: 224 TRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 283
TR+ +Q++ + +L I+H DLK +N+ N K + I DFG G
Sbjct: 132 TRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYDNGK---VVITDFGLFSISGVLQAGR 186
Query: 284 IQSRF--------YRSPEVL---------LGIPYDLAIDMWSLGCILVEMHTGEPLFSGS 326
+ + + +PE++ +P+ D+++LG I E+H E F
Sbjct: 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
Query: 327 N 327
Sbjct: 247 P 247
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 9e-26
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 18/264 (6%)
Query: 82 QQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKF-LDRYEIDSLIGKGSFGQVVKAFD 140
+Q + K + + + + ++ L + ++GKGSFG+V+ +
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSER 362
Query: 141 LEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVF 200
A+KI+K K + +E ++E A ++ +L F + L V
Sbjct: 363 KGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421
Query: 201 ELLS--YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258
E ++ +Y + + F ++ ++ L FL II+ DLK +N++L
Sbjct: 422 EYVNGGDLMYHIQQVGRF---KEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLD 476
Query: 259 NPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGIPYDLAIDMWSLGCIL 313
IKI DFG C+ F Y +PE++ PY ++D W+ G +L
Sbjct: 477 --SEGHIKIADFGM-CKENIW-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 532
Query: 314 VEMHTGEPLFSGSNEVDQMNKIVE 337
EM G+ F G +E + I+E
Sbjct: 533 YEMLAGQAPFEGEDEDELFQSIME 556
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ +EI +G G+FG+V KA + E A K+I+ K + ++E ++EI A +
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCD 74
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
+ YIV+L + L ++ E + ++ + RG++ + +Q+ AL F
Sbjct: 75 HP-YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNF 132
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRSPEV 294
L IIH DLK N+L+ I++ DFG S + + + + +I + ++ +PEV
Sbjct: 133 LH--SKRIIHRDLKAGNVLMTL--EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 295 LL-----GIPYDLAIDMWSLGCILVEMHTGEP 321
++ PYD D+WSLG L+EM EP
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 54/240 (22%), Positives = 104/240 (43%), Gaps = 24/240 (10%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKA 175
++ + + +IG+G FG+V + A+K + KK + + L E +++
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQGETLALNERIMLSLV 246
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFEL-----LSYNLYDLLRNTNFRGVSLNLTRKFSQQ 230
+ +IV + F + L + +L L Y+L S R ++ +
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS------QHGVFSEADMRFYAAE 300
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-GQRIYQYIQSRFY 289
+ L + +++ DLKP NILL + ++I D G +C ++ + + + Y
Sbjct: 301 IILGLEHMH--NRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASVGTHGY 356
Query: 290 RSPEVLL-GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ---MNKIVEV-LGLPPK 344
+PEVL G+ YD + D +SLGC+L ++ G F D+ + + + LP
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 416
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 51/237 (21%), Positives = 100/237 (42%), Gaps = 30/237 (12%)
Query: 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL---LEIM 172
K + +Y + L+G+GS+G+V + D E C A+KI+ KK E + ++++
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKIL-KKKKLRRIPNGEANVKKEIQLL 60
Query: 173 NKADVNNTYYIVRLKRHFMW---RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229
+ N +++L ++ + + +V E + ++L + + + +
Sbjct: 61 RRLRHKN---VIQLV-DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC 116
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 288
QL L +L I+H D+KP N+LL +KI G + + ++ +
Sbjct: 117 QLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGT--LKISALG----VAEALHPFAADDTC 168
Query: 289 --------YRSPEVLLGI-PYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
++ PE+ G+ + +D+WS G L + TG F G N I
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL--EIMNKAD 176
D YE+ +IG G+ V A+ ++ VAIK I L + Q + L EI +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-----LEKCQTSMDELLKEIQAMSQ 69
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQ------ 229
++ IV F+ ++ L LV +LLS ++ D++++ +G + S
Sbjct: 70 CHHP-NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR-- 287
++ L +L + IH D+K NILL +++I DFG S L
Sbjct: 129 EVLEGLEYLH--KNGQIHRDVKAGNILLGE--DGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 288 ------FYRSPEVLL-GIPYDLAIDMWSLGCILVEMHTGEPLFS 324
+ +PEV+ YD D+WS G +E+ TG +
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+E+ L+G G++GQV K ++ AIK++ + + E EI +
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-----VTGDEEEEIKQEINMLKKYS 78
Query: 179 NTYYIVR-----LKRHFM-WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQL 231
+ I +K++ + L LV E ++ DL++NT + +++
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRF 288
L L + +IH D+K +N+LL + + +K+VDFG S QL + + + +I + +
Sbjct: 139 LRGLSHLH--QHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 289 YRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEP 321
+ +PEV+ YD D+WSLG +EM G P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 48/252 (19%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAFDLEEQCH--VAIKIIKNKKPFLNQAQIEVKLL 169
D +EI IG GSFG V K + H VA+K++ P Q++
Sbjct: 17 DDWEIPDGQITVGQRIGSGSFGTVYKG-----KWHGDVAVKMLNVTAP--TPQQLQAFKN 69
Query: 170 EIMNKADVNNTYYIVRLKRH-----FM---WRNHLCLVFELLSY-NLYDLLRNTNFRGVS 220
E+ ++R RH FM L +V + +LY L +
Sbjct: 70 EVG----------VLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASE-TKFE 118
Query: 221 LNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 280
+ ++Q + +L +IIH DLK NI L + + +KI DFG + + +
Sbjct: 119 MKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLH--EDNTVKIGDFGLATEKSRWS 174
Query: 281 Y--QYIQSRF---YRSPEVLLG---IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQM 332
Q+ Q + +PEV+ PY D+++ G +L E+ TG+ +S N DQ+
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234
Query: 333 NKIVEVLGLPPK 344
++V L P
Sbjct: 235 IEMVGRGSLSPD 246
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 61/269 (22%), Positives = 99/269 (36%), Gaps = 49/269 (18%)
Query: 77 KKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVV 136
K + E + D D D I + I IG GSFG V
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGD--DMDIPWCD-----LNIKEKIGAGSFGTVH 54
Query: 137 KAFDLEEQCH---VAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH- 189
+A + H VA+KI+ + +N+ EV +++ + RH
Sbjct: 55 RA-----EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL---------------RHP 94
Query: 190 ----FM----WRNHLCLVFELLSY-NLYDLLRNTNFRG-VSLNLTRKFSQQLCTALLFLS 239
FM +L +V E LS +LY LL + R + + + + +L
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR---FYRSPEVLL 296
I+H +LK N+L+ +K+ DFG S + + +PEVL
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 297 GIPYDLAIDMWSLGCILVEMHTGEPLFSG 325
P + D++S G IL E+ T + +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 18/272 (6%)
Query: 80 RAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAF 139
++ + + N G ++ ++ +E L+GKG+FG+V+
Sbjct: 109 GLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVK 168
Query: 140 DLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199
+ + A+KI+K K+ + + ++ L E + + + + LK F + LC V
Sbjct: 169 EKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSRHPF-LTALKYSFQTHDRLCFV 226
Query: 200 FELLSYN--LYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILL 257
E + + L R F S + R + ++ +AL +L + E N+++ DLK EN++L
Sbjct: 227 MEYANGGELFFHLSRERVF---SEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLML 282
Query: 258 CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGIPYDLAIDMWSLGCI 312
K IKI DFG C+ G + +++ F Y +PEVL Y A+D W LG +
Sbjct: 283 D--KDGHIKITDFGL-CKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 338
Query: 313 LVEMHTGEPLFSGSNEVDQMNKIV-EVLGLPP 343
+ EM G F + I+ E + P
Sbjct: 339 MYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 370
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 23/232 (9%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKA 175
+ +EI +IG+G+FG+V A+KI+ K L +A+ E ++
Sbjct: 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNG 131
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
++ +I L F N+L LV + +L LL R + + R + ++ A
Sbjct: 132 ---DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIA 187
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----Y 289
+ + +L+ +H D+KP+NIL+ I++ DFGS C S Y
Sbjct: 188 IDSVH--QLHYVHRDIKPDNILM--DMNGHIRLADFGS-CLKLMEDGTVQSSVAVGTPDY 242
Query: 290 RSPEVLLGIP-----YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
SPE+L + Y D WSLG + EM GE F + V+ KI+
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 20/228 (8%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
++ ++ L+GKG+FG+V+ + + A+KI++ K+ + + ++ + E +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNT 62
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLS--YNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
+ + + LK F + LC V E + + L R F + R + ++ +AL
Sbjct: 63 RHPF-LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGAEIVSAL 118
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR-F-----Y 289
+L ++++ D+K EN++L K IKI DFG C+ G I + F Y
Sbjct: 119 EYLH--SRDVVYRDIKLENLMLD--KDGHIKITDFGL-CKEG--ISDGATMKTFCGTPEY 171
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+PEVL Y A+D W LG ++ EM G F + I+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL--EIMNKAD 176
+ + IGKGSFG+V K D Q VAIKII L +A+ E++ + EI +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQ 76
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
++ Y+ + ++ L ++ E L + DLL + +++ L
Sbjct: 77 CDSP-YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---ILREILKGL 132
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRSP 292
+L IH D+K N+LL +K+ DFG + QL + ++ + F+ +P
Sbjct: 133 DYLH--SEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 188
Query: 293 EVLLGIPYDLAIDMWSLGCILVEMHTGEP 321
EV+ YD D+WSLG +E+ GEP
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEP 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 23/230 (10%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
+D +E ++GKGSFG+V+ A E A+K++K K L +E + E +
Sbjct: 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLA 80
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLS-----YNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
N ++ +L F + L V E ++ +++ ++ F R ++ ++
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRF---DEARARFYAAEII 134
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF---- 288
+AL+FL + II+ DLK +N+LL K+ DFG C+ G + F
Sbjct: 135 SALMFLH--DKGIIYRDLKLDNVLLD--HEGHCKLADFG-MCKEGIC-NGVTTATFCGTP 188
Query: 289 -YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
Y +PE+L + Y A+D W++G +L EM G F NE D I+
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKADVNN 179
++ +IG G FG+V +AF + + VA+K ++ IE E + N
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
I+ L+ + +LCLV E L +L + + ++ ++ Q+ + +L
Sbjct: 68 ---IIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYL 121
Query: 239 -STPELNIIHCDLKPENILL------CNPKRSAIKIVDFGSSCQLGQRI-------YQYI 284
+ IIH DLK NIL+ + +KI DFG + + + Y ++
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWM 181
Query: 285 QSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325
+PEV+ + D+WS G +L E+ TGE F G
Sbjct: 182 ------APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 25/231 (10%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
L + ++GKGSFG+V+ + A+KI+K K + +E ++E A
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALP 77
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLS-----YNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
++ +L F + L V E ++ Y++ + F ++ ++
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRF---KEPHAVFYAAEIA 131
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR-F--- 288
L FL II+ DLK +N++L IKI DFG C+ I+ + ++ F
Sbjct: 132 IGLFFLQ--SKGIIYRDLKLDNVML--DSEGHIKIADFGM-CKEN--IWDGVTTKTFCGT 184
Query: 289 --YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
Y +PE++ PY ++D W+ G +L EM G+ F G +E + I+E
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ +++ +G+GS+G V KA E VAIK + + + Q +K + IM +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQ---C 81
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
++ ++V+ + L +V E ++ D++R N + ++ + Q L +
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEY 140
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYRSPEV 294
L + IH D+K NILL K+ DFG + QL + + I + F+ +PEV
Sbjct: 141 LH--FMRKIHRDIKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEP 321
+ I Y+ D+WSLG +EM G+P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 19/229 (8%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL---LE 170
++ + Y I +G+GSFG+V A + Q VA+K I + L ++ + +++ +
Sbjct: 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL--LKKSDMHMRVEREIS 61
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRG-VSLNLTRKFSQ 229
+ + I++L + +V E L+D + + ++ + R+F Q
Sbjct: 62 YLKLLRHPH---IIKLYDVITTPTDIVMVIEYAGGELFDYIVE---KKRMTEDEGRRFFQ 115
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSR 287
Q+ A+ + I+H DLKPEN+LL +KI DFG S G + S
Sbjct: 116 QIICAIEYCHR--HKIVHRDLKPENLLL--DDNLNVKIADFGLSNIMTDGNFLKTSCGSP 171
Query: 288 FYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
Y +PEV+ G Y +D+WS G +L M G F + K+
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 30/240 (12%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKA 175
+ +IGKGSFG+V+ A E+ A+K+++ KK L + + + + E ++ K
Sbjct: 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ-KKAILKKKEEKHIMSERNVLLKN 95
Query: 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLS-----YNLYDLLRNTNFRGVSLNLTRKFSQQ 230
V + + +V L F + L V + ++ Y+L R F R ++ +
Sbjct: 96 -VKHPF-LVGLHFSFQTADKLYFVLDYINGGELFYHLQ---RERCF---LEPRARFYAAE 147
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR-F- 288
+ +AL +L LNI++ DLKPENILL + I + DFG C+ I + F
Sbjct: 148 IASALGYLH--SLNIVYRDLKPENILLD--SQGHIVLTDFG-LCKEN--IEHNSTTSTFC 200
Query: 289 ----YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV-EVLGLPP 343
Y +PEVL PYD +D W LG +L EM G P F N + + I+ + L L P
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP 260
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
++ + + ++GKGSFG+V A + AIK +K K L +E ++E +
Sbjct: 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLA 74
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLS-----YNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
++ + F + +L V E L+ Y++ F L+ ++ ++
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKF---DLSRATFYAAEII 128
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIY------QY 283
L FL I++ DLK +NILL K IKI DFG + Y
Sbjct: 129 LGLQFLH--SKGIVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184
Query: 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
I +PE+LLG Y+ ++D WS G +L EM G+ F G +E + + I
Sbjct: 185 I------APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 39/246 (15%)
Query: 118 LDRYEIDSLIGKGSFGQV--VKAFDLEEQCHV-AIKIIKNKKPFLNQAQIEVKLLE--IM 172
+ +E+ ++GKG +G+V V+ + A+K++K N E I+
Sbjct: 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-----YNLYDLLRNTNFRGVSLNLTRKF 227
+V + + IV L F L L+ E LS L R F + +
Sbjct: 76 --EEVKHPF-IVDLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIF---MEDTACFY 126
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIY--- 281
++ AL L + II+ DLKPENI+L + +K+ DFG G +
Sbjct: 127 LAEISMALGHLH--QKGIIYRDLKPENIML--NHQGHVKLTDFGLCKESIHDGTVTHTFC 182
Query: 282 ---QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV-E 337
+Y+ +PE+L+ ++ A+D WSLG ++ +M TG P F+G N ++KI+
Sbjct: 183 GTIEYM------APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
Query: 338 VLGLPP 343
L LPP
Sbjct: 237 KLNLPP 242
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 14/229 (6%)
Query: 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEI 171
G + Y + +G G+FG+V VA+KI+ N++ + + EI
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKIL-NRQKIRSLDVVGKIKREI 62
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRG-VSLNLTRKFSQ 229
N + +I++L + +V E +S L+D + G V R+ Q
Sbjct: 63 QNLKLFRHP-HIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQ 118
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSR 287
Q+ +A+ + ++H DLKPEN+LL KI DFG S G+ + S
Sbjct: 119 QILSAVDYCH--RHMVVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDGEFLRTSCGSP 174
Query: 288 FYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
Y +PEV+ G Y +D+WS G IL + G F + KI
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 55/286 (19%), Positives = 115/286 (40%), Gaps = 31/286 (10%)
Query: 70 NEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKF-LDRYEIDSLIG 128
+ ++ ++ + + G + + + + H EK ++ +E+ ++G
Sbjct: 4 HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLG 63
Query: 129 KGSFGQVV---KAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IMNKADVNNTYYI 183
G++G+V K + A+K++K E E ++ + + ++
Sbjct: 64 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL--EHIRQSPFL 121
Query: 184 VRLKRHFMWRNHLCLVFELLS-----YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
V L F L L+ + ++ +L + F + + + + ++ AL L
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLS---QRERF---TEHEVQIYVGEIVLALEHL 175
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE 293
+L II+ D+K ENILL + + DFG + F Y +P+
Sbjct: 176 H--KLGIIYRDIKLENILLD--SNGHVVLTDFGL-SKEFVADETERAYDFCGTIEYMAPD 230
Query: 294 VLLGIP--YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
++ G +D A+D WSLG ++ E+ TG F+ E + +I
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 33/242 (13%)
Query: 118 LDRYEIDSLIGKGSFGQVV---KAFDLEEQCHVAIKIIKNKKPFLNQAQIEVK----LLE 170
++E+ ++G+GSFG+V K + + A+K++K K + ++ K +L
Sbjct: 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERDILV 81
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-----YNLYDLLRNTNFRGVSLNLTR 225
+N +IV+L F L L+ + L L + F + +
Sbjct: 82 EVNHP------FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMF---TEEDVK 129
Query: 226 KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQ 282
+ +L AL L L II+ DLKPENILL + IK+ DFG S ++ Y
Sbjct: 130 FYLAELALALDHLH--SLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYS 185
Query: 283 YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV-EVLGL 341
+ + Y +PEV+ + + D WS G ++ EM TG F G + + M I+ LG+
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM 245
Query: 342 PP 343
P
Sbjct: 246 PQ 247
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 44/229 (19%), Positives = 83/229 (36%), Gaps = 33/229 (14%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKADVNN 179
+ IGKG FG+V + + VA+KI ++ + +A E+ ++ N
Sbjct: 45 VLQESIGKGRFGEVWRG-KWRGE-EVAVKIFSSREERSWFREA--EIYQTVMLRHE--NI 98
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
+I + L LV + + +L+D L V++ K + + L L
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHL 155
Query: 239 ------STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS------ 286
+ + I H DLK +NIL+ I D G + + +
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 287 -RFYRSPEVLLG------IPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
+ Y +PEVL D++++G + E+ + +
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 46/233 (19%), Positives = 80/233 (34%), Gaps = 41/233 (17%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN--N 179
+ +GKG +G+V + + + +VA+KI ++ E E+ N + N
Sbjct: 11 TLLECVGKGRYGEVWRG-SWQGE-NVAVKIFSSRD--EKSWFRET---ELYNTVMLRHEN 63
Query: 180 TYYIVRL----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
I+ L L+ +LYD L+ T + + +
Sbjct: 64 ---ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL---DTVSCLRIVLSIASG 117
Query: 235 LLFL------STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS-- 286
L L + + I H DLK +NIL+ + I D G + Q Q
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTNQLDVGNN 175
Query: 287 -----RFYRSPEVLLGIP------YDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
+ Y +PEVL +D+W+ G +L E+ +
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
L +++ +IG+GS+ +V+ + A+K++K K+ + I+ E
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQA 66
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLS-----YNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+N ++V L F + L V E ++ +++ R R +S ++
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKL---PEEHARFYSAEIS 120
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF---- 288
AL +L E II+ DLK +N+LL IK+ D+G C+ G R S F
Sbjct: 121 LALNYLH--ERGIIYRDLKLDNVLLD--SEGHIKLTDYG-MCKEGLR-PGDTTSTFCGTP 174
Query: 289 -YRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQM 332
Y +PE+L G Y ++D W+LG ++ EM G F D
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 219
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 58/267 (21%), Positives = 105/267 (39%), Gaps = 28/267 (10%)
Query: 81 AQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEID-----SLIGKGSFGQV 135
+ + + G +++ + K + +IG+GS+ +V
Sbjct: 9 HHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKV 68
Query: 136 VKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195
+ + A++++K K+ + I+ E +N ++V L F +
Sbjct: 69 LLVRLKKTDRIYAMRVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127
Query: 196 LCLVFELLS-----YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDL 250
L V E ++ +++ R R +S ++ AL +L E II+ DL
Sbjct: 128 LFFVIEYVNGGDLMFHMQ---RQRKL---PEEHARFYSAEISLALNYLH--ERGIIYRDL 179
Query: 251 KPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGIPYDLAID 305
K +N+LL IK+ D+G C+ G R S F Y +PE+L G Y ++D
Sbjct: 180 KLDNVLLD--SEGHIKLTDYG-MCKEGLR-PGDTTSTFCGTPNYIAPEILRGEDYGFSVD 235
Query: 306 MWSLGCILVEMHTGEPLFSGSNEVDQM 332
W+LG ++ EM G F D
Sbjct: 236 WWALGVLMFEMMAGRSPFDIVGSSDNP 262
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 6e-22
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 20/232 (8%)
Query: 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKL--- 168
G + Y + +G G+FG+V VA+KI+ +K + + K+
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK--IRSLDVVGKIRRE 66
Query: 169 LEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRG-VSLNLTRK 226
++ + + I++L + + + +V E +S L+D + G + +R+
Sbjct: 67 IQNLKLFRHPH---IIKLYQVISTPSDIFMVMEYVSGGELFDYICK---NGRLDEKESRR 120
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYI 284
QQ+ + + + ++H DLKPEN+LL KI DFG S G+ +
Sbjct: 121 LFQQILSGVDYCH--RHMVVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDGEFLRTSC 176
Query: 285 QSRFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
S Y +PEV+ G Y +D+WS G IL + G F + KI
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI 228
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 41/229 (17%), Positives = 86/229 (37%), Gaps = 42/229 (18%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN-----KKPFLNQAQIEVKLLEIMNKAD 176
++GKG FGQ +K E + +K + ++ FL + ++ M +
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV-------MRCLE 65
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR--KFSQQLCT 233
N +++ L + E + L ++++ ++ F++ + +
Sbjct: 66 HPN---VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIAS 119
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--- 290
+ +L +NIIH DL N L+ + + + DFG + + Q R +
Sbjct: 120 GMAYLH--SMNIIHRDLNSHNCLV--RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 291 --------------SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325
+PE++ G YD +D++S G +L E+
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 61/344 (17%), Positives = 106/344 (30%), Gaps = 100/344 (29%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKADVNN 179
++ IGKG +G+V + VA+K+ + + + +I
Sbjct: 40 QMVKQIGKGRYGEVWMG-KWRGE-KVAVKVFFTTEEASWFRETEI--------------- 82
Query: 180 TYYIVRLKRH-----FM--------WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR 225
Y L RH F+ L L+ + +LYD L++T +
Sbjct: 83 --YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSML 137
Query: 226 KFSQQLCTALLFL------STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279
K + + L L + + I H DLK +NIL+ I D G + +
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISD 195
Query: 280 IYQYIQS-------RFYRSPEVLLG------IPYDLAIDMWSLGCILVEMHTGEPLFSGS 326
+ + Y PEVL + DM+S G IL E+
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255
Query: 327 NEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHD 386
E P H L + + ++ M + + K +P P +
Sbjct: 256 EEYQL-----------PYHDLVPSDPS---YEDMREI--VCIK---KLRPSFPNRWSSDE 296
Query: 387 ILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430
L + L+ ++P +R+T
Sbjct: 297 CL----------------------RQMGKLMTECWAHNPASRLT 318
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 60/245 (24%), Positives = 107/245 (43%), Gaps = 36/245 (14%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI-----EVKLLEIM 172
D +EI IGKGSFG+V + + A+K + K+ + + ++ E+++++ +
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQGL 72
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLS-----YNLYDLLRNTNFRGVSLNLTRKF 227
++V L F + +V +LL Y+L +N +F + F
Sbjct: 73 EHP------FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHF---KEETVKLF 120
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQ 285
+L AL +L IIH D+KP+NILL + + I DF + L +I
Sbjct: 121 ICELVMALDYLQ--NQRIIHRDMKPDNILLD--EHGHVHITDFNIAAMLPRETQITTMAG 176
Query: 286 SRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLF---SGSNEVDQMNKIVEV- 338
++ Y +PE+ G Y A+D WSLG E+ G + S ++ + ++
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236
Query: 339 LGLPP 343
+ P
Sbjct: 237 VTYPS 241
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 64/241 (26%), Positives = 98/241 (40%), Gaps = 53/241 (21%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN--------KKPFLNQAQIE 165
G+ +RY+I +G G V A D VAIK I K F +
Sbjct: 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 166 VKLL--EIMNKADV---NNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRG- 218
+L I++ DV ++ YY+V M E + L + + + G
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLV------M---------EYIEGPTLSEYIES---HGP 107
Query: 219 VSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG------- 271
+S++ F+ Q+ + ++ I+H D+KP+NIL+ +KI DFG
Sbjct: 108 LSVDTAINFTNQILDGIKH--AHDMRIVHRDIKPQNILI--DSNKTLKIFDFGIAKALSE 163
Query: 272 -SSCQLGQRI--YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
S Q + QY SPE G D D++S+G +L EM GEP F+G
Sbjct: 164 TSLTQTNHVLGTVQYF------SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217
Query: 329 V 329
V
Sbjct: 218 V 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 4e-20
Identities = 47/253 (18%), Positives = 95/253 (37%), Gaps = 55/253 (21%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQC-HVAIKIIKN------KKPFLNQAQIEV 166
G+ +YE+ I G G + A D V +K + + + + + Q
Sbjct: 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLA 134
Query: 167 KL-----LEIMN-----KADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTN 215
++ ++I N + YIV M E + +L
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIV------M---------EYVGGQSLKRSKG--- 176
Query: 216 FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275
+ + + + ++ AL +L + +++ DLKPENI+L +K++D G+ +
Sbjct: 177 -QKLPVAEAIAYLLEILPALSYLH--SIGLVYNDLKPENIMLT---EEQLKLIDLGAVSR 230
Query: 276 LGQR--IY---QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVD 330
+ +Y + +PE++ P A D++++G L + P +G VD
Sbjct: 231 INSFGYLYGTPGFQ------APEIVRTGPTV-ATDIYTVGRTLAALTLDLPTRNGRY-VD 282
Query: 331 QMNKIVEVLGLPP 343
+ + VL
Sbjct: 283 GLPEDDPVLKTYD 295
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKI--IKNKKPFLNQAQIEVKLLEIMNKADV 177
+ + IG G+FG++ +L +VAIK+ +K++ P L+ E + + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL---EYRFYKQL----- 61
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQ--LCTAL 235
+ I ++ + +V ELL +L DL + R FS + L A+
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD---------RTFSLKTVLMIAI 112
Query: 236 LFLSTPEL----NIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF 288
+S E N+I+ D+KPEN L+ N + I I+DF ++
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL-------------AKE 159
Query: 289 YRSPEVLLGIPYD-----------------LAI------DMWSLGCILVEMHTGEPL--- 322
Y PE IPY L D+ +LG + + G L
Sbjct: 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS-LPWQ 218
Query: 323 -FSGSNEVDQMNKIVEV-LGLPPKHLLDGAHKTRKY--------FDKMPDGSYILK 368
++ KI + P + L + + Y F + PD Y+ K
Sbjct: 219 GLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 74/295 (25%), Positives = 112/295 (37%), Gaps = 75/295 (25%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKI--IKNKKPFLNQAQIEVKLLEIMNKAD 176
+RY + IG GSFG + D+ VAIK+ +K K P L IE K+ ++M
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMM---- 61
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQ--LCTA 234
I ++ ++ +V ELL +L DL + RKFS + L A
Sbjct: 62 -QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---------RKFSLKTVLLLA 111
Query: 235 LLFLSTPEL----NIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY 289
+S E N IH D+KP+N L+ K + + I+DFG ++ Y
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL-------------AKKY 158
Query: 290 RSPEVLLGIPYD-----------------LAI------DMWSLGCILVEMHTGE---PLF 323
R IPY L I D+ SLG +L+ + G
Sbjct: 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
Query: 324 SGSNEVDQMNKIVEV-LGLPPKHLLDG---------AHKTRKYFDKMPDGSYILK 368
+ + + +I E + P + L G FD PD SY+ +
Sbjct: 219 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 47/241 (19%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN--------KKPFLNQAQIE 165
DRYE+ ++G G +V A DL + VA+K+++ F +AQ
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 166 VKLL--EIMNKADV-------NNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTN 215
L I+ D YIV M E + L D++
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPYIV------M---------EYVDGVTLRDIVHT-- 109
Query: 216 FRG-VSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG--- 271
G ++ + C AL F + + IIH D+KP NI++ +A+K++DFG
Sbjct: 110 -EGPMTPKRAIEVIADACQALNF--SHQNGIIHRDVKPANIMIS--ATNAVKVMDFGIAR 164
Query: 272 SSCQLGQRIYQ---YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328
+ G + Q I + Y SPE G D D++SLGC+L E+ TGEP F+G +
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
Query: 329 V 329
V
Sbjct: 225 V 225
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 65/285 (22%), Positives = 103/285 (36%), Gaps = 53/285 (18%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKI--IKNKKPFLNQAQIEVKLLEIMNKAD 176
Y++ IG+GSFG + + +L VAIK ++ P L E + +++
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD---EYRTYKLL---- 62
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQ--LCTA 234
I + H LV +LL +L DLL RKFS + A
Sbjct: 63 -AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---------RKFSVKTVAMAA 112
Query: 235 LLFLSTPEL----NIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQ-LGQRIYQYIQS 286
L+ + ++++ D+KP+N L+ + + I +VDFG Q+I
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 172
Query: 287 R---------FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPL----FSGSNEVDQMN 333
R Y S LG D+ +LG + + G L + +
Sbjct: 173 REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYE 231
Query: 334 KIVEV-LGLPPKHLLDG--------AHKTRKY-FDKMPDGSYILK 368
+I E P + L G H R FD PD Y+
Sbjct: 232 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 53/233 (22%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN--------KKPFLNQAQIEVKLL 169
Y + L+G+G G V +A D + VA+K++ + +A+ +L
Sbjct: 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ 92
Query: 170 E--IMNKADV---NNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRG-VSLN 222
E ++ D + Y+ M L++ +L +LR +G ++
Sbjct: 93 EPHVVPIHDFGEIDGQLYVD------M---------RLINGVDLAAMLRR---QGPLAPP 134
Query: 223 LTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG--------SSC 274
+Q+ +AL H D+KPENIL+ +VDFG
Sbjct: 135 RAVAIVRQIGSALDA--AHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKLT 190
Query: 275 QLGQRI--YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325
QLG + Y+ +PE D+++L C+L E TG P + G
Sbjct: 191 QLGNTVGTLYYM------APERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 60/250 (24%), Positives = 95/250 (38%), Gaps = 47/250 (18%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIM---NKAD 176
++ + +G FG V KA L E +VA+KI +K+ + N+ EV L M N
Sbjct: 27 QLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSWQNEY--EVYSLPGMKHEN--- 79
Query: 177 VNNTYYIVRL----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQL 231
I++ KR L L+ +L D L+ VS N ++ +
Sbjct: 80 ------ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETM 130
Query: 232 CTALLFL--------STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 283
L +L + I H D+K +N+LL N I DFG + +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLALKFEAGKSAG 188
Query: 284 IQSRF-----YRSPEVL-----LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 333
Y +PEVL L IDM+++G +L E+ + G + +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 334 KIVEVLGLPP 343
E +G P
Sbjct: 249 -FEEEIGQHP 257
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 37/242 (15%), Positives = 69/242 (28%), Gaps = 65/242 (26%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNN 179
++ + IG G FG + AF + A ++K + E+K + + K D
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 180 TYYIVRLKRH-----FMW--------RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRK 226
+ + + F R++ +V E L +L +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKI----------SGQNGT 147
Query: 227 FSQQ--LCTALLFLSTPEL----NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 280
F + L + L E +H D+K N+LL + + D+G S +
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR----- 202
Query: 281 YQYIQSRFYRSPEVLLGIPYDLAI-----------------------DMWSLGCILVEMH 317
Y + D+ LG ++
Sbjct: 203 --------YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254
Query: 318 TG 319
G
Sbjct: 255 CG 256
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKI--IKNKKPFLNQAQIEVKLLEIMNKAD 176
+++ + IG GSFG++ +++ VAIK+ +K K P L E K+ I+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL---LYESKIYRIL---- 59
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQ--LCTA 234
I ++ + ++ LV +LL +L DL + RK S + L A
Sbjct: 60 -QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS---------RKLSLKTVLMLA 109
Query: 235 LLFLSTPEL----NIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQ-LGQRIYQYIQSR- 287
++ E + +H D+KP+N L+ + + + I+DFG + + +Q+I R
Sbjct: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Query: 288 --------FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTG 319
Y S LGI D+ SLG +L+ G
Sbjct: 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 56/250 (22%), Positives = 85/250 (34%), Gaps = 52/250 (20%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKA 175
LD ++ LIG+G +G V K L+E+ VA+K+ N++ F+N E I
Sbjct: 12 LDNLKLLELIGRGRYGAVYKG-SLDER-PVAVKVFSFANRQNFIN----EK---NIYRVP 62
Query: 176 DVN--NTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKF 227
+ N I R + R LV E +L L + +
Sbjct: 63 LMEHDN---IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRL 116
Query: 228 SQQLCTALLFL-------STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 280
+ + L +L + I H DL N+L+ N I DFG S +L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLSMRLTGNR 174
Query: 281 YQYIQSRF-----------YRSPEVLLGI-------PYDLAIDMWSLGCILVEMHTGEPL 322
Y +PEVL G +DM++LG I E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 323 FSGSNEVDQM 332
V +
Sbjct: 235 LFPGESVPEY 244
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 40/221 (18%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVK 167
D++E++ +G G +G+V + + VA+K +K + FL +A
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA---- 268
Query: 168 LLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRK 226
+M + N +V+L ++ E ++Y NL D LR N + VS +
Sbjct: 269 ---VMKEIKHPN---LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 322
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---Y 283
+ Q+ +A+ +L + N IH +L N L+ +K+ DFG S R+ Y
Sbjct: 323 MATQISSAMEYLE--KKNFIHRNLAARNCLVGE--NHLVKVADFGLS-----RLMTGDTY 373
Query: 284 IQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ +PE L + + D+W+ G +L E+ T
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 40/221 (18%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVK 167
D++E++ +G G +G+V + + VA+K +K + FL +A
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA---- 61
Query: 168 LLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRK 226
+M + N +V+L ++ E ++Y NL D LR N + VS +
Sbjct: 62 ---VMKEIKHPN---LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ---Y 283
+ Q+ +A+ +L + N IH DL N L+ +K+ DFG S R+ Y
Sbjct: 116 MATQISSAMEYLE--KKNFIHRDLAARNCLVGENH--LVKVADFGLS-----RLMTGDTY 166
Query: 284 IQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ +PE L + + D+W+ G +L E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 42/221 (19%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVK 167
D +EI +G+G FG+V VAIK +K + + FL +AQ+
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSPEAFLQEAQV--- 232
Query: 168 LLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSL 221
M K +V+L + +V E +S +L D L+ + + L
Sbjct: 233 ----MKKLRHEK---LVQLYAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRL 279
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281
+ Q+ + + ++ +N +H DL+ NIL+ K+ DFG + + Y
Sbjct: 280 PQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEY 335
Query: 282 QYIQSR----FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
Q + +PE L + + D+WS G +L E+ T
Sbjct: 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 27/174 (15%), Positives = 60/174 (34%), Gaps = 24/174 (13%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDL--------EEQCHVAIKIIKNKKPFLNQAQIEVKLLEI 171
++++ S + + G + +A ++ ++K+ N E +
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFN----EQNFFQR 98
Query: 172 MNKADVNNTYYIVRLKRH-----FMW-----RNHLCLVFELLSYNLYDLLRNTNFRGVSL 221
K N + + M + LV L +L L + +S
Sbjct: 99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSE 158
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275
+ + +L AL FL E +H ++ ENI + +S + + +G + +
Sbjct: 159 RSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 49/252 (19%)
Query: 119 DRYEID-------SLIGKGSFGQVVKA----FDLEEQCHVAIKIIK-----NKKPFLNQA 162
D + + +GKG+FG V VA+K ++ + + F +
Sbjct: 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI 93
Query: 163 QIEVKLLEIMNKADVNNTYYIVRLKR--HFMWRNHLCLVFELLSY-NLYDLLRNTNFRGV 219
+ I+ +N IV+ K + R +L L+ E L Y +L D L+
Sbjct: 94 E-------ILKSLQHDN---IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKE 140
Query: 220 SLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277
++ + +++ Q+C + +L IH DL NIL+ N R +KI DFG + L
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENR--VKIGDFGLTKVLP 196
Query: 278 QRIYQYIQSR------FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ 331
Q Y F+ +PE L + +A D+WS G +L E+ T
Sbjct: 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY-----IEKSKSP 251
Query: 332 MNKIVEVLGLPP 343
+ + ++G
Sbjct: 252 PAEFMRMIGNDK 263
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 57/252 (22%), Positives = 100/252 (39%), Gaps = 49/252 (19%)
Query: 119 DRYEID-------SLIGKGSFGQVVKA----FDLEEQCHVAIKIIK-----NKKPFLNQA 162
D + + +GKG+FG V VA+K ++ + + F +
Sbjct: 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI 62
Query: 163 QIEVKLLEIMNKADVNNTYYIVRLKR--HFMWRNHLCLVFELLSY-NLYDLLRNTNFRGV 219
+ I+ +N IV+ K + R +L L+ E L Y +L D L+
Sbjct: 63 E-------ILKSLQHDN---IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKE 109
Query: 220 SLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277
++ + +++ Q+C + +L IH DL NIL+ N R +KI DFG + L
Sbjct: 110 RIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENR--VKIGDFGLTKVLP 165
Query: 278 QRIYQYIQSR------FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ 331
Q + F+ +PE L + +A D+WS G +L E+ T
Sbjct: 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY-----IEKSKSP 220
Query: 332 MNKIVEVLGLPP 343
+ + ++G
Sbjct: 221 PAEFMRMIGNDK 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 31/206 (15%), Positives = 67/206 (32%), Gaps = 49/206 (23%)
Query: 120 RYEIDSLIGKGSFGQVVKAF-----DLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
+++ IG+G FG + A + +K+ + L E+K + K
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF---TELKFYQRAAK 92
Query: 175 ADVNNTYYIVRLKR-----HFMW--------RNHLCLVFELLSYNLYDLLRNTNFRGVSL 221
+ + R + + +++ ++ + +L +
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------ 146
Query: 222 NLTRKFSQQ--LCTALLFLSTPEL----NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275
++FS++ L +L L E +H D+K N+LL + +VD+G + +
Sbjct: 147 ---KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 276 LGQRIYQYIQSRFYRSPEVLLGIPYD 301
Y V D
Sbjct: 204 -------------YCPEGVHKAYAAD 216
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 42/221 (19%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVK 167
D +EI +G+G FG+V VAIK +K + + FL +AQ+
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSPEAFLQEAQV--- 315
Query: 168 LLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSL 221
M K +V+L + +V E +S +L D L+ + + L
Sbjct: 316 ----MKKLRHEK---LVQLYAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRL 362
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281
+ Q+ + + ++ +N +H DL+ NIL+ K+ DFG + + Y
Sbjct: 363 PQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEY 418
Query: 282 QYIQSR----FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
Q + +PE L + + D+WS G +L E+ T
Sbjct: 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 38/277 (13%)
Query: 82 QQSQGEDSSHKKEK----KLYNEGYDDDNHDYIIQHGEKFLDRYEI--DSLIGKGSFGQV 135
S G ++ + + K + Y E + + + + ++ I + +IG G G+V
Sbjct: 6 HHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEV 65
Query: 136 VKA---FDLEEQCHVAIKIIK------NKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL 186
+ VAIK +K ++ FL++A IM + D N I+RL
Sbjct: 66 CYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS-------IMGQFDHPN---IIRL 115
Query: 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNI 245
+ +V E + +L LR + + + L + + + +LS +L
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG-MLRGVGAGMRYLS--DLGY 172
Query: 246 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR------SPEVLLGIP 299
+H DL N+L+ + K+ DFG S L + + +PE +
Sbjct: 173 VHRDLAARNVLVDSNL--VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 300 YDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335
+ A D+WS G ++ E+ GE + D ++ +
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 42/221 (19%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVK 167
D +EI +G G FG+V A + VA+K +K + + FL +A +
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVEAFLAEANV--- 236
Query: 168 LLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSL 221
M + +V+L K ++ E ++ +L D L++ L
Sbjct: 237 ----MKTLQHDK---LVKLHAVVTKEPIY------IITEFMAKGSLLDFLKSDEGSKQPL 283
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281
FS Q+ + F+ + N IH DL+ NIL+ KI DFG + + Y
Sbjct: 284 PKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSA--SLVCKIADFGLARVIEDNEY 339
Query: 282 QYIQ-SRF---YRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ ++F + +PE + + + D+WS G +L+E+ T
Sbjct: 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 50/225 (22%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVK 167
D +E+ +G G FG+V + VA+K +K + FL +A
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEAN---- 60
Query: 168 LLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSL 221
+M + +VRL + ++ E + +L D L+ + +++
Sbjct: 61 ---LMKQLQHQR---LVRLYAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTI 108
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 281
N + Q+ + F+ E N IH DL+ NIL+ + + KI DFG L + I
Sbjct: 109 NKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTL--SCKIADFG----LARLIE 160
Query: 282 --QYIQS---RF-YR--SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+Y +F + +PE + + + D+WS G +L E+ T
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 60/243 (24%), Positives = 94/243 (38%), Gaps = 45/243 (18%)
Query: 119 DRYEID-------SLIGKGSFGQVVKA----FDLEEQCHVAIKIIKNKKP-----FLNQA 162
D + S +GKG+FG V VA+K +++ P F +
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 75
Query: 163 QIEVKLLEIMNKADVNNTYYIVRLKR--HFMWRNHLCLVFELLSY-NLYDLLRNTNFRGV 219
Q I+ + IV+ + + R L LV E L L D L+
Sbjct: 76 Q-------ILKALHSDF---IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRA 122
Query: 220 SLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277
L+ +R +S Q+C + +L +H DL NIL+ + +KI DFG + L
Sbjct: 123 RLDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAH--VKIADFGLAKLLP 178
Query: 278 QRIYQYIQSR------FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVD 330
Y+ F+ +PE L + D+WS G +L E+ T + S S E
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL 238
Query: 331 QMN 333
+M
Sbjct: 239 RMM 241
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 44/233 (18%)
Query: 106 NHDYIIQHGEKFLDRYEID-------SLIGKGSFGQVVKAFDLEEQCHVAIKIIKN---K 155
+ E + + ++ IGKG FG V+ + VA+K IKN
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA 230
Query: 156 KPFLNQAQIEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYD 209
+ FL +A + M + +N +V+L + + L +V E ++ +L D
Sbjct: 231 QAFLAEASV-------MTQLRHSN---LVQLLGVIVEE----KGGLYIVTEYMAKGSLVD 276
Query: 210 LLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269
LR+ + + KFS +C A+ +L N +H DL N+L+ + K+ D
Sbjct: 277 YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSE--DNVAKVSD 332
Query: 270 FGSSCQLGQRIYQYIQ-SRF-YR--SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
FG L + + + +PE L + D+WS G +L E+++
Sbjct: 333 FG----LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 52/221 (23%), Positives = 82/221 (37%), Gaps = 45/221 (20%)
Query: 118 LDRYEI--DSLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEI 171
L R EI +G G FG V + Q VA+K+IK ++ F +AQ
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQ-------T 56
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR--KFS 228
M K +V+ + +V E +S L + LR+ G L ++ +
Sbjct: 57 MMKLSHPK---LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMC 110
Query: 229 QQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF 288
+C + FL IH DL N L+ +K+ DFG + + Y
Sbjct: 111 YDVCEGMAFLE--SHQFIHRDLAARNCLVDRDL--CVKVSDFGMTRYVLDDQY------- 159
Query: 289 YRS-----------PEVLLGIPYDLAIDMWSLGCILVEMHT 318
S PEV Y D+W+ G ++ E+ +
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 8e-14
Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 44/220 (20%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAFDLEEQCHVAIKIIKN---KKPFLNQAQIEVKL 168
+ ++ IGKG FG V+ VA+K IKN + FL +A
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLAEAS----- 66
Query: 169 LEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLN 222
+M + +N +V+L + + L +V E ++ +L D LR+ + +
Sbjct: 67 --VMTQLRHSN---LVQLLGVIVEE----KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 223 LTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 282
KFS +C A+ +L N +H DL N+L+ K+ DFG L +
Sbjct: 118 CLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDN--VAKVSDFG----LTKEASS 169
Query: 283 YIQ-SRF-YR--SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ + +PE L + D+WS G +L E+++
Sbjct: 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 46/227 (20%)
Query: 116 KFLDRYEI--DSLIGKGSFGQVVKAF----DLEEQCHVAIKIIK------NKKPFLNQAQ 163
+ L E ++G G+FG V K + + VAIK ++ K L++A
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 164 IEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFR 217
+M D + + RL L+ +L+ + L D +R +
Sbjct: 70 -------VMASVDNPH---VCRLLGICLTSTVQ------LITQLMPFGCLLDYVRE-HKD 112
Query: 218 GVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277
+ + Q+ + +L + ++H DL N+L+ P +KI DFG + LG
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLG 168
Query: 278 QRIYQYIQS------RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+Y ++ + E +L Y D+WS G + E+ T
Sbjct: 169 AEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 47/222 (21%)
Query: 118 LDRYEI--DSLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEI 171
+D E+ IG G FG V + + VAIK I+ +++ F+ +A+ +
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAE-------V 56
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR--KFS 228
M K +V+L + + +CLV E + + L D LR +
Sbjct: 57 MMKLSHPK---LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMC 110
Query: 229 QQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF 288
+C + +L E +IH DL N L+ IK+ DFG + +++
Sbjct: 111 LDVCEGMAYLE--EACVIHRDLAARNCLVGE--NQVIKVSDFGMT--------RFVLDDQ 158
Query: 289 YRS------------PEVLLGIPYDLAIDMWSLGCILVEMHT 318
Y S PEV Y D+WS G ++ E+ +
Sbjct: 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 34/237 (14%)
Query: 118 LDRYEI--DSLIGKGSFGQVVKA---FDLEEQCHVAIKIIK------NKKPFLNQAQIEV 166
LD I D ++G G FG+V +++ VAIK +K ++ FL +A
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS--- 98
Query: 167 KLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR 225
IM + D N I+RL+ + +V E + +L LR + + + L
Sbjct: 99 ----IMGQFDHPN---IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 226 KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 285
+ + + + +LS ++ +H DL NIL+ + K+ DFG L
Sbjct: 152 -MLRGIASGMKYLS--DMGYVHRDLAARNILINSNL--VCKVSDFGLGRVLEDDPEAAYT 206
Query: 286 SRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335
+R + SPE + + A D+WS G +L E+ + GE + + D + +
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 44/231 (19%), Positives = 87/231 (37%), Gaps = 52/231 (22%)
Query: 118 LDRYEI--DSLIGKGSFGQVVKA-------FDLEEQCHVAIKIIKN-----KKPFLNQAQ 163
+ ++ + +G+G+F ++ K + + V +K++ + F A
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 164 IEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLN 222
+M+K + +V + + LV E + + +L L+ +N
Sbjct: 65 -------MMSKLSHKH---LVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCIN 111
Query: 223 LTRK--FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA------IKIVDFGSSC 274
+ K ++QL A+ FL E +IH ++ +NILL + IK+ D G
Sbjct: 112 ILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG--- 166
Query: 275 QLGQRIYQYIQSRFYR------SPEVLL-GIPYDLAIDMWSLGCILVEMHT 318
+ + + PE + +LA D WS G L E+ +
Sbjct: 167 -ISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 52/226 (23%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVK 167
+EID +G G FG V Q VAIK+IK ++ F+ +A+
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAK---- 71
Query: 168 LLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR- 225
+M +V+L + + ++ E ++ L + LR +
Sbjct: 72 ---VMMNLSHEK---LVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQL 122
Query: 226 -KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 284
+ + +C A+ +L +H DL N L+ + + +K+ DFG S +Y+
Sbjct: 123 LEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVND--QGVVKVSDFGLS--------RYV 170
Query: 285 QSRFYRS------------PEVLLGIPYDLAIDMWSLGCILVEMHT 318
Y S PEVL+ + D+W+ G ++ E+++
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 57/261 (21%), Positives = 103/261 (39%), Gaps = 35/261 (13%)
Query: 95 KKLYNEGYDDDNHDYIIQHGEKFLDRYEI--DSLIGKGSFGQVVKAF----DLEEQCHVA 148
+ LY +G + + + + + +IG G FG+V K +++ VA
Sbjct: 18 ENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVA 77
Query: 149 IKIIK------NKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFEL 202
IK +K + FL +A IM + +N I+RL+ + ++ E
Sbjct: 78 IKTLKAGYTEKQRVDFLGEAG-------IMGQFSHHN---IIRLEGVISKYKPMMIITEY 127
Query: 203 LSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK 261
+ L LR + L L + + + +L+ +N +H DL NIL+ +
Sbjct: 128 MENGALDKFLREKDGEFSVLQLVG-MLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNL 184
Query: 262 RSAIKIVDFGSSCQLGQRIYQYIQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVE 315
K+ DFG S L + + +PE + + A D+WS G ++ E
Sbjct: 185 --VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 242
Query: 316 MHT-GEPLFSGSNEVDQMNKI 335
+ T GE + + + M I
Sbjct: 243 VMTYGERPYWELSNHEVMKAI 263
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 47/240 (19%), Positives = 87/240 (36%), Gaps = 60/240 (25%)
Query: 118 LDRYEID-------SLIGKGSFGQVVKAF---DLEEQCHVAIKIIKN-------KKPFLN 160
L+ ID ++G+G FG V++ + VA+K +K + FL+
Sbjct: 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 161 QAQIEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNT 214
+A M N ++RL + ++ + Y +L+ L +
Sbjct: 86 EA-------ACMKDFSHPN---VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 215 NFRGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270
++ + F + + +LS N +H DL N +L + + + DF
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLRDDM--TVCVADF 191
Query: 271 GSSCQLGQRIYQYIQSRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
G L ++IY +YR + E L Y D+W+ G + E+ T
Sbjct: 192 G----LSKKIY---SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 50/241 (20%), Positives = 88/241 (36%), Gaps = 61/241 (25%)
Query: 118 LDRYEID-------SLIGKGSFGQVVKAF---DLEEQCHVAIKIIK-------NKKPFLN 160
L+ I ++GKG FG V +A + VA+K++K + + FL
Sbjct: 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 161 QAQIEVKLLEIMNKADVNNTYYIVRL------KRHFMWRNHLCLVFELLSY-NLYDLLRN 213
+A M + D + + +L R ++ + + +L+ L
Sbjct: 75 EA-------ACMKEFDHPH---VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 214 TNFRGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269
+ NL + F + + +LS N IH DL N +L + + D
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNCMLAEDM--TVCVAD 180
Query: 270 FGSSCQLGQRIYQYIQSRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMH 317
FG L ++IY +YR + E L Y + D+W+ G + E+
Sbjct: 181 FG----LSRKIY---SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
Query: 318 T 318
T
Sbjct: 234 T 234
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 57/246 (23%), Positives = 91/246 (36%), Gaps = 50/246 (20%)
Query: 119 DRYEID--------SLIGKGSFGQVVKAF--DLEEQCHVAIKIIK------NKKPFLNQA 162
+ + +G G+FG V + ++Q VAIK++K + + + +A
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 163 QIEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNF 216
QI M++ D IVRL M LV E+ L+ L
Sbjct: 62 QI-------MHQLDNPY---IVRLIGVCQAEALM------LVMEMAGGGPLHKFLVGKRE 105
Query: 217 RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
N+ + Q+ + +L E N +H DL N+LL N KI DFG S L
Sbjct: 106 EIPVSNVA-ELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRH--YAKISDFGLSKAL 160
Query: 277 GQRIYQYIQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEV 329
G Y + +PE + + D+WS G + E + G+ +
Sbjct: 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220
Query: 330 DQMNKI 335
+ M I
Sbjct: 221 EVMAFI 226
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 51/234 (21%), Positives = 86/234 (36%), Gaps = 57/234 (24%)
Query: 119 DRYEID-------SLIGKGSFGQVVKA----FDLEEQCHVAIKIIK------NKKPFLNQ 161
D + +G+G FG+V VA+K +K + +
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE 73
Query: 162 AQIEVKLLEIMNKADVNNTYYIVRLKR--HFMWRNHLCLVFELLSY-NLYDLLRNTNFRG 218
+ I+ N IV+ K N + L+ E L +L + L
Sbjct: 74 IE-------ILRNLYHEN---IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NK 120
Query: 219 VSLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
+NL + K++ Q+C + +L +H DL N+L+ + + +KI DFG L
Sbjct: 121 NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQ--VKIGDFG----L 172
Query: 277 GQRIYQYIQSRFYRS------------PEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ I +Y PE L+ + +A D+WS G L E+ T
Sbjct: 173 TKAIET--DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 52/227 (22%), Positives = 80/227 (35%), Gaps = 46/227 (20%)
Query: 117 FLDRYEI--DSLIGKGSFGQVVKAF---DLEEQCHVAIKIIKN--------KKPFLNQAQ 163
+ ++ +G GSFG V + + VA+K +K F+ +
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 164 IEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFR 217
M+ D N ++RL +V EL +L D LR +
Sbjct: 74 -------AMHSLDHRN---LIRLYGVVLTPPMK------MVTELAPLGSLLDRLRK-HQG 116
Query: 218 GVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277
L +++ Q+ + +L IH DL N+LL +KI DFG L
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALP 172
Query: 278 QRIYQYIQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
Q Y+ + +PE L + A D W G L EM T
Sbjct: 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 52/225 (23%), Positives = 82/225 (36%), Gaps = 46/225 (20%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAFDLEEQCHVAIKIIKN------KKPFLNQAQIE 165
D++ ++ IG+G+FG+V + VA+K + K FL +A+
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR-- 164
Query: 166 VKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLT 224
I+ + N IVRL + + +V EL+ + LR G L +
Sbjct: 165 -----ILKQYSHPN---IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVK 213
Query: 225 RK--FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY- 281
+ +L IH DL N L+ +KI DFG + +
Sbjct: 214 TLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKN--VLKISDFG----MSREEAD 265
Query: 282 -QYIQSRFYR-------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
Y S R +PE L Y D+WS G +L E +
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 69/330 (20%), Positives = 113/330 (34%), Gaps = 48/330 (14%)
Query: 33 PGDILAMQARIPLQFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHK 92
G I ++ P A+ T H +S
Sbjct: 244 DGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPD 303
Query: 93 KEKKLYNEGYDD---DNHDYIIQHGEKFLDRYEI---DSLIGKGSFGQVVKAF--DLEEQ 144
K + + + + ++ + FL R + D +G G+FG V + ++Q
Sbjct: 304 KPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ 363
Query: 145 CHVAIKIIK------NKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL-----KRHFMWR 193
VAIK++K + + + +AQI +L + YIVRL M
Sbjct: 364 IDVAIKVLKQGTEKADTEEMMREAQIMHQL----------DNPYIVRLIGVCQAEALM-- 411
Query: 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKP 252
LV E+ L+ L N+ Q+ + +L E N +H +L
Sbjct: 412 ----LVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMKYLE--EKNFVHRNLAA 464
Query: 253 ENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR------SPEVLLGIPYDLAIDM 306
N+LL N R KI DFG S LG Y + +PE + + D+
Sbjct: 465 RNVLLVN--RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 522
Query: 307 WSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335
WS G + E + G+ + + M I
Sbjct: 523 WSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 54/243 (22%), Positives = 92/243 (37%), Gaps = 49/243 (20%)
Query: 119 DRYEIDSLIGKGSFGQVVKA----FDLEEQCHVAIKIIK------NKKPFLNQAQIEVKL 168
+ +G+G FG+V + VA+K +K ++ + +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEID----- 85
Query: 169 LEIMNKADVNNTYYIVRLKR--HFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR 225
I+ + I++ K L LV E + +L D L + L
Sbjct: 86 --ILRTLYHEH---IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL---L 137
Query: 226 KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 285
F+QQ+C + +L + IH DL N+LL N + +KI DFG L + + +
Sbjct: 138 LFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRL--VKIGDFG----LAKAVPE--G 187
Query: 286 SRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQM 332
+YR +PE L + A D+WS G L E+ T + S + ++
Sbjct: 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
Query: 333 NKI 335
I
Sbjct: 248 IGI 250
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 61/278 (21%), Positives = 104/278 (37%), Gaps = 46/278 (16%)
Query: 64 KTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEI 123
+ K +Q + E Y E D+++ + + + R I
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392
Query: 124 --DSLIGKGSFGQVVKAF---DLEEQCHVAIKIIK------NKKPFLNQAQIEVKLLEIM 172
IG+G FG V + VAIK K ++ FL +A M
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-------TM 445
Query: 173 NKADVNNTYYIVRL----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR-- 225
+ D + IV+L + +W ++ EL + L L+ R SL+L
Sbjct: 446 RQFDHPH---IVKLIGVITENPVW-----IIMELCTLGELRSFLQV---RKFSLDLASLI 494
Query: 226 KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 285
++ QL TAL +L +H D+ N+L+ + +K+ DFG S + Y Y
Sbjct: 495 LYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY-YKA 549
Query: 286 SR-----FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
S+ + +PE + + A D+W G + E+
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 3e-12
Identities = 45/252 (17%), Positives = 72/252 (28%), Gaps = 59/252 (23%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV- 177
++ + IG+G FG+V + VAIKII + P L + EI+ + +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 178 -----------NNTYYIVRLKRHFMWR------------------------------NHL 196
N T + L + + L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256
+V E L + SL + QL +L L H DL N+L
Sbjct: 138 FIVLEFE--FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVL 194
Query: 257 LCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEM 316
L + G S + Q I Y L+ + ++
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSI------------IDYTLSRLERDGIVVFCDV 242
Query: 317 HTGEPLFSGSNE 328
E LF+G +
Sbjct: 243 SMDEDLFTGDGD 254
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 58/228 (25%), Positives = 87/228 (38%), Gaps = 46/228 (20%)
Query: 115 EKFLDRYEI---DSLIGKGSFGQVVKAF--DLEEQCHVAIKIIKN-------KKPFLNQA 162
E +LDR + D +G G+FG V K + + VA+KI+KN K L +A
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 163 QIEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNF 216
+ M + D IVR+ +M LV E+ L L+
Sbjct: 70 NV-------MQQLDNPY---IVRMIGICEAESWM------LVMEMAELGPLNKYLQQN-- 111
Query: 217 RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
R V + Q+ + +L E N +H DL N+LL KI DFG S L
Sbjct: 112 RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKAL 167
Query: 277 GQRIYQYIQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
Y + +PE + + D+WS G ++ E +
Sbjct: 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 47/224 (20%), Positives = 84/224 (37%), Gaps = 44/224 (19%)
Query: 118 LDRYEI--DSLIGKGSFGQVVKAF----DLEEQCHVAIKIIKN------KKPFLNQAQIE 165
E+ ++G G FG V K + V IK+I++ + +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML-- 67
Query: 166 VKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGV 219
+ D + IVRL LV + L +L D +R + +
Sbjct: 68 -----AIGSLDHAH---IVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQ-HRGAL 112
Query: 220 SLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279
L + Q+ + +L E ++H +L N+LL +P S +++ DFG + L
Sbjct: 113 GPQLLLNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSP--SQVQVADFGVADLLPPD 168
Query: 280 IYQYIQS--RF---YRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
Q + S + + + E + Y D+WS G + E+ T
Sbjct: 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 63/294 (21%), Positives = 112/294 (38%), Gaps = 84/294 (28%)
Query: 73 YYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEID-------S 125
Y K+K + + + E Y+ +++ +I + +++E
Sbjct: 4 YKYKQKPK-----------YQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGK 52
Query: 126 LIGKGSFGQVVKA--FDL---EEQCHVAIKIIKN------KKPFLNQAQIEVKLLEIMNK 174
+G G+FG+VV+A F L + VA+K++K+ K+ +++ +I L + N
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN- 111
Query: 175 ADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNT--------NFRGVS 220
IV L + ++ E Y +L + LR F +
Sbjct: 112 --------IVNLLGACTHGG-----PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 221 LNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
+ + FS Q+ + FL+ N IH D+ N+LL N KI DFG L
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVAARNVLLTNGH--VAKIGDFG----L 210
Query: 277 GQRIYQYIQSRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ I Y +PE + Y + D+WS G +L E+ +
Sbjct: 211 ARDIM---NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 46/227 (20%)
Query: 116 KFLDRYEI--DSLIGKGSFGQVVKAF----DLEEQCHVAIKIIK------NKKPFLNQAQ 163
+ L E ++G G+FG V K + + VAIK ++ K L++A
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 164 IEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFR 217
+M D + + RL L+ +L+ + L D +R +
Sbjct: 70 -------VMASVDNPH---VCRLLGICLTSTVQ------LITQLMPFGCLLDYVRE-HKD 112
Query: 218 GVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277
+ + Q+ + +L + ++H DL N+L+ P +KI DFG + LG
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLG 168
Query: 278 QRIYQYIQS------RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+Y ++ + E +L Y D+WS G + E+ T
Sbjct: 169 AEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 4e-12
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 57/231 (24%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAF---DLEEQCHVAIKIIK------NKKPFLNQA 162
+Y I ++G+G FG+V + E+ +VA+K K NK+ F+++A
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEA 64
Query: 163 QIEVKLLEIMNKADVNNTYYIVRL----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFR 217
IM D + IV+L + W ++ EL Y L L
Sbjct: 65 V-------IMKNLDHPH---IVKLIGIIEEEPTW-----IIMELYPYGELGHYLER---N 106
Query: 218 GVSLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275
SL + +S Q+C A+ +L +N +H D+ NIL+ +P +K+ DFG
Sbjct: 107 KNSLKVLTLVLYSLQICKAMAYLE--SINCVHRDIAVRNILVASP--ECVKLGDFG---- 158
Query: 276 LGQRIY--QYIQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
L + I Y ++ R SPE + + A D+W + E+ +
Sbjct: 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 61/274 (22%)
Query: 84 SQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEI--DSLIGKGSFGQVVKA--- 138
G S + K +G+ +N Y + R +I +G+G+FG+V A
Sbjct: 4 GSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECH 63
Query: 139 --FDLEEQCHVAIKIIKN-----KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191
+++ VA+K +K ++ F +A E++ + IVR
Sbjct: 64 NLLPEQDKMLVAVKALKEASESARQDFQREA-------ELLTMLQHQH---IVRFFGVCT 113
Query: 192 WRNHLCLVFELLSY-NLYDLLR-----------NTNFRGVSLNLTR--KFSQQLCTALLF 237
L +VFE + + +L LR + L L + + Q+ +++
Sbjct: 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR------- 290
L+ L+ +H DL N L+ +KI DFG + + IY + +YR
Sbjct: 174 LA--GLHFVHRDLATRNCLV-GQGLV-VKIGDFG----MSRDIY---STDYYRVGGRTML 222
Query: 291 -----SPEVLL-GIPYDLAIDMWSLGCILVEMHT 318
PE +L + D+WS G +L E+ T
Sbjct: 223 PIRWMPPESILYRK-FTTESDVWSFGVVLWEIFT 255
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 45/252 (17%), Positives = 83/252 (32%), Gaps = 62/252 (24%)
Query: 98 YNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAF---DLEEQCHVAIKIIKN 154
N +I + + +IG+G FG V + ++ H A+K +
Sbjct: 7 LNPELVQAVQHVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 155 ------KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELL 203
FL + IM N ++ L + +V +
Sbjct: 64 ITDIGEVSQFLTEG-------IIMKDFSHPN---VLSLLGICLRS----EGSPLVVLPYM 109
Query: 204 SY-NLYDLLRNTNFRGVSLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP 260
+ +L + +RN + + F Q+ + +L+ +H DL N +L
Sbjct: 110 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEK 164
Query: 261 KRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--------------SPEVLLGIPYDLAIDM 306
+K+ DFG L + +Y +Y + E L + D+
Sbjct: 165 F--TVKVADFG----LARDMY---DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDV 215
Query: 307 WSLGCILVEMHT 318
WS G +L E+ T
Sbjct: 216 WSFGVLLWELMT 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 55/252 (21%), Positives = 100/252 (39%), Gaps = 60/252 (23%)
Query: 106 NHDYIIQHGEKFLDRYEID-------SLIGKGSFGQVVKA-----FDLEEQCHVAIKIIK 153
N +Y D +E+ +G+GSFG V + E + VAIK +
Sbjct: 5 NPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 64
Query: 154 ------NKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-N 206
+ FLN+A +M + + ++ +VRL ++ EL++ +
Sbjct: 65 EAASMRERIEFLNEA-------SVMKEFNCHH---VVRLLGVVSQGQPTLVIMELMTRGD 114
Query: 207 LYDLLRN------TNFRGVSLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258
L LR+ N +L++ + + ++ + +L+ +H DL N ++
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMV- 171
Query: 259 NPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR------------SPEVLLGIPYDLAIDM 306
+KI DFG + + IY ++ +YR SPE L + D+
Sbjct: 172 AEDF-TVKIGDFG----MTRDIY---ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 223
Query: 307 WSLGCILVEMHT 318
WS G +L E+ T
Sbjct: 224 WSFGVVLWEIAT 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 53/293 (18%), Positives = 98/293 (33%), Gaps = 57/293 (19%)
Query: 54 PLRKLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQH 113
P +D I + + ++ Y K QG ++ H + N +I
Sbjct: 28 PRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHI-DLSALNPELVQAVQHVVIGP 86
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAF---DLEEQCHVAIKIIKN------KKPFLNQAQI 164
+ + +IG+G FG V + ++ H A+K + FL +
Sbjct: 87 SSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG-- 141
Query: 165 EVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRG 218
IM N ++ L + +V + + +L + +RN
Sbjct: 142 -----IIMKDFSHPN---VLSLLGICLRS----EGSPLVVLPYMKHGDLRNFIRN---ET 186
Query: 219 VSLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
+ + F Q+ + FL+ +H DL N +L +K+ DFG L
Sbjct: 187 HNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKF--TVKVADFG----L 238
Query: 277 GQRIYQYIQSRFYR-----------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ +Y + + E L + D+WS G +L E+ T
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 53/229 (23%)
Query: 119 DRYEID-------SLIGKGSFGQVVKA---FDLEEQCHVAIKIIK------NKKPFLNQA 162
YEI IG+G FG V + VAIK K ++ FL +A
Sbjct: 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 163 QIEVKLLEIMNKADVNNTYYIVRL----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFR 217
M + D + IV+L + +W ++ EL + L L+ R
Sbjct: 68 L-------TMRQFDHPH---IVKLIGVITENPVW-----IIMELCTLGELRSFLQV---R 109
Query: 218 GVSLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275
SL+L ++ QL TAL +L +H D+ N+L+ + +K+ DFG S
Sbjct: 110 KYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSND--CVKLGDFGLSRY 165
Query: 276 LGQRIYQYIQS------RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ Y Y S ++ +PE + + A D+W G + E+
Sbjct: 166 MEDSTY-YKASKGKLPIKWM-APESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 57/285 (20%), Positives = 100/285 (35%), Gaps = 58/285 (20%)
Query: 71 EVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEID------ 124
E Y + ++ E K Y+ + D E+
Sbjct: 18 ENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNP--NYCFAGKTSSISDLKEVPRKNITL 75
Query: 125 -SLIGKGSFGQVVKAF-----DLEEQCHVAIKIIK------NKKPFLNQAQIEVKLLEIM 172
+G G+FG+V + + VA+K + ++ FL +A I+
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA-------LII 128
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRN---TNFRGVSLNLTR--K 226
+K + N IVR + ++ EL++ +L LR + SL +
Sbjct: 129 SKFNHQN---IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQLGQRIYQYIQ 285
++ + +L E + IH D+ N LL C KI DFG + + IY +
Sbjct: 186 VARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIY---R 236
Query: 286 SRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ +YR PE + + D WS G +L E+ +
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 56/240 (23%), Positives = 88/240 (36%), Gaps = 60/240 (25%)
Query: 119 DRYEIDSLIGKGSFGQVVKA-----FDLEEQCHVAIKIIK------NKKPFLNQAQIEVK 167
+R +G G+FG+VV+A + VA+K++K ++ +++ ++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 168 LLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRN------------T 214
L MN IV L ++ E Y +L + LR
Sbjct: 83 LGNHMN---------IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 215 NFRGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270
L L + FS Q+ + FL+ N IH DL NILL + + KI DF
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGR--ITKICDF 189
Query: 271 GSSCQLGQRIYQYIQSRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
G L + I Y +PE + Y D+WS G L E+ +
Sbjct: 190 G----LARDIK---NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 56/248 (22%), Positives = 96/248 (38%), Gaps = 68/248 (27%)
Query: 118 LDRYEID-------SLIGKGSFGQVVKAF-----DLEEQCHVAIKIIK------NKKPFL 159
++E +G+G+FGQV++A VA+K++K + +
Sbjct: 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 78
Query: 160 NQAQIEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRN 213
++ +I + + +N +V L K L ++ E + NL LR+
Sbjct: 79 SELKILIHIGHHLN---------VVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRS 125
Query: 214 ----------TNFRGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCN 259
LT + +S Q+ + FL+ IH DL NILL
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSE 183
Query: 260 PKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYR------SPEVLLGIPYDLAIDMWSLG 310
+KI DFG L + IY+ Y++ R +PE + Y + D+WS G
Sbjct: 184 KN--VVKICDFG----LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 311 CILVEMHT 318
+L E+ +
Sbjct: 238 VLLWEIFS 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 52/237 (21%), Positives = 90/237 (37%), Gaps = 56/237 (23%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAF-----DLEEQCHVAIKIIK------NKKPFLN 160
D E+ +G G+FG+V + + VA+K + ++ FL
Sbjct: 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 161 QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRN---TNF 216
+A I++K + N IVR + ++ EL++ +L LR
Sbjct: 83 EA-------LIISKFNHQN---IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS 132
Query: 217 RGVSLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILL-CNPKRSAIKIVDFGSS 273
+ SL + ++ + +L E + IH D+ N LL C KI DFG
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG-- 188
Query: 274 CQLGQRIYQYIQSRFYR------------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
+ + IY ++ +YR PE + + D WS G +L E+ +
Sbjct: 189 --MARDIY---RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 24/228 (10%), Positives = 53/228 (23%), Gaps = 39/228 (17%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVK--LLEIMNKAD 176
RY + G Q +A D VA+ + P ++ L + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD---PQGVLPDDVLQETLSRTLRLSR 87
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
++ + R+ R +V E + +L ++ S + Q L A
Sbjct: 88 IDKPG-VARVLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGAIRAMQSLAAAA 142
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVL 295
+ P + + + +
Sbjct: 143 DAAH--RAGVALSIDHPSRVRVSI--DGDVVLAYPA-----------------TMPDA-- 179
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343
+ D+ +G L + + + P
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 50/235 (21%), Positives = 92/235 (39%), Gaps = 70/235 (29%)
Query: 127 IGKGSFGQVVKA-----FDLEEQCHVAIKIIKN-----KKPFLNQAQIEVKLLEIMNKAD 176
+G+G+FG+V A +++ VA+K +K+ +K F +A E++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA-------ELLTNLQ 75
Query: 177 VNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLR----------NTNFRGVS 220
+ IV+ L +VFE + + +L LR + R
Sbjct: 76 HEH---IVKFYGVCGDGD-----PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 221 LNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
L + Q+ + +++L+ + +H DL N L+ +KI DFG +
Sbjct: 128 GELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLV-GANLL-VKIGDFG----M 179
Query: 277 GQRIYQYIQSRFYR------------SPEVLL-GIPYDLAIDMWSLGCILVEMHT 318
+ +Y + +YR PE ++ + D+WS G IL E+ T
Sbjct: 180 SRDVY---STDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFT 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 62/309 (20%), Positives = 110/309 (35%), Gaps = 64/309 (20%)
Query: 57 KLSVDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEK 116
S D +K + ++ + +S +S+ ++ + + E
Sbjct: 9 HHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEY 68
Query: 117 FL---DRYEID-------SLIGKGSFGQVVKA-------FDLEEQCHVAIKIIK------ 153
L ++E +G+G FGQVV A +E VA+K++K
Sbjct: 69 ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 128
Query: 154 NKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLR 212
+ +++ ++ + + N I+ L L ++ E S NL + LR
Sbjct: 129 DLSDLVSEMEMMKMIGKHKN---------IINLLGACTQDGPLYVIVEYASKGNLREYLR 179
Query: 213 N----------TNFRGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLC 258
R +T K + QL + +L+ IH DL N+L+
Sbjct: 180 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLVT 237
Query: 259 NPKRSAIKIVDFGSSCQLGQRIYQ---YIQSRFYR------SPEVLLGIPYDLAIDMWSL 309
+KI DFG L + I Y ++ R +PE L Y D+WS
Sbjct: 238 ENN--VMKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291
Query: 310 GCILVEMHT 318
G ++ E+ T
Sbjct: 292 GVLMWEIFT 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 55/242 (22%), Positives = 93/242 (38%), Gaps = 64/242 (26%)
Query: 119 DRYEIDSLIGKGSFGQVVKA-------FDLEEQCHVAIKIIK------NKKPFLNQAQIE 165
D+ + +G+G+FGQVV A +E VA+K++K + +++ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 166 VKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRN------ 213
+ + N I+ L + L ++ E S NL + LR
Sbjct: 95 KMIGKHKN---------IINLLGACTQDG-----PLYVIVEYASKGNLREYLRARRPPGM 140
Query: 214 ----TNFRGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265
R +T K + QL + +L+ IH DL N+L+ +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLVTENN--VM 196
Query: 266 KIVDFGSSCQLGQRIYQ---YIQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEM 316
KI DFG L + I Y ++ R +PE L Y D+WS G ++ E+
Sbjct: 197 KIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 317 HT 318
T
Sbjct: 253 FT 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 55/306 (17%), Positives = 102/306 (33%), Gaps = 73/306 (23%)
Query: 63 IKTYKHINEVYYAKKKR-RAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRY 121
+ ++ + H + Y + ++ R+
Sbjct: 6 HHHHHD-YDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRW 64
Query: 122 EID-------SLIGKGSFGQVVKA-------FDLEEQCHVAIKIIK------NKKPFLNQ 161
E+ +G+G+FGQVV A VA+K++K + +++
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 162 AQIEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRN-- 213
++ + + N I+ L + L ++ E S NL + L+
Sbjct: 125 MEMMKMIGKHKN---------IINLLGACTQDG-----PLYVIVEYASKGNLREYLQARR 170
Query: 214 --------TNFRGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK 261
L+ K + Q+ + +L+ IH DL N+L+
Sbjct: 171 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDN 228
Query: 262 RSAIKIVDFGSSCQLGQRIYQ---YIQSRFYR------SPEVLLGIPYDLAIDMWSLGCI 312
+KI DFG L + I+ Y ++ R +PE L Y D+WS G +
Sbjct: 229 --VMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 282
Query: 313 LVEMHT 318
L E+ T
Sbjct: 283 LWEIFT 288
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 52/258 (20%), Positives = 93/258 (36%), Gaps = 84/258 (32%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAF-----DLEEQCHVAIKIIK------NKKPFLN 160
++E +G+G FG+VVKA VA+K++K + L+
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 161 QAQIEVKLLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRN- 213
+ ++ + + + +++L + L L+ E Y +L LR
Sbjct: 76 EF-------NVLKQVNHPH---VIKLYGACSQDG-----PLLLIVEYAKYGSLRGFLRES 120
Query: 214 -----------------TNFRGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKP 252
+ LT F+ Q+ + +L+ E+ ++H DL
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAA 178
Query: 253 ENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR------------SPEVLLGIPY 300
NIL+ + +KI DFG L + +Y + Y + E L Y
Sbjct: 179 RNILVAEGR--KMKISDFG----LSRDVY---EEDSYVKRSQGRIPVKWMAIESLFDHIY 229
Query: 301 DLAIDMWSLGCILVEMHT 318
D+WS G +L E+ T
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 86/299 (28%)
Query: 74 YAKKKRRAQQSQGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEID-------SL 126
Y K+ R Q Q + + + + + + +D ++E +
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYD----------LKWEFPRENLEFGKV 52
Query: 127 IGKGSFGQVVKA-----FDLEEQCHVAIKIIK------NKKPFLNQAQIEVKLLEIMNKA 175
+G G+FG+V+ A VA+K++K ++ +++ ++ +L N
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN-- 110
Query: 176 DVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRN---------------- 213
IV L + L+FE Y +L + LR+
Sbjct: 111 -------IVNLLGACTLSG-----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 214 -TNFRGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268
LT + F+ Q+ + FL + +H DL N+L+ + K +KI
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGK--VVKIC 214
Query: 269 DFGSSCQLGQRIYQ---YIQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
DFG L + I Y+ R +PE L Y + D+WS G +L E+ +
Sbjct: 215 DFG----LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 58/250 (23%), Positives = 93/250 (37%), Gaps = 53/250 (21%)
Query: 105 DNHDYIIQHGEKFLDRYEID-------SLIGKGSFGQVVKAF--DLEEQCHVAIKIIKN- 154
+H + ++ +D +IG+G+FGQV+KA + AIK +K
Sbjct: 4 HHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 155 -----KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLY 208
+ F + ++ KL N I+ L R +L L E + NL
Sbjct: 64 ASKDDHRDFAGELEVLCKLGHHPN---------IINLLGACEHRGYLYLAIEYAPHGNLL 114
Query: 209 DLLRN----------TNFRGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPEN 254
D LR + L+ + F+ + + +LS + IH DL N
Sbjct: 115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARN 172
Query: 255 ILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR------SPEVLLGIPYDLAIDMWS 308
IL+ KI DFG L + Y++ R + E L Y D+WS
Sbjct: 173 ILVGENY--VAKIADFG----LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 226
Query: 309 LGCILVEMHT 318
G +L E+ +
Sbjct: 227 YGVLLWEIVS 236
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 49/239 (20%), Positives = 93/239 (38%), Gaps = 61/239 (25%)
Query: 119 DRYEIDSLIGKGSFGQVVKA-----FDLEEQCHVAIKIIKN------KKPFLNQAQIEVK 167
+G+ FG+V K E+ VAIK +K+ ++ F ++A
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA----- 63
Query: 168 LLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRN----------TNF 216
+ + N +V L L ++F S+ +L++ L +
Sbjct: 64 --MLRARLQHPN---VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 217 RGVSLNLTRK----FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272
R V L Q+ + +LS +++H DL N+L+ K + +KI D G
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLATRNVLV-YDKLN-VKISDLG- 173
Query: 273 SCQLGQRIYQYIQSRFYR------------SPEVLL-GIPYDLAIDMWSLGCILVEMHT 318
L + +Y + +Y+ +PE ++ G + + D+WS G +L E+ +
Sbjct: 174 ---LFREVY---AADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFS 225
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 44/225 (19%), Positives = 79/225 (35%), Gaps = 53/225 (23%)
Query: 122 EIDSLIGKGSFGQVVKAF---DLEEQCHVAIKIIKN------KKPFLNQAQIEVKLLEIM 172
D +IGKG FG V + + AIK + + FL + +M
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL-------LM 76
Query: 173 NKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR- 225
+ N ++ L ++ + + +L +R+ + +
Sbjct: 77 RGLNHPN---VLALIGIMLPP----EGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDL 126
Query: 226 -KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-- 282
F Q+ + +L+ E +H DL N +L +K+ DFG L + I
Sbjct: 127 ISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESF--TVKVADFG----LARDILDRE 178
Query: 283 YIQSRFYR---------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
Y + +R + E L + D+WS G +L E+ T
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 56/252 (22%), Positives = 97/252 (38%), Gaps = 79/252 (31%)
Query: 119 DRYEIDSLIGKGSFGQVVKA-----FDLEEQCHVAIKIIK------NKKPFLNQAQIEVK 167
+ E IG+G+FG+V +A E VA+K++K + F +A
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA----- 101
Query: 168 LLEIMNKADVNNTYYIVRL-----KRHFMWRNHLCLVFELLSY-NLYDLLRN-------- 213
+M + D N IV+L +CL+FE ++Y +L + LR+
Sbjct: 102 --ALMAEFDNPN---IVKLLGVCAVGK-----PMCLLFEYMAYGDLNEFLRSMSPHTVCS 151
Query: 214 ------------TNFRGVSLNLTR--KFSQQLCTALLFLSTPELNIIHCDLKPENILLCN 259
++ L+ ++Q+ + +LS E +H DL N L+
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLV-G 208
Query: 260 PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR------------SPEVLL-GIPYDLAIDM 306
+KI DFG L + IY + +Y+ PE + Y D+
Sbjct: 209 ENMV-VKIADFG----LSRNIY---SADYYKADGNDAIPIRWMPPESIFYNR-YTTESDV 259
Query: 307 WSLGCILVEMHT 318
W+ G +L E+ +
Sbjct: 260 WAYGVVLWEIFS 271
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 3e-08
Identities = 67/508 (13%), Positives = 133/508 (26%), Gaps = 183/508 (36%)
Query: 65 TYKHINEVYYAKKKRRAQQSQGEDSSH----KKE-KKLYNEGYDDDNHDYIIQHGEKFLD 119
YK I V+ +D K+E + D + +
Sbjct: 17 QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK-DAVSGTLRL-------- 67
Query: 120 RYEIDSLIGKGSFGQVVKAF--DLEEQCH--VAIKI-IKNKKPFLNQAQIEVKLLEIMNK 174
+L+ K ++V+ F ++ + + I + ++P + + + N
Sbjct: 68 ---FWTLLSKQE--EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 175 ADVNNTYYIVRLKRHFMWRNHL--------------------CLVFELLSYNLYDLLRNT 214
V Y + RL+ + R L + ++ Y +
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS--YKVQCKM 180
Query: 215 NFRG--VSL--------------NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258
+F+ ++L L + + S +L I + +L
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240
Query: 259 NPKRSAIKIVD----------FGSSCQL-----GQRIYQYIQSRFYRSP---EVLLGIPY 300
P + + ++ F SC++ +++ ++ + + +
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 301 DLAIDMWS--LGCIL----VEMHTGEPL-----------------FSGSNEVDQMNKIVE 337
D + L C E+ T P D++ I+E
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360
Query: 338 --VLGLPPKHLLDGAHKTRKYFDKM---PDGSYI-------------------------- 366
+ L P RK FD++ P ++I
Sbjct: 361 SSLNVLEPAEY-------RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 367 ----LKKPKDGR----------KPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLK 412
K+PK+ K K+ LH R + V Y
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENEYALH------------RSI------VDHYNI 455
Query: 413 FKDLIFRMLDYDPKTRITPY---YALQH 437
K +D I PY Y H
Sbjct: 456 PK-------TFDSDDLIPPYLDQYFYSH 476
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 6e-06
Identities = 46/278 (16%), Positives = 83/278 (29%), Gaps = 86/278 (30%)
Query: 3 FSVSLNTESAGEAVSHAPLYGRLVAEEPSCPGDILAMQARIPLQ----------FRDPA- 51
SLN E + ++ RL + A IP D
Sbjct: 359 IESSLNVLEPAE---YRKMFDRLS---------VFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 52 -TAPLRKLSVDLIK------TYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEGYDD 104
L K S L++ T I +Y K + + E + H+ YN
Sbjct: 407 VVNKLHKYS--LVEKQPKESTI-SIPSIYLELK----VKLENEYALHRSIVDHYNIPKTF 459
Query: 105 DNHDYIIQHGEKFLDRYEIDSLIG----KGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN 160
D+ D I + LD+Y S IG + + F + FL+
Sbjct: 460 DSDDLIPPY----LDQY-FYSHIGHHLKNIEHPERMTLF---------------RMVFLD 499
Query: 161 QAQIEVKL----LEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNF 216
+E K+ + NT ++ + ++ N +E L + +L
Sbjct: 500 FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDP--KYERL---VNAIL----- 549
Query: 217 RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPEN 254
F ++ L+ + +++ L E+
Sbjct: 550 ---------DFLPKIEENLI--CSKYTDLLRIALMAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 42/302 (13%), Positives = 83/302 (27%), Gaps = 95/302 (31%)
Query: 3 FSVSLNTESAG---EAVSHAPLYGRLVAEEPSCPGDILAMQARIPLQFRDPATAPLRKLS 59
L+ E ++ P ++AE RD
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIAES-----------------IRDG--------- 340
Query: 60 VDLIKTYKHINEVYYAKKKRRAQQSQGEDSSHKKEKKLYNEG--YDDDNH---------- 107
+ +KH+N K +S + +K+++ + H
Sbjct: 341 LATWDNWKHVN----CDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIW 396
Query: 108 -DYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEV 166
D I +++ SL+ K + + ++ K N+ +
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI---------YLELKVKLENEYALHR 447
Query: 167 KLLE---IMNKADVNNT-------YYIVRLKRHFMWRNHLCLVFELLSYNLY-DL----- 210
+++ I D ++ Y+ + H H L ++ D
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP-ERMTLFR-MVFLDFRFLEQ 505
Query: 211 -LRNT----NFRGVSLNL--------------TRKFSQQLCTALLFLSTPELNII---HC 248
+R+ N G LN K+ + + L FL E N+I +
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYT 565
Query: 249 DL 250
DL
Sbjct: 566 DL 567
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 7e-05
Identities = 62/415 (14%), Positives = 129/415 (31%), Gaps = 111/415 (26%)
Query: 102 YDDDNHDY----IIQHG-EKF---LDRYEI-DSL---IGKGSFGQVVKAFDLEEQCHVAI 149
++ H Y I+ + F D ++ D + K ++ + D
Sbjct: 9 FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLF 68
Query: 150 KIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLY- 208
+ +K Q ++ K +E + + + + + +K + Y
Sbjct: 69 WTLLSK-----QEEMVQKFVEEVLRINYK--FLMSPIKTEQRQPS-----MMTRMYIEQR 116
Query: 209 DLLRNTNFRGVSLNLTR-KFSQQLCTALLFLSTPELNIIHCDLKPE-NILLCNPKRS--- 263
D L N N N++R + +L ALL +L+P N+L+ S
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALL------------ELRPAKNVLIDGVLGSGKT 164
Query: 264 --AIKIV-DFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGE 320
A+ + + C++ +I+ ++ + SPE +L + + L ++ +
Sbjct: 165 WVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETVLEM-------LQKL-LYQIDPNWTS 215
Query: 321 PLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKV-- 378
SN +++ I L + LL K++ Y + +L + + K
Sbjct: 216 RSDHSSNIKLRIHSIQAEL----RRLL----KSKPY----ENCLLVLL---NVQNAKAWN 260
Query: 379 ---PGSRRL---HDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432
+ L V+D+L LD+ T +TP
Sbjct: 261 AFNLSCKILLTTRFK------------------QVTDFLSAATTTHISLDHHSMT-LTPD 301
Query: 433 YALQHNFFKRTADESTNTGGTSGLGSMSTSPASAGGSLPLLLSSL--EVQPPPST 485
+ D P + P LS + ++ +T
Sbjct: 302 EVKS--LLLKYLDCRP-----------QDLPREVLTTNPRRLSIIAESIRDGLAT 343
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 42/163 (25%), Positives = 68/163 (41%), Gaps = 33/163 (20%)
Query: 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIK------NKKPFLNQAQIEVKLLEIMNKADV 177
+++G+G FG+V K L + VA+K +K + F EV E+++ A
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT----EV---EMISMAVH 86
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCTA-- 234
N ++RL+ M LV+ ++ + LR L+ ++ L +A
Sbjct: 87 RN---LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 235 LLFL---STPELNIIHCDLKPENILL---CNPKRSAIKIVDFG 271
L +L P IIH D+K NILL + DFG
Sbjct: 144 LAYLHDHCDP--KIIHRDVKAANILLDEEFEA-----VVGDFG 179
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 41/171 (23%), Positives = 64/171 (37%), Gaps = 53/171 (30%)
Query: 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK-----KPFLNQAQIEVKLLEIMNKADVN 178
LIG G FG+V K L + VA+K + + F E++ L
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFET----EIETLS-------- 90
Query: 179 NTYYIVRLKRHFMWRN------------HLCLVFELLSY-NLYDLLRNTNFRGVSLN-LT 224
RH + + L+++ + NL L ++ +S++
Sbjct: 91 ------FC-RH---PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 225 RKFSQQLCT----ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271
R ++C L +L T IIH D+K NILL + KI DFG
Sbjct: 141 R---LEICIGAARGLHYLHTR--AIIHRDVKSINILL-DENFVP-KITDFG 184
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 31/102 (30%), Positives = 47/102 (46%), Gaps = 17/102 (16%)
Query: 226 KFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ--- 282
+S Q+ + FL+ IH DL NILL +KI DFG L + IY+
Sbjct: 197 CYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKN--VVKICDFG----LARDIYKDPD 248
Query: 283 YIQSRFYR------SPEVLLGIPYDLAIDMWSLGCILVEMHT 318
Y++ R +PE + Y + D+WS G +L E+ +
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 36/208 (17%), Positives = 75/208 (36%), Gaps = 26/208 (12%)
Query: 119 DRYEID-------SLIGKGSFGQVVKAF-----DLEEQCHVAIKIIKNKKPFLNQAQIEV 166
++E +G+G+FGQV++A VA+K++K + ++ + +
Sbjct: 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALM 73
Query: 167 KLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTR 225
L+I+ ++ + L L ++ E + NL LR+
Sbjct: 74 SELKIL-IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR---------N 123
Query: 226 KFSQQLCTALLFLSTPE-LNIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQY 283
+F F + + I DLK + + + SA V+ S + +
Sbjct: 124 EFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183
Query: 284 IQSRFYRSPEVLLGIPYDLAIDMWSLGC 311
+ + + E L+ + +A M L
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLAS 211
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 493 | |||
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.14 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.56 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.55 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.1 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.71 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.58 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.18 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.78 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.57 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.14 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 91.17 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.47 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.66 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.11 |
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=479.30 Aligned_cols=350 Identities=83% Similarity=1.368 Sum_probs=314.8
Q ss_pred hhccCCCCCCCCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhc
Q psy16081 96 KLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKA 175 (493)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~ 175 (493)
...+.++++...++++..++.+.++|++.++||+|+||+||+|++..+++.||||+++.......+...|..+++.+.+.
T Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~ 110 (382)
T 2vx3_A 31 KVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH 110 (382)
T ss_dssp -CBGGGTBCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHC
T ss_pred CcCcCCcCCCCCcEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhc
Confidence 34455667777788999999999999999999999999999999999999999999986665667778899999999888
Q ss_pred CCCCcceEEEeceeeeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcE
Q psy16081 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENI 255 (493)
Q Consensus 176 ~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NI 255 (493)
....+++|+++++++...+++||||||++++|.+++.......+++..++.++.||+.||.|||+++.|||||||||+||
T Consensus 111 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NI 190 (382)
T 2vx3_A 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190 (382)
T ss_dssp SSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGE
T ss_pred ccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccE
Confidence 88888899999999999999999999999999999988766679999999999999999999998778999999999999
Q ss_pred EeeCCCCCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy16081 256 LLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 256 Ll~~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i 335 (493)
|++++.++.+||+|||+++..+......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++..+
T Consensus 191 ll~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i 270 (382)
T 2vx3_A 191 LLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270 (382)
T ss_dssp EESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEecCCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99766678899999999998888778889999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCC-CCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRK-PKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (493)
.+.++.++..++...+..+.+|..++++.|.+........ +..+....+.+++......+..++.++..+...+...++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (382)
T 2vx3_A 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350 (382)
T ss_dssp HHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHH
T ss_pred HHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHH
Confidence 9999999999999999999999999999998776665543 455667788888888888888888888888888888999
Q ss_pred HHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 415 DLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 415 dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
|||.+||.+||++|||++|||+||||+...+
T Consensus 351 dli~~mL~~dP~~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 351 DLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred HHHHHhcCCChhhCCCHHHHhcCcccccCCC
Confidence 9999999999999999999999999997643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-61 Score=478.70 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=209.6
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ...+.+|+.++..+ +|||||+++++|.+.+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIV~~~~~~~~~~ 96 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM------KHPNIVQYRESFEENG 96 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC------CCTTBCCEEEEEEETT
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC------CCCCCCcEEEEEEECC
Confidence 46899999999999999999999999999999999754322 22344455444433 5888999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|||||||+ |+|.++|.......+++..++.|+.||+.||.|||+ .|||||||||+|||| +.++.+||+|||+|
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl--~~~g~vKl~DFGla 172 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFL--TKDGTVQLGDFGIA 172 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEE--CTTCCEEECSTTEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEE--CCCCCEEEcccccc
Confidence 9999999996 599999986655568999999999999999999995 789999999999999 67889999999999
Q ss_pred cccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 274 CQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 274 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
+.+... ....+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+|......+.
T Consensus 173 ~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~------- 245 (350)
T 4b9d_A 173 RVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV------- 245 (350)
T ss_dssp SCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-------
T ss_pred eeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-------
Confidence 887543 3467899999999999999999999999999999999999999999999988888876311100
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
+. ..+ .++++||.+||..||++|||
T Consensus 246 ------------------------------~~-----------------------~~s--~~~~~li~~~L~~dP~~R~s 270 (350)
T 4b9d_A 246 ------------------------------SL-----------------------HYS--YDLRSLVSQLFKRNPRDRPS 270 (350)
T ss_dssp ------------------------------CT-----------------------TSC--HHHHHHHHHHTCSSGGGSCC
T ss_pred ------------------------------Cc-----------------------cCC--HHHHHHHHHHccCChhHCcC
Confidence 00 011 17899999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy16081 431 PYYALQHNFFKRT 443 (493)
Q Consensus 431 ~~e~L~Hp~~~~~ 443 (493)
++|+|+||||++.
T Consensus 271 ~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 271 VNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTSHHHHTT
T ss_pred HHHHhcCHHhhcC
Confidence 9999999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-60 Score=470.43 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=214.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
+.|+++++||+|+||+||+|+++.+|+.||||++.... .......+|+.++..+ +|||||+++++|.+.+.+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l------~HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY------QHENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC------CCTTBCCEEEEEEETTEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC------CCCCCCcEEEEEEECCEEE
Confidence 56999999999999999999999999999999996432 2334456677766554 4788999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
||||||+| +|.+++.+. .+++..++.++.||+.||.|||+ .|||||||||+|||| +.++.+||+|||+|+.+
T Consensus 148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl--~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILL--THDGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEE--CCCCCEEEecCcCceec
Confidence 99999965 899988763 59999999999999999999995 789999999999999 67899999999999877
Q ss_pred CC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 277 GQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 277 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
.. ...+.+||+.|||||++.+..|+.++||||||||||||++|.+||.+.+..+.+..|.+........
T Consensus 221 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~-------- 292 (346)
T 4fih_A 221 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN-------- 292 (346)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSC--------
T ss_pred CCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc--------
Confidence 43 3457899999999999999999999999999999999999999999999988888776532111000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
+. .++ .+++|||.+||..||++|||++|
T Consensus 293 ---~~-----------------------------------------------~~s--~~~~dli~~~L~~dP~~R~ta~e 320 (346)
T 4fih_A 293 ---LH-----------------------------------------------KVS--PSLKGFLDRLLVRDPAQRATAAE 320 (346)
T ss_dssp ---GG-----------------------------------------------GSC--HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ---cc-----------------------------------------------cCC--HHHHHHHHHHcCCChhHCcCHHH
Confidence 00 011 17899999999999999999999
Q ss_pred HhcCCCCCCC
Q psy16081 434 ALQHNFFKRT 443 (493)
Q Consensus 434 ~L~Hp~~~~~ 443 (493)
+|+||||++.
T Consensus 321 ~l~Hp~~~~~ 330 (346)
T 4fih_A 321 LLKHPFLAKA 330 (346)
T ss_dssp HTTCGGGGGC
T ss_pred HhcCHhhcCC
Confidence 9999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-60 Score=465.97 Aligned_cols=255 Identities=28% Similarity=0.423 Sum_probs=215.6
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|+++++||+|+||+||+|+++.+++.||||++.+.. .......+|+.++ ...+|||||+++++|++.
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il------~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM------SRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHH------TTCCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHH------HhCCCCCCCeEEEEEEeC
Confidence 357999999999999999999999999999999997431 2223344454443 344688999999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+++|||||||.| +|.+++.+.. .+++..++.++.||+.||.|||+ .|||||||||+|||| +.++.+||+|||+
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl--~~~g~vKl~DFGl 178 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILL--NEDMHIQITDFGT 178 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEE--cCCCCEEEEEcCC
Confidence 999999999965 9999998764 69999999999999999999995 789999999999999 7889999999999
Q ss_pred ccccCC-----ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 273 SCQLGQ-----RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 273 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
|+.+.. ...+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+.+.+|.+.-...|..
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~-- 256 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEK-- 256 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc--
Confidence 987642 2456799999999999999999999999999999999999999999999998888887632111100
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
.+ .+++|||.+||..||++
T Consensus 257 -----------------------------------------------------------~s--~~~~dli~~lL~~dp~~ 275 (311)
T 4aw0_A 257 -----------------------------------------------------------FF--PKARDLVEKLLVLDATK 275 (311)
T ss_dssp -----------------------------------------------------------CC--HHHHHHHHHHSCSSGGG
T ss_pred -----------------------------------------------------------cC--HHHHHHHHHHccCCHhH
Confidence 11 16899999999999999
Q ss_pred CCCHHH------HhcCCCCCCCccCC
Q psy16081 428 RITPYY------ALQHNFFKRTADES 447 (493)
Q Consensus 428 R~t~~e------~L~Hp~~~~~~~~~ 447 (493)
|||++| +++||||+.+..+.
T Consensus 276 R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 276 RLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp STTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred CcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 999998 58999999875543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-60 Score=457.73 Aligned_cols=250 Identities=30% Similarity=0.436 Sum_probs=199.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .......+|+.++..+ +|||||+++++|.+.
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL------RHPHIIKLYDVIKSK 85 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC------CCTTBCCEEEEEECS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC------CCCCCCeEEEEEEEC
Confidence 368999999999999999999999999999999997432 1223455566555443 478899999999999
Q ss_pred ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 194 NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 194 ~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
+.+|||||||+|+|.+++.+.. .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+|
T Consensus 86 ~~~~ivmEy~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl--~~~~~vkl~DFGla 159 (275)
T 3hyh_A 86 DEIIMVIEYAGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLL--DEHLNVKIADFGLS 159 (275)
T ss_dssp SEEEEEEECCCEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEE--CTTCCEEECCSSCC
T ss_pred CEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEE--CCCCCEEEeecCCC
Confidence 9999999999999999997653 69999999999999999999995 789999999999999 67889999999999
Q ss_pred cccCC--ccccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 274 CQLGQ--RIYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 274 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
+.... ...+.+||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+..+.+..|.+.....|..
T Consensus 160 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~----- 234 (275)
T 3hyh_A 160 NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF----- 234 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-----
T ss_pred eecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCC-----
Confidence 87643 3456799999999999999886 579999999999999999999999988888777776531111100
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.+ .++++||.+||+.||++|||
T Consensus 235 --------------------------------------------------------~s--~~~~~li~~~L~~dP~~R~s 256 (275)
T 3hyh_A 235 --------------------------------------------------------LS--PGAAGLIKRMLIVNPLNRIS 256 (275)
T ss_dssp --------------------------------------------------------SC--HHHHHHHHHHSCSSGGGSCC
T ss_pred --------------------------------------------------------CC--HHHHHHHHHHccCChhHCcC
Confidence 01 17899999999999999999
Q ss_pred HHHHhcCCCCCC
Q psy16081 431 PYYALQHNFFKR 442 (493)
Q Consensus 431 ~~e~L~Hp~~~~ 442 (493)
++|+|+||||+.
T Consensus 257 ~~eil~hpw~k~ 268 (275)
T 3hyh_A 257 IHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHCHHHHT
T ss_pred HHHHHcCccccc
Confidence 999999999973
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=471.26 Aligned_cols=253 Identities=27% Similarity=0.387 Sum_probs=215.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.+.|+++++||+|+||+||+|+++.+|+.||||++.... .....+.+|+.++..+ +|||||+++++|.+.+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l------~HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY------QHENVVEMYNSYLVGDEL 223 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC------CCTTBCCEEEEEEETTEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC------CCCCCCceEEEEEECCEE
Confidence 457999999999999999999999999999999997443 2334566677766554 478899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|||||||+| +|.+++... .+++..++.++.||+.||.|||+ .|||||||||+|||| +.++.+||+|||+|+.
T Consensus 224 ~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl--~~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILL--THDGRVKLSDFGFCAQ 296 (423)
T ss_dssp EEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEE--CTTCCEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEE--cCCCCEEEecCccceE
Confidence 999999965 999988754 59999999999999999999995 789999999999999 7789999999999987
Q ss_pred cCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
+.. .....+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..|.........
T Consensus 297 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~-------- 368 (423)
T 4fie_A 297 VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK-------- 368 (423)
T ss_dssp CCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--------
T ss_pred CCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCc--------
Confidence 643 345789999999999999999999999999999999999999999999998888877653211000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
....++. +++|||.+||..||++|||+.
T Consensus 369 --------------------------------------------------~~~~~s~--~~~dli~~~L~~dP~~R~ta~ 396 (423)
T 4fie_A 369 --------------------------------------------------NLHKVSP--SLKGFLDRLLVRDPAQRATAA 396 (423)
T ss_dssp --------------------------------------------------CTTSSCH--HHHHHHHHHSCSSTTTSCCHH
T ss_pred --------------------------------------------------ccccCCH--HHHHHHHHHcCCChhHCcCHH
Confidence 0001111 789999999999999999999
Q ss_pred HHhcCCCCCCC
Q psy16081 433 YALQHNFFKRT 443 (493)
Q Consensus 433 e~L~Hp~~~~~ 443 (493)
|||+||||++.
T Consensus 397 ell~Hp~~~~~ 407 (423)
T 4fie_A 397 ELLKHPFLAKA 407 (423)
T ss_dssp HHTTCGGGGGC
T ss_pred HHhcCHHhcCC
Confidence 99999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=466.55 Aligned_cols=283 Identities=31% Similarity=0.517 Sum_probs=224.4
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchH---HHHHHHHHHHHhhcCCCCcceEEEeceeeee-
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ---AQIEVKLLEIMNKADVNNTYYIVRLKRHFMW- 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~---~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~- 192 (493)
+.++|++++.||+|+||+||+|+++.+|+.||||++++....... ..+|+.++.. .+|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~------l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH------FKHDNIIAIKDILRPT 125 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHH------CCCTTBCCEEEECCCS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHh------cCCCCcceEeeeeecc
Confidence 346899999999999999999999999999999999754433222 3334444433 357889999998764
Q ss_pred -----cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 193 -----RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 193 -----~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
.+++|||||||+|+|.+++... +.+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~--~~~~~~Ki 199 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLV--NENCELKI 199 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE--CTTCCEEE
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCcccccc--CCCCCEEE
Confidence 3679999999999999999765 369999999999999999999995 789999999999999 78899999
Q ss_pred EecccccccCC-------ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy16081 268 VDFGSSCQLGQ-------RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL 339 (493)
Q Consensus 268 ~DFG~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 339 (493)
+|||+|+.+.. ...+.+||+.|||||++.+. .|+.++||||||||+|||++|++||.+.+..+++..|.+..
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 99999986632 24467999999999999886 57999999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccc--hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHH
Q psy16081 340 GLPPKHLLDGAHK--TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417 (493)
Q Consensus 340 ~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi 417 (493)
+.|+...+..... ...++...+.. ....+..+.. ..+ .+++|||
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~----------------~~s--~~~~dLl 325 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPR----------------QPVPWETVYP----------------GAD--RQALSLL 325 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCC----------------CCCCHHHHST----------------TCC--HHHHHHH
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCc----------------CCCCHHHhCC----------------CCC--HHHHHHH
Confidence 9998776654321 12222222110 0011111110 011 1789999
Q ss_pred hHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 418 FRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 418 ~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.+||.+||++|||++|||+||||+...+
T Consensus 326 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 326 GRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp HHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred HHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 9999999999999999999999997654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=444.71 Aligned_cols=253 Identities=26% Similarity=0.349 Sum_probs=199.6
Q ss_pred cE-EEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee---
Q psy16081 120 RY-EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW--- 192 (493)
Q Consensus 120 ~y-~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~--- 192 (493)
+| ++.++||+|+||+||+|.+..+++.||||++....... ..+.+|+.++ ...+|||||+++++|.+
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il------~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEML------KGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHH------HTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHH------HhCCCCCCCcEEEEEeeccC
Confidence 44 77889999999999999999999999999997543222 2233333333 33468899999999975
Q ss_pred -cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 193 -RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 193 -~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
.+.+|||||||+ |+|.+++.+.. .+++..++.++.||+.||.|||++..+||||||||+||||+ +.++.+||+||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~-~~~g~vKl~DF 176 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-GPTGSVKIGDL 176 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES-STTSCEEECCT
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE-CCCCCEEEEeC
Confidence 457899999995 59999997653 69999999999999999999997444599999999999993 24789999999
Q ss_pred ccccccCC-ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 271 GSSCQLGQ-RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 271 G~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
|+|+.... ...+.+||+.|||||++.+ .|+.++|||||||+||||+||++||.+.+....+.+.+.....| ..+.
T Consensus 177 Gla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~~-- 252 (290)
T 3fpq_A 177 GLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFD-- 252 (290)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-GGGG--
T ss_pred cCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-CCCC--
Confidence 99986543 3456799999999999876 69999999999999999999999998766555444333211111 1000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
. .. ..++.+||.+||..||++||
T Consensus 253 ------------------------------------~-------------------~~--~~~~~~li~~~L~~dP~~R~ 275 (290)
T 3fpq_A 253 ------------------------------------K-------------------VA--IPEVKEIIEGCIRQNKDERY 275 (290)
T ss_dssp ------------------------------------G-------------------CC--CHHHHHHHHHHSCSSGGGSC
T ss_pred ------------------------------------c-------------------cC--CHHHHHHHHHHccCChhHCc
Confidence 0 00 01689999999999999999
Q ss_pred CHHHHhcCCCCCC
Q psy16081 430 TPYYALQHNFFKR 442 (493)
Q Consensus 430 t~~e~L~Hp~~~~ 442 (493)
|++|+|+||||++
T Consensus 276 s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 276 SIKDLLNHAFFQE 288 (290)
T ss_dssp CHHHHHTSGGGC-
T ss_pred CHHHHhcCccccC
Confidence 9999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=454.20 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=209.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
++|++++.||+|+||+||+|++. .+++.||||++++... ......+| +..+...+|||||+++++|.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E------~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME------RDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHH------HHHHHHCCCCCCCeEEEEEEE
Confidence 57999999999999999999874 4688999999974321 12223333 334455679999999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+|||||||+ |+|.+++.+.. .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl--~~~g~vKl~DFG 171 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILL--DEEGHIKLTDFG 171 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEE--CTTSCEEEESSE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEE--cCCCCEEecccc
Confidence 999999999996 59999998754 69999999999999999999995 789999999999999 788999999999
Q ss_pred cccccC---CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 272 SSCQLG---QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 272 ~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
+|+... ....+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+|.+.....|..
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~--- 248 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF--- 248 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT---
T ss_pred cceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCc---
Confidence 998653 23456799999999999999999999999999999999999999999999998888887532111100
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.+ .+++|||.+||+.||++|
T Consensus 249 ----------------------------------------------------------~s--~~~~~li~~~L~~dP~~R 268 (304)
T 3ubd_A 249 ----------------------------------------------------------LS--PEAQSLLRMLFKRNPANR 268 (304)
T ss_dssp ----------------------------------------------------------SC--HHHHHHHHHHTCSSGGGS
T ss_pred ----------------------------------------------------------CC--HHHHHHHHHHcccCHHHC
Confidence 11 178999999999999999
Q ss_pred CC-----HHHHhcCCCCCCCcc
Q psy16081 429 IT-----PYYALQHNFFKRTAD 445 (493)
Q Consensus 429 ~t-----~~e~L~Hp~~~~~~~ 445 (493)
|| ++|+++||||+.+..
T Consensus 269 ~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 269 LGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp TTCSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCcCCHHHHHcCccccCCCH
Confidence 98 589999999997643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-57 Score=448.26 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=206.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.+.|++.++||+|+||+||+|+++.+|+.||||+++..... .+|+. .+...+|||||+++++|.+.+.+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~------il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELV------ACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHH------TTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHH------HHHhCCCCCCCcEEEEEEECCEEE
Confidence 45799999999999999999999999999999999754321 12333 344557899999999999999999
Q ss_pred EEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC-cEEEEecccccc
Q psy16081 198 LVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS-AIKIVDFGSSCQ 275 (493)
Q Consensus 198 lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~-~ikL~DFG~a~~ 275 (493)
||||||+ |+|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||| +.++ .+||+|||+|+.
T Consensus 127 ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl--~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLL--SSDGSRAALCDFGHALC 200 (336)
T ss_dssp EEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEE--CTTSCCEEECCCTTCEE
T ss_pred EEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEE--eCCCCEEEEeeCCCCeE
Confidence 9999996 49999998654 69999999999999999999995 789999999999999 5565 699999999987
Q ss_pred cCCc--------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 276 LGQR--------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 276 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
+... ....+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+|... .++..
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~~-- 276 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPPIR-- 276 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCGGG--
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCCch--
Confidence 6432 12358999999999999999999999999999999999999999988776666666542 11100
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
.++ ...+ ..+.+||.+||..||.+
T Consensus 277 -----------~~~-------------------------------------------~~~s--~~~~~li~~~L~~dP~~ 300 (336)
T 4g3f_A 277 -----------EIP-------------------------------------------PSCA--PLTAQAIQEGLRKEPVH 300 (336)
T ss_dssp -----------GSC-------------------------------------------TTSC--HHHHHHHHHHTCSSGGG
T ss_pred -----------hcC-------------------------------------------ccCC--HHHHHHHHHHccCCHhH
Confidence 000 0011 17899999999999999
Q ss_pred CCCHHHH-------------hcCCCCCCCcc
Q psy16081 428 RITPYYA-------------LQHNFFKRTAD 445 (493)
Q Consensus 428 R~t~~e~-------------L~Hp~~~~~~~ 445 (493)
|||+.|+ |+|||+....+
T Consensus 301 R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 301 RASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp SCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred CcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 9999997 68999987644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-57 Score=455.28 Aligned_cols=296 Identities=25% Similarity=0.395 Sum_probs=215.2
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++.++||+|+||+||+|+++ .+++.||||++.... ......+|+.++..+ .+|||||+++++|.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~-----~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVA-----GGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHT-----CSBTTBCCCSEEEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHh-----cCCCCCceEEEEEEE
Confidence 45678999999999999999999875 468899999987543 234455565555433 368889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+++|||||||+ ++|.+++. .+++..++.++.||+.||.|||+ .|||||||||+|||++. +.+.+||+|||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~-~~~~~kl~DFG 163 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNR-RLKKYALVDFG 163 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEET-TTTEEEECCCT
T ss_pred CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeC-CCCeEEECcCC
Confidence 999999999996 49999883 48999999999999999999995 79999999999999952 44789999999
Q ss_pred cccccCC-------------------------------ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhC
Q psy16081 272 SSCQLGQ-------------------------------RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTG 319 (493)
Q Consensus 272 ~a~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG 319 (493)
+|+.... .....+||+.|+|||++.+. .|+.++||||+|||+|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9975432 12345899999999999886 589999999999999999999
Q ss_pred CCCC-CCCCHHHHHHHHHHHhCCCChhhhhhccchhhhh-ccCCCCCceecCCCCCCCCCCCCCccchh-hccccCCCCC
Q psy16081 320 EPLF-SGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYF-DKMPDGSYILKKPKDGRKPKVPGSRRLHD-ILGVESGGPG 396 (493)
Q Consensus 320 ~~pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~ 396 (493)
++|| .+.++.+++..|...+|.++............+. ...+.... +.+.+ +.+.....|.
T Consensus 244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~----------------~~~~~~~~~~~~~~p~ 307 (361)
T 4f9c_A 244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDL----------------RKLCERLRGMDSSTPK 307 (361)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCH----------------HHHHHHHC--------
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhh----------------hHHHHhhccccccccc
Confidence 9988 5677889999999999876544333211110000 00000000 00000 0000000000
Q ss_pred -------CCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 397 -------GRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 397 -------~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.....+.+..+++ +++|||.+||.+||++|||++|||+||||+.+
T Consensus 308 ~~~~~~~~~~~~~~~~~is~--~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 308 LTSDIQGHATNLEGWNEVPD--EAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp --------------CTTCCH--HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccCCH--HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000112223333 78999999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=444.89 Aligned_cols=326 Identities=46% Similarity=0.803 Sum_probs=268.2
Q ss_pred cCCCCCCCCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCC
Q psy16081 99 NEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178 (493)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~ 178 (493)
+.++++....+.....+.+.++|+++++||+|+||+||+|.+..+++.||||+++.......+...|+.+++.+.+....
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~ 156 (429)
T 3kvw_A 77 NGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156 (429)
T ss_dssp HHTTBCTTSCBCCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred CCCCCccCCCccccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhcccc
Confidence 33455666666666778889999999999999999999999999999999999987665567788899999999999999
Q ss_pred CcceEEEeceeeeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee
Q psy16081 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258 (493)
Q Consensus 179 ~~~~Iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~ 258 (493)
+|+||+++++++...+++|+||||++++|.+++.......+++..++.++.||+.||.|||+ .|||||||||+|||++
T Consensus 157 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~ 234 (429)
T 3kvw_A 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLK 234 (429)
T ss_dssp SCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEES
T ss_pred CCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEc
Confidence 99999999999999999999999999999999988776679999999999999999999995 6899999999999994
Q ss_pred CCCCCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy16081 259 NPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338 (493)
Q Consensus 259 ~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 338 (493)
.+....+||+|||+++.........+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+++..+++.
T Consensus 235 ~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~ 314 (429)
T 3kvw_A 235 QQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314 (429)
T ss_dssp STTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cCCCcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 33333399999999988887778889999999999999999999999999999999999999999999999999999999
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCC-CCC------------CCCCCCCCccchhhccccCCCCCCCcCCCCCC
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKP-KDG------------RKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 405 (493)
++.|+..++........|++......+..... .+. +....+....+...+.
T Consensus 315 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---------------- 378 (429)
T 3kvw_A 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK---------------- 378 (429)
T ss_dssp HCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTT----------------
T ss_pred cCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhcc----------------
Confidence 99999999998888888876543222210000 000 0000011111111110
Q ss_pred CcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 406 ~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
..+...+.|||.+||.+||++|||+.|||+||||++.
T Consensus 379 -~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 379 -GCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp -TCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred -ccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 0112378999999999999999999999999999964
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-55 Score=429.35 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=189.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc--
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN-- 194 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~-- 194 (493)
+.++|++++.||+|+||+||+|+++.+|+.||||+++..... . ....+++++..+...+|||||+++++|.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE---L-AREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH---H-HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH---H-HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 346799999999999999999999999999999999743311 1 1112333444444557899999999997654
Q ss_pred ----------eeEEEEEecc-cCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC
Q psy16081 195 ----------HLCLVFELLS-YNLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR 262 (493)
Q Consensus 195 ----------~~~lV~E~~~-~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~ 262 (493)
++|||||||. |+|.+++..... ....+..++.++.||+.||.|||+ .|||||||||+|||+ +.+
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl--~~~ 154 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFF--TMD 154 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTT
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEE--CCC
Confidence 4799999995 499999975432 235667789999999999999995 689999999999999 678
Q ss_pred CcEEEEecccccccCCc---------------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 263 SAIKIVDFGSSCQLGQR---------------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
+.+||+|||+|+.+... ....+||+.|||||++.+..|+.++|||||||+||||++ ||.+..
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 89999999999876432 234589999999999999999999999999999999996 776432
Q ss_pred HHHHHHHHHHHhC-CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCC
Q psy16081 328 EVDQMNKIVEVLG-LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHS 406 (493)
Q Consensus 328 ~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 406 (493)
+....+..... ..|..+..
T Consensus 232 --~~~~~~~~~~~~~~p~~~~~---------------------------------------------------------- 251 (299)
T 4g31_A 232 --ERVRTLTDVRNLKFPPLFTQ---------------------------------------------------------- 251 (299)
T ss_dssp --HHHHHHHHHHTTCCCHHHHH----------------------------------------------------------
T ss_pred --HHHHHHHHHhcCCCCCCCcc----------------------------------------------------------
Confidence 22222222211 11111100
Q ss_pred cchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 407 VSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 407 ~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
....+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 252 --~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 252 --KYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp --HCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred --cCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 011567999999999999999999999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=460.84 Aligned_cols=263 Identities=24% Similarity=0.435 Sum_probs=219.9
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+.+.++|++++.||+|+||+||+|+++.+|+.||||++..... ......+|+.++..+ +|||||+++++|.+.
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL------RHPTLVNLHDAFEDD 226 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT------CCTTBCCEEEEEECS
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC------CCCCCCeEEEEEEEC
Confidence 3456899999999999999999999999999999999975432 123344455554443 578899999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+++|||||||. |+|+++|.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.+..+.+||+|||+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred CEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeeccc
Confidence 99999999995 59999987543 369999999999999999999995 789999999999999655668999999999
Q ss_pred ccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 273 SCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 273 a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
|+.+.. .....+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+++..|......++...+.
T Consensus 304 a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-- 381 (573)
T 3uto_A 304 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS-- 381 (573)
T ss_dssp CEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGT--
T ss_pred eeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccccc--
Confidence 988754 3457799999999999999999999999999999999999999999999999988887643222211110
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.+++ .++|||.+||.+||.+|||
T Consensus 382 -------------------------------------------------------~~s~--~~~dli~~~L~~dp~~R~t 404 (573)
T 3uto_A 382 -------------------------------------------------------GISE--DGKDFIRKLLLADPNTRMT 404 (573)
T ss_dssp -------------------------------------------------------TSCH--HHHHHHHTTSCSSGGGSCC
T ss_pred -------------------------------------------------------CCCH--HHHHHHHHHccCChhHCcC
Confidence 0111 7899999999999999999
Q ss_pred HHHHhcCCCCCCCcc
Q psy16081 431 PYYALQHNFFKRTAD 445 (493)
Q Consensus 431 ~~e~L~Hp~~~~~~~ 445 (493)
+.|||+||||+....
T Consensus 405 ~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 405 IHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHSTTTSCCCC
T ss_pred HHHHhcCcCcCCCCC
Confidence 999999999997543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=457.50 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=209.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.. ........|..++.. ....+|||||+++++|++.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~l---l~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL---VSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH---HSSSCCTTBCCEEEEEECS
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHH---HhhCCCCCEeEEEEEEEEC
Confidence 578999999999999999999999999999999997432 122233444444444 3455789999999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+++|||||||. |+|.++|.+.. .+++..++.|+.||+.||.|||+ .|||||||||+|||| +.+|++||+|||+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILl--d~~G~vKL~DFGl 338 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGL 338 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEE--CTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEE--eCCCCEEecccce
Confidence 99999999995 59999998754 69999999999999999999995 799999999999999 7889999999999
Q ss_pred ccccCC-ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhh
Q psy16081 273 SCQLGQ-RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNE---VDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 273 a~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~p~~~~ 347 (493)
|+.+.. ...+.+||+.|||||++.+ ..|+.++||||||||||||++|.+||.+.+. .+....+...-...|.
T Consensus 339 A~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~--- 415 (689)
T 3v5w_A 339 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--- 415 (689)
T ss_dssp CEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT---
T ss_pred eeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc---
Confidence 987754 4567899999999999974 5799999999999999999999999986432 2333333221000000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
..+ .+++|||.+||..||.+
T Consensus 416 ----------------------------------------------------------~~S--~~a~dLI~~lL~~dP~~ 435 (689)
T 3v5w_A 416 ----------------------------------------------------------SFS--PELRSLLEGLLQRDVNR 435 (689)
T ss_dssp ----------------------------------------------------------TSC--HHHHHHHHHHTCSCGGG
T ss_pred ----------------------------------------------------------cCC--HHHHHHHHHHccCCHhH
Confidence 011 17899999999999999
Q ss_pred CCC-----HHHHhcCCCCCCCccC
Q psy16081 428 RIT-----PYYALQHNFFKRTADE 446 (493)
Q Consensus 428 R~t-----~~e~L~Hp~~~~~~~~ 446 (493)
|++ ++||++||||+.+...
T Consensus 436 Rl~~~~~ga~ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 436 RLGCLGRGAQEVKESPFFRSLDWQ 459 (689)
T ss_dssp CTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred CCCCCCCCHHHHhcCccccCCCHH
Confidence 998 7999999999987643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=413.45 Aligned_cols=252 Identities=20% Similarity=0.265 Sum_probs=201.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
++|.+.+.||+|+||+||+|++. .++..||||+++.... . ....+.+++..+...+|||||+++++|.+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--N---ARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH--H---HHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--H---HHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 57999999999999999999865 3688999999975321 1 112233344444455789999999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccC-----------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTN-----------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK 261 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~ 261 (493)
+.+|||||||+ |+|.++|.... ...+++..+..++.||+.||.|||+ .+||||||||+|||+ +.
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl--~~ 163 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLV--GE 163 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEE--CC
Confidence 99999999995 59999997532 2469999999999999999999995 689999999999999 77
Q ss_pred CCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy16081 262 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 262 ~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i 335 (493)
++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+| |++||.+.+..+.+..+
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 889999999999766432 123468999999999999999999999999999999998 99999999988888777
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
.+....+.. . ....++.+
T Consensus 244 ~~~~~~~~p-----------------------------------------------------------~---~~~~~~~~ 261 (299)
T 4asz_A 244 TQGRVLQRP-----------------------------------------------------------R---TCPQEVYE 261 (299)
T ss_dssp HHTCCCCCC-----------------------------------------------------------T---TCCHHHHH
T ss_pred HcCCCCCCC-----------------------------------------------------------c---cchHHHHH
Confidence 653211100 0 00117899
Q ss_pred HHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 416 LIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 416 Li~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
||.+||+.||++|||+.|++ +|++..
T Consensus 262 li~~cl~~dP~~RPs~~~i~--~~L~~~ 287 (299)
T 4asz_A 262 LMLGCWQREPHMRKNIKGIH--TLLQNL 287 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence 99999999999999999994 566644
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=415.91 Aligned_cols=248 Identities=20% Similarity=0.253 Sum_probs=194.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
++|.+.++||+|+||+||+|+.. .+++.||||+++.... . ....+++++..+...+|||||+++++|.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--S---ARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH--H---HHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH--H---HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 57889999999999999999864 3689999999975321 1 111233344444455789999999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTN-------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN 259 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~ 259 (493)
+.+|||||||+ |+|.+++.... ...+++..+..|+.||+.||.|||+ .+||||||||+||||
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl-- 191 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLV-- 191 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEE--
Confidence 99999999995 59999987542 1358999999999999999999995 789999999999999
Q ss_pred CCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy16081 260 PKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMN 333 (493)
Q Consensus 260 ~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~ 333 (493)
+.++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+| |++||.+.+..+.+.
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 67889999999999866332 234678999999999999999999999999999999999 999999998888877
Q ss_pred HHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhH
Q psy16081 334 KIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413 (493)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (493)
.+.+....+.. . ....++
T Consensus 272 ~i~~g~~~~~p-----------------------------------------------------------~---~~~~~~ 289 (329)
T 4aoj_A 272 CITQGRELERP-----------------------------------------------------------R---ACPPEV 289 (329)
T ss_dssp HHHHTCCCCCC-----------------------------------------------------------T---TCCHHH
T ss_pred HHHcCCCCCCc-----------------------------------------------------------c---cccHHH
Confidence 77653211100 0 001178
Q ss_pred HHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 414 KDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 414 ~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
.+||.+||+.||++|||+.|++++
T Consensus 290 ~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 290 YAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCcChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=410.95 Aligned_cols=254 Identities=25% Similarity=0.285 Sum_probs=192.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.+++++.++||+|+||+||+|+.. ..||||+++......... ..+.+++..+...+|||||++++++. ++.+|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~---~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~ 107 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQF---QAFRNEVAVLRKTRHVNILLFMGYMT-KDNLA 107 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHH---HHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHH---HHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEE
Confidence 467889999999999999999753 359999987443222221 22333444444557899999999875 46789
Q ss_pred EEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
||||||+ |+|.++|.... ..+++..+..|+.||+.||.|||+ .+||||||||+|||| ++++.+||+|||+|+..
T Consensus 108 iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl--~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFL--HEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEE--ETTEEEEECCCSSCBC-
T ss_pred EEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEE--CCCCcEEEeeccCceec
Confidence 9999996 59999997554 469999999999999999999995 689999999999999 67889999999999765
Q ss_pred CC-----ccccccccCcCCchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 277 GQ-----RIYQYIQSRFYRSPEVLLG---IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 277 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
.. .....+||+.|||||++.+ ..|+.++|||||||+||||+||++||.+.+..+.+..++.....+|..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~--- 259 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL--- 259 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS---
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc---
Confidence 42 2345689999999999974 359999999999999999999999999877766666555432111100
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
..+ .......+.+||.+||+.||++|
T Consensus 260 ---------------------------------~~~---------------------~~~~~~~l~~li~~cl~~dP~~R 285 (307)
T 3omv_A 260 ---------------------------------SKL---------------------YKNCPKAMKRLVADCVKKVKEER 285 (307)
T ss_dssp ---------------------------------TTS---------------------CTTSCHHHHHHHHHHTCSSSTTS
T ss_pred ---------------------------------ccc---------------------cccchHHHHHHHHHHcCCCHhHC
Confidence 000 00011278999999999999999
Q ss_pred CCHHHH------hcCCCC
Q psy16081 429 ITPYYA------LQHNFF 440 (493)
Q Consensus 429 ~t~~e~------L~Hp~~ 440 (493)
||+.|+ |+|+|-
T Consensus 286 Ps~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 286 PLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CCHHHHHHHHHHHHTTCC
T ss_pred cCHHHHHHHHHHHhccCC
Confidence 999976 567654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=417.49 Aligned_cols=316 Identities=30% Similarity=0.564 Sum_probs=250.2
Q ss_pred CCCCCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcce
Q psy16081 103 DDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYY 182 (493)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~ 182 (493)
+++...+.+..+..+.++|+++++||+|+||+||+|++..+++.||||+++...........|..+++.+.. ...+|+|
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~-~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN-DDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCC-CSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcc-cCCCCCC
Confidence 445566778888999999999999999999999999999999999999998655455566778877777764 3456999
Q ss_pred EEEeceeeeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC---
Q psy16081 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN--- 259 (493)
Q Consensus 183 Iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~--- 259 (493)
|+++++++...+++|+||||++++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTC
T ss_pred eecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEccccc
Confidence 9999999999999999999998899999987766679999999999999999999995 78999999999999943
Q ss_pred --------------------CCCCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhC
Q psy16081 260 --------------------PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTG 319 (493)
Q Consensus 260 --------------------~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG 319 (493)
...+.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 137889999999998877777778999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh--hhhccCCCCCceecCCCCCCCCCCCCCc-cchhhccccCCCCC
Q psy16081 320 EPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR--KYFDKMPDGSYILKKPKDGRKPKVPGSR-RLHDILGVESGGPG 396 (493)
Q Consensus 320 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~~ 396 (493)
.+||.+.+..+.+..+....+.+|..++....... .++.... +.. ..|... ....+.......+
T Consensus 256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~---------~~p~~~~~~~~~~~~~~~~~- 322 (360)
T 3llt_A 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDE---LKL---------AWPENASSINSIKHVKKCLP- 322 (360)
T ss_dssp SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTT---TEE---------CTTTTCSCHHHHHHHHTCCC-
T ss_pred CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCccc---cee---------cCcccccchhhhhhhhhccc-
Confidence 99999999999999999999988888776543221 1111100 000 000000 0000000000000
Q ss_pred CCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCC
Q psy16081 397 GRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441 (493)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~ 441 (493)
.........+.+||.+||.+||++|||+.|+|+||||+
T Consensus 323 -------~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 323 -------LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp -------HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred -------ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 00000112688999999999999999999999999996
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=413.43 Aligned_cols=248 Identities=21% Similarity=0.261 Sum_probs=201.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.+.+++.++||+|+||+||+|... .+++.||||+++... .....+..|+.++..+ +|||||++++++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l------~HpNIV~l~g~~ 98 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL------QHPNVVCLLGVV 98 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC------CCCCCCCcceEE
Confidence 356889999999999999999853 467899999997432 2234566666665544 578899999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcE
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENI 255 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NI 255 (493)
.+.+.+|||||||+ |+|.++|.... ...+++..+..++.||+.||.|||+ .+||||||||+||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NI 176 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNV 176 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccce
Confidence 99999999999995 59999996432 1348999999999999999999995 6899999999999
Q ss_pred EeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy16081 256 LLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEV 329 (493)
Q Consensus 256 Ll~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~ 329 (493)
|| ++++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+..
T Consensus 177 Ll--~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 177 LV--YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp EE--CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred EE--CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99 77889999999999866322 334678999999999999999999999999999999998 89999999988
Q ss_pred HHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcch
Q psy16081 330 DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409 (493)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (493)
+.+..+.+....|.. . ..
T Consensus 255 ~~~~~i~~~~~~~~p-----------------------------------------------------------~---~~ 272 (308)
T 4gt4_A 255 DVVEMIRNRQVLPCP-----------------------------------------------------------D---DC 272 (308)
T ss_dssp HHHHHHHTTCCCCCC-----------------------------------------------------------T---TC
T ss_pred HHHHHHHcCCCCCCc-----------------------------------------------------------c---cc
Confidence 877776542111100 0 00
Q ss_pred hhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 410 YLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 410 ~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
...+.+||.+||..||++|||+.|++++
T Consensus 273 ~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 273 PAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1168899999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=419.62 Aligned_cols=312 Identities=31% Similarity=0.535 Sum_probs=252.3
Q ss_pred CcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcC--CCCcceEE
Q psy16081 107 HDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKAD--VNNTYYIV 184 (493)
Q Consensus 107 ~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~--~~~~~~Iv 184 (493)
..+.+..++.+.++|++.++||+|+||+||+|++..+++.||||+++...........|+.++..+.+.. +.+|+||+
T Consensus 25 ~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 25 GYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp -CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred CceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 3456677888899999999999999999999999999999999999865555567778889888888654 45689999
Q ss_pred Eeceeee----ecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCC-CccccCCCCCcEEeeC
Q psy16081 185 RLKRHFM----WRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL-NIIHCDLKPENILLCN 259 (493)
Q Consensus 185 ~l~~~~~----~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~-~iiHrDlKp~NILl~~ 259 (493)
+++++|. ...++||||||++++|.+.+.......+++..++.++.||+.||.|||+ . ||+||||||+|||++.
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSV 182 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEECC
T ss_pred eeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEec
Confidence 9999998 5668999999999999998877665679999999999999999999995 5 8999999999999942
Q ss_pred CC-----------------------------------------------CCcEEEEecccccccCCccccccccCcCCch
Q psy16081 260 PK-----------------------------------------------RSAIKIVDFGSSCQLGQRIYQYIQSRFYRSP 292 (493)
Q Consensus 260 ~~-----------------------------------------------~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aP 292 (493)
+. ...+||+|||+++.........+||+.|+||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aP 262 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCH
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCC
Confidence 21 1379999999998887777778999999999
Q ss_pred hhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCce
Q psy16081 293 EVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN------EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYI 366 (493)
Q Consensus 293 E~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 366 (493)
|++.+..|+.++|||||||+||+|++|.+||.+.+ ..+.+..+.+.++.+|..++........+|.........
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 99999999999999999999999999999998755 677889999999999999887777776776653321100
Q ss_pred ecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCC
Q psy16081 367 LKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441 (493)
Q Consensus 367 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~ 441 (493)
.......+.+.+.. ...........+.+||.+||.+||++|||+.|||+||||+
T Consensus 343 ----------~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 343 ----------TKLKPWGLFEVLVE-----------KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp ----------CCCCCCCHHHHHHH-----------TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ----------cccCCcchhHhhhh-----------hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 00000011111110 0111223334789999999999999999999999999997
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=401.41 Aligned_cols=315 Identities=34% Similarity=0.587 Sum_probs=252.4
Q ss_pred ceeeccceecCcEEEeeeEeeeCCeEEEEEEE-cCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEec
Q psy16081 109 YIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFD-LEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLK 187 (493)
Q Consensus 109 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~ 187 (493)
..++.++.+.++|++.+.||+|+||+||+|.+ ..+++.||||+++...........|..++..+.+.+...|++|++++
T Consensus 4 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp GTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred eeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 45567788899999999999999999999998 56889999999986655566788899999999998888899999999
Q ss_pred eeeeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC------
Q psy16081 188 RHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK------ 261 (493)
Q Consensus 188 ~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~------ 261 (493)
+++...+++|+||||++++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||++.+.
T Consensus 84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 84 EWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred cccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999998899999987765678999999999999999999995 6899999999999995322
Q ss_pred -----------CCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy16081 262 -----------RSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVD 330 (493)
Q Consensus 262 -----------~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~ 330 (493)
++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred CccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999887777777889999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchh
Q psy16081 331 QMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410 (493)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (493)
.+..+....+.+|..++....... ++.... ..|. ............ ..+.... ........
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~-~~~~-------------~~~~~~~~~~~~-~~~~~~~---~~~~~~~~ 302 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRK-YFHHDR-LDWD-------------EHSSAGRYVSRA-CKPLKEF---MLSQDVEH 302 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGG-GEETTE-ECCC-------------TTSHHHHHHHHH-CCCGGGG---CSCCSHHH
T ss_pred HHHHHHHHhCCCCHHHHhhccchh-HHhhcc-cccc-------------ccccccchhhhc-Ccchhhh---cccchhhH
Confidence 999999999999888877654332 221100 0000 000000000000 0000000 00011222
Q ss_pred hhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 411 LKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 411 ~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 303 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 4789999999999999999999999999998653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=402.82 Aligned_cols=322 Identities=31% Similarity=0.563 Sum_probs=258.8
Q ss_pred CCCCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCC-eEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcce
Q psy16081 104 DDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQ-CHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYY 182 (493)
Q Consensus 104 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~ 182 (493)
+....+.+..++.+.++|++.+.||+|+||+||+|.+..++ +.||||+++...........|+.++..+.+.+..++++
T Consensus 4 ~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 83 (355)
T 2eu9_A 4 DKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL 83 (355)
T ss_dssp CTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSC
T ss_pred ccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCcee
Confidence 44566778888999999999999999999999999998877 79999999865555567788999999999988888888
Q ss_pred EEEeceeeeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC---
Q psy16081 183 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN--- 259 (493)
Q Consensus 183 Iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~--- 259 (493)
++.+.+++...+++||||||++++|.+.+.......+++..++.++.||+.||.|||+ .||+||||||+|||+..
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 84 CVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp BCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCE
T ss_pred EEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccc
Confidence 9999999999999999999999999998887665679999999999999999999995 79999999999999943
Q ss_pred --------------CCCCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 260 --------------PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 260 --------------~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
+.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 246789999999998877777778999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCC
Q psy16081 326 SNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405 (493)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 405 (493)
.+..+.+..+.+.++.+|..++........++.... .+. ........+.... .+.. .....
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~-----------~~~~~~~~~~~~~-~~~~---~~~~~ 302 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGL----VWD-----------ENSSDGRYVKENC-KPLK---SYMLQ 302 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEE----CCC-----------TTSHHHHHHHHHC-CCGG---GGCSC
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccc----ccc-----------cccchhccccccC-Cccc---ccccc
Confidence 999999999999999999888776544333322100 000 0000000000000 0000 00001
Q ss_pred CcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 406 ~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
.......+.+||.+||..||++|||+.|+|+||||+.....
T Consensus 303 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 303 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp CSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHH
T ss_pred cchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCChh
Confidence 11223378899999999999999999999999999976543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=398.04 Aligned_cols=287 Identities=31% Similarity=0.533 Sum_probs=226.9
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc------ccchHHHHHHHHHHHHhhcCCCCcceEEEec
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK------PFLNQAQIEVKLLEIMNKADVNNTYYIVRLK 187 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~ 187 (493)
+..+.++|++++.||+|+||+||+|++..+++.||||++.... ........|..++..+...+ ||||++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~---h~niv~~~ 80 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE---HPNVVRLM 80 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHC---CTTBCCEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcC---CCCeEEee
Confidence 3456789999999999999999999999999999999986322 22346677888887776553 67799999
Q ss_pred eeeeecc-----eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC
Q psy16081 188 RHFMWRN-----HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR 262 (493)
Q Consensus 188 ~~~~~~~-----~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~ 262 (493)
+++.... .+|+||||++++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||+ +.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~--~~~ 156 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILV--TSG 156 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEE--CTT
T ss_pred eeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--cCC
Confidence 9998755 5899999999999999987765569999999999999999999995 689999999999999 678
Q ss_pred CcEEEEecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy16081 263 SAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 340 (493)
+.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+.++.+.++
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 8999999999986643 34567899999999999999999999999999999999999999999999999999999999
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
.++...+........ +.+ .......+..+.. ..+ ..+.+||.+|
T Consensus 237 ~~~~~~~~~~~~~~~-------~~~-----------~~~~~~~~~~~~~----------------~~~--~~~~~li~~~ 280 (308)
T 3g33_A 237 LPPEDDWPRDVSLPR-------GAF-----------PPRGPRPVQSVVP----------------EME--ESGAQLLLEM 280 (308)
T ss_dssp CCCTTTSCSSCSSCG-------GGS-----------CCCCCCCHHHHSC----------------SCC--HHHHHHHHHH
T ss_pred CCChhhccchhhccc-------ccc-----------CCCCCCcHHHhCc----------------ccc--HHHHHHHHHH
Confidence 887665433211100 000 0000111111110 011 2789999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
|.+||++|||+.|+|+||||++.
T Consensus 281 L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 281 LTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TCSSTTTSCCHHHHHTSTTC---
T ss_pred hcCCCccCCCHHHHhcCccccCC
Confidence 99999999999999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=421.07 Aligned_cols=292 Identities=30% Similarity=0.477 Sum_probs=220.1
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|+++++||+|+||+||+|++..+++.||||++...... .....+|+.++. . .+||||++++++|..
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~---~---l~hpnIv~l~~~~~~ 132 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK---C---VNHKNIISLLNVFTP 132 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHH---H---CCCTTBCCCSEEECS
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHH---h---CCCCCCCcEEEEEcc
Confidence 4568999999999999999999999999999999999753222 122233333333 2 357889999999965
Q ss_pred c------ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 R------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
. .++||||||++++|.+.+.. .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 133 ~~~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll--~~~~~~k 204 (464)
T 3ttj_A 133 QKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVV--KSDCTLK 204 (464)
T ss_dssp CCSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTSCEE
T ss_pred CCccccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEE--eCCCCEE
Confidence 4 46799999999999888854 38999999999999999999995 689999999999999 6788999
Q ss_pred EEecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 267 IVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 267 L~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|+|||+++..... ....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+++.+|++.++.|+.
T Consensus 205 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 205 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp ECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999999877543 45678999999999999999999999999999999999999999999999999999999999988
Q ss_pred hhhhhccc-hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 345 HLLDGAHK-TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 345 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
.++..... ...|+...+... ...+..++.... ..............++|||.+||.+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~------~~~~~~~~~~~s~~~~dLl~~mL~~ 342 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYA----------------GLTFPKLFPDSL------FPADSEHNKLKASQARDLLSKMLVI 342 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCC----------------CCCHHHHSCGGG------SCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred HHHHHcchhhhhHhhcccccC----------------CCChHHhCcccc------cccccccccccCHHHHHHHHHHcCC
Confidence 77765432 233333222100 000111100000 0000000000123689999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q psy16081 424 DPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~ 443 (493)
||++|||++|||+||||+.+
T Consensus 343 dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 343 DPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp STTTSCCHHHHHTSTTTGGG
T ss_pred ChhhCCCHHHHhcChhhhhc
Confidence 99999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=411.53 Aligned_cols=302 Identities=28% Similarity=0.482 Sum_probs=215.7
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
..+.++|++++.||+|+||+||+|.+..+++.||||++...................+... .+|+||++++++|...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL--SGHENIVNLLNVLRADN 82 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHT--TTCTTBCCEEEEEECTT
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhc--cCCCCCCeeeeEEecCC
Confidence 3567899999999999999999999999999999999864322222222222222222222 25888999999997544
Q ss_pred --eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 195 --HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 195 --~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
.+|+|||||+++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll--~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 83 DRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILL--NAECHVKVADFGL 155 (388)
T ss_dssp SSCEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTCCEEECCCTT
T ss_pred CCEEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEE--cCCCCEEecCCcc
Confidence 78999999999999998764 58999999999999999999995 789999999999999 7788999999999
Q ss_pred ccccCC------------------------ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 273 SCQLGQ------------------------RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 273 a~~~~~------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
|+.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 976532 1234689999999999987 679999999999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccc--hhhhhccCCCCCceecCCCCCCCCCCCCCccch---hhccccCCCCCCCcCCC
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHK--TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLH---DILGVESGGPGGRRLGE 402 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~~~~~~~~~ 402 (493)
..+++.+|.+.++.|+...+..... ...++...+... . .........+. ..+....
T Consensus 236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------~---~~~~~~~~~~~~~~~~~~~~~---------- 296 (388)
T 3oz6_A 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV------E---IRQSNKRDIFTKWKNLLLKIN---------- 296 (388)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHC------C--------CCCCHHHHHHHHHHHC----------
T ss_pred HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccc------c---ccCCCHHHhCcchhhhccccc----------
Confidence 9999999999999998876654221 112211111000 0 00000000000 0000000
Q ss_pred CCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 403 PGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 403 ~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
+....+ ..+.|||.+||.+||++|||++|||+||||+.....
T Consensus 297 ~~~~~~--~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 297 PKADCN--EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338 (388)
T ss_dssp TTCCCC--HHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCG
T ss_pred ccccCC--HHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCC
Confidence 000111 278999999999999999999999999999976543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=408.04 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=197.7
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCC-----CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEE-----QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
-.++|++.++||+|+||+||+|.+..+ ++.||||+++..... ...+..|+.++..+. +|||||+++++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~-----hhpnIV~l~g~ 136 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLGA 136 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEEE
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcC-----CCCcEEEEEEE
Confidence 357899999999999999999987654 468999999754321 223444555544442 46789999999
Q ss_pred eee-cceeEEEEEecc-cCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 190 FMW-RNHLCLVFELLS-YNLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 190 ~~~-~~~~~lV~E~~~-~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
|.. .+.+|||||||+ |+|.++|+... ...+++..+..++.||+.||.|||+ .+||||||||+
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDLK~~ 214 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR 214 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCccCcc
Confidence 876 457999999995 59999997532 1348999999999999999999995 68999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ ++++.+||+|||+|+.+... ....+||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+
T Consensus 215 NILl--~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 215 NILL--SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GEEE--CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ceee--CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999 67889999999999876432 234678999999999999999999999999999999998 999999876
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+.+.+++.....++ .| ..
T Consensus 293 ~~~~~~~~i~~g~~~~----------------------------------~p------------------------~~-- 312 (353)
T 4ase_A 293 IDEEFCRRLKEGTRMR----------------------------------AP------------------------DY-- 312 (353)
T ss_dssp CSHHHHHHHHHTCCCC----------------------------------CC------------------------TT--
T ss_pred HHHHHHHHHHcCCCCC----------------------------------CC------------------------cc--
Confidence 5444444433211110 00 00
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
...++.+||.+||..||++|||+.|+++|
T Consensus 313 -~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 313 -TTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 01178999999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=395.08 Aligned_cols=287 Identities=30% Similarity=0.478 Sum_probs=224.7
Q ss_pred ccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 113 HGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 113 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
.++.+.++|++++.||+|+||+||+|.+. +++.||||++...... ......|..++..+ +||||++++++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~ 87 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL------HHPNIVSLIDV 87 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc------CCCCEeeeeeE
Confidence 34567889999999999999999999985 5899999999744322 22344455444433 47889999999
Q ss_pred eeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 190 FMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
+.+.+.+|+||||++++|.+.+.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~--~~~~~~kl~D 162 (311)
T 3niz_A 88 IHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLI--NSDGALKLAD 162 (311)
T ss_dssp ECCSSCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTCCEEECC
T ss_pred EccCCEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEE--CCCCCEEEcc
Confidence 99999999999999999999887654 469999999999999999999995 799999999999999 6788999999
Q ss_pred cccccccCC---ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 270 FGSSCQLGQ---RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 270 FG~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
||++...+. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++..
T Consensus 163 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 242 (311)
T 3niz_A 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242 (311)
T ss_dssp CTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred CcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence 999987653 2345678999999999987 568999999999999999999999999999999999999999988766
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
.+........+...... ......+..+.. ..+ .++++||.+||.+||
T Consensus 243 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~----------------~~~--~~~~~li~~~L~~dP 289 (311)
T 3niz_A 243 EWPQVQELPLWKQRTFQ---------------VFEKKPWSSIIP----------------GFC--QEGIDLLSNMLCFDP 289 (311)
T ss_dssp TSGGGTTSHHHHSCCCC---------------CCCCCCHHHHST----------------TCC--HHHHHHHHHHSCSCT
T ss_pred Hhhhhhccchhhhcccc---------------cccCCcHHHhCc----------------ccC--HHHHHHHHHHcCCCh
Confidence 65554433333221100 000001111110 011 268899999999999
Q ss_pred CCCCCHHHHhcCCCCCCCc
Q psy16081 426 KTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~~ 444 (493)
++|||++|+|+||||+...
T Consensus 290 ~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 290 NKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTSCCHHHHHTSGGGTTSC
T ss_pred hHCCCHHHHhcCcccccCC
Confidence 9999999999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=387.21 Aligned_cols=283 Identities=29% Similarity=0.467 Sum_probs=221.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++++.||+|+||+||+|.+..+++.||||++.............. +++......+||||+++++++.+.+.+|+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL---REICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHH---HHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHH---HHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 689999999999999999999999999999999975443222222222 22233334458889999999999999999
Q ss_pred EEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 199 VFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 199 V~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
||||++++|.+.+.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.....
T Consensus 79 v~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLI--NRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCTTCEECCS
T ss_pred EEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--cCCCCEEEeecccceecCC
Confidence 99999999888886644 469999999999999999999995 689999999999999 6788999999999987653
Q ss_pred c---cccccccCcCCchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 279 R---IYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPL-FSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 279 ~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
. ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.++...+......
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 2 34567899999999998766 89999999999999999987655 7888888999999999998877665544332
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
..+... ...+....+... ....+ ..+.+||.+||..||++|||++|
T Consensus 234 ~~~~~~----------------~~~~~~~~~~~~----------------~~~~~--~~~~~li~~~L~~dP~~R~t~~e 279 (292)
T 3o0g_A 234 PDYKPY----------------PMYPATTSLVNV----------------VPKLN--ATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp TTCCCC----------------CCCCTTCCCTTT----------------STTCC--HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cccccc----------------ccccCCcchhhc----------------ccccC--hHHHHHHHHHhccChhhCCCHHH
Confidence 221100 000000000000 00111 27899999999999999999999
Q ss_pred HhcCCCCCCC
Q psy16081 434 ALQHNFFKRT 443 (493)
Q Consensus 434 ~L~Hp~~~~~ 443 (493)
+|+||||+..
T Consensus 280 ~l~hp~f~~~ 289 (292)
T 3o0g_A 280 ALQHPYFSDF 289 (292)
T ss_dssp HHTSGGGTTC
T ss_pred HhcCcccccC
Confidence 9999999965
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=394.96 Aligned_cols=195 Identities=23% Similarity=0.238 Sum_probs=158.2
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc----
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN---- 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~---- 194 (493)
.+|.+.++||+|+||+||+|++ +|+.||||+++... ......|. ++......+|||||++++++.+.+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~--~~~~~~e~----Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREA----EIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHH----HHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhhHHHHH----HHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 4689999999999999999975 68999999997432 12222232 233344557999999999998764
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP------ELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~------~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
.+|||||||+ |+|.+++... .+++..+.+++.|++.||.|||++ ..+||||||||+|||| +.++.+||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl--~~~~~~Ki 149 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCI 149 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE--CTTSCEEE
T ss_pred EEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE--CCCCCEEE
Confidence 6899999996 5999999764 599999999999999999999974 3489999999999999 78899999
Q ss_pred EecccccccCCc-------cccccccCcCCchhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy16081 268 VDFGSSCQLGQR-------IYQYIQSRFYRSPEVLLGI------PYDLAIDMWSLGCILVEMHTGEPLFSGS 326 (493)
Q Consensus 268 ~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~pf~~~ 326 (493)
+|||+|+..... ....+||+.|||||++.+. .|+.++|||||||+||||+||.+||...
T Consensus 150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 999999766432 2245899999999999864 3678999999999999999999887643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=394.40 Aligned_cols=255 Identities=28% Similarity=0.391 Sum_probs=211.8
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch---HHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN---QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
...++|++++.||+|+||.||+|.+..+|+.||||++........ ...+|+.++.. . +||||+++++++..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~---l---~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI---L---NHPNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHH---C---CCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHh---C---CCCCEeeEEEEEEE
Confidence 456789999999999999999999999999999999975432222 23334443333 3 47889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll--~~~~~~kl~DFG 159 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLL--DADMNIKIADFG 159 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTSCEEECSTT
T ss_pred CCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEE--cCCCCEEEeecc
Confidence 999999999995 59999987653 59999999999999999999995 789999999999999 788899999999
Q ss_pred cccccC--CccccccccCcCCchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 272 SSCQLG--QRIYQYIQSRFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 272 ~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
++.... ......+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.+..+...++.......|..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~--- 236 (328)
T 3fe3_A 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY--- 236 (328)
T ss_dssp CCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT---
T ss_pred CceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC---
Confidence 997654 345567899999999999998875 79999999999999999999999998887777765421111100
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.+ ..+.+||.+||..||.+|
T Consensus 237 ----------------------------------------------------------~s--~~~~~li~~~L~~dP~~R 256 (328)
T 3fe3_A 237 ----------------------------------------------------------MS--TDCENLLKRFLVLNPIKR 256 (328)
T ss_dssp ----------------------------------------------------------SC--HHHHHHHHHHCCSSTTTS
T ss_pred ----------------------------------------------------------CC--HHHHHHHHHHCCCChhHC
Confidence 00 168899999999999999
Q ss_pred CCHHHHhcCCCCCCCcc
Q psy16081 429 ITPYYALQHNFFKRTAD 445 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~~~ 445 (493)
||++|+|+||||+....
T Consensus 257 ~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 257 GTLEQIMKDRWINAGHE 273 (328)
T ss_dssp CCHHHHTTCTTTTTTCT
T ss_pred cCHHHHhcCHhhcCCCc
Confidence 99999999999986543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=399.13 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=214.8
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-------chHHHHHHHHHHHHhhcCCCCcceEEEec
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-------LNQAQIEVKLLEIMNKADVNNTYYIVRLK 187 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~ 187 (493)
..+.++|++.+.||+|+||+||+|.+..+|+.||||+++..... ......|+.++ ...+||||++++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il------~~l~hpnIv~l~ 81 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL------RQVLHPNIITLH 81 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHH------TTCCCTTBCCEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHH------HhCCCcCCCcEE
Confidence 35677899999999999999999999999999999999754321 23344444443 333588899999
Q ss_pred eeeeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC---
Q psy16081 188 RHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS--- 263 (493)
Q Consensus 188 ~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~--- 263 (493)
++|.+.+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+. .++
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~--~~~~~~ 155 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLL--DKNIPI 155 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEES--CTTSSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEe--CCCCCc
Confidence 99999999999999995 5999999764 369999999999999999999995 7899999999999994 333
Q ss_pred -cEEEEecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy16081 264 -AIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340 (493)
Q Consensus 264 -~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 340 (493)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..|.....
T Consensus 156 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 235 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235 (361)
T ss_dssp CCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred cCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 799999999987644 34567899999999999999999999999999999999999999999998888887765433
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
..+...+ ..+ + ..+++||.+|
T Consensus 236 ~~~~~~~----------~~~-----------------------------------------------s--~~~~~li~~~ 256 (361)
T 2yab_A 236 DFDEEFF----------SQT-----------------------------------------------S--ELAKDFIRKL 256 (361)
T ss_dssp CCCHHHH----------TTS-----------------------------------------------C--HHHHHHHHHH
T ss_pred CCCchhc----------cCC-----------------------------------------------C--HHHHHHHHHH
Confidence 2222211 110 0 1689999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
|..||.+|||+.|+|+||||+...
T Consensus 257 L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 257 LVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp SCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CCCChhHCcCHHHHhcCcCcCCCc
Confidence 999999999999999999999653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=401.44 Aligned_cols=311 Identities=33% Similarity=0.531 Sum_probs=244.2
Q ss_pred ccee-cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcC-----CCCcceEEEec
Q psy16081 114 GEKF-LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKAD-----VNNTYYIVRLK 187 (493)
Q Consensus 114 ~~~~-~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~-----~~~~~~Iv~l~ 187 (493)
++.+ .++|++.+.||+|+||+||+|.+..+++.||||++............|..++..+.+.. ...|+||++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 3343 46899999999999999999999999999999999865545566778888888887654 22477899999
Q ss_pred eeeeecc----eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCC-CccccCCCCCcEEeeC---
Q psy16081 188 RHFMWRN----HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPEL-NIIHCDLKPENILLCN--- 259 (493)
Q Consensus 188 ~~~~~~~----~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~-~iiHrDlKp~NILl~~--- 259 (493)
+++...+ ++++|||+++++|.+++.......+++..++.++.||+.||.|||+ . ||+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEET
T ss_pred HHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeEEeccCC
Confidence 9998765 8999999998899999987655679999999999999999999995 5 8999999999999942
Q ss_pred -CCCCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHH
Q psy16081 260 -PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN------EVDQM 332 (493)
Q Consensus 260 -~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~~~~ 332 (493)
+..+.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+ ..+.+
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 23347999999999888777777889999999999999999999999999999999999999998754 56788
Q ss_pred HHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhh
Q psy16081 333 NKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLK 412 (493)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (493)
..+.+.++.+|..++........+|....... .... .....+.+++... ..........
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~------~~~~~~~~~~~~~-----------~~~~~~~~~~ 309 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLR----NISK------LKFWPLEDVLTEK-----------YKFSKDEAKE 309 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBS----SCCC------CCBCCHHHHHHHT-----------TCCCHHHHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhc----cccc------ccccchhhhhhhc-----------ccCCcchHHH
Confidence 89999999999999888877777776432100 0000 0000111111100 0011223347
Q ss_pred HHHHHhHccCCCCCCCCCHHHHhcCCCCCCCccCC
Q psy16081 413 FKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447 (493)
Q Consensus 413 ~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~~ 447 (493)
+.+||.+||..||++|||+.|+|+||||+......
T Consensus 310 ~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344 (373)
T ss_dssp HHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred HHHHHHHHhccCccccCCHHHHhhChhhhcccCcc
Confidence 89999999999999999999999999999764443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=396.39 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=218.4
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++............|+.++..+ +||||+++++++.+.+.
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~~ 75 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA------RHRNILHLHESFESMEE 75 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS------CCTTBCCEEEEEEETTE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC------CCCCCCeEeEEEecCCE
Confidence 456899999999999999999999999999999999975543334445555555433 47889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+|||||.+ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.+.++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 9999999965 9999987543 369999999999999999999995 79999999999999954447899999999998
Q ss_pred ccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 275 QLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 275 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......++...+..
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--- 229 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE--- 229 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT---
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhcc---
Confidence 7643 34456899999999999998899999999999999999999999999998888888876543333221110
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.+ ..+.+||.+||..||.+|||+.
T Consensus 230 ------------------------------------------------------~s--~~~~~li~~~L~~dp~~Rpt~~ 253 (321)
T 1tki_A 230 ------------------------------------------------------IS--IEAMDFVDRLLVKERKSRMTAS 253 (321)
T ss_dssp ------------------------------------------------------SC--HHHHHHHHTTSCSSGGGSCCHH
T ss_pred ------------------------------------------------------CC--HHHHHHHHHHcCCChhHCcCHH
Confidence 00 1789999999999999999999
Q ss_pred HHhcCCCCCCCc
Q psy16081 433 YALQHNFFKRTA 444 (493)
Q Consensus 433 e~L~Hp~~~~~~ 444 (493)
|+|+||||+...
T Consensus 254 e~l~hp~~~~~~ 265 (321)
T 1tki_A 254 EALQHPWLKQKI 265 (321)
T ss_dssp HHHHSHHHHSCG
T ss_pred HHhcChhhccCc
Confidence 999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=402.61 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=208.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|+++++||+|+||+||+|++..+++.||||++++.. ........|..++..+ .+||||++++++|.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~-----~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-----RNHPFLTQLFCCFQTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHT-----TTCTTBCCEEEEEECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhc-----cCCCceeeEEEEEEeC
Confidence 578999999999999999999999999999999997431 1122333444444332 2688899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|||||||.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl--~~~g~ikL~DFG~ 170 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLL--DHEGHCKLADFGM 170 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE--CTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEE--CCCCCEEEccccc
Confidence 999999999965 9999987653 69999999999999999999995 789999999999999 7789999999999
Q ss_pred ccccC---CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQLG---QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
|+... ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+.+|.......|..
T Consensus 171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~---- 246 (353)
T 3txo_A 171 CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW---- 246 (353)
T ss_dssp CBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----
T ss_pred eeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC----
Confidence 97642 23456789999999999999899999999999999999999999999999988888887532111100
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.+ ..+.+||.+||..||.+||
T Consensus 247 ---------------------------------------------------------~~--~~~~~li~~lL~~dP~~R~ 267 (353)
T 3txo_A 247 ---------------------------------------------------------LH--EDATGILKSFMTKNPTMRL 267 (353)
T ss_dssp ---------------------------------------------------------SC--HHHHHHHHHHTCSSGGGST
T ss_pred ---------------------------------------------------------CC--HHHHHHHHHHhhhCHHHcc
Confidence 00 1688999999999999999
Q ss_pred CH------HHHhcCCCCCCCcc
Q psy16081 430 TP------YYALQHNFFKRTAD 445 (493)
Q Consensus 430 t~------~e~L~Hp~~~~~~~ 445 (493)
++ +|+++||||+.+..
T Consensus 268 ~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 268 GSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp TSGGGTCTHHHHTSGGGTTCCH
T ss_pred CCcccCCHHHHhhCCcccCCCH
Confidence 99 89999999998653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=411.39 Aligned_cols=286 Identities=31% Similarity=0.518 Sum_probs=210.3
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|+++++||+|+||+||+|++..+++.||||++....... ....+|+.++..+ +|+||++++++|..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL------NHDHVVKVLDIVIP 123 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC------CCTTBCCEEEECCC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC------CCCCCCceEEEEec
Confidence 34578999999999999999999999999999999996532222 2333444444433 57889999999853
Q ss_pred -----cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 193 -----RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 193 -----~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
.+.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||
T Consensus 124 ~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl--~~~~~~kl 197 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIADSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLV--NQDCSVKV 197 (458)
T ss_dssp SCTTTCCCEEEEECCCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE--CTTCCEEE
T ss_pred CCcccCceEEEEEeccccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEE--CCCCCEee
Confidence 3579999999999999999765 369999999999999999999995 689999999999999 77889999
Q ss_pred EecccccccCC------------------------------ccccccccCcCCchhhhc-CCCCCchhhHHHHHHHHHHH
Q psy16081 268 VDFGSSCQLGQ------------------------------RIYQYIQSRFYRSPEVLL-GIPYDLAIDMWSLGCILVEM 316 (493)
Q Consensus 268 ~DFG~a~~~~~------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~el 316 (493)
+|||+|+.... .....+||+.|+|||++. +..|+.++||||||||||||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 99999976532 234568899999999874 56799999999999999999
Q ss_pred Hh-----------CCCCCCCCC--------------------HHHHHHHHHHHhCCCChhhhhhccc--hhhhhccCCCC
Q psy16081 317 HT-----------GEPLFSGSN--------------------EVDQMNKIVEVLGLPPKHLLDGAHK--TRKYFDKMPDG 363 (493)
Q Consensus 317 lt-----------G~~pf~~~~--------------------~~~~~~~i~~~~~~~p~~~~~~~~~--~~~~~~~~~~~ 363 (493)
++ |.++|.+.+ ..+++..|.+.+|.|+...+..... ...|....+..
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 788887765 3688999999999999888765432 22333322210
Q ss_pred CceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 364 SYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
. ...+.+.+ ...+ ..++|||.+||.+||++|||++|||+||||+.+
T Consensus 358 ~----------------~~~~~~~~----------------~~~s--~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 358 E----------------GTDLAERF----------------PASS--ADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp C----------------CCCGGGGS----------------TTSC--HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred C----------------CCCHHHHC----------------CCCC--HHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 0 00011100 0011 278999999999999999999999999999987
Q ss_pred ccCC
Q psy16081 444 ADES 447 (493)
Q Consensus 444 ~~~~ 447 (493)
....
T Consensus 404 ~~~~ 407 (458)
T 3rp9_A 404 RIAE 407 (458)
T ss_dssp CCGG
T ss_pred CCCc
Confidence 6544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=393.93 Aligned_cols=291 Identities=31% Similarity=0.533 Sum_probs=214.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|++++.||+|+||+||+|.+..+++.||||+++.... .......|+.++. ..+||||+++++++...+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~------~l~hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMK------ELKHENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHT------TCCBTTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHH------hcCCCCcceEEEEEEECCe
Confidence 3579999999999999999999999999999999974332 2234444544433 3358889999999999999
Q ss_pred eEEEEEecccCHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 196 LCLVFELLSYNLYDLLRNTN----FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
+|+||||++++|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLI--NKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTCCEEECCCS
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEE--cCCCCEEECcCc
Confidence 99999999999999886532 2358999999999999999999995 799999999999999 678899999999
Q ss_pred cccccCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 272 SSCQLGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 272 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++...+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 99876532 3456789999999999874 6899999999999999999999999999999999999999998887766
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
........+...+.. .....+...+.... ....+ ..+.+||.+||..||++
T Consensus 234 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~-----------~~~~~--~~l~~li~~~L~~dP~~ 284 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQ----------------RPPRDLRQVLQPHT-----------KEPLD--GNLMDFLHGLLQLNPDM 284 (317)
T ss_dssp GGGGGCTTCCTTCCC----------------CCCCCSHHHHGGGC-----------SSCCC--HHHHHHHHHHSCSSGGG
T ss_pred hhhhhhhhccccccc----------------ccchhHHHhhcccc-----------cccCC--HHHHHHHHHHCCCCccc
Confidence 654433222111110 00111111111000 00111 27899999999999999
Q ss_pred CCCHHHHhcCCCCCCCccCC
Q psy16081 428 RITPYYALQHNFFKRTADES 447 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~~~~~ 447 (493)
|||+.|+|+||||+......
T Consensus 285 Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 285 RLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp SCCHHHHTTSGGGGGGCC--
T ss_pred CCCHHHHhCChhhhcccchh
Confidence 99999999999999765543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=399.27 Aligned_cols=285 Identities=29% Similarity=0.510 Sum_probs=223.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++++.||+|+||+||+|.+..+|+.||||++...... .....+|+.++.. . +|+||+++++++..
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~---l---~hpnIv~l~~~~~~ 95 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH---M---RHENVIGLLDVFTP 95 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHH---C---CBTTBCCCSEEECS
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHh---C---CCcCCCCceeeEec
Confidence 3467899999999999999999999999999999998643221 1223334444333 2 47889999999986
Q ss_pred cc------eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 RN------HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~~------~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.+ .+|+||||++++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll--~~~~~~k 168 (367)
T 1cm8_A 96 DETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAV--NEDCELK 168 (367)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTCCEE
T ss_pred CCccccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEE--cCCCCEE
Confidence 53 46999999988999998763 58999999999999999999995 789999999999999 6788999
Q ss_pred EEecccccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 267 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 267 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+|||+++.........++|+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|.+..+.|+..
T Consensus 169 l~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 169 ILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp ECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred EEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999999988777778899999999999987 679999999999999999999999999999999999999999999988
Q ss_pred hhhhccc--hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 346 LLDGAHK--TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 346 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
++..... ...|+...+... ...+..++. ..+ ..+.+||.+||..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~----------------~~~--~~~~~ll~~mL~~ 294 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELE----------------KKDFASILT----------------NAS--PLAVNLLEKMLVL 294 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCC----------------CCCGGGTCT----------------TCC--HHHHHHHHHHSCS
T ss_pred HHHHhhhHHHHHHHHhCCCCC----------------CCCHHHHCC----------------CCC--HHHHHHHHHHccC
Confidence 8765432 233443332100 001111110 011 2789999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccCC
Q psy16081 424 DPKTRITPYYALQHNFFKRTADES 447 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~~~ 447 (493)
||.+|||++|+|+||||+...+..
T Consensus 295 dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 295 DAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp STTTSCCHHHHHHSGGGTTTC---
T ss_pred ChhHCCCHHHHhcChHHHhhcCCc
Confidence 999999999999999999875543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=393.69 Aligned_cols=290 Identities=31% Similarity=0.506 Sum_probs=218.9
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
....++|+++++||+|+||+||+|++..+++.||||+++.......... .+++++......+||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG---TAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccch---hHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 4556899999999999999999999999999999999974432111111 1122223333346888999999999999
Q ss_pred eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC---CCCCcEEEEecc
Q psy16081 195 HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN---PKRSAIKIVDFG 271 (493)
Q Consensus 195 ~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~---~~~~~ikL~DFG 271 (493)
.+|+||||++++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+.. +..+.+||+|||
T Consensus 107 ~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 999999999999999997654 59999999999999999999995 78999999999999953 234569999999
Q ss_pred cccccCC---ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 272 SSCQLGQ---RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 272 ~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
++..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.++...+
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 9977653 33456789999999999875 4899999999999999999999999999999999999999998877665
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
........+....+. .....+...+... . ...+.+||.+||.+||++
T Consensus 263 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~---------------~--~~~~~~li~~~L~~dP~~ 309 (329)
T 3gbz_A 263 PGVTALPDWKQSFPK----------------FRGKTLKRVLGAL---------------L--DDEGLDLLTAMLEMDPVK 309 (329)
T ss_dssp TTGGGSTTCCTTCCC----------------CCCCCHHHHHGGG---------------S--CHHHHHHHHHHTCSSGGG
T ss_pred hhhhhhhhhhhhhhh----------------hccccHhhhcccc---------------c--CHHHHHHHHHHccCChhh
Confidence 543332222211110 0001111111100 0 127899999999999999
Q ss_pred CCCHHHHhcCCCCCCCc
Q psy16081 428 RITPYYALQHNFFKRTA 444 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~~ 444 (493)
|||+.|+|+||||+...
T Consensus 310 R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 310 RISAKNALEHPYFSHND 326 (329)
T ss_dssp SCCHHHHHTSGGGSSSC
T ss_pred CCCHHHHhCCcccCCCC
Confidence 99999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=394.70 Aligned_cols=286 Identities=28% Similarity=0.445 Sum_probs=220.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
++|++++.||+|+||+||+|.+..+++.||||+++..... ......|+.++ ...+|+||+++++++...+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l------~~l~h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLL------KDLKHANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHH------SCCCCTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHH------HhcCCCCCCeeeeEEeeCCEE
Confidence 6899999999999999999999999999999998643211 01112233333 334588899999999999999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLI--NERGELKLADFGLARAK 150 (324)
T ss_dssp EEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEE--CTTCCEEECSSSEEECC
T ss_pred EEEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEE--CCCCCEEEccCcccccc
Confidence 9999999999999987654 469999999999999999999995 789999999999999 67889999999999766
Q ss_pred CCc---cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+++..+...++.|+...+.....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 151 SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 432 334578999999999987 5689999999999999999999999999999999999999999988777665443
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
...+..... ..+ ....+.... ...+ ..+.+||.+||.+||.+|||++
T Consensus 231 ~~~~~~~~~-~~~--------------~~~~~~~~~----------------~~~~--~~~~~li~~~L~~dP~~R~t~~ 277 (324)
T 3mtl_A 231 NEEFKTYNY-PKY--------------RAEALLSHA----------------PRLD--SDGADLLTKLLQFEGRNRISAE 277 (324)
T ss_dssp CHHHHHTCC-CCC--------------CCCCHHHHC----------------TTSC--HHHHHHHHHHSCSSGGGSCCHH
T ss_pred chhhccccc-ccc--------------cchhhhhhc----------------CCCC--HHHHHHHHHHcCcCcccCCCHH
Confidence 333221100 000 000000000 0011 2789999999999999999999
Q ss_pred HHhcCCCCCCCccCCC
Q psy16081 433 YALQHNFFKRTADEST 448 (493)
Q Consensus 433 e~L~Hp~~~~~~~~~~ 448 (493)
|+|+||||+.......
T Consensus 278 e~l~hp~f~~~~~~~~ 293 (324)
T 3mtl_A 278 DAMKHPFFLSLGERIH 293 (324)
T ss_dssp HHTTSGGGGGGCSTTS
T ss_pred HHhcChhhhhcccccc
Confidence 9999999997755433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=382.64 Aligned_cols=278 Identities=32% Similarity=0.510 Sum_probs=215.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|++++.||+|+||+||+|.+ .+++.||||++...... ......|+.+ ....+||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~------l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISI------LKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHG------GGGCCCTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHH------HHhcCCCCEeeeeeEEccCCe
Confidence 5899999999999999999998 67899999999754321 2333344433 333458889999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 75 LVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLI--NREGELKIADFGLARA 149 (288)
T ss_dssp EEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTSCEEECCTTHHHH
T ss_pred EEEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--cCCCCEEEeECccccc
Confidence 99999999999999987644 469999999999999999999995 689999999999999 6788999999999977
Q ss_pred cCC---ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQ---RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++...+....
T Consensus 150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 643 23455789999999999864 58999999999999999999999999999999999999988887665444322
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
....+-.... .. ....+.... ...+ ..+.+||.+||..||++|||+
T Consensus 230 ~~~~~~~~~~-------------~~---~~~~~~~~~----------------~~~~--~~~~~li~~~L~~dP~~Rpt~ 275 (288)
T 1ob3_A 230 ELPKYDPNFT-------------VY---EPLPWESFL----------------KGLD--ESGIDLLSKMLKLDPNQRITA 275 (288)
T ss_dssp GSTTCCTTCC-------------CC---CCCCGGGTC----------------CSCC--HHHHHHHHHHTCSSTTTSCCH
T ss_pred cccccccccc-------------cc---cCccHHHHh----------------hhcC--HHHHHHHHHHcCCCcccCCCH
Confidence 2111100000 00 000000000 0011 278899999999999999999
Q ss_pred HHHhcCCCCCC
Q psy16081 432 YYALQHNFFKR 442 (493)
Q Consensus 432 ~e~L~Hp~~~~ 442 (493)
.|+|+||||+.
T Consensus 276 ~e~l~hp~f~~ 286 (288)
T 1ob3_A 276 KQALEHAYFKE 286 (288)
T ss_dssp HHHHTSGGGGC
T ss_pred HHHhcCcchhh
Confidence 99999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=390.53 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=214.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++++.||+|+||+||+|++..+|+.||||+++... ........|..++. ..+||||++++++|.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~------~l~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS------IVTHPFIIRMWGTFQDA 78 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH------SCCBTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHh------hCCCCCCceEeEEEEeC
Confidence 468999999999999999999999999999999997431 11222333443332 34688899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll--~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILL--DKNGHIKITDFGF 152 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEE--CTTSCEEECCCSS
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEE--cCCCCEEEeecCc
Confidence 999999999965 9999997653 69999999999999999999994 789999999999999 7789999999999
Q ss_pred ccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 273 SCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 273 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
+..........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+.+|.......|.
T Consensus 153 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~-------- 224 (318)
T 1fot_A 153 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP-------- 224 (318)
T ss_dssp CEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--------
T ss_pred ceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--------
Confidence 998877777889999999999999999999999999999999999999999999888888777652111100
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC---
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI--- 429 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~--- 429 (493)
..+ ..+.+||.+||..||++||
T Consensus 225 -----------------------------------------------------~~~--~~~~~li~~lL~~dp~~R~~~~ 249 (318)
T 1fot_A 225 -----------------------------------------------------FFN--EDVKDLLSRLITRDLSQRLGNL 249 (318)
T ss_dssp -----------------------------------------------------TSC--HHHHHHHHHHTCSCTTTCTTSS
T ss_pred -----------------------------------------------------CCC--HHHHHHHHHHhccCHHHcCCCc
Confidence 000 1789999999999999999
Q ss_pred --CHHHHhcCCCCCCCcc
Q psy16081 430 --TPYYALQHNFFKRTAD 445 (493)
Q Consensus 430 --t~~e~L~Hp~~~~~~~ 445 (493)
+++|+++||||+.+..
T Consensus 250 ~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 250 QNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp TTTTHHHHTSGGGSSCCH
T ss_pred CCCHHHHhcCccccCCCH
Confidence 9999999999997653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=401.51 Aligned_cols=286 Identities=31% Similarity=0.502 Sum_probs=221.7
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++++.||+|+||+||+|++..+++.||||++....... ....+|+.++.. + +|+||+++++++..
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~---l---~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR---L---KSDYIIRLYDLIIP 96 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHH---C---CCTTBCCEEEECCC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHH---c---CCCCcceEEEEEec
Confidence 45679999999999999999999999999999999997533222 223334444333 3 47789999999987
Q ss_pred c-----ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 193 R-----NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 193 ~-----~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
. +.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl--~~~~~~kL 170 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIADSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLL--NQDCSVKV 170 (432)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTCCEEE
T ss_pred CCCCcCCeEEEEEecCCcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEE--CCCCCEEE
Confidence 6 579999999999999999764 359999999999999999999995 689999999999999 77889999
Q ss_pred EecccccccCCc-------------------------cccccccCcCCchhhhc-CCCCCchhhHHHHHHHHHHHHh---
Q psy16081 268 VDFGSSCQLGQR-------------------------IYQYIQSRFYRSPEVLL-GIPYDLAIDMWSLGCILVEMHT--- 318 (493)
Q Consensus 268 ~DFG~a~~~~~~-------------------------~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ellt--- 318 (493)
+|||+|+..... ....+||+.|+|||++. +..|+.++||||||||+|||++
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999876432 35678999999999974 5569999999999999999998
Q ss_pred --------CCCCCCCCC-----------------HHHHHHHHHHHhCCCChhhhhhccc--hhhhhccCCCCCceecCCC
Q psy16081 319 --------GEPLFSGSN-----------------EVDQMNKIVEVLGLPPKHLLDGAHK--TRKYFDKMPDGSYILKKPK 371 (493)
Q Consensus 319 --------G~~pf~~~~-----------------~~~~~~~i~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 371 (493)
|.++|.+.+ ..+++..|.+.+|.|+...+..... ...+....+..
T Consensus 251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~-------- 322 (432)
T 3n9x_A 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR-------- 322 (432)
T ss_dssp TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC--------
T ss_pred ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCC--------
Confidence 667776654 4789999999999999887765432 22232222110
Q ss_pred CCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCccCC
Q psy16081 372 DGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447 (493)
Q Consensus 372 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~~ 447 (493)
....+..... ..+ ..++|||.+||.+||++|||++|||+||||+.+....
T Consensus 323 --------~~~~~~~~~~----------------~~s--~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 323 --------KPINLKQKYP----------------SIS--DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp --------CCCCHHHHST----------------TSC--HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred --------CCCCHHHHCC----------------CCC--HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 0000111100 011 2789999999999999999999999999999876554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=397.04 Aligned_cols=284 Identities=28% Similarity=0.529 Sum_probs=208.7
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++++.||+|+||.||+|.+..+|+.||||++....... ....+|+.++. .+ +|+||+++++++..
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---~l---~hpnIv~~~~~~~~ 99 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK---HM---KHENVIGLLDVFTP 99 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHH---HC---CCTTBCCCSEEECS
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHH---hC---CCCCCCcEEEEEec
Confidence 45689999999999999999999999999999999986432222 22233443333 33 47889999999875
Q ss_pred c------ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 R------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
. ..+|+|+|+++++|.+++.. ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll--~~~~~~k 172 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAV--NEDCELK 172 (367)
T ss_dssp CSSGGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTCCEE
T ss_pred CCccccCCeEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEE--CCCCCEE
Confidence 4 56899999998899988865 359999999999999999999995 789999999999999 6788999
Q ss_pred EEecccccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 267 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 267 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+|||+++.........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|.+.++.|+..
T Consensus 173 L~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 173 ILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred EeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999999888777777899999999999987 679999999999999999999999999999999999999999999888
Q ss_pred hhhhccc--hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 346 LLDGAHK--TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 346 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
.+..... ...|+..++... ...+..++. .. ...+.|||.+||.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~----------------~~--~~~~~dLl~~mL~~ 298 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMP----------------KMNFANVFI----------------GA--NPLAVDLLEKMLVL 298 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCC----------------CCCHHHHTT----------------TC--CHHHHHHHHHHSCS
T ss_pred HHHHhhhHHHHHHHhccCCCC----------------CCCHHHHCC----------------CC--CHHHHHHHHHhCCC
Confidence 7765432 223333322100 001111110 00 12689999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccC
Q psy16081 424 DPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
||.+|||+.|+|+||||+...+.
T Consensus 299 dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 299 DSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp SGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CcccCcCHHHHhcChhhhhccCC
Confidence 99999999999999999976544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=393.55 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=213.4
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
-.++|++.+.||+|+||+||+|+++.+++.||||++++.. ........|..++..+ .+||||++++++|.+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~-----~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHMFCTFQT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH-----TTCTTBCCEEEEEEC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhc-----CCCCCCCcEEEEEEe
Confidence 3578999999999999999999999999999999997431 2233444555555433 357889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll--~~~g~vkL~DFG 163 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILL--DKDGHIKIADFG 163 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE--CTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEE--CCCCCEEEeECh
Confidence 999999999995 59999997653 59999999999999999999995 689999999999999 778899999999
Q ss_pred cccccC---CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 272 SSCQLG---QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 272 ~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
+++... ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..|.......|..
T Consensus 164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--- 240 (345)
T 1xjd_A 164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW--- 240 (345)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT---
T ss_pred hhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc---
Confidence 997642 23456789999999999999999999999999999999999999999998888877775421111000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.+ ..+.+||.+||..||++|
T Consensus 241 ----------------------------------------------------------~s--~~~~~li~~lL~~dp~~R 260 (345)
T 1xjd_A 241 ----------------------------------------------------------LE--KEAKDLLVKLFVREPEKR 260 (345)
T ss_dssp ----------------------------------------------------------SC--HHHHHHHHHHSCSSGGGS
T ss_pred ----------------------------------------------------------cC--HHHHHHHHHHhcCCHhHc
Confidence 00 168999999999999999
Q ss_pred CCHH-HHhcCCCCCCCcc
Q psy16081 429 ITPY-YALQHNFFKRTAD 445 (493)
Q Consensus 429 ~t~~-e~L~Hp~~~~~~~ 445 (493)
|++. ++++||||+.+..
T Consensus 261 ~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 261 LGVRGDIRQHPLFREINW 278 (345)
T ss_dssp BTTBSCGGGSGGGTTCCH
T ss_pred CCChHHHHcCccccCCCH
Confidence 9998 9999999998753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=391.83 Aligned_cols=294 Identities=32% Similarity=0.530 Sum_probs=218.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce-
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH- 195 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~- 195 (493)
..++|++.+.||+|+||+||+|.+..+++.||||++............+...+ ... +||||++++++|...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l---~~l---~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDL---AVL---HHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHH---HHH---CCTTBCCEEEEEEEECSS
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHH---Hhc---CCCCcccHHHhhhccccc
Confidence 35789999999999999999999999999999999876554444444444333 333 47789999999976443
Q ss_pred ------eEEEEEecccCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 196 ------LCLVFELLSYNLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 196 ------~~lV~E~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
+|+||||++++|.+.+.. .....+++..++.++.||+.||.|||.|+.||+||||||+|||++ ..++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~-~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN-EADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE-TTTTEEEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe-CCCCcEEE
Confidence 899999999988776653 223468999999999999999999997668999999999999994 23789999
Q ss_pred EecccccccCCc--cccccccCcCCchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 268 VDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 268 ~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.++.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 999999876433 34567899999999997654 899999999999999999999999999999999999999999998
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.++.........++.... ....+..++. .........+.+||.+||.+|
T Consensus 254 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~--------------~~~~~~~~~~~~li~~~L~~d 302 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNS-----------------KGIPWSNVFS--------------DHSLKDAKEAYDLLSALLQYL 302 (360)
T ss_dssp HHHHHHCTTCCCGGGGCC-----------------CCCCHHHHTT--------------TCCCTTHHHHHHHHHHHTCSS
T ss_pred HHHHhcccchhhcccccc-----------------ccCCcccccc--------------hhhccccHHHHHHHHHHhccC
Confidence 877654322111111000 0000111110 011122337899999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCccCCC
Q psy16081 425 PKTRITPYYALQHNFFKRTADEST 448 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~~~~~~~~~ 448 (493)
|.+|||+.|+|+||||+.......
T Consensus 303 P~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 303 PEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp GGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred ccccCCHHHHhcCccccccCCccc
Confidence 999999999999999998765443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=391.49 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=210.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++++.||+|+||+||+|++..+++.||||++++.. ........|..++. ..+||||++++++|.+.
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~------~l~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ------NTRHPFLTALKYAFQTH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH------SCCCTTBCCEEEEEECS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHH------hCCCCcCcceEEEEEeC
Confidence 468999999999999999999999999999999997431 11223333433332 34688899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll--~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLML--DKDGHIKITDFGL 151 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE--CTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEE--CCCCCEEEeeccc
Confidence 999999999965 9999887653 58999999999999999999995 789999999999999 7788999999999
Q ss_pred ccccC---CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQLG---QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
++... ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....|.......|.
T Consensus 152 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----- 226 (337)
T 1o6l_A 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----- 226 (337)
T ss_dssp CBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-----
T ss_pred hhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence 97642 3345678999999999999999999999999999999999999999998887777766542110000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
..+ ..+.+||.+||..||++||
T Consensus 227 --------------------------------------------------------~~s--~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 227 --------------------------------------------------------TLS--PEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp --------------------------------------------------------TSC--HHHHHHHHHHTCSSTTTST
T ss_pred --------------------------------------------------------CCC--HHHHHHHHHHhhcCHHHhc
Confidence 001 1789999999999999999
Q ss_pred -----CHHHHhcCCCCCCCcc
Q psy16081 430 -----TPYYALQHNFFKRTAD 445 (493)
Q Consensus 430 -----t~~e~L~Hp~~~~~~~ 445 (493)
+++|+++||||..+..
T Consensus 249 g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 249 GGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp TCSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCCCHHHHHcCCCcCCCCH
Confidence 9999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=396.72 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=206.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|+++++||+|+||+||+|++..+++.||||++++.. ........|..++..+. +||||++++++|.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~-----~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT-----TCTTBCCEEEEEECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC-----CCCCcCeeEEEEEEC
Confidence 468999999999999999999999999999999997532 22334556666655442 578899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|||||||.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl--~~~g~ikL~DFGl 199 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGM 199 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE--CTTSCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEE--CCCCCEEEeecce
Confidence 999999999965 9999887653 69999999999999999999995 789999999999999 7889999999999
Q ss_pred cccc---CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHHhC
Q psy16081 273 SCQL---GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE---------VDQMNKIVEVLG 340 (493)
Q Consensus 273 a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---------~~~~~~i~~~~~ 340 (493)
|+.. .......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+... ......+.....
T Consensus 200 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 200 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp CBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred eeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 9753 3345677999999999999999999999999999999999999999974321 112222222100
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
..| . ..+ ..+.+||.+|
T Consensus 280 ~~p--------------------------------------~-----------------------~~s--~~~~~li~~l 296 (396)
T 4dc2_A 280 RIP--------------------------------------R-----------------------SLS--VKAASVLKSF 296 (396)
T ss_dssp CCC--------------------------------------T-----------------------TSC--HHHHHHHHHH
T ss_pred CCC--------------------------------------C-----------------------cCC--HHHHHHHHHH
Confidence 000 0 001 1689999999
Q ss_pred cCCCCCCCCCH------HHHhcCCCCCCCcc
Q psy16081 421 LDYDPKTRITP------YYALQHNFFKRTAD 445 (493)
Q Consensus 421 L~~dP~~R~t~------~e~L~Hp~~~~~~~ 445 (493)
|..||.+||++ +|+++||||+.+..
T Consensus 297 L~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 297 LNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp TCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred hcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 99999999995 89999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.57 Aligned_cols=282 Identities=26% Similarity=0.363 Sum_probs=222.1
Q ss_pred CCCCCCCCcceeeccceecCcEEEe-eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhc
Q psy16081 100 EGYDDDNHDYIIQHGEKFLDRYEID-SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKA 175 (493)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~ 175 (493)
.|.|+......++..+.+.++|.+. +.||+|+||+||+|.+..+++.||||+++.... .......|..++..+.
T Consensus 9 ~~~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-- 86 (327)
T 3lm5_A 9 SGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK-- 86 (327)
T ss_dssp -------CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT--
T ss_pred ccccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc--
Confidence 4556666677778888999999998 899999999999999999999999999975332 2334455555554433
Q ss_pred CCCCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCc
Q psy16081 176 DVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPEN 254 (493)
Q Consensus 176 ~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~N 254 (493)
+||||+++++++...+.+|+||||+.+ +|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 87 ---~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~N 161 (327)
T 3lm5_A 87 ---SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQN 161 (327)
T ss_dssp ---TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGG
T ss_pred ---CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHH
Confidence 467899999999999999999999965 99998876555679999999999999999999995 789999999999
Q ss_pred EEeeCC-CCCcEEEEecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy16081 255 ILLCNP-KRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ 331 (493)
Q Consensus 255 ILl~~~-~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~ 331 (493)
||++.. ..+.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 162 Il~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 241 (327)
T 3lm5_A 162 ILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241 (327)
T ss_dssp EEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 999421 2688999999999876543 3456899999999999999999999999999999999999999999988887
Q ss_pred HHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhh
Q psy16081 332 MNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYL 411 (493)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (493)
+..+.......+..... ... .
T Consensus 242 ~~~i~~~~~~~~~~~~~---------------------------------------------------------~~~--~ 262 (327)
T 3lm5_A 242 YLNISQVNVDYSEETFS---------------------------------------------------------SVS--Q 262 (327)
T ss_dssp HHHHHHTCCCCCTTTTT---------------------------------------------------------TSC--H
T ss_pred HHHHHhcccccCchhhc---------------------------------------------------------ccC--H
Confidence 77766532222111000 001 1
Q ss_pred hHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCccCC
Q psy16081 412 KFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447 (493)
Q Consensus 412 ~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~~ 447 (493)
.+.+||.+||..||++|||++|+|+||||+.+....
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 688999999999999999999999999999875543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=401.88 Aligned_cols=260 Identities=28% Similarity=0.421 Sum_probs=212.4
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
..+.++|++++.||+|+||+||+|.+..+|+.||+|++....... .....|+.++..+ +||||+++++++.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~~~~ 80 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL------KHPNIVRLHDSIS 80 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC------CBTTBCCEEEEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC------CCcCCCeEEEEEE
Confidence 356789999999999999999999999999999999997544221 2233444444332 5888999999999
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEEe
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVD 269 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~D 269 (493)
+.+.+|+|||||.+ +|.+.+.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.+ .++.+||+|
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~D 156 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLAD 156 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEcc
Confidence 99999999999955 9999987654 59999999999999999999995 789999999999999533 467899999
Q ss_pred cccccccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 270 FGSSCQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 270 FG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 157 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 157 FGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp CSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred CceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence 9999776543 3456899999999999999999999999999999999999999999998888887765422221110
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
+ ...+ ..+++||.+||..||.
T Consensus 237 ~---------------------------------------------------------~~~s--~~~~~li~~~L~~dP~ 257 (444)
T 3soa_A 237 W---------------------------------------------------------DTVT--PEAKDLINKMLTINPS 257 (444)
T ss_dssp T---------------------------------------------------------TTSC--HHHHHHHHHHSCSSTT
T ss_pred c---------------------------------------------------------ccCC--HHHHHHHHHHcCCChh
Confidence 0 0011 1789999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q psy16081 427 TRITPYYALQHNFFKRT 443 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~ 443 (493)
+|||+.|+|+||||+..
T Consensus 258 ~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 258 KRITAAEALKHPWISHR 274 (444)
T ss_dssp TSCCHHHHHHSCTTHHH
T ss_pred HCCCHHHHhcCccccCC
Confidence 99999999999999753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=392.35 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=214.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++++.||+|+||+||+|++..+++.||||++.... ........|. ..+...+||||++++++|.+.
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~------~~l~~l~hp~iv~~~~~~~~~ 113 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK------RILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH------HHHTTCCCTTBCCEEEEEECS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHH------HHHHhCCCCCCCeEEEEEEcC
Confidence 468999999999999999999999999999999996432 1112222233 333444788999999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll--~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLI--DQQGYIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEE--CCCCCEEEccccc
Confidence 99999999995 59999997653 59999999999999999999995 789999999999999 7788999999999
Q ss_pred ccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 273 SCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 273 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
++.........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..|.......|..
T Consensus 188 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~------- 260 (350)
T 1rdq_E 188 AKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH------- 260 (350)
T ss_dssp CEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-------
T ss_pred ceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCC-------
Confidence 9988777778899999999999999999999999999999999999999999998888887776531111100
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC--
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT-- 430 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t-- 430 (493)
.+ ..+.+||.+||..||.+||+
T Consensus 261 ------------------------------------------------------~~--~~~~~li~~lL~~dp~~R~~~~ 284 (350)
T 1rdq_E 261 ------------------------------------------------------FS--SDLKDLLRNLLQVDLTKRFGNL 284 (350)
T ss_dssp ------------------------------------------------------CC--HHHHHHHHHHSCSCTTTCTTSS
T ss_pred ------------------------------------------------------CC--HHHHHHHHHHhhcCHHhccCCc
Confidence 00 17899999999999999999
Q ss_pred ---HHHHhcCCCCCCCcc
Q psy16081 431 ---PYYALQHNFFKRTAD 445 (493)
Q Consensus 431 ---~~e~L~Hp~~~~~~~ 445 (493)
++|+++||||+....
T Consensus 285 ~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 285 KNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp TTTTHHHHTSGGGTTCCH
T ss_pred cCCHHHHHhCcCcCCCCH
Confidence 999999999997653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=385.29 Aligned_cols=259 Identities=28% Similarity=0.447 Sum_probs=215.1
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-------cchHHHHHHHHHHHHhhcCCCCcceEEEec
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-------FLNQAQIEVKLLEIMNKADVNNTYYIVRLK 187 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~ 187 (493)
+.+.++|++.+.||+|+||+||+|.+..+++.||||++..... .......|+.++..+ +||||++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~ 80 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI------QHPNVITLH 80 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC------CCTTBCCEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC------CCCCCCcEE
Confidence 3566789999999999999999999999999999999975432 134455666665544 377899999
Q ss_pred eeeeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC---
Q psy16081 188 RHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS--- 263 (493)
Q Consensus 188 ~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~--- 263 (493)
++|.+.+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++ .++
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~--~~~~~~ 154 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLL--DRNVPK 154 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEES--CSSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEe--cCCCCC
Confidence 99999999999999995 5999998754 369999999999999999999995 7899999999999994 444
Q ss_pred -cEEEEecccccccC--CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy16081 264 -AIKIVDFGSSCQLG--QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340 (493)
Q Consensus 264 -~ikL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 340 (493)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234 (326)
T ss_dssp CCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred CCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence 79999999998764 334567899999999999999999999999999999999999999999888888777765433
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
..+...+. .. + ..+.+||.+|
T Consensus 235 ~~~~~~~~----------~~-----------------------------------------------~--~~~~~li~~~ 255 (326)
T 2y0a_A 235 EFEDEYFS----------NT-----------------------------------------------S--ALAKDFIRRL 255 (326)
T ss_dssp CCCHHHHT----------TS-----------------------------------------------C--HHHHHHHHHH
T ss_pred CcCccccc----------cC-----------------------------------------------C--HHHHHHHHHH
Confidence 22221110 00 0 1678999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
|..||++|||+.|+|+||||+...
T Consensus 256 L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 256 LVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp SCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred ccCChhhCCCHHHHhcCCCccCCc
Confidence 999999999999999999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=415.55 Aligned_cols=355 Identities=27% Similarity=0.354 Sum_probs=233.7
Q ss_pred ecccccccccccCCCCC--cchhhh---------hccCCcccCCCCCCc-hhhhhHHHHHHhhhhhHHHHHHHHHHhhhh
Q psy16081 17 SHAPLYGRLVAEEPSCP--GDILAM---------QARIPLQFRDPATAP-LRKLSVDLIKTYKHINEVYYAKKKRRAQQS 84 (493)
Q Consensus 17 ~~~~~~~~~~~~~~~~~--~~~~~~---------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~ 84 (493)
....-..|+|||+++|+ .+.+.+ +++|+..+++..... ......|...+.+++|.....+.+++....
T Consensus 23 ~~l~~~~~~iGR~~~~~~~~~~~~~~~~~~~~~vS~~H~~i~~~~~~~~~~~~~i~D~S~nGt~vn~~~~~~~~~~~l~~ 102 (419)
T 3i6u_A 23 LECVNDNYWFGRDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTELVGKGKRRPLNN 102 (419)
T ss_dssp EEECSSEEEEESSTTSSEETTCTTGGGCSGGGGSCTTCEEEECCEETTTEECCEEEECCSSCEEETTEECCTTCEEECCT
T ss_pred eEecCCCEEecCCCccCEEECCcccccccccccccccceEEEEEcCCCCceEEEEEECCcCCceECcccccCCCcccCCC
Confidence 34455679999999999 555544 889999988642211 112222233455555544333322221111
Q ss_pred cCCCCchhhhhhhccCCCCCCCCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc------
Q psy16081 85 QGEDSSHKKEKKLYNEGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF------ 158 (493)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~------ 158 (493)
.............+. +.+............+.++|.+.+.||+|+||+||+|.+..+++.||||++......
T Consensus 103 ~d~i~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~ 180 (419)
T 3i6u_A 103 NSEIALSLSRNKVFV--FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180 (419)
T ss_dssp TEEEEESSTTCEEEE--EEESCSSCGGGSCHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC----
T ss_pred CCEeeeeccccceEE--EeccccccccccchhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccccccc
Confidence 110000000000000 000000000011234568999999999999999999999999999999999753211
Q ss_pred ---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHH
Q psy16081 159 ---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234 (493)
Q Consensus 159 ---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~a 234 (493)
......|+.++..+ +||||+++++++. .+.+|+||||+.+ +|.+++... ..+++..++.++.||+.|
T Consensus 181 ~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~ 251 (419)
T 3i6u_A 181 ADPALNVETEIEILKKL------NHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLA 251 (419)
T ss_dssp ----CCHHHHHHHHHHC------CCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhC------CCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHH
Confidence 11234555555443 5788999999975 4568999999955 898888654 369999999999999999
Q ss_pred HHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEEecccccccCCc--cccccccCcCCchhhhcC---CCCCchhhHHH
Q psy16081 235 LLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLG---IPYDLAIDMWS 308 (493)
Q Consensus 235 L~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS 308 (493)
|.|||+ .||+||||||+|||++.+ .+..+||+|||+++..+.. ....+||+.|+|||++.+ ..|+.++||||
T Consensus 252 l~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diws 329 (419)
T 3i6u_A 252 VQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329 (419)
T ss_dssp HHHHHH--TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHH
T ss_pred HHHHHH--CCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHh
Confidence 999995 689999999999999532 3456999999999877543 346789999999999864 56889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhh
Q psy16081 309 LGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG-LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDI 387 (493)
Q Consensus 309 lGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 387 (493)
|||++|+|++|.+||.+......+...+.... ..+... +..
T Consensus 330 lG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~----------~~~---------------------------- 371 (419)
T 3i6u_A 330 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV----------WAE---------------------------- 371 (419)
T ss_dssp HHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH----------HTT----------------------------
T ss_pred HHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh----------hcc----------------------------
Confidence 99999999999999987543322222222111 000000 000
Q ss_pred ccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 388 LGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.+ ..+.+||.+||.+||++|||++|+|+||||+..
T Consensus 372 -------------------~~--~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 372 -------------------VS--EKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp -------------------SC--HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred -------------------cC--HHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 01 178999999999999999999999999999854
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=392.09 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=211.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|+++++||+|+||+||+|++..+++.||||++++.. ........|..++ ....+||+|++++++|.+.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l-----~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL-----ALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHH-----TCTTCCTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHH-----HhcCCCCEEeeEEEEEEcC
Confidence 568999999999999999999999999999999997432 1112222333322 2233789999999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+.| +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll--~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVML--DSEGHIKIADFGM 167 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE--CTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEE--cCCCcEEEEeCCc
Confidence 999999999955 9999997653 59999999999999999999995 799999999999999 7888999999999
Q ss_pred ccccC---CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQLG---QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
++... ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..|.......|.
T Consensus 168 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----- 242 (353)
T 2i0e_A 168 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----- 242 (353)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-----
T ss_pred ccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC-----
Confidence 97642 3345678999999999999999999999999999999999999999999988888877652111110
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
..+ ..+.+||.+||..||.+||
T Consensus 243 --------------------------------------------------------~~s--~~~~~li~~lL~~dP~~R~ 264 (353)
T 2i0e_A 243 --------------------------------------------------------SMS--KEAVAICKGLMTKHPGKRL 264 (353)
T ss_dssp --------------------------------------------------------TSC--HHHHHHHHHHTCSCTTSCT
T ss_pred --------------------------------------------------------CCC--HHHHHHHHHHhhcCHHHcC
Confidence 001 1789999999999999999
Q ss_pred -----CHHHHhcCCCCCCCcc
Q psy16081 430 -----TPYYALQHNFFKRTAD 445 (493)
Q Consensus 430 -----t~~e~L~Hp~~~~~~~ 445 (493)
+++++++||||+.+..
T Consensus 265 ~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 265 GCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp TCSTTHHHHHHTSGGGTTCCH
T ss_pred CCCCCCHHHHhcCccccCCCH
Confidence 4799999999997653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=380.13 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=210.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
..++|++++.||+|+||+||+|.+..+++.||||++..... .......|..++.. .+||||++++++|...+.
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~------l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------NKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHH------CCCTTBCCEEEEEEETTE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhc------CCCCCCCeEeEEEEECCE
Confidence 35689999999999999999999999999999999864332 22334445544443 357889999999999999
Q ss_pred eEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+. ++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILL--GMDGSVKLTDFGFCA 164 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEE--CCCCCEEEeeCCCce
Confidence 999999995 5999998764 48999999999999999999995 689999999999999 678899999999997
Q ss_pred ccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 275 QLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 275 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 237 (297)
T 3fxz_A 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ------- 237 (297)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-------
T ss_pred ecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-------
Confidence 76432 34568999999999999999999999999999999999999999998887776666543211100
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
.+.. . ...+.+||.+||..||++|||+
T Consensus 238 ----------------------------~~~~-----------------------~--~~~~~~li~~~l~~dp~~Rps~ 264 (297)
T 3fxz_A 238 ----------------------------NPEK-----------------------L--SAIFRDFLNRCLEMDVEKRGSA 264 (297)
T ss_dssp ----------------------------CGGG-----------------------S--CHHHHHHHHHHSCSSTTTSCCH
T ss_pred ----------------------------Cccc-----------------------c--CHHHHHHHHHHccCChhHCcCH
Confidence 0000 0 0168899999999999999999
Q ss_pred HHHhcCCCCCCCc
Q psy16081 432 YYALQHNFFKRTA 444 (493)
Q Consensus 432 ~e~L~Hp~~~~~~ 444 (493)
.|+|+||||+...
T Consensus 265 ~ell~h~~~~~~~ 277 (297)
T 3fxz_A 265 KELLQHQFLKIAK 277 (297)
T ss_dssp HHHTTCGGGGGCC
T ss_pred HHHhhChhhcccC
Confidence 9999999998643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=398.28 Aligned_cols=283 Identities=31% Similarity=0.554 Sum_probs=219.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec----
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR---- 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~---- 193 (493)
..+|++.++||+|+||+||+|++..+++.||||++...... ..+|+.++..+ +|+||++++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~il~~l------~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKL------DHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHHTC------CCTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---HHHHHHHHHHc------CCCCccceeeEEeccCCCC
Confidence 45799999999999999999999999999999998754432 22455555433 578899999998642
Q ss_pred --ceeEEEEEecccCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 194 --NHLCLVFELLSYNLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 194 --~~~~lV~E~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
.++++||||++++|.+.+.. .....+++..++.++.||+.||.|||+ .||+||||||+|||++. +.+.+||+|
T Consensus 124 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~-~~~~~kl~D 200 (420)
T 1j1b_A 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDP-DTAVLKLCD 200 (420)
T ss_dssp TEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEET-TTTEEEECC
T ss_pred cceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeC-CCCeEEecc
Confidence 35789999999988877653 223569999999999999999999995 78999999999999942 456789999
Q ss_pred cccccccC--CccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 270 FGSSCQLG--QRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 270 FG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
||+++... ......+||+.|+|||++.+. .|+.++||||||||||||++|++||.+.+..+++.+|++.++.|....
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99998653 334567899999999999875 799999999999999999999999999999999999999999998776
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
+...... +.. +.+. .. ....+..++.. ....+++|||.+||.+||.
T Consensus 281 ~~~~~~~---~~~-----~~~p--------~~-~~~~~~~~~~~-----------------~~~~~~~~Li~~~L~~dP~ 326 (420)
T 1j1b_A 281 IREMNPN---YTE-----FKFP--------QI-KAHPWTKVFRP-----------------RTPPEAIALCSRLLEYTPT 326 (420)
T ss_dssp HHHHCSC---CCC-----CCCC--------CC-CCCCHHHHSCT-----------------TSCHHHHHHHHHHSCSSGG
T ss_pred HHhhChh---hhh-----hccC--------cc-CCCCHHHhcCC-----------------CCCHHHHHHHHHhccCChh
Confidence 6543210 000 0000 00 00011111100 0012789999999999999
Q ss_pred CCCCHHHHhcCCCCCCCccC
Q psy16081 427 TRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~~~~ 446 (493)
+|||+.|+|+||||+...+.
T Consensus 327 ~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 327 ARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp GSCCHHHHHTSGGGGGGGCT
T ss_pred HCCCHHHHhCCHhhcccccc
Confidence 99999999999999876544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=387.95 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=203.7
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+.++|++++.||+|+||+||+|++..+++.||||++..... .......|..++..+ +|+||+++++++.+.
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML------NHENVVKFYGHRREG 77 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC------CCTTBCCEEEEEECS
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC------CCCCCCeEEEEEecC
Confidence 456899999999999999999999999999999999864332 123344455544433 477899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+..|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll--~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLL--DERDNLKISDFGL 151 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCCEEECCCTT
T ss_pred CeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEE--eCCCCEEEEEeec
Confidence 999999999965 898888654 369999999999999999999994 789999999999999 6788999999999
Q ss_pred ccccCC-----ccccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 273 SCQLGQ-----RIYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 273 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
+..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.................
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 229 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-- 229 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST--
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC--
Confidence 976532 2345689999999999998775 77999999999999999999999876543222111111000000
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
... ..+ ..+.+||.+||..||+
T Consensus 230 ---------------------------------~~~-----------------------~~~--~~~~~li~~~L~~dP~ 251 (323)
T 3tki_A 230 ---------------------------------PWK-----------------------KID--SAPLALLHKILVENPS 251 (323)
T ss_dssp ---------------------------------TGG-----------------------GSC--HHHHHHHHHHSCSSTT
T ss_pred ---------------------------------ccc-----------------------cCC--HHHHHHHHHHccCChh
Confidence 000 000 1678999999999999
Q ss_pred CCCCHHHHhcCCCCCCCccC
Q psy16081 427 TRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~~~~ 446 (493)
+|||+.|+|+||||+.....
T Consensus 252 ~R~t~~eil~h~~~~~~~~~ 271 (323)
T 3tki_A 252 ARITIPDIKKDRWYNKPLKK 271 (323)
T ss_dssp TSCCHHHHTTCTTTTCCCCC
T ss_pred hCcCHHHHhhChhhcccccc
Confidence 99999999999999875443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=391.13 Aligned_cols=265 Identities=28% Similarity=0.401 Sum_probs=213.5
Q ss_pred ceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEE
Q psy16081 109 YIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVR 185 (493)
Q Consensus 109 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~ 185 (493)
+.......+.++|++.+.||+|+||.||+|.+..+++.||||++....... .....|+.++..+ +||||++
T Consensus 19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~ 92 (362)
T 2bdw_A 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL------QHPNIVR 92 (362)
T ss_dssp -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC------CCTTBCC
T ss_pred EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC------CCCCCCe
Confidence 344455567789999999999999999999999999999999997543222 2333444444333 4788999
Q ss_pred eceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCC
Q psy16081 186 LKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRS 263 (493)
Q Consensus 186 l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~ 263 (493)
+++++.+.+..|+||||+.+ +|.+.+.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.+ ..+
T Consensus 93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~ 168 (362)
T 2bdw_A 93 LHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGA 168 (362)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTC
T ss_pred EEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCC
Confidence 99999999999999999965 9999987653 58999999999999999999995 689999999999999533 235
Q ss_pred cEEEEecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 264 AIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 264 ~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 169 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 248 (362)
T 2bdw_A 169 AVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 248 (362)
T ss_dssp CEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 6999999999876543 34568999999999999999999999999999999999999999998888877777653222
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
.+...+. . .. ..+.+||.+||
T Consensus 249 ~~~~~~~----------~-----------------------------------------------~~--~~~~~li~~~L 269 (362)
T 2bdw_A 249 YPSPEWD----------T-----------------------------------------------VT--PEAKSLIDSML 269 (362)
T ss_dssp CCTTGGG----------G-----------------------------------------------SC--HHHHHHHHHHS
T ss_pred CCccccc----------C-----------------------------------------------CC--HHHHHHHHHHc
Confidence 1111000 0 00 17899999999
Q ss_pred CCCCCCCCCHHHHhcCCCCCC
Q psy16081 422 DYDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~Hp~~~~ 442 (493)
..||++|||+.|+|+||||..
T Consensus 270 ~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 270 TVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CSSGGGSCCHHHHTTSHHHHT
T ss_pred CCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=382.49 Aligned_cols=260 Identities=25% Similarity=0.299 Sum_probs=203.3
Q ss_pred eeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 111 IQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 111 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
...++.+.++|+++++||+|+||+||+|.+..+++.||||++.......... +..+.+.........|+||++++++|
T Consensus 49 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR--ARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp TSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH--HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH--HHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 3445566789999999999999999999999999999999986543222222 22222222223334688899999999
Q ss_pred eecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 191 MWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 191 ~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
.+.+.+||||||++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+||
T Consensus 127 ~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll--~~~~~~kl~DF 201 (311)
T 3p1a_A 127 EEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFL--GPRGRCKLGDF 201 (311)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CGGGCEEECCC
T ss_pred EeCCEEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEE--CCCCCEEEccc
Confidence 9999999999999999999887654 469999999999999999999995 689999999999999 67889999999
Q ss_pred ccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 271 GSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 271 G~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
|++...... .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+. +.. +..+..+
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~~~~-- 273 (311)
T 3p1a_A 202 GLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLPPEF-- 273 (311)
T ss_dssp TTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCCHHH--
T ss_pred eeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCCccc--
Confidence 999776543 334568999999999987 799999999999999999999877765432221 111 1111110
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
... . ...+.+||.+||..||++|
T Consensus 274 --------~~~-----------------------------------------------~--~~~l~~li~~~L~~dP~~R 296 (311)
T 3p1a_A 274 --------TAG-----------------------------------------------L--SSELRSVLVMMLEPDPKLR 296 (311)
T ss_dssp --------HTT-----------------------------------------------S--CHHHHHHHHHHSCSSTTTS
T ss_pred --------ccC-----------------------------------------------C--CHHHHHHHHHHcCCChhhC
Confidence 000 0 0178999999999999999
Q ss_pred CCHHHHhcCCCCCC
Q psy16081 429 ITPYYALQHNFFKR 442 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~ 442 (493)
||+.|+|+||||++
T Consensus 297 pt~~ell~hp~~~~ 310 (311)
T 3p1a_A 297 ATAEALLALPVLRQ 310 (311)
T ss_dssp CCHHHHHTSGGGSC
T ss_pred cCHHHHHhCccccC
Confidence 99999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=393.45 Aligned_cols=294 Identities=31% Similarity=0.490 Sum_probs=215.2
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++++.||+|+||+||+|++..+++.||||++....... .....|+.++. . .+||||+++++++..
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---~---l~hpniv~~~~~~~~ 95 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK---C---VNHKNIIGLLNVFTP 95 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHH---H---CCCTTBCCEEEEECS
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHH---h---cCCCCccceEEeecc
Confidence 45689999999999999999999999999999999997533222 22233433333 2 357889999999976
Q ss_pred cc------eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 RN------HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~~------~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.+ .+|+||||++++|.+.+.. .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~--~~~~~~k 167 (371)
T 2xrw_A 96 QKSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVV--KSDCTLK 167 (371)
T ss_dssp CCSTTTCCEEEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTSCEE
T ss_pred ccccccccceEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEE--cCCCCEE
Confidence 65 7899999999999998853 48999999999999999999995 789999999999999 6788999
Q ss_pred EEecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 267 IVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 267 L~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..+.+.++.+..
T Consensus 168 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 168 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp ECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred EEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999999876543 34568999999999999999999999999999999999999999999999999999999998887
Q ss_pred hhhhhccch-hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 345 HLLDGAHKT-RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 345 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
.++...... ..++...+... ...+..++.... .|. ...........+++||.+||.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~li~~mL~~ 305 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYA----------------GYSFEKLFPDVL-FPA-----DSEHNKLKASQARDLLSKMLVI 305 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCC----------------CCCHHHHSCGGG-SCC-----SSHHHHHHHHHHHHHHHHHSCS
T ss_pred HHHHHhhhHHHHHHhhCcccc----------------ccchhhhccccc-Ccc-----cccccccccHHHHHHHHHHCcC
Confidence 776554322 22222211100 000111000000 000 0000001123689999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q psy16081 424 DPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
||.+|||++|+|+||||+.+.+
T Consensus 306 dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 306 DASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp SGGGSCCHHHHHHSHHHHTTCC
T ss_pred ChhhCCCHHHHhCCcchhhhcC
Confidence 9999999999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=387.28 Aligned_cols=283 Identities=28% Similarity=0.509 Sum_probs=222.1
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|.+.+.||+|+||+||+|.+..+|+.||||++....... .....|..++.. . +||||++++++|..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~---l---~h~niv~~~~~~~~ 112 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH---M---QHENVIGLLDVFTP 112 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHH---C---CCTTBCCCSEEECS
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHh---c---CCCCchhhhhheec
Confidence 46689999999999999999999999999999999997543221 223334433333 2 47789999999987
Q ss_pred ccee------EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 RNHL------CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~~~~------~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.+.. |+||||++++|.+.+.. .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 113 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll--~~~~~~k 184 (371)
T 4exu_A 113 ASSLRNFYDFYLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAV--NEDCELK 184 (371)
T ss_dssp CSSSTTCCCCEEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTCCEE
T ss_pred cCCcccceeEEEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEE--CCCCCEE
Confidence 7655 99999999999888743 48999999999999999999995 689999999999999 6788999
Q ss_pred EEecccccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 267 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 267 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++..
T Consensus 185 L~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 185 ILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp ECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred EEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 9999999988777778899999999999987 679999999999999999999999999999999999999999999888
Q ss_pred hhhhccch--hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 346 LLDGAHKT--RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 346 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
++...... ..++..++... ...+..+.. . ....+.+||.+||.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~----------------~--~~~~~~~li~~~L~~ 310 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTP----------------RKDFTQLFP----------------R--ASPQAADLLEKMLEL 310 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCC----------------CCCHHHHST----------------T--SCHHHHHHHHHHSCS
T ss_pred HHHHhhhhhhhhhhhccCCCc----------------chhHHHhcc----------------c--cChHHHHHHHHHCCC
Confidence 77654321 22222221100 000111100 0 112789999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccC
Q psy16081 424 DPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
||.+|||+.|+|+||||+.....
T Consensus 311 dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 311 DVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp CTTTSCCHHHHHTSGGGTTTCCG
T ss_pred ChhhcCCHHHHhcCcccccCCCc
Confidence 99999999999999999976543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=388.87 Aligned_cols=282 Identities=30% Similarity=0.513 Sum_probs=218.2
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc------cchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
..++|++++.||+|+||+||+|.+..+|+.||||++..... .......|+.++..+ +|+||++++++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~ 81 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL------SHPNIIGLLDAF 81 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC------CCCCCCeEEEEE
Confidence 35689999999999999999999999999999999874321 122344555555443 478899999999
Q ss_pred eecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 191 MWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 191 ~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
.+.+.+|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 82 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~--~~~~~~kl~Df 156 (346)
T 1ua2_A 82 GHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLL--DENGVLKLADF 156 (346)
T ss_dssp CCTTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTCCEEECCC
T ss_pred eeCCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEE--cCCCCEEEEec
Confidence 9999999999999999999887644 468999999999999999999995 789999999999999 67889999999
Q ss_pred ccccccCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 271 GSSCQLGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 271 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
|++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++.+..+.++...
T Consensus 157 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp GGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 999876432 3456789999999999764 589999999999999999999999999999999999999988887665
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
+........+.... ..+ ...+..+.. ... ..+.+||.+||..||+
T Consensus 237 ~~~~~~~~~~~~~~----------------~~~-~~~~~~~~~----------------~~~--~~~~~li~~~L~~dP~ 281 (346)
T 1ua2_A 237 WPDMCSLPDYVTFK----------------SFP-GIPLHHIFS----------------AAG--DDLLDLIQGLFLFNPC 281 (346)
T ss_dssp SSSTTSSTTCCCCC----------------CCC-CCCHHHHCT----------------TCC--HHHHHHHHHHHCSSTT
T ss_pred hhhhccCccccccc----------------ccC-CCChHHhhc----------------cCC--HHHHHHHHHHhccChh
Confidence 54332221111000 000 000111100 011 2789999999999999
Q ss_pred CCCCHHHHhcCCCCCCCc
Q psy16081 427 TRITPYYALQHNFFKRTA 444 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~~ 444 (493)
+|||+.|+|+||||+...
T Consensus 282 ~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 282 ARITATQALKMKYFSNRP 299 (346)
T ss_dssp TSCCHHHHHTSGGGTSSS
T ss_pred hCCCHHHHhcChhhhcCC
Confidence 999999999999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=392.91 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=212.7
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
..++|+++++||+|+||+||+|++..+++.||||++++.. ........|..++..+ +||||++++++|.+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQLFYAFQD 140 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC------CCTTBCCEEEEEEC
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEE
Confidence 4568999999999999999999999999999999996421 1223345566555433 57889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+++|||||||. |+|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl--~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLL--DKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeE--CCCCCEEEeccc
Confidence 999999999995 5999988754 58999999999999999999995 789999999999999 788999999999
Q ss_pred cccccCCc----cccccccCcCCchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 272 SSCQLGQR----IYQYIQSRFYRSPEVLLGIP----YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 272 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
+|+..... ....+||+.|+|||++.+.. |+.++|||||||+||||++|.+||.+.+..+.+.+|+.......
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence 99876543 34678999999999998765 88999999999999999999999999999888888875311000
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
.|.. ...+ ..+++||.+||..
T Consensus 294 ----------------------------------~p~~-----------------------~~~s--~~~~~li~~lL~~ 314 (410)
T 3v8s_A 294 ----------------------------------FPDD-----------------------NDIS--KEAKNLICAFLTD 314 (410)
T ss_dssp ----------------------------------CCTT-----------------------CCCC--HHHHHHHHHHSSC
T ss_pred ----------------------------------CCCc-----------------------cccc--HHHHHHHHHHccC
Confidence 0000 0011 1789999999999
Q ss_pred CCCC--CCCHHHHhcCCCCCCCcc
Q psy16081 424 DPKT--RITPYYALQHNFFKRTAD 445 (493)
Q Consensus 424 dP~~--R~t~~e~L~Hp~~~~~~~ 445 (493)
+|.+ |++++||++||||+....
T Consensus 315 ~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 315 REVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp GGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred hhhhCCCCCHHHHhcCccccCCCH
Confidence 9988 999999999999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=398.43 Aligned_cols=293 Identities=27% Similarity=0.473 Sum_probs=210.7
Q ss_pred eecCcEEE-eeeEeeeCCeEEEEEEEc--CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEI-DSLIGKGSFGQVVKAFDL--EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~-~~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.+.|++ .++||+|+||+||+|.+. .+++.||||++.... ......+|+.++..+ +||||++++++|..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l------~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLREL------KHPNVISLQKVFLS 89 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHC------CCTTBCCCCEEEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhc------CCCCeeeEeeEEec
Confidence 45567887 458999999999999965 578999999997443 334566677766655 37789999999954
Q ss_pred --cceeEEEEEecccCHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC--CC
Q psy16081 193 --RNHLCLVFELLSYNLYDLLRNTN-------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN--PK 261 (493)
Q Consensus 193 --~~~~~lV~E~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~--~~ 261 (493)
...+||||||++++|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||+.. +.
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 90 HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTT
T ss_pred CCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCC
Confidence 67899999999999998886321 1248999999999999999999995 78999999999999943 35
Q ss_pred CCcEEEEecccccccCC------ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Q psy16081 262 RSAIKIVDFGSSCQLGQ------RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNE------ 328 (493)
Q Consensus 262 ~~~ikL~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~------ 328 (493)
++.+||+|||+++.... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+.
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 67899999999987643 23456889999999999885 599999999999999999999999987665
Q ss_pred ---HHHHHHHHHHhCCCChhhhhhccchhhhhc---cCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCC
Q psy16081 329 ---VDQMNKIVEVLGLPPKHLLDGAHKTRKYFD---KMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGE 402 (493)
Q Consensus 329 ---~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 402 (493)
.+++..|.+.++.|+...+........+.. ......+ .. ..+...+...
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~-~~~~~~~~~~----------- 302 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY-------------TN-CSLIKYMEKH----------- 302 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGG-------------TT-CCHHHHHHTT-----------
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCC-------------Cc-chhhhhHhhc-----------
Confidence 488999999999998776655433222111 1100000 00 0001111000
Q ss_pred CCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 403 PGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 403 ~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.......+++||.+||.+||.+|||++|||+||||+....
T Consensus 303 ---~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 303 ---KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp ---TCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 0001127899999999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=390.75 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=212.6
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.++|++++.||+|+||+||+|.+..+++.||+|++..... .. ...+.+++..+...+||||++++++|.+.+.
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hh---HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 456789999999999999999999999999999999975321 11 1122233333344568899999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.+..+.+||+|||++.
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEecccce
Confidence 9999999955 9999987543 369999999999999999999995 78999999999999964466789999999998
Q ss_pred ccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 275 QLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 275 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
..... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 273 (387)
T 1kob_A 200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA------ 273 (387)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST------
T ss_pred ecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc------
Confidence 76543 3456899999999999999999999999999999999999999999888877776654211110000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
+ ...+ ..+.+||.+||..||++|||+.
T Consensus 274 ----~-----------------------------------------------~~~s--~~~~~li~~~L~~dP~~Rpt~~ 300 (387)
T 1kob_A 274 ----F-----------------------------------------------SSVS--PEAKDFIKNLLQKEPRKRLTVH 300 (387)
T ss_dssp ----T-----------------------------------------------TTSC--HHHHHHHHTTSCSSGGGSCCHH
T ss_pred ----c-----------------------------------------------ccCC--HHHHHHHHHHcCCChhHCcCHH
Confidence 0 0011 1789999999999999999999
Q ss_pred HHhcCCCCCCCc
Q psy16081 433 YALQHNFFKRTA 444 (493)
Q Consensus 433 e~L~Hp~~~~~~ 444 (493)
|+|+||||+...
T Consensus 301 ell~hp~~~~~~ 312 (387)
T 1kob_A 301 DALEHPWLKGDH 312 (387)
T ss_dssp HHHTSTTTSSCC
T ss_pred HHhhCccccCCc
Confidence 999999998643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=385.48 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=204.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++++.||+|+||+||+|++..+++.||||++++.... ......|..++..+ .+||||++++++|.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~-----~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-----SNHPFLVGLHSCFQTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHT-----TTCTTBCCEEEEEECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhc-----CCCCccCeEEEEEEeC
Confidence 46899999999999999999999999999999999754321 12233444444332 3688899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll--~~~g~~kL~DFG~ 156 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGM 156 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE--CTTSCEEECCGGG
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEE--CCCCCEEEEeccc
Confidence 999999999955 9999987653 69999999999999999999995 789999999999999 7788999999999
Q ss_pred cccc---CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHHHhC
Q psy16081 273 SCQL---GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN---------EVDQMNKIVEVLG 340 (493)
Q Consensus 273 a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---------~~~~~~~i~~~~~ 340 (493)
++.. .......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.... .......+.....
T Consensus 157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 236 (345)
T 3a8x_A 157 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236 (345)
T ss_dssp CBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC
T ss_pred cccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC
Confidence 9764 234456789999999999999999999999999999999999999997521 1122222221100
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
. .| . ..+ ..+.+||.+|
T Consensus 237 ~------------------------------------~p--~-----------------------~~s--~~~~~li~~l 253 (345)
T 3a8x_A 237 R------------------------------------IP--R-----------------------SLS--VKAASVLKSF 253 (345)
T ss_dssp C------------------------------------CC--T-----------------------TSC--HHHHHHHHHH
T ss_pred C------------------------------------CC--C-----------------------CCC--HHHHHHHHHH
Confidence 0 00 0 001 1689999999
Q ss_pred cCCCCCCCCCH------HHHhcCCCCCCCcc
Q psy16081 421 LDYDPKTRITP------YYALQHNFFKRTAD 445 (493)
Q Consensus 421 L~~dP~~R~t~------~e~L~Hp~~~~~~~ 445 (493)
|..||.+||++ .|+++||||+.+..
T Consensus 254 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 254 LNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp TCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred hcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 99999999995 89999999997653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=374.43 Aligned_cols=286 Identities=31% Similarity=0.458 Sum_probs=212.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.++|++++.||+|+||+||+|.+..+++.||||++....... .....|..++.. . +|+||+++++++...+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~---l---~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ---L---KHPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHH---C---CCTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHh---C---CCCCccchhheeecCC
Confidence 578999999999999999999999999999999986543222 222334443333 3 4788999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILI--TKHSVIKLCDFGFA 149 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCTTC
T ss_pred eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEE--cCCCCEEEeeCCCc
Confidence 99999999987 555555443 469999999999999999999995 789999999999999 67889999999999
Q ss_pred cccCCc---cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 274 CQLGQR---IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 274 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.........
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 150 RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp EECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 776532 345678999999999986 5689999999999999999999999999999999999999888776554433
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
... ..++..... . .......+.... ...+ ..+.+||.+||..||.+||
T Consensus 230 ~~~-~~~~~~~~~-----~--------~~~~~~~~~~~~----------------~~~~--~~~~~li~~~L~~dP~~Rp 277 (311)
T 4agu_A 230 FST-NQYFSGVKI-----P--------DPEDMEPLELKF----------------PNIS--YPALGLLKGCLHMDPTERL 277 (311)
T ss_dssp HHT-CGGGTTCCC-----C--------CCSSCCCHHHHC----------------TTCC--HHHHHHHHHHCCSSTTTSC
T ss_pred ccc-ccccccCcC-----C--------Cccccchhhhhc----------------cccc--HHHHHHHHHHccCChhhcC
Confidence 221 112211100 0 000000000000 0011 2689999999999999999
Q ss_pred CHHHHhcCCCCCCCccCC
Q psy16081 430 TPYYALQHNFFKRTADES 447 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~~~~ 447 (493)
|++|+|+||||+...+..
T Consensus 278 t~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 278 TCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CHHHHHTSGGGTTCC---
T ss_pred CHHHHhcChHHHhccCHH
Confidence 999999999999875543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=385.54 Aligned_cols=285 Identities=29% Similarity=0.454 Sum_probs=223.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW- 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~- 192 (493)
..++|++++.||+|+||+||+|++..+++.||||++..... .......|+.++..+ +|+||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL------KHENVVNLIEICRTK 88 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC------CCTTBCCEEEEEEEC
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc------cCCCcccHhheeecc
Confidence 35789999999999999999999999999999999864332 233455566665544 37779999999887
Q ss_pred -------cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 193 -------RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 193 -------~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
.+.+|+||||++++|.+.+.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~--~~~~~~ 163 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLI--TRDGVL 163 (351)
T ss_dssp --------CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCE
T ss_pred ccccccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEE--cCCCCE
Confidence 45789999999999999887654 469999999999999999999995 789999999999999 678899
Q ss_pred EEEecccccccCC-------ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q psy16081 266 KIVDFGSSCQLGQ-------RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337 (493)
Q Consensus 266 kL~DFG~a~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 337 (493)
||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999976531 2345678999999999987 4589999999999999999999999999999999999999
Q ss_pred HhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHH
Q psy16081 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417 (493)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi 417 (493)
..+.++...+........ +..... .......+.+.+... .....+.+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~-~~~~~~--------------~~~~~~~~~~~~~~~----------------~~~~~~~~li 292 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYEL-YEKLEL--------------VKGQKRKVKDRLKAY----------------VRDPYALDLI 292 (351)
T ss_dssp HHCCCCTTTSTTGGGCGG-GTSSCC--------------CSSCCCCHHHHHHHH----------------HCCHHHHHHH
T ss_pred HhCCCChhhccccccchh-hccccc--------------ccccccCHHHHhhhc----------------cCChHHHHHH
Confidence 999887776654433221 111100 000001111111000 0012688999
Q ss_pred hHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 418 FRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 418 ~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.+||.+||++|||++|+|+||||+..
T Consensus 293 ~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 293 DKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred HHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 99999999999999999999999854
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=390.46 Aligned_cols=257 Identities=27% Similarity=0.393 Sum_probs=209.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHh-hcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMN-KADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~-~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.++|+++++||+|+||+||+|++..+++.||||++++.... ....+..++.+.. .....+||||++++++|.+.+.+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 56899999999999999999999999999999999754321 1111222222222 24567899999999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+.| +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++.
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll--~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILL--DSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTSCEEECCCCBCGG
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEE--CCCCCEEEeeCccccc
Confidence 999999965 9999987653 68999999999999999999995 789999999999999 7889999999999976
Q ss_pred cC---CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LG---QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..|.......+.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 260 (373)
T 2r5t_A 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP-------- 260 (373)
T ss_dssp GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS--------
T ss_pred cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC--------
Confidence 42 2345678999999999999999999999999999999999999999999888888877652110000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH-
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP- 431 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~- 431 (493)
..+ ..+.+||.+||..||.+||++
T Consensus 261 -----------------------------------------------------~~~--~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 261 -----------------------------------------------------NIT--NSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp -----------------------------------------------------SSC--HHHHHHHHHHTCSSGGGSTTTT
T ss_pred -----------------------------------------------------CCC--HHHHHHHHHHcccCHHhCCCCC
Confidence 000 168999999999999999997
Q ss_pred ---HHHhcCCCCCCCcc
Q psy16081 432 ---YYALQHNFFKRTAD 445 (493)
Q Consensus 432 ---~e~L~Hp~~~~~~~ 445 (493)
.++++||||+.+..
T Consensus 286 ~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 286 DDFMEIKSHVFFSLINW 302 (373)
T ss_dssp TTHHHHHTSGGGTTCCH
T ss_pred CCHHHHhCCccccCCCH
Confidence 69999999997653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=378.84 Aligned_cols=287 Identities=31% Similarity=0.516 Sum_probs=228.8
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEc-CCCeEEEEEEEccCc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDL-EEQCHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vAvK~~~~~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
.+.++|++++.||+|+||+||+|.+. .+++.||||+++... ........|..++..+... .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~~i~~~~~~~~ 84 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCT 84 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhcc---CCCCeEeeeeeee
Confidence 34578999999999999999999985 678999999986432 2233556777777776554 4778999999987
Q ss_pred -----ecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 192 -----WRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 192 -----~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
....+++||||++++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili--~~~~~~k 160 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILV--TSSGQIK 160 (326)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTCCEE
T ss_pred ecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEE--cCCCCEE
Confidence 5678999999999999999987665569999999999999999999995 789999999999999 6788999
Q ss_pred EEecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 267 IVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 267 L~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.++.
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred EecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 9999999776533 34567899999999999999999999999999999999999999999999999999999888766
Q ss_pred hhhhhccchh-hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 345 HLLDGAHKTR-KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 345 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
..+....... ..|... ....+..+. .... ..+.+||.+||..
T Consensus 241 ~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~----------------~~~~--~~~~~li~~~L~~ 283 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSK-------------------SAQPIEKFV----------------TDID--ELGKDLLLKCLTF 283 (326)
T ss_dssp GGSCTTCSSCGGGSCCC-------------------CCCCGGGTC----------------CSCC--HHHHHHHHHHSCS
T ss_pred ccCccccccchhhhccc-------------------Ccchhhhcc----------------ccCC--HHHHHHHHHHcCC
Confidence 5443221100 000000 000000000 0111 2788999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccC
Q psy16081 424 DPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
||.+|||+.|+|+||||+.....
T Consensus 284 dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 284 NPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp STTTSCCHHHHHTSGGGTTCCCC
T ss_pred CcccCCCHHHHhcCccccccchh
Confidence 99999999999999999976544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=389.56 Aligned_cols=284 Identities=31% Similarity=0.590 Sum_probs=220.0
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee---
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW--- 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~--- 192 (493)
...++|++++.||+|+||+||+|.+..+|+.||||++....... .+|..++. ..+|+||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~---~~E~~il~------~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMK------VLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC---CHHHHHHT------TCCCTTBCCEEEEEEEC--
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH---HHHHHHHH------HcCCCCccchhheeeecCc
Confidence 34578999999999999999999999999999999987544322 24554443 3358889999999844
Q ss_pred -----------------------------------cceeEEEEEecccCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHH
Q psy16081 193 -----------------------------------RNHLCLVFELLSYNLYDLLRN--TNFRGVSLNLTRKFSQQLCTAL 235 (493)
Q Consensus 193 -----------------------------------~~~~~lV~E~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL 235 (493)
..++++||||++++|.+.+.. .....+++..++.++.||+.||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 345899999999998887753 2335699999999999999999
Q ss_pred HHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC--CccccccccCcCCchhhhcCCC-CCchhhHHHHHHH
Q psy16081 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCI 312 (493)
Q Consensus 236 ~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvi 312 (493)
.|||+ .||+||||||+|||++ ..++.+||+|||++.... ......+||+.|+|||++.+.. ++.++|||||||+
T Consensus 155 ~~LH~--~gi~H~Dikp~Nil~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 155 GFIHS--LGICHRDIKPQNLLVN-SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHT--TTEECSCCCGGGEEEE-TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHH--CcCccCccCHHHEEEc-CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99994 7999999999999994 257889999999998663 3445678899999999998754 9999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccC
Q psy16081 313 LVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVES 392 (493)
Q Consensus 313 l~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 392 (493)
+|+|++|.+||.+.+..+++..+++.++.|+...+...... +.... + .......+...+..
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~---~~~~~---~-----------~~~~~~~~~~~~~~-- 292 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH---YTEVR---F-----------PTLKAKDWRKILPE-- 292 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT---C--CC---C-----------CCCCCCCHHHHSCT--
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcc---ccccc---C-----------CccCcccHHhhCCC--
Confidence 99999999999999999999999999999987765543211 00000 0 00000111111100
Q ss_pred CCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 393 GGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.. ...+.+||.+||.+||.+|||+.|+|+||||+.+..
T Consensus 293 -------------~~--~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 293 -------------GT--PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp -------------TC--CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred -------------CC--CHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 00 126899999999999999999999999999987643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=395.38 Aligned_cols=263 Identities=26% Similarity=0.335 Sum_probs=214.1
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
...++|+++++||+|+||+||+|++..+++.||||++++.. ........|..++.. .+||||++++++|.
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~------~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN------GDSKWITTLHYAFQ 144 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHH------SCTTTBCCEEEEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHh------CCCCCEEEEEEEEe
Confidence 44678999999999999999999999999999999996421 112234555555543 25788999999999
Q ss_pred ecceeEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
+.+.+||||||| +|+|.+++.... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl--~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILM--DMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeE--cCCCCEEEcch
Confidence 999999999999 559999997643 469999999999999999999994 789999999999999 78899999999
Q ss_pred ccccccCCc----cccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 271 GSSCQLGQR----IYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 271 G~a~~~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
|+|+..... ....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+..+.+.+|+.....
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 999766432 23468999999999997 557999999999999999999999999999998888888653110
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
.+ .+. . ....+ ..++|||++||
T Consensus 300 ~~----------------~p~------------------~----------------------~~~~s--~~~~dLi~~lL 321 (437)
T 4aw2_A 300 FQ----------------FPT------------------Q----------------------VTDVS--ENAKDLIRRLI 321 (437)
T ss_dssp CC----------------CCS------------------S----------------------CCCSC--HHHHHHHHTTS
T ss_pred cc----------------CCc------------------c----------------------cccCC--HHHHHHHHHHh
Confidence 00 000 0 00011 17899999999
Q ss_pred CCCCCC--CCCHHHHhcCCCCCCCccCC
Q psy16081 422 DYDPKT--RITPYYALQHNFFKRTADES 447 (493)
Q Consensus 422 ~~dP~~--R~t~~e~L~Hp~~~~~~~~~ 447 (493)
..+|++ |++++|+++||||+.+....
T Consensus 322 ~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 322 CSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp SCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred cccccccCCCCHHHHhCCCccCCCCHHH
Confidence 999988 99999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=390.07 Aligned_cols=288 Identities=32% Similarity=0.565 Sum_probs=222.1
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
++....+|++.++||+|+||+||+|++..+++ ||+|++....... .+|..++..+ +|+||++++++|...
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~---~~E~~il~~l------~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK---NRELQIMRIV------KHPNVVDLKAFFYSN 104 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC---CHHHHHHHTC------CCTTBCCEEEEEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH---HHHHHHHHhC------CCCCcceEEEEEEec
Confidence 44566789999999999999999999877766 8888776443322 2455554433 478899999999654
Q ss_pred c------eeEEEEEecccCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 194 N------HLCLVFELLSYNLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 194 ~------~~~lV~E~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
+ ++|+||||+++++.+.+.. .....+++..++.++.||+.||.|||+ .||+||||||+|||++ ..++.+
T Consensus 105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~-~~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLD-PPSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEE-TTTTEE
T ss_pred CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEc-CCCCcE
Confidence 4 3899999999987776542 223469999999999999999999995 7899999999999994 268899
Q ss_pred EEEecccccccC--CccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 266 KIVDFGSSCQLG--QRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 266 kL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
||+|||+++... ......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+++..|++.++.|
T Consensus 182 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp EECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999997763 344567899999999999875 59999999999999999999999999999999999999999999
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
+...+..... .|... .+ .......+...+.. .. ..++.+||.+||.
T Consensus 262 ~~~~~~~~~~--~~~~~----~~-----------~~~~~~~~~~~~~~---------------~~--~~~~~~li~~~L~ 307 (394)
T 4e7w_A 262 SREQIKTMNP--NYMEH----KF-----------PQIRPHPFSKVFRP---------------RT--PPDAIDLISRLLE 307 (394)
T ss_dssp CHHHHHHHCG--GGSSS----CC-----------CCCCCCCHHHHSCT---------------TC--CHHHHHHHHHHCC
T ss_pred CHHHHHhhCh--hhhhh----cc-----------ccccCCcHHHhccc---------------cC--CHHHHHHHHHHhC
Confidence 8877654321 11110 00 00000111111100 01 1278999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCccCCC
Q psy16081 423 YDPKTRITPYYALQHNFFKRTADEST 448 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~~~~~~ 448 (493)
+||.+|||+.|+|+||||+.+.....
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 308 YTPSARLTAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp SSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred CChhhCCCHHHHhcChhhhhhccccc
Confidence 99999999999999999998765443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=388.67 Aligned_cols=261 Identities=28% Similarity=0.357 Sum_probs=207.8
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
..+.++|++.+.||+|+||+||+|.+..+++.||||++...... ...|+.++..+ .+||||++++++|.+.+
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~-----~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRY-----GQHPNIITLKDVYDDGK 89 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHH-----TTSTTBCCEEEEEECSS
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHh-----cCCCCcCeEEEEEEcCC
Confidence 35678999999999999999999999999999999999755422 23455554433 25788999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC--CcEEEEecc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR--SAIKIVDFG 271 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~--~~ikL~DFG 271 (493)
.+|+|||||.+ +|.+.+.... .+++..++.++.||+.||.|||+ .||+||||||+|||+.++.. +.+||+|||
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 99999999954 9999987653 59999999999999999999995 68999999999999853222 359999999
Q ss_pred cccccCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCChh
Q psy16081 272 SSCQLGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS---NEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 272 ~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~---~~~~~~~~i~~~~~~~p~~ 345 (493)
++..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+. +..+.+..+.......+..
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 9986643 234678999999999999888999999999999999999999999863 3444444443311100000
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
.+...++ .+++||.+||..||
T Consensus 246 ---------------------------------------------------------~~~~~s~--~~~~li~~~L~~dP 266 (342)
T 2qr7_A 246 ---------------------------------------------------------YWNSVSD--TAKDLVSKMLHVDP 266 (342)
T ss_dssp ---------------------------------------------------------TTTTSCH--HHHHHHHHHTCSST
T ss_pred ---------------------------------------------------------ccccCCH--HHHHHHHHHCCCCh
Confidence 0001111 78999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCccC
Q psy16081 426 KTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
++|||+.|+|+||||..+...
T Consensus 267 ~~R~t~~~il~hp~~~~~~~~ 287 (342)
T 2qr7_A 267 HQRLTAALVLRHPWIVHWDQL 287 (342)
T ss_dssp TTSCCHHHHTTSHHHHTGGGS
T ss_pred hHCcCHHHHhcCCeecCcccc
Confidence 999999999999999775443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=384.57 Aligned_cols=281 Identities=31% Similarity=0.543 Sum_probs=223.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR-- 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~-- 193 (493)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......|+.++..+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF------RHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC------CCTTBCCCCEEECCSST
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc------CCCCCccceeEEecCCc
Confidence 4689999999999999999999999999999999974321 113334454444433 478899999998755
Q ss_pred ---ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 194 ---NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 194 ---~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
..+|+||||++++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 100 ~~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~--~~~~~~kl~Df 172 (364)
T 3qyz_A 100 EQMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLL--NTTCDLKICDF 172 (364)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTCCEEECCC
T ss_pred cccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEE--CCCCCEEEEeC
Confidence 468999999999999998764 49999999999999999999995 789999999999999 67889999999
Q ss_pred ccccccCCc------cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 271 GSSCQLGQR------IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 271 G~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
|++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|+
T Consensus 173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252 (364)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999776432 2345899999999997654 589999999999999999999999999999999999999999998
Q ss_pred hhhhhhccch--hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 344 KHLLDGAHKT--RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 344 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
...+...... ..+....+.. ....+..+.. ..+ ..+.+||.+||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~----------------~~~--~~~~~li~~~L 298 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHK----------------NKVPWNRLFP----------------NAD--SKALDLLDKML 298 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCC----------------CCCCHHHHCT----------------TSC--HHHHHHHHHHT
T ss_pred HHHHHHhhhhhHHHHHHhcCCc----------------cCCCHHHhCC----------------CCC--HHHHHHHHHHc
Confidence 8777654322 2222222110 0000111100 011 27899999999
Q ss_pred CCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 422 DYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.+||.+|||+.|+|+||||+....
T Consensus 299 ~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 299 TFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp CSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred CCChhhCCCHHHHhcCcchhhccC
Confidence 999999999999999999998644
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=393.23 Aligned_cols=254 Identities=29% Similarity=0.422 Sum_probs=204.1
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
....++|.+.+.||+|+||+||+|.+..+++.||||++.... .......+|+.++ ...+||||+++++++
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l------~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL------KLLRHPHIIKLYDVI 78 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHH------TTCCCTTBCCEEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHH------HhCCCCCCCeEEEEE
Confidence 345689999999999999999999999999999999986421 1122344444433 344688899999999
Q ss_pred eecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 191 MWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 191 ~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
...+.+|+||||++|+|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 79 ~~~~~~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll--~~~~~~kl~DF 152 (336)
T 3h4j_B 79 TTPTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLL--DDNLNVKIADF 152 (336)
T ss_dssp ECSSEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEE--CTTCCEEECCS
T ss_pred EeCCEEEEEEECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEE--cCCCCEEEEEe
Confidence 9999999999999889999987653 69999999999999999999995 689999999999999 67889999999
Q ss_pred ccccccCC--ccccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 271 GSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 271 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
|++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+....+
T Consensus 153 G~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------- 215 (336)
T 3h4j_B 153 GLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------------- 215 (336)
T ss_dssp SCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------------
T ss_pred ccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------------
Confidence 99976643 3456789999999999998876 789999999999999999999997543211
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
.+..+..+.+. .| ...+ ..+.+||++||..||.+
T Consensus 216 --------~~~~i~~~~~~-----------~p-------------------------~~~s--~~~~~li~~~L~~dP~~ 249 (336)
T 3h4j_B 216 --------LFKKVNSCVYV-----------MP-------------------------DFLS--PGAQSLIRRMIVADPMQ 249 (336)
T ss_dssp --------CBCCCCSSCCC-----------CC-------------------------TTSC--HHHHHHHHTTSCSSGGG
T ss_pred --------HHHHHHcCCCC-----------Cc-------------------------ccCC--HHHHHHHHHHcCCChhH
Confidence 11111111100 00 0011 17899999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy16081 428 RITPYYALQHNFFKRT 443 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~ 443 (493)
|||++|+++||||+..
T Consensus 250 Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 250 RITIQEIRRDPWFNVN 265 (336)
T ss_dssp SCCHHHHTTCHHHHTT
T ss_pred CcCHHHHHhChhhccC
Confidence 9999999999999853
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=388.87 Aligned_cols=261 Identities=30% Similarity=0.370 Sum_probs=198.3
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|++++.||+|+||+||+|++..+++.||||++...........+|+.++..+ +||||+++++++.+.+.+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL------RHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC------CCTTBCCEEEEEECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC------CCCCCCcEEEEEeeCCEE
Confidence 35789999999999999999999999999999999986655556666777666544 477899999999999999
Q ss_pred EEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.+..+.+||+|||+++.
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 99999995 59999987654 59999999999999999999994 789999999999999544445699999999974
Q ss_pred cC--CccccccccCcCCchhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LG--QRIYQYIQSRFYRSPEVLLGIPYDLA-IDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.. ......+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+.+.......+.......
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---------- 237 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV---------- 237 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT----------
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC----------
Confidence 42 33456789999999999998888765 899999999999999999998755433333322211000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.+ ..+... ..+ ..+.+||.+||..||++|||+.
T Consensus 238 -----------~~-----------~~~~~~-----------------------~~s--~~~~~li~~~L~~dP~~Rps~~ 270 (361)
T 3uc3_A 238 -----------KY-----------SIPDDI-----------------------RIS--PECCHLISRIFVADPATRISIP 270 (361)
T ss_dssp -----------CC-----------CCCTTS-----------------------CCC--HHHHHHHHHHSCSCTTTSCCHH
T ss_pred -----------CC-----------CCCCcC-----------------------CCC--HHHHHHHHHHccCChhHCcCHH
Confidence 00 000000 001 1789999999999999999999
Q ss_pred HHhcCCCCCCCc
Q psy16081 433 YALQHNFFKRTA 444 (493)
Q Consensus 433 e~L~Hp~~~~~~ 444 (493)
|+|+||||.+..
T Consensus 271 ell~hp~f~~~~ 282 (361)
T 3uc3_A 271 EIKTHSWFLKNL 282 (361)
T ss_dssp HHHTSHHHHTTC
T ss_pred HHHhCcchhcCC
Confidence 999999997643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=389.43 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=207.2
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc------ccchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK------PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... .......+|+.++..+ +||||++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~ 94 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML------KHPHIVELLET 94 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC------CCCCCCcEEEE
Confidence 35578999999999999999999999999999999986321 1234455666665544 47889999999
Q ss_pred eeecceeEEEEEecc-cCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcE
Q psy16081 190 FMWRNHLCLVFELLS-YNLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAI 265 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~-~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~i 265 (493)
|.+.+.+|+|||||. ++|.+.+... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.+ ..+.+
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCE
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcE
Confidence 999999999999996 4898877543 22348999999999999999999995 789999999999999532 23459
Q ss_pred EEEecccccccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 266 KIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 266 kL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.. .+.+..+.......
T Consensus 173 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp EECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred EEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 99999999877543 345689999999999999999999999999999999999999998753 34444444322111
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
+...+ .. .+ ..+.+||.+||.
T Consensus 252 ~~~~~----------~~-----------------------------------------------~s--~~~~~li~~~L~ 272 (351)
T 3c0i_A 252 NPRQW----------SH-----------------------------------------------IS--ESAKDLVRRMLM 272 (351)
T ss_dssp CHHHH----------TT-----------------------------------------------SC--HHHHHHHHHHTC
T ss_pred Ccccc----------cc-----------------------------------------------CC--HHHHHHHHHHCC
Confidence 11100 00 00 178999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCC
Q psy16081 423 YDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.||++|||+.|+|+||||+..
T Consensus 273 ~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 273 LDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp SSTTTSCCHHHHHTSHHHHTH
T ss_pred CChhHCcCHHHHhcChhhcCC
Confidence 999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=397.44 Aligned_cols=259 Identities=27% Similarity=0.379 Sum_probs=209.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|+++++||+|+||.||+|.+..+++.||||+++..... .......++.++......+||||++++++|...+.+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV--AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh--hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 457899999999999999999999999999999999742110 111122334445556667799999999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
||||||+++ +|.+++.... .+++..++.++.||+.||.|||+ ..|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll--~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLML--DKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEE--CSSSCEEECCCCCCCT
T ss_pred EEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEE--CCCCCEEEccCCCcee
Confidence 999999965 8988887653 69999999999999999999995 2689999999999999 6788999999999976
Q ss_pred cC---CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LG---QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.. ......+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+....+.......|..
T Consensus 299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~------- 371 (446)
T 4ejn_A 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT------- 371 (446)
T ss_dssp TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-------
T ss_pred ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCcc-------
Confidence 43 23456789999999999999999999999999999999999999999988877777765421111100
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC---
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI--- 429 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~--- 429 (493)
.. ..+.+||.+||..||.+||
T Consensus 372 ------------------------------------------------------~~--~~~~~li~~~L~~dP~~R~~~~ 395 (446)
T 4ejn_A 372 ------------------------------------------------------LG--PEAKSLLSGLLKKDPKQRLGGG 395 (446)
T ss_dssp ------------------------------------------------------SC--HHHHHHHHHHTCSSTTTSTTCS
T ss_pred ------------------------------------------------------CC--HHHHHHHHHHcccCHHHhCCCC
Confidence 00 1789999999999999999
Q ss_pred --CHHHHhcCCCCCCCcc
Q psy16081 430 --TPYYALQHNFFKRTAD 445 (493)
Q Consensus 430 --t~~e~L~Hp~~~~~~~ 445 (493)
|++|+|+||||+....
T Consensus 396 ~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 396 SEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp TTTHHHHHTSGGGTTCCH
T ss_pred CCCHHHHHhCccccCCCH
Confidence 9999999999997643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=382.41 Aligned_cols=260 Identities=28% Similarity=0.401 Sum_probs=196.7
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+.+.++|++.+.||+|+||+||+|.+..+++.||||+++... .......|+.++..+ +||||++++++|...+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL------SHPNIIKLKEIFETPT 121 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC------CCTTBCCEEEEEECSS
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC------CCCCCcceeeeEecCC
Confidence 456788999999999999999999999999999999997532 223445566555544 4778999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEEeccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVDFGS 272 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~DFG~ 272 (493)
.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++. +.++.+||+|||+
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred eEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 99999999964 9999987653 58999999999999999999995 78999999999999953 3478899999999
Q ss_pred ccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVD-QMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~ 349 (493)
+...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+....+ .+..+.......+..+
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~--- 274 (349)
T 2w4o_A 198 SKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW--- 274 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT---
T ss_pred ccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch---
Confidence 9876443 345679999999999999999999999999999999999999998765544 3344332111000000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
+ .... ..+.+||.+||..||++||
T Consensus 275 -------~-----------------------------------------------~~~~--~~~~~li~~~L~~dP~~Rp 298 (349)
T 2w4o_A 275 -------W-----------------------------------------------DEVS--LNAKDLVRKLIVLDPKKRL 298 (349)
T ss_dssp -------T-----------------------------------------------TTSC--HHHHHHHHTTSCSSGGGSC
T ss_pred -------h-----------------------------------------------hhCC--HHHHHHHHHHccCChhhCc
Confidence 0 0011 1789999999999999999
Q ss_pred CHHHHhcCCCCCCCc
Q psy16081 430 TPYYALQHNFFKRTA 444 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~ 444 (493)
|+.|+|+||||+...
T Consensus 299 t~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 299 TTFQALQHPWVTGKA 313 (349)
T ss_dssp CHHHHHHSTTTTSTT
T ss_pred CHHHHhcCcccCCCc
Confidence 999999999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=365.99 Aligned_cols=262 Identities=28% Similarity=0.386 Sum_probs=212.2
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++.+.||+|+||.||+|.+..+++.||||++....... .....|..++..+ +|+||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL------QHPNIVRLHDSIQE 76 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC------CCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc------CCCCcCeEEEEEEc
Confidence 56789999999999999999999999999999999997543222 2233444444333 47889999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEEec
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDF 270 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~DF 270 (493)
.+..|+||||+.+ +|.+.+.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.+ ..+.+||+||
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~Df 152 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADF 152 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEeec
Confidence 9999999999965 8988887653 58999999999999999999995 789999999999999432 2345999999
Q ss_pred ccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 271 GSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 271 G~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.......+...+
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 231 (284)
T 3kk8_A 153 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW- 231 (284)
T ss_dssp TTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT-
T ss_pred eeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh-
Confidence 999776543 33567999999999999999999999999999999999999999998888777776553221111000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.... ..+.+||.+||..||++|
T Consensus 232 --------------------------------------------------------~~~~--~~~~~li~~~l~~dp~~R 253 (284)
T 3kk8_A 232 --------------------------------------------------------DTVT--PEAKSLIDSMLTVNPKKR 253 (284)
T ss_dssp --------------------------------------------------------TTSC--HHHHHHHHHHSCSSTTTS
T ss_pred --------------------------------------------------------cccC--HHHHHHHHHHcccChhhC
Confidence 0001 178999999999999999
Q ss_pred CCHHHHhcCCCCCCCccC
Q psy16081 429 ITPYYALQHNFFKRTADE 446 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~~~~ 446 (493)
||+.|+|+||||+.....
T Consensus 254 ps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 254 ITADQALKVPWICNRERV 271 (284)
T ss_dssp CCHHHHTTSHHHHSCCCG
T ss_pred CCHHHHhcCccccCChhH
Confidence 999999999999875443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=378.55 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=204.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCcc-----cchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKP-----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
.++|++++.||+|+||+||+|++. .+++.||||+++.... .......|..++..+ +||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV------KHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC------CCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC------CCCCccceeEE
Confidence 468999999999999999999875 6899999999975321 122334455554443 47889999999
Q ss_pred eeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 190 FMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
+...+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill--~~~~~~kl~ 163 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIML--NHQGHVKLT 163 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEE--CTTSCEEEC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEE--CCCCcEEEE
Confidence 9999999999999964 9999987653 58999999999999999999995 689999999999999 678899999
Q ss_pred ecccccccCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 269 DFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 269 DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.......|..
T Consensus 164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~ 243 (327)
T 3a62_A 164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243 (327)
T ss_dssp CCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT
T ss_pred eCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 9999976432 2345689999999999999999999999999999999999999999998888877776531111100
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
.. ..+.+||.+||..||
T Consensus 244 -------------------------------------------------------------~~--~~~~~li~~~L~~dp 260 (327)
T 3a62_A 244 -------------------------------------------------------------LT--QEARDLLKKLLKRNA 260 (327)
T ss_dssp -------------------------------------------------------------SC--HHHHHHHHHHSCSCG
T ss_pred -------------------------------------------------------------CC--HHHHHHHHHHHhcCH
Confidence 00 168899999999999
Q ss_pred CCCC-----CHHHHhcCCCCCCCcc
Q psy16081 426 KTRI-----TPYYALQHNFFKRTAD 445 (493)
Q Consensus 426 ~~R~-----t~~e~L~Hp~~~~~~~ 445 (493)
.+|| ++.|+++||||+....
T Consensus 261 ~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 261 ASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp GGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred hhccCCCCCCHHHHHcCCcccCCCH
Confidence 9999 8999999999997643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=392.21 Aligned_cols=258 Identities=28% Similarity=0.365 Sum_probs=211.5
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
..++|+++++||+|+||+||+|+++.+++.||||++++.. ........|..++.. .+|+||++++++|.+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~------~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN------GDRRWITQLHFAFQD 132 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHH------SCTTTBCCEEEEEEC
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHh------cCCCCeeeEEEEEee
Confidence 3578999999999999999999999999999999996421 112234455555443 257889999999999
Q ss_pred cceeEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+++||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl--d~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILL--DRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeee--cCCCCEEEeech
Confidence 99999999999 559999997653 369999999999999999999995 789999999999999 788999999999
Q ss_pred cccccCCc----cccccccCcCCchhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-
Q psy16081 272 SSCQLGQR----IYQYIQSRFYRSPEVLL-------GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL- 339 (493)
Q Consensus 272 ~a~~~~~~----~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~- 339 (493)
+++..... ....+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+.+.+|+...
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 287 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 99876443 23468999999999998 4569999999999999999999999999999888888887521
Q ss_pred --CCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHH
Q psy16081 340 --GLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417 (493)
Q Consensus 340 --~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi 417 (493)
..|.. . ...+ .++++||
T Consensus 288 ~~~~p~~------------------------------------~-----------------------~~~s--~~~~dli 306 (412)
T 2vd5_A 288 HLSLPLV------------------------------------D-----------------------EGVP--EEARDFI 306 (412)
T ss_dssp HCCCC---------------------------------------------------------------CCC--HHHHHHH
T ss_pred CcCCCcc------------------------------------c-----------------------cCCC--HHHHHHH
Confidence 11100 0 0001 1789999
Q ss_pred hHccCCCCCCC---CCHHHHhcCCCCCCCccCC
Q psy16081 418 FRMLDYDPKTR---ITPYYALQHNFFKRTADES 447 (493)
Q Consensus 418 ~~mL~~dP~~R---~t~~e~L~Hp~~~~~~~~~ 447 (493)
++||. ||.+| ++++|+++||||+.+....
T Consensus 307 ~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 307 QRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp HTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred HHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 99999 99998 5999999999999876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=390.16 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=196.8
Q ss_pred eecCcEEEe-eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 116 KFLDRYEID-SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 116 ~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
.+.++|.+. ++||+|+||+||+|.+..+++.||||++... .....|+.++..+ .+|+||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~-----~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRA-----SQCPHIVRIVDVYENLY 128 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHH-----TTSTTBCCEEEEEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHh-----cCCCCcceEeEEEeecc
Confidence 345678887 7999999999999999999999999999743 3455565554332 257889999999876
Q ss_pred --cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEE
Q psy16081 193 --RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIV 268 (493)
Q Consensus 193 --~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~ 268 (493)
.+++|||||||.+ +|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||++.+ .++.+||+
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEEE
Confidence 6789999999965 99999987654569999999999999999999995 789999999999999432 16889999
Q ss_pred ecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCC
Q psy16081 269 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVD----QMNKIVEVLGLP 342 (493)
Q Consensus 269 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~----~~~~i~~~~~~~ 342 (493)
|||+++.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+... ....+.......
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred ecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 9999987643 3456789999999999999999999999999999999999999998754321 122222110000
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
+. + .+...+ ..+.+||++||.
T Consensus 287 ~~----------------------------------~-----------------------~~~~~s--~~~~~li~~~L~ 307 (400)
T 1nxk_A 287 PN----------------------------------P-----------------------EWSEVS--EEVKMLIRNLLK 307 (400)
T ss_dssp CT----------------------------------T-----------------------TTTTSC--HHHHHHHHTTSC
T ss_pred CC----------------------------------c-----------------------ccccCC--HHHHHHHHHHCC
Confidence 00 0 000111 178999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCC
Q psy16081 423 YDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.||++|||+.|+|+||||...
T Consensus 308 ~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 308 TEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp SSGGGSCCHHHHHHSHHHHTT
T ss_pred CChhHCcCHHHHhcCccccCC
Confidence 999999999999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=385.81 Aligned_cols=301 Identities=21% Similarity=0.223 Sum_probs=205.5
Q ss_pred cCcEEEeeeEeee--CCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKG--SFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G--~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|+++++||+| +||+||+|++..+++.||||++....... .....|+.++..+ +||||++++++|.+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~ 97 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF------NHPNIVPYRATFIA 97 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC------CCTTBCCEEEEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC------CCCCCCcEeEEEEE
Confidence 4589999999999 99999999999999999999997543222 2233344443333 47889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+|+|||||. ++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll--~~~~~~kl~dfg 173 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILI--SVDGKVYLSGLR 173 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTCCEEECCGG
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--cCCCCEEEcccc
Confidence 999999999996 499999987655679999999999999999999995 789999999999999 678899999999
Q ss_pred cccccCC----------ccccccccCcCCchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy16081 272 SSCQLGQ----------RIYQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL 339 (493)
Q Consensus 272 ~a~~~~~----------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 339 (493)
++..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 9854421 1223478999999999998 579999999999999999999999999877666555444321
Q ss_pred CCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhH
Q psy16081 340 GLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFR 419 (493)
Q Consensus 340 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~ 419 (493)
. +. +..........+........ ....+.+.+......+.................+.+||.+
T Consensus 254 ~--~~-~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 316 (389)
T 3gni_B 254 V--PC-LLDTSTIPAEELTMSPSRSV--------------ANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316 (389)
T ss_dssp ---------------------------------------------------------------------CCHHHHHHHHH
T ss_pred C--Cc-cccccccccccccccccccc--------------cccccccccccCccccccCCCCCCccccccCHHHHHHHHH
Confidence 1 00 00000000000000000000 0000000000000000000000000000111278999999
Q ss_pred ccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 420 MLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 420 mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
||.+||++|||+.|+|+||||+....
T Consensus 317 ~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 317 CLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred HhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 99999999999999999999997654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=378.35 Aligned_cols=282 Identities=27% Similarity=0.509 Sum_probs=219.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|.+.+.||+|+||+||+|.+..+|+.||||++....... .....|..++.. . +||||+++++++..
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~---l---~h~~iv~~~~~~~~ 94 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH---M---QHENVIGLLDVFTP 94 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHH---C---CCTTBCCCSEEECS
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHh---c---CCCCcccHhheEec
Confidence 45678999999999999999999999999999999997533221 223334443333 2 47889999999987
Q ss_pred cce------eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 RNH------LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ~~~------~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.+. +|+||||++++|.+++.. .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~--~~~~~~k 166 (353)
T 3coi_A 95 ASSLRNFYDFYLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAV--NEDCELK 166 (353)
T ss_dssp CSSGGGCCCCEEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEE--CTTCCEE
T ss_pred ccccccceeEEEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeE--CCCCcEE
Confidence 654 499999999988877642 48999999999999999999995 689999999999999 6788999
Q ss_pred EEecccccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 267 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 267 L~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+|||++...........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++..
T Consensus 167 l~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 167 ILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp ECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred EeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999999887776677789999999999987 679999999999999999999999999999999999999999999888
Q ss_pred hhhhccch--hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 346 LLDGAHKT--RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 346 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
++...... ..++..++... ...+..+. ... ...+.+||.+||..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~----------------~~~--~~~~~~li~~~L~~ 292 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTP----------------RKDFTQLF----------------PRA--SPQAADLLEKMLEL 292 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCS----------------SCCTTTTC----------------TTS--CHHHHHHHHHHSCS
T ss_pred HHHHHhhHHHHHHHHhCcCCC----------------CccHHHhc----------------CCc--CHHHHHHHHHHcCC
Confidence 77654322 22222221100 00000000 001 12789999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q psy16081 424 DPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
||++|||+.|+|+||||+....
T Consensus 293 dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 293 DVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp CTTTSCCHHHHHTSGGGTTTCC
T ss_pred CcccCCCHHHHhcCcchhhccC
Confidence 9999999999999999997644
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=374.08 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=214.3
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-------cchHHHHHHHHHHHHhhcCCCCcceEEEec
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-------FLNQAQIEVKLLEIMNKADVNNTYYIVRLK 187 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~ 187 (493)
..+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......|..++..+ .||||++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~ 81 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV------LHHNVITLH 81 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC------CCTTBCCEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC------CCCCcceEE
Confidence 3566789999999999999999999999999999999975432 133455666665544 377899999
Q ss_pred eeeeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC---
Q psy16081 188 RHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS--- 263 (493)
Q Consensus 188 ~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~--- 263 (493)
+++.+.+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++ .++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~--~~~~~~ 155 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLL--DKNIPI 155 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEES--CTTSSS
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEe--cCCCCc
Confidence 99999999999999995 5999999764 368999999999999999999995 6899999999999994 444
Q ss_pred -cEEEEecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy16081 264 -AIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340 (493)
Q Consensus 264 -~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 340 (493)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 156 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 235 (321)
T 2a2a_A 156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235 (321)
T ss_dssp CCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred CCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 7999999999776543 3456799999999999999999999999999999999999999999888887777665332
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
..+.... ... + ..+.+||.+|
T Consensus 236 ~~~~~~~----------~~~-----------------------------------------------~--~~~~~li~~~ 256 (321)
T 2a2a_A 236 DFDEEFF----------SHT-----------------------------------------------S--ELAKDFIRKL 256 (321)
T ss_dssp CCCHHHH----------TTC-----------------------------------------------C--HHHHHHHHTT
T ss_pred ccChhhh----------ccc-----------------------------------------------C--HHHHHHHHHH
Confidence 2222111 000 0 1688999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
|..||++|||+.|+|+||||+...
T Consensus 257 l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 257 LVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp SCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred cCCChhhCcCHHHHhcCccccCCC
Confidence 999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=398.22 Aligned_cols=276 Identities=29% Similarity=0.405 Sum_probs=219.6
Q ss_pred CCCCCCCCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--------------cchHHHHH
Q psy16081 100 EGYDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--------------FLNQAQIE 165 (493)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--------------~~~~~~~e 165 (493)
.+..-....+.......+.++|+++++||+|+||+||+|.+..+++.||||++..... .......|
T Consensus 17 ~~~~~~~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 96 (504)
T 3q5i_A 17 QGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96 (504)
T ss_dssp CCCCCCGGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHH
T ss_pred cceeechhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHH
Confidence 3344445566667777888999999999999999999999999999999999975321 12233344
Q ss_pred HHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC
Q psy16081 166 VKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN 244 (493)
Q Consensus 166 ~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~ 244 (493)
+.++. ..+||||++++++|.+.+.+|+|||||.+ +|.+.+.... .+++..++.++.||+.||.|||+ .|
T Consensus 97 ~~~l~------~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~ 166 (504)
T 3q5i_A 97 ISLLK------SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHK--HN 166 (504)
T ss_dssp HHHHH------TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred HHHHH------hCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CC
Confidence 44433 33588899999999999999999999965 9999887653 59999999999999999999995 78
Q ss_pred ccccCCCCCcEEeeCCCC-CcEEEEecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q psy16081 245 IIHCDLKPENILLCNPKR-SAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEP 321 (493)
Q Consensus 245 iiHrDlKp~NILl~~~~~-~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 321 (493)
|+||||||+|||++.+.. ..+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+
T Consensus 167 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 245 (504)
T 3q5i_A 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245 (504)
T ss_dssp EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCC
Confidence 999999999999953221 3699999999987654 3456789999999999875 69999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCC
Q psy16081 322 LFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401 (493)
Q Consensus 322 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 401 (493)
||.+.+..+.+..+.......+...+..
T Consensus 246 pf~~~~~~~~~~~i~~~~~~~~~~~~~~---------------------------------------------------- 273 (504)
T 3q5i_A 246 PFGGQNDQDIIKKVEKGKYYFDFNDWKN---------------------------------------------------- 273 (504)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCHHHHTT----------------------------------------------------
T ss_pred CCCCCCHHHHHHHHHcCCCCCCccccCC----------------------------------------------------
Confidence 9999999888888776432222111100
Q ss_pred CCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 402 ~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.+ ..+++||.+||.+||.+|||+.|+|+||||+....
T Consensus 274 -----~s--~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 274 -----IS--DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp -----SC--HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred -----CC--HHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 01 17899999999999999999999999999986543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=380.92 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=185.8
Q ss_pred eecCcEEEe---eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEID---SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~---~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.|.++|++. +.||+|+||+||+|.+..+++.||||++... .......|+.++..+. +||||+++++++.+
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~-----~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCE-----GHPNIVKLHEVFHD 77 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTT-----TCTTBCCEEEEEEC
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhc-----CCCCeeEEEEEEEc
Confidence 345678875 7899999999999999999999999999643 2344555666555443 58889999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEEec
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDF 270 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~DF 270 (493)
.+..|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.+ ....+||+||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCC
T ss_pred CCEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEecc
Confidence 9999999999965 999999765 369999999999999999999995 789999999999999532 2237999999
Q ss_pred ccccccCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhC
Q psy16081 271 GSSCQLGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV-------DQMNKIVEVLG 340 (493)
Q Consensus 271 G~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-------~~~~~i~~~~~ 340 (493)
|++..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.. +.+..+.....
T Consensus 154 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 154 GFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp TTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred ccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 99976543 234667899999999999999999999999999999999999999875432 22222221111
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
..+...+. ..+ ..+++||.+|
T Consensus 234 ~~~~~~~~---------------------------------------------------------~~s--~~~~~li~~~ 254 (325)
T 3kn6_A 234 SFEGEAWK---------------------------------------------------------NVS--QEAKDLIQGL 254 (325)
T ss_dssp CCCSHHHH---------------------------------------------------------TSC--HHHHHHHHHH
T ss_pred CCCccccc---------------------------------------------------------CCC--HHHHHHHHHH
Confidence 00000000 001 1789999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
|..||.+|||+.|+++||||+..
T Consensus 255 L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 255 LTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCCChhHCCCHHHHhcChhhccC
Confidence 99999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=385.44 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=205.5
Q ss_pred cCcEEE--eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 118 LDRYEI--DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 118 ~~~y~~--~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.+.|.+ .+.||+|+||.||+|.+..+|+.||||+++.... ....+..| +......+||||+++++++...+
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E------~~~l~~l~hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE------ISVMNQLDHANLIQLYDAFESKN 159 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHH------HHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHH------HHHHHhCCCCCCCeEEEEEEECC
Confidence 344555 6789999999999999999999999999975431 11222333 33334446889999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+||||||+++ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+.++..+.+||+|||++
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 99999999965 8999886543 358999999999999999999995 7899999999999997667789999999999
Q ss_pred cccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 274 CQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 274 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+......++...+
T Consensus 237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~---- 312 (373)
T 2x4f_A 237 RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF---- 312 (373)
T ss_dssp EECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGG----
T ss_pred eecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhh----
Confidence 876432 34567999999999999989999999999999999999999999999988888887764222111000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
. ... ..+.+||.+||..||.+|||+
T Consensus 313 ------~-----------------------------------------------~~~--~~~~~li~~~L~~dp~~Rps~ 337 (373)
T 2x4f_A 313 ------Q-----------------------------------------------DIS--EEAKEFISKLLIKEKSWRISA 337 (373)
T ss_dssp ------T-----------------------------------------------TSC--HHHHHHHHTTSCSSGGGSCCH
T ss_pred ------c-----------------------------------------------cCC--HHHHHHHHHHcCCChhhCCCH
Confidence 0 001 178999999999999999999
Q ss_pred HHHhcCCCCCCCc
Q psy16081 432 YYALQHNFFKRTA 444 (493)
Q Consensus 432 ~e~L~Hp~~~~~~ 444 (493)
.|+|+||||+...
T Consensus 338 ~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 338 SEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHSHHHHCHH
T ss_pred HHHhcCcCcCCCc
Confidence 9999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=367.33 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=207.9
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|++.+.||+|+||+||+|.+..+++.||||++..... .....+..+.+++......+||||+++++++.+.+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc--chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 35789999999999999999999999999999999864221 1111122333344444455688999999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++.... .+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||++..
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili--~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLL--GSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEE--CTTSCEEECSCCEESC
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEE--cCCCCEEEEecccccc
Confidence 999999965 8999887653 5999999999999999999999 4799999999999999 6788999999999866
Q ss_pred cCCc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 276 LGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 276 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......|..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 229 (279)
T 3fdn_A 159 APSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--------- 229 (279)
T ss_dssp C--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT---------
T ss_pred CCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCc---------
Confidence 5433 356689999999999999999999999999999999999999999988877776665422111100
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
.. ..+.+||.+||..||.+|||+.|+
T Consensus 230 ----------------------------------------------------~~--~~~~~li~~~l~~~p~~Rps~~e~ 255 (279)
T 3fdn_A 230 ----------------------------------------------------VT--EGARDLISRLLKHNPSQRPMLREV 255 (279)
T ss_dssp ----------------------------------------------------SC--HHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ----------------------------------------------------CC--HHHHHHHHHHhccChhhCCCHHHH
Confidence 00 168899999999999999999999
Q ss_pred hcCCCCCCCc
Q psy16081 435 LQHNFFKRTA 444 (493)
Q Consensus 435 L~Hp~~~~~~ 444 (493)
|+||||+...
T Consensus 256 l~h~~~~~~~ 265 (279)
T 3fdn_A 256 LEHPWITANS 265 (279)
T ss_dssp HHCHHHHHHC
T ss_pred hhCccccCCc
Confidence 9999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=382.11 Aligned_cols=264 Identities=27% Similarity=0.396 Sum_probs=207.6
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc------ccchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK------PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.++..+ +||||++++++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~ 96 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL------HHPNIARLYEV 96 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC------CCCCcceeehh
Confidence 45679999999999999999999999999999999986431 1223444555555443 47889999999
Q ss_pred eeecceeEEEEEecc-cCHHHHHhccC--------------------------------------CCCCCHHHHHHHHHH
Q psy16081 190 FMWRNHLCLVFELLS-YNLYDLLRNTN--------------------------------------FRGVSLNLTRKFSQQ 230 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~-~~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~q 230 (493)
+.+.+.+|+|||||. ++|.+++.... ...+++..++.++.|
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 176 (345)
T 3hko_A 97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176 (345)
T ss_dssp EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence 999999999999995 59999885210 112467788899999
Q ss_pred HHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC-------ccccccccCcCCchhhhcC--CCCC
Q psy16081 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-------RIYQYIQSRFYRSPEVLLG--IPYD 301 (493)
Q Consensus 231 i~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~ 301 (493)
|+.||.|||+ .||+||||||+|||++.+..+.+||+|||++..... ......||+.|+|||++.+ ..++
T Consensus 177 i~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 177 IFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 9999999995 689999999999999544444899999999976532 1345679999999999976 6799
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCC
Q psy16081 302 LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGS 381 (493)
Q Consensus 302 ~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (493)
.++|||||||++|+|++|..||.+.+..+.+..+.......+.....
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------- 301 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYN--------------------------------- 301 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGG---------------------------------
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccc---------------------------------
Confidence 99999999999999999999999999888877776532211110000
Q ss_pred ccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 382 RRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 382 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
.. ...+.+||.+||..||.+|||+.|+|+||||+...+.
T Consensus 302 ------------------------~~--~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 302 ------------------------VL--SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp ------------------------GS--CHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred ------------------------cC--CHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence 00 0178999999999999999999999999999976543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=372.31 Aligned_cols=286 Identities=28% Similarity=0.469 Sum_probs=214.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--cce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW--RNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~--~~~ 195 (493)
.++|++++.||+|+||+||+|.+..+++.||||+++... ......|..++..+. +|+||+++++++.+ ...
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR-----GGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcC-----CCCCEEEeeeeeccCCCCc
Confidence 478999999999999999999999999999999997433 456777877777664 46789999999987 678
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.++||||+.+ +|.+++. .+++..++.++.||+.||.|||+ .||+||||||+|||++. +...+||+|||++.
T Consensus 108 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~-~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEET-TTTEEEECCCTTCE
T ss_pred eEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcC-CCCEEEEEeCCCce
Confidence 9999999965 7877764 38899999999999999999995 78999999999999942 33489999999997
Q ss_pred ccCC--ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 275 QLGQ--RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLF-SGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 275 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+...++.+.....
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--- 256 (330)
T 3nsz_A 180 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY--- 256 (330)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH---
T ss_pred EcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH---
Confidence 6543 3456688999999999987 67999999999999999999999998 456777888888777664322111
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcC-CCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRL-GEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
..... ......+.+++.......+.... .+.....+ ..+.+||.+||.+||++||
T Consensus 257 ------~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rp 312 (330)
T 3nsz_A 257 ------IDKYN----------------IELDPRFNDILGRHSRKRWERFVHSENQHLVS--PEALDFLDKLLRYDHQSRL 312 (330)
T ss_dssp ------HHHTT----------------CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCC--HHHHHHHHTTSCSSGGGSC
T ss_pred ------HHHhc----------------cccccchhhhhhhccccchhhhccccccccCC--HHHHHHHHHHhcCCcccCC
Confidence 00000 00001111111111111111000 00011111 2789999999999999999
Q ss_pred CHHHHhcCCCCCCCcc
Q psy16081 430 TPYYALQHNFFKRTAD 445 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~~ 445 (493)
|++|+|+||||+.+..
T Consensus 313 ta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 313 TAREAMEHPYFYTVVK 328 (330)
T ss_dssp CHHHHHTSGGGTTCC-
T ss_pred CHHHHhcCccHhhhcc
Confidence 9999999999997653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=412.41 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=212.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|+++++||+|+||+||+|++..+++.||||++++.. ........|..++ ....+|++|++++++|.+.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l-----~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL-----ALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHH-----TCTTCCTTBCCEEEECBCS
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHH-----HhccCCCeEEEEEEEEEeC
Confidence 578999999999999999999999999999999997421 1122223333322 2334788999999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+||||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||| +.++.+||+|||+
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl--~~~g~ikL~DFGl 488 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVML--DSEGHIKIADFGM 488 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEE--CSSSCEEECCCTT
T ss_pred CEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEE--cCCCcEEEeecce
Confidence 999999999955 9999998654 69999999999999999999995 789999999999999 7889999999999
Q ss_pred cccc---CCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQL---GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
|+.. +......+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+.+..|.......|.
T Consensus 489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----- 563 (674)
T 3pfq_A 489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----- 563 (674)
T ss_dssp CEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT-----
T ss_pred eeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence 9764 23345678999999999999999999999999999999999999999999998888887652111110
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
..+ .++.+||++||..||++||
T Consensus 564 --------------------------------------------------------~~s--~~~~~li~~lL~~dP~~R~ 585 (674)
T 3pfq_A 564 --------------------------------------------------------SMS--KEAVAICKGLMTKHPGKRL 585 (674)
T ss_dssp --------------------------------------------------------TSC--HHHHHHHHHHSCSSSTTCT
T ss_pred --------------------------------------------------------cCC--HHHHHHHHHHccCCHHHCC
Confidence 001 1789999999999999999
Q ss_pred CH-----HHHhcCCCCCCCcc
Q psy16081 430 TP-----YYALQHNFFKRTAD 445 (493)
Q Consensus 430 t~-----~e~L~Hp~~~~~~~ 445 (493)
++ +||++||||+.+..
T Consensus 586 ~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 586 GCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp TCSTTHHHHHHSSGGGSSCCH
T ss_pred CCCCCcHHHHhcCccccCCCH
Confidence 97 99999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=370.89 Aligned_cols=252 Identities=28% Similarity=0.418 Sum_probs=198.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---------------------------chHHHHHHHHH
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---------------------------LNQAQIEVKLL 169 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---------------------------~~~~~~e~~~~ 169 (493)
..++|++.+.||+|+||+||+|++..+++.||||++...... ...+..|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 357899999999999999999999999999999999754211 12333444443
Q ss_pred HHHhhcCCCCcceEEEeceeeee--cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCcc
Q psy16081 170 EIMNKADVNNTYYIVRLKRHFMW--RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNII 246 (493)
Q Consensus 170 ~~l~~~~~~~~~~Iv~l~~~~~~--~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~ii 246 (493)
. ..+||||+++++++.+ .+.+|+||||+++ +|.+++.. ..+++..++.++.||+.||.|||+ .||+
T Consensus 91 ~------~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~iv 159 (298)
T 2zv2_A 91 K------KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY--QKII 159 (298)
T ss_dssp H------TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred H------hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCee
Confidence 3 3358889999999986 5689999999965 77665432 369999999999999999999995 6899
Q ss_pred ccCCCCCcEEeeCCCCCcEEEEecccccccCCc---cccccccCcCCchhhhcCCC---CCchhhHHHHHHHHHHHHhCC
Q psy16081 247 HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGIP---YDLAIDMWSLGCILVEMHTGE 320 (493)
Q Consensus 247 HrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~ 320 (493)
||||||+|||+ +.++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 160 H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 160 HRDIKPSNLLV--GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp CCCCCGGGEEE--CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCHHHEEE--CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 99999999999 67889999999999876433 34568999999999998765 478999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcC
Q psy16081 321 PLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRL 400 (493)
Q Consensus 321 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 400 (493)
+||.+.+.......+.......+ ...
T Consensus 238 ~pf~~~~~~~~~~~~~~~~~~~~------------------------------------~~~------------------ 263 (298)
T 2zv2_A 238 CPFMDERIMCLHSKIKSQALEFP------------------------------------DQP------------------ 263 (298)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCC------------------------------------SSS------------------
T ss_pred CCCCCccHHHHHHHHhcccCCCC------------------------------------Ccc------------------
Confidence 99998876665555433110000 000
Q ss_pred CCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCC
Q psy16081 401 GEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 401 ~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~ 442 (493)
... ..+.+||.+||..||++|||+.|+|+||||++
T Consensus 264 -----~~~--~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 264 -----DIA--EDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp -----CCC--HHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred -----ccC--HHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 001 17899999999999999999999999999963
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=372.16 Aligned_cols=262 Identities=29% Similarity=0.385 Sum_probs=197.2
Q ss_pred eecCcEEEe-eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 116 KFLDRYEID-SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 116 ~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+.++|++. ++||+|+||+||+|.+..+++.||||++..... .......|+.++..+ .+||||+++++++.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~-----~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC-----QGHRNVLELIEFFEEE 83 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHT-----CCCTTBCCEEEEEEET
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHh-----cCCCCeeeEEEEEeeC
Confidence 566789995 789999999999999999999999999975432 234445555554332 3688899999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC-CCcEEEEecc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK-RSAIKIVDFG 271 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~-~~~ikL~DFG 271 (493)
+.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.+. ...+||+|||
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred CEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 99999999996 59999997653 68999999999999999999995 6899999999999994322 1349999999
Q ss_pred cccccCC----------ccccccccCcCCchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------
Q psy16081 272 SSCQLGQ----------RIYQYIQSRFYRSPEVLLG-----IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV------- 329 (493)
Q Consensus 272 ~a~~~~~----------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~------- 329 (493)
++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 9875531 1234569999999999975 45889999999999999999999999875421
Q ss_pred --------HHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCC
Q psy16081 330 --------DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401 (493)
Q Consensus 330 --------~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 401 (493)
.....+.......+...+.
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------------------------------- 266 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYEFPDKDWA----------------------------------------------------- 266 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCCCCHHHHT-----------------------------------------------------
T ss_pred ccchhHHHHHHHHHhccCcccCchhcc-----------------------------------------------------
Confidence 1222222211111100000
Q ss_pred CCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 402 ~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
..+ ..+.+||.+||..||.+|||+.|+|+||||+....
T Consensus 267 ----~~~--~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 267 ----HIS--CAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp ----TSC--HHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred ----cCC--HHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 000 16899999999999999999999999999996543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=394.67 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=210.0
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+....++|.+++.||+|+||+||+|.+..+|+.||||++..... ........+.+++......+||||+++++++...
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 34556789999999999999999999999999999999964321 0000111222333334455688999999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll--~~~~~vkL~DFG~ 162 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLL--DAHMNAKIADFGL 162 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEE--CTTCCEEECCCSS
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEE--ecCCCeEEEeccc
Confidence 99999999995 5999998754 369999999999999999999995 789999999999999 6788999999999
Q ss_pred ccccCC--ccccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQLGQ--RIYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
+..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+....+.++.......|..
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~---- 238 (476)
T 2y94_A 163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY---- 238 (476)
T ss_dssp CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTT----
T ss_pred hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCcc----
Confidence 987643 3456789999999999998876 689999999999999999999999888777766665421111100
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.+ ..+.+||.+||..||.+||
T Consensus 239 ---------------------------------------------------------~s--~~~~~Li~~~L~~dP~~Rp 259 (476)
T 2y94_A 239 ---------------------------------------------------------LN--PSVISLLKHMLQVDPMKRA 259 (476)
T ss_dssp ---------------------------------------------------------CC--HHHHHHHHHHTCSSTTTSC
T ss_pred ---------------------------------------------------------CC--HHHHHHHHHHcCCCchhCc
Confidence 00 1688999999999999999
Q ss_pred CHHHHhcCCCCCC
Q psy16081 430 TPYYALQHNFFKR 442 (493)
Q Consensus 430 t~~e~L~Hp~~~~ 442 (493)
|+.|+++||||+.
T Consensus 260 t~~eil~hp~~~~ 272 (476)
T 2y94_A 260 TIKDIREHEWFKQ 272 (476)
T ss_dssp CHHHHHTCHHHHT
T ss_pred CHHHHHhCHHhhh
Confidence 9999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=383.38 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=205.1
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
...++|++++.||+|+||.||+|.+..+++.||||++.... ........|+.++. ..+||||++++++|.
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~------~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ------GLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH------TCCCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHH------hCCCCCCCcEEEEEE
Confidence 34578999999999999999999999999999999996432 11223334444433 336888999999999
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
+.+.+|+||||+.| +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll--~~~g~vkL~DF 159 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILL--DEHGHVHITDF 159 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEE--CCCCCEEEecc
Confidence 99999999999955 999988764 369999999999999999999995 789999999999999 78899999999
Q ss_pred ccccccCC--ccccccccCcCCchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC
Q psy16081 271 GSSCQLGQ--RIYQYIQSRFYRSPEVLLG---IPYDLAIDMWSLGCILVEMHTGEPLFSGSNE---VDQMNKIVEVLGLP 342 (493)
Q Consensus 271 G~a~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~ 342 (493)
|++..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+. .+....+.......
T Consensus 160 G~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 239 (384)
T 4fr4_A 160 NIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY 239 (384)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC
T ss_pred ceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC
Confidence 99987643 3457789999999999974 4589999999999999999999999975432 22333222211000
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
|. ..+ ..+.+||.+||.
T Consensus 240 p~-------------------------------------------------------------~~s--~~~~~li~~lL~ 256 (384)
T 4fr4_A 240 PS-------------------------------------------------------------AWS--QEMVSLLKKLLE 256 (384)
T ss_dssp CT-------------------------------------------------------------TSC--HHHHHHHHHHSC
T ss_pred CC-------------------------------------------------------------cCC--HHHHHHHHHHhc
Confidence 00 001 178999999999
Q ss_pred CCCCCCCC-HHHHhcCCCCCCCcc
Q psy16081 423 YDPKTRIT-PYYALQHNFFKRTAD 445 (493)
Q Consensus 423 ~dP~~R~t-~~e~L~Hp~~~~~~~ 445 (493)
.||.+||+ ++++++||||..+..
T Consensus 257 ~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 257 PNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp SSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred CCHhHhcccHHHHHcChhhhcCCH
Confidence 99999998 999999999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=377.40 Aligned_cols=258 Identities=31% Similarity=0.472 Sum_probs=210.6
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---------chHHHHHHHHHHHHhhcCCCCcceEEE
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---------LNQAQIEVKLLEIMNKADVNNTYYIVR 185 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---------~~~~~~e~~~~~~l~~~~~~~~~~Iv~ 185 (493)
..+.++|++.+.||+|+||+||+|.+..+|+.||||++...... ......|..++..+. +||||++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~ 164 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA-----GHPHIIT 164 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCC
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc-----CCCCEeE
Confidence 34567899999999999999999999999999999999754321 123334444444432 5778999
Q ss_pred eceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc
Q psy16081 186 LKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 186 l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ 264 (493)
+++++...+..|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~--~~~~~ 238 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILL--DDNMQ 238 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--CCCCC
Confidence 99999999999999999965 9999987653 69999999999999999999995 689999999999999 67889
Q ss_pred EEEEecccccccCC--ccccccccCcCCchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy16081 265 IKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLG------IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 265 ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~ 336 (493)
+||+|||++..+.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.
T Consensus 239 ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999999977643 3456789999999999963 358899999999999999999999999888877777766
Q ss_pred HHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHH
Q psy16081 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDL 416 (493)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL 416 (493)
.....++...+. . . ...+.+|
T Consensus 319 ~~~~~~~~~~~~----------~-----------------------------------------------~--~~~~~~l 339 (365)
T 2y7j_A 319 EGQYQFSSPEWD----------D-----------------------------------------------R--SSTVKDL 339 (365)
T ss_dssp HTCCCCCHHHHS----------S-----------------------------------------------S--CHHHHHH
T ss_pred hCCCCCCCcccc----------c-----------------------------------------------C--CHHHHHH
Confidence 532222111110 0 0 0168899
Q ss_pred HhHccCCCCCCCCCHHHHhcCCCCCC
Q psy16081 417 IFRMLDYDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 417 i~~mL~~dP~~R~t~~e~L~Hp~~~~ 442 (493)
|.+||..||++|||+.|+|+||||++
T Consensus 340 i~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 340 ISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHcCCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=396.13 Aligned_cols=268 Identities=29% Similarity=0.411 Sum_probs=213.2
Q ss_pred CCcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcce
Q psy16081 106 NHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYY 182 (493)
Q Consensus 106 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~ 182 (493)
...++......+.++|++++.||+|+||+||+|++..+++.||||++..... .......|+.+ ....+|||
T Consensus 24 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~------l~~l~hpn 97 (494)
T 3lij_A 24 PGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAV------LKLLDHPN 97 (494)
T ss_dssp GGGGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHH------HTTCCCTT
T ss_pred hhheeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHH------HHhCCCCC
Confidence 3445555556778899999999999999999999999999999999975421 12333334433 34446889
Q ss_pred EEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-
Q psy16081 183 IVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP- 260 (493)
Q Consensus 183 Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~- 260 (493)
|++++++|.+.+.+|+|||||.+ +|.+.+.... .+++..++.++.||+.||.|||+ .||+||||||+|||++..
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~ 173 (494)
T 3lij_A 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKE 173 (494)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSS
T ss_pred CCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCC
Confidence 99999999999999999999955 9999887653 59999999999999999999995 789999999999999532
Q ss_pred CCCcEEEEecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy16081 261 KRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338 (493)
Q Consensus 261 ~~~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 338 (493)
..+.+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 174 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 252 (494)
T 3lij_A 174 KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG 252 (494)
T ss_dssp TTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 246699999999977643 3456789999999999874 6999999999999999999999999999988888877664
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
....+...+. ..+ ..+++||.
T Consensus 253 ~~~~~~~~~~---------------------------------------------------------~~s--~~~~~li~ 273 (494)
T 3lij_A 253 KYTFDSPEWK---------------------------------------------------------NVS--EGAKDLIK 273 (494)
T ss_dssp CCCCCSGGGT---------------------------------------------------------TSC--HHHHHHHH
T ss_pred CCCCCchhcc---------------------------------------------------------cCC--HHHHHHHH
Confidence 3222111100 011 16899999
Q ss_pred HccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 419 RMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 419 ~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
+||.+||.+|||+.|+|+||||+..
T Consensus 274 ~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 274 QMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHCCCChhhCccHHHHhcCcccccC
Confidence 9999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=363.88 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=213.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.+.++|++.+.||+|+||+||+|.+..++..||+|++.... .....+..|..++..+ +||||+++++++.+.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL------DHPNIIRLYETFEDNT 79 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC------CCTTBCCEEEEEECSS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC------CCCCEeeEEEEEecCC
Confidence 45678999999999999999999999999999999987432 2234455555554433 5788999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEEeccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVDFGS 272 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~DFG~ 272 (493)
.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+.. +.++.+||+|||+
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 155 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred eEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence 99999999965 9999887653 58999999999999999999995 78999999999999943 3567899999999
Q ss_pred ccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 273 SCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 273 a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
+..... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+.......+...+..
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (277)
T 3f3z_A 156 AARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLN- 233 (277)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTT-
T ss_pred ceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhc-
Confidence 976643 33456799999999998764 99999999999999999999999999988888877766443333222110
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.. ..+.+||.+||..||.+|||
T Consensus 234 --------------------------------------------------------~~--~~~~~li~~~l~~dp~~R~s 255 (277)
T 3f3z_A 234 --------------------------------------------------------VS--PQAESLIRRLLTKSPKQRIT 255 (277)
T ss_dssp --------------------------------------------------------SC--HHHHHHHHHHTCSSTTTSCC
T ss_pred --------------------------------------------------------CC--HHHHHHHHHHccCChhhCcC
Confidence 00 17889999999999999999
Q ss_pred HHHHhcCCCCCCCc
Q psy16081 431 PYYALQHNFFKRTA 444 (493)
Q Consensus 431 ~~e~L~Hp~~~~~~ 444 (493)
+.|+|+||||+...
T Consensus 256 ~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 256 SLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHTTSHHHHHHH
T ss_pred HHHHhcCHHHhccc
Confidence 99999999998643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=397.06 Aligned_cols=265 Identities=32% Similarity=0.463 Sum_probs=214.9
Q ss_pred eeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEE
Q psy16081 110 IIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVR 185 (493)
Q Consensus 110 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~ 185 (493)
.......+.++|++.++||+|+||+||+|.+..+++.||||++.... ........|+.++ ...+||||++
T Consensus 17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l------~~l~hpniv~ 90 (484)
T 3nyv_A 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL------KQLDHPNIMK 90 (484)
T ss_dssp --CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHH------TTCCCTTBCC
T ss_pred eccCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHH------HhCCCCCCCc
Confidence 33445567789999999999999999999999999999999986432 1223344444433 3336888999
Q ss_pred eceeeeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCC
Q psy16081 186 LKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRS 263 (493)
Q Consensus 186 l~~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~ 263 (493)
++++|.+.+.+|+|||||. ++|.+.+.... .+++..++.++.||+.||.|||+ .||+||||||+|||+.. +.++
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 91 LYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTC
T ss_pred EEEEEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCC
Confidence 9999999999999999995 59999887653 69999999999999999999995 68999999999999943 2567
Q ss_pred cEEEEecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 264 AIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 264 ~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
.+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 167 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 245 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245 (484)
T ss_dssp CEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred cEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 899999999977643 3456789999999999987 6999999999999999999999999999998888877653221
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
.+...+. ..+ ..+++||.+||
T Consensus 246 ~~~~~~~---------------------------------------------------------~~s--~~~~~li~~~L 266 (484)
T 3nyv_A 246 FELPQWK---------------------------------------------------------KVS--ESAKDLIRKML 266 (484)
T ss_dssp CCSGGGG---------------------------------------------------------GSC--HHHHHHHHHHT
T ss_pred CCCcccc---------------------------------------------------------cCC--HHHHHHHHHHC
Confidence 1110000 001 17899999999
Q ss_pred CCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 422 DYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
.+||.+|||+.|+|+||||+...
T Consensus 267 ~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 267 TYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCChhHCcCHHHHhhChhhcccc
Confidence 99999999999999999998653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=395.99 Aligned_cols=259 Identities=33% Similarity=0.490 Sum_probs=212.0
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|+++++||+|+||+||+|.+..+++.||||++.... ........|+.++..+ +||||+++++++.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~ 92 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL------DHPNIMKLFEILED 92 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC------CCTTBCCEEEEEEC
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC------CCCCcCeEEEEEEc
Confidence 46679999999999999999999999999999999986322 2234455566555544 47889999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEEec
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVDF 270 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~DF 270 (493)
.+.+|+|||||.+ +|.+.+.... .+++..++.++.||+.||.|||+ .||+||||||+|||++. +.++.+||+||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence 9999999999955 9999887653 69999999999999999999995 78999999999999953 24567999999
Q ss_pred ccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 271 GSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 271 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
|++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+...+
T Consensus 169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~- 246 (486)
T 3mwu_A 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW- 246 (486)
T ss_dssp SCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG-
T ss_pred CcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc-
Confidence 99976643 3446689999999999987 5999999999999999999999999999988888877653221111000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
. ..+ ..+++||.+||..||.+|
T Consensus 247 ---------~-----------------------------------------------~~s--~~~~~li~~~L~~dp~~R 268 (486)
T 3mwu_A 247 ---------R-----------------------------------------------TIS--DDAKDLIRKMLTFHPSLR 268 (486)
T ss_dssp ---------G-----------------------------------------------GSC--HHHHHHHHHHTCSSTTTS
T ss_pred ---------C-----------------------------------------------CCC--HHHHHHHHHHcCCChhhC
Confidence 0 001 168999999999999999
Q ss_pred CCHHHHhcCCCCCCCc
Q psy16081 429 ITPYYALQHNFFKRTA 444 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~~ 444 (493)
||+.|+|+||||+...
T Consensus 269 ~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 269 ITATQCLEHPWIQKYS 284 (486)
T ss_dssp CCHHHHHHCHHHHHTC
T ss_pred cCHHHHhcCHhhccCc
Confidence 9999999999998653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=373.30 Aligned_cols=284 Identities=31% Similarity=0.483 Sum_probs=213.2
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch---HHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN---QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
..++|++++.||+|+||.||+|.+..+++.||||++........ ....|..++.. . +||||+++++++.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~---l---~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ---L---RHENLVNLLEVCKKK 96 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHH---C---CCTTBCCEEEEEEET
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhh---C---CCCCEeeEEEEeecC
Confidence 35789999999999999999999999999999999865432222 22334443333 3 478899999999999
Q ss_pred ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 194 NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 194 ~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
+.+|+||||+++++++.+.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILV--SQSGVVKLCDFGFA 171 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred CEEEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEE--cCCCcEEEEeCCCc
Confidence 9999999999885544443222 369999999999999999999995 789999999999999 67889999999999
Q ss_pred cccCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 274 CQLGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 274 ~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+..+......
T Consensus 172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 766432 3456789999999999876 789999999999999999999999999999999999999888776655433
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
...... +.... + ............. ...+ ..+.+||.+||..||++||
T Consensus 252 ~~~~~~-~~~~~-----~--------~~~~~~~~~~~~~----------------~~~~--~~l~~li~~~L~~dP~~Rp 299 (331)
T 4aaa_A 252 FNKNPV-FAGVR-----L--------PEIKEREPLERRY----------------PKLS--EVVIDLAKKCLHIDPDKRP 299 (331)
T ss_dssp HHHCGG-GTTCC-----C--------CCCSSCCCHHHHS----------------TTSC--HHHHHHHHHHTCSSGGGSC
T ss_pred hhhccc-ccccc-----C--------ccccccchhhhcc----------------cchh--HHHHHHHHHHhccCcccCC
Confidence 222111 11100 0 0000000000000 0011 2789999999999999999
Q ss_pred CHHHHhcCCCCCCC
Q psy16081 430 TPYYALQHNFFKRT 443 (493)
Q Consensus 430 t~~e~L~Hp~~~~~ 443 (493)
|+.|+|+||||+..
T Consensus 300 t~~ell~hp~f~~~ 313 (331)
T 4aaa_A 300 FCAELLHHDFFQMD 313 (331)
T ss_dssp CGGGGGGSHHHHGG
T ss_pred CHHHHhcCchhccC
Confidence 99999999999853
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=371.79 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=208.8
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
...+.++|++.+.||+|+||+||+|.+..+++.||||+++..... .......+.+++......+||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR--DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT--SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC--CHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 456788999999999999999999999999999999999754321 122233445566666677899999999999876
Q ss_pred ce----eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 194 NH----LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 194 ~~----~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
.. .|+||||+++ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~--~~~~~~kl~ 158 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMI--SATNAVKVM 158 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--ETTSCEEEC
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEE--cCCCCEEEe
Confidence 54 4999999964 9999987653 69999999999999999999995 789999999999999 567889999
Q ss_pred ecccccccCCc------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 269 DFGSSCQLGQR------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 269 DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238 (311)
T ss_dssp CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence 99999766432 234578999999999999999999999999999999999999999988877766665533322
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
+...... .. ..+.+||.+||.
T Consensus 239 ~~~~~~~---------------------------------------------------------~~--~~l~~li~~~l~ 259 (311)
T 3ork_A 239 PSARHEG---------------------------------------------------------LS--ADLDAVVLKALA 259 (311)
T ss_dssp HHHHSTT---------------------------------------------------------CC--HHHHHHHHHHTC
T ss_pred cccccCC---------------------------------------------------------CC--HHHHHHHHHHHh
Confidence 2111000 00 168899999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCC
Q psy16081 423 YDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.||++||++.++|.|+|++..
T Consensus 260 ~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 260 KNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp SSGGGSCSSHHHHHHHHHHHH
T ss_pred cCHhhChhhHHHHHHHHHHHh
Confidence 999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=373.74 Aligned_cols=284 Identities=30% Similarity=0.482 Sum_probs=217.6
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+.++|++.+.||+|+||+||+|.+..+|+.||||++..... .......|+.++..+ +|+||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF------KHENIITIFNIQRPD 81 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC------CCTTBCCEEEECCCS
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC------cCCCcCCeeeeeccc
Confidence 456899999999999999999999999999999999964321 112233444444333 477899999987654
Q ss_pred -----ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 194 -----NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 194 -----~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
..+|+||||++++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 82 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~--~~~~~~kl~ 154 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLI--NSNCDLKVC 154 (353)
T ss_dssp CSTTCCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE--CTTCCEEEC
T ss_pred ccCccceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEE--cCCCcEEEE
Confidence 679999999999999998763 59999999999999999999995 789999999999999 678899999
Q ss_pred ecccccccCCc-------------cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy16081 269 DFGSSCQLGQR-------------IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334 (493)
Q Consensus 269 DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~ 334 (493)
|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 99999766422 223578999999999865 6799999999999999999999999999999999999
Q ss_pred HHHHhCCCChhhhhhcc---chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhh
Q psy16081 335 IVEVLGLPPKHLLDGAH---KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYL 411 (493)
Q Consensus 335 i~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (493)
+....+.++........ ....++...+.. + ...+.... .... .
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~-~~~~~~~~----------------~~~~--~ 280 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMY---------------P-AAPLEKMF----------------PRVN--P 280 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCC---------------C-CCCHHHHS----------------TTSC--H
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCC---------------C-Ccchhhhc----------------ccCC--H
Confidence 99888877633221111 111122211100 0 00000000 0011 2
Q ss_pred hHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 412 KFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 412 ~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
.+.+||.+||..||++|||+.|+|+||||+.....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 281 KGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred HHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 78999999999999999999999999999976543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=365.77 Aligned_cols=260 Identities=22% Similarity=0.313 Sum_probs=194.2
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|++++.||+|+||+||+|.+..+++.||||+++...... .....+.+........+||||+++++++.+.+..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ---EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH---HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 3578999999999999999999999999999999997543211 1122223333334556789999999999999999
Q ss_pred EEEEEecccCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 197 CLVFELLSYNLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
|+||||++++|.+++.. .....+++..++.++.||+.||.|||++ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-LSVIHRDVKPSNVLI--NALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-SCCCCCCCSGGGCEE--CTTCCEEBCCC----
T ss_pred EEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEE--CCCCCEEEeecCCcc
Confidence 99999999998887754 2234699999999999999999999951 389999999999999 678899999999997
Q ss_pred ccCCc--cccccccCcCCchhhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChhhh
Q psy16081 275 QLGQR--IYQYIQSRFYRSPEVL----LGIPYDLAIDMWSLGCILVEMHTGEPLFSG-SNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 275 ~~~~~--~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
..... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||.. ......+..+........
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 234 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---- 234 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC----
T ss_pred cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc----
Confidence 76443 2345799999999997 456789999999999999999999999986 344444443332110000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
+ ....+ ..+.+||.+||..||++
T Consensus 235 -------------------------------~------------------------~~~~~--~~~~~li~~~l~~~p~~ 257 (290)
T 3fme_A 235 -------------------------------P------------------------ADKFS--AEFVDFTSQCLKKNSKE 257 (290)
T ss_dssp -------------------------------C------------------------TTTSC--HHHHHHHHHHTCSSGGG
T ss_pred -------------------------------c------------------------cccCC--HHHHHHHHHHhhcChhh
Confidence 0 00001 16899999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy16081 428 RITPYYALQHNFFKRT 443 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~ 443 (493)
|||+.|+|+||||+..
T Consensus 258 Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 258 RPTYPELMQHPFFTLH 273 (290)
T ss_dssp SCCHHHHTTSHHHHHH
T ss_pred CcCHHHHHhCcccccC
Confidence 9999999999999854
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=376.56 Aligned_cols=288 Identities=30% Similarity=0.480 Sum_probs=215.4
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc------------chHHHHHHHHHHHHhhcCCCCcc
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF------------LNQAQIEVKLLEIMNKADVNNTY 181 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~------------~~~~~~e~~~~~~l~~~~~~~~~ 181 (493)
...+.++|++++.||+|+||.||+|.+.. ++.||||++...... ...+..|+.++..+ +||
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~ 89 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF------HHP 89 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC------CCT
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC------CCc
Confidence 34567899999999999999999998754 899999998643211 13344555554443 478
Q ss_pred eEEEeceeeee-----cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 182 YIVRLKRHFMW-----RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 182 ~Iv~l~~~~~~-----~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
||+++++++.. ...+|+||||++++|.+.+.... ..+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus 90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGNIL 166 (362)
T ss_dssp TBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEE
T ss_pred CccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CcCEecCCChHHEE
Confidence 89999999854 34689999999999999987654 469999999999999999999995 68999999999999
Q ss_pred eeCCCCCcEEEEecccccccCC--ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16081 257 LCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 333 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~ 333 (493)
+ +.++.+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 167 ~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 L--ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp E--CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred E--cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9 6788999999999975533 3345688999999999987 679999999999999999999999999999999999
Q ss_pred HHHHHhCCCChhhhhhccc--hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhh
Q psy16081 334 KIVEVLGLPPKHLLDGAHK--TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYL 411 (493)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (493)
.+.+..+.++......... ...++..... ..+ ...+.... .....
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~-~~~~~~~~------------------~~~~~ 291 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLS--------------NVP-ARAWTAVV------------------PTADP 291 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCC--------------CCC-CCCHHHHS------------------TTSCH
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcc--------------cCC-hhhHHhhC------------------CCCCH
Confidence 9999999887665443221 1122211100 000 00000000 00112
Q ss_pred hHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 412 KFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 412 ~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
.+.+||.+||.+||.+|||+.|+|+||||+.....
T Consensus 292 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 292 VALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 68999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=366.20 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=205.0
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
.|+..+.||+|+||+||+|++..+|+.||||++...... ......|..++ ...+|+||+++++++...+.+|+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l------~~l~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM------RDYQHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHH------TTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHH------HhCCCCCcceEEEEEEECCEEEE
Confidence 477888999999999999999999999999999754322 22333444333 33468889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+.+ +|.+++... .+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 120 v~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILL--TLDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp EECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--CCCCcEEEeeeeeeeecc
Confidence 9999965 898888653 59999999999999999999995 789999999999999 678899999999997764
Q ss_pred Cc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 278 QR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 278 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------- 262 (321)
T 2c30_A 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK---------- 262 (321)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT----------
T ss_pred cCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC----------
Confidence 32 34568999999999999999999999999999999999999999988877766655432110000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
... .. ...+.+||.+||..||++|||+.|+
T Consensus 263 -------------------------~~~-----------------------~~--~~~l~~li~~~l~~dp~~Rps~~el 292 (321)
T 2c30_A 263 -------------------------NSH-----------------------KV--SPVLRDFLERMLVRDPQERATAQEL 292 (321)
T ss_dssp -------------------------TGG-----------------------GS--CHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred -------------------------ccc-----------------------cC--CHHHHHHHHHHccCChhhCcCHHHH
Confidence 000 00 0168899999999999999999999
Q ss_pred hcCCCCCCC
Q psy16081 435 LQHNFFKRT 443 (493)
Q Consensus 435 L~Hp~~~~~ 443 (493)
|+||||...
T Consensus 293 l~hp~~~~~ 301 (321)
T 2c30_A 293 LDHPFLLQT 301 (321)
T ss_dssp HTSGGGGGC
T ss_pred hcChhhccC
Confidence 999999854
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=388.17 Aligned_cols=253 Identities=14% Similarity=0.187 Sum_probs=195.6
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEec-----
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLK----- 187 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~----- 187 (493)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ....+..|+.++ ..+...+||||++++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL---RLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGG---GGSTTCCSHHHHHHHHCBCC
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHH---HhccccCCHHHHHHHhhhhh
Confidence 35689999999999999999999999999999999974321 123334444333 445555799999998
Q ss_pred --eeeeecc-----------------eeEEEEEecccCHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhCCCC
Q psy16081 188 --RHFMWRN-----------------HLCLVFELLSYNLYDLLRNTNF-----RGVSLNLTRKFSQQLCTALLFLSTPEL 243 (493)
Q Consensus 188 --~~~~~~~-----------------~~~lV~E~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~Lhs~~~ 243 (493)
+++...+ ..||||||++|+|.+++..... ..+++..+..++.||+.||.|||+ .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~ 225 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--Y 225 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH--T
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh--C
Confidence 5555443 3899999998899999975421 113347888899999999999995 6
Q ss_pred CccccCCCCCcEEeeCCCCCcEEEEecccccccCCccccccccCcCCchhhhcCC-----------CCCchhhHHHHHHH
Q psy16081 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI-----------PYDLAIDMWSLGCI 312 (493)
Q Consensus 244 ~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvi 312 (493)
||+||||||+|||+ +.++.+||+|||+++..+......+| +.|+|||++.+. .|+.++|||||||+
T Consensus 226 ~ivHrDikp~NIll--~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 226 GLVHTYLRPVDIVL--DQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp TEECSCCCGGGEEE--CTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEE--cCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 89999999999999 67789999999999987777777888 999999999987 89999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccC
Q psy16081 313 LVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVES 392 (493)
Q Consensus 313 l~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 392 (493)
||||++|.+||.+.+..+....+. .. .
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~~---------------------~~---------------------~----------- 329 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWIF---------------------RS---------------------C----------- 329 (377)
T ss_dssp HHHHHHSSCCC------CCSGGGG---------------------SS---------------------C-----------
T ss_pred HHHHHHCCCCCcccccccchhhhh---------------------hh---------------------c-----------
Confidence 999999999997644221111000 00 0
Q ss_pred CCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 393 GGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
.... ..+.+||.+||..||++|||+.|+|+||||+...
T Consensus 330 ------------~~~~--~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 330 ------------KNIP--QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp ------------CCCC--HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred ------------cCCC--HHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 0001 1789999999999999999999999999998653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=360.84 Aligned_cols=263 Identities=30% Similarity=0.426 Sum_probs=210.3
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----------cchHHHHHHHHHHHHhhcCCCCcceEE
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----------FLNQAQIEVKLLEIMNKADVNNTYYIV 184 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----------~~~~~~~e~~~~~~l~~~~~~~~~~Iv 184 (493)
..+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......|..++..+. +||||+
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~ 87 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-----GHPNII 87 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBC
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc-----CCCCEe
Confidence 3567899999999999999999999999999999999974321 1122334444444332 578899
Q ss_pred EeceeeeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC
Q psy16081 185 RLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS 263 (493)
Q Consensus 185 ~l~~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~ 263 (493)
++++++...+.+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~ 161 (298)
T 1phk_A 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILL--DDDM 161 (298)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTC
T ss_pred eeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEE--cCCC
Confidence 99999999999999999996 49999997653 68999999999999999999995 789999999999999 6788
Q ss_pred cEEEEecccccccCC--ccccccccCcCCchhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy16081 264 AIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLL------GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 264 ~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i 335 (493)
.+||+|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 241 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241 (298)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH
Confidence 999999999977643 344567899999999985 456899999999999999999999999988887777666
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
.......+...+ . .. ...+.+
T Consensus 242 ~~~~~~~~~~~~----------------------------------~-----------------------~~--~~~l~~ 262 (298)
T 1phk_A 242 MSGNYQFGSPEW----------------------------------D-----------------------DY--SDTVKD 262 (298)
T ss_dssp HHTCCCCCTTTG----------------------------------G-----------------------GS--CHHHHH
T ss_pred hcCCcccCcccc----------------------------------c-----------------------cc--CHHHHH
Confidence 553211110000 0 00 016899
Q ss_pred HHhHccCCCCCCCCCHHHHhcCCCCCCCccCC
Q psy16081 416 LIFRMLDYDPKTRITPYYALQHNFFKRTADES 447 (493)
Q Consensus 416 Li~~mL~~dP~~R~t~~e~L~Hp~~~~~~~~~ 447 (493)
||.+||..||.+|||+.|+|+||||+....+.
T Consensus 263 li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (298)
T 1phk_A 263 LVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294 (298)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred HHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence 99999999999999999999999999765543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=362.97 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=203.1
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+.++|.+.+.||+|+||+||+|.+..+++.||||++..... .......|..++..+ +||||+++++++.+.
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL------DHPNIIKIFEVFEDY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC------CCTTBCCEEEEEECS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC------CCchHHhHHHheecC
Confidence 456789999999999999999999999999999999875432 234455555554433 578899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEEe
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVD 269 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~D 269 (493)
+.+|+||||+.+ +|.+.+... ....+++..++.++.||+.||.|||+ .||+||||||+|||+.+ +.++.+||+|
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 999999999965 999988543 22469999999999999999999995 78999999999999954 2457899999
Q ss_pred cccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 270 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 270 FG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.......+..
T Consensus 171 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 247 (285)
T 3is5_A 171 FGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-- 247 (285)
T ss_dssp CCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---
T ss_pred eecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc--
Confidence 999976543 234567899999999986 478999999999999999999999999887766655443211000000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
..... ..+.+||.+||..||++
T Consensus 248 --------------------------------------------------------~~~~~--~~~~~li~~~L~~dP~~ 269 (285)
T 3is5_A 248 --------------------------------------------------------CRPLT--PQAVDLLKQMLTKDPER 269 (285)
T ss_dssp ---------------------------------------------------------CCCC--HHHHHHHHHHTCSCTTT
T ss_pred --------------------------------------------------------cCcCC--HHHHHHHHHHccCChhh
Confidence 00001 16889999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q psy16081 428 RITPYYALQHNFFKR 442 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~ 442 (493)
|||+.|+|+||||++
T Consensus 270 Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 270 RPSAAQVLHHEWFKQ 284 (285)
T ss_dssp SCCHHHHHTSGGGGC
T ss_pred CcCHHHHhcCHHhhc
Confidence 999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=397.68 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=207.6
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
..++|++.++||+|+||.||+|++..+|+.||||++.... ........|..++..+ +||||++++++|.+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l------~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV------NSRFVVSLAYAYET 255 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC------CCTTBCCEEEEEEC
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc------CCCCEeeEEEEEee
Confidence 3568999999999999999999999999999999996431 1223344455554433 57889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+||||||+. ++|.+++.......+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILl--d~~g~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILL--DDHGHIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTSCEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEE--eCCCCeEEEecc
Confidence 999999999995 599999987655569999999999999999999995 689999999999999 788999999999
Q ss_pred cccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChh
Q psy16081 272 SSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE----VDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 272 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~~p~~ 345 (493)
++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+. ......+...-...+
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p-- 409 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS-- 409 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--
T ss_pred cceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--
Confidence 9987643 33567899999999999999999999999999999999999999987542 222222221100000
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
. ..+ ..+.+||.+||..||
T Consensus 410 ------------------------------------~-----------------------~~s--~~~~dLI~~lL~~dP 428 (576)
T 2acx_A 410 ------------------------------------E-----------------------RFS--PQARSLCSQLLCKDP 428 (576)
T ss_dssp ------------------------------------T-----------------------TSC--HHHHHHHHHHTCSSG
T ss_pred ------------------------------------c-----------------------cCC--HHHHHHHHHhccCCH
Confidence 0 001 178999999999999
Q ss_pred CCCC-----CHHHHhcCCCCCCCc
Q psy16081 426 KTRI-----TPYYALQHNFFKRTA 444 (493)
Q Consensus 426 ~~R~-----t~~e~L~Hp~~~~~~ 444 (493)
.+|| +++|+++||||+.+.
T Consensus 429 ~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 429 AERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp GGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred HHcCCCCCCCHHHHHhChhhccCC
Confidence 9999 899999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=374.81 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=206.6
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc----hHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL----NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+.|++++.||+|+||+||+|.+..+++.||||++....... ..+..|+.++..+ +||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL------RHPNTIQYRGCYLRE 126 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEEEEET
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC------CCCCEeeEEEEEEEC
Confidence 457999999999999999999999999999999997433211 2233344443332 478899999999999
Q ss_pred ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 194 NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 194 ~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
+..|+||||+.|+|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll--~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILL--SEPGLVKLGDFGSA 201 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEE--ETTTEEEECCCTTC
T ss_pred CeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEE--CCCCCEEEeeccCc
Confidence 9999999999999999886543 469999999999999999999995 689999999999999 57789999999999
Q ss_pred cccCCccccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 274 CQLGQRIYQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
...... ...+||+.|+|||++. +..++.++|||||||++|||++|.+||.+.+..+.+..+.........
T Consensus 202 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 274 (348)
T 1u5q_A 202 SIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ------ 274 (348)
T ss_dssp BSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC------
T ss_pred eecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC------
Confidence 776543 4568999999999995 467999999999999999999999999988877776665442110000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
. .... ..+.+||.+||..||++|||
T Consensus 275 ------------------------------~-----------------------~~~~--~~l~~li~~~l~~dP~~Rps 299 (348)
T 1u5q_A 275 ------------------------------S-----------------------GHWS--EYFRNFVDSCLQKIPQDRPT 299 (348)
T ss_dssp ------------------------------C-----------------------TTSC--HHHHHHHHHHTCSSGGGSCC
T ss_pred ------------------------------C-----------------------CCCC--HHHHHHHHHHcccChhhCcC
Confidence 0 0001 16889999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy16081 431 PYYALQHNFFKRT 443 (493)
Q Consensus 431 ~~e~L~Hp~~~~~ 443 (493)
++|+|+||||...
T Consensus 300 ~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 300 SEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHTTCHHHHSC
T ss_pred HHHHhhChhhhcc
Confidence 9999999999754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=374.29 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=197.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.++|++++.||+|+||+||+|.+ .+++.||||++...... ...+..|+.++..+.+ +|+||+++++++...+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~----~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ----HSDKIIRLYDYEITDQ 82 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSS
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhh----cCCceEEEeeeEeeCC
Confidence 45799999999999999999987 56899999999754322 2345566666666653 3467999999999999
Q ss_pred eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 195 HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 195 ~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.+|||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++ ++.+||+|||++.
T Consensus 83 ~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~---~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 83 YIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV---DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEEEECCCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE---TTEEEECCCSSSC
T ss_pred EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE---CCcEEEeeccccc
Confidence 99999998788999999865 369999999999999999999995 7899999999999993 4679999999998
Q ss_pred ccCCc-----cccccccCcCCchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH
Q psy16081 275 QLGQR-----IYQYIQSRFYRSPEVLLG-----------IPYDLAIDMWSLGCILVEMHTGEPLFSGSNE-VDQMNKIVE 337 (493)
Q Consensus 275 ~~~~~-----~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~i~~ 337 (493)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..... ...+..+..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 76432 235679999999999965 6789999999999999999999999986433 222222221
Q ss_pred HhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHH
Q psy16081 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417 (493)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi 417 (493)
.... ...+ ......+.+||
T Consensus 236 ~~~~----------------------------------~~~~---------------------------~~~~~~l~~li 254 (343)
T 3dbq_A 236 PNHE----------------------------------IEFP---------------------------DIPEKDLQDVL 254 (343)
T ss_dssp TTSC----------------------------------CCCC---------------------------CCSCHHHHHHH
T ss_pred CCcc----------------------------------cCCc---------------------------ccCCHHHHHHH
Confidence 0000 0000 00001688999
Q ss_pred hHccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 418 FRMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 418 ~~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
.+||..||.+|||+.|+|+||||+...
T Consensus 255 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 255 KCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHcCCChhHCCCHHHHHhCccccccC
Confidence 999999999999999999999998543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=392.37 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=207.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++.++||+|+||+||+|++..+|+.||||++.+.. ........|..++..+ +||||++++++|.+.
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l------~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV------HSRFIVSLAYAFETK 257 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC------CCTTBCCEEEEEECS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc------CCCCEeeEEEEEeeC
Confidence 478999999999999999999999999999999996432 1223444555555443 578899999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTN--FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
+.+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl--~~~g~vkL~DF 333 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLL--DDDGNVRISDL 333 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTSCEEECCC
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEE--eCCCCEEEeec
Confidence 99999999996 49999887543 3469999999999999999999995 789999999999999 78899999999
Q ss_pred ccccccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCC
Q psy16081 271 GSSCQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN----EVDQMNKIVEVLGLPP 343 (493)
Q Consensus 271 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~----~~~~~~~i~~~~~~~p 343 (493)
|+++..... ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+ ..+....+.......|
T Consensus 334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p 413 (543)
T 3c4z_A 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413 (543)
T ss_dssp TTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC
T ss_pred ceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC
Confidence 999876433 234689999999999999999999999999999999999999998753 3344444433110000
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
. ..+ ..+.+||.+||..
T Consensus 414 ~-------------------------------------------------------------~~s--~~~~~li~~lL~~ 430 (543)
T 3c4z_A 414 D-------------------------------------------------------------KFS--PASKDFCEALLQK 430 (543)
T ss_dssp T-------------------------------------------------------------TSC--HHHHHHHHHHSCS
T ss_pred c-------------------------------------------------------------ccC--HHHHHHHHHhccC
Confidence 0 000 1789999999999
Q ss_pred CCCCCCC-----HHHHhcCCCCCCCcc
Q psy16081 424 DPKTRIT-----PYYALQHNFFKRTAD 445 (493)
Q Consensus 424 dP~~R~t-----~~e~L~Hp~~~~~~~ 445 (493)
||.+||+ ++++++||||+.+..
T Consensus 431 dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 431 DPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp SGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred CHhHCCCCcccCHHHHHcCccccCCCH
Confidence 9999996 589999999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=368.53 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=194.0
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+.++|++++.||+|+||+||+|++..+++.||||+++.... .......|+.+ +...+||||++++++|.+.
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~------l~~l~hpniv~~~~~~~~~ 76 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA------LAKLEHPGIVRYFNAWLET 76 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHH------HTSCCCTTBCCEEEEEEEC
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHH------HHhCCCCCEeeEEEEEEEe
Confidence 456789999999999999999999999999999999974332 12223333333 3344688999999998654
Q ss_pred c---------------------------------------------------------eeEEEEEeccc-CHHHHHhccC
Q psy16081 194 N---------------------------------------------------------HLCLVFELLSY-NLYDLLRNTN 215 (493)
Q Consensus 194 ~---------------------------------------------------------~~~lV~E~~~~-~L~~~l~~~~ 215 (493)
. ++|+|||||.+ +|.+++....
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 156 (332)
T 3qd2_B 77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156 (332)
T ss_dssp CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence 3 38999999965 9999987643
Q ss_pred C-CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc---------------
Q psy16081 216 F-RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--------------- 279 (493)
Q Consensus 216 ~-~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~--------------- 279 (493)
. ...++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++......
T Consensus 157 ~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 157 SLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp SGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTCCEEECCCTTCEECSCC--------------C
T ss_pred CccchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEE--eCCCCEEEeecCcccccccchhhcccccccccccc
Confidence 2 235667789999999999999995 789999999999999 67889999999999876543
Q ss_pred cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChhhhhhccchhhhhc
Q psy16081 280 IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG-LPPKHLLDGAHKTRKYFD 358 (493)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~~~ 358 (493)
....+||+.|+|||++.+..++.++|||||||++|+|++|..|+. +....+..... ..+....
T Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~~~~----------- 296 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPLLFT----------- 296 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCHHHH-----------
T ss_pred ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCcccc-----------
Confidence 133579999999999999999999999999999999999887653 11111111111 1111000
Q ss_pred cCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCC
Q psy16081 359 KMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHN 438 (493)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp 438 (493)
.....+.+||.+||..||++|||+.|+|+||
T Consensus 297 -------------------------------------------------~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 297 -------------------------------------------------QKYPQEHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp -------------------------------------------------HHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred -------------------------------------------------cCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence 0011678999999999999999999999999
Q ss_pred CCCCC
Q psy16081 439 FFKRT 443 (493)
Q Consensus 439 ~~~~~ 443 (493)
||+.+
T Consensus 328 ~f~~~ 332 (332)
T 3qd2_B 328 IFENL 332 (332)
T ss_dssp TCCCC
T ss_pred hhhcC
Confidence 99853
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=378.16 Aligned_cols=265 Identities=15% Similarity=0.150 Sum_probs=189.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEece-----
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKR----- 188 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~----- 188 (493)
...|++.+.||+|+||+||+|.+..+++.||||++..... .......|..++..+.. +||||++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~----~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG----ESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC--------------CBCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc----cChhhhhhceeEEee
Confidence 3469999999999999999999999999999999986432 12233445444555543 6888887553
Q ss_pred --eeeec-----------------ceeEEEEEecccCHHHHHhccCCCCCCHHHH------HHHHHHHHHHHHHHhCCCC
Q psy16081 189 --HFMWR-----------------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLT------RKFSQQLCTALLFLSTPEL 243 (493)
Q Consensus 189 --~~~~~-----------------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~~Lhs~~~ 243 (493)
.+... ..+|||||||+++|.+++.... ..+.+... ..++.||+.||.|||+ .
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~--~ 213 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS--K 213 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH--T
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH--C
Confidence 33322 4489999999999999997643 23455555 6777999999999995 7
Q ss_pred CccccCCCCCcEEeeCCCCCcEEEEecccccccCCccccccccCcCCchhhhcC--CCCCchhhHHHHHHHHHHHHhCCC
Q psy16081 244 NIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHTGEP 321 (493)
Q Consensus 244 ~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~ 321 (493)
|||||||||+|||+ +.++.+||+|||+++..+.......+|+.|+|||++.+ ..|+.++|||||||+||||++|.+
T Consensus 214 ~ivHrDikp~NIll--~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 214 GLVHGHFTPDNLFI--MPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp TEEETTCSGGGEEE--CTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCcCCHHHEEE--CCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 89999999999999 67889999999999988776656777899999999988 679999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCC
Q psy16081 322 LFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401 (493)
Q Consensus 322 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 401 (493)
||.+...... ..+.... ... ........+..
T Consensus 292 Pf~~~~~~~~-----------------------~~~~~~~-----~~~-~~~~~~~~~~~-------------------- 322 (371)
T 3q60_A 292 PFGLVTPGIK-----------------------GSWKRPS-----LRV-PGTDSLAFGSC-------------------- 322 (371)
T ss_dssp STTBCCTTCT-----------------------TCCCBCC-----TTS-CCCCSCCCTTS--------------------
T ss_pred CCCCcCcccc-----------------------cchhhhh-----hhh-ccccccchhhc--------------------
Confidence 9986532100 0000000 000 00000000000
Q ss_pred CCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 402 ~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
...+ ..+.+||.+||..||++|||+.|+|+||||+....
T Consensus 323 ---~~~~--~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 323 ---TPLP--DFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp ---SCCC--HHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred ---cCCC--HHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 0111 27899999999999999999999999999987644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=361.37 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=208.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-------cchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|++.+.||+|+||+||+|.+..+++.||||+++.... ....+..|..++..+ +||||+++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~ 77 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI------RHPNIITLHDIF 77 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC------CCCCeeehhhee
Confidence 4689999999999999999999999999999999875321 134455666665544 377899999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC--CCcEEE
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK--RSAIKI 267 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~--~~~ikL 267 (493)
...+..|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.+. ...+||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 78 ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred cCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCceEE
Confidence 99999999999995 59999987653 68999999999999999999995 7999999999999994322 227999
Q ss_pred EecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 268 VDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 268 ~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.......+..
T Consensus 154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T 3bhy_A 154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE 233 (283)
T ss_dssp CCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH
T ss_pred EecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch
Confidence 99999977643 2345678999999999999999999999999999999999999999988877766665432221111
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
.. .. . ...+.+||.+||..||
T Consensus 234 ~~----------~~-----------------------------------------------~--~~~~~~li~~~l~~dp 254 (283)
T 3bhy_A 234 YF----------SN-----------------------------------------------T--SELAKDFIRRLLVKDP 254 (283)
T ss_dssp HH----------TT-----------------------------------------------C--CHHHHHHHHTTSCSSG
T ss_pred hc----------cc-----------------------------------------------C--CHHHHHHHHHHccCCH
Confidence 10 00 0 0168899999999999
Q ss_pred CCCCCHHHHhcCCCCCCCccC
Q psy16081 426 KTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
++|||+.|+|+||||+.....
T Consensus 255 ~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 255 KRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp GGSCCHHHHHHCHHHHHHHHC
T ss_pred hHCcCHHHHHhCHHHHHHHHH
Confidence 999999999999999876444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=378.15 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=198.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+|++++.||+|+||+||+|.+.. ++.||||++...... ...+..|+.++..+.+ +|+||+++++++...+.
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~----~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ----HSDKIIRLYDYEITDQY 130 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSSE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHccc----CCCeEEEEEEEEecCCE
Confidence 469999999999999999998765 899999999754322 2345566666666543 46789999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ + ++.+||+|||++..
T Consensus 131 ~~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll--~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 131 IYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLI--V-DGMLKLIDFGIANQ 203 (390)
T ss_dssp EEEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEE--S-SSCEEECCCSSSCC
T ss_pred EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEE--E-CCeEEEEecCcccc
Confidence 99999977779999997654 68999999999999999999995 789999999999999 2 47899999999987
Q ss_pred cCCc-----cccccccCcCCchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH
Q psy16081 276 LGQR-----IYQYIQSRFYRSPEVLLG-----------IPYDLAIDMWSLGCILVEMHTGEPLFSGSNE-VDQMNKIVEV 338 (493)
Q Consensus 276 ~~~~-----~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~ 338 (493)
.... ....+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+... ...+..+...
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 6432 235679999999999976 3689999999999999999999999986532 2333333210
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
.... ..+ .. . ...+.+||.
T Consensus 284 ~~~~----------------------------------~~~------------------------~~-~--~~~~~~li~ 302 (390)
T 2zmd_A 284 NHEI----------------------------------EFP------------------------DI-P--EKDLQDVLK 302 (390)
T ss_dssp TSCC----------------------------------CCC------------------------CC-S--CHHHHHHHH
T ss_pred cccC----------------------------------CCC------------------------cc-c--hHHHHHHHH
Confidence 0000 000 00 0 116889999
Q ss_pred HccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 419 RMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 419 ~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
+||..||.+|||+.|+|+||||+...
T Consensus 303 ~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 303 CCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHcccChhhCCCHHHHhhCcCccccC
Confidence 99999999999999999999998543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=365.02 Aligned_cols=286 Identities=28% Similarity=0.415 Sum_probs=211.9
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee-
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM- 191 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~- 191 (493)
+..+.++|++++.||+|+||+||+|.+..+++.||||++..... .......|..++. ..+||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~------~l~h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIR------RLDHDNIVKVFEILGP 79 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHH------TCCCTTBCCEEEEECT
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHH------hcCCCCeeEEEEeccc
Confidence 45677899999999999999999999999999999999874431 1222333433333 335788999998873
Q ss_pred -------------ecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee
Q psy16081 192 -------------WRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258 (493)
Q Consensus 192 -------------~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~ 258 (493)
..+.+|+||||++++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFIN 154 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEE
T ss_pred cccccccccccccccCceeEEeeccCCCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEc
Confidence 44688999999999999998653 58999999999999999999995 7899999999999994
Q ss_pred CCCCCcEEEEecccccccCC------ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy16081 259 NPKRSAIKIVDFGSSCQLGQ------RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ 331 (493)
Q Consensus 259 ~~~~~~ikL~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~ 331 (493)
..++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 155 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 155 -TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp -TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2567899999999986642 2334567899999999876 6799999999999999999999999999999999
Q ss_pred HHHHHHHhCCCChhhhhhccch-hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchh
Q psy16081 332 MNKIVEVLGLPPKHLLDGAHKT-RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410 (493)
Q Consensus 332 ~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (493)
+..+......+........... ..+...... . ....+..+.. ..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~-~~~~~~~~~~----------------~~~-- 279 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMT---------------E-PHKPLTQLLP----------------GIS-- 279 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTT---------------S-CCCCHHHHST----------------TCC--
T ss_pred HHHHHHhcCCCchhhhhhhhhcCccccccccc---------------C-CCCChhHhcc----------------hhh--
Confidence 9999888776655443322111 001000000 0 0000000000 011
Q ss_pred hhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 411 LKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 411 ~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
..+.+||.+||..||++|||+.|+|+||||+....
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 280 REAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 27899999999999999999999999999986543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=364.25 Aligned_cols=259 Identities=28% Similarity=0.359 Sum_probs=210.7
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.+.++|.+.+.||+|+||+||+|.+..+++.||||+++.... .......|..++..+ +||||+++++++.+.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI------KHENIVTLEDIYESTT 79 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC------CCTTBCCEEEEEECSS
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC------CCCCeeehhhhcccCC
Confidence 456789999999999999999999999999999999975432 123344555554443 4778999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEEeccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVDFGS 272 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~DFG~ 272 (493)
.+|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||+.. +.++.+||+|||+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~ 155 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGL 155 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence 99999999965 9999887653 58999999999999999999995 78999999999999943 3567899999999
Q ss_pred ccccCCc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 273 SCQLGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 273 a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----- 230 (304)
T 2jam_A 156 SKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF----- 230 (304)
T ss_dssp TCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT-----
T ss_pred ceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc-----
Confidence 9765443 3456799999999999999999999999999999999999999999888777777655321111000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
+. ... ..+.+||.+||..||++|||+
T Consensus 231 -----~~-----------------------------------------------~~~--~~~~~li~~~l~~dp~~Rps~ 256 (304)
T 2jam_A 231 -----WD-----------------------------------------------DIS--ESAKDFICHLLEKDPNERYTC 256 (304)
T ss_dssp -----TT-----------------------------------------------TSC--HHHHHHHHHHHCSSTTTSCCH
T ss_pred -----cc-----------------------------------------------cCC--HHHHHHHHHHcCCChhHCcCH
Confidence 00 001 178999999999999999999
Q ss_pred HHHhcCCCCCCC
Q psy16081 432 YYALQHNFFKRT 443 (493)
Q Consensus 432 ~e~L~Hp~~~~~ 443 (493)
.|+|+||||+..
T Consensus 257 ~~~l~h~~~~~~ 268 (304)
T 2jam_A 257 EKALSHPWIDGN 268 (304)
T ss_dssp HHHHTSHHHHSS
T ss_pred HHHhcCccccCC
Confidence 999999999854
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=363.01 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=204.3
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee--ec
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM--WR 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~--~~ 193 (493)
.+.++|++.+.||+|+||.||+|.+..+++.||||++....... ....+..+.+++......+|+||+++++++. ..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence 35678999999999999999999999999999999997432100 0011222333333444456889999999984 45
Q ss_pred ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 194 NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 194 ~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
+.+|+||||+.++|.+++.......+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~--~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLL--TTGGTLKISALGVA 156 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCCEEECCCTTC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEE--cCCCcEEeeccccc
Confidence 68999999999888888877655679999999999999999999995 689999999999999 67889999999999
Q ss_pred cccCC-----ccccccccCcCCchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 274 CQLGQ-----RIYQYIQSRFYRSPEVLLGIP--YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 274 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-- 234 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG-- 234 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS--
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC--
Confidence 76532 223557899999999998754 478999999999999999999999988877666655432100000
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
.....+.+||.+||..||.
T Consensus 235 -------------------------------------------------------------~~~~~l~~li~~~l~~dp~ 253 (305)
T 2wtk_C 235 -------------------------------------------------------------DCGPPLSDLLKGMLEYEPA 253 (305)
T ss_dssp -------------------------------------------------------------SSCHHHHHHHHHHTCSSTT
T ss_pred -------------------------------------------------------------ccCHHHHHHHHHHccCChh
Confidence 0011688999999999999
Q ss_pred CCCCHHHHhcCCCCCCCc
Q psy16081 427 TRITPYYALQHNFFKRTA 444 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~~ 444 (493)
+|||+.|+++||||+...
T Consensus 254 ~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 254 KRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp TSCCHHHHHHSHHHHSCC
T ss_pred hCCCHHHHhcCcccccCC
Confidence 999999999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=364.43 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=207.9
Q ss_pred ccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 113 HGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 113 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
......++|++++.||+|+||.||+|.+..+++.||||++............|..++..+. +|+||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC-----CSTTBCCEEEEEEE
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc-----CCCCeeeeeeEEee
Confidence 3445678999999999999999999999999999999999765555566777777666552 47789999999987
Q ss_pred ------cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 193 ------RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 193 ------~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
.+.+|+||||+++ +|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~--~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLL--TENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEE--CTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEE--cCCCCE
Confidence 5689999999966 99999976544569999999999999999999995 689999999999999 678899
Q ss_pred EEEecccccccCCc---cccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q psy16081 266 KIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337 (493)
Q Consensus 266 kL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 337 (493)
||+|||++...... .....||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 99999999776432 34567899999999997 56789999999999999999999999998887666554433
Q ss_pred HhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHH
Q psy16081 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417 (493)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi 417 (493)
... +. . . . .... ..+.+||
T Consensus 249 ~~~-~~-~---------------~-------------------~-----------------------~~~~--~~l~~li 267 (326)
T 2x7f_A 249 NPA-PR-L---------------K-------------------S-----------------------KKWS--KKFQSFI 267 (326)
T ss_dssp SCC-CC-C---------------S-------------------C-----------------------SCSC--HHHHHHH
T ss_pred Ccc-cc-C---------------C-------------------c-----------------------cccC--HHHHHHH
Confidence 100 00 0 0 0 0001 1789999
Q ss_pred hHccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 418 FRMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 418 ~~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
.+||..||.+|||+.|+|+||||+...
T Consensus 268 ~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 268 ESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHhccChhhCCCHHHHhhChHHhhCc
Confidence 999999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=373.48 Aligned_cols=304 Identities=24% Similarity=0.318 Sum_probs=209.7
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
...++|++++.||+|+||+||+|.+..+++.||+|++..... ......+.+++......+|+||+++++++...+.
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC----HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 445789999999999999999999999999999999975421 1111223344444444578999999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||+ ..||+||||||+|||+ +.++.+||+|||++.
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILV--NSRGEIKLCDFGVSG 180 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEE--CTTCCEEECCCCCCH
T ss_pred EEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEE--CCCCCEEEEECCCCc
Confidence 9999999965 9999997654 58999999999999999999995 1389999999999999 678899999999997
Q ss_pred ccCC-ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 275 QLGQ-RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 275 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..................
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 6533 334568999999999999999999999999999999999999999988766554333221111111100000000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
...+..... ... ......+++......+. ...+....+ ..+.+||.+||.+||++|||++|
T Consensus 261 ~~~~~~~~~-------------~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~e 321 (360)
T 3eqc_A 261 GRPLNKFGM-------------DSR-PPMAIFELLDYIVNEPP---PKLPSGVFS--LEFQDFVNKCLIKNPAERADLKQ 321 (360)
T ss_dssp ---------------------------CCCHHHHHHHHHHSCC---CCCCTTTSC--HHHHHHHHHHHCSSTTTSCCHHH
T ss_pred CCccccccc-------------CCC-CcccchhhhhHHhccCC---CCCCccccc--HHHHHHHHHHhhcChhhCCCHHH
Confidence 000000000 000 00000111110000000 000111112 27899999999999999999999
Q ss_pred HhcCCCCCCCccCC
Q psy16081 434 ALQHNFFKRTADES 447 (493)
Q Consensus 434 ~L~Hp~~~~~~~~~ 447 (493)
+|+||||+......
T Consensus 322 ll~hp~~~~~~~~~ 335 (360)
T 3eqc_A 322 LMVHAFIKRSDAEE 335 (360)
T ss_dssp HHTSHHHHHHHHSC
T ss_pred HhhChHhhcchHhh
Confidence 99999999765443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=366.53 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=206.9
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
..++|.+.+.||+|+||.||+|.+..+++.||+|++...... ......|..+ ....+|+||+++++++.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~------l~~l~h~~iv~~~~~~~~ 112 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI------HRSLAHQHVVGFHGFFED 112 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHH------HHTCCCTTBCCEEEEEEC
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHH------HHhCCCCCCCeEEEEEec
Confidence 356899999999999999999999999999999998743211 1222223332 233468889999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~--~~~~~~kl~Dfg 186 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFL--NEDLEVKIGDFG 186 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE--CTTCCEEECCCT
T ss_pred CCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEE--cCCCCEEEeecc
Confidence 9999999999965 8999887653 69999999999999999999995 689999999999999 678899999999
Q ss_pred cccccCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 272 SSCQLGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 272 ~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 262 (335)
T 2owb_A 187 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK---- 262 (335)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----
T ss_pred CceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----
Confidence 9976642 234567899999999999999999999999999999999999999988877666555432110000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
... ..+.+||.+||..||++|
T Consensus 263 ---------------------------------------------------------~~~--~~~~~li~~~l~~dp~~R 283 (335)
T 2owb_A 263 ---------------------------------------------------------HIN--PVAASLIQKMLQTDPTAR 283 (335)
T ss_dssp ---------------------------------------------------------TSC--HHHHHHHHHHTCSSGGGS
T ss_pred ---------------------------------------------------------cCC--HHHHHHHHHHccCChhHC
Confidence 000 167899999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q psy16081 429 ITPYYALQHNFFKRT 443 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~ 443 (493)
||+.|+|+||||+..
T Consensus 284 ps~~ell~~~~~~~~ 298 (335)
T 2owb_A 284 PTINELLNDEFFTSG 298 (335)
T ss_dssp CCGGGGGGSHHHHTS
T ss_pred cCHHHHhcCccccCC
Confidence 999999999999854
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=357.94 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=206.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ........|..++. ..+|+||+++++++.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~------~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS------HLRHPNILRMYNYFHDR 86 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHH------TCCCTTBCCEEEEEECS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHh------cCCCCCEeeEEEEEEcC
Confidence 468999999999999999999999999999999986421 11223344444433 33578899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLM--GYKGELKIADFGW 160 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEE--CTTCCEEECCCTT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEE--cCCCCEEEecccc
Confidence 999999999965 9999987654 58999999999999999999994 789999999999999 6788999999999
Q ss_pred ccccCC-ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 273 SCQLGQ-RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 273 a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
+..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......|.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 233 (284)
T 2vgo_A 161 SVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP------- 233 (284)
T ss_dssp CEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT-------
T ss_pred cccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC-------
Confidence 976643 334567899999999999999999999999999999999999999988877766655431100000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
..+ ..+.+||.+||..||.+|||+
T Consensus 234 ------------------------------------------------------~~~--~~~~~li~~~l~~~p~~Rps~ 257 (284)
T 2vgo_A 234 ------------------------------------------------------FLS--DGSKDLISKLLRYHPPQRLPL 257 (284)
T ss_dssp ------------------------------------------------------TSC--HHHHHHHHHHSCSSGGGSCCH
T ss_pred ------------------------------------------------------cCC--HHHHHHHHHHhhcCHhhCCCH
Confidence 001 168899999999999999999
Q ss_pred HHHhcCCCCCC
Q psy16081 432 YYALQHNFFKR 442 (493)
Q Consensus 432 ~e~L~Hp~~~~ 442 (493)
.|+++||||+.
T Consensus 258 ~~ll~h~~~~~ 268 (284)
T 2vgo_A 258 KGVMEHPWVKA 268 (284)
T ss_dssp HHHHTCHHHHH
T ss_pred HHHhhCHHHHh
Confidence 99999999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=358.11 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=205.9
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|.+.+.||+|+||+||+|.+..+++.||+|++......... . ...+..++......+|+||+++++++.+.+.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~-~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH-Q-REKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHH-H-HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHH-H-HHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 356899999999999999999999999999999998743221111 1 11122222222334688899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFL--NEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEE--cCCCCEEEEeccCcee
Confidence 999999965 8998887653 68999999999999999999995 689999999999999 6788999999999976
Q ss_pred cCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+.......+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 236 (294)
T 2rku_A 165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK-------- 236 (294)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--------
T ss_pred cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc--------
Confidence 542 334567899999999999999999999999999999999999999988876665554321100000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
... ..+.+||.+||..||++|||+.
T Consensus 237 -----------------------------------------------------~~~--~~~~~li~~~l~~~p~~Rps~~ 261 (294)
T 2rku_A 237 -----------------------------------------------------HIN--PVAASLIQKMLQTDPTARPTIN 261 (294)
T ss_dssp -----------------------------------------------------TSC--HHHHHHHHHHTCSSGGGSCCGG
T ss_pred -----------------------------------------------------ccC--HHHHHHHHHHcccChhhCcCHH
Confidence 000 1688999999999999999999
Q ss_pred HHhcCCCCCCC
Q psy16081 433 YALQHNFFKRT 443 (493)
Q Consensus 433 e~L~Hp~~~~~ 443 (493)
|+|+||||+..
T Consensus 262 ~ll~~~~~~~~ 272 (294)
T 2rku_A 262 ELLNDEFFTSG 272 (294)
T ss_dssp GGGGSHHHHTS
T ss_pred HHhhChheecC
Confidence 99999999854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.90 Aligned_cols=252 Identities=33% Similarity=0.517 Sum_probs=179.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++.+.||+|+||+||+|.+..+++.||||++..... .......|.. .....+||||+++++++.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~------~l~~l~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK------IHCQLKHPSILELYNYFEDS 83 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH------HHTTBCCTTBCCEEEEEECS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHH------HHHhCCCCCeEeEEEEEccC
Confidence 4689999999999999999999999999999999964221 1122333333 33344688899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili--~~~~~~kl~dfg~ 158 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLL--TRNMNIKIADFGL 158 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEE--CTTCCEEECCCTT
T ss_pred CeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--cCCCCEEEEeecc
Confidence 999999999965 8999887543 468999999999999999999995 689999999999999 6788999999999
Q ss_pred ccccCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQLGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 226 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------ 226 (278)
T ss_dssp CEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence 977643 23456789999999999998999999999999999999999999986543222211100
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
..+ ..+ ...+ ..+.+||.+||..||++||
T Consensus 227 -------------~~~-----------~~~-------------------------~~~~--~~~~~li~~~l~~dp~~Rp 255 (278)
T 3cok_A 227 -------------ADY-----------EMP-------------------------SFLS--IEAKDLIHQLLRRNPADRL 255 (278)
T ss_dssp -------------SCC-----------CCC-------------------------TTSC--HHHHHHHHHHSCSSGGGSC
T ss_pred -------------ccc-----------CCc-------------------------cccC--HHHHHHHHHHcccCHhhCC
Confidence 000 000 0011 1688999999999999999
Q ss_pred CHHHHhcCCCCCCC
Q psy16081 430 TPYYALQHNFFKRT 443 (493)
Q Consensus 430 t~~e~L~Hp~~~~~ 443 (493)
|+.|+|+||||...
T Consensus 256 s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 256 SLSSVLDHPFMSRN 269 (278)
T ss_dssp CHHHHTTSTTTC--
T ss_pred CHHHHhcCccccCC
Confidence 99999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=352.66 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=199.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee----cc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW----RN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~----~~ 194 (493)
..|++.+.||+|+||+||+|.+..++..||+|++........... .+.+++......+||||++++++|.. ..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHH---HHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHH---HHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 358999999999999999999999999999999975432222222 22233333344468899999999875 46
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+||||+++ +|.+++.... .+++..++.++.||+.||.|||++..+|+||||||+|||++ +.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-GPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-STTSCEEECCTTGG
T ss_pred eEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE-CCCCCEEEeeCCCc
Confidence 78999999955 9999997653 58999999999999999999996322399999999999993 26789999999999
Q ss_pred cccCCc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 274 CQLGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 274 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+................+ ...
T Consensus 180 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~------ 251 (290)
T 1t4h_A 180 TLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASF------ 251 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-GGG------
T ss_pred ccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-ccc------
Confidence 766543 345679999999998875 59999999999999999999999998765544433322211100 000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
. . .....+.+||.+||..||.+|||+.
T Consensus 252 -----~---------------------------~---------------------~~~~~l~~li~~~l~~dp~~Rps~~ 278 (290)
T 1t4h_A 252 -----D---------------------------K---------------------VAIPEVKEIIEGCIRQNKDERYSIK 278 (290)
T ss_dssp -----G---------------------------G---------------------CCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred -----C---------------------------C---------------------CCCHHHHHHHHHHccCChhhCCCHH
Confidence 0 0 0001689999999999999999999
Q ss_pred HHhcCCCCCC
Q psy16081 433 YALQHNFFKR 442 (493)
Q Consensus 433 e~L~Hp~~~~ 442 (493)
|+|+||||+.
T Consensus 279 ell~h~~f~~ 288 (290)
T 1t4h_A 279 DLLNHAFFQE 288 (290)
T ss_dssp HHHTSGGGC-
T ss_pred HHhhCccccc
Confidence 9999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=354.82 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=196.7
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
..+.++|++.+.||+|+||+||+|.+..+++.||||++...................+.. ..+||||+++++++.+.+
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~--l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV--LGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHH--SCSCTTBCCEEEEEEETT
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHH--hCCCCCeeeeeeeeecCC
Confidence 356678999999999999999999999999999999997543222222111111122222 226888999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-----------
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTN--FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP----------- 260 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~----------- 260 (493)
.+|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC-------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 99999999965 9999987542 1458999999999999999999995 789999999999999422
Q ss_pred ------CCCcEEEEecccccccCCccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy16081 261 ------KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 333 (493)
Q Consensus 261 ------~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~ 333 (493)
....+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...+.. .
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~ 238 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---H 238 (289)
T ss_dssp -------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---H
T ss_pred cccccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---H
Confidence 34579999999998775543 35699999999999876 5678999999999999999999887654322 2
Q ss_pred HHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhH
Q psy16081 334 KIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413 (493)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (493)
.+... ..+ . .+ . ..+ ..+
T Consensus 239 ~~~~~--~~~---------------~------------------~~--~-----------------------~~~--~~~ 256 (289)
T 1x8b_A 239 EIRQG--RLP---------------R------------------IP--Q-----------------------VLS--QEF 256 (289)
T ss_dssp HHHTT--CCC---------------C------------------CS--S-----------------------CCC--HHH
T ss_pred HHHcC--CCC---------------C------------------CC--c-----------------------ccC--HHH
Confidence 22110 000 0 00 0 001 178
Q ss_pred HHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 414 ~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.+||.+||..||++|||+.|+|+||||+..
T Consensus 257 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 257 TELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 999999999999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=367.40 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=202.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCc-----ccchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKK-----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~-----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
.++|+++++||+|+||+||+|++. .+++.||||+++... ........|..++..+. +|+||++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~ 127 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYA 127 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH-----TCTTBCCEEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc-----CCCceeEEEEE
Confidence 468999999999999999999884 589999999986422 22344556777776664 46779999999
Q ss_pred eeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 190 FMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
+...+.+||||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll--~~~~~~kl~ 201 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILL--DSNGHVVLT 201 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTSCEEES
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCcEEEe
Confidence 9999999999999965 9999997654 59999999999999999999995 789999999999999 678899999
Q ss_pred ecccccccCC----ccccccccCcCCchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHH
Q psy16081 269 DFGSSCQLGQ----RIYQYIQSRFYRSPEVLLGI--PYDLAIDMWSLGCILVEMHTGEPLFSGSNEV----DQMNKIVEV 338 (493)
Q Consensus 269 DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~----~~~~~i~~~ 338 (493)
|||+++.... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+...
T Consensus 202 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 202 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281 (355)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence 9999976532 23456899999999999863 4889999999999999999999999754322 222222110
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
....+ . ... ..+.+||.
T Consensus 282 ~~~~~--------------------------------------~-----------------------~~~--~~~~~li~ 298 (355)
T 1vzo_A 282 EPPYP--------------------------------------Q-----------------------EMS--ALAKDLIQ 298 (355)
T ss_dssp CCCCC--------------------------------------T-----------------------TSC--HHHHHHHH
T ss_pred CCCCC--------------------------------------c-----------------------ccC--HHHHHHHH
Confidence 00000 0 000 16789999
Q ss_pred HccCCCCCCCC-----CHHHHhcCCCCCCCc
Q psy16081 419 RMLDYDPKTRI-----TPYYALQHNFFKRTA 444 (493)
Q Consensus 419 ~mL~~dP~~R~-----t~~e~L~Hp~~~~~~ 444 (493)
+||..||.+|| |++|+++||||+...
T Consensus 299 ~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 299 RLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp HHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 99999999999 999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=371.15 Aligned_cols=248 Identities=29% Similarity=0.433 Sum_probs=201.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---------cchHHHHHHHHHHHHhhcCCCCcceEEEe
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---------FLNQAQIEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
.+.++|++++.||+|+||+||+|.+..+++.||||+++.... ....+..|+.++.. .+||||+++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~------l~h~~Iv~~ 94 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR------VEHANIIKV 94 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTT------CCCTTBCCE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHh------CCCCCEeeE
Confidence 466799999999999999999999999999999999975431 11233345554433 357889999
Q ss_pred ceeeeecceeEEEEEec-cc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc
Q psy16081 187 KRHFMWRNHLCLVFELL-SY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 187 ~~~~~~~~~~~lV~E~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ 264 (493)
+++|.+.+.+++||||+ .+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.
T Consensus 95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll--~~~~~ 168 (335)
T 3dls_A 95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVI--AEDFT 168 (335)
T ss_dssp EEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTSC
T ss_pred EEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEE--cCCCc
Confidence 99999999999999998 45 8999887653 59999999999999999999995 689999999999999 67889
Q ss_pred EEEEecccccccCCc--cccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 265 IKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 265 ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..
T Consensus 169 ~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~---- 238 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE---- 238 (335)
T ss_dssp EEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT----
T ss_pred EEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh----
Confidence 999999999876443 346789999999999998876 78999999999999999999999642110 00
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
.. ... ....+ ..+.+||.+||
T Consensus 239 -----------------~~---------------~~~-------------------------~~~~~--~~l~~li~~~L 259 (335)
T 3dls_A 239 -----------------AA---------------IHP-------------------------PYLVS--KELMSLVSGLL 259 (335)
T ss_dssp -----------------TC---------------CCC-------------------------SSCCC--HHHHHHHHHHT
T ss_pred -----------------hc---------------cCC-------------------------CcccC--HHHHHHHHHHc
Confidence 00 000 00011 17899999999
Q ss_pred CCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 422 DYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
..||++|||+.|+|+||||+...
T Consensus 260 ~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 260 QPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CSSGGGSCCHHHHHHCTTTTCCC
T ss_pred cCChhhCcCHHHHhcCccccCCc
Confidence 99999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=354.84 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=204.1
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.....++|++++.||+|+||+||+|.+..+++.||+|++.... .....+..|..++..+ +||||+++++++..
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC------DHPYIVKLLGAYYH 87 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC------CCTTBCCEEEEEEC
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC------CCCCEeeeeeeeee
Confidence 3355678999999999999999999999999999999987432 2233444555554433 47889999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~--~~~~~~kl~Dfg 162 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLM--TLEGDIRLADFG 162 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEE--CTTSCEEECCCH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEE--CCCCCEEEEECC
Confidence 9999999999966 8888876543 469999999999999999999995 789999999999999 678899999999
Q ss_pred cccccCC---ccccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 272 SSCQLGQ---RIYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 272 ~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
++..... ......||+.|+|||++. +..++.++|||||||++|+|++|.+||...+..+.+..+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T 2j7t_A 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL 242 (302)
T ss_dssp HHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred CCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc
Confidence 9854322 233567899999999984 66789999999999999999999999998887776665544211000
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
. .... . ...+.+||.+||..
T Consensus 243 --~---------------------------------~~~~-----------------------~--~~~l~~li~~~l~~ 262 (302)
T 2j7t_A 243 --L---------------------------------TPSK-----------------------W--SVEFRDFLKIALDK 262 (302)
T ss_dssp --S---------------------------------SGGG-----------------------S--CHHHHHHHHHHSCS
T ss_pred --C---------------------------------Cccc-----------------------c--CHHHHHHHHHHccc
Confidence 0 0000 0 01688999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCc
Q psy16081 424 DPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
||++|||+.|+++||||+...
T Consensus 263 dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 263 NPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp CTTTSCCHHHHTTSTTTTTCC
T ss_pred ChhhCCCHHHHhcChHHhhhc
Confidence 999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=354.71 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=199.5
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
+....++|++.+.||+|+||.||+|.+..+++.||||++.... ........|..++. ..+|+||++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~------~l~h~~i~~~~~~ 79 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK------LFRHPHIIKLYQV 79 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH------TCCCTTBCCEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHh------cCCCCCEeEEEEE
Confidence 3455689999999999999999999999999999999986422 11223333443332 3357889999999
Q ss_pred eeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 190 FMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
+...+.+|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~~~~l~ 153 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLL--DAHMNAKIA 153 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEE--CTTSCEEEC
T ss_pred EecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEE--CCCCCEEEe
Confidence 9999999999999965 9999997653 58999999999999999999995 789999999999999 678899999
Q ss_pred ecccccccCCc--cccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 269 DFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 269 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|||++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+.......|.
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 232 (276)
T 2h6d_A 154 DFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE- 232 (276)
T ss_dssp CCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-
T ss_pred ecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch-
Confidence 99999776543 345678999999999998766 68999999999999999999999988776666555432111000
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
... ..+.+||.+||..||
T Consensus 233 ------------------------------------------------------------~~~--~~l~~li~~~l~~~p 250 (276)
T 2h6d_A 233 ------------------------------------------------------------YLN--RSVATLLMHMLQVDP 250 (276)
T ss_dssp ------------------------------------------------------------TSC--HHHHHHHHHHTCSSG
T ss_pred ------------------------------------------------------------hcC--HHHHHHHHHHccCCh
Confidence 000 168899999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy16081 426 KTRITPYYALQHNFFKRT 443 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~ 443 (493)
.+|||+.|+++||||+..
T Consensus 251 ~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 251 LKRATIKDIREHEWFKQD 268 (276)
T ss_dssp GGSCCHHHHHHSHHHHTT
T ss_pred hhCCCHHHHHhChhhccC
Confidence 999999999999999853
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=352.64 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=201.8
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+.++|++.+.||+|+||+||+|.+..+++.||||++...... ......|..++. ..+|+||+++++++.+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~------~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK------MLNHENVVKFYGHRREGN 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHH------TCCCTTBCCEEEEEEETT
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHH------hcCCCCceeeeeEEEcCC
Confidence 457899999999999999999999999999999999743321 223333443332 235788999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
..|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+||++ +.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLL--DERDNLKISDFGLA 152 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCCEEECCCTTC
T ss_pred EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEE--ccCCCEEEeeCCCc
Confidence 99999999965 898888654 369999999999999999999995 789999999999999 67889999999999
Q ss_pred cccCC-----ccccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhh
Q psy16081 274 CQLGQ-----RIYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ-MNKIVEVLGLPPKHL 346 (493)
Q Consensus 274 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~~p~~~ 346 (493)
..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.... +..+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 228 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---- 228 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS----
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc----
Confidence 76532 1345678999999999988775 7899999999999999999999987654322 22211100000
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
+... ..+ ..+.+||.+||..||.
T Consensus 229 --------------------------------~~~~-----------------------~~~--~~~~~li~~~l~~~p~ 251 (276)
T 2yex_A 229 --------------------------------NPWK-----------------------KID--SAPLALLHKILVENPS 251 (276)
T ss_dssp --------------------------------TTGG-----------------------GSC--HHHHHHHHHHSCSSTT
T ss_pred --------------------------------Cchh-----------------------hcC--HHHHHHHHHHCCCCch
Confidence 0000 000 1688999999999999
Q ss_pred CCCCHHHHhcCCCCCCCcc
Q psy16081 427 TRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~~~ 445 (493)
+|||+.|+++||||+....
T Consensus 252 ~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 252 ARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp TSCCHHHHTTCTTTTCCCC
T ss_pred hCCCHHHHhcCccccChhh
Confidence 9999999999999996543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.92 Aligned_cols=259 Identities=33% Similarity=0.481 Sum_probs=207.6
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+.++|++++.||+|+||+||+|.+..+++.||||++..... .......|..++.. .+||||+++++++..
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~------l~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK------LDHPNIMKLFEILED 92 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHT------CCCTTBCCEEEEEEC
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHh------ccCCCccEEEEEEeC
Confidence 456789999999999999999999999999999999864322 22334445444433 257889999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEEec
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIVDF 270 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~DF 270 (493)
.+.+|+||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.+ ..+.+||+||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred CCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999954 9989887653 58999999999999999999995 789999999999999532 2457999999
Q ss_pred ccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 271 GSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 271 G~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
|++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.......+...+
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 246 (287)
T 2wei_A 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW- 246 (287)
T ss_dssp TGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG-
T ss_pred CcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhh-
Confidence 999766432 334568999999999976 4899999999999999999999999998887776666542111100000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
...+ ..+.+||.+||..||.+|
T Consensus 247 --------------------------------------------------------~~~~--~~~~~li~~~l~~dp~~R 268 (287)
T 2wei_A 247 --------------------------------------------------------RTIS--DDAKDLIRKMLTFHPSLR 268 (287)
T ss_dssp --------------------------------------------------------TTSC--HHHHHHHHHHTCSSGGGS
T ss_pred --------------------------------------------------------hhcC--HHHHHHHHHHcccChhhC
Confidence 0001 168999999999999999
Q ss_pred CCHHHHhcCCCCCCCc
Q psy16081 429 ITPYYALQHNFFKRTA 444 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~~ 444 (493)
||+.|+|+||||++..
T Consensus 269 ps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 269 ITATQCLEHPWIQKYS 284 (287)
T ss_dssp CCHHHHHHSHHHHHHC
T ss_pred cCHHHHhcCHHHhccc
Confidence 9999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=353.45 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=204.1
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
++.+.++|++++.||+|+||+||+|.+..+++.||||++......... ....+.+++......+||||+++++++...
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEE--TLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHH--HHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHH--HHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 456778999999999999999999999999999999998643322111 112223333334445688999999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~--~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILI--DSNKTLKIFDFGI 157 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTSCEEECCCSS
T ss_pred CeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCCEEEEeCCC
Confidence 999999999965 9999997653 69999999999999999999995 789999999999999 6788999999999
Q ss_pred ccccCCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 273 SCQLGQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 273 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+...+..... .+....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~- 234 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS--VPNVTT- 234 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC--CCCHHH-
T ss_pred ccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc--CCCcch-
Confidence 9876433 234579999999999999999999999999999999999999999988766654443211 110000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.+.. .. ...+.++|.+||..||.+|
T Consensus 235 ------~~~~-----------------------------------------------~~--~~~l~~li~~~l~~dp~~R 259 (294)
T 4eqm_A 235 ------DVRK-----------------------------------------------DI--PQSLSNVILRATEKDKANR 259 (294)
T ss_dssp ------HSCT-----------------------------------------------TS--CHHHHHHHHHHSCSSGGGS
T ss_pred ------hccc-----------------------------------------------CC--CHHHHHHHHHHhcCCHhHc
Confidence 0000 00 0178899999999999999
Q ss_pred CCHHHHhcCCCCCCCc
Q psy16081 429 ITPYYALQHNFFKRTA 444 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~~ 444 (493)
|+..+.+.+.|..-..
T Consensus 260 ~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 260 YKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CSSHHHHHHHHHTSSS
T ss_pred cccHHHHHHHHHHHHh
Confidence 9777777777765443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=366.55 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=178.2
Q ss_pred eecCcEEEee-eEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 116 KFLDRYEIDS-LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 116 ~~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
.+.++|.+.+ +||+|+||+||+|.+..+++.||||++.... ....|.. ..+.. ..|+||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~--~~~~~---~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVD--HHWQA---SGGPHIVCILDVYENMH 95 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHH--HHHHH---TTSTTBCCEEEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHH--HHHHh---cCCCChHHHHHHHhhcc
Confidence 4668899965 6999999999999999999999999997532 2222222 22222 357779999999876
Q ss_pred --cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEE
Q psy16081 193 --RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIV 268 (493)
Q Consensus 193 --~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~ 268 (493)
...+|+||||+.+ +|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||++.+ .++.+||+
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEEEe
Confidence 5568999999966 99999987665679999999999999999999995 689999999999999532 35669999
Q ss_pred ecccccccCCc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 269 DFGSSCQLGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 269 DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+.....
T Consensus 174 Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 246 (336)
T 3fhr_A 174 DFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR------- 246 (336)
T ss_dssp CCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh-------
Confidence 99999766543 3456789999999999988899999999999999999999999986654332111111000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
.+.+.. ..+. ..... ..+.+||.+||..||.+
T Consensus 247 --------------~~~~~~---------~~~~-----------------------~~~~~--~~~~~li~~~L~~dP~~ 278 (336)
T 3fhr_A 247 --------------LGQYGF---------PNPE-----------------------WSEVS--EDAKQLIRLLLKTDPTE 278 (336)
T ss_dssp ------------------CC---------CTTT-----------------------STTCC--HHHHHHHHHHSCSSGGG
T ss_pred --------------cccccc---------Cchh-----------------------hccCC--HHHHHHHHHHCCCChhH
Confidence 000000 0000 00011 27899999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy16081 428 RITPYYALQHNFFKRT 443 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~ 443 (493)
|||+.|+|+||||+..
T Consensus 279 Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 279 RLTITQFMNHPWINQS 294 (336)
T ss_dssp SCCHHHHHHSHHHHTG
T ss_pred CcCHHHHhcCcccccc
Confidence 9999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.52 Aligned_cols=259 Identities=32% Similarity=0.456 Sum_probs=198.6
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---------chHHHHHHHHHHHHhhcCCCCcceEEEe
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---------LNQAQIEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---------~~~~~~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ......|+.++..+ +||||+++
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~ 80 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL------NHPCIIKI 80 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC------CCTTBCCE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC------CCCCCceE
Confidence 4567899999999999999999999999999999998743211 11234455544433 57889999
Q ss_pred ceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCc
Q psy16081 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSA 264 (493)
Q Consensus 187 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ 264 (493)
++++...+ +|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.+ ....
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~ 155 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCL 155 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSSCC
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCCCe
Confidence 99987654 8999999965 999988654 369999999999999999999995 789999999999999432 2345
Q ss_pred EEEEecccccccCCc--cccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHH
Q psy16081 265 IKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN-KIVEV 338 (493)
Q Consensus 265 ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~-~i~~~ 338 (493)
+||+|||++...... .....||+.|+|||++. +..++.++|||||||++|+|++|.+||........+. .+...
T Consensus 156 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (322)
T 2ycf_A 156 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235 (322)
T ss_dssp EEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred EEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence 999999999877543 23567999999999984 4578999999999999999999999998654332222 22221
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
........+ .. .. ..+.+||.
T Consensus 236 ~~~~~~~~~----------~~-----------------------------------------------~~--~~~~~li~ 256 (322)
T 2ycf_A 236 KYNFIPEVW----------AE-----------------------------------------------VS--EKALDLVK 256 (322)
T ss_dssp CCCCCHHHH----------TT-----------------------------------------------SC--HHHHHHHH
T ss_pred ccccCchhh----------hh-----------------------------------------------cC--HHHHHHHH
Confidence 111000000 00 00 17889999
Q ss_pred HccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 419 RMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 419 ~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
+||..||++|||+.|+|+||||+...
T Consensus 257 ~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 257 KLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred HHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 99999999999999999999998654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=354.90 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=203.3
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... .......|..++..+ +||||+++++++...+.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC------DSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC------CCTTBCCEEEEEEETTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC------CCCCCccEEEEEEeCCE
Confidence 34568999999999999999999999999999999997543 334555555554432 57889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||. .||+||||||+|||+ +.++.+||+|||++.
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILL--NTEGHAKLADFGVAG 173 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEE--CCCCCEEEeecccch
Confidence 9999999966 9999886433 469999999999999999999995 789999999999999 678899999999997
Q ss_pred ccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 275 QLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 275 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... +..
T Consensus 174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~------ 245 (314)
T 3com_A 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP--PTF------ 245 (314)
T ss_dssp ECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCC------
T ss_pred hhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC--ccc------
Confidence 66443 3456789999999999999999999999999999999999999998776655444332100 000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
.... .. ...+.+||.+||..||.+|||+
T Consensus 246 ---------------------------~~~~-----------------------~~--~~~l~~li~~~l~~dp~~Rpt~ 273 (314)
T 3com_A 246 ---------------------------RKPE-----------------------LW--SDNFTDFVKQCLVKSPEQRATA 273 (314)
T ss_dssp ---------------------------SSGG-----------------------GS--CHHHHHHHHHHTCSCTTTSCCH
T ss_pred ---------------------------CCcc-----------------------cC--CHHHHHHHHHHccCChhhCcCH
Confidence 0000 00 0168999999999999999999
Q ss_pred HHHhcCCCCCCCc
Q psy16081 432 YYALQHNFFKRTA 444 (493)
Q Consensus 432 ~e~L~Hp~~~~~~ 444 (493)
.|+|+||||+...
T Consensus 274 ~~ll~~~~~~~~~ 286 (314)
T 3com_A 274 TQLLQHPFVRSAK 286 (314)
T ss_dssp HHHTTSHHHHTCC
T ss_pred HHHHhCHHHhcCC
Confidence 9999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=357.66 Aligned_cols=250 Identities=21% Similarity=0.231 Sum_probs=202.7
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+.++|++.+.||+|+||+||+|.+..+++.||||++.... .......|..++..+. +|+||+++++++...+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-----~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLG-----SGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHC-----SCTTSCCEEEEEEETTEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhh-----CCCCCCEEEEEEecCCcc
Confidence 4578999999999999999999999999999999987443 2345677887777663 467799999999999999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc-----EEEEecc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA-----IKIVDFG 271 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~-----ikL~DFG 271 (493)
|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++. +||+|||
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill--~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 81 AMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLI--GRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CCGGGTCTTSEEECCCT
T ss_pred EEEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeee--ccCCCCCCceEEEEEcc
Confidence 9999999779999997643 469999999999999999999995 689999999999999 55555 9999999
Q ss_pred cccccCCc----------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHH
Q psy16081 272 SSCQLGQR----------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN---EVDQMNKIVEV 338 (493)
Q Consensus 272 ~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~ 338 (493)
++...... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+ ..+.+..+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 99865332 235689999999999999999999999999999999999999998743 34444444432
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
....+...+. .....+.+||.
T Consensus 236 ~~~~~~~~~~-----------------------------------------------------------~~~p~~~~li~ 256 (330)
T 2izr_A 236 KRATPIEVLC-----------------------------------------------------------ENFPEMATYLR 256 (330)
T ss_dssp HHHSCHHHHT-----------------------------------------------------------TTCHHHHHHHH
T ss_pred hccCCHHHHh-----------------------------------------------------------ccChHHHHHHH
Confidence 1111111000 00016789999
Q ss_pred HccCCCCCCCCCHHHHhc
Q psy16081 419 RMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 419 ~mL~~dP~~R~t~~e~L~ 436 (493)
+||..||.+|||+.++++
T Consensus 257 ~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 257 YVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHCCTTCCCCHHHHHH
T ss_pred HHHhCCCCCCCCHHHHHH
Confidence 999999999999998876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=352.45 Aligned_cols=251 Identities=28% Similarity=0.439 Sum_probs=206.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.|++++.||+|+||+||+|.+..+++.||||++.... ........|..++..+ .|+||+++++++...+.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYVTKYYGSYLKDTK 94 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC------CCTTBCCEEEEEEETTE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC------CCCCEeEEEEEEecCCe
Confidence 457999999999999999999999999999999997443 2234444555544432 57789999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||+++ +|.+++... .+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 95 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLL--SEHGEVKLADFGVAG 167 (303)
T ss_dssp EEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEE--CCCCCEEEeecccce
Confidence 9999999966 899988653 58999999999999999999995 789999999999999 678899999999997
Q ss_pred ccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 275 QLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 275 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+.... ++.
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~------- 238 (303)
T 3a7i_A 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--PPT------- 238 (303)
T ss_dssp ECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCC-------
T ss_pred ecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--CCC-------
Confidence 76432 345678999999999999999999999999999999999999999887766555443210 000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
. .. .. ...+.+||.+||..||.+|||+
T Consensus 239 --------~--------------------~~-----------------------~~--~~~l~~li~~~l~~dp~~Rps~ 265 (303)
T 3a7i_A 239 --------L--------------------EG-----------------------NY--SKPLKEFVEACLNKEPSFRPTA 265 (303)
T ss_dssp --------C--------------------CS-----------------------SC--CHHHHHHHHHHCCSSGGGSCCH
T ss_pred --------C--------------------cc-----------------------cc--CHHHHHHHHHHcCCChhhCcCH
Confidence 0 00 00 0168999999999999999999
Q ss_pred HHHhcCCCCCCC
Q psy16081 432 YYALQHNFFKRT 443 (493)
Q Consensus 432 ~e~L~Hp~~~~~ 443 (493)
.|+|+||||...
T Consensus 266 ~~ll~~~~~~~~ 277 (303)
T 3a7i_A 266 KELLKHKFILRN 277 (303)
T ss_dssp HHHTTCHHHHHH
T ss_pred HHHhhChhhhcC
Confidence 999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=356.30 Aligned_cols=277 Identities=20% Similarity=0.267 Sum_probs=203.0
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+.++|++.++||+|+||+||+|.+..+++.||||++..... .......|..++..+ +||||+++++++...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL------NHKNIVKLFAIEEET 79 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC------CCTTBCCEEEEEECT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc------CCCCcceEEEEeecC
Confidence 345789999999999999999999999999999999974331 223444555555443 477899999999876
Q ss_pred c--eeEEEEEecc-cCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee--CCCCCcEEE
Q psy16081 194 N--HLCLVFELLS-YNLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC--NPKRSAIKI 267 (493)
Q Consensus 194 ~--~~~lV~E~~~-~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~--~~~~~~ikL 267 (493)
+ ++|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||+. ++..+.+||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEEE
Confidence 5 7899999996 599999976432 238999999999999999999995 7899999999999973 234567999
Q ss_pred EecccccccCCc--cccccccCcCCchhhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHH
Q psy16081 268 VDFGSSCQLGQR--IYQYIQSRFYRSPEVLL--------GIPYDLAIDMWSLGCILVEMHTGEPLFSGSN----EVDQMN 333 (493)
Q Consensus 268 ~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltG~~pf~~~~----~~~~~~ 333 (493)
+|||+++..... ....+||+.|+|||++. +..++.++|||||||++|||++|.+||.... ..+.+.
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred ccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 999999876433 34567999999999987 5679999999999999999999999997533 233444
Q ss_pred HHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhH
Q psy16081 334 KIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413 (493)
Q Consensus 334 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (493)
++... .|...+.... ....+.+.+.. ..+.... -+......+
T Consensus 238 ~~~~~---~p~~~~~~~~-------~~~~~~~~~~~-------~~~~~~~---------------------~~~~~~~~l 279 (319)
T 4euu_A 238 KIITG---KPSGAISGVQ-------KAENGPIDWSG-------DMPVSCS---------------------LSRGLQVLL 279 (319)
T ss_dssp HHHHH---CCTTCCEEEE-------CSTTCCEEEES-------SCCTTCS---------------------SCHHHHHHH
T ss_pred HHhcC---CCcccchhhh-------cccCCccccCc-------cCCcccc---------------------cchhHHHHh
Confidence 44432 2211111110 01111111100 0000000 011222368
Q ss_pred HHHHhHccCCCCCCCCCHHHHhcCC
Q psy16081 414 KDLIFRMLDYDPKTRITPYYALQHN 438 (493)
Q Consensus 414 ~dLi~~mL~~dP~~R~t~~e~L~Hp 438 (493)
.+||++||++||++|||++|+|+||
T Consensus 280 ~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 280 TPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHHHHhccCChhhhccHHHhhhcc
Confidence 8999999999999999999999997
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=348.49 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=202.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
.++|++++.||+|+||+||+|.+..+++.||+|++....... ..+..|..++.. . +||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~---l---~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE---L---KHPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHH---C---CCTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHh---c---CCCCCCeEEEEEecCC
Confidence 468999999999999999999999999999999997543222 223334433333 2 47889999998854
Q ss_pred cceeEEEEEeccc-CHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhCCCCC-----ccccCCCCCcEEeeCCCCCc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTN--FRGVSLNLTRKFSQQLCTALLFLSTPELN-----IIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~-----iiHrDlKp~NILl~~~~~~~ 264 (493)
.+.+|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||+ .+ |+||||||+|||+ +.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~--~~~~~ 154 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFL--DGKQN 154 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEE--CSSSC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEE--cCCCC
Confidence 5689999999965 9999986532 2348999999999999999999995 56 9999999999999 67889
Q ss_pred EEEEecccccccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 265 IKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 265 ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+......
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~ 234 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234 (279)
T ss_dssp EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc
Confidence 999999999776543 23457899999999999999999999999999999999999999988877666665442110
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
. ++ . ... ..+.+||.+||
T Consensus 235 ~-----------------~~--------------------~-----------------------~~~--~~l~~li~~~l 252 (279)
T 2w5a_A 235 R-----------------IP--------------------Y-----------------------RYS--DELNEIITRML 252 (279)
T ss_dssp C-----------------CC--------------------T-----------------------TSC--HHHHHHHHHHT
T ss_pred c-----------------CC--------------------c-----------------------ccC--HHHHHHHHHHc
Confidence 0 00 0 000 17889999999
Q ss_pred CCCCCCCCCHHHHhcCCCCCCC
Q psy16081 422 DYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
..||.+|||+.|+|+|+|+..-
T Consensus 253 ~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 253 NLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CSSGGGSCCHHHHHTSTTCCGG
T ss_pred CCCcccCCCHHHHHhChhhhhh
Confidence 9999999999999999999853
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=357.06 Aligned_cols=269 Identities=25% Similarity=0.372 Sum_probs=188.5
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|++.+.||+|+||+||+|.+..+++.||||++..... ......+.+++.......||||+++++++...+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC----QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc----chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 35789999999999999999999988999999998864321 11122334455556666899999999999999999
Q ss_pred EEEEEecc-cCHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 197 CLVFELLS-YNLYDLLRNT------NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 197 ~lV~E~~~-~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
|+||||+. ++|.+++... ....+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~~~kl~d 164 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILL--GEDGSVQIAD 164 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEE--CTTCCEEECC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEE--cCCCCEEEEe
Confidence 99999995 5999988641 22458999999999999999999995 689999999999999 6788999999
Q ss_pred cccccccCCc--------cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy16081 270 FGSSCQLGQR--------IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340 (493)
Q Consensus 270 FG~a~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 340 (493)
||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.+.......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~- 243 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 243 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS-
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC-
Confidence 9998765321 234578999999999976 568999999999999999999999998876655443322210
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
++. ... ... .... .... ...+.+||.+|
T Consensus 244 -~~~-~~~----------~~~----------------------~~~~----------------~~~~--~~~~~~li~~~ 271 (303)
T 2vwi_A 244 -PPS-LET----------GVQ----------------------DKEM----------------LKKY--GKSFRKMISLC 271 (303)
T ss_dssp -CCC-TTC-------------------------------------CC----------------CCCC--CHHHHHHHHHH
T ss_pred -CCc-ccc----------ccc----------------------cchh----------------hhhh--hHHHHHHHHHH
Confidence 000 000 000 0000 0000 12789999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
|..||.+|||+.|+++||||+.....
T Consensus 272 l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 272 LQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp CCSSGGGSCCHHHHHTSTTC------
T ss_pred ccCChhhCcCHHHHhhChhhhcCCCC
Confidence 99999999999999999999976543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=354.41 Aligned_cols=254 Identities=29% Similarity=0.397 Sum_probs=190.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee----
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW---- 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~---- 192 (493)
+.++|++++.||+|+||+||+|++..+++.||||++............|. ......+||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~------~~l~~l~h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV------MLLASLNHQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHH------HHHTTCCCTTBCCEEEEEEECCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHH------HHHHhcCchHHHHHHHHHHhhcch
Confidence 45789999999999999999999999999999999964332222233333 33334468889999998865
Q ss_pred ---------cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC
Q psy16081 193 ---------RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR 262 (493)
Q Consensus 193 ---------~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~ 262 (493)
.+.+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.+
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~--~~~ 152 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFI--DES 152 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTT
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEE--cCC
Confidence 4678999999965 9999997543 458889999999999999999995 689999999999999 678
Q ss_pred CcEEEEecccccccCC-----------------ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 263 SAIKIVDFGSSCQLGQ-----------------RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~-----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
+.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 8999999999976542 22345789999999999865 68999999999999999998 554
Q ss_pred CC-CHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCC
Q psy16081 325 GS-NEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403 (493)
Q Consensus 325 ~~-~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 403 (493)
.. +..+....+.......|..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~---------------------------------------------------------- 251 (303)
T 1zy4_A 230 TGMERVNILKKLRSVSIEFPPD---------------------------------------------------------- 251 (303)
T ss_dssp SHHHHHHHHHHHHSTTCCCCTT----------------------------------------------------------
T ss_pred CchhHHHHHHhccccccccCcc----------------------------------------------------------
Confidence 32 2222222222110000000
Q ss_pred CCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 404 ~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
........+.+||++||..||.+|||+.|+|+||||+..
T Consensus 252 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 252 -FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp -CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred -ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 000011267899999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=346.16 Aligned_cols=254 Identities=20% Similarity=0.209 Sum_probs=202.6
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+..+.++|++.+.||+|+||+||+|.+..+++.||||++.... .......|..++..+. +|++|+++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~-----~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLA-----GCTGIPNVYYFGQEG 78 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTT-----TCTTCCCEEEEEEET
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHh-----cCCCCCeEEeecCCC
Confidence 3456788999999999999999999999999999999986433 3345666776666553 355688888899999
Q ss_pred ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc-----EEEE
Q psy16081 194 NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA-----IKIV 268 (493)
Q Consensus 194 ~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~-----ikL~ 268 (493)
...|+||||++++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||++ .++. +||+
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~--~~~~~~~~~~kl~ 153 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIG--RPNSKNANMIYVV 153 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEEC--CSSSTTTTCEEEC
T ss_pred ceeEEEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEec--cCCCCCCCeEEEE
Confidence 9999999999779999997653 459999999999999999999994 7899999999999994 4443 9999
Q ss_pred ecccccccCCc----------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH
Q psy16081 269 DFGSSCQLGQR----------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS---NEVDQMNKI 335 (493)
Q Consensus 269 DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~---~~~~~~~~i 335 (493)
|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +..+.+..+
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 99999766432 23557899999999999999999999999999999999999999874 344445554
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
......++.... ...+ ...+.+
T Consensus 234 ~~~~~~~~~~~~---------~~~~-------------------------------------------------~~~l~~ 255 (298)
T 1csn_A 234 GEKKQSTPLREL---------CAGF-------------------------------------------------PEEFYK 255 (298)
T ss_dssp HHHHHHSCHHHH---------TTTS-------------------------------------------------CHHHHH
T ss_pred HhhccCccHHHH---------HhhC-------------------------------------------------cHHHHH
Confidence 443221111100 0000 017899
Q ss_pred HHhHccCCCCCCCCCHHHHhc
Q psy16081 416 LIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 416 Li~~mL~~dP~~R~t~~e~L~ 436 (493)
||.+||..||++|||++++++
T Consensus 256 li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 256 YMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhcCCcccCCCHHHHHH
Confidence 999999999999999999876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=363.81 Aligned_cols=279 Identities=20% Similarity=0.306 Sum_probs=210.2
Q ss_pred eeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc------------------hHHHHHHHHHHHH
Q psy16081 111 IQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL------------------NQAQIEVKLLEIM 172 (493)
Q Consensus 111 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~------------------~~~~~e~~~~~~l 172 (493)
+.....+.++|++.+.||+|+||.||+|.+ +++.||||++....... ..+..|..++.
T Consensus 23 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-- 98 (348)
T 2pml_X 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT-- 98 (348)
T ss_dssp ESSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT--
T ss_pred hhhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH--
Confidence 345567788999999999999999999987 89999999987432110 44444544433
Q ss_pred hhcCCCCcceEEEeceeeeecceeEEEEEeccc-CHHHH------HhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCc
Q psy16081 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDL------LRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNI 245 (493)
Q Consensus 173 ~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~i 245 (493)
..+||||+++++++.+.+.+|+||||+++ +|.++ +.......+++..++.++.||+.||.|||+ +.||
T Consensus 99 ----~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i 173 (348)
T 2pml_X 99 ----DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNI 173 (348)
T ss_dssp ----TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCE
T ss_pred ----hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCE
Confidence 33588899999999999999999999966 89888 655434679999999999999999999995 2789
Q ss_pred cccCCCCCcEEeeCCCCCcEEEEecccccccCC-ccccccccCcCCchhhhcCC-CCCc-hhhHHHHHHHHHHHHhCCCC
Q psy16081 246 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-RIYQYIQSRFYRSPEVLLGI-PYDL-AIDMWSLGCILVEMHTGEPL 322 (493)
Q Consensus 246 iHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltG~~p 322 (493)
+||||||+|||+ +.++.+||+|||++..... ......||+.|+|||++.+. .++. ++|||||||++|+|++|.+|
T Consensus 174 ~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 174 CHRDVKPSNILM--DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp ECCCCCGGGEEE--CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred eecCCChHhEEE--cCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999 6788999999999987643 34566889999999999987 6776 99999999999999999999
Q ss_pred CCCCCH-HHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCC
Q psy16081 323 FSGSNE-VDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401 (493)
Q Consensus 323 f~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 401 (493)
|.+.+. .+....+.......+.. ...++... ..... .
T Consensus 252 f~~~~~~~~~~~~i~~~~~~~~~~-------~~~~~~~~--------------------~~~~~---------------~ 289 (348)
T 2pml_X 252 FSLKISLVELFNNIRTKNIEYPLD-------RNHFLYPL--------------------TNKKS---------------T 289 (348)
T ss_dssp SCCSSCSHHHHHHHTSCCCCCCCS-------SSSSTTTT--------------------CC-------------------
T ss_pred CCCCCcHHHHHHHHhccCcCCccc-------hhhhhccc--------------------ccccc---------------c
Confidence 998766 45544443211111000 00000000 00000 0
Q ss_pred CCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 402 ~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
......+ ..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 290 ~~~~~~~--~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 290 CSNNFLS--NEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp ----CCC--HHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cchhhcC--HHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 0000111 2789999999999999999999999999999754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=345.57 Aligned_cols=246 Identities=22% Similarity=0.284 Sum_probs=202.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.+.||+|+||+||+|.+. +++.||||++.........+..|..++..+ +||||+++++++.+.+.+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL------SHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC------CCTTBCCEEEEECSSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC------CCCCEeeEEEEEecCCceE
Confidence 358999999999999999999876 577899999986654455566666655544 4788999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLV--GENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CGGGCEEECCTTGGGGB
T ss_pred EEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEE--cCCCCEEeccccccccc
Confidence 99999965 8999986544 468999999999999999999994 789999999999999 67789999999999876
Q ss_pred CCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+..........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 230 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR------ 230 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT------
T ss_pred cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCC------
Confidence 443 223456778999999998899999999999999999999 999999988877766664421111000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
.. ...+.+||.+||..||++|||+
T Consensus 231 ------------------------------------------------------~~--~~~~~~li~~~l~~~p~~Rps~ 254 (269)
T 4hcu_A 231 ------------------------------------------------------LA--STHVYQIMNHCWRERPEDRPAF 254 (269)
T ss_dssp ------------------------------------------------------TS--CHHHHHHHHHHTCSSGGGSCCH
T ss_pred ------------------------------------------------------cC--CHHHHHHHHHHccCCcccCcCH
Confidence 00 0168899999999999999999
Q ss_pred HHHhcC
Q psy16081 432 YYALQH 437 (493)
Q Consensus 432 ~e~L~H 437 (493)
.|+++|
T Consensus 255 ~~ll~~ 260 (269)
T 4hcu_A 255 SRLLRQ 260 (269)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=358.63 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=204.8
Q ss_pred eccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-------cchHHHHHHHHHHHHhhcCCCCcceEE
Q psy16081 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-------FLNQAQIEVKLLEIMNKADVNNTYYIV 184 (493)
Q Consensus 112 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~e~~~~~~l~~~~~~~~~~Iv 184 (493)
..++.+.++|++.+.||+|+||+||+|.+..+++.||||++..... .......|..++..+.+ .|+||+
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~----~~~~i~ 111 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS----GFSGVI 111 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS----SSCSBC
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc----CCCCce
Confidence 3445677899999999999999999999999999999999974321 11334557777766653 467899
Q ss_pred EeceeeeecceeEEEEEecc--cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC
Q psy16081 185 RLKRHFMWRNHLCLVFELLS--YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR 262 (493)
Q Consensus 185 ~l~~~~~~~~~~~lV~E~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~ 262 (493)
++++++...+..++|||++. ++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++ ..+
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~-~~~ 186 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILID-LNR 186 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEE-TTT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEe-CCC
Confidence 99999999999999999995 58999987653 68999999999999999999995 7899999999999994 267
Q ss_pred CcEEEEecccccccCCc-cccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy16081 263 SAIKIVDFGSSCQLGQR-IYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLG 340 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 340 (493)
+.+||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|..||...+. +...
T Consensus 187 ~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~-- 258 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-- 258 (320)
T ss_dssp TEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--
T ss_pred CCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--
Confidence 88999999999877543 345679999999999987765 6889999999999999999999975321 1110
Q ss_pred CCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 341 LPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 341 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
.. .+. . ... ..+.+||.+|
T Consensus 259 ~~-------------~~~-----------------------~-----------------------~~~--~~~~~li~~~ 277 (320)
T 3a99_A 259 QV-------------FFR-----------------------Q-----------------------RVS--SECQHLIRWC 277 (320)
T ss_dssp CC-------------CCS-----------------------S-----------------------CCC--HHHHHHHHHH
T ss_pred cc-------------ccc-----------------------c-----------------------cCC--HHHHHHHHHH
Confidence 00 000 0 000 1789999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCCc
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
|..||++|||+.|+++||||+...
T Consensus 278 l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 278 LALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp TCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ccCChhhCcCHHHHhcCHhhcCcc
Confidence 999999999999999999999754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=359.06 Aligned_cols=204 Identities=14% Similarity=0.180 Sum_probs=170.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCC-----CeEEEEEEEccCcccchHHHHHHHHHHHHh---------hcCCCCcceE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEE-----QCHVAIKIIKNKKPFLNQAQIEVKLLEIMN---------KADVNNTYYI 183 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~---------~~~~~~~~~I 183 (493)
.++|++.++||+|+||+||+|.+..+ ++.||||++.... .....|..++..+. .....+|+||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 45899999999999999999988765 5889999987543 34455555554443 3456689999
Q ss_pred EEeceeeeec----ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC
Q psy16081 184 VRLKRHFMWR----NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN 259 (493)
Q Consensus 184 v~l~~~~~~~----~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~ 259 (493)
+++++++... .++||||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEEec
Confidence 9999999875 5689999999779999987643 469999999999999999999995 69999999999999964
Q ss_pred CCCCcEEEEecccccccCCc----------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 260 PKRSAIKIVDFGSSCQLGQR----------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 260 ~~~~~ikL~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
+.++.+||+|||+++.+... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 47889999999999765432 133459999999999999999999999999999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=346.35 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=192.8
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch---HHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN---QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
..++|++.+.||+|+||+||+|.+ +++.||||++........ .+..|+.++..+ +||||+++++++...
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL------RHPNIVLFMGAVTQP 106 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC------CCTTBCCEEEEECST
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC------CCCCEeeEEEEEEEC
Confidence 356899999999999999999965 688999999975432222 233444444333 478899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCC--ccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPELN--IIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~Lhs~~~~--iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
+.+|+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+ .| |+||||||+|||+ +.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll--~~~~~~kL~D 182 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLV--DKKYTVKVCD 182 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEE--CTTCCEEECC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEE--eCCCcEEECC
Confidence 999999999965 99999875431 238999999999999999999995 57 9999999999999 6788999999
Q ss_pred cccccccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 270 FGSSCQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 270 FG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--- 259 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--- 259 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC---
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---
Confidence 9999765433 3456899999999999999999999999999999999999999998887766655532111000
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
. +. ... ..+.+||.+||..||.
T Consensus 260 -------------------------------~--~~-----------------------~~~--~~l~~li~~~l~~dP~ 281 (309)
T 3p86_A 260 -------------------------------I--PR-----------------------NLN--PQVAAIIEGCWTNEPW 281 (309)
T ss_dssp -------------------------------C--CT-----------------------TSC--HHHHHHHHHHTCSSGG
T ss_pred -------------------------------C--Cc-----------------------cCC--HHHHHHHHHHccCChh
Confidence 0 00 000 1789999999999999
Q ss_pred CCCCHHHHhc--CCCCC
Q psy16081 427 TRITPYYALQ--HNFFK 441 (493)
Q Consensus 427 ~R~t~~e~L~--Hp~~~ 441 (493)
+|||+.|+++ +++++
T Consensus 282 ~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 282 KRPSFATIMDLLRPLIK 298 (309)
T ss_dssp GSCCHHHHHHHHHHHHC
T ss_pred hCcCHHHHHHHHHHHHH
Confidence 9999999997 45554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=342.15 Aligned_cols=246 Identities=20% Similarity=0.264 Sum_probs=201.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++++.||+|+||+||+|.+. ++..||||+++...........|..++..+ +||||+++++++.+.+.+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL------SHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC------CCTTBCCEEEEECSSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC------CCCCEeeEEEEEccCCceE
Confidence 468999999999999999999765 577899999986655555666666666554 3778999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~--~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLV--DRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEE--CTTCCEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEE--CCCCCEEEccCccceec
Confidence 99999955 8999987653 359999999999999999999995 789999999999999 67889999999999766
Q ss_pred CCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.... ....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+.........
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 227 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP------- 227 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC-------
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC-------
Confidence 4432 22345667999999999899999999999999999999 99999988877766655432111000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
.... ..+.+||.+||..||.+|||+
T Consensus 228 -----------------------------------------------------~~~~--~~l~~li~~~l~~~p~~Rps~ 252 (268)
T 3sxs_A 228 -----------------------------------------------------HLAS--DTIYQIMYSCWHELPEKRPTF 252 (268)
T ss_dssp -----------------------------------------------------TTSC--HHHHHHHHHTTCSSGGGSCCH
T ss_pred -----------------------------------------------------CcCh--HHHHHHHHHHcCCChhhCcCH
Confidence 0001 168899999999999999999
Q ss_pred HHHhcC
Q psy16081 432 YYALQH 437 (493)
Q Consensus 432 ~e~L~H 437 (493)
.|+++|
T Consensus 253 ~~ll~~ 258 (268)
T 3sxs_A 253 QQLLSS 258 (268)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.11 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=187.6
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++++.||+|+||.||+|.+..+++.||||++............ +.+........+|+||+++++++...+.+|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI---LMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHH---HHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHH---HHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 56899999999999999999999999999999999754322111111 122222233446888999999999999999
Q ss_pred EEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 198 LVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
+||||+++.+..++.... ..+++..++.++.||+.||.|||+ ..||+||||||+|||+ +.++.+||+|||++....
T Consensus 101 lv~e~~~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILL--DERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEECCCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEE--CTTSCEEECCCTTC----
T ss_pred EEEeccCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEE--CCCCCEEEEECCCchhcc
Confidence 999999666665554432 469999999999999999999995 1389999999999999 678899999999997664
Q ss_pred Cc--cccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhhhh
Q psy16081 278 QR--IYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGS-NEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 278 ~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
.. .....||+.|+|||++. +..++.++|||||||++|+|++|..||... ...+.+..+.......
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 249 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL------- 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-------
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-------
Confidence 32 33557899999999995 456899999999999999999999999873 4445554444311000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.+... .. ...+.+||.+||..||.+||
T Consensus 250 ----------------------------~~~~~-----------------------~~--~~~l~~li~~~l~~dp~~Rp 276 (318)
T 2dyl_A 250 ----------------------------LPGHM-----------------------GF--SGDFQSFVKDCLTKDHRKRP 276 (318)
T ss_dssp ----------------------------CCSSS-----------------------CC--CHHHHHHHHHHTCSCTTTSC
T ss_pred ----------------------------CCccC-----------------------CC--CHHHHHHHHHHccCChhHCc
Confidence 00000 00 01789999999999999999
Q ss_pred CHHHHhcCCCCCCCcc
Q psy16081 430 TPYYALQHNFFKRTAD 445 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~~ 445 (493)
|+.|+|+||||+....
T Consensus 277 s~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 277 KYNKLLEHSFIKRYET 292 (318)
T ss_dssp CHHHHTTSHHHHHHHH
T ss_pred CHHHHhhCHHHHhccc
Confidence 9999999999986543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=363.44 Aligned_cols=257 Identities=18% Similarity=0.200 Sum_probs=201.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEE-----EcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAF-----DLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
...++|++++.||+|+||+||+|. +..+++.||||+++..... ...+..|..++..+ +||||+++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~ 141 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF------NHQNIVRCIG 141 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC------CCTTBCCEEE
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC------CCCCCCeEEE
Confidence 345789999999999999999998 4567889999998643211 12233344443332 5788999999
Q ss_pred eeeecceeEEEEEeccc-CHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-C
Q psy16081 189 HFMWRNHLCLVFELLSY-NLYDLLRNTNF-----RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-K 261 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~~-~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~ 261 (493)
++...+..|+|||||.+ +|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.+ .
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSST
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCC
Confidence 99999999999999955 99999976432 348999999999999999999995 789999999999999422 3
Q ss_pred CCcEEEEecccccccC-----CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy16081 262 RSAIKIVDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 262 ~~~ikL~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i 335 (493)
+..+||+|||+++... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 3459999999997542 22334567899999999999999999999999999999998 99999998887777666
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
......++. ......+.+
T Consensus 300 ~~~~~~~~~--------------------------------------------------------------~~~~~~l~~ 317 (367)
T 3l9p_A 300 TSGGRMDPP--------------------------------------------------------------KNCPGPVYR 317 (367)
T ss_dssp HTTCCCCCC--------------------------------------------------------------TTCCHHHHH
T ss_pred HcCCCCCCC--------------------------------------------------------------ccCCHHHHH
Confidence 542211100 000016889
Q ss_pred HHhHccCCCCCCCCCHHHHhcCCCCCC
Q psy16081 416 LIFRMLDYDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 416 Li~~mL~~dP~~R~t~~e~L~Hp~~~~ 442 (493)
||.+||..||.+|||+.|+++|.++..
T Consensus 318 li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 318 IMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 999999999999999999999987753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.87 Aligned_cols=264 Identities=22% Similarity=0.321 Sum_probs=200.1
Q ss_pred CcceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceE
Q psy16081 107 HDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYI 183 (493)
Q Consensus 107 ~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~I 183 (493)
..+.++......++|++++.||+|+||.||+|.+. +++.||||++..... ....+..|+.++..+.+ +|+||
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~----~~~~i 90 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ----HSDKI 90 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGG----GCTTB
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccc----cCCce
Confidence 34444555555678999999999999999999875 589999999964432 23445667777766654 25679
Q ss_pred EEeceeeeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCC
Q psy16081 184 VRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRS 263 (493)
Q Consensus 184 v~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~ 263 (493)
+++++++...+.+|+|||+.+++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++ ++
T Consensus 91 v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~---~~ 163 (313)
T 3cek_A 91 IRLYDYEITDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV---DG 163 (313)
T ss_dssp CCEEEEEECSSEEEEEECCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE---TT
T ss_pred EEEEEEeecCCEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEE---CC
Confidence 99999999999999999977889999997653 68999999999999999999995 6899999999999993 37
Q ss_pred cEEEEecccccccCCcc-----ccccccCcCCchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 264 AIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLG-----------IPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 264 ~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 89999999998764322 34578999999999976 468899999999999999999999998654
Q ss_pred HH-HHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCC
Q psy16081 328 EV-DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHS 406 (493)
Q Consensus 328 ~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 406 (493)
.. ..+..+...... ...+ . .
T Consensus 244 ~~~~~~~~~~~~~~~----------------------------------~~~~------------------------~-~ 264 (313)
T 3cek_A 244 NQISKLHAIIDPNHE----------------------------------IEFP------------------------D-I 264 (313)
T ss_dssp SHHHHHHHHHCTTSC----------------------------------CCCC------------------------C-C
T ss_pred HHHHHHHHHHhcccc----------------------------------cCCc------------------------c-c
Confidence 32 222222110000 0000 0 0
Q ss_pred cchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 407 VSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 407 ~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
. ...+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 265 ~--~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 265 P--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp S--CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred c--hHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 0 1168899999999999999999999999999854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=344.70 Aligned_cols=247 Identities=20% Similarity=0.258 Sum_probs=199.8
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|++++.||+|+||+||+|.+. ++..||||+++........+..|..++..+ +|+||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL------SHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC------CCTTBCCEEEEECSSSSE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC------CCCCEeeEEEEEecCCCe
Confidence 3568999999999999999999765 678899999986654445555665555443 477899999999999999
Q ss_pred EEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili--~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLV--NDQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEE--CTTSCEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEE--cCCCCEEEcccccccc
Confidence 99999995 59999997643 359999999999999999999995 789999999999999 6788999999999987
Q ss_pred cCCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
.... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+..........
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 244 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH----- 244 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT-----
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCC-----
Confidence 6443 223445778999999998899999999999999999998 999999988877776665432111000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.. ...+.+||.+||..||.+|||
T Consensus 245 -------------------------------------------------------~~--~~~l~~li~~~l~~~p~~Rps 267 (283)
T 3gen_A 245 -------------------------------------------------------LA--SEKVYTIMYSCWHEKADERPT 267 (283)
T ss_dssp -------------------------------------------------------TC--CHHHHHHHHHTTCSSGGGSCC
T ss_pred -------------------------------------------------------cC--CHHHHHHHHHHccCChhHCcC
Confidence 00 016889999999999999999
Q ss_pred HHHHhcC
Q psy16081 431 PYYALQH 437 (493)
Q Consensus 431 ~~e~L~H 437 (493)
+.|+++|
T Consensus 268 ~~~ll~~ 274 (283)
T 3gen_A 268 FKILLSN 274 (283)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=358.38 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=197.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc-------CCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL-------EEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
.++|++.+.||+|+||+||+|.+. .++..||||+++.... ....+..|..++..+ .+||||+++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~~hpnIv~~~~ 154 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-----GKHKNIINLLG 154 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHS-----CCCTTBCCEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHh-----cCCCCEeeEEE
Confidence 478999999999999999999875 3567899999975421 122334444444333 25888999999
Q ss_pred eeeecceeEEEEEeccc-CHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 189 HFMWRNHLCLVFELLSY-NLYDLLRNTNF--------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~~-~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
+|...+.+|+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+ .||+||||||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~ 232 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAAR 232 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGG
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchh
Confidence 99999999999999965 99999976431 348899999999999999999995 78999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ +.++.+||+|||+++..... .....+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 233 NIll--~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 233 NVLV--TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GEEE--CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hEEE--CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999 67889999999999866432 233456788999999999999999999999999999999 999999877
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+....+....... .+ .
T Consensus 311 ~~~~~~~~~~~~~~~-----------------------------------~~---------------------------~ 328 (370)
T 2psq_A 311 VEELFKLLKEGHRMD-----------------------------------KP---------------------------A 328 (370)
T ss_dssp GGGHHHHHHTTCCCC-----------------------------------CC---------------------------T
T ss_pred HHHHHHHHhcCCCCC-----------------------------------CC---------------------------C
Confidence 665554443211000 00 0
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
.....+.+||.+||..||.+|||+.|++++
T Consensus 329 ~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 329 NCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001178999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=351.76 Aligned_cols=250 Identities=21% Similarity=0.231 Sum_probs=197.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCe---EEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQC---HVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
...++|++.+.||+|+||+||+|.+..+++ .||||+++..... .. ...+.+++......+||||+++++++.+
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQ---RRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH-HH---HHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH-HH---HHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 345789999999999999999999886554 5999999753211 11 1122333333344468899999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+|+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll--~~~~~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLV--DSNLVCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCCEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEE--CCCCCEEECCCC
Confidence 9999999999955 9999986543 469999999999999999999995 789999999999999 678899999999
Q ss_pred cccccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 272 SSCQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 272 ~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+......+..
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP 276 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC
Confidence 998764321 22345678999999998899999999999999999999 99999998888777666543211100
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
. .....+.+||.+||..|
T Consensus 277 -------------------------------------~-------------------------~~~~~l~~li~~~l~~d 294 (325)
T 3kul_A 277 -------------------------------------M-------------------------GCPHALHQLMLDCWHKD 294 (325)
T ss_dssp -------------------------------------T-------------------------TCCHHHHHHHHHHTCSS
T ss_pred -------------------------------------C-------------------------CcCHHHHHHHHHHccCC
Confidence 0 00117889999999999
Q ss_pred CCCCCCHHHHhc
Q psy16081 425 PKTRITPYYALQ 436 (493)
Q Consensus 425 P~~R~t~~e~L~ 436 (493)
|.+|||+.|+++
T Consensus 295 p~~Rps~~eil~ 306 (325)
T 3kul_A 295 RAQRPRFSQIVS 306 (325)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=351.64 Aligned_cols=260 Identities=20% Similarity=0.272 Sum_probs=182.4
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCe---EEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQC---HVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
...++|++.+.||+|+||+||+|.+..++. .||||+++.......... .+.+++......+||||+++++++..
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE---EFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHH---HHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHH---HHHHHHHHHHHCCCCceehhhceeec
Confidence 345689999999999999999999877765 899999875322222221 22233333344468899999999987
Q ss_pred ccee------EEEEEeccc-CHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC
Q psy16081 193 RNHL------CLVFELLSY-NLYDLLRNTNF----RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK 261 (493)
Q Consensus 193 ~~~~------~lV~E~~~~-~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~ 261 (493)
.+.. ++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli--~~ 172 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCML--AE 172 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEE--cC
Confidence 7655 999999965 99998864321 248999999999999999999995 789999999999999 67
Q ss_pred CCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy16081 262 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 262 ~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i 335 (493)
++.+||+|||+++..... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 889999999999766432 123456778999999999999999999999999999999 99999988776666555
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
......+. . ......+.+
T Consensus 253 ~~~~~~~~-------------------------------------~-------------------------~~~~~~l~~ 270 (323)
T 3qup_A 253 IGGNRLKQ-------------------------------------P-------------------------PECMEEVYD 270 (323)
T ss_dssp HTTCCCCC-------------------------------------C-------------------------TTCCHHHHH
T ss_pred hcCCCCCC-------------------------------------C-------------------------CccCHHHHH
Confidence 43211000 0 000117899
Q ss_pred HHhHccCCCCCCCCC-------HHHHhcCCCCCCCc
Q psy16081 416 LIFRMLDYDPKTRIT-------PYYALQHNFFKRTA 444 (493)
Q Consensus 416 Li~~mL~~dP~~R~t-------~~e~L~Hp~~~~~~ 444 (493)
||.+||..||++||| ++++++|||+....
T Consensus 271 li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 271 LMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 999999999999999 88999999999643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=349.37 Aligned_cols=263 Identities=25% Similarity=0.332 Sum_probs=182.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+........+||||+++++++...+..|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE---KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH---HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc---hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 47899999999999999999999999999999999754321 111122222222445567899999999999999999
Q ss_pred EEEEecccCHHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHhCCCC-CccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 198 LVFELLSYNLYDLLRN---TNFRGVSLNLTRKFSQQLCTALLFLSTPEL-NIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 198 lV~E~~~~~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~-~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
+||||++++|.+++.. .....+++..+..++.|++.||.|||+ . ||+||||||+|||+ +.++.+||+|||++
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll--~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILL--DRSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEE--ETTTEEEECCCSSS
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEE--cCCCCEEEccCCCc
Confidence 9999999998887753 223568999999999999999999995 5 89999999999999 67889999999999
Q ss_pred cccCCc--cccccccCcCCchhhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhh
Q psy16081 274 CQLGQR--IYQYIQSRFYRSPEVL----LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV-DQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 274 ~~~~~~--~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~~p~~~ 346 (493)
...... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.. +.+..+
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----------- 242 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV----------- 242 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-----------
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-----------
Confidence 776443 2344789999999999 4567999999999999999999999999864321 110000
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
..+ .....+. ...... ...+.+||.+||..||+
T Consensus 243 --------------~~~----------~~~~~~~---------------------~~~~~~--~~~l~~li~~~l~~dp~ 275 (327)
T 3aln_A 243 --------------VKG----------DPPQLSN---------------------SEEREF--SPSFINFVNLCLTKDES 275 (327)
T ss_dssp --------------CCS----------CCCCCCC---------------------CSSCCC--CHHHHHHHHHHTCSSGG
T ss_pred --------------hcC----------CCCCCCC---------------------cccccC--CHHHHHHHHHHhhCChh
Confidence 000 0000000 000001 12789999999999999
Q ss_pred CCCCHHHHhcCCCCCCCcc
Q psy16081 427 TRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~~~~ 445 (493)
+|||+.|+++||||.....
T Consensus 276 ~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 276 KRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp GSCCHHHHTTSHHHHHHHH
T ss_pred hCcCHHHHHhChHHHHhHh
Confidence 9999999999999986543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=349.39 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=193.2
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-------chHHHHHHHHHHHHhhcCCCCcceEEEe
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-------LNQAQIEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
.+.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ......|..++..+.. ...|+||+++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~h~~i~~~ 103 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA--GGGHPGVIRL 103 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHS--SCCCSSBCCE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcc--cCCCCCeeeE
Confidence 456678999999999999999999999999999999999644321 1223346666555532 2368889999
Q ss_pred ceeeeecceeEEEEEe-cc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc
Q psy16081 187 KRHFMWRNHLCLVFEL-LS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 187 ~~~~~~~~~~~lV~E~-~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ 264 (493)
++++...+..++|||+ +. ++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++ ..++.
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~-~~~~~ 178 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILID-LRRGC 178 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEE-TTTTE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEe-CCCCe
Confidence 9999999999999999 54 59999997653 59999999999999999999995 6899999999999994 26788
Q ss_pred EEEEecccccccCC-ccccccccCcCCchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 265 IKIVDFGSSCQLGQ-RIYQYIQSRFYRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 265 ikL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
+||+|||++..... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... +.......
T Consensus 179 ~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~ 252 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHF 252 (312)
T ss_dssp EEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCCCC
T ss_pred EEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------HhhhccCC
Confidence 99999999987654 34456789999999999877664 599999999999999999999975321 11100000
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
+ . ... ..+.+||.+||.
T Consensus 253 ------------------~--------------------~-----------------------~~~--~~~~~li~~~l~ 269 (312)
T 2iwi_A 253 ------------------P--------------------A-----------------------HVS--PDCCALIRRCLA 269 (312)
T ss_dssp ------------------C--------------------T-----------------------TSC--HHHHHHHHHHTC
T ss_pred ------------------c--------------------c-----------------------cCC--HHHHHHHHHHcc
Confidence 0 0 000 168899999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 423 YDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.||++|||+.|+|+||||+...+
T Consensus 270 ~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 270 PKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp SSTTTSCCHHHHHHSTTTCC---
T ss_pred CChhhCcCHHHHhcChhhcCchh
Confidence 99999999999999999996543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=351.71 Aligned_cols=258 Identities=15% Similarity=0.170 Sum_probs=192.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcC---CCeEEEEEEEccCcccchHHHHHHHHHH---------HHhhcCCCCcceEEE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLE---EQCHVAIKIIKNKKPFLNQAQIEVKLLE---------IMNKADVNNTYYIVR 185 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~e~~~~~---------~l~~~~~~~~~~Iv~ 185 (493)
.++|++.+.||+|+||+||+|.+.. ++..||||++..... ....|..++. ++......+|+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C---HHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc---chHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 3689999999999999999999987 788999999875432 2233333322 233344557899999
Q ss_pred eceeeee----cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC
Q psy16081 186 LKRHFMW----RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK 261 (493)
Q Consensus 186 l~~~~~~----~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~ 261 (493)
+++++.. ...+|+||||++++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.+.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEESSS
T ss_pred eecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEccCC
Confidence 9999988 78899999999779999987654 69999999999999999999995 6899999999999996544
Q ss_pred CCcEEEEecccccccCCc----------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--CCHH
Q psy16081 262 RSAIKIVDFGSSCQLGQR----------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG--SNEV 329 (493)
Q Consensus 262 ~~~ikL~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~--~~~~ 329 (493)
.+.+||+|||+++.+... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+ .+..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 459999999999765322 2445789999999999999999999999999999999999999965 3333
Q ss_pred HHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcch
Q psy16081 330 DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409 (493)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (493)
.............+..+..... .+ ..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~----------~~------------------------------------------~~-- 294 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAP----------SG------------------------------------------SS-- 294 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSC----------TT------------------------------------------SC--
T ss_pred HHHHHHHhhcccccHHHHhhcc----------cc------------------------------------------cc--
Confidence 3333332222222222211000 00 00
Q ss_pred hhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 410 YLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 410 ~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
...+.+||.+||..||++|||++++++
T Consensus 295 ~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 295 CCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 017899999999999999999999887
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=344.98 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=205.7
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+...++|++.+.||+|+||+||+|.+..+++.||||++.........+..|..++..+ +|+||+++++++.+.+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI------KHPNLVQLLGVCTREP 82 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC------CCTTBCCEEEEECSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC------CCCCEeeEEEEEccCC
Confidence 3456789999999999999999999999999999999986554445566666665554 3778999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+||||+. ++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~--~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLV--GENHLVKVADFGLS 158 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEE--CGGGCEEECCCCGG
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEE--cCCCCEEEccCccc
Confidence 9999999997 599999987665679999999999999999999995 789999999999999 67789999999999
Q ss_pred cccCCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 274 CQLGQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 274 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 233 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER----- 233 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC-----
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC-----
Confidence 8765432 23456778999999999899999999999999999999 9999988776555444432111000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.. .. ...+.+||.+||..||.+|
T Consensus 234 --------------------------------~~-----------------------~~--~~~l~~li~~~l~~dp~~R 256 (288)
T 3kfa_A 234 --------------------------------PE-----------------------GC--PEKVYELMRACWQWNPSDR 256 (288)
T ss_dssp --------------------------------CT-----------------------TC--CHHHHHHHHHHTCSSGGGS
T ss_pred --------------------------------CC-----------------------CC--CHHHHHHHHHHhCCChhhC
Confidence 00 00 0178999999999999999
Q ss_pred CCHHHHhc
Q psy16081 429 ITPYYALQ 436 (493)
Q Consensus 429 ~t~~e~L~ 436 (493)
||+.|+++
T Consensus 257 ps~~~~~~ 264 (288)
T 3kfa_A 257 PSFAEIHQ 264 (288)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=338.58 Aligned_cols=254 Identities=25% Similarity=0.292 Sum_probs=199.9
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.++|++.+.||+|+||+||+|++..+++.||||++.... .......|..++..+.+.+ ++..+..++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~-----~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGV-----GIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTST-----TCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCC-----CCCccccccCCCCc
Confidence 45679999999999999999999999999999999987443 3456778888888776543 24444455567788
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~DFG~a~ 274 (493)
.|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++. +.++.+||+|||++.
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 80 NVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred eEEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 99999999779999997443 469999999999999999999995 78999999999999931 256789999999997
Q ss_pred ccCCc----------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCC
Q psy16081 275 QLGQR----------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN---EVDQMNKIVEVLGL 341 (493)
Q Consensus 275 ~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~ 341 (493)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+ ..+.+..+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 76432 235678999999999999999999999999999999999999998743 22333333332111
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
.+...+. .. .. ..+.+||.+||
T Consensus 237 ~~~~~~~---------~~-----------------------------------------------~~--~~l~~li~~~l 258 (296)
T 3uzp_A 237 TPIEVLC---------KG-----------------------------------------------YP--SEFATYLNFCR 258 (296)
T ss_dssp SCHHHHT---------TT-----------------------------------------------SC--HHHHHHHHHHH
T ss_pred CchHHHH---------hh-----------------------------------------------CC--HHHHHHHHHHH
Confidence 1110000 00 00 17899999999
Q ss_pred CCCCCCCCCHHHHhc
Q psy16081 422 DYDPKTRITPYYALQ 436 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~ 436 (493)
..||.+|||+.++++
T Consensus 259 ~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 259 SLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TSCTTCCCCHHHHHH
T ss_pred hcCcCcCCCHHHHHH
Confidence 999999999999886
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=366.60 Aligned_cols=255 Identities=25% Similarity=0.317 Sum_probs=191.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
.+|.+.++||+|+||+||. ....+++.||||++.... ......|+.++..+. +||||+++++++.+.+.+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~-----~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESD-----EHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSC-----CCTTBCCEEEEEEETTEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhcc-----CCCCcCeEEEEEecCCEEEE
Confidence 3699999999999999764 346789999999996432 233456666665432 68889999999999999999
Q ss_pred EEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC---CCCCcEEEEecccccc
Q psy16081 199 VFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN---PKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 199 V~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~---~~~~~ikL~DFG~a~~ 275 (493)
|||||+++|.+++..... .+.+..+..++.||+.||.|||+ .||+||||||+|||++. +....+||+|||+|+.
T Consensus 96 v~E~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEECCSEEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEECCCCCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 999999999999986652 35555677899999999999995 68999999999999942 2334688999999987
Q ss_pred cCC------ccccccccCcCCchhhhcC---CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 276 LGQ------RIYQYIQSRFYRSPEVLLG---IPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 276 ~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++ |.+||........ ..+. +.....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~---~~~~~~ 248 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILL---GACSLD 248 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHT---TCCCCT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHh---ccCCcc
Confidence 643 2345679999999999984 567889999999999999999 9999975543322 1111 000000
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
. . .+ .......+.+||.+||..||
T Consensus 249 ~-------------------------------~-----------------------~~--~~~~~~~~~~li~~~L~~dP 272 (432)
T 3p23_A 249 C-------------------------------L-----------------------HP--EKHEDVIARELIEKMIAMDP 272 (432)
T ss_dssp T-------------------------------S-----------------------CT--TCHHHHHHHHHHHHHSCSSG
T ss_pred c-------------------------------c-----------------------Cc--cccccHHHHHHHHHHHhCCH
Confidence 0 0 00 00111257899999999999
Q ss_pred CCCCCHHHHhcCCCCCCCc
Q psy16081 426 KTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~~ 444 (493)
.+|||+.|+|+||||....
T Consensus 273 ~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 273 QKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp GGSCCHHHHHTSTTTCCHH
T ss_pred hhCCCHHHHHhCccccChH
Confidence 9999999999999998643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.33 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=201.4
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCC-------CeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEe
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEE-------QCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
...++|.+.+.||+|+||+||+|.+..+ +..||||+++.... .......|+.++..+. +||||+++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~ 140 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINL 140 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc-----CCchhhhh
Confidence 3457899999999999999999987543 36899999975432 1233445555554442 57789999
Q ss_pred ceeeeecceeEEEEEeccc-CHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCC
Q psy16081 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLK 251 (493)
Q Consensus 187 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlK 251 (493)
++++...+.+|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+ .||+|||||
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlk 218 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLA 218 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCC
Confidence 9999999999999999965 9999997643 1358999999999999999999995 689999999
Q ss_pred CCcEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q psy16081 252 PENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSG 325 (493)
Q Consensus 252 p~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~ 325 (493)
|+|||+ +.++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 219 p~NIll--~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 219 ARNVLV--TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GGGEEE--CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cceEEE--cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999 67889999999999866432 234466888999999999999999999999999999999 9999998
Q ss_pred CCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCC
Q psy16081 326 SNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405 (493)
Q Consensus 326 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 405 (493)
.+..+....+........ .
T Consensus 297 ~~~~~~~~~~~~~~~~~~-------------------------------------~------------------------ 315 (382)
T 3tt0_A 297 VPVEELFKLLKEGHRMDK-------------------------------------P------------------------ 315 (382)
T ss_dssp CCHHHHHHHHHTTCCCCC-------------------------------------C------------------------
T ss_pred CCHHHHHHHHHcCCCCCC-------------------------------------C------------------------
Confidence 887766655543211000 0
Q ss_pred CcchhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 406 ~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
......+.+||.+||..||++|||+.|++++
T Consensus 316 -~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 316 -SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp -SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0001178999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=354.99 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=197.9
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEE-----EcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAF-----DLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
...++|++.+.||+|+||.||+|. +..+++.||||+++..... ...+..|+.++..+. +||||+++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpniv~~~~ 93 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLG 93 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc-----CCcceeeeee
Confidence 345789999999999999999998 5567799999999753321 223455555555442 5788999999
Q ss_pred eeeecc-eeEEEEEeccc-CHHHHHhccCC--------------------------------------------------
Q psy16081 189 HFMWRN-HLCLVFELLSY-NLYDLLRNTNF-------------------------------------------------- 216 (493)
Q Consensus 189 ~~~~~~-~~~lV~E~~~~-~L~~~l~~~~~-------------------------------------------------- 216 (493)
++...+ .+|+|||||.+ +|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 988755 49999999965 99999976432
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc---
Q psy16081 217 --------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--- 279 (493)
Q Consensus 217 --------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~--- 279 (493)
..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++......
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILL--SEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CGGGCEEECCCGGGSCTTSCTTC
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEE--cCCCcEEEEeccceeeecccccc
Confidence 118999999999999999999995 689999999999999 67889999999999766332
Q ss_pred --cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhh
Q psy16081 280 --IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKY 356 (493)
Q Consensus 280 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 356 (493)
.....||+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+.+...+.....++.
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 317 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA------------ 317 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC------------
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC------------
Confidence 234567889999999999999999999999999999998 99999887655544444332111100
Q ss_pred hccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 357 FDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
+ . .. ...+.+||.+||..||.+|||+.|+++
T Consensus 318 ----------------------~--~-----------------------~~--~~~l~~li~~~l~~dP~~Rps~~ell~ 348 (359)
T 3vhe_A 318 ----------------------P--D-----------------------YT--TPEMYQTMLDCWHGEPSQRPTFSELVE 348 (359)
T ss_dssp ----------------------C--T-----------------------TC--CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------C--C-----------------------CC--CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0 00 017899999999999999999999998
Q ss_pred C
Q psy16081 437 H 437 (493)
Q Consensus 437 H 437 (493)
|
T Consensus 349 ~ 349 (359)
T 3vhe_A 349 H 349 (359)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=342.31 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=194.2
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
|....+||+|+||+||+|.+..+++.||||++..... .......|..++.. .+|+||+++++++...+.+++|
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~------l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH------LKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHT------CCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHh------CCCCCEeeEeeEEEeCCcEEEE
Confidence 4445699999999999999999999999999875432 22334444444433 3578899999999999999999
Q ss_pred EEecc-cCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 200 FELLS-YNLYDLLRNTN-FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 200 ~E~~~-~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|||+. ++|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||++ ..++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~-~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEE-TTTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEE-CCCCCEEEeecccccccC
Confidence 99995 49999887643 2346789999999999999999995 7899999999999994 237899999999997764
Q ss_pred Cc---cccccccCcCCchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 278 QR---IYQYIQSRFYRSPEVLLGIP--YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 278 ~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.. .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...................+.
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 246 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE-------- 246 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC--------
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc--------
Confidence 32 34567899999999997653 899999999999999999999999764433221111111110000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.+ .... ..+.+||.+||..||++|||+.
T Consensus 247 -------------------------~~-------------------------~~~~--~~~~~li~~~l~~dp~~Rps~~ 274 (295)
T 2clq_A 247 -------------------------IP-------------------------ESMS--AEAKAFILKCFEPDPDKRACAN 274 (295)
T ss_dssp -------------------------CC-------------------------TTSC--HHHHHHHHHTTCSSTTTSCCHH
T ss_pred -------------------------cc-------------------------ccCC--HHHHHHHHHHccCChhhCCCHH
Confidence 00 0001 1788999999999999999999
Q ss_pred HHhcCCCCCCC
Q psy16081 433 YALQHNFFKRT 443 (493)
Q Consensus 433 e~L~Hp~~~~~ 443 (493)
|+|+||||+..
T Consensus 275 ~ll~~~~~~~~ 285 (295)
T 2clq_A 275 DLLVDEFLKVS 285 (295)
T ss_dssp HHHTSGGGCC-
T ss_pred HHhcChhhhhc
Confidence 99999999854
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=342.70 Aligned_cols=198 Identities=20% Similarity=0.324 Sum_probs=166.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.++|++.++||+|+||+||+|.+..+++.||+|++.... .....+..|.. .....+||||+++++++.+.+.+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~------~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVK------VMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHH------HHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHH------HHHhCCCcCcccEEEEEecCCee
Confidence 468999999999999999999999999999999886432 11222233333 33344688999999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLV--RENKNVVVADFGLARL 157 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEE--CTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEE--CCCCCEEEeeccccee
Confidence 999999965 9999997643 469999999999999999999995 789999999999999 6788999999999976
Q ss_pred cCCcc-----------------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy16081 276 LGQRI-----------------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS 326 (493)
Q Consensus 276 ~~~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~ 326 (493)
..... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 63321 1457999999999999999999999999999999999999998653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=339.23 Aligned_cols=199 Identities=25% Similarity=0.300 Sum_probs=165.4
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc--------hHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL--------NQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
..++|++.+.||+|+||+||+|.+..+++.||||++....... ..+..|..+ ....+|+||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~------l~~l~h~~i~~~~~ 90 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI------MSNLNHPNIVKLYG 90 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHH------HTTCCCTTBCCEEE
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHH------HHhCCCCCchhhhe
Confidence 3578999999999999999999999999999999986433221 223333333 33346888999999
Q ss_pred eeeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC--ccccCCCCCcEEeeCCCCCc-
Q psy16081 189 HFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN--IIHCDLKPENILLCNPKRSA- 264 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~--iiHrDlKp~NILl~~~~~~~- 264 (493)
++.+.. ++||||+. ++|.+.+.... ..+++..++.++.||+.||.|||+ .| |+||||||+|||++ .++.
T Consensus 91 ~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~~ivH~dikp~Nil~~--~~~~~ 163 (287)
T 4f0f_A 91 LMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQ--SLDEN 163 (287)
T ss_dssp EETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCSCCSGGGEEES--CCCTT
T ss_pred eecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHh--CCCCeecCCCCcceEEEe--ccCCC
Confidence 987654 79999996 59999887654 469999999999999999999996 56 99999999999994 4444
Q ss_pred ----EEEEecccccccCCccccccccCcCCchhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q psy16081 265 ----IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLL--GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328 (493)
Q Consensus 265 ----ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~ 328 (493)
+||+|||++...........||+.|+|||++. ...++.++|||||||++|+|++|..||...+.
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 99999999988777777788999999999994 45688999999999999999999999986553
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=350.53 Aligned_cols=197 Identities=25% Similarity=0.279 Sum_probs=160.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc----
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN---- 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~---- 194 (493)
++|+++++||+|+||+||+|++. ++.||||++............ ++......+||||+++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~------E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEY------EVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHH------HHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHH------HHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 57999999999999999999764 799999999754321112222 333344557899999999998754
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC--------CCCccccCCCCCcEEeeCCCCCcE
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP--------ELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~--------~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
.+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||+. ..||+||||||+|||+ +.++.+
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill--~~~~~~ 170 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--KNNLTA 170 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE--CTTCCE
T ss_pred eEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE--CCCCeE
Confidence 47999999965 999999764 499999999999999999999952 1199999999999999 678899
Q ss_pred EEEecccccccCCc-----cccccccCcCCchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q psy16081 266 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGI-----PYDLAIDMWSLGCILVEMHTGEPLFSGSNE 328 (493)
Q Consensus 266 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~ 328 (493)
||+|||+++..... ....+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+...
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999999766432 2346789999999999873 466789999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=359.08 Aligned_cols=246 Identities=21% Similarity=0.287 Sum_probs=196.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.++|++.+.||+|+||+||+|.+..+++.||||+++.... ....+..|..+ ....+||||+++++++...+.
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~------l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI------LKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHH------HTTCCCTTBCCEEEEECSSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHH------HHhCCCCCEEEEEEEEecCCC
Confidence 4689999999999999999999999999999999874321 11122233333 334468899999999999999
Q ss_pred eEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+||||++ ++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~--~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLV--TEKNVLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCCEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEE--cCCCcEEECcCCCce
Confidence 999999995 59999987643 358999999999999999999995 789999999999999 678899999999998
Q ss_pred ccCCcccc-----ccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 275 QLGQRIYQ-----YIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 275 ~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
........ ..+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+......+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----- 336 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC----- 336 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC-----
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 76543222 234667999999998899999999999999999998 9999998877665554432111100
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
+.. ....+.+||.+||..||++|
T Consensus 337 --------------------------------~~~-------------------------~~~~l~~li~~cl~~dP~~R 359 (377)
T 3cbl_A 337 --------------------------------PEL-------------------------CPDAVFRLMEQCWAYEPGQR 359 (377)
T ss_dssp --------------------------------CTT-------------------------CCHHHHHHHHHHTCSSGGGS
T ss_pred --------------------------------CCC-------------------------CCHHHHHHHHHHcCCCchhC
Confidence 000 01168899999999999999
Q ss_pred CCHHHHhc
Q psy16081 429 ITPYYALQ 436 (493)
Q Consensus 429 ~t~~e~L~ 436 (493)
||+.++++
T Consensus 360 ps~~~i~~ 367 (377)
T 3cbl_A 360 PSFSTIYQ 367 (377)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=362.09 Aligned_cols=260 Identities=26% Similarity=0.331 Sum_probs=191.1
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.+.|.+.++||+|+||+||.+ ...+|+.||||++.... ......|+.++..+. +||||+++++++.+.+.
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESD-----DHPNVIRYYCSETTDRF 83 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECSSE
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhcc-----CCCCcCeEEEEEecCCe
Confidence 34567788899999999999875 46789999999986432 344556666655432 57889999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCC-----CCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC----------
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRG-----VSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP---------- 260 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~---------- 260 (493)
+|||||||+++|.+++....... .++..+..++.||+.||.|||+ .||+||||||+|||++.+
T Consensus 84 ~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 84 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred EEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCcccccccccC
Confidence 99999999999999997654211 1233456799999999999995 689999999999999532
Q ss_pred -CCCcEEEEecccccccCCc-------cccccccCcCCchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCC
Q psy16081 261 -KRSAIKIVDFGSSCQLGQR-------IYQYIQSRFYRSPEVLLG-------IPYDLAIDMWSLGCILVEMHT-GEPLFS 324 (493)
Q Consensus 261 -~~~~ikL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~pf~ 324 (493)
.++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 3458999999999876542 224579999999999976 578999999999999999999 999997
Q ss_pred CCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCC
Q psy16081 325 GSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404 (493)
Q Consensus 325 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 404 (493)
+....+ ..+.......+. ... .
T Consensus 242 ~~~~~~--~~i~~~~~~~~~------------------------------------~~~--------------------~ 263 (434)
T 2rio_A 242 DKYSRE--SNIIRGIFSLDE------------------------------------MKC--------------------L 263 (434)
T ss_dssp STTTHH--HHHHHTCCCCCC------------------------------------CTT--------------------C
T ss_pred CchhhH--HHHhcCCCCccc------------------------------------ccc--------------------c
Confidence 654332 222221000000 000 0
Q ss_pred CCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 405 ~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
........+.+||.+||..||.+|||+.|+|+||||...
T Consensus 264 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 264 HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 000111268999999999999999999999999999753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=338.58 Aligned_cols=203 Identities=28% Similarity=0.357 Sum_probs=166.0
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... .......|..++..+.+.+ +|..+..++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~-----~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGV-----GIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTST-----TCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCC-----CCCeeeeecCCCCc
Confidence 45678999999999999999999999999999999876433 2345677888877776443 35555556677889
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee-CCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC-NPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~-~~~~~~ikL~DFG~a~ 274 (493)
.|+||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+. ++.++.+||+|||++.
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 80 NVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred eEEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 99999999889999987543 469999999999999999999995 6899999999999993 1356789999999997
Q ss_pred ccCCc----------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 275 QLGQR----------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 275 ~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 76432 225678999999999999999999999999999999999999998744
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=334.82 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=200.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.+.||+|+||.||+|.+. +++.||||++............|..++..+ +||||+++++++.+.+.+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL------SHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC------CCTTBCCEEEEECSSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC------CCCCEeeEEEEEccCCCeE
Confidence 358999999999999999999875 678999999986554445555555554433 5788999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+||||+++ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLV--GENQVIKVSDFGMTRFV 154 (267)
T ss_dssp EEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEE--CGGGCEEECCTTGGGGB
T ss_pred EEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEE--CCCCCEEEccccccccc
Confidence 99999965 9999987643 458999999999999999999995 789999999999999 67889999999999776
Q ss_pred CCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.........
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------- 227 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP------- 227 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC-------
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC-------
Confidence 432 223456778999999998899999999999999999999 89999988877766655432110000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
. .. ...+.+||.+||..||++|||+
T Consensus 228 ------------------------------~-----------------------~~--~~~l~~li~~~l~~~p~~Rps~ 252 (267)
T 3t9t_A 228 ------------------------------R-----------------------LA--STHVYQIMNHCWRERPEDRPAF 252 (267)
T ss_dssp ------------------------------T-----------------------TS--CHHHHHHHHHHTCSSGGGSCCH
T ss_pred ------------------------------c-----------------------cC--cHHHHHHHHHHccCChhhCcCH
Confidence 0 00 0168899999999999999999
Q ss_pred HHHhcC
Q psy16081 432 YYALQH 437 (493)
Q Consensus 432 ~e~L~H 437 (493)
.|++++
T Consensus 253 ~~ll~~ 258 (267)
T 3t9t_A 253 SRLLRQ 258 (267)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=360.18 Aligned_cols=245 Identities=22% Similarity=0.283 Sum_probs=196.9
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc-e
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN-H 195 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~-~ 195 (493)
-.++|++.+.||+|+||.||+|.+ +++.||||+++... ....+..|..++..+ +||||+++++++...+ .
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQL------RHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-TSHHHHHHHHHHHTC------CCTTBCCEEEEEECTTSC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-HHHHHHHHHHHHHhc------cCCCEEEEEEEEEcCCCc
Confidence 356899999999999999999976 47899999998543 345566666655443 5788999999987655 7
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|||||||.+ +|.+++.......+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill--~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLV--SEDNVAKVSDFGLTK 337 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEE--CCCCCEEEeeCCCcc
Confidence 9999999965 99999987654457999999999999999999995 789999999999999 678899999999998
Q ss_pred ccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
..........+++.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+......+.
T Consensus 338 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---------- 407 (450)
T 1k9a_A 338 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---------- 407 (450)
T ss_dssp ECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC----------
T ss_pred cccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 76555555577889999999999999999999999999999998 9999998776655555433211100
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
+. .....+.+||.+||..||++|||+.+
T Consensus 408 ---------------------------p~-------------------------~~~~~l~~li~~cl~~dp~~Rpt~~~ 435 (450)
T 1k9a_A 408 ---------------------------PD-------------------------GCPPAVYDVMKNCWHLDAATRPTFLQ 435 (450)
T ss_dssp ---------------------------CT-------------------------TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---------------------------CC-------------------------cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 00 00117899999999999999999999
Q ss_pred Hhc
Q psy16081 434 ALQ 436 (493)
Q Consensus 434 ~L~ 436 (493)
+++
T Consensus 436 l~~ 438 (450)
T 1k9a_A 436 LRE 438 (450)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=369.41 Aligned_cols=256 Identities=16% Similarity=0.212 Sum_probs=191.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcC----------CCCcceE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKAD----------VNNTYYI 183 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~----------~~~~~~I 183 (493)
...|.+.++||+|+||+||+|.+..+|+.||||++.... .....+..|..++..+.+.. ......+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 446889999999999999999999999999999987322 12345556666555444311 0111112
Q ss_pred EEec------eeeee-----cceeEEEEEecccCHHHHHh-----ccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccc
Q psy16081 184 VRLK------RHFMW-----RNHLCLVFELLSYNLYDLLR-----NTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIH 247 (493)
Q Consensus 184 v~l~------~~~~~-----~~~~~lV~E~~~~~L~~~l~-----~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiH 247 (493)
+.+. ..+.. ...++++|+++.++|.+++. ......+++..+..++.||+.||.|||+ .||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iiH 234 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVH 234 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--TTEEC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCccc
Confidence 2221 11111 23578999999999999885 2222347888999999999999999995 78999
Q ss_pred cCCCCCcEEeeCCCCCcEEEEecccccccCCccccccccCcCCchhhh----------cCCCCCchhhHHHHHHHHHHHH
Q psy16081 248 CDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVL----------LGIPYDLAIDMWSLGCILVEMH 317 (493)
Q Consensus 248 rDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvil~ell 317 (493)
|||||+|||+ +.++.+||+|||+++..+......+| +.|+|||++ .+..|+.++|||||||++|||+
T Consensus 235 rDiKp~NILl--~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 235 TYLRPVDIVL--DQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp SCCCGGGEEE--CTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CCcccceEEE--ecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999 67888999999999888877777888 999999999 5556899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCC
Q psy16081 318 TGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGG 397 (493)
Q Consensus 318 tG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 397 (493)
+|+.||.+.+..+....+ +...
T Consensus 312 tg~~Pf~~~~~~~~~~~~---------------------~~~~------------------------------------- 333 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWI---------------------FRSC------------------------------------- 333 (413)
T ss_dssp HSSCCCCTTGGGSCSGGG---------------------GSSC-------------------------------------
T ss_pred HCCCCCCCcchhhhHHHH---------------------Hhhc-------------------------------------
Confidence 999999865422110000 0000
Q ss_pred CcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 398 RRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 398 ~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.... ..+.+||.+||..||++|||+.|+|+||||+.+..
T Consensus 334 -------~~~~--~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 334 -------KNIP--QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp -------CCCC--HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred -------ccCC--HHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence 0000 17899999999999999999999999999987643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=360.14 Aligned_cols=203 Identities=25% Similarity=0.347 Sum_probs=172.2
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.++|+++++||+|+||.||+|.+..+++.||||++.... ...+...|..++..+.+.. +|..+..++...+.
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~-----~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGT-----GIPNVRWFGVEGDY 77 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTST-----TCCCEEEEEEETTE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCC-----CCCeEEEEEeeCCE
Confidence 45689999999999999999999999999999999987443 2345677888877766433 35555666778889
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~DFG~a~ 274 (493)
.||||||++++|.+++.... ..+++..++.++.||+.||.|||. .|||||||||+||||+. +..+.+||+|||+++
T Consensus 78 ~~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 99999999889999997543 469999999999999999999995 78999999999999942 257789999999998
Q ss_pred ccCCcc----------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 275 QLGQRI----------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 275 ~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
...... ...+||+.|+|||++.+..++.++|||||||+||||++|..||.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 764332 25679999999999999999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=350.09 Aligned_cols=246 Identities=20% Similarity=0.258 Sum_probs=188.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEE----EEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHV----AIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v----AvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
.++|++.++||+|+||+||+|++..+++.+ |+|.++... .....+..|..++..+ +||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~ 87 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------DNPHVCRLLGICL 87 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC------CBTTBCCEEEEEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC------CCCCEeEEEEEEe
Confidence 357999999999999999999988887654 777765322 2233445555555443 4788999999998
Q ss_pred ecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
..+ .++|+||+. ++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll--~~~~~~kl~Df 161 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLV--KTPQHVKITDF 161 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--EETTEEEECCT
T ss_pred cCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEE--CCCCCEEEccC
Confidence 654 788999995 59999987654 469999999999999999999995 689999999999999 56788999999
Q ss_pred ccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 271 GSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 271 G~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|+++...... ....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+......+.
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~- 240 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 240 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC-
Confidence 9997764322 23456778999999999999999999999999999999 9999998776554443332111000
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
. ......+.+||.+||..|
T Consensus 241 ------------------------------------~-------------------------~~~~~~~~~li~~~l~~~ 259 (327)
T 3poz_A 241 ------------------------------------P-------------------------PICTIDVYMIMVKCWMID 259 (327)
T ss_dssp ------------------------------------C-------------------------TTBCHHHHHHHHHHTCSC
T ss_pred ------------------------------------C-------------------------ccCCHHHHHHHHHHcCCC
Confidence 0 001116889999999999
Q ss_pred CCCCCCHHHHhcC
Q psy16081 425 PKTRITPYYALQH 437 (493)
Q Consensus 425 P~~R~t~~e~L~H 437 (493)
|.+|||+.|+++|
T Consensus 260 p~~Rps~~ell~~ 272 (327)
T 3poz_A 260 ADSRPKFRELIIE 272 (327)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.33 Aligned_cols=250 Identities=17% Similarity=0.192 Sum_probs=199.0
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec--c
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR--N 194 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~--~ 194 (493)
-.++|++.+.||+|+||+||+|.+ +++.||||+++....... ....+.+++......+||||+++++++.+. +
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTR---KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHH---HHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHH---HHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 356899999999999999999987 488999999975432211 123345566666667899999999999877 7
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+++||||+.+ +|.+++.......+++..+..++.||+.||.|||+++..|+||||||+|||+ +.++.++|+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDMTARISMADVK 160 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE--CTTSCEEEEGGGSC
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE--cCCcceeEEeccce
Confidence 89999999965 9999998765446899999999999999999999632239999999999999 67888999999987
Q ss_pred cccCCccccccccCcCCchhhhcCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 274 CQLGQRIYQYIQSRFYRSPEVLLGIPYDL---AIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
..... ....||+.|+|||++.+..++. ++|||||||++|+|++|..||.+.+..+....+......++
T Consensus 161 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 231 (271)
T 3kmu_A 161 FSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------- 231 (271)
T ss_dssp CTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC-------
T ss_pred eeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC-------
Confidence 55332 3457899999999999866554 89999999999999999999998887776665543211110
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
. +. ... ..+.+||.+||..||++|||
T Consensus 232 ---------------------------~--~~-----------------------~~~--~~~~~li~~~l~~~p~~Rps 257 (271)
T 3kmu_A 232 ---------------------------I--PP-----------------------GIS--PHVSKLMKICMNEDPAKRPK 257 (271)
T ss_dssp ---------------------------C--CT-----------------------TCC--HHHHHHHHHHTCSSGGGSCC
T ss_pred ---------------------------C--CC-----------------------CCC--HHHHHHHHHHcCCChhhCcC
Confidence 0 00 001 17899999999999999999
Q ss_pred HHHHhc
Q psy16081 431 PYYALQ 436 (493)
Q Consensus 431 ~~e~L~ 436 (493)
+.|+++
T Consensus 258 ~~~il~ 263 (271)
T 3kmu_A 258 FDMIVP 263 (271)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=355.31 Aligned_cols=246 Identities=20% Similarity=0.235 Sum_probs=191.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeE----EEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCH----VAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
.++|+++++||+|+||+||+|.+..+++. ||+|++.... ........|..++.. .+|+||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~------l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS------LDHAHIVRLLGLCP 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHT------CCCTTBCCEEEEEC
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhc------CCCCCcCeEEEEEc
Confidence 35899999999999999999999888775 7777775322 122333444444332 25788999999886
Q ss_pred ecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
.+..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~--~~~~~~kl~Df 159 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLL--KSPSQVQVADF 159 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEE--SSSSCEEECSC
T ss_pred -CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEE--CCCCeEEECCC
Confidence 567899999996 59999987643 368999999999999999999995 689999999999999 67889999999
Q ss_pred ccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 271 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 271 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+......+..
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP 239 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC
Confidence 999876432 234567789999999999899999999999999999999 99999987765554444321100000
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
. .....+.+||.+||..|
T Consensus 240 -------------------------------------~-------------------------~~~~~~~~li~~~l~~d 257 (325)
T 3kex_A 240 -------------------------------------Q-------------------------ICTIDVYMVMVKCWMID 257 (325)
T ss_dssp -------------------------------------T-------------------------TBCTTTTHHHHHHTCSC
T ss_pred -------------------------------------C-------------------------cCcHHHHHHHHHHcCCC
Confidence 0 00015679999999999
Q ss_pred CCCCCCHHHHhcC
Q psy16081 425 PKTRITPYYALQH 437 (493)
Q Consensus 425 P~~R~t~~e~L~H 437 (493)
|.+|||+.|+++|
T Consensus 258 p~~Rps~~el~~~ 270 (325)
T 3kex_A 258 ENIRPTFKELANE 270 (325)
T ss_dssp TTTSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=367.78 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=204.6
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
-.++|++.++||+|+||.||+|.+..++..||||+++........+..|+.++..+ +||||+++++++...+.+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI------KHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC------CCTTBCCEEEEECSSSSC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc------CCCCEeeEEEEEecCCcE
Confidence 35689999999999999999999999999999999986655556666677666554 477899999999999999
Q ss_pred EEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|||||||. ++|.+++.......+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++.
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLV--GENHLVKVADFGLSRL 367 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CGGGCEEECCTTCEEC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEE--CCCCcEEEeeccccee
Confidence 99999996 599999987655679999999999999999999995 789999999999999 6788999999999987
Q ss_pred cCCccc----cccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQRIY----QYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
...... ...++..|+|||++.+..++.++|||||||+||||++ |.+||.+.+..+....+......+.
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------- 440 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER------- 440 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC-------
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 643321 2345678999999998899999999999999999999 9999998776655544432111000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
+. .....+.+||.+||..||.+|||
T Consensus 441 ------------------------------~~-------------------------~~~~~l~~li~~cl~~dP~~RPs 465 (495)
T 1opk_A 441 ------------------------------PE-------------------------GCPEKVYELMRACWQWNPSDRPS 465 (495)
T ss_dssp ------------------------------CT-------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ------------------------------CC-------------------------CCCHHHHHHHHHHcCcChhHCcC
Confidence 00 00117889999999999999999
Q ss_pred HHHHhc
Q psy16081 431 PYYALQ 436 (493)
Q Consensus 431 ~~e~L~ 436 (493)
+.++++
T Consensus 466 ~~el~~ 471 (495)
T 1opk_A 466 FAEIHQ 471 (495)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=347.37 Aligned_cols=203 Identities=25% Similarity=0.364 Sum_probs=150.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee-----
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM----- 191 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~----- 191 (493)
..+|++.++||+|+||+||+|.+..+++.||||++..... .......|..++..+. +|+||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS-----GHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT-----TSTTBCCEEEEEEECTTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc-----cCCChhhccccccccccc
Confidence 4589999999999999999999999999999998854321 1233344555544442 5788999999984
Q ss_pred ---ecceeEEEEEecccCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 192 ---WRNHLCLVFELLSYNLYDLLRNT-NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 192 ---~~~~~~lV~E~~~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
....+++||||++++|.+++... ....+++..++.++.||+.||.|||+++.+|+||||||+|||+ +.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~--~~~~~~kl 179 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQGTIKL 179 (337)
T ss_dssp STTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE--CTTSCEEB
T ss_pred cccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE--CCCCCEEE
Confidence 44568999999999999988652 2245999999999999999999999632239999999999999 67889999
Q ss_pred EecccccccCCcc---------------ccccccCcCCchhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 268 VDFGSSCQLGQRI---------------YQYIQSRFYRSPEVL---LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 268 ~DFG~a~~~~~~~---------------~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
+|||++....... ...+||+.|+|||++ .+..++.++|||||||++|+|++|..||....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 9999997764321 145689999999999 56678999999999999999999999997544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=347.97 Aligned_cols=250 Identities=23% Similarity=0.291 Sum_probs=198.1
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
...++|++++.||+|+||.||+|.+. .+++.||||+++..... ...+..|..++. ..+||||+++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~------~l~hp~iv~~~~ 117 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA------EFDNPNIVKLLG 117 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHH------TCCCTTBCCEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHH------hCCCCCEEEEEE
Confidence 34578999999999999999999987 45689999999753211 122333443333 235888999999
Q ss_pred eeeecceeEEEEEeccc-CHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCc
Q psy16081 189 HFMWRNHLCLVFELLSY-NLYDLLRNTN----------------------FRGVSLNLTRKFSQQLCTALLFLSTPELNI 245 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~~-~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~i 245 (493)
++.+.+.+|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+ .||
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~i 195 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKF 195 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCe
Confidence 99999999999999965 9999987632 1468999999999999999999995 689
Q ss_pred cccCCCCCcEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-C
Q psy16081 246 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-G 319 (493)
Q Consensus 246 iHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G 319 (493)
+||||||+|||+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 196 vH~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 196 VHRDLATRNCLV--GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp CCSCCSGGGEEE--CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred ecCCCCcceEEE--CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 999999999999 67889999999999765432 234567889999999999899999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCc
Q psy16081 320 EPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRR 399 (493)
Q Consensus 320 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 399 (493)
..||.+.+..+....+.+....+. + .
T Consensus 274 ~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------~--~----------------- 299 (343)
T 1luf_A 274 LQPYYGMAHEEVIYYVRDGNILAC-----------------------------------P--E----------------- 299 (343)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCC-----------------------------------C--T-----------------
T ss_pred CCcCCCCChHHHHHHHhCCCcCCC-----------------------------------C--C-----------------
Confidence 999998887776665543210000 0 0
Q ss_pred CCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 400 LGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 400 ~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
.. ...+.+||.+||..||.+|||+.+++++
T Consensus 300 ------~~--~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 300 ------NC--PLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp ------TC--CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CC--CHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 00 0168899999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=343.41 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=202.5
Q ss_pred eeccceecCcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEE
Q psy16081 111 IQHGEKFLDRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVR 185 (493)
Q Consensus 111 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~ 185 (493)
....+...++|++.+.||+|+||+||+|.+. .+++.||||++...... .. ...+.+++......+|+||++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~---~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RE---RIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HH---HHHHHHHHHHGGGCCCTTBCC
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-HH---HHHHHHHHHHHHhcCCCCEee
Confidence 3444566789999999999999999999876 46789999999743321 11 122333344444456888999
Q ss_pred eceeeeecceeEEEEEeccc-CHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 186 LKRHFMWRNHLCLVFELLSY-NLYDLLRNTN--------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 186 l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
+++++.+.+..|+||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+ .||+||||||+|||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIl 170 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCM 170 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEE
Confidence 99999999999999999965 9999886532 1357899999999999999999995 68999999999999
Q ss_pred eeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy16081 257 LCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVD 330 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~ 330 (493)
+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+
T Consensus 171 i--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 171 V--AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp E--CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred E--cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence 9 67889999999999766432 223456888999999999899999999999999999999 899999888776
Q ss_pred HHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchh
Q psy16081 331 QMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410 (493)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (493)
....+......+. .. .. .
T Consensus 249 ~~~~~~~~~~~~~-------------------------------------~~-----------------------~~--~ 266 (322)
T 1p4o_A 249 VLRFVMEGGLLDK-------------------------------------PD-----------------------NC--P 266 (322)
T ss_dssp HHHHHHTTCCCCC-------------------------------------CT-----------------------TC--C
T ss_pred HHHHHHcCCcCCC-------------------------------------CC-----------------------CC--C
Confidence 6655543110000 00 00 1
Q ss_pred hhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 411 LKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 411 ~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
..+.+||.+||..||.+|||+.|+++|
T Consensus 267 ~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 267 DMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 168899999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.45 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=196.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|.+.+.||+|+||.||+|.+. .+++.||||++..... .... ..+.+++......+||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSEL---RDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHH---HHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHH---HHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 468999999999999999999873 4568999999974321 1111 122333333344468899999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccC
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNF----------------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCD 249 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrD 249 (493)
.+.+|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+ .||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~d 175 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRD 175 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECCC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCcccc
Confidence 999999999996 599999976432 248999999999999999999995 6899999
Q ss_pred CCCCcEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q psy16081 250 LKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLF 323 (493)
Q Consensus 250 lKp~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf 323 (493)
|||+|||+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||
T Consensus 176 ikp~NIli--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 176 LAARNILV--AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CSGGGEEE--ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cchheEEE--cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999 57788999999999766432 223456788999999999899999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCC
Q psy16081 324 SGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEP 403 (493)
Q Consensus 324 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 403 (493)
.+.+.......+....... . .
T Consensus 254 ~~~~~~~~~~~~~~~~~~~-----------------------------------~--~---------------------- 274 (314)
T 2ivs_A 254 PGIPPERLFNLLKTGHRME-----------------------------------R--P---------------------- 274 (314)
T ss_dssp TTCCGGGHHHHHHTTCCCC-----------------------------------C--C----------------------
T ss_pred CCCCHHHHHHHhhcCCcCC-----------------------------------C--C----------------------
Confidence 8877655544433211000 0 0
Q ss_pred CCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 404 GHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 404 ~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
... ...+.+||.+||..||.+|||+.|++++
T Consensus 275 -~~~--~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 275 -DNC--SEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp -TTC--CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -ccC--CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 1178999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=338.66 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=184.8
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
...++|++.+.||+|+||+||+|.+..+ +..||||++...... ...+..|..+ ....+||||+++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~------l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT------MRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHH------HHTCCCTTBCCEEEEE
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHH------HHhCCCCccceEEEEE
Confidence 4457899999999999999999998654 567999998743211 1122223332 2333688899999998
Q ss_pred eecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 191 MWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 191 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
. .+..|+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~--~~~~~~kl~D 159 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLV--SSNDCVKLGD 159 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--EETTEEEECC
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEE--CCCCCEEECc
Confidence 5 5678999999975 9999987543 468999999999999999999995 789999999999999 5678999999
Q ss_pred cccccccCCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 270 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 270 FG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+.+..+......+.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~- 238 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM- 238 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-
T ss_pred cccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC-
Confidence 9999776442 223456778999999998899999999999999999996 9999998877666655543211000
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.. .....+.+||.+||..|
T Consensus 239 ------------------------------------~~-------------------------~~~~~l~~li~~~l~~~ 257 (281)
T 1mp8_A 239 ------------------------------------PP-------------------------NCPPTLYSLMTKCWAYD 257 (281)
T ss_dssp ------------------------------------CT-------------------------TCCHHHHHHHHHHTCSS
T ss_pred ------------------------------------CC-------------------------CCCHHHHHHHHHHccCC
Confidence 00 00117889999999999
Q ss_pred CCCCCCHHHHhcC
Q psy16081 425 PKTRITPYYALQH 437 (493)
Q Consensus 425 P~~R~t~~e~L~H 437 (493)
|++|||+.|++++
T Consensus 258 p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 258 PSRRPRFTELKAQ 270 (281)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=338.93 Aligned_cols=198 Identities=24% Similarity=0.315 Sum_probs=161.1
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
..+.++|++++.||+|+||+||+|.+ +++.||||++.... ......|.+++... ..+||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~----~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTV----MLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHT----CCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHh----hccCcCeeeEEEeecccc
Confidence 35667999999999999999999976 78999999996432 23334444443332 2468889999998664
Q ss_pred --cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCccccCCCCCcEEeeCCCCC
Q psy16081 193 --RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP------ELNIIHCDLKPENILLCNPKRS 263 (493)
Q Consensus 193 --~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~------~~~iiHrDlKp~NILl~~~~~~ 263 (493)
...+|+||||+.+ +|.+++... .+++..+..++.||+.||.|||+. +.||+||||||+|||+ +.++
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill--~~~~ 150 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV--KKNG 150 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE--CTTS
T ss_pred CCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE--cCCC
Confidence 3568999999965 999999653 599999999999999999999932 3689999999999999 6788
Q ss_pred cEEEEecccccccCCcc-------ccccccCcCCchhhhcCC------CCCchhhHHHHHHHHHHHHhC----------C
Q psy16081 264 AIKIVDFGSSCQLGQRI-------YQYIQSRFYRSPEVLLGI------PYDLAIDMWSLGCILVEMHTG----------E 320 (493)
Q Consensus 264 ~ikL~DFG~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG----------~ 320 (493)
.+||+|||++....... ...+||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999997654322 234799999999999886 455799999999999999999 8
Q ss_pred CCCCC
Q psy16081 321 PLFSG 325 (493)
Q Consensus 321 ~pf~~ 325 (493)
+||..
T Consensus 231 ~pf~~ 235 (301)
T 3q4u_A 231 PPFYD 235 (301)
T ss_dssp CTTTT
T ss_pred ccccc
Confidence 88865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=333.27 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=184.6
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|++.+.||+|+||+||+|.+ +++.||||+++.... .......|..++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 77 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML------KHPNIIALRGVCLK 77 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC------CCTTBCCEEEEECC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc------CCCCEeeEEEEEec
Confidence 46899999999999999999986 489999999874322 123344455444433 47789999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCC---ccccCCCCCcEEeeCC------CC
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELN---IIHCDLKPENILLCNP------KR 262 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~---iiHrDlKp~NILl~~~------~~ 262 (493)
.+.+|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||+ .| |+||||||+|||++.+ .+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred CCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEecccccccccC
Confidence 9999999999965 88888754 359999999999999999999996 45 9999999999999431 26
Q ss_pred CcEEEEecccccccCCc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy16081 263 SAIKIVDFGSSCQLGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGL 341 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 341 (493)
+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 153 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232 (271)
T ss_dssp CCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred cceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence 78999999999766443 33567899999999999999999999999999999999999999988776655444321000
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
++ ... .. ...+.+||.+||
T Consensus 233 ~~------------------------------------~~~-----------------------~~--~~~~~~li~~~l 251 (271)
T 3dtc_A 233 LP------------------------------------IPS-----------------------TC--PEPFAKLMEDCW 251 (271)
T ss_dssp CC------------------------------------CCT-----------------------TC--CHHHHHHHHHHT
T ss_pred CC------------------------------------CCc-----------------------cc--CHHHHHHHHHHh
Confidence 00 000 00 116899999999
Q ss_pred CCCCCCCCCHHHHhcC
Q psy16081 422 DYDPKTRITPYYALQH 437 (493)
Q Consensus 422 ~~dP~~R~t~~e~L~H 437 (493)
..||.+|||+.|+++|
T Consensus 252 ~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 252 NPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCCcccCcCHHHHHHH
Confidence 9999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=338.85 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=199.4
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEE-----cCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFD-----LEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
..++|++.+.||+|+||+||+|.+ ..+++.||||+++.... .......|..++..+ .+||||++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~~h~~i~~~~~~ 95 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL-----GNHMNIVNLLGA 95 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH-----CCCTTBCCEEEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhc-----ccCCCeeeEEEE
Confidence 346899999999999999999985 45788999999975432 123344555555444 257889999999
Q ss_pred eeecceeEEEEEeccc-CHHHHHhccCC----------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCC
Q psy16081 190 FMWRNHLCLVFELLSY-NLYDLLRNTNF----------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKP 252 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp 252 (493)
+...+..|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp 173 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAA 173 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCcc
Confidence 9999999999999965 99999976532 248999999999999999999995 6899999999
Q ss_pred CcEEeeCCCCCcEEEEecccccccCCcc-----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy16081 253 ENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGS 326 (493)
Q Consensus 253 ~NILl~~~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~ 326 (493)
+|||+ +.++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.
T Consensus 174 ~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 174 RNILL--THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GGEEE--ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ceEEE--cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999 577899999999998765432 23456788999999999999999999999999999998 99999887
Q ss_pred CHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCC
Q psy16081 327 NEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHS 406 (493)
Q Consensus 327 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 406 (493)
.....+..+......++. . ..
T Consensus 252 ~~~~~~~~~~~~~~~~~~------------------------------------~-----------------------~~ 272 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRMLS------------------------------------P-----------------------EH 272 (313)
T ss_dssp CSSHHHHHHHHHTCCCCC------------------------------------C-----------------------TT
T ss_pred cchhHHHHHhccCCCCCC------------------------------------c-----------------------cc
Confidence 655554444432111000 0 00
Q ss_pred cchhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 407 VSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 407 ~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
. ...+.+||.+||..||.+|||+.|++++
T Consensus 273 ~--~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 273 A--PAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp S--CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C--CHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 0 1178999999999999999999999974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=360.02 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=200.8
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+...++|++.+.||+|+||+||+|.+. ++..||||+++........+..|+.++. ..+||||+++++++. .+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMK------TLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHT------TCCCTTBCCEEEEEC-SS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHh------hCCCCCEeeEEEEEe-CC
Confidence 344678999999999999999999875 5788999999865544455555555443 345888999999986 67
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+|||||. ++|.+++.......+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill--~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILV--SASLVCKIADFGLA 331 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEE--CTTCCEEECSTTGG
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEE--CCCCcEEEeeCCCc
Confidence 8999999995 599999976543458899999999999999999995 689999999999999 67889999999999
Q ss_pred cccCCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 274 CQLGQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 274 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
+...... ....++..|+|||++.+..++.++|||||||+||||++ |.+||.+.+..+.+..+......+...
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~--- 408 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE--- 408 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT---
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---
Confidence 8765432 22345678999999998899999999999999999999 999999988887777665432211100
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
.....+.+||.+||..||++|
T Consensus 409 -----------------------------------------------------------~~~~~l~~li~~cl~~dp~~R 429 (454)
T 1qcf_A 409 -----------------------------------------------------------NCPEELYNIMMRCWKNRPEER 429 (454)
T ss_dssp -----------------------------------------------------------TSCHHHHHHHHHHTCSSGGGS
T ss_pred -----------------------------------------------------------CCCHHHHHHHHHHccCChhHC
Confidence 000178899999999999999
Q ss_pred CCHHHHhc
Q psy16081 429 ITPYYALQ 436 (493)
Q Consensus 429 ~t~~e~L~ 436 (493)
||++++++
T Consensus 430 Pt~~~i~~ 437 (454)
T 1qcf_A 430 PTFEYIQS 437 (454)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=339.03 Aligned_cols=244 Identities=20% Similarity=0.290 Sum_probs=190.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCC-------eEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQ-------CHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
.++|++.+.||+|+||+||+|.+..++ ..||+|++..... ....+..|..++.. .+||||++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~------l~h~~iv~~~~~ 80 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK------LSHKHLVLNYGV 80 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHT------SCCTTBCCEEEE
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHh------CCCCCEeEEEEE
Confidence 468999999999999999999988877 5799999864332 22334444444333 247889999999
Q ss_pred eeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc----
Q psy16081 190 FMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA---- 264 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~---- 264 (493)
+.+.+..|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||++ .++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~--~~~~~~~~ 155 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLI--REEDRKTG 155 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE--ECCBGGGT
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEe--cCCccccc
Confidence 999999999999996 59999997653 348999999999999999999995 7899999999999994 4444
Q ss_pred ----EEEEecccccccCCccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHH
Q psy16081 265 ----IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTG-EPLFSGSNEVDQMNKIVEV 338 (493)
Q Consensus 265 ----ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~ 338 (493)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||...+...........
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred ccceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence 999999999766443 34568899999999998 6799999999999999999995 5666655544333222110
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
...++ .. ...+.+||.
T Consensus 235 ~~~~~--------------------------------------------------------------~~--~~~l~~li~ 250 (289)
T 4fvq_A 235 HQLPA--------------------------------------------------------------PK--AAELANLIN 250 (289)
T ss_dssp CCCCC--------------------------------------------------------------CS--SCTTHHHHH
T ss_pred CCCCC--------------------------------------------------------------CC--CHHHHHHHH
Confidence 00000 00 015789999
Q ss_pred HccCCCCCCCCCHHHHhcC
Q psy16081 419 RMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 419 ~mL~~dP~~R~t~~e~L~H 437 (493)
+||..||.+|||+.|+++|
T Consensus 251 ~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 251 NCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHSCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHH
Confidence 9999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=345.77 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=198.6
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEE-----cCCCeEEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFD-----LEEQCHVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
..++|++.+.||+|+||+||+|.+ ..++..||||++.... ........|..++..+. +||||++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~ 117 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLLGA 117 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEEE
Confidence 357899999999999999999987 3467789999997432 23345566666665552 57789999999
Q ss_pred eeecceeEEEEEeccc-CHHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccc
Q psy16081 190 FMWRNHLCLVFELLSY-NLYDLLRNTNF---------------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIH 247 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiH 247 (493)
+...+.+|+||||+++ +|.+++..... ..+++..++.++.||+.||.|||+ .||+|
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH 195 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVH 195 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccc
Confidence 9999999999999955 99999976432 237899999999999999999995 78999
Q ss_pred cCCCCCcEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCC
Q psy16081 248 CDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEP 321 (493)
Q Consensus 248 rDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~ 321 (493)
|||||+|||+ +.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++ |.+
T Consensus 196 ~Dikp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 196 RDLAARNVLV--THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TTCSGGGEEE--ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCCChhhEEE--cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 9999999999 57789999999999766432 223456788999999999999999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCC
Q psy16081 322 LFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401 (493)
Q Consensus 322 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 401 (493)
||.+......+..++.....++ . +
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~~----------------------------------~--~-------------------- 297 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKMD----------------------------------Q--P-------------------- 297 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCC----------------------------------C--C--------------------
T ss_pred CcccCCcHHHHHHHHhcCCCCC----------------------------------C--C--------------------
Confidence 9988765544444433110000 0 0
Q ss_pred CCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcCC
Q psy16081 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHN 438 (493)
Q Consensus 402 ~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp 438 (493)
......+.+||.+||..||.+|||+.|+++|-
T Consensus 298 -----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 298 -----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 00012789999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=345.83 Aligned_cols=201 Identities=15% Similarity=0.117 Sum_probs=164.8
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCC--------CeEEEEEEEccCcccchHHHHHHHHHHHHhhc---------CCCCcc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEE--------QCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKA---------DVNNTY 181 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~--------~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~---------~~~~~~ 181 (493)
++|++.+.||+|+||+||+|++..+ ++.||||++... .....|..++..+.+. ....+.
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 6899999999999999999999874 889999999754 3456677777666431 122233
Q ss_pred eEEEeceeeee-cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC
Q psy16081 182 YIVRLKRHFMW-RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP 260 (493)
Q Consensus 182 ~Iv~l~~~~~~-~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~ 260 (493)
+++++++++.. .+.+|+||||++++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl~~-- 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFVD-- 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEEEE--
T ss_pred CccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEEc--
Confidence 45557777776 678999999997799999986533569999999999999999999995 6999999999999994
Q ss_pred CCC--cEEEEecccccccCCc----------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 261 KRS--AIKIVDFGSSCQLGQR----------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 261 ~~~--~ikL~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
.++ .+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||+|++|..||.+..
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 555 8999999999766432 133478999999999999999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=346.74 Aligned_cols=245 Identities=20% Similarity=0.252 Sum_probs=186.6
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEE----EEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHV----AIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v----AvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
.++|+++++||+|+||+||+|.+..+++.| |+|.+.... .....+..|..++ ...+||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l------~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM------ASVDNPHVCRLLGICL 87 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHH------TTCCBTTBCCCCEEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHH------HhCCCCCeeEEEEEEe
Confidence 468999999999999999999998888765 666664322 1223334444433 3346888999999998
Q ss_pred ecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
... .++|+|++. ++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~--~~~~~~kL~Df 161 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLV--KTPQHVKITDF 161 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--EETTEEEECCT
T ss_pred cCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEE--cCCCCEEEccC
Confidence 654 788899985 59999987654 469999999999999999999995 789999999999999 56788999999
Q ss_pred ccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 271 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 271 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+......+..
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 999776432 223456778999999999999999999999999999999 99999987766554444321111000
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
. . ....+.+||++||..|
T Consensus 242 -------------------------------------~-----------------------~--~~~~l~~li~~~l~~d 259 (327)
T 3lzb_A 242 -------------------------------------P-----------------------I--CTIDVYMIMRKCWMID 259 (327)
T ss_dssp -------------------------------------T-----------------------T--BCHHHHHHHHHHTCSS
T ss_pred -------------------------------------c-----------------------c--CCHHHHHHHHHHcCCC
Confidence 0 0 0116889999999999
Q ss_pred CCCCCCHHHHhc
Q psy16081 425 PKTRITPYYALQ 436 (493)
Q Consensus 425 P~~R~t~~e~L~ 436 (493)
|.+|||+.|+++
T Consensus 260 p~~Rps~~ell~ 271 (327)
T 3lzb_A 260 ADSRPKFRELII 271 (327)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhHCcCHHHHHH
Confidence 999999999997
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.25 Aligned_cols=205 Identities=22% Similarity=0.318 Sum_probs=160.9
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|++.+.||+|+||+||+|.+..+++.||||++........ .....+.+++......+||||+++++++...+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDP--VFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCH--HHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 45789999999999999999999999999999999975432111 1112223333334445688999999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~--~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILV--SADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTSCEEECSCCC---
T ss_pred EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEE--cCCCCEEEecCccCcc
Confidence 999999976 9999987653 59999999999999999999995 789999999999999 6778999999999976
Q ss_pred cCCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy16081 276 LGQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV 329 (493)
Q Consensus 276 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~ 329 (493)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (309)
T 2h34_A 184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS 241 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH
T ss_pred ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH
Confidence 6432 23557899999999999999999999999999999999999999876654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=342.53 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=197.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc-------CCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL-------EEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
.++|++.+.||+|+||+||+|.+. .++..||||+++.... .......|..++..+. +||||+++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~ 108 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINLLG 108 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh-----cCCCEeeEEE
Confidence 478999999999999999999875 4678899999975321 1233445555554442 5788999999
Q ss_pred eeeecceeEEEEEeccc-CHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 189 HFMWRNHLCLVFELLSY-NLYDLLRNTNF--------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~~-~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
++...+.+|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~ 186 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAAR 186 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGG
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccc
Confidence 99999999999999965 99999976431 248999999999999999999995 78999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 187 NIll--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 187 NVLV--TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GEEE--CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEE--cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999 67889999999999776542 223456788999999998889999999999999999999 999999888
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+....+......+. . .
T Consensus 265 ~~~~~~~~~~~~~~~~-------------------------------------~-------------------------~ 282 (334)
T 2pvf_A 265 VEELFKLLKEGHRMDK-------------------------------------P-------------------------A 282 (334)
T ss_dssp HHHHHHHHHHTCCCCC-------------------------------------C-------------------------T
T ss_pred HHHHHHHHhcCCCCCC-------------------------------------C-------------------------c
Confidence 7766655543211000 0 0
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
.....+.+||.+||..||.+|||+.|++++
T Consensus 283 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001168899999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=350.95 Aligned_cols=248 Identities=22% Similarity=0.271 Sum_probs=187.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc---CCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.++|++.+.||+|+||+||+|++. .++..||||+++.... .. ....+.+++......+||||+++++++...+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EK---QRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 468999999999999999999876 4677899999974321 11 1122333334444456889999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+||||++ ++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILI--NSNLVCKVSDFGLG 194 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTCCEEECCC---
T ss_pred ceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEE--cCCCCEEECcCccc
Confidence 9999999995 59999997643 469999999999999999999995 789999999999999 67889999999999
Q ss_pred cccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 274 CQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 274 ~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
+...... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+......++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~-- 272 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP-- 272 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC--
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 8764321 12234678999999999999999999999999999998 99999988877766555432111100
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
......+.+||.+||..||.
T Consensus 273 ------------------------------------------------------------~~~~~~l~~li~~cl~~dp~ 292 (373)
T 2qol_A 273 ------------------------------------------------------------MDCPAALYQLMLDCWQKDRN 292 (373)
T ss_dssp ------------------------------------------------------------TTCBHHHHHHHHHHTCSSGG
T ss_pred ------------------------------------------------------------ccccHHHHHHHHHHhCcChh
Confidence 00112788999999999999
Q ss_pred CCCCHHHHhc
Q psy16081 427 TRITPYYALQ 436 (493)
Q Consensus 427 ~R~t~~e~L~ 436 (493)
+|||+.|+++
T Consensus 293 ~RPs~~~i~~ 302 (373)
T 2qol_A 293 NRPKFEQIVS 302 (373)
T ss_dssp GSCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=332.20 Aligned_cols=247 Identities=20% Similarity=0.286 Sum_probs=199.1
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
...++|++++.||+|+||+||+|.+. ++..||||++.........+..|..++..+ +|+||+++++++. .+.
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~-~~~ 81 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL------QHQRLVRLYAVVT-QEP 81 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC------CCTTBCCEEEEEC-SSS
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC------CCcCcceEEEEEc-CCC
Confidence 34578999999999999999999864 577899999986554555666666666554 4677999999886 556
Q ss_pred eEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.|+||||+. ++|.+++.......+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILV--SDTLSCKIADFGLAR 157 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEE--cCCCCEEECCCcccc
Confidence 899999995 599999876433358999999999999999999995 789999999999999 678899999999998
Q ss_pred ccCCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 275 QLGQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 275 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
...... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+.+..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 231 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------ 231 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC------
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC------
Confidence 765432 23346778999999998889999999999999999999 9999998887766655543211000
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.. .. ...+.+||.+||..||++||
T Consensus 232 -------------------------------~~-----------------------~~--~~~l~~li~~~l~~~p~~Rp 255 (279)
T 1qpc_A 232 -------------------------------PD-----------------------NC--PEELYQLMRLCWKERPEDRP 255 (279)
T ss_dssp -------------------------------CT-----------------------TC--CHHHHHHHHHHTCSSGGGSC
T ss_pred -------------------------------cc-----------------------cc--cHHHHHHHHHHhccChhhCC
Confidence 00 00 01789999999999999999
Q ss_pred CHHHHhc
Q psy16081 430 TPYYALQ 436 (493)
Q Consensus 430 t~~e~L~ 436 (493)
|+.++++
T Consensus 256 s~~~l~~ 262 (279)
T 1qpc_A 256 TFDYLRS 262 (279)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999886
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=337.02 Aligned_cols=244 Identities=26% Similarity=0.444 Sum_probs=184.3
Q ss_pred eecCcEEEe-eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 116 KFLDRYEID-SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 116 ~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
.+.++|.+. ++||+|+||.||+|.+..+++.||||+++.. .....|..++..+ .+||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~-----~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRA-----SQCPHIVRIVDVYENLY 84 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHH-----TTSTTBCCEEEEEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHh-----ccCCCchhHHhhhhhhc
Confidence 456778887 7899999999999999999999999999743 3455565554322 257789999999987
Q ss_pred --cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC-CCcEEEE
Q psy16081 193 --RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK-RSAIKIV 268 (493)
Q Consensus 193 --~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~-~~~ikL~ 268 (493)
...+|+||||+.+ +|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||++.+. ++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 7889999999965 99999987665579999999999999999999995 7899999999999994322 6889999
Q ss_pred ecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 269 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 269 DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
|||++.... +..++.++|||||||++|+|++|.+||.+.+.......+.
T Consensus 163 Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~------------ 211 (299)
T 3m2w_A 163 DFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK------------ 211 (299)
T ss_dssp CCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC------------
T ss_pred ccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH------------
Confidence 999986443 2457889999999999999999999997654332110000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
..+..+.+ ..+ . ... ...+ ..+.+||.+||..||.+|
T Consensus 212 ---------~~~~~~~~-----------~~~--~--~~~-----------------~~~~--~~~~~li~~~l~~dP~~R 248 (299)
T 3m2w_A 212 ---------TRIRMGQY-----------EFP--N--PEW-----------------SEVS--EEVKMLIRNLLKTEPTQR 248 (299)
T ss_dssp ---------CSSCTTCC-----------SSC--H--HHH-----------------TTSC--HHHHHHHHHHTCSSTTTS
T ss_pred ---------HHHhhccc-----------cCC--c--hhc-----------------ccCC--HHHHHHHHHHcccChhhC
Confidence 00000000 000 0 000 0011 278999999999999999
Q ss_pred CCHHHHhcCCCCCCCc
Q psy16081 429 ITPYYALQHNFFKRTA 444 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~~~ 444 (493)
||+.|+|+||||+...
T Consensus 249 ps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 249 MTITEFMNHPWIMQST 264 (299)
T ss_dssp CCHHHHHTSHHHHTGG
T ss_pred CCHHHHhcChhhcccc
Confidence 9999999999998643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=335.27 Aligned_cols=248 Identities=24% Similarity=0.305 Sum_probs=199.5
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
..+.++|++++.||+|+||.||+|.+..+++.||||++.... .....|..++..+ +||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKL------DHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHC------CCTTBCCEEEEEEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhC------CCCCEEEEeeeEeccc
Confidence 355678999999999999999999999999999999997543 3445566665544 47779999998864
Q ss_pred --------------cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEe
Q psy16081 193 --------------RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILL 257 (493)
Q Consensus 193 --------------~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl 257 (493)
...+|+||||+++ +|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFL 155 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHEEE
Confidence 4568999999976 99999976544579999999999999999999995 689999999999999
Q ss_pred eCCCCCcEEEEecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy16081 258 CNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 258 ~~~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i 335 (493)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .....+
T Consensus 156 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~ 231 (284)
T 2a19_B 156 --VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDL 231 (284)
T ss_dssp --EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHH
T ss_pred --cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHh
Confidence 56788999999999776442 345678999999999999999999999999999999999998874211 111111
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
.. +..+ + ... ..+.+
T Consensus 232 ~~--~~~~------------------------------------------~-------------------~~~--~~~~~ 246 (284)
T 2a19_B 232 RD--GIIS------------------------------------------D-------------------IFD--KKEKT 246 (284)
T ss_dssp HT--TCCC------------------------------------------T-------------------TSC--HHHHH
T ss_pred hc--cccc------------------------------------------c-------------------cCC--HHHHH
Confidence 00 0000 0 000 16789
Q ss_pred HHhHccCCCCCCCCCHHHHhcCCCCCC
Q psy16081 416 LIFRMLDYDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 416 Li~~mL~~dP~~R~t~~e~L~Hp~~~~ 442 (493)
||.+||..||.+|||+.|+++|.|.-.
T Consensus 247 li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 247 LLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999987654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=345.05 Aligned_cols=257 Identities=18% Similarity=0.200 Sum_probs=197.0
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEE-----EcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAF-----DLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
...++|++++.||+|+||+||+|+ +..+++.||||++..... ....+..|..++.. .+||||+++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~------l~h~~iv~~~~ 100 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK------FNHQNIVRCIG 100 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHH------CCCTTBCCEEE
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhh------CCCCCCCeEEE
Confidence 345789999999999999999998 556788999999964321 11223333333332 35888999999
Q ss_pred eeeecceeEEEEEecc-cCHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-C
Q psy16081 189 HFMWRNHLCLVFELLS-YNLYDLLRNTNF-----RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-K 261 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~-~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~ 261 (493)
++...+..|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.+ .
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSST
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCC
Confidence 9999999999999995 599999976532 348999999999999999999995 789999999999999422 3
Q ss_pred CCcEEEEecccccccCC-----ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy16081 262 RSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 262 ~~~ikL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i 335 (493)
...+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 45699999999975432 2234567889999999999899999999999999999998 99999988877666555
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
.......+. ... ...+.+
T Consensus 259 ~~~~~~~~~------------------------------------------------------------~~~--~~~l~~ 276 (327)
T 2yfx_A 259 TSGGRMDPP------------------------------------------------------------KNC--PGPVYR 276 (327)
T ss_dssp HTTCCCCCC------------------------------------------------------------TTC--CHHHHH
T ss_pred hcCCCCCCC------------------------------------------------------------CCC--CHHHHH
Confidence 432110000 000 116889
Q ss_pred HHhHccCCCCCCCCCHHHHhcCCCCCC
Q psy16081 416 LIFRMLDYDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 416 Li~~mL~~dP~~R~t~~e~L~Hp~~~~ 442 (493)
||.+||..||.+|||+.|+++|.|+..
T Consensus 277 li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 277 IMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999988753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=341.53 Aligned_cols=253 Identities=22% Similarity=0.278 Sum_probs=199.0
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCe-----EEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEec
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQC-----HVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLK 187 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~ 187 (493)
+...++|++.+.||+|+||+||+|.+..+++ .||||++..... .......|..++..+. +||||++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~ 116 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-----QHENIVNLL 116 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc-----CCCCeeeEE
Confidence 3446789999999999999999999877664 799999975432 1233445555555442 577899999
Q ss_pred eeeeecceeEEEEEeccc-CHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCc
Q psy16081 188 RHFMWRNHLCLVFELLSY-NLYDLLRNTN------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPEN 254 (493)
Q Consensus 188 ~~~~~~~~~~lV~E~~~~-~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~N 254 (493)
+++...+.+|+||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+ .||+||||||+|
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~N 194 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARN 194 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGG
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccce
Confidence 999999999999999965 9999986532 2357999999999999999999995 689999999999
Q ss_pred EEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q psy16081 255 ILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNE 328 (493)
Q Consensus 255 ILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~ 328 (493)
||+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+...
T Consensus 195 Il~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 195 VLL--TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp CEE--EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred EEE--CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999 56788999999999765332 123456778999999999899999999999999999998 9999988765
Q ss_pred HHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcc
Q psy16081 329 VDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVS 408 (493)
Q Consensus 329 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 408 (493)
...+..+......++. . ..
T Consensus 273 ~~~~~~~~~~~~~~~~------------------------------------~-------------------------~~ 291 (333)
T 2i1m_A 273 NSKFYKLVKDGYQMAQ------------------------------------P-------------------------AF 291 (333)
T ss_dssp SHHHHHHHHHTCCCCC------------------------------------C-------------------------TT
T ss_pred hHHHHHHHhcCCCCCC------------------------------------C-------------------------CC
Confidence 5555444432111000 0 00
Q ss_pred hhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 409 DYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 409 ~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
....+.+||.+||..||.+|||+.|++++
T Consensus 292 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 292 APKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 01168899999999999999999999873
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=337.03 Aligned_cols=199 Identities=27% Similarity=0.368 Sum_probs=160.4
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEE----EcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAF----DLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
..++|++++.||+|+||+||+|+ +..+++.||||++..... ....+..|..++.. .+||||+++++++.
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~------l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS------LQHDNIVKYKGVCY 81 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHT------CCCTTBCCEEEEEC
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHh------CCCCCEeeEEEEEe
Confidence 35689999999999999999998 567899999999975331 12233344444333 34788999999986
Q ss_pred ec--ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 192 WR--NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 192 ~~--~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
.. ..+|+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~--~~~~~~kl~ 156 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILV--ENENRVKIG 156 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--EETTEEEEC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEE--cCCCeEEEc
Confidence 53 568999999955 9999997654 358999999999999999999995 789999999999999 567889999
Q ss_pred ecccccccCCc------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy16081 269 DFGSSCQLGQR------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS 326 (493)
Q Consensus 269 DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~ 326 (493)
|||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 99999876432 12345677899999999999999999999999999999999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=341.85 Aligned_cols=249 Identities=24% Similarity=0.264 Sum_probs=195.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEE--EEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHV--AIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v--AvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++.+.||+|+||.||+|.+..++..+ |||+++... ........|..++.. ..+||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~-----l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-----LGHHPNIINLLGACEHR 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTT-----CCCCTTBCCEEEEEEET
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHh-----ccCCCchhhhceeeeeC
Confidence 368999999999999999999999998865 999887422 122333444443322 22688999999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~ 258 (493)
+.+|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~- 175 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV- 175 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE-
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceEEE-
Confidence 999999999955 9999987542 2368999999999999999999995 789999999999999
Q ss_pred CCCCCcEEEEecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy16081 259 NPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKI 335 (493)
Q Consensus 259 ~~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i 335 (493)
+.++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+
T Consensus 176 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 176 -GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp -CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred -cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 67889999999999754322 234456888999999998889999999999999999998 99999988776655444
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
....... . . .... ..+.+
T Consensus 255 ~~~~~~~-----------------------------------~--~-----------------------~~~~--~~l~~ 272 (327)
T 1fvr_A 255 PQGYRLE-----------------------------------K--P-----------------------LNCD--DEVYD 272 (327)
T ss_dssp GGTCCCC-----------------------------------C--C-----------------------TTBC--HHHHH
T ss_pred hcCCCCC-----------------------------------C--C-----------------------CCCC--HHHHH
Confidence 2210000 0 0 0001 17899
Q ss_pred HHhHccCCCCCCCCCHHHHhcC
Q psy16081 416 LIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 416 Li~~mL~~dP~~R~t~~e~L~H 437 (493)
||.+||..||.+|||+.|+++|
T Consensus 273 li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 273 LMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=331.26 Aligned_cols=254 Identities=25% Similarity=0.305 Sum_probs=185.2
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
++...++|++.++||+|+||+||+|.+. ..||||+++........... +.+++......+|+||+++++++ ..
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHH---HHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHH---HHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 3455678999999999999999999753 35999999754432222222 22233333445688899999854 56
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~--~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFL--HEDNTVKIGDFGL 166 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--ETTTEEEECCCC-
T ss_pred CccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEE--CCCCCEEEcccee
Confidence 678999999965 9999886543 469999999999999999999995 789999999999999 5678999999999
Q ss_pred ccccCC-----ccccccccCcCCchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 273 SCQLGQ-----RIYQYIQSRFYRSPEVLL---GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 273 a~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
+..... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+.+..++.....++.
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 976532 233457899999999997 567899999999999999999999999987766666555543222110
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
. ... .......+.+||.+||..|
T Consensus 247 ~------------~~~---------------------------------------------~~~~~~~l~~li~~~l~~~ 269 (289)
T 3og7_A 247 L------------SKV---------------------------------------------RSNCPKRMKRLMAECLKKK 269 (289)
T ss_dssp T------------TSS---------------------------------------------CTTSCHHHHHHHHHHTCSS
T ss_pred h------------hhc---------------------------------------------cccCCHHHHHHHHHHccCC
Confidence 0 000 0000127899999999999
Q ss_pred CCCCCCHHHHhc
Q psy16081 425 PKTRITPYYALQ 436 (493)
Q Consensus 425 P~~R~t~~e~L~ 436 (493)
|.+|||+.|+++
T Consensus 270 p~~Rps~~ell~ 281 (289)
T 3og7_A 270 RDERPSFPRILA 281 (289)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHHH
Confidence 999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=339.09 Aligned_cols=250 Identities=22% Similarity=0.257 Sum_probs=190.7
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCC----eEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQ----CHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
..++|++.+.||+|+||+||+|.+..++ ..||||+++..... .. ...+..++......+||||+++++++..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQ---RVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HH---HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-HH---HHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3468999999999999999999876553 46999999743211 11 1122222333333468889999999999
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+|+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~--~~~~~~kl~Dfg 192 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILV--NSNLVCKVSDFG 192 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTCCEEECCCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEE--CCCCcEEECCCC
Confidence 9999999999966 9999987643 469999999999999999999995 689999999999999 678899999999
Q ss_pred cccccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 272 SSCQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 272 ~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+......+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~ 272 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc
Confidence 997764321 12345778999999999999999999999999999998 99999988877766655432111100
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
......+.+||.+||..|
T Consensus 273 --------------------------------------------------------------~~~~~~l~~li~~~l~~~ 290 (333)
T 1mqb_A 273 --------------------------------------------------------------MDCPSAIYQLMMQCWQQE 290 (333)
T ss_dssp --------------------------------------------------------------TTCBHHHHHHHHHHTCSS
T ss_pred --------------------------------------------------------------ccCCHHHHHHHHHHcCCC
Confidence 000116889999999999
Q ss_pred CCCCCCHHHHhcC
Q psy16081 425 PKTRITPYYALQH 437 (493)
Q Consensus 425 P~~R~t~~e~L~H 437 (493)
|.+|||+.+++++
T Consensus 291 p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 291 RARRPKFADIVSI 303 (333)
T ss_dssp TTTSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=349.72 Aligned_cols=207 Identities=22% Similarity=0.286 Sum_probs=169.0
Q ss_pred ceeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEe
Q psy16081 109 YIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 109 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
+.........++|++.+.||+|+||+||+|.+ .+++.||||++..... ....+..|.. .....+|+||+++
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~------~l~~l~h~~iv~~ 92 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE------MISMAVHRNLLRL 92 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHH------GGGTCCCTTBCCC
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHH------HHHhccCCCccce
Confidence 34445556678999999999999999999974 4689999999875321 1123333333 3344568899999
Q ss_pred ceeeeecceeEEEEEeccc-CHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhCC-CCCccccCCCCCcEEeeCCCC
Q psy16081 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTNF--RGVSLNLTRKFSQQLCTALLFLSTP-ELNIIHCDLKPENILLCNPKR 262 (493)
Q Consensus 187 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~Lhs~-~~~iiHrDlKp~NILl~~~~~ 262 (493)
++++...+..|+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||++ ..||+||||||+|||+ +.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~--~~~ 170 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL--DEE 170 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE--CTT
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE--CCC
Confidence 9999999999999999965 99999976432 3489999999999999999999952 1289999999999999 678
Q ss_pred CcEEEEecccccccCCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 263 SAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 263 ~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 89999999999766432 234568999999999998899999999999999999999999996
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=353.42 Aligned_cols=202 Identities=21% Similarity=0.318 Sum_probs=166.6
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+.++|++.++||+|+||+||+|.+..+++.||||++..... .......|..++..+ +||||+++++++...
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL------NHKNIVKLFAIEEET 79 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC------CCTTBCCEEEEEECT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc------CCCCCCeEEEeeccC
Confidence 445789999999999999999999999999999999974321 223344555555444 477899999999876
Q ss_pred c--eeEEEEEeccc-CHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee--CCCCCcEEE
Q psy16081 194 N--HLCLVFELLSY-NLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC--NPKRSAIKI 267 (493)
Q Consensus 194 ~--~~~lV~E~~~~-~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~--~~~~~~ikL 267 (493)
+ ++|+|||||.+ +|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||+. ++.++.+||
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEEE
Confidence 5 78999999964 99999876432 239999999999999999999995 7899999999999983 234566999
Q ss_pred EecccccccCCc--cccccccCcCCchhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 268 VDFGSSCQLGQR--IYQYIQSRFYRSPEVLLG--------IPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 268 ~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 158 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp CCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999876543 345679999999999875 4678899999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=356.37 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=199.1
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
...++|++.+.||+|+||+||+|.+.. +..||||+++........+..|+.++..+ +||||+++++++.. +.
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC------CCTTBCCEEEEECS-SS
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC------CCCCEeeEEEEEcC-Cc
Confidence 345789999999999999999998764 46799999986554445666677666554 47789999999876 77
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+||||||+.+ +|.+++.......+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill--~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILV--GENLVCKVADFGLAR 328 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CGGGCEEECCCCTTC
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEE--CCCCCEEECCCccce
Confidence 9999999964 99999976443468999999999999999999995 789999999999999 678899999999998
Q ss_pred ccCCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 275 QLGQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 275 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
...... ....++..|+|||++.+..++.++|||||||+||||++ |.+||.+....+.+..+......+..
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~----- 403 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP----- 403 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC-----
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence 764322 23345778999999999899999999999999999999 99999998887776665432111100
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
. .....+.+||.+||..||++||
T Consensus 404 --------------------------------~-------------------------~~~~~l~~li~~cl~~dP~~Rp 426 (452)
T 1fmk_A 404 --------------------------------P-------------------------ECPESLHDLMCQCWRKEPEERP 426 (452)
T ss_dssp --------------------------------T-------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred --------------------------------C-------------------------CCCHHHHHHHHHHccCChhhCc
Confidence 0 0011688999999999999999
Q ss_pred CHHHHhc--CCCCC
Q psy16081 430 TPYYALQ--HNFFK 441 (493)
Q Consensus 430 t~~e~L~--Hp~~~ 441 (493)
|++++++ ..+++
T Consensus 427 t~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 427 TFEYLQAFLEDYFT 440 (452)
T ss_dssp CHHHHHHHHHTTTS
T ss_pred CHHHHHHHHHHHhc
Confidence 9999987 24554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=334.54 Aligned_cols=197 Identities=29% Similarity=0.443 Sum_probs=154.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.+.||+|+||+||+|.+ +++.||||++.... ....+..|..++..+ +||||+++++++. +..|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l------~hp~iv~~~~~~~--~~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-ERKAFIVELRQLSRV------NHPNIVKLYGACL--NPVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-HHHHHHHHHHHHHHC------CCTTBCCEEEBCT--TTTE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-HHHHHHHHHHHHhcC------CCCCcCeEEEEEc--CCcE
Confidence 35799999999999999999976 47899999986432 233445555554443 4788999999886 4589
Q ss_pred EEEEeccc-CHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhCCC-CCccccCCCCCcEEeeCCCCCc-EEEEecccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNF-RGVSLNLTRKFSQQLCTALLFLSTPE-LNIIHCDLKPENILLCNPKRSA-IKIVDFGSS 273 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~Lhs~~-~~iiHrDlKp~NILl~~~~~~~-ikL~DFG~a 273 (493)
+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+.. .||+||||||+|||++ .++. +||+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTA 153 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC-
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEcccccc
Confidence 99999965 99999975432 23788999999999999999999632 6899999999999994 4554 899999999
Q ss_pred cccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 274 CQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 154 CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred cccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 877666666789999999999999999999999999999999999999998543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.21 Aligned_cols=199 Identities=20% Similarity=0.288 Sum_probs=168.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEE-----EEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKA-----FDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~-----~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|.+.++||+|+||+||+| .+..+++.||||+++.. ....+..|..+++.+. ...|++|+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~---~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLK---PSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSC---GGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhh---hhhhhhhhhhheeeec
Confidence 568999999999999999999 46778999999999743 3456666776666554 4458889999999999
Q ss_pred cceeEEEEEecc-cCHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC-------
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNT---NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK------- 261 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~------- 261 (493)
.+..|||||||. ++|.+++... ....+++..++.++.||+.||.|||+ .|||||||||+|||+ +.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll--~~~~~~~~~ 214 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFIL--GNGFLEQDD 214 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEE--CGGGTCC--
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEe--cccccCccc
Confidence 999999999996 5999998642 23469999999999999999999995 789999999999999 44
Q ss_pred ----CCcEEEEecccccccC-----CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 262 ----RSAIKIVDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 262 ----~~~ikL~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
++.+||+|||+|+... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 7899999999996542 234466899999999999999999999999999999999999999964
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=336.50 Aligned_cols=195 Identities=24% Similarity=0.262 Sum_probs=157.9
Q ss_pred ccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 113 HGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 113 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
....+.++|++.+.||+|+||.||+|.+. ++.||||++..... .....|..+ ......+|+||+++++++..
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~----~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEI----YQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHH----HTSTTCCCTTBCCEEEEEEE
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHH----HHHHhhcCCCeeeEEEEEcc
Confidence 34456789999999999999999999764 89999999864321 222223222 22233478999999999987
Q ss_pred c----ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCccccCCCCCcEEeeCCC
Q psy16081 193 R----NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP------ELNIIHCDLKPENILLCNPK 261 (493)
Q Consensus 193 ~----~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~------~~~iiHrDlKp~NILl~~~~ 261 (493)
. ..+|+||||+.+ +|.+++... .+++..+..++.||+.||.|||++ ..||+||||||+|||+ +.
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill--~~ 177 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--KK 177 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE--CT
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE--CC
Confidence 7 789999999965 999999764 599999999999999999999963 2299999999999999 67
Q ss_pred CCcEEEEecccccccCCcc-------ccccccCcCCchhhhcCCCCCch------hhHHHHHHHHHHHHhCC
Q psy16081 262 RSAIKIVDFGSSCQLGQRI-------YQYIQSRFYRSPEVLLGIPYDLA------IDMWSLGCILVEMHTGE 320 (493)
Q Consensus 262 ~~~ikL~DFG~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltG~ 320 (493)
++.+||+|||++....... ...+||+.|+|||++.+..++.. +|||||||++|||++|.
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 8899999999997664321 24579999999999998776654 99999999999999993
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=339.78 Aligned_cols=207 Identities=23% Similarity=0.265 Sum_probs=170.4
Q ss_pred eeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-chHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 110 IIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 110 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
.....+...++|++.+.||+|+||+||+|.+ .+++.||||++...... ...+. +++......+||||+++++
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~------~E~~~l~~l~h~~iv~~~~ 102 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFE------TEIETLSFCRHPHLVSLIG 102 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHH------HHHHGGGSCCCTTBCCEEE
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHH------HHHHHHHhCCCCCEeeEEE
Confidence 3444556788999999999999999999985 47899999988654321 12222 3333344456889999999
Q ss_pred eeeecceeEEEEEeccc-CHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 189 HFMWRNHLCLVFELLSY-NLYDLLRNTNF--RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~~-~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
++...+.+|+||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~--~~~~~~ 178 (321)
T 2qkw_B 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILL--DENFVP 178 (321)
T ss_dssp ECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEE--CTTCCE
T ss_pred EEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEE--CCCCCE
Confidence 99999999999999965 99988865432 248999999999999999999995 799999999999999 678899
Q ss_pred EEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 266 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 266 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 99999999765321 234568999999999998899999999999999999999999998654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.03 Aligned_cols=247 Identities=22% Similarity=0.292 Sum_probs=193.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcC---CCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLE---EQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
..++|++.+.||+|+||+||+|.+.. ++..||||++..... ....+..|..++..+ +||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL------DHPHIVKLIGIIE 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH------CCTTBCCEEEEEC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC------CCCCcceEEEEEc
Confidence 35689999999999999999998654 345799999875421 223444555555554 4778999999987
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
+ +..|+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~--~~~~~~kl~Df 157 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILV--ASPECVKLGDF 157 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEE--EETTEEEECCC
T ss_pred C-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEE--CCCCcEEeCcc
Confidence 4 567999999965 9999987654 458999999999999999999995 789999999999999 56789999999
Q ss_pred ccccccCCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 271 GSSCQLGQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 271 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+......+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~- 236 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP- 236 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC-
T ss_pred CCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC-
Confidence 999776443 223456788999999998899999999999999999998 99999877766655544432111100
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
. .. ...+.+||.+||..||
T Consensus 237 ------------------------------------~-----------------------~~--~~~l~~li~~~l~~~p 255 (281)
T 3cc6_A 237 ------------------------------------D-----------------------LC--PPVLYTLMTRCWDYDP 255 (281)
T ss_dssp ------------------------------------T-----------------------TC--CHHHHHHHHHHTCSSG
T ss_pred ------------------------------------C-----------------------CC--CHHHHHHHHHHccCCc
Confidence 0 00 0168899999999999
Q ss_pred CCCCCHHHHhcC
Q psy16081 426 KTRITPYYALQH 437 (493)
Q Consensus 426 ~~R~t~~e~L~H 437 (493)
.+|||+.|++++
T Consensus 256 ~~Rps~~ell~~ 267 (281)
T 3cc6_A 256 SDRPRFTELVCS 267 (281)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=331.49 Aligned_cols=247 Identities=23% Similarity=0.272 Sum_probs=193.9
Q ss_pred cCcEEEee-eEeeeCCeEEEEEEEc--CCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDS-LIGKGSFGQVVKAFDL--EEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~-~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|.+.+ .||+|+||+||+|.+. .++..||||+++.... .......|..++..+ +||||+++++++ .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC------CCTTBCCEEEEE-E
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC------CCCCEeEEEEEe-c
Confidence 35788877 9999999999999854 4688999999975421 122334444444433 478899999999 5
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+.+|+||||+++ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili--~~~~~~kl~Dfg 155 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLL--VNRHYAKISDFG 155 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--EETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEE--cCCCCEEECccc
Confidence 6679999999966 9999886543 469999999999999999999995 789999999999999 567899999999
Q ss_pred cccccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 272 SSCQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 272 ~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~-- 233 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-- 233 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC--
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC--
Confidence 998764321 23345788999999998889999999999999999998 999999887766655543311000
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.+ . .....+.+||.+||..|
T Consensus 234 ---------------------------------~~--~-------------------------~~~~~l~~li~~~l~~~ 253 (287)
T 1u59_A 234 ---------------------------------CP--P-------------------------ECPPELYALMSDCWIYK 253 (287)
T ss_dssp ---------------------------------CC--T-------------------------TCCHHHHHHHHHTTCSS
T ss_pred ---------------------------------CC--C-------------------------CcCHHHHHHHHHHcCCC
Confidence 00 0 00117899999999999
Q ss_pred CCCCCCHHHHhcCC
Q psy16081 425 PKTRITPYYALQHN 438 (493)
Q Consensus 425 P~~R~t~~e~L~Hp 438 (493)
|++|||+.|+++|.
T Consensus 254 p~~Rps~~~l~~~l 267 (287)
T 1u59_A 254 WEDRPDFLTVEQRM 267 (287)
T ss_dssp GGGSCCHHHHHHHH
T ss_pred hhhCcCHHHHHHHH
Confidence 99999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.29 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=195.6
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEE-----cCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFD-----LEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
..++|++.+.||+|+||+||+|.+ ..+++.||||+++..... ......|..++..+. +||||++++++
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~ 99 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLGA 99 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEEE
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc-----cCCCeeeEEEE
Confidence 357899999999999999999985 457799999999754321 123344555544442 57889999999
Q ss_pred eeecc-eeEEEEEeccc-CHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 190 FMWRN-HLCLVFELLSY-NLYDLLRNTNF--------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 190 ~~~~~-~~~lV~E~~~~-~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
+...+ .+|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~ 177 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR 177 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccCccc
Confidence 87654 59999999965 99999976542 128899999999999999999995 68999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+..
T Consensus 178 Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 178 NILL--SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GEEE--CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEE--CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999 67889999999999766432 224567889999999999999999999999999999998 999998766
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+.+...+.....++ .+ . ..
T Consensus 256 ~~~~~~~~~~~~~~~~----------------------------------~~--~-----------------------~~ 276 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMR----------------------------------AP--D-----------------------YT 276 (316)
T ss_dssp CSHHHHHHHHHTCCCC----------------------------------CC--T-----------------------TC
T ss_pred hhHHHHHHhccCccCC----------------------------------CC--C-----------------------CC
Confidence 4444333332211000 00 0 00
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
...+.+||.+||..||.+|||+.|+++|
T Consensus 277 --~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 277 --TPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0168999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.25 Aligned_cols=244 Identities=21% Similarity=0.280 Sum_probs=185.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-ccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-RNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-~~~~ 196 (493)
.++|++.+.||+|+||+||+|.+ +++.||||+++... ....+..|..++ ...+|+||+++++++.. .+.+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l------~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVM------TQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHH------TTCCCTTBCCEEEEECCC--CC
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHH------HhCCCCCEeeEEEEEEcCCCce
Confidence 46899999999999999999976 58899999997543 233344444443 33358889999998654 4579
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|+||||+++ +|.+++.......+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKE 166 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CTTSCEEECCCCC---
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEE--eCCCcEEEeecccccc
Confidence 999999966 99999976543348899999999999999999995 789999999999999 6788999999999987
Q ss_pred cCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 276 LGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.........+++.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+.......
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------ 234 (278)
T 1byg_A 167 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD------------ 234 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC------------
T ss_pred ccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC------------
Confidence 7666566678899999999999899999999999999999998 999998776555444332210000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
. .. .. ...+.+||.+||..||.+|||+.|+
T Consensus 235 -----------------------~--~~-----------------------~~--~~~l~~li~~~l~~~p~~Rps~~~l 264 (278)
T 1byg_A 235 -----------------------A--PD-----------------------GC--PPAVYEVMKNCWHLDAAMRPSFLQL 264 (278)
T ss_dssp -----------------------C--CT-----------------------TC--CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------------C--cc-----------------------cC--CHHHHHHHHHHhcCChhhCCCHHHH
Confidence 0 00 00 1178999999999999999999998
Q ss_pred hc
Q psy16081 435 LQ 436 (493)
Q Consensus 435 L~ 436 (493)
++
T Consensus 265 ~~ 266 (278)
T 1byg_A 265 RE 266 (278)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=331.60 Aligned_cols=202 Identities=27% Similarity=0.458 Sum_probs=156.2
Q ss_pred ceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc----chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF----LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 115 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
....++|++.+.||+|+||.||+|.+..+++.||||++...... ......|..++ ...+|+||+++++++
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l------~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL------KQLNHPNVIKYYASF 101 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHH------HTCCCTTBCCEEEEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHH------HhCCCCCEeeEEEEE
Confidence 34567899999999999999999999999999999999743221 11222333332 233588899999999
Q ss_pred eecceeEEEEEeccc-CHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 191 MWRNHLCLVFELLSY-NLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 191 ~~~~~~~lV~E~~~~-~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
...+.+++||||+.+ +|.+++.. .....+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~--~~~~~~kl 177 (310)
T 2wqm_A 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFI--TATGVVKL 177 (310)
T ss_dssp EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTSCEEE
T ss_pred EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEE--cCCCCEEE
Confidence 999999999999966 99998864 223458999999999999999999995 789999999999999 67889999
Q ss_pred EecccccccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy16081 268 VDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS 326 (493)
Q Consensus 268 ~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~ 326 (493)
+|||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp CCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred EeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999999766432 23457899999999999999999999999999999999999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=329.26 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=189.5
Q ss_pred cCcEEEee-eEeeeCCeEEEEEEE--cCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 118 LDRYEIDS-LIGKGSFGQVVKAFD--LEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 118 ~~~y~~~~-~LG~G~fg~V~~~~~--~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
.++|.+.+ .||+|+||+||+|.+ ..+++.||||+++..... ...+..|..++. ..+||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~------~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ------QLDNPYIVRMIGIC- 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHH------TCCCTTBCCEEEEE-
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHH------hCCCCCEEEEEEEE-
Confidence 35799988 999999999999954 567899999999754322 222333333333 23578899999998
Q ss_pred ecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
..+.+|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~--~~~~~~kl~Df 161 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLL--VTQHYAKISDF 161 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--EETTEEEECCC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEE--eCCCcEEEccC
Confidence 56788999999965 999999764 359999999999999999999995 689999999999999 56789999999
Q ss_pred ccccccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 271 GSSCQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 271 G~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
|++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~- 240 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG- 240 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 9997764321 22345688999999998889999999999999999999 999999888766555443211000
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
.+ . .. ...+.+||.+||..
T Consensus 241 ----------------------------------~~--~-----------------------~~--~~~l~~li~~~l~~ 259 (291)
T 1xbb_A 241 ----------------------------------CP--A-----------------------GC--PREMYDLMNLCWTY 259 (291)
T ss_dssp ----------------------------------CC--T-----------------------TC--CHHHHHHHHHHTCS
T ss_pred ----------------------------------CC--C-----------------------CC--CHHHHHHHHHHcCC
Confidence 00 0 00 11789999999999
Q ss_pred CCCCCCCHHHHhc
Q psy16081 424 DPKTRITPYYALQ 436 (493)
Q Consensus 424 dP~~R~t~~e~L~ 436 (493)
||.+|||+.++++
T Consensus 260 dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 260 DVENRPGFAAVEL 272 (291)
T ss_dssp STTTSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999885
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=332.00 Aligned_cols=251 Identities=18% Similarity=0.243 Sum_probs=185.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcC---CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLE---EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.++|.+.+.||+|+||+||+|.+.. +++.||||+++........... +..++......+||||+++++++...+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE---FLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHH---HHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHH---HHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 4689999999999999999998765 5668999998754322222221 222222223335888999999998654
Q ss_pred -----eeEEEEEeccc-CHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc
Q psy16081 195 -----HLCLVFELLSY-NLYDLLRNT----NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 195 -----~~~lV~E~~~~-~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ 264 (493)
..|+||||+.+ +|.+++... ....+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli--~~~~~ 185 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCML--RDDMT 185 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEE--CTTSC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEE--cCCCc
Confidence 45999999965 999988432 22469999999999999999999995 689999999999999 67889
Q ss_pred EEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q psy16081 265 IKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEV 338 (493)
Q Consensus 265 ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~ 338 (493)
+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 999999999766432 223456788999999999999999999999999999999 99999987776655554432
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
...+. .. .. ...+.+||.
T Consensus 266 ~~~~~-------------------------------------~~-----------------------~~--~~~l~~li~ 283 (313)
T 3brb_A 266 HRLKQ-------------------------------------PE-----------------------DC--LDELYEIMY 283 (313)
T ss_dssp CCCCC-------------------------------------BT-----------------------TC--CHHHHHHHH
T ss_pred CCCCC-------------------------------------Cc-----------------------cc--cHHHHHHHH
Confidence 11000 00 00 016899999
Q ss_pred HccCCCCCCCCCHHHHhcC
Q psy16081 419 RMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 419 ~mL~~dP~~R~t~~e~L~H 437 (493)
+||..||.+|||+.++++|
T Consensus 284 ~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 284 SCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=328.54 Aligned_cols=244 Identities=20% Similarity=0.280 Sum_probs=188.8
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCe---EEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQC---HVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.|.+.++||+|+||+||+|.+..+++ .||||++...... ...+..|..++. ..+||||+++++++.+.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMR------GLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHH------TCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHH------hCCCCCeeeEEEEEecCC
Confidence 57788999999999999998765544 7999999743321 122233333332 235888999999998766
Q ss_pred ee-EEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 195 HL-CLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 195 ~~-~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
.. ++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili--~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCML--DESFTVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CTTCCEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEE--cCCCcEEeCcCCC
Confidence 65 99999994 59999997643 468999999999999999999995 689999999999999 6788999999999
Q ss_pred ccccCCc-------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 273 SCQLGQR-------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 273 a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
+...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+......+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP 250 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC
Confidence 9765332 234567889999999999999999999999999999999 56667666665554444332111000
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
. .. ...+.+||.+||..|
T Consensus 251 -------------------------------------~-----------------------~~--~~~l~~li~~~l~~~ 268 (298)
T 3pls_A 251 -------------------------------------E-----------------------YC--PDSLYQVMQQCWEAD 268 (298)
T ss_dssp -------------------------------------T-----------------------TC--CHHHHHHHHHHTCSS
T ss_pred -------------------------------------c-----------------------cc--hHHHHHHHHHHccCC
Confidence 0 00 016899999999999
Q ss_pred CCCCCCHHHHhc
Q psy16081 425 PKTRITPYYALQ 436 (493)
Q Consensus 425 P~~R~t~~e~L~ 436 (493)
|.+|||+.++++
T Consensus 269 p~~Rps~~~ll~ 280 (298)
T 3pls_A 269 PAVRPTFRVLVG 280 (298)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999999886
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=360.29 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=203.4
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
...++|++.++||+|+||+||+|.+.. +..||||+++........+..|+.++..+ +|+||+++++++.+ +.
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC------CCTTBCCEEEEECS-SS
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC------CCCCEeeEEEEEee-cc
Confidence 345789999999999999999998765 46799999986554445666676666554 47789999999876 77
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|||||||.+ +|.+++.......+++..+..++.||+.||.|||+ .+||||||||+|||+ +.++.+||+|||+++
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILV--GENLVCKVADFGLAR 411 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CGGGCEEECCTTSTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEE--cCCCcEEEcccccce
Confidence 9999999965 99999976443468999999999999999999995 789999999999999 678899999999998
Q ss_pred ccCCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 275 QLGQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 275 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
...... ....++..|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+......+..
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~----- 486 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP----- 486 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCC-----
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence 765432 22345678999999999899999999999999999999 99999998887776665432111100
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
. .....+.+||.+||..||++||
T Consensus 487 --------------------------------~-------------------------~~~~~l~~li~~cl~~dP~~RP 509 (535)
T 2h8h_A 487 --------------------------------P-------------------------ECPESLHDLMCQCWRKEPEERP 509 (535)
T ss_dssp --------------------------------T-------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred --------------------------------C-------------------------CCCHHHHHHHHHHcCCChhHCc
Confidence 0 0011688999999999999999
Q ss_pred CHHHHhcC--CCCC
Q psy16081 430 TPYYALQH--NFFK 441 (493)
Q Consensus 430 t~~e~L~H--p~~~ 441 (493)
|++++++. .+|.
T Consensus 510 t~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 510 TFEYLQAFLEDYFT 523 (535)
T ss_dssp CHHHHHHHHHTSSC
T ss_pred CHHHHHHHHHHHhh
Confidence 99999874 4554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=331.63 Aligned_cols=196 Identities=24% Similarity=0.349 Sum_probs=162.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEE----EcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAF----DLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
.++|++++.||+|+||.||+|+ +..+++.||||++..... .......|..++..+ +|+||+++++++.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL------YHENIVKYKGICT 93 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC------CCTTBCCEEEEEE
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC------CCCCeeeeeeEEe
Confidence 4579999999999999999998 577899999999974332 223444555544433 4788999999998
Q ss_pred ec--ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 192 WR--NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 192 ~~--~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
.. +.+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~--~~~~~~kl~ 168 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLV--ESEHQVKIG 168 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--EETTEEEEC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEE--cCCCCEEEC
Confidence 76 678999999965 9999986554 469999999999999999999995 789999999999999 567899999
Q ss_pred ecccccccCCc------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 269 DFGSSCQLGQR------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 269 DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 99999776432 224567888999999999899999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=329.69 Aligned_cols=245 Identities=18% Similarity=0.257 Sum_probs=188.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee-ee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF-MW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~-~~ 192 (493)
.+|++.++||+|+||+||+|.+..+ ...||||++...... ...+..|..++. ..+||||+++++++ ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK------DFSHPNVLSLLGICLRS 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHH------TCCCTTBCCCCEEECCS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHH------hCCCCCEeeeeeEEEcC
Confidence 4699999999999999999986543 346899998753321 122333333332 23588899999985 45
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
++..|+||||+++ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~--~~~~~~kl~Dfg 173 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCML--DEKFTVKVADFG 173 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CTTCCEEECSCG
T ss_pred CCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEE--CCCCCEEECccc
Confidence 6788999999966 9999997643 468999999999999999999995 789999999999999 678899999999
Q ss_pred cccccCCc-------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 272 SSCQLGQR-------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 272 ~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+........
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 253 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC
Confidence 99766432 223456788999999999999999999999999999999 7788887766555554433211100
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
. . ... ..+.+||.+||..
T Consensus 254 ~-----------------------------------------------------------~-~~~--~~l~~li~~~l~~ 271 (298)
T 3f66_A 254 P-----------------------------------------------------------E-YCP--DPLYEVMLKCWHP 271 (298)
T ss_dssp C-----------------------------------------------------------T-TCC--HHHHHHHHHHTCS
T ss_pred C-----------------------------------------------------------c-cCC--HHHHHHHHHHcCC
Confidence 0 0 000 1689999999999
Q ss_pred CCCCCCCHHHHhc
Q psy16081 424 DPKTRITPYYALQ 436 (493)
Q Consensus 424 dP~~R~t~~e~L~ 436 (493)
||.+|||+.|+++
T Consensus 272 ~p~~Rps~~ell~ 284 (298)
T 3f66_A 272 KAEMRPSFSELVS 284 (298)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=338.45 Aligned_cols=194 Identities=25% Similarity=0.285 Sum_probs=154.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-----
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW----- 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~----- 192 (493)
.++|++++.||+|+||+||+|.+ +++.||||++.... ......|. .+......+|+||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~----~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN--RQNFINEK----NIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG--HHHHHHHH----HHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc--hhhHHHHH----HHHHHHhccCcchhhheecccccccCC
Confidence 57899999999999999999965 78999999996432 12222232 2223445678899999875542
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC-------CCCccccCCCCCcEEeeCCCCCc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP-------ELNIIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~-------~~~iiHrDlKp~NILl~~~~~~~ 264 (493)
...+|+||||++ ++|.+++... ..++..+..++.||+.||.|||++ ..||+||||||+|||+ +.++.
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill--~~~~~ 158 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV--KNDGT 158 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE--CTTSC
T ss_pred CceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE--cCCCc
Confidence 346899999995 5999999765 368999999999999999999953 1199999999999999 67789
Q ss_pred EEEEecccccccCCc-----------cccccccCcCCchhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 265 IKIVDFGSSCQLGQR-----------IYQYIQSRFYRSPEVLLG-------IPYDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 265 ikL~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999999765421 224579999999999987 356789999999999999999966553
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=342.81 Aligned_cols=247 Identities=18% Similarity=0.251 Sum_probs=183.6
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCC---eEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeee-ecce
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQ---CHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM-WRNH 195 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~-~~~~ 195 (493)
.|++.++||+|+||+||+|.+..++ ..||||+++..... . ....+++++......+||||+++++++. ..+.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-G---EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS-H---HHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH-H---HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 5889999999999999999875433 46899998643211 1 1223344444555567999999999865 4568
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
.|+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll--~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCML--DEKFTVKVADFGLAR 240 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTCCEEECCC----
T ss_pred eEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEE--CCCCCEEEeeccccc
Confidence 8999999965 9999997543 458999999999999999999995 789999999999999 678899999999997
Q ss_pred ccCCc-------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 275 QLGQR-------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 275 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
..... .....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+......+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~--- 317 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ--- 317 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 65332 123456778999999999999999999999999999999 7889987665554444332110000
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
+. . ....+.+||.+||..||+
T Consensus 318 --------------------------------------------------------p~-~--~~~~l~~li~~cl~~dp~ 338 (373)
T 3c1x_A 318 --------------------------------------------------------PE-Y--CPDPLYEVMLKCWHPKAE 338 (373)
T ss_dssp --------------------------------------------------------CT-T--CCHHHHHHHHHHTCSSGG
T ss_pred --------------------------------------------------------CC-C--CCHHHHHHHHHHcCCChh
Confidence 00 0 011688999999999999
Q ss_pred CCCCHHHHhcC
Q psy16081 427 TRITPYYALQH 437 (493)
Q Consensus 427 ~R~t~~e~L~H 437 (493)
+|||+.|++++
T Consensus 339 ~RPs~~ell~~ 349 (373)
T 3c1x_A 339 MRPSFSELVSR 349 (373)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.29 Aligned_cols=198 Identities=20% Similarity=0.235 Sum_probs=159.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---------cchHHHHHHHHHHHHhhcCC---CC------
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---------FLNQAQIEVKLLEIMNKADV---NN------ 179 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~e~~~~~~l~~~~~---~~------ 179 (493)
.++|+++++||+|+||+||+|++ +|+.||||++..... .......|+.++..+..... ..
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999987 789999999975421 22677889998888874322 12
Q ss_pred -----------cceEEEeceeeee-------------cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHH
Q psy16081 180 -----------TYYIVRLKRHFMW-------------RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234 (493)
Q Consensus 180 -----------~~~Iv~l~~~~~~-------------~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~a 234 (493)
||||++++++|.+ .+.+|||||||.+ ++++.+.. ..+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 5555555665554 6899999999954 57766644 358999999999999999
Q ss_pred HHHHh-CCCCCccccCCCCCcEEeeCCC------------------CCcEEEEecccccccCCccccccccCcCCchhhh
Q psy16081 235 LLFLS-TPELNIIHCDLKPENILLCNPK------------------RSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVL 295 (493)
Q Consensus 235 L~~Lh-s~~~~iiHrDlKp~NILl~~~~------------------~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~ 295 (493)
|.||| + .|||||||||+|||++.+. ...+||+|||+|+..... ..+||+.|+|||++
T Consensus 174 L~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGG
T ss_pred HHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhh
Confidence 99999 6 6899999999999995322 128999999999876543 45899999999999
Q ss_pred cCCCCCchhhHHHHHHH-HHHHHhCCCCCCC
Q psy16081 296 LGIPYDLAIDMWSLGCI-LVEMHTGEPLFSG 325 (493)
Q Consensus 296 ~~~~~~~~~DvwSlGvi-l~elltG~~pf~~ 325 (493)
.+.. +.++||||||++ .++++.|..||.+
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 9876 899999998777 7788899999953
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=336.64 Aligned_cols=198 Identities=26% Similarity=0.371 Sum_probs=163.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEE----EcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee--
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAF----DLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM-- 191 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~-- 191 (493)
++|++++.||+|+||.||+|. +..+++.||||++..... ....+..|..++..+ +|+||+++++++.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL------HSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC------CCTTBCCEEEEEECS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc------CCCceeEEEEEEecC
Confidence 589999999999999999998 577899999999975432 122234444444332 6788999999886
Q ss_pred ecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
..+.+|+||||++ ++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~--~~~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILV--ESEAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--EETTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEE--CCCCCEEEccc
Confidence 4567999999995 59999987643 358999999999999999999995 799999999999999 57788999999
Q ss_pred ccccccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 271 GSSCQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 271 G~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
|++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 9998764322 23457788999999999899999999999999999999999997543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=332.99 Aligned_cols=197 Identities=24% Similarity=0.303 Sum_probs=159.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee----
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW---- 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~---- 192 (493)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ....+..|..++. ..+||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR------LFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHH------TCCCTTBCCCCEEEEEEETT
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHh------hcCCCCeeeEEEEEEeccCC
Confidence 3589999999999999999999999999999999864321 1223334444333 2368889999999873
Q ss_pred cceeEEEEEeccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
...+|+||||+.+ +|.+++... ....+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~--~~~~~~kl~d 177 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILL--GDEGQPVLMD 177 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTSCEEECC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEE--cCCCCEEEEe
Confidence 4578999999966 999988652 23469999999999999999999995 689999999999999 6788999999
Q ss_pred cccccccCCc------------cccccccCcCCchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 270 FGSSCQLGQR------------IYQYIQSRFYRSPEVLLGIP---YDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 270 FG~a~~~~~~------------~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 9998765321 12346799999999998654 7899999999999999999999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=332.93 Aligned_cols=204 Identities=22% Similarity=0.247 Sum_probs=165.8
Q ss_pred eeeccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 110 IIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 110 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
.+..+..+.++|++.+.||+|+||+||+|.+ +++.||||++.... ......|..++..+ ..+||||++++++
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~----~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTV----MLRHENILGFIAA 104 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHS----CCCCTTBCCEEEE
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHh----hcCCCcEEEEEee
Confidence 3334455678999999999999999999976 58999999996432 23444455444332 2468889999999
Q ss_pred eeecc----eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCccccCCCCCcEEee
Q psy16081 190 FMWRN----HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP------ELNIIHCDLKPENILLC 258 (493)
Q Consensus 190 ~~~~~----~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~------~~~iiHrDlKp~NILl~ 258 (493)
+...+ .+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||+. +.||+||||||+|||+
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll- 180 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV- 180 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE-
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE-
Confidence 98776 89999999966 999999764 589999999999999999999932 3689999999999999
Q ss_pred CCCCCcEEEEecccccccCCc-------cccccccCcCCchhhhcCCC------CCchhhHHHHHHHHHHHHhC------
Q psy16081 259 NPKRSAIKIVDFGSSCQLGQR-------IYQYIQSRFYRSPEVLLGIP------YDLAIDMWSLGCILVEMHTG------ 319 (493)
Q Consensus 259 ~~~~~~ikL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG------ 319 (493)
+.++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 181 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 181 -KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp -CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred -CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 67889999999999766432 23457899999999998763 34789999999999999999
Q ss_pred ----CCCCCCC
Q psy16081 320 ----EPLFSGS 326 (493)
Q Consensus 320 ----~~pf~~~ 326 (493)
..||...
T Consensus 260 ~~~~~~p~~~~ 270 (342)
T 1b6c_B 260 HEDYQLPYYDL 270 (342)
T ss_dssp CCCCCCTTTTT
T ss_pred ccccccCcccc
Confidence 7788653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=330.91 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=190.5
Q ss_pred EeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 123 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
..+.||+|+||+||+|.+ +++.||||++..... ....+..|..++..+ +||||+++++++.+.+..|
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC------QHENLVELLGFSSDGDDLC 106 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC------CCTTBCCEEEEECSSSSCE
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc------CCCCeEEEEEEEecCCceE
Confidence 348999999999999974 688999999874321 123444555555443 4778999999999999999
Q ss_pred EEEEecc-cCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 198 LVFELLS-YNLYDLLRNTN-FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 198 lV~E~~~-~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+||||+. ++|.+++.... ...+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILL--DEAFTAKISDFGLARA 182 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEE--cCCCcEEEeecccccc
Confidence 9999995 59999886432 2458999999999999999999995 789999999999999 6788999999999976
Q ss_pred cCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+.+........
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 256 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT----- 256 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC-----
T ss_pred cccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh-----
Confidence 6432 234578999999999876 58999999999999999999999998765443333333221111000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
...+++... +.........+.+||.+||..||.+|||
T Consensus 257 --~~~~~~~~~-----------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps 293 (307)
T 2nru_A 257 --IEDYIDKKM-----------------------------------------NDADSTSVEAMYSVASQCLHEKKNKRPD 293 (307)
T ss_dssp --HHHHSCSSC-----------------------------------------SCCCHHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred --hhhhccccc-----------------------------------------cccchHHHHHHHHHHHHHcCCCcccCcC
Confidence 011111000 0001112236889999999999999999
Q ss_pred HHHHhcC
Q psy16081 431 PYYALQH 437 (493)
Q Consensus 431 ~~e~L~H 437 (493)
+.+++++
T Consensus 294 ~~~l~~~ 300 (307)
T 2nru_A 294 IKKVQQL 300 (307)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=356.40 Aligned_cols=244 Identities=23% Similarity=0.257 Sum_probs=189.7
Q ss_pred cCcEEEee-eEeeeCCeEEEEEEEc--CCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDS-LIGKGSFGQVVKAFDL--EEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~-~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.+++.+.+ .||+|+||+||+|.+. .++..||||+++.... ....+..|+.++ ...+|||||++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il------~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM------HQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHH------TTCCCTTBCCEEEEEES
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHH------HhCCCCCEeeEEEEecc
Confidence 34566666 8999999999999875 3567899999975321 233444454443 33468889999999875
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
+.+|||||||.+ +|.+++.... ..+++..+..++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl--~~~~~vkL~DFG 481 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLL--VNRHYAKISDFG 481 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--EETTEEEECCCS
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEE--cCCCcEEEeecc
Confidence 679999999965 8999986543 469999999999999999999995 789999999999999 567899999999
Q ss_pred cccccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 272 SSCQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 272 ~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
+++...... ....+++.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+.+..+......+.
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~- 560 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC- 560 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC-
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence 998764321 12345678999999999999999999999999999998 9999999887777666543211100
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
+ . .....+.+||.+||..|
T Consensus 561 ----------------------------------p--~-------------------------~~~~~l~~li~~cl~~d 579 (613)
T 2ozo_A 561 ----------------------------------P--P-------------------------ECPPELYALMSDCWIYK 579 (613)
T ss_dssp ----------------------------------C--T-------------------------TCCHHHHHHHHHTTCSS
T ss_pred ----------------------------------C--C-------------------------cCCHHHHHHHHHHcCCC
Confidence 0 0 00127899999999999
Q ss_pred CCCCCCHHHHh
Q psy16081 425 PKTRITPYYAL 435 (493)
Q Consensus 425 P~~R~t~~e~L 435 (493)
|++|||+.+++
T Consensus 580 P~~RPs~~~l~ 590 (613)
T 2ozo_A 580 WEDRPDFLTVE 590 (613)
T ss_dssp TTTSCCHHHHH
T ss_pred hhHCcCHHHHH
Confidence 99999999974
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.66 Aligned_cols=198 Identities=27% Similarity=0.355 Sum_probs=161.6
Q ss_pred eecCcE-EEeeeEeeeCCeEEEEEE----EcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 116 KFLDRY-EIDSLIGKGSFGQVVKAF----DLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 116 ~~~~~y-~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
.+.++| ++++.||+|+||+||+|. +..+++.||||+++.... ....+..|+.++..+ +||||+++++
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~ 100 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL------YHEHIIKYKG 100 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC------CCTTBCCEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC------CCcchhhEEE
Confidence 355566 999999999999998874 445789999999975431 123344455544443 3778999999
Q ss_pred eeee--cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 189 HFMW--RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 189 ~~~~--~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
++.+ ...+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~--~~~~~~ 173 (318)
T 3lxp_A 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLL--DNDRLV 173 (318)
T ss_dssp EEEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCCE
T ss_pred EEecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEE--cCCCCE
Confidence 9987 4688999999965 999998764 48999999999999999999995 789999999999999 678899
Q ss_pred EEEecccccccCCc------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy16081 266 KIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS 326 (493)
Q Consensus 266 kL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~ 326 (493)
||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 99999999876542 22446788899999999989999999999999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=354.76 Aligned_cols=241 Identities=23% Similarity=0.290 Sum_probs=189.2
Q ss_pred EEE-eeeEeeeCCeEEEEEEE--cCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 121 YEI-DSLIGKGSFGQVVKAFD--LEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 121 y~~-~~~LG~G~fg~V~~~~~--~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+.+ .+.||+|+||+||+|.+ ..+++.||||+++..... ...+..|+.++..+ +|+|||++++++. .+
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~~~~-~~ 442 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL------DNPYIVRMIGICE-AE 442 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC------CCTTBCCEEEEEE-SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCEeeEEEEEe-cC
Confidence 444 35899999999999954 456789999999754322 24455566555544 4778999999986 45
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.++||||||.+ +|.+++... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||++
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl--~~~~~~kL~DFGla 516 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLL--VTQHYAKISDFGLS 516 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--EETTEEEECCTTHH
T ss_pred CEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEE--eCCCCEEEEEcCCc
Confidence 68999999965 999999754 369999999999999999999995 789999999999999 56789999999999
Q ss_pred cccCCc------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 274 CQLGQR------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 274 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
+.+... .....+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+......+..
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p-- 594 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-- 594 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC--
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 876432 123346778999999999999999999999999999998 99999998887776666542111000
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
. .....+.+||.+||..||+
T Consensus 595 -----------------------------------~-------------------------~~~~~l~~li~~cl~~dP~ 614 (635)
T 4fl3_A 595 -----------------------------------A-------------------------GCPREMYDLMNLCWTYDVE 614 (635)
T ss_dssp -----------------------------------T-------------------------TCCHHHHHHHHHHTCSSTT
T ss_pred -----------------------------------C-------------------------CCCHHHHHHHHHHcCCCHh
Confidence 0 0011789999999999999
Q ss_pred CCCCHHHHhc
Q psy16081 427 TRITPYYALQ 436 (493)
Q Consensus 427 ~R~t~~e~L~ 436 (493)
+|||+.++++
T Consensus 615 ~RPs~~~l~~ 624 (635)
T 4fl3_A 615 NRPGFAAVEL 624 (635)
T ss_dssp TSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=363.83 Aligned_cols=282 Identities=23% Similarity=0.266 Sum_probs=196.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW- 192 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~- 192 (493)
...++|++.++||+|+||+||+|.+..+|+.||||+++.... ....+..|..++..+ +||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L------~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL------NHPNVVSAREVPDGL 84 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC------CBTTBCCEEECCTTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC------CCCCCCceeeeeccc
Confidence 345789999999999999999999999999999999874321 122334455554443 47889999988765
Q ss_pred -----cceeEEEEEecc-cCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC-CCc
Q psy16081 193 -----RNHLCLVFELLS-YNLYDLLRNTN-FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK-RSA 264 (493)
Q Consensus 193 -----~~~~~lV~E~~~-~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~-~~~ 264 (493)
.+..|+|||||. ++|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.+. ...
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSCE
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCcee
Confidence 678899999995 59999997643 2358999999999999999999995 7899999999999995332 234
Q ss_pred EEEEecccccccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 265 IKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 265 ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.............
T Consensus 163 vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~---- 238 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE---- 238 (676)
T ss_dssp EEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred EEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc----
Confidence 899999999876543 34568999999999999999999999999999999999999999876543221100000
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
. ............+.+... ...+.+. .........+.+||.+||.
T Consensus 239 --~-----~~~~~~~~~~l~g~~~~~-------~~lp~p~---------------------~l~~~ls~~L~dLI~~mL~ 283 (676)
T 3qa8_A 239 --K-----SNEHIVVYDDLTGAVKFS-------SVLPTPN---------------------HLSGILAGKLERWLQCMLM 283 (676)
T ss_dssp ------------CCSCCCCSSSCCCC-------SSSCCSC---------------------CCCGGGHHHHHHHHHHHSC
T ss_pred --c-----cchhhhhhhhhccccccc-------cccCCch---------------------hhchhhhHHHHHHHHHHcc
Confidence 0 000000000000000000 0000000 0111122378999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCc
Q psy16081 423 YDPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 423 ~dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
+||++|||+.|+|+||||+.+.
T Consensus 284 ~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 284 WHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp SSCC---CCTTCCCCTTHHHHH
T ss_pred CCHhhCcCHHHHhcCHHHHHHH
Confidence 9999999999999999997543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.56 Aligned_cols=246 Identities=24% Similarity=0.278 Sum_probs=184.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcC-CC--eEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLE-EQ--CHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~--~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|++.+.||+|+||+||+|.+.. ++ ..||||+++.... ....+..|..++..+ +|+||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~ 90 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------DHRNLIRLYGVV 90 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC------CCCCcccEEEEE
Confidence 3589999999999999999998643 33 3689999874321 122333444443332 478899999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
...+ .++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili--~~~~~~kl~D 164 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLL--ATRDLVKIGD 164 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE--EETTEEEECC
T ss_pred ccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEE--cCCCCEEEcc
Confidence 8654 899999996 59999987643 358999999999999999999995 689999999999999 5678899999
Q ss_pred cccccccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 270 FGSSCQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 270 FG~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+.+..+......+
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 99997764322 23456778999999998889999999999999999999 999999988777666554311100
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
+ ... .. ...+.+||.+||.
T Consensus 245 ~------------------------------------~~~-----------------------~~--~~~l~~li~~~l~ 263 (291)
T 1u46_A 245 P------------------------------------RPE-----------------------DC--PQDIYNVMVQCWA 263 (291)
T ss_dssp C------------------------------------CCT-----------------------TC--CHHHHHHHHHHTC
T ss_pred C------------------------------------CCc-----------------------Cc--CHHHHHHHHHHcc
Confidence 0 000 00 1178999999999
Q ss_pred CCCCCCCCHHHHhc
Q psy16081 423 YDPKTRITPYYALQ 436 (493)
Q Consensus 423 ~dP~~R~t~~e~L~ 436 (493)
.||.+|||+.++++
T Consensus 264 ~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 264 HKPEDRPTFVALRD 277 (291)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999997
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=326.78 Aligned_cols=197 Identities=27% Similarity=0.388 Sum_probs=161.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEE----EcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAF----DLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|++++.||+|+||.||+|. +..+++.||||++..... ....+..|..++..+ +|+||+++++++..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL------QHDNIVKYKGVCYS 113 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC------CCTTBCCEEEEECC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC------CCCCeeeEEEEEEe
Confidence 4579999999999999999998 467899999999975332 122344444444332 57889999998876
Q ss_pred cc--eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 193 RN--HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 193 ~~--~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
.+ .+++||||+++ +|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli--~~~~~~kL~D 188 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILV--ENENRVKIGD 188 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE--EETTEEEECC
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEE--cCCCcEEEec
Confidence 44 78999999965 9999997654 458999999999999999999995 789999999999999 5678999999
Q ss_pred cccccccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 270 FGSSCQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 270 FG~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
||++....... ....++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 99998765432 233567789999999998899999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=326.34 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=192.2
Q ss_pred cceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 114 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.+...++|++.+.||+|+||+||+|.+.. .||||+++.... ....+..|. ......+|+||+++++++
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~------~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREV------MAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTG------GGGTTCCCTTBCCCCEEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHH------HHHhcCCCCCEeEEEEEE
Confidence 33446789999999999999999998754 399999874321 112222333 333445688999999999
Q ss_pred eecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 191 MWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 191 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
...+.+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ + ++.+||+|
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~--~-~~~~~l~D 172 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFY--D-NGKVVITD 172 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEE--C---CCEECC
T ss_pred ecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEE--e-CCCEEEee
Confidence 999999999999965 9999987643 468999999999999999999995 689999999999999 3 56899999
Q ss_pred cccccccC--------CccccccccCcCCchhhhcC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy16081 270 FGSSCQLG--------QRIYQYIQSRFYRSPEVLLG---------IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQM 332 (493)
Q Consensus 270 FG~a~~~~--------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~ 332 (493)
||++.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.....
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99986542 12234568999999999975 35889999999999999999999999988877665
Q ss_pred HHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhh
Q psy16081 333 NKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLK 412 (493)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (493)
..+......... .... ...
T Consensus 253 ~~~~~~~~~~~~-----------------------------------------------------------~~~~--~~~ 271 (319)
T 2y4i_B 253 WQMGTGMKPNLS-----------------------------------------------------------QIGM--GKE 271 (319)
T ss_dssp HHHHTTCCCCCC-----------------------------------------------------------CSSC--CTT
T ss_pred HHhccCCCCCCC-----------------------------------------------------------cCCC--CHH
Confidence 554321100000 0000 016
Q ss_pred HHHHHhHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 413 FKDLIFRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 413 ~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
+.+||.+||..||.+|||+.++++ .|+.+
T Consensus 272 l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l 300 (319)
T 2y4i_B 272 ISDILLFCWAFEQEERPTFTKLMD--MLEKL 300 (319)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHH--HHTTC
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH--HHHHH
Confidence 889999999999999999999997 34443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.04 Aligned_cols=247 Identities=23% Similarity=0.286 Sum_probs=193.6
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
...++|++.+.||+|+||+||+|.+..+ +..||||+++..... ...+..|..++.. .+||||+++++++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~------l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ------FDHPHIVKLIGVI 460 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHH------CCCTTBCCEEEEE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHh------CCCCCCCeEEEEE
Confidence 3457899999999999999999988653 567999998643211 1223333333332 3588899999998
Q ss_pred eecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
. ++.+|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl--~~~~~vkL~D 534 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLV--SSNDCVKLGD 534 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--EETTEEEECC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEE--eCCCCEEEEe
Confidence 5 567899999996 59999987543 358999999999999999999995 689999999999999 5678999999
Q ss_pred cccccccCCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 270 FGSSCQLGQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 270 FG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
||++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+......+..
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 614 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 614 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 99998764432 23456788999999999899999999999999999997 99999999888877776543111100
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
. .....+.+||.+||..|
T Consensus 615 -------------------------------------~-------------------------~~~~~l~~li~~~l~~d 632 (656)
T 2j0j_A 615 -------------------------------------P-------------------------NCPPTLYSLMTKCWAYD 632 (656)
T ss_dssp -------------------------------------T-------------------------TCCHHHHHHHHHHTCSS
T ss_pred -------------------------------------c-------------------------cccHHHHHHHHHHcCCC
Confidence 0 00017889999999999
Q ss_pred CCCCCCHHHHhc
Q psy16081 425 PKTRITPYYALQ 436 (493)
Q Consensus 425 P~~R~t~~e~L~ 436 (493)
|.+|||+.|+++
T Consensus 633 P~~RPs~~el~~ 644 (656)
T 2j0j_A 633 PSRRPRFTELKA 644 (656)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhHCcCHHHHHH
Confidence 999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=352.90 Aligned_cols=247 Identities=19% Similarity=0.294 Sum_probs=191.5
Q ss_pred eccceecCcEEEeeeEeeeCCeEEEEEEEcC-CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 112 QHGEKFLDRYEIDSLIGKGSFGQVVKAFDLE-EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 112 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
..++.+.++|++.++||+|+||+||+|.+.. +++.||||++..... .. ....+..+.......+||||++++++|
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~ 148 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AE---AQAMAMAERQFLAEVVHPSIVQIFNFV 148 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HH---HHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HH---HHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence 4566778999999999999999999999976 789999999864321 11 111223333334445689999999999
Q ss_pred eecce-----eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCc
Q psy16081 191 MWRNH-----LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA 264 (493)
Q Consensus 191 ~~~~~-----~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ 264 (493)
...+. .||||||++| +|.+++.. .+++..++.++.||+.||.|||+ .|||||||||+|||++ . +.
T Consensus 149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~--~-~~ 219 (681)
T 2pzi_A 149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLT--E-EQ 219 (681)
T ss_dssp EEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEC--S-SC
T ss_pred eecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEe--C-Cc
Confidence 98766 7999999965 88776643 58999999999999999999995 6899999999999994 3 38
Q ss_pred EEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 265 IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 265 ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
+||+|||++...... ...+||+.|+|||++.+. ++.++|||||||+||+|++|.+||.+.... ..+.
T Consensus 220 ~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~- 286 (681)
T 2pzi_A 220 LKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPE- 286 (681)
T ss_dssp EEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCT-
T ss_pred EEEEecccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc----------cccc-
Confidence 999999999877554 556799999999999875 489999999999999999999998742100 0000
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.... ......+.+||.+||..|
T Consensus 287 ------------------------------------~~~~----------------------~~~~~~l~~li~~~l~~d 308 (681)
T 2pzi_A 287 ------------------------------------DDPV----------------------LKTYDSYGRLLRRAIDPD 308 (681)
T ss_dssp ------------------------------------TCHH----------------------HHHCHHHHHHHHHHTCSS
T ss_pred ------------------------------------cccc----------------------cccCHHHHHHHhhhccCC
Confidence 0000 000126889999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q psy16081 425 PKTRITPYYALQHNFFKR 442 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~~~ 442 (493)
|.+||+..+++.|+|+.-
T Consensus 309 P~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 309 PRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp GGGSCSSHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHH
Confidence 999999999999999854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=310.96 Aligned_cols=183 Identities=13% Similarity=0.034 Sum_probs=146.1
Q ss_pred eeccc-eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 111 IQHGE-KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 111 ~~~~~-~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
+..+. .+.++|++.+.||+|+||+||+|.+..+++.||||++......... ....+.++.......+|+||++++++
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~ 99 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDD--VLQETLSRTLRLSRIDKPGVARVLDV 99 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHH--HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHH--HHHHHHHHHHHHhcCCCCCcceeeEE
Confidence 34455 5567899999999999999999999999999999999754322111 11112222222333468889999999
Q ss_pred eeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 190 FMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
+.+.+.+|+||||+.| +|.+++... .....+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 100 ~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll--~~~g~~kl~ 171 (286)
T 3uqc_A 100 VHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRV--SIDGDVVLA 171 (286)
T ss_dssp EEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEE--ETTSCEEEC
T ss_pred EEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEE--cCCCCEEEE
Confidence 9999999999999965 999998542 4566788899999999999995 799999999999999 567889987
Q ss_pred ecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 269 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 269 DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
++| |++ .++.++|||||||++|||++|+.||.+.+
T Consensus 172 ~~~-----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 172 YPA-----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp SCC-----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred ecc-----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 543 343 37899999999999999999999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=286.55 Aligned_cols=183 Identities=18% Similarity=0.080 Sum_probs=124.2
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-----------chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-----------LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
...+.|++|.+..++....|+.||||++.+.... ..++.+|+.+++ ...+|+||++++++++++
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-----~~~~~~~i~~~~~~~ed~ 314 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLT-----QPPAGFDAPAVLAHGENA 314 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHH-----SCCTTCCCCCEEEEEECS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHH-----hcCCCCCeeEEEEEEEEC
Confidence 4567888888888888889999999999754211 122333444333 234688899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|||||||+| +|.++|.... .+++. .|+.||+.||.|+|+ .|||||||||+|||| +.++.+||+|||+
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL--~~dg~vKL~DFGl 385 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMV--DARQHARLIDFGS 385 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEE--CTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEE--CCCCCEEEeeccc
Confidence 999999999976 9999997653 46654 589999999999994 799999999999999 6788999999999
Q ss_pred ccccCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q psy16081 273 SCQLGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPL 322 (493)
Q Consensus 273 a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p 322 (493)
|+.... ...+.+||+.|+|||++.+ .+..++|+||+|+++++|.+|..+
T Consensus 386 Ar~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 386 IVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 987644 3456789999999999987 467789999999999887666443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=244.81 Aligned_cols=179 Identities=16% Similarity=0.164 Sum_probs=136.3
Q ss_pred EEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc---------hHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL---------NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 122 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---------~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
...++||+|+||+||+| ...++.+|+|+...+.... ..+.+|..++..+ +||||+++..++..
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~~~~~~~~ 410 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV------KDFGIPAPYIFDVD 410 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG------GGGTCCCCCEEEEE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc------CCCCcCceEEEEEe
Confidence 44679999999999999 4567889999875432211 1234555555554 46779966666667
Q ss_pred cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
.+..||||||++ ++|.+++.. +..++.||+.||.|||+ .||+||||||+|||+ +. .+||+|||
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl--~~--~~kL~DFG 474 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIF--DK--DLYIIDFG 474 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEE--SS--SEEECCCT
T ss_pred CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEE--CC--eEEEEECc
Confidence 888899999996 599999865 55799999999999995 789999999999999 34 89999999
Q ss_pred cccccCCc----------cccccccCcCCchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy16081 272 SSCQLGQR----------IYQYIQSRFYRSPEVLLG--IPYDLAIDMWSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 272 ~a~~~~~~----------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~ 324 (493)
+++..... ....+||+.|+|||++.+ ..|+..+|+||..+-..+-+.++.+|.
T Consensus 475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 99887653 135689999999999987 568889999999999888888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-23 Score=204.72 Aligned_cols=143 Identities=20% Similarity=0.275 Sum_probs=108.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-------------------cchHHHHHHHHHHHHhhcCCCCc
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-------------------FLNQAQIEVKLLEIMNKADVNNT 180 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------------------~~~~~~~e~~~~~~l~~~~~~~~ 180 (493)
.|.+.+.||+|+||.||+|.+ .+|+.||||+++.... ....+..|..++..+.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~------- 162 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------- 162 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-------
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-------
Confidence 466779999999999999998 8899999999964321 1234556777766665
Q ss_pred ceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC
Q psy16081 181 YYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN 259 (493)
Q Consensus 181 ~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~ 259 (493)
| +++.+++. .+..|+||||++| +|.+ +.. .....++.||+.||.||| +.||+||||||+|||+
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH--~~giiHrDlkp~NILl-- 226 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLV-- 226 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEE--
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH--HCCCEeCCCCHHHEEE--
Confidence 1 23333333 3667999999966 8877 421 234579999999999999 4799999999999999
Q ss_pred CCCCcEEEEecccccccCCccccccccCcCCchhhhcC
Q psy16081 260 PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG 297 (493)
Q Consensus 260 ~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~ 297 (493)
+ ++.+||+|||+|+. +..++|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~----------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE----------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE----------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE----------CCCCCHHHHHHH
Confidence 4 78999999999863 445799999853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.2e-20 Score=179.76 Aligned_cols=138 Identities=19% Similarity=0.200 Sum_probs=105.6
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeE--EEEEEEccCccc-------------------------chHHHHHHHHHHHHh
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCH--VAIKIIKNKKPF-------------------------LNQAQIEVKLLEIMN 173 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~--vAvK~~~~~~~~-------------------------~~~~~~e~~~~~~l~ 173 (493)
|++.+.||+|+||.||+|.+..+|+. ||||+++..... ......|...+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78899999999999999998788999 999997543111 024677888888887
Q ss_pred hcCCCCcceEEEeceeeeecceeEEEEEeccc------CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-CCCCCcc
Q psy16081 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY------NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS-TPELNII 246 (493)
Q Consensus 174 ~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~~------~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lh-s~~~~ii 246 (493)
+... .+|.++.. +..||||||+++ .|.+.... .++..+..++.||+.||.||| . .|||
T Consensus 129 ~~~i-~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~--~giv 193 (258)
T 1zth_A 129 EAGV-SVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE--AELV 193 (258)
T ss_dssp HTTC-CCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT--SCEE
T ss_pred hCCC-CCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH--CCEE
Confidence 6642 34444431 357899999953 56665432 235567889999999999999 6 6899
Q ss_pred ccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 247 HCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 247 HrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||||+|||+ +. .++|+|||+|....
T Consensus 194 HrDlkp~NILl--~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 194 HADLSEYNIMY--ID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSSCSTTSEEE--SS--SEEECCCTTCEETT
T ss_pred eCCCCHHHEEE--cC--cEEEEECcccccCC
Confidence 99999999999 34 89999999997543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=160.84 Aligned_cols=138 Identities=20% Similarity=0.264 Sum_probs=94.2
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc----------cc-------------hHHHHHHHHHHHHhhcCC
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP----------FL-------------NQAQIEVKLLEIMNKADV 177 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----------~~-------------~~~~~e~~~~~~l~~~~~ 177 (493)
|++..+||.|+||.||+|.+ .+|+.||||+++.... +. .....|...+..+.....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999986 4699999999863210 00 012335555555544332
Q ss_pred CCcceEEEeceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 178 NNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 178 ~~~~~Iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
. +...+ .. ...+|||||++| .|.++. .......++.||+.+|.+|| +.|||||||||.|||
T Consensus 176 ~----vp~p~---~~-~~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH--~~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 176 P----VPEPI---AQ-SRHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLA--KHGLIHGDFNEFNIL 237 (397)
T ss_dssp S----CCCEE---EE-ETTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEE
T ss_pred C----CCeee---ec-cCceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEE
Confidence 1 11111 11 234799999977 654332 12245678899999999999 479999999999999
Q ss_pred eeCCCCC--------cEEEEecccccccC
Q psy16081 257 LCNPKRS--------AIKIVDFGSSCQLG 277 (493)
Q Consensus 257 l~~~~~~--------~ikL~DFG~a~~~~ 277 (493)
+.++.++ .+.||||+-+....
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EeCCCCcccccccccceEEEEeCCcccCC
Confidence 9543322 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.6e-11 Score=115.08 Aligned_cols=141 Identities=13% Similarity=0.099 Sum_probs=103.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.+.|++...++.|+++.||++.. .++.+++|+..... ........|..+++.+.. .. .+.++++++...+..
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~--~~---~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG--KL---PVPKVLHFERHDGWS 85 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT--TS---CCCCEEEEEEETTEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc--CC---CCCeEEEEEecCCce
Confidence 45788999999999999999963 36889999986421 223457788888888754 12 255667777778899
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP---------------------------------- 241 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~---------------------------------- 241 (493)
|+|||+++| +|.+.+. +......++.+++.+|..||..
T Consensus 86 ~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999988 7766531 1122346788899999999961
Q ss_pred -----------------------CCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 242 -----------------------ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 242 -----------------------~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
...++|+|++|.|||+. +...+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~--~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK--DGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE--TTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE--CCcEEEEEEchhcc
Confidence 04589999999999993 44456799999873
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=2.4e-10 Score=108.70 Aligned_cols=138 Identities=16% Similarity=0.042 Sum_probs=95.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
...|.+..+.+.|..+.||++. ..+|..++||+.... .......|..++..+.... .. +.+++.+....+..+
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~-~~---vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTG-VP---CAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTT-CC---BCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCC-CC---CCeEEEeccCCCCCE
Confidence 3456665444566679999995 456778999997643 2355678888888886542 11 455666677777889
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCC----------------------------------
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPE---------------------------------- 242 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~---------------------------------- 242 (493)
+||||++| .| + .. ... ...++.+++..|..||...
T Consensus 92 ~v~e~i~G~~l-~-~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 92 LLLGEVPGQDL-L-SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEECCSSEET-T-TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEEecCCccc-C-cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999987 55 3 21 111 2256777777788887532
Q ss_pred ----------------------CCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 243 ----------------------LNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 243 ----------------------~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
..++|+|++|.|||++ +++.+.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~--~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE--NGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE--TTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE--CCcEEEEEcchhcc
Confidence 1299999999999993 44556799999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=6.6e-10 Score=108.81 Aligned_cols=185 Identities=18% Similarity=0.127 Sum_probs=114.7
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc---eeEEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN---HLCLVFE 201 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~---~~~lV~E 201 (493)
+.++.|....||++. ..+++|+.... ........|..+++.+........|.++ ......+ ..|+|||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~---~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVV---FTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEE---EECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceE---eecCCCCCCCcceEEEc
Confidence 568999999999872 45889986532 2345677788888777543222233333 2222222 3489999
Q ss_pred eccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q psy16081 202 LLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP--------------------------------------- 241 (493)
Q Consensus 202 ~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~--------------------------------------- 241 (493)
+++| .|.+.... .++......++.+++..|..||..
T Consensus 97 ~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 97 KIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred ccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9987 55443221 356666777777777777777741
Q ss_pred -----------------CCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCccccccccCcC---CchhhhcC----
Q psy16081 242 -----------------ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY---RSPEVLLG---- 297 (493)
Q Consensus 242 -----------------~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y---~aPE~~~~---- 297 (493)
...++|+|++|.|||++++....+.|+||+.+..-.. .........+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHH
Confidence 1347999999999999532245678999999864322 1111111111 22322210
Q ss_pred CC----------CCchhhHHHHHHHHHHHHhCCCCC
Q psy16081 298 IP----------YDLAIDMWSLGCILVEMHTGEPLF 323 (493)
Q Consensus 298 ~~----------~~~~~DvwSlGvil~elltG~~pf 323 (493)
.+ .....+.|++|.++|.+.+|.++|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 122368999999999999999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=9.4e-10 Score=110.34 Aligned_cols=142 Identities=14% Similarity=0.207 Sum_probs=98.9
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEc--cCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec---cee
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR---NHL 196 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~--~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~---~~~ 196 (493)
++.|+.|.++.||++.. .+..+++|+.. ... ........|..+++.+..... .+.+++.++.+. +..
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~v----pvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDV----PVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSS----CCCCEEEEECCTTTTSSC
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCC----CCCcEEEECCCCCccCCe
Confidence 57789999999999864 34678888765 222 113456778888888875322 255666666655 458
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP---------------------------------- 241 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~---------------------------------- 241 (493)
|+||||++| .+.+. ....++......++.+++..|..||..
T Consensus 117 ~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999999987 44321 123477888889999999999999962
Q ss_pred ----------------------CCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 242 ----------------------ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 242 ----------------------~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
...+||+|++|.|||++.+....+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 2569999999999999432223468999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.4e-06 Score=85.11 Aligned_cols=139 Identities=17% Similarity=0.138 Sum_probs=83.7
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceee-eecceeEEEEEe
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF-MWRNHLCLVFEL 202 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~-~~~~~~~lV~E~ 202 (493)
++.++.|....||+. +..++||+-. ..........|..+++.+....... +.+.+.+. ...+..++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~---VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVN---IPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSB---CCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCC---CCCeEeecccCCCceEEEEec
Confidence 356888999999988 4668888853 2223456778888888887532222 23333333 234567899999
Q ss_pred ccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q psy16081 203 LSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLST----------------------------------------- 240 (493)
Q Consensus 203 ~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs----------------------------------------- 240 (493)
++| .+.+.... .++......++.++...|.-||+
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 987 55442111 12333333333333333333332
Q ss_pred -----------------CCCCccccCCCCCcEEeeCC-CCCc-EEEEecccccc
Q psy16081 241 -----------------PELNIIHCDLKPENILLCNP-KRSA-IKIVDFGSSCQ 275 (493)
Q Consensus 241 -----------------~~~~iiHrDlKp~NILl~~~-~~~~-ikL~DFG~a~~ 275 (493)
....++|+|++|.|||++.+ .++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 13457999999999999421 1344 48999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5.2e-06 Score=79.19 Aligned_cols=134 Identities=14% Similarity=0.154 Sum_probs=87.6
Q ss_pred eEeeeCCe-EEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 126 LIGKGSFG-QVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 126 ~LG~G~fg-~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
.+..|..| .||+......+..++||+-... .......|...++.+.. . .. +-+++.++.+.+..++|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~-~-vP---VP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTA-F-MP---LPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTT-T-SC---CCCEEEEEEETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhcc-C-CC---cCeEEEEEEECCeEEEEEEeeC
Confidence 44555554 6999877777788999986532 23456778887777753 1 22 5566677778889999999998
Q ss_pred c-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q psy16081 205 Y-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP------------------------------------------ 241 (493)
Q Consensus 205 ~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~------------------------------------------ 241 (493)
| .+.+..... ......+..++...|.-||..
T Consensus 104 G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 104 GKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp SEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred CccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 7 655543221 112233444455555555431
Q ss_pred --------------CCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 242 --------------ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 242 --------------~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
...++|+|+.|.|||+ +..+.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~--~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIF--DEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEE--ECCeEEEEEECcccc
Confidence 1137899999999999 445556799999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.3e-05 Score=81.13 Aligned_cols=77 Identities=22% Similarity=0.148 Sum_probs=48.3
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc--------ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK--------PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.||.|.++.||++....+++.|+||...... ........|..++..+....... +.+++.+ +.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~---vP~~~~~--d~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHL---VPRVFYS--DTEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGG---SCCEEEE--ETTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCC---cCeEEEE--cCCc
Confidence 467999999999999766667889999764321 12345577888888776432111 2233322 3456
Q ss_pred eEEEEEeccc
Q psy16081 196 LCLVFELLSY 205 (493)
Q Consensus 196 ~~lV~E~~~~ 205 (493)
.++|||++++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 7899999965
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=2.3e-05 Score=77.11 Aligned_cols=75 Identities=17% Similarity=0.165 Sum_probs=43.9
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEec-e--eeeecceeEEEEE
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLK-R--HFMWRNHLCLVFE 201 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~-~--~~~~~~~~~lV~E 201 (493)
+.|+.|..+.||++.. . +..+++|+.... ......|..+++.+..... ..|.++... + +....+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~-~-~~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~-~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT-D-SGAVCLKRIHRP---EKKALFSIFAQDYLAKKGM-NVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEE-T-TEEEEEEEECSC---HHHHHHHHHHHHHHHHHTC-SSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEe-C-CCCEEEEecCCC---HHHHHHHHHHHHHHHHcCC-CCCceeecCCCCEEEEECCEEEEEEE
Confidence 4567778899999864 3 345899998752 2344556777777765443 323333311 1 1234667899999
Q ss_pred eccc
Q psy16081 202 LLSY 205 (493)
Q Consensus 202 ~~~~ 205 (493)
|++|
T Consensus 112 ~i~G 115 (346)
T 2q83_A 112 WIEG 115 (346)
T ss_dssp CCCC
T ss_pred eecC
Confidence 9976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=1.1e-05 Score=80.19 Aligned_cols=79 Identities=8% Similarity=0.104 Sum_probs=51.4
Q ss_pred EeeeE-eeeCCeEEEEEEEc--C----CCeEEEEEEEccCc---c-cchHHHHHHHHHHHHhhc-CCCCcceEEEeceee
Q psy16081 123 IDSLI-GKGSFGQVVKAFDL--E----EQCHVAIKIIKNKK---P-FLNQAQIEVKLLEIMNKA-DVNNTYYIVRLKRHF 190 (493)
Q Consensus 123 ~~~~L-G~G~fg~V~~~~~~--~----~~~~vAvK~~~~~~---~-~~~~~~~e~~~~~~l~~~-~~~~~~~Iv~l~~~~ 190 (493)
..+.| +.|....+|++... . +++.+++|+..... . .......|..+++.+... .. . +.+++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~v-p---vP~v~~~~ 99 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDV-P---VPRVRWIE 99 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCS-C---CCCEEEEE
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCC-C---CCcEEEEc
Confidence 45678 88888999998643 0 25678899865322 1 124567888888888765 32 2 34444444
Q ss_pred eec---ceeEEEEEeccc
Q psy16081 191 MWR---NHLCLVFELLSY 205 (493)
Q Consensus 191 ~~~---~~~~lV~E~~~~ 205 (493)
.+. +..++|||+++|
T Consensus 100 ~~~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEG 117 (357)
T ss_dssp CSSTTTSSCEEEEECCCC
T ss_pred cCCCccCCceEEEEecCC
Confidence 433 356899999976
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00057 Score=66.14 Aligned_cols=69 Identities=13% Similarity=-0.042 Sum_probs=46.0
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
++.|+.|....+|++ ..+++|+.............|...++.+...... |-++. . +.+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~--P~~~~---~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS--PEVLH---V--DPATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS--CCEEE---E--CTTTCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC--CceEE---E--ECCCCEEEEeec
Confidence 578999999999998 4588998764332223346688888888876643 43442 2 233457899999
Q ss_pred -cc
Q psy16081 204 -SY 205 (493)
Q Consensus 204 -~~ 205 (493)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 66
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00054 Score=69.72 Aligned_cols=75 Identities=12% Similarity=0.033 Sum_probs=45.5
Q ss_pred CCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCc--cccccc--cCcCCchhhhcCCC---CCchhhHHHHHHHHH
Q psy16081 242 ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQ--SRFYRSPEVLLGIP---YDLAIDMWSLGCILV 314 (493)
Q Consensus 242 ~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~--~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwSlGvil~ 314 (493)
...++|+|++|.|||+. .++ ++|+||+.+..-... ...... ...|.+|+...... -....++.++...+|
T Consensus 231 ~~~liHGDl~~~Nil~~--~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVT--QDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEEC--SSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEe--CCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 46899999999999993 444 999999998643221 111111 12356666554211 112344557777777
Q ss_pred HHHhC
Q psy16081 315 EMHTG 319 (493)
Q Consensus 315 elltG 319 (493)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0025 Score=61.14 Aligned_cols=78 Identities=9% Similarity=0.035 Sum_probs=53.5
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
...-++.+|.|..+.||++. ..+|+.|.||+-.... .....+..|...++.+........|-++. . +.-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~---~----~~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAG---W----DDRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEE---E----ETTEE
T ss_pred CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEe---c----cCceE
Confidence 35567889999999999996 4678999999865332 23356788999898886543333333332 2 23478
Q ss_pred EEEeccc
Q psy16081 199 VFELLSY 205 (493)
Q Consensus 199 V~E~~~~ 205 (493)
|||++.+
T Consensus 88 v~e~l~~ 94 (288)
T 3f7w_A 88 AMEWVDE 94 (288)
T ss_dssp EEECCCC
T ss_pred EEEeecc
Confidence 9999853
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0024 Score=62.31 Aligned_cols=78 Identities=12% Similarity=0.045 Sum_probs=48.1
Q ss_pred eeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEece--eeeecceeEEEEEe
Q psy16081 125 SLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKR--HFMWRNHLCLVFEL 202 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~--~~~~~~~~~lV~E~ 202 (493)
..|+ |....||++. ..+|+.+++|+.............|..+++.+.....+ -|.++..-+ .....+..++||++
T Consensus 32 ~~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~-vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVP-VAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCS-BCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEE-cCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCe-ecceeecCCcEEEEECCEEEEEEEe
Confidence 3566 8888999874 33566799999864322345667788888888765421 121222111 12235567899999
Q ss_pred ccc
Q psy16081 203 LSY 205 (493)
Q Consensus 203 ~~~ 205 (493)
++|
T Consensus 109 i~G 111 (328)
T 1zyl_A 109 VGG 111 (328)
T ss_dssp CCC
T ss_pred cCC
Confidence 976
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0031 Score=61.47 Aligned_cols=75 Identities=19% Similarity=0.174 Sum_probs=54.9
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
.+.|+.|....+|+... ++..++||+.... ....+..|...++.+....... +.+++.+....+..++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~---VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSIN---VPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSB---CCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCC---cceEEEEeecCCceEEEEEec
Confidence 46789999999999863 4678889987532 2456788888888887643222 555555666667899999999
Q ss_pred cc
Q psy16081 204 SY 205 (493)
Q Consensus 204 ~~ 205 (493)
+|
T Consensus 114 ~G 115 (312)
T 3jr1_A 114 NK 115 (312)
T ss_dssp CC
T ss_pred cC
Confidence 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0044 Score=60.22 Aligned_cols=146 Identities=13% Similarity=0.154 Sum_probs=78.0
Q ss_pred EeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEec-e--eeeecceeEEE
Q psy16081 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLK-R--HFMWRNHLCLV 199 (493)
Q Consensus 123 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~-~--~~~~~~~~~lV 199 (493)
-++.|+.|....||++... ++ .+++|+.... ........|..+++.+.....+ .|.++... + +....+..++|
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~-vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLS-CPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCC-CCCBCCBTTCCSCEEETTEEEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCC-CCcccCCCCCCEEEEECCEEEEE
Confidence 3467888888999998643 33 6889988642 1234566788888888765432 22233211 1 11234567899
Q ss_pred EEeccc-CH-----------HHH---Hhcc--CCC-C----CC---HHHHH-H-----------HHHHHHHHHHHHhC--
Q psy16081 200 FELLSY-NL-----------YDL---LRNT--NFR-G----VS---LNLTR-K-----------FSQQLCTALLFLST-- 240 (493)
Q Consensus 200 ~E~~~~-~L-----------~~~---l~~~--~~~-~----l~---~~~~~-~-----------i~~qi~~aL~~Lhs-- 240 (493)
+++++| .+ .+. +... ... . .. |.... . +...+...+..+..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999976 21 011 1111 100 0 01 11100 0 00112333444431
Q ss_pred ---CCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 241 ---PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 241 ---~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
...++||+|+.+.|||+. .+..+.|+||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~--~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFL--GDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEE--TTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEe--CCceEEEecchhcc
Confidence 135799999999999994 44445799999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0016 Score=63.76 Aligned_cols=34 Identities=18% Similarity=0.438 Sum_probs=26.8
Q ss_pred CCCccccCCCCCcEEeeCCC--CCcEEEEecccccc
Q psy16081 242 ELNIIHCDLKPENILLCNPK--RSAIKIVDFGSSCQ 275 (493)
Q Consensus 242 ~~~iiHrDlKp~NILl~~~~--~~~ikL~DFG~a~~ 275 (493)
...+||+|+.+.|||+..+. .+.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 46799999999999994321 25789999998853
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0051 Score=63.21 Aligned_cols=73 Identities=18% Similarity=0.211 Sum_probs=45.7
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEec
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELL 203 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~ 203 (493)
++.|+.|-...+|++....++..|++|+........-....|..++..+..... ..+++..+. + .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl-----~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNI-----AKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSS-----BCCEEEEET--T--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCC-----CCCEEEEeC--C--eEEEEee
Confidence 467888888999999765445889999875432222233678888888876543 233444442 2 2599999
Q ss_pred cc
Q psy16081 204 SY 205 (493)
Q Consensus 204 ~~ 205 (493)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 65
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0029 Score=63.34 Aligned_cols=141 Identities=13% Similarity=0.165 Sum_probs=78.9
Q ss_pred eeEeeeCCeEEEEEEEcC-------CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 125 SLIGKGSFGQVVKAFDLE-------EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
+.|..|-...+|++.... +++.|++|+............+|..++..+...... |-+ +..+.+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~--P~l---l~~~~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLG--PQL---YGVFPE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSS--CCE---EEEETT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCC--CeE---EEEcCC----c
Confidence 567777788889886532 357899998643322345566888999888876652 323 344432 2
Q ss_pred EEEEeccc-CHH--------------HHHh---ccC---CCCC--CHHHHHHHHHHHHH-------------------HH
Q psy16081 198 LVFELLSY-NLY--------------DLLR---NTN---FRGV--SLNLTRKFSQQLCT-------------------AL 235 (493)
Q Consensus 198 lV~E~~~~-~L~--------------~~l~---~~~---~~~l--~~~~~~~i~~qi~~-------------------aL 235 (493)
+||||++| .|. +.|. ... .+.. -+..+.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 89999976 321 1111 111 0111 23455555544422 12
Q ss_pred H----HHhC--CCCCccccCCCCCcEEeeCC--CCCcEEEEeccccc
Q psy16081 236 L----FLST--PELNIIHCDLKPENILLCNP--KRSAIKIVDFGSSC 274 (493)
Q Consensus 236 ~----~Lhs--~~~~iiHrDlKp~NILl~~~--~~~~ikL~DFG~a~ 274 (493)
. .|.. ....++|+|+.+.|||+..+ ..+.+.|+||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 2321 13569999999999999543 13679999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0069 Score=60.19 Aligned_cols=73 Identities=18% Similarity=0.070 Sum_probs=43.0
Q ss_pred eeeEeeeCCeEEEEEEEcC--------CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 124 DSLIGKGSFGQVVKAFDLE--------EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
...|+.|....||++.... .+..+++|+.............|..+++.+..... .|-++ ..+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~--~P~~~---~~~--~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI--APQLL---NTF--N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS--SCCEE---EEE--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC--CCceE---Eec--C--
Confidence 3567888888999987543 13688899876433222234678888888876553 22233 222 2
Q ss_pred eEEEEEeccc
Q psy16081 196 LCLVFELLSY 205 (493)
Q Consensus 196 ~~lV~E~~~~ 205 (493)
-++||||++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 2689999976
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.019 Score=58.43 Aligned_cols=72 Identities=15% Similarity=0.085 Sum_probs=46.7
Q ss_pred eeeEeeeCCeEEEEEEEcC-------CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 124 DSLIGKGSFGQVVKAFDLE-------EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
++.|+.|-...||++.... +++.|++|+.... ........|..++..+...... | ++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~--P---~l~~~~~--~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLG--P---KLYGIFS--G-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSS--S---CEEEEET--T--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCC--C---cEEEEeC--C--
Confidence 4678888889999997542 2578999988432 1113455688888888765542 2 2333332 2
Q ss_pred EEEEEeccc
Q psy16081 197 CLVFELLSY 205 (493)
Q Consensus 197 ~lV~E~~~~ 205 (493)
.+|+||++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 289999865
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.027 Score=55.30 Aligned_cols=71 Identities=8% Similarity=0.201 Sum_probs=42.5
Q ss_pred eeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEec-e--eeeecceeEEEEEecc
Q psy16081 128 GKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLK-R--HFMWRNHLCLVFELLS 204 (493)
Q Consensus 128 G~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~-~--~~~~~~~~~lV~E~~~ 204 (493)
|.|....||++.. .+| .+++|+..... ...|..+++.+.....+..|-++... + +....+..++||+|++
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYH-----DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSS-----CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCcc-----chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444678999863 345 89999876433 14567777777654433122233221 1 1233567899999997
Q ss_pred c
Q psy16081 205 Y 205 (493)
Q Consensus 205 ~ 205 (493)
|
T Consensus 105 G 105 (339)
T 3i1a_A 105 A 105 (339)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.78 E-value=0.047 Score=49.73 Aligned_cols=98 Identities=14% Similarity=0.050 Sum_probs=62.6
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCCccccccc
Q psy16081 206 NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 285 (493)
Q Consensus 206 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~~~~~~g 285 (493)
+|.+.|...+ .++++++++.++.|.+.+|.-+-. +..-..+=+-|..|+| ..+|.|...+ +.+. ..
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l--~~dG~V~f~~-~~s~---------~~ 99 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRV--WRDGAVTLAP-AADD---------AG 99 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEE--ETTSCEEECC-C--------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEE--ecCCceeccc-cccc---------cc
Confidence 6888887655 589999999999999999876621 0111233446789999 5677776543 1110 12
Q ss_pred cCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh
Q psy16081 286 SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT 318 (493)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt 318 (493)
...+.|||... ...+.+.=|||||+++|.-+-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 33467888764 345678899999999998874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.14 E-value=0.07 Score=54.07 Aligned_cols=73 Identities=12% Similarity=0.153 Sum_probs=47.8
Q ss_pred eeeEeeeCCeEEEEEEEcCC-------CeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 124 DSLIGKGSFGQVVKAFDLEE-------QCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~-------~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
++.|..|-...+|++..... ++.|++|+........-...+|..++..+..... .|-++ +.+ . -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi--~P~l~---~~~--~--~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI--APNII---ADF--P--E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS--SCCEE---EEE--T--T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC--CCCEE---EEc--C--C
Confidence 46677788889999875421 5789999875443333345678888888887654 22233 222 2 2
Q ss_pred EEEEEeccc
Q psy16081 197 CLVFELLSY 205 (493)
Q Consensus 197 ~lV~E~~~~ 205 (493)
++||||++|
T Consensus 146 ~~I~efI~G 154 (424)
T 3mes_A 146 GRIEEFIDG 154 (424)
T ss_dssp EEEEECCCS
T ss_pred CEEEEEeCC
Confidence 689999976
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=91.17 E-value=0.059 Score=37.06 Aligned_cols=22 Identities=14% Similarity=-0.014 Sum_probs=20.4
Q ss_pred CcceeeeeccccCcceeccccc
Q psy16081 1 MNFSVSLNTESAGEAVSHAPLY 22 (493)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~ 22 (493)
||||||+.||...+.|++..|.
T Consensus 20 v~VGFSAsTG~~~~~h~IlsWs 41 (52)
T 2ltn_B 20 VRIGFSATTGAEYAAHEVLSWS 41 (52)
T ss_dssp EEEEEEEECCSSCCEEEEEEEE
T ss_pred EEEEEEeccCCcceeEEEEEeE
Confidence 7999999999999999999984
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.47 E-value=2.1 Score=38.63 Aligned_cols=113 Identities=10% Similarity=0.157 Sum_probs=73.6
Q ss_pred cceEEEeceeeeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEee
Q psy16081 180 TYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLC 258 (493)
Q Consensus 180 ~~~Iv~l~~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~ 258 (493)
+|+.+.. ..-..++.+.+.++.-+ +--+..++ .++....++++.+|+....++++ -+|--|.|+||++
T Consensus 44 ~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f- 112 (215)
T 4ann_A 44 SPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF- 112 (215)
T ss_dssp CTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE-
T ss_pred CCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE-
Confidence 4445543 34445566666666553 22223333 47788999999999988876664 4788899999999
Q ss_pred CCCCCcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhH-HHHHHHHHHHHhCCCCCC
Q psy16081 259 NPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDM-WSLGCILVEMHTGEPLFS 324 (493)
Q Consensus 259 ~~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-wSlGvil~elltG~~pf~ 324 (493)
+.++.++++-.|+...+. |. .++ ..|. -.+=|++..++.++..|.
T Consensus 113 -~~~~~p~i~~RGik~~l~--------------P~-----~~~-ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 -TRDGLPIAKTRGLQNVVD--------------PL-----PVS-EAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp -CTTSCEEESCCEETTTBS--------------CC-----CCC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred -cCCCCEEEEEccCccCCC--------------CC-----CCC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 789999998888743221 11 112 2233 347788888999888773
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.66 E-value=5.7 Score=35.95 Aligned_cols=102 Identities=14% Similarity=0.213 Sum_probs=69.4
Q ss_pred eecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHH-HHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL-FLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~-~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
.+++.+.+.++.-. +.-+..++ .++....++++.+|+.... ++++ -+|--|.|+||++ +.++.++|.
T Consensus 58 ~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~f--~~~~~p~i~ 126 (219)
T 4ano_A 58 VSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLMF--NRALEPFFL 126 (219)
T ss_dssp ECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEEE--CTTCCEEES
T ss_pred EeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEEE--eCCCcEEEE
Confidence 55677777777663 33444443 3778899999999888776 5553 6788899999999 789999999
Q ss_pred ecccccccCCccccccccCcCCchhhhcCCCCCchhhHH-HHHHHHHHHHhCCCCC
Q psy16081 269 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMW-SLGCILVEMHTGEPLF 323 (493)
Q Consensus 269 DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw-SlGvil~elltG~~pf 323 (493)
-.|+-..+ +|. .. ...|.| .+=|++..++.++.-|
T Consensus 127 hRGi~~~l--------------pP~-----e~-~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 127 HVGVKESL--------------PPD-----EW-DDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CCEETTTB--------------SSC-----SC-CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred EcCCcccC--------------CCC-----CC-CHHHHHHHHHHHHHHHHcCCCCH
Confidence 88874322 221 11 122332 4667777888887766
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.11 E-value=0.74 Score=46.01 Aligned_cols=32 Identities=28% Similarity=0.433 Sum_probs=26.1
Q ss_pred CccccCCCCCcEEeeC----CCCCcEEEEecccccc
Q psy16081 244 NIIHCDLKPENILLCN----PKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 244 ~iiHrDlKp~NILl~~----~~~~~ikL~DFG~a~~ 275 (493)
.++|+|+.+.|||+.. ++...+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 4689999999999953 3456799999998853
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 493 | ||||
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-60 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-57 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-56 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-56 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-56 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-54 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-54 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-53 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-53 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-04 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-04 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 0.001 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-05 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-04 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-04 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-04 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-40 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-32 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-29 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-28 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-18 |
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 202 bits (514), Expect = 3e-61
Identities = 104/359 (28%), Positives = 161/359 (44%), Gaps = 42/359 (11%)
Query: 109 YIIQHGEKFLD-RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVK 167
+ GE + D RY + +G G F V A D+ HVA+KI++ K + A+ E+K
Sbjct: 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK 61
Query: 168 LLEIMNKADVN-----NTYYIVRLKRHFMWRN----HLCLVFELLSYNLYDLLRNTNFRG 218
LL+ +N AD +I++L HF + H+ +VFE+L NL L++ RG
Sbjct: 62 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121
Query: 219 VSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILL----CNPKRSAIKIVDFGSSC 274
+ L ++ S+QL L ++ IIH D+KPEN+L+ IKI D G++C
Sbjct: 122 IPLIYVKQISKQLLLGLDYM-HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 275 QLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSG------SNE 328
+ IQ+R YRSPEVLLG P+ D+WS C++ E+ TG+ LF + +
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 329 VDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDIL 388
D + +I+E+LG P +LL TR +F+ I K + + +
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300
Query: 389 GVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
E D + ML DP+ R + H + K T
Sbjct: 301 AKE---------------------ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-60
Identities = 80/335 (23%), Positives = 123/335 (36%), Gaps = 34/335 (10%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKAD 176
D +E S +G G+ G V K +A K+I K NQ E+++L N
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP- 64
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
YIV F + + E + D + R + + K S + L
Sbjct: 65 -----YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-GQRIYQYIQSRFYRSPEVL 295
+L + I+H D+KP NIL+ + IK+ DFG S QL ++ +R Y SPE L
Sbjct: 119 YLRE-KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 296 LGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN-EVDQMNKIVEVLGLPPKHLLDGAHKTR 354
G Y + D+WS+G LVEM G + + ++ +V G + R
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414
D SR I + P S +F+
Sbjct: 236 PLSSYGMD------------------SRPPMAIFELLDYIVNEPPPKLPSGVFSL--EFQ 275
Query: 415 DLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
D + + L +P R + H F KR+ E +
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 310
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-57
Identities = 84/332 (25%), Positives = 139/332 (41%), Gaps = 44/332 (13%)
Query: 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQC-HVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
+ +YE + IG+G++G+V KA DL+ VA+K ++ + ++ + ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 175 ADVNNTYYIVRLKRHFMW-----RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229
+ +VRL L LVFE + +L L GV +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY 289
QL L FL ++H DLKP+NIL+ + + + + + + +Y
Sbjct: 124 QLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 181
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
R+PEVLL Y +D+WS+GCI EM +PLF GS++VDQ+ KI++V+GLP +
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409
+ I K D + +
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTD----------------------------------IDE 267
Query: 410 YLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
KDL+ + L ++P RI+ Y AL H +F+
Sbjct: 268 --LGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 1e-56
Identities = 91/336 (27%), Positives = 153/336 (45%), Gaps = 45/336 (13%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
Y +IG GSFG V +A + VAIK + K F N+ E++++ ++ ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNIV 76
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNL--TRKFSQQLCTALL 236
Y +L LV + + +Y + R+ + +L + + + QL +L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEV 294
++ I H D+KP+N+LL +P + +K+ DFGS+ QL G+ YI SR+YR+PE+
Sbjct: 137 YI--HSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 295 LLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353
+ G Y +ID+WS GC+L E+ G+P+F G + VDQ+ +I++VLG P + + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413
F ++ K R P +
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPP----------------------------------EA 279
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
L R+L+Y P R+TP A H+FF D +
Sbjct: 280 IALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 2e-56
Identities = 86/348 (24%), Positives = 147/348 (42%), Gaps = 33/348 (9%)
Query: 106 NHDYIIQHGEKF---LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK---KPFL 159
N Y ++ G+ L RY+ IG G+ G V A+D +VAIK + +
Sbjct: 1 NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60
Query: 160 NQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGV 219
+A E+ L++ +N ++ + + ++ + LV EL+ NL +++ +
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MEL 116
Query: 220 SLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 279
Q+ + L IIH DLKP NI++ + I +
Sbjct: 117 DHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174
Query: 280 IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL 339
+ Y+ +R+YR+PEV+LG+ Y +D+WS+GCI+ EM + LF G + +DQ NK++E L
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
Query: 340 GLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRR 399
G P + T + + + L PK P + + +
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-------- 286
Query: 400 LGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
+DL+ +ML DP RI+ ALQH + D +
Sbjct: 287 -------------ARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA 321
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 2e-56
Identities = 92/328 (28%), Positives = 143/328 (43%), Gaps = 45/328 (13%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
++ ++ IG+G++G V KA + VA+K I+ ++ + ++ + +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
N IV+L N L LVFE L +L + + G+ L L + + QL L F
Sbjct: 61 PN---IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEV 294
++H DLKP+N+L+ AIK+ DFG + G + + + +YR+PE+
Sbjct: 118 C--HSHRVLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 295 LLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353
LLG Y A+D+WSLGCI EM T LF G +E+DQ+ +I LG P + + G
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413
Y P +D K P
Sbjct: 234 PDYKPSFPK-----WARQDFSKVVPPLDE-----------------------------DG 259
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFK 441
+ L+ +ML YDP RI+ AL H FF+
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-54
Identities = 85/337 (25%), Positives = 142/337 (42%), Gaps = 49/337 (14%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNK 174
+ +YE + IG+G+FG+V KA + VA+K + K+ F A E+K+L+++
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 175 ADVNNTYYIVRLK--RHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+V N I R K + + + LVF+ ++L LL N + +L+ ++ Q L
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLL 127
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-------QRIYQYIQ 285
L ++ I+H D+K N+L+ + +K+ DFG + R +
Sbjct: 128 NGLYYI--HRNKILHRDMKAANVLIT--RDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 286 SRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
+ +YR PE+LLG Y ID+W GCI+ EM T P+ G+ E Q+ I ++ G
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPG 404
+ Y +E R++ +
Sbjct: 244 EVWPNVDNYELYEK-------------------------------LELVKGQKRKVKDRL 272
Query: 405 HSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
+ DLI ++L DP RI AL H+FF
Sbjct: 273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-54
Identities = 91/338 (26%), Positives = 151/338 (44%), Gaps = 49/338 (14%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNKAD 176
RY S IG+G++G V A+D + VAIK I + + + E+K+L +
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 177 VNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
+ I+R + LV L+ +LY LL+ + +S + F Q+ L
Sbjct: 68 IIGINDIIRAP-TIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLK 123
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG------QRIYQYIQSRFYR 290
++ N++H DLKP N+LL +KI DFG + + +Y+ +R+YR
Sbjct: 124 YIH--SANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 291 SPEVLL-GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
+PE++L Y +ID+WS+GCIL EM + P+F G + +DQ+N I+ +LG P + L+
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409
+ +Y+L P + P +
Sbjct: 240 -------IINLKARNYLLSLPHKNKVP-----------------------WNRLFPNADS 269
Query: 410 YLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
K DL+ +ML ++P RI AL H + ++ D S
Sbjct: 270 --KALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-53
Identities = 81/336 (24%), Positives = 139/336 (41%), Gaps = 43/336 (12%)
Query: 110 IIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEV 166
+ + + Y +G G++G V A D VAIK + + F +A E+
Sbjct: 9 VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68
Query: 167 KLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRK 226
+LL+ M +V + LV + +L L+++ + +
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL---GEDRIQF 125
Query: 227 FSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS 286
Q+ L ++ IIH DLKP N+ + + +KI+DFG + Q + Y+ +
Sbjct: 126 LVYQMLKGLRYIH--AAGIIHRDLKPGNLAVN--EDCELKILDFGLARQADSEMTGYVVT 181
Query: 287 RFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
R+YR+PEV+L Y +D+WS+GCI+ EM TG+ LF GS+ +DQ+ +I++V G PP
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGH 405
+ Y+ P+ +K
Sbjct: 242 FVQRLQSDEAKN-------YMKGLPELEKKDFASILTNASP------------------- 275
Query: 406 SVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
+L+ +ML D + R+T AL H +F+
Sbjct: 276 ------LAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 178 bits (451), Expect = 7e-53
Identities = 91/328 (27%), Positives = 145/328 (44%), Gaps = 47/328 (14%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
+++Y IG+G++G V KA + + A+K I+ +K ++ + I+ +
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
+N IV+L + L LVFE L +L LL G+ + F QL + +
Sbjct: 60 SN---IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAY 115
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEV 294
+ ++H DLKP+N+L+ +KI DFG + G ++ I + +YR+P+V
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 295 LLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353
L+G Y ID+WS+GCI EM G PLF G +E DQ+ +I +LG P +
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKF 413
KY P+ + P + + S
Sbjct: 232 PKY---DPNFTVYEPLPWESFLKGLDES-------------------------------G 257
Query: 414 KDLIFRMLDYDPKTRITPYYALQHNFFK 441
DL+ +ML DP RIT AL+H +FK
Sbjct: 258 IDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-52
Identities = 81/327 (24%), Positives = 139/327 (42%), Gaps = 50/327 (15%)
Query: 122 EIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL---EIMNKADVN 178
E +G+G F V KA D VAIK IK + I L +++ +
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
N I+ L F ++++ LVF+ + +L ++++ N ++ + + + L +L
Sbjct: 61 N---IIGLLDAFGHKSNISLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEVL 295
+ I+H DLKP N+LL +K+ DFG + G + + +R+YR+PE+L
Sbjct: 117 H--QHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
Query: 296 LGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354
G Y + +DMW++GCIL E+ P G +++DQ+ +I E LG P +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE---------- 222
Query: 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414
++ PD + P +P + D
Sbjct: 223 ---EQWPDMCSLPDYVTFKSFPGIPLHHIFS--------------------AAGD--DLL 257
Query: 415 DLIFRMLDYDPKTRITPYYALQHNFFK 441
DLI + ++P RIT AL+ +F
Sbjct: 258 DLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (451), Expect = 5e-52
Identities = 57/260 (21%), Positives = 115/260 (44%), Gaps = 17/260 (6%)
Query: 98 YNEGYDDDNHDYIIQHGE----KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK 153
Y++ Y+D Y+ Q E D Y+I +G G+FG V + + K I
Sbjct: 4 YDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN 63
Query: 154 NKKPF-LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLL 211
P + E+ ++ ++ ++ L F + + L+ E LS L+D +
Sbjct: 64 TPYPLDKYTVKNEISIMNQLHHP------KLINLHDAFEDKYEMVLILEFLSGGELFDRI 117
Query: 212 RNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271
+++ +S + +Q C L + E +I+H D+KPENI+ K S++KI+DFG
Sbjct: 118 AAEDYK-MSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFG 174
Query: 272 SSCQL--GQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEV 329
+ +L + + + + +PE++ P DMW++G + + +G F+G +++
Sbjct: 175 LATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234
Query: 330 DQMNKIVEVLGLPPKHLLDG 349
+ + + +
Sbjct: 235 ETLQNVKRCDWEFDEDAFSS 254
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 40.8 bits (95), Expect = 2e-04
Identities = 12/37 (32%), Positives = 20/37 (54%)
Query: 413 FKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTN 449
KD I +L +P+ R+T + AL+H + K T+
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 295
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (448), Expect = 1e-51
Identities = 83/336 (24%), Positives = 147/336 (43%), Gaps = 43/336 (12%)
Query: 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK---KPFLNQAQIEVKLLEIM 172
+ +RY+ S +G G++G V AFD + VA+K + + E++LL+ M
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+V + R N + LV L+ +L ++++ + ++ + + Q+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQIL 131
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSP 292
L ++ +IIH DLKP N+ + +KI+DFG + + Y+ +R+YR+P
Sbjct: 132 RGLKYIH--SADIIHRDLKPSNLA--VNEDCELKILDFGLARHTDDEMTGYVATRWYRAP 187
Query: 293 EVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351
E++L + Y+ +D+WS+GCI+ E+ TG LF G++ +DQ+ I+ ++G P LL
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYL 411
+ + PK G+ L
Sbjct: 248 SESARNYIQS----LTQMPKMNFANVFIGANPL--------------------------- 276
Query: 412 KFKDLIFRMLDYDPKTRITPYYALQHNFFKRTADES 447
DL+ +ML D RIT AL H +F + D
Sbjct: 277 -AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (448), Expect = 1e-51
Identities = 54/239 (22%), Positives = 107/239 (44%), Gaps = 13/239 (5%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-LNQAQIEVKLLEIMN 173
+ LD Y+I +G G+FG V + + + A K + + E++ + ++
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 81
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
+V L F N + +++E +S L++ + + + + +S + ++ +Q+C
Sbjct: 82 HP------TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVC 134
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYR 290
L + E N +H DLKPENI+ + + +K++DFG + L Q + + +
Sbjct: 135 KGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 192
Query: 291 SPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
+PEV G P DMWS+G + + +G F G N+ + + + G
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 41.2 bits (96), Expect = 2e-04
Identities = 12/38 (31%), Positives = 20/38 (52%)
Query: 413 FKDLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNT 450
KD I ++L DP TR+T + AL+H + ++
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-51
Identities = 64/336 (19%), Positives = 130/336 (38%), Gaps = 75/336 (22%)
Query: 116 KFLDRYEIDS-LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
+D Y++ S ++G G G+V++ F+ Q A+K++++ + ++ + + +
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPH- 66
Query: 175 ADVNNTYYIVRLKRHF----MWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQ 229
IVR+ + R L +V E L L+ +++ + + + +
Sbjct: 67 --------IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQL--GQRIYQYIQS 286
+ A+ +L +NI H D+KPEN+L + + +A +K+ DFG + + + +
Sbjct: 119 SIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
+Y +PEVL YD + DMWSLG I+ + G P F ++ + +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------- 225
Query: 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHS 406
++ G Y P+ +
Sbjct: 226 ----------KTRIRMGQYEFPNPEWSEVSE----------------------------- 246
Query: 407 VSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
+ K LI +L +P R+T + H + +
Sbjct: 247 -----EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 4e-51
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 18/239 (7%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMN 173
L+ +EI +GKG FG V A + + + +A+K++ K +Q + EV++ +
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
I+RL +F + L+ E +Y L+ T + +L
Sbjct: 65 H------PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELA 116
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-GQRIYQYIQSRFYRS 291
AL + +IH D+KPEN+LL + +KI DFG S R + Y
Sbjct: 117 NALSYCH--SKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSSRRTTLCGTLDYLP 172
Query: 292 PEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350
PE++ G +D +D+WSLG + E G+P F + + +I V P + +GA
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 231
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (89), Expect = 0.001
Identities = 9/29 (31%), Positives = 15/29 (51%)
Query: 413 FKDLIFRMLDYDPKTRITPYYALQHNFFK 441
+DLI R+L ++P R L+H +
Sbjct: 231 ARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-50
Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 12/238 (5%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
++ ++Y I +G+G FG V + + + K +K K + E+ +L I
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
I+ L F L ++FE +S ++++ + + F ++ + Q+C
Sbjct: 61 R------NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCE 113
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRS 291
AL FL NI H D++PENI+ + S IKI++FG + QL G + Y +
Sbjct: 114 ALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 292 PEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
PEV A DMWSLG ++ + +G F + I+ +
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (99), Expect = 8e-05
Identities = 11/30 (36%), Positives = 18/30 (60%)
Query: 413 FKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
D + R+L + K+R+T ALQH + K+
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 172 bits (436), Expect = 3e-50
Identities = 79/344 (22%), Positives = 155/344 (45%), Gaps = 46/344 (13%)
Query: 102 YDDDNHDYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQ 161
+D ++H +++ G D Y++ +G+G + +V +A ++ V +KI+K K +
Sbjct: 22 WDYESH--VVEWGN--QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKK 75
Query: 162 AQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSL 221
+ E+K+LE + I+ L N D + ++ ++
Sbjct: 76 IKREIKILENLRGGP-----NIITLADIVKDPVSRTPALVFEHVNNTDFKQ--LYQTLTD 128
Query: 222 NLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQR 279
R + ++ AL + + I+H D+KP N+++ + R ++++D+G + GQ
Sbjct: 129 YDIRFYMYEILKALDYC--HSMGIMHRDVKPHNVMIDHEHRK-LRLIDWGLAEFYHPGQE 185
Query: 280 IYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGE-PLFSGSNEVDQMNKIVE 337
+ SR+++ PE+L+ YD ++DMWSLGC+L M + P F G + DQ+ +I +
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
Query: 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGG 397
VLG + + + + P + IL + R + S
Sbjct: 246 VLGTEDLY----DYIDKYNIELDPRFNDILGRHSRKRWERFVHS---------------- 285
Query: 398 RRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
E H VS + D + ++L YD ++R+T A++H +F
Sbjct: 286 ----ENQHLVSP--EALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-50
Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADV 177
D +EI +G G+FG+V KA + E A K+I K L +E+ +L +
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP-- 69
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
IV+L F + N+L ++ E + D + R ++ + + +Q AL +
Sbjct: 70 ----NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRSPEV 294
L + IIH DLK NIL IK+ DFG S + QR +I + ++ +PEV
Sbjct: 126 L--HDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181
Query: 295 LLGI-----PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
++ PYD D+WSLG L+EM EP N + + KI +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-48
Identities = 70/336 (20%), Positives = 119/336 (35%), Gaps = 76/336 (22%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKII-KNKKPFLNQAQIEVKLLEIMNKADV 177
+Y IG+G+ G V A D+ VAI+ + ++P E+ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP-- 77
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
IV ++ + L +V E L+ L + ++ AL F
Sbjct: 78 ----NIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALEF 131
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRSPEV 294
L +IH D+K +NILL +K+ DFG Q+ + + + ++ +PEV
Sbjct: 132 LH--SNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354
+ Y +D+WSLG + +EM GEP + N + + I
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT----------------- 230
Query: 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFK 414
+G+ L+ P+ +S +
Sbjct: 231 -------NGTPELQNPEK----------------------------------LSAIFR-- 247
Query: 415 DLIFRMLDYDPKTRITPYYALQHNFFKRTADESTNT 450
D + R LD D + R + LQH F K S+ T
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-48
Identities = 86/332 (25%), Positives = 141/332 (42%), Gaps = 53/332 (15%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK---NKKPFLNQAQIEVKLLEIMNK 174
+ +YE IG+G++G V KA + E VA+K ++ + + + A E+ LL+ +
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
IVRL L LVFE +L + N + + + F QL
Sbjct: 61 K------NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKG 113
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRS 291
L F + N++H DLKP+N+L+ +K+ +FG + + + + +YR
Sbjct: 114 LGFCHSR--NVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 292 PEVLLGIP-YDLAIDMWSLGCILVEMHTGE-PLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349
P+VL G Y +IDMWS GCI E+ PLF G++ DQ+ +I +LG P +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409
+ K P P P + L +++ +
Sbjct: 230 ----------------MTKLPDYKPYPMYPATTSLVNVVPKLNA---------------- 257
Query: 410 YLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
+DL+ +L +P RI+ ALQH +F
Sbjct: 258 --TGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (420), Expect = 5e-48
Identities = 84/334 (25%), Positives = 126/334 (37%), Gaps = 75/334 (22%)
Query: 114 GEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLLEI 171
E D Y+ ++G G+F +V+ A D Q VAIK I K + + E+ +L
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQ 230
+ IV L + HL L+ +L+S L+D + F + + Q
Sbjct: 64 IKHP------NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQ 115
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQL--GQRIYQYIQSR 287
+ A+ +L +L I+H DLKPEN+L + + S I I DFG S G + +
Sbjct: 116 VLDAVKYL--HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 173
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
Y +PEVL PY A+D WS+G I + G P F N+ +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ------------- 220
Query: 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407
ILK + P +
Sbjct: 221 ------------------ILKAEYEFDSPYWDD--------------------------I 236
Query: 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFK 441
SD KD I +++ DP+ R T ALQH +
Sbjct: 237 SD--SAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (416), Expect = 9e-48
Identities = 68/247 (27%), Positives = 106/247 (42%), Gaps = 20/247 (8%)
Query: 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLL-----EI 171
F + YE ++G+G V + A+KII A+ +L E+
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQ 230
V+ I++LK + LVF+L+ L+D L +S TRK +
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRA 118
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRF 288
L + L +LNI+H DLKPENILL + IK+ DFG SCQL G+++ + +
Sbjct: 119 LLEVICALH--KLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 289 YRSPEVLLG------IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342
Y +PE++ Y +DMWS G I+ + G P F ++ + I+
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 343 PKHLLDG 349
D
Sbjct: 235 GSPEWDD 241
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-46
Identities = 63/332 (18%), Positives = 122/332 (36%), Gaps = 78/332 (23%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ YE+ IG GS+G+ K + + K + + +A+ ++ + E+ ++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELK 61
Query: 179 NTYYIVRLKRHFMWR--NHLCLVFELLSY-NLYDLLRNTNFRGVSLN--LTRKFSQQLCT 233
+ IVR + R L +V E +L ++ L+ + QL
Sbjct: 62 HPN-IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 234 ALLFL---STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSR 287
AL S ++H DLKP N+ L + +K+ DFG + L ++ +
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKAFVGTP 178
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
+Y SPE + + Y+ D+WSLGC+L E+ P F+ ++ +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----------------- 221
Query: 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407
+ K ++G+ ++P +
Sbjct: 222 ------------------LAGKIREGKFRRIP-------------------------YRY 238
Query: 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQHNF 439
SD + ++I RML+ R + L++
Sbjct: 239 SD--ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 8e-46
Identities = 67/244 (27%), Positives = 110/244 (45%), Gaps = 18/244 (7%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE--IM 172
+K + ++ ++G+GSF VV A +L AIKI++ K+ + + ++ E +M
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVTRERDVM 62
Query: 173 NKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQL 231
++ D V+L F L L +R TR ++ ++
Sbjct: 63 SRLDHPF---FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEI 117
Query: 232 CTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQS 286
+AL +L IIH DLKPENILL I+I DFG++ L R ++ +
Sbjct: 118 VSALEYLHGK--GIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGT 173
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
Y SPE+L + D+W+LGCI+ ++ G P F NE KI+++ P+
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF 233
Query: 347 LDGA 350
A
Sbjct: 234 FPKA 237
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-45
Identities = 61/233 (26%), Positives = 107/233 (45%), Gaps = 11/233 (4%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
++ + + ++GKGSFG+V A + AIK +K K L +E ++E +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLA 59
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
++ + F + +L V E L+ +L +++ L+ ++ ++ L
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQ 117
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRSPE 293
FL I++ DLK +NILL IKI DFG + + + + Y +PE
Sbjct: 118 FL--HSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 294 VLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
+LLG Y+ ++D WS G +L EM G+ F G +E + + I P+ L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 226
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 1e-44
Identities = 62/335 (18%), Positives = 121/335 (36%), Gaps = 81/335 (24%)
Query: 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLLEIMNK 174
F++ +++ +G+G++G+V A + + VA+KI+ K+ I E+ + +++N
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNL-YDLLRNTNFRGVSLNLTRKFSQQLCT 233
+V+ H N L E S +D + G+ ++F QL
Sbjct: 63 E------NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMA 114
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-----QRIYQYIQSRF 288
+++L + I H D+KPEN+LL +R +KI DFG + + + + +
Sbjct: 115 GVVYLH--GIGITHRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 289 YRSPEVLLGIPYD-LAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347
Y +PE+L + +D+WS G +L M G
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG---------------------------- 202
Query: 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407
+D+ D K+ + P +
Sbjct: 203 ------ELPWDQPSDSCQEYSDWKEKKTYL------------------------NPWKKI 232
Query: 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQHNFFKR 442
L+ ++L +P RIT + ++ +
Sbjct: 233 DS--APLALLHKILVENPSARITIPDIKKDRWYNK 265
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 5e-44
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 16/228 (7%)
Query: 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-------PFLNQAQIEVKLL 169
+Y++ L+G G FG V + + VAIK ++ + P + +EV LL
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 170 EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229
+ ++ ++RL F + L+ E T + L R F
Sbjct: 62 KKVSSGFSG----VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-QYIQSRF 288
Q+ A+ ++H D+K ENIL+ + R +K++DFGS L +Y + +R
Sbjct: 118 QVLEAVRHC--HNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 289 YRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKI 335
Y PE + Y + +WSLG +L +M G+ F E+ +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 222
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (90), Expect = 8e-04
Identities = 7/29 (24%), Positives = 10/29 (34%)
Query: 413 FKDLIFRMLDYDPKTRITPYYALQHNFFK 441
+ LI L P R T H + +
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (391), Expect = 9e-44
Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 7/229 (3%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
L ++I +G GSFG+V + A+K++K K+ + Q+E E + + V
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIV 61
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
+ + I+R+ F + ++ + + L + R + + ++ ++C AL +
Sbjct: 62 THPF-IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEY 119
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG 297
L +II+ DLKPENILL K IKI DFG + + Y + Y +PEV+
Sbjct: 120 LH--SKDIIYRDLKPENILLD--KNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVST 175
Query: 298 IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
PY+ +ID WS G ++ EM G F SN + KI+ P
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF 224
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 3e-42
Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 19/230 (8%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLE 170
+ + IG GSFG V A D+ VAIK + EV+ L+
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQ 230
+ ++ + ++ + LV E + DLL + + +
Sbjct: 71 KLRHP------NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHG 123
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR 290
L +L N+IH D+K NILL P +K+ DFGS+ + ++ + ++
Sbjct: 124 ALQGLAYLH--SHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA-NSFVGTPYWM 178
Query: 291 SPEVLLGI---PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+PEV+L + YD +D+WSLG +E+ +P N + + I +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.8 bits (95), Expect = 2e-04
Identities = 9/36 (25%), Positives = 15/36 (41%)
Query: 413 FKDLIFRMLDYDPKTRITPYYALQHNFFKRTADEST 448
F++ + L P+ R T L+H F R +
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-42
Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 14/243 (5%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLE---- 170
E D Y+ +G G F V K + A K IK ++ ++ + + +E
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQ 230
I+ + N ++ L + + + L+ EL++ L + SL
Sbjct: 66 ILKEIQHPN---VITLHEVYENKTDVILILELVAG---GELFDFLAEKESLTEEEATEFL 119
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLC--NPKRSAIKIVDFGSSCQL--GQRIYQYIQS 286
L I H DLKPENI+L N + IKI+DFG + ++ G +
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 287 RFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
+ +PE++ P L DMWS+G I + +G F G + + + + V
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 347 LDG 349
Sbjct: 240 FSN 242
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 1e-04
Identities = 14/29 (48%), Positives = 18/29 (62%)
Query: 413 FKDLIFRMLDYDPKTRITPYYALQHNFFK 441
KD I R+L DPK R+T +LQH + K
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (375), Expect = 8e-42
Identities = 48/239 (20%), Positives = 88/239 (36%), Gaps = 22/239 (9%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
Y++ IG+GSFG + + +L VAIK ++ Q + E + +++
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCT-- 61
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
I + H LV +LL +L DLL R S+ ++Q+ + +
Sbjct: 62 ---GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 117
Query: 239 STPELNIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQL----------GQRIYQYIQ 285
E ++++ D+KP+N L+ + + I +VDFG +
Sbjct: 118 --HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 286 SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
+ Y S LG D+ +LG + + G + G K +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-41
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 13/230 (5%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNT 180
+ D IG+GSF V K D E VA ++++K ++ Q + E++ N
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN- 69
Query: 181 YYIVRLKRHFMW----RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
IVR + + + LV EL++ L L+ F+ + + + R + +Q+ L
Sbjct: 70 --IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGL 125
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-GQRIYQYIQSRFYRSPEV 294
FL T IIH DLK +NI + P S +KI D G + I + + +PE+
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGS-VKIGDLGLATLKRASFAKAVIGTPEFMAPEM 184
Query: 295 LLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
YD ++D+++ G ++EM T E +S Q+ + V P
Sbjct: 185 YEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 233
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (376), Expect = 4e-41
Identities = 53/234 (22%), Positives = 104/234 (44%), Gaps = 16/234 (6%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQI----EVKLLEIMN 173
++ + + +IG+G FG+V + A+K + K+ + Q + E +L +++
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
D IV + F + L + +L++ +L+ L S R ++ ++
Sbjct: 63 TGDCPF---IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEII 117
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-QRIYQYIQSRFYRS 291
L + +++ DLKP NILL ++I D G +C ++ + + + Y +
Sbjct: 118 LGLEHMH--NRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKKKPHASVGTHGYMA 173
Query: 292 PEVLL-GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
PEVL G+ YD + D +SLGC+L ++ G F D+ L + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 145 bits (367), Expect = 9e-41
Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 23/244 (9%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLEIMNK 174
DRYE+ ++G G +V A DL VA+K+++ F + + E + +N
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 175 ADVNNTYYIVRLKRHFMWRNH----LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQ 229
IV + +V E + L D++ ++ +
Sbjct: 67 P------AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIA 118
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF----GSSCQLGQRIYQYIQ 285
C AL F + IIH D+KP NI++ + S + I
Sbjct: 119 DACQALNFS--HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176
Query: 286 SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345
+ Y SPE G D D++SLGC+L E+ TGEP F+G + V + V +PP
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236
Query: 346 LLDG 349
+G
Sbjct: 237 RHEG 240
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-40
Identities = 51/239 (21%), Positives = 99/239 (41%), Gaps = 17/239 (7%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
+ ++ IGKG FG V+ + VA+K IKN E ++ + +
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDA-TAQAFLAEASVMTQLRHS-- 60
Query: 178 NNTYYIVRLKRHFMW-RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTAL 235
+V+L + + L +V E ++ +L D LR+ + + KFS +C A+
Sbjct: 61 ----NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 236 LFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVL 295
+L N +H DL N+L+ + + K+ DFG + + + +PE L
Sbjct: 117 EYLE--GNNFVHRDLAARNVLVS--EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEAL 172
Query: 296 LGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP-PKHLLDGAHK 352
+ D+WS G +L E+++ G + D + ++ + + P ++
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-39
Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 21/235 (8%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ + IG GSFG V K + VA+K++ P Q Q + ++ K
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
N I+ + L +V + +LY L + + ++Q + +
Sbjct: 65 N---ILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDY 119
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSP 292
L +IIH DLK NI L +KI DFG + + + + + +P
Sbjct: 120 LHAK--SIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 293 EVLLGI---PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344
EV+ PY D+++ G +L E+ TG+ +S N DQ+ +V L P
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (362), Expect = 2e-39
Identities = 67/247 (27%), Positives = 113/247 (45%), Gaps = 10/247 (4%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
LD+++ +G GSFG+V+ E H A+KI+ K+ + QIE L E V
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAV 98
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYN-LYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
N ++V+L+ F ++L +V E ++ ++ LR S R ++ Q+
Sbjct: 99 NF-PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLL 296
+L L++I+ DLKPEN+L+ I++ DFG + ++ R + + +PE++L
Sbjct: 156 YLH--SLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGRTWTLCGTPEALAPEIIL 211
Query: 297 GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK-TRK 355
Y+ A+D W+LG ++ EM G P F + KIV P H R
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 356 YFDKMPD 362
Sbjct: 272 LLQVDLT 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 9e-39
Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 20/229 (8%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+RY + IG GSFG + D+ VAIK+ K Q IE K+ ++M
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVG- 64
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
I ++ ++ +V ELL +L DL + R SL + Q+ + + ++
Sbjct: 65 ----IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYI 119
Query: 239 STPELNIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLG----------QRIYQYIQSR 287
N IH D+KP+N L+ K+ + I+DFG + + + +
Sbjct: 120 H--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 288 FYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIV 336
Y S LGI D+ SLG +L+ + G + G + K
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 3e-37
Identities = 55/233 (23%), Positives = 105/233 (45%), Gaps = 12/233 (5%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
++ ++ L+GKG+FG+V+ + + A+KI++ K+ + + ++ + E +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNT 62
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALL 236
+ + + LK F + LC V E + L+ L + R + ++ +AL
Sbjct: 63 RHPF-LTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALE 119
Query: 237 FLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRSPE 293
+ ++++ D+K EN++L K IKI DFG + G + + + Y +PE
Sbjct: 120 Y--LHSRDVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 294 VLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346
VL Y A+D W LG ++ EM G F + I+ P+ L
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 228
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-34
Identities = 46/240 (19%), Positives = 93/240 (38%), Gaps = 17/240 (7%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ ++ +G+G FG+V VAIK +K E ++++ +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 71
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
+V+L + + +L D L+ + + L + Q+ + + ++
Sbjct: 72 --EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----FYRSPEV 294
N +H DL+ NIL+ K+ DFG + + Y Q + +PE
Sbjct: 130 ERM--NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 295 LLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP-PKHLLDGAHK 352
L + + D+WS G +L E+ T G + G + ++++ +P P + H
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-34
Identities = 54/235 (22%), Positives = 105/235 (44%), Gaps = 15/235 (6%)
Query: 113 HGEKF-LDRYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNKKPFLNQAQIEVKL 168
H EK ++ +E+ ++G G++G+V + + A+K++K E
Sbjct: 17 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76
Query: 169 LEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFS 228
E + + ++V L F L L+ + ++ + R + + + +
Sbjct: 77 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYV 135
Query: 229 QQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL----GQRIYQYI 284
++ AL L +L II+ D+K ENILL + + + DFG S + +R Y +
Sbjct: 136 GEIVLALEHLH--KLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETERAYDFC 191
Query: 285 QSRFYRSPEVLLGIP--YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+ Y +P+++ G +D A+D WSLG ++ E+ TG F+ E + +I
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (320), Expect = 5e-34
Identities = 51/228 (22%), Positives = 94/228 (41%), Gaps = 15/228 (6%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
E + +G G +G+V + + VA+K +K + + E +M +
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA---AVMKE 69
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
N +V+L ++ E ++Y NL D LR N + VS + + Q+ +
Sbjct: 70 IKHPN---LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----FY 289
A+ +L N IH DL N L+ +K+ DFG S + Y +
Sbjct: 127 AMEYLEKK--NFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 290 RSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337
+PE L + + D+W+ G +L E+ T ++ Q+ +++E
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-34
Identities = 48/241 (19%), Positives = 100/241 (41%), Gaps = 19/241 (7%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ ++ +G G FG+V + VA+K +K + E L++ +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ--- 68
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
+VRL + + + ++ E + +L D L+ + +++N + Q+ + F
Sbjct: 69 ---RLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----FYRSPE 293
+ E N IH DL+ NIL+ + KI DFG + + Y + + +PE
Sbjct: 125 IE--ERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 294 VLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP-PKHLLDGAH 351
+ + + D+WS G +L E+ T G + G + + + + P + + +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240
Query: 352 K 352
+
Sbjct: 241 Q 241
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 9e-34
Identities = 48/243 (19%), Positives = 92/243 (37%), Gaps = 24/243 (9%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDL---EEQCHVAIKIIKNK--KPFLNQAQIEVKLL 169
E + +I+ +IG G FG+V + + VAIK +K+ + E ++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 170 EIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQ 229
+ ++ L+ + ++ E + D N ++ +
Sbjct: 82 GQFDHP------NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135
Query: 230 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 288
+ + +L+ N +H DL NIL+ + K+ DFG S L +
Sbjct: 136 GIAAGMKYLADM--NYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 289 -------YRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLG 340
+ +PE + + A D+WS G ++ E+ + GE + D +N I +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 341 LPP 343
LPP
Sbjct: 252 LPP 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-33
Identities = 50/235 (21%), Positives = 86/235 (36%), Gaps = 16/235 (6%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
IG G FG V + L + VAIK I+ E +++ ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFIEEAEVMMKLSHP--- 60
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
+V+L + + +CLVFE + + T + +C + +L
Sbjct: 61 ---KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ----SRFYRSPEV 294
E +IH DL N L+ + IK+ DFG + + Y + SPEV
Sbjct: 118 --EEACVIHRDLAARNCLVG--ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173
Query: 295 LLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348
Y D+WS G ++ E+ + G+ + + + + I L L
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 228
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 4e-33
Identities = 52/252 (20%), Positives = 100/252 (39%), Gaps = 40/252 (15%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMN 173
+ E ++G G+FG+V+ A VA+K++K K + ++ E + E+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKM 93
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRG-------------- 218
+ + IV L + L+FE Y +L + LR+ +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 219 -------VSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271
++ F+ Q+ + FL + +H DL N+L+ + K +KI DFG
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKV--VKICDFG 209
Query: 272 SSCQLGQRIYQYIQSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSG 325
+ + ++ + +PE L Y + D+WS G +L E+ + G + G
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 326 SNEVDQMNKIVE 337
K+++
Sbjct: 270 IPVDANFYKLIQ 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-32
Identities = 52/241 (21%), Positives = 89/241 (36%), Gaps = 25/241 (10%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAF---DLEEQCHVAIKIIK----NKKPFLNQAQIEVKLLE 170
+ +G GSFG V + + VA+K +K ++ ++ EV +
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 171 IMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQ 230
++ ++RL + + +V EL + L +++ Q
Sbjct: 67 SLDHR------NLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 231 LCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-- 288
+ + +L IH DL N+LL +KI DFG L Q Y+
Sbjct: 120 VAEGMGYLE--SKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 289 ----YRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPP 343
+ +PE L + A D W G L EM T G+ + G N ++KI + P
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 344 K 344
+
Sbjct: 236 R 236
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-32
Identities = 45/235 (19%), Positives = 87/235 (37%), Gaps = 16/235 (6%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+G G FG V Q VAIK+IK ++ E K++ ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE--- 59
Query: 179 NTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFL 238
+V+L + + ++ E ++ + + +C A+ +L
Sbjct: 60 ---KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 239 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ----YIQSRFYRSPEV 294
+ +H DL N L+ + +K+ DFG S + Y + PEV
Sbjct: 117 ESK--QFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 295 LLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348
L+ + D+W+ G ++ E+++ G+ + + I + L L HL
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-32
Identities = 55/240 (22%), Positives = 94/240 (39%), Gaps = 16/240 (6%)
Query: 108 DYIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVK 167
DY IQ +R E+ IG+G FG V + + + IK K + + E
Sbjct: 1 DYEIQR-----ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF 55
Query: 168 LLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKF 227
L E + ++ +IV+L + N + ++ EL + + L +
Sbjct: 56 LQEALTMRQFDHP-HIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-- 285
+ QL TAL +L +H D+ N+L+ + +K+ DFG S + Y
Sbjct: 114 AYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKG 169
Query: 286 --SRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP 342
+ +PE + + A D+W G + E+ G F G D + +I LP
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 229
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 9e-32
Identities = 53/244 (21%), Positives = 92/244 (37%), Gaps = 23/244 (9%)
Query: 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADV 177
+ + +IG+G+FGQV+KA ++ + I K K + ++ E+ +
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAI-KRMKEYASKDDHRDFAGELEVLCKL 67
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNF--------------RGVSLN 222
+ I+ L R +L L E + NL D LR + +S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 223 LTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRI 280
F+ + + +L + IH DL NIL+ KI DFG S ++ +
Sbjct: 128 QLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKK 183
Query: 281 YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVL 339
+ + E L Y D+WS G +L E+ + G + G + K+ +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243
Query: 340 GLPP 343
L
Sbjct: 244 RLEK 247
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 50/242 (20%), Positives = 95/242 (39%), Gaps = 14/242 (5%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKI-IKNKKPFLNQAQIEVKLLEIMNKADV 177
++ ++G G+FG V K + E V I + IK + + + L E A V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 178 NNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLF 237
+N ++ RL + + L+ +L+ + + + + Q+ + +
Sbjct: 69 DN-PHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 238 LSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSP 292
L ++H DL N+L+ P+ +KI DFG + LG +Y + +
Sbjct: 127 LEDR--RLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 293 EVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP-PKHLLDGA 350
E +L Y D+WS G + E+ T G + G + + + + LP P
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 351 HK 352
+
Sbjct: 243 YM 244
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-30
Identities = 49/265 (18%), Positives = 93/265 (35%), Gaps = 32/265 (12%)
Query: 115 EKFLDRYEIDSLIGKGSFGQVVKAFDL-------EEQCHVAIKIIKNKKPFLNQAQIEVK 167
E DR + +G+G+FGQVV A + VA+K++K+ + +
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDL 65
Query: 168 LLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLT-- 224
+ E+ + I+ L L ++ E S NL + L+ G+ +
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 225 ------------RKFSQQLCTALLFLSTPELNIIHCDLKPENILL---CNPKRSAIKIVD 269
+ Q+ + +L+ IH DL N+L+ K + +
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 270 FGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNE 328
++ + +PE L Y D+WS G +L E+ T G + G
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 329 VDQMNKIVEVLGLP-PKHLLDGAHK 352
+ + E + P + + +
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNELYM 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-30
Identities = 54/242 (22%), Positives = 94/242 (38%), Gaps = 29/242 (11%)
Query: 117 FLDRYEI---DSLIGKGSFGQVVKAFDLEEQCH--VAIKIIKNKKP---FLNQAQIEVKL 168
+LDR + D +G G+FG V K + ++ VA+KI+KN+ ++ E +
Sbjct: 2 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61
Query: 169 LEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKF 227
++ ++ YIVR+ LV E+ L L+ R V +
Sbjct: 62 MQQLDNP------YIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIEL 112
Query: 228 SQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR 287
Q+ + +L N +H DL N+LL KI DFG S L Y
Sbjct: 113 VHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQT 168
Query: 288 F------YRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLG 340
+ +PE + + D+WS G ++ E + G+ + G + + +
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 228
Query: 341 LP 342
+
Sbjct: 229 MG 230
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 9e-30
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 25/237 (10%)
Query: 119 DRYEIDSL-IGKGSFGQVVKAFD--LEEQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMN 173
D I + +G G+FG V + ++Q VAIK++K +K + E +++ ++
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLC 232
YIVRL L LV E+ L+ L + ++ + Q+
Sbjct: 68 NP------YIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVS 119
Query: 233 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----- 287
+ +L N +H DL N+LL N R KI DFG S LG Y
Sbjct: 120 MGMKYLEEK--NFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 288 -FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP 342
+ +PE + + D+WS G + E + G+ + + M I + +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-29
Identities = 54/336 (16%), Positives = 104/336 (30%), Gaps = 78/336 (23%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN 178
+ IGKG FG+V + E+ VA+KI +++ + E+ ++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHE--- 57
Query: 179 NTYYIVRLKRHFMWRN----HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
I+ N L LV + + +L+D L V++ K + +
Sbjct: 58 ---NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTAS 111
Query: 234 ALLFL------STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---- 283
L L + + I H DLK +NIL+ K I D G + +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK--KNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 284 ---IQSRFYRSPEVLLG------IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNK 334
+ ++ Y +PEVL D++++G + E+ + G +E Q+
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPY 228
Query: 335 IVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGG 394
V P + +K +P+ + +
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR----------------------- 265
Query: 395 PGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430
++ + R+T
Sbjct: 266 -----------------VMAKIMRECWYANGAARLT 284
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (289), Expect = 1e-29
Identities = 53/255 (20%), Positives = 97/255 (38%), Gaps = 46/255 (18%)
Query: 119 DRYEIDSLIGKGSFGQVVKA-----FDLEEQCHVAIKIIKNKKPFLNQAQI--EVKLLEI 171
+ E IG+G+FG+V +A E VA+K++K + QA E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 172 MNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGV----------- 219
+ ++ + +CL+FE ++Y +L + LR+ + V
Sbjct: 73 FDNPNIVKLLGV------CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 220 -----------SLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268
S ++Q+ + +LS E +H DL N L+ + +KI
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVG--ENMVVKIA 182
Query: 269 DFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPL 322
DFG S + Y + PE + Y D+W+ G +L E+ + G
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 323 FSGSNEVDQMNKIVE 337
+ G + + + +
Sbjct: 243 YYGMAHEEVIYYVRD 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-28
Identities = 56/247 (22%), Positives = 97/247 (39%), Gaps = 35/247 (14%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMN 173
+R +G G+FG+VV+A + VA+K++ KP + + E + E+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKV 79
Query: 174 KADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLRN----------------TNF 216
+ + N IV L ++ E Y +L + LR +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 217 RGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276
+ L FS Q+ + FL+ N IH DL NILL + + KI DFG + +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRI--TKICDFGLARDI 195
Query: 277 GQRIYQYIQSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVD 330
++ + +PE + Y D+WS G L E+ + G + G
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 331 QMNKIVE 337
+ K+++
Sbjct: 256 KFYKMIK 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 5e-28
Identities = 43/248 (17%), Positives = 94/248 (37%), Gaps = 25/248 (10%)
Query: 120 RYEIDSLIGKGSFGQVVKAFDLE---EQCHVAIKIIK--NKKPFLNQAQIEVKLLEIMNK 174
+ +IG+G FG V L+ ++ H A+K + ++Q E +++ +
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 175 ADVNNTYYIVRLKRHFMWR-NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCT 233
++ L + +V + + ++ F Q+
Sbjct: 88 P------NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 141
Query: 234 ALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR------ 287
+ FL++ +H DL N +L +K+ DFG + + + + + ++
Sbjct: 142 GMKFLASK--KFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 288 -FYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP-PK 344
+ + E L + D+WS G +L E+ T G P + N D +++ L P+
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 257
Query: 345 HLLDGAHK 352
+ D ++
Sbjct: 258 YCPDPLYE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 9e-28
Identities = 50/235 (21%), Positives = 87/235 (37%), Gaps = 19/235 (8%)
Query: 119 DRYEIDSLIGKGSFGQVVKAF----DLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNK 174
+IG G FG+V K +++ VAIK +K + IM +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 175 ADVNNTYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTA 234
+N I+RL+ + ++ E + D S+ + +
Sbjct: 66 FSHHN---IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 235 LLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR------F 288
+ +L+ N +H DL NIL+ K+ DFG S L +
Sbjct: 123 MKYLANM--NYVHRDLAARNILVN--SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 289 YRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLP 342
+ +PE + + A D+WS G ++ E+ T GE + + + M I + LP
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 50/249 (20%), Positives = 98/249 (39%), Gaps = 28/249 (11%)
Query: 109 YIIQHGEKFLDRYEIDSLIGKGSFGQVVKAFD-----LEEQCHVAIKIIKNKKPFLNQAQ 163
Y+ E ++ + +G+GSFG V + E + VAIK + + +
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 164 IEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLSY-NLYDLLR--------NT 214
+ +M + + ++ +VRL ++ EL++ +L LR N
Sbjct: 70 F-LNEASVMKEFNCHH---VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 215 NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274
SL+ + + ++ + +L +H DL N ++ +KI DFG +
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYL--NANKFVHRDLAARNCMVAEDFT--VKIGDFGMTR 181
Query: 275 QLGQRIYQYIQSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHTG-EPLFSGSNE 328
+ + Y + + SPE L + D+WS G +L E+ T E + G +
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 329 VDQMNKIVE 337
+ ++E
Sbjct: 242 EQVLRFVME 250
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-24
Identities = 51/246 (20%), Positives = 98/246 (39%), Gaps = 34/246 (13%)
Query: 119 DRYEIDSLIGKGSFGQVVKAFDLEEQC-----HVAIKIIKNKKPFLNQAQIEVKLLEIMN 173
DR ++ +G+G+FGQV++A VA+K++K ++ + E+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKI 69
Query: 174 KADVNNTYYIVRLKRHFMW-RNHLCLVFELLS-YNLYDLLRNTNFRGV------------ 219
+ + +V L L ++ E NL LR+ V
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 220 --SLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277
+L +S Q+ + FL+ IH DL NILL +++ +KI DFG + +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLS--EKNVVKICDFGLARDIY 185
Query: 278 QRIYQYIQSRF-----YRSPEVLLGIPYDLAIDMWSLGCILVEMHTG-EPLFSGSNEVDQ 331
+ + + +PE + Y + D+WS G +L E+ + + G ++
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 332 MNKIVE 337
+ ++
Sbjct: 246 FCRRLK 251
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 6e-18
Identities = 30/196 (15%), Positives = 62/196 (31%), Gaps = 7/196 (3%)
Query: 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIK-NKKPFLNQAQIEVKLLEIMNKADVNN 179
I L+G+G V + + +K K F + + + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 180 TYYIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLS 239
R + + + L +L+ V + + + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 240 TPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP 299
I+H DL N+L+ I I+DF S ++G+ ++ I R R+
Sbjct: 121 --HRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175
Query: 300 YDLAIDMWSLGCILVE 315
Y D+ S +++
Sbjct: 176 YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 493 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.31 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.73 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.64 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.47 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-58 Score=442.01 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=210.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++++.||+|+||+||+|+++.+++.||||++.+.. .......+|+.++. ..+|||||++++++.+.
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~------~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS------HLRHPNILRLYGYFHDA 78 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH------TCCCTTBCCEEEEEECS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHH------hcCCCCCCeEEEEEEEC
Confidence 468999999999999999999999999999999986321 22233444544443 33588899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|||||||++ +|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill--~~~~~~kl~DFG~ 152 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLL--GSAGELKIADFGW 152 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTSCEEECCCCS
T ss_pred CEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeecccccee--cCCCCEeecccce
Confidence 999999999964 9999997654 69999999999999999999995 789999999999999 6788999999999
Q ss_pred ccccCC-ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 273 SCQLGQ-RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 273 a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
|..... .....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+.++.+.-...|.
T Consensus 153 a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~------- 225 (263)
T d2j4za1 153 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------- 225 (263)
T ss_dssp CSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT-------
T ss_pred eeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc-------
Confidence 987654 345678999999999999999999999999999999999999999999888877776542111100
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
..+ .++++||.+||+.||++|||+
T Consensus 226 ------------------------------------------------------~~s--~~~~~li~~~L~~dp~~R~t~ 249 (263)
T d2j4za1 226 ------------------------------------------------------FVT--EGARDLISRLLKHNPSQRPML 249 (263)
T ss_dssp ------------------------------------------------------TSC--HHHHHHHHHHTCSSGGGSCCH
T ss_pred ------------------------------------------------------cCC--HHHHHHHHHHccCCHhHCcCH
Confidence 001 178999999999999999999
Q ss_pred HHHhcCCCCCC
Q psy16081 432 YYALQHNFFKR 442 (493)
Q Consensus 432 ~e~L~Hp~~~~ 442 (493)
+|+|+||||+.
T Consensus 250 ~eil~hp~~~~ 260 (263)
T d2j4za1 250 REVLEHPWITA 260 (263)
T ss_dssp HHHHTCHHHHH
T ss_pred HHHHcCcCcCC
Confidence 99999999973
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=439.41 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=203.2
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
|.++|+++++||+|+||+||+|+++.+|+.||||++..... ....+.+|+.++.. .+|||||++++++.+.+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~------l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM------LNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHT------CCCTTBCCEEEEEEETT
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHh------CCCCCEeeEeeeeccCc
Confidence 56789999999999999999999999999999999974321 12234445544433 35888999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|||||||.+ +|.+++... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+|
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl--~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLL--DERDNLKISDFGLA 150 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE--CTTCCEEECCCTTC
T ss_pred eeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEE--CCCCCEEEccchhh
Confidence 99999999965 999998654 369999999999999999999995 789999999999999 67789999999999
Q ss_pred cccCC-----ccccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 274 CQLGQ-----RIYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 274 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
+.... .....+||+.|+|||++.+..+ +.++|||||||+||||++|++||.+.+.................
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~--- 227 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--- 227 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTST---
T ss_pred eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Confidence 87632 2346789999999999998876 57899999999999999999999876544333222221110000
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
. ....+ .++++||.+||..||++
T Consensus 228 --------------------------------~-----------------------~~~~s--~~~~~li~~~L~~dP~~ 250 (271)
T d1nvra_ 228 --------------------------------P-----------------------WKKID--SAPLALLHKILVENPSA 250 (271)
T ss_dssp --------------------------------T-----------------------GGGSC--HHHHHHHHHHSCSSTTT
T ss_pred --------------------------------c-----------------------cccCC--HHHHHHHHHHcCCChhH
Confidence 0 00011 17889999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q psy16081 428 RITPYYALQHNFFKR 442 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~ 442 (493)
|||++|+|+||||++
T Consensus 251 R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 251 RITIPDIKKDRWYNK 265 (271)
T ss_dssp SCCHHHHTTCTTTTC
T ss_pred CcCHHHHhcCHhhCc
Confidence 999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-57 Score=445.34 Aligned_cols=261 Identities=30% Similarity=0.386 Sum_probs=201.7
Q ss_pred ccceecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 113 HGEKFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 113 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
..+.+.+.|+++++||+|+||+||+|+++.+++.||||++...... ...+.+|+.++. ..+|||||+++++|
T Consensus 3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~------~l~HpnIv~l~~~~ 76 (307)
T d1a06a_ 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH------KIKHPNIVALDDIY 76 (307)
T ss_dssp ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHH------TCCCTTBCCEEEEE
T ss_pred CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHH------hCCCCCCCcEEEEE
Confidence 3456778899999999999999999999999999999999754321 122334544443 33588899999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEE
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIV 268 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~ 268 (493)
.+.+.+|||||||+ ++|.+++... ..+++..++.++.||+.||.|||+ .|||||||||+|||+.. ++++.+||+
T Consensus 77 ~~~~~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~ 152 (307)
T d1a06a_ 77 ESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMIS 152 (307)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EECCEEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEe
Confidence 99999999999996 5999999765 369999999999999999999994 79999999999999954 357889999
Q ss_pred ecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 269 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 269 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
|||+|+.... .....+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+....|......++...
T Consensus 153 DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (307)
T d1a06a_ 153 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232 (307)
T ss_dssp CC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTT
T ss_pred ccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcc
Confidence 9999987643 34567899999999999999999999999999999999999999999988888777765321111000
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
.. ..+ ..+.+||.+||..||+
T Consensus 233 ----------------------------------~~-----------------------~~s--~~~~~li~~~L~~dP~ 253 (307)
T d1a06a_ 233 ----------------------------------WD-----------------------DIS--DSAKDFIRHLMEKDPE 253 (307)
T ss_dssp ----------------------------------TT-----------------------TSC--HHHHHHHHHHSCSSGG
T ss_pred ----------------------------------cc-----------------------CCC--HHHHHHHHHHccCCHh
Confidence 00 011 1789999999999999
Q ss_pred CCCCHHHHhcCCCCCC
Q psy16081 427 TRITPYYALQHNFFKR 442 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~ 442 (493)
+|||++|+|+||||+.
T Consensus 254 ~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 254 KRFTCEQALQHPWIAG 269 (307)
T ss_dssp GSCCHHHHHHSTTTTS
T ss_pred HCcCHHHHhcCHhhCC
Confidence 9999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-56 Score=449.56 Aligned_cols=261 Identities=25% Similarity=0.440 Sum_probs=217.5
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.+.++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+|+.++..+ +|||||+++++|.+.+
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL------RHPTLVNLHDAFEDDN 96 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT------CCTTBCCEEEEEEETT
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC------CCCCCCcEEEEEEECC
Confidence 456799999999999999999999999999999999975432 122334444444333 4788999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
++|||||||. |+|.+++.... ..+++..++.++.||+.||.|||+ .|||||||||+|||+..+.++.+||+|||+|
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecchh
Confidence 9999999996 59999986543 369999999999999999999995 7999999999999997656789999999999
Q ss_pred cccCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 274 CQLGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 274 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
+.+... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..|......++......
T Consensus 174 ~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-- 251 (350)
T d1koaa2 174 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG-- 251 (350)
T ss_dssp EECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGG--
T ss_pred eecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC--
Confidence 877543 3467899999999999999999999999999999999999999999999988888876433222111100
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
.+ ..++|||.+||..||++|||+
T Consensus 252 -------------------------------------------------------~s--~~~~~li~~~L~~dP~~R~t~ 274 (350)
T d1koaa2 252 -------------------------------------------------------IS--EDGKDFIRKLLLADPNTRMTI 274 (350)
T ss_dssp -------------------------------------------------------CC--HHHHHHHHHHCCSSGGGSCCH
T ss_pred -------------------------------------------------------CC--HHHHHHHHHHccCChhHCcCH
Confidence 00 178999999999999999999
Q ss_pred HHHhcCCCCCCCc
Q psy16081 432 YYALQHNFFKRTA 444 (493)
Q Consensus 432 ~e~L~Hp~~~~~~ 444 (493)
+|||+||||+...
T Consensus 275 ~eil~hp~~~~~~ 287 (350)
T d1koaa2 275 HQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHSTTTSCTT
T ss_pred HHHhcCcccCCCC
Confidence 9999999998654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=439.08 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=211.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .......+|+.++..+ +|||||+++++|.+.+++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC------CCTTBCCEEEEEEETTEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC------CCCCEeeEeEEEEECCEE
Confidence 357999999999999999999999999999999987433 2234455666655443 478899999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|||||||.| +|.+++.+. .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 93 ~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl--~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEE--CCCCcEeeccchhhee
Confidence 999999965 888887653 59999999999999999999995 799999999999999 6778999999999987
Q ss_pred cCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 276 LGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
+.. .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 237 (293)
T d1yhwa1 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-------- 237 (293)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS--------
T ss_pred eccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC--------
Confidence 643 345678999999999999999999999999999999999999999999988887777654211100
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.+.. .+ ..+++||.+||..||++|||++
T Consensus 238 ---------------------------~~~~-----------------------~s--~~~~~li~~~L~~dP~~R~s~~ 265 (293)
T d1yhwa1 238 ---------------------------NPEK-----------------------LS--AIFRDFLNRCLDMDVEKRGSAK 265 (293)
T ss_dssp ---------------------------SGGG-----------------------SC--HHHHHHHHHHTCSSTTTSCCHH
T ss_pred ---------------------------Cccc-----------------------CC--HHHHHHHHHHccCChhHCcCHH
Confidence 0000 01 1789999999999999999999
Q ss_pred HHhcCCCCCC
Q psy16081 433 YALQHNFFKR 442 (493)
Q Consensus 433 e~L~Hp~~~~ 442 (493)
|+|+||||+.
T Consensus 266 eil~Hp~~~~ 275 (293)
T d1yhwa1 266 ELLQHQFLKI 275 (293)
T ss_dssp HHTTCGGGGG
T ss_pred HHhcCHhhCC
Confidence 9999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-56 Score=437.75 Aligned_cols=287 Identities=31% Similarity=0.498 Sum_probs=228.1
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCC-CeEEEEEEEccC---cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEE-QCHVAIKIIKNK---KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vAvK~~~~~---~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
..++|+++++||+|+||+||+|++..+ ++.||||+++.. ........+|+.++..+... +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~---~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTV 81 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc---CCCCcceeeeeecc
Confidence 357899999999999999999999765 678999998642 22334566777777766644 57789999999853
Q ss_pred -----cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 193 -----RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 193 -----~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
..++|+|||||++++..+........+++..++.++.||+.||.|||+ .|||||||||+|||+ +..+.+||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi--~~~~~~kl 157 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILV--TSSGQIKL 157 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTCCEEE
T ss_pred cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEE--cCCCCeee
Confidence 457899999998877776665555679999999999999999999995 789999999999999 77889999
Q ss_pred EecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 268 VDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 268 ~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+|.+.++.++..
T Consensus 158 ~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 158 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred cchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 99999976643 3457789999999999999999999999999999999999999999999999999999999988766
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
.+............. .....+..+. ...+ ..++|||.+||.+||
T Consensus 238 ~~~~~~~~~~~~~~~------------------~~~~~~~~~~----------------~~~s--~~~~dli~~mL~~dP 281 (305)
T d1blxa_ 238 DWPRDVALPRQAFHS------------------KSAQPIEKFV----------------TDID--ELGKDLLLKCLTFNP 281 (305)
T ss_dssp GSCTTCSSCGGGSCC------------------CCCCCGGGTC----------------CSCC--HHHHHHHHHHSCSST
T ss_pred cccccccchhhhhcc------------------ccccchhhcc----------------ccCC--HHHHHHHHHHCcCCh
Confidence 554322111100000 0000000000 0111 268999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCccC
Q psy16081 426 KTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
++|||++|||+||||+.+..+
T Consensus 282 ~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 282 AKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp TTSCCHHHHHTSGGGTTCCCC
T ss_pred hHCcCHHHHhcChhhcCchhh
Confidence 999999999999999987554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-56 Score=446.17 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=215.4
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+.++|++++.||+|+||+||+|+++.+|+.||||+++..... . ...+.+++..+...+|||||+++++|.+++++
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--D---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--H---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh--H---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 457899999999999999999999999999999999754311 1 11222333333445689999999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|||||||+| +|.+.+.... ..+++..++.++.||+.||.||| +.|||||||||+|||++...++.+||+|||+|..
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEeeccccee
Confidence 999999964 9999876544 46999999999999999999999 4799999999999999545778999999999987
Q ss_pred cCCc--cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccch
Q psy16081 276 LGQR--IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 276 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
.... ....+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+..+.+.+|......++...+.
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~----- 253 (352)
T d1koba_ 179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS----- 253 (352)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT-----
T ss_pred cCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc-----
Confidence 7543 456789999999999999999999999999999999999999999999998888887643222211100
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
.++ .+++|||.+||.+||.+|||++|
T Consensus 254 ----------------------------------------------------~~s--~~~~~li~~~L~~dp~~R~s~~e 279 (352)
T d1koba_ 254 ----------------------------------------------------SVS--PEAKDFIKNLLQKEPRKRLTVHD 279 (352)
T ss_dssp ----------------------------------------------------TSC--HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ----------------------------------------------------CCC--HHHHHHHHHHccCChhHCcCHHH
Confidence 011 17899999999999999999999
Q ss_pred HhcCCCCCCC
Q psy16081 434 ALQHNFFKRT 443 (493)
Q Consensus 434 ~L~Hp~~~~~ 443 (493)
||+||||+..
T Consensus 280 il~Hp~~~~~ 289 (352)
T d1koba_ 280 ALEHPWLKGD 289 (352)
T ss_dssp HHTSTTTSSC
T ss_pred HhcCHhhCCC
Confidence 9999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=435.92 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=210.4
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccC----cccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNK----KPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|+++++||+|+||+||+|+++.+++.||||++... .........|+.++..+ +||||++++++|.+.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL------DHPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC------CSTTBCCEEEEEECSS
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc------CCCCeeEEEEEEEECC
Confidence 5799999999999999999999999999999999642 12234455566655443 4788999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|||||||+| +|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||+ ++++.+||+|||+|
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll--~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILL--NEDMHIQITDFGTA 155 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCcccccc--CCCceEEecccccc
Confidence 99999999965 9999887654 69999999999999999999995 789999999999999 67889999999999
Q ss_pred cccCC-----ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 274 CQLGQ-----RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 274 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
+.+.. .....+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+.+.+|.+.-...|.
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~---- 231 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---- 231 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----
Confidence 87642 234568999999999999999999999999999999999999999999988888777642111100
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
..+ ..++|||.+||+.||++|
T Consensus 232 ---------------------------------------------------------~~s--~~~~~li~~~L~~dP~~R 252 (288)
T d1uu3a_ 232 ---------------------------------------------------------KFF--PKARDLVEKLLVLDATKR 252 (288)
T ss_dssp ---------------------------------------------------------TCC--HHHHHHHHTTSCSSGGGS
T ss_pred ---------------------------------------------------------cCC--HHHHHHHHHHccCCHhHC
Confidence 001 178999999999999999
Q ss_pred CCHHH------HhcCCCCCCCcc
Q psy16081 429 ITPYY------ALQHNFFKRTAD 445 (493)
Q Consensus 429 ~t~~e------~L~Hp~~~~~~~ 445 (493)
||++| +++||||+.+..
T Consensus 253 ~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 253 LGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp TTSGGGTCHHHHHTSGGGTTCCC
T ss_pred cCHHHHcCCHHHHcCCccCCCCH
Confidence 99998 589999987643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-57 Score=448.05 Aligned_cols=300 Identities=25% Similarity=0.341 Sum_probs=208.0
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
..++|+++++||+|+||+||+|+++.+|+.||||+++..... .. ...+.+++..+...+|||||+++++|.+.+++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AI---RNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-TH---HHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH-HH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 457899999999999999999999999999999999743211 11 12233344444455789999999999999999
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|||||||.| +|.+++.+.. .+++..++.++.||+.||.|||+ ..|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~-~~~IiHRDiKP~NILl--~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILV--NSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEE--CTTCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH-hCCEEccccCHHHeeE--CCCCCEEEeeCCCccc
Confidence 999999965 9999997654 59999999999999999999995 2489999999999999 6788999999999987
Q ss_pred cCC-ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhhccch
Q psy16081 276 LGQ-RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQ-MNKIVEVLGLPPKHLLDGAHKT 353 (493)
Q Consensus 276 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~~ 353 (493)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+. ...+....+.+...........
T Consensus 155 ~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred cCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 643 34567999999999999999999999999999999999999999987654332 2222222222211110000000
Q ss_pred hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHH
Q psy16081 354 RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYY 433 (493)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e 433 (493)
..... + .....+ .....+.+......++.. .+....+ .+++|||.+||.+||++|||++|
T Consensus 235 ~~~~~------~--------~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~s--~~~~dli~~~L~~dP~~R~ta~e 294 (322)
T d1s9ja_ 235 RPLSS------Y--------GMDSRP-PMAIFELLDYIVNEPPPK---LPSGVFS--LEFQDFVNKCLIKNPAERADLKQ 294 (322)
T ss_dssp -------------------------C-CCCHHHHHHHHHTSCCCC---CCBTTBC--HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ccccc------c--------cccccc-chhHHHHHhhhhccCCcc---CccccCC--HHHHHHHHHHcCCChhHCcCHHH
Confidence 00000 0 000000 001111111111010000 0011112 27899999999999999999999
Q ss_pred HhcCCCCCCCcc
Q psy16081 434 ALQHNFFKRTAD 445 (493)
Q Consensus 434 ~L~Hp~~~~~~~ 445 (493)
+|+||||++...
T Consensus 295 ~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 295 LMVHAFIKRSDA 306 (322)
T ss_dssp HHTSHHHHHHHH
T ss_pred HhhCHhhCcCCc
Confidence 999999986543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-56 Score=434.03 Aligned_cols=253 Identities=31% Similarity=0.442 Sum_probs=210.6
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
+.|++++.||+|+||+||+|+++.+++.||||+++... .....+..|+.++..+ +|||||+++++|.+.+.+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC------DHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC------CCTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEeeCCeEE
Confidence 56999999999999999999999999999999997532 3345566777766554 4788999999999999999
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
||||||.+ +|.+++.+.. ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+|+..
T Consensus 86 lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll--~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILF--TLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeE--CCCCCEEEEechhhhcc
Confidence 99999965 8888876543 469999999999999999999995 789999999999999 67889999999999766
Q ss_pred CC---ccccccccCcCCchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 277 GQ---RIYQYIQSRFYRSPEVLL-----GIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 277 ~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
.. .....+||+.|+|||++. +..|+.++|||||||+||||++|++||.+.+..+.+.++........
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~----- 235 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL----- 235 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-----
T ss_pred CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 43 234678999999999995 45689999999999999999999999999888887777765211000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
+.+.. .+ .++++||.+||+.||++|
T Consensus 236 ------------------------------~~~~~-----------------------~s--~~~~~li~~~L~~dp~~R 260 (288)
T d2jfla1 236 ------------------------------AQPSR-----------------------WS--SNFKDFLKKCLEKNVDAR 260 (288)
T ss_dssp ------------------------------SSGGG-----------------------SC--HHHHHHHHHHSCSSTTTS
T ss_pred ------------------------------Ccccc-----------------------CC--HHHHHHHHHHccCChhHC
Confidence 00000 00 178999999999999999
Q ss_pred CCHHHHhcCCCCCC
Q psy16081 429 ITPYYALQHNFFKR 442 (493)
Q Consensus 429 ~t~~e~L~Hp~~~~ 442 (493)
||++|+|+||||+.
T Consensus 261 ~t~~ell~hp~~~~ 274 (288)
T d2jfla1 261 WTTSQLLQHPFVTV 274 (288)
T ss_dssp CCHHHHTTSGGGCC
T ss_pred cCHHHHhcCcccCC
Confidence 99999999999984
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=437.36 Aligned_cols=275 Identities=29% Similarity=0.512 Sum_probs=215.5
Q ss_pred EeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc------cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 123 IDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 123 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
.+++||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.++..+ +|||||+++++|.+++++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~~~~~~~~~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL------SHPNIIGLLDAFGHKSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC------CCTTBCCEEEEECCTTCC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC------CCCCEeEEEeeeccCCce
Confidence 46899999999999999999999999999864322 123455566555444 478899999999999999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
|||||||.+++...+.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+|+..
T Consensus 76 ~ivmE~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli--~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLL--DENGVLKLADFGLAKSF 150 (299)
T ss_dssp EEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTCCEEECCCGGGSTT
T ss_pred eehhhhhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEe--cCCCccccccCcccccc
Confidence 9999999886666655433 469999999999999999999995 789999999999999 78899999999999876
Q ss_pred CCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 277 GQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 277 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
... ....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.++.+++.+|.+.++.|+...+.....
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 151 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred CCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 543 3456899999999999754 589999999999999999999999999999999999999999887665443222
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
...+... ...+ ...+..+.. ..+ .+++|||.+||.+||++|||++
T Consensus 231 ~~~~~~~----------------~~~~-~~~~~~~~~----------------~~s--~~~~dll~~~L~~dP~~R~sa~ 275 (299)
T d1ua2a_ 231 LPDYVTF----------------KSFP-GIPLHHIFS----------------AAG--DDLLDLIQGLFLFNPCARITAT 275 (299)
T ss_dssp STTCCCC----------------CCCC-CCCHHHHCT----------------TCC--HHHHHHHHHHHCSSTTTSCCHH
T ss_pred cchhhhh----------------ccCC-CCChHHhcc----------------cCC--HHHHHHHHHHccCChhhCcCHH
Confidence 1111000 0000 011111111 011 2789999999999999999999
Q ss_pred HHhcCCCCCCC
Q psy16081 433 YALQHNFFKRT 443 (493)
Q Consensus 433 e~L~Hp~~~~~ 443 (493)
|||+||||+..
T Consensus 276 e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 276 QALKMKYFSNR 286 (299)
T ss_dssp HHHTSGGGTSS
T ss_pred HHhCCHhhCCC
Confidence 99999999853
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=441.23 Aligned_cols=260 Identities=26% Similarity=0.416 Sum_probs=221.2
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++.++|++++.||+|+||+||+|+++.+++.||||+++..........+|+.++..+ +|||||+++++|.+.++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l------~HpnIv~~~~~~~~~~~ 75 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA------RHRNILHLHESFESMEE 75 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS------CCTTBCCEEEEEEETTE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC------CCCCCCeEEEEEEECCE
Confidence 467899999999999999999999999999999999986554334455566555443 47889999999999999
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|||||||.| +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++++....+||+|||+++
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccchhh
Confidence 9999999965 9999997654 359999999999999999999994 79999999999999965567789999999998
Q ss_pred ccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 275 QLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 275 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.... .....++|+.|+|||.+.+..|+.++|||||||++|+|++|.+||.+.+..+.+.+|.+....++...+..
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~--- 229 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE--- 229 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT---
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccC---
Confidence 7643 34567899999999999999999999999999999999999999999999999998887544443332211
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.+ .+++|||.+||..||.+|||++
T Consensus 230 ------------------------------------------------------~s--~~~~~li~~~L~~dp~~R~s~~ 253 (321)
T d1tkia_ 230 ------------------------------------------------------IS--IEAMDFVDRLLVKERKSRMTAS 253 (321)
T ss_dssp ------------------------------------------------------SC--HHHHHHHHTTSCSSGGGSCCHH
T ss_pred ------------------------------------------------------CC--HHHHHHHHHHccCChhHCcCHH
Confidence 00 1689999999999999999999
Q ss_pred HHhcCCCCCCC
Q psy16081 433 YALQHNFFKRT 443 (493)
Q Consensus 433 e~L~Hp~~~~~ 443 (493)
|+|+||||++.
T Consensus 254 eil~hp~~~~~ 264 (321)
T d1tkia_ 254 EALQHPWLKQK 264 (321)
T ss_dssp HHHHSHHHHSC
T ss_pred HHhcCHhhccC
Confidence 99999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=430.91 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=215.8
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-------cchHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
.+.++|++++.||+|+||+||+|+++.+|+.||||++++... ....+.+|+.++..+ +|||||++++
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~ 80 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI------QHPNVITLHE 80 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC------CCTTBCCEEE
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC------CCCCCCcEEE
Confidence 456789999999999999999999999999999999964321 234566677666554 4788999999
Q ss_pred eeeecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC--CCcE
Q psy16081 189 HFMWRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK--RSAI 265 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~--~~~i 265 (493)
+|.+.+++|||||||. |+|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||++.+. ...+
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCCE
T ss_pred EEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccce
Confidence 9999999999999996 59999997654 69999999999999999999995 7899999999999994322 2359
Q ss_pred EEEecccccccC--CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 266 KIVDFGSSCQLG--QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 266 kL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
||+|||+|.... .......||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..|......++
T Consensus 157 kl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236 (293)
T ss_dssp EECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred EecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 999999998764 344567899999999999999999999999999999999999999999999888888765433222
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
...... .+ ..++|||.+||..
T Consensus 237 ~~~~~~---------------------------------------------------------~s--~~~~~li~~~L~~ 257 (293)
T d1jksa_ 237 DEYFSN---------------------------------------------------------TS--ALAKDFIRRLLVK 257 (293)
T ss_dssp HHHHTT---------------------------------------------------------SC--HHHHHHHHTTSCS
T ss_pred chhcCC---------------------------------------------------------CC--HHHHHHHHHHccC
Confidence 221110 00 1688999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCc
Q psy16081 424 DPKTRITPYYALQHNFFKRTA 444 (493)
Q Consensus 424 dP~~R~t~~e~L~Hp~~~~~~ 444 (493)
||.+|||++|+|+||||+...
T Consensus 258 dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 258 DPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp SGGGSCCHHHHHHSTTTCC--
T ss_pred ChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=424.60 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=199.0
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee----ccee
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW----RNHL 196 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~----~~~~ 196 (493)
|++.++||+|+||+||+|++..+++.||||++..........+ .+.+++..+...+|||||+++++|.+ ...+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~---~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHH---HHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHH---HHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 3677899999999999999999999999999875432222211 22333344445568999999999875 4568
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|||||||++ +|.+++.+.. .+++..++.++.||+.||.|||++..+||||||||+|||++ ++++.+||+|||+|+.
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~-~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-GPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-STTSCEEECCTTGGGG
T ss_pred EEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee-CCCCCEEEeecCccee
Confidence 999999965 9999997653 69999999999999999999996434499999999999994 3578899999999986
Q ss_pred cCCc-cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 276 LGQR-IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 276 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.... ....+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+......+.+.+.. +..|....
T Consensus 165 ~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~~~~------- 235 (270)
T d1t4ha_ 165 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFD------- 235 (270)
T ss_dssp CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGGGG-------
T ss_pred ccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCcccC-------
Confidence 6443 456789999999999876 6999999999999999999999999876554443333221 11111000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
. .. ..++.+||.+||..||++|||++|+
T Consensus 236 -------------------------------~-------------------~~--~~~~~~li~~~l~~dp~~R~s~~el 263 (270)
T d1t4ha_ 236 -------------------------------K-------------------VA--IPEVKEIIEGCIRQNKDERYSIKDL 263 (270)
T ss_dssp -------------------------------G-------------------CC--CHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred -------------------------------c-------------------cC--CHHHHHHHHHHccCCHhHCcCHHHH
Confidence 0 00 0168999999999999999999999
Q ss_pred hcCCCCC
Q psy16081 435 LQHNFFK 441 (493)
Q Consensus 435 L~Hp~~~ 441 (493)
|+||||+
T Consensus 264 l~Hp~fk 270 (270)
T d1t4ha_ 264 LNHAFFQ 270 (270)
T ss_dssp HTSGGGC
T ss_pred hCCcccC
Confidence 9999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=432.28 Aligned_cols=281 Identities=33% Similarity=0.553 Sum_probs=223.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
++|+++++||+|+||+||+|++..+|+.||||+++.... ...+..+|+.++ ...+|||||+++++|.+.++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il------~~l~Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL------KELNHPNIVKLLDVIHTENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHH------TTCCCTTBCCEEEEEEETTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHH------HhCCCCcEEEeccccccccc
Confidence 689999999999999999999999999999999964321 233444454443 34468899999999999999
Q ss_pred eEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 196 LCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 196 ~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
+|+||||+++++.+++......++++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~--~~~~~~kl~DFG~a~~ 151 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLI--NTEGAIKLADFGLARA 151 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTSCEEECSTTHHHH
T ss_pred eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheee--cccCcceeccCCccee
Confidence 999999999988888876666679999999999999999999994 789999999999999 6788999999999977
Q ss_pred cCCc---cccccccCcCCchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 276 LGQR---IYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
.... ....+||+.|+|||++.... ++.++|||||||++|+|++|++||.+.+..+++.++....+.+....+....
T Consensus 152 ~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp HCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccc
Confidence 6433 34568999999999988766 5789999999999999999999999999999999999998888766554432
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
....+....+. .....+.... ...+ ..++|||.+||.+||++|||+
T Consensus 232 ~~~~~~~~~~~----------------~~~~~~~~~~----------------~~~s--~~~~dll~~mL~~dP~~R~t~ 277 (298)
T d1gz8a_ 232 SMPDYKPSFPK----------------WARQDFSKVV----------------PPLD--EDGRSLLSQMLHYDPNKRISA 277 (298)
T ss_dssp GSTTCCTTSCC----------------CCCCCHHHHS----------------TTCC--HHHHHHHHHHTCSSTTTSCCH
T ss_pred ccccccccccc----------------ccccchhhhc----------------cCCC--HHHHHHHHHHccCChhHCcCH
Confidence 22211111100 0000000000 0111 278999999999999999999
Q ss_pred HHHhcCCCCCCC
Q psy16081 432 YYALQHNFFKRT 443 (493)
Q Consensus 432 ~e~L~Hp~~~~~ 443 (493)
+|+|+||||+.+
T Consensus 278 ~ell~H~ff~~~ 289 (298)
T d1gz8a_ 278 KAALAHPFFQDV 289 (298)
T ss_dssp HHHHTSGGGTTC
T ss_pred HHHhCCHhhccC
Confidence 999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-56 Score=428.23 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=197.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--ccee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW--RNHL 196 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~--~~~~ 196 (493)
++|++++.||+|+||+||+|+++.+|+.||||++......... ...+.+++..+...+|||||++++++.+ .+.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH---HHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH---HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 6799999999999999999999999999999999754322111 1223445555666679999999999865 4678
Q ss_pred EEEEEeccc-CHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhCCC---CCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 197 CLVFELLSY-NLYDLLRNT--NFRGVSLNLTRKFSQQLCTALLFLSTPE---LNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~Lhs~~---~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
|||||||++ +|.+++... ....+++..++.++.||+.||.|||+.. .+||||||||+|||+ +.++.+||+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll--~~~~~vkl~DF 158 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDF 158 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE--CTTSCEEECCH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc--CCCCcEEEeec
Confidence 999999965 999988642 2346999999999999999999999621 249999999999999 67889999999
Q ss_pred ccccccCCc---cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 271 GSSCQLGQR---IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 271 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
|+|+..... ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+...+|.+....+
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~----- 233 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR----- 233 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-----
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence 999876442 345789999999999999999999999999999999999999999998888777775521100
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
++ ...+ .++.+||.+||..||.+
T Consensus 234 ------------~~-------------------------------------------~~~s--~~l~~li~~~L~~dp~~ 256 (269)
T d2java1 234 ------------IP-------------------------------------------YRYS--DELNEIITRMLNLKDYH 256 (269)
T ss_dssp ------------CC-------------------------------------------TTSC--HHHHHHHHHHTCSSGGG
T ss_pred ------------CC-------------------------------------------cccC--HHHHHHHHHHcCCChhH
Confidence 00 0011 17899999999999999
Q ss_pred CCCHHHHhcCCCC
Q psy16081 428 RITPYYALQHNFF 440 (493)
Q Consensus 428 R~t~~e~L~Hp~~ 440 (493)
|||++|+|+|||+
T Consensus 257 Rps~~ell~hp~i 269 (269)
T d2java1 257 RPSVEEILENPLI 269 (269)
T ss_dssp SCCHHHHHTSTTC
T ss_pred CcCHHHHHhCCcC
Confidence 9999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-55 Score=436.62 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=215.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........|+.++ ...+|||||++++++.+.
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il------~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML------SIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHH------HSCCBTTBCCEEEEEECS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHH------HhccCcChhheeeeEeeC
Confidence 357999999999999999999999999999999996421 1223344444443 334688999999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+|||||.| +|..++.... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl--~~~g~vkL~DFG~ 150 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILL--DKNGHIKITDFGF 150 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEE--CTTSCEEECCCSS
T ss_pred CeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeE--cCCCCEEEecCcc
Confidence 999999999965 7777776554 68999999999999999999995 789999999999999 7789999999999
Q ss_pred ccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 273 SCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 273 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
|+.........+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+..+.+.+|...-...|..
T Consensus 151 a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~------- 223 (316)
T d1fota_ 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF------- 223 (316)
T ss_dssp CEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTT-------
T ss_pred ceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCC-------
Confidence 9998888888999999999999999999999999999999999999999999999988888876531111100
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC---
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI--- 429 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~--- 429 (493)
.+ ..+.+||.+||..||.+|+
T Consensus 224 ------------------------------------------------------~s--~~~~~li~~~L~~dp~~R~~~~ 247 (316)
T d1fota_ 224 ------------------------------------------------------FN--EDVKDLLSRLITRDLSQRLGNL 247 (316)
T ss_dssp ------------------------------------------------------SC--HHHHHHHHHHTCSCTTTCTTSS
T ss_pred ------------------------------------------------------CC--HHHHHHHHHHhhhCHHhccccc
Confidence 00 1689999999999999996
Q ss_pred --CHHHHhcCCCCCCCcc
Q psy16081 430 --TPYYALQHNFFKRTAD 445 (493)
Q Consensus 430 --t~~e~L~Hp~~~~~~~ 445 (493)
|++++|+||||+.+..
T Consensus 248 r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 248 QNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp TTTTHHHHTSGGGSSCCH
T ss_pred hhhHHHHHcCcccccCCH
Confidence 9999999999998643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=439.19 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=212.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+|+.++. ..+||||++++++|.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~------~l~hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ------NTRHPFLTALKYAFQTH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH------SCCCTTBCCEEEEEECS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHH------hCCCCCEEEEEeeeccc
Confidence 468999999999999999999999999999999997431 22333444544443 34688899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+++|+|||||.| +|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.+|.+||+|||+
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl--~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLML--DKDGHIKITDFGL 151 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE--CTTSCEEECCCTT
T ss_pred cccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEe--cCCCCEEEeeccc
Confidence 999999999965 9999987764 69999999999999999999995 799999999999999 7789999999999
Q ss_pred ccccCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Q psy16081 273 SCQLGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDG 349 (493)
Q Consensus 273 a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 349 (493)
|+.... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.......|.
T Consensus 152 a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----- 226 (337)
T d1o6la_ 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----- 226 (337)
T ss_dssp CBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-----
T ss_pred ccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc-----
Confidence 986532 345689999999999999999999999999999999999999999999988887777653111110
Q ss_pred ccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 350 AHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
..+ .+++|||.+||++||.+|+
T Consensus 227 --------------------------------------------------------~~s--~~~~dli~~~L~~dP~~R~ 248 (337)
T d1o6la_ 227 --------------------------------------------------------TLS--PEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp --------------------------------------------------------TSC--HHHHHHHHHHTCSSTTTST
T ss_pred --------------------------------------------------------cCC--HHHHHHHHhhccCCchhhc
Confidence 011 1689999999999999999
Q ss_pred -----CHHHHhcCCCCCCCc
Q psy16081 430 -----TPYYALQHNFFKRTA 444 (493)
Q Consensus 430 -----t~~e~L~Hp~~~~~~ 444 (493)
+++|+++||||..+.
T Consensus 249 ~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 249 GGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp TCSTTTHHHHHTSGGGTTCC
T ss_pred ccccccHHHHHcCcccccCC
Confidence 499999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-55 Score=432.45 Aligned_cols=256 Identities=24% Similarity=0.324 Sum_probs=206.0
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
+.|++++.||+|+||+||+|++..+++.||||++........ .....+..++..+...+|||||+++++|.+.+.+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCH--HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 469999999999999999999999999999999975432111 111223333344445568999999999999999999
Q ss_pred EEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 199 VFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 199 V~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
|||||.+++.+.+.... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+|.....
T Consensus 93 v~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl--~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILL--SEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSS
T ss_pred EEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEE--CCCCCEEEeecccccccCC
Confidence 99999775444433322 469999999999999999999995 789999999999999 6788999999999987654
Q ss_pred ccccccccCcCCchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchhh
Q psy16081 279 RIYQYIQSRFYRSPEVLLG---IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRK 355 (493)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 355 (493)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.++......++.
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 235 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----------- 235 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-----------
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC-----------
Confidence 345789999999999975 35899999999999999999999999998888887777652111000
Q ss_pred hhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHh
Q psy16081 356 YFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYAL 435 (493)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L 435 (493)
. ...+ ..+++||.+||..||++|||++|+|
T Consensus 236 -------------------------~-----------------------~~~s--~~~~~li~~~L~~dP~~Rpt~~ell 265 (309)
T d1u5ra_ 236 -------------------------S-----------------------GHWS--EYFRNFVDSCLQKIPQDRPTSEVLL 265 (309)
T ss_dssp -------------------------C-----------------------TTSC--HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred -------------------------C-----------------------CCCC--HHHHHHHHHHCcCChhHCcCHHHHH
Confidence 0 0001 1789999999999999999999999
Q ss_pred cCCCCCCC
Q psy16081 436 QHNFFKRT 443 (493)
Q Consensus 436 ~Hp~~~~~ 443 (493)
+||||++.
T Consensus 266 ~Hp~~~~~ 273 (309)
T d1u5ra_ 266 KHRFVLRE 273 (309)
T ss_dssp TCHHHHSC
T ss_pred hCHHhcCC
Confidence 99999853
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-55 Score=439.42 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=215.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.. ........|+. .+...+|||||+++++|.+.
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~------il~~l~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR------ILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH------HHTTCCCTTBCCEEEEEECS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHH------HHHHcCCCcEeecccccccc
Confidence 368999999999999999999999999999999986321 11222333333 33445688999999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl--~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLI--DQQGYIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCTT
T ss_pred cccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHccc--CCCCCEEeeecee
Confidence 999999999954 8988887654 69999999999999999999995 789999999999999 6788999999999
Q ss_pred ccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 273 SCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 273 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
|+.+.......+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+....+.+|......+|..
T Consensus 188 a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~------- 260 (350)
T d1rdqe_ 188 AKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH------- 260 (350)
T ss_dssp CEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-------
T ss_pred eeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCcc-------
Confidence 9998887788899999999999999999999999999999999999999999999888888876532211110
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCC---
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRI--- 429 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~--- 429 (493)
.+ .++.+||++||..||.+|+
T Consensus 261 ------------------------------------------------------~s--~~~~~li~~~L~~dP~kR~~~~ 284 (350)
T d1rdqe_ 261 ------------------------------------------------------FS--SDLKDLLRNLLQVDLTKRFGNL 284 (350)
T ss_dssp ------------------------------------------------------CC--HHHHHHHHHHSCSCTTTCTTSS
T ss_pred ------------------------------------------------------CC--HHHHHHHHHHhhhCHHhccccc
Confidence 01 1789999999999999995
Q ss_pred --CHHHHhcCCCCCCCcc
Q psy16081 430 --TPYYALQHNFFKRTAD 445 (493)
Q Consensus 430 --t~~e~L~Hp~~~~~~~ 445 (493)
|++|+|+||||+.+..
T Consensus 285 r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 285 KNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp TTTTHHHHTSGGGTTCCH
T ss_pred cccHHHHHcCccccCCCH
Confidence 9999999999997653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.8e-54 Score=417.93 Aligned_cols=257 Identities=31% Similarity=0.432 Sum_probs=211.9
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccc----------hHHHHHHHHHHHHhhcCCCCcceEEEe
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFL----------NQAQIEVKLLEIMNKADVNNTYYIVRL 186 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----------~~~~~e~~~~~~l~~~~~~~~~~Iv~l 186 (493)
|.++|++.+.||+|+||+||+|++..+|+.||||++....... ..+.+|+.++..+. .||||+++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~ 75 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-----GHPNIIQL 75 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCCE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEE
Confidence 4679999999999999999999999999999999997543211 12333444444332 47789999
Q ss_pred ceeeeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcE
Q psy16081 187 KRHFMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAI 265 (493)
Q Consensus 187 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~i 265 (493)
+++|.+++++|||||||++ +|.+++.... .+++..++.++.||+.||.|||. .|||||||||+|||+ +.++.+
T Consensus 76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill--~~~~~~ 149 (277)
T d1phka_ 76 KDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILL--DDDMNI 149 (277)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCCE
T ss_pred EeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEE--cCCCCe
Confidence 9999999999999999965 9999997654 69999999999999999999994 799999999999999 788899
Q ss_pred EEEecccccccCC--ccccccccCcCCchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q psy16081 266 KIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLG------IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVE 337 (493)
Q Consensus 266 kL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 337 (493)
||+|||+++.++. .....+||+.|+|||++.+ ..++.++||||+||+||||++|++||.+.+..+.+..+.+
T Consensus 150 kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence 9999999987754 3456789999999999963 3578999999999999999999999999998888887776
Q ss_pred HhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHH
Q psy16081 338 VLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLI 417 (493)
Q Consensus 338 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi 417 (493)
.-..++.... .. .+ .+++|||
T Consensus 230 ~~~~~~~~~~----------------------------------~~-----------------------~s--~~~~~li 250 (277)
T d1phka_ 230 GNYQFGSPEW----------------------------------DD-----------------------YS--DTVKDLV 250 (277)
T ss_dssp TCCCCCTTTG----------------------------------GG-----------------------SC--HHHHHHH
T ss_pred CCCCCCCccc----------------------------------cc-----------------------CC--HHHHHHH
Confidence 3221111000 00 01 1789999
Q ss_pred hHccCCCCCCCCCHHHHhcCCCCCCC
Q psy16081 418 FRMLDYDPKTRITPYYALQHNFFKRT 443 (493)
Q Consensus 418 ~~mL~~dP~~R~t~~e~L~Hp~~~~~ 443 (493)
.+||+.||.+|||++|||+||||++.
T Consensus 251 ~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 251 SRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHHccCChhHCcCHHHHHcCHHHHHh
Confidence 99999999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-55 Score=431.04 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=210.1
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|+++++||+|+||+||+|+++.+++.||||++++.. ........|..++. ...+|||||+++++|.+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~-----~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS-----LAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-----HHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHH-----HhCCCCcEEEEEEEEccCC
Confidence 68999999999999999999999999999999997421 11222333333222 2346888999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
++|||||||.+ +|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+|
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~--~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILL--DKDGHIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceee--cCCCceeccccchh
Confidence 99999999965 9999997654 69999999999999999999995 689999999999999 78899999999999
Q ss_pred cccCC---ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 274 CQLGQ---RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 274 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
+.... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+.+|...-...|.
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~------ 224 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR------ 224 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc------
Confidence 76542 344568999999999999999999999999999999999999999999988888777542111000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
..+ .++.|||++||..||.+|||
T Consensus 225 -------------------------------------------------------~~s--~~~~dli~~~L~~dP~~R~s 247 (320)
T d1xjda_ 225 -------------------------------------------------------WLE--KEAKDLLVKLFVREPEKRLG 247 (320)
T ss_dssp -------------------------------------------------------TSC--HHHHHHHHHHSCSSGGGSBT
T ss_pred -------------------------------------------------------cCC--HHHHHHHHHhcccCCCCCcC
Confidence 001 17899999999999999999
Q ss_pred HH-HHhcCCCCCCCc
Q psy16081 431 PY-YALQHNFFKRTA 444 (493)
Q Consensus 431 ~~-e~L~Hp~~~~~~ 444 (493)
+. |+++||||+.+.
T Consensus 248 ~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 248 VRGDIRQHPLFREIN 262 (320)
T ss_dssp TBSCGGGSGGGTTCC
T ss_pred HHHHHHhCchhccCC
Confidence 96 899999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-54 Score=434.89 Aligned_cols=258 Identities=23% Similarity=0.366 Sum_probs=206.8
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc----ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.++|+++++||+|+||+||+|++..+|+.||||++.... ........|..+++ .....+|||||+++++|.+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~---~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS---LVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHH---HHSSSCCTTBCCEEEEEECS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHH---HHhcCCCCcEEEEEEEEEEC
Confidence 468999999999999999999999999999999986322 11222334444444 44555688999999999999
Q ss_pred ceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|||||||. ++|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl--~~~g~iKl~DFGl 153 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGL 153 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CSSSCEEECCCTT
T ss_pred CEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEE--cCCCcEEEeeece
Confidence 99999999996 59999997654 68999999999999999999994 799999999999999 7889999999999
Q ss_pred ccccCC-ccccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 273 SCQLGQ-RIYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 273 a~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
|+.... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+...........++.
T Consensus 154 a~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~------ 227 (364)
T d1omwa3 154 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------ 227 (364)
T ss_dssp CEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCC------
T ss_pred eeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC------
Confidence 987754 3456789999999999975 56999999999999999999999999876543332211111110000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.+ ...+ .++.+||.+||..||++|||
T Consensus 228 -----------------------------~~-----------------------~~~s--~~~~~li~~~L~~dP~~R~t 253 (364)
T d1omwa3 228 -----------------------------LP-----------------------DSFS--PELRSLLEGLLQRDVNRRLG 253 (364)
T ss_dssp -----------------------------CC-----------------------SSSC--HHHHHHHHHHTCSSTTTSTT
T ss_pred -----------------------------CC-----------------------CCCC--HHHHHHHHHHcccCHHHhCC
Confidence 00 0011 17899999999999999999
Q ss_pred -----HHHHhcCCCCCCCc
Q psy16081 431 -----PYYALQHNFFKRTA 444 (493)
Q Consensus 431 -----~~e~L~Hp~~~~~~ 444 (493)
++|+++||||+.+.
T Consensus 254 ~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 254 CLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp TSSSTHHHHHTSGGGTTCC
T ss_pred CcccCHHHHHcCccccCCC
Confidence 79999999999764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-53 Score=417.03 Aligned_cols=279 Identities=32% Similarity=0.518 Sum_probs=217.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc---cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP---FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.++|+++++||+|+||+||+|+++ +|+.||||+++.... ....+.+|+.++. ..+|||||+++++|.+.+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~------~l~hpnIv~~~~~~~~~~ 73 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILK------ELKHSNIVKLYDVIHTKK 73 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGG------GCCCTTBCCEEEEEECSS
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHH------hCCCCcEEeeeeecccCC
Confidence 368999999999999999999885 789999999975432 2334444544433 335888999999999999
Q ss_pred eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 195 HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 195 ~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
..|+|||++.+++...+.... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+|.
T Consensus 74 ~~~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll--~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLI--NREGELKIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTSCEEECCTTHHH
T ss_pred ceeEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeE--cCCCCEEecccccce
Confidence 999999999887777665544 579999999999999999999995 789999999999999 678999999999997
Q ss_pred ccCCc---cccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 275 QLGQR---IYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 275 ~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
..... .....+++.|+|||++.+. .++.++|||||||++|||++|++||.+.++.+++.++.+.++.++...+...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp HHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence 76543 3455789999999999865 5789999999999999999999999999999999999999998876665543
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.....+....... ... .....+ ...+ ..+.|||.+||.+||++|||
T Consensus 229 ~~~~~~~~~~~~~------------~~~----~~~~~~----------------~~~s--~~~~dli~~~L~~dP~~R~s 274 (286)
T d1ob3a_ 229 TELPKYDPNFTVY------------EPL----PWESFL----------------KGLD--ESGIDLLSKMLKLDPNQRIT 274 (286)
T ss_dssp GGSTTCCTTCCCC------------CCC----CGGGTC----------------CSCC--HHHHHHHHHHTCSSTTTSCC
T ss_pred hhhhhcccccccc------------cCc----chhhhc----------------ccCC--HHHHHHHHHHccCChhHCcC
Confidence 3322211110000 000 000000 0111 27899999999999999999
Q ss_pred HHHHhcCCCCCC
Q psy16081 431 PYYALQHNFFKR 442 (493)
Q Consensus 431 ~~e~L~Hp~~~~ 442 (493)
++|+|+||||++
T Consensus 275 ~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 275 AKQALEHAYFKE 286 (286)
T ss_dssp HHHHHTSGGGGC
T ss_pred HHHHhcCcccCc
Confidence 999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=425.78 Aligned_cols=281 Identities=31% Similarity=0.553 Sum_probs=220.1
Q ss_pred cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee------c
Q psy16081 120 RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW------R 193 (493)
Q Consensus 120 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~------~ 193 (493)
+|+.+++||+|+||+||+|++..+|+.||||+++...... .+|+.++..+ +|+||++++++|.. .
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~Ei~il~~l------~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKL------DHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSC---CHHHHHHHHC------CCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHH---HHHHHHHHhc------CCCCCCcEEEEEEecCccCCc
Confidence 6999999999999999999999999999999997655332 3466665543 47789999999854 3
Q ss_pred ceeEEEEEecccCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCC-CcEEEEec
Q psy16081 194 NHLCLVFELLSYNLYDLLRN--TNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKR-SAIKIVDF 270 (493)
Q Consensus 194 ~~~~lV~E~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~-~~ikL~DF 270 (493)
.++|||||||++++.+.+.. .....+++..++.++.||+.||.|||+ .|||||||||+|||+ +.+ ..+||+||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl--~~~~~~~kl~DF 167 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLL--DPDTAVLKLCDF 167 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEE--CTTTCCEEECCC
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEE--ecCCCceeEecc
Confidence 46899999999877766542 233469999999999999999999995 799999999999999 444 48999999
Q ss_pred ccccccC--CccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy16081 271 GSSCQLG--QRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLL 347 (493)
Q Consensus 271 G~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 347 (493)
|++.... ......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+++..|.+.++.++...+
T Consensus 168 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp TTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 9997764 345567899999999998764 6999999999999999999999999999999999999999999988776
Q ss_pred hhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCC
Q psy16081 348 DGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKT 427 (493)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~ 427 (493)
........ . ..+ .. .....+..+. ....+ .+++|||.+||.+||++
T Consensus 248 ~~~~~~~~--~----~~~--~~---------~~~~~~~~~~---------------~~~~s--~~~~dLl~~mL~~dP~~ 293 (350)
T d1q5ka_ 248 REMNPNYT--E----FKF--PQ---------IKAHPWTKVF---------------RPRTP--PEAIALCSRLLEYTPTA 293 (350)
T ss_dssp HHHCC-----C----CCC--CC---------CCCCCGGGTS---------------CTTSC--HHHHHHHHHHSCSSGGG
T ss_pred hhhccchh--h----ccc--cc---------cccCchhhhc---------------ccCCC--HHHHHHHHHHccCChhH
Confidence 64322100 0 000 00 0000000000 00011 26899999999999999
Q ss_pred CCCHHHHhcCCCCCCCccCC
Q psy16081 428 RITPYYALQHNFFKRTADES 447 (493)
Q Consensus 428 R~t~~e~L~Hp~~~~~~~~~ 447 (493)
|||+.|||+||||+...+..
T Consensus 294 R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 294 RLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp SCCHHHHHTSGGGGGGGCTT
T ss_pred CcCHHHHhcCHhhccccCCC
Confidence 99999999999999775543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=426.62 Aligned_cols=283 Identities=29% Similarity=0.500 Sum_probs=222.2
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+.++|+++++||+|+||+||+|+++.+|+.||||+++..... .....+|+.++.. .+|||||+++++|...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~------l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH------MRHENVIGLLDVFTPD 89 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHH------CCBTTBCCCSEEECSC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHh------cCCCCeeEEEEEeccC
Confidence 678999999999999999999999999999999999743322 2233444444433 3477899999999865
Q ss_pred c------eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 194 N------HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 194 ~------~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
+ ++|||||||+.+|..++... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||
T Consensus 90 ~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~--~~~~~~kl 162 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAV--NEDCELKI 162 (346)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTCCEEE
T ss_pred ccccccceEEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhc--cccccccc
Confidence 4 57999999988888887653 59999999999999999999995 799999999999999 78899999
Q ss_pred EecccccccCCccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 268 VDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 268 ~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
+|||+|+.........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+.++..+
T Consensus 163 ~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 163 LDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 9999999998888889999999999999875 578999999999999999999999999999999999999999999888
Q ss_pred hhhccchh--hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 347 LDGAHKTR--KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 347 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
+....... .+....+.. ....+..++. ..+ ..++|||.+||.+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~----------------~~s--~~~~dli~~mL~~d 288 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPEL----------------EKKDFASILT----------------NAS--PLAVNLLEKMLVLD 288 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCC----------------CCCCGGGTCT----------------TCC--HHHHHHHHHHSCSS
T ss_pred HhhhcchhhhhhhccCCcc----------------cccchHHhcc----------------CCC--HHHHHHHHHHCcCC
Confidence 76543321 111111100 0000111100 011 26899999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCccC
Q psy16081 425 PKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
|.+|||++|||+||||+...+.
T Consensus 289 P~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 289 AEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp TTTSCCHHHHHHSGGGTTTC--
T ss_pred hhHCcCHHHHhcChhhCcCCCc
Confidence 9999999999999999976543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=429.95 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=204.3
Q ss_pred eecCcEEEee-eEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 116 KFLDRYEIDS-LIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 116 ~~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
.+.++|+++. +||+|+||+||+|++..+++.||||+++.. ....+|+.++..+ .+|||||+++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~-----~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRA-----SQCPHIVRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHH-----TTSTTBCCEEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHh-----cCCCCCCeEEEEEeecc
Confidence 4567899875 599999999999999999999999999743 3455666554332 358889999999976
Q ss_pred --cceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC-CCCcEEEE
Q psy16081 193 --RNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP-KRSAIKIV 268 (493)
Q Consensus 193 --~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~-~~~~ikL~ 268 (493)
++++|||||||+ |+|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||++++ ..+.+||+
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH--cCCcccccccccccccccccccccccc
Confidence 578999999996 499999987655679999999999999999999994 799999999999999532 35679999
Q ss_pred ecccccccC--CccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 269 DFGSSCQLG--QRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 269 DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
|||+|+... ......+||+.|+|||++.+..|+.++|||||||+||+|+||++||.+.+..+....+.....
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~------ 230 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------ 230 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC------
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh------
Confidence 999998664 344567899999999999999999999999999999999999999987665444333322100
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
.+.+ ..|.. ... ..+ .+++|||++||.+||+
T Consensus 231 ---------------~~~~-----------~~~~~--~~~-------------------~~s--~~~~~li~~~L~~dP~ 261 (335)
T d2ozaa1 231 ---------------MGQY-----------EFPNP--EWS-------------------EVS--EEVKMLIRNLLKTEPT 261 (335)
T ss_dssp ---------------SCSS-----------SCCTT--HHH-------------------HSC--HHHHHHHHHHSCSSTT
T ss_pred ---------------cCCC-----------CCCCc--ccc-------------------cCC--HHHHHHHHHHccCChh
Confidence 0000 00000 000 001 1789999999999999
Q ss_pred CCCCHHHHhcCCCCCC
Q psy16081 427 TRITPYYALQHNFFKR 442 (493)
Q Consensus 427 ~R~t~~e~L~Hp~~~~ 442 (493)
+|||+.|+|+||||+.
T Consensus 262 ~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 262 QRMTITEFMNHPWIMQ 277 (335)
T ss_dssp TSCCHHHHHHSHHHHT
T ss_pred HCcCHHHHHcCHHhhC
Confidence 9999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=421.80 Aligned_cols=303 Identities=30% Similarity=0.470 Sum_probs=221.5
Q ss_pred Ccceeeccc-e--ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch---HHHHHHHHHHHHhhcCCCCc
Q psy16081 107 HDYIIQHGE-K--FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN---QAQIEVKLLEIMNKADVNNT 180 (493)
Q Consensus 107 ~~~~~~~~~-~--~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~e~~~~~~l~~~~~~~~ 180 (493)
..|.+..++ . +.++|+++++||+|+||+||+|+++.+|+.||||+++....... ...+|+.++.. .+|
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~------l~h 75 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC------VNH 75 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHH------CCC
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHh------cCC
Confidence 345677777 3 34899999999999999999999999999999999975432222 23344444333 357
Q ss_pred ceEEEeceeeee------cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCc
Q psy16081 181 YYIVRLKRHFMW------RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPEN 254 (493)
Q Consensus 181 ~~Iv~l~~~~~~------~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~N 254 (493)
||||+++++|.. .+++|+|||||.+++++.+.. .+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 76 pnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~N 149 (355)
T d2b1pa1 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSN 149 (355)
T ss_dssp TTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGG
T ss_pred CCeeEEEEEEecccccccCceeEEEEeccchHHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccc
Confidence 889999999964 468999999999988887743 48999999999999999999995 799999999999
Q ss_pred EEeeCCCCCcEEEEecccccccCC--ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy16081 255 ILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQM 332 (493)
Q Consensus 255 ILl~~~~~~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~ 332 (493)
||+ +.++.+|++|||+++.... .....+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+..+++
T Consensus 150 il~--~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~ 227 (355)
T d2b1pa1 150 IVV--KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_dssp EEE--CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ccc--ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH
Confidence 999 6788899999999876643 345668999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCChhhhhhccc-hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhh
Q psy16081 333 NKIVEVLGLPPKHLLDGAHK-TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYL 411 (493)
Q Consensus 333 ~~i~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (493)
.++...++.++...+..... ...++....... ......++.... . ............
T Consensus 228 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~-~-----~~~~~~~~~~s~ 285 (355)
T d2b1pa1 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA----------------GLTFPKLFPDSL-F-----PADSEHNKLKAS 285 (355)
T ss_dssp HHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCC----------------CCCHHHHSCGGG-S-----CCSSHHHHHHHH
T ss_pred HHHHHhccCCCHHHHHHhhhhHHHHhhcCcccc----------------cccccccccccc-c-----cccccccccCCH
Confidence 99999999887777665433 233333222100 000000000000 0 000000011123
Q ss_pred hHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 412 KFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 412 ~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
.++|||.+||.+||++||||+|||+||||+...+
T Consensus 286 ~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 286 QARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 6899999999999999999999999999997543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-53 Score=410.53 Aligned_cols=249 Identities=26% Similarity=0.420 Sum_probs=202.4
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc-------cchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP-------FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
+.++|++.++||+|+||+||+|++..+|+.||||+++.... .......|+.++..+.. .|||||+++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~----~h~nIv~~~~~ 77 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS----GFSGVIRLLDW 77 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS----SSCSBCCEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc----CCCCccEEEEE
Confidence 45789999999999999999999999999999999874321 11234567777766542 47889999999
Q ss_pred eeecceeEEEEEeccc--CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 190 FMWRNHLCLVFELLSY--NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
|.+.+.+|+||||+.+ ++.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||++. +++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~-~~~~vkl 152 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDL-NRGELKL 152 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEET-TTTEEEE
T ss_pred EeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEec-CCCeEEE
Confidence 9999999999999953 7778877653 69999999999999999999995 79999999999999942 4578999
Q ss_pred EecccccccCCc-cccccccCcCCchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 268 VDFGSSCQLGQR-IYQYIQSRFYRSPEVLLGIPY-DLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 268 ~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
+|||+|+..... ....+||+.|+|||++.+..+ +.++|||||||++|||++|++||.+.+ .+......
T Consensus 153 ~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~---- 222 (273)
T d1xwsa_ 153 IDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF---- 222 (273)
T ss_dssp CCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC----
T ss_pred CccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccC----
Confidence 999999876543 456789999999999987765 578999999999999999999997632 12110000
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
+ .. ..+ .++++||.+||..||
T Consensus 223 -----------~-----------------------~~-----------------------~~s--~~~~~li~~~L~~dp 243 (273)
T d1xwsa_ 223 -----------F-----------------------RQ-----------------------RVS--SECQHLIRWCLALRP 243 (273)
T ss_dssp -----------C-----------------------SS-----------------------CCC--HHHHHHHHHHTCSSG
T ss_pred -----------C-----------------------CC-----------------------CCC--HHHHHHHHHHccCCH
Confidence 0 00 011 178999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy16081 426 KTRITPYYALQHNFFKRT 443 (493)
Q Consensus 426 ~~R~t~~e~L~Hp~~~~~ 443 (493)
++|||++|+|+||||+..
T Consensus 244 ~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 244 SDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp GGSCCHHHHHTSGGGSSC
T ss_pred hHCcCHHHHhcCHhhCCC
Confidence 999999999999999865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=412.02 Aligned_cols=283 Identities=29% Similarity=0.456 Sum_probs=216.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc---ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK---PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-- 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-- 192 (493)
.++|+++++||+|+||+||+|++..+|+.||||++.... ....+..+|+.++..+ +|+||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL------KHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC------CCTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh------cCCCccceEeeeeccc
Confidence 579999999999999999999999999999999986432 2345566677666554 36678888888754
Q ss_pred ------cceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 193 ------RNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 193 ------~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.+++|+|||||++++...+.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~-~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl--~~~~~~k 157 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLI--TRDGVLK 157 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTT-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTSCEE
T ss_pred ccccccCceEEEEEeccCCCccchhhhcc-cccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheee--cCCCcEE
Confidence 45789999999887777665443 579999999999999999999995 799999999999999 7788999
Q ss_pred EEecccccccCC-------ccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy16081 267 IVDFGSSCQLGQ-------RIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEV 338 (493)
Q Consensus 267 L~DFG~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 338 (493)
|+|||++..... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.++.+.+..+...
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 999999976542 23346799999999999875 6899999999999999999999999999999999999999
Q ss_pred hCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHh
Q psy16081 339 LGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIF 418 (493)
Q Consensus 339 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 418 (493)
.+.++............+.. +. ........+.+.+.. ......++|||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~--------------~~~~~~~~~~~~~~~----------------~~~~~~~~dLl~ 286 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEK-LE--------------LVKGQKRKVKDRLKA----------------YVRDPYALDLID 286 (318)
T ss_dssp HCCCCTTTSTTCCCC----------------------CCSSCCBCHHHHHHH----------------HHCCHHHHHHHH
T ss_pred cCCCChhhccccchhhhhhh-hc--------------ccccccccchhhhcc----------------ccCCHHHHHHHH
Confidence 98887665544332211110 00 000000111111110 000126789999
Q ss_pred HccCCCCCCCCCHHHHhcCCCCCC
Q psy16081 419 RMLDYDPKTRITPYYALQHNFFKR 442 (493)
Q Consensus 419 ~mL~~dP~~R~t~~e~L~Hp~~~~ 442 (493)
+||.+||++|||++|+|+||||+.
T Consensus 287 ~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 287 KLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred HHCcCChhHCcCHHHHHcChhhcc
Confidence 999999999999999999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=397.00 Aligned_cols=282 Identities=28% Similarity=0.444 Sum_probs=214.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|+++++||+|+||+||+|++..+++.||||+++.......... .+.+++..+...+|+||++++++|.+.+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~---~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHH---HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHH---HHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 689999999999999999999999999999999975432222221 22222233334568889999999999999999
Q ss_pred EEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|+|++.+ .|..++... +.+++..++.++.|++.||.|||. .|||||||||+|||+ +.++.+||+|||.|+...
T Consensus 79 v~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli--~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLI--NRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred Eeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCccccc--ccCCceeeeecchhhccc
Confidence 9999977 555554433 468999999999999999999994 799999999999999 678899999999998775
Q ss_pred Cc---cccccccCcCCchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 278 QR---IYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPL-FSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 278 ~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.. .....+++.|+|||++.+.. ++.++|||||||++|||++|+.| |.+.+..+++.++....+.+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 43 23456788899999998765 68999999999999999999877 567788888999988888877655443322
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
...+... ...+.......+ ....+ ..+.|||.+||++||.+|||++
T Consensus 233 ~~~~~~~----------------~~~~~~~~~~~~----------------~~~~s--~~~~dll~~mL~~dP~~R~sa~ 278 (292)
T d1unla_ 233 LPDYKPY----------------PMYPATTSLVNV----------------VPKLN--ATGRDLLQNLLKCNPVQRISAE 278 (292)
T ss_dssp STTCCCC----------------CCCCTTCCCTTT----------------STTCC--HHHHHHHHHHSCSSGGGSCCHH
T ss_pred ccccccc----------------ccccccchhhhc----------------cccCC--HHHHHHHHHHccCChhHCcCHH
Confidence 2111100 000000000000 00111 2789999999999999999999
Q ss_pred HHhcCCCCCCC
Q psy16081 433 YALQHNFFKRT 443 (493)
Q Consensus 433 e~L~Hp~~~~~ 443 (493)
|+|+||||+..
T Consensus 279 e~L~Hp~f~~~ 289 (292)
T d1unla_ 279 EALQHPYFSDF 289 (292)
T ss_dssp HHTTSGGGSSC
T ss_pred HHhcChhhcCC
Confidence 99999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-51 Score=408.02 Aligned_cols=286 Identities=27% Similarity=0.443 Sum_probs=213.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee--cce
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW--RNH 195 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~--~~~ 195 (493)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .....+|+.++..+. +||||++++++|.. ..+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~-----~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR-----GGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECTTTCS
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhcc-----CCCCCcEEEEEEEecCCCc
Confidence 368999999999999999999999999999999997433 456677887776664 47789999999974 457
Q ss_pred eEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 196 LCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 196 ~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
+|+|||||++ +|..+. +.+++..++.++.||+.||.|||+ .|||||||||+|||++. +++.+||+|||+|.
T Consensus 107 ~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~-~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEET-TTTEEEECCGGGCE
T ss_pred eeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcC-CCCeeeecccccce
Confidence 9999999976 665442 359999999999999999999995 78999999999999952 44569999999997
Q ss_pred ccC--CccccccccCcCCchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 275 QLG--QRIYQYIQSRFYRSPEVLLGI-PYDLAIDMWSLGCILVEMHTGEPLFSG-SNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 275 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
... ......++|+.|+|||++.+. .|+.++|||||||++|+|++|..||.. .+..++...+...++.+....+...
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 764 345667899999999999875 489999999999999999999999975 4566777788777775433222111
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcC-CCCCCCcchhhhHHHHHhHccCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRL-GEPGHSVSDYLKFKDLIFRMLDYDPKTRI 429 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dLi~~mL~~dP~~R~ 429 (493)
.... ....+.+++.......+.... .......+ .+++|||++||.+||++||
T Consensus 259 ~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dli~~mL~~dP~~R~ 311 (328)
T d3bqca1 259 YNIE-------------------------LDPRFNDILGRHSRKRWERFVHSENQHLVS--PEALDFLDKLLRYDHQSRL 311 (328)
T ss_dssp TTCC-------------------------CCGGGGGTCCCCCCCCGGGGCCTTTGGGCC--HHHHHHHHHHSCSSGGGSC
T ss_pred cccc-------------------------cCcccchhcccccccchhhcccccccccCC--HHHHHHHHHHccCChhHCc
Confidence 0000 000000000000000000000 00011112 2789999999999999999
Q ss_pred CHHHHhcCCCCCCCcc
Q psy16081 430 TPYYALQHNFFKRTAD 445 (493)
Q Consensus 430 t~~e~L~Hp~~~~~~~ 445 (493)
|++|||+||||+.+..
T Consensus 312 ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 312 TAREAMEHPYFYTVVK 327 (328)
T ss_dssp CHHHHHTSGGGTTSCC
T ss_pred CHHHHhcCcccCCCCC
Confidence 9999999999997643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-52 Score=403.77 Aligned_cols=248 Identities=20% Similarity=0.260 Sum_probs=202.5
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
-.++|++.+.||+|+||+||+|++..+++.||||+++.......++.+|+.++..+ +|||||+++++|.+.+.+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI------KHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC------CCTTBCCEEEEECSSSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC------CCCCEecCCccEeeCCee
Confidence 35689999999999999999999999999999999986665556667777666554 478899999999999999
Q ss_pred EEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
|||||||+ |+|.+++.......+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl--~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLV--GENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CGGGCEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEE--CCCCcEEEccccceee
Confidence 99999996 599999987666679999999999999999999995 789999999999999 6788999999999987
Q ss_pred cCCcc----ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhhhhc
Q psy16081 276 LGQRI----YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPL-FSGSNEVDQMNKIVEVLGLPPKHLLDGA 350 (493)
Q Consensus 276 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~p~~~~~~~ 350 (493)
..... ....||+.|+|||++.+..|+.++|||||||++|||++|..| |.+.+..+....+......+
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~-------- 236 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-------- 236 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC--------
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC--------
Confidence 65432 233578889999999999999999999999999999996555 55555444433332211000
Q ss_pred cchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCC
Q psy16081 351 HKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRIT 430 (493)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t 430 (493)
.+. ... ..+.+||.+||..||++|||
T Consensus 237 -----------------------------~~~-----------------------~~~--~~l~~li~~cl~~dP~~Rps 262 (287)
T d1opja_ 237 -----------------------------RPE-----------------------GCP--EKVYELMRACWQWNPSDRPS 262 (287)
T ss_dssp -----------------------------CCT-----------------------TCC--HHHHHHHHHHTCSSGGGSCC
T ss_pred -----------------------------CCc-----------------------cch--HHHHHHHHHHcCCCHhHCcC
Confidence 000 001 17899999999999999999
Q ss_pred HHHHhc
Q psy16081 431 PYYALQ 436 (493)
Q Consensus 431 ~~e~L~ 436 (493)
+.|+++
T Consensus 263 ~~ei~~ 268 (287)
T d1opja_ 263 FAEIHQ 268 (287)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=409.97 Aligned_cols=282 Identities=28% Similarity=0.524 Sum_probs=218.6
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccch---HHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLN---QAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
+.++|+++++||+|+||+||+|++..+|+.||||+++....... ...+|+.++..+ +|+|||+++++|...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l------~h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM------KHENVIGLLDVFTPA 89 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC------CCTTBCCCSEEECSC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc------CCCCeeeEEEEEeec
Confidence 46799999999999999999999999999999999975432222 233444444333 477899999998643
Q ss_pred ------ceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEE
Q psy16081 194 ------NHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKI 267 (493)
Q Consensus 194 ------~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL 267 (493)
+.+|+++++++++|.+++... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+|+
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi--~~~~~~kl 162 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAV--NEDCELKI 162 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTCCEEE
T ss_pred cccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccc--cccccccc
Confidence 345665555577999998653 59999999999999999999995 799999999999999 77899999
Q ss_pred EecccccccCCccccccccCcCCchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 268 VDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIP-YDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 268 ~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
+|||++...........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......|....+.++..+
T Consensus 163 ~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 163 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp CCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 99999998888888889999999999988764 68999999999999999999999999999999999999999888877
Q ss_pred hhhccchh--hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 347 LDGAHKTR--KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 347 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
........ .+...... . ....+.... ...+ ..++|||.+||.+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~---------------~-~~~~~~~~~----------------~~~s--~~~~dli~~mL~~d 288 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQ---------------M-PKMNFANVF----------------IGAN--PLAVDLLEKMLVLD 288 (348)
T ss_dssp HTTCCCHHHHHHHTTSCC---------------C-CCCCHHHHS----------------TTCC--HHHHHHHHHHSCSS
T ss_pred hhhccchhhhhhhhhccc---------------C-CCcchhhhc----------------CCCC--HHHHHHHHHHCcCC
Confidence 65443221 11111110 0 000111110 0111 27899999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCcc
Q psy16081 425 PKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~~~~~~ 445 (493)
|++|||++|||+||||++..+
T Consensus 289 P~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 289 SDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp GGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhCcCHHHHhcCHhhCCCCC
Confidence 999999999999999997644
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=409.24 Aligned_cols=283 Identities=31% Similarity=0.538 Sum_probs=217.0
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
+.++|+++++||+|+||+||+|++..+|+.||||++..... ....+.+|+.++..+ +||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l------~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF------RHENIIGINDIIRAPT 79 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC------CCTTBCCCCEEECCSS
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc------CCCCCCcEEEEEeecc
Confidence 34689999999999999999999999999999999974331 123344555555443 4777999999987543
Q ss_pred -----eeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEe
Q psy16081 195 -----HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVD 269 (493)
Q Consensus 195 -----~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~D 269 (493)
++|||+++++++|.+++... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl--~~~~~~kl~D 152 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLL--NTTCDLKICD 152 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTCCEEECC
T ss_pred ccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEE--CCCCCEEEcc
Confidence 46777777788999999754 59999999999999999999995 799999999999999 6788999999
Q ss_pred cccccccCCc------cccccccCcCCchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 270 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG-IPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 270 FG~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
||+|...... ....+||+.|+|||++.. ..|+.++||||+||++|+|++|++||.+.+..++...+...+..+
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 9999765332 345679999999999854 468899999999999999999999999999999999999998888
Q ss_pred Chhhhhhccch--hhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHc
Q psy16081 343 PKHLLDGAHKT--RKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRM 420 (493)
Q Consensus 343 p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~m 420 (493)
........... ..++...+... ...+..++. ..+ .++++||.+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~----------------~~s--~~~~~li~~~ 278 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKN----------------KVPWNRLFP----------------NAD--SKALDLLDKM 278 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCC----------------CCCHHHHCT----------------TSC--HHHHHHHHHH
T ss_pred ChhhhhhhhhhhhhcccccCCccC----------------CCCHHHhCC----------------CCC--HHHHHHHHHH
Confidence 77665433221 12222111100 000111100 111 1689999999
Q ss_pred cCCCCCCCCCHHHHhcCCCCCCCccC
Q psy16081 421 LDYDPKTRITPYYALQHNFFKRTADE 446 (493)
Q Consensus 421 L~~dP~~R~t~~e~L~Hp~~~~~~~~ 446 (493)
|.+||.+|||++|||+||||+.....
T Consensus 279 L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 279 LTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp SCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred ccCChhHCcCHHHHhcCHhhccCCCC
Confidence 99999999999999999999976544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=395.62 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=194.9
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|++++.||+|+||+||+|.+. +++.||||+++.......++.+|+.++..+ +|||||++++++.+.+.+|+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL------SHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC------CCTTBCCEEEEECSSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc------CCCCcccccceeccCCceEE
Confidence 47999999999999999999865 578899999986655555666666665544 47889999999999999999
Q ss_pred EEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
|||||. |+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+|+...
T Consensus 78 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLV--GENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEE--CGGGCEEECSCC------
T ss_pred EEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheee--cCCCCeEecccchheecc
Confidence 999995 58999887554 468999999999999999999995 789999999999999 778899999999997764
Q ss_pred Cc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 278 QR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 278 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.. .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.+..+......+...
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~------- 225 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR------- 225 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCT-------
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcc-------
Confidence 32 234578999999999999999999999999999999999 678888888777777665532111000
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
.....+.+||.+||..||++|||++
T Consensus 226 -------------------------------------------------------~~~~~l~~li~~cl~~~p~~Rps~~ 250 (263)
T d1sm2a_ 226 -------------------------------------------------------LASTHVYQIMNHCWKERPEDRPAFS 250 (263)
T ss_dssp -------------------------------------------------------TSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred -------------------------------------------------------ccCHHHHHHHHHHccCCHhHCcCHH
Confidence 0011688999999999999999999
Q ss_pred HHhcC
Q psy16081 433 YALQH 437 (493)
Q Consensus 433 e~L~H 437 (493)
|+++|
T Consensus 251 ~il~~ 255 (263)
T d1sm2a_ 251 RLLRQ 255 (263)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-51 Score=400.54 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=198.3
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc-
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN- 194 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~- 194 (493)
.+.++|++.+.||+|+||+||+|++..+|+.||||+++....... .....+.+++......+|||||++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH--HHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 567899999999999999999999999999999999975332111 11122233333334457888999999998764
Q ss_pred ---eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 195 ---HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 195 ---~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
.+|||||||+| +|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.++|+||
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll--~~~~~~~l~d~ 155 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMI--SATNAVKVMDF 155 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--ETTSCEEECCC
T ss_pred CCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCccccc--Cccccceeehh
Confidence 48999999965 8988887653 69999999999999999999994 799999999999999 57788999999
Q ss_pred ccccccCC------ccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 271 GSSCQLGQ------RIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 271 G~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
|.+..... .....+||+.|+|||++.+..|+.++|||||||++|||+||.+||.+.+..+.+.+++.....++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc
Confidence 99865532 234568999999999999999999999999999999999999999999988888777654332221
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
.... ..+ ..+.+||.+||..|
T Consensus 236 ~~~~---------------------------------------------------------~~s--~~l~~li~~~L~~d 256 (277)
T d1o6ya_ 236 ARHE---------------------------------------------------------GLS--ADLDAVVLKALAKN 256 (277)
T ss_dssp GTSS---------------------------------------------------------SCC--HHHHHHHHHHTCSS
T ss_pred hhcc---------------------------------------------------------CCC--HHHHHHHHHHccCC
Confidence 1100 011 17899999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q psy16081 425 PKTRITPYYALQHNFF 440 (493)
Q Consensus 425 P~~R~t~~e~L~Hp~~ 440 (493)
|.+||+..+.|.|+|+
T Consensus 257 p~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 257 PENRYQTAAEMRADLV 272 (277)
T ss_dssp GGGSCSSHHHHHHHHH
T ss_pred HhHCHhHHHHHHHHHH
Confidence 9999954444556654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-50 Score=406.96 Aligned_cols=314 Identities=33% Similarity=0.513 Sum_probs=242.3
Q ss_pred eeeccceecC-cEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCC-----CcceE
Q psy16081 110 IIQHGEKFLD-RYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVN-----NTYYI 183 (493)
Q Consensus 110 ~~~~~~~~~~-~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~-----~~~~I 183 (493)
.+..|+.|.+ +|+++++||+|+||+||+|++..+|+.||||+++...........|+.+++.+.+.+.. .|+||
T Consensus 3 p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp CCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 4556788874 69999999999999999999999999999999987655566778899999999876543 57889
Q ss_pred EEeceeeeec--ceeEEEEEec--ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC
Q psy16081 184 VRLKRHFMWR--NHLCLVFELL--SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN 259 (493)
Q Consensus 184 v~l~~~~~~~--~~~~lV~E~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~ 259 (493)
+++++++... ...++|++++ .++............+++..++.++.||+.||.|||+ ..||+||||||+|||+..
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeec
Confidence 9999998754 4566777766 3355555555555679999999999999999999996 478999999999999943
Q ss_pred CCC----CcEEEEecccccccCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HH
Q psy16081 260 PKR----SAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN------EV 329 (493)
Q Consensus 260 ~~~----~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~ 329 (493)
+.. ..+||+|||.|..........+||+.|+|||++.+..|+.++||||+||++++|++|++||...+ ..
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 222 24899999999888877788899999999999999999999999999999999999999997543 45
Q ss_pred HHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcch
Q psy16081 330 DQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSD 409 (493)
Q Consensus 330 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (493)
+.+..++..++.++..++........+|+.......... .....+.+.+.. ........
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~-----------~~~~~~~~ 300 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK----------LKFWPLEDVLTE-----------KYKFSKDE 300 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCC----------CCBCCHHHHHHH-----------TTCCCHHH
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhcccc----------ccCCchhhhccc-----------ccccCccc
Confidence 678888899999999998887777777765332111000 000011111110 00112223
Q ss_pred hhhHHHHHhHccCCCCCCCCCHHHHhcCCCCCCCcc
Q psy16081 410 YLKFKDLIFRMLDYDPKTRITPYYALQHNFFKRTAD 445 (493)
Q Consensus 410 ~~~~~dLi~~mL~~dP~~R~t~~e~L~Hp~~~~~~~ 445 (493)
...++|||.+||.+||.+|||++|||+||||+....
T Consensus 301 ~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 301 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp HHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC
Confidence 347899999999999999999999999999996543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=397.84 Aligned_cols=251 Identities=21% Similarity=0.325 Sum_probs=203.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.+.||+|+||+||+|.+. +++.||||+++........+.+|+.++..+ +|||||++++++. ++.+|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~g~~~-~~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL------QHQRLVRLYAVVT-QEPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC------CCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC------CCCCEeEEEeeec-cCCeE
Confidence 468999999999999999999864 678999999986655555666676665544 4778999999875 46789
Q ss_pred EEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
||||||. |+|.+++.......+++..+..++.||+.||.|||+ .+|+||||||+|||+ ++++.+||+|||+|+..
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll--~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILV--SDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheee--ecccceeeccccceEEc
Confidence 9999995 489888766554569999999999999999999995 789999999999999 78899999999999877
Q ss_pred CCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.+..+......+.
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~-------- 231 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------- 231 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--------
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC--------
Confidence 532 234568899999999998899999999999999999999 5667777777776666543211110
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
| . ... ..+.+||.+||+.||++|||+
T Consensus 232 ---------------------------p--~-----------------------~~~--~~l~~li~~cl~~~P~~Rpt~ 257 (272)
T d1qpca_ 232 ---------------------------P--D-----------------------NCP--EELYQLMRLCWKERPEDRPTF 257 (272)
T ss_dssp ---------------------------C--T-----------------------TCC--HHHHHHHHHHTCSSGGGSCCH
T ss_pred ---------------------------c--c-----------------------cCh--HHHHHHHHHHcCCCHhHCcCH
Confidence 0 0 000 168999999999999999999
Q ss_pred HHHhc--CCCCCC
Q psy16081 432 YYALQ--HNFFKR 442 (493)
Q Consensus 432 ~e~L~--Hp~~~~ 442 (493)
+|+++ |+||+.
T Consensus 258 ~ei~~~L~~~fts 270 (272)
T d1qpca_ 258 DYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHhhhhhhc
Confidence 99998 888863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-51 Score=390.86 Aligned_cols=245 Identities=20% Similarity=0.265 Sum_probs=203.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEE
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCL 198 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~l 198 (493)
++|+++++||+|+||+||+|++ .+++.||||+++.......++.+|+.++.. .+||||++++++|.+++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~------l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMN------LSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHT------CCCTTBCCEEEEECCSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHh------cCCCceeeEEEEEeeCCceEE
Confidence 4688999999999999999997 478899999998766555555666555443 357889999999999999999
Q ss_pred EEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccC
Q psy16081 199 VFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 277 (493)
Q Consensus 199 V~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~ 277 (493)
||||+. |+|.+++.... ..+++..+.+++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++...
T Consensus 77 v~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill--~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLV--NDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEE--CTTCCEEECCCSSCCBCS
T ss_pred EEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEE--cCCCcEEECcchhheecc
Confidence 999996 58888876544 468999999999999999999995 789999999999999 678899999999997664
Q ss_pred Cc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccc
Q psy16081 278 QR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHK 352 (493)
Q Consensus 278 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 352 (493)
.. .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+...++.+....+...
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~------- 224 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH------- 224 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT-------
T ss_pred CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc-------
Confidence 32 224568899999999999999999999999999999998 899999999888877776432211100
Q ss_pred hhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHH
Q psy16081 353 TRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPY 432 (493)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~ 432 (493)
. ....+.+||.+||+.||++|||++
T Consensus 225 ----------------------------------------------------~---~~~~l~~li~~cl~~dP~~RPt~~ 249 (258)
T d1k2pa_ 225 ----------------------------------------------------L---ASEKVYTIMYSCWHEKADERPTFK 249 (258)
T ss_dssp ----------------------------------------------------T---CCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred ----------------------------------------------------c---ccHHHHHHHHHHccCCHhHCcCHH
Confidence 0 001789999999999999999999
Q ss_pred HHhcC
Q psy16081 433 YALQH 437 (493)
Q Consensus 433 e~L~H 437 (493)
|+|+|
T Consensus 250 eil~~ 254 (258)
T d1k2pa_ 250 ILLSN 254 (258)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-50 Score=396.85 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=189.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCe---EEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQC---HVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
.++|++.++||+|+||+||+|.++.+++ .||||++...... .. ...+++++..+...+|||||++++++...+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~---~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQ---RRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HH---HHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HH---HHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 3579999999999999999999877664 6889988643211 11 112333344444557899999999999999
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccc
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSS 273 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a 273 (493)
.+|+|||||++ +|.+++.... ..+++..+..++.||+.||.|||+ .+||||||||+|||+ +.++.+||+|||+|
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl--~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILV--NSNLVCKVSDFGLS 175 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTCCEEECCC---
T ss_pred EEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEE--CCCCcEEECCcccc
Confidence 99999999965 8888877543 469999999999999999999995 789999999999999 78899999999999
Q ss_pred cccCCcc--------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy16081 274 CQLGQRI--------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPK 344 (493)
Q Consensus 274 ~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~ 344 (493)
+.+.... ....||+.|+|||++.+..|+.++|||||||+||||+| |.+||.+.+..+.+..+......++.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 255 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP 255 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 8764321 12457889999999999999999999999999999998 89999998888777766543221110
Q ss_pred hhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCC
Q psy16081 345 HLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYD 424 (493)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~d 424 (493)
. .....+.+||.+||..|
T Consensus 256 ~--------------------------------------------------------------~~~~~l~~li~~cl~~~ 273 (299)
T d1jpaa_ 256 M--------------------------------------------------------------DCPSALHQLMLDCWQKD 273 (299)
T ss_dssp T--------------------------------------------------------------TCCHHHHHHHHHHTCSS
T ss_pred c--------------------------------------------------------------cchHHHHHHHHHHcCCC
Confidence 0 00117899999999999
Q ss_pred CCCCCCHHHHhcC
Q psy16081 425 PKTRITPYYALQH 437 (493)
Q Consensus 425 P~~R~t~~e~L~H 437 (493)
|++|||+.|++++
T Consensus 274 P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 274 RNHRPKFGQIVNT 286 (299)
T ss_dssp TTTSCCHHHHHHH
T ss_pred HhHCcCHHHHHHH
Confidence 9999999998864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=401.35 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=199.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCe-----EEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQC-----HVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|++.++||+|+||+||+|++..+++ .||||++.... .....+..|..++..+ .+|||||+++++|
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL-----GSHENIVNLLGAC 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHH-----CCCTTBCCEEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHh-----cCCCcEeEEEEEE
Confidence 3689999999999999999999876543 79999986432 2233445555555443 2588899999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCcccc
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTNF---------------------RGVSLNLTRKFSQQLCTALLFLSTPELNIIHC 248 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHr 248 (493)
.+.+.+|||||||+ |+|.+++..... ..+++..++.++.||+.||.|||+ .+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHR 188 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHR 188 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEET
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeec
Confidence 99999999999995 599999975431 248999999999999999999995 689999
Q ss_pred CCCCCcEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCC
Q psy16081 249 DLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPL 322 (493)
Q Consensus 249 DlKp~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p 322 (493)
||||+|||+ +.++.+||+|||+|+..... .....||+.|+|||++.+..|+.++|||||||+||||++ |.+|
T Consensus 189 DlKp~Nill--~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 189 DLAARNVLV--THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp TCSGGGEEE--ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCchhcccc--ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999 67889999999999766432 234567999999999999999999999999999999997 8999
Q ss_pred CCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCC
Q psy16081 323 FSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGE 402 (493)
Q Consensus 323 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 402 (493)
|.+.+..+.+.+++..-..++.
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~---------------------------------------------------------- 288 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQ---------------------------------------------------------- 288 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCC----------------------------------------------------------
T ss_pred CCCCCHHHHHHHHHhcCCCCCC----------------------------------------------------------
Confidence 9987766666666542111100
Q ss_pred CCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 403 PGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 403 ~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
+. ..+ .++++||.+||+.||++|||++|+++|
T Consensus 289 p~-~~~--~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 289 PF-YAT--EEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CT-TCC--HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-cCC--HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 00 001 178999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=390.41 Aligned_cols=251 Identities=25% Similarity=0.277 Sum_probs=191.9
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.++||+|+||+||+|+.. ..||||+++.........+ .+.+++......+|||||++++++. .+.+|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~---~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQ---AFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHH---HHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHH---HHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 467999999999999999999643 3599999975433222222 2223333334456889999999865 56789
Q ss_pred EEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
||||||+ |+|.+++.... ..+++..+..++.||+.||.|||+ .+||||||||+|||+ +.++.+||+|||+|+..
T Consensus 80 lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl--~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFL--HEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--ETTSSEEECCCCCSCC-
T ss_pred EEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEE--cCCCCEEEccccceeec
Confidence 9999996 49999997554 359999999999999999999995 689999999999999 67889999999999766
Q ss_pred CC-----ccccccccCcCCchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Q psy16081 277 GQ-----RIYQYIQSRFYRSPEVLLGI---PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 277 ~~-----~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
.. ......||+.|+|||++.+. .|+.++|||||||+||||+||+.||.+.+..+.+..++.....+|...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~-- 232 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-- 232 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG--
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch--
Confidence 43 23456899999999999753 589999999999999999999999998877766666655432222100
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
..+ ......+.+||.+||..||++|
T Consensus 233 ----------~~~---------------------------------------------~~~~~~l~~li~~cl~~dp~~R 257 (276)
T d1uwha_ 233 ----------KVR---------------------------------------------SNCPKAMKRLMAECLKKKRDER 257 (276)
T ss_dssp ----------GSC---------------------------------------------TTCCHHHHHHHHHHTCSSGGGS
T ss_pred ----------hcc---------------------------------------------ccchHHHHHHHHHHcCCCHhHC
Confidence 000 0001278999999999999999
Q ss_pred CCHHHHhcC
Q psy16081 429 ITPYYALQH 437 (493)
Q Consensus 429 ~t~~e~L~H 437 (493)
||+.|+++|
T Consensus 258 Pt~~~il~~ 266 (276)
T d1uwha_ 258 PLFPQILAS 266 (276)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=390.90 Aligned_cols=249 Identities=23% Similarity=0.287 Sum_probs=196.5
Q ss_pred CcEEEeee-EeeeCCeEEEEEEEcC--CCeEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 119 DRYEIDSL-IGKGSFGQVVKAFDLE--EQCHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 119 ~~y~~~~~-LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.... ....+.+|+.++.. .+|||||++++++.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~------l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ------LDNPYIVRLIGVCQA- 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHH------CCCTTBCCEEEEEES-
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHh------CCCCCEeeEeeeecc-
Confidence 56888885 9999999999997654 456899999974332 12333444444433 357889999999864
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+|||||||++ +|.+++.... ..+++..+..++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill--~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLL--VNRHYAKISDFGL 155 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--EETTEEEECCCTT
T ss_pred CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheee--ccCCceeeccchh
Confidence 568999999965 9999876543 469999999999999999999995 789999999999999 5788999999999
Q ss_pred ccccCCc------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 273 SCQLGQR------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 273 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+.+... ....+||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+.+..|.+....+.
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~-- 233 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-- 233 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC--
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 9876432 224568899999999999999999999999999999998 9999998887777666643211100
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
| . .. ..++.+||.+||..||
T Consensus 234 ---------------------------------p--~-----------------------~~--~~~l~~li~~cl~~~p 253 (285)
T d1u59a_ 234 ---------------------------------P--P-----------------------EC--PPELYALMSDCWIYKW 253 (285)
T ss_dssp ---------------------------------C--T-----------------------TC--CHHHHHHHHHTTCSSG
T ss_pred ---------------------------------C--C-----------------------cC--CHHHHHHHHHHcCCCH
Confidence 0 0 00 0178999999999999
Q ss_pred CCCCCHHHH---hcCCCCC
Q psy16081 426 KTRITPYYA---LQHNFFK 441 (493)
Q Consensus 426 ~~R~t~~e~---L~Hp~~~ 441 (493)
++|||+.++ |+|+|+.
T Consensus 254 ~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 254 EDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp GGSCCHHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHHHH
Confidence 999999887 6788874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=389.60 Aligned_cols=242 Identities=22% Similarity=0.294 Sum_probs=187.7
Q ss_pred eeEeeeCCeEEEEEEEc--CCCeEEEEEEEccCccc---chHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEE
Q psy16081 125 SLIGKGSFGQVVKAFDL--EEQCHVAIKIIKNKKPF---LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLV 199 (493)
Q Consensus 125 ~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~~---~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV 199 (493)
++||+|+||+||+|.+. .+++.||||+++..... ...+.+|+.++ ...+|||||++++++.. +..|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il------~~l~HpnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM------QQLDNPYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHH------HTCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHH------HhCCCCCCceEEEEecc-CCEEEE
Confidence 57999999999999754 45688999999743322 12233344333 33468889999999864 567999
Q ss_pred EEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccccCC
Q psy16081 200 FELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 278 (493)
Q Consensus 200 ~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~~~ 278 (493)
||||++ +|.+++.... .+++..+..++.||+.||.|||+ .+||||||||+|||+ +.++.+||+|||+|+....
T Consensus 86 mE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill--~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLL--VTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--EETTEEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcc--cccCcccccchhhhhhccc
Confidence 999965 8999887653 69999999999999999999995 689999999999999 6788999999999987643
Q ss_pred c------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 279 R------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 279 ~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
. .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+....+.+....+.
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~-------- 231 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-------- 231 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--------
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 2 223568899999999999999999999999999999998 8999999888776665543211000
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
+. .. ..++.+||.+||..||++|||+
T Consensus 232 -----------------------------p~-----------------------~~--~~~~~~li~~cl~~dp~~RPs~ 257 (277)
T d1xbba_ 232 -----------------------------PA-----------------------GC--PREMYDLMNLCWTYDVENRPGF 257 (277)
T ss_dssp -----------------------------CT-----------------------TC--CHHHHHHHHHHTCSSTTTSCCH
T ss_pred -----------------------------Cc-----------------------cc--CHHHHHHHHHHcCCCHhHCcCH
Confidence 00 00 0178999999999999999999
Q ss_pred HHH---hcCCCCC
Q psy16081 432 YYA---LQHNFFK 441 (493)
Q Consensus 432 ~e~---L~Hp~~~ 441 (493)
.++ |+|+|+.
T Consensus 258 ~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 258 AAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHhhCHHhh
Confidence 998 5676653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-50 Score=395.40 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=207.2
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEE---cCCCeEEEEEEEccCc-----ccchHHHHHHHHHHHHhhcCCCCcceEEEecee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFD---LEEQCHVAIKIIKNKK-----PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRH 189 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~---~~~~~~vAvK~~~~~~-----~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~ 189 (493)
.++|++++.||+|+||+||+|++ ..+|+.||||+++... ........|+.++..+.+ ||||++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h-----~pnIv~~~~~ 97 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTLHYA 97 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT-----CTTBCCEEEE
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC-----CCeEEEeeee
Confidence 47899999999999999999987 4478999999986432 234556678888887764 4579999999
Q ss_pred eeecceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEE
Q psy16081 190 FMWRNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIV 268 (493)
Q Consensus 190 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~ 268 (493)
+.+.+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .+||||||||+|||+ +.++.+||+
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill--~~~~~vkL~ 171 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILL--DSNGHVVLT 171 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTSCEEES
T ss_pred eccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceee--cCCCCEEEe
Confidence 9999999999999965 9999987664 57899999999999999999994 789999999999999 678899999
Q ss_pred ecccccccCC----ccccccccCcCCchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy16081 269 DFGSSCQLGQ----RIYQYIQSRFYRSPEVLLGI--PYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVLGLP 342 (493)
Q Consensus 269 DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 342 (493)
|||+|..... ......|++.|+|||.+.+. .++.++|||||||+||+|++|..||.+.+..+....+.......
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 9999976643 23456889999999999865 47889999999999999999999998876655555554321100
Q ss_pred ChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccC
Q psy16081 343 PKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLD 422 (493)
Q Consensus 343 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~ 422 (493)
.. +.+. ..+ .++.+||.+||.
T Consensus 252 ~~----------------------------------~~~~-----------------------~~s--~~~~~li~~~l~ 272 (322)
T d1vzoa_ 252 EP----------------------------------PYPQ-----------------------EMS--ALAKDLIQRLLM 272 (322)
T ss_dssp CC----------------------------------CCCT-----------------------TSC--HHHHHHHHHHTC
T ss_pred CC----------------------------------CCcc-----------------------cCC--HHHHHHHHHHcc
Confidence 00 0000 001 178999999999
Q ss_pred CCCCCCC-----CHHHHhcCCCCCCCc
Q psy16081 423 YDPKTRI-----TPYYALQHNFFKRTA 444 (493)
Q Consensus 423 ~dP~~R~-----t~~e~L~Hp~~~~~~ 444 (493)
+||++|| |++|+|+||||+++.
T Consensus 273 ~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 273 KDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred cCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 9999999 589999999999764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=386.66 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=199.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeE
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLC 197 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~ 197 (493)
.++|++.+.||+|+||+||+|++..+ +.||||+++........+.+|+.++..+ +|+|||++++++.+ +.++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l------~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC------CCTTBCCEEEEECS-SSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc------ccCCEeEEEEEEec-CCeE
Confidence 46899999999999999999987655 6799999986655555566666555443 57779999999864 5689
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+|||||.+ +|.+++.......+++..+..++.||+.||.|||. .||+||||||+|||| +.++.+||+|||+|+..
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll--~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILV--GENLVCKVADFGLARLI 163 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CGGGCEEECCCCTTC--
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEE--CCCCcEEEcccchhhhc
Confidence 99999965 78888876544569999999999999999999995 789999999999999 67889999999999866
Q ss_pred CCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhhhhcc
Q psy16081 277 GQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTG-EPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAH 351 (493)
Q Consensus 277 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 351 (493)
... .....||+.|+|||++.+..++.++|||||||++|||++| .+||.+....+.+..+......+.
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~-------- 235 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------- 235 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--------
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC--------
Confidence 432 2345789999999999999999999999999999999995 666777777777666653221110
Q ss_pred chhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCH
Q psy16081 352 KTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITP 431 (493)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~ 431 (493)
+. ..+ .++++||.+||+.||++|||+
T Consensus 236 -----------------------------~~-----------------------~~~--~~l~~li~~cl~~dP~~Rps~ 261 (285)
T d1fmka3 236 -----------------------------PP-----------------------ECP--ESLHDLMCQCWRKEPEERPTF 261 (285)
T ss_dssp -----------------------------CT-----------------------TSC--HHHHHHHHHHTCSSGGGSCCH
T ss_pred -----------------------------Cc-----------------------ccC--HHHHHHHHHHcccCHhHCcCH
Confidence 00 001 178999999999999999999
Q ss_pred HHHhc--CCCCCCC
Q psy16081 432 YYALQ--HNFFKRT 443 (493)
Q Consensus 432 ~e~L~--Hp~~~~~ 443 (493)
+++++ |+||+..
T Consensus 262 ~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 262 EYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHTTTSCS
T ss_pred HHHHHHHhhhhcCC
Confidence 99988 8999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=380.93 Aligned_cols=248 Identities=21% Similarity=0.246 Sum_probs=186.7
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCC----eEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeec
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQ----CHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWR 193 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~ 193 (493)
.+.|++.++||+|+||+||+|..+.++ ..||||++...... .. +..+++++......+|||||++++++.+.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~-~~---~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQ---RVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HH---HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh-HH---HHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 457999999999999999999877654 47999999643211 11 11223333333344688899999999999
Q ss_pred ceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccc
Q psy16081 194 NHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGS 272 (493)
Q Consensus 194 ~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~ 272 (493)
+.+++|||||.+ ++.+++.... ..+++..+..++.||+.||.|||+ .+||||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl--~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILV--NSNLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEE--CCCCeEEEcccch
Confidence 999999999966 6777665543 469999999999999999999995 789999999999999 7889999999999
Q ss_pred ccccCCc------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 273 SCQLGQR------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTG-EPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 273 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
|+..... .....||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+..+.+..+.+....+..
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~- 235 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP- 235 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC-
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc-
Confidence 9876432 2234678999999999999999999999999999999995 5666666666665554432111100
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
. .....+.+||.+||..||
T Consensus 236 ------------------------------------~-------------------------~~~~~l~~li~~cl~~~p 254 (283)
T d1mqba_ 236 ------------------------------------M-------------------------DCPSAIYQLMMQCWQQER 254 (283)
T ss_dssp ------------------------------------T-------------------------TCBHHHHHHHHHHTCSST
T ss_pred ------------------------------------h-------------------------hhHHHHHHHHHHHCcCCH
Confidence 0 001168999999999999
Q ss_pred CCCCCHHHHhc
Q psy16081 426 KTRITPYYALQ 436 (493)
Q Consensus 426 ~~R~t~~e~L~ 436 (493)
++|||+.|+++
T Consensus 255 ~~RPt~~eil~ 265 (283)
T d1mqba_ 255 ARRPKFADIVS 265 (283)
T ss_dssp TTSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=381.38 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=186.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|++.+.||+|+||+||+|++..+ +..||||+++..... ...+..|..+ +...+|||||++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~------l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT------MRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHH------HHTCCCTTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHH------HHhCCCCCEeeEEEEEe-
Confidence 46899999999999999999988654 356899988643211 1222233333 33346889999999986
Q ss_pred cceeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
++.+|+|||||.+ +|.+++.... ..+++..++.++.||+.||.|||+ .+||||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll--~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLV--SSNDCVKLGDFG 153 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--EETTEEEECC--
T ss_pred cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheee--cCCCcEEEccch
Confidence 5789999999965 8888776543 469999999999999999999995 789999999999999 677899999999
Q ss_pred cccccCCc----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy16081 272 SSCQLGQR----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHL 346 (493)
Q Consensus 272 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~ 346 (493)
+|+..... .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+.++.+....+.
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~--- 230 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM--- 230 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---
T ss_pred hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 99876432 234567899999999999999999999999999999998 8999999888777776654211100
Q ss_pred hhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCC
Q psy16081 347 LDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPK 426 (493)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~ 426 (493)
+. ... ..+.+||.+||..||+
T Consensus 231 ----------------------------------~~-----------------------~~~--~~~~~li~~cl~~dp~ 251 (273)
T d1mp8a_ 231 ----------------------------------PP-----------------------NCP--PTLYSLMTKCWAYDPS 251 (273)
T ss_dssp ----------------------------------CT-----------------------TCC--HHHHHHHHHHTCSSGG
T ss_pred ----------------------------------CC-----------------------CCC--HHHHHHHHHHcCCCHh
Confidence 00 000 1789999999999999
Q ss_pred CCCCHHHHhcC
Q psy16081 427 TRITPYYALQH 437 (493)
Q Consensus 427 ~R~t~~e~L~H 437 (493)
+|||+.|+++|
T Consensus 252 ~Rps~~ei~~~ 262 (273)
T d1mp8a_ 252 RRPRFTELKAQ 262 (273)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=382.72 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=185.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
.++|+++++||+|+||+||+|.+.. +++.||||+++.... .............+. ...+|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~--~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILI--HIGHHLNVVNLLGACTK 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHH--HHCCCTTBCCEEEEECS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHH--hhcCCCeEEEeeeeecc
Confidence 3689999999999999999998754 457899999874321 111122222222222 22357789999998765
Q ss_pred c-ceeEEEEEecc-cCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEE
Q psy16081 193 R-NHLCLVFELLS-YNLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENIL 256 (493)
Q Consensus 193 ~-~~~~lV~E~~~-~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NIL 256 (493)
. +.+++|||||+ |+|.+++.... ...+++..++.++.||+.||.|||+ .+||||||||+|||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~NIL 166 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNIL 166 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCcccee
Confidence 4 56899999996 59999986532 1248999999999999999999995 78999999999999
Q ss_pred eeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHH
Q psy16081 257 LCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTG-EPLFSGSNEVD 330 (493)
Q Consensus 257 l~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~ 330 (493)
+ +.++.+||+|||+|+..... ....+||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+..+
T Consensus 167 l--~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 167 L--SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp E--CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred E--CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9 67889999999999765332 2345789999999999999999999999999999999986 57898776555
Q ss_pred HHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchh
Q psy16081 331 QMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDY 410 (493)
Q Consensus 331 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (493)
.+..++.....++. | . .. .
T Consensus 245 ~~~~~~~~~~~~~~----------------------------------~------------------------~-~~--~ 263 (299)
T d1ywna1 245 EFCRRLKEGTRMRA----------------------------------P------------------------D-YT--T 263 (299)
T ss_dssp HHHHHHHHTCCCCC----------------------------------C------------------------T-TC--C
T ss_pred HHHHHHhcCCCCCC----------------------------------C------------------------c-cC--C
Confidence 55544432111100 0 0 00 0
Q ss_pred hhHHHHHhHccCCCCCCCCCHHHHhcC
Q psy16081 411 LKFKDLIFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 411 ~~~~dLi~~mL~~dP~~R~t~~e~L~H 437 (493)
.++++||.+||..||++|||+.|+++|
T Consensus 264 ~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 264 PEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 178999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=387.81 Aligned_cols=245 Identities=20% Similarity=0.262 Sum_probs=190.7
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCe----EEEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQC----HVAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW 192 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~ 192 (493)
++|+++++||+|+||+||+|.+..+|+ .||||.++... .....+.+|+.++..+ +|||||++++++.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------DNPHVCRLLGICLT 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC------CCTTBCCEEEEEES
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC------CCCCEeeEEEEEec
Confidence 469999999999999999999988876 58888876322 2234455566555443 57889999999986
Q ss_pred cceeEEEEEec-ccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecc
Q psy16081 193 RNHLCLVFELL-SYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFG 271 (493)
Q Consensus 193 ~~~~~lV~E~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG 271 (493)
. ..++|+|++ +++|.+.+.... ..+++..++.++.||+.||.|||+ .+||||||||+|||+ +.++.+||+|||
T Consensus 83 ~-~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll--~~~~~~kl~DFG 156 (317)
T d1xkka_ 83 S-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLV--KTPQHVKITDFG 156 (317)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--EETTEEEECCCS
T ss_pred C-CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhccee--CCCCCeEeeccc
Confidence 5 466777777 568998887654 569999999999999999999995 689999999999999 678899999999
Q ss_pred cccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy16081 272 SSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKH 345 (493)
Q Consensus 272 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~ 345 (493)
+|+..... .....||+.|+|||++.+..|+.++|||||||+||||+| |.+||.+.+..+....+.+....+..
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p- 235 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP- 235 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC-
T ss_pred cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence 99876432 223468999999999999999999999999999999998 89999988776665555432111100
Q ss_pred hhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCC
Q psy16081 346 LLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDP 425 (493)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP 425 (493)
. .. ...+.+||.+||..||
T Consensus 236 ------------------------------------~-----------------------~~--~~~~~~li~~cl~~dP 254 (317)
T d1xkka_ 236 ------------------------------------P-----------------------IC--TIDVYMIMVKCWMIDA 254 (317)
T ss_dssp ------------------------------------T-----------------------TB--CHHHHHHHHHHTCSSG
T ss_pred ------------------------------------c-----------------------cc--CHHHHHHHHHhCCCCh
Confidence 0 00 0168999999999999
Q ss_pred CCCCCHHHHhcC
Q psy16081 426 KTRITPYYALQH 437 (493)
Q Consensus 426 ~~R~t~~e~L~H 437 (493)
++|||+.|+++|
T Consensus 255 ~~RPs~~eil~~ 266 (317)
T d1xkka_ 255 DSRPKFRELIIE 266 (317)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=375.11 Aligned_cols=245 Identities=22% Similarity=0.286 Sum_probs=189.3
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-ccee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-RNHL 196 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-~~~~ 196 (493)
.++|++.+.||+|+||.||+|.+ +|+.||||++++.. ....+.+|+.++ ...+||||+++++++.+ .+.+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-~~~~~~~E~~~l------~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVM------TQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHH------TTCCCTTBCCEEEEECCC--CC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-HHHHHHHHHHHH------HhCCCCCEeeEEEEEEecCCcE
Confidence 46799999999999999999986 57899999997543 334455555543 33468889999998854 5678
Q ss_pred EEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEecccccc
Q psy16081 197 CLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~ 275 (493)
||||||+++ +|.+++.......+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~--~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKE 152 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CTTSCEEECCCCC---
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhhee--cCCCCEeeccccccee
Confidence 999999955 99999876543458999999999999999999995 789999999999999 7889999999999998
Q ss_pred cCCccccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhccchh
Q psy16081 276 LGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTR 354 (493)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 354 (493)
.........+|..|+|||++.+..++.++|||||||++|||+| |++||...+..+.+..+.+....+
T Consensus 153 ~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~------------ 220 (262)
T d1byga_ 153 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD------------ 220 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC------------
T ss_pred cCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 8777777789999999999999999999999999999999998 799998877766665553211000
Q ss_pred hhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCCCCHHHH
Q psy16081 355 KYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYA 434 (493)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~ 434 (493)
.+ . ....++.+||.+||..||.+|||+.++
T Consensus 221 -----------------------~~--~-------------------------~~~~~~~~li~~cl~~dP~~Rps~~~l 250 (262)
T d1byga_ 221 -----------------------AP--D-------------------------GCPPAVYEVMKNCWHLDAAMRPSFLQL 250 (262)
T ss_dssp -----------------------CC--T-------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------------CC--c-------------------------cCCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 00 0 001278999999999999999999999
Q ss_pred hcC
Q psy16081 435 LQH 437 (493)
Q Consensus 435 L~H 437 (493)
+++
T Consensus 251 ~~~ 253 (262)
T d1byga_ 251 REQ 253 (262)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=377.35 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=191.5
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCC-------eEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEece
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQ-------CHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKR 188 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~ 188 (493)
.++|++++.||+|+||.||+|++..++ ..||||+++..... ..++..|...+. ...+|||||++++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~-----~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK-----MIGKHKNIINLLG 86 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHH-----HHCCCTTBCCEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHH-----HhcCCCeEEeccc
Confidence 468999999999999999999876654 47999999754321 122222322222 2236889999999
Q ss_pred eeeecceeEEEEEecc-cCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 189 HFMWRNHLCLVFELLS-YNLYDLLRNTN--------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 189 ~~~~~~~~~lV~E~~~-~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
+|.+++.+++|||||. |+|.+++.... ...+++..++.++.||+.||.|||+ .+||||||||+
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~ 164 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAAR 164 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeeccc
Confidence 9999999999999995 59999996543 2348999999999999999999995 78999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ +.++.+||+|||+++..... .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 165 NiLl--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 165 NVLV--TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GEEE--CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceee--cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999 77889999999999876432 334678999999999999999999999999999999998 799999888
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+....+.+....+. | .+ .
T Consensus 243 ~~~~~~~i~~~~~~~~-----------------------------------p------------------------~~-~ 262 (299)
T d1fgka_ 243 VEELFKLLKEGHRMDK-----------------------------------P------------------------SN-C 262 (299)
T ss_dssp HHHHHHHHHTTCCCCC-----------------------------------C------------------------SS-C
T ss_pred HHHHHHHHHcCCCCCC-----------------------------------C------------------------cc-c
Confidence 7766555433211000 0 00 0
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
. ..+.+||.+||+.||++|||+.|+++
T Consensus 263 ~--~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 263 T--NELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp C--HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h--HHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 0 17899999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-47 Score=375.46 Aligned_cols=247 Identities=22% Similarity=0.266 Sum_probs=196.1
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|++.+.||+|+||+||+|+.+. +++.||||+++..... ...+.+|+.++ ...+||||+++++++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il------~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALM------AEFDNPNIVKLLGVC 85 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHH------HTCCCTTBCCEEEEE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHH------HhcCCCCcccceeee
Confidence 5689999999999999999998753 5689999998743221 22233443333 334688899999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccc
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTN----------------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIH 247 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiH 247 (493)
...+.+++||||+. |+|.+++.... ...+++..+..++.||+.||.|||+ .+|||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEe
Confidence 99999999999995 59999886432 1247899999999999999999995 78999
Q ss_pred cCCCCCcEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCC-C
Q psy16081 248 CDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGE-P 321 (493)
Q Consensus 248 rDlKp~NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~ 321 (493)
|||||+|||+ +.++.+||+|||+|+..... .....||+.|+|||++.+..|+.++|||||||+||||++|. +
T Consensus 164 rDlKp~NILl--d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 164 RDLATRNCLV--GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp SCCSGGGEEE--CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEEcccceEE--CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999 67889999999999765332 23457888999999999999999999999999999999985 7
Q ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCC
Q psy16081 322 LFSGSNEVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLG 401 (493)
Q Consensus 322 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 401 (493)
||.+.+..+.+..+.+....+ . +.
T Consensus 242 p~~~~~~~e~~~~v~~~~~~~-----------------------------------~--p~------------------- 265 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDGNILA-----------------------------------C--PE------------------- 265 (301)
T ss_dssp TTTTSCHHHHHHHHHTTCCCC-----------------------------------C--CT-------------------
T ss_pred CCCCCCHHHHHHHHHcCCCCC-----------------------------------C--Cc-------------------
Confidence 899998888877765421100 0 00
Q ss_pred CCCCCcchhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 402 EPGHSVSDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 402 ~~~~~~~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
.. ..++.+||.+||+.||++|||+.|+++
T Consensus 266 ----~~--~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 266 ----NC--PLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp ----TC--CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----cc--hHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 016899999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=369.95 Aligned_cols=257 Identities=24% Similarity=0.281 Sum_probs=199.5
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+-++|++++.||+|+||+||+|++..+|+.||||++.... ...+...|..++..+.+ |++|+.+..++.+.+..
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~-----~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQG-----GVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTT-----STTCCCEEEEEEETTEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccC-----CCcccEEEEEEecCCEE
Confidence 3468999999999999999999999999999999987543 23456677777766543 44577777778888999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC-CCCCcEEEEecccccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQ 275 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~-~~~~~ikL~DFG~a~~ 275 (493)
++||||++++|.+.+.... +.+++..+..++.||+.||.|||+ .|||||||||+|||++. +.+..+||+|||+|+.
T Consensus 79 ~ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 79 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 9999999999888776544 569999999999999999999995 78999999999999842 2456799999999987
Q ss_pred cCCc----------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh----CC
Q psy16081 276 LGQR----------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNKIVEVL----GL 341 (493)
Q Consensus 276 ~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~----~~ 341 (493)
.... ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||......+....+.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 6432 234579999999999999999999999999999999999999998866555444332211 11
Q ss_pred CChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHcc
Q psy16081 342 PPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRML 421 (493)
Q Consensus 342 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL 421 (493)
+.... .... ..++.+||.+||
T Consensus 236 ~~~~~----------~~~~-------------------------------------------------p~~~~~li~~cl 256 (299)
T d1ckia_ 236 PIEVL----------CKGY-------------------------------------------------PSEFATYLNFCR 256 (299)
T ss_dssp CHHHH----------TTTS-------------------------------------------------CHHHHHHHHHHH
T ss_pred ChhHh----------ccCC-------------------------------------------------CHHHHHHHHHHc
Confidence 11110 0000 016899999999
Q ss_pred CCCCCCCCCHH---HHhcCCCCC
Q psy16081 422 DYDPKTRITPY---YALQHNFFK 441 (493)
Q Consensus 422 ~~dP~~R~t~~---e~L~Hp~~~ 441 (493)
..||++||++. ++|+|+|.+
T Consensus 257 ~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 257 SLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999986 557887754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=376.75 Aligned_cols=248 Identities=24% Similarity=0.254 Sum_probs=196.1
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCCCeE--EEEEEEccCc--ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEEQCH--VAIKIIKNKK--PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~--vAvK~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
++|++.++||+|+||+||+|+++.++.. ||||+++... .....+.+|+.++.. ..+|||||++++++.+.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~-----l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-----LGHHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTT-----CCCCTTBCCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHh-----ccCCCCEeeEEEEEecCC
Confidence 5899999999999999999999888875 6777765322 122344445444332 226889999999999999
Q ss_pred eeEEEEEecc-cCHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeC
Q psy16081 195 HLCLVFELLS-YNLYDLLRNT--------------NFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCN 259 (493)
Q Consensus 195 ~~~lV~E~~~-~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~ 259 (493)
.+|+||||++ |+|.++|... ....+++..+..++.||+.||.|||+ .+||||||||+|||+
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~-- 160 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV-- 160 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEE--
Confidence 9999999996 5999998643 23569999999999999999999995 789999999999999
Q ss_pred CCCCcEEEEecccccccCCcc--ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Q psy16081 260 PKRSAIKIVDFGSSCQLGQRI--YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTG-EPLFSGSNEVDQMNKIV 336 (493)
Q Consensus 260 ~~~~~ikL~DFG~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i~ 336 (493)
+.++.+||+|||+|+...... ....||..|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..+.+..+.
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 678899999999997665432 345689999999999999999999999999999999996 46898888777766654
Q ss_pred HHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHH
Q psy16081 337 EVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDL 416 (493)
Q Consensus 337 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL 416 (493)
+....+ .+. ... .++.+|
T Consensus 241 ~~~~~~-------------------------------------~~~-----------------------~~~--~~~~~l 258 (309)
T d1fvra_ 241 QGYRLE-------------------------------------KPL-----------------------NCD--DEVYDL 258 (309)
T ss_dssp GTCCCC-------------------------------------CCT-----------------------TBC--HHHHHH
T ss_pred hcCCCC-------------------------------------CCc-----------------------cCC--HHHHHH
Confidence 321100 000 011 178999
Q ss_pred HhHccCCCCCCCCCHHHHhcC
Q psy16081 417 IFRMLDYDPKTRITPYYALQH 437 (493)
Q Consensus 417 i~~mL~~dP~~R~t~~e~L~H 437 (493)
|.+||+.||++|||+.|+++|
T Consensus 259 i~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 259 MRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=368.61 Aligned_cols=245 Identities=24% Similarity=0.280 Sum_probs=184.5
Q ss_pred CcEEEeeeEeeeCCeEEEEEEEcCC---CeEEEEEEEccCcc----cchHHHHHHHHHHHHhhcCCCCcceEEEeceeee
Q psy16081 119 DRYEIDSLIGKGSFGQVVKAFDLEE---QCHVAIKIIKNKKP----FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFM 191 (493)
Q Consensus 119 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~----~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~ 191 (493)
++|++++.||+|+||+||+|+...+ ...||||+++.... ....+..|+.++.. .+|||||++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~------l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS------LDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHH------CCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHh------CCCCCEEEEEEEEe
Confidence 5799999999999999999986433 24689999874322 12233444443333 35888999999997
Q ss_pred ecceeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEec
Q psy16081 192 WRNHLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 270 (493)
Q Consensus 192 ~~~~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DF 270 (493)
+ +.+++|||||. +++.+.+.... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll--~~~~~vkl~Df 155 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLL--ATRDLVKIGDF 155 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE--EETTEEEECCC
T ss_pred e-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhcc--ccccceeeccc
Confidence 5 57899999995 48888776543 359999999999999999999995 689999999999999 56789999999
Q ss_pred ccccccCCcc------ccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q psy16081 271 GSSCQLGQRI------YQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSNEVDQMNKIVEVLGLPP 343 (493)
Q Consensus 271 G~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~p 343 (493)
|+++...... ....|+..|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+.+.++.+....++
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence 9998774432 23456788999999999999999999999999999998 8999999999888877754211110
Q ss_pred hhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCC
Q psy16081 344 KHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDY 423 (493)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~ 423 (493)
.+. ... ..+.+||.+||..
T Consensus 236 ------------------------------------~~~-----------------------~~~--~~l~~li~~cl~~ 254 (273)
T d1u46a_ 236 ------------------------------------RPE-----------------------DCP--QDIYNVMVQCWAH 254 (273)
T ss_dssp ------------------------------------CCT-----------------------TCC--HHHHHHHHHHTCS
T ss_pred ------------------------------------Ccc-----------------------ccc--HHHHHHHHHHcCC
Confidence 000 000 1788999999999
Q ss_pred CCCCCCCHHHHhc
Q psy16081 424 DPKTRITPYYALQ 436 (493)
Q Consensus 424 dP~~R~t~~e~L~ 436 (493)
||++|||+.|+++
T Consensus 255 dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 255 KPEDRPTFVALRD 267 (273)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhHCcCHHHHHH
Confidence 9999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=369.95 Aligned_cols=257 Identities=21% Similarity=0.273 Sum_probs=204.3
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcC-----CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLE-----EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.-.++|++.++||+|+||+||+|.+.. +++.||||+++.... .. .+..+++++......+|||||++++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-~~---~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MR---ERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HH---HHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC-hH---HHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 335789999999999999999998753 357899999974321 11 122334444445555788999999999
Q ss_pred eecceeEEEEEecc-cCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC
Q psy16081 191 MWRNHLCLVFELLS-YNLYDLLRNTN--------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK 261 (493)
Q Consensus 191 ~~~~~~~lV~E~~~-~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~ 261 (493)
...+.+++|||||. |+|.+++.... ...+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLl--d~ 168 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMV--AE 168 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEE--CT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceee--cC
Confidence 99999999999995 58988875321 2346889999999999999999995 689999999999999 78
Q ss_pred CCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q psy16081 262 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTG-EPLFSGSNEVDQMNKI 335 (493)
Q Consensus 262 ~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~i 335 (493)
++.+||+|||+|+..... .....||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+.+..+
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 899999999999866433 2334678999999999999999999999999999999998 5899988888877776
Q ss_pred HHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHH
Q psy16081 336 VEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKD 415 (493)
Q Consensus 336 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 415 (493)
.+....+. +.. . ...+.+
T Consensus 249 ~~~~~~~~-------------------------------------p~~-----------------------~--~~~l~~ 266 (308)
T d1p4oa_ 249 MEGGLLDK-------------------------------------PDN-----------------------C--PDMLFE 266 (308)
T ss_dssp HTTCCCCC-------------------------------------CTT-----------------------C--CHHHHH
T ss_pred HhCCCCCC-------------------------------------ccc-----------------------c--hHHHHH
Confidence 54211100 000 0 017899
Q ss_pred HHhHccCCCCCCCCCHHHHhc------CCCCCC
Q psy16081 416 LIFRMLDYDPKTRITPYYALQ------HNFFKR 442 (493)
Q Consensus 416 Li~~mL~~dP~~R~t~~e~L~------Hp~~~~ 442 (493)
||.+||+.||.+|||+.|+++ +|+|++
T Consensus 267 li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 267 LMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 999999999999999999998 777754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=369.50 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=198.4
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEc-----CCCeEEEEEEEccCccc--chHHHHHHHHHHHHhhcCCCCcceEEEeceee
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDL-----EEQCHVAIKIIKNKKPF--LNQAQIEVKLLEIMNKADVNNTYYIVRLKRHF 190 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~ 190 (493)
.++|++.++||+|+||.||+|+.. .+++.||||+++..... ...+..|..++..+ .+|||||++++++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l-----~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL-----GNHMNIVNLLGAC 96 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH-----CCCTTBCCEEEEE
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhc-----cCCCCEEEEEEEE
Confidence 478999999999999999999753 46789999999754321 12233344443332 3688999999999
Q ss_pred eecceeEEEEEeccc-CHHHHHhccC----------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q psy16081 191 MWRNHLCLVFELLSY-NLYDLLRNTN----------------FRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPE 253 (493)
Q Consensus 191 ~~~~~~~lV~E~~~~-~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~ 253 (493)
.+.+.+|||||||++ +|.+++.... ...+++..+..++.||+.||.|||+ .+||||||||+
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~ 174 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAAR 174 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccccc
Confidence 999999999999965 8999886532 2258999999999999999999995 68999999999
Q ss_pred cEEeeCCCCCcEEEEecccccccCCc-----cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy16081 254 NILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHT-GEPLFSGSN 327 (493)
Q Consensus 254 NILl~~~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~ 327 (493)
|||+ +..+.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+
T Consensus 175 NIl~--~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 175 NILL--THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GEEE--ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccc--cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999 67889999999999876532 224578999999999999999999999999999999998 778888877
Q ss_pred HHHHHHHHHHHhCCCChhhhhhccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCc
Q psy16081 328 EVDQMNKIVEVLGLPPKHLLDGAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSV 407 (493)
Q Consensus 328 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 407 (493)
..+.+.++++....+.. +.+
T Consensus 253 ~~~~~~~~i~~~~~~~~----------------------------------------------------------~~~-- 272 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLS----------------------------------------------------------PEH-- 272 (311)
T ss_dssp SSHHHHHHHHHTCCCCC----------------------------------------------------------CTT--
T ss_pred HHHHHHHHHhcCCCCCC----------------------------------------------------------ccc--
Confidence 76776666653111100 000
Q ss_pred chhhhHHHHHhHccCCCCCCCCCHHHHhc
Q psy16081 408 SDYLKFKDLIFRMLDYDPKTRITPYYALQ 436 (493)
Q Consensus 408 ~~~~~~~dLi~~mL~~dP~~R~t~~e~L~ 436 (493)
....+.+||.+||..||++|||+.|+|+
T Consensus 273 -~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 273 -APAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0117899999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=365.43 Aligned_cols=195 Identities=23% Similarity=0.232 Sum_probs=159.0
Q ss_pred cCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc---
Q psy16081 118 LDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN--- 194 (493)
Q Consensus 118 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~--- 194 (493)
..+|.+.++||+|+||+||+|+. +|+.||||+++... ......|. ++......+|||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~----ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREA----EIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHH----HHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHH----HHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 35789999999999999999974 68999999996432 12222232 233344467999999999998764
Q ss_pred -eeEEEEEecc-cCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCccccCCCCCcEEeeCCCCCcEE
Q psy16081 195 -HLCLVFELLS-YNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP------ELNIIHCDLKPENILLCNPKRSAIK 266 (493)
Q Consensus 195 -~~~lV~E~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~------~~~iiHrDlKp~NILl~~~~~~~ik 266 (493)
.+|||||||. |+|.+++... .+++..+..++.|++.||.|||+. ..|||||||||+|||+ +.++.+|
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl--~~~~~~K 148 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCC 148 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE--CTTSCEE
T ss_pred eEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE--cCCCCeE
Confidence 6899999995 4999999764 599999999999999999999963 3699999999999999 7889999
Q ss_pred EEecccccccCCc-------cccccccCcCCchhhhcCCC------CCchhhHHHHHHHHHHHHhCCCCCCC
Q psy16081 267 IVDFGSSCQLGQR-------IYQYIQSRFYRSPEVLLGIP------YDLAIDMWSLGCILVEMHTGEPLFSG 325 (493)
Q Consensus 267 L~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG~~pf~~ 325 (493)
|+|||++...... ....+||+.|+|||++.+.. ++.++|||||||+||||+||.+||..
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 9999999766332 23567999999999998653 67899999999999999999998854
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-45 Score=357.74 Aligned_cols=202 Identities=23% Similarity=0.265 Sum_probs=171.7
Q ss_pred ecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 117 FLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 117 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
+-++|+++++||+|+||+||+|++..+|+.||||++.... .......|.+++..+.+ |+||+.+++++......
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~-----~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAG-----CTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTT-----CTTCCCEEEEEEETTEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcC-----CCCCCEEEEEeecCCcc
Confidence 4568999999999999999999999999999999986433 23445667766666543 34588888999999999
Q ss_pred EEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCC---CCCcEEEEecccc
Q psy16081 197 CLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNP---KRSAIKIVDFGSS 273 (493)
Q Consensus 197 ~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~---~~~~ikL~DFG~a 273 (493)
|+||||++++|.+++.... ..+++..+..++.|++.||.|||+ .|||||||||+|||++.+ ..+.+||+|||+|
T Consensus 77 ~~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 77 VLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEccccee
Confidence 9999999999999886544 469999999999999999999994 799999999999999532 3578999999999
Q ss_pred cccCCc----------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy16081 274 CQLGQR----------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGSN 327 (493)
Q Consensus 274 ~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~ 327 (493)
+..... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 775321 234679999999999999999999999999999999999999998643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=360.74 Aligned_cols=241 Identities=18% Similarity=0.237 Sum_probs=181.2
Q ss_pred eeeEeeeCCeEEEEEEEcCCC---eEEEEEEEccCcc--cchHHHHHHHHHHHHhhcCCCCcceEEEeceeeee-cceeE
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQ---CHVAIKIIKNKKP--FLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMW-RNHLC 197 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~-~~~~~ 197 (493)
.++||+|+||+||+|++..++ ..||||+++.... ....+..|+.++. ..+||||+++++++.. ++.++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~------~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK------DFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHH------TCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHH------hCCCCCEeEEeEEEEecCCceE
Confidence 578999999999999876643 3699999964321 1223333433332 3358889999999875 46899
Q ss_pred EEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCCCCcEEEEeccccccc
Q psy16081 198 LVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 276 (493)
Q Consensus 198 lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~~~ 276 (493)
+|||||++ +|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ ++++.+||+|||+++..
T Consensus 106 lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl--~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCML--DEKFTVKVADFGLARDM 180 (311)
T ss_dssp EEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE--CTTCCEEECSSGGGCCT
T ss_pred EEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeE--CCCCCEEEecccchhhc
Confidence 99999965 8888776544 467888999999999999999995 789999999999999 78899999999999866
Q ss_pred CCc-------cccccccCcCCchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhhh
Q psy16081 277 GQR-------IYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGS-NEVDQMNKIVEVLGLPPKHLLD 348 (493)
Q Consensus 277 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~p~~~~~ 348 (493)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||... +..+....+......+
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~------ 254 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------ 254 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC------
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 432 22346889999999999999999999999999999999977666543 3333333332210000
Q ss_pred hccchhhhhccCCCCCceecCCCCCCCCCCCCCccchhhccccCCCCCCCcCCCCCCCcchhhhHHHHHhHccCCCCCCC
Q psy16081 349 GAHKTRKYFDKMPDGSYILKKPKDGRKPKVPGSRRLHDILGVESGGPGGRRLGEPGHSVSDYLKFKDLIFRMLDYDPKTR 428 (493)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~mL~~dP~~R 428 (493)
. +.+ ....+.+||.+||..||++|
T Consensus 255 -----------------------------~------------------------p~~---~~~~l~~li~~cl~~dP~~R 278 (311)
T d1r0pa_ 255 -----------------------------Q------------------------PEY---CPDPLYEVMLKCWHPKAEMR 278 (311)
T ss_dssp -----------------------------C------------------------CTT---CCHHHHHHHHHHTCSSGGGS
T ss_pred -----------------------------C------------------------ccc---CcHHHHHHHHHHcCCCHhHC
Confidence 0 000 01278999999999999999
Q ss_pred CCHHHHhcC
Q psy16081 429 ITPYYALQH 437 (493)
Q Consensus 429 ~t~~e~L~H 437 (493)
||+.|+++|
T Consensus 279 Ps~~ei~~~ 287 (311)
T d1r0pa_ 279 PSFSELVSR 287 (311)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=3e-24 Score=195.11 Aligned_cols=163 Identities=18% Similarity=0.209 Sum_probs=108.0
Q ss_pred EEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCccc-------------------chHHHHHHHHHHHHhhcCCCCcc
Q psy16081 121 YEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPF-------------------LNQAQIEVKLLEIMNKADVNNTY 181 (493)
Q Consensus 121 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-------------------~~~~~~e~~~~~~l~~~~~~~~~ 181 (493)
+.+.++||+|+||+||+|.+ .+|+.||||+++..... ......|...+.. . .++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~---l---~~~ 74 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK---L---QGL 74 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH---T---TTS
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHH---c---cCC
Confidence 45789999999999999987 47899999987632110 0111122222222 2 233
Q ss_pred eEEEeceeeeecceeEEEEEecccCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCcEEeeCCC
Q psy16081 182 YIVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTPELNIIHCDLKPENILLCNPK 261 (493)
Q Consensus 182 ~Iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~~~~iiHrDlKp~NILl~~~~ 261 (493)
+++..+++. ..++||||+++... ..+++.....++.||+.+|.|||. .||+||||||+|||++ +
T Consensus 75 ~v~~~~~~~----~~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~--~ 138 (191)
T d1zara2 75 AVPKVYAWE----GNAVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVS--E 138 (191)
T ss_dssp SSCCEEEEE----TTEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEE--T
T ss_pred CcceEEEec----CCEEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeee--C
Confidence 455544332 23799999987321 124556677899999999999994 7999999999999994 3
Q ss_pred CCcEEEEecccccccCCccccccccCcCCc------hhhhcCCCCCchhhHHHHHHHH
Q psy16081 262 RSAIKIVDFGSSCQLGQRIYQYIQSRFYRS------PEVLLGIPYDLAIDMWSLGCIL 313 (493)
Q Consensus 262 ~~~ikL~DFG~a~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwSlGvil 313 (493)
..++|+|||+|.....+.... |.. .|. ..+.|+.++|+||+.--+
T Consensus 139 -~~~~liDFG~a~~~~~~~~~~-----~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 139 -EGIWIIDFPQSVEVGEEGWRE-----ILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp -TEEEECCCTTCEETTSTTHHH-----HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred -CCEEEEECCCcccCCCCCcHH-----HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 348999999997765432211 111 111 235688999999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.31 E-value=9.5e-07 Score=81.64 Aligned_cols=143 Identities=14% Similarity=0.131 Sum_probs=88.8
Q ss_pred eecCcEEEeeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCc-ccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecc
Q psy16081 116 KFLDRYEIDSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKK-PFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRN 194 (493)
Q Consensus 116 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~ 194 (493)
...+.|++.+..+.++.+.||+.. .++..+.||+..... ........|...++.+... .. +.+++.+....+
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~--vp---vP~vl~~~~~~~ 83 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGK--LP---VPKVLHFERHDG 83 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTT--SC---CCCEEEEEEETT
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhcc--CC---CCcEEEEEecCC
Confidence 344567777766666668999984 456667888875332 2334567788877776531 22 345556667778
Q ss_pred eeEEEEEeccc-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q psy16081 195 HLCLVFELLSY-NLYDLLRNTNFRGVSLNLTRKFSQQLCTALLFLSTP-------------------------------- 241 (493)
Q Consensus 195 ~~~lV~E~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~Lhs~-------------------------------- 241 (493)
..++||++++| .+.+..... .....++.++...|.-||+.
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred ceEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 89999999987 554433211 11122333334444444421
Q ss_pred -------------------------CCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 242 -------------------------ELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 242 -------------------------~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
...++|+|+.|.|||+ ++++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~--~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceee--cCCceEEEeechhcc
Confidence 1137999999999999 444455699999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.90 E-value=6e-05 Score=73.78 Aligned_cols=77 Identities=22% Similarity=0.136 Sum_probs=47.9
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEcc--------CcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecce
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKN--------KKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNH 195 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~--------~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~ 195 (493)
.+.||.|....||++.+..+++.|+||.-.. ..........|...+..+....... +.+++. .+.+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~---vP~v~~--~d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHL---VPRVFY--SDTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGG---SCCEEE--EETTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCC---cceEEE--EcCCC
Confidence 3568999999999998877788999996431 1122345567888777766442222 333332 34556
Q ss_pred eEEEEEeccc
Q psy16081 196 LCLVFELLSY 205 (493)
Q Consensus 196 ~~lV~E~~~~ 205 (493)
.++|||++++
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEeccCC
Confidence 6899999965
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.73 E-value=5.1e-05 Score=69.16 Aligned_cols=73 Identities=14% Similarity=-0.006 Sum_probs=49.8
Q ss_pred eEeeeC-CeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeecceeEEEEEecc
Q psy16081 126 LIGKGS-FGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHLCLVFELLS 204 (493)
Q Consensus 126 ~LG~G~-fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~~lV~E~~~ 204 (493)
.+..|. -+.||+.. ..++..+++|...... ......|...++.+.....+ +.+++.+..+.+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvp----vP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVP----CAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCC----BCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCC----CCceeeecccccceEEEEEeee
Confidence 344454 46899986 4556678899875432 34567788888888765432 4455566667788899999997
Q ss_pred c
Q psy16081 205 Y 205 (493)
Q Consensus 205 ~ 205 (493)
|
T Consensus 90 G 90 (255)
T d1nd4a_ 90 G 90 (255)
T ss_dssp S
T ss_pred c
Confidence 6
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.17 E-value=0.0017 Score=61.31 Aligned_cols=71 Identities=13% Similarity=0.056 Sum_probs=47.3
Q ss_pred eEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEec--eeeeecceeEEEEEeccc
Q psy16081 133 GQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLK--RHFMWRNHLCLVFELLSY 205 (493)
Q Consensus 133 g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~--~~~~~~~~~~lV~E~~~~ 205 (493)
-.||++. ..+|+.|++|+.+.......+...|...+..|.....+- +..+..- ..+...+..+.|+++++|
T Consensus 36 N~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv-~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPV-AAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSB-CCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCC-CCceecCCCeeeeeeeEEEEEEeecCC
Confidence 5799996 357888999998765444567788888888888765431 1111111 123345678899999865
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.64 E-value=0.0056 Score=59.18 Aligned_cols=72 Identities=15% Similarity=0.069 Sum_probs=47.9
Q ss_pred eeeEeeeCCeEEEEEEEcC-------CCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEeceeeeeccee
Q psy16081 124 DSLIGKGSFGQVVKAFDLE-------EQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRLKRHFMWRNHL 196 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l~~~~~~~~~~ 196 (493)
++.|+.|---.+|++.... ..+.|.+++.... .......+|..+++.+..... ..+++.+|. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl-----~Pkll~~~~--~-- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHL-----GPKLYGIFS--G-- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTS-----SSCEEEEET--T--
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCC-----CCeEEEEcC--C--
Confidence 3678888888999987543 3467888887633 333456678888888877653 224444443 2
Q ss_pred EEEEEeccc
Q psy16081 197 CLVFELLSY 205 (493)
Q Consensus 197 ~lV~E~~~~ 205 (493)
.+|+||+.|
T Consensus 117 g~I~efi~g 125 (395)
T d1nw1a_ 117 GRLEEYIPS 125 (395)
T ss_dssp EEEECCCCE
T ss_pred ceEEEEecc
Confidence 578999865
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.47 E-value=0.0073 Score=56.17 Aligned_cols=145 Identities=12% Similarity=0.069 Sum_probs=74.2
Q ss_pred eeeEeeeCCeEEEEEEEcCCCeEEEEEEEccCcccchHHHHHHHHHHHHhhcCCCCcceEEEe-cee--eeecceeEEEE
Q psy16081 124 DSLIGKGSFGQVVKAFDLEEQCHVAIKIIKNKKPFLNQAQIEVKLLEIMNKADVNNTYYIVRL-KRH--FMWRNHLCLVF 200 (493)
Q Consensus 124 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~Iv~l-~~~--~~~~~~~~lV~ 200 (493)
.+.|..|---+.|++.. .+| .+++|+.... ........+..++..+.....+- |..+.. -+. .........++
T Consensus 23 ~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pv-p~pi~~~~g~~~~~~~~~~~~~~ 98 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSC-PLPLPRKDGELLGELSGRPAALI 98 (316)
T ss_dssp EEEECC---EEEEEEEE-SSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCC-CCBCCBTTCCSCEEETTEEEEEE
T ss_pred eecCCCCcccCeEEEEE-CCC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccc-cccceecCCCcceeeecccceee
Confidence 34566777788999863 334 5899998643 23466777888888887765432 111111 111 11234455666
Q ss_pred Eeccc-CH--------------HHHHhc--cCCC-----------------------CCCHHHHHHHHHHHHHHHHHHhC
Q psy16081 201 ELLSY-NL--------------YDLLRN--TNFR-----------------------GVSLNLTRKFSQQLCTALLFLST 240 (493)
Q Consensus 201 E~~~~-~L--------------~~~l~~--~~~~-----------------------~l~~~~~~~i~~qi~~aL~~Lhs 240 (493)
.++.+ .. ...+.. .... ..........+..+...+.-...
T Consensus 99 ~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (316)
T d2ppqa1 99 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 178 (316)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred eecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCc
Confidence 66532 10 000100 0000 00011112223333333333332
Q ss_pred --CCCCccccCCCCCcEEeeCCCCCcEEEEeccccc
Q psy16081 241 --PELNIIHCDLKPENILLCNPKRSAIKIVDFGSSC 274 (493)
Q Consensus 241 --~~~~iiHrDlKp~NILl~~~~~~~ikL~DFG~a~ 274 (493)
...|+||+|+.++||++ +.+...-|+||+.++
T Consensus 179 ~~L~~giIHgDl~~dNvl~--~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 179 KDLPAGVIHADLFQDNVFF--LGDELSGLIDFYFAC 212 (316)
T ss_dssp CSSCEEEECSCCCGGGEEE--ETTEEEEECCCTTCE
T ss_pred cccccccccCCcchhhhhc--ccccceeEecccccc
Confidence 14689999999999999 455556899999985
|